233-241.pdf	23
	American Psychiatric Association. Diagnostic andStatistical Manual of Mental Disorders, Third Edition,Revised. Washington, DC: the Association, 1987.	NO_MATCH
	American Psychiatric Association. Diagnostic andStatistical Manual of Mental Disorders, FourthEdition.Washington, DC: the Association, 1994.	NO_MATCH
	BERGEN, A.W.; KORCZAK, J.F.; WEISSBECKER,K.A.; ANDGOLDSTEIN, A.M.A genome-wide search for loci contributing to smoking and alcoholism. Genetic Epidemiology17(Suppl. 1):S55?60, 1999.	10597412
	BIERUT, L.J.; DINWIDDIE, S.H.; BEGLEITER, H.; ETAL.Familial transmission of substance dependence:Alcohol, marijuana, cocaine, and habitual smoking:A report from the Collaborative Study on the Geneticsof Alcoholism [see comments]. Archives of GeneralPsychiatry55:982?988, 1998.	9819066
	BIERUT, L.J.; RICE, J.P.; EDENBERG, H.J.; ETAL.Family-based study of the association of the dopamineD2 receptor gene (DRD2) with habitual smoking.AmericanJournal of Medical Genetics90:299?302,2000.	10710227
	BRESLAU, N.Psychiatric comorbidity of smokingand nicotine dependence. Behavior Genetics25:95?101, 1995.	7733862
	BUCHOLZ, K.K.; CADORET, R.; CLONINGER, C.R.;ETAL.A new, semi-structured psychiatric interviewfor use in genetic linkage studies: A report on thereliability of the SSAGA. Journal of Studies on Alcohol55:149?158, 1994.	8189735
	Centers for Disease Control and Prevention. Achieve-mentsin public health, 1900?1999: Tobaccouse?United States, 1900?1999. Morbidity and MortalityWeeklyReport 48:993?996, 1999a.	NO_MATCH
	Centers for Disease Control and Prevention. Cigarettesmoking among adults?United States, 1997. Morbidityand Mortality Weekly Report 48:993?996, 1999b. 	NO_MATCH
	CHATTERJI, S.; SAUNDERS, J.B.; VRASTI, R.; ETAL.Reliability of the alcohol and drug modules of theAlcohol Use Disorder and Associated DisabilitiesInterview Schedule?Alcohol/Drug-Revised(AUDADIS?ADR): An international comparison.Drug & Alcohol Dependence47:171?185, 1997.	9306043
	EDENBERGH, H.J.; FOROUD, T.; KOLLER, D.L.; ETAL.A family-based analysis of the association of thedopamine D2 receptor (DRD2) with alcoholism.Alcoholism: Clinical and Experimental Research 22(2):505?512, 1998.	9581660
	FEIGHNER, J.P.; ROBINS, E.; GUZE, S.B.; ETAL.Diagnostic criteria for use in psychiatric research.Archives of General Psychiatry26:57?63, 1972.	5009428
	FOROUD, T.; EDENBERG, H.J.; GOATE, A.; ETAL.Alcoholism susceptibility loci: Confirmation studiesin a replicate sample and further mapping. Alcoholism:Clinicaland Experimental Research24(7):933?945, 2000.	10923994
	GLASSMAN, A.H.; HELZER, J.E.; COVEY, L.S.; ETAL.Smoking, smoking cessation, and major depres-sion. Journal of the American Medical Association264:1546?1549, 1990.	2395194
	GRANT, B.F., ANDHARFORD, T.C. Comorbiditybetween DSM?IV alcohol use disorders and majordepression: Results of a national survey. Drug &Alcohol Dependence 39:197?206, 1995.	8556968
	HEATH, A.C.; BUCHOLZ, K.K.; MADDEN, P.A.; ETAL.Genetic and environmental contributions toalcohol dependence risk in a national twin sample:Consistency of findings in women and men.Psychological Medicine27:1381?1396, 1997.	9403910
	HESSELBROCK, M.; EASTON, C.; BUCHOLZ, K.K.;SCHUCKIT, M.; ANDHESSELBROCK, V.A validitystudy of the SSAGA?A comparison with the SCAN.Addiction 94(9):1361?1370, 1999. 10615721
	National Institute on Alcohol Abuse and Alcoholism.Economic analysis aids alcohol research. AlcoholResearch & Health(?Highlights From the 10thSpecial Report to Congress?) 24(1):62?71, 2000.	NO_MATCH
	REICHT.; EDENBERG, H.J.; GOATE, A.; ETAL.Genome-wide search for genes affecting the risk foralcohol dependence. American Journal of MedicalGenetics(Neuropsychiatric Genetics) 81:207?215,1998.	9603606
	SMITH, S.S.; O?HARA, B.F.; PERSICO, A.M.; ETAL.Genetic vulnerability to drug abuse: The D2 dopaminereceptor Taq I B1 restriction fragment length poly-morphism appears more frequently in polysubstanceabusers. Archives of General Psychiatry49:723?727,1992.	1355337
	SPITZ, M.R.; SHI, H.; YANG, F.; ETAL.Case-con-trol study of the D2 dopamine receptor gene andsmoking status in lung cancer patients. Journal ofthe NationalCancer Institute90:358?363, 1998.	9498477
	TRUE, W.R.; HEATH, A.C.; SHERRER, J.F.; ETAL.Genetic and environmental contributions to smok-ing. Addiction92:1277?1287, 1997.	9498485
	TRUE, W.R.; XIAN, H.; SCHERRER, J.F.; ETAL.Common genetic vulnerability for nicotine andalcohol dependence in men. Archives of GeneralPsychiatry56:655?661, 1999.	10401514
201-208.pdf	4
	American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders, Third Edition, Revised.Washington,DC: the Association, 1987.
	ANTHONY, J.C.; WARNER, L.A.; ANDKESSLER, R.C.Comparativeepidemiology of dependence on tobacco, alcohol, controlledsubstances, and inhalants: Basic findings from the NationalComorbidity Survey. Experimental and Clinical Psychopharmacology2:244?268, 1994.
	KESSLER, R.C.; MCGONAGLE, K.A.; ZHAO, S.; ETAL. Lifetimeand 12-month prevalence of DSM?III?R psychiatric disorders inthe United States. Results from the National ComorbiditySurvey. Archives in General Psychiatry51(1):8?19, 1994.	8279933
	WARNER, L.A.; KESSLER, R.C.; HUGHES, M.; ANTHONY, J.C.;ANDNELSON, C.B. Prevalence and correlates of drug use anddependence in the United States. Results from the NationalComorbidity Survey. Archives in General Psychiatry52(3):219?229, 1995.	7872850
12249_2008_Article_1310.pdf	22
	1. Arneodo C, Benoit JP, Thies C. Etudeprï¿½liminaire de la microencapsulation d?huilesessentielles par coacervation complexe. STPPharma Sciences. 1986; 2:303-306.
	2. Benoit JP, Thies C. Microencapsulation -methods and industrial applications. In: BenitaS, ed. Drugs and the Pharmaceutical Sciences., Vol. 73. New York: Marcel Dekker;1996.
	3. Benita S, Benoit JP, Puisieux F, Thies C.Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci.1984;73:1721-1724.	6527243
	4. Mathews BR, Nixon JR. Surface characteristicsof gelatin microcapsules by scanning electronmicroscopy. J Pharm Pharmacol.1974;26:383-384.	4153096
	5. Bodmeier R, McGinity J. Polylactic acidmicrospheres containing quinidine base andquinidine sulphate prepared by the solventevaporation technique. I. Methods andmorphology. J Microencapsul. 1987;4:279-288.	3504509
	6. Cutts LS, Hibberd S, Adler J, Davies MC,Melia CD. Characterising drug releaseprocesses within controlled release dosageforms using the confocal laser-scanningmicroscope. J Controlled Rel. 1996;42:115-124.
	7. De Smedt SC, Meyvis TKL, Van Oostveldt P,Demeester J. A new microphotolysis basedapproach for mapping the mobility of drugs inmicroscopic drug delivery devices. Pharm Res.1999;16:1639-1642.	10554110
	8. Bouillot P, Babak V, Dellacherie E. Novelbioresorbable and bioeliminable surfactants formicrosphere preparation. Pharm Res.1999;16:148-154.	9950294
	9. Adler J, Jayan A, Melia CD. A method forquantifying differential expansion withinhydrating hydrophilic matrixes by trackingembedded fluorescent microspheres. J PharmSci. 1999;88:371-377.	10052997
	10. Rojas J, Pinto-Alphandary H, Leo E, PecquetS, Couvreur P, Gulik A, Fattal E. Apolysorbate-based non-ionic surfactant canmodulate loading and release of beta-lactoglobulin entrapped in multiphasepoly(DL-lactide-co-glycolide) microspheres.Pharm Res. 1999;16:255-260.	10100311
	11. Caponetti G, Hrkach JS, Kriwet B, Poh M,Lotan N, Colombo P, Langer R. Microparticlesof novel branched copolymers of lactic acidand amino acids: preparation andcharacterization. J Pharm. Sci 1999;88:136-141.	9874715
	12. Lamprecht A, Schï¿½fer UF, Lehr, CM.Characterisation of microcapsules by confocallaser scanning microscopy: analysis ofstructure, capsule wall composition and ofencapsulation rate. Eur J Pharm Biopharm.2000;49:1-9.	10613921
	13. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solventevaporation method. I. Effect of process andformulation variables on drug entrapment. JMicroencapsul. 1989;7:347-355.	2384837
	14. Iwata M, McGinity JW. Preparation of multi-phase microspheres of poly(lactic acid) andpoly(lactic-co-glycolic acid) containing a W/Oemulsion by a multiple solvent evaporationtechnique. J Microencapsul. 1992;9:201-214.	1593404
	15. Schreiber AB, Haimovich J. Quantitativefluorometric assay for detection andcharacterization of Fc receptors. Meth Enzymol.1983;93:147-155.	6865782
	16. Luzzi LA, Gerraughty RJ. Effects of selectedvariables on the extractability of oils fromcoacervate capsules. J Pharm Sci.1964;53:429-431.	14189940
	17. Mussellwhite PR. The surface properties of anoil-water emulsion stabilized by mixtures ofcasein and gelatin. J Colloid and InterfaceScience. 1966;21:99-102.	5906905
	18. Boury F, Ivanova T, Panaiotov I, Proust JE.Dilatational properties of adsorbed poly(D,L-lactide) and bovine serum albumin monolayersat the dichloromethane/water interface.Langmuir. 1995;11:1636-1644.
	19. Nihant N, Schugens C, Grandfils C, Jerome R,Teyssie P. Polylactide microparticles preparedby double emulsion/evaporation technique. I.Effect of primary emulsion stability. PharmRes. 1994;11:1479-1484.	7855056
	20. Sezer AD, Akbuga J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. JMicroencapsul. 1999;16:195-203.	10080113
	21. Hari PR, Chandy T, Sharma CP.Chitosan/calcium alginate microcapsules forintestinal delivery of nitrofurantoin. JMicroencapsul. 1996;13:319-329.	8860687
	22. Murata Y, Toniwa S, Miyamoto E, KawashimaS. Preparation of alginate gel beads containingchitosan nicotinic acid salt and the functions.Eur J Pharm Biopharm. 1999;48:49-52.	10477328
12249_2008_Article_1255.pdf	20
	1. Yamashita F, Bando H, Koyama Y, Kitagawa S,Takakura, Y, Hashida, M. In vivo and in vitro analysis ofskin penetration enhancement based on a two-layer modelwith polar and non-polar routes in the stratum corneum.Pharm Res. 1994;11:185-191.	8165175
	2. Phillips CA, Michiniak BB. Transdermal delivery ofdrugs with differing lipophilicities using azone analogs asdermal penetration enhances. J Pharm Sci. 1995;84:1427-1437.	8748324
	3. Flynn GL, Yalkowsky SH, Roseman TJ. Masstransport phenomena and models: theoretical concepts. JPharm Sci. 1974;63:479-510.	4828694
	4. Ozawa T, Takahashi M. Skin hydration: Recent Advances. Acta Derm Venereol. Suppl. 1994;185:26-28.	8091923
	5. Iazzo PA, Olsen RA, Seewald MJ, Powis G, Stier A,Van Dyke RA. Transient increases of intracellular Ca++induced by volatile anesthetics in rat hepatocytes. CellCalcium. 1990;11:515-524.	2265428
	6. Reed PW, Lardy HA. A23187: A divalent Cation ionophore. J Biol Chem. 1972;247:6970.	4263618
	7. Wallace BA. Gramicidin channels and pores. Ann RevBiophysic Chem. 1990; 19:127	1694667
	8. Araki M, Inaba H, Kon S, Imai M, Mizuguchi T.Effects of volatile anesthetics on the calcium ionophoreA23187-mediated alterations in hepatic flow andmetabolism in the perfused liver in fasted rats. ActaAnesthesiol Scan. 1997;41:55-61.	9061115
	9. Plakas SM, James MO. Bioavailability, metabolism,and renal excretion of benzoic acid in the channel catfish(Ictalurus punctatus). Drug Metab Dispos.1990;18(5):552-556.	1981701
	10. French DL, Haglund BO, Himmelstein KJ, MaugerJW: Controlled release of substituted benzoic andnaphthoic acids using Carbopol gels: measurement ofdrug concentration profiles and correlation to release ratekinetics. Pharm Res. 1995;12(10):1513-1520.	8584491
	11. Miller GR, Smith CA, Stauber WT. Determination offibrosis from cryostat sections using high performanceliquid chromatography: skeletal muscle. Histochem J.1999;31:89-94.	10416680
	12. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959;234:466-468.	13641241
	13. Kabadi MB, Chien YW. Intravaginal controlledadministration of flurogestone acetate IV: in-vitro and in-vivo correlation for intravaginal drug delivery from rate-control vaginal pessary. Drug Develop Ind Pharm. 1985;11:1313-1361.
	14. Lee CH, Vyavahare N, Zand R, Kruth H, SchoenFJ,Bianco R,. Levy RJ. Inhibition of aortic wallcalcification in bioprosthetic heart valves by ethanolpretreatment: Biochemical and biophysical mechanisms. JBiomed Mater Res. 1998;42(1):30-37.	9740004
	15. Hu W, Cross TA. Tryptophan hydrogen bonding andelectric dipole moments: functional roles in the gramicidinchannel and implications for membrane proteins.Biochemistry. 1995;34:14,147-14,155.	7578012
	16. Heitz F, Gavach C. Ca+2 gramicidin A interactionsand blocking effects on the ionic channel. BiophysicalChemistry. 1983; 18:153-163.	6194829
	17. Mitchell DC, Litman BJ. Effect of hydration onreceptor conformation: decreased levels of bound waterpromote metarhodopsin II formation.Biochemistry. 1999;38: 7617-7623.	10387000
	18. Kuruc M, Krupey J. Application of an insolubleprotein precipitation reagent. Am Biotechnol.1992;10(3):12-14.
	19. Hwang J, Tamm LK, Bohm C, Ramalingam TS,Betzig E, Edidin M. Nanoscale complexity ofphospholipid monolayers investigated by near-fieldscanning optical microscopy. Science. 1995; 270:610-614.	7570018
	20. Carruthers A, Melchior DL. Human erythrocytehexose transporter activity is governed by bilayerlipid composition in reconstituted vesicles.Biochemistry. 1984;23(26):6901-6911.	6543323
JVS001-02-03.pdf	19
	1.Bredt, D.S and Snyder, S.H. Nitric oxide, a novel neuronal messenger. Neuron 1992, 8, 3-11.	1370373
	2.Cooper, J. and Walker, R.D. Listeriosis. Vet. Clin. North.Am. Food Anim. Pract. 1998, 14, 113-125.	9532671
	3.Charlton, K.M. and Garcia, M.M. Spontaneous listericencephalitis and neuritis in sheep. Light microscopic studies.Vet. Pathol. 1997, 14, 297-313.	560741
	4.Dramsi, S., Levi, S., Triller, A. and Cossart, P. Entry ofListeria monocytogenes into neurons occurrs by cell-to-cellspread: an in vitro study. Infect. Immun. 1998, 66, 4461-4468.	1425736
	5.Greenberg, S.S., Ouyang, J., Zhao, X. and Giles, T.D.Human and rat neutrophils constitutively express neuronalnitric oxide synthase mRNA. Nitric Oxide 1998, 2, 203-212.	9731638
	6.Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y.,Dietzschold, B. and Koprowski, H.Local nitric oxideproduction in viral and autoimmune disease of the centralnervous system. Proc. Natl. Acad. Sci. U.S.A. 1995, 92,5312-5316.	7522969
	7.Johnson, G.C., Fales, W.H., Maddox, C.W. and Ramos-Vara, J.A. Evaluation of laboratory test for confirming thediagnosis of encephalitic listeriosis in ruminants. J. Vet.Diagn. Invest. 1995, 7, 223-228.	7542480
	8.Jungi, T.W., Pfister, H., Sager, H., Fatzer, R., Vandevelde,M. and Zurbriggen, A.Comparison of inducible nitricoxide synthase expression in the brain of Listeriamonocytogenes-infected cattle, sheep and goats and inmacrophages stimulated in vitro. Infect. Immun. 1997, 65,5279-5288.	8876774
	9.Krueger, N., Low, C. and Donachie, W. Phenotypiccharacterization of the cells of the inflammatory response inovine encephalitic listeriosis. J. Comp. Pathol. 1995, 113,263-275.	8592052
	10.Kim, S., Moon, C., Wie, M., Kim, H., Tanuma, N.,Matsumoto, Y. and Shin, T.Enhanced expression ofconstitutive and inducible forms of nitric oxide synthase inautoimmune encephalomyelitis. J. Vet. Sci., 2000, 1, 11-17.	14612615
	11.Moncada, S., Palmer, R.M.J. and Higgs, E.A. Nitricoxide: physiology, pathophysiology, and pharmacology.Pharmacol. Rev., 1991, 43, 109-134.	1852778
	12.Murphy, S., Simmons, M.L., Agullo, L., Carcia, A.,Feinstein, D.L., Galea, E., Reis, D.J., Minc-Golomb, D.and Schwartz, J.P.Synthesis of nitric oxide in CNS glialcells. T.I.N.S. 1993, 16, 323-328.	7515524
	13.Nathan, C. and Xie, Q.-W. Nitric oxide synthases: Roles,tolls and controls. Cell 1994, 78, 915-918.	7522969
	14.Otter, A. and Blackmore, W.F. Observation on thepresence of Listeria monocytogenes in axons. ActaMicrobiol. Hung. 1989, 36, 125-131.	2517159
	15.Reiling, N., Ulmer, A.J., Duchrow, M., Ernst, M., Flad,H.D. and Hauschildt, S.Nitric oxide synthase: mRNAexpression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 1994, 24, 1941-1944.	7520003
	16.Reiling, N., Kroncke, R., Ulmer, A.J., Gerdes, J., Flad,H.D. and Hauschildt, S.Nitric oxide synthase: expressionof the endothelial, Ca2+/calmodulin-dependent isoform inhuman B and T lymphocytes. Eur. J. Immunol. 1996, 26,511-516.	8605914
	17.Rouquette, C. and Berche, P. The pathogenesis of infectionby Listeria monocytogenes. Microbiologia 1996, 12, 245-258.	8767708
	18.Sinz, E.H., Kochanek, P.M., Dixon, C.E., Clark, R.S.,Carcillo, J.A., Schiding, J.K., Chen, M., Wisniewski,S.R., Carlos, T.M., William, D., DeKosky, S.T., Watkins,S.C., Marion, D.W. and Billiar, T.R.Inducible nitric oxidesynthase is an endogenous neuroprotectant after traumaticbrain injury in rats and mice. J. Clin. Invest. 1999, 104, 647-656.	9229135
	19.Wu, J., Lin, Q., Lu, Y., Willis, W.D. and Westlund, K.N.Changes in nitric oxide synthase isoforms in the spinal cordof rat following induction of chronic arthritis. Exp. BrainRes. 1998, 118, 457-465	9504841
Nucleic Acids Symp Ser-2000-Inoue-279-80.pdf	4
	1. Trawick, B. N., Daniher, A. T., and Bashkin, J. K.(1998) Chem. Rev., 98,939-960.
	2. Inoue, H., Furukawa, T., Shimizu, M., Tamura, T.,Matsui, M., and Ohtsuka, E. (1999) Chem.Commun., 45-46.
	3. Tamura, T., Furukawa, T., Komatsu, Y., Ohtsuka,E., and Inoue, H. (1999) Nucleic Acids Symp. Ser.No. 42, 109-110.
	4. Cuenoud, B., Casset, F., Hiisken, D., Natt, F.,Wolf, R. M., Altmann, K.-H., Martin, P., andMoser, H. E. (1998) Angew. Chem. Int. Ed. Engl.,
20008720.pdf	12
20008706.pdf	8
J. Biol. Chem.-2001-Choosakoonkriang-8037-43.pdf	41
	1.Hyde,S.C.,Southern,K.W.,Gileadi,U.,Fitzjohn,E.M.,Mofford,K.A.,Waddell,B.E.,Gooi,H.C.,Goddard,C.A.,Hannavy,K.,Smyth,S.E.,Egan,J.J.,Sorgi,F.L.,Huang,L.,Cuthbert,A.W.,Evans,M.J.,Colledge,W.H.,Higgins,C.F.,Webb,A.K.,andGill,D.R.(2000)GeneTher.7,1156?1165
	2.Welsh,M.J.,andZabner,J.(1999)Hum.GeneTher.10,1559?1572
	3.Crook,K.,Stevenson,B.J.,Dubouchet,M.,andPorteous,D.J.(1998)GeneTher.5,137?143
	4.Liu,Y.,Mounkes,L.C.,Liggitt,H.D.,Brown,C.S.,Solodin,I.,Heath,T.D.,andDebs,R.J.(1997)Nat.Biotechnol.15,167?173
	5.Farhood,H.,Serbina,N.,andHuang,L.(1995)Biochim.Biophys.Acta1235,289?295
	6.Birchall,J.C.,Kellaway,I.W.,andMills,S.N.(1999)Int.J.Pharm.(Amst.)183,195?207
	7.Ross,P.C.,andHui,S.W.(1999)GeneTher.6,651?659
	8.Zuidam,N.J.,andBarenholz,Y.(1997)Biochim.Biophys.Acta1329,211?222
	9.Zuidam,N.J.,andBarenholz,Y.(1998)Biochim.Biophys.Acta1368,115?128
	10.Hirsch-Lerner,D.,andBarenholz,Y.(1998)Biochim.Biophys.Acta1370,17?30
	11.Bhattacharya,S.,andMandal,S.S.(1998)Biochemistry37,7764?7777
	12.Hirsch-Lerner,D.,andBarenholz,Y.(1999)Biochim.Biophys.Acta1461,47?57
	13.Radler,J.O.,Koltover,I.,Salditt,T.,andSafinya,C.R.(1997)Science275,810?814
	14.Koltover,I.,Salditt,T.,Radler,J.O.,andSafinya,C.R.(1998)Science281,78?81
	15.Huebner,S.,Battersby,B.J.,Grimm,R.,andCevc,G.(1999)Biophys.J.76,3158?3166
	16.Xu,Y.,Hui,S.W.,Frederik,P.,andSzoka,F.C.,Jr.(1999)Biophys.J.77,341?353
	17.Koltover,I.,Salditt,T.,andSafinya,C.R.(1999)Biophys.J.77,915?924
	18.Zuidam,N.J.,Barenholz,Y.,andMinsky,A.(1999)FEBSLett.457,419?422
	19.Zuidam,N.J.,andBarenholz,Y.(1999)Int.J.Pharm.(Amst.)183,43?46
	20.Braun,C.S.,Kueltzo,L.A.,andMiddaugh,C.R.(2001)MethodsMol.Med.,inpress
	21.Mendelsohn,R.,Davies,M.A.,Brauner,J.W.,Schuster,H.F.,andDluhy,R.A.(1989)Biochemistry28,8934?8939
	22.Davies,M.A.,Schuster,H.F.,Brauner,J.W.,andMendelsohn,R.(1990)Biochemistry29,4368?4373
	23.Lewis,R.N.,Pohle,W.,andMcElhaney,R.N.(1996)Biophys.J.70,2736?2746
	24.Smith,S.O.,Kustanovich,I.,Bhamidipati,S.,Salmon,A.,andHamilton,J.A.(1992)Biochemistry31,11660?11664
	25.Binder,H.,Gutberlet,T.,Anikin,A.,andKlose,G.(1998)Biophys.J.74,1908?1923
	26.Neault,J.F.,Naoui,M.,Manfait,M.,andTajmir-Riahi,H.A.(1996)FEBSLett.382,26?30
	27.Neault,J.F.,andTajmir-Riahi,H.A.(1999)Biophys.J.76,2177?2182
	28.Alex,S.,andDupuis,P.(1989)Inorg.Chim.Acta157,271?281
	29.Koppel,D.E.(1962)J.Chem.Phys.57,4814
	30.Taillandier,E.,andLiquier,J.(1992)MethodsEnzymol.211,307?335
	31.Akao,T.,Fukumoto,T.,Ihara,H.,andIto,A.(1996)FEBSLett.391,215?218
	32.Bloomfield,V.,Crothers,D.M.,andIgnacio,T.J.(2000)inNucleicAcids,pp.31,UniversityScienceBooks,Sausalito,CA
	33.Mohammadi,S.,Perree-Fauvet,M.,Gresh,N.,Hillairet,K.,andTaillandier,E.(1998)Biochemistry37,6165?6178
	34.Ahmad,R.,Naoui,M.,Neault,J.F.,Diamantoglou,S.,andTajmir-Riahi,H.A.(1996)J.Biomol.Struct.Dyn.13,795?802
	35.Tajmir-Riahi,H.A.,Naoui,M.,andAhmad,R.(1993)J.Biomol.Struct.Dyn.11,83?93
	36.Arakawa,H.,Ahmad,R.,Naoui,M.,andTajmir-Riahi,H.A.(2000)J.Biol.Chem.275,10150?10153
	37.Kennedy,M.T.,Pozharski,E.V.,Rakhmanova,V.A.,andMacDonald,R.C.(2000)BiophysJ.78,1620?1633
	38.Lobo,B.A.,Rogers,S.,Wiethoff,C.M.,Choosakoonkriang,S.,Bogdanovich-Knipp,S.,andMiddaugh,C.R.(2001)MethodsMol.Med.,inpress
	39.Cullis,P.R.,anddeKruijff,B.(1979)Biochim.BiophysActa559,399?420
	40.Regelin,A.E.,Fankhaenel,S.,Gurtesch,L.,Prinz,C.,vonKiedrowski,G.,andMassing,U.(2000)Biochim.BiophysActa1464,151?164
	41.Tilcock,C.P.(1986)Chem.Phys.Lipids40,109?125FTIRofCationicLipid-DNAComplexes8043
J. Biol. Chem.-2001-Arimura-8550-6.pdf	48
	1.Banchereau,J.,Bazan,F.,Blanchard,D.,Briere,F.,Galizzi,J.P.,vanKooten,C.,Liu,Y.J.,Rousset,F.,andSaeland,S.(1994)Annu.Rev.Immunol.12,881?922
	2.Foy,T.M.,Aruffo,A.,Bajorath,J.,Buhlman,J.E.,andNeolle,R.J.(1994)Annu.Rev.Immunol.14,591?617
	3.Clark,L.B.,Foy,T.M.,andNoelle,R.J.(1994)Adv.Immunol.63,43?78
	4.vanKooten,C.,andBanchereau,J.(1996)Adv.Immunol.61,1?77
	5.Grewal,I.S.,andFlavel,R.A.(1998)Annu.Rev.Immunol.16,111?135
	6.Liu,Y.J.,Joshua,D.E.,Williams,G.T.,Smith,C.A.,Gordon,J.,andMacLennan,I.C.(1989)Nature342,929?931
	7.Gregory,C.D.,Dive,C.,Henderson,S.,Smith,C.A.,Williams,G.T.,Gordon,J.,andRickinson,A.B.(1991)Nature349,612?614
	8.Banchereau,J.,dePaoli,P.,Valle,A.,Garcia,E.,andRousset,F.(1991)Science251,70?72
	9.Tsubata,T.,Wu,J.,andHonjo,T.(1993)Nature364,645?648
	10.Inui,S.,Kaisho,T.,Kikutani,H.,Stamenkovic,I.,Seed,B.,Clark,E.A.,andKishimoto,T.(1990)Eur.J.Immunol.20,1747?1753
	11.Heath,A.W.,Chang,R.,Harada,N.,Santos-Argumedo,L.,Gordon,J.,Han-num,C.,Campbell,D.,Shanafelt,A.B.,Clark,E.A.,Torres,P.,andHoward,M.(1993)CellImmunol.152,468?480
	12.Funakoshi,S.,Longo,D.L.,Beckwith,M.,Conley,D.K.,Tsarfaty,G.,Tsarfaty,I.,Armitage,R.J.,Fanslow,W.C.,Spriggs,M.K.,andMurphy,W.J.(1994)Blood83,2787?2794
	13.Hess,S.,andEngelmann,H.(1996)J.Exp.Med.183,159?167
	14.Eliopoulos,A.G.,Dawson,C.W.,Mosialos,G.,Floettmann,J.E.,Rowe,M.,Armitage,R.J.,Dawson,J.,Zapata,J.M.,Kerr,D.J.,Wakelam,M.J.O.,Reed,J.C.,Kieff,E.,andYoung,L.S.(1996)Oncogene13,2243?2254
	15.Peguet-Navarro,J.,Dalbiez-Gauthier,C.,Moulon,C.,Berthier,O.,Reano,A.,Gaucherand,M.,Banchereau,J.,Rousset,F.,andSchmitt,D.(1997)J.Im-munol.158,144?152
	16.Faris,M.,Gaskin,F.,Parsons,J.T.,andFu,S.M.(1994)J.Exp.Med.179,1923?1931
	17.Ren,C.L.,Morio,T.,Fu,S.M.,andGeha,R.S.(1994)J.Exp.Med.179,673?680
	18.Hanissian,S.H.,andGeha,R.S.(1997)Immunity6,379?387
	19.Berberich,I.,Shu,G.,andClark,E.A.(1994)J.Immunol.153,4357?4366
	20.Rothe,M.,Sarma,V.,Dixit,V.M.,andGoeddel,D.V.(1995)Science269,1424?1427
	21.Schauer,S.L.,Wang,Z.,Sonenshein,G.E.,andRothstein,T.L.(1996)J.Immunol.157,81?86
	22.Grumont,R.J.,Rasko,J.E.,Strasser,A.,andGerondakis,S.(1996)Mol.Cell.Biol.16,2913?2921
	23.Ishida,T.,Kobayashi,N.,Tojo,T.,Ishida,S.,Yamamoto,T.,andInoue,J.(1995)J.Immunol.155,5527?5535
	24.Lederman,S.,Yellin,M.J.,Inghirami,G.,Lee,J.J.,Knowles,D.M.,andChess,L.(1992)J.Immunol.149,3817?3826
	25.Barrett,T.B.,Shu,G.,andClark,E.A.(1991)J.Immunol.146,1722?1729
	26.Ranheim,E.A.,andKipps,T.J.(1993)J.Exp.Med.177,925?935
	27.Liu,Y.J.,Barthelemy,C.,deBouteiller,O.,Arpin,C.,Durand,I.,andBanche-reau,J.(1995)Immunity2,239?248
	28.Schattner,E.J.,Elkon,K.B.,Yoo,D.-H.,Tumang,J.,Krammer,P.H.,Crow,M.K.,andFriedman,S.M.(1995)J.Exp.Med.182,1557?1565
	29.Klaus,S.J.,Berberich,I.,Shu,G.,andClark,E.A.(1994)Semin.Immunol.6,279?286
	30.Berberich,I.,Shu,G.,Siebelt,F.,Woodgett,J.R.,Kyriakis,J.M.,andClark,E.A.(1996)EMBOJ.15,92?101
	31.Sutherland,C.L.,Heath,A.W.,Pelech,S.L.,Young,P.R.,andGold,M.R.(1996)J.Immunol.157,3381?3390
	32.Kashiwada,M.,Kaneko,Y.,Yagita,H.,Okumura,K.,andTakemori,T.(1996)Eur.J.Immunol.26,1451?1458
	33.Purkerson,J.M.,andParker,D.C.(1998)J.Immunol.160,2121?2129
	34.Craxton,A.,Shu,G.,Graves,J.D.,Saklatvala,J.,Krebs,E.G.,andClark,E.A.(1998)J.Immunol.161,3225?3236
	35.Ogimoto,M.,Katagiri,T.,Mashima,K.,Hasegawa,K.,Mizuno,K.,andYakura,H.(1994)Int.Immunol.6,647?654
	36.Ogimoto,M.,Katagiri,T.,Mashima,K.,Hasegawa,K.,Mizuno,K.,andYakura,H.(1995)Eur.J.Immunol.25,2265?2271
	37.Yakura,H.,Shen,F.-W.,Bourcet,E.,andBoyse,E.A.(1983)J.Exp.Med.157,1077?1088
	38.Volarevic,S.,Niklinska,B.B.,Burns,C.M.,June,C.H.,Weissman,A.M.,andAshwell,J.D.(1993)Science260,541?544
	39.Yan,M.,Dai,T.,Deak,J.C.,Kyriakis,J.M.,Zon,L.I.,Woodgett,J.R.,Templeton,D.J.(1994)Nature372,798?800
	40.Reinhard,C.,Shamoon,B.,Shyamala,V.,andWilliams,L.T.(1997)EMBOJ.16,1080?1092
	41.Lee,S.Y.,Reichlin,A.,Santana,A.,Sokol,K.A.,Nussenzweig,M.C.,and2Choi,Y.(1997)Immunity7,703?713Y.
	42.Song,H.Y.,Regnier,C.H.,Kirchning,C.J.,Goeddel,D.V.,andRothe,M.(1997)Proc.Natl.Acad.Sci.U.S.A.94,9792?9796
	43.Regnier,C.H.,Song,H.Y.,Gao,X.,Goeddel,D.V.,Cao,Z.,andRothe,M.(1997)Cell90,373?383
	44.Mercurio,F.,Zhu,H.,Murray,B.W.,Shevchenko,A.,Bennett,B.L.,Li,J.W.,Young,D.B.,Barbosa,M.,Mann,M.,Manning,A.,andRao,A.(1997)Science278,860?866
	45.Lee,F.S.,Hagler,J.,Chen,Z.J.,andManiatis,T.(1997)Cell88,213?222
	46.Gruber,M.F.,Bjorndahl,J.M.,Nakamura,S.,andFu,S.M.(1989)J.Im-munol.142,4144?4152
	47.Byth,K.F.,Conroy,L.A.,Howlett,S.,Smith,A.J.H.,May,J.,Alexander,D.R.,andHolmes,N.(1996)J.Exp.Med.183,1707?1718
	48.Miyamoto,S.,Chiao,P.J.,andVerma,I.M.(1994)Mol.Cell.Biol.14,3276?3282
J. Biol. Chem.-2001-Deutsch-6967-73.pdf	39
	1.Devane,W.A.,Hanus,L.,Breuer,A.,Pertwee,R.G.,Stevenson,L.A.,Griffin,G.,Gibson,D.,Mandelbaum,A.,Etinger,A.,andMechoulam,R.(1992)Science258,1946?1949
	2.Sugiura,T.,Kondo,S.,Sukagawa,A.,Nakane,S.,Shinoda,A.,Itoh,K.,Yamashita,A.,andWaku,K.(1995)Biochem.Biophys.Res.Commun.215,89?97
	3.Mechoulam,R.,Ben-Shabat,S.,Hanus,L.,Ligumsky,M.,Kaminski,N.E.,Schatz,A.R.,Gopher,A.,Almog,S.,Martin,B.R.,Compton,D.R.,Pertwee,R.G.,Griffin,G.,Bayewitch,M.,Barg,J.,andVogel,Z.(1995)Biochem.Pharmacol.50,83?90
	4.Martin,B.R.,Mechoulam,R.,andRazdan,R.K.(1999)LifeSci.65,573?595
	5.Deutsch,D.G.,andChin,S.A.(1993)Biochem.Pharmacol.46,791?796
	6.Koutek,B.,Prestwich,G.D.,Howlett,A.C.,Chin,S.A.,Salehani,D.,Akha-van,N.,andDeutsch,D.G.(1994)J.Biol.Chem.269,22937?22940
	7.DiMarzo,V.,Fontana,A.,Cadas,H.,Schinelli,S.,Cimino,G.,Schwartz,J.C.,andPiomelli,D.(1994)Nature372,686?691
	8.Hillard,C.J.,Edgemond,W.S.,Jarrahian,A.,andCampbell,W.B.(1997)J.Neurochem.69,631?638
	9.DiMarzo,V.,Bisogno,T.,Melck,D.,Ross,R.,Brockie,H.,Stevenson,L.,Pertwee,R.,andDePetrocellis,L.(1998)FEBSLett.436,449?454
	10.Maccarrone,M.,Bari,M.,Menichelli,A.,DelPrincipe,D.,andAgro,A.F.(1999)FEBSLett.447,277?282
	11.Hillard,C.J.,andCampbell,W.B.(1997)J.LipidRes.38,2383?2398
	12.Rakhshan,F.,Day,T.A.,Blakely,R.D.,andBarker,E.L.(2000)J.Pharma-col.Exp.Ther.292,960?967
	13.Piomelli,D.,Beltramo,M.,Glasnapp,S.,Lin,S.Y.,Goutopoulos,A.,Xie,X.Q.,andMakriyannis,A.(1999)Proc.Natl.Acad.Sci.U.S.A.96,5802?5807
	14.Beltramo,M.,Stella,N.,Calignano,A.,Lin,S.Y.,Makriyannis,A.,andPiomelli,D.(1997)Science277,1094?1097
	15.Melck,D.,DePetrocellis,L.,Orlando,P.,Bisogno,T.,Laezza,C.,Bifulco,M.,andDiMarzo,V.(2000)Endocrinology141,118?126
	16.Jarrahian,A.,Manna,S.,Edgemond,W.S.,Campbell,W.B.,andHillard,C.J.(2000)J.Neurochem.74,2597?2606
	17.DiMarzo,V.,andDeutsch,D.G.(1998)Neurobiol.CannabinoidTransmission5,386?404
	18.Omeir,R.L.,Arreaza,G.,andDeutsch,D.G.(1999)Biochem.Biophys.Res.Commun.264,316?320
	19.Patricelli,M.P.,Lovato,M.A.,andCravatt,B.F.(1999)Biochemistry38,9804?9812
	20.Goparaju,S.K.,Kurahashi,Y.,Suzuki,H.,Ueda,N.,andYamamoto,S.(1999)Biochim.Biophys.Acta1441,77?84
	21.Deutsch,D.G.,Omeir,R.,Arreaza,G.,Salehani,D.,Prestwich,G.D.,Huang,Z.,andHowlett,A.(1997)Biochem.Pharmacol.53,255?260
	22.Deutsch,D.G.,Lin,S.,Hill,W.A.,Morse,K.L.,Salehani,D.,Arreaza,G.,Omeir,R.L.,andMakriyannis,A.(1997)Biochem.Biophys.Res.Commun.231,217?221
	23.DePetrocellis,L.,Melck,D.,Ueda,N.,Maurelli,S.,Kurahashi,Y.,Yamamoto,S.,Marino,G.,andDiMarzo,V.(1997)Biochem.Biophys.Res.Commun.231,82?88
	24.Omeir,R.L.,Chin,S.,Hong,Y.,Ahern,D.G.,andDeutsch,D.G.(1995)LifeSci.56,1999?2005
	25.Maccarrone,M.,vanderStelt,M.,Rossi,A.,Veldink,G.A.,Vliegenthart,J.F.,andAgro,A.F.(1998)J.Biol.Chem.273,32332?32339
	26.Abumrad,N.,Harmon,C.,andIbrahimi,A.(1998)J.LipidRes.39,2309?2318
	27.Giang,D.K.,andCravatt,B.F.(1997)Proc.Natl.Acad.Sci.U.S.A.94,2238?2242
	28.Arreaza,G.,andDeutsch,D.G.(1999)FEBSLett.454,57?60
	29.Cravatt,B.F.,Prospero-Garcia,O.,Siuzdak,G.,Gilula,N.B.,Henriksen,S.J.,Boger,D.L.,andLerner,R.A.(1995)Science268,1506?1509
	30.Arreaza,G.,Devane,W.A.,Omeir,R.L.,Sajnani,G.,Kunz,J.,Cravatt,B.F.,andDeutsch,D.G.(1997)Neurosci.Lett.234,59?62
	31.Ueda,N.,Yamanaka,K.,Terasawa,Y.,andYamamoto,S.(1999)FEBSLett.454,267?270
	32.Hillard,C.J.,andJarrahian,A.(2000)Chem.Phys.Lipids108,123?134
	33.McArthur,M.J.,Atshaves,B.P.,Frolov,A.,Foxworth,W.D.,Kier,A.B.,andSchroeder,F.(1999)J.LipidRes.40,1371?1383
	34.Bisogno,T.,Maurelli,S.,Melck,D.,Depetrocellis,L.,andDiMarzo,V.(1997)J.Biol.Chem.272,3315?3323
	35.Gifford,A.N.,Bruneus,M.,Lin,S.,Goutopoulos,A.,Makriyannis,A.,Volkow,N.D.,andGatley,S.J.(1999)Eur.J.Pharmacol.383,9?14
	36.Martin,B.R.,Beletskaya,I.,Patrick,G.,Deutsch,D.,DiMarzo,V.,andRazdan,R.K.(2000)J.Pharmacol.Exp.Ther.294,1209?1218
	37.Chan,P.H.,Kerlan,R.,andFishman,R.A.(1982)J.Neurosci.Res.8,67?72
	38.Madshus,I.H.,Tonnessen,T.I.,Olsnes,S.,andSandvig,K.(1987)J.Cell.Physiol.131,6?13
53_979.pdf	6
	1)Horinouchi,S.:7-ButyrolactonesthatcontrolsecondarymetabolismandcelldifferentiationinStreptomyces,InCell-cellsignalinginBacteria.Ed.,G.M.Dunny,etal,pp.193-207,AmericanSocietyforMicrobiology,Washington,D.C,1999
	2)Yamada,Y.:AutoregulatoryfactorsandregulationofantibioticproductioninStreptomyces,InMicrobialsignallingandcommunication.Ed.,R.England,etal.,pp.177-196,SocietyforGeneralMicrobiology,CambridgeUniversityPress.,Cambridge,1999
	3)Takano,E.;T.Nihira,YHara,IJ.Jones,C.J.Gershater,YYamada&M.Bibb:PurificationandstructuraldeterminationofSCB1,a7-butyrolactonethat
	4)Grafe,U;W.Schade,I.Eritt,W.F.Fleck&L.Radics:AnewinduceroftheanthracyclinebiosynthesisfromStreptomycesviridochromogenes.J.Antibiotics35:1208-1215,1982
	5)Grafe,U;G.Reinhardt,W.Schade,I.Eritt,W.F.Fleck&L.Radics:InterspecificinducersofcytodifferntiationandanthracyclinebiosynthesisfromStreptomycesbikiniensisandS.cyanofuscatus.Biotech-nol.Lett.5:591-596,1983
	6)Hara,O.&T.Beppu:MutantsblockedinstreptomycinproductioninStreptomycesgriseus-theroleofA-factor.J.Antibiotics35:349-358,1982
53_954.pdf	10
	Fuhrmann,U;E.Bause,&P.Hidde:Inhibitiorsofoligosacharideprocessing.Biochim.Biophys.Acta95-110,825:1985
	Truscheit,E.;W.Frommer,B.Junge&W.Wingender:Chemistryandbiochemistryofmicrobiala-glucosidaseinhibitors.Angew.Chem.Int.Ed.Engl.20:744-761,1981
	Bischoft,H.:Pharmacologyofa-glucosidasesinhibition.Eur.J.Clin.Invest.24(Suppl.3):3-10,1994
	Watanabe,I;J.Kawabata,H.Kurihara&R.Niki:Isolationandidentificationofa-glucosidaseinhibitorsfromTochu-ch2L(Eucommiaulmoides).Biosci.Biotech.Biochem.61:.177-178,"1997
	Matsui,T.;C.Yoshimoto,K.Osajima,T.Oki&Y.Osajima:Invitrosurveyofa-glucosidaseinhibitoryfoodcomponents.Biosci.Biotech.Biochem.60:2019-2022,1996
	Nitecki,D.E.&B.Halpern:Asimpleroutetostericallypurediketopiperazines.J.Org.Chem.33:864-866,1968
	Lee,S.;T.Kanmera,H.Aoyagi&N.Izumiya:Cyclicpeptides.VI.Asymmetrichydrogenationofdehydro-alanineordehydroaminobutanoicacidresidueincyclic-dipeptides.Int.J.PeptideProteinRes.13:207-217,1979
	Pan,YT.;J.Ghidoni&A.D.Elbein:Theeffectsofcastanospermineandswainsonineontheactivityandsynthesisofintestinalsucrase.Archi.ofBiochem.andBiophys.303:134-144,1993
	Bell,R.;S.Carmeli&N.Sar:VibrindoleA,ametaboliteofthemarinebacterium,Vibrioparahaemolyticus,isolatedfromthetoxicmucusoftheboxfishOstracioncubicus.J.Nat.Prod.57:1587-1590,1994
	Fenouillet,E.;M.J.Papandreou&L.Jones:RecombinantHIVenvelopeexpressedinana-glucosi-daseI-deficientCHOcelllineanditsparentalcelllineinthepresenceof1-deoxynojirimycinisfunctional.Virology231:89-95,1997
53_903.pdf	31
	1)Cabib,E.;J.A.Shaw,P.C.Mol,B.Bower&W.J.Choi:Chitinbiosynthesisandmorphogeneticprocess.InTheMycota.BiochemistryandMolecularBiology.Vol.III.Ed.R.Brambl&G.A.Marzluf,pp.243-267,Springer-Verlag,Berlin,1996
	2)Bulawa,C.E.:CSD2,CSD3,andCSD4,genesrequiredforchitinsynthesisinSaccharomycescerevisiae:theCSD2geneproductisrelatedtochitinsynthasesandtodevelopmentallyregulatedproteinsinRhizobiumspeciesandXenopuslaevis.Mol.Cell.Biol.12:1764-1776,1992
	3)Takita,M.A.&B.Castilho-Valavicius:AbsenceofcellwallchitininSaccharomycescerevisiaeleadsto
	Bulawa,C.E.&B.C.Osmond:ChitinsynthaseIandchitinsynthaseIIarenotrequiredforchitinsynthesisinvivoinSaccharomycescerevisiae.Proc.Natl.Acad.Sci.U.S.A.87:7424-7428,1990
	Shaw,J.A.;P.C.Mol,B.Bowers,S.J.Silverman,M.M.Valdivieso,A.Duran&E.Cabib:Thefunctionofchitinsynthases2and3intheSaccharomycescerevisiaecellcycle.J.CellBiol.114:111-123,1991
	Cabib,E.;B.Sburlati,B.Bowers&S.J.Silverman:ChitinsynthaseI,anauxiliaryenzymeforchitinsynthesisinSaccharomycescerevisiae.XCellBiol.108:1665-1672,1989
	Cabib,E.;S.J.Silverman&J.A.Shaw:ChitinaseandchitinsynthaseI:counterbalancingactivitiesincellseparationofSaccharomycescerevisiae.XGen.Microbiol.138:97-102,1992
	Silverman,S.X:Similaranddifferentdomainsofchitinsynthases1and2ofSaccharomycescerevisiae:twoisozymewithdistinctfunctions.Yeast5:459-467,1989
	Silverman,S.X;A.Sburlati,M.Slater&E.Cabib:Chitinsynthase2isessentialfunctionandcelldivisioninSaccharomycescerevisiae.Proc.Natl.Acad.Sci.U.S.A.85:4735-4739,1988
	Sburlati,A.&E.Cabib:Chitinsynthethase2,apresumptiveparticipantinseptumformationinSaccharomycescerevisiae.XBiol.Chem.261:15147-15152,1986
	Gilbertson,R.L.&L.Ryvarden:NorthAmericanPolypores.Vol.2.pp.541-623,Fungiflora,Oslo,Norway,1987
	Choi,W.J.&E.Cabib:TheuseofdivalentcationsandpHforthedeterminationofspecificyeastchitinsynthetases.Anal.Biochem.219:368-372,1994
	Lowry,O.H.;N.IRosebrough,A.L.Farr&R.XRandall:Proteinmeasurementwiththefolinphenolreagent.XBiol.Chem.193:265-275,1951
	Stalpers,XA.:StudiesinMycology.No16;Identificationofwood-inhibitingfungiinpureculture,p.Netherlands,1978
	Ryvarden,L.&R.L.Gilbertson:EuropeanPolypores.Vol.1-2.p.743,Fungiflora,Oslo,Norway,1993
	Larsen,M.X&L.A.Cobb-Poulle:SynopsisFungorum3:Phellinus(Hymenochaetaecae)-Asurveyoftheworldtaxa.p.206,Fungiflora,Oslo,Norway,1990
	Gilbertson,R.L.&L.Ryvarden:NorthAmericanPolypores.Vol.1-2.p.885,Fungiflora,Oslo,Norway,1987
	Dai,Y.C.&M.Q.Xu:Studiesonthemedicinalpolypore,Phellinusbaumil,anditskin,P.linteus.Mycotaxon62:191-200,1998
	Cabib,E.:Differentialinhibitionofchitinsynthases1and2fromSaccharomycescerevisiaebypolyoxinDandnikkomycinZ.Antimicrob.AgentsChemother.35:170-173,1991
	Georgopapadakou,N.H.:Antifungalstargetedtothecellwall.Exp.Opin.Invest.Drugs.6:147-150,1997
	Denning,D.W.:Echinocandinsandpneumocandins-anewantifungalclasswithanovelmodeofaction.XAntimicrob.Chemother.40:611-614,1997
	Sakurai,T.;N.Cheepthan,T.Mikawa,A.Yokota&F.VOL.53NO.9THEJOURNALOFANTIBIOTICS
	23)Naowarat,C;T.Higashiyama,N.Phay&F.Tomita:Rapidanduniquescreeningsystemforthediscoveryofnewantifungalantibioticsagainstchitinsynthesisinfungalcellwalls.ThaiJ.Biotechnol.1(1):31-36,1999
	24)Naowarat,C;N.Phay,T.Higashiyama,E.Fukushi,H.Matsuura,T.Mikawa,A.Yokota,A.Ichihara&F.Tomita:StudiesonanantifungiantibioticfromEllisiodothisinguinansL1588-A8.ThaiJ.Biotechnol.1(1):37-45,1999
	25)Pfefferle,W.;H.Anke&M.Bross:Inhibitionofsolubilizedchitinsynthasebychlorinatedaromaticcompoundsisolatedfrommushroomcultures.Agric.Biol.Chem.54(6):1381-1384,1990
	26)Hector,R.F.&P.C.Braun:SynergicactionofnikkomycinXandZwithpapulacandinBonwholecellsandregeneratingprotoplastsofCandidaalbicans.Antimicrob.AgentsChemother.29:389-394,1986
	27)Gaughram,J.P.;M.H.Lai,D.R.Kirsch&S.J.Silverman:NikkomycinZisaspecificinhibitorofSaccharomycescerevisiaechitinsynthaseisozymechs3invitroandinvivo.J.Bacteriol.176:5857-5860,1994
	Cabib,E.;R.Roberts&B.Bowers:Synthesisoftheyeastcellwallanditsregulation.Ann.Rev.Biochem.51:763-793,1982
	Hwang,E.L;B.S.Yun,Y.K.Kim,B.M.Kwon,H.G.Kim,H.B.Lee,K.S.Bae&S.U.Kim:ChaetoatrosinA,anovelehitinsynthaseIIinhibitorproducedbyChaetomiumatrobrunneumF449.J.Antibiotics53:248-255,2000
	Kim,S.U;E.I.Hwang,J.Y.Nam,K.H.Son,S.H.Bok,H.E.Kim&B.M.Kwon:InhibitionofchitinsynthaseIIbycatechinsfromstembarkofTaxuscuspidata.PlantaMedica65:97-98,1999
	Jeong,T.S.;E.I.Hwang,H.B.Lee,E.S.Lee,YK.Kim,B.S.Min,K.H.Bae,S.H.Bok&S.U.Kim:ChitinstnthaseIIInhibitoryactivityofursolicacid,isolatedfromCrataeguspinnatifida.PlantaMedica65:261-263,1999
262.pdf	22
241.pdf	22
207.pdf	28
196.pdf	14
J Neurophysiol-2000-Samson-1330-45.pdf	39
	ADRIAï¿½NHO,LIFSCHITZWM,TAVITASRJ,ANDGALLIFP.Activityofneuralunitsinmedialgeniculatebodyofcatandrabbit.JNeurophysiol29:1046?1060,1966.
	AITKINLM.Medialgeniculatebodyofthecat:responsestotonalstimuliofneuronsinmedialdivision.JNeurophysiol36:275?283,1973.
	AITKINLMANDDUNLOPCW.Interplayofexcitationandinhibitioninthecatmedialgeniculatebody.JNeurophysiol31:44?61,1968.
	AITKINLMANDMARTINRL.Therepresentationofstimulusazimuthbyhighbest-frequencyazimuth-selectiveneuronsinthecentralnucleusoftheinferiorcolliculusofthecat.JNeurophysiol57:1185?1200,1987.
	AITKINLMANDWEBSTERWR.Medialgeniculatebodyofthecat:organizationandresponsestotonalstimuliofneuronsinventraldivision.JNeurophysiol35:365?380,1972.
	ALTMANJA,SYKAJ,ANDSHMIGIDINAGN.Neuronalactivityinthemedialgeniculatebodyofthecatduringmonauralandbinauralstimulation.ExpBrainRes10:81?93,1970.
	ANDERSENRA,KNIGHTPL,ANDMERZENICHMM.ThethalamocorticalandcorticothalamicconnectionsofAI,AII,andtheanteriorauditoryfield(AAF)inthecat:evidencefortwolargelysegregatedsystemsofconnec-tions.JCompNeurol194:663?701,1980.
	BARONEP,CLAREYJC,IRONSWA,ANDIMIGTJ.Corticalsynthesisofazimuth-sensitivesingle-unitresponseswithnonmonotonicleveltuning:athalamo-corticalcomparisoninthecat.JNeurophysiol75:1206?1220,1996.
	CLAREYJC,BARONEP,ANDIMIG,T.J.Physiologyofthalamusandcortex.In:TheMammalianAuditoryPathway:Neurophysiology,editedbyFayRRandPopperA.NewYork:Springer-Verlag,1992,chapt.5,p.232?334.
	CLAREYJC,BARONEP,IRONSWA,SAMSONFK,ANDIMIGTJ.Comparisonofnoiseandtoneazimuthtuningofneuronsincatprimaryauditorycortexandmedialgeniculatebody.JNeurophysiol74:961?980,1995.
	DELGUTTEB,JORISPX,LITOVSKYRY,ANDYINTCT.Receptivefieldsandbinauralinteractionsforvirtual-spacestimuliinthecatinferiorcolliculus.JNeurophysiol81:2833?2851,1999.
	FUZESSERYZM,WENSTRUPJJ,ANDPOLLAKGD.Determinantsofhorizontalsoundlocationselectivityofbinaurallyexcitedneuronsinanisofrequencyregionofthemustachebatinferiorcolliculus.JNeurophysiol63:1128?1147,1990.
	HIRSCHJA,CHANJC,ANDYINTC.Responsesofneuronsinthecat?ssuperiorcolliculustoacousticstimuli.I.Monauralandbinauralresponseproperties.JNeurophysiol53:726?745,1985.
	IMIGTJANDADRIAï¿½NHO.Binauralcolumnsintheprimaryfield(AI)ofthecatauditorycortex.BrainRes138:241?257,1977.
	IMIGTJ,BIBIKOVNG,POIRIERP,ANDSAMSONFK.Directionalityderivedfrompinna-cuespectralnotchesinthecat?sdorsalcochlearnucleus.JNeuro-physiol83:907?925,2000.
	IMIGTJ,IRONSWA,ANDSAMSONFR.Single-unitselectivitytoazimuthaldirectionandsoundpressurelevelofnoiseburstsincathigh-frequencyprimaryauditorycortex.JNeurophysiol63:1448?1466,1990.
	IMIGTJANDMORELA.Tonotopicorganizationintheventralnucleusofthemedialgeniculatebodyinthecat.JNeurophysiol53:309?340,1985a.
	IMIGTJANDMORELA.Tonotopicorganizationofthelateralpartoftheposteriorgroupofthalamicnucleiinthecat.JNeurophysiol53:836?851,1985b.
	IMIGTJ,POIRIERP,IRONSWA,ANDSAMSONFK.Amonauralspectralcontrastmechanismforneuralsensitivitytosounddirectioninthemedialgeniculatebodyofthecat.JNeurophysiol78:2754?2771,1997.
	IVARSSONC,DERIBAUPIERREY,ANDDERIBAUPIERREF.Influenceofauditorylocalizationcuesonneuronalactivityintheauditorythalamusofthecat.JNeurophysiol59:586?606,1988.
	JORISPX.Responseclassesinthedorsalcochlearnucleusanditsoutputtractinthechloralose-anesthetizedcat.JNeurosci18:3955?3966,1998.
	KITZESLM,WREGEKS,ANDCASSADYJM.Patternsofresponsesofcorticalcellstobinauralstimulation.JCompNeurol192:455?472,1980.
	KITZESLMANDDOHERTYD.Influenceofcallosalactivityonunitsintheauditorycortexoftheferret(Mustelaputorius).JNeurophysiol71:1740?1751,1994.
	MIDDLEBROOKSJCANDGREENDM.Soundlocalizationbyhumanlisteners.AnnuRevPsychol42:135?159,1991.
	MORELAANDIMIGTJ.ThalamicprojectionstofieldsA,AI,P,andVPinthecatauditorycortex.JCompNeurol265:119?144,1987.
	MUSICANTAD,CHANJCK,ANDHINDJE.Direction-dependentspectralprop-ertiesofcatexternalear:newdataandcross-speciescomparisons.JAcoustSocAm87:757?781,1990.
	NELKENIANDYOUNGED.TwoseparateinhibitorymechanismsshapetheresponsesofdorsalcochlearnucleustypeIVunitstonarrowbandandwidebandnoise.JNeurophysiol71:2446?2462,1994.
	POIRIER,P,SAMSONFK,ANDIMIGTJ.Directionalmechanismsandspatialpreferencesofsingleunitsinthecat?sinferiorcolliculus.SocNeurosciAbstr22:889,1996.
	RAJANR,AITKINLM,IRVINEDRF,ANDMCKAYJ.Azimuthalsensitivityofneuronsinprimaryauditorycortexofcats.I.Typesofsensitivityandeffectsofvariationsinstimulusparameters.JNeurophysiol64:872?887,1990.
	RICEJJ,MAYBJ,SPIROUGA,ANDYOUNGED.Pinna-basedspectralcuesforsoundlocalizationincat.HearRes58:132?152,1992.
	SAMSONFK,BARONEP,CLAREYJC,ANDIMIGTJ.Effectsofearpluggingonsingle-unitazimuthsensitivityincatprimaryauditorycortex.II.Azimuthtuningdependentuponbinauralstimulation.JNeurophysiol71:2194?2216,1994.
	SAMSONFK,CLAREYJC,BARONEP,ANDIMIGTJ.Effectsofearpluggingonsingle-unitazimuthsensitivityincatprimaryauditorycortex.I.Evidenceformonauraldirectionalcues.JNeurophysiol70:492?511,1993.
	SAMSONFK,POIRIERP,IRONSWA,ANDIMIGTJ.Effectsofearpluggingonresponsesofazimuthsensitiveneuronsinmedialgeniculatebody(MGB)andprimaryauditorycortex(AI)ofbarbiturateanesthetizedcats.SocNeurosciAbstr22:889,1996.
	SPIROUGAANDYOUNGED.OrganizationofdorsalcochlearnucleustypeIVunitresponsemapsandtheirrelationshiptoactivationbyband-limitednoise.JNeurophysiol66:1750?1766,1991.
	WENSTRUPJJ,FUZESSERYZM,ANDPOLLAKGD.Binauralneuronsinthemustachebat?sinferiorcolliculus.I.Responsesof60-kHz.EIunitstodichoticsoundstimulation.JNeurophysiol60:1369?1383,1988a.
	WENSTRUPJJ,FUZESSERYZM,ANDPOLLAKGD.Binauralneuronsinthemustachebat?sinferiorcolliculus.II.Determinantsofspatialresponsesamong60-kHzEIunits.JNeurophysiol60:1384?1404,1988b.
	WISELZANDIRVINEDRF.Topographicorganizationofinterauralintensitydifferencesensitivityindeeplayersofthecatsuperiorcolliculus:implica-tionsforauditoryspatialrepresentation.JNeurophysiol54:185?211,1985.
	YOUNGED,SPIROUGA,ANDRICEJJ.Representationofpinna-producedspectralnotchesindorsalcochlearnucleus(DCN).SocNeurosciAbstr18:1037,1992a.
	YOUNGED,SPIROUGA,RICEJJ,ANDVOIGTHF.Neuralorganizationandresponsestocomplexstimuliinthedorsalcochlearnucleus.PhilosTransRSocLondBBiolSci336:407?413,1992b.
J Neurophysiol-2000-Keller-1303-13.pdf	32
	AMADORN,SCHLAG-REYM,ANDSCHLAGJ.Primateantisaccades.I.Behav-ioralcharacteristics.JNeurophysiol80:1775?1786,1998.
	CHIMOTOS,IWAMOTOY,SHIMAZUH,ANDYOSHIDAK.Monosynapticactiva-tionofmedium-leadburstneuronsfromthesuperiorcolliculusinthealertcat.JNeurophysiol75:2658?2661,1996.
	EDELMANJAANDKELLEREL.Activityofvisuomotorburstneuronsinthesuperiorcolliculusaccompanyingexpresssaccades.JNeurophysiol76:908?926,1996.
	EDELMANJAANDKELLEREL.Dependenceontargetconfigurationofexpresssaccade-relatedactivityintheprimatesuperiorcolliculus.JNeurophysiol80:1407?1426,1998.
	EVERLINGS,DORRISMC,KLEINRM,ANDMUNOZDP.Roleofprimatesuperiorcolliculusinpreparationandexecutionofanti-saccadesandpro-saccades.JNeurosci19:2740?2754,1999.
	FRENSMAANDVANOPSTALAJ.Monkeysuperiorcolliculusactivityduringshort-termsaccadicadaptation.BrainResBull43:473?483,1997.
	FUCHSAF,KANEKOCRS,ANDSCUDDERCA.Brainstemcontrolofsaccadiceyemovements.AnnuRevNeurosci8:307?337,1985.
	FUCHSAFANDROBINSONDA.Amethodformeasuringhorizontalandverticaleyemovementchronicallyinthemonkey.JApplPhysiol21:1068?1070,1966.
	FUNAHASHIS,CHAFEEMV,ANDGOLDMAN-RAKICPS.PrefrontalneuronalactivityinRhesusmonkeysperformingadelayedanti-saccadetask.Nature365:753?756,1993.
	GRANTYNAAANDGRANTYNR.Synapticactionsoftectofugalpathwaysonabducensmotoneuronsinthecat.BrainRes105:269?285,1976.
	GRAYBIELAM.Directandindirectpreoculomotorpathwaysofthebrainstem:anautoradiographicstudyofthepontinereticularformationinthecat.JCompNeurol175:37?78,1977.
	GUITTONDANDMUNOZDP.Controlofgazeshiftsbythetectoreticulospinalsysteminthehead-freecat.I.Identification,localizationandeffectsofbehavioronsensoryresponses.JNeurophysiol66:1605?1623,1991.
	HARTINGJK.Descendingpathwaysfromthesuperiorcolliculus:anautoradio-graphicanalysisintherhesusmonkey(Macacamulatta).JCompNeurol173:583?612,1977.
	HEPPKANDHENNH.Spatio-temporalrecordingofrapideyemovementsignalsinthemonkeyparamedianpontinereticularformation(PPRF).ExpBrainRes52:105?120,1983.
	HEPPK,HENNV,VILIST,ANDCOHENB.Brainstemregionsrelatedtosaccadegeneration.In:TheNeurobiologyofSaccadicEyeMovements,editedbyWurtzRHandGoldbergME.Amsterdam:Elsevier,1989,p.105?212.
	JUDGESJ,RICHMONDBJ,ANDCHUFC.Implantationofmagneticsearchcoilsformeasurementofeyeposition:animprovedmethod.VisionRes20:535?538,1980.
	KELLEREL.Thebrainstem.In:EyeMovements,editedbyCarpenterRHS.London:Macmillan,1991,p.200?223.1312E.L.KELLER,R.M.MCPEEK,ANDT.SALZ
	KELLERELANDEDELMANJA.Useofinterruptedsaccadeparadigmtostudyspatialandtemporaldynamicsofsaccadicburstcellsinsuperiorcolliculusinmonkey.JNeurophysiol72:2754?2770,1994.
	KELLEREL,GANDHINJ,ANDWEIRPT.Dischargeofsuperiorcollicularneuronsduringsaccadesmadetomovingtargets.JNeurophysiol76:3573?3577,1996.
	KELLERELANDMCPEEKRM.Statedependentactivationofparamedianpontinereticularformation(PPRF)burstneuronsbysuperiorcollicularstimulationinmonkey.SocNeurosciAbstr25:6,1999.
	LEICHNETZG,SMITHDJ,ANDSPENCERRF.Corticalprojectionstothepara-mediantegmentalandbasilarponsinthemonkey.JCompNeurol228:388?408,1984.
	MIYASHITANANDHIKOSAKAO.Minimalsynapticdelayinthesaccadicoutputpathwayofthesuperiorcolliculusstudiedinawakemonkey.ExpBrainRes112:187?196,1996.
	MOSCHOVAKISAK,KITAMAT,DALEZIOSY,PETITJ,BRANDIAM,ANDGRANTYNA.Ananatomicalsubstrateforthespatiotemporaltransformation.JNeurosci18:10219?10229,1998.
	MOSCHOVAKISAK,SCUDDERCA,ANDHIGHSTEINSM.Themicroscopicanat-omyandphysiologyofthemammaliansaccadicsystem.ProgNeurobiol50:133?254,1996.
	OLIVIERE,GRANTYNA,CHATM,ANDBERTHOZA.Thecontrolofsloworientingeyemovementsbytectoreticulospinalneuronsinthecat?behav-ior,dischargepatternsandunderlyingconnections.ExpBrainRes93:435?449,1993.
	PAREï¿½MANDGUITTOND.Thefixationareaofthecatsuperiorcolliculus:effectsofelectricalstimulationanddirectconnectionwithbrainstemom-nipauseneurons.ExpBrainRes101:109?122,1994.
	RAYBOURNMSANDKELLEREL.Colliculoreticularorganizationinprimateoculomotorsystem.JNeurophysiol40:861?878,1977.
	SEGRAVESMA.Activityofmonkeyfrontaleyefieldneuronsprojectingtooculomotorregionsofthepons.JNeurophysiol68:1967?1985,1992.
	STANFORDTRANDSPARKSDL.Systematicerrorsforsaccadestorememberedtargets:evidenceforadissociationbetweensaccademetricsandactivityinthesuperiorcolliculus.VisionRes34:93?106,1994.
	STANTONGB,GOLDBERGME,ANDBRUCEC.Frontaleyefieldefferentsinthemacaquemonkey.I.Subcorticalpathwaysandtopographyofstriatalandthalamicterminalfields.JCompNeurol271:473?492,1988.
	STRASSMANA,EVINGERC,MCCREARA,BAKERRG,ANDHIGHSTEINSM.Anatomyandphysiologyofintracellularlylabelledomnipauseneuronsinthecatandsquirrelmonkey.ExpBrainRes67:436?440,1987.
	STRASSMANA,HIGHSTEINSM,ANDMCCREARA.Anatomyandphysiologyofsaccadicburstneuronsinthealertsquirrelmonkey.II.Inhibitoryburstneurons.JCompNeurol249:358?380,1986.
1279.full.pdf	51
	ABRAHAMWCANDBEARMF.Metaplasticity:theplasticityofsynapticplas-ticity.TrendsNeurosci19:126?130,1996.
	ANWYLR,WALSHEJ,ANDROWANM.Electroconvulsivetreatmentreduceslong-termpotentiationinrathippocampus.BrainRes435:377?379,1987.
	BARRDS,HOYTKL,MOORESD,ANDWILSONWA.Post-ictaldepressiontransientlyinhibitsinductionofLTPinareaCA1oftherathippocampalslice.EpilepsyRes27:111?118,1997.
	BEARMF.Mechanismforaslidingsynapticmodificationthreshold.Neuron15:1?4,1995.
	BIENENSTOCKEL,COOPERLN,ANDMUNROPW.Theoryforthedevelopmentofneuronselectivity:orientationspecificityandbinocularinteractioninvisualcortex.JNeurosci2:32?48,1982
	BLISSTVPANDCOLLINGRIDGEGL.Asynapticmodelofmemory:Long-termpotentiationinthehippocampus.Nature361:31?39,1993.
	BLITZERRD,WONGT,NOURANIFARR,IYENGARR,ANDLANDAUEM.Postsyn-apticcAMPpathwaygatesearlyLTPinhippocampalCA1region.Neuron15:1403?1414,1995.
	BORTOLOTTOZAANDCOLLINGRIDGEGL.Involvementofcalcium/calmodulin-dependentproteinkinasesinthesettingofamolecularswitchinvolvedinhippocampalLTP.Neuropharmacology37:535?544,1998.
	CHRISTIEBRANDABRAHAMWC.Primingofassociativelong-termdepressioninthedentategyrusbyufrequencysynapticactivity.Neuron9:79?84,1992.
	CLARKKA,RANDALLAD,ANDCOLLINGRIDGEGL.Acomparisonofpaired-pulsefacilitationofAMPAandNMDAreceptor-mediatedexcitatorypostsynapticcurrentsinthehippocampus.ExpBrainRes101:272?278,1994.
	COANEJANDCOLLINGRIDGEGL.MagnesiumionsblockanN-methyl-D-aspartatereceptor-mediatedcomponentofsynaptictransmissioninrathip-pocampus.NeurosciLett53:21?26,1985.
	COHENASANDABRAHAMWC.Facilitationoflong-termpotentiationbyprioractivationofmetabotropicglutamatereceptors.JNeurophysiol76:953?962,1996.
	COUSSENSC,KERRDS,ANDABRAHAMWC.GlucocorticoidreceptoractivationlowersthethresholdforNMDA-receptor?dependenthomosynapticlong-termdepressioninthehippocampusthroughactivationofvoltage-dependentcalciumchannels.JNeurophysiol78:1?9,1997.
	FREYU,HUANGYY,ANDKANDELER.EffectsofcAMPstimulatesalatestageofLTPinhippocampalCA1neurons.Science260:1661?1664,1993.
	FUJIIS,SAITOK,MIYAKAWAH,ITOK,ANDKATOH.Reversaloflong-termpotentiation(depotentiation)inducedbytetanusstimulationoftheinputtoCA1neuronsofguineapighippocampalslices.BrainRes555:112?122,1991.
	GEANPW.NMDAreceptor-independentepileptiformactivityinducedbymagnesium-freesolutioninratamygdalaneuronsisblockedbyCNQX.NeurosciLett119:53?55,1990.
	GODAYANDSTEVENSCF.Synapticplasticity:thebasisofparticulartypesoflearning.CurrOpinNeurobiol6:375?378,1996.
	GOLDJIANDBEARMF.AmodelofdendriticspineCa21concentrationexploringpossiblebasesforaslidingsynapticmodificationthreshold.ProcNatlAcadSciUSA91:3941?3945,1994.
	HALGRENEANDWILSONCL.Recalldefictsproducedbyafterdischargesinthehumanhippocampalformationandamygdala.ClinNeurophysiol61:375?380,1985.
	HEBBDO.OrganizationofBehavior.NewYork:Wiley,1949.
	HERRONCE,WILLIAMSONR,ANDCOLLINGRIDGEGL.AselectiveN-methyl-D-aspartateantagonistdepressesepileptiformactivityinrathippocampalslices.NeurosciLett61:255?260,1985.
	HESSEGWANDTEYLERTJ.Reversiblelossofhippocampallong-termpoten-tiationfollowingelectroconvulsiveseizure.Nature264:562?564,1976.
	HOLLANDLLANDWAGNERJJ.Primedfacilitationofhomosynapticlong-termdepressionanddepotentiationinrathippocampus.JNeurosci18:887?894,1998.
	HSUKS.Characterizationofdopaminereceptorsmediatinginhibitionofexcitatorysynaptictransmissionintherathippocampalslices.JNeuro-physiol76:1887?1895,1996.
	HSUKSANDHUANGCC.Characterizationoftheanoxia-inducedlong-termsynapticpotentiationinareaCA1oftherathippocampus.BrJPharmacol122:671?681,1997.
	HSUKS,HUANGCC,HOWC,ANDTSAIJJ.Priorshort-termsynapticdisinhi-bitionbyGABA-antagonistfacilitateslong-termpotentiationandsuppresseslong-termdepressionatCA1hippocampalsynapses.EurJNeurosci11:4059?4069,1999.
	HUANGYY,COLINOA,SELIGDK,ANDMALENKARC.Theinfluenceofpriorsynapticactivityontheinductionoflong-termpotentiation.Science255:730?733,1992.
	HUANGYYANDKANDELER.PostsynapticinductionandPKA-dependentexpressionofLTPinthelateralamygdala.Neuron21:169?178,1998.
	IZUMIY,CLIFFORDDB,ANDZORUMSKICF.LowconcentrationsofN-methyl-D-aspartateinhibittheinductionoflong-termpotentiationinrathippocam-palslices.NeurosciLett137:245?248,1992.
	JENSENLHANDSHEARDOWNM.Lackofpotentantiepilepticeffectofspecificnon-NMDAEAAreceptorantagonist.In:FrontiersinExcitatoryAminoAcidResearch,editedbyCavalheiroEA,LehmannL,andTurskiL.NewYork:Liss,1988,p.219?226.
	LINDENDJANDCONNORJA.ParticipationofpostsynapticPKCincerebellarlong-termdepressioninculture.Neuron15:1393?1401,1991.
	MALINOWR,SCHULMANH,ANDTSIENRW.InhibitionofpostsynapticPKCorCaMKIIblocksinductionbutnotexpressionofLTP.Science245:862?866,1989.
	MALINOWRANDTSIENRW.Presynapticenhancementshownbywhole-cellrecordingsoflong-termpotentiationinhippocampalslices(Abstract).Na-ture346:177,1990.
	MARTINEZJLJANDDERRICKBE.Long-termpotentiationandlearning.AnnuRevPsychol47:173?203,1996.
	MAYFORDM,WANGJ,KANDELER,ANDO?DELLTJ.CaMKIIregulatesthefrequency-responsefunctionofhippocampalsynapsesfortheproductionofbothLTDandLTP.Cell81:891?904,1995.
	MCNAMARAJO.Cellularandmolecularbasisofepilepsy.JNeurosci14:3413?3425,1994.
	MODYI,LAMBERTJDC,ANDHEINEMANNU.Lowextracellularmagnesiuminducesepileptiformactivityandspreadingdepressioninrathippocampalslices.JNeurophysiol57:869?888,1987.
	MOORESD,BARRDS,ANDWILSONWA.Seizure-likeactivitydisruptsLTPinvitro.NeurosciLett163:117?119,1993.
	MOYERJR,THOMPSONLT,BLACKJP,ANDDISTERHOFTJF.Nimodipinein-creasesexcitabilityofrabbitCA1pyramidalneuronsinanage-andcon-centration-dependentmanner.JNeurophysiol68:2100?2109,1992.
	MULLERDANDLYNCHG.Evidencethatchangesinpresynapticcalciumcurrentsarenotresponsibleforlong-termpotentiationinhippocampus.BrainRes479:290?299,1989.
	PSARROPOULOUCANDKOSTOPOULOSG.Long-termenhancementofpostsyn-apticexcitabilityafterbriefexposuretoMg21-freemediuminnormalandepilepticmice.BrainRes508:70?75,1990.
	RAYMONDCR,THOMPSONVL,TATEWP,ANDABRAHAMWC.Metabotropicglutamatereceptorstriggerhomosynapticproteinsynthesistoprolonglong-termpotentiation.JNeurosci20:969?976,2000.
	SANESJRANDLICHTMANW.Canmoleculesexplainlong-termpotentiation?NatureNeurosci2:597?604,1999.
	SCHULZPE,COOKEP,ANDJOHNSTOND.Changesinpaired-pulsefacilitationsuggestpresynapticinvolvementinlong-termpotentiation.JNeurosci14:5327?5337,1994.
	SONENBURGN.mRNA59cap-bindingproteineIF4Eandcontrolofcellgrowth.In:TranscriptionalControl,editedbyHersheyJWB,MathewsMB,andSonenburgN.NewYork:ColdSpringHarborLaboratory,1996,p.245?269.
	SQUIRELRANDSPANISCW.Longgradientofretrogradeamnesiainmice,continuitywiththefindingsinhumans.BehavNeurosci98:345?348,1984.
	STANTONPK.TransientproteinkinaseCactivationprimeslong-termdepres-sionandsuppresseslong-termpotentiationofsynaptictransmissioninhippocampus.ProcNatlAcadSciUSA92:1724?1728,1995.
	SUZUKIT.Messengersfromthesynapsestothenucleus(MSNs)thatestablishlatephaseoflong-termpotentiation(LTP)andlong-termmemory.NeurosciRes25:1?6,1996.
	THOMPSONPJ.Memoryfunctioninpatientswithepilepsy.AdvNeurol55:369?384,1991.
	TOMPAPANDFRIEDRICHP.Synapticmetaplasticityandthelocalchargeeffectinpostsynapticdendrites.TrendsNeurosci21:97?102,1998.
	WEXLEREMANDSTANTONPK.Primingofhomosynapticlong-termdepres-sioninhippocampusbyprevioussynapticactivity.Neuroreport4:591?594,1993.
Blood-2000-Mudry-1926-32.pdf	31
	1.GouldenN,LanglandsK,StewardC,etal.PCRassessmentofbonemarrowstatusin?isolated?extramedullaryrelapseofchildhoodB-precursoracutelymphoblasticleukaemia.BrJHaematol.1994;87:282-285.
	2.MinieroR,SaraccoP,PastoreG,etal.Relapseafterfirstcessationoftherapyinchildhoodacutelymphoblasticleukemia:a10-yearfollow-upstudy,ItalianAssociationofPediatricHematol-ogy-Oncology(AIEOP).MedPediatrOncol.1995;24:71-76.
	3.MiyakeK,MedinaK,IshiharaK,KimotoM,Auer-bachR,KincadePW.AVCAM-likeadhesionmol-eculeonmurinebonemarrowstromalcellsmedi-atesbindingoflymphocyteprecursorsinculture.JCellBiol.1991;114:557-565.
	4.RyanDH.AdherenceofnormalandneoplastichumanBcellprecursorstothebonemarrowmi-croenvironment.BloodCells.1993;19:225-241.
	5.KinashiT,SpringerTA.Adhesionmoleculesinhematopoieticcells.BloodCells.1994;20:25-44.
	6.KincadePW.Cellinteractionmoleculesandcyto-kineswhichparticipateinBlymphopoiesis.Bail-lieresClinHaematol.1992;5:575-598.
	7.MakrynikolaV,KabralA,BradstockKF.Effectsofrecombinanthumancytokinesonprecursor-Bacutelymphoblasticleukemiacells.ExpHematol.1991;19:674-679.
	8.ManabeA,Coustan-SmithE,BehmFG,Rai-mondiSC,CampanaD.Bonemarrow-derivedstromalcellspreventapoptoticcelldeathinB-lineageacutelymphoblasticleukemia.Blood.1992;79:2370-2377.
	9.GibsonLF,FortneyJ,LandrethKS,PiktelD,Eric-sonSG,LynchJP.Disruptionofbonemarrowstromalcellfunctionbyetoposide.BiolBloodMarrowTransplant.1997;3:122-132.
	10.HaskellCM,BerekJS.CancerTreatment,4thed.Philadelphia:WBSaunders;1995.
	11.RobertsRA,SpooncerE,ParkinsonEK,LordBI,AllenTD,DexterTM.Metabolicallyinactive3T3cellscansubstituteformarrowstromalcellstopromotetheproliferationanddevelopmentofmultipotenthaemopoieticstemcells.JCellPhysiol.1987;132:203-214.
	12.HasslenSR,BurnsAR,SimonSI,etal.Preserva-tionofspatialorganizationandantigenicityofleu-kocytesurfacemoleculesbyaldehydefixation:flowcytometryandhigh-resolutionFESEMstud-iesofCD62L,CD11b,andThy-1.JHistochemCytochem.1996;44:1115-1122.
	13.WilmannsC,FanD,O?BrianCA,BucanaCD,FidlerIJ.Orthotopicandectopicorganenviron-mentsdifferentiallyinfluencethesensitivityofmu-rinecoloncarcinomacellstodoxorubicinand5-fluorouracil.IntJCancer.1992;52:98-104.
	14.StaroselskyAN,FanD,O?BrianCA,BucanaCD,GuptaKP,FidlerIJ.Site-dependentdifferencesinresponseoftheUV-2237murinefibrosarcomatosystemictherapywithadriamycin.CancerRes.1990;50:7775-7780.
	15.MurtiKG,BrownPS,KumagaiM,CampanaD.MolecularinteractionsbetweenhumanB-cellpro-genitorsandthebonemarrowmicroenvironment.ExpCellRes.1996;226:47-58.
	16.VandV,SmitsAJ,VerdaasdonkMA,etal.b1-Integrinsdominatecelltrafficofleukemiccellsinhumanbone-marrowstroma.IntJCancer.1996;66:225-233.
	17.BradstockK,MakrynikolaV,BianchiA,BythK.Analysisofthemechanismofadhesionofprecur-sor-Bacutelymphoblasticleukemiacellstobonemarrowfibroblasts.Blood.1993;82:3437-3444.
	18.RyanDH,NuccieBL,AbboudCN,WinslowJM.Vascularcelladhesionmolecule-1andtheinte-grinVLA-4mediateadhesionofhumanBcellprecursorstoculturedbonemarrowadherentcells.JClinInvest.1991;88:995-1004.
	19.FilshieR,GottliebD,BradstockK.VLA-4isinvolvedintheengraftmentofthehumanpre-Bacutelympho-blasticleukaemiacelllineNALM-6inSCIDmice.BrJHaematol.1998;102:1292-1300.
	20.BriscoMJ,CondonJ,HughesE,etal.Outcomepredictioninchildhoodacutelymphoblasticleu-kaemiabymolecularquantificationofresidualdiseaseattheendofinduction[seecomments].Lancet.1994;343:196-200.
	21.ShahN,OsethL,LeBienTW.Developmentofamodelforevaluatingtheinteractionbetweenhu-manpre-Bacutelymphoblasticleukemiccellsandthebonemarrowstromalcellmicroenviron-ment.Blood.1998;92:3817-3828.
	22.GibsonLF,PiktelD,NarayananR,NunezG,Lan-drethKS.Stromalcellsregulatebcl-2andbaxexpressioninpro-Bcells.ExpHematol.1996;24:628-637.
	23.MiyashitaT,ReedJC.Bcl-2oncoproteinblockschemotherapy-inducedapoptosisinahumanleu-kemiacellline.Blood.1993;81:151-157.
	24.ThomasA,ElRoubyS,ReedJC,etal.Drug-in-ducedapoptosisinB-cellchroniclymphocyticleukemia:relationshipbetweenp53genemuta-tionandbcl-2/baxproteinsindrugresistance.Oncogene.1996;12:1055-1062.
	25.McConkeyDJ,ChandraJ,WrightS,etal.Apop-tosissensitivityinchroniclymphocyticleukemiaisdeterminedbyendogenousendonucleasecon-tentandrelativeexpressionofBCL-2andBAX.JImmunol.1996;156:2624-2630.
	26.TaylorST,HickmanJA,DiveC.Epigeneticdeter-minantsofresistancetoetoposideregulationofBcl-X(L.andBaxbytumormicroenvironmentalfactors[seecomments].JNatlCancerInst.2000;92:18-23.
	27.JiangH,SugimotoK,SawadaH,etal.Mutualeducationbetweenhematopoieticcellsandbonemarrowstromalcellsthroughdirectcell-to-cellcontact:factorsthatdeterminethegrowthofbonemarrowstroma-dependentleukemic(HB-1)cells.Blood.1998;92:834-841.
	28.ElicesMJ,OsbornL,TakadaY,etal.VCAM-1onactivatedendotheliuminteractswiththeleu-kocyteintegrinVLA-4atasitedistinctfromtheVLA-4/fibronectinbindingsite.Cell.1990;60:577-584.
	29.MenardS,SquicciariniP,LuiniA,etal.Immuno-detectionofbonemarrowmicrometastasesinbreastcarcinomapatientsanditscorrelationwithprimarytumourprognosticfeatures.BrJCancer.1994;69:1126-1129.
	30.MansiJL,BergerU,WilsonP,ShearerR,CoombesRC.Detectionoftumorcellsinbonemarrowofpatientswithprostaticcarcinomabyimmunocytochemicaltechniques.JUrol.1988;139:545-548.
	31.Kamel-ReidS,LetarteM,DoedensM,etal.Bonemarrowfromchildreninrelapsewithpre-Bacutelym-phoblasticleukemiaproliferatesanddisseminatesrapidlyinscidmice.Blood.1991;78:2973-2981.1932
1906.full.pdf	74
	1.LookAT.Oncogenictranscriptionfactorsinthehumanacuteleukemias.Science.1997;278:1059-1064.
	2.RauskolbC,PeiferM,WeischausE.extraden-ticle,aregulatorofhomeoticgeneactivity,isahomologofthehomeobox-containinghumanproto-oncogenePBX1.Cell.1993;74:1101-1112.
	3.ChanSK,JaffeL,CapovillaM,BotasJ,MannRS.TheDNAbindingspecificityofUltrabithoraxismodulatedbycooperativeinteractionswithex-tradenticle,anotherhomeoprotein.Cell.1994;78:603-615.
	4.ChangC-P,ShenW-F,RozenfeldS,LawrenceHJ,LargmanC,ClearyML.Pbxproteinsdisplayhexapeptide-dependentcooperativeDNAbindingwithasubsetofHoxproteins.GenesDev.1995;9:663-674.
	5.LuQ,KnoepflerPS,ScheeleJ,WrightDD,KampsMP.BothPbx1andE2A-Pbx1bindtheDNAmotifATCAATCAAcooperativelywiththeproductsofmultiplemurineHoxgenes,someofwhicharethemselvesoncogenes.MolCellBiol.1995;15:3786-3795.
	6.MannRS,ChanS-K.Extraspecificityfromextra-denticle:thepartnershipbetweenHOXandPBX/EXDhomeodomainproteins.TrendsGenet.1996;12:258-262.
	7.VanDijkMA,MurreC.extradenticleraisestheDNAbindingspecificityofhomeoticselectorgeneproducts.Cell.1994;78:617-624.
	8.MaconochieMK,NonchevS,StuderM,etal.Cross-regulationinthemouseHoxBcomplex:theexpressionofHoxb2inrhombomere4isregu-latedbyHoxb1.GenesDev.1997;11:1885-1895.
	9.Poï¿½pperlH,BienzM,StuderM,etal.SegmentalexpressionofHoxb-1iscontrolledbyahighlyconservedautoregulatoryloopdependentuponexd/pbx.Cell.1995;81:1031-1042.
	10.RauskolbC,WeischausE.Coordinateregulationofdownstreamgenesbyextradenticleandthehomeoticselectorproteins.EMBOJ.1994;13:3561-3569.
	11.KampsMP,MurreCM,SunX-H,BaltimoreD.AnewhomeoboxgenecontributestheDNAbindingdomainofthet(1;19)translocationproteininpre-BALL.Cell.1990;60:547-555.
	12.NourseJ,MellentinJD,GaliliN,etal.Chromo-somaltranslocationt(1;19)resultsinsynthesisofahomeoboxfusionmRNAthatcodesforapoten-tialchimerictranscriptionfactor.Cell.1990;60:535-545.
	13.BainG,MurreC.TheroleofE-proteinsinB-andT-lymphocytedevelopment.SeminImmunol.1998;10:143-153.
	14.LeBrunDP,ClearyML.FusionwithE2AaltersthetranscriptionalpropertiesofthehomeodomainproteinPBX1int(1;19)leukemias.Oncogene.1994;9:1641-1647.
	15.LuQ,WrightDD,KampsMP.FusionwithE2AconvertsthePbx1homeodomainproteinintoaconstitutivetranscriptionalactivatorinhumanleu-kemiascarryingthet(1;19)translocation.MolCellBiol.1994;14:3938-3948.
	16.VanDijkMA,VoorhoevePM,MurreC.Pbx1isconvertedintoatranscriptionalactivatoruponacquiringtheN-terminalregionofE2Ainpre-Bcellacutelymphoblasticleukemia.ProcNatlAcadSciUSA.1993;90:6061-6065.
	17.ChangC-P,DeVivoI,ClearyML.TheHoxcoop-erativitymotifofchimericoncoproteinE2a-Pbx1isnecessaryandsufficientforoncogenesis.MolCellBiol.1997;17:81-88.
	18.KampsMP,WrightDD,LuQ.DNA-bindingbyoncoproteinE2A-Pbx1isimportantforblockingdifferentiationbutdispensibleforfibroblasttrans-formation.Oncogene.1996;12:19-30.
	19.Artavanis-TsakonasS,MatsuroK,FortiniME.Notchsignaling.Science.1995;268:225-232.
	20.GreenwaldI.Structure/functionstudiesoflin-12/Notchproteins.CurrOpinGenetDev.1994;4:556-562.
	21.WeinmasterG.TheinsandoutsofNotchsignal-ing.MolCellNeurosci.1997;9:91-102.
	22.KopanR,SchroeterE,WeintraubH,NyeJS.Sig-naltransductionbyactivatedmNotch:importanceofproteolyticprocessinganditsregulationbytheextracellulardomain.ProcNatlAcadSciUSA.1996;93:1683-1688.
	23.SchroeterEH,KisslingerJA,KopanR.Notch-1signallingrequiresligand-inducedproteolyticre-leaseofintracellulardomain.Nature.1998;393:382-386.
	24.StruhlG,AdachiA.Nuclearaccessandactionofnotchinvivo.Cell.1998;93:649-660.
	25.ChitnisAB.TheroleofNotchinlateralinhibitionandcellfatespecification.MolCellNeurosci.1995;6:311-321.
	26.KopanR,NyeJS,WeintraubH.TheintracellulardomainofmouseNotch:aconstitutivelyactivatedrepressorofmyogenesisdirectedatthebasichelix-loop-helixregionofMyoD.Development.1994;120:2385-2396.
	27.LieberT,KiddS,AlcamoE,CorbinV,YoungMW.AntineurogenicphenotypesinducedbytruncatedNotchproteinsindicatearoleinsignaltransduc-tionandmaypointtoanovelfunctionforNotchinnuclei.GenesDev.1993;7:1949-1965.
	28.RobeyE,ChangD,ItanoA,etal.AnactivatedformofNotchinfluencesthechoicebetweenCD4andCD8Tcelllineages.Cell.1996;87:483-492.
	29.EllisenLW,BirdJ,WestDC,etal.TAN-1,thehu-manhomologueoftheDrosophilaNotchgene,isbrokenbychromosomaltranslocationsinTlym-phoblasticneoplasms.Cell.1991;66:649-661.
	30.AsterJ,PearW,HasserjianR,etal.FunctionalanalysisoftheTAN-1gene,ahumanhomologofDrosophilanotch.ColdSpringHarborSympQuantBiol.1994;59:125-136.
	31.CapobiancoAJ,ZagourasP,BlaumuellerCM,Artavanis-TsakonasS,BishopJM.NeoplastictransformationbytruncatedallelesofhumanNOTCH1/TAN1andNOTCH2.MolCellBiol.1997;17:6265-6273.
	32.PearWS,AsterJC,ScottML,etal.Exclusivede-velopmentofTcellneoplasmsinmicetrans-plantedwithbonemarrowexpressingactivatedNotchalleles.JExpMed.1996;183:2283-2291.
	33.DederaDA,WallerEK,LeBrunDP,etal.Chi-merichomeoboxgeneE2A-PBX1inducesprolif-eration,apoptosis,andmalignantlymphomasintransgenicmice.Cell.1993;74:833-843.
	34.HoganB,ConstantiniF,LacyE.ManipulatingtheMouseEmbryo:ALaboratoryManual.ColdSpringHarbor,NY:ColdSpringHarborLabora-toryPress;1986.
	35.AbrahamKM,LevinSD,MartinJD,ForbushKA,PerlmutterRM.Thymictumorigenesisinducedbyoverexpressionofp56lck.ProcNatlAcadSciUSA.1991;88:3977-3981.
	36.SambrookJ,FritschEF,ManiatisT.MolecularCloning:ALaboratoryManual,2nded.ColdSpringHarbor,NY:ColdSpringHarborLabora-toryPress;1989:18.53-18.73.
	37.NatarajanD,BoultenA.Isolationofgenomicse-quencesflankingaretroviralinsertionsiteusinganovelPCR-basedmethod.Gene.1995;161:195-196.
	38.HauptY,AlexanderWS,BarriG,KlinkenSP,AdamsJM.Novelzincfingergeneimplicatedasmyccollaboratorbyretrovirallyacceleratedlym-phomagenesisinEm-myctransgenicmice.Cell.1991;65:753-763.
	39.VanLohuizenM,VerbeekS,ScheijenB,WientjensE,vanderGuldenH,BernsA.Identifi-cationofcooperatingoncogenesinEm-myctransgenicmicebyprovirustagging.Cell.1991;65:737-752.
	40.CuypersHT,SeltenG,QuintW,etal.Murineleu-kemiavirus-inducedT-celllymphomagenesis:integrationofprovirusesinadistinctchromo-somalregion.Cell.1984;37:141-150.
	41.GirardL,HannaZ,BeaulieuN,etal.FrequentprovirusinsertionalmutagenesisofNotch1inthy-momasofMMTVD/myctransgenicmicesuggestscollaborationofc-mycandNotch1foroncogen-esis.GenesDev.1996;10:1930-1944.
	42.KurookaH,KurodaK,HonjoT.RolesoftheankyrinrepeatsandC-terminalregionofthemousenotch1intracellularregion.NuclAcidsRes.1998;26:5448-5455.
	43.FeldmanBJ,ReidTR,ClearyML.Pim1cooper-ateswithE2a-Pbx1tofacilitatetheprogressionofthymiclymphomasintransgenicmice.Onco-gene.1997;15:2735-2742.
	44.FortiniME,Artavanis-TsakonasS.Thesuppres-sorofhairlessproteinparticipatesinnotchrecep-torsignaling.Cell.1994;79:273-282.
	45.NofzigerD,MiyamotoA,LyonsKM,WeinmasterG.NotchsignalingimposestwodistinctblocksinthedifferentiationofC2C12myoblasts.Develop-ment.1999;126:1689-1702.
	46.ShawberC,NofzigerD,HsiehJJ,etal.NotchsignalinginhibitsmusclecelldifferentiationthroughaCBF1-independentpathway.Develop-ment.1996;122:3765-3773.
	47.OrdentlichP,LinA,ShenC-P,etal.NotchinhibitionofE47supportstheexistenceofanovelsignalingpathway.MolCellBiol.1998;18:2230-2239.
	48.AplanPD,LombardiDP,GinsbergAM,CossmanJ,BertnessVI,KirschIR.DisruptionofthehumanSCLlocusby?illegitimate?V-(D)-Jrecombinaseactivity.Science.1991;250:1426-1429.
	49.BegleyCG,AplanPD,DaveyMP,etal.Chromo-somaltranslocationinahumanleukemicstemcelllinedisruptstheT-cellantigenreceptordelta-chaindiversityregionandresultsinapreviouslyunreportedfusiontranscript.ProcNatlAcadSciUSA.1989;86:2031-2035.1912
	50.BrownL,ChengJT,ChenQ,etal.Site-specificrecombinationofthetal-1geneisacommonoc-currenceinhumanTcellleuekmia.EMBOJ.1990;9:3343-3351.
	51.ChenQ,ChengJT,TasiLH,etal.ThetalgeneundergoeschromosometranslocationinTcellleukemiaandpotentiallyencodesahelix-loop-helixprotein.EMBOJ.1990;9:415-424.
	52.FingerLR,KaganJ,ChristopherG,etal.Involve-mentoftheTCL5geneonhumanchromosome1inT-cellleukemiaandmelanoma.ProcNatlAcadSciUSA.1989;86:5039-5043.
	53.HsuHL,WadmanI,BaerR.FormationofinvivocomplexesbetweentheTAL1andE2Apolypep-tidesofleukemicTcells.ProcNatlAcadSciUSA.1994;91:3181-3185.
	54.ParkST,SunXH.TheTal1oncoproteininhibitsE47-mediatedtranscription:mechanismsofinhi-bition.JBiolChem.1998;273:7030-7037.
	55.BainG,EngelI,RobanusMaandagEC,etal.E2Adeficiencyleadstoabnormalitiesina/bT-celldevelopmentandtorapiddevelopmentofT-celllymphomas.MolCellBiol.1997;17:4782-4791.
	56.YanW,YoungAZ,SoaresVC,KelleyR,BenezraR,ZhuangY.HighincidenceofT-celltumorsinE2A-nullmiceandE2A/Id1doubleknockoutmice.MolCellBiol.1997;17:7317-7327.
	57.SawadaS,LittmanDR.AheterodimerofHebandanE12-relatedproteininteractswiththeCD4en-hancerandregulatesitsactivityinT-celllines.MolCellBiol.1993;13:5620-5628.
	58.HasserjianRP,AsterJC,DaviF,WeinbergDS,SklarJ.ModulatedexpressionofNotch1duringthymocytedevelopment.Blood.1996;88:970-976.
	59.WashingtonT,SchweighofferE,GridleyT,etal.NotchactivityinfluencestheabversusgDTcelllineagedecision.Cell.1997;88:833-843.
	60.JehnBM,BielkeW,PearWS,OsborneBA.Cut-tingedge:protectiveeffectsofNotch-1onTCR-inducedapoptosis.JImmunol.1999;162:635-638.
	61.SmithKS,JacobsY,ChangC-P,ClearyML.Chi-mericoncoproteinE2a-Pbx1inducesapoptosisofhematopoieticcellsbyap53-independentmechanismthatissuppressedbyBcl-2.Onco-gene.1997;14:2917-2926.
	62.NazarovV,WolffL.Novelintegrationsiteatthedistal39endofthec-myblocusinretrovirus-in-ducedpromonocyticleukemias.JVirol.1995;69:3885-3888.
	63.CeciJD,PatriotisCP,TsatsanisC,etal.Tpl-2isanoncogenickinasethatisactivatedbycarboxy-terminaltruncation.GenesDev.1997;11:688-700.
	64.SakuraH,Kanei-IshiiC,NagaseT,NakagoshiH,GondaTJ,IshiiS.Delineationofthreefunctionaldomainsofthetranscriptionalactivatorencodedbythec-mycproto-oncogene.ProcNatlAcadSciUSA.1989;86:5758-5762.
	65.RogersS,WellsR,RechsteinerM.Aminoacidscommontorapidlydegradedproteins:thePESThypothesis.Science.1986;234:364-368.
	66.MangoSE,MaineEM,KimbleJ.Carboxyl-termi-naltruncationactivatesglp-1proteintospecifyvulvalfatesinCaenorhabditiselegans.Nature.1991;352:811-815.
	67.RebayI,FehonRG,Artavanis-TsakonasS.Spe-cifictruncationsofDrosophilaNotchdefinedomi-nantactivatedanddominantnegativeformsofthereceptor.Cell.1993;74:319-329.
	68.AxelrodJD,MatsunoK,Artavanis-TsakonasS,PerrimonN.InteractionbetweenWinglessandNotchsignalingpathwaysmediatedbyDishev-elled.Science.1996;271:1826-1832.
	69.GuoM,JanLY,JanYN.Controlofdaughtercellfatesduringasymmetricdivision:InteractionofNumbandNotch.Neuron.1996;17:27-41.
	70.ZhongW,FederJN,JiangMM,JanLY,JanYN.Asymmetriclocalizationofamammaliannumbhomologduringmousecorticalneurogenesis.Neuron.1996;17:43-53.
	71.LymanD,YoungMW.Furtherevidenceforfunc-tionoftheDrosophilaNotchproteinasatrans-membranereceptor.ProcNatlAcadSciUSA.1993;90:10395-10399.
	72.LuoB,AsterJC,HasserjianRP,KuoF,SklarJ.IsolationandfunctionalanalysisofacDNAforhumanJagged2,ageneencodingaligandfortheNotch1receptor.MolCellBiol.1997;17:6057-6067.
	73.Varnum-FinneyB,PurtonLE,YuM,etal.TheNotchligand,Jagged-1,influencesthedevelop-mentofprimitivehematopoieticprecursorcells.Blood.1998;91:4084-4091.
	74.BashJ,ZongW-X,BangaS,etal.Rel/NF-kBcantriggertheNotchsignalingpathwaybyinducingtheexpressionofJagged1,aligandforNotchre-ceptors.EMBOJ.1999;18:2803-2811.
Blood-2000-Anagnostopoulos-1889-99.pdf	55
	1.LukesRJ,CraverLF,HallTC,RappaportH,RubenP.Reportofthenomenclaturecommittee.CancerRes.1966;26:1311.
	2.JacksonH.ClassificationandprognosisofHodgkin?sdiseaseandallieddisorders.SurgGy-necolObstet.1937;64:465.
	3.JacksonH,ParkerF.Hodgkin?sdisease.I.Gen-eralconsiderations.NEnglJMed.1944;230:1.
	4.RappaportH,WinterWJ,HicksEB.Follicularlymphoma:are-evaluationofitspositionintheschemeofmalignantlymphoma,basedonasur-veyof253cases.Cancer.1956;4:792.
	5.LukesRJ,ButlerJJ.Thepathologyandnomen-clatureofHodgkin?sdisease.CancerRes.1966;26:1063.
	6.LukesRJ,ButlerJJ,HicksEB.NaturalhistoryofHodgkin?sdiseaseasrelatedtoitspathologicpic-ture.Cancer.1966;19:317.
	7.HansmannM-L,WackerHH,RadzunHJ.Para-granulomaisavariantofHodgkin?sdiseasewithpredominanceofBcells.VirchowsArch(PatholAnat).1986;409:171.
	8.HansmannM-L,ZwingersT,Boï¿½skeA,Loï¿½fflerH,LennertK.Clinicalfeaturesofnodularparagranu-loma(Hodgkin?sdisease,lymphocytepredomi-nancetype,nodular).JCancerResClinOncol.1984;108:321.
	9.PinkusGS,SaidJW.Hodgkin?sdisease,lympho-cytepredominancetype,nodular?adistincten-tity?UniquestainingprofileforL&HvariantsofReed-Sternbergcellsdefinedbymonoclonalan-tibodiestoleucocytecommonantigen,granulo-cytespecificantigen,andBcellspecificantigen.AmJPathol.1985;118:1-6.
	10.PoppemaS,KaiserlingE,LennertK.Epidemiol-ogyofnodularparagranuloma(Hodgkin?sdis-easewithlymphocytepredominance,nodular).JCancerResClinOncol.1979;95:57.
	11.PoppemaS,KaiserlingE,LennertK.Nodularparagranulomaandprogressivelytransformedgerminalcenters:ultrastructuralandimmunohis-tologicalfindings.VirchowsArch(CellPathol).1979;31:211.
	12.SteinH,HansmannM-L,LennertK,BrandtzaegP,GatterKC,MasonDY.Reed-SternbergandHodgkincellsinlymphocyte-predominantHodgkin?sdiseaseofnodularsubtypecontainJchain.AmJClinPathol.1986;86:292.
	13.TimensW,VisserL,PoppemaS.Nodularlym-phocytepredominancetypeofHodgkin?sdiseaseisagerminalcenterlymphoma.LabInvest.1986;54:457.
	14.ColesFB,CartunRW,PastuszakWT.Hodgkin?sdisease,lymphocytepredominanttype:immuno-reactivitywithBcellantibodies.ModPathol.1988;1:274.
	15.ChittalSM,CaveriviereP,SchwartingR,etal.MonoclonalantibodiesinthediagnosisofHodgkin?sdisease:thesearchforarationalpanel.AmJSurgPathol.1988;12:9.
	16.PinkusGS,SaidJW.Hodgkin?sdisease,lympho-cytepredominancetype,nodular-furtherevi-denceforaBcellderivation:L&HvariantsofReed-SternbergcellsexpressL26,apanBcellmarker.AmJPathol.1988;133:211.
	17.NicholasDS,HarrisS,WrightDH.LymphocytepredominanceHodgkin?sdisease?animmuno-histochemicalstudy.Histopathol.1990;16:157.
	18.ChittalSM,AlardC,RossiJ-F,etal.Furtherphe-notypicevidencethatnodular,lymphocyte-pre-dominantHodgkin?sdiseaseisalargeB-celllym-phomainevolution.AmJSurgPathol.1990;14:1024.
	19.PileriS,SabattiniE,TazzariPL,etal.Hodgkin?sdisease:updateoffindings.Haematologica.1991;76:175.
	20.HarrisNL,JaffeES,SteinH,etal.ArevisedEu-ropean-Americanclassificationoflymphoidneo-plasms:aproposalfromtheInternationalLym-phomaStudyGroup.Blood.1994;84:1361.
	21.MasonDY,BanksPM,ChanJ,etal.Nodularlym-phocytepredominanceHodgkin?sdisease:adis-tinctclinicopathologicalentity.AmJSurgPathol.1994;18:526.
	22.RegulaDP,HoppeRT,WeissLM.NodularanddiffusetypesoflymphocytepredominanceHodgkin?sdisease.NEnglJMed.1988;318:214.
	23.Borg-GrechA,RadfordJA,CrowtherD,SwindellR,HarrisM.Acomparativestudyofthenodularanddiffusevariantsoflymphocyte-predominantHodgkin?sdisease.JClinOncol.1989;7:1303.
	24.TefferiA,ZellersRA,BanksPM,TherneauTM,ColganJP.Clinicalcorrelatesofdistinctimmuno-phenotypicandhistologicsubcategoriesoflym-phocyte-predominanceHodgkin?sdisease.JClinOncol.1990;8:1959.
	25.HansmannM-L,SteinH,DallenbachF,FellbaumC.Diffuselymphocyte-predominantHodgkin?sdisease(diffuseparagranuloma):avariantoftheB-cellderivednodulartype.AmJPathol.1991;138:29.
	26.JaffeES,LongoDL,CossmanJ,HsuS-M,ArnoldA,KosrmeyerSJ.DiffuseB-celllymphomaswithT-cellpredominanceinpatientswithfollicularlym-phomaor?pseudoT-celllymphoma?[abstract].LabInvest.1984;50:27a.
	27.ChittalSM,BroussetP,VoigtJJ,DelsolG.LargeB-celllymphomarichinT-cellsandsimulatingHodgkin?sdisease.Histopathology.1991;19:211.
	28.MaconWR,WilliamsNE,GreerJP,SteinRS,CollinsRD,CousarJB.T-cellrichB-celllympho-mas:aclinicopathologicstudyof19cases.AmJSurgPathol.1992;16:351.
	29.NgCS,ChanJKC,HuiPK,LauWH.LargeB-celllymphomaswithhighcontentofreactiveTcells.HumPathol.1989;20:1145.
	30.OsborneBM,ButlerJJ,PughWC.ThevalueofimmunophenotypingonparaffinsectionsintheidentificationofT-cellrichB-celllarge-celllym-phomas:lineageconfirmedbyJHrearrangement.AmJSurgPathol.1990;14:933.
	31.RamsayAD,SmithWJ,IsaacsonPG.T-cellrichB-celllymphoma.AmJSurgPathol.1988;12:433.
	32.KrishnanJ,WallbergK,FrizzeraG.T-cellrichlargeB-celllymphoma.AmJSurgPathol.1994;18:455.
	33.RodriguezJ,PughWC,CabanillasF.T-cellrichB-celllymphoma.Blood.1993;82:1586.
	34.deWolfPeetersC,PittalugaS.T-cellrichB-celllymphoma:amorphologicalvariantofnonHodgkin?slymphomasoraclinico-pathologicalentity?Histopathology.1995;26:383.
	35.deJongD,vanGorpJ,Sie-GoD,vanHeerdeP.T-cellrichB-cellnonHodgkin?slymphoma:apro-gressedformoffolliclecentrecelllymphomaandlymphocytepredominanceHodgkin?sdisease.Histopathology.1996;28:15.
	36.Ashton-KeyM,ThorpePA,AllenJP,IsaacsonPG.FollicularHodgkin?sdisease.AmJSurgPathol.1995;19:1294.
	37.DiehlV,SextroM,FranklinJ,etal.Clinicalpre-sentation,courseandprognosticfactorsinlym-phocytepredominantHodgkin?sdiseaseandlym-phocyte-richclassicalHodgkin?sdisease:reportfromtheEuropeanTaskForceonLymphomaProjectonlymphocyte-predominantHodgkin?sdisease.JClinOncol.1999;117:776.
	38.NortonAJ,JordanS,YeomansP.Brief,high-tem-peratureheatdenaturation(pressurecooking):asimpleandeffectivemethodofantigenretrievalforroutinelyprocessedtissues.JPathol.1994;173:371.
	39.HummelM,AnagnostopoulosI,DallenbachF,KorbjuhnP,DimmlerC,SteinH.EBVinfectionpatternsinHodgkin?sdiseaseandnormallym-phoidtissue:expressionandcellularlocalizationofEBVgeneproducts.BrJHaematol.1992;83:689.
	40.GeorgiiA,FischerR,Huï¿½bnerK,SchwarzeEW,BernhardsJ.ClassificationofHodgkin?sdiseasebiopsiesbyapaneloffourhistopathologists:re-portof1140patientsfromtheGermannationaltrial.LeukLymphoma.1993;9:365.
	41.vonWasielewskiR,WernerM,FischerR,etal.Lymphocyte-predominantHodgkin?sdisease:animmunohistochemicalanalysisof208reviewedHodgkin?sdiseasecasesfromtheGermanHodgkinStudyGroup.AmJPathol.1997;150:793.
	42.KadinME,GlatsteinE,DorfmanRF.Clinico-pathologicalstudiesof117untreatedpatientssubjectedtolaparotomyforthestagingofHodgkin?sdisease.Cancer.1971;27:1277.
	43.LukesRJ.Criteriaforinvolvementoflymphnode,bonemarrow,spleenandliverinHodgkin?sdis-ease.CancerRes.1971;31:1755.
	44.PoppemaS,KaiserlingE,LennertK.Hodgkin?sdiseasewithlymphocyticpredominance,nodulartype(nodularparagranuloma)andprogressivelytransformedgerminalcenters:acytohistologicalstudy.Histopathology.1979;3:295.
	45.KorkolopoulouP,CordellJ,JonesM,etal.TheexpressionoftheB-cellmarkermb-1(CD79a)inHodgkin?sdisease.Histopathology.1994;24:511.
	46.HallPA,D?ArdenneAJ.ValueofCD15immuno-stainingindiagnosingHodgkin?sdisease:are-viewofpublishedliterature.JClinPathol.1987;40:1298.
	47.AngelCA,WarfordA,CampbellAC,PringleJH,LauderI.TheimmunohistologyofHodgkin?sdis-ease:Reed-Sternbergcellsandtheirvariants.JPathol.1987;153:21.
	48.AlgaraP,MartinezP,SachezL,etal.LymphocytepredominanceHodgkin?sdisease(nodularpara-granuloma)-abcl-2negativegerminalcentrelym-phoma.Histopathology.1991;19:69.
	49.FellbaumC,HansmannM-L,NiedermeyerH,etal.InfluenceofEpstein-BarrvirusgenomesonpatientsurvivalinHodgkin?sdisease.AmJClinPathol.1992;98:319.
	50.PallesenG,Hamilton-DutoitSJ,RoweM,YoungLS.ExpressionofEpstein-BarrviruslatentgeneproductsintumorcellsofHodgkin?sdisease.Lan-cet.1991;337:320.
	51.DelsolG,BroussetP,ChittalS,RigalHuguetF.CorrelationoftheexpressionofEpstein-Barrvi-ruslatentmembraneproteinandinsituhybridiza-tionwithbiotinylatedBamHI-WprobesinHodgkin?sdisease.AmJPathol.1992;140:247.
	52.MurrayPG,YoungLS,RoweM,CrockerJ.Im-munohistochemicaldemonstrationoftheEpstein-BarrvirusencodedlatentmembraneproteininparaffinsectionsofHodgkin?sdisease.JPathol.1992;166:1.
	53.WeissLM,ChenYY,LiuXF,ShibataD.Epstein-BarrvirusandHodgkin?sdisease:acorrelationinsituhybridizationandpolymerasechainreactionstudy.AmJPathol.1991;139:1259.
	54.CoatesPJ,SlavinG,d?ArdenneAJ.PersistenceofEpstein-BarrvirusinReed-SternbergcellsthroughoutthecourseofHodgkin?sdisease.JPathol.1991;164:291.
	55.AlkanS,RossCW,HansonCA,SchnitzerB.Ep-stein-Barrvirusandbcl-2proteinoverexpressionarenotdetectedinneoplasticcellsofnodularlymphocytepredominanceHodgkin?sdisease.ModPathol.1995;8:544.
Blood-2000-Merad-1865-72.pdf	155
	1.BanchereauJ,SteinmanRM.Dendriticcellsandthecontrolofimmunity.Nature.1998;392:245-252.
	2.LarsenCP,SteinmanRM,Witmer-PackM,HankinsDF,MorrisPJ,AustynJM.MigrationandmaturationofLangerhanscellsinskintransplantsandexplants.JExpMed.1990;172:1483-1493.
	3.BujdosoR,HopkinsJ,DutiaBM,YoungP,Mc-ConnellI.Characterizationofsheepafferentlymphdendriticcellsandtheirroleinantigencar-riage.JExpMed.1989;170:1285-1301.
	4.MacatoniaSE,KnightSC,EdwardsAJ,GriffithsS,FryerP.Localizationofantigenonlymphnodedendriticcellsafterexposuretothecontactsensi-tizerfluoresceinisothiocyanate:functionalandmorphologicalstudies.JExpMed.1987;166:1654-1667.
	5.VremecD,ZorbasM,ScollayR,etal.Thesur-facephenotypeofdendriticcellspurifiedfrommousethymusandspleen:investigationoftheCD8expressionbyasubpopulationofdendriticcells.JExpMed.1992;176:47-58.
	6.MaurerD,StinglG.Dendriticcellsinthecontextofskinimmunity.In:LotzeMT,ThomsonAW,eds.DendriticCells:BiologyandClinicalImplications.SanDiego:AcademicPress;1999.
	7.GeissmannF,ProstC,MonnetJP,DyM,BrousseN,HermineO.Transforminggrowthfactorbeta1,inthepresenceofgranulocyte/macrophagecolony-stimulatingfactorandinterleukin4,in-ducesdifferentiationofhumanperipheralbloodmonocytesintodendriticLangerhanscells.JExpMed.1998;187:961-966.
	8.ZhangY,ZhangYY,OgataM,etal.Transforminggrowthfactor-b1polarizesmurinehematopoieticprogenitorcellstogenerateLangheranscell-likedendriticcellsthroughamonocyte/macrophagedifferentiationpathway.Blood.1999;93:1208-1220.
	9.SprentJ,WebbSR.IntrathymicandextrathymicclonaldeletionofTcells.CurrOpinImmunol.1995;7:196-205.
	10.ArdavinC,WuL,LiCL,ShortmanK.Thymicden-driticcellsandTcellsdevelopsimultaneouslyinthethymusfromacommonprecursorpopulation.Nature.1993;362:761-763.
	11.VestweberD,KemlerR.Rabbitantiserumagainstapurifiedsurfaceglycoproteindecompactsmousepreimplantationembryosandreactswithspecificadulttissues.ExpCellRes.1984;152:169-178.
	12.SchulerG,SteinmanRM.MurineepidermalLangerhanscellsmatureintopotentimmuno-stimulatorydendriticcellsinvitro.JExpMed.1985;161:526-546.
	13.MetlayJP,Witmer-PackMD,AggerR,CrowleyMT,LawlessD,SteinmanRM.Thedistinctleuko-cyteintegrinsofmousespleendendriticcellsasidentifiedwithnewhamstermonoclonalantibod-ies.JExpMed.1990;171:1753-1771.
	14.KraalG,BreelM,JanseM,BruinG.Langerhans?cells,veiledcells,andinterdigitatingcellsinthemouserecognizedbyamonoclonalantibody.JExpMed.1986;163:981-997.
	15.BorkowskiTA,VanDykeBJ,SchwarzenbergerK,McFarlandVW,FarrA,UdeyMC.ExpressionofE-cadherinbymurinedendriticcells:E-cadherinasadendriticcelldifferentiationantigencharac-teristicofepidermalLangerhanscellsandrelatedcells.EurJImmunol.1994;24:2767-2774.
	16.WuL,LiC,ShortmanK.Thymicdendriticcellprecursors:relationshiptotheTlymphocytelin-eageandphenotypeofthedendriticcellprogeny.JExpMed.1996;184:903-911.
	17.WuL,VremecD,ArdavinC,etal.Mousethymusdendriticcells:kineticsofdevelopmentandchangesinsurfacemarkersduringmaturation.EurJImmunol.1995;25:418-425.
	18.BrockerT,RiedingerM,KarjalainenK.Targetedexpressionofmajorhistocompatibilitycomplex(MHC)classIImoleculesdemonstratesthatden-driticcellscaninducenegativebutnotpositiveselectionofthymocytesinvivo.JExpMed.1997;185:541-550.
	19.PulendranB,SmithJL,CasparyG,etal.Distinctdendriticcellsubsetsdifferentiallyregulatetheclassofimmuneresponseinvivo.ProcNatlAcadSciUSA.1999;96:1036-1041.
	20.Maldonado-LopezR,DeSmedtT,MichelP,etal.CD8a1andCD8a-subclassesofdendriticcellsdirectthedevelopmentofdistinctThelpercellsinvivo.JExpMed.1999;189:587-592.
	21.Fung-LeungWP,SchilhamMW,RahemtullaA,etal.CD8isneededfordevelopmentofcytotoxicTcellsbutnothelperTcells.Cell.1991;65:443-449.
	22.PowerCA,ChurchDJ,MeyerA,etal.CloningandcharacterizationofaspecificreceptorforthnovelCCchemokineMIP-3alphafromlungden-driticcells.JExpMed.1997;186:825-835.
	23.GreavesDR,WangW,DairaghiDJ,etal.CCR6,aCCchemokinereceptorthatinteractswithmac-rophageinflammatoryprotein3alphaandishighlyexpressedinhumandendriticcells.JExpMed.1997;186:837-844.
	24.RossiDL,VicariAP,Franz-BaconK,McClanahanTK,ZlotnikA.Identificationthroughbioinformaticsoftwonewmacrophageproinflammatoryhumanchemokines:MIP-3alphaandMIP-3beta.JIm-munol.1997;158:1033-1036.
	25.DieuMC,VanbervlietB,VicariA,etal.Selectiverecruitmentofimmatureandmaturedendriticcellsbydistinctchemokinesexpressedindiffer-entanatomicsites.JExpMed.1998;188:373-386.
	26.YangD,ChertovO,BykovskaiaSN,etal.beta-Defensins:linkinginnateandadaptiveimmunitythroughdendriticandTcellCCR6.Science.1999;286:525-528.
	27.SchweickartVL,RaportCJ,GodiskaR,etal.CloningofhumanandmouseEBI1,alymphoid-specificG-protein-coupledreceptorencodedonhumanchromosome17q12?q21.2.Genomics.1994;23:643-650.
	28.HedrickJA,ZlotnikA.Identificationandcharac-terizationofanovelbetachemokinecontainingsixconservedcysteines.JImmunol.1997;159:1589-1593.
	29.GunnMD,TangemannK,TamC,CysterJG,RosenSD,WilliamsLT.AchemokineexpressedinlymphoidhighendothelialvenulespromotestheadhesionandchemotaxisofnaiveTlympho-cytes.ProcNatlAcadSciUSA.1998;95:258-263.
	30.ChanVW,KothakotaS,RohanMC,etal.Sec-ondarylymphoid-tissuechemokine(SLC)ische-motacticformaturedendriticcells.Blood.1999;93:3610-3616.
	31.GunnMD,KyuwaS,TamC,etal.Micelackingexpressionofsecondarylymphoidorganchemo-kinehavedefectsinlymphocytehomingandden-driticcelllocalization[seecomments].JExpMed.1999;189:451-460.
	32.SaekiH,MooreAM,BrownMJ,HwangST.Cut-tingedge:secondarylymphoid-tissuechemokine(SLC)andCCchemokinereceptor7(CCR7)par-ticipateintheemigrationpathwayofmatureden-driticcellsfromtheskintoregionallymphnodes.JImmunol.1999;162:2472-2475.
	33.GodiskaR,ChantryD,RaportCJ,etal.Humanmacrophage-derivedchemokine(MDC),anovelchemoattractantformonocytes,monocyte-deriveddendriticcells,andnaturalkillercells.JExpMed.1997;185:1595-1604.
	34.TangHL,CysterJG.Chemokineup-regulationandactivatedTcellattractionbymaturingden-driticcells.Science.1996;284:819-822.
	35.ImaiT,YoshidaT,BabaM,NishimuraM,KakizakiM,YoshieO.MolecularcloningofanovelTcell-directedCCchemokineexpressedinthymusbysignalsequencetrapusingEpstein-Barrvirusvector.JBiolChem.1996;271:21514-21521.
	36.DeStGrothB.Theevolutionofself-tolerance:anewcellarisestomeetthechallengeofself-reac-tivity.ImmunolToday.1998;19:448-454.
	37.ReiseSousaC,GermainR.Analysisofadjuvantfunctionbydirectvisualizationofaccumulationofantigen-bearingdendriticcellsintheTcellareaoflymphoidtissue.JImmunol.1999;162:65526561.
	38.InabaK,PackM,InabaM,SakutaH,IsdellF,SteinmanRM.Highlevelsofamajorhistocom-patibilitycomplexII?self-peptidecomplexonden-driticcellsfromtheTcellareasoflymphnodes.JExpMed.1997;186:665-672.
	39.ReiseSousaC,HienyS,Scharton-KerstenT,etal.InvivomicrobialstimulationinducesrapidCD40ligand-independentproductionofinterleu-kin12bydendriticcellsandtheirredistributiontoTcellareas[seecomments].JExpMed.1997;186:1819-1829.
	40.OhtekiT,FukaoT,SuzueK,etal.Interleukin12-dependentinterferongammaproductionbyCD8alpha1lymphoiddendriticcells.JExpMed.1999;189:1981-1986.
v017p00286.pdf	0
Am J Clin Nutr-2000-Borchers-339-47.pdf	88
	1. Scimone A,Scimone A. US sees the green in herbal supplements.Chem Market Rep 1998;254:FR3?4.
	2. Thomson WAR. Medicines from the earth:a guide to healing plants.New York:Harper & Row,1983.
	3. Foster S,Duke JA. A field guide to medicinal plants:eastern andcentral North America. Boston:Houghton Mifflin Company,1990.
	4. Tierra M. The way of herbs. New York:Pocket Books,1990.
	5. Duke JA. The green pharmacy. Emmaus,PA:Rodale Press,1997.
	6. Blumenthal M. New world plants; new world drugs. Allergy Proc1992;13:345?52.
	7. Schacter L. Etoposide phosphate:what,why,where,and how?Semin Oncol 1996;23:1?7.
	8. Moerman DE. An analysis of the food plants and drug plants ofnative North America. J Ethnopharmacol 1996;52:1?22.
	9. Moerman DE. Medicinal plants of North America. Ann Arbor,MI:Museum of Anthropology,University of Michigan,1986.
	10. Johnson Gottesfeld LM,Anderson B. Gitksan traditional medicine:herbs and healing. J Ethnobiol 1988;8:13?33.
	11. Turner NJ,Hebda RJ. Contemporary use of bark for medicine bytwo Salishan native elders of Southeast Vancouver Island,Canada.J Ethnopharmacol 1990;29:59?72.
	12. Johnson Gottesfeld LM. Wet?suwet?en ethnobotany:traditionalplant uses. J Ethnobiol 1994;14:185?200.
	13. Ritch-Krc EM,Thomas S,Turner NJ,Towers GHN. Carrier herbalmedicine:traditional and contemporary plant use. J Ethnopharma-col 1996;52:85?94.
	14. Moerman DE. The medicinal flora of native North America:ananalysis. J Ethnopharmacol 1991;31:1?42.
	15. Reichard GA. Navaho religion:a study of symbolism. Princeton,NJ:Princeton University Press,1990.
	16. Vogel VJ. American Indian medicine:University of OklahomaPress,1970.
	17. Arnason T. Use of plants for food and medicine by native peoples ofeastern Canada. Can J Bot 1981;59:2189?325.
	18. Herrick JW. Iroquois medical botany. Syracuse,NY:Syracuse Uni-versity Press,1995.
	19. Hobbs C. Echinacea:a literature review. Botany,history,chemistry,pharmacology,toxicology,and clinical uses. Herbalgram 1994;33:35?48.
	20. Schwarz H-D. 100 Jahre Lobelin. Z Phytother 1990;11:159?60.
	21. Orvis KS,Goldman IL. Relationship between antiplatelet activityand sulfur fertility in hydroponic and field-grown onions (Alliumcepa). Hort Sci 1997;32:523 (abstr).
	22. Weber ND,Andersen DO,North JA,Murray BK,Lawson LD,Hughes BG. In vitro virucidal effects of Allium sativum(garlic)extract and compounds. Planta Med 1992;58:417?23.
	23. Goldman IL. Strength of onion-induced human antiplatelet activityis associated with plant development. Hort Sci 1997;32:523 (abstr).
	24. McCutcheon AR,Ellis SM,Hancock REW,Towers GHN. Antibi-otic screening of medicinal plants of the British Columbian nativepeoples. J Ethnopharmacol 1992;37:213?23.
	25. McCutcheon AR,Roberts TE,Gibbons E,et al. Antiviral screeningof British Columbian medicinal plants. J Ethnopharmacol 1995;49:101?10.NATIVE AMERICAN BOTANICALS345
	26. Tunï¿½n H,Olavsdotter C,Bohlin L. Evaluation of anti-inflammatoryactivity of some Swedish medicinal plants. Inhibition of prostaglandinbiosynthesis and PAF-induced exocytosis. J Ethnopharmacol 1995;48:61?76.
	27. Yesilada E,Sezik E. Screening of some Turkish medicinal plants usedin the treatment of rheumatoid arthritis and inflammatory diseases fortheir anti-inflammatory activities. Planta Med 1990;56:659.
	28. Wagner H. Search for new plant constituents with potentialantiphlogistic and antiallergic activity. Planta Med 1989;55:235?41.
	29. Mï¿½ller-Jakic B,Breu W,Prï¿½bstle A,Redl K,Greger H,Bauer R. Invitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamidesfrom Echinaceaand Achilleaspecies. Planta Med 1994;60:37?40.
	30. Wagner H,Breu W,Willer F,Wierer M,Remiger P,Schwenker G.In vitro inhibition of arachidonate metabolism by some alkamidesand prenylated phenols. Planta Med 1989;55:566?7.
	31. Hartisch C,Kolodziej H,von Bruchhausen F. Dual inhibitory activ-ities of tannins from Hamamelis virginianaand related polyphenolson 5-lipoxygenase and lyso-PAF:acetyl-CoA acetyltransferase.Planta Med 1997;63:106?10.
	32. Vavreckovï¿½ C,Gawlik I,Mï¿½ller K. Benzophenanthridine alkaloidsof Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by anon-redox mechanism. Planta Med 1996;62:397?401. 
	33. Sumner H,Salan U,Knight DW,Hoult JRS. Inhibition of 5-lipoxy-genase and cyclo-oxygenase in leukocytes by feverfew. Involvementof sesquiterpene lactones and other components. Biochem Pharma-col 1992;43:2313?20.
	34. Obertreis B,Giller K,Teucher T,Behnke B,Schmitz H. Antiphlo-gistische Effekte von Extractum Urticae dioicaefoliorum im Ver-gleich zu kaffeoylï¿½pfelsï¿½ure. (Antiphlogistic effects of Urticadioicaleaf extract compared to caffeic malic acid.) Arzneimit-telforschung1996;46:52?6.
	35. Agarwal S,Reynolds MA,Pou S,Peterson DE,Charon JA,SuzukiJB. The effect of sanguinarine on human peripheral blood neutrophilviability and functions. Oral Microbiol Immunol 1991;6:51?61.
	36. Chaturvedi MM,Kumar A,Darnay BG,Chainy GBN,Agarwal S,Aggarwal BB. Sanguinarine (pseudochelerythrine) is a potentinhibitor of NF-B activation,IBphosphorylation,and degrada-tion. J Biol Chem 1997;272:30129?34.
	37. Erdelmeier CAJ,Cinatl J Jr,Rabenau H,Doerr HW,Biber A,KochE. Antiviral and antiphlogistic activities of Hamamelis virginianabark. Planta Med 1996;62:241?5.
	38. Duwiejua M,Zeitlin IJ,Waterman PG,Gray AI. Anti-inflammatoryactivity of Polygonum bistorta,Guaiacum officinaleand Hamamelisvirginianain rats. J Pharm Pharmacol 1994;46:286?90.
	39. Hughes-Formella BJ,Bohnsack K,Rippke F,et al. Anti-inflamma-tory effect of hamamelis lotion in a UVB erythema test. Dermatol-ogy 1998;196:316?22.
	40. Korting HC,Schafer-Korting M,Hart H,Laux P,Schmid M. Anti-inflammatory activity of hamamelis distillate applied topically tothe skin. Influence of vehicle and dose. Eur J Clin Pharmacol1993;44:315?8.
	41. Korting HC,Schafer-Korting M,Klovekorn W,Klovekorn G,MartinC,Laux P. Comparative efficacy of hamamelis distillate and hydrocor-tisone cream in atopic eczema. Eur J Clin Pharmacol 1995;48:461?5.
	42. Yesilada E,ï¿½stï¿½n O,Sezik E,Takaishi Y,Ono Y,Honda G.Inhibitory effects of Turkish folk remedies on inflammatorycytokines:interleukin-1,interleukin-1and tumor necrosis factor. J Ethnopharmacol 1997;58:59?73.
	43. Zakay-Rones Z,Varsano N,Zlotnik M,et al. Inhibition of severalstrains of influenza virus in vitro and reduction of symptoms by anelderberry extract (Sambucus nigraL.) during an outbreak ofinfluenza B Panama. J Altern Complement Med 1995;1:361?9.
	44. Bauer R,Remiger P,Jurcic K,Wagner H. Beeinflussung der Phagozy-tose-aktivitï¿½t durch Echinacea-Extrakte. (Effects of Echinaceaextracts on phagocytic activity.) Z Phytotherapie 1989;10:43?8 (inGerman).
	45. Bauer R,Remiger P. TLC and HPLC analysis of alkamides in Echi-naceadrugs. Planta Med 1989;55:367?71.
	46. Perry NB,van Klink JW,Burgess EJ,Parmenter GA. Alkamide lev-els in Echinacea purpurea:a rapid analytical method revealing dif-ferences among roots,rhizomes,stems,leaves and flowers. PlantaMed 1997;63:58?62.
	47. Bauer R,Jurcic K,Puhlmann J,Wagner H. Immunologische In-vivo-und In-vitro-Untersuchungen mit Echinacea-Extrakten. (Immuno-logical in vivo and in vitro examinations of Echinacea extracts.)Arzneimittelforschung 1988;38:276?81 (in German).
	48. O?Hara MA,Kiefer D,Farrell K,Kemper K. A review of 12 com-monly used medicinal herbs. Arch Fam Med 1998;7:523?36.
	49. Tympner K-D. Der immunbiologische Wirkungsnachweis vonPflanzenextrakten. (The demonstration of immunobiological effec-tiveness of plant extracts.). Z Angewandte Phytother 1981;5:181?4(in German).
	50. Gaisbauer M,Schleich T,Stickl HA,Wilczek I. Untersuchungenzum Einfluï¿½von EchinaceapurpureaMoench auf die Phagozytosevon Granulozyten mittels Messung der Chemilumineszenz. (Theeffect of Echinacea purpureaMoench on the phagocytosis in gran-ulocytes measured by chemiluminescence.) Arzneim-Forsch/DrugRes 1990;40:594?8 (in German).
	51. Jurcic K,Melchart D,Holzmann M,et al. Zwei Probandenstudienzur Stimulierung der Granulozyten-Phagozytose durch Echinacea-extrakt-haltige prï¿½parate. (Two clinical studies on the stimulation ofgranulocyte phagocytosis by preparations containing Echinacea.)Z Phytother 1989;10:67?70.
	52. Burger RA,Torres AR,Warren RP,Caldwell VD,Hughes BG. Echi-nacea-induced cytokine production by human macrophages. Int JImmunopharmacol 1997;19:371?9.
	53. Wagner H,Proksch A,Vollmar A,Kreutzkamp B,Bauer J. In-vitro-Phagozytose-Stimulierung durch isolierte Pflanzenstoffe gemessenim Phagozytose-Chemilumineszenz-(CL)-Modell. (In vitro phagocy-tosis stimulation by isolated plant materials in a chemoluminescence-phagocytosis model.) Planta Med 1985;2:139?44 (in German).
	54. Roesler J,Emmendï¿½rffer A,Steinmï¿½ller C,Luettig B,Wagner H,Lohmann-Matthes M-L. Application of purified polysaccharidesfrom cell cultures of the plant Echinacea purpureato test subjectsmediates activation of the phagocytic system. Int J Immunopharma-col 1991;13:931?41.
	55. See DM,Broumand N,Sahl L,Tilles JG. In vitro effects of echi-nacea and ginseng on natural killer and antibody-dependent cellcytotoxicity in healthy subjects and chronic fatigue syndrome oracquired immunodeficiency syndrome patients. Immunopharmacol-ogy 1997;35:229?35.
	56. Steinmï¿½ller C,Roesler J,Grï¿½ttrup E,Franke G,Wagner H,Lohmann-Matthes M-L. Polysaccharides isolated from plant cell cultures ofEchinacea purpureaenhance the resistance of immunosuppressedmice against systemic infections with Candida albicansand Listeriamonocytogenes. Int J Immunopharmacol 1993;15:605?14.
	57. Roesler J,Steinmï¿½ller C,Kinderlein A,Emmendï¿½rffer A,WagnerH,Lohmann-Matthes M-L. Application of purified polysaccharidesfrom cell cultures of the plant Echinacea purpureato mice mediatesprotection against systemic infections with Listeria monocytogenesand Candida albicans. Int J Immunopharmacol 1991;13:27?37.
	58. Mï¿½se JR. Zur Wirkung von Echinacin auf Phagozytoseaktivitï¿½t undnatural killer cells. (On the effect of Echinacin on phagocytic activityand natural killer cells.) Medwelt 1983;51/52:1463?7 (in German).
	59. Melchart D,Linde K,Worku F,et al. Results of five randomizedstudies on the immunomodulatory activity of preparations of Echi-nacea. J Altern Complement Med 1995;1:145?60.
	60. Elsï¿½sser-Beile U,Willenbacher W,Bartsch HH,Gallati H,SchulteMï¿½nting J,von Kleist S. Cytokine production in leukocyte culturesduring therapy with Echinacea extract. J Clin Lab Anal 1996;10:441?5.
	61. Brï¿½unig B,Dorn M,Knick E. Echinaceae purpureaeradix:zurStï¿½rkung der kï¿½rpereigenen Abwehr bei grippalen Infekten.(Echinacea purpurea radix:for strengthening host immunity in res-piratory infections.) Z Phytother 1992;13:7?13 (in German).346BORCHERS ET AL
	62. Schmidt U,Albrecht M,Schenk N. Pflanzliches Immunstimulanssenkt Hï¿½ufigkeit grippaler Infekte. (A plant-derived immunostimu-lant reduces the frequency of upper respiratory infections.) NaturGanzheits Medizin 1990;3:277?81 (in German).
	63. Melchart D,Walther E,Linde K,Brandmaier R,Lersch C. Echi-nacea root extracts for the prevention of upper respiratory tractinfections. Arch Fam Med 1998;7:541?5.
	64. Mengs U,Clare CB,Poiley JA. Toxicity of Echinacea purpurea.Arzneimittelforschung 1991;41:1076?81.
	65. Schimmer O,Abel G,Behninger C. Untersuchungen zur Gentoxi-schen Potenz eines neutralen Polysaccharids aus Echinacea-Gewe-bekulturen in menschlichen Lymphozytenkulturen. (Investigationsof the genotoxic potential of a neutral polysaccharide from Echi-naceatissue cultures in cultures of human lymphocytes.) Z Phy-tother 1989;10:39?42.
	66. Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998;168:170?1.
	67. Myers SP,Wohlmuth H. Echinacea-associated anaphylaxis. Med JAust 1998;168:583?4.
	68. Bauer R,Khan IA,Wagner H. Neue Mï¿½glichkeiten zur Standar-disierung von Echinacea-Extrakten. (New possibilities for stan-dardization of Echinacea extracts.) Sci Pharm 1986;54:145 (abstr)(in German).
	69. Obertreis B,Ruttkowski T,Teucher T,Behnke B,Schmitz H. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumornecrosis factor-and interleukin-1secretion in human whole bloodby extractum Urticae dioicaefoliorum. Arzneimittelforschung1996;46:389?94.
	70. Riehemann K,Behnke B,Schulze-Osthoff K. Plant extracts fromstinging nettle (Urtica dioica),an antirheumatic remedy,inhibit theproinflammatory transcription factor NF-B. FEBS Lett 1999;442:89?94.
	71. Feldmann M,Brennan FM,Maini RN. Rheumatoid arthritis. Cell1996;85:307?10.
	72. Feldmann M,Brennan FM,Maini RN. Role of cytokines in rheuma-toid arthritis. Annu Rev Immunol 1996;14:397?440.
	73. Marok R,Winyard PG,Coumbe A,et al. Activation of the tran-scription factor nuclear factor-B in human inflamed synovial tis-sue. Arthritis Rheum 1996;39:583?91.
	74. Shiozawa S,Shimizu K,Tanaka K,Hino K. Studies on the contri-bution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest1997;99:1210?6.
	75. Miyazawa K,Mori A,Yamamoto K,Okudaira H. Constitutive tran-scription of the human interleukin-6 gene by rheumatoid synovio-cytes. Spontaneous activation of NF-B and CBF1. Am J Pathol1998;152:793?803.
	76. Teucher T,Obertreis B,Ruttkowski T,Schmitz H. Zytokin-Sekre-tion im Vollblut gesunder Probanden nach oraler Einnahme einesUrtica dioicaL.-Blattextraktes. (Cytokine secretion in whole bloodof healthy volunteers after oral ingestion of an Urtica dioicaL. leafextract.) Arzneimittelforschung 1996;46:906?10.
	77. Le Moal MA,Truffa-Bachi P. Urtica dioicaagglutinin,a new mito-gen for murine T lymphocytes:unaltered interleukin-1 productionbut late interleukin 2-mediated proliferation. Cell Immunol 1988;115:24?35.
	78. Le Moal MA,Colle J-H,Galelli A,Truffa-Bachi P. Mouse T-lym-phocyte activation by Urtica dioicaagglutinin. II. Original patternof cell activation and cytokine production induced by UDA. ResImmunol 1992;143:701?9.
	79. Galelli A,Truffa-Bachi P. Urtica dioicaagglutinin. A superanti-genic lectin from stinging nettle rhizome. J Immunol 1993;151:1821?31.
	80. Musette P,Galelli A,Truffa-Bachi P,Peumans W,Kourilsky P,Gachelin G. The Jsegment of the T cell receptor contributes to theV-specific T cell expansion caused by staphylococcal enterotoxinB and Urtica dioicasuperantigens. Eur J Immunol 1996;26:618?22.
	81. Galelli A,Delcourt M,Wagner M-C,Peumans W,Truffa-Bachi P.Selective expansion followed by profound deletion of matureV8.3+T cells in vivo after exposure to the superantigenic lectinUrtica dioicaagglutinin. J Immunol 1995;154:2600?11.
	82. Delcourt M,Peumans WJ,Wagner M-C,Truffa-Bachi P. V-spe-cific deletion of mature thymocytes induced by plant superantigenUrtica dioicaagglutinin. Cell Immunol 1996;168:158?64.
	83. Thompson SD,Murray KJ,Grom AA,Passo MH,Choi E,GlassDN. Comparative sequence analysis of the human T cell receptorchain in juvenile rheumatoid arthritis and juvenile spondy-larthropathies. Arthritis Rheum 1998;41:482?97.
	84. Robinson CP,Cornelius J,Bounous DE,Yamamoto H,Humphreys-Beher MG,Peck AB. Characterization of the changing lymphocytepopulations and cytokine expression in the exocrine tissues ofautoimmune NOD mice. Autoimmunity 1998;27:29?44.
	85. Suzuki M,Cheng KC,Krug MS,Yoo TJ. Successful prevention ofretrocochlear hearing loss in murine experimental allergic encephalo-myelitis with T cell receptor V8-specific antibody. Ann Otol Rhi-nol Laryngol 1998;107:917?27.
	86. Goldman-Brezinski S,Brezinski K,Zhang X-M,et al. Effects oforal tolerance induction by myelin basic protein on V8+Lewis ratT cells. J Neurosci Res 1998;51:67?75.
	87. Musette P,Pannetier C,Gachelin G,Kourilsky P. The expansion ofa CD4+T cell population bearing a distinctive chain in MRLlpr/lprmice suggests a role for the fas protein in peripheral T cellselection. Eur J Immunol 1994;24:2761?6.
	88. Musette P,Galelli A,Chabre H,et al. Urtica dioicaagglutinin,aV8.3-specific superantigen,prevents the development of the sys-temic lupus erythematosus-like pathology of MRL lpr/lprmice. EurJ Immunol 1996;26:1707?11.NATIVE AMERICAN BOTANICALS347
Am J Clin Nutr-2000-Scott-333-4.pdf	7
	1. McCully KS. Vascular pathology of homocysteinemia:implicationsfor the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111?28.
	2. BrattstrÃ¶m L, Wilcken DEL. Homocysteine and cardiovascular disease:cause or effect? Am J Clin Nutr 2000;72:315?23.
	3. Mudd SH,Skovby F,Levy HL,et al. The natural history of homo-cystinuria due to cystathionine beta-synthase deficiency. Am J HumGenet 1985;37:1?31.
	4. Nygard O,Vollset SE,Refsum H,et al. Total plasma homocysteineand cardiovascular risk profile. The Hordaland HomosycteineStudy. JAMA 1995;274:1526?33.
	5. Bostom A,Brosnan JT,Hall B,Nadeau MR,Selhub J. Net uptake ofplasma homocysteine by the rat kidney in vivo. Atherosclerosis1995;116:59?62.
	6. Guttormsen AB,Ueland PM,Svarstad E,Refsum H. Kinetic basisof hyperhomocysteinemia in patients with chronic renal failure.Kidney Int 1997;52:495?502.
	7. Ueland PM,Refsum H,Beresford SAA,Vollset SE.The contro-versy over homocysteine and cardiovascular risk. Am J Clin Nutr2000;72:324?32.
1203626a.pdf	63
	AguirreKM,McCormickRJandSchwarzbauerJE.(1994).J.Biol.Chem.,269,27863?29868.
	Bar-SagiDandFeramiscoJR.(1986).Science,233,1061?1068.
	BarbacidM.(1987).Annu.Rev.Biochem.,56,779?827.
	BoudreauNandBissellMJ.(1998).Curr.Opin.Cell.Biol.,10,640?646.
	BourdoulousS,OrendG,MacKennaDA,PasqualiniRandRuoslahtiE.(1998).J.CellBiol.,143,267?276.
	DamskyCH,FitzgeraldMLandFisherSJ.(1992).J.Clin.Invest.,89,210?222.
	DudleyDT,PangL,DeckerSJ,BridgesAJandSaltielAR.(1995).Proc.Natl.Acad.Sci.USA,92,7686?7689.
	EfimovaT,LaCelleP,WelterJFandEckertRL.(1998).J.Biol.Chem.,273,24387?24395.
	EsparzaJ,VilardellC,CalvoJ,JuanM,VivesJ,Urbano-MarquezA,YagueJandCidMC.(1999).Blood,94,2754?2766.
	FurchtLT,MosherDF,Wendelschafer-CrabbGandFoidartJM.(1979).CancerRes.,39,2077?2083.
	GailitJandRuoslahtiE.(1988).J.Biol.Chem.,263,12927?12932.
	GiancottiFGandRuoslahtiE.(1990).Cell,60,849?859.
	GrenzH,CarbonettoSandGoodmanSL.(1993).J.CellSci.,105,739?751.
	HallA,MarshallCJ,SpurrNKandWeissRA.(1983).Nature,303,396?400.
	HemlerME,Sanchez-MadridF,FlotteTJ,KrenskyAM,Burakoï¿½SJ,BhanAK,SpringerTAandStromingerJL.(1984).J.Immunol.,132,3011?3018.
	HughesPE,RenshawMW,Pfaï¿½M,ForsythJ,KeivensVM,SchwartzMAandGinsbergMH.(1997).Cell.,88,521?530.
	HulleyPA,GordonFandHoughFS.(1998).Endocrinology,139,2423?2431.
	HynesRO.(1990).Fibronectins.Springer-Verlag,NewYork.
	HynesRO,DestreeAT,MautnerVMandAliIU.(1977).J.Supramol.Struct.,7,397?408.
	HynesROandWykeJA.(1975).Virology,64,492?504.
	Kapron-BrasC,Fitz-GibbonL,JeevaratnamP,WilkinsJandDedharS.(1993).J.Biol.Chem.,268,20701?20704.
	KazlauskasAandCooperJA.(1988).J.Cell.Biol.,106,1395?1402.
	KeelyP,PariseLandJulianoR.(1998).Trends.Cell.Biol.,8,101?106.
	KohnoM.(1985).J.Biol.Chem.,260,1771?1779.
	MaderSandWhiteJH.(1993).Proc.Natl.Acad.Sci.USA.,90,5603?5607.
	MalumbresMandPellicerA.(1998).FrontBiosci.,3,d887?d912.
	MarcantonioEEandHynesRO.(1988).J.Cell.Biol.,106,1765?1772.
	MatsumotoT,YokoteK,TamuraK,TakemotoM,UenoH,SaitoYandMoriS.(1999).J.Biol.Chem.,274,13954?13960.
	McKeown-LongoPJandEtzlerCA.(1987).J.Cell.Biol.,104,601?610.
	McKeown-LongoPJandMosherDF.(1983).J.Cell.Biol.,97,466?472.
	MeyerM,MalyK,UberallF,HoflacherJandGrunickeH.(1991).J.Biol.Chem.,266,8230?8235.
	MorinoN,MimuraT,HamasakiK,TobeK,UekiK,KikuchiK,TakeharaK,KadowakiT,YazakiYandNojimaY.(1995).J.Biol.Chem.,270,269?273.
	MosherDF.(1993).Curr.Opin.Struct.Biol.,3,214?222
	MouldAP,AkiyamaSKandHumphriesMJ.(1995).J.Biol.Chem.,270,26270?26277.
	MoustakasAandStournarasC.(1999).J.Cell.Sci.,112,1169?1179.
	OldenKandYamadaKM.(1977).Cell.,11,957?969.
	OliverN,NewbyRF,FurchtLTandBourgeoisS.(1983).Cell.,33,287?296.
	PlantefaberLCandHynesRO.(1989).Cell.,56,281?290.
	RasheedS,Nelson-ReesWA,TothEM,ArnsteinPandGardnerMB.(1974).Cancer,33,1027?1033.
	SchlaepferDD,HanksSK,HunterTandvanderGeerP.(1994).Nature,372,786?791.
	SchwarzbauerJEandSechlerJL.(1999).Curr.Opin.Cell.Biol.,11,622?627.
	SchwarzbauerJE,SpencerCSandWilsonCL.(1989).J.Cell.Biol.,109,3445?3453.
	SechlerJL,CorbettSAandSchwarzbauerJE.(1997).Mol.Biol.Cell.,8,2563?2573.
	SechlerJLandSchwarzbauerJE.(1997).Cell.Adhes.Commun.,4,413?424.
	SechlerJLandSchwarzbauerJE.(1998).J.Biol.Chem.,273,25533?25536.
	SechlerJL,TakadaYandSchwarzbauerJE.(1996).J.Cell.Biol.,134,573?583.
	Seuï¿½erleinT,WithersDJ,MannDandRozengurtE.(1996).Mol.Biol.Cell.,7,1865?1875.
	SinghRP,DhawanP,GoldenC,KapoorGSandMehtaKD.(1999).J.Biol.Chem.,274,19593?19600.
	SottileJ,HockingDCandSwiatekPJ.(1998).J.Cell.Sci.,111,2933?2943.
	SticeLL,VaziriCandFallerDV.(1999).Front.Biosci.,4,D72?D86.
	StoneKR,SmithREandJoklikWK.(1974).Virology,58,86?100.
	UhtRM,AndersonCM,WebbPandKushnerPJ.(1997).Endocrinology,138,2900?2908.
	VarnerJAandChereshDA.(1996).Curr.Opin.Cell.Biol.,8,724?730.
	WahrmanMZ,GagnierSE,KobrinDR,HigginsPJandAugenlichtLH.(1985).Tumour.Biol.,6,41?56.
	WerbZ,TremblePM,BehrendtsenO,CrowleyEandDamskyCH.(1989).J.Cell.Biol.,109,877?889.
	WuC.(1997).Histol.Histopathol.,12,233?240.
	YamadaKM,KennedyDW,YamadaSS,GralnickH,ChenWTandAkiyamaSK.(1990).Cancer.Res.,50,4485?4496.
	YamadaKM,YamadaSSandPastanI.(1976).Proc.Natl.Acad.Sci.USA.,73,1217?1221.
	YoungPR,McLaughlinMM,KumarS,KassisS,DoyleML,McNultyD,GallagherTF,FisherS,McDonnellPC,CarrSA,HuddlestonMJ,SeibelG,PorterTG,LiviGP,AdamsJLandLeeJC.(1997).J.Biol.Chem.,272,12116?12121.
	ZhangQ,ChecovichWJ,PetersDM,AlbrechtRMandMosherDF.(1994).J.Cell.Biol.,127,1447?1459.
	ZhangQ,MagnussonMKandMosherDF.(1997).Mol.Biol.Cell.,8,1415?1425.
	ZhongC,Chrzanowska-WodnickaM,BrownJ,ShaubA,BelkinAMandBurridgeK.(1998).J.Cell.Biol.,141,539?551.
	ZhuX,OhtsuboM,BohmerRM,RobertsJMandAssoianRK.(1996).J.Cell.Biol.,133,391?403.
j.1432-1327.2000.01418.x.pdf	36
	1.Wolff,I.A.(1966)Seedlipids.Seedtriglycerideoilsarechemicallydiverse,scientificallyinteresting,andversatileinutility.Science154,1140ï¿½1149.
	2.Shanklin,J.&Cahoon,E.B.(1998)Desaturationandrelatedmodifi-cationsoffattyacids.Annu.Rev.PlantPhysiol.PlantMol.Biol.49,611ï¿½641.
	3.Girke,T.,Sperling,P.&Heinz,E.(1998)Cloningofdesaturaseswithnewspecificities.InAdvancesinPlantLipidResearch(Sanchez,J.,Cerda-Olmedo,E.&Martï¿½nez-Force,E.,eds),pp.103ï¿½109.SecretariadodePublicacionesdelaUniversidaddeSevilla,Seville,Spain.
	4.vandeLoo,F.J.,Broun,P.,Turner,S.&Somerville,C.(1995)Anoleate12-hydroxylasefromRicinuscommunisL.isafattyacyldesaturasehomologue.Proc.NatlAcad.Sci.USA92,6743ï¿½6747.
	5.Broun,P.,Boddupalli,S.&Somerville,C.(1998)Abifunctionaloleate12-hydroxylase:desaturasefromLesquerellafendleri.PlantJ.13,201ï¿½210.
	6.Broun,P.,Shanklin,J.,Whittle,E.&Somerville,C.(1998)Catalyticplasticityoffattyacidmodificationenzymesunderlyingchemicaldiversityofplantlipids.Science282,1315ï¿½1317.
	7.Haigh,W.G.,Morris,L.J.&James,A.T.(1968)AcetylenicacidbiosynthesisinCrepisrubra.Lipids3,307ï¿½312.
	8.Lee,M.,Lenman,M.,Banaï¿½,A.,Bafor,M.,Singh,S.,Schweizer,M.,Nilsson,R.,Liljenberg,C.,Dahlqvist,A.,Gummeson,P.-O.,Sjodahl,S.,Green,A.&Stymne,S.(1998)Identificationofnon-hemediironproteinsthatcatalyzetriplebondandepoxygroupformation.Science280,915ï¿½918.
	9.Kohn,G.,Hartman,E.,Stymne,S.&Beutelmannn,J.(1994)Biosyn-thesisofacetylenicfattyacidsinthemossCeratodonpurpureus(Hedw.)Brid.*.J.PlantPhysiol.144,265ï¿½271.
	10.Cahoon,E.B.,Carlson,T.J.,Ripp,K.G.,Schweiger,B.J.,Cook,G.A.,Hall,S.E.&Kinney,A.J.(1999)Biosyntheticoriginofconjugateddoublebonds:Productionoffattyacidcomponentsofhigh-valuedryingoilsintransgenicsoybeanembryos.Proc.NatlAcad.Sci.USA96,12935ï¿½12940.
	11.Fritsche,K.,Hornung,E.,Peitzsch,N.,Renz,A.&Feussner,I.(1999)Isolationandcharacterizationofacalendicproducing(8,11)-linoleoyldesaturase.FEBSLett462,249ï¿½253.
	12.Wallis,J.G.&Browse,J.(1999)TheD-desaturaseofEuglenagracilis:analternativepathwayforsynthesisof20-carbonpoly-unsaturatedfattyacids.Arch.Biochem.Biophys.365,307ï¿½316.
	13.Napier,J.,Sayanova,O.,Sperling,P.&Heinz,E.(1999)Agrowingfamilyofcytochromeb-domainfusionproteins.TrendsPlantSci.4,
	14.Pasentsis,K.,Paulo,N.,Algarra,P.,Dittrich,P.&Thummler,F.(1998)CharacterizationandexpressionofthephytochromegenefamilyinthemossCeratodonpurpureus.PlantJ.13,51ï¿½61.
	15.Riggs,M.G.&McLachlan,A.(1986)Asimplifiedscreeningprocedureforlargenumbersofplasmidminipreparations.Biotechniques4,310ï¿½313.
	16.Dohmen,R.J.,Strasser,A.W.M.,Honer,C.B.&Hollenberg,C.P.(1991)Anefficienttransformationprocedureenablinglong-termstorageofcompetentcellsofvariousyeastgenera.Yeast7,691ï¿½692.
	17.Ausubel,F.M.,Brent,R.,Kingston,R.E.,Moore,D.D.,Seidman,J.G.,Smith,J.A.,Struhl,K.,Albright,L.M.,Coen,D.M.&Varki,A.(1995).CurrentProtocolsinMolecularBiology.JohnWiley&Sons.NewYork,USA.
	18.Avery,S.V.,Howlett,N.G.&Radice,S.(1996)CoppertoxicitytowardsS.cerevisiae:dependenceonplasmamembranefattyacidcomposi-tion.Appl.Environ.Microbiol.62,3960ï¿½3966.
	19.Girke,T.,Schmidt,H.,Zahringer,U.,Reski,R.&Heinz,E.(1998)IdentificationofanovelD6-acyl-groupdesaturasebytargetedgenedisruptioninPhyscomitrellapatens.PlantJ.15,39ï¿½48.
	20.Christie,W.W.(1998)Massspectrometryoffattyacidswithmethylene-interruptedene-ynesystems.Chem.Phys.Lipids94,35ï¿½41.
	21.Huang,Y.S.,Chaudhary,S.,Thurmond,J.M.,Bobik,E.G.Jr,Yuan,L.,Chan,G.M.,Kirchner,S.J.,Mukerji,P.&Knutzon,D.S.(1999)CloningofD12-andD6-desaturasesfromMortierellaalpinaandrecombinantproductionofg-linolenicacidinS.cerevisiae.Lipids34,649ï¿½659.
	22.Sayanova,O.,Smith,M.A.,Lapinskas,P.,Stobart,A.K.,Dobson,G.,Christie,W.W.,Shewry,P.R.&Napier,J.A.(1997)ExpressionofaboragedesaturasecDNAcontaininganN-terminalcytochromebdomainresultsintheaccumulationofhighlevelsofD-desaturatedfattyacidsintransgenictobacco.Proc.NatlAcad.Sci.USA94,4211ï¿½4216.
	23.Napier,J.A.,Hey,S.J.,Lacey,D.J.&Shewry,P.R.(1998)IdentificationofaCaenorhabditiselegansD-fatty-acid-desaturasebyheterlogousexpressioninS.cerevisiae.Biochem.J.330,611ï¿½614.
	24.Cho,H.P.,Nakamura,M.T.&Clarke,S.D.(1999)Cloning,expression,andnutritionalregulationofthemammalianD-6-desaturase.J.Biol.Chem.274,471ï¿½477.
	25.Reddy,A.S.,Nuccio,M.L.,Gross,L.M.&Thomas,T.L.(1993)IsolationofaD-desaturasegenefromthecyanobacteriumSynechocystissp.strainPCC6803bygain-of-functionexpressioninAnabaenasp.strainPCC7120.PlantMol.Biol.27,293ï¿½300.
	26.Murata,N.,Deshnium,P.&Tasaka,Y.(1996)Biosynthesisofg-linolenicacidinthecyanobacteriumSpirulinaplatensis.Ing-LinolenicAcid,MetabolismanditsRolesinNutritionandMedicine(Huang,Y.&Milles,D.E.,eds),pp.22ï¿½32.AOCPress,Champaign,IL,USA.
	27.Lederer,F.(1994)Thecytochromeb-fold:anadaptablemodule.Biochimie76,674ï¿½692.
	28.Sperling,P.,Schmidt,H.&Heinz,E.(1995)Acytochromebcontainingfusionproteinsimilartoacyllipiddesaturases.Eur.J.Biochem.232,798ï¿½805.
	29.Kohn,G.,Vierengel,A.,Vandekerkhove,O.&Hartmann,E.(1987)9-Octadecen-6-ynoicacidfromRicciafluitans.Phytochemistry26,2101ï¿½2102.
	30.Fay,L.&Richli,U.(1991)Locationofdoublebondsinpolyunsatu-ratedfattyacidsbygaschromatography-massspectrometryafter4,4-dimethyloxazolinederivatization.J.Chromatogr.541,89ï¿½98.
	31.Andersson,B.,Anderson,W.H.,Chipault,J.R.,Ellison,E.C.,Fenton,S.W.,Gellerman,J.L.,Hawkins,J.M.&Schlenk,H.(1974)9,12,15-Octadecatrien-6-ynoicacid,anewacetylenicacidfrommosses.Lipids9,506ï¿½511.
	32.Mitchell,A.G.&Martin,C.E.(1995)Anovelcytochromeb-likedomainislinkedtothecarboxylterminusoftheS.cerevisiaeDfattyaciddesaturase.J.Biol.Chem.270,29766ï¿½29772.
	33.Sayanova,O.,Shewry,P.R.&Napier,J.A.(1999)Histidine-41ofthecytochromebdomainoftheborageDfattyaciddesaturaseisessentialforenzymeactivity.PlantPhysiol.121,641ï¿½646.
	34.Heinz,E.(1993)Biosynthesisofpolyunsaturatedfattyacids.InLipid3810P.Sperlingetal.(Eur.J.Biochem.267)qFEBS2000MetabolisminPlants(Moore,T.S.Jr,ed.),pp.33ï¿½89.CRCPress,BocaRaton,FL.
	35.Sperling,P.,Zahringer,U.&Heinz,E.(1998)Asphingolipiddesaturasefromhigherplants.Identificationofanewcytochromefusionprotein.J.Biol.Chem.273,28590ï¿½28596.
	36.Meckenstock,R.U.,Krieger,R.,Ensign,S.,Kroneck,P.M.H.&Schink,B.(1999)AcetylenehydrataseofPelobacteracetylenicus.Molecularandspectroscopicpropertiesofthetungsteniron-sulfurenzyme.Eur.J.Biochem.264,176ï¿½182.q
j.1432-1327.2000.01408.x.pdf	39
	1.Mauro,A.(1961)Satellitecellofskeletalmusclefibers.J.Biophys.Biochem.Cytol.9,493ï¿½498.
	2.Plaghki,L.(1985)Regenerationandmyogenesisofstriatedmuscle.J.Physiol.(Paris)80,51ï¿½110.
	3.Zomzely-Neurath,C.E.(1983)Enolase.EnzymesintheNervousSystem.HandbookNeurochem.4,403ï¿½433.
	4.Lucas,M.,Goblet,C.,Keller,A.,Lamande,N.,Gros,F.,Whalen,R.G.&Lazar,M.(1992)Modulationofembryonicandmuscle-specificenolasegeneproductsinthedevelopingmousehindlimb.Differentiation51,1ï¿½7.
	5.Keller,A.,Ott,M.O.,Lamande,N.,Lucas,M.,Gros,F.,Buckingham,M.&Lazar,M.(1992)Activationofthegeneencodingtheglycolyticenzymebeta-enolaseduringearlymyogenesisprecedesanincreasedexpressionduringfetalmuscledevelopment.Mech.Dev.38,41ï¿½54.
	6.Kato,K.,Shimizu,A.,Semba,R.&Satoh,T.(1985)Tissuedistribution,developmentalprofilesandeffectofdenervationonenolaseisozymesinratmuscles.Biochim.Biophys.Acta841,50ï¿½58.
	7.Merkulova,T.,Thornell,L.E.,Butler-Browne,G.,Oberlin,C.,Lucas,M.,Lamande,N.,Lazar,M.&Keller,A.(1999)Thebetaenolasesubunitdisplaysthreedifferentpatternsofmicroheterogeneityinhumanstriatedmuscle.J.MuscleRes.Cell.Motil.20,55ï¿½63.
	8.Keller,A.,Rouzeau,J.D.,Farhadian,F.,Wisnewsky,C.,Marotte,F.,Lamande,N.,Samuel,J.L.,Schwartz,K.,Lazar,M.&Lucas,M.(1995)Differentialexpressionofalphaandbeta-enolasegenesduringratheartdevelopmentandhypertrophy.Am.J.Physiol.HeartCirc.Physiol.38,H1843ï¿½H1851.
	9.Nozais,M.,Merkulova,T.,Keller,A.,Janmot,C.,Lompred'Albis,A.&Lucas,M.(1999)Denervationofrabbitgastrocnemiusandsoleusmusclesï¿½effectonmuscle-specificenolase.Eur.J.Biochem.263,195ï¿½201.
	10.Merkulova,T.,Keller,A.,Oliviero,P.,Marotte,F.,Samuel,J.-L.,Rappaport,L.,Lamande,N.&Lucas,M.(2000)Thyroidhormonesmodulatedifferentiallyisozymicenolasegeneexpressionsduringratskeletalandcardiacmuscledevelopment.Am.J.Physiol.278,E330ï¿½E339.
	11.Discher,D.,Bishopric,N.,Wu,X.,Peterson,C.&Webster,K.(1998)Hypoxiaregulatesb-enolaseandpyruvatekinase-MpromotersbymodulatingSp1/Sp3bindingtoaconservedGCelement.J.Biol.Chem.273,26087ï¿½26093.
	12.Semenza,G.,Jiang,B.-H.,Leung,S.,Passantino,R.,Concordet,J.-P.,Maire,P.&Giallongo,A.(1996)HypoxiaresponseelementsinthealdolaseA,enolase1,andlactatedehydrogenaseAgenepromoterscontainessentialbindingsitesforhypoxia-induciblefactor1.J.Biol.Chem.271,32529ï¿½32537.
	13.Merkulova,T.,Lucas,M.,Jabet,C.,Lamande,N.,Rouzeau,J.D.,Gros,F.,Lazar,M.&Keller,A.(1997)Biochemicalcharacterizationofthemousemuscle-specificenolase:Developmentalchangesinelectrophoreticvariantsandselectivebindingtootherproteins.Biochem.J.323,791ï¿½800.
	14.Knull,H.&Minton,A.(1996)Structurewithineukaryoticcytoplasmanditsrelationshiptoglycolyticmetabolism.CellBiochem.Funct.14,237ï¿½248.
	15.Wojtas,K.,Slepecky,N.,vonKalm,L.&Sullivan,D.(1997)FlightmusclefunctioninDrosophilarequirescolocalizationofglycolyticenzymes.Mol.Biol.Cell8,1665ï¿½1675.
	16.Foucault,G.,Vacher,M.,Cribier,S.&Arrio-Dupont,M.(2000)Interactionsbetweenb-enolaseandcreatinekinaseinthecytosolofskeletalmusclecells.Biochem.J.346,127ï¿½131.
	17.Foucault,G.,Vacher,M.,Merkulova,T.,Keller,A.&Arrio-Dupont,M.(1999)PresenceofenolaseintheM-bandofskeletalmuscleandpossibleindirectinteractionwiththecytosolicmuscleisoformofcreatinekinase.Biochem.J.338,115ï¿½121.
	18.Angelov,D.N.,Neiss,W.F.,Gunkel,A.,Guntinaslichius,O.&Stennert,E.(1994)Axotomyinducesintranuclearimmuno-localizationofneuron-specificenolaseinfacialandhypoglossalneuronsoftherat.J.Neurocytol.23,218ï¿½233.
	19.Kherif,S.,Lafuma,C.,Dehaupas,M.,Lachkar,S.,Fournier,J.,Verdiere-Sahuque,M.,Fardeau,M.&Alameddine,H.(1999)Expressionofmatrixmetalloproteinases2and9inregeneratingskeletalmuscle:astudyinexperimentallyinjuredandmdxmuscles.Dev.Biol.205,158ï¿½170.
	20.Bradford,M.M.(1976)Arapidandsensitivemethodforthequantitationofmicrogramquantitiesofproteinsutilizingtheprincipleofprotein-dyebinding.Anal.Biochem.72,248ï¿½254.
	21.Keller,A.,Scarna,H.,Mermet,A.&Pujol,J.F.(1981)Biochemicalandimmunologicalpropertiesofthemousebrainenolasespurifiedbyasimplemethod.J.Neurochem.36,1389ï¿½1397.
	22.Creminon,C.,Pilard,F.,Grassi,J.,Perly,B.&Pradelles,P.(1994)Asensitiveandspecificenzymeimmunoassayforcyclomaltoheptaoseandsomederivatives.Carbohydr.Res.258,179ï¿½186.
	23.McLaughlin,L.,Wei,V.,Stockman,P.,Leahy,K.,Needleman,P.,Grassi,J.&Pradelles,P.(1987)Development,validationandapplicationofanenzymeimmunoassay(EIA)ofatriopeptin.Biochem.Biophys.Res.Commun.144,469ï¿½476.
	24.Pradelles,P.,Grassi,J.,Chabardes,D.&Guiso,N.(1989)Enzymeimmunoassaysofadenosinecyclic3-monophosphateandguano-sinecyclic3-monophosphateusingacetylcholinesterase.Anal.Chem.61,447ï¿½453.
	25.Ellman,G.,Courtney,K.,Andres,V.&Featherstone,R.(1961)Anewandrapidcolorimetricdeterminationofacetylcholineesteraseactivity.Biochem.Pharmacol.7,88ï¿½95.
	26.d'Albis,A.,Couteaux,R.,Janmot,C.,Roulet,A.&Mira,J.-C.(1988)Regenerationaftercardiotoxininjuryofinnervatedanddenervatedslowandfastmusclesofmammals.Myosinisoformanalysis.Eur.J.Biochem.174,103ï¿½110.
	27.Ovadi,J.&Srere,P.(1996)Metabolicconsequencesofenzymeinteractions.CellBiochem.Funct.14,249ï¿½258.
	28.Dolken,G.,Leisner,E.&Pette,D.(1975)Immunofluorescentlocalizationofglycogenolyticandglycolyticenzymeproteinsand3742T.Merkulovaetal.(Eur.J.Biochem.267)qFEBS2000ofmalatedehydrogenaseisozymesincross-striatedskeletalmuscleandheartoftherabbit.Histochemistry43,113ï¿½121.
	29.Dechesne,C.&Keller,A.(1996)Differentialaenolaseimmuno-reactivityinthetwoneurontypesoftheratspiralganglionduringpostnataldevelopment.Comparisonwithneurofilamentproteinimmunoreactivity.AuditoryNeurosci.2,33ï¿½46.
	30.Popanda,O.,Fox,G.&Thielmann,H.(1998)ModulationofDNApolymerasea,dand:bylactatedehydrogenaseand3-phos-phoglyceratekinase.Biochim.Byophys.Acta1397,102ï¿½117.
	31.Green,G.,Girardot,R.,Baldacini,O.,Ledig,M.&Monteil,H.(1993)CharacterizationofenolasefromClostridiumdifficile.Curr.Microbiol.26,53ï¿½56.
	32.alGiery,A.&Brewer,J.M.(1992)Characterizationoftheinteractionofyeastenolasewithpolynucleotides.Biochim.Biophys.Acta1159,134ï¿½140.
	33.Babbitt,P.C.,Hasson,M.S.,Wedekind,J.E.,Palmer,D.R.,Barrett,W.C.,Reed,G.H.,Rayment,I.,Ringe,D.,Kenyon,G.L.&Gerlt,J.A.(1996)Theenolasesuperfamily:ageneralstrategyforenzyme-catalyzedabstractionofthealpha-protonsofcarboxylicacids.Biochemistry35,16489ï¿½16501.
	34.Gorsich,S.W.,Barrows,V.,Halbert,J.&Farrar,W.W.(1999)Purificationandpropertiesofgg-enolasefrompigbrain.J.ProteinChem.18,103ï¿½115.
	35.Hattori,T.,Takei,N.,Mizuno,Y.,Kato,K.&Kohsaka,S.(1995)Neurotrophicandneuroprotectiveeffectsofneuron-specificenolaseonculturedneuronsfromembryonicratbrain.Neurosci.Res.21,191ï¿½198.
	36.Piatigorsky,J.&Wistow,G.(1989)Enzyme/crystallins:genesharingasanevolutionarystrategy.Cell57,197ï¿½199.
	37.Redlitz,A.,Fowler,B.,Plow,E.&Miles,L.(1995)Theroleofanenolase-relatedmoleculeinplasminogenbindingtocells.Eur.J.Biochem.227,407ï¿½415.
	38.Haimoto,H.,Takahashi,Y.,Koshikawa,T.,Nagura,H.&Kato,K.(1985)Immunohistochemicallocalizationofgamma-enolaseinnormalhumantissuesotherthannervousandneuroendocrinetissues.Lab.Invest.52,257ï¿½263.
	39.Couteaux,R.,Mira,J.C.&d'Albis,A.(1988)Regenerationofmusclesaftercardiotoxininjury.I.Cytologicalaspects.Biol.Cell62,171ï¿½182.
j.1432-1327.2000.01405.x.pdf	21
	1.Matthews,D.M.(1991)ProteinAbsorption.DevelopmentandPresentStateoftheSubject.Wiley-Liss,NewYork.
	2.Ganapathy,V.,Brandsch,M.&Leibach,F.H.(1994)PhysiologyoftheGastro-IntestinalTract(Johnson,L.R.,ed.),3rdedn,pp.1773ï¿½1794.RavenPress,NewYork.
	3.Temple,C.S.,Stewart,A.K.,Meredith,D.,Lister,N.A.,Morgan,K.M.,Collier,I.D.,Vaughan-Jones,R.D.,Boyd,C.A.R.,Bailey,P.D.&Bronk,J.R.(1998)Peptidemimicsassubstratesfortheintestinalpeptidetransporter.J.Biol.Chem.273,20ï¿½22.
	4.Borner,V.,Fei,Y.J.,Hartrodt,B.,Ganapathy,V.,Leibach,F.H.,Neubert,K.&Brandsch,M.(1998)TransportofaminoacidarylamidesbytheintestinalH/peptidecotransportsystem,PEPT1.Eur.J.Biochem.255,698ï¿½702.
	5.Doring,F.,Will,J.,Amasheh,S.,Clauss,W.,Ahlbrecht,H.&Daniel,H.(1998)Minimalmoleculardeterminantsofsubstratesforrecognitionbytheintestinalpeptidetransporter.J.Biol.Chem.273,23211ï¿½23218.
	6.Lister,N.A.,Sykes,A.P.,Bailey,P.D.,Boyd,C.A.R.&Bronk,J.R.(1994)Dipeptidetransportandhydrolysisinisolatedloopsofratsmallintestine.Effectsofstereospecificity.J.Physiol.484,173ï¿½182.
	7.Guha,N.,Boyd,C.A.R.&Meredith,D.(1999)ModifiedaminoacidsandpeptidesasinhibitorsoftherabbitpeptidetransporterPepT1expressedinXenopuslaevisoocytes.J.Physiol.517P,27P.
	8.Fei,Y.J.,Kanai,Y.,Nussberger,S.,Ganapathy,V.,Leibach,F.H.,Romero,M.F.,Singh,S.M.,Boron,M.F.&Hediger,M.A.(1994)Expressioncloningofamammalianproton-coupledoligopeptidetransporter.Nature368,563ï¿½566.
	9.Meredith,D.&Boyd,C.A.R.(1996)Hisisanessentialresidueforthetransportoftheanionicdipeptided-Phe-l-GlubyPepT1expressedinXenopuslaevisoocytes.J.Physiol.497,89Pï¿½90P.
	10.Deves,R.,Chavez,P.&Boyd,C.A.R.(1992)Identificationofanewtransportsystem(yL)inhumanerythrocytesthatrecogniseslysineandleucinewithhighaffinity.J.Physiol.454,491ï¿½501.
	11.Daniel,H.,Morse,E.L.&Adibi,S.A.(1992)Determinantsofsubstrateaffinityfortheoligopeptide/Hsymporterintherenalbrushbordermembrane.J.Biol.Chem.267,9565ï¿½9573.
	12.Ganapathy,M.E.,Huang,W.,Wang,H.,Ganapathy,V.&Leibach,F.H.(1998)Valacyclovir:asubstratefortheintestinalandrenalpeptidetransportersPEPT1andPEPT2.Biochem.Biophys.Res.Commun.246,470ï¿½475.
	13.Miyamoto,Y.,Ganapathy,V.&Leibach,F.H.(1986)Identificationofhistidylandthiolgroupsattheactivesiteofrabbitrenaldipeptidetransporter.J.Biol.Chem.261,16133ï¿½16140.
	14.Temple,C.S.,Bronk,J.R.,Bailey,P.D.&Boyd,C.A.R.(1995)Substrate-chargedependenceofstoichiometryshowsmembranepotentialisthedrivingforceforprotonï¿½peptidecotransportinratrenalcortex.Eur.J.Physiol.430,825ï¿½829.
	15.Terada,T.,Saito,H.,Mukai,M.&Inui,K.I.(1996)Identificationofthehistidineresiduesinvolvedinsubstraterecognitionbyarat/peptidecotransporter,PEPT1.FEBSLett.394,196ï¿½200.
	16.Fei,Y.J.,Lui,W.,Prasad,P.D.,Kekuda,R.,Oblak,T.G.,Ganapathy,V.&Leibach,F.H.(1997)IdentificationofthehistidylresidueobligatoryforthecatalyticactivityofthehumanH/peptidecotransportersPEPT1andPEPT2.Biochemistry36,452ï¿½460.
	17.Meredith,D.&Boyd,C.A.R.(1995)Oligopeptidetransportbyepithelialcells.J.Memb.Biol.145,1ï¿½12.qFEBS2000ModifiedaminoacidsandpeptidesasPepT1ligands(Eur.J.Biochem.267)3727
	18.Terada,T.,Saito,H.&Inui,K.I.(1998)Interactionofbeta-lactamantibioticswithhistidineresidueofratH/peptidecotransporters,PEPT1andPEPT2.J.Biol.Chem.273,5582ï¿½5585.
	19.Bolger,M.B.,Haworth,I.S.,Yeung,A.K.,Ann.,D.,vonGrafenstein,H.,Hamm-Alvarez,S.,Okamoto,C.T.,Kim,K.J.,Basu,S.K.,Wu,S.&Lee,V.H.(1998)Structure,function,andmolecularmodelingapproachestothestudyoftheintestinaldipeptidetransporterPepT1.J.Pharmac.Sci.87,1286ï¿½1291.
	20.Temple,C.S.,Collier,I.D.,Bronk,J.R.,Bailey,P.D.&Boyd,C.A.R.(1998)Structuralrequirementsfornon-peptidesubstratebindingtotheepithelialproton-coupledoligopeptidetransporter.J.Physiol.511P,26Pï¿½27P.
	21.Doring,F.,Walter,J.,Will,J.,Focking,M.,Boll,M.,Amasheh,S.,Clauss,W.&Daniel,H.(1998)Delta-aminolevulinicacidtransportbyintestinalandrenalpeptidetransportersanditsphysiologicalandclinicalimplications.J.Clin.Invest.101,2761ï¿½2767.
j.1432-1327.2000.01399.x.pdf	59
	1.Peck,H.D.&Gest,H.(1957)Formicdehydrogenaseandthehydro-genlyaseenzymecomplexincoli-aerogenesbacteria.J.Bacteriol.73,706ï¿½721.
	2.Bohm,R.,Sauter,M.&Bock,A.(1990)NucleotidesequenceandexpressionofanoperoninEscherichiacolicodingforformatehydrogenlyasecomponents.Mol.Microbiol.4,231ï¿½243.
	3.Lutz,S.,Jacobi,A.,Schlensog,V.,Bohm,R.,Sawers,G.&Bock,A.(1991)Molecularcharacterizationofanoperon(hyp)necessaryfortheactivityofthethreehydrogenaseisoenzymesinEscherichiacoli.Mol.Microbiol.5,123ï¿½135.
	4.Pecher,A.,Zinoni,F.&Bock,A.(1985)Theseleno-polypeptideofformicdehydrogenase(formatehydrogen-lyaselinked)fromEscherichiacoli:geneticanalysis.Arch.Microbiol.141,359ï¿½363.
	5.Maier,T.,Binder,U.&Bock,A.(1996)AnalysisofthehydAlocusofEscherichiacoli:twogenes(hydNandhypF)involvedinformateandhydrogenmetabolism.Arch.Microbiol.165,333ï¿½341.
	6.Sankar,P.,Lee,J.H.&Shanmugam,K.T.(1988)Gene-productrelationshipsoffhlAandfdvgenesofEscherichiacoli.J.Bacteriol.170,5440ï¿½5445.
	7.Schlensog,V.&Bock,A.(1990)IdentificationandsequenceanalysisofthegeneencodingthetranscriptionalactivatoroftheformatehydrogenlyasesystemofEscherichiacoli.Mol.Microbiol.4,1319ï¿½1327.
	8.Sauter,M.,Bohm,R.&Bock,A.(1992)Mutationalanalysisoftheoperon(hyc)determininghydrogenase3formationinEscherichiacoli.Mol.Microbiol.6,1523ï¿½1532.
	9.Birkmann,A.&Bock,A.(1989)CharacterizationofacisregulatoryDNAelementnecessaryforformateinductionoftheformatedehydrogenasegene(fdhF)ofEscherichiacoli.Mol.Microbiol.3,187ï¿½195.
	10.Birkmann,A.,Sawers,R.G.&Bock,A.(1987)InvolvementofthentrAgeneproductintheanaerobicmetabolismofEscherichiacoli.Mol.Gen.Genet.210,535ï¿½542.
	11.Lutz,S.,Bohm,A.,Beier,A.&Bock,A.(1990)CharacterisationofdivergentNtrA-dependendpromotorsintheanaerobicallyexpressedgeneclustercodingforhydrogenase3componentsofEscherichiacoli.Mol.Microbiol.4,13ï¿½20.
	12.Schlensog,V.,Lutz,S.&Bock,A.(1994)PurificationandDNA-bindingpropertiesofFHLA,thetranscriptionalactivatoroftheformatehydrogenlyasesystemfromEscherichiacoli.J.Biol.Chem.269,19590ï¿½19596.
	13.Hopper,S.&Bock,A.(1995)Effector-mediatedstimulationofATPaseactivitybythes-dependenttranscriptionalactivatorFHLAfromEscherichiacoli.J.Bacteriol.177,2798ï¿½2803.
	14.Hopper,S.,Korsa,I.&Bock,A.(1996)Thenucleotideconcentrationdeterminesthespecificityofinvitrotranscriptionactivationbythe-dependentactivatorFhlA.J.Bacteriol.178,199ï¿½203.
	15.Morett,E.&Segovia,L.(1993)Thesbacterialenhancer-bindingproteinfamily:mechanismofactionandphylogeneticrelationshipoftheirfuncionaldomains.J.Bacteriol.175,6067ï¿½6074.
	16.Shingler,V.(1996)Signalsensingbys-dependentregulators:derepressionasacontrolmechanism.Mol.Microbiology19,409ï¿½416.
	17.Weiss,V.&Magasanik,B.(1988)PhosphorylationofnitrogenregulatorI(NRI)ofEscherichiacoli.Proc.NatlAcad.Sci.USA85,8919ï¿½8923.
	18.Henderson,N.,Austin,S.A.&Dixon,R.A.(1989)RoleofmetalionsinnegativeregulationofnitrogenfixationbythenifLgeneproductfromKlebsiellapneumoniae.Mol.Gen.Genet.216,484ï¿½491.
	19.Pavel,H.,Forsman,M.&Shingler,V.(1994)AnaromaticeffectorspecificitymutantofthetranscriptionalregulatorDmpRovercomesthegrowthconstraintsofPseudomonassp.strainCF600onpara-substitutedmethylphenols.J.Bacteriol.176,7550ï¿½7557.
	20.Abril,M.A.,Michan,C.,Timmis,K.N.&Ramos,J.L.(1989)RegulatorandenzymespecificitiesoftheTOLplasmid-encodedupperpathwayfordegradationofaromatichydrocarbonsandexpansionofthesubstraterangeofthepathway.J.Bacteriol.171,6782ï¿½6790.
	21.Shingler,V.&Moore,T.(1994)SensingofaromaticcompoundsbytheDmpRtranscriptionalactivatorofphenol-catabolizingPseudomonassp.strainCF600.J.Bacteriol.176,1555ï¿½1560.
	22.Weiss,D.S.,Batut,J.,Klose,K.E.,Keener,J.&Kustu,S.(1991)Thephosphorylatedformoftheenhancer-bindingproteinNTRChasanATPaseacivitythatisessentialforactivationoftranscription.Cell67,155ï¿½167.
	23.Cornish,E.C.,Argyropoulos,V.P.,Pittard,J.&Davidson,B.E.(1986)StructureoftheEscherichiacoliK12regulatorygenetyrR.Nucleotidesequenceandsitesofinitiationoftranscriptionandtranslation.J.Biol.Chem.261,403ï¿½410.
	24.North,A.K.,Klose,K.E.,Stedman,K.M.&Kustu,S.(1993)Prokaryoticenhancer-bindingproteinsreflecteukaryote-likemod-ularity:thepuzzleofnitrogenregulatoryproteinC.J.Bacteriol.175,4267ï¿½4273.
	25.Pelton,J.G.,Kustu,S.&Wemmer,D.E.(1999)SolutionstructureoftheDNA-bindingdomainofNtrCwiththreealaninesubstitutions.J.Mol.Biol.292,1095ï¿½1110.
	26.Perez-Martï¿½n,J.&Lorenzo,V.(1996)InvitroactivitiesofanN-terminaltruncatedformofXylR,as-dependenttranscriptionalactivatorofPseudomonasputida.J.Mol.Biol.258,575ï¿½587.
	27.Shingler,V.&Pavel,H.(1995)DirectregulationoftheATPaseactivityofthetranscriptionalactivatorDmpRbyaromaticcompounds.Mol.Microbiol.17,505ï¿½513.
	28.Fernandez,S.,Lorenzo,V.&Perez-Martï¿½n,J.(1995)ActivationofthetranscriptionalregulatorXylRofPseudomonasputidabyreleaseofrepressionbetweenfunctionaldomains.Mol.Microbiol.16,205ï¿½213.
	29.Lee,J.H.,Scholl,D.,Nixon,B.T.&Hoover,T.R.(1994)ConstitutiveATPhydrolysisandtranscriptionactivationbyastable,truncatedformofRhizobiummelilotiDctD,asigma54-dependenttranscrip-tionalactivator.J.Biol.Chem.269,20401ï¿½20409.
	30.Delgado,A.,Salto,R.,Marques,S.&Ramos,J.L.(1995)SingleaminoacidchangesinthesignalreceptiondomainofXylRresultinmutationsthatstimulatetranscriptionintheabsenceofeffectors.J.Biol.Chem.270,5144ï¿½5150.
	31.Perez-Martï¿½n,J.&Lorenzo,V.(1995)Theamino-terminaldomainoftheprocaryoticenhancer-bindingproteinXylRisaspecificintramolecularrepressor.Proc.NatlAcad.Sci.USA92,9392ï¿½9396.
	32.Korsa,I.&Bock,A.(1997)CharacterizationoffhlAmutationsresultinginligandï¿½independenttranscriptionalactivationandATPhydrolysis.J.Bacteriol.179,41ï¿½45.
	33.Begg,Y.A.,Whyte,J.A.&Haddock,B.Y.(1977)Theidentifica-tionofmutantsofEscherichiacolideficientinformatedehydrogenaseandnitratereductaseactivitiesusingdyeindicatorplates.FEMSMicrobiol.Lett.2,47ï¿½50.
	34.Balch,W.E.&Wolfe,R.S.(1976)Newapproachtothecultivationofmethanogenicbacteria:2-mercaptoethanesulfonicacid(HS-CoM)-dependentgrowthofMethanobacteriumruminan-tiuminapressurizedatmosphere.Appl.Environ.Microbiol.32,781ï¿½791.
	35.Miller,J.H.(1972)ExperimentsinMolecularGenetics.ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NewYork.
	36.Sambrook,J.,Fritsch,E.F.&Maniatis,T.(1989)MolecularCloning:aLaboratoryManual.ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NewYork.
	37.Fiedler,S.&Wirth,R.(1988)TransformationofbacteriawithplasmidDNAbyelectroporation.Anal.Biochem.170,38ï¿½44.
	38.Dixon,W.J.,Hayes,J.J.,Levin,J.R.,Weidner,M.F.,Dombroski,B.A.&Tullius,T.D.(1991)Hydroxylradicalfootprinting.MethodsEnzymol.208,380ï¿½413.
	39.Schickor,P.&Heumann,H.(1994)Hydroxylradicalfootprinting.InDNAï¿½ProteinInteractions:PrinciplesandProtocols(Kneanle,G.G.,ed.),pp.21ï¿½32.HumanaPressInc,Totowa.
	40.Maxam,A.M.&Gilbert,W.(1977)AnewmethodforsequencingDNA.Proc.NatlAcad.Sci.USA74,560ï¿½564.
	41.Whitaker,J.R.&Granum,P.E.(1980)Anabsolutemethodforproteindeterminationbasedondifferenceinabsorbanceat235and280nm.Anal.Biochem.109,156ï¿½159.
	42.Laemmli,U.K.(1970)CleavageofstructuralproteinsduringtheassemblyoftheheadofbacteriophageT4.Nature227,680ï¿½685.
	43.Fiedler,G.,Pajatsch,M.&Bock,A.(1996)GeneticsofanovelstarchutilisationpathwaypresentinKlebsiellaoxytoca.J.Mol.Biol.256,279ï¿½291.
	44.Mills,D.M.,Bajaj,V.&Lee,C.A.(1995)A40kbchromosomalfragmentencodingSalmonellatyphimuriuminvasiongenesisabsentfromthecorrespondingregionoftheEscherichiacoliK-12chromosome.Mol.Microbiol.15,749ï¿½759.
	45.Hopper,S.(1995)DasFormiat-RegulonvonEscherichiacoli:Unter-suchungenzurFhlA-abhangigenRegulation.PhDThesis,Ludwig-Maximilians-Universitat,Muï¿½nchen.
	46.Bantscheff,M.,Weiss,V.&Glocker,M.O.(1999)IdentificationoflinkerregionsanddomainbordersofthetranscriptionactivatorproteinNtrCfromEscherichiacolibylimitedproteolysis,in-geldigestion,andmassspectrometry.Biochemistry38,11012ï¿½11020.
	47.Flashner,Y.,Weiss,D.S.,Keener,J.&Kustu,S.(1995)Constitutiveformsoftheenhancer-bindingproteinNtrC:evidencethatessentialoligomerizationdeterminantslieinthecentralactivationdomain.J.Mol.Biol.249,700ï¿½713.
	48.Perez-Martï¿½n,J.&Lorenzo,V.(1996)Physicalandfunctionalanalysisoftheprokaryoticenhancerofthes-promotorsoftheTOLplasmidofPseudomonasputida.J.Mol.Biol.258,562ï¿½574.
	49.Csonka,L.N.(1981)Prolineover-productionresultsinenhancedosmotoleranceinSalmonellatyphimurium.Mol.Gen.Genet.182,82ï¿½86.
	50.Bender,H.(1977)CyclodextringlucanotransferasefromKlebsiellapneumoniae.2.SignificanceoftheenzymeforthemetabolismofcyclodextrinsbyKlebsiellapneumoniaeM5al.Arch.Microbiol.113,49ï¿½56.
	51.Casadaban,M.J.&Cohen,S.N.(1979)LactosegenesfusedtoexogenouspromotersinonestepusingaMu-lacbacteriophage:invivoprobefortranscriptionalcontrolsequences.Proc.NatlAcad.Sci.USA76,4530ï¿½4533.
	52.Hopper,S.,Babst,M.,Schlensog,V.,Fischer,H.M.,Hennecke,H.&ck,A.(1994)RegulatedexpressioninvitroofgenescodingforformatehydrogenlyasecomponentsofEscherichiacoli.J.Biol.Chem.269,19597ï¿½19604.
	53.Schlensog,V.(1993)GenetischeAnalyse,StrukturundFunktiondesFormiat-Hydrogen-Lyase-Aktivatorproteins(FhlA)vonEscherichiacoli.PhDThesis,Ludwig-Maximilians-Universitat,Muï¿½nchen.
	54.Sawers,G.&Suppmann,B.(1992)AnaerobicinductionofpyruvateqFEBS2000DomainstructureandDNAbindingsiteofFhlA(Eur.J.Biochem.267)3683formate-lyasegeneexpressionismediatedbytheArcAandFNRproteins.J.Bacteriol.174,3474ï¿½3478.
	55.Yanisch-Perron,C.,Vieira,J.&Messing,J.(1985)ImprovedM13phagecloningvectorsandhoststrains:nucleotidesequencesoftheM13mp18andpUC19vectors.Gene33,103ï¿½109.
	56.Studier,F.W.&Moffatt,B.A.(1986)UseofbacteriophageT7RNApolymerasetodirectselectivehigh-levelexpressionofclonedgenes.J.Mol.Biol.189,113ï¿½130.
	57.Bolivar,F.,Rodriguez,R.L.,Greene,P.J.,Betlach,M.C.,Heynecker,H.L.&Boyer,H.W.(1977)Constructionandcharacterizationofnewcloningvehicles.II.Amultipurposecloningsystem.Gene2,95ï¿½113.
	58.Tabor,S.&Richardson,C.C.(1985)AbacteriophageT7RNApolymerase/promotersystemforcontrolledexclusiveexpressionofspecificgenes.Proc.NatlAcad.Sci.USA82,1074ï¿½1078.
	59.Martinez,E.,Bartolome,B.&delaCruz,F.(1988)pACYC184-derivedcloningvectorscontainingthemultiplecloningsiteandlacZalphareportergeneofpUC8/9andpUC18/19plasmids.Gene(Amst.)68,159ï¿½162.
2_ftp.pdf	45
J Immunol-2000-Baurain-6057-66.pdf	55
J Immunol-2000-Watarai-6027-33.pdf	50
1049.pdf	12
	1.Kalender WA, Sissler W, Klotz E, Vock P. Spiralvolumetric CT with single-breath-hold technique,continuous transport, and continuous scanner ro-tation. Radiology1990;176:181?183	2353088
	2.Crawford CR, King K. Computed tomographyscanning with simultaneous patient translation.Med Phys 1990;17:967?982	2280740
	3.Remy-Jardin M, Remy J, Giraud F, MarquetteCH. Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiol-ogy1993;187:513?520	8475300
	4.Buckley JA, Scott WW, Siegelman SS, et al. Pul-monary nodules: effect of increased data sam-pling on detection with spiral CT and confidencein diagnosis. Radiology1995;196:395?400	7617851
	5.Costello P. Thoracic helical CT. RadioGraphics1994;14:913?918	7938778
	6.Costello P, Dupuy DE, Ecker CP, Tello R. Spiral CTof the thorax with reduced volume of contrastmaterial: a comparative study. Radiology1992;183:663?666	1584915
	7.Cascade PN, Gross BH, Kazerooni EA, et al.Variability in the detection of enlarged mediasti-nal lymph nodes in staging lung cancer: a com-parison of contrast-enhanced and unenhanced CT.AJR1998;170:927?931	9530036
	8.Hopper KD. With helical CT, is nonionic contrasta better choice than ionic contrast for rapid andlarge IV bolus injections (answer to question)?AJR1996;166:715	8623657
	9.Debatin J, Cohan RH, Leder RA, Zakrzewski CB,Dunnick NR. Selective use of low-osmolar con-trast media. Invest Radiol 1991;26:17?21	2022448
	10.Cohan RH, Dunnick NR, Leder RA, et al. Extrava-sation of nonionic contrast media: efficacy of con-servative treatment. Radiology1990;176:65?67	2353113
	11.Hopper KD, Mosher TJ, Kasales CJ, TenHave TR,Tully DA, Weaver JS. Thoracic spiral CT: deliveryof contrast material pushed with injectable saline so-lution in a power injector. Radiology1997;205:269?271	9314997
	12.Rubin GD, Lane MJ, Bloch DA, Leung AN, StarkP. Optimization of thoracic spiral CT: effects ofiodinated contrast medium concentration. Radiol-ogy1996;201:785?791	8939232
1033.pdf	36
	1.Shuman WP, Moss AA. The adrenal glands. In:Moss AA, Gamsu G, Genant HK, eds. Computedtomography of the body, 2nd ed. Philadelphia:Saunders, 1992:1045?1056
	2.Oliver TW Jr, Bernardino ME, Miller JI, MansourK, Greene D, Davis WA. Isolated adrenal massesin nonsmall-cell bronchogenic carcinoma. Radiol-ogy1984;153:217?218	6473783
	3.Welch TJ, Sheedy PF II, Stephens DH, JohnsonCM, Swenson SJ. Percutaneous adrenal biopsy: re-view of 10-year experience. Radiology1994;193:341?344	7972740
	4.Mody MK, Kazerooni EA, Korobkin M. Percuta-neous CT-guided biopsy of adrenal masses: imme-diate and delayed complications. J Comput AssistTomogr 1995;19:434?439	7790554
	5.Lee MJ, Hahn PF, Papanicolaou N, et al. Benignand malignant adrenal masses: CT distinction withattenuation coefficients, size, and observer analy-sis. Radiology1991;179:415?418	2014283
	6.van Erkel AR, van Gils APG, Lequin M, Kruit-wagen C, Bloem JL, Falke THM. CT and MR dis-tinction of adenomas and nonadenomas of theadrenal glands. J Comput Assist Tomogr1994432?438	8188912
	7.Singer AA, Obuchowski NA, Einstein DM, Paush-ter DM. Metastasis or adenoma? Computed tomo-graphic evaluation of the adrenal mass. Cleve ClinJ Med1994;61:200?205
	8.Korobkin M, Brodeur FJ, Yutzy GG, et al. Differen-tiation of adrenal adenomas from nonadenomas us-ing CT attenuation values. AJR1996;166:531?536	8623622
	9.Mitchell DG, Crovello M, Matteucci T, PetersenRO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology1992;185:345?351	1410334
	10.Tsushima Y, Ishizaka H, Matsumoto M. Adrenalmasses: differentiation with chemical shift, fastlow-angle shot MR imaging. Radiology1993;186:705?709	8430178
	11.Mayo-Smith WW, Lee MJ, McNicholas MM,Hahn PF, Boland GW, Saini S. Characterization ofadrenal masses (<5 cm) by use of chemical shiftMR imaging: observer performance versus quanti-tative measures. AJR1995;165:91?95	7785642
	12.Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology1995;197:411?418	7480685
	13.McNicholas MMJ, Lee MJ, Mayo-Smith WW,Hahn PF, Boland GW, Mueller PR. An imaging al-gorithm for the differential diagnosis of adrenal ad-enomas and metastases. AJR1995;165:1453?1459	7484585
	14.Schwartz LH, Panicek DM, Doyle MV, et al. Com-parison of two algorithms and their associatedcharges when evaluating adrenal masses in patientswith malignancies. AJR1997;168:1575?1578	9168729
	15.Dwamena BA, Kloos RT, Fendrick AM, et al. Di-agnostic evaluation of the adrenal incidentaloma:decision and cost-effectiveness analyses. Nucl Med1998;39:707?712	9544685
	16.Smith TJ, Hillner BE, Neighbors DM, McSorleyPA, Le Chevalier T. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. J Clin On-col1995;13:2166?2173	8636797
	17.Sandler MA, Pearlberg JL, Madrazo BL, GitschlagKF, Gross SC. Computed tomographic evaluationof the adrenal gland in the preoperative assessmentof bronchogenic carcinoma. Radiology1982;145:733?736	7146405
	18.Pagani JJ. Non-small cell lung carcinoma adrenalmetastases: computed tomography and percutane-ous needle biopsy in their diagnosis. Cancer198453:1058?60	6692299
	19.Salvatierra A, Baamonde C, Llamas JM, Cruz F,Lopez-Pujol J. Extrathoracic staging of bron-chogenic carcinoma. Chest1990;97:1052?1058	2184992
	20.Silverman SG, Mueller PR, Pinkney LP, KoenkerRM, Seltzer SE. Predictive value of image-guidedadrenal biopsy: analysis of results of 101 biopsies.Radiology1993;187:715?718	8497619
	21.Malenka DJ, Colice GL, Jacobs C, Beck JR. Medi-astinal staging in non-small-cell lung cancer. MedDecis Making1989;9:231?242	2552250
	22.Damhuis RA, Schutte PR. Resection rates andpostoperative mortality in 7,899 patients with lungcancer. Euro Respir J 1996;9:7?10	8834326
	23.Vrdoljak E, Mise K, Sapunar D, Rozga A, MarusicM. Survival analysis of untreated patients with non-small-cell lung cancer. Chest1994;106:1797?1800	7988203
	24.Bunn PA Jr. The treatment of non-small cell lung can-cer: current perspectives and controversies, future di-rections. Semin Oncol1994;21[suppl 6]:49?59	8052874
	25.Ginsberg RJ, Kris MG, Armstrong JG. Cancer of theLung. In: DeVita VT, Hellman S, Rosenberg SA,eds. Cancer: principles & practice of oncology, 4thed. Philadelphia: Lippincott, 1993:673?712
	26.Eisenberg JM. Clinical economics: a guide to theeconomic analysis of clinical practices. JAMA1989;262:2879?2886	2509745
	27.Smith TJ, Hillner BE, Desch CE. Efficacy andcost-effectiveness in oncology: rational allocationof cancer care resources. J Natl Cancer Inst199385:1460?1474
	28.Outwater EK, Siegelman ES, Huang AB, Birn-baum BA. Adrenal masses: correlation betweenCT attenuation value and chemical shift ratio atMR imaging with in-phase and opposed-phase se-quences. Radiology1996;200:749?752	8756926
	29.Korobkin M, Giordano TJ, Brodeur FJ, et al. Adre-nal adenomas: relationship between histologiclipid and CT and MR findings. Radiology1996200:743?747	8756925
	30.Ries LA. Influence of extent of disease, histology,and demographic factors on lung cancer survival inthe SEER population-based data. Semin Surg On-col1994;10:21?30	8115783
	31.Jaakkimainen L, Goodwin PJ, Pater J, Warde P,Murray N, Rapp E. Counting the costs of chemo-therapy in a National Cancer Institute of Canadarandomized trial in nonsmall-cell lung cancer. Clin Oncol1990;8:1301?1309	2166142
	32.Korobkin M, Brodeur FJ, Francis IR, Quint LE,Dunnick NR, Goodsitt M. Delayed enhanced CTfor differentiation of benign from malignant adre-nal masses. Radiology1996;200:737?742	8756924
	33.Boland GW, Hahn PF, Pena C, Mueller PR. Adre-nal masses: characterization with delayed contrast-enhanced CT. Radiology1997;202:693?696	9051018
	34.Boland GW, Goldberg MA, Lee MJ, et al. Indeter-minate adrenal mass in patients with cancer:evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology1995;194:131?134	7997539
	35.Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positronemission tomography. AJR1997;168:1357?1360	9129445
	36.Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal1995;15:369?390Adrenal Mass EvaluationAJR:174, April 20001039	8638035
1009.pdf	7
	1.Puri P, Blake N, O?Donnell B, Guiney EJ. De-layed primary anastomosis following spontane-ous growth of esophageal segments in esophagealatresia.J Pediatr Surg1981;16:180?183	7241321
	2.Tam PKH, Chan FL, Saing H. Diagnosis andevaluation of esophageal atresia by direct sagittalPediatr Radiol1987;17:68?70	3822585
	3.Tam PKH, Chan FL, Saing H. Direct sagittal CTscan: a new diagnostic approach for surgical neo-nates. J Pediatr Surg1987;22:397?400	3585662
	4.Higgins WE, Ramaswamy K, Swift RD, McLen-nan G, Hoffman EA. Virtual bronchoscopy forthree-dimensional pulmonary image assessment:state of the art and future needs. RadioGraphics1998;18:761?778	9599397
	5.Ferretti GR, Vining DJ, Knoplioch J, CoulombM. Tracheobronchial tree: three-dimensional spi-ral CT with bronchoscopic perspective. J ComputAssist Tomogr1996;20:777?781	8797912
	6.Summers RM, Shaw DJ, Shelhamer JH. CT virtualbronchoscopy of simulated endobronchial lesions:effect of scanning, reconstruction, and display set-tings and potential pitfalls. AJR1998;170:947?950	9530041
	7.Konen E, Katz M, Rozenman J, Ben-Shlush A,Itzchak Y, Szeinberg A. Virtual bronchoscopy inchildren: early clinical experience. AJR1998171:1699?1702	9843316
Cancer Res-2000-Paige-1690-7.pdf	55
	1.Lisitsyn,N.,Lisitsyn,N.,andWigler,M.Cloningthedifferencesbetweentwocomplexgenomes.Science(WashingtonDC),259:946?951,1993.
	2.Friend,S.,Bernards,R.,Roggel,J.,Weinberg,R.,Rapaport,J.,Albert,D.,andDryja,T.AhumanDNAsegmentwithpropertiesofthegenethatpredisposestoretino-blastomaandosteosarcoma.Nature(Lond.),323:643?646,1986.
	3.Call,K.M.,Glaser,T.,Ito,C.Y.,Buckler,A.J.,Pelletier,J.,Haber,D.A.,Rose,E.A.,Kral,A.,Yeger,H.,andLewis,W.H.Isolationandcharacterizationofazincfingerpolypeptidegeneatthehumanchromosome11Wilms?tumorlocus.Cell,60:509?520,1990.
	4.Schutte,M.,da-Costa,L.T.,Hahn,S.A.,Moskaluk,C.,Hoque,A.T.,Rozenblum,E.,Weinstein,C.L.,Bittner,M.,Meltzer,P.S.,Trent,J.M.,Yeo,C.J.,Hruban,R.H.,andKern,S.E.IdentificationbyrepresentationaldifferenceanalysisofahomozygousdeletioninpancreaticcarcinomathatlieswithintheBRCA2region.Proc.Natl.Acad.Sci.USA,92:5950?5954,1995.
	5.Kamb,A.,Gruis,N.A.,Weaver-Feldhaus,J.,Liu,Q.,Harshman,K.,Tavtigian,S.V.,Stockert,E.,Day,R.R.,Johnson,B.E.,andSkolnick,M.H.Acellcycleregulatorpotentiallyinvolvedingenesisofmanytumortypes.Science(WashingtonDC),264:436?440,1994.
	6.Ohta,M.,Inoue,H.,Cotticelli,M.G.,Kastury,K.,Baffa,R.,Palazzo,J.,Siprashvili,Z.,Mori,M.,McCue,P.,Druck,T.,Croce,C.M.,andHuebner,K.TheFHITgene,spanningthechromosome3p14.2fragilesiteandrenalcarcinoma-associatedt(3;8)breakpoint,isabnormalindigestivetractcancers.Cell,84:587?597,1996.
	7.Hannon,G.J.,andBeach,D.p15INK4BisapotentialeffectorofTGF-b-inducedcellcyclearrest.Nature(Lond.),371:257?261,1994.
	8.Quelle,D.E.,Zindy,F.,Ashmun,R.A.,andSherr,C.J.AlternativereadingframesoftheINK4atumorsuppressorgeneencodetwounrelatedproteinscapableofinducingcellcyclearrest.Cell,83:993?1000,1995.
	9.Watson,J.E.V.,Gabra,H.,Taylor,K.J.,Rabiasz,G.J.,Morrison,H.,Perry,P.,Smyth,J.F.,andPorteous,D.J.Identificationandcharacterizationofahomozygousdeletionfoundinovarianascitesbyrepresentationaldifferenceanalysis.GenomeRes.,9:226?233,1999.
	10.Li,C.,Berx,G.,Larsson,C.,Auer,G.,Aspenblad,U.,Pan,Y.,Sundelin,B.,Ekman,P.,Nordenskjold,M.,vanRoy,F.,andBergerheim,U.S.R.Distinctdeletedregionsonchromosomesegment16q23?24associatedwithmetastasesinprostatecancer.GenesChromosomesCancer,24:175?182,1999.
	11.Latil,A.,Cussenot,O.,Fournier,G.,Driouch,K.,andLidereau,R.Lossofheterozy-gosityatchromosome16qinprostateadenocarcinoma:identificationofthreeinde-pendentregions.CancerRes.,57:1058?1062,1997.
	12.Driouch,K.,Dorion-Bonnet,F.,Briffod,M.,Champeme,M.H.,Longy,M.,andLidereau,R.Lossofheterozygosityonchromosomearm16qinbreastcancermetastases.GenesChromosomesCancer,19:185?191,1997.
	13.Iida,A.,Isobe,R.,Yoshimoto,M.,Kasumi,F.,Nakamura,Y.,andEmi,M.Local-izationofabreastcancertumour-suppressorgenetoa3-cMintervalwithinchromo-somalregion16q22.Br.J.Cancer,75:264?267,1997.
	14.Chen,T.,Sahin,A.,andAldaz,C.M.Deletionmapofchromosome16qinductalcarcinomainsituofthebreast:refiningaputativetumorsuppressorgeneregion.CancerRes.,56:5605?5609,1996.
	15.Roylance,R.,Gorman,P.,Harris,W.,Liebmann,R.,Barnes,D.,Hanby,A.,andSheer,D.Comparativegenomichybridizationofbreasttumorsstratifiedbyhisto-logicalgraderevealsnewinsightsintothebiologicalprogressionofbreastcancer.CancerRes.,59:1433?1436,1999.
	16.Chou,Y-H.,Chung,K-C.,Jeng,L-B.,Chen,T-C,andLiaw,Y-F.Frequentalleliclossonchromosomes4qand16qassociatedwithhumanhepatocellularcarcinomainTaiwan.CancerLett.,123:1?6,1998.
	17.Iwabuchi,H.,Sakamoto,M.,Sakunaga,H.,Ma,Y.Y.,Carcangiu,M.L.,Pinkel,D.,Yang-Feng,T.L.,andGray,J.W.Geneticanalysisofbenign,low-grade,andhigh-gradeovariantumors.CancerRes.,55:6172?6180,1995.
	18.Doggett,N.A.,Breuning,M.H.,andCallen,D.F.Reportofthefourthinternationalworkshoponhumanchromosome16mapping1995.Cytogenet.CellGenet.,72:271?293,1996.
	19.Smith,D.I.,Huang,H.,andWang,L.Commonfragilesitesandcancer.Int.J.Oncol.,12:187?196,1998.
	20.Lisitsyn,N.A.,Lisitsina,N.M.,Dalbagni,G.,Barker,P.,Sanchez,C.A.,Gnarra,J.,Linehan,W.M.,Reid,B.J.,andWigler,M.H.Comparativegenomicanalysisoftumors:detectionofDNAlossesandamplification.Proc.Natl.Acad.Sci.USA,92:151?155,1995.
	21.Wolf,C.,Hayward,I.,Lawrie,S.,Buckton,K.,McIntyre,M.,Adams,D.,Lewis,A.,Scott,A.,andSmyth,J.Cellularheterogeneityanddrugresistanceintwoovarianadenocarcinomacelllinesderivedfromasinglepatient.Int.J.Cancer,39:695?702,1987.
	22.Hay,F.G.,Duncan,L.W.,andLeonard,R.C.F.Establishmentandcharacterisationoftwonewsmallcelllungcancercelllines?onefromapatientwithpreviousfamilialretinoblastoma.Br.J.Cancer,63:43?45,1991.
	23.Brattain,M.G.,Fine,W.D.,Khaled,F.M.,Thompson,J.,andBrattain,D.E.Heterogeneityofmalignantcellsfromahumancoloniccarcinoma.CancerRes.,41:1751?1756,1981.
	24.Boyd,A.C.Turbocloning:afast,efficientmethodforcloningPCRproductsandotherblunt-endedDNAfragmentsintoplasmids.NucleicAcidsRes.,21:817?821,1993.
	25.Doggett,N.A.,Goodwin,L.A.,Tesmer,J.G.,Meincke,L.J.,Bruce,D.C.,Clark,L.M.,Altherr,M.R.,Ford,A.A.,Chi,H.C.,Marrone,B.L.,Longmire,J.L.,Lane,S.A.,Whitmore,S.A.,Lowenstein,M.G.,Sutherland,R.D.,Mundt,M.O.,Knill,E.H.,Bruno,W.J.,Macken,C.A.,Torney,D.C.,Wu,J-R.,Griffith,J.,Sutherland,G.R.,Deaven,L.L.,Callen,D.F.,andMoyzis,R.K.Anintegratedphysicalmapofhumanchromosome16.Nature(Lond.),377:335?365,1995.
	26.Chumakov,I.,Rigault,P.,Guillou,S.,Ougen,P.,Billaut,A.,Guasconi,G.,Gervy,P.,LeGall,I.,Soularue,P.,andGrinas,L.Continuumofoverlappingclonesspanningtheentirehumanchromosome21q.Nature(Lond.),359:380?387,1992.
	27.Wu,C.,Zhu,S.,Simpson,S.,anddeJong,P.J.DOP-vectorPCR:amethodforrapidisolationandsequencingofinsertterminifromPACclones.NucleicAcidsRes.,24:2614?2615,1996.
	28.Church,D.M.,Stotler,C.J.,Rutter,J.L.,Murrell,J.R.,Trofatter,J.A.,andBuckler,A.J.IsolationofgenesfromcomplexsourcesofmammaliangenomicDNAusingexonamplification.Nat.Genet.,6:98?105,1994.
	29.Nelson,D.L.,Ledbetter,S.A.,Corbo,L.,Victoria,M.F.,Ramirez-Solis,R.,Webster,T.D.,Ledbetter,D.H.,andCaskey,C.T.Alupolymerasechainreaction:amethodforrapidisolationofhuman-specificsequencesfromcomplexDNAsources.Proc.Natl.Acad.Sci.USA,86:6686?6690,1989.
	30.Staden,R.TheStadensequenceanalysispackage.Mol.Biotechnol.,5:233?241,1996.
	31.Glover,T.W.,Berger,C.,Coyle,J.,andEcho,B.DNApolymeraseainhibitionbyaphidicolininducesgapsandbreaksatcommonfragilesitesinhumanchromosomes.Hum.Genet.,67:136?142,1984.
	32.Lichter,P.,andCremer,T.Chromosomeanalysisbynon-isotopicinsituhybridiza-tion.In:D.E.RooneyandB.H.Czepulkowski(eds.),HumanCytogenetics:APracticalApproach,Ed.1,Vol.1,pp.157?192.Oxford,UnitedKingdom:OxfordUniversityPress,1992.
	33.Suzuki,S.,Sano,K.,andTanihara,H.Diversityofthecadherinfamily:evidenceforeightnewcadherinsinnervoustissue.CellRegul.,2:261?270,1991.
	34.Bussemakers,M.J.,vanBokhoven,A.,Mees,S.G.,Kemler,R.,andSchalken,J.A.MolecularcloningandcharacterizationofthehumanE-cadherincDNA.Mol.Biol.Rep.,17:123?128,1993.
	35.Kastury,K.,Baffa,R.,Druck,T.,Ohta,M.,Cotticelli,M.G.,Inoue,H.,Negrini,M.,Rugge,M.,Huang,D.,Croce,C.M.,Palazzo,J.,andHuebner,K.Potentialgastro-intestinaltumorsuppressorlocusatthe3p14.2FRA3Bsiteidentifiedbyhomozygousdeletionsintumorcelllines.CancerRes.,56:978?983,1996.
	36.Mangelsdorf,M.,Ried,K.,Woollatt,E.,Dayan,S.,Eyre,H.,Finnis,M.,Hobson,L.,Nancarrow,J.,Venter,D.,Baker,E.,andRichards,R.I.ChromosomalfragilesiteFRA16DandDNAinstabilityincancer.CancerRes.,60:1683?1689,2000.
	37.Bednarek,A.K.,andAldaz,C.M.Characterizationoftranscriptsfromacommonlydeletedareaofchromosome16(q23.3?q24.1).Proc.Am.Assoc.CancerRes.,39:128,1998.
	38.Becker-Follmann,J.,Gaa,A.,Bausch,E.,Natt,E.,Scherer,G.,andvonDeimling,O.High-resolutionmappingofalinkagegrouponmousechromosome8conservedonhumanchromosome16Q.Mamm.Genome,8:172?177,1997.
	39.Yoshida,M.C.,Nishizawa,M.,Kataoka,K.,Goto,N.,Fujiwara,K.T.,andKawai,S.LocalizationofthehumanMAFprotooncogeneonchromosome16tobandsq22?q23.Cytogenet.CellGenet.,58:2003,1991.
	40.Mourelatos,Z.,Gonatas,J.O.,Cinato,E.,andGonatas,N.K.CloningandsequenceanalysisofthehumanMG160,afibroblastgrowthfactorandE-selectinbindingmembranesialoglycoproteinoftheGolgiapparatus.DNACellBiol.,15:1121?1128,1996.
	41.Peyrard,M.,Parveneh,S.,Lagercrantz,S.,Ekman,M.,Fransson,I.,Sahlen,S.,andDumanski,J.P.Cloning,expressionpattern,andchromosomalassignmentto16q23ofthehumang-adaptingene(ADTG).Genomics,50:275?280,1998.
	42.Nomura,N.,Nagase,T.,Miyajima,N.,Sazuka,T.,Tanaka,A.,Sato,S.,Seki,N.,Kawarabayasi,Y.,Ishikawa,K.,andTabata,S.Predictionofthecodingsequencesofunidentifiedhumangenes.II.Thecodingsequencesof40newgenes(KIAA0041?KIAA0080)deducedbyanalysisofcDNAclonesfromhumancelllineKG-1.DNARes.,1:223?229,1994.
	43.Pan,M.G.,Xiong,J.,Copeland,N.G.,Gilbert,D.J.,Jenkins,N.A.,andGoeddel,D.V.Sequence,genomicorganization,andchromosomelocalizationofthemouseTRADDgene.J.Inflamm.,46:168?175,1995.
	44.Kremmidiotis,G.,Baker,E.,Crawford,J.,Eyre,H.J.,Nahmias,J.,andCallen,D.F.Localizationofhumancadheringenestochromosomeregionsexhibitingcancer-relatedlossofheterozygosity.Genomics,49:467?471,1998.
	45.Berx,G.,Cleton-Jansen,A.M.,Nollet,F.,deLeeuw,W.J.,vandeVijver,M.,Cornelisse,C.,andvanRoy,F.E-cadherinisatumour/invasionsuppressorgenemutatedinhumanlobularbreastcancers.EMBOJ.,14:6107?6115,1995.
	46.Yunis,J.J.,Soreng,A.L.,andBowe,A.E.Fragilesitesaretargetsofdiversemutagensandcarcinogens.Oncogene,1:59?69,1987.
	47.Chesi,M.,Bergsagel,P.L.,Shonukan,O.O.,Martelli,M.L.,Brents,L.A.,Chen,T.,Schrock,E.,Ried,T.,andKuehl,W.M.Frequentdysregulationofthec-mafproto-oncogeneat16q23bytranslocationtoanIglocusinmultiplemyeloma.Blood,91:4457?4463,1998.
	48.Boldog,F.,Gemmill,R.M.,West,J.,Robinson,M.,Robinson,L.,Li,E.,Roche,J.,Todd,S.,Waggoner,B.,Lundstrom,R.,Jacobson,J.,Mullokandov,M.R.,Klinger,H.,andDrabkin,H.A.Chromosome3p14homozygousdeletionsandsequenceanalysisofFRA3B.Hum.Mol.Genet.,6:193?203,1997.
	49.Mimori,K.,Druck,T.,Inoue,H.,Alder,H.,Berk,L.,Mori,M.,Huebner,K.,andCroce,C.M.Cancer-specificchromosomealterationsintheconstitutivefragileregionFRA3B.Proc.Natl.Acad.Sci.USA,96:7456?7461,1999.
	50.Huang,H.,Qian,J.,Proffit,J.,Wilber,K.,Jenkins,R.,andSmith,D.I.FRA7Gextendsoverabroadregion:coincidenceofhumanendogenousretroviralsequences(HERV-H)andsmallpolydispersedcircularDNAs(spcDNA)andfragilesites.Oncogene,16:2311?2319,1998.
	51.Mishmar,D.,Rahat,A.,Scherer,S.W.,Nyakatura,G.,Hinzmann,B.,Kohwi,Y.,Mandel-Gutfroind,Y.,Lee,J.R.,Drescher,B.,Sas,D.E.,Margalit,H.,Platzer,M.,Weiss,A.,Tsui,L.C.,Rosenthal,A.,andKerem,B.Molecularcharacterizationofacommonfragilesite(FRA7H)onhumanchromosome7bythecloningofasimianvirus40integrationsite.Proc.Natl.Acad.Sci.USA,95:8141?8146,1998.
	52.Wang,L.,Darling,J.,Zhang,J.S.,Huang,H.,Liu,W.,andSmith,D.I.Allele-specificlatereplicationandfragilityofthemostactivecommonfragilesite,FRA3B.Hum.Mol.Genet.,8:431?437,1999.
	53.LeBeau,M.M.,Rassool,F.V.,Neilly,M.E.,Espinosa,R.,III,Glover,T.W.,Smith,D.I.,andMcKeithan,T.W.Replicationofacommonfragilesite,FRA3B,occurslateinSphaseandisdelayedfurtheruponinduction:implicationsforthemechanismoffragilesiteinduction.Hum.Mol.Genet.,7:755?761,1998.
	54.Lengauer,C.,Kinzler,K.W.,andVogelstein,B.Geneticinstabilitiesinhumancancers.Nature(Lond.),396:643?649,1998.
	55.Lengauer,C.,Kinzler,K.W.,andVogelstein,B.Geneticinstabilityincolorectalcancers.Nature(Lond.),386:623?627,1997.
Cancer Res-2000-Boucher-1631-6.pdf	39
	1.Moolten,F.L.Drugsensitivity(?suicide?)genesforselectivecancerchemotherapy.CancerGeneTher.,1:279?287,1994.
	2.Bridgewater,J.A.,Springer,C.J.,Knox,R.J.,Minton,N.P.,Michael,N.P.,andCollins,M.K.ExpressionofthebacterialnitroreductaseenzymeinmammaliancellsrendersthemselectivelysensitivetokillingbytheprodrugCB1954.Eur.J.Cancer,31A:2362?2370,1995.
	3.Mullen,C.A.,Kilstrup,M.,andBlaese,R.M.Transferofthebacterialgeneforcytosinedeaminasetomammaliancellsconferslethalsensitivityto5-fluorocytosine:anegativeselectionsystem.Proc.Natl.Acad.Sci.USA,89:33?37,1992.
	4.Moolten,F.L.Tumorchemosensitivityconferredbyinsertedherpesthymidinekinasegenes:paradigmforaprospectivecancercontrolstrategy.CancerRes.,46:5276?5281,1986.
	5.Balzarini,J.,Bohman,C.,andDeClercq,E.Differentialmetabolismofcytostaticof(E)-5-(2-bromovinyl)-29-deoxyuridine,9-(1,3-dihydroxy-2-propoxymethyl)guanine,andotherantiherpeticdrugsontumorcellstransfectedbythethymidinekinasegeneofherpessimplexvirustype1ortype2.J.Biol.Chem.,269:6332?6337,1993.
	6.Ilsley,D.D.,Lee,S-H.,Miller,W.H.,andKuchta,R.D.AcyclicguanosineanalogsinhibitDNApolymerasesa,d,andI?withverydifferentpotenciesandhaveuniquemechanismsofaction.Biochemistry,34:2504?2510,1995.
	7.Freeman,S.M.,Abboud,C.N.,Whartenby,K.A.,Packman,C.H.,Koeplin,D.S.,Moolten,F.L.,andAbraham,G.N.The?bystandereffect?:tumorregressionwhenafractionofthetumormassisgeneticallymodified.CancerRes.,53:5274?5283,1993.
	8.DiMaio,J.M.,Clary,B.M.,Via,D.F.,Coveney,E.,Pappas,T.N.,andLyerly,H.K.Directedenzymepro-druggenetherapyforpancreaticcancerinvivo.Surgery,116:205?213,1994.
	9.Ezzeddine,Z.D.,Martuza,R.L.,Platika,D.,Short,M.P.,Malick,A.,Choi,B.,andBreakefield,X.O.Selectivekillingofgliomacellsincultureandinvivobyretrovirustransferoftheherpessimplexvirusthymidinekinasegene.NewBiol.,3:608?614,1991.
	10.Caruso,M.,Panis,Y.,Gagandeep,S.,Houssin,D.,Salzmann,J-L.,andKlatzmann,D.Regressionofestablishedmacroscopiclivermetastasesafterinsitutransductionofasuicidegene.Proc.Natl.Acad.Sci.USA,90:7024?7028,1993.
	11.Ram,Z.,Culver,K.W.,Walbridge,S.,Blaese,R.M.,andOldfield,E.H.Insituretroviral-mediatedgenetransferforthetreatmentofbraintumorsinrats.CancerRes.,53:83?88,1993.
	12.Vile,R.G.,andHart,I.R.Useoftissue-specificexpressionoftheherpessimplexvirusthymidinekinasegenetoinhibitgrowthofestablishedmurinemelanomasfollowingdirectintratumoralinjectionofDNA.CancerRes.,53:3860?3864,1993.
	13.Ido,A.,Nakata,K.,Kato,Y.,Nakao,K.,Murata,K.,Fujita,M.,Ishii,N.,Tamaoki,T.,Shiku,H.,andNagataki,S.Genetherapyforhepatomacellsusingaretrovirusvectorcarryingherpessimplexvirusthymidinekinasegeneunderthecontrolofhumana-fetoproteingenepromoter.CancerRes.,55:3105?3109,1995.
	14.O?Malley,B.W.,Jr.,Chen,S-H.,Schwartz,M.R.,andWoo,S.L.C.Adenovirus-mediatedgenetherapyforhumanheadandnecksquamouscellcancerinanudemousemodel.CancerRes.,55:1080?1085,1995.
	15.Yoshida,K.,Kawami,H.,Yamaguchi,Y.,Kuniyasu,H.,Nishiyama,M.,Hirai,T.,Yanagihara,K.,Tahara,E.,andToge,T.Retrovirallytransmittedgenetherapyforgastriccarcinomausingherpessimplexvirusthymidinekinasegene.Cancer(Phila.),75:1467?1471,1995.
	16.Roth,J.A.,andCristiano,R.J.Genetherapyforcancer:whathavewedoneandwherearewegoing?J.Natl.CancerInst.,89:21?39,1997.
	17.Denning,C.,andPitts,J.D.Bystandereffectsofdifferentenzyme-prodrugsystemsforcancergenetherapydependondifferentpathwaysforintercellulartransferoftoxicmetabolites,afactorthatwillgovernclinicalchoiceofappropriateregimes.Hum.GeneTher.,8:1825?1835,1997.
	18.Rubsam,L.Z.,Boucher,P.D.,Murphy,P.J.,KuKuruga,M.,andShewach,D.S.Cytotoxicityandaccumulationofganciclovirtriphosphateinbystandercellscocul-turedwithherpessimplexvirustype1thymidinekinase-expressinghumanglioblas-tomacells.CancerRes.,59:669?675,1999.
	19.Bi,W.L.,Parysek,L.M.,Warnick,R.,andStambrook,P.J.InvitroevidencethatmetaboliccooperationisresponsibleforthebystandereffectobservedwithHSVtkretroviralgenetherapy.Hum.GeneTher.,4:725?731,1993.
	20.Boucher,P.D.,Ruch,R.J.,andShewach,D.S.Differentialganciclovir-mediatedcytotoxicityandbystanderkillinginhumancoloncarcinomacelllinesexpressingherpessimplexvirusthymidinekinase.Hum.GeneTher.,9:801?814,1998.
	21.Machado,S.G.,andRobinson,G.A.Adirect,generalapproachbasedonisobolo-gramsforassessingthejointactionofdrugsinpre-clinicalexperiments.Stat.Med.,13:2289?2309,1994.
	22.Griffiths,G.M.,Berek,C.,Kaartinen,M.,andMilstein,C.Somaticmutationandmaturationofimmuneresponseto2-phenyl-oxazolone.Nature(Lond.),312:271?275,1984.
	23.Hoogenboom,H.R.,Griffiths,A.D.,Johnson,K.S.,Chriswell,D.J.,Hudson,P.,andWinter,G.Multi-subunitproteinsonthesurfaceoffilamentousphage:methodologiesfordisplayingantibody(Fab)heavyandlightchains.NucleicAcidsRes.,19:4133?4137,1991.
	24.Coloma,M.J.,Hastings,A.,Wims,L.A.,andMorrison,S.L.Novelvectorsfortheexpressionofantibodymoleculesusingvariableregionsgeneratedbypolymerasechainreaction.J.Immunol.Methods,152:89?104,1992.
	25.Samejima,Y.,andMeruelo,D.?Bystanderkilling?inducesapoptosisandisinhibitedbyforskolin.GeneTher.,2:50?58,1995.
	26.Mesnil,M.,Piccoli,C.,Tiraby,G.,Willecke,K.,andYamasaki,H.Bystanderkillingofcancercellsbyherpessimplexvirusthymidinekinasegeneismediatedbyconnexins.Proc.Natl.Acad.Sci.USA,93:1831?1835,1996.
	27.Elshami,A.A.,Saavedra,A.,Zhang,H.,Kucharczuk,J.C.,Spray,D.C.,Fishman,G.I.,Amin,K.M.,Kaiser,L.R.,andAlbelda,S.M.Gapjunctionsplayaroleinthe?bystandereffect?oftheherpessimplexvirusthymidinekinase/ganciclovirsysteminvitro.GeneTher.,3:85?92,1996.
	28.Yeager,M.,andNicholson,B.J.Structureofgapjunctionintercellularchannels.Curr.Opin.Struct.Biol.,6:183?192,1996.
	29.Fick,J.,Barker,F.G.I.,Dazin,P.,Westphale,E.M.,Beyer,E.C.,andIsrael,M.A.Theextentofheterocellularcommunicationmediatedbygapjunctionsispredictiveofbystandertumorcytotoxicityinvitro.Proc.Natl.Acad.Sci.USA,92:11071?11075,1995.
	30.Yang,L.,Chiang,Y.,Lenz,H.,Danenberg,K.D.,Spears,C.P.,Gordon,E.M.,Anderson,W.F.,andParekh,D.Intercellularcommunicationmediatesthebystandereffectduringherpessimplexthymidinekinase/ganciclovir-basedgenetherapyofhumangastrointestinaltumorcells.Hum.GeneTher.,9:719?728,1998.
	31.Rogulski,K.R.,Kim,J.H.,Kim,S.H.,andFreytag,S.O.GliomacellstransducedwithanEscherichiacoliCD/HSV-1TKfusiongeneexhibitenhancedmetabolicsuicideandradiosensitivity.Hum.GeneTher.,8:73?85,1997.
	32.Aghi,M.,Kramm,C.M.,Chou,T.,Breakefield,X.O.,andChiocca,E.A.Syner-gisticanticancereffectsofganciclovir/thymidinekinaseand5-fluorocytosine/cyto-sinedeaminasegenetherapies.J.Natl.CancerInst.,90:370?380,1998.
	33.Gwilt,P.R.,andTracewell,W.G.Pharmacokineticsandpharmacodynamicsofhydroxyurea.Clin.Pharmacokinet.,34:347?358,1998.
	34.Donehower,R.C.Hydroxyurea.In:B.A.Chabner,andD.L.Longo(eds.),CancerChemotherapyandBiotherapy,pp.253?261.Philadelphia:Lippincott-RavenPub-lishers,1996.
	35.Bianchi,V.,Pontis,E.,andReichard,P.Changesofdeoxyribonucleosidetriphos-phatepoolsinducedbyhydroxyureaandtheirrelationtoDNAsynthesis.J.Biol.Chem.,261:16037?16042,1986.
	36.Rubsam,L.Z.,Davidson,B.L.,andShewach,D.S.Superiorcytotoxicitywithganciclovircomparedwithacyclovirand1-b-D-arabinofuranosylthymineinherpessimplexvirus-thymidinekinase-expressingcells:anovelparadigmforcellkilling.CancerRes.,58:3873?3882,1998.
	37.Yoshioka,A.,Tanaka,S.,Osamu,H.,Koyama,Y.,Hirota,Y.,Ayusawa,D.,Seno,T.,Garrett,C.,andWataya,Y.Deoxyribonucleosidetriphosphateimbalance.J.Biol.Chem.,262:8235?8241,1987.
	38.Wadler,S.,Horowitz,R.,Zhang,H.,andSchwartz,E.L.Effectsofperturbationsofpoolsofdeoxyribonucleosidetriphosphatesonexpressionofribonucleotidereduc-tase,aG1/Stransitionstateenzyme,inp53-mutatedcells.Biochem.Pharmacol.,55:1353?1360,1998.
	39.Collins,A.,andOates,D.J.Hydroxyurea:effectsondeoxyribonucleotidepoolsizescorrelatedwitheffectsonDNArepairinmammaliancells.Eur.J.Biochem.,169:299?305,1987.
992266.pdf	48
	1.Cotran, R.S. 1999. Inflammation: historical perspectives. InInflammation: Basic Principles and Clinical Correlates, 3rded. J.I. Gallin, R. Snyderman, D.T. Fearon, B.F. Haynes,and C. Nathan, editors. Lippincott Williams & Wilkins, Phil-adelphia. 5?10.
	2.Weissmann, G., J.E. Smolen, and H.M. Korchak. 1980. Re-lease of inflammatory mediators from stimulated neutrophils.N. Engl. J. Med. 303:27?34.	6246431
	3.Samuelsson, B. 1982. From studies of biochemical mecha-nisms to novel biological mediators: prostaglandin endoper-oxides, thromboxanes and leukotrienes. In Les Prix Nobel:Nobel Prizes, Presentations, Biographies and Lectures. T.Frï¿½ngsmyr, editor. Almqvist & Wiksell, Stockholm. 153?174.	6315101
	4.Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T.Shimizu. 1997. A G-protein-coupled receptor for leuko-triene B4 that mediates chemotaxis. Nature. 387:620?624.	9177352
	5.Perez, H.D. 1994. Chemoattractant receptors. Curr. Opin.Hematol. 1:40?44.	9371258
	6.Pillinger, M.H., and S.B. Abramson. 1995. The neutrophilin rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21:691?714.
	7.Serhan, C.N., J.Z. Haeggstrom, and C.C. Leslie. 1996. Lipidmediator networks in cell signaling: update and impact of cy-tokines. FASEB J. 10:1147?1158.	8751717
	8.Diamond, P., A. McGinty, D. Sugrue, H.R. Brady, and C.Godson. 1999. Regulation of leukocyte trafficking by li-poxins. Clin. Chem. Lab. Med. 37:293?297.	10353475
	9.Node, K., Y. Huo, X. Ruan, B. Yang, M. Spiecker, K. Ley,D.C. Zeldin, and J.K. Liao. 1999. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.Science. 285:1276?1279.	2356865
	10.Munger, K.A., A. Montero, M. Fukunaga, S. Uda, T. Yura,E. Imai, Y. Kaneda, J.M. Valdivielso, and K.F. Badr. 1999.Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Natl. Acad. Sci. USA. 96:13375?13380.	2911748
	11.Weissmann, G. 1991. Aspirin. Sci. Am. 264:84?90.
	12.Marcus, A.J. 1995. Aspirin as prophylaxis against colorectal cancer. N. Eng. J. Med. 333:656?658.	7637720
	13.Takano, T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Peta-sis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxinA4 (LXA4) and LXA4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory recep-tors. J. Exp. Med. 185:1693?1704.	1322894
	14.Clish, C.B., J.A. O?Brien, K. Gronert, G.L. Stahl, N.A. Peta-sis, and C.N. Serhan. 1999. Local and systemic delivery of astable aspirin-triggered lipoxin prevents neutrophil recruit-ment in vivo. Proc. Natl. Acad. Sci. USA. 96:8247?8252.	9317159
	15.Chiang, N., K. Gronert, C.B. Clish, J.A. O?Brien, M.W.Freeman, and C.N. Serhan. 1999. Leukotriene B4 receptortransgenic mice reveal novel protective roles for lipoxins andaspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104:309?316.	1655904
	16.Hachicha, M., M. Pouliot, N.A. Petasis, and C.N. Serhan.1999. Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4inhibit tumor necrosis factor a?initiated neutrophil responses and trafficking: regulators of a cytokine?chemokine axis. J.Exp. Med. 189:1923?1929.	9317159
	17.Fiore, S., J.F. Maddox, H.D. Perez, and C.N. Serhan. 1994.Identification of a human cDNA encoding a functional highaffinity lipoxin A4 receptor. J. Exp. Med. 180:253?260.	6325475
	18.Fiore, S., and C.N. Serhan. 1995. Lipoxin A4 receptor acti-vation is distinct from that of the formyl peptide receptor inmyeloid cells: inhibition of CD11/18 expression by lipoxinA4-lipoxin A4 receptor interaction. Biochemistry. 34:16678?16686.	8527441
	19.Quehenberger, O., E.R. Prossnitz, S.L. Cavanagh, C.G. Coch-rane, and R.D. Ye. 1993. Multiple domains of the N-formylpeptide receptor are required for high-affinity ligand binding.Construction and analysis of chimeric N-formyl peptide re-1207Chiang et al.ceptors. J. Biol. Chem. 268:18167?18175.	8349692
	20.Castano, A.R., S. Tangri, J.E. Miller, H.R. Holcombe,M.R. Jackson, W.D. Huse, M. Kronenberg, and P.A. Peter-son. 1995. Peptide binding and presentation by mouse CD1.Science. 269:223?226.	7542402
	21.Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar,S.T. Furlong, and M.B. Brenner. 1994. Recognition of alipid antigen by CD1-restricted ab1 T cells. Nature. 372:691?694.	7527497
	22.Brezinski, D.A., and C.N. Serhan. 1991. Characterization oflipoxins by combined gas chromatography and electron-cap-ture negative ion chemical ionization mass spectrometry: for-mation of lipoxin A4 by stimulated human whole blood. Biol.Mass Spectrom. 20:45?52.	1883860
	23.Falk, W., R.H. Goodwin, and E. Leonard. 1980. A 48-wellmicrochemotaxis assembly for rapid and accurate measure-ment of leukocyte migration. J. Immunol. Methods. 33:239?247.	6989919
	24.Gronert, K., S.P. Colgan, and C.N. Serhan. 1998. Charac-terization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry:impact of reoxygenation. J. Pharmacol. Exp. Ther. 285:252?261.	9536019
	25.Wang, C.R., A.R. Castano, P.A. Peterson, C. Slaughter,K.F. Lindahl, and J. Deisenhofer. 1995. Nonclassical bindingof formylated peptide in crystal structure of the MHC class Ibmolecule H2-M3. Cell. 82:655?664.	7664344
	26.Shawar, S.M., R.R. Rich, and E.L. Becker. 1995. Peptidesfrom the amino-terminus of mouse mitochondrially encodedNADH dehydrogenase subunit 1 are potent chemoattracta-nts. Biochem. Biophys. Res. Commun. 211:812?818.	7598710
	27.Serhan, C.N., J.F. Maddox, N.A. Petasis, I. Akritopoulou-Zanze, A. Papayianni, H.R. Brady, S.P. Colgan, and J.L.Madara. 1995. Design of lipoxin A4 stable analogs that blocktransmigration and adhesion of human neutrophils. Biochem-istry. 34:14609?14615.	7578068
	28.Klein, C., J.I. Paul, K. Sauve, M.M. Schmidt, L. Arcangeli, J.Ransom, J. Trueheart, J.P. Manfredi, J.R. Broach, and A.J.Murphy. 1998. Identification of surrogate agonists for thehuman FPRL-1 receptor by autocrine selection in yeast. Nat.Biotechnol. 16:1334?1337.	9853614
	29.Tessier, P.A., P.H. Naccache, I. Clark-Lewis, R.P. Gladue,K.S. Neote, and S.R. McColl. 1997. Chemokine networksin vivo: involvement of C-X-C and C-C chemokines inneutrophil extravasation in vivo in response to TNF-a. J.Immunology. 159:3595?3602.	9317159
	30.Gabay, C., and I. Kushner. 1999. Acute-phase proteins andother systemic responses to inflammation. N. Engl. J. Med.340:448?454.	9971870
	31.Su, S.B., W. Gong, J.L. Gao, W. Shen, P.M. Murphy, J.J.Oppenheim, and J.M. Wang. 1999. A seven-transmembrane,G protein?coupled receptor, FPRL1, mediates the chemo-tactic activity of serum amyloid A for human phagocyticcells. J. Exp. Med. 189:395?402.	8947601
	32.Miettinen, H.M., J.M. Gripentrog, and A.J. Jesaitis. 1998.Chemotaxis of chinese hamster ovary cells expressing the hu-man neutrophil formyl peptide receptor: role of signal trans-duction molecules and a5b1 integrin. J. Cell Sci. 111:1921?1928.	9645940
	33.Maddox, J.F., M. Hachicha, T. Takano, N.A. Petasis, V.V.Fokin, and C.N. Serhan. 1997. Lipoxin A4 stable analogs arepotent mimetics that stimulate human monocytes and THP-1cells via a G-protein-linked lipoxin A4 receptor. J. Biol.Chem. 272:6972?6978.	9054386
	34.Villanueva, M.S., C.J. Becker, and E.G. Pamer. 1994. Infection with Listeria monocytogenes impairs sialic acid addition tohost cell glycoproteins. J. Exp. Med. 180:2137?2145.	1587794
	35.Olofsson, S., B. Khanna, and E. Lycke. 1980. Altered kineticproperties of sialyl and galactosyl transferases associated withherpes simplex virus infection of GMK and BHK cells. J.Gen. Virol. 47:1?9.	6154121
	36.Kim, J.W., and J.M. Cunningham. 1993. N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. J. Biol. Chem. 268:16316?16320.	8393858
	37.Miettinen, H.M., J.S. Mills, J.M. Gripentrog, E.A. Dratz,B.L. Granger, and A.J. Jesaitis. 1997. The ligand binding siteof the formyl peptide receptor maps in the transmembraneregion. J. Immunol. 159:4045?4054.	9378994
	38.Quehenberger, O., Z.K. Pan, E.R. Prossnitz, S.L. Cavanagh,C.G. Cochrane, and R.D. Ye. 1997. Identification of anN-formyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem. Biophys. Res. Commun. 238:377?381.	9299516
	39.Tai, H.H., C. Huang, and N. Chiang. 1997. Structure andfunction of prostanoid receptors as revealed by site-directedmutagenesis. In Eicosanoids and Other Bioactive Lipids inCancer, Inflammation and Radiation Injury. K.V. Honn, L.J.Marnett, R. Jones, and P.Y.-K. Wong, editors. PlenumPress, New York. 205?209.	9321954
	40.Fiore, S., S.W. Ryeom, P.F. Weller, and C.N. Serhan. 1992.Lipoxin recognition sites. Specific binding of labeled lipoxinA4 with human neutrophils. J. Biol. Chem. 267:16168?16176.	1322894
	41.Liang, J.S., and J.D. Sipe. 1995. Recombinant human serumamyloid A (apoSAAp) binds cholesterol and modulates cho-lesterol flux. J. Lipid Res. 36:37?46.	7706946
	42.Linke, R.P., V. Bock, G. Valet, and G. Rothe. 1991. Inhibi-tion of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem.Biophys. Res. Commun. 176:1100?1105.	2039494
	43.Deng, X., H. Ueda, S.B. Su, W. Gong, N.M. Dunlop, J.-L.Gao, P.M. Murphy, and J.M. Wang. 1999. A synthetic pep-tide derived from human immunodeficiency virus type 1gp120 downregulates the expression and function ofchemokine receptors CCR5 and CXCR4 in monocytes byactivating the 7-transmembrane G-protein-coupled receptorFPRL1/LXA4R. Blood. 94:1165?1173.	10438703
	44.Pettit, E.J., and F.S. Fay. 1998. Cytosolic free calcium andthe cytoskeleton in the control of leukocyte chemotaxis.Physiol. Rev. 28:949?960.	9790567
	45.Serhan, C.N. 1994. Lipoxin biosynthesis and its impact in in-flammatory and vascular events. Biochim. Biophys. Acta. 1212:1?25.	8155718
	46.Levy, B.D., V.V. Fokin, J.M. Clark, M.J.O. Wakelam, N.A.Petasis, and C.N. Serhan. 1999. Polyisoprenyl phosphate(PIPP) signaling regulates phospholipase D activity: a ?stop?signaling switch for aspirin-triggered lipoxin A4. FASEB J.13:903?911.	10224233
	47.Schaldach, C.M., J. Riby, and L.F. Bjeldanes. 1999. LipoxinA4: a new class of ligand for the Ah receptor. Biochemistry. 38:7594?7600.	10360957
	48.Fernandez-Salguero, P., T. Pineau, D.M. Hilbert, T.McPhail, S.S.T. Lee, S. Kimura, D.W. Nebert, S. Rudikoff,J.M. Ward, and F.J. Gonzalez. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-bindingAh receptor. Science. 268:722?726.	7732370
992200.pdf	52
	1.Janeway, C.A., Jr. 1992. The immune system evolved to dis-tinguish infectious nonself from non-infectious self. Immunol.Today. 13:11?16.	1739426
	2.Takahashi, K., M.J. Donovan, R.A. Rogers, and R.A.B.Ezekowitz. 1998. Distribution of murine mannose receptorexpression from early embryogenesis through to adulthood.Cell Tissue Res. 292:311?323.	9560474
	3.Linehan, S.A., L. Martï¿½nez-Pomares, P.D. Stahl, and S. Gor-don. 1999. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages,endothelial cell, perivascular microglia, and mesangial cells,but not dendritic cells. J. Exp. Med. 189:1961?1972.	1333549
	4.Stahl, P.D., and R.A.B. Ezekowitz. 1998. The mannose re-ceptor is a pattern recognition receptor involved in host de-fense. Curr. Opin. Immunol. 10:50?55.	9523111
	5.Sallusto, F., M.I. Cella, C. Danieli, and A. Lanzavecchia.1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389?400.	7629494
	6.Prigozy, T.I., P.A. Sieling, D. Clemens, P.L. Stewart, S.M.1114Structure of Mannose Receptor Cysteine-rich DomainBehar, S.A. Porcelli, M.B. Brenner, R.L. Modlin, and M.Kronenberg. 1997. The mannose receptor delivers lipoglycanantigens to endosomes for presentation to T cells by CD1bmolecules. Immunity. 6:187?197.	9047240
	7.Ishizaki, J., K. Hanasaki, K. Higashino, J. Kishimo, N. Kiku-chi, O. Ohara, and H. Arita. 1994. Molecular cloning of pan-creatic group I phospholipase A2 receptor. J. Biol. Chem.269:12156?12162.	7509792
	8.Lambeau, G., P. Ancian, J. Barhanin, and M. Lazdunski.1994. Cloning and expression of a membrane receptor forsecretory phospholipases A2. J. Biol. Chem. 269:1575?1578.	8294398
	9.Ancian, P., G. Lambeau, M.-G. Madei, and M. Lazdunski.1995. The human 180 kDa receptor for secretory phospholipases A2. J. Biol. Chem. 270:8963?8970.	7721806
	10.Jiang, W.P., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza,R.M. Steinman, and M.C. Nussenzweig. 1995. The receptorDEC-205 expressed by dendritic cells and thymic epithelialcells is involved in antigen processing. Nature. 375:151?155.	7753172
	11.Wu, K., J. Yuan, and L.A. Lasky. 1996. Characterization of anovel member of the macrophage mannose receptor type Clectin family. J. Biol. Chem. 271:21323?21330.	8702911
	12.Taylor, M.E., K. Bezouska, and K. Drickamer. 1992. Contri-bution to ligand binding by multiple carbohydrate recogni-tion domains in the macrophage mannose receptor. J. Biol.Chem. 267:1719?1726.	1730714
	13.Taylor, M.E., and K. Drickamer. 1993. Structural require-ments for high affinity binding of complex ligands by themannose receptor. J. Biol. Chem. 268:399?404.	8416946
	14.Weis, W.I., M.E. Taylor, and K. Drickamer. 1998. TheC-type lectin superfamily in the immune system. Immunol.Rev. 163:19?34.	9700499
	15.Mullin, N.P., P.G. Hitchen, and M.E. Taylor. 1997. Mecha-nism of Ca21 and monosaccharide binding to a C-type car-bohydrate-recognition domain of the macrophage mannosereceptor. J. Biol. Chem. 272:5668?5681.	9038177
	16.Fiete, D., and J.U. Baenziger. 1997. Isolation of the SO4-4-GalNAcb1, 4GlcNAcb1, 2Mana-specific receptor fromrat liver. J. Biol. Chem. 272:14629?14637.	9169424
	17.Fiete, D., M.C. Beranek, and J.U. Baenziger. 1997. Themacrophage endothelial cell mannose receptor cDNA encodes a protein that binds oligosaccharides terminating with SO4-4-GalNAcb1,4GlcNAcb or Man at independent sites.Proc. Natl. Acad. Sci. USA. 94:11256?11261.	1421407
	18.Fiete, D.J., M.C. Beranek, and J.U. Baenziger. 1998. A cysteine-rich domain of the ?mannose? receptor mediates Gal-NAc-4-SO4 binding. Proc. Natl. Acad. Sci. USA. 95:2089?2093.	1421407
	19.Leteux, C., W. Chai, R.W. Loveless, C.-T. Yuen, L. Uhlin-Hansen, Y. Combarnous, M. Jankovic, S.C. Maric, Z. Misu-lovin, M.C. Nussenzweig, and T. Feizi. 2000. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin which recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood-group Lewisa and Lewisxtypes in addition to the sulfated N-glycans of luteinizing hormone. J. Exp. Med. 191:1117?1126.	10485259
	20.Baenziger, J.U., S. Kumar, R.M. Brodbeck, P.L. Smith, andM.C. Beranek. 1992. Circulatory half-life but not interaction with the lutropin chorionic-gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. Proc.Natl. Acad. Sci. USA. 89:334?338.	168103
	21.Smith, P.L., G.R. Bousfield, S. Kuman, D. Fiete, and J.U.Baenziger. 1993. Equine lutropin and chorionic gonadotro-pin bear oligosaccharides terminating with SO4-4-GalNAcand Sia-a-2,3Gal, respectively. J. Biol. Chem. 268:795?802.	8419356
	22.Martï¿½nez-Pomares, L., M. Kosco-Vilbois, E. Darley, P. Tree,S. Herren, J.-Y. Bonnefoy, and S. Gordon. 1996. Fc chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers. J. Exp. Med. 184:1927?1937.	2369918
	23.Taylor, M.E., J.T. Conary, M.R. Lennartz, P.D. Stahl, andK. Drickmer. 1990. Primary structure of the mannose recep-tor contains multiple motifs resembling carbohydrate-recog-nition domains. J. Biol. Chem. 265:12156?12162.	2373685
	24.Otwinowski, Z., and W. Minor. 1997. Processing of X-raydiffraction data collected in oscillation mode. Methods Enzy-mol. 276:307?326.
	25.De La Fortelle, E., and G. Bricogne. 1997. Maximum-likeli-hood heavy-atom parameter refinement for multiple isomor-phous replacement and multiwavelength anomalous diffrac-tion methods. Methods Enzymol. 276:472?494.
	26.Abrahams, J.P., and A.G.W. Leslie. 1996. Methods used inthe structure determination of bovine mitochondrial F1 ATP-ase. Acta Crystallogr. D. 52:30?42.	15299723
	27.Kleywegt, G.J., and T.A. Jones. 1997. Template convolutionto enhance or detect structural features in macromolecularelectron density maps. Acta Crystallogr. D. 53:179?185.	15299952
	28.Jones, T.A., and M. Kjeldgaard. 1997. Electron density mapinterpretation. Methods Enzymol. 277:173?208.	18488310
	29.Brï¿½nger, A.T., P.D. Adams, G.M. Clore, P. Gros, R.W.Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Nilges, N.S.Pannu, R.J. Read, et al. 1998. Crystallography and NMRsystem: a new software system for macromolecular structuredetermination. Acta Crystallogr. D. 54:905?921.	9757107
	30.Brï¿½nger, A.T. 1992. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:472?475.	18481394
	31.Kraulis, P.J. 1991. MOLSCRIPT: a program to produceboth detailed and schematic plots of protein structures. J.Appl. Crystallogr. 24:946?950.
	32.Merritt, E.A., and M.E.P. Murphy. 1994. Raster3D version2.0, a program for photorealistic molecular graphics. ActaCrystallogr. D. 50:869-873.
	33.Nicholls, A., R. Bharadwaj, and B. Honig. 1993. GRASP:graphical representation and analysis of surface properties.Biophys. J. 64:A166.
	34.Murzin, A.G., A.M. Lesk, and C. Chothia. 1992. Beta-trefoilfold patterns of structure and sequence in the Kunitz inhibi-tors, interleukins-1b and 1a and fibroblast growth factors. J.Mol. Biol. 223:531?543.	1738162
	35.McLachlan, A.D. 1979. Three-fold structural pattern in thesoybean trypsin inhibitory (Kunitz). J. Mol. Biol. 133:557?563.	537058
	36.Rutenber, E., and J.D. Robertus. 1991. Structure of ricinB-chain at 2.5 ï¿½ resolution. Proteins. 10:260?269.	1881882
	37.Zhu, X., H. Komiya, A. Chirino, S. Faham, G.M. Fox, T.Arakawa, B.T. Hsu, and D.C. Rees. 1991. Three-dimensional structures of acidic and basic fibroblast growth factors.Science. 251:90?93.	1702556
	38.Finzel, B.C., L.L. Clancy, D.R. Holland, S.W. Muchmore,K.D. Watenpaugh, and H.M. Einspahr. 1989. Crystal struc-ture of recombinant human interleukin-1b at 2.0 ï¿½ resolu-tion. J. Mol. Biol. 209:779?791.	2585509
	39.Graves, B.J., M.H. Hatada, W.A. Hendrickson, J.K. Miller,V.S. Madison, and Y. Satow. 1990. Structure of interleukin-1a at 2.7 ï¿½ resolution. Biochemistry. 29:2679?2684.1115Liu et al.	2346741
	40.Habazetti, J., D. Gondol, R. Wiltscheck, J. Otlewski, M.Schleicher, and T.A. Holak. 1992. Structure of hisactophilinis similar to interleukin-1b and fibroblast growth factor. Na-ture. 359:855?858.	1436061
	41.Harris, N., L.L. Peters, E.M. Eicher, M. Rits, D. Raspberry,Q.G. Eichbaum, M. Super, and R.A. Ezekowitz. 1994. Theexon-intron structure and chromosomal localization of themouse macrophage mannose receptor gene Mrc1: identifica-tion of a ricin-like domain at the N-terminus of the receptor.Biochem. Biophys. Res. Commun. 198:682?692.	8297379
	42.Weis, W.I., and K. Drickamer. 1996. Structural basis of lec-tin-carbohydrate recognition. Annu. Rev. Biochem. 65:441?473.	8811186
	43.Pflugrath, J.W., and F.A. Quiocho. 1988. The 2 ï¿½ resolutionstructure of the sulfate-binding protein involved in activetransport in Salmonella typhimurium. J. Mol. Biol. 200:163?180.	3288756
	44.Quiocho, F.A., J.S. Sack, and N.K. Vyas. 1987. Stabilizationof charges on isolated ionic groups sequestered in proteins bypolarized peptide units. Nature. 329:561?564.	3657977
	45.DiGabriele, A.D., I. Lax, D.I. Chen, C.M. Svahn, M. Jaye, J.Schlessinger, and W.A. Hendrickson. 1998. Structure of aheparin-linked biologically active dimer of fibroblast growthfactor. Nature. 393:812?817.	9655399
	46.Perez, S., N. Mouhous-Riou, N.E. Nifant?ev, Y.E. Tsvet-kov, B. Bachet, and A. Imberty. 1996. Crystal and molecularstructure of a histo-blood group antigen involved in cell ad-hesion: the Lewisx trisaccharide. Glycobiology. 6:537?542.	8877374
	47.Ng, K.K.-S., and W.I. Weis. 1997. Structure of a selectin-like mutant of mannose binding protein complexed with sial-ylated and sulfated Lewisx oligosaccharides. Biochemistry. 36:979?988.	9033386
	48.Kogelberg, H., T.A. Frenkiel, S.W. Homans, A. Lubineau,and T. Feizi. 1996. Conformational studies on the selectinand natural killer cell receptor ligands sulfo- and sialyl-lacto-N-fucopentaoses (SuLNFPII and SLNFPII) using NMRspectroscopy and molecular dynamics simulations. Compari-sons with the nonacidic parent molecule LNFPII. Biochemis-try. 35:1954?1964.	8639679
	49.Simpson, D.Z., P.G. Hitchen, E.L. Elmhirst, and M.E. Tay-lor. 1999. Multiple interactions between pituitary hormones and the mannose receptor. Biochem. J. 343:403?411.	9700499
	50.Martï¿½nez-Pomares, L., J.A. Mahoney, R. Kï¿½poszta, S.A.Linehan, P.D. Stahl, and S. Gordon. 1998. A functional solu-ble form of the murine mannose receptor is produced bymacrophages in vitro and is present in mouse serum. J. Biol.Chem. 273:23376?23380.	9722572
	51.Hodel, A., S.-H. Kim, and A.T. Brï¿½nger. 1992. Model biasin macromolecular crystal structures. Acta Crystallogr. A. 48:851?858.
	52.Kolatkar, A.R., and W.I. Weis. 1996. Structural basis of ga-lactose recognition by C-type animal lectins. J. Biol. Chem.271:6679?6685.	8636086
J. Biol. Chem.-2000-Askarian-Amiri-17241-8.pdf	41
	1.Tate,W.P.,andMannering,S.A.(1996)Mol.Microbiol.21,213?219
	2.Freistroffer,D.V.,Pavlov,M.Y.,MacDougall,J.,Buckingham,R.H.,andEhrenberg,M.(1997)EMBOJ.16,4126?4133
	3.Craigen,W.J.,Cook,R.G.,Tate,W.P.,andCaskey,C.T.(1985)Proc.Natl.Acad.Sci.U.S.A.82,3616?3620
	4.Mikuni,O.,Ito,K.,Moffat,J.,Matsumura,K.,McCaughan,K.,Nobukuni,T.,Tate,W.P.,andNakamura,Y.(1994)Proc.Natl.Acad.Sci.U.S.A.91,5798?5802
	5.Tate,W.P.,Beaudet,A.L.,andCaskey,C.T.(1973)Proc.Natl.Acad.Sci.U.S.A.70,2350?2355
	6.Zhouravleva,G.,Frolova,L.,LeGoff,X.,LeGuellec,R.,Inge-Vechtomov,S.,Kisselev,L.,andPhilippe,M.(1995)EMBOJ.14,4065?4072
	7.Ito,K.,Ebihara,K.,Uno,M.,andNakamura,Y.(1996)Proc.Natl.Acad.Sci.U.S.A.93,5443?5448
	8.Lee,C.C.,Timms,K.M.,Trotman,C.N.,andTate,W.P.(1987)J.Biol.Chem.262,3548?3552
	9.Pel,H.J.,Maat,C.,Rep,M.,andGrivell,L.A.(1992)NucleicAcidsRes.20,6339?6346
	10.Pel,H.J.,Rozenfeld,S.,andBolotin-Fukuhara,M.(1996)Curr.Genetics30,19?28
	11.Zhang,Y.L.,andSpremulli,L.L.(1998)Biochim.Biophys.Acta1443,245?250
	12.Tate,W.P.,Poole,E.S.,andMannering,S.A.(1996)Prog.NucleicAcidsRes.Mol.Biol.52,293?335
	13.Jukes,T.H.,andOsawa,S.(1993)Comp.Biochem.Physiol.106B,489?494
	14.Weiss-Brummer,B.,Huttenhofer,A.,andKaudewitz,F.(1984)Mol.Gen.Genet.198,62?68
	15.John,U.P.,Willson,T.A.,Linnane,A.W.,andNagley,P.(1986)NucleicAcidsRes.14,7437?7451
	16.Pel,H.J.,Rep,M.,Dubbink,H.J.,andGrivell,L.A.(1993)NucleicAcidsRes.21,5308?5315
	17.Papadopoulou,B.,Dekker,P.,Blom,J.,andGrivell,L.A.(1990)EMBOJ.9,4135?4143
	18.Matthews,D.E.,Hessler,R.A.,Denslow,N.D.,Edwards,J.E.,andO?Brien,T.W.(1982)J.Biol.Chem.257,8788?8794
	19.Daum,G.,Boï¿½hni,P.C.,andSchatz,G.(1982)J.Biol.Chem.257,13028?13033
	20.Lowry,O.H.,Rosebrough,N.J.,Farr,A.L.,andRandall,R.J.(1951)J.Biol.Chem.193,265?275
	21.Caskey,C.T.,Beaudet,A.L.,Scolnick,E.M.,andRosman,M.(1971)Proc.Natl.Acad.Sci.U.S.A.68,3163?3167
	22.Poole,E.S.,Brimacombe,R.,andTate,W.P.(1997)RNA3,974?982
	23.Claros,M.G.,andVincens,P.(1996)Eur.J.Biochem.241,779?786
	24.Brown,C.M.,andTate,W.P.(1994)J.Biol.Chem.269,33164?33170
	25.Pel,H.J.,Rep,M.,andGrivell,L.A.(1992)NucleicAcidsRes.20,4423?4428
	26.Devereux,J.,Haeberili,P.,andSnithies,O.(1984)NucleicAcidsRes.14,387?395
	27.Nakamura,Y.,andIto,K.(1998)GenesCells3,265?278
	28.Wilson,D.N.,Dalphin,M.E.,Pel,H.J.,Major,L.L.,Manson,J.B.,andTate,W.P.(2000)inTheRibosome:Structure,Function,Antibiotics,andCellularInteractions(Garrett,R.A.,Douthwaite,S.R.,Liljas,A.,Matheson,A.T.,Moore,P.B.,andNoller,H.F.,eds.),pp.495?507,ASMPress,Washington,
	29.Moffat,J.G.,andTate,W.P.(1994)J.Biol.Chem.269,18899?18903
	30.Yoshimura,K.,Ito,K.,andNakamura,Y.(1999)GenesCells4,253?266
	31.Clemons,W.M.,Jr.,May,J.L.C.,Wimberly,B.T.,McCutcheon,J.P.,Capel,M.S.,andRamakrishnan,V.(1999)Nature400,833?840
	32.Cate,J.H.,Yusupov,M.S.,Yusupova,G.Zh.,Earnest,T.N.,andNoller,H.F.(1999)Science285,2095?2104
	33.Moazed,D.,andNoller,H.F.(1986)Cell47,985?994
	34.Moazed,D.,andNoller,H.F.(1990)J.Mol.Biol.211,135?145
	35.Mueller,F.,andBrimacombe,R.(1997)J.Mol.Biol.271,524?544
	36.Ito,K.,Uno,M.,andNakamura,Y.(2000)Nature403,680?684
	37.Moazed,D.,Samaha,R.R.,Gualerzi,C.,andNoller,H.F.(1995)J.Mol.Biol.248,207?210
	38.Dahlquist,K.,andPuglisi,J.D.(1995)NucleicAcidsSymp.Ser.33,170?171
	39.Spurio,R.,Paci,M.,Pawlik,R.T.,Lateana,A.,Digiacco,B.V.,Pon,C.L.,andGualerzi,C.O.(1991)Biochimie73,1001?1006
	40.McCaughan,K.K.,Poole,E.S.,Pel,H.J.,Mansell,J.B.,Mannering,S.A.,andTate,W.P.(1998)Biol.Chem.379,857?866
	41.Yoshizawa,S.,Fourmy,D.,andPuglisi,J.D.(1999)Science285,1722?172517248FunctionalCharacterizationofYeastmRF1
J. Biol. Chem.-2000-Newton-15128-34.pdf	45
	1.Chrivia,J.C.,Kwok,R.P.,Lamb,N.,Hagiwara,M.,Montminy,M.R.,andGoodman,R.H.(1993)Nature365,855?859
	2.Eckner,R.,Ewen,M.E.,Newsome,D.,Gerdes,M.,DeCaprio,J.A.,Lawrence,J.B.,andLivingston,D.M.(1994)GenesDev.8,869?884
	3.Shikama,N.,Lyon,J.,andLaThangue,N.B.(1997)TrendsCellBiol.7,230?236
	4.Horvai,A.E.,Xu,L.,Korzus,E.,Brard,G.,Kalafus,D.,Mullen,T.M.,Rose,D.W.,Rosenfeld,M.G.,andGlass,C.K.(1997)Proc.Natl.Acad.Sci.U.S.A.94,1074?1079
	5.Xu.L.,Lavinsky,R.M.,Dasen,J.S.,Flynn,S.E.,McInerney,E.M.,Mullen,T.M.,Heinzel,T.,Szeto,D.,Korzus,E.,Kurokawa,R.,Aggarwal,A.K.,Rose,D.W.,Glass,C.K.,andRosenfeld,M.G.(1997)Nature395,301?306
	6.Boyes,J.,Byfield,P.,Nakatani,Y.,andOgryzko,V.(1998)Nature396,594?598
	7.Zhang,W.,andBieker,J.J.(1998)Proc.Natl.Acad.Sci.U.S.A.95,9855?9860
	8.Gingras,S.,Simard,J.,Groner,B.,andPfitzner,E.(1999)NucleicAcidsRes.27,2722?2729
	9.Hung,H.L.,Lau,J.,Kim,A.Y.,Weiss,M.J.,andBlobel,G.A.(1999)Mol.Cell.Biol.19,3496?3505
	10.Yang,X.J.,Ogryzko,V.V.,Nishikawa,J.,Howard,B.H.,andNakatani,Y.(1996)Nature382,319?324
	11.Bannister,A.J.,andKouzarides,T.(1996)Nature384,641?643
	12.Wolffe,A.P.,andHayes,J.J.(1999)NucleicAcidsRes.27,711?720
	13.Nakajima,T.,Uchida,C.,Anderson,S.F.,Lee,C.G.,Hurwitz,J.,Parvin,J.D.,andMontminy,M.(1997)Cell90,1107?1112
	14.Cho,H.,Orphanides,G.,Sun,X.,Yang,X.J.,Ogryzko,V.,Lees,E.,Nakatani,Y.,andReinberg,D.(1998)Mol.Cell.Biol.18,5355?5363
	15.Kamei,Y.,Xu,L.,Heinzel,T.,Torchia,J.,Kurokawa,R.,Gloss,B.,Lin,S.C.,Heyman,R.A.,Rose,D.W.,Glass,C.K.,andRosenfeld,M.G.(1996)Cell85,403?414
	16.Kwok,R.P.,Lundblad,J.R.,Chrivia,J.C.,Richards,J.P.,Bachinger,H.P.,Brennan,R.G.,Roberts,S.G.,Green,M.R.,andGoodman,R.H.(1994)Nature370,223?226
	17.Parker,D.,Ferreri,K.,Nakajima,T.,LaMorte,V.J.,Evans,R.,Koerber,S.C.,Hoeger,C.,andMontminy,M.R.(1996)Mol.Cell.Biol.16,694?703
	18.Radhakrishnan,I.,Perez-Alvarado,G.C.,Parker,D.,Dyson,H.J.,Montminy,M.R.,andWright,P.E.(1997)Cell91,741?752
	19.Schwabe,J.W.,andKlug,A.(1994)Nat.Struct.Biol.1,345?349
	20.Mackay,J.P.,andCrossley,M.(1998)TrendsBiochem.Sci.23,1?4
	21.Johnson,M.L.,Correia,J.J.,Yphantis,D.A.,andHalvorson,H.R.(1981)Biophys.J.36,575?588
	22.Hayes,D.B.,Laue,T.,andPhilo,J.(1995)SEDNTERP,UniversityofNewHampshire,Durham,NH
	23.Bax,A.,andDavis,D.G.(1985)J.Magn.Reson.65,355?360
	24.Kumar,A.,Ernst,R.R.,andWuï¿½thrich,K.(1980)Biochem.Biophys.Res.Commun.95,1?6
	25.Piantini,U.,Sï¿½rensen,O.W.,andErnst,R.R.(1982)J.Am.Chem.Soc.104,6800?6801
	26.Kowalski,K.,Czolij,R.,King,G.F.,Crossley,M.,andMackay,J.P.(1999)J.Biomol.NMR13,249?262ZincBundleswithinCBP15133
	27.Ausubel,F.,Brent,R.,Kingston,R.E.,Moore,D.D.,Seidman,J.G.,Smith,J.A.,andStruhl,K.(1997)ShortProtocolsinMolecularBiology,3rdEd.,JohnWiley&Sons,Inc.,NewYork
	28.Sambrook,J.,Fritsch,E.F.,andManiatis,T.(1989)MolecularCloning:ALaboratoryManual,2ndEd.,ColdSpringHarborLaboratory,ColdSpringHarbor,NY
	29.Wuï¿½thrich,K.(1986)NMRofProteinsandNucleicAcids,JohnWiley&Sons,Inc.,NewYork
	30.Wishart,D.S.,Sykes,B.D.,andRichards,F.M.(1992)Biochemistry31,1647?1651
	31.Bisotto,S.,Minorgan,S.,andRehfuss,R.P.(1996)J.Biol.Chem.271,17746?17750
	32.Swope,D.L.,Mueller,C.L.,andChrivia,J.C.(1996)J.Biol.Chem.271,28138?28145
	33.Yoshida,E.,Nakajima,T.,Murakami,K.,andFukamizu,A.(1998)Gene(Amst.)208,307?314
	34.Arany,Z.,Huang,L.E.,Eckner,R.,Bhattacharya,S.,Jiang,C.,Goldberg,M.A.,Bunn,H.F.,andLivingston,D.M.(1996)Proc.Natl.Acad.Sci.U.S.A.93,12969?12973
	35.Gerritsen,M.E.,Williams,A.J.,Neish,A.S.,Moore,S.,Shi,Y.,andCollins,T.(1997)Proc.Natl.Acad.Sci.U.S.A.94,2927?2932
	36.Bhattacharya,S.,Michels,C.L.,Leung,M.K.,Arany,Z.P.,Kung,A.L.,andLivingston,D.M.(1999)GenesDev.13,64?75
	37.Wang,G.L.,andSemenza,G.L.(1995)J.Biol.Chem.270,1230?1237
	38.Thanos,D.,andManiatis,T.(1995)Cell80,529?532
	39.Glenn,D.J.,andMaurer,R.A.(1999)J.Biol.Chem.274,36159?36167
	40.Schmeichel,K.L.,andBeckerle,M.C.(1994)Cell79,211?219
	41.Saurin,A.J.,Borden,K.L.,Boddy,M.N.,andFreemont,P.S.(1996)TrendsBiochem.Sci.21,208?214
	42.Fox,A.H.,Liew,C.,Holmes,M.,Kowalski,K.,Mackay,J.,andCrossley,M.(1999)EMBOJ.18,2812?2822
	43.Shioda,T.,Lechleider,R.J.,Dunwoodie,S.L.,Li,H.,Yahata,T.,deCae-stecker,M.P.,Fenner,M.H.,Roberts,A.B.,andIsselbacher,K.J.(1998)Proc.Natl.Acad.Sci.U.S.A.959785?9790
	44.Saha,V.,Chaplin,T.,Gregorini,A.,Ayton,P.,andYoung,B.D.(1995)Proc.Natl.Acad.Sci.U.S.A.92,9737?9741
	45.Aasland,R.,Gibson,T.J.,andStewart,A.F.(1995)TrendsBiochem.Sci.20,56?59
J. Biol. Chem.-2000-Shanmugavelu-1802-6.pdf	27
	1.Hammock,B.D.(1985)inComprehensiveInsectPhysiology,Biochemistry,andPharmacology(Kerkut,G.A.,andGilbert,L.I.,eds)pp.431?72,PergamonPress,NewYork
	2.Abdel-Aal,Y.A.I.,andHammock,B.D.(1986)Science233,1073?1076
	3.Wroblewski,V.J.,Harshman,L.G.,Hanzlik,T.N.,andHammock,B.D.(1990)Arch.Biochem.Biophys.278,461?466
	4.Crossley,A.C.(1985)inComprehensiveInsectPhysiology,Biochemistry,andPharmacology(Kerkut,G.A.,andGilbert,L.I.,eds)pp.487?515,PergamonPress,NewYork
	5.Locke,M.,andRussell,V.W.(1998)inMicroscopicAnatomyofInvertebrates.(Harrison,F.W.,andLocke,M.,eds)Vol.11B,pp.687?709,Wiley-LissInc.,NewYork
	6.Booth,T.F.,Bonning,B.C.,andHammock,B.D.(1992)Tissue&Cell24,267?282
	7.Ichinose,R.,Nakamura,A.,Yamoto,T.,Booth,T.F.,Maeda,S.,andHammock,B.D.(1992)InsectBiochem.Mol.Biol.22,893?904
	8.Ichinose,R.,Kamita,S.G.,Maeda,S.,andHammock,B.D.(1992)Pestic.Biochem.Physiol.42,13?23
	9.Bonning,B.C.,Booth,T.F.,andHammock,B.D.(1997)Arch.InsectBiochem.Physiol.34,275?286
	10.Bonning,B.C.,Ward,V.K.,vanMeer,M.,Booth,T.F.,andHammock,B.D.(1997)Proc.Natl.Acad.Sci.U.S.A.94(12),6007?6012
	11.Chomczynski,P.,andSacchi,N.(1987)Anal.Biochem.162,156?159
	12.Vaughn,J.L.,Goodwin,R.H.,Tompkins,G.J.,andMcCawley,P.(1977)InVitro13,213?217
	13.Bonning,B.C.,Hirst,M.,Possee,R.D.,andHammock,B.D.(1992)InsectBiochem.Mol.Biol.22,453?458
	14.O?Reilly,D.R.,Miller,L.K.,andLuckow,V.A.(1992)BaculovirusExpressionVectorsaLaboratoryManual,W.H.FreemanandCompany,NewYork
	15.Hammock,B.D.,andRoe,R.M.(1985)MethodsinEnzymol.111,487?495
	16.Hammock,B.D.,Bonning,B.,Possee,R.D.,Hanzlik,T.N.,andMaeda,S.(1990)Nature344,458?461
	17.Crameri,R.,andSuter,M.(1993)Gene137,69?75
	18.Crameri,R.,Jaussi,R.,Menz,G.,andBlaser,K.(1994)Eur.J.Biochem.226,53?58
	19.Altschul,S.F.,Gish,W.,Miller,W.M.,Eyers,E.W.,andLipman,D.J.(1990)J.Mol.Biol.215,403?410
	20.Luo,W.,andLin,S.(1997)BioTechniques23,631?632
	21.Sambrook,J.,Fritsch,E.F.,andManiatis,T.(1989)MolecularCloning,ALaboratoryManual,ColdSpringHarborLaboratory,NewYork
	22.Snyder,M.J.,Walding,J.K.,andFeyereisen,F.(1995)InsectBiochem.Mol.Biol.25,455?465
	23.Snyder,M.J.,Stevens,J.L.,Anderson,J.F.,andFeyereisen,R.(1995)Arch.InsectBiochem.Biophys.321,13?20
	24.Bonning,B.C.,Possee,R.D.,andHammock,B.D.(1999)J.Invertebr.Pathol.73,234?236
	25.Haunerland,N.H.(1996)InsectBiochem.Molec.Biol.26,755?765
	26.Hanzlik,T.N.,Abdel-Aal,Y.A.I.,Harshman,L.G.,andHammock,B.D.(1989)J.Biol.Chem.264,12419?12425
	27.Carcamo,J.,Ravera,M.W.,Brissette,R.,Dedova,O.,Beasley,J.R.,Alam-Moghe,A.,Wan,C.,Blume,A.,andMandecki,W.(1998)Proc.Natl.Acad.Sci.U.S.A.95,11146?11151
J. Biol. Chem.-2000-Choi-1723-30.pdf	52
	1.Zeevaart,J.A.D.,andCreelman,R.A.(1988)Annu.Rev.PlantPhysiol.PlantMol.Biol.39,439?473
	2.Leung,J.,andGiraudat,J.(1998)Annu.Rev.PlantPhysiol.PlantMol.Biol.49,199?222
	3.Shinozaki,K.,andYamaguchi-Shinozaki,K.(1996)Curr.Opin.Biotechnol.7,161?167
	4.Thomashow,M.F.(1998)PlantPhysiol.118,1?7
	5.Ingram,J.,andBartels,D.(1996)Annu.Rev.PlantPhysiol.PlantMol.Biol.47,377?403
	6.Busk,P.K.,andPages,M.(1998)PlantMol.Biol.37,425?435
	7.Guiltinan,M.J.,Marcotte,W.R.,andQuatrano,R.S.(1990)Science250,267?271
	8.Giuliano,G,Pichersky,E.,Malik,V.S.,Timko,M.P.,Scolnik,P.A.,andCashmore,A.R.(1988)Proc.Natl.Acad.Sci.U.S.A.85,7089?7093
	9.Menkens,A.E.,Schindler,U.,andCashmore,A.R.(1995)TrendBiochemSci.20,506?510
	10.Izawa,T.,Foster,R.,andChua,N.-H.(1993)J.Mol.Biol.230,1131?1144
	11.Oeda,K.,Salinas,J.,andChua,N.-H.(1991)EMBOJ.10,1793?1802
	12.Schindler,U.,Menkens,A.E.,Beckmann,H.,Ecker,J.R.,andCashmore,A.R.(1992)EMBOJ.4,1261?1273
	13.Lu,G.,Paul,A.-L.,McCartyD.R.,andFerl,R.J.(1996)PlantCell8,847?857
	14.Kim,S.Y.,andThomas,T.L.(1998)J.PlantPhysiol.152,607?613
	15.Kim,S.Y.,Chung,H.-J.,andThomas,T.L.(1997)PlantJ.11,1237?1251
	16.Foster,R.,Izawa,T.,andChua,N.-H.(1994)FASEBJ.8,192?200
	17.Meshi,T.,andIwabuchi,M.(1995)PlantCellPhysiol.36,1405?1420
	18.Kusano,T.,Berberich,T.,Harada,M.,Suzuki,N.,andSugawara,K.(1995)Mol.Gen.Genet.248,507?517
	19.Nakagawa,H.,Ohmiya,K.,andHattori,T.(1996)PlantJ.9,217?227
	20.Yamaguchi-Shinozaki,K.,andShinozaki,K.(1994)PlantCell6,251?264
	21.Busk,P.K.,Jensen,A.B.,andPages,M.(1997)PlantJ.11,1285?1295
	22.Ono,A.,Izawa,T.,Chua,N.-H.,andShimamoto,K.(1996)PlantPhysiol.112,483?491
	23.Chung,H.-J.(1996)Analysisofthe59UpstreamRegionoftheCarrotDc3Gene:BipartiteStructureoftheDc3PromoterforEmbryo-specificandABA-inducibleExpression.DoctoralDissertation,TexasA&MUniversity
	24.Pla,M.,Vilardell,J.,Guiltinan,M.J.,Marcotte,W.R.,Niogret,M.F.,Quatrano,R.S.,andPages,M.(1993)PlantMol.Biol.21,259?266
	25.Ausubel,F.M.,Brent,R.,Kingston,R.E.,Moore,D.D.,Seidman,J.G.,Smith,J.A.,andStruhl,K.(1994)CurrentProtocolsinMolecularBiology,GreenPublishingAssociates/WileyInterscience,NewYork
	26.Sambrook,J.,Fritsch,E.F.,andManiatis,T.(1989)MolecularCloning:ALaboratoryManual,2ndEd.,ColdSpringHarborLaboratory,ColdSpringHarbor,NY
	27.Guthrie,C.,andFink,G.R.(eds)(1991)GuidetoYeastGeneticsandMolecularBiology,MethodsinEnzymology,Vol.194,AcademicPress,SanDiego
	28.Altschul,S.F.,Gish,W.,Miller,W.,Myers,E.W.,andLipman,D.J.(1990)J.Mol.Biol.215,403?410
	29.Thompson,J.D.,Higgins,D.G.,andGibson,T.J.(1994)NucleicAcidsRes.22,4673?4680
	30.Chomczynski,P.,andMackey,K.(1995)Biotechniques19,942?945
	31.Ma,J.,andPtashne,M.(1987)Cell51,113?119
	32.Landschulz,W.H.,Johnson,P.F.,andMcKnight,S.L.(1988)Science240,1759?1764
	33.Kemp,B.E.,andPearson,R.B.(1990)TrendsBiochem.Sci.15,342?346
	34.Lam,E.,andChua,N.-H.(1991)J.Biol.Chem.266,17131?17135
	35.Pollock,R.,andTreisman.R.(1990)NucleicAcidsRes.18,6197?6204
	36.Thomas,T.L.,Chung,H.-J.,andNunberg,A.N.(1997)inSignalTransductioninPlants(Aducci,P.ed.)pp.23?43,BirkhaeuserVerlag,Basel,Switzerland
	37.deBruxellesG.L.,Peacock,W.J.,Dennis,E.S.,andDolferus,R.(1996)PlantPhysiol.111,381?391
	38.Jaglo-Ottosen,K.R.,GilmourS.J.,Zarka,D.G.,Schabenberger,andThomashow,M.F.(1998)Science280,104?106
	39.Liu,Q,Kasuga,M.,Sakuma,Y.,Abe,H.,Miura,S.,Yamaguchi-Shinozaki,K.,andShinozaki,K.(1998)PlantCell10,1391?1406
	40.Hollung,K.,Espelund,M.,Schou,K.,andJakobsen,K.S.(1997)PlantMol.Biol.35,561?571
	41.Ishitani,M.,Xiong,L.,Stevenson,B.,andZhu,J.-K.(1997)PlantCell9,1935?1949
J Pharmacol Exp Ther-2000-Cousins-104-13.pdf	40
	AndersonIMandCowenPJ(1992)Effectofpindololonendocrineandtemperatureresponsestobuspironeinhealthyvolunteers.PsychopharmacolSer(Berl)106:428?432.
	AndersonIM,CowenPJandGrahame-SmithDG(1990)Theeffectsofgepironeonneuroendocrinefunctionandtemperatureinhumans.PsychopharmacolSer(Berl)100:498?503.
	AzmitiaEC(1981)Bilateralserotonergicprojectionstothedorsalhippocampusoftherat:Simultaneouslocalizationof3H?5HTandHRPafterretrogradetransport.JCompNeurol203:737?743.
	Balcells-OliveroM,CousinsMSandSeidenLS(1998)HoltzmanandHarlanSprague-Dawleyrats:Differencesin72-secperformanceand8-hydroxy-di-propylamino-tetralin-inducedhypothermia.JPharmacolExpTher286:742?752.
	ChenNHandReithME(1994)Effectsoflocallyappliedcocaine,lidocaine,andvariousuptakeblockersonmonoaminetransmissionintheventraltegmentalareaoffreelymovingrats:Amicrodialysisstudyonmonoamineinterrelationships.JNeurochem63:1701?1713.
	CousinsMSandSalamoneJD(1996)Involvementofventrolateralstriataldopamineinmovementinitiationandexecution:Amicrodialysisandbehavioralinvestiga-tion.Neuroscience70:849?859.
	CowenPJ,PowerAC,WareCJandAndersonIM(1994)5-HT1Areceptorsensitivityinmajordepression.Aneuroendocrinestudywithbuspirone.BrJPsychiatry164:372?379.112Cousinsetal.Vol.292
	DeVryJ(1995)5-HT1Areceptoragonists:Recentdevelopmentsandcontroversialissues.PsychopharmacolSer(Berl)121:1?26.
	FletcherPJ(1994)Effectsof8-OH-DPAT,5-CTandmuscimolonbehaviourmain-tainedbyaDRL20scheduleofreinforcement,followingmicroinjectionintothedorsalormedianraphenuclei.BehavPharmacol5:326?336.
	FletcherPJ(1995)Effectsofcombinedorseparate5,7-dihydroxytryptaminelesionsofthedorsalandmedianraphenucleionrespondingmaintainedbyaDRL20sscheduleoffoodreinforcement.BrainRes675:45?54.
	ForsterEA,CliffeIA,BillDJ,DoverGM,JonesD,ReillyYandFletcherA(1995)Apharmacologicalprofileoftheselectivesilent5-HT1Areceptorantagonist,WAY-100635.EurJPharmacol281:81?88.
	FowlerSCandLiouJR(1994)Microcatalepsyanddisruptionofforelimbusageduringoperantbehavior:DifferencesbetweendopamineD1(SCH-23390)andD2(raclopride)antagonists.Psychopharmacology115:24?30.
	GershonES,BadnerJA,GoldinLR,SandersAR,CravchikAandDetera-WadleighSD(1998)Closinginongenesformanic-depressiveillnessandschizophrenia.Neuropsychopharmacology18:233?242.
	GonzalezLE,FileSEandOverstreetDH(1998)Selectivelybredlinesofratsdifferinsocialinteractionandhippocampal5-HT1Areceptorfunction:Alinkbetweenanxietyanddepression?PharmacolBiochemBehav59:787?792.
	GudelskyGA,KoenigJIandMeltzerHY(1986)Thermoregulatoryresponsestoserotonin(5-HT)receptorstimulationintherat:Evidenceforopposingrolesof5-HT2and5-HT1Areceptors.Neuropharmacology25:1307?1313.
	GuptaML,GuptaTKandBhargavaKP(1967)Centralanticholinergicactivityofimipramineandallieddrugs.CanJPhysiolPharmacol45:353?355.
	HeffnerTG,HartmanJAandSeidenLS(1980)Arapidmethodfortheregionaldissectionoftheratbrain.PharmacolBiochemBehav13:453?456.
	JollyDC,RichardsJBandSeidenLS(1999)SerotonergicmediationofDRL72-sbehavior:Receptorsubtypeinvolvementinabehavioralscreenforantidepressantdrugs.BiolPsychiatry45:1151?1162.
	JordanS,KramerGL,ZukasPK,MoellerMandPettyF(1994)Invivobiogenicamineeffluxinmedialprefrontalcortexwithimipramine,fluoxetine,andfluvox-amine.Synapse(NY)18:294?297.
	KeppelG(1991)DesignandAnalysis:AResearcher?sHandbook,Prentice-Hall,Inc.,UpperSaddleRiver,NJ.
	KnappDJ,OverstreetDHandCrewsFT(1998)Brain5-HT1Areceptorautoradiog-raphyandhypothermicresponsesinratsbredfordifferencesin8-OH-DPATsensitivity.BrainRes782:1?10.
	KoenigJI,MeltzerHYandGudelskyGA(1988)5-Hydroxytryptamine1Areceptor-mediatedeffectsofbuspirone,gepironeandipsapirone.PharmacolBiochemBehav29:711?715.
	KostowskiW,DyrW,KrzascikP,JarbeTandArcherT(1992)5-Hydroxytrypt-amine1Areceptoragonistsinanimalmodelsofdepressionandanxiety.PharmacolToxicol71:24?30.
	LeschKP,MayerS,Disselkamp-TietzeJ,HohA,SchoellnhammerGandSchulteHM(1990)Subsensitivityofthe5-hydroxytryptamine1A(5-HT1A)receptor-mediatedhypothermicresponsetoipsapironeinunipolardepression.LifeSci46:1271?1277.
	LinMT,WuJJandTsayBL(1983)Serotonergicmechanismsinthehypothalamusmediatethermoregulatoryresponsesinrats.Naunyn-Schmiedeberg?sArchPhar-macol322:271?278.
	LuckiI(1998)Thespectrumofbehaviorsinfluencedbyserotonin.BiolPsychiatry44:151?162.
	MarekGJ,LiAAandSeidenLS(1989)Evidenceforinvolvementof5-hydroxy-tryptamine1receptorsinantidepressant-likedrugeffectsondifferential-reinforcement-of-low-rate72-secondbehavior.JPharmacolExpTher250:60?
	McGuirePSandSeidenLS(1980)Theeffectsoftricyclicantidepressantsonperfor-manceunderadifferential-reinforcement-of-low-ratesscheduleinrats.JPhar-macolExpTher214:635?641.
	MeltzerHYandMaesM(1995)Effectsofipsapironeonplasmacortisolandbodytemperatureinmajordepression.BiolPsychiatry38:450?457.
	OverstreetDH,DawsLC,SchillerGD,OrbachJandJanowskyDS(1998)Cholin-ergic/serotonergicinteractionsinhypothermia:Implicationsforratmodelsofdepression.PharmacolBiochemBehav59:777?785.
	OverstreetDH,RezvaniAH,KnappDJ,CrewsFTandJanowskyDS(1996)Furtherselectionofratlinesdifferingin5-HT1Areceptorsensitivity:Behavioralandfunctionalcorrelates.PsychiatrGenet6:107?117.
	OverstreetDH,RezvaniAH,PucilowskiO,GauseLandJanowskyDS(1994)Rapidselectionforserotonin-1Asensitivityinrats.PsychiatrGenet4:57?62.
	PollardGTandHowardJL(1986)Similareffectsofantidepressantandnon-antidepressantdrugsonbehaviorunderaninterresponse-timegreaterthan72-sschedule.PsychopharmacolSer(Berl)89:253?258.
	PorsoltRD,AntonG,BlavetNandJalfreM(1978)Behaviouraldespairinrats:Anewmodelsensitivetoantidepressanttreatments.EurJPharmacol47:379?391.
	RichardsJB,SabolKEandSeidenLS(1993a)DRLinterresponse-timedistributions:Quantificationbypeakdeviationanalysis.JExpAnalBehav60:361?385.
	RichardsJB,SabolKEandSeidenLS(1993b)Fluoxetinepreventsthedisruptiveeffectsoffenfluramineondifferential-reinforcement-of-low-rate72-secondsched-uleperformance.JPharmacolExpTher267:1256?1263.
	RichardsJBandSeidenLS(1991)Aquantitativeinterresponse-timeanalysisofDRLperformancedifferentiatessimilareffectsoftheantidepressantdesipramineandthenovelanxiolyticgepirone.JExpAnalBehav56:173?192.
	SchreiberRandDeVryJ(1993)Neuroanatomicalbasisfortheantidepressant-likeeffectsofthe5-HT1Areceptoragonists8-OH-DPATandipsapironeintheratforcedswimmingtest.BehavPharmacol4:625?636.
	TatarczynskaEandChojnacka-WojcikE(1989)Effectsof8-OH-DPATandipsapi-roneinthetestsusedforevaluationoftheantidepressantaction.PolJPharmacolPharm41:321?330.
	WogarMA,BradshawCMandSzabadiE(1993)Doestheeffectofcentral5-hydroxy-tryptaminedepletionontimingdependonmotivationalchange?Psychopharma-cology112:86?92
76.full.pdf	47
	AghajanianGKandMarekGJ(1997)Serotonininducesexcitatorypostsynapticpotentialsinapicaldendritesofneocorticalpyramidalcells.Neuropharmacology36:589?599.
	AghajanianGKandMarekGJ(1999a)Serotonin,via5-HT2Areceptors,increasesEPSCsinlayerVpyramidalcellsofprefrontalcortexbyanasynchronousmodeofglutamaterelease.BrainRes825:161?171.
	AghajanianGKandMarekGJ(1999b)Serotonin-glutamateinteractions:Anewtargetforantipsychoticdrugs.Neuropsychopharmacology,inpress.
	AghajanianGKandRasmussenK(1989)Intracellularstudiesinthefacialnucleusillustratingasimplenewmethodforobtainingviablemotoneuronsinadultratbrainslices.Synapse3:331?338.
	ArunlakshanaOandSchildHO(1959)Somequantitativeusesofdrugantagonists.BrJPharmacol14:48?58.
	BerendseHWandGroenewegenHJ(1991)Restrictedcorticalterminationfieldsofthemidlineandintralaminarthalamicnucleiintherat.Neuroscience42:73?102.
	BlueME,YagaloffKA,MamounasLA,HartigPRandMolliverME(1988)Corre-spondencebetween5-HT2receptorsandserotonergicaxonsinratneocortex.BrainRes453:315?328.
	ConnPJandPinJ-P(1997)Pharmacologyandfunctionsofmetabotropicglutamatereceptors.AnnuRevPharmacolToxicol37:205?237.
	ConnorsBWandGutnickMJ(1990)Intrinsicfiringpatternsofdiverseneocorticalneurons.TrendsNeurosci13:99?104.
	deBoerT(1996)Thepharmacologicprofileofmirtazepine.JClinPsychiatry57:19?
	EisonAS,EisonMS,TorrenteJR,WrightRNandYoccaFD(1990)Nefazodone:Preclinicalpharmacologyofanewantidepressant.PsychopharmacolBull26:311?315.
	FitzjohnSM,BortolottoZA,PalmerMJ,DohertyAJ,OrnsteinPL,SchoeppDD,KingstonAE,LodgeDandCollingridgeGL(1998)ThepotentmGlureceptorantagonistLY341495identifiesrolesforbothclonedandnovelmGlureceptorsinhippocampalsynapticplasticity.Neuropharmacology37:1445?1458.
	GodaYandStevensCF(1994)Twocomponentsoftransmitterreleaseatacentralsynapse.ProcNatlAcadSciUSA91:12942?12946.
	HeltonDR,TizzanoJP,MonnJA,SchoeppDDandKallmanMJ(1997)LY354740:Ametabotropicglutamatereceptoragonistwhichamelioratessymptomsofnicotinewithdrawalinrats.Neuropharmacology36:1511?1516.
	HeltonDR,TizzanoJP,MonnJA,SchoeppDDandKallmanMJ(1998)Anxiolyticandside-effectprofileofLY354740:Apotent,highlyselective,orallyactiveagonistforGroupIImetabotropicglutamatereceptors.JPharmacolExpTher284:651?660.
	JohnsonBG,WrightRA,ArnoldMB,WheelerWJ,OrnsteinPLandSchoeppDD(1999)[3H]-LY341495asanovelantagonistradioligandforgroupIImetabotropicglutamate(mGlu)receptors:CharacterizationofbindingtomembranesofmGlureceptorsubtypeexpressingcells.Neuropharmacology,38:1519?1529.
	KingstonAE,OrnsteinPL,WrightRA,JohnsonBG,MayneNG,BurnettJP,Bel-agajeR,WuSandSchoeppDD(1998)LY341495isananomolarpotentandselectiveantagonistofgroupIImetabotropicglutamatereceptors.Neuropharma-cology37:1?12.
	KroezeWKandRothBL(1998)Themolecularbiologyofserotoninreceptors:Ther-apeuticimplicationsfortheinterfaceofmoodandpsychosis.BiolPsychiatry44:1128?1142.
	LiH,WeissSRB,ChuangD-M,PostRMandRogawskiMA(1998)Bidirectionalsynapticplasticityintheratbasolateralamygdala:Characterizationofanactiv-ity-dependentswitchsensitivetothepresynapticmetabotropicglutamatereceptorantagonist2S-a-ethylglutamicacid.JNeurosci18:1662?1670.
	LovingerDMandMcCoolBA(1995)Metabotropicglutamatereceptor-mediatedpresynapticdepressionatcorticostriatalsynapsesinvolvesmGlu2or3.JNeuro-physiol73:1076?1083.
	MarekGJandAghajanianGK(1998a)5-HT-inducedEPSCsinneocorticallayerVpyramidalcells:Suppressionbym-opiatereceptoractivation.Neuroscience86:485?497.
	MarekGJandAghajanianGK(1998b)Theelectrophysiologyofprefrontal5-HTsystems:Therapeuticimplicationsformoodandpsychosis.BiolPsychiatry44:1118?1127.
	MarekGJandAghajanianGK(1999)5-HT2Areceptorora1-adrenoceptoractivationinducesexcitatorypostsynapticcurrentsinlayerVpyramidalcellsofthemedialprefrontalcortex.EurJPharmacol367:197?206.
	MarekGJandGewirtzJC(1999)Serotonin2Areceptor-inducedEPSCsinlayerVpyramidalcellsofprefrontalcortex:Blockbylesionsofmedialthalamus.SocNeurosciAbstr25:449.
	MarekGJ,McDougleCJ,PriceLHandSeidenLS(1992)Acomparisonoftrazodoneandfluoxetine:Implicationsforaserotonergicmechanismofantidepressantac-tion.Psychopharmacology109:2?11.
	McCormickDA,ConnorsBW,LighthallJWandPrinceDA(1985)Comparativeelectrophysiologyofpyramidalandsparselyspinyneuronsoftheneocortex.JNeu-rophysiol54:782?806.
	MoghaddamBandAdamsBW(1998)ReversalofphencyclidineeffectsbyagroupIImetabotropicglutamatereceptoragonistsinrats.Science(WashDC)281:1349?1352.
	MonnJA,ValliMJ,MasseySM,HansenMM,KressTJ,WepsiecJP,HarknessAR,GrutschJL,WrightRA,JohnsonBG,AndisSL,KingstonA,TomlinsonR,LewisR,GriffeyKR,TizzanoJPandSchoeppDD(1999)Synthesis,pharmacologicalcharacterization,andmolecularmodelingofheterobicyclicaminoacidsrelatedto(1)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylicacid(LY354740):Identificationoftwonewpotent,selectiveandsystemicallyactiveagonistsforgroupIImetabo-tropicglutamatereceptors.JMedChem42:1027?1040.
	MonnJA,ValliMJ,MasseySM,WrightRA,SalhoffCR,JohnsonBG,HoweT,AltCA,RhodesGA,RobeyRL,GriffeyKR,TizzanoJP,KallmanMJ,HeltonDRandSchoeppDD(1997)Design,synthesis,andpharmacologicalcharacterizationof(1)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylicacid(LY354740):Apotent,selec-tive,andorallyactivegroup2metabotropicglutamatereceptoragonistpossessinganticonvulsantandanxiolyticproperties.JMedChem40:528?537.
	OhishiH,AkazawaC,ShigemotoR,NakanishiSandMizunoN(1995)DistributionsofthemRNAsforL-2-amino-4-phosphonobutyrate-sensitivemetabotropicgluta-matereceptors,mGluR4andmGluR7,intheratbrain.JCompNeurol360:555?570.
	OhishiH,NekiAandMizunoN(1997)Distributionofametabotropicglutamatereceptor,mGluR2,inthecentralnervoussystemoftheratandmouse:Animmu-nohistochemicalstudywithamonoclonalantibody.NeurosciRes30:65?82.
	OhishiH,ShigemotoR,NakanishiSandMizunoN(1993a)DistributionofthemessengerRNAforametabotropicglutamatereceptor,mGluR2,inthecentralnervoussystemoftherat.Neuroscience53:1009?1018.
	OhishiH,ShigemotoR,NakanishiSandMizunoN(1993b)DistributionofthemRNAforametabotropicglutamatereceptor(mGluR3)intheratbrain:Aninsituhybridizationstudy.JCompNeurol335:252?266.
	PaxinosGandWatsonC(1986)TheRatBraininStereotaxicCoordinates,2nded.,plates9and10,AcademicPress,NewYork.
	PetraliaRS,WangY-X,NiedzielskiASandWentholdRJ(1996)Themetabotropicglutamatereceptors,mGluR2andmGluR3,showuniquepostsynaptic,presynap-ticandgliallocalizations.Neuroscience71:949?976.
	RichelsonEandNelsonA(1984)Antagonismbyantidepressantsofneurotransmit-terreceptorsofnormalhumanbraininvitro.JPharmacolExpTher230:94?102.
	SaugstadJA,KinzieJM,ShinoharaMM,SegersonTPandWestbrookGL(1997)Cloningandexpressionofratmetabotropicglutamatereceptor8revealsadistinctpharmacologicalprofile.JPharmacolExpTher51:119?125.
	ScanzianiM,SalinPA,VogtKE,MalenkaRCandNicollRA(1997)Use-dependentincreasesinglutamateconcentrationactivatepresynapticmetabotropicglutamatereceptors.Nature(Lond)385:630?634.
	SchillerJ,SchillerY,StuartGandSakmanB(1997)Calciumactionpotentialsrestrictedtodistalapicaldendritesofratneocorticalpyramidalcells.JPhysiol505:605?616.
	SchoeppDD,JaneDEandMonnJA(1999)Pharmacologicalagentsactingatsub-typesofmetabotropicglutamatereceptors.Neuropharmacology38:1431?1476.
	SchoeppDD,JohnsonBG,WrightRA,SalhoffCR,MayneNG,WuS,CockerhamSL,BurnettJP,BelagajeR,BleakmanDandMonnJA(1997)LY354740isapotentandhighlyselectivegroupIImetabotropicglutamatereceptoragonistincellsexpressinghumanglutamatereceptors.Neuropharmacology36:1?11.
	SchoeppDD,JohnsonBG,WrightRA,SalhoffCRandMonnJA(1998)Potent,stereoselective,andbrainregionselectivemodulationofsecondmessengersintheratbrainby(1)LY354740,anovelgroupIImetabotropicglutamatereceptoragonist.Naunyn-Schmiedeberg?sArchPharmacol358:175?180.
	SchwindtPCandCrillWE(1997)Localandpropagateddendriticactionpotentialsevokedbyglutamateiontophoresisonratneocorticalpyramidalneurons.JNeu-rophysiol77:2466?2483.
	VanderKlootW(1991)Theregulationofquantalsize.ProgNeurobiol(NY)36:93?130.
	VollenweiderFX,Vollenweider-ScherpenhuyzenMFI,BablerA,VogelHandHellD(1998)Psilocybininducesschizophrenia-likepsychosisinhumansviaaseroto-nin-2agonistaction.Neuroreport9:3897?3902.
	WanderTJ,NelsonA,OkazakiHandRichelsonE(1986)Antagonismbyantide-pressantsofserotoninS1andS2receptorsofnormalhumanbraininvitro.EurJPharmacol132:115?121.
	WrightRA,McDonaldJWandSchoeppDD(1994)Distributionandontogenyof1S,3R-1-aminocyclopentane-1,3-dicarboxylicacidsensitiveandquisqualateinsen-sitive[3H]glutamatebindingsitesintheratbrain.JNeurochem63:938?945.
J Pharmacol Exp Ther-2000-Bauer-31-7.pdf	29
	BerlinJ,TutschKD,HutsonP,ClearyJ,RagoRP,ArzoomanianRZ,AlbertiD,FeierabendCandWildingG(1997)PhaseIclinicalandpharmacokineticstudyoforalcarboxyamidotriazole,asignaltransductioninhibitor.JClinOncol15:781?789.
	BerridgeMJandIrvineRF(1989)Inositolphosphatesandcellsignaling.Nature(Lond)341:197?205.
	FiggWD,ColeKA,ReedE,SteinbergSM,PiscitelliSC,DavisPA,SoltisMJ,JacobJ,BoudoilasS,GoldspielB,SarosyG,LiottaLAandKohnEC(1995)Pharmaco-kineticsoforallyadministeredcarboxyamido-triazole,aninhibitorofcalciummediatedsignaltransduction.ClinCancerRes1:797?803.
	FolkmanJ(1966)Tumorbehaviorinisolatedperfuseorgans:Invitrogrowthandmetastasesofbiopsymaterialinrabbitthyroidandcanineintestinalsegments.AnnSurg164:493?502.
	FolkmanJ(1971)Tumorangiogenesis:Therapeuticimplications.NEnglJMed285:1182?1186.
	FrankS,KolbN,WernerERandPfeilschifterJ(1998)CoordinatedinductionofinduciblenitricoxidesynthaseandGTP-cyclohydrolaseIisdependentoninflam-matorycytokinesandinterferon-gammainHaCaTkeratinocytes:Implicationsforthemodelofcutaneouswoundrepair.JInvestDermatol111:1065?1071.
	GimroneMAJr,AsterRHandCotranRS(1969)Preservationofvascularintegrityinorgansperfusedinvitrowithaplatelet-richmedium.Nature(Lond)221:33?36.
	GusovskyF,LuedersJE,KohnECandFelderCC(1993)Muscarinicreceptor-mediatedtyrosinephosphorylationofphospholipaseC-gamma.JBiolChem268:7768?7772.
	HortiJ,DixonSC,LogothetisCJ,GuoY,ReedEandFiggWD(1999)Increasedtranscriptionalactivityofprostate-specificantigeninthepresenceofTNP-470,anangiogenesisinhibitor.BrJCancer79:1588?1593.
	HupeDJ,BehrensNDandBoltzR(1990)Anti-proliferativeactivityofL-651,582correlateswithcalcium-mediatedregulationofnucleotidemetabolismatphospho-ribosylpyrophosphatesynthetase.JCellPhysiol144:457?466.
	HupeDJ,BoltzR,CohenCJ,FelixJ,HamE,MillerD,SodermanDandVanSkiverD(1991)Theinhibitionofreceptor-mediatedandvoltage-dependentcalciumentrybytheantiproliferativeL-651,582.JBiolChem266:10136?10142.
	JacobsW,MikkelsenT,SmithR,NelsonK,RosenblumMLandKohnEC(1997)InhibitoryeffectsofCAIinglioblastomagrowthandinvasion.JNeuro-Oncol32:93?101.
	KobayashiS,SomlyoAPandSomlyoAV(1988)Guaninenucleotide-andinositol1,4,5-trisphosphate-inducedcalciumreleaseinrabbitmainpulmonaryartery.JPhysiol403:601?619.
	KohnEC,AlessandroR,SpoonsterJ,WerstoRPandLiottaLA(1995)Angiogenesis:Role of calcium-mediated signal transduction. 
	KohnEC,FiggWD,SarosyGA,BauerKS,DavisPA,SoltisMJ,ThompkinsA,LiottaLAandReedE(1997).PhaseItrialofmicronizedformulationcarboxyamidotria-zoleinpatientswithrefractorysolidtumors:Pharmacokinetics,clinicaloutcome,andcomparisonofformulations.JClinOncol15:1985?1993.
	KohnEC,JacobsW,KimYS,AlessandroR,Stetler-StevensonWGandLiottaLA(1994)Calciuminfluxmodulatesexpressionofmatrixmetalloproteinase-2(72-kDatypeIVcollagenase,gelatinaseA).JBiolChem269:21505?21511.
	KohnECandLiottaLA(1990)L651582:Anovelantiproliferativeandantimetasta-sisagent.JNatlCancerInst82:54?60.
	KrollJandWaltenbergerJ(1998)VEGF-AinducesexpressionofeNOSandiNOSinendothelialcellsviaVEGFreceptor-2(KDR).252:716?743.
	LambertPA,SomersKD,KohnECandPerryRR(1997)Antiproliferativeandanti-invasiveeffectsofcarboxyamido-triazoleonbreastcancercelllines.Surgery122:372?379.
	MiyazakiS(1988).Inositol1,4,5-trisphosphate-inducedcalciumreleaseandguaninenucleotide-bindingprotein-mediatedperiodiccalciumrisesingoldenhamstereggs.JCellBiol106:345?353.
	MorbidelliL,ChangC-H,DouglasJG,GrangerHJ,LeddaFandZicheM(1996)NitricoxidemediatesmitogeniceffectofVEGFoncoronaryendothelium.AmPhysiolSoc363:H411?H415.
	ParkYC,JunCD,KangHS,KimHD,KimHMandChungHT(1996)Roleofintracellularcalciumasaprimingsignalfortheinductionofnitricoxidesynthesisinmurineperitonealmacrophages.Immunology87:296?302.
	PinkusGS,EtheridgeCLandO?ConnorEM(1986)Arekeratinproteinsabettertumormarkerthanepithelialmembraneantigen?Acomparativeimmunohisto-chemicalstudyofvariousparaffin-embeddedneoplasmsusingmonoclonalandpolyclonalantibodies.AmJClinPathol85:269?277.
	SunyerT,RotheL,KirschD,JiangX,AndersonF,OsdobyPandCollin-OsdobyP(1997)Ca21orphorbolesterbutnotinflammatorystimulielevateinduciblenitricoxidesynthasemessengerribonucleicacidandnitricoxide(NO)releaseinavianosteoclasts:AutocrineNOmediatesCa21-inhibitedboneresorption.Endocrinol-ogy138:2148?2162.
	TrachtmanH,FutterweitS,FrankiNandSinghalPC(1998)Effectofvascularendothelialgrowthfactoronnitricoxideproductionbyculturedratmesangialcells.BiochemBiophysResCommun245:443?446.
	WasilenkoWJ,PaladAJ,SomersKD,BlackmorePF,KohnEC,RhimJS,WrightGLandSchellhammerPF(1996)Effectsofthecalciuminfluxinhibitorcarboxyamido-triazoleontheproliferationandinvasivenessofhumanprostatetumorcelllines.IntlJCancer68:259?264.
	WeidnerN,CarrollPR,FlaxJ,BlumenfeldWandFolkmanJ(1993)Tumorangio-genesiscorrelateswithmetastasisininvasiveprostatecarcinoma.AmJPathol143:401?409.
	WeidnerN,SempleJP,WelchWRandFolkmanJ(1991)Tumorangiogenesisandmetastasiscorrelationininvasivebreastcarcinoma.NEnglJMed324:1?8.
	WeikertS,FreyerD,WeihM,IsaevN,BuschC,SchultzeJ,MegowDandDirnaglU(1997)RapidCa21-dependentNO-productionfromcentralnervoussystemcellsinculturemeasuredbyNO-nitrite/ozonechemoluminescence.BrainRes748:1?11.
spp-01-1-38.pdf	35
spp-01-1-21.pdf	0
nihms226142.pdf	11
nihms59621.pdf	138
nihms38938.pdf	74
	1. Bairey Merz C, Dwyer J, Nordstrom C, Walton K, Salerno J, Schneider R. Psychosocial stress andcardiovascular disease: Pathophysiological links. Behav Med 2002;27:141?146. [PubMed: 12165968]	12165968
	2. Tennant CC. Life stress and hypertension. J Cardiovasc Risk 2001;8:51?56. [PubMed: 11234726]	11234726
	3. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: Results from a community based longitudinal study. Arch Gen Psychiatry 2001;58:221?227. [PubMed: 11231827]	11231828
	4. Tennant CC, Mclean L. Mood disturbances and coronary heart disease: Progress in the past decade.Med J Aust 2000;172:151?152. [PubMed: 10772583]	11130360
	5. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192?2217. [PubMed:10217662]	10779477
	6. Bairey Merz C, Subramanian R. Efficacy of psychosocial interventions and stress management forreduction of coronary artery disease events. Preventive Cardiology 1999;1:1?6.
	7. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease.Arch Intern Med 1996;156:745?752. [PubMed: 8615707]	8996051
	8. Nunes E, Frank K, Kornfeld D. Psychologic treatment for Type A behavior pattern and for coronaryartery disease: A meta-analysis of the literature. Psychosom Med 1987;49:159?173. [PubMed:3554294]	3554294
	9. Polk, DM.; Nordstrom, CK.; Dwyer, J.; Kop, WJ.; Krantz, DS.; Bairey Merz, CN. Novel psychosocialfactors and cardiovascular disease. In: Shah, PK., editor. Risk Factors in Coronary Disease. New York:Marcel Dekker; 2003.
	10. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomized trial of home-based psychosocialnursing intervention for patients recovering from myocardial infarction. Lancet 1997;350:473?479.[PubMed: 9274583]	9365475
	11. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: Multicentre randomised controlled trial. BMJ 1996;313:1517?1521. [PubMed: 8978226]	8978216
	12. Orme-Johnson DW, Walton KG. All approaches to preventing or reversing effects of stress are notthe same. American Journal of Health Promotion 1998;12:297?299. [PubMed: 10181138]	10181138
	13. Murphy LR. Stress management in work settings: A critical review of the health effects. AmericanJournal of Health Promotion 1996;11:112?135. [PubMed: 10163598]	10163598
	14. Murphy, M.; Donovan, S.; Taylor, E. The Physical and Psychological Effects of Meditation: A Reviewof Contemporary Research with a Comprehensive Bibliography. Sausalito, California: Institute ofNoetic Sciences; 1997. p. 1931-1996.
	15. Alexander, CN.; Davies, JL.; Dixon, CA., et al. Growth of higher stages of consciousness: Maharishi?sVedic psychology of human development. In: Alexander, CN.; Langer, EJ., editors. Higher Stagesof Human Development: Perspectives on Adult Growth. New York: Oxford University Press; 1990.p. 286-341.
	16. Schneider RH, Alexander CN, Salerno J, Robinson D, Fields J, Nidich S. Disease prevention andhealth promotion in the aging with a traditional system of natural medicine: Maharishi VedicMedicine (MVM). The Journal of Aging and Health 2002;14:57?78.
	17. Nader T, Rothenberg S, Averbach R, Charles B, Fields J, Schneider R. Improvements in chronic diseases with a comprehensive natural medicine approach: A review and case studies. Behav Med2000;26:34?46. [PubMed: 10971882]	4758999
	18. Walton K, Pugh N. Stress, steroids, and ?ojas?: Neuroendocrine mechanisms and current promise ofancient approaches to disease prevention. Indian J Physiol Pharmacol 1995;39:3?36. [PubMed:7705867]	7705867
	19. Orme-Johnson, DW.; Farrow, J. Scientific Research on the Transcendental Meditation Program:Collected Papers. Vol. 1. Rheinweiler, West Germany: MERU Press; 1977. p. 722
	20. Chalmers, R.; Clements, G.; Schenkluhn, H.; Weinless, M. Scientific Research on the TranscendentalMeditation Program: Collected Papers. Vol. 2?4. Vlodrop, The Netherlands: MVU Press; 1990.
	21. Wallace, RK.; Orme-Johnson, DW.; Dillbeck, MC. Scientific Research on the TranscendentalMeditation Program: Collected Papers. Vol. 5. Fairfield, Iowa: MIU Press; 1990.
	22. Jevning R, Wallace RK, Biedebach M. The physiology of meditation: A review. A wakefulhypometabolic integrated response. Neurosci Biobehav Rev 1992;16:415?424. [PubMed: 1528528]	1528528
	23. Hawkins MA. Effectiveness of the Transcendental Meditation program in criminal rehabilitation andsubstance abuse recovery: A review of the research. Journal of Offender Rehabilitation 2002;36:47
	24. Roth, R. Maharishi Mahesh Yogi?s Transcendental Meditation. Washington, DC: Primus; 1994. p.90-102.
	25. Williams R, Barefoot J, Califf R. Prognostic importance of social and economic resources amongmedically treated patients with angiographically documented coronary artery disease. JAMA1992:267.
	26. Julkunen J, Salonen R, Kaplan G, Chesney M, Salonen J. Hostility and the progression of carotidatherosclerosis. Psychosom Med 1994;56:519?525. [PubMed: 7871107]	7871107
	27. Reed DM, LaCroix AZ, Karasek RA, Miller D, MacLean CA. Occupational strain and the incidenceof coronary heart disease. Am J Epidemiol 1989;129:495?502. [PubMed: 2916542]	2916542
	28. Hlatky MA, Lam LC, Lee KL, et al. Job strain and the prevalence and outcome of coronary artery disease. Circulation 1995;92:327?333. [PubMed: 7634445]	8790061
	29. Grundy SM, Pasternak R, Greenland P, Smith SJ, Fuster V. AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statementfor healthcare professionals from the American Heart Association and the American College ofCardiology. J Am Coll Cardiol 1999;34:1348?1359. [PubMed: 10520820]	10520820
	30. Schneider RH, Staggers F, Alexander C, et al. A randomized controlled trial of stress reduction forhypertension in older African Americans. Hypertension 1995;26:820?827. [PubMed: 7591024]	7591024
	31. Alexander C, Schneider R, Staggers F, et al. A trial of stress reduction for hypertension in olderAfrican Americans (Part II): Sex and risk factor subgroup analysis. Hypertension 1996;28:228?237.[PubMed: 8707387]	8707387
	32. Alexander CN, Langer EJ, Newman RI, Chandler HM, Davies JL. Transcendental Meditation,mindfulness, and longevity: an experimental study with the elderly. J Person Soc Psychol1989;57:950?964.
	33. Wenneberg S, Schneider R, Walton K, et al. A controlled study of the effects of the TranscendentalMeditation program on cardiovascular reactivity and ambulatory blood pressure. Int J Neurosci1997;89:15?28. [PubMed: 9134445]	9134445
	34. Barnes VA, Treiber FA, Davis H. Impact of Transcendental Meditation on cardiovascular functionat rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res2001;51:597?605. [PubMed: 11595248]	11595248
	35. De Armond, DL. Effects of the Transcendental Meditation program on psychological, physiological,behavioral and organizational consequences of stress in managers and executives in management.Fairfield, Iowa: Maharishi University of Management; 1996. p. 161
	36. Schneider R, Nidich S, Salerno J, et al. Lower lipid peroxide levels in practitioners of theTranscendental Meditation program. Psychosom Med 1998;60:38?41. [PubMed: 9492237]	9492237
	37. Calderon, R. Effects of Nonpharmacological Approaches on Cholesterol Levels in Mild HypertensiveAfrican Americans: A Pilot Study of the Transcendental Meditation Program and a Health EducationProgram dissertation. Fairfield, Iowa: Maharishi University of Management; 2000. p. 122
	38. Alexander, CN.; Robinson, P.; Rainforth, M. Treating and preventing alcohol, nicotine and drug abusethrough Transcendental Meditation Technique: A review and statistical analysis. In: O?Connell, DF.;Alexander, CN., editors. Self Recovery?Treating Addictions Using Transcendental Meditation andMaharishi Ayur-Veda. New York: Haworth Press; 1994. p. 13-88.
	39. Collins R, Petro R, MacMahone S, et al. Blood pressure, stroke, and coronary heart disease, part 2,Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiologicalcontext. Lancet 1990;335:827?838. [PubMed: 1969567]	1975346
	40. Collins P, Fox K. Pathophysiology of angina. Lancet 1990;335:94?96. [PubMed: 1967428]	1967428
	41. Cooper MJ, Aygen MM. Transcendental Meditation in the management of hypercholesterolemia.Journal of Human Stress 1979;5:24?27. [PubMed: 392003]	392003
	42. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883?887. [PubMed: 1348295]	1353150
	43. Naito C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. AnnN Y Academ Sci 1990:27?45.
	44. Berliner J, Navab M, Fogelman A, et al. Atherosclerosis: Basic mechanisms. Oxidation, inflammationand genetics. Circulation 1995;91:2488?2496. [PubMed: 7729036]	7729036
	45. Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future bloodpressure status. Hypertension 1993;22:479?485. [PubMed: 8406652]	8406652
	46. Kamarck TW, Jennings JR, Pogue-Geile M, Manuck SB. A multidimensional measurement modelfor cardiovascular reactivity: Stability and cross-validation in two adult samples. Health Psychol1994;13:471?478. [PubMed: 7889901]	7889901
	47. Eppley K, Abrams AI, Shear J. Differential effects of relaxation techniques on trait anxiety: A meta-analysis. J Clin Psychol 1989;45:957?974. [PubMed: 2693491]	2693491
	48. Gaylord C, Orme-Johnson D, Travis F. The effects of the Transcendental Meditation technique andprogressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults.Intern J Neurosci 1989;46:77?86.	2670798
	49. Alexander CN, Rainforth MV, Gelderloos P. Transcendental Meditation, self actualization, andpsychological health: A conceptual overview and statistical meta-analysis. Journal of Social Behaviorand Personality 1991;6:189?247.
	50. Ferguson, PC. An integrative meta-analysis of psychological studies investigating the treatmentoutcomes of meditation techniques. In: Chalmers, R.; Clements, G.; Schenkluhn, H.; Weinless, M.,editors. Scientific Research on Maharishi?s Transcendental Meditation and TM-Sidhi Programme:Collected Papers. Vol. 4. Vlodrop, Holland: Maharishi European Research University, MVU Press;1991. p. 2039-2048.
	51. Jevning R, Wilson AF, Smith WR. Adrenocortical activity during meditation. Hormones and Behavior1978;10:54?60. [PubMed: 350747]	350747
	52. Dillbeck MC, Orme-Johnson DW. Physiological differences between Transcendental Meditation andrest. American Psychologist 1987;42:879?881.
	53. Michaels RR, Huber MJ, McCann DS. Evaluation of Transcendental Meditation as a method ofreducing stress. Science 1976;192:1242?1244. [PubMed: 775639]	775639
	54. Mills PJ, Schneider RH, Hill D, Walton KG, Wallace RK. Beta-adrenergic receptor sensitivity insubjects practicing transcendental meditation. J Psychosom Res 1990;34:29?33. [PubMed: 2156071]	2156071
	55. Alexander CN, Swanson GC, Rainforth MV, Carlisle TW, Todd CC, Oates RM. Effects of theTranscendental Meditation program on stress reduction, health, and employee development: Aprospective study in two occupational settings. Anxiety, Stress and Coping: An International Journal1993;6:245?262.
	56. Walton KG, Pugh N, Gelderloos P, Macrae P. Stress reduction and preventing hypertension:Preliminary support for a psychoneuroendocrine mechanism. Journal of Alternative andComplementary Medicine 1995;1:263?283.
	57. Levitsky, DK. Effects of the Transcendental Meditation program on neuroendocrine indicators ofchronic stress dissertation. Fairfield, Iowa: Maharishi University of Management; 1997. p. 298
	58. MacLean C, Walton K, Wenneberg S, et al. Effects of the Transcendental Meditation program onadaptive mechanisms: Changes in hormone levels and responses to stress after 4 months of practice.Psychoneuroendocrinology 1997;22:277?295. [PubMed: 9226731]	9226731
	59. Infante JR, Peran F, Martinez M, et al. ACTH and beta-endorphin in Transcendental Meditation.Physiol Behav 1998;64:311?315. [PubMed: 9748098]	9748098
	60. Infante JR, Torres-Avisbal M, Pinel P, et al. Catecholamines in practitioners of the TranscendentalMeditation technique. Physio Behav 2001;72:141?146.
	61. Barnes VA, Treiber FA, Turner JR, Davis H, Strong WB. Acute effects of Transcendental Meditationon hemodynamic functioning in middle-aged adults. Psychosom Med 1999;61:525?531. [PubMed:10443761]	10443761
	62. Alexander C, Walton K, Goodman R. Walpole study of the TM program in maximum securityprisoners I: Cross-sectional differences in development and psychopathology. Journal of OffenderRehabilitation 2002;36:97?125.
	63. Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotidatherosclerosis in hypertensive African Americans. Stroke 2000;31:568?573. [PubMed: 10700487]	10700487
	64. Fields JZ, Walton KG, Schneider RH, et al. Effect of a multimodality natural medicine program oncarotid atherosclerosis in older subjects: A pilot trial of Maharishi Vedic Medicine. Am J Cardiol2002;89:952?958. [PubMed: 11950434]	11950434
	65. Blankenhorn DH, Hodis HN. Arterial imaging and atherosclerosis reversal. George Lyman DuffMemorial Lecture. Arteriosclerosis & Thrombosis 1994;14:177?192. [PubMed: 8305407]	8305407
	66. Kondwani, KA. Psychology. Fairfield, Iowa: Maharishi University of Management; 1998.Nonpharmacologic treatment of hypertension and hypertensive heart disease in African Americans:A trial of the Transcendental Meditation program and a health education program; p. 130
	67. Zamarra JW, Schneider RH, Besseghini I, Robinson DK, Salerno JW. Usefulness of theTranscendental Meditation program in the treatment of patients with coronary artery disease. Am JCardio 1996;78:77?80.
	68. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atheroscleroticprogression. Circulation 1993;87(Suppl 2):56?65.
	69. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass andgeometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med1991;114:345?352. [PubMed: 1825164]	1825164
	70. Kondwani K, Schneider RH, Alexander CN, et al. Left ventricular mass regression with theTranscendental Meditation technique and a health education program in hypertensive AfricanAmericans. Journal of Social Behavior and Personality. In press
	71. Devereux RB, Okin PM, Roman MJ. Pre-clinical cardiovascular disease and surrogate end-points inhypertension: Does race influence target organ damage independent of blood pressure? Ethnicity andDisease 1998;8:138?148. [PubMed: 9681280]	9681280
	72. Devereux RB, Roman MJ, Ganau A, de Simone G, Okin PM, Kligfield P. Cardiac and arterialhypertrophy and atherosclerosis in hypertension. Hypertension 1994;23:802?809. [PubMed:8206580]	8206580
	73. Devereux R, Roman M. Hypertensive left ventricular hypertrophy: Pathogenesis, prognosticimportance and treatment. CVR & R 1992 August;:24?33.
	74. Alexander CN, Barnes VA, Schneider RH, et al. A randomized controlled trial of stress reduction oncardiovascular and all-cause mortality in the elderly: Results of 8 and 15 year follow-ups. Circulation1996;93:629.[abstract]Walton et al.Page 12FIGURE 1.Behavioral model of psychosocial stress and cardiovascular disease.
Mol Cancer Ther-2002-Yokoi-275-86.pdf	38
	1.Schreiber,S.L.Target-orientedanddiversity-orientedorganicsynthe-sisindrugdiscovery.Science(Wash.DC),287:1964?1969,2000.
	2.Drews,J.Drugdiscovery:ahistoricalperspective.Science(Wash.DC),287:1960?1964,2000.
	3.Maren,T.H.Relationsbetweenstructureandbiologicalactivityofsulfonamides.Ann.Rev.Pharmacol.Toxicol.,16:309?327,1976.
	4.Supuran,C.T.,andScozzafava,A.Carbonicanhydraseinhibitorsandtheirtherapeuticpotential.Exp.Opin.Ther.Patents,10:575?600,2000.
	5.Yoshino,H.,Ueda,N.,Niijima,J.,Sugumi,H.,Kotake,Y.,Koyanagi,N.,Yoshimatsu,K.,Asada,M.,Watanabe,T.,Nagasu,T.,Tsukahara,K.,Iijima,A.,andKitoh,K.Novelsulfonamidesaspotential,systemicallyactiveantitumoragents.J.Med.Chem.,35:2496?2497,1992.
	6.Owa,T.,Yoshino,H.,Okauchi,T.,Yoshimatsu,K.,Ozawa,Y.,Sugi,N.H.,Nagasu,T.,Koyanagi,N.,andKitoh,K.DiscoveryofnovelantitumorsulfonamidestargetingG1phaseofthecellcycle.J.Med.Chem.,42:3789?3799,1999.
	7.Owa,T.,Okauchi,T.,Yoshimatsu,K.,Sugi,N.H.,Ozawa,Y.,Nagasu,T.,Koyanagi,N.,Okabe,T.,Kitoh,K.,andYoshino,H.Afocusedcom-poundlibraryofnovelN-(7-indolyl)benzenesulfonamidesforthediscoveryofpotentcellcycleinhibitors.Bioorg.Med.Chem.Lett.,10:1223?1226,2000.
	8.Owa,T.,andNagasu,T.Novelsulphonamidederivativesforthetreat-mentofcancer.Exp.Opin.Ther.Patents,10:1725?1740,2000.
	9.Yoshimatsu,K.,Yamaguchi,A.,Yoshino,H.,Koyanagi,N.,andKitoh,K.MechanismofactionofE7010:inhibitionofmitosisbybindingtothecolchicinesiteoftubulin.CancerRes.,57:3208?3213,1997.
	10.Koyanagi,N.,Nagasu,T.,Fujita,F.,Watanabe,T.,Tsukahara,K.,Funahashi,Y.,Fujita,M.,Taguchi,T.,Yoshino,H.,andKitoh,K.Invivotumorgrowthinhibitionproducedbyanovelsulfonamide,E7010,againstrodentandhumantumors.CancerRes.,54:1702?1706,1994.
	11.Yamamoto,K.,Noda,K.,Yoshimura,A.,Fukuoka,M.,Furuse,K.,andNiitani,H.PhaseIstudyofE7010.CancerChemother.Pharmacol.,42:127?134,1998.
	12.Ozawa,Y.,Sugi,N.H.,Nagasu,T.,Owa,T.,Watanabe,T.,Koyanagi,N.,Yoshino,H.,Kitoh,K.,andYoshimatsu,K.E7070,anovelsulfonamideagentwithpotentantitumoractivityinvitroandinvivo.Eur.J.Cancer,37:2275?2282,2001.
	13.Punt,C.J.,Fumoleau,P.,vandeWalle,B.,Faber,M.N.,Ravic,M.,andCampone,M.PhaseIandpharmacokineticstudyofE7070,anovelsulfonamide,givenatadailytimesfivescheduleinpatientswithsolidtumors.AstudybytheEORTC-earlyclinicalstudiesgroup(ECSG).Ann.Oncol.,12:1289?1293,2001.
	14.Punt,C.J.A.,Fumoleau,P.,Walle,B.V.D.,Deporte-Fety,R.,Bourcier,C.,Faber,M.,Ravic,M.,andT.Wagener,D.J.Proc.Am.Assoc.CancerRes.,41:609,2000.
	15.Raymond,E.,tenBokkel-Huinink,W.W.,Taieb,J.,Beijnen,J.H.,Mekhaldi,S.,Kroon,K.,Wanders,J.,Ravic,M.,Fumoleau,P.,Ducreux,M.,Escudier,B.,andArmand,J.P.Proc.Am.Assoc.CancerRes.,41:611,2000.
	16.Schena,M.,Shalon,D.,Davis,R.W.,andBrown,P.O.QuantitativemonitoringofgeneexpressionpatternswithacomplementaryDNAmi-croarray.Science(Wash.DC),270:467?470,1995.
	17.Lockhart,D.J.,Dong,H.,Byrne,M.C.,Follettie,M.T.,Gallo,M.V.,Chee,M.S.,Mittmann,M.,Wang,C.,Kobayashi,M.,Horton,H.,andBrown,E.L.Expressionmonitoringbyhybridizationtohigh-densityoli-gonucleotidearrays.Nat.Biotechnol.,14:1675?1680,1996.
	18.Stockwell,B.R.,Hardwick,J.S.,Tong,J.K.,andSchreiber,S.L.Chemicalgeneticandgenomicapproachesrevealaroleforcopperinspecificgeneactivation.J.Am.Chem.Soc.,121:10662?10663,1999.
	19.Marton,M.J.,DeRisi,J.L.,Bennett,H.A.,Iyer,V.R.,Meyer,M.R.,Roberts,C.J.,Stoughton,R.,Burchard,J.,Slade,D.,Dai,H.,Bassett,D.E.,Jr.,Hartwell,L.H.,Brown,P.O.,andFriend,S.H.DrugtargetvalidationandidentificationofsecondarydrugtargeteffectsusingDNAmicroarrays.Nat.Med.,4:1293?1301,1998.
	20.Hardwick,J.S.,Kuruvilla,F.G.,Tong,J.K.,Shamji,A.F.,andSchreiber,S.L.Rapamycin-modulatedtranscriptiondefinesthesubsetofnutrient-sensitivesignalingpathwaysdirectlycontrolledbytheTorpro-teins.Proc.Natl.Acad.Sci.USA,96:14866?14870,1999.
	21.Scherf,U.,Ross,D.T.,Waltham,M.,Smith,L.H.,Lee,J.K.,Tanabe,L.,Kohn,K.W.,Reinhold,W.C.,Myers,T.G.,Andrews,D.T.,Scudiero,D.A.,Eisen,M.B.,Sausville,E.A.,Pommier,Y.,Botstein,D.,Brown,P.O.,andWeinstein,J.N.Ageneexpressiondatabaseforthemolecularpharmacologyofcancer.Nat.Genet.,24:236?244,2000.
	22.Dittrich,C.,Dumez,H.,Calvert,H.,Hanauske,A.R.,Ravic,M.,Faber,M.,vanHouten,T.,Wanders,J.,andFumoleau,P.Proc.Am.Assoc.CancerRes.,41:609,2000.
	23.Mosmann,T.Rapidcolorimetricassayforcellulargrowthandsur-vival:applicationtoproliferationandcytotoxicityassays.J.Immunol.Methods,65:55?63,1983.
	24.Roï¿½dicker,F.,Stiewe,T.,Zimmermann,S.,andPuï¿½tzer,B.M.Thera-peuticefficacyofE2F1inpancreaticcancercorrelateswithTP73induc-tion.CancerRes.,61:7052?7055,2001.
	25.Liu,X.M.,Wang,L.G.,Kreis,W.,Budman,D.R.,andAdams,L.M.DifferentialeffectofvinorelbineversuspaclitaxelonERK2kinaseactivityduringapoptosisinMCF-7cells.Br.J.Cancer,85:1403?1411,2001.
	26.Kumar,R.,andKorutla,L.Inductionofexpressionofinterferon-stimulatedgenefactor-3(ISGF-3)proteinsbyinterferons.Exp.CellRes.,216:143?148,1995.
	27.Hwang,L.H.,andMurray,A.W.AnovelyeastscreenformitoticarrestmutantsidentifiesDOC1,anewgeneinvolvedincyclinproteolysis.Mol.Biol.Cell,8:1877?1887,1997.
	28.Rosania,G.R.,Chang,Y-T.,Perez,O.,Sutherlin,D.,Dong,H.,Lock-hart,D.J.,andSchultz,P.G.Myoseverin,amicrotubule-bindingmoleculewithnovelcellulareffects.Nat.Biotechnol.,18:304?308,2000.
	29.Ben-Ze?ev,A.,Farmer,S.R.,andPenman,S.Mechanismsofregu-latingtubulinsynthesisinculturedmammaliancells.Cell,17:319?325,1979.
	30.Chen,Y.,McPhie,D.L.,Hirschberg,J.,andNeve,R.L.Theamyloidprecursorprotein-bindingproteinAPP-BP1drivesthecellcyclethroughtheS-Mcheckpointandcausesapoptosisinneurons.J.Biol.Chem.,275:8929?8935,2000.
	31.Nigg,E.A.Cyclin-dependentkinase7:atthecross-roadsoftran-scription,DNArepairandcellcyclecontrol?Curr.Opin.CellBiol.,8:312?317,1996.
	32.Rossignol,M.,Kolb-Cheynel,I.,andEgly,J.M.Substratespecificityofthecdk-activatingkinase(CAK)isaltereduponassociationwithTFIIH.EMBOJ.,16:1628?1637,1997.Molecular285CancerTherapeutics
	33.Yankulov,K.Y.,andBentley,D.L.RegulationofCDK7substratespecificitybyMAT1andTFIIH.EMBOJ.,16:1638?1646,1997.
	34.Araujo,S.J.,Tirode,F.,Coin,F.,Pospiech,H.,Syvaoja,J.E.,Stucki,M.,Hubscher,U.,Egly,J.M.,andWood,R.D.NucleotideexcisionrepairofDNAwithrecombinanthumanproteins:definitionoftheminimalsetoffactors,activeformsofTFIIH,andmodulationbyCAK.GenesDev.,14:349?359,2000.
	35.Korn,E.L.,Arbuck,S.G.,Pluda,J.M.,Simon,R.,Kaplan,R.S.,andChristian,M.C.Clinicaltrialdesignsforcytostaticagents:arenewap-proachesneeded?J.Clin.Oncol.,19:265?272.2001.
	36.McKendrick,L.,Thompson,E.,Ferreira,J.,Morley,S.J.,andLewis,J.D.Interactionofeukaryotictranslationinitiationfactor4Gwiththenuclearcap-bindingcomplexprovidesalinkbetweennuclearandcyto-plasmicfunctionsofthem(7)guanosinecap.Mol.Cell.Biol.,21:3632?3641,2001.
	37.Basse,F.,Stout,J.G.,Sims,P.J.,andWiedmer,T.IsolationofanerythrocytemembraneproteinthatmediatesCa2-dependenttrans-bilayermovementofphospholipid.J.Biol.Chem.,271:17205?17210,1996.
	38.Kawakami,T.,Furukawa,Y.,Sudo,K.,Saito,H.,Takami,S.,Taka-hashi,E.,andNakamura,Y.Isolationandmappingofahumangene(PDCD2)thatishighlyhomologoustoRp8,aratgeneassociatedwithprogrammedcelldeath.Cytogenet.CellGenet.,71:41?43,1995.286ProfilingNovelSulfonamideAntitumorAgents
Mol Cancer Ther-2002-Raymond-227-35.pdf	100
	1.Cvitkovic,E.Ahistoricalperspectiveonoxaliplatin:rethinkingtheroleofplatinumcompoundsandlearningfromnearmisses.Semin.Oncol.,25:1?3,1998.
	2.Raymond,E.,Chaney,S.G.,Taamma,A.,andCvitkovic,E.Oxaliplatin:areviewofpreclinicalandclinicalstudies.Ann.Oncol.,9:1053?1071,1998.
	3.Raymond,E.,Faivre,S.,Woynarowski,J.M.,andChaney,S.G.Oxaliplatin:mechanismofactionandantineoplasticactivity.Semin.On-col.,25:4?12,1998.
	4.Soulieï¿½,P.,Raymond,E.,Brienza,S.,andCvitkovic,E.Oxaliplatin:thefirstDACHplatinuminclinicalpractice.Bull.Cancer,84:665?673,1997.
	5.Cvitkovic,E.Ongoingandunsaidonoxaliplatin:thehope.Br.J.Can-cer,77(Suppl.4):8?11,1998.
	6.Llory,J.F.,Soulieï¿½,P.,Cvitkovic,E.,andMisset,J.L.Feasibilityofhigh-doseplatinumdeliverywithcombinedcarboplatinandoxaliplatin.J.Natl.CancerInst.(Bethesda),86:1098?1099,1994.
	7.Soulieï¿½,P.,Bensmaine,A.,Garrino,C.,Chollet,P.,Brain,E.,Fereres,M.,Jasmin,C.,Musset,M.,Misset,J.L.,andCvitkovic,E.Oxaliplatin/cisplatin(L-OHP/CDDP)combinationinheavilypretreatedovariancancer.Eur.J.Cancer,33:1400?1406,1997.
	8.Kidani,Y.,Iigo,M.,Inagaki,K.,Hoshi,A.,andKuretani,K.Antitumoractivityof1,2-diaminocyclohexane?platinumcomplexesagainstsarco-ma-180ascitesform.J.Med.Chem.,21:1315?1318,1978.
	9.Loehrer,P.J.,Turner,S.,Kubilis,P.,Hui,S.,Correa,J.,Ansari,R.,Stephens,D.,Woodburn,R.,andMeyer,S.Aprospectiverandomizedtrial232CellularandMolecularPharmacologyofOxaliplatin
	10.Kemeny,N.,Israel,K.,Niedzwiecki,D.,Chapman,D.,Botet,J.,Min-sky,B.,Vinciguerra,V.,Rosenbluth,R.,Bosselli,B.,andCochran,C.Randomizedstudyofcontinuousinfusionfluorouracilversusfluorouracilpluscisplatininpatientswithmetastaticcolorectalcancer.J.Clin.Oncol.,8:313?318,1990.
	11.Sasaki,K.,Yamamitsu,S.,Hirata,K.,Koide,S.,Takasaka,H.,Hiraike,N.,Katsuramaki,T.,Denno,R.,andShirasaka,T.Combinationchemo-therapyofintermittentinfusion5-FUandCDDPforadvancedcolorectaladenocarcinoma:aSapporoCancerStudyTrial.Proc.Am.Soc.Clin.Oncol.,17:302a,1998.
	12.Rixe,O.,Ortuzar,W.,Alvarez,M.,Parker,R.,Reed,E.,Paull,K.,andFojo,T.Oxaliplatin,tetraplatin,cisplatin,andcarboplatin:spectrumofactivityindrug-resistantcelllinesandinthecelllinesoftheNationalCancerInstitute?sAnticancerDrugScreenpanel.Biochem.Pharmacol.,52:1855?1865,1996.
	13.Pendyala,L.,Kidani,Y.,Perez,R.,Wilkes,J.,Bernacki,R.J.,andCreaven,P.J.Cytotoxicity,cellularaccumulationandDNAbindingofoxaliplatinisomers.CancerLett.,97:177?184,1995.
	14.Pendyala,L.,andCreaven,P.J.Invitrocytotoxicity,proteinbinding,redbloodcellpartitioning,andbiotransformationofoxaliplatin.CancerRes.,53:5970?5976,1993.
	15.Holmes,J.,Stanko,J.,Varchenko,M.,Ding,H.,Madden,V.J.,Bagnell,C.R.,Wyrick,S.D.,andChaney,S.G.Comparativeneurotoxicityofoxaliplatin,cisplatin,andormaplatininaWistarratmodel.J.Toxicol.Sci.,46:342?351,1998.
	16.Raymond,E.,Lawrence,R.,Izbicka,E.,Faivre,S.,andVonHoff,D.D.Activityofoxaliplatinagainsthumantumorcolony-formingunits.Clin.CancerRes.,4:1021?1029,1998.
	17.Kraker,A.,Steinkampf,R.W.,andMoore,C.W.TransportofCis-PtandCis-Ptanalogsinsensitiveandresistantmurineleukemiacelllines.Proc.Am.Assoc.CancerRes.,27:286,1986.
	18.Fukuda,M.,Ohe,Y.,Kanzawa,F.,Oka,M.,Hara,K.,andSaijo,N.Evaluationofnovelplatinumcomplexes,inhibitorsoftopoisomeraseIandIIinnon-smallcelllungcancer(NSCLC)sublinesresistanttocisplatin.AnticancerRes.,15:393?398,1995.
	19.Raymond,E.,Buquet-Fagot,C.,Djelloul,S.,Mester,J.,Cvitkovic,E.,Allain,P.,Louvet,C.,andGespach,C.Antitumoractivityofoxaliplatinincombinationwith5-fluorouracilandthethymidylatesynthaseinhibitorAG337inhumancolon,breastandovariancancers.AnticancerDrugs,8:876?885,1997.
	20.Saris,C.P.,vandeVaart,P.J.M.,Rietbroek,R.C.,andBlommaert,F.A.InvitroformationofDNAadductsbycisplatin,lobaplatinandoxali-platinincalfthymusDNAinsolutionandinculturedhumancells.Carci-nogenesis(Lond.),17:2763?2769,1996.
	21.Woynarowski,J.M.,Faivre,S.,Herzig,M.C.,Arnett,B.,Chapman,W.G.,Trevino,A.V.,Raymond,E.,Chaney,S.G.,Vaisman,A.,Varch-enko,M.,etal.Oxaliplatin-induceddamageofcellularDNA.Mol.Phar-macol.,58:920?927,2000.
	22.Woynarowski,J.M.,Chapman,W.G.,Napier,C.,Herzig,M.C.,andJuniewicz,P.Sequence-andregion-specificityofoxaliplatinadductsinnakedandcellularDNA.Mol.Pharmacol.,54:770?777,1998.
	23.Luo,F.R.,Wyrick,S.D.,andChaney,S.G.Cytotoxicity,cellularuptake,andcellularbiotransformationsofoxaliplatininhumancoloncarcinomacells.Oncol.Res.,10:595?603,1998.
	24.Luo,F.R.,Yen,T.Y.,Wyrick,S.D.,andChaney,S.G.High-perfor-manceliquidchromatographicseparationofthebiotransformationprod-uctsofoxaliplatin.J.Chromatogr.BBiomed.Sci.Appl.,724:345?356,1999.
	25.Luo,F.R.,Wyrick,S.D.,andChaney,S.G.Biotransformationsofoxaliplatininratbloodinvitro.J.Biochem.Mol.Toxicol.,13:159?169,1999.
	26.Faivre,S.,andWoynarowski,J.M.OxaliplatineffectsonDNAintegrityandapoptosisinductioninhumantumorcells.Proc.Am.Assoc.CancerRes.,39:158,1998.
	27.Vaisman,A.,Varchenko,M.,Umar,A.,Kunkel,T.A.,Risinger,J.I.,Barrett,J.C.,Hamilton,T.C.,andChaney,S.G.TheroleofhMLH1,hMSH3,andhMSH6defectsincisplatinandoxaliplatinresistance:cor-relationwithreplicativebypassofplatinum-DNAadducts.CancerRes.,58:3579?3585,1998.
	28.Reardon,J.T.,Vaisman,A.,Chaney,S.G.,andSancar,A.Efficientnucleotideexcisionrepairofcisplatin,oxaliplatin,andBis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV)(JM216)platinumintrastrandDNAdiadducts.CancerRes.,59:3968?3971,1999.
	29.Vaisman,A.,Lim,S.E.,Patrick,S.M.,Copeland,W.C.,Hinkle,D.C.,Turchi,J.J.,andChaney,S.G.EffectofDNApolymerasesandhighmobilitygroupprotein1onthecarrierligandspecificityfortranslesionsynthesispastplatinum-DNAadducts.Biochemistry,38:11026?11039,1999.
	30.Scheeff,E.D.,Briggs,J.M.,andHowell,S.B.Molecularmodelingoftheintrastrandguanine-guanineDNAadductsproducedbycisplatinandoxaliplatin.Mol.Pharmacol.,56:633?643,1999.
	31.Sharp,S.Y.,O?Neill,C.F.,Boxall,F.,Rogers,P.,Stephens,T.,andKelland,L.R.Non-crossresistancebetweenoxaliplatinandZD0473inacquiredoxaliplatin-resistantcolonandovariancarcinomacelllines.Clin.CancerRes.(suppl.),6:4537s,2000.
	32.Damia,G.,Guidi,G.,andD?Incalci,M.Expressionofgenesinvolvedinnucleotideexcisionrepairandsensitivitytocisplatinandmelphalaninhumancancercelllines.Eur.J.Cancer,34:1783?1788,1998.
	33.Hibino,Y.,Hiraoka,Y.,Kamiuchi,S.,Kusashio,E.,andSugano,N.Enhancementofexcisionrepairofcisplatin-DNAadductsbycell-freeextractfromacisplatin-resistantratcellline.Biochem.Pharmacol.,57:1415?1422,1999.
	34.Petersen,L.N.,Mamenta,E.L.,Stevnsner,T.,Chaney,S.G.,andBohr,V.A.Increasedgenespecificrepairofcisplatininducedinterstrandcrosslinksincisplatinresistantcelllinesandstudiesoncarrierligandspecificity.Carcinogenesis(Lond.),17:2597?2602,1996.
	35.Issa,J.P.Theepigeneticsofcolorectalcancer.Ann.N.Y.Acad.Sci.,910:140?153,2000.
	36.Thibodeau,S.N.,French,A.,Roche,P.,Cunningham,J.,Tester,D.,Lindor,N.,Moslein,G.,Baker,S.,Liskay,R.,Burgart,L.,etal.AlteredexpressionofhMSH2andhMSH1intumorswithmicrosatelliteinstabilityandgeneticalterationsinmismatchrepairgenes.CancerRes.,56:4836?4840,1996.
	37.Wheeler,J.M.,Beck,N.E.,Kim,H.C.,Tomlinson,I.P.,Mortensen,N.J.,andBodmer,W.F.Mechanismsofinactivationofmismatchrepairgenesinhumancolorectalcancercelllines:thepredominantroleofhMLH1.Proc.Natl.Acad.Sci.USA,96:10296?10301,1999.
	38.Kuismanen,S.A.,Holmberg,M.T.,Salovaara,R.,Schweizer,P.,Aaltonen,L.A.,dela,C.A.,Nystrom-Lahti,M.,andPeltomaki,P.Epige-neticphenotypesdistinguishmicrosatellite-stableand-unstablecolorec-talcancers.Proc.Natl.Acad.Sci.USA,96:12661?12666,1999.
	39.Herman,J.,Umar,A.,Polyak,K.,Graff,J.,Ahuja,N.,Issa,J.,Markow-itz,S.,Willson,J.,Hamilton,S.R.,andKinzler,K.W.,etal.IncidenceandfunctionalconsequencesofhMLH1promoterhypermethylationincolo-rectalcarcinoma.Proc.Natl.Acad.Sci.USA,95:6870?6875,1998.
	40.Thibodeau,S.N.,French,A.,Cunningham,J.,Tester,D.,Burgart,L.,Roche,P.,McDonnel,S.,Schaid,D.,Vockely,C.,Michels,V.,etal.Microsatelliteinstabilityincolorectalcancer:differentmutatorphenotypesandtheprincipalinvolvementofhMLH1.CancerRes.,58:1713?1718,1998.
	41.Strathdee,G.,Mackean,M.,Illand,M.,andBrown,R.AroleformethylationofthehMLH1promoterinlossofhMLH1expressionanddrugresistanceinovariancancer.Oncogene,18:2335?2341,1999.
	42.Kuismanen,S.A.,Holmberg,M.T.,Salovaara,R.,dela,C.A.,andPeltomaki,P.GeneticandepigeneticmodificationofMLH1accountsforamajorshareofmicrosatellite-unstablecolorectalcancers.Am.J.Pathol.,156:1773?1779,2000.
	43.King,B.L.,Carcangiu,M.L.,Carter,D.,Kiechle,M.,Pfisterer,J.,Pfleiderer,A.,andKacinski,B.M.Microsatelliteinstabilityinovarianneoplasms.Br.J.Cancer,72:376?382,1995.
	44.Kolodner,R.D.Mismatchrepair:mechanismsandrelationshiptocancersusceptibility.TrendsBiochem.Sci.,20:397?401,1995.
	45.Paulson,T.G.,Wright,F.A.,Parker,B.A.,Russack,V.,andWahl,G.M.Microsatelliteinstabilitycorrelateswithreducedsurvivalandpoordiseaseprognosisinbreastcancer.CancerRes.,56:4021?4026,1996.
	46.Herfarth,K.K.,Kodner,I.J.,Whelan,A.J.,Ivanovich,J.L.,Bra-camontes,J.R.,Wells,S.A.,Jr.,andGoodfellow,P.J.MutationsinMLH1aremorefrequentthaninMSH2insporadiccolorectalcancerswithmicrosatelliteinstability.GenesChromosomesCancer,18:42?49,1997.
	47.Brown,R.,Hirst,G.L.,Gallagher,W.,Mcllwrath,A.,Margison,G.P.,vanderZee,A.,andAnthoney,D.A.hMLH1expressionandcellularresponsesofovariantumourcellstotreatmentwithcytotoxicanticanceragents.Oncogene,15:45?52,1997.
	48.Mackay,H.J.,Cameron,D.,Rahilly,M.,Mackean,M.J.,Paul,J.,Kaye,S.B.,andBrown,R.ReducedMLH1expressioninbreasttumorsafterprimarychemotherapypredictsdisease-freesurvival.J.Clin.Oncol.,18:87?93,2000.
	49.Herman,J.,Umar,A.,Polyak,K.,Graff,J.,Ahuja,N.,Issa,J.P.,Markowitz,S.,Willson,J.,Hamilton,S.R.,Kinzler,K.W.,etal.IncidenceandfunctionalconsequencesofhMLH1promoterhypermethylationincolorectalcarcinoma.Proc.Natl.Acad.Sci.USA,95:6870?6875,1998.
	50.Brown,R.,Hirst,G.L.,Gallagher,W.,Mcllwrath,A.,Margison,G.P.,vanderZee,A.,andAnthoney,D.A.hMLH1expressionandcellularresponsesofovariantumourcellstotreatmentwithcytotoxicanticanceragents.Oncogene,15:45?52,1997.
	51.Plumb,J.A.,Strathdee,G.,Sludden,J.,Kaye,S.,andBrown,R.Reversalofdrugresistanceinhumantumorxenograftsby2-deoxy-5-azacytidine-induceddemethylationofthehMLH1genepromoter.CancerRes.,60:6039?6044,2000.
	52.Aebi,S.,Kurdi-Haidar,B.,Gordon,R.,Cenni,B.,Zheng,H.,Fink,D.,Christen,R.D.,Boland,C.R.,Koi,M.,Fishel,R.,etal.LossofDNAmismatchrepairinacquiredresistancetocisplatin.CancerRes.,56:3087?3090,1996.
	53.Ferry,K.V.,Fink,D.,Johnson,S.W.,Nebel,S.,Hamilton,T.C.,andHowell,S.B.Decreasedcisplatindamage-dependentDNAsynthesisincellularextractsofmismatchrepairdeficientcells.Biochem.Pharmacol.,57:861?867,1999.
	54.Fink,D.,Nebel,S.,Aebi,S.,Zheng,H.,Cenni,B.,Nehme,A.,Chris-ten,R.D.,andHowell,S.B.TheroleofDNAmismatchrepairinplatinumdrugresistance.CancerRes.,56:4881?4886,1996.
	55.Strathdee,G.,Mackean,M.J.,Illand,M.,andBrown,R.AroleformethylationofthehMLH1promoterinlossofhMLH1expressionanddrugresistanceinovariancancer.Oncogene,18:2335?2341,1999.
	56.Strathdee,G.,Appleton,K.,Illand,M.,Millan,D.W.,Sargent,J.,Paul,J.,andBrown,R.Primaryovariancarcinomasdisplaymultiplemethylatorphenotypesinvolvingknowntumorsuppressorgenes.Am.J.Pathol.,158:1121?1127,2001.
	57.deGramont,A.,Vignoud,J.,Tournigand,C.,Louvet,C.,Andre,T.,Varette,C.,Raymond,E.,Moreau,S.,LeBail,N.,andKrulik,M.Oxaliplatinwithhigh-doseleucovorinand5-fluorouracil48-hourcontinuousinfusioninpretreatedmetastaticcolorectalcancer.Eur.J.Cancer,33:214?219,1997.
	58.Fink,D.,Zheng,H.,Nebel,S.,Norris,P.S.,Aebi,S.,Lin,T.P.,Nehme,A.,Christen,R.D.,Haas,M.,MacLeod,C.L.,etal.InvitroandinvivoresistancetocisplatinincellsthathavelostDNAmismatchrepair.CancerRes.,57:1841?1845,1997.
	59.Nebel,S.,Fink,D.,Nehme,A.,Aebi,S.,Christen,R.D.,andHowell,S.B.RoleoftheDNAmismatchrepairproteinsintherecognitionofplatinumDNAadducts.Proc.Am.Assoc.CancerRes.,38:359,1997.
	60.Nehme,A.,Baskaran,R.,Nebel,S.,Fink,D.,Howell,S.B.,Wang,J.Y.,andChristen,R.D.InductionofJNKandc-Ablsignallingbycisplatinandoxaliplatininmismatchrepair-proficientand-deficientcells.Br.J.Cancer,79:1104?1110,1999.
	61.Moreland,N.J.,Illand,M.,Kim,Y.T.,Paul,J.,andBrown,R.Mod-ulationofdrugresistancemediatedbylossofmismatchrepairbytheDNApolymeraseinhibitoraphidicolin.CancerRes.,59:2102?2106,1999.
	62.Durant,S.T.,Morris,M.M.,Illand,M.,McKay,H.J.,McCormick,C.,Hirst,G.L.,Borts,R.H.,andBrown,R.DependenceonRAD52andRAD1foranticancerdrugresistancemediatedbyinactivationofmismatchrepairgenes.Curr.Biol.,9:51?54,1999.
	63.Akaboshi,M.,Kawai,K.,Ujeno,Y.,Takada,S.,andMiyahara,T.Bindingcharacteristicsof(-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobu-tanedicarboxylato)-2-platinum(II)toDNA,RNAandproteinmoleculesinHeLacellsanditslethaleffect:comparisonwithcis-andtrans-diam-minedichloroplatinums(II).Jpn.J.CancerRes.,85:106?111,1994.
	64.Akaboshi,M.,Kawai,K.,Maki,H.,Akuta,K.,Ujeno,Y.,andMiyahara,T.ThenumberofplatinumatomsbindingtoDNA,RNAandproteinmoleculesofHeLacellstreatedwithcisplatinatitsmeanlethalconcen-tration.Jpn.J.CancerRes.,83:522?526,1992.
	65.Woynarowski,J.M.,Koester,S.,Woynarowska,B.,Arnett,B.,Trevino,A.V.,Chan,D.,Higdon,A.,Munoz,R.,Herzig,M.C.,andFaivre,S.Isdrug-induceddamagesufficientforapoptosisinduction?Proc.Am.Assoc.CancerRes.,40:736,1999.
	66.Chaney,S.,andSancar,A.DNArepair:enzymaticmechanismsandrelevancetodrugresponse.J.Natl.CancerInst.(Bethesda),88:1346?1360,1996.
	67.Graham,M.,Lockwood,G.,Greenslade,D.,Brienza,S.,Bayssas,M.,andGamelin,E.Clinicalpharmacokineticsofoxaliplatin:acriticalreview.Clin.CancerRes.,6:1205?1218,2000.
	68.Misset,J.L.,Bleiberg,H.,Sutherland,W.,Bekradda,M.,andCvitk-ovic,E.Oxaliplatinclinicalactivity:areview.Crit.Rev.Oncol.Hematol.,35:75?93,2000.
	69.Mavroudis,D.,Kourousis,C.,Kakolyris,S.,Agelaki,S.,Kalbakis,K.,Androulakis,N.,Souglakos,J.,Vardakis,N.,Samonis,G.,andGeor-goulias,V.PhaseIstudyofgemcitabine/oxaliplatincombinationinpa-tientswithadvancedsolidtumors:apreliminaryreport.Semin.Oncol.,27:25?30,2000.
	70.Carethers,J.M.,Chauhan,D.P.,Fink,D.,Nebel,S.,Bresalier,R.S.,Howell,S.B.,andBoland,C.R.Mismatchrepairproficiencyandinvitroresponseto5-fluorouracil.Gastroenterology,117:123?131,1999.
	71.Meyers,M.,Wagner,M.W.,Hwang,H.S.,Kinsella,T.J.,andBooth-man,D.A.RoleofthehMLH1DNAmismatchrepairproteininfluoropy-rimidine-mediatedcelldeathandcellcycleresponses.CancerRes.,61:5193?5201,2001.
	72.Plasencia,C.,Taron,M.,Martinez,E.,Rossell,R.,andAbad,A.Down-regulationofthymidylatesynthasegeneexpressionafteroxaliplatinadministration:implicationsforthesynergisticactivityofsequentialox-aliplatin/5FUinsensitiveand5FU-resistantcelllines.Proc.Am.Assoc.CancerRes.,42:508,2001.
	73.Fischel,J.L.,Etienne,M.C.,Formento,P.,andMilano,G.Searchfortheoptimalschedulefortheoxaliplatin/5-fluorouracilassociationmodu-latedornotbyfolinicacid:preclinicaldata.Clin.CancerRes.,4:2529?2535,1998.
	74.Metzger,G.,Massari,C.,Etienne,M.C.,Comisso,M.,Brienza,S.,Touitou,Y.,Milano,G.,Bastian,G.,Misset,J.L.,andLevi,F.Spontane-ousorimposedcircadianchangesinplasmaconcentrationsof5-fluorouracilcoadministeredwithfolinicacidandoxaliplatin:relationshipwithmucosaltoxicityinpatientswithcancer.Clin.Pharmacol.Ther.,56:190?201,1994.
	75.Gale,G.R.,Loretta,M.,Atkins,L.M.,Schwartz,P.,andMeischen,S.J.Potentiatingactionof5-fluorouracilwhenusedincombinationwithplatinumcompoundsandcyclophosphamideintreatmentofadvancedL1210leukemia.Bioinorg.Chem.,8:445?451,1978.
	76.Ducreux,M.,Louvet,C.,Bekradda,M.,andCvitkovic,E.Oxaliplatinforthetreatmentofadvancedcolorectalcancer:futuredirections.Semin.Oncol.,25:47?53,1998.
	77.Louvet,C.,Raymond,E.,Coudray,A.M.,Chazard,M.,andGespach,C.AntitumoractivityofUFTfolinicacid(FA)incombinationwithoxaliplatin(Ox)againsthumanHT29coloncancerxenograftsinathymicnudemice.Proc.Am.Assoc.CancerRes.,40:292,1999.
	78.Raymond,E.,Djelloul,S.,Buquet-Fagot,C.,Goldwasser,F.,Mester,J.,Cvitkovic,E.,Louvet,C.,andGespach,C.Oxaliplatin(LOHP),andcisplatin(CDDP)incombinationwith5FU,specificthymidylatesynthase(TS)inhibitors(AG337,ZD1694),andtopoisomeraseI(TOPO-I)inhibitors(SN38,CPT-11),inhumancolonic,ovarianandbreastcancers(meetingabstract).Proc.Am.Assoc.CancerRes.,37:291,1996.
	79.Faivre,S.,Raymond,E.,Woynarowski,J.M.,andCvitkovic,E.Su-praadditiveeffectof2,2-difluorodeoxycytidine(gemcitabine)incombi-234CellularandMolecularPharmacologyofOxaliplatinnationwithoxaliplatininhumancancercelllines.CancerChemother.Pharmacol.,44:117?123,1999.
	80.Lin,X.,Ramamurthi,K.,Mishima,M.,Kondo,A.,Christen,R.D.,andHowell,S.B.P53modulatestheeffectsoflossofDNAmismatchrepaironsensitivityofhumancoloncancercellstothecytotoxicandmutageniceffectsofcisplatin.CancerRes.,61:1508?1516,2001.
	81.Mathe,G.,Chenu,E.,Bourut,C.,andFlorentin,I.Experimentalstudyofthreeplatinumcomplexes:CDDP,CBDCAandL-OHPonL1210leu-kemia.Proc.Am.Assoc.CancerRes.,30:471,1989.
	82.Mathe,G.,Kidani,Y.,Segiguchi,M.,Eriguchi,M.,Fredj,G.,Peytavin,G.,Misset,J.L.,Brienza,S.,deVassals,F.,andChenu,E.Oxalato-platinumor1-OHP,athird-generationplatinumcomplex:anexperimentalandclinicalappraisalandpreliminarycomparisonwithcis-platinumandcarboplatinum.Biomed.Pharmacother.,43:237?250,1989.
	83.Goldwasser,F.,Bozec,L.,Zeghari-Squalli,N.,andMisset,J.L.CellularpharmacologyofthecombinationofoxaliplatinwithtopotecanintheIGROV-1humanovariancancercellline.AnticancerDrugs,10:195?201,1999.
	84.Zeghari-Squalli,N.,Raymond,E.,Cvitkovic,E.,andGoldwasser,F.CellularpharmacologyofthecombinationoftheDNAtopoisomeraseIinhibitorSN-38andthediaminocyclohexaneplatinumderivativeoxalipla-tin.Clin.CancerRes.,5:1189?1196,1999.
	85.Bissery,M.C.,Vrignaud,P.,andLavelle,F.Invivoevaluationoftheirinotecan-oxaliplatincombination.Proc.Am.Assoc.CancerRes.,39:526,1998.
	86.Mailliet,P.,Segal-Bendirdjian,E.,Kozelka,J.,Barreau,M.,Baudoin,B.,Bissery,M.C.,Gontier,S.,Laoui,A.,Lavelle,F.,andLePecq,J.B.Asymmetricallysubstitutedethylenediamineplatinum(II)complexesasantitumoragents:synthesisandstructure-activityrelationships.Antican-cerDrugDes.,10:51?73,1995.
	87.Skou,G.,Mangold,G.,Dexter,D.,andVonHoff,D.D.Comparisonofanoxaliplatin-taxolversuscarboplatin-taxolregimeninthetreatmentoftheMV-522humanlungtumorxenograft.Proc.Am.Assoc.CancerRes.,37:375,1996.
	88.Debner,J.,Dexter,D.,Mangold,G.,Juniewicz,P.,Rake,J.,andVonHoff,D.D.Evaluationofoxaliplatin-tirapazamine-taxolcombinationsintheMV-522humanlungcarcinomaxenograftmodel.Proc.Am.Assoc.CancerRes.,38:312,1997.
	89.Faivre,S.,Kalla,S.,Cvitkovic,E.,Bourdon,O.,Hauteville,D.,Dourte,L.M.,Bensmaine,A.,Itzhaki,M.,Marty,M.,andExtra,J.M.Oxaliplatinandpaclitaxelcombinationinpatientswithplatinum-pretreatedovariancarcinoma:aninvestigator-originatedcompassionateuseexperience.Ann.Oncol.,10:1125?1128,1999.
	90.Giacchetti,S.,Perpoint,B.,Zidani,R.,LeBail,N.,Faggiuolo,R.,Focan,C.,Chollet,P.,Llory,J.F.,Letourneau,Y.,Coudert,B.,Bertheaut-Cvitkovic,F.,Larregain-Fournier,D.,LeRol,A.,Walter,S.,Adam,R.,Misset,J.L.,andLevi,F.PhaseIIImulticenterrandomizedtrialofoxali-platinaddedtochronomodulatedfluorouracil-leucovorinasfirst-linetreat-mentofmetastaticcolorectalcancer.J.Clin.Oncol.,18:136?147,2000.
	91.DeGramont,A.,Figer,A.,Seymour,M.,Homerin,M.,Hmissi,A.,Cassidy,J.,Boni,C.,Cortes-Funes,H.,Cervantes,A.,Freyer,G.,etal.Leucovorinandfluorouracilwithorwithoutoxaliplatinasfirst-linetreat-mentinadvancedcolorectalcancer.J.Clin.Oncol.,18:2938?2947,2000.
	92.Fizazi,K.,Ducreux,M.,Ruffie,P.,Bonnay,M.,Daniel,C.,Soria,J.C.,Hill,C.,Fandi,A.,Poterre,M.,Smith,M.,etal.PhaseI,dose-finding,andpharmacokineticstudyofraltitrexedcombinedwithoxaliplatininpatientswithadvancedcancer.J.Clin.Oncol.,18:2293?2300,2000.
	93.Wasserman,E.,Cuvier,C.,Lokiec,F.,Goldwasser,F.,Kalla,S.,Meï¿½ry-Mignard,D.,OuldKaci,M.,Bensmaine,A.,Dupont-Andreï¿½,G.,Mah-joubi,M.,etal.Combinationofoxaliplatinplusirinotecaninpatientswithgastrointestinaltumors:resultsoftwoindependentphaseIstudieswithpharmacokinetics.J.Clin.Oncol.,17:1751?1759,1999.
	94.Scheithauer,W.,Kornek,G.V.,Raderer,M.,Valencak,J.,Weinlander,G.,Hejna,M.,Haider,K.,Kwasny,W.,andDepisch,D.Combinedirino-tecanandoxaliplatinplusgranulocytecolony-stimulatingfactorinpa-tientswithadvancedfluoropyrimidine/leucovorin-pretreatedcolorectalcancer.J.Clin.Oncol.,17:902?906,1999.
	95.Kemeny,N.,Tong,W.,Stockman,J.,Blanchette,J.,andSaltz,L.PhaseItrialofweeklyoxaliplatinandirinotecaninpreviouslytreatedpatientswithmetastaticcolorectalcancer.Proc.Am.Soc.Clin.Oncol.,19:245a,2000.
	96.Goldwasser,F.,Gross-Goupil,M.,Tigaud,J.M.,DiPalma,M.,Marceau-Suissa,J.,Wasserman,E.,Yovine,A.,Misset,J.L.,andCvit-kovic,E.DoseescalationofCPT-11incombinationwithoxaliplatinusinganeverytwoweeksschedule:aphaseIstudyinadvancedgastrointes-tinalcancerpatients.Ann.Oncol.,11:1463?1470,2000.
	97.Misset,J.L.,Goldwasser,F.,Riofrio,M.,Gross,M.,Romain,D.,andLokiec,F.Topotecan-oxaliplatineverythreeweeks:aphaseIandphar-macologicalstudy.Proc.Am.Soc.Clin.Oncol.,18:220a,1999.
	98.Delaloge,S.,Laadem,A.,Chouaki,N.,Pautier,P.,Taamma,A.,Misset,J.L.,Cvitkovic,E.,andLhomme,C.Feasibilitystudyofthepaclitaxel(PXL),oxaliplatin(LOHP)andciplatin(CDDP)combinationinadvancedovariancancer(AOC).Proc.Am.Soc.Clin.Oncol.,18:365a,1999.
	99.Buechele,T.,Schmoll,H.,Grothey,A.,andVoigt,W.BiweeklyDo-cetaxel(Doc),Gemcitabine(Gem),Oxaliplatin(LOHP)inheavilypretreatedpatientswithsolidtumors?apilotstudy.Proc.Am.Soc.Clin.Oncol.,18:205a,1999.
	100.el-akawi,Z.,Abu-hadid,M.,Perez,R.,Glavy,J.,Zdanowicz,J.,Creaven,P.J.,andPendyala,L.Alteredglutathionemetabolisminoxali-platinresistantovariancarcinomacells.CancerLett.,105:5?14,1996.
J Infect Dis.-2002-Greene-1790-6.pdf	50
	1.PinnerRW,TeutschSM,SimonsenL,KlugLA,ClarkeMJ,BerkelmanRL.InfectiousdiseaseintheUnitedStates.JAMA1996;275:189?93.
	2.CenterforDiseaseControlandPrevention.Prematuredeaths,monthlymor-talityandmonthlyphysiciancontacts:UnitedStates.MMWRMorbMor-talWklyRep1997;46:556?61.
	3.ArstonBJ,PlouffeJF,FileTMJr,etal.Incidenceofcommunity-acquiredpneumoniarequiringhospitalisation:resultsofapopulation-basedactivesurveillancestudyinOhio.TheCommunity-BasedIncidenceStudyGroup.ArchInternMed1997;157:1709?22.
	4.NiedermanMS,McCombsJS,UngerAN,KumarA,PopovianR.Thecostoftreatingcommunity-acquiredpneumonia.ClinTher1998;20:820?37.
	5.FineMJ,SmithMA,CarsonCA,etal.Prognosisandoutcomesofpatientswithcommunity-acquiredpneumonia:ameta-analysis.JAMA1996;275:134?41.
	6.MontonC,TorresA,El-EbiaryM,FilellaX,XaubetA,delaBellacasaJP.Cytokineexpressioninseverepneumonia:abronchoalveolarlavagestudy.CritCareMed1999;27:1745?53.
	7.KosmasEN,BaxevanisCN,PapamichailM,KordossisT.Dailyvariationincirculatingcytokinesandacute-phaseproteinscorrelateswithclinicalandlaboratoryindicesincommunity-acquiredpneumonia.EurJClinInvest1997;27:308?15.
	8.PurenAJ,FeldmanC,SavageN,BeckerPJ,SmithC.Patternsofcytokineexpressionincommunity-acquiredpneumonia.Chest1995;107:1342?9.
	9.DehouxMS,BouttenA,OstinelliJ,etal.Compartmentalizedcytokineproductionwithinthehumanlunginunilateralpneumonia.AmJRes-pirCritCareMed1994;150:710?6.
	10.GlynnP,CoakleyR,KilgallenI,MurphyN,O?NeillSJ.Circulatinginter-leukin6andinterleukin10incommunityacquiredpneumonia.Thorax1999;54:51?5.
	11.BlackRA,RauchCT,KozloskyCJ,etal.AmetalloproteinasedisintegrinthatreleasesTNF-afromcells.Nature1997;385:729?33.
	12.NelsonS,BagbyGJ,BaintonBG,WilsonLA,ThompsonJJ,SummerWR.Compartmentalizationofintraalveolarandsystemiclipopolysaccharide-inducedtumornecrosisfactorandthepulmonaryinflammatoryresponse.JInfectDis1989;159:189?94.
	13.BouttenA,DehouxMS,SetaN,etal.CompartmentalisedIL-8andelastasereleasewithinthehumanlunginunilateralpneumonia.AmJRespirCritCareMed1996;153:336?42.
	14.MunfordRS,PuginJ.Normalresponsestoinjurypreventsystemicinflam-mationandcanbeimmunosuppressive.AmJRespirCritCareMed2001;163:316?21.
	15.PeschonJJ,SlackJL,ReddyP,etal.Anessentialroleforectodomainshed-dinginmammaliandevelopment.Science1998;282:1281?4.
	16.HansenHP,DietrichS,KisselevaT,etal.CD30sheddingfromKarpas299lymphomacellsismediatedbyTNF-alpha?convertingenzyme.JImmu-nol2000;165:6703?9.
	17.LumL,WongBR,JosienR,etal.Evidenceforaroleofatumornecrosisfactor?alpha(TNF-alpha)?convertingenzyme?likeproteaseinsheddingofTRANCE,aTNFfamilymemberinvolvedinosteoclastogenesisanddendriticcellsurvival.JBiolChem1999;274:13613?8.
	18.ZhangY,JiangJ,BlackRA,BaumannG,FrankSJ.Tumornecrosisfac-tor?alphaconvertingenzyme(TACE)isagrowthhormonebindingpro-tein(GHBP)sheddase:themetalloproteaseTACE/ADAM-17iscriticalfor(PMA-induced)GHreceptorproteolysisandGHBPgeneration.En-docrinology2000;141:4342?8.
	19.RovidaE,PaccagniniA,DelRossoM,PeschonJ,DelloSbarbaP.TNF-alpha?convertingenzymecleavesthemacrophagecolony-stimulatingfac-torreceptorinmacrophagesundergoingactivation.JImmunol2001;166:1583?9.
	20.GartonKJ,GoughPJ,BlobelCP,etal.TACE(ADAM17)mediatesthecleavageandsheddingofFractalkine(CX3CL1).JBiolChem2001;276:37993?8001.
	21.MonteroJC,YusteL,Diaz-RodriguezE,Esparis-OgandoA,PandiellaA.Dif-ferentialsheddingoftransmembraneneuregulinisoformsbythetumorne-crosisfactor?alpha?convertingenzyme.MolCellNeurosci2000;16:631?48.
	22.RioC,BuxbaumJD,PeschonJJ,CorfasG.Tumornecrosisfactor?alpha?convertingenzymeisrequiredforcleavageoferbB4/HER4.JBiolChem2000;275:10379?87.
	23.BuxbaumJD,LiuKN,LuoY,etal.Evidencethattumornecrosisfactoralphaconvertingenzymeisinvolvedinregulatedalpha-secretasecleavageoftheAlzheimeramyloidproteinprecursor.JBiolChem1998;273:27765?7.
	24.ReddyP,SlackJL,DavisR,etal.Functionalanalysisofthedomainstructureoftumornecrosisfactor?alphaconvertingenzyme.JBiolChem2000;275:14608?14.
	25.AlthoffK,ReddyP,VoltzN,Rose-JohnS,MullbergJ.Sheddingofinter-leukin-6receptorandtumornecrosisfactoralpha:contributionofthestalksequencetothecleavagepatternoftransmembraneproteins.EurJBiochem2000;267:2624?31.
	26.Montero-JulianFA.ThesolubleIL-6receptors:serumlevelsandbiologicalfunction.CellMolBiol(Noisy-le-grand)2001;4:583?97.
	27.HurstSM,WilkinsonTS,McLoughlinRM,etal.IL-6anditssolublereceptororchestrateatemporalswitchinthepatternofleukocyterecruitmentseenduringacuteinflammation.Immunity2001;14:705?14.
	28.FineMJ,AubleTE,YealyDM,etal.Apredictionruletoidentifylow-riskpatientswithcommunity-acquiredpneumonia.NEnglJMed1997;336:243?50.
	29.AmericanCollegeofChestPhysicians/SocietyofCriticalCareMedicineCon-sensusConference.Definitionsforsepsisandorganfailureandguidelinesfortheuseofinnovativetherapiesinsepsis.CritCareMed1992;20:864?74.
	30.KlechH,PohlW.Technicalrecommendationsandguidelinesforbronchoal-veolarlavage(BAL).ReportoftheEuropeanSocietyofPneumologyTaskGroup.EurRespirJ1989;2:561?84.
	31.BartlettJG,DowellSF,MandellLA,FileTMJr,MusherDM,FineMJ.GuidelinesfromtheInfectiousDiseasesSocietyofAmerica:practicalguidelinesforthemanagementofcommunity-acquiredpneumoniainadults.ClinInfectDis2000;31:347?82.
	32.NiedermanMS,BassJBJr,CampbellGD,etal.Guidelinesfortheinitialmanagementofadultswithcommunity-acquiredpneumonia:diagnosis,assessmentofseverity,andinitialantimicrobialtherapy.AmericanTho-racicSociety.MedicalSectionoftheAmericanLungAssociation.AmRevRespirDis1993;148:1418?26.
	33.RennardSI,BassetG,LecossierD,etal.Estimationofvolumeofepithelialliningfluidrecoveredbylavageusingureaasamarkerofdilution.JApplPhysiol1986;60:532?8.
	34.FlickDA,GiffordGE.Comparisonofinvitrocellcytotoxicassaysfortumournecrosisfactor.JImmunolMethods1984;68:167?75.
	35.KamentskyLA,BurgerDE,GershmanRJ,KamentskyLD,LutherE.Slide-basedlaserscanningcytometry.ActaCytol1997;41:123?43.
	36.WoltmannG,WardR,SymonF,RewD,PavordI,WardlawA.Objectivequantitativeanalysisofeosinophilsandbronchialepithelialcellsinin-ducedsputumbylaserscanningcytometry.Thorax1999;54:124?30.
	37.LuettigB,DeckerT,Lohmann-MatthesML.Evidencefortheexistenceoftwoformsofmembranetumournecrosisfactor:anintegralproteinandamoleculeattachedtoitsreceptor.JImmunol1989;143:4034?8.
	38.DineralloC.A.Biologicbasisforinterleukin-1indisease.Blood1996;87:2095?47.
	39.DoedensJR,BlackRA.Stimulation-induceddown-regulationoftumournecrosisfactor?a?convertingenzyme.JBiolChem2000;275:14598?607.
	40.ArendWP,WelgusHG,ThompsonRC,EisenbergSP.Biologicalpropertiesofrecombinanthumanmonocyte-derivedinterleukin-1receptorantago-nist.JClinInvest1990;85:1694?97.
	41.ArendWP,MalyakM,SmithMF,etal.BindingofIL-1a,IL-1bandIL-1receptorantagonistbysolubleIL-1receptorsandlevelsofsolubleIL-1receptorsinsynovialfluid.JImmunol1994;153:4766?74.
	42.RooneyM,VarsaniH,MartinK,LombardPR,DayerJM,WooP.Tumournecrosisfactor?aanditsreceptorsinjuvenilechronicarthritis.Rheu-matology2000;39:432?8.
	43.O?GradyNP,PreasHL,PuginJ,etal.Localinflammatoryresponsesfol-lowingbronchialendotoxininstillationinhumans.AmJRespirCritCareMed2001;163:1591?8.
	44.ReF,MuzioM,DeRossiMetal.ThetypeII?receptor?asadecoytargetforinterleukin1inpolymorphonuclearleukocytes:characterisationofinductionbydexamethasoneandligandbindingpropertiesofthereleaseddecoyreceptor.JExpMed1994;179:739?43.
	45.ThabardW,ColletteM,MellerinMP,etal.IL-6upregulatesitsownreceptoronsomehumanmyelomacelllines.Cytokine2001;14:352?6.
	46.RemickDG,CallDR,EbongSJ,etal.Combinationimmunotherapywithsolubletumornecrosisfactorreceptorsplusinterleukin1receptorantag-onistdecreasessepsismortality.CritCareMed2001;29:473?81.
	47.CoxG.IL-10enhancesresolutionofpulmonaryinflammationinvivobypromotingapoptosisofneutrophils.AmJPhysiol1996;271:L566?71.
	48.FiorentinoDF,ZlotnikA,MosmannTR,HowardM,O?GarraA.IL-10inhibitscytokineproductionbyactivatedmacrophages.JImmunol1991;147:3815?22.
	49.vanderPollT,MarchantA,KeoghCV,GoldmanM,LowrySFl.Interleukin-10impairshostdefenseinmurinepneumococcalpneumonia.JInfectDis1996;174:994?1000.
	50.CoeshottC,OhnemusC,PilyavskayaA,etal.Convertingenzyme?independentreleaseoftumornecrosisfactoralphaandIL-1betafromastimulatedhumanmonocyticcelllineinthepresenceofactivatedneu-trophilsorpurifiedproteinase3.ProcNatlAcadSciUSA1999;96:6261?6.
4536.full.pdf	40
	1.Ben-JonathanN,HnaskoR2001Dopamineasaprolactin(PRL)inhibitor.EndocrRev22:724?763
	2.AutelitanoDJ,SnyderL,SealfonSC,RobertsJL1989DopamineD2-receptormessengerRNAisdifferentiallyregulatedbydopaminergicagentsinratanteriorandneurointermediatepituitary.MolCellEndocrinol67:101?105
	3.MansourA,Meador-WoodruffJH,BunzowJR,CivelliO,AkilH,WatsonSJ1990LocalizationofdopamineD2receptormRNAandD1andD2receptorbindingintheratbrainandpituitary:aninsituhybridization-receptorauto-radiographicanalysis.JNeurosci10:2587?2600
	4.KellyMA,RubinsteinM,AsaSL,ZhangG,SaezC,BunzowJR,AllenRG,HnaskoR,Ben-JonathanN,GrandyDK,LowMJ1997PituitarylactotrophhyperplasiaandchronichyperprolactinemiaindopamineD2receptor-defi-cientmice.Neuron19:103?113
	5.SaiardiA,BozziY,BaikJH,BorrelliE1997Antiproliferativeroleofdopa-mine:lossofD2receptorscauseshormonaldysfunctionandpituitaryhyper-plasia.Neuron19:115?126
	6.AsaSL,KellyMA,GrandyDK,LowMJ1999PituitarylactotrophadenomasdevelopafterprolongedlactotrophhyperplasiaindopamineD2receptor-deficientmice.Endocrinology140:5348?5355
	7.FreemanME,KanyicskaB,LerantA,NagyG2000Prolactin:structure,func-tion,andregulationofsecretion.PhysiolRev80:1523?1631
	8.DePaulAL,PonsP,AokiA,TorresAI1997Heterogeneityofpituitarylactotrophs:immunocytochemicalidentificationoffunctionalsubtypes.ActaHistochem99:277?289
	9.ChenCL,MeitesJ1970Effectsofestrogenandprogesteroneonserumandpituitaryprolactinlevelsinovariectomizedrats.Endocrinology86:503?505
	10.NeillJD,FreemanME,TillsonSA1971Controloftheproestrussurgeofprolactinandluteinizinghormonesecretionbyestrogensintherat.Endocri-nology89:1448?1453
	11.SarkarDK,GottschallPE,XieQW,MeitesJ1984Reducedtuberoinfundibulardopaminergicneuronalfunctioninratswithinsituprolactin-secretingpitu-itarytumors.Neuroendocrinology38:498?503
	12.PerezRL,MachiavelliGA,RomanoMI,BurdmanJA1986Prolactinrelease,oestrogensandproliferationofprolactin-secretingcellsintheanteriorpitu-itaryglandofadultmalerats.JEndocrinol108:399?403
	13.RaymondV,BeaulieuM,LabrieF,BoissierJ1978Potentantidopaminergicactivityofestradiolatthepituitarylevelonprolactinrelease.Science200:1173?1175
	14.WestB,DanniesPS1980Effectsofestradiolonprolactinproductionanddihydroergocryptine-inducedinhibitionofprolactinproductioninprimaryculturesofratpituitarycells.Endocrinology106:1108?1113
	15.GudelskyGA,PorterJC1981Sex-relateddifferenceinthereleaseofdopamineintohypophysialportalblood.Endocrinology109:1394?1398
	16.Diaz-TorgaG,FeiersteinC,LibertunC,GelmanD,KellyMA,LowMJ,RubinsteinM,Becu-VillalobosD2002DisruptionoftheD2dopaminere-ceptoraltersGHandIGF-Isecretionandcausesdwarfisminmalemice.Endocrinology143:1270?1279
	17.WynickD,SmallCJ,BaconA,HolmesFE,NormanM,OrmandyCJ,KilicE,KerrNC,GhateiM,TalamantesF,BloomSR,PachnisV1998Galaninregulatesprolactinreleaseandlactotrophproliferation.ProcNatlAcadSciUSA95:12671?12676
	18.BartonAC,DemarestKT,LookinglandKJ,MooreKE1989Asexdifferenceinthestimulatoryafferentregulationoftuberoinfundibulardopaminergicneuronalactivity.Neuroendocrinology49:361?366
	19.GunnetJW,LookinglandKJ,MooreKE1986Comparisonoftheeffectsofcastrationandsteroidreplacementonincertohypothalamicdopaminergicneu-ronsinmaleandfemalerats.Neuroendocrinology44:269?275
	20.ArbogastLA,HydeJF2000Estradiolattenuatestheforskolin-inducedincreaseinhypothalamictyrosinehydroxylaseactivity.Neuroendocrinology71:219?227
	20a.SchuffKG,HentgesST,KellyMA,BinartN,KellyPA,IuovonePM,AsaSL,LowMJ,Lackofprolactinreceptorsignalinginmiceresultsinlactotrophproliferationandprolactinomasbydopamine-dependentandindependentmechanisms.JClinInvest,inpress
	21.SinhaYN,GilliganTA1982Estrogeninhighdosesinhibitsperphenazine-inducedprolactinrelease.Endocrinology110:126?130
	22.ChunTY,GreggD,SarkarDK,GorskiJ1998Differentialregulationbyestrogensofgrowthandprolactinsynthesisinpituitarycellssuggeststhatonlyasmallpoolofestrogenreceptorsisrequiredforgrowth.ProcNatlAcadSciUSA95:2325?2330
	23.SarkarDK,HentgesST,DeA,ReddyRHR1998Hormonalcontrolofpitu-itaryprolactin-secretingtumors.FrontBiosci3:d934?d943
	24.HoltzmanS,StoneJP,ShellabargerCJ1979InfluenceofdiethylstilbestroltreatmentonprolactincellsoffemaleACIandSprague-Dawleyrats.CancerRes39:779?784
	25.LloydRV,ColemanK,FieldsK,NathV1987Analysisofprolactinandgrowthhormoneproductioninhyperplasticandneoplasticratpituitarytissuesbythehemolyticplaqueassay.CancerRes47:1087?1092
	26.ShullJD,SpadyTJ,SnyderMC,JohanssonSL,PenningtonKL1997Ovary-intact,butnotovariectomizedfemaleACIratstreatedwith17-estradiolrapidlydevelopmammarycarcinoma.Carcinogenesis18:1595?1601
	27.SpadyTJ,HarvellDM,SnyderMC,PenningtonKL,McCombRD,ShullJD1998Estrogen-inducedtumorigenesisintheCopenhagenrat:disparatesus-ceptibilitiestodevelopmentofprolactin-producingpituitarytumorsandmammarycarcinomas.CancerLett124:95?103
	28.StoneJP,HoltzmanS,ShellabargerCJ1979Neoplasticresponsesandcor-relatedplasmaprolactinlevelsindiethylstilbestrol-treatedACIandSprague-Dawleyrats.CancerRes39:773?778
	29.WendellDL,HermanA,GorskiJ1996Geneticseparationoftumorgrowthandhemorrhagicphenotypesinanestrogen-inducedtumor.ProcNatlAcadSciUSA93:8112?81164542Endocrinology,December2002,143(12):4536?4543HentgesandLowHormone-DependentTumorigenesisinD2R/Mice
	30.WiklundJ,WertzN,GorskiJ1981AcomparisonofestrogeneffectsonuterineandpituitarygrowthandprolactinsynthesisinF344andHoltzmanrats.Endocrinology109:1700?1707
	31.GardnerW,StrongL1940Thestrain-limiteddevelopmentoftumorsofthepituitaryglandinmicereceivingestrogens.YaleJBiolMed12:543?548
	32.ShidaN,IkedaH,YoshimotoT,OshimaM,TaketoMM,MiyoshiI1998Estrogen-inducedtumorigenesisinthepituitaryglandofTGF-beta(/)knockoutmice.BiochimBiophysActa1407:79?83
	33.GriffithJS,JensenSM,LuncefordJK,KahnMW,ZhengY,FalaseEA,LyttleCR,TeuscherC1997Evidenceforthegeneticcontrolofestradiol-regulatedresponses.Implicationsforvariationinnormalandpathologicalhormone-dependentphenotypes.AmJPathol150:2223?2230
	34.SpearowJL,BarkleyM1999Geneticcontrolofhormone-inducedovulationrateinmice.BiolReprod61:851?856
	35.SpearowJL,DoemenyP,SeraR,LefflerR,BarkleyM1999Geneticvariationinsusceptibilitytoendocrinedisruptionbyestrogeninmice.Science285:1259?1261
	36.ShenES,HardenburgJL,MeadeEH,AreyBJ,MerchenthalerI,LopezFJ1999Estradiolinducesgalaningeneexpressioninthepituitaryofthemouseinanestrogenreceptor-dependentmanner.Endocrinology140:2628?2631
	37.BrownAE,ManiS,TobetSA1999Thepreopticarea/anteriorhypothalamusofdifferentstrainsofmice:sexdifferencesanddevelopment.BrainResDevBrainRes115:171?182
	38.MathiesonWB,TaylorSW,MarshallM,NeumannPE2000Strainandsexdifferencesinthemorphologyofthemedialpreopticnucleusofmice.JCompNeurol428:254?265
	39.CaiA,HayesJD,PatelN,HydeJF1999Targetedoverexpressionofgalanininlactotrophsoftransgenicmiceinduceshyperprolactinemiaandpituitaryhyperplasia.Endocrinology140:4955?4964
4505.full.pdf	44
	1.BoisclairYR,RhoadsRP,UekiI,WangJ,OoiGT2001Theacid-labilesubunit(ALS)ofthe150kDaIGF-bindingproteincomplex:animportantbutforgottencomponentofthecirculatingIGFsystem.JEndocrinol170:63?70
	2.DelhantyPJD1998TheregulationandactionsofALS.In:TakanoK,HizukaN,TakahashiS-I,eds.Molecularmechanismstoregulatetheactivitiesofinsulin-likegrowthfactors.Amsterdam:Elsevier;135?143
	3.TwiggSM,BaxterRC1998Insulin-likegrowthfactor(IGF)-bindingprotein5formsanalternativeternarycomplexwithIGFsandtheacid-labilesubunit.JBiolChem273:6074?6079
	4.BaxterRC,MekaS,FirthSM2002MoleculardistributionofIGFbindingprotein-5inhumanserum.JClinEndocrinolMetab87:271?276
	5.DaiJ,ScottCD,BaxterRC1994Regulationoftheacid-labilesubunitoftheinsulin-likegrowthfactorcomplexinculturedrathepatocytes.Endocrinology135:1066?1072
	6.OoiGT,CohenFJ,TsengLYH,RechlerMM,BoisclairYR1997Growthhormonestimulatestranscriptionofthegeneencodingtheacid-labilesubunit(ALS)ofthecirculatinginsulin-likegrowthfactor-bindingproteincomplexandALSpromoteractivityinratliver.MolEndocrinol11:997?1007
	7.UekiI,OoiGT,TremblayML,HurstKR,BachLA,BoisclairYR2000In-activationoftheacidlabilesubunitgeneinmiceresultsinmildretardationofpostnatalgrowthdespiteprofounddisruptionsinthecirculatinginsulin-likegrowthfactorsystem.ProcNatlAcadSciUSA97:6868?6873
	8.YakarS,RosenCJ,BeamerWG,Ackert-BicknellCL,WuY,LiuJL,OoiGT,SetserJ,FrystykJ,BoisclairYR,LeRoithD2002CirculatinglevelsofIGF-1directlyregulatebonegrowthanddensity.JClinInvest110:771?781
	9.ThissenJP,KetelslegersJM,UnderwoodLE1994Nutritionalregulationoftheinsulin-likegrowthfactors.EndocrRev15:80?101
	10.HaydenJM,MartenNW,BurkeEJ,StrausDS1994Theeffectoffastingoninsulin-likegrowthfactor-Inucleartranscriptabundanceinratliver.Endo-crinology134:760?768
	11.StrausDS,TakemotoCD1990Effectoffastingoninsulin-likegrowthfactor-I(IGF-I)andgrowthhormonereceptormRNAlevelsandIGF-Igenetranscrip-tioninratliver.MolEndocrinol4:91?100
	12.DaiJ,BaxterRC1994Regulationinvivooftheacid-labilesubunitoftheratseruminsulin-likegrowthfactor-bindingproteincomplex.Endocrinology135:2335?2341
	13.FrystykJ,DelhantyPJ,SkjaerbaekC,BaxterRC1999Changesinthecircu-latingIGFsystemduringshort-termfastingandrefeedinginrats.AmJPhysiol277:E245?E252
	14.OsterMH,LevinN,FielderPJ,RobinsonIC,BaxterRC,CroninMJ1996DevelopmentaldifferencesintheIGF-Isystemresponsetosevereandchroniccaloriemalnutrition.AmJPhysiol270:E646?E653
	15.ClemmonsDR,ThissenJP,MaesM,KetelslegersJM,UnderwoodLE1989Insulin-likegrowthfactor-I(IGF-I)infusionintohypophysectomizedorpro-tein-deprivedratsinducesspecificIGF-bindingproteinsinserum.Endocri-nology125:2967?2972
	16.TannenbaumGS,EpelbaumJ,ColleE,BrazeauP,MartinJB1978Antiserumtosomatostatinreversesstarvation-inducedinhibitionofgrowthhormonebutnotinsulinsecretion.Endocrinology102:1909?1914
	17.BeauloyeV,WillemsB,deConinckV,FrankSJ,EderyM,ThissenJ-P2002ImpairmentofliverGHreceptorsignalingbyfasting.Endocrinology143:792?800
	18.DelhantyPJD,BaxterRC1998Theregulationofacid-labilesubunitgeneexpressionandsecretionbycyclicadenosine3,5-monophosphate.Endocri-nology139:260?265
	19.ThissenJP,TriestS,Moats-StaatsBM,UnderwoodLE,MauerhoffT,MaiterD,KetelslegersJM1991Evidencethatpretranslationalandtranslationalde-fectsdecreaseseruminsulin-likegrowthfactor-Iconcentrationsduringdietaryproteinrestriction.Endocrinology129:429?435
	20.FliesenT,MaiterD,GerardG,UnderwoodLE,MaesM,KetelslegersJM1989Reductionofseruminsulin-likegrowthfactor-Ibydietaryproteinrestrictionisagedependent.PediatrRes26:415?419
	21.SmithWJ,UnderwoodLE,ClemmonsDR1995Effectsofcaloricorproteinrestrictiononinsulin-likegrowthfactor-I(IGF-I)andIGF-bindingproteinsinchildrenandadults.JClinEndocrinolMetab80:443?449
	22.BaxterRC,DaiJ1994Purificationandcharacterizationoftheacid-labilesubunitofratseruminsulin-likegrowthfactorbindingproteincomplex.En-docrinology134:848?852
	23.FrystykJ,BaxterRC1998Competitivebindingassayfordeterminationofratinsulin-likegrowthfactorbindingprotein-3.Endocrinology139:1454?1457
	24.CrawfordBA,MartinJL,HoweCJ,HandelsmanDJ,BaxterRC1992Com-parisonofextractionmethodsforinsulin-likegrowthfactor-Iinratserum.JEndocrinol134:169?176
	25.LewittMS,SaundersH,PhyualJL,BaxterRC1994Regulationofinsulin-likegrowthfactor-bindingprotein-1inratserum.Diabetes43:232?239
	26.DelhantyPJ,HanVK1993Theexpressionofinsulin-likegrowthfactor(IGF)-bindingprotein-2andIGF-IIgenesinthetissuesofthedevelopingovinefetus.Endocrinology132:41?52
	27.BaxterRC,TurtleJR1978Regulationofhepaticgrowthhormonereceptorsbyinsulin.BiochemBiophysResCommun84:350?357
	28.RhoadsRP,GreenwoodPL,BellAW,BoisclairYR2000Nutritionalregula-tionofthegenesencodingtheacid-labilesubunitandothercomponentsofthecirculatinginsulin-likegrowthfactorsysteminthesheep.JAnimSci78:2681?2689
	29.BaxterRC1997Editorial:thebindingprotein?sbindingprotein?clinicalap-plicationsofacid-labilesubunit(ALS)measurement.JClinEndocrinolMetab82:3941?3943
	30.ShimatsuA,RotweinP1987Mosaicevolutionoftheinsulin-likegrowthfactors.Organization,sequence,andexpressionoftheratinsulin-likegrowthfactorIgene.JBiolChem262:7894?7900
	31.VandeHaarMJ,Moats-StaatsBM,DavenportML,WalkerJL,KetelslegersJM,SharmaBK,UnderwoodLE1991Reducedserumconcentrationsofin-sulin-likegrowthfactor-I(IGF-I)inprotein-restrictedgrowingratsareaccom-paniedbyreducedIGF-ImRNAlevelsinliverandskeletalmuscle.JEndo-crinol130:305?312
	32.ZhangJ,ChrysisD,UnderwoodLE1998Reductionofhepaticinsulin-likegrowthfactorI(IGF-I)messengerribonucleicacid(mRNA)duringfastingisassociatedwithdiminishedsplicingofIGF-Ipre-mRNAanddecreasedsta-bilityofcytoplasmicIGF-ImRNA.Endocrinology139:4523?4530
	33.ZimmermannEM,LiL,HoytEC,PucilowskaJB,LichtmanS,LundPK2000Cell-specificlocalizationofinsulin-likegrowthfactorbindingproteinmRNAsinratliver.AmJPhysiol278:G447?G457
	34.DavisTA,FiorottoML,NguyenHV,ReedsPJ1993Enhancedresponseofmuscleproteinsynthesisandplasmainsulintofoodintakeinsuckledrats.AmJPhysiol265:R334?R340
	35.LeePD,GiudiceLC,ConoverCA,PowellDR1997Insulin-likegrowthfactorbindingprotein-1:recentfindingsandnewdirections.ProcSocExpBiolMed216:319?357
	36.RajaramS,BaylinkDJ,MohanS1997Insulin-likegrowthfactor-bindingproteinsinserumandotherbiologicalfluids?regulationandfunctions.En-docrRev18:801?831
	37.OldhamJM,MartynJA,HuaKM,MacDonaldNA,HodgkinsonSC,BassJJ1999NutritionalregulationofIGF-II,butnotIGF-I,isagedependentinsheep.JEndocrinol163:395?402
	38.YoshizawaF,KimballSR,JeffersonLS1997Modulationoftranslationini-tiationinratskeletalmuscleandliverinresponsetofoodintake.BiochemBiophysResCommun240:825?831
	39.DavisTA,BurrinDG,FiorottoML,NguyenHV1996Proteinsynthesisinskeletalmuscleandjejunumismoreresponsivetofeedingin7-thanin26-day-oldpigs.AmJPhysiol270:E802?E809
	40.HaysteadTA,HaysteadCM,HuC,LinTA,LawrenceJrJC1994Phosphor-ylationofPHAS-Ibymitogen-activatedprotein(MAP)kinase.IdentificationofasitephosphorylatedbyMAPkinaseinvitroandinresponsetoinsulininratadipocytes.JBiolChem269:23185?23191
	41.DavisTA,NguyenHV,SuryawanA,BushJA,JeffersonLS,KimballSR2000Developmentalchangesinthefeeding-inducedstimulationoftranslationini-tiationinmuscleofneonatalpigs.AmJPhysiol279:E1226?E1234
	42.DavisTA,BurrinDG,FiorottoML,ReedsPJ,JahoorF1998Rolesofinsulinandaminoacidsintheregulationofproteinsynthesisintheneonate.JNutr128:347S?350S
	43.DavisTA,FiorottoML,BurrinDG,ReedsPJ,NguyenHV,BeckettPR,VannRC,O?ConnorPM2002Stimulationofproteinsynthesisbybothinsulinandaminoacidsisuniquetoskeletalmuscleinneonatalpigs.AmJPhysiol282:E880?E890
	44.SuryawanA,NguyenHV,BushJA,DavisTA2001Developmentalchangesinthefeeding-inducedactivationoftheinsulin-signalingpathwayinneonatalpigs.AmJPhysiol281:E908?E915
Chest-2002-Light-1506-8.pdf	5
	1LightRW,MacgregorMI,LuchsingerPC,etal.Pleuraleffusions:thediagnosticseparationoftransudatesandexu-dates.AnnInternMed1972;77:507?513
	2Valdeï¿½sL,PoseA,Sua`rezJ,etal.Cholesterol:ausefulparameterfordistinguishingbetweenpleuralexudatesandtransudates.Chest1991;99:1097?1102
	3RothBJ,O?MearaTF,CragunWH.Theserum-effusionalbumingradientintheevaluationofpleuraleffusions.Chest1990;98:546?549
	4MeiselS,ShamissA,ThalerM,etal.Pleuralfluidtoserumbilirubinconcentrationratiofortheseparationoftransudatesandexudates.Chest1990;98:141?144
	5HeffnerJE,SahnSA,BrownLK.Multilevellikelihoodratiosforidentifyingexudativepleuraleffusions.Chest2002;121:
Am J Physiol Renal Physiol-2002-Devuyst-F1176-91.pdf	196
	1.Abdulnour-NakhoulSandBoulpaepEL.Transcellularchloridepathwaysinambystomaproximaltubule.JMembrBiol166:15?35,1998.
	2.AdachiS,UchidaS,ItoH,HataM,HiroeM,MarumoF,andSasakiS.Twoisoformsofachloridechannelpredomi-nantlyexpressedinthickascendinglimbofHenle?sloopandcollectingductsofratkidney.JBiolChem269:17677?17683,1994.
	3.AkizukiN,UchidaS,SasakiS,andMarumoF.ImpairedsoluteaccumulationininnermedullaofClcnk1/micekidney.AmJPhysiolRenalPhysiol280:F79?F87,2001.
	4.AladjemM,LotanD,BoichisH,OrdaS,andKatznelsonD.Renalfunctioninpatientswithcysticfibrosis.Nephron34:84?86,1983.
	5.AlperSL.Theband3-relatedanionexchanger(AE)genefam-ily.AnnuRevPhysiol53:549?564,1991.
	6.AndersonMP,SheppardDN,BergerHA,andWelshMJ.Chloridechannelsintheapicalmembraneofnormalandcysticfibrosisairwayandintestinalepithelia.AmJPhysiolLungCellMolPhysiol263:L1?L14,1992.
	7.AnientoF,GuF,PartonRG,andGruenbergJ.Anendo-somalbetaCOPisinvolvedinthepH-dependentformationoftransportvesiclesdestinedforlateendosomes.JCellBiol133:29?41,1996.
	8.AssaelBM,MarraG,TirelliAS,CavannaG,ClarisAp-pianiA,GiuntaA,AmorettiM,andMilaniS.Renalfunc-tionincysticfibrosis.IntJPediatrNephrol7:213?216,1986.
	9.BaeHRandVerkmanAS.ProteinkinaseAregulateschlo-rideconductanceinendocyticvesiclesfromproximaltubule.Nature348:637?639,1990.
	10.BaileyMAandWalterSJ.Renaleffectsofglibenclamide:amicropuncturestudy.JPharmacolExpTher285:464?467,1998.
	11.BaillyC.TransducingpathwaysinvolvedinthecontrolofNaClreabsorptioninthethickascendinglimbofHenle?sloop.KidneyInt65:S29?S35,1998.
	12.BaraschJ,KissB,PrinceA,SaimanL,GruenertD,andal-AwqatiQ.Defectiveacidificationofintracellularorganellesincysticfibrosis.Nature352:70?73,1991.F1186INVITEDREVIEW
	13.BargS,HuangP,EliassonL,NelsonDJ,ObermullerS,RorsmanP,ThevenodF,andRenstromE.PrimingofinsulingranulesforexocytosisbygranularCluptakeandacidification.JCellSci114:2145?2154,2001.
	14.BeckL,KaraplisAC,AmizukaN,HewsonAS,OzawaH,andTenenhouseHS.TargetedinactivationofNpt2inmiceleadstosevererenalphosphatewasting,hypercalciuria,andskeletalabnormalities.ProcNatlAcadSciUSA95:5372?5377,1998.
	15.BenharougaM,FritschJ,BantingG,andEdelmanA.Propertiesofchloride-conductivepathwaysinratkidneycorti-calandouter-medullabrush-bordermembranes?inhibitionbyanti-(cysticfibrosistransmembraneregulator)mAbs.EurJBiochem246:367?372,1997.
	16.BenturL,KeremE,CouperR,BaumalR,CannyG,DurieP,andLevisonH.Renalcalciumhandlingincysticfibrosis:lackofevidenceforaprimaryrenaldefect.JPediatr116:556?560,1990.
	17.BergU,KusoffskyE,andStrandvikB.Renalfunctionincysticfibrosiswithspecialreferencetotherenalsodiumhan-dling.ActaPaediatrScand71:833?838,1982.
	18.BirkenhagerR,OttoE,SchurmannMJ,VollmerM,RufEM,Maier-LutzI,BeekmannF,FeketeA,OmranH,FeldmannD,MilfordDV,JeckN,KonradM,LandauD,KnoersNV,AntignacC,SudbrakR,KispertA,andHilde-brandtF.MutationofBSNDcausesBarttersyndromewithsensorineuraldeafnessandkidneyfailure.NatGenet29:310?314,2001.
	19.BlaisdellCJandGugginoWB.Anionchannels.In:TheKidney:PhysiologyandPathophysiology,editedbySeldinDWandGiebischG.Philadelphia,PA:LippincottWilliams&Wilkins,2000,p.277?291.
	20.BoatTF.Cysticfibrosis.In:NelsonTextbookofPediatrics(16thed.),editedbyBehrmanRE,KliegmanRM,andJensonHB.Philadelphia,PA:Saunders,2000,p.1315?1327.
	21.Boï¿½slMR,SteinV,HubnerC,ZdebikAA,JordtSE,Muk-hopadhyayAK,DavidoffMS,HolsteinAF,andJentschTJ.Malegermcellsandphotoreceptors,bothdependentonclosecell-cellinteractions,degenerateuponClC-2Clchanneldisruption.EMBOJ20:1289?1299,2001.
	22.BradburyNA.IntracellularCFTR:localizationandfunction.PhysiolRev79:S175?S191,1999.
	23.BradburyNA,JillingT,BertaG,SorscherEJ,BridgesRJ,andKirkKL.RegulationofplasmamembranerecyclingbyCFTR.Science256:530?532,1992.
	24.BradburyNA,JillingT,KirkKL,andBridgesRJ.Regu-latedendocytosisinachloridesecretoryepithelialcellline.AmJPhysiolCellPhysiol262:C752?C759,1992.
	25.BrillSR,RossKE,DavidowCJ,YeM,GranthamJJ,andCaplanMJ.Immunolocalizationofiontransportproteinsinhumanautosomaldominantpolycystickidneyepithelialcells.ProcNatlAcadSciUSA93:10206?10211,1996.
	26.BushinskyDA,ParkerWR,andAsplinJR.Calciumphos-phatesupersaturationregulatesstoneformationingenetichypercalciuricstone-formingrats.KidneyInt57:550?560,2000.
	27.CalvetJPandGranthamJJ.Thegeneticsandphysiologyofpolycystickidneydisease.SeminNephrol21:107?123,2001.
	28.ChoiJY,MuallemD,KiselyovK,LeeMG,ThomasPJ,andMuallemS.AberrantCFTR-dependentHCO3transportinmutationsassociatedwithcysticfibrosis.Nature410:94?97,2001.
	29.ChristensenEIandBirnH.Megalinandcubilin:synergisticendocyticreceptorsinrenalproximaltubule.AmJPhysiolRenalPhysiol280:F562?F573,2001.
	30.ChristensenEI,BirnH,VerroustP,andMoestrupSK.Membranereceptorsforendocytosisintherenalproximaltu-bule.IntRevCytol180:237?284,1998.
	31.ClarkeLL,GrubbBR,YankaskasJR,CottonCU,Mc-KenzieA,andBoucherRC.Relationshipofanon-cysticfibrosistransmembraneconductanceregulator-mediatedchlo-rideconductancetoorgan-leveldiseaseinCftr(/)mice.ProcNatlAcadSciUSA91:479?483,1994.
	32.ClarkeLLandHarlineMC.DualroleofCFTRincAMP-stimulatedHCO3secretionacrossmurineduodenum.AmJPhysiolGastrointestLiverPhysiol274:G718?G726,1998.
	33.CleirenE,BenichouO,VanHulE,GramJ,BollerslevJ,SingerFR,BeaversonK,AledoA,WhyteMP,YoneyamaT,deVernejoulMC,andVanHulW.Albers-Schonbergdis-ease(autosomaldominantosteopetrosis,typeII)resultsfrommutationsintheClCN7chloridechannelgene.HumMolGenet10:2861?2867,2001.
	34.ColledgeWH,AbellaBS,SouthernKW,RatcliffR,JiangC,ChengSH,MacVinishLJ,AndersonJR,CuthbertAW,andEvansMJ.GenerationandcharacterizationofadeltaF508cysticfibrosismousemodel.NatGenet10:445?452,1995.
	35.CrawfordITandMaloneyPC.Identificationofcysticfibrosistransmembraneconductanceregulatorinrenalendosomes.MethodsEnzymol292:652?663,1998.
	36.CrawfordI,MaloneyPC,ZeitlinPL,GugginoWB,HydeSC,TurleyH,GatterKC,HarrisA,andHigginsCF.ImmunocytochemicallocalizationofthecysticfibrosisgeneproductCFTR.ProcNatlAcadSciUSA88:9262?9266,1991.
	37.CuttingGR.Cysticfibrosis.In:EmoryandRimoin?sPrincipleandPracticeofMedicalGenetics(4thed.),editedbyRimoinDL,ConnorJM,PyeritzRE,andKorfBR.London:ChurchillLiv-ingstone,2002,p.1561?1606.
	38.DavidowCJ,MaserRL,RomeLA,CalvetJP,andGranthamJJ.Thecysticfibrosistransmembraneconductanceregulatormediatestransepithelialfluidsecretionbyhumanautosomaldominantpolycystickidneydiseaseepitheliuminvitro.KidneyInt50:208?218,1996.
	39.DelaneySJ,AltonEW,SmithSN,LunnDP,FarleyR,LovelockPK,ThomsonSA,HumeDA,LambD,PorteousDJ,DorinJR,andWainwrightBJ.CysticfibrosismicecarryingthemissensemutationG551Dreplicatehumangeno-type-phenotypecorrelations.EMBOJ15:955?963,1996.
	40.DevuystO.Dietarysaltandrenalstonedisease.Lancet349:507,1997.
	41.DevuystO,BurrowCR,SchwiebertEM,GugginoWB,andWilsonPD.DevelopmentalregulationofCFTRexpres-sionduringhumannephrogenesis.AmJPhysiolRenalFluidElectrolytePhysiol271:F723?F735,1996.
	42.DevuystO,ChristiePT,CourtoyPJ,BeauwensR,andThakkerRV.Intra-renalandsubcellulardistributionofthehumanchloridechannel,CLC-5,revealsapathophysiologicalbasisforDent?sdisease.HumMolGenet8:247?257,1999.
	43.DiGiovanniSR,NielsenS,ChristensenEI,andKnepperMA.RegulationofcollectingductwaterchannelexpressionbyvasopressininBrattlebororat.ProcNatlAcadSciUSA91:8984?8988,1994.
	44.DonckerwolckeRA,vanDiemen-SteenvoordeR,vanderLaagJ,KoomansHA,andBoerWH.Impaireddilutingsegmentchloridereabsorptioninpatientswithcysticfibrosis.ChildNephrolUrol12:186?191,1992.
	45.DorinJR,DickinsonP,AltonEW,SmithSN,GeddesDM,StevensonBJ,KimberWL,FlemingS,ClarkeAR,HooperML,AndersonL,BeddingtonRSP,andPortgeousDJ.Cysticfibrosisinthemousebytargetedinsertionalmutagene-sis.Nature359:211?215,1992.
	46.DutzlerR,CampbellEB,CadeneM,ChaitBT,andMac-KinnonR.X-raystructureofaClCchloridechannelat3.0ï¿½revealsthemolecularbasisofanionselectivity.Nature415:287?294,2002.
	47.EdmondsRD,SilvaIV,GugginoWB,ButlerRB,ZeitlinPL,andBlaisdellCJ.ClC-5:ontogenyofanalternativechlo-ridechannelinrespiratoryepithelia.AmJPhysiolLungCellMolPhysiol282:L501?L507,2002.
	48.EstevezR,BoettgerT,SteinV,BirkenhagerR,OttoE,HildebrandtF,andJentschTJ.BarttinisaClchannelbeta-subunitcrucialforrenalClreabsorptionandinnerearKsecretion.Nature414:558?561,2001.
	49.FahlkeC,RhodesTH,DesaiRR,andGeorgeALJr.Porestoichiometryofavoltage-gatedchloridechannel.Nature394:687?690,1998.
	50.FahlkeC,YuHT,BeckCL,RhodesTH,andGeorgeALJr.Pore-formingsegmentsinvoltage-gatedchloridechannels.Na-ture390:529?532,1997.
	51.FisherSE,BlackGC,LloydSE,HatchwellE,WrongO,ThakkerRV,andCraigIW.Isolationandpartialcharacter-izationofachloridechannelgenewhichisexpressedinkidneyandisacandidateforDent?sdisease(anX-linkedhereditarynephrolithiasis).HumMolGenet3:2053?2059,1994.
	52.FriedrichT,BreiderhoffT,andJentschTJ.MutationalanalysisdemonstratesthatClC-4andClC-5directlymediateplasmamembranecurrents.JBiolChem274:896?902,1999.
	53.FullerCM,JiHL,ToussonA,ElbleRC,PauliBU,andBenosDJ.Ca2-activatedClchannels:anewlyemerginganiontransportfamily.Pfluï¿½gersArch443,Suppl1:S107?S110,2001.
	54.GabrielSE,ClarkeLL,BoucherRC,andStuttsMJ.CFTRandoutwardrectifyingchloridechannelsaredistinctproteinswitharegulatoryrelationship.Nature363:263?268,1993.
	55.GibsonGA,HillWG,andWeiszOA.Evidenceagainsttheacidificationhypothesisincysticfibrosis.AmJPhysiolCellPhysiol279:C1088?C1099,2000.
	56.GregerR.IontransportmechanismsinthickascendinglimbofHenle?sloopofmammaliannephron.PhysiolRev65:760?797,1985.
	57.GrubbBR.Iontransportacrossthejejunuminnormalandcysticfibrosismice.AmJPhysiolGastrointestLiverPhysiol268:G505?G513,1995.
	58.GrubbBRandBoucherRC.EnhancedcolonicNaabsorp-tionincysticfibrosismiceversusnormalmice.AmJPhysiolGastrointestLiverPhysiol272:G393?G400,1997.
	59.GrubbBRandBoucherRC.Pathophysiologyofgene-tar-getedmousemodelsforcysticfibrosis.PhysiolRev79:S193?S214,1999.
	60.GrubbBR,VickRN,andBoucherRC.HyperabsorptionofNaandraisedCa2-mediatedClsecretioninnasalepitheliaofCFmice.AmJPhysiolCellPhysiol266:C1478?C1483,1994.
	61.GuinamardR,ChraibiA,andTeulonJ.Asmall-conduc-tanceClchannelinthemousethickascendinglimbthatisactivatedbyATPandproteinkinaseA.JPhysiol485:97?112,1995.
	62.Guï¿½ntherW,LuchowA,CluzeaudF,VandewalleA,andJentschTJ.ClC-5,thechloridechannelmutatedinDent?sdisease,colocalizeswiththeprotonpumpinendocytoticallyactivekidneycells.ProcNatlAcadSciUSA95:8075?8080,1998.
	63.GutknechtDR.Kidneystonesandcysticfibrosis(Abstract).AmJMed111:83,2001.
	64.HanaokaK,DevuystO,SchwiebertEM,WilsonPD,andGugginoWB.AroleforCFTRinhumanautosomaldominantpolycystickidneydisease.AmJPhysiolCellPhysiol270:C389?C399,1996.
	65.HarrisPC.Molecularbasisofpolycystickidneydisease:PKD1,PKD2andPKHD1.CurrOpinNephrolHypertens11:309?314,2002.
	66.HastyP,O?NealWK,LiuKQ,MorrisAP,BebokZ,ShumyatskyGB,JillingT,SorscherEJ,BradleyA,andBeaudetAL.Severephenotypeinmicewithterminationmu-tationinexon2ofcysticfibrosisgene.SomatCellMolGenet21:177?187,1995.
	67.HigginsJTJr,GeblerB,andFromterE.Electricalproper-tiesofamphibianurinarybladderepithelia.II.Thecellpoten-tialprofileinNecturusmaculosus.Pfluï¿½gersArch371:87?97,1977.
	68.HilpertJ,NykjaerA,JacobsenC,WallukatG,NielsenR,MoestrupSK,HallerH,LuftFC,ChristensenEI,andWillnowTE.Megalinantagonizesactivationoftheparathy-roidhormonereceptor.JBiolChem274:5620?5625,1999.
	69.HoenderopJG,WillemsPH,andBindelsRJ.Towardacomprehensivemolecularmodelofactivecalciumreabsorption.AmJPhysiolRenalPhysiol278:F352?F360,2000.
	70.HoopesRRJr,HueberPA,ReidRJJr,BradenGL,GoodyerPR,MelnykAR,MidgleyJP,MoelDI,NeuAM,VanWhySK,andScheinmanSJ.CLCN5chloride-channelmutationsinsixnewNorthAmericanfamilieswithX-linkednephrolithiasis.KidneyInt54:698?705,1998.
	71.HorsterM.Embryonicepithelialmembranetransporters.AmJPhysiolRenalPhysiol279:F982?F996,2000.
	72.HuberS,BraunG,Burger-KentischerA,ReinhartB,LuckowB,andHorsterM.CFTRmRNAanditstruncatedsplicevariant(TRN-CFTR)aredifferentiallyexpressedduringcollectingductontogeny.FEBSLett423:362?366,1998.
	73.HuberS,SchroppelB,KretzlerM,SchlondorffD,andHorsterM.SinglecellRT-PCRanalysisofClC-2mRNAex-pressioninuretericbudtip.AmJPhysiolRenalPhysiol274:F951?F957,1998.
	74.HustedRF,VolkKA,SigmundRD,andStokesJB.Anionsecretionbytheinnermedullarycollectingduct.Evidenceforinvolvementofthecysticfibrosistransmembraneconductanceregulator.JClinInvest95:644?650,1995.
	75.IgarashiT,GuntherW,SekineT,InatomiJ,ShiragaH,TakahashiS,SuzukiJ,TsuruN,YanagiharaT,ShimazuM,JentschTJ,andThakkerRV.Functionalcharacteriza-tionofrenalchloridechannel,CLCN5,mutationsassociatedwithDent?sJapandisease.KidneyInt54:1850?1856,1998.
	76.IllekB,YankaskasJR,andMachenTE.cAMPandgenisteinstimulateHCO3conductancethroughCFTRinhu-manairwayepithelia.AmJPhysiolLungCellMolPhysiol272:L752?L761,1997.
	77.ImaiMandKokkoJP.Sodiumchloride,urea,andwatertransportinthethinascendinglimbofHenle.Generationofosmoticgradientsbypassivediffusionofsolutes.JClinInvest53:393?402,1974.
	78.ImaiM,TaniguchiJ,andTabeiK.FunctionofthinloopsofHenle.KidneyInt31:565?579,1987.
	79.JentschTJ,SteinV,WeinreichF,andZdebikAA.Molec-ularstructureandphysiologicalfunctionofchloridechannels.PhysiolRev82:503?568,2002.
	80.JentschTJ,SteinmeyerK,andSchwarzG.Primarystruc-tureofTorpedomarmoratachloridechannelisolatedbyexpres-sioncloninginXenopusoocytes.Nature348:510?514,1990.
	81.KalinN,ClaassA,SommerM,PuchelleE,andTummlerB.DeltaF508CFTRproteinexpressionintissuesfrompatientswithcysticfibrosis.JClinInvest103:1379?1389,1999.
	82.KatzSM,KruegerLJ,andFalknerB.Microscopicnephro-calcinosisincysticfibrosis.NEnglJMed319:263?266,1988.
	83.KawasakiM,UchidaS,MonkawaT,MiyawakiA,Miko-shibaK,MarumoF,andSasakiS.CloningandexpressionofaproteinkinaseC-regulatedchloridechannelabundantlyex-pressedinratbrainneuronalcells.Neuron12:597?604,1994.
	84.KearnsGL,BerryPL,BocchiniJAJr,HilmanBC,andWilsonJT.Renalhandlingofbeta2-microglobulininpatientswithcysticfibrosis.DICP23:1013?1017,1989.
	85.KibbleJD,BallochKJ,NealAM,HillC,WhiteS,RobsonL,GreenR,andTaylorCJ.RenalproximaltubulefunctionispreservedinCftr(tm2cam)deltaF508cysticfibrosismice.JPhysiol532:449?457,2001.
	86.KibbleJD,NealAM,ColledgeWH,GreenR,andTaylorCJ.Evidenceforcysticfibrosistransmembraneconductanceregulator-dependentsodiumreabsorptioninkidney,usingCftr(tm2cam)mice.JPhysiol526:27?34,2000.
	87.KibbleJ,NealA,WhiteS,GreenR,EvansS,andTaylorC.Renaleffectsofglibenclamideincysticfibrosismice.JAmSocNephrol12:2507?2510,2001.
	88.KieferleS,FongP,BensM,VandewalleA,andJentschTJ.TwohighlyhomologousmembersoftheClCchloridechan-nelfamilyinbothratandhumankidney.ProcNatlAcadSciUSA91:6943?6947,1994.
	89.KishoreBK,FumingL,MaldagueP,TulkensPM,andCourtoyPJ.Mechanismofthethesaurismosisandalteredlysosomaldynamicsinducedbypoly-D-glutamicacidinkidneyproximaltubularcells.LabInvest74:1025?1037,1996.
	90.KnepperMAandInoueT.Regulationofaquaporin-2waterchanneltraffickingbyvasopressin.CurrOpinCellBiol9:560?564,1997.
	91.KobayashiK,UchidaS,MizutaniS,SasakiS,andMa-rumoF.IntrarenalandcellularlocalizationofCLC-K2proteininthemousekidney.JAmSocNephrol12:1327?1334,2001.
	92.KokkoJPandRectorFCJr.Countercurrentmultiplicationsystemwithoutactivetransportininnermedulla.KidneyInt2:214?223,1972.
	93.KondoY,YoshitomiK,andImaiM.Effectsofaniontrans-portinhibitorsandionsubstitutiononCltransportinTALofHenle?sloop.AmJPhysiolRenalFluidElectrolytePhysiol253:F1206?F1215,1987.
	94.KornakU,KasperD,BoslMR,KaiserE,SchweizerM,SchulzA,FriedrichW,DellingG,andJentschTJ.LossoftheClC-7chloridechannelleadstoosteopetrosisinmiceandman.Cell104:205?215,2001.
	95.KrivanHC,GinsburgV,andRobertsDD.PseudomonasaeruginosaandPseudomonascepaciaisolatedfromcysticfibro-sispatientsbindspecificallytogangliotetraosylceramide(asialoGM1)andgangliotriaosylceramide(asialoGM2).ArchBiochemBiophys260:493?496,1988.
	96.LangF,BuschGL,RitterM,VolklH,WaldeggerS,Gul-binsE,andHaussingerD.Functionalsignificanceofcellvolumeregulatorymechanisms.PhysiolRev78:247?306,1998.
	97.LeeMG,ChoiJY,LuoX,StricklandE,ThomasPJ,andMuallemS.Cysticfibrosistransmembraneconductanceregu-latorregulatesluminalCl/HCO3exchangeinmousesubman-dibularandpancreaticducts.JBiolChem274:14670?14677,1999.
	98.LetzBandKorbmacherC.cAMPstimulatesCFTR-likeClchannelsandinhibitsamiloride-sensitiveNachannelsinmouseCCDcells.AmJPhysiolCellPhysiol272:C657?C666,1997.
	99.LevyJ,SmithAL,KoupJR,Williams-WarrenJ,andRamseyB.Dispositionoftobramycininpatientswithcysticfibrosis:aprospectivecontrolledstudy.JPediatr105:117?124,1984.
	100.LiuW,MorimotoT,KondoY,IinumaK,UchidaS,SasakiS,MarumoF,andImaiM.AnalysisofNaCltransportinthinascendinglimbofHenle?sloopinCLC-K1nullmice.AmJPhysiolRenalPhysiol282:F451?F457,2002.
	101.LloydSE,GuntherW,PearceSH,ThomsonA,BianchiML,BosioM,CraigIW,FisherSE,ScheinmanSJ,WrongO,JentschTJ,andThakkerRV.Characterisationofrenalchloridechannel,CLCN5,mutationsinhypercalciuricnephro-lithiasis(kidneystones)disorders.HumMolGenet6:1233?1239,1997.
	102.LloydSE,PearceSH,FisherSE,SteinmeyerK,Schwap-pachB,ScheinmanSJ,HardingB,BolinoA,DevotoM,GoodyerP,RigdenSP,WrongO,JentschTJ,CraigIW,andThakkerRV.Acommonmolecularbasisforthreeinher-itedkidneystonediseases.Nature379:445?449,1996.
	103.LloydSE,PearceSH,GuntherW,KawaguchiH,IgarashiT,JentschTJ,andThakkerRV.Idiopathiclowmolecularweightproteinuriaassociatedwithhypercalciuricnephrocalci-nosisinJapanesechildrenisduetomutationsoftherenalchloridechannel(CLCN5).JClinInvest99:967?974,1997.
	104.LuW,PeisselB,BabakhanlouH,PavlovaA,GengL,FanX,LarsonC,BrentG,andZhouJ.PerinatallethalitywithkidneyandpancreasdefectsinmicewithatargettedPkd1mutation.NatGenet17:179?181,1997.
	105.LudewigU,PuschM,andJentschTJ.TwophysicallydistinctporesinthedimericClC-0chloridechannel.Nature383:340?343,1996.
	106.LukacsGL,ChangXB,KartnerN,RotsteinOD,RiordanJR,andGrinsteinS.Thecysticfibrosistransmembranereg-ulatorispresentandfunctionalinendosomes.Roleasadeter-minantofendosomalpH.JBiolChem267:14568?14572,1992.
	107.LuyckxVA,GodaFO,MountDB,NishioT,HallA,HebertSC,HammondTG,andYuAS.IntrarenalandsubcellularlocalizationofratCLC5.AmJPhysiolRenalPhysiol275:F761?F769,1998.
	108.LuyckxVA,LeclercqB,DowlandLK,andYuAS.Diet-dependenthypercalciuriaintransgenicmicewithreducedCLC5chloridechannelexpression.ProcNatlAcadSciUSA96:12174?12179,1999.
	109.MarvaoP,DeJesusFerreiraMC,BaillyC,PaulaisM,BensM,GuinamardR,MoreauR,VandewalleA,andTeulonJ.Clabsorptionacrossthethickascendinglimbisnotalteredincysticfibrosismice.Aroleforapseudo-CFTRClchannel.JClinInvest102:1986?1993,1998.
	110.MasilamaniS,KnepperMA,andBurgMB.Urineconcen-trationanddilution.In:TheKidney(6thed.),editedbyBrennerBM.Philadelphia,PA:Saunders,2000,p.595?635.
	111.MatsumuraY,UchidaS,KondoY,MiyazakiH,KoSB,HayamaA,MorimotoT,LiuW,ArisawaM,SasakiS,andMarumoF.Overtnephrogenicdiabetesinsipidusinmicelack-ingtheCLC-K1chloridechannel.NatGenet21:95?98,1999.
	112.McNicholasCM,GugginoWB,SchwiebertEM,HebertSC,GiebischG,andEganME.SensitivityofarenalKchannel(ROMK2)totheinhibitorysulfonylureacompoundglibenclamideisenhancedbycoexpressionwiththeATP-bind-ingcassettetransportercysticfibrosistransmembraneregula-tor.ProcNatlAcadSciUSA93:8083?8088,1996.
	113.MellmanI,FuchsR,andHeleniusA.Acidificationoftheendocyticandexocyticpathways.AnnuRevBiochem55:663?700,1986.
	114.MoestrupSK,CuiS,VorumH,BregengardC,BjornSE,NorrisK,GliemannJ,andChristensenEI.Evidencethatepithelialglycoprotein330/megalinmediatesuptakeofpolyba-sicdrugs.JClinInvest96:1404?1413,1995.
	115.Mohammad-PanahR,AckerleyC,RommensJ,ChoudhuryM,WangY,andBearCE.ThechloridechannelClC-4co-localizeswithcysticfibrosistransmembraneconduc-tanceregulatorandmaymediatechloridefluxacrosstheapicalmembraneofintestinalepithelia.JBiolChem277:566?574,2002.
	116.MoralesMM,CarrollTP,MoritaT,SchwiebertEM,DevuystO,WilsonPD,LopesAG,StantonBA,DietzHC,CuttingGR,andGugginoWB.Boththewild-typeandafunctionalisoformofCFTRareexpressedinkidney.AmJPhysiolRenalFluidElectrolytePhysiol270:F1038?F1048,1996.
	117.MoralesMM,NascimentoDS,CapellaMA,LopesAG,andGugginoWB.ArgininevasopressinregulatesCFTRandClC-2mRNAexpressioninratkidneycortexandmedulla.Pfluï¿½gersArch443:202?211,2001.
	118.MorelloJPandBichetDG.Nephrogenicdiabetesinsipidus.AnnuRevPhysiol63:607?630,2001.
	119.MurrayCB,ChuS,andZeitlinPL.Gestationalandtissue-specificregulationofC1C-2chloridechannelexpression.AmJPhysiolLungCellMolPhysiol271:L829?L837,1996.
	120.MurrayCB,MoralesMM,FlotteTR,McGrath-MorrowSA,GugginoWB,andZeitlinPL.ClC-2:adevelopmentallydependentchloridechannelexpressedinthefetallunganddownregulatedafterbirth.AmJRespirCellMolBiol12:597?604,1995.
	121.NadeauJH.Modifiergenesinmiceandhumans.NatRevGenet2:165?174,2001.
	122.ObermullerN,GretzN,KrizW,ReillyRF,andWitzgallR.Theswelling-activatedchloridechannelClC-2,thechloridechannelClC-3,andClC-5,achloridechannelmutatedinkid-neystonedisease,areexpressedindistinctsubpopulationsofrenalepithelialcells.JClinInvest101:635?642,1998.
	123.O?NealWK,HastyP,McCrayPBJr,CaseyB,Rivera-PerezJ,WelshMJ,BeaudetAL,andBradleyA.Aseverephenotypeinmicewithaduplicationofexon3inthecysticfibrosislocus.HumMolGenet2:1561?1569,1993.
	124.OrnellasDS,NascimentoDS,ChristophDH,GugginoWB,andMoralesMM.Aldosteroneandhigh-NaCldietmod-ulateClC-2chloridechannelgeneexpressioninratkidney.Pfluï¿½gersArch444:193?201,2002.
	125.PearsonH.Survivingaknockoutblow.Nature415:8?9,2002.
	126.Perez-BrayfieldMR,CaplanD,GattiJM,SmithEA,andKirschAJ.Metabolicriskfactorsforstoneformationinpa-tientswithcysticfibrosis.JUrol167:480?484,2002.
	127.PersuAandDevuystO.Transepithelialchloridesecretionandcystogenesisinautosomaldominantpolycystickidneydis-ease.NephrolDialTransplant15:747?750,2000.
	128.PersuA,DevuystO,LannoyN,MaterneR,BrosnahanG,GabowPA,PirsonY,andVerellen-DumoulinC.CFgeneandcysticfibrosistransmembraneconductanceregulatorex-pressioninautosomaldominantpolycystickidneydisease.JAmSocNephrol11:2285?2296,2000.
	129.PiwonN,GuntherW,SchwakeM,BoslMR,andJentschTJ.ClC-5ClchanneldisruptionimpairsendocytosisinamousemodelforDent?sdisease.Nature408:369?373,2000.
	130.PoschetJF,SkidmoreJ,BoucherJC,FirovedAM,VanDykeRW,andDereticV.Hyperacidificationofcellubrevinendocyticcompartmentsanddefectiveendosomalrecyclingincysticfibrosisrespiratoryepithelialcells.JBiolChem277:13959?13965,2002.
	131.QuintonPM.Theneglectedion:HCO3.NatMed7:292?293,2001.
	132.RaoSandVerkmanAS.Analysisoforganphysiologyintransgenicmice.AmJPhysiolCellPhysiol279:C1?C18,2000.
	133.RatcliffR,EvansMJ,CuthbertAW,MacVinishLJ,Fos-terD,AndersonJR,andColledgeWH.Productionofaseverecysticfibrosismutationinmicebygenetargeting.NatGenet4:35?41,1993.
	134.ReenstraWW,SabolicI,BaeHR,andVerkmanAS.Pro-teinkinaseAdependentmembraneproteinphosphorylationandchlorideconductanceinendosomalvesiclesfromkidneycortex.Biochemistry31:175?181,1992.
	135.ReinhartSC,NordenAG,LapsleyM,ThakkerRV,PangJ,MosesAM,FrymoyerPA,FavusMJ,HoepnerJA,andScheinmanSJ.Characterizationofcarrierfemalesandaf-fectedmaleswithX-linkedrecessivenephrolithiasis.JAmSocNephrol5:1451?1461,1995.
	136.RosensteinBJandZeitlinPL.Cysticfibrosis.Lancet351:277?282,1998.
	137.RozmahelR,WilschanskiM,MatinA,PlyteS,OliverM,AuerbachW,MooreA,ForstnerJ,DurieP,NadeauJ,BearC,andTsuiLC.Modulationofdiseaseseverityincysticfibrosistransmembraneconductanceregulatordeficientmicebyasecondarygeneticfactor.NatGenet12:280?287,1996.
	138.SakamotoH,SadoY,NaitoI,KwonTH,InoueS,EndoK,KawasakiM,UchidaS,NielsenS,SasakiS,andMarumoF.CellularandsubcellularimmunolocalizationofClC-5chan-nelinmousekidney:colocalizationwithH-ATPase.AmJPhysiolRenalPhysiol277:F957?F965,1999.
	139.Samaniego-PicotaMDandWheltonA.Aminoglycoside-in-ducednephrotoxicityincysticfibrosis:acasepresentationandreviewoftheliterature.AmJTher3:248?257,1996.
	140.SasakiSandYoshiyamaN.Interactionofchlorideandbicarbonatetransportacrossthebasolateralmembraneofrab-bitproximalstraighttubule.JClinInvest81:1004?1011,1988.
	141.ScheinmanSJ.X-linkedhypercalciuricnephrolithiasis:clini-calsyndromesandchloridechannelmutations.KidneyInt53:3?17,1998.
	142.ScheinmanSJ,Guay-WoodfordLM,ThakkerRV,andWarnockDG.Geneticdisordersofrenalelectrolytetransport.NEnglJMed340:1177?1187,1999.
	143.SchmidA,BurckhardtG,andGogeleinH.Singlechloridechannelsinendosomalvesiclepreparationsfromratkidneycortex.JMembrBiol111:265?275,1989.
	144.Schmidt-RoseTandJentschTJ.TransmembranetopologyofaCLCchloridechannel.ProcNatlAcadSciUSA94:7633?7638,1997.
	145.SchwakeM,FriedrichT,andJentschTJ.Aninternaliza-tionsignalinClC-5,anendosomalClchannelmutatedinDent?sdisease.JBiolChem276:12049?12054,2001.
	146.SchwiebertEM,BenosDJ,EganME,StuttsMJ,andGugginoWB.CFTRisaconductanceregulatoraswellasachloridechannel.PhysiolRev79:S145?S166,1999.
	147.SchwiebertEM,Cid-SotoLP,StaffordD,CarterM,Blais-dellCJ,ZeitlinPL,GugginoWB,andCuttingGR.Analy-sisofClC-2channelsasanalternativepathwayforchlorideconductionincysticfibrosisairwaycells.ProcNatlAcadSciUSA95:3879?3884,1998.
	148.SchwiebertEM,EganME,HwangTH,FulmerSB,AllenSS,CuttingGR,andGugginoWB.CFTRregulatesout-wardlyrectifyingchloridechannelsthroughanautocrinemech-anisminvolvingATP.Cell81:1063?1073,1995.
	149.SekiG,TaniguchiS,UwatokoS,SuzukiK,andKuro-kawaK.ActivationofthebasolateralClconductancebycAMPinrabbitrenalproximaltubuleS3segments.Pfluï¿½gersArch430:88?95,1995.
	150.SeksekO,BiwersiJ,andVerkmanAS.Evidenceagainstdefectivetrans-Golgiacidificationincysticfibrosis.JBiolChem271:15542?15548,1996.
	151.SheppardDNandWelshMJ.StructureandfunctionoftheCFTRchloridechannel.PhysiolRev79:S23?S45,1999.
	152.ShiLB,FushimiK,BaeHR,andVerkmanAS.Heteroge-neityinATP-dependentacidificationinendocyticvesiclesfromkidneyproximaltubule.MeasurementofpHinindividualen-docyticvesiclesinacell-freesystem.BiophysJ59:1208?1217,1991.
	153.ShimketsRA,LiftonRP,andCanessaCM.Theactivityoftheepithelialsodiumchannelisregulatedbyclathrin-mediatedendocytosis.JBiolChem272:25537?25541,1997.
	154.SilvaIV,BlaisdellCJ,GugginoSE,andGugginoWB.PTHregulatesexpressionofClC-5chloridechannelinthekidney.AmJPhysiolRenalPhysiol278:F238?F245,2000.
	155.SimonDB,BindraRS,MansfieldTA,Nelson-WilliamsC,MendoncaE,StoneR,SchurmanS,NayirA,AlpayH,BakkalogluA,Rodriguez-SorianoJ,MoralesJM,SanjadSA,TaylorCM,PilzD,BremA,TrachtmanH,GriswoldW,RichardGA,JohnE,andLiftonRP.Mutationsinthechloridechannelgene,CLCNKB,causeBartter?ssyndrometypeIII.NatGenet17:171?178,1997.
	156.SimonDB,KaretFE,HamdanJM,DiPietroA,SanjadSA,andLiftonRP.Bartter?ssyndrome,hypokalaemicalkalosiswithhypercalciuria,iscausedbymutationsintheNa-K-2ClcotransporterNKCC2.NatGenet13:183?188,1996.
	157.SimonDB,KaretFE,Rodriguez-SorianoJ,HamdanJH,DiPietroA,TrachtmanH,SanjadSA,andLiftonRP.GeneticheterogeneityofBartter?ssyndromerevealedbymuta-tionsintheKchannel,ROMK.NatGenet14:152?156,1996.
	158.SnouwaertJN,BrigmanKK,LatourAM,MaloufNN,BoucherRC,SmithiesO,andKollerBH.Ananimalmodelforcysticfibrosismadebygenetargeting.Science257:1083?1088,1992.
	159.StantonBA.Cysticfibrosistransmembraneconductancereg-ulator(CFTR)andrenalfunction.WienKlinWochenschr109:457?464,1997.
	160.SteinmeyerK,SchwappachB,BensM,VandewalleA,andJentschTJ.CloningandfunctionalexpressionofratCLC-5,achloridechannelrelatedtokidneydisease.JBiolChem270:31172?31177,1995.
	161.StenvinkelP,HjelteL,AlvanG,HedmanA,HultmanE,andStrandvikB.Decreasedrenalclearanceofsodiumincysticfibrosis.ActaPaediatrScand80:194?198,1991.
	162.StobrawaSM,BreiderhoffT,TakamoriS,EngelD,SchweizerM,ZdebikAA,BoslMR,RuetherK,JahnH,DraguhnA,JahnR,andJentschTJ.DisruptionofClC-3,achloridechannelexpressedonsynapticvesicles,leadstoalossofthehippocampus.Neuron29:185?196,2001.
	163.StrangeK,EmmaF,andJacksonPS.Cellularandmolec-ularphysiologyofvolume-sensitiveanionchannels.AmJPhysiolCellPhysiol270:C711?C730,1996.
	164.StuttsMJ,CanessaCM,OlsenJC,HamrickM,CohnJA,RossierBC,andBoucherRC.CFTRasacAMP-dependentregulatorofsodiumchannels.Science269:847?850,1995.
	165.SullivanLP,WallaceDP,andGranthamJJ.Epithelialtransportinpolycystickidneydisease.PhysiolRev78:1165?1191,1998.
	166.TakahashiN,ChernavvskyDR,GomezRA,IgarashiP,GitelmanHJ,andSmithiesO.UncompensatedpolyuriainamousemodelofBartter?ssyndrome.ProcNatlAcadSciUSA97:5434?5439,2000.
	167.TaucM,BidetM,andPoujeolP.ChloridecurrentsactivatedbycalcitoninandcAMPinprimaryculturesofrabbitdistalconvolutedtubule.JMembrBiol150:255?273,1996.
	168.ThiemannA,GrunderS,PuschM,andJentschTJ.Achloridechannelwidelyexpressedinepithelialandnon-epithe-lialcells.Nature356:57?60,1992.
	169.TraebertM,RothJ,BiberJ,MurerH,andKaisslingB.InternalizationofproximaltubulartypeIINa-PicotransporterbyPTH:immunogoldelectronmicroscopy.AmJPhysiolRenalPhysiol278:F148?F154,2000.
	170.TraebertM,VolklH,BiberJ,MurerH,andKaisslingB.Luminalandcontraluminalactionof1?34and3?34PTHpeptidesonrenaltypeIIaNa-Picotransporter.AmJPhysiolRenalPhysiol278:F792?F798,2000.
	171.TreziseAE,ChambersJA,WardleCJ,GouldS,andHar-risA.Expressionofthecysticfibrosisgeneinhumanfoetaltissues.HumMolGenet2:213?218,1993.
	172.UchidaS.InvivoroleofCLCchloridechannelsinthekidney.AmJPhysiolRenalPhysiol279:F802?F808,2000.
	173.UchidaS,SasakiS,FurukawaT,HiraokaM,ImaiT,HirataY,andMarumoF.Molecularcloningofachloridechannelthatisregulatedbydehydrationandexpressedpre-dominantlyinkidneymedulla.JBiolChem268:3821?3824,1993.
	174.UchidaS,SasakiS,FushimiK,andMarumoF.Isolationofhumanaquaporin-CDgene.JBiolChem269:23451?2355,1994.
	175.UchidaS,SasakiS,NittaK,UchidaK,HoritaS,NiheiH,andMarumoF.Localizationandfunctionalcharacterizationofratkidney-specificchloridechannel,ClC-K1.JClinInvest95:104?113,1995.
	176.VandewalleA,CluzeaudF,BensM,KieferleS,Stein-meyerK,andJentschTJ.LocalizationandinductionbydehydrationofClC-Kchloridechannelsintheratkidney.AmJPhysiolRenalPhysiol272:F678?F688,1997.
	177.VandewalleA,CluzeaudF,PengKC,BensM,LuchowA,GuntherW,andJentschTJ.Tissuedistributionandsubcel-lularlocalizationoftheClC-5chloridechannelinratintestinalcells.AmJPhysiolCellPhysiol280:C373?C381,2001.
	178.VanDoorninckJH,FrenchPJ,VerbeekE,PetersRH,MorreauH,BijmanJ,andScholteBJ.AmousemodelforthecysticfibrosisdeltaF508mutation.EMBOJ14:4403?4411,1995.
	179.VandorpeD,KizerN,CiampolliloF,MoyerB,KarlsonK,GugginoWB,andStantonBA.CFTRmediateselectrogenicchloridesecretioninmouseinnermedullarycollectingduct(mIMCD-K2)cells.AmJPhysiolCellPhysiol269:C683?C689,1995.
	180.VanKuijckMA,vanAubelRA,BuschAE,LangF,RusselFG,BindelsRJ,vanOsCH,andDeenPM.MolecularcloningandexpressionofacyclicAMP-activatedchloridecon-ductanceregulator:anovelATP-bindingcassettetransporter.ProcNatlAcadSciUSA93:5401?5406,1996.
	181.VanSlegtenhorstMA,BassiMT,BorsaniG,WapenaarMC,FerreroGB,deConciliisL,RugarliEI,GrilloA,FrancoB,ZoghbiHY,andBallabioA.AgenefromtheXp22.3regionshareshomologywithvoltage-gatedchloridechannels.HumMolGenet3:547?552,1994.
	182.VanWeertAW,DunnKW,GuezeHJ,MaxfieldFR,andStoorvogelW.Transportfromlateendosomestolysosomes,butnotsortingofintegralmembraneproteinsinendosomes,dependsonthevacuolarprotonpump.JCellBiol130:821?834,1995.
	183.WaldeggerSandJentschTJ.Fromtonustotonicity:phys-iologyofCLCchloridechannels.JAmSocNephrol11:1331?1339,2000.
	184.WangSS,DevuystO,CourtoyPJ,WangXT,WangH,WangY,ThakkerRV,GugginoS,andGugginoWB.Micelackingrenalchloridechannel,ClC-5,areamodelforDent?sdisease,anephrolithiasisdisorderassociatedwithdefectivereceptor-mediatedendocytosis.HumMolGenet9:2937?2945,2000.
	185.WangT,SegalAS,GiebischG,andAronsonPS.Stimula-tionofchloridetransportbycAMPinratproximaltubules.AmJPhysiolRenalFluidElectrolytePhysiol268:F204?F210,1995.
	186.WelshMJ,RamseyBW,AccursoF,andCuttingGR.Cysticfibrosis.In:TheMetabolicandMolecularBasesofInheritedDisease,editedbyScriverCR,BeaudetAL,SlyWS,andValleD.NewYork:McGraw-Hill,2001,p.5121?5188.
	187.WelshMJandSmithAE.MolecularmechanismsofCFTRchloridechanneldysfunctionincysticfibrosis.Cell73:1251?1254,1993.
	188.WrongOM,NordenAG,andFeestTG.Dent?sdisease;afamilialproximalrenaltubularsyndromewithlow-molecular-weightproteinuria,hypercalciuria,nephrocalcinosis,metabolicbonedisease,progressiverenalfailureandamarkedmalepredominance.QJMed87:473?493,1994.
	189.WuG,D?AgatiV,CaiY,MarkowitzG,ParkJH,ReynoldsDM,MaedaY,LeTC,HouHJr,KucherlapatiR,Edel-mannW,andSomloS.SomaticinactivationofPkd2resultsinpolycystickidneydisease.Cell93:177?188,1998.
	190.YasuiM,HazamaA,KwonTH,NielsenS,GugginoWB,andAgreP.Rapidgatingandanionpermeabilityofanintra-cellularaquaporin.Nature402:184?187,1999.
	191.YasuiM,KwonTH,KnepperMA,NielsenS,andAgreP.Aquaporin-6:anintracellularvesiclewaterchannelproteininrenalepithelia.ProcNatlAcadSciUSA96:5808?5813,1999.
	192.YoshikawaM,UchidaS,YamauchiA,MiyaiA,TanakaY,SasakiS,andMarumoF.LocalizationofratCLC-K2chloridechannelmRNAinthekidney.AmJPhysiolRenalPhysiol276:F552?F558,1999.
	193.YoshitomiK,KondoY,andImaiM.EvidenceforconductiveClpathwaysacrossthecellmembranesofthethinascendinglimbofHenle?sloop.JClinInvest82:866?871,1988.
	194.YuAS.RoleofClC-5inthepathogenesisofhypercalciuria:recentinsightsfromtransgenicmousemodels.CurrOpinNephrolHypertens10:415?420,2001.
	195.ZeiherBG,EichwaldE,ZabnerJ,SmithJJ,PugaAP,McCrayPBJr,CapecchiMR,WelshMJ,andThomasKR.AmousemodelforthedeltaF508alleleofcysticfibrosis.JClinInvest96:2051?2064,1995.
	196.ZimniakL,WintersCJ,ReevesWB,andAndreoliTE.Clchannelsinbasolateralrenalmedullaryvesicles.X.CloningofaClchannelfromrabbitoutermedulla.KidneyInt48:1828?1836,1995.
1745.pdf	81
	1.MaronDJ,FazioS,LintonMF.Currentperspectivesonstatins.Circu-lation.2000;101:207?223.
	2.FaggiottoA,PaolettiR.State-of-the-Artlecture:statinsandblockersoftherenin-angiotensinsystem?vascularprotectionbeyondtheirprimarymodeofaction.Hypertension.1999;34:987?996.
	3.LaufsU,LiaoJK.DirectvasculareffectsofHMG-CoAreductaseinhib-itors.TrendsCardiovascMed.2000;10:143?148.
	4.NapoliC,deNigrisF,PalinskiW.Multipleroleofreactiveoxygenspeciesinthearterialwall.JCellBiochem.2001;82:674?682.
	5.RosensonRS,TangneyCC.Antiatherothromboticpropertiesofstatins:Implicationsforcardiovasculareventreduction.JAMA.1998;279:1643?1650.
	6.LaRosaJC.Pleiotropiceffectsofstatinsandtheirclinicalsignificance.AmJCardiol.2001;88:291?293.
	7.PalinskiW,TsimikasS.Immunomodulatoryeffectsofstatins:Mech-anismsandpotentialimpactonarteriosclerosis.JAmSocNephrol.2002;13:1673?1681.
	8.Weitz-SchmidtG,WelzenbachK,BrinkmannV,KamataT,KallenJ,BrunsC,CottensS,TakadaY,HommelU.Statinsselectivelyinhibitleukocytefunctionantigen-1bybindingtoanovelregulatoryintegrinsite.NatureMed.2001;7:687?692.
	9.IgnarroLJ,NapoliC,LoscalzoJ.Nitricoxidedonorsandcardiovascularagentsmodulatingthebioactivityofnitricoxide:anoverview.CircRes.2002;90:21?28.
	10.BeaF,BlessingE,BennetB,LevitzM,WallaceEP,RosenfeldME.SimvastatinpromotesatheroscleroticplaquestabilityinapolipoproteinEdeficientmiceindependentlyoflipid-lowering.ArteriosclerThrombVascBiol.2002;22:1832?1837.
	11.SparrowCP,BurtonCA,HernandezM,MundtS,HassingH,PatelS,RosaR,Hermanowski-VosatkaA,WangP-R,ZhangD,PetersonL,DetmersPA,ChaoY-S,WrightSD.Simvastatinhasanti-inflammatoryandanti-atheroscleroticactivitiesindependentofplasmacholesterol-lowering.ArteriosclerThrombVascBiol.2001;21:115?121.
	12.RekhterMD.Howtoevaluateplaquevulnerabilityinanimalmodelsofatherosclerosis?CardiovascRes.2002;54:36?41.
	13.ReddickRL,ZhangSH,MaedaN.AtherosclerosisinmicelackingapoE:evaluationoflesionaldevelopmentandprogression.ArteriosclerThromb.1994;14:141?147.
	14.NakashimaY,PlumpAS,RainesEW,BreslowJL,RossR.ApoE-deficientmicedeveloplesionsofallphasesofatherosclerosisthroughouttheaortictree.ArteriosclerThromb.1994;14:133?140.
	15.PalinskiW,OrdV,PlumpAS,BreslowJL,SteinbergD,WitztumJL.ApoE-deficientmiceareamodeloflipoproteinoxidationinathero-genesis:demonstrationofoxidation-specificepitopesinlesionsandhightitersofautoantibodiestomalondialdehyde-lysineinserum.ArteriosclerThromb.1994;14:605?616.
	16.CalaraF,SilvestreM,CasanadaF,YuanN,NapoliC,PalinskiW.SpontaneousplaqueruptureandsecondarythrombosisinapolipoproteinE-deficientandLDLreceptor-deficientmice.JPathol.2001;195:257?263.
	17.CarmelietP,MoonsL,CollenD.Mousemodelsofangiogenesis,arterialstenosis,atherosclerosisandhemostasis.CardiovascRes.1998;39:8?33.
	18.PalinskiW,NapoliC,ReavenPD.Mousemodelsofatherosclerosis.In:SimonsDI,RogersC,eds.ContemporaryCardiology:VascularDiseaseandInjury:PreclinicalResearch.Totowa,NJ:HumanaPress;2000:149?174.
	19.BennetMR.Breakingtheplaque:evidenceforplaqueruptureinanimalmodelsofatherosclerosis.ArteriosclerThrombVascBiol.2002;1:713?714.
	20.SeoHS,LombardiDM,PolinskyP,Powell-BraxtonL,BuntingS,SchwartzSM,RosenfeldME.Peripheralvascularstenosisinapoli-poproteinE-deficientmice:potentialrolesoflipiddeposition,medialatrophy,andadventitialinflammation.ArteriosclerThrombVascBiol.1997;17:3593?3601.
	21.JohnsonJL,JacksonCL.Atheroscleroticplaqueruptureintheapoli-poproteinEknockoutmouse.Atherosclerosis.2001;154:399?406.
	22.WilliamsH,JohnsonJL,CarsonKGS,JacksonCL.CharacteristicsofintactandrupturedatheroscleroticplaquesinbrachiocephalicarteriesofapolipoproteinEknockoutmice.ArteriosclerThrombVascBiol.2002;22:788?792.
	23.NapoliC,deNigrisF,WelchJ,CalaraFB,StuartRO,GlassCK,PalinskiW.MaternalhypercholesterolemiaduringpregnancypromotesearlyatherogenesisinLDLreceptor-deficientmiceandaltersaorticgeneexpressiondeterminedbymicroarray.Circulation.2002;105:1360?1367.
	24.vonderThusenJH,vanVlijmenBJ,HoebenRC,KockxMM,HavekesLM,vanBerkelTJ,BiessenEA.InductionofatheroscleroticplaqueruptureinapolipoproteinE-/-miceafteradenovirus-mediatedtransferofp53.Circulation.2002;105:2064?2070.
	25.NakataY,MaedaN.VulnerableatheroscleroticplaquemorphologyinapolipoproteinE?deficientmiceunabletomakeascorbicacid.Circu-lation.2002;105:1485?1490.
	26.CaligiuriG,LevyB,PernowJ,Thorï¿½nP,HanssonGK.Myocardialinfarctionmediatedbyendothelinreceptorsignalinginhypercholesterol-emicmice.ProcNatlAcadSciUSA.1999;96:6920?6924.1748ArteriosclerThrombVascBiol.November2002
	27.LibbyP.Molecularbasesoftheacutecoronarysyndromes.Circulation.1995;91:2844?2850.
	28.BraunA,TrigattiBL,PostMJ,SatoK,SimonsM,EdelbergJM,RosenbergRD,SchrenzelM,KriegerM.LossofSR-BIexpressionleadstotheearlyonsetofocclusiveatheroscleroticcoronaryarterydisease,spontaneousmyocardialinfarctions,severecardiacdysfunction,andpre-maturedeathinapolipoproteinE?deficientmice.CircRes.2002;90:270?276.
	29.WilliamsJK,SukhovaGK,HerringtonDM,LibbyP.Pravastatinhascholesterol-loweringindependenteffectsonthearterywallofathero-scleroticmonkeys.JAmCollCardiol.1998;31:684?691.
	30.ShahPK,FalkE,BadimonJJ,Fernandez-OrtizA,MailhacA,Villareal-LevyG,FallonJT,RegnstromJ,FusterV.Humanmonocyte-derivedmacrophagesinducecollagenbreakdowninfibrouscapsofath-eroscleroticplaques:potentialroleofmatrix-degradingmetallopro-teinasesandimplicationsforplaquerupture.Circulation.1995;92:1565?1569.
	31.Lemaï¿½treV,O?ByrneTK,BorczukAC,OkadaY,TallAR,D?ArmientoJ.ApoEknockoutmiceexpressinghumanmatrixmetalloproteinase-1inmacrophageshavelessadvancedatherosclerosis.JClinInvest.2001;107:1227?1234.
	32.SilenceJ,CollenD,LijnenHR.Reducedatheroscleroticplaquebutenhancedaneurysmformationinmicewithinactivationofthetissueinhibitorofmetalloproteinase-1(TIMP-1)gene.CircRes.2002;90:897?903.
	33.SilenceJ,LupuF,CollenD,LijnenHR.Persistenceofatheroscleroticplaquebutreducedaneurysmformationinmicewithstromelysin-1(MMP-3)geneinactivation.ArteriosclerThrombVascBiol.2001;21:1440?1445.
	34.CrisbyM,Nordin-FredrikssonG,ShahPK,YanoJ,ZhuJ,NilssonJ.Pravastatintreatmentincreasescollagencontentanddecreaseslipidcontent,inflammation,metalloproteinases,andcelldeathinhumancarotidplaques:implicationsforplaquestabilization.Circulation.2001;103:926?933.
	35.HanssonGK.Immunemechanismsinatherosclerosis.ArteriosclerThrombVascBiol.2001;21:1876?1890.
	36.Hernandez-PereraO,Perez-SalaD,Navarro-AntolinJ,Sanchez-PascualaR,HernandezG,DiazC,LamasS.Effectsofthe3-hydroxy-3-methylglutaryl-CoAreductaseinhibitors,atorvastatinandsimvastatin,ontheexpressionofendothelin-1andendothelialnitricoxidesynthaseinvascularendothelialcells.JClinInvest.1998;101:2711?2719.
	37.LaufsU,LaFataV,PlutzkyJ,LiaoJK.UpregulationofendothelialnitricoxidesynthasebyHMG-CoAreductaseinhibitors.Circulation.1998;97:1129?1135.
	38.LaufsU,LiaoJK.Post-transcriptionalregulationofendothelialnitricoxidesynthasemRNAstabilitybyRhoGTPase.JBiolChem.1998;273:24266?24271.
	39.EndresM,LaufsU,HuangZ,NakamuraT,HuangP,MoskowitzMA,LiaoJK.Strokeprotectionby3-hydroxy-3-methylglutaryl(HMG)-CoAreductaseinhibitorsmediatedbyendothelialnitricoxidesynthase.ProcNatlAcadSciUSA.1998;95:8880?8885.
	40.WilsonSH,SimariRD,BestPJM,PetersonTE,LermanLO,AviramM,NathKA,HolmesDRJr,LermanA.Simvastatinpreservescoronaryendothelialfunctioninhypercholesterolemiaintheabsenceoflipidlowering.ArteriosclerThrombVascBiol.2001;21:122?128.
	41.WilsonSH,HerrmannJ,LermanLO,HolmesDRJr,NapoliC,RitmanEL,LermanA.Simvastatinpreservesthestructureofcoronaryadventitialvasavasoruminexperimentalhypercholesterolemiaindependentoflipidlowering.Circulation.2002;105:415?418.
	42.BonettiPO,WilsonSH,Rodriguez-PorcelM,HolmesDRJr,LermanLO,LermanA.Simvastatinpreservesmyocardialperfusionandcoronarymicrovascularpermeabilityinexperimentalhypercholesterolemiainde-pendentoflipidlowering.JAmCollCardiol.2002;40:546?554.
	43.KimuraM,KuroseI,RussellJ,GrangerDN.Effectsoffluvastatinonleukocyte-endothelialcelladhesioninhypercholesterolemicrats.Arte-riosclerThrombVascBiol.1997;17:1521?1526.
	44.WeberC,ErlW,WeberKS,WeberPC.HMG-CoAreductaseinhibitorsdecreaseCD11bexpressionandCD11b-dependentadhesionofmonocytestoendotheliumandreduceincreasedadhesivenessofmonocytesisolatedfrompatientswithhypercholesterolemia.JAmCollCardiol.1997;30:1212?1217.
	45.RomanoM,DiomedeL,SironiM,MassimilianoL,SottocornoM,PolentaruttiN,GuglielmottiA,AlbaniD,BrunoA,FruscellaP,SalmonaM,VecchiA,PinzaM,MantovaniA.Inhibitionofmonocytechemotacticprotein-1synthesisbystatins.LabInvest.2000;80:1095?1100.
	46.LiuL,MoesnerP,KovachNL,BaileyR,HamiltonAD,SebtiSM,HarlanJM.Integrin-dependentleukocyteadhesioninvolvesgeranylgeranylatedprotein(s).JBiolChem.1999;274:33334?33340.
	47.KwakB,MulhauptF,MyitS,MachF.Statinsasanewlyrecognizedtypeofimmunosuppressor.NatureMed.2000;6:1399?1402.
	48.Weitz-SchmidtG,WelzenbachK,BrinkmannV,KamataT,KallenJ,BrunsC,CottensS,TakadaY,HommelU.Statinsselectivelyinhibitleukocytefunctionantigen-1bybindingtoanovelregulatoryintegrinsite.NatureMed.2001;7:687?692.
	49.CuttsJL,ScallenTJ,WatsonJ,BankhurstAD.Roleofmevalonicacidintheregulationofnaturalkillercellcytotoxicity.JCellPhysiol.1989;139:550?557.
	50.PahanK,SheikhFG,NamboodiriAM,SinghI.Lovastatinandphenyl-acetateinhibittheinductionofnitricoxidesynthaseandcytokinesinratprimaryastrocytes,microglia,andmacrophages.JClinInvest.1997;100:2671?2679.
	51.RudichSM,MonginiPK,PerezRV,KatznelsonS.HMG-CoAreductaseinhibitorspravastatinandsimvastatininhibithumanB-lymphocyteacti-vation.TransplantProc.1998;30:992?995.
	52.BustosC,Hernï¿½ndez-PresaMA,OrtegoM,Tuï¿½ï¿½nJ,OrtegaL,Pï¿½rezF,Dï¿½azC,Hernï¿½ndezG,EgidoJ.HMG-CoAreductaseinhibitionbyator-vastatinreducesneointimalinflammationinarabbitmodelofatheroscle-rosis.JAmCollCardiol.1998;32:2057?2064.
	53.InoueI,GotoS,MizotaniK,AwataT,MastunagaT,KawaiS,NakajimaT,HokariS,KomodaT,KatayamaS.LipophilicHMG-CoAreductaseinhibitorhasananti-inflammatoryeffect:reductionofMRNAlevelsforinterleukin-1beta,interleukin-6,cyclooxygenase-2,andp22phoxbyreg-ulationofperoxisomeproliferator-activatedreceptoralpha(PPARalpha)inprimaryendothelialcells.LifeSci.2000;67:863?876.
	54.ItoT,IkedaU,ShimpoM,OhkiR,TakahashiM,YamamotoK,ShimadaK.HMG-CoAreductaseinhibitorsreduceinterleukin-6synthesisinhumanvascularsmoothmusclecells.CardiovascDrugsTher.2002;16:121?126.
	55.BellostaS,ViaD,CanavesiM,PfisterP,FumagalliR,PaolettiR,BerniniF.HMG-CoAreductaseinhibitorsreduceMMP-9secretionbymacro-phages.ArteriosclerThrombVascBiol.1998;18:1671?1678.
	56.AikawaM,RabkinE,SugiyamaS,VoglicSJ,FukumotoY,FurukawaY,ShiomiM,SchoenFJ,LibbyP.AnHMG-CoAreductaseinhibitor,cerivastatin,suppressesgrowthofmacrophagesexpressingmatrixmet-alloproteinasesandtissuefactorinvivoandinvitro.Circulation.;2001;103:276?283.
	57.LaufsU,MarraD,NodeK,LiaoJK.3-Hydroxy-3-methylglutaryl-CoAreductaseinhibitorsattenuatevascularsmoothmuscleproliferationbypreventingrhoGTPase-induceddown-regulationofp27(Kip1).JBiolChem.1999;274:21926?21931.
	58.GuijarroC,Blanco-ColioLM,OrtegoM,AlonsoC,OrtizA,PlazaJJ,DiazC,HernandezG,EdigoJ.3-hydroxy-3-methylglutarylcoenzymeAreductaseandisoprenylationinhibitorsinduceapoptosisofvascularsmoothmusclecellsinculture.CircRes.1998;83:490?500.
	59.FukumotoY,LibbyP,RabkinE,HillCC,EnomotoM,HirouchiY,ShiomiM,AikawaM.Statinsaltersmoothmusclecellaccumulationandcollagencontentinestablishedatheromaofwatanabeheritablehyperlip-idemicrabbits.Circulation.2001;103:993?999.
	60.KureishiY,LuoZ,ShiojimaI,BialikA,FultonD,LeferDJ,SessaWC,WalshK.TheHMG-CoAreductaseinhibitorsimvastatinactivatestheproteinkinaseAktandpromotesangiogenesisinnormocholesterolemicanimals.NatureMed.2000;6:1004?1010.
	61.VincentL,ChenW,HongL,MirshahiF,MishalZ,Mirshahi-KhorassaniT,VannierJP,SoriaJ,SoriaC.Inhibitionofendothelialcellmigrationbycerivastatin,anHMG-CoAreductaseinhibitor:contributiontoitsanti-angiogeniceffect.FEBSLett.2001;495:159?166.
	62.CrisbyM,Nordin-FredrikssonG,ShahPK,YanoJ,ZhuJ,NilssonJ.Pravastatintreatmentincreasescollagencontentanddecreaseslipidcontent,inflammation,metalloproteinases,andcelldeathinhumancarotidplaques:implicationsforplaquestabilization.Circulation.2001;103:926?933.
	63.WongB,LummaWC,SmithAM,SiskoJT,WrightSD,CaiTQ.StatinssuppressTHP-1cellmigrationandsecretionofmatrixmetalloproteinase9byinhibitinggeranylgeranylation.JLeukocBiol.2001;69:959?962.
	64.GirouxLM,DavignonJ,NaruszewiczM.Simvastatininhibitstheoxi-dationoflow-densitylipoproteinsbyactivatedhumanmonocyte-derivedmacrophages.BiochimBiophysActa.1993;1165:335?338.
	65.TakemotoM,NodeK,NakagamiH,LiaoY,GrimmM,TakemotoY,KitakazeM,LiaoJK.Statinsasantioxidanttherapyforpreventingcardiacmyocytehypertrophy.JClinInvest.2001;108:1429?1437.PalinskiandNapoliPleiotropicEffectsofStatinsonPlaqueRupture1749
	66.WassmannS,LaufsU,BaumerAT,MullerK,AhlboryK,LinzW,ItterG,RosenR,BohmM,NickenigG.HMG-CoAreductaseinhibitorsimproveendothelialdysfunctioninnormocholesterolemichypertensionviareducedproductionofreactiveoxygenspecies.Hypertension.2001;37:1450?1457.
	67.EssigM,NguyenG,PrieD,EscoubetB,SraerJD,FriedlanderG.3-hydroxy-3-methylglutarylcoenzymeAreductaseinhibitorsincreasefibrinolyticactivityinrataorticendothelialcells:roleofgeranylgerany-lationandRhoproteins.CircRes.1998;83:683?690.
	68.LaufsU,GertzK,HuangP,NickenigG,BohmM,DirnaglU,EndresM.AtorvastatinupregulatestypeIIInitricoxidesynthaseinthrombocytes,decreasesplateletactivation,andprotectsfromcerebralischemiainnormocholesterolemicmice.Stroke.2000;31:2442?2449.
	69.ColliS,EliginiS,LalliM,CameraM,PaolettiR,TremoliE.Vastatinsinhibittissuefactorinculturedhumanmacrophages:anovelmechanismofprotectionagainstatherothrombosis.ArteriosclerThrombVascBiol.17:265?272.
	70.BaettaR,CameraM,ComparatoC,AltanaC,EzekowitzMD,TremoliE.Fluvastatinreducestissuefactorexpressionandmacrophageaccumu-lationincarotidlesionsofcholesterol-fedrabbitsintheabsenceoflipidlowering.ArteriosclerThrombVascBiol.2001;22:692?698.
	71.Hernandez-PresaMA,Martin-VenturaJL,OrtegoM,Gomez-HernandezA,TunonJ,Hernandez-VargasP,Blanco-ColioLM,MasS,AparicioC,OrtegaL,VivancoF,GeriqueJG,DiazC,HernandezG,EgidoJ.Atorvastatinreducestheexpressionofcyclooxygenase-2inarabbitmodelofatherosclerosisandinculturedvascularsmoothmusclecells.Atherosclerosis.2002;160:49?58.
	72.RosensonRS,TangneyCC.Antiatherothromboticpropertiesofstatins:implicationsforcardiovasculareventreduction.JAMA.1998;279:1643?1650.
	73.ScandinavianSimvastatinSurvivalStudyGroup.Randomisedtrialofcholesterolloweringin4444patientswithcoronaryheartdisease:theScandinavianSimvastatinSurvivalStudy(4S).Lancet.1994;344:1383?1389.
	74.ShepherdJ,CobbeSM,FordI,IslesCG,LorimerAR,MacFarlanePW,McKillopJH,PackardCJ.Preventionofcoronaryheartdiseasewithpravastatininmenwithhypercholesterolemia:.WestofScotlandCoro-naryPreventionStudyGroup.NEnglJMed.1995;333:1301?1307.
	75.SacksFM,PfefferMA,MoyeLA,RouleauJL,RutherfordJD,ColeTG,BrownL,WarnicaJW,ArnoldJM,WunCC,DavisBR,BraunwaldE.Theeffectofpravastatinoncoronaryeventsaftermyocardialinfarctioninpatientswithaveragecholesterollevels:CholesterolandRecurrentEventsTrialinvestigators.NEnglJMed.1996;335:1001?1009.
	76.HeartProtectionStudyCollaborativeGroup.MRC/BHFHeartProtectionStudyofcholesterolloweringwithsimvastatinin20,536high-riskindi-viduals:arandomisedplacebo-controlledtrial.Lancet.2002;360:7?22.
	77.SchwartzGG,OlssonAG,EzekowitzMD,GanzP,OliverMF,WatersD,ZeiherA,ChaitmanBR,LeslieS,SternT.Effectsofatorvastatinonearlyrecurrentischemiceventsinacutecoronarysyndromes:theMIRACLstudy?arandomizedcontrolledtrial.JAMA.2001;285:1711?1718.
	78.ChanAW,BhattDL,ChewDP,QuinnMJ,MoliternoDJ,TopolEJ,EllisSG.Earlyandsustainedsurvivalbenefitassociatedwithstatintherapyatthetimeofpercutaneouscoronaryintervention.Circulation.2002;105:691?696.
	79.KobashigawaJA,KatznelsonS,LaksH,JohnsonJA,YeatmanL,WangXM,ChiaD,TerasakiPI,SabadA,CogertGA,TrosianK,HamiltonMA,KoriguchiJD,KawataN,HageA,DrinkwaterDC,StevensonLW.Effectofpravastatinonoutcomesaftercardiactransplantation.NEnglJMed.1995;333:621?627.
	80.WenkeK,MeiserB,ThieryJ,NagelD,vonScheidtW,SteinbeckG,SeidelD,ReichartB.Simvastatinreducesgraftvesseldiseaseandmor-talityafterhearttransplantation:afour-yearrandomizedtrial.Circu-lation.1997;96:1398?1402.
	81.EllisSG,ChewD,ChanA,WhitlowPL,SchneiderJP,TopolEJ.Deathfollowingcreatinekinase-MBelevationaftercoronaryintervention:iden-tificationofanearlyriskperiod:importanceofcreatinekinase-MBlevel,completenessofrevascularization,ventricularfunction,andprobablebenefitofstatintherapy.Circulation.2002;106:1205?1210.
ehp110s-000851.pdf	24
2301.full.pdf	10
	1.WolcottCD,RallisonML:Infancy-onsetdiabetesmellitusandmultipleepiphysealdysplasia.JPediatr80:292?297,1972
	2.DelepineM,NicolinoM,BarrettT,GolamaullyM,LathropGM,JulierC:EIF2AK3,encodingtranslationinitiationfactor2-alphakinase3,ismu-tatedinpatientswithWolcott-Rallisonsyndrome.NatGenet25:406?409,2000
	3.HardingHP,ZhangY,RonD:Translationandproteinfoldingarecoupledbytheendoplasmicreticulumresidentkinase.Nature397:271?274,1992
	4.ShiY,VattemKA,SoodR,AnJ,LiangJ,StrammL,WekR:Identificationandcharacterizationofpancreaticeukaryoticinitiationfactor2-subunitkinase,PEK,involvedintranslationalcontrol.MolCellBiol18:7499?7509,1998
	5.BertolottiA,ZhangY,HendershotLM,HardingHP,RonD:DynamicinteractionofBiPandERstresstransducersintheunfolded-proteinresponse.NatureCellBiol2:326?332,2000
	6.LiuCY,SchroderM,KaufmanRJ:Ligand-independentdimerizationacti-vatesthestressresponsekinasesIRE1andPERKinthelumenoftheendoplasmicreticulum.JBiolChem275:24881?24885,2000
	7.HardingHP,ZengH,ZhangY,JungriesR,ChungP,PleskenH,SabatiniDD,RonD:DiabetesmellitusandexocrinepancreasdysfunctioninPerk?/?micerevealsarolefortranslationalcontrolinsecretorycellsurvival.MolCell7:1153?1163,2001
	8.ThortonCM,CarsonDJ,StewartFJ:AutopsyfindingsintheWolcott-Rallisonsyndrome.PediatrPatholLabMed17:487?496,1997
	9.VonMuï¿½hlendahlKE,HerkenhoffH:Long-termcourseofneonataldiabetes.NEnglJMed333:704?708,1995
	10.ScheunerD,SongB,McEwenE,LiuC,LaybuttR,GillespieP,SaundersT,Bonner-WeirS,KaufmanRJ:Translationalcontrolisrequiredfortheunfoldedproteinresponseandinvivoglucosehomeostasis.MolCell7:1165?1176,2001
2264.full.pdf	29
	1.WakisakaM,HeQ,SpiroMJ,SpiroRG:GlucoseentryintoratmesangialcellsismediatedbybothNa-coupledandfacilitativetransporters.Diabetologia38:291?297,1995
	2.HeiligCW,LiuY,EnglandRL,FreytagSO,GilbertJD,HeiligKO,ZhuM,ConcepcionLA,BrosiusFCIII:D-glucosestimulatesmesangialcellGLUT1expressionandbasalandIGF-1?sensitiveglucoseuptakeinratmesangialcells:implicationsfordiabeticnephropathy.Diabetes46:1030?1039,1997
	3.LarkinsRG,DunlopME:Thelinkbetweenhyperglycemiaanddiabeticnephropathy.Diabetologia35:499?504,1992
	4.VlassaraH:Recentprogressinadvancedglycationendproductsanddiabeticcomplications.Diabetes46(Suppl.2):S19?S25,1997
	5.KoyaD,KingGL:ProteinkinaseCactivationandthedevelopmentofdiabeticcomplications(Review).Diabetes47:859?866,1998
	6.HeiligCW,ConcepcionLA,RiserBL,FreytagSO,ZhuM,CortesP:Overexpressionofglucosetransportersinratmesangialcellsculturedinanormalglucosemilieumimicsthediabeticphenotype.JClinInvest96:1802?1814,1995
	7.HeiligCW,BrosiusFCIII,HenryDN:Glucosetransportersoftheglomer-ulusandtheimplicationsfordiabeticnephropathy.KidneyInt60:S91?S99,1997
	8.MogyorosiA,ZiyadehFN:GLUT1andTGF-:thelinkbetweenhypergly-caemiaanddiabeticnephropathy.NephrolDialTransplant14:2827?2829,1999
	9.GutierrezC,VendrellJ,PastorR,BrochM,AguilarC,LlorC,SimonI,RichartC:GLUT1genepolymorphisminnon-insulin-dependentdiabetesmellitus:geneticsusceptibilityrelationshipwithcardiovascularriskfac-torsandmicroangiopathiccomplicationsinaMediterraneanpopulation.DiabetesResClinPract41:113?120,1998
	10.LiuZH,GuanTJ,ChenZH,LiLS:Glucosetransporter(GLUT1)allele(XbaI-)associatedwithnephropathyinnon-insulin-dependentdiabetesmellitus.KidneyInt55:1843?1848,1999
	11.GrzeszczakW,MoczulskiDK,ZychmaM,Zukowska-SzczechowskaE,TrautsoltW,SzydlowskaI:RoleofGLUT1geneinsusceptibilitytodiabeticnephropathyintype2diabetes.KidneyInt59:631?636,2001
	12.HodgkinsonAD,MillwardBA,DemaineAG:Polymorphismsoftheglucosetransporter(GLUT1)geneareassociatedwithdiabeticnephropathy.KidneyInt59:985?989,2001
	13.TarnowL,GrarupN,HansenT,ParvingHH,PedersenO:DiabeticmicrovascularcomplicationsarenotassociatedwithtwopolymorphismsintheGLUT-1andPC-1genesregulatingglucosemetabolisminCaucasiantype1diabeticpatients.NephrolDialTransplant16:1653?1656,2001
	14.MurakamiT,NishiyamaT,ShirotaniT,ShinoharaY,KanM,IshiiK,KanaiF,NakazuruS,EbinaY:Identificationoftwoenhancerelementsinthegeneencodingthetype1glucosetransporterfromthemousewhichareresponsivetoserum,growthfactorandoncogenes.JBiolChem267:9300?9306,1992
	15.BehroozA,Ismail-BeigiF:DualcontrolofGlut1glucosetransportergeneexpressionbyhypoxiaandbyinhibitionofoxidativephosphorylation.JBiolChem272:5555?5562,1997
	16.TaoT,TanizawaY,MatsutaniA,MatsubaraA,KanekoT,KakuK:HepG2/erythrocyteglucosetransporter(GLUT1)geneinNIDDM:apopu-lationassociationstudyandmolecularscanninginJapanesesubjects.Diabetologia38:942?947,1995
	17.WarramJH,GearinG,LaffelL,KrolewskiAS:Effectofdurationoftype1diabetesontheprevalenceofstagesofdiabeticnephropathydefinedbyurinaryalbumin/creatinineratio.JAmSocNephrol7:930?937,1996
	18.FukumotoH,SeinoS,ImuraH,SeinoY,BellGI:CharacterizationandexpressionofhumanHepG2/erythrocyteglucose-transportergene.Diabe-tes37:657?661,1988
	19.ShowsTB,EddyRL,ByersMG,FukushimaY,DehavenCR,MurrayJC,BellGI:Polymorphichumanglucosetransportergene(GLUT)isonchromosome1p31.33p35.Diabetes36:546?549,1987
	20.ArakiS,MoczulskiDK,HannaL,ScottLJ,WarramJH,KrolewskiAS:APOEpolymorphismsandthedevelopmentofdiabeticnephropathyinType1diabetes:resultsofcase-controlandfamilybasedstudies.Diabetes49:2190?2195,2000
	21.TerwillingerJ,OttJ:HandbookofHumanGeneticLinkage.Baltimore,MD,JohnHopkinsUniversity,1994,p.188?198
	22.HennekensCH,BuringJE:EpidemiologyinMedicine.MayrentSL,Ed.Boston,Little,BrownandCompany,p.54?98
	23.BaroniMG,D?AndreaMP,CapiciF,BuzzettiR,CavalloMG,FalluccaF,GiovanniniC,PozzilliP:HighfrequencyofpolymorphismbutnomutationsfoundintheGLUT1glucosetransportergeneinNIDDMandfamilialobesitybySSCPanalysis.HumGenet102:479?482,1998
	24.TodakaM,NishiyamaT,MurakamiT,SaitoS,ItoK,KanaiF,KanM,IshiiK,HayashiH,ShichiriM,EbinaY:TheroleofinsulininactivationoftwoenhancersinthemouseGLUT1gene.JBiolChem269:29265?29270,1994
	25.LeFrancois-MartinezAM,MartinezA,AntoineB,RaymondjeanM,KahnA:UpstreamstimulatoryfactorproteinsaremajorcomponentsoftheglucoseresponsecomplexoftheL-typepyruvatekinasegenepromoter.JBiolChem270:2640?2643,1995
	26.TraversMT,VallanceAJ,GourlayHT,GillCA,KleinI,BottemaCB,BarberMC:PromoterIoftheovineacteyl-CoAcarboxylase-aï¿½gene:anE-boxmotifat114intheproximalpromoterbindsupstreamstimulatoryfactor(USF)-1andUSF-2andactsasaninsulin-responsesequenceindifferen-tiatingadipocytes.BiochemJ359:273?284,2001
	27.ArnqvistHJ,BallermannBJ,KingGL:ReceptorsforandeffectsofinsulinandIGF-Iinratglomerularmesangialcells.AmJPhysiol254:C411?C416,1988
	28.HenryDN,BusikJV,BrosiusFCIII,HeiligCW:Glucosetransporterscontrolgeneexpressionofaldosereductase,PKC,andGLUT1inmesangialcellsinvitro.AmJPhysiol277:F97?F104,1999
	29.DuXL,EdelsteinD,RossettiL,FantusIG,GoldbergH,ZiyadehF,WuJ,BrownleeM:Hyperglycemia-inducedmitochondrialsuperoxideoverpro-ductionactivatesthehexosaminepathwayandinducesplasminogenactivatorinhibitor-1expressionbyincreasingSp1glycosylation.ProcNatlAcadSciUSA97:12222?12226,2000
1562.pdf	42
	1.Bedard,D.L.,R.Unterman,L.H.Bopp,M.J.Brennan,M.L.Haberl,andC.Johnson.1986.Rapidassayforscreeningandcharacterizingmicroorgan-ismsfortheabilitytodegradepolychlorinatedbiphenyls.Appl.Environ.Microbiol.51:761?768.
	2.Bedard,D.L.,R.E.Wagner,M.J.Brennan,M.L.Haberl,andJ.F.Brown,Jr.1987.ExtensivedegradationofAroclorsandenvironmentallytrans-formedpolychlorinatedbiphenylsbyAlcaligeneseutrophusH850.Appl.En-viron.Microbiol.53:1094?1102.
	3.Bedard,D.L.,andM.L.Haberl.1990.Influenceofchlorinesubstitutionpatternonthedegradationofpolychlorinatedbiphenylsbyeightbacterialstrains.Microb.Ecol.20:87?102.
	4.Beil,S.,J.R.Mason,K.N.Timmis,andD.H.Pieper.1998.Identificationofchlorobenzenedioxygenasesequenceelementsinvolvedindechlorinationof1,2,4,5-tetrachlorobenzene.J.Bacteriol.180:5520?5528.
	5.Brï¿½hlmann,F.,andW.Chen.1999.Tuningbiphenyldioxygenaseforex-tendedsubstratespecificity.Biotechnol.Bioeng.63:544?551.
	6.Butler,C.S.,andJ.R.Mason.1997.Structure-functionanalysisofthebacterialaromaticring-hydroxylatingdioxygenases.Adv.Microb.Physiol.38:47?84.
	7.Carredano,E.,A.Karlsson,B.Kauppi,D.Choudhury,R.E.Parales,J.V.Parales,K.Lee,D.T.Gibson,H.Eklund,andS.Ramaswamy.2000.Sub-stratebindingsiteofnaphthalene1,2-dioxygenase:functionalimplicationsofindolebinding.J.Mol.Biol.296:701?712.
	8.Erickson,B.D.,andF.J.Mondello.1993.Enhancedbiodegradationofpolychlorinatedbiphenylsaftersite-directedmutagenesisofabiphenyldi-oxygenasegene.Appl.Environ.Microbiol.59:3858?3862.
	9.Furukawa,K.,N.Tomizuka,andA.Kamibayashi.1979.Effectofchlorinesubstitutiononthebacterialmetabolismofvariouspolychlorinatedbiphe-nyls.Appl.Environ.Microbiol.38:301?310.
	10.Furukawa,K.1982.Microbialdegradationofpolychlorinatedbiphenyls,p.33?57.InA.M.Chakrabarty(ed.),Biodegradationanddetoxificationofenvironmentalpollutants.CRCPress,BocaRaton,Fla.
	11.Furukawa,K.,andT.Miyazaki.1986.CloningofgeneclusterencodingbiphenyldegradationinPseudomonaspseudoalcaligenes.J.Bacteriol.166:392?398.
	12.Furukawa,K.1994.MoleculargeneticsandevolutionaryrelationshipofPCB-degradingbacteria.Biodegradation5:289?300.
	13.Gibson,D.T.,D.L.Cruden,J.D.Haddock,G.J.Zlstra,andJ.M.Brand.1993.OxidationofpolychlorinatedbiphenylsbyPseudomonassp.strainLB400andPseudomonaspseudoalcaligenesKF707.J.Bacteriol.175:4561?4564.
	14.Graham-Lorence,S.,M.W.Khalil,M.C.Lorence,C.R.Mendelson,andE.R.Simpson.1991.Structure-functionrelationshipsofhumanaromatasecytochromeP-450byusingmolecularmodelingandsite-directedmutagen-esis.J.Biol.Chem.266:11939?11946.
	15.Haddock,J.D.,J.R.Horton,andD.T.Gibson.1995.Dihydroxylationanddechlorinationofchlorinatedbiphenylsbypurifiedbiphenyl2,3-dioxygenasefromPseudomonassp.strainLB400.J.Bacteriol.177:20?26.
	16.Hegg,E.L.,andL.Que,Jr.1997.The2-His-1-carboxylatefacialtriad?anemergingstructuralmotifinmononuclearnonhemeiron(II)enzymes.Eur.J.Biochem.250:625?629.
	17.Hirose,J.,A.Suyama,S.Hayashida,andK.Furukawa.1994.Constructionofhybridbiphenyl(bph)andtoluene(tod)genesforfunctionalanalysisofaromaticringdioxygenases.Gene138:27?33.
	18.Hurtubise,Y.,D.Barriault,andM.Sylvestre.1998.Involvementoftheterminaloxygenasesubunitinthebiphenyldioxygenasereactivitypatternforchlorobiphenyls.J.Bacteriol.180:5828?5835.
	19.Iwasaki,M.,T.A.Darden,L.G.Pedersen,D.G.Davis,R.O.Juvonen,T.Sueyoshi,andM.Negishi.1993.EngineeringmouseP450cohtoanovelcorticosterone15alpha-hydroxylaseandmodelingsteroid-bindingorienta-tioninthesubstratepocket.J.Biol.Chem.268:759?762.
	20.Iwasaki,M.,T.A.Darden,C.E.Perker,K.B.Tomer,L.G.Pedersen,andM.Negishi.1994.InherentversatilityofP450oxygenase.Conferringdehy-droepiandrosteronehydroxylaseactivitytoP4502a-4byasingleaminoacidmutationatposition117.J.Biol.Chem.269:9079?9083.
	21.Jiang,H.,R.E.Parales,N.A.Lynch,andD.T.Gibson.1996.Site-directedmutagenesisofconservedaminoacidsinthesubunitoftoluenedioxyge-nase:potentialmononuclearnonhemeironcoordinationsites.J.Bacteriol.178:3133?3139.
	22.Kauppi,B.,K.Lee,E.Carredano,R.E.Parales,D.T.Gibson,H.Eklund,andS.Ramaswamy.1998.Structureofanaromaticring-hydroxylatingdi-oxygenase-naphthalene1,2-dioxygenase.Structure6:571?586.
	23.Kimura,N.,A.Nishi,M.Goto,andK.Furukawa.1997.Functionalanalysesofavarietyofchimericdioxygenasesconstructedfromtwobiphenyldioxy-genasesthataresimilarstructurallybutdifferentfunctionally.J.Bacteriol.179:3936?3943.
	24.Kumamaru,T.,H.Suenaga,M.Mitsuoka,T.Watanabe,andK.Furukawa.1998.Enhanceddegradationofpolychlorinatedbiphenylsbydirectedevo-lutionofbiphenyldioxygenase.Nat.Biotechnol.16:663?666.
	25.Maeda,T.,Y.Takahashi,H.Suenaga,A.Suyama,M.Goto,andK.Fu-rukawa.2001.FunctionalanalysesofBph-Todhybriddioxygenase,whichexhibitshighdegradationactivityfortrichloroethylene.J.Biol.Chem.276:29833?29838.
	26.Mason,J.R.,andR.Cammack.1992.Theelectron-transportproteinsofhydroxylatingbacterialdioxygenases.Annu.Rev.Microbiol.46:277?305.
	27.Masse,R.,F.Messier,L.Peloquin,C.Ayotte,andM.Sylvestre.1984.Microbialbiodegradationof4-chlorobiphenyl,amodelcompoundofchlo-rinatedbiphenyls.Appl.Environ.Microbiol.47:947?951.
	28.Mondello,F.J.1989.CloningandexpressioninEscherichiacoliofPseudo-monasstrainLB400genesencodingpolychlorinatedbiphenyldegradation.J.Bacteriol.171:1725?1732.
	29.Mondello,F.J.,M.P.Turcich,J.H.Lobos,andB.D.Erickson.1997.Identificationandmodificationofbiphenyldioxygenasesequencethatde-terminethespecificityofpolychlorinatedbiphenyldegradation.Appl.Envi-ron.Microbiol.63:3096?3103.
	30.Parales,R.E.,J.V.Parales,andD.T.Gibson.1999.Aspartate205inthecatalyticdomainofnaphthalenedioxygenaseisessentialforactivity.J.Bac-teriol.181:1831?1837.
	31.Parales,R.E.,S.M.Resnick,C.-L.Yu,D.R.Boyd,N.D.Sharma,andD.T.Gibson.2000.Regioselectivityandenantioselectivityofnaphthalenedioxy-genaseduringarenecis-dihydroxylation:controlbyphenylalanine352inthesubunit.J.Bacteriol.182:5495?5504.
	32.Parales,R.E.,K.Lee,S.M.Resnick,H.Jiang,D.J.Lessner,andD.T.Gibson.2000.Substratespecificityofnaphthalenedioxygenase:effectofspecificaminoacidsattheactivesiteoftheenzyme.J.Bacteriol.182:1641?1649.
	33.Pikus,J.D.,J.M.Studts,K.McClay,R.J.Steffan,andB.G.Fox.1997.Changesintheregiospecificityofaromatichydroxylationproducedbyactivesiteengineeringinthediironenzymetoluene4-monooxygenase.Biochem-istry36:9283?9289.
	34.Poulos,T.L.,B.C.Finzel,I.C.Gunsalus,G.C.Wagner,andJ.Kraut.1985.The2.6-AcrystalstructureofPseudomonasputidacytochromeP-450.J.Biol.Chem.260:16122?16130.
	35.Poulos,T.L.,B.C.Finzel,andA.Howard.1987.High-resolutioncrystalstructureofcytochromeP450.J.Mol.Biol.195:687?700.
	36.Seeger,M.,M.Zielinski,K.N.Timmis,andB.Hofer.1999.Regiospecificityofdioxygenationofdi-topentachlorobiphenylsandtheirdegradationtochlorobenzoatesbybph-encodedcatabolicpathwayofBurkholderiasp.strainLB400.Appl.Environ.Microbiol.65:3614?3621.
	37.Suenaga,H.,A.Nishi,T.Watanabe,M.Sakai,andK.Furukawa.1999.EngineeringahybridPseudomonadtoacquire3,4-dioxygenaseactivityforpolychlorinatedbiphenyls.J.Biosci.Bioeng.87:430?435.
	38.Suenaga,H.,M.Goto,andK.Furukawa.2001.Emergenceofmultifunc-tionaloxygenaseactivitiesbyrandomprimingrecombination.J.Biol.Chem.276:22500?22506.
	39.Suenaga,H.,M.Mitsuoka,Y.Ura,T.Watanabe,andK.Furukawa.2001.Directedevolutionofbiphenyldioxygenase:emergenceofenhanceddegra-dationcapacityforbenzene,toluene,andalkylbenzenes.J.Bacteriol.183:5441?5444.
	40.Sylvestre,M.,andM.Sondossi.1994.Selectionofenhancedpolychlorinatedbiphenyl-degradingbacterialstrainsforbioremediation:considerationofbranchingpathways,p.47?73.InG.R.Chaudhry(ed.),Biologicaldegrada-tionandbioremediationoftoxicchemicals.DioscoridesPress,Portland,Oreg.
	41.Szklarz,G.D.,Y.A.He,andJ.R.Halpert.1995.Site-directedmutagenesisasatoolformolecularmodelingofcytochromeP4502B1.Biochemistry34:14312?14322.
	42.Taira,K.,J.Hirose,S.Hayashida,andK.Furukawa.1992.Analysisofbphoperonfromthepolychlorinatedbiphenyl-degradingstrainofPseudomonaspseudoalcaligenesKF707.J.Biol.Chem.267:4844?4853.
1459.pdf	57
	1.Akiyama,Y.,A.Kihara,H.Tokuda,andK.Ito.1996.FtsH(HflB)isanATP-dependentproteaseselectivelyactingonSecYandsomeothermem-braneproteins.J.Biol.Chem.271:31196?31201.
	2.Amerik,A.,V.K.Antonov,A.E.Gorbalenya,S.A.Kotova,T.V.Rotanova,andE.V.Shimbarevich.1991.Site-directedmutagenesisofLaprotease.Acatalyticallyactiveserineresidue.FEBSLett.287:211?214.
	3.Black,M.J.,andM.E.Jones.1983.Inorganicphosphatedeterminationinthepresenceofalabileorganicphosphate:assayforcarbamylphosphatephosphataseactivity.Anal.Biochem.135:233?238.
	4.Bochtler,M.,C.Hartmann,H.K.Song,G.P.Bourenkov,H.D.Bartunik,andR.Huber.2000.ThestructuresofHsIUandtheATP-dependentpro-teaseHsIU-HsIV.Nature403:800?805.
	4a.Bradford,M.M.1976.Arapidandsensitivemethodforthequantitationofmicrogramquantitiesofproteinutilizingtheprincipleofprotein-dyebind-ing.Anal.Biochem.72:248?254.
	5.Chin,D.T.,S.A.Goff,T.Webster,T.Smith,andA.L.Goldberg.1988.SequenceofthelongeneinEscherichiacoli.Aheat-shockgenewhichencodestheATP-dependentproteaseLa.J.Biol.Chem.263:11718?11728.
	6.Chung,C.H.,andA.L.Goldberg.1981.Theproductofthelon(capR)geneinEscherichiacoliistheATP-dependentprotease,proteaseLa.Proc.Natl.Acad.Sci.USA78:4931?4935.
	7.Ebel,W.,M.M.Skinner,K.P.Dierksen,J.M.Scott,andJ.E.Trempy.1999.AconserveddomaininEscherichiacoliLonproteaseisinvolvedinsubstratediscriminatoractivity.J.Bacteriol.181:2236?2243.
	8.Ezaki,S.,N.Maeda,T.Kishimoto,H.Atomi,andT.Imanaka.1999.Pres-enceofastructurallynoveltyperibulose-bisphosphatecarboxylase/oxygen-aseinthehyperthermophilicarchaeon,PyrococcuskodakaraensisKOD1.J.Biol.Chem.274:5078?5082.
	9.Fischer,H.,andR.Glockshuber.1993.ATPhydrolysisisnotstoichiomet-ricallylinkedwithproteolysisintheATP-dependentproteaseLafromEsch-erichiacoli.J.Biol.Chem.268:22502?22507.
	10.Frank,E.G.,D.G.Ennis,M.Gonzalez,A.S.Levine,andR.Woodgate.1996.RegulationofSOSmutagenesisbyproteolysis.Proc.Natl.Acad.Sci.USA93:10291?10296.
	11.Goldberg,A.L.,R.P.Moerschell,C.H.Chung,andM.R.Maurizi.1994.ATP-dependentproteaseLa(Lon)fromEscherichiacoli.MethodsEnzymol.244:350?375.
	12.Goldberg,A.L.,andL.Waxman.1985.TheroleofATPhydrolysisinthebreakdownofproteinsandpeptidesbyproteaseLafromEscherichiacoli.J.Biol.Chem.260:12029?12034.
	13.Gottesman,S.1999.Regulationbyproteolysis:developmentalswitches.Curr.Opin.Microbiol.2:142?147.
	14.Gottesman,S.,andM.R.Maurizi.1992.Regulationbyproteolysis:energy-dependentproteasesandtheirtargets.Microbiol.Rev.56:592?621.
	15.Gottesman,S.,M.R.Maurizi,andS.Wickner.1997.Regulatorysubunitsofenergy-dependentproteases.Cell91:435?438.
	16.Gottesman,S.,andD.Zipser.1978.DegphenotypeofEscherichiacolilonmutants.J.Bacteriol.133:844?851.
	17.Grossman,A.D.,R.R.Burgess,W.Walter,andC.A.Gross.1983.MutationsintheLongeneofE.coliK12phenotypicallysuppressamutationinthesigmasubunitofRNApolymerase.Cell32:151?159.
	18.Hashimoto,H.,M.Nishioka,S.Fujiwara,M.Takagi,T.Imanaka,T.Inoue,andY.Kai.2001.CrystalstructureofDNApolymerasefromhyperthermo-philicarchaeonPyrococcuskodakaraensisKOD1.J.Mol.Biol.306:469?477.
	19.Hoskins,J.R.,M.Pak,M.R.Maurizi,andS.Wickner.1998.TheroleoftheClpAchaperoneinproteolysisbyClpAP.Proc.Natl.Acad.Sci.USA95:12135?12140.
	20.Hoskins,J.R.,S.K.Singh,M.R.Maurizi,andS.Wickner.2000.ProteinbindingandunfoldingbythechaperoneClpAanddegradationbythepro-teaseClpAP.Proc.Natl.Acad.Sci.USA97:8892?8897.
	21.Jubete,Y.,M.R.Maurizi,andS.Gottesman.1996.RoleoftheheatshockproteinDnaJinthelon-dependentdegradationofnaturallyunstablepro-teins.J.Biol.Chem.271:30798?30803.
	22.Kessel,M.,M.R.Maurizi,B.Kim,E.Kocsis,B.L.Trus,S.K.Singh,andA.C.Steven.1995.HomologyinstructuralorganizationbetweenE.coliClpAPproteaseandtheeukaryotic26Sproteasome.J.Mol.Biol.250:587?594.
	23.Kihara,A.,Y.Akiyama,andK.Ito.1998.DifferentpathwaysforproteindegradationbytheFtsH/HflKCmembrane-embeddedproteasecomplex:animplicationfromtheinterferencebyamutantformofanewsubstrateprotein,YccA.J.Mol.Biol.279:175?188.
	24.Kitano,K.,N.Maeda,T.Fukui,H.Atomi,T.Imanaka,andK.Miki.2001.Crystalstructureofanovel-typearchaealRubiscowithpentagonalsymme-try.Structure9:473?481.
	25.Larimore,F.S.,L.Waxman,andA.L.Goldberg.1982.StudiesoftheATP-dependentproteolyticenzyme,proteaseLa,fromEscherichiacoli.J.Biol.Chem.257:4187?4195.
	26.Maeda,N.,K.Kitano,T.Fukui,S.Ezaki,H.Atomi,K.Miki,andT.Imanaka.1999.Ribulosebisphosphatecarboxylase/oxygenasefromthehy-perthermophilicarchaeonPyrococcuskodakaraensisKOD1iscomposedsolelyoflargesubunitsandformsapentagonalstructure.J.Mol.Biol.293:57?66.
	27.Maupin-Furlow,J.A.,H.C.Aldrich,andJ.G.Ferry.1998.Biochemicalcharacterizationofthe20SproteasomefromthemethanoarchaeonMeth-anosarcinathermophila.J.Bacteriol.180:1480?1487.
	28.Maurizi,M.R.1987.DegradationinvitroofbacteriophagelambdaNpro-teinbyLonproteasefromEscherichiacoli.J.Biol.Chem.262:2696?2703.
	29.Menon,A.S.,andA.L.Goldberg.1987.BindingofnucleotidestotheATP-dependentproteaseLafromEscherichiacoli.J.Biol.Chem.262:14921?14928.
	30.Menon,A.S.,andA.L.Goldberg.1987.ProteinsubstratesactivatetheATP-dependentproteaseLabypromotingnucleotidebindingandreleaseofboundADP.J.Biol.Chem.262:14929?14934.
	31.Mizusawa,S.,andS.Gottesman.1983.ProteindegradationinEscherichiacoli:thelongenecontrolsthestabilityofsulAprotein.Proc.Natl.Acad.Sci.USA80:358?362.
	32.Morikawa,M.,Y.Izawa,N.Rashid,T.Hoaki,andT.Imanaka.1994.Puri-ficationandcharacterizationofathermostablethiolproteasefromanewlyisolatedhyperthermophilicPyrococcussp.Appl.Environ.Microbiol.60:4559?4566.
	33.Nakatani,M.,S.Ezaki,H.Atomi,andT.Imanaka.2000.ADNAligasefromahyperthermophilicarchaeonwithuniquecofactorspecificity.J.Bacteriol.182:6424?6433.
	34.Neuwald,A.F.,L.Aravind,J.L.Spouge,andE.V.Koonin.1999.AAA:aclassofchaperone-likeATPasesassociatedwiththeassembly,operation,anddisassemblyofproteincomplexes.GenomeRes.9:27?43.
	35.Rep,M.,J.M.vanDijl,K.Suda,G.Schatz,L.A.Grivell,andC.K.Suzuki.1996.Promotionofmitochondrialmembranecomplexassemblybyapro-teolyticallyinactiveyeastLon.Science274:103?106.
	36.Sambrook,J.,andD.W.Russell.2001.Molecularcloning:alaboratorymanual,3rded.ColdSpringHarborLaboratory,ColdSpringHarbor,N.Y.
	37.Schumann,W.1999.FtsH?asingle-chaincharonin?FEMSMicrobiol.Rev.23:1?11.
	38.Seemuller,E.,A.Lupas,D.Stock,J.Lowe,R.Huber,andW.Baumeister.1995.ProteasomefromThermoplasmaacidophilum:athreonineprotease.Science268:579?582.
	39.Singh,S.K.,R.Grimaud,J.R.Hoskins,S.Wickner,andM.R.Maurizi.2000.UnfoldingandinternalizationofproteinsbytheATP-dependentpro-teasesClpXPandClpAP.Proc.Natl.Acad.Sci.USA97:8898?8903.
	40.Smith,C.K.,T.A.Baker,andR.T.Sauer.1999.LonandClpfamilyproteasesandchaperonessharehomologoussubstrate-recognitiondomains.Proc.Natl.Acad.Sci.USA96:6678?6682.
	41.Sousa,M.C.,C.B.Trame,H.Tsuruta,S.M.Wilbanks,V.S.Reddy,andD.B.McKay.2000.CrystalandsolutionstructuresofanHslUVprotease-chaperonecomplex.Cell103:633?643.
	42.Starkova,N.N.,E.P.Koroleva,L.D.Rumsh,L.M.Ginodman,andT.V.Rotanova.1998.MutationsintheproteolyticdomainofEscherichiacoliproteaseLonimpairtheATPaseactivityoftheenzyme.FEBSLett.422:218?220.
	43.Straus,D.B.,W.A.Walter,andC.A.Gross.1988.Escherichiacoliheatshockgenemutantsaredefectiveinproteolysis.GenesDev.2:1851?1858.
	44.Swamy,K.H.,andA.L.Goldberg.1981.E.colicontainseightsolubleproteolyticactivities,onebeingATPdependent.Nature292:652?654.
	45.Takagi,M.,M.Nishioka,H.Kakihara,M.Kitabayashi,H.Inoue,B.Kawakami,M.Oka,andT.Imanaka.1997.CharacterizationofDNApoly-merasefromPyrococcussp.strainKOD1anditsapplicationtoPCR.Appl.Environ.Microbiol.63:4504?4510.
	46.Tomoyasu,T.,K.Yamanaka,K.Murata,T.Suzaki,P.Bouloc,A.Kato,H.Niki,S.Hiraga,andT.Ogura.1993.TopologyandsubcellularlocalizationofFtsHproteininEscherichiacoli.J.Bacteriol.175:1352?1357.
	47.Torres-Cabassa,A.S.,andS.Gottesman.1987.CapsulesynthesisinEsch-erichiacoliK-12isregulatedbyproteolysis.J.Bacteriol.169:981?989.
	48.vanMelderen,L.,M.H.D.Thi,P.Lecchi,S.Gottesman,M.Couturier,andM.R.Maurizi.1996.ATP-dependentdegradationofCcdAbyLonprotease.Effectsofsecondarystructureandheterologoussubunitinteractions.J.Biol.Chem.271:27730?27738.
	49.Wang,J.,J.A.Hartling,andJ.M.Flanagan.1997.ThestructureofClpPat2.3ï¿½resolutionsuggestsamodelforATP-dependentproteolysis.Cell91:447?456.
	50.Wang,J.,J.J.Song,M.C.Franklin,S.Kamtekar,Y.J.Im,S.H.Rho,I.S.Seong,C.S.Lee,C.H.Chung,andS.H.Eom.2001.CrystalstructuresoftheHslVUpeptidase-ATPasecomplexrevealanATP-dependentproteolysismechanism.Structure9:177?184.
	51.Watanabe,S.,T.Muramatsu,H.Ao,Y.Hirayama,K.Takahashi,M.Tano-kura,andY.Kuchino.1999.MolecularcloningoftheLonproteasegenefromThermusthermophilusHB8andcharacterizationofitsgeneproduct.Eur.J.Biochem.266:811?819.
	52.Waxman,L.,andA.L.Goldberg.1985.ProteaseLa,thelongeneproduct,cleavesspecificfluorogenicpeptidesinanATP-dependentreaction.J.Biol.Chem.260:12022?12028.
	53.Waxman,L.,andA.L.Goldberg.1986.Selectivityofintracellularproteoly-sis:proteinsubstratesactivatetheATP-dependentprotease(La).Science232:500?503.
	54.Wickner,S.,andM.R.Maurizi.1999.Here?sthehook:similarsubstratebindingsitesinthechaperonedomainsofClpandLon.Proc.Natl.Acad.Sci.USA96:8318?8320.
	55.Wickner,S.,M.R.Maurizi,andS.Gottesman.1999.Posttranslationalqual-itycontrol:folding,refolding,anddegradingproteins.Science286:1888?1893.
	56.Zwickl,P.,D.Ng,K.M.Woo,H.P.Klenk,andA.L.Goldberg.1999.AnarchaebacterialATPase,homologoustoATPasesintheeukaryotic26Sproteasome,activatesproteinbreakdownby20Sproteasomes.J.Biol.Chem.274:26008?26014.
12051215.pdf	70
	1.National Audit Office. The performance of the NHS cervicalscreening programme in England: report by the comptroller andauditor general.London: Stationery Office, 1998.
	2.Quinn MJ, Babb PJ, Jones J, Allen E. Effect of screening on incidence and mortality from cancer of the cervix: evaluation based on routinely collected statistics. BMJ1999; 318:904-908.	10473491
	3.Parkin DM, Nguyen-Dinh X, Day N. The impact of screening onthe incidence of cervical cancer in England and Wales. Br JObstet Gynaecol1985; 92:150-157.	3970894
	4.Sasieni PD, Cuzick J, Lynch-Farmery E, NCN Working Group. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer1996; 73:1001-1005.	3390504
	5.Cervical Screening Programme, England: 1999-2000. Departmentof Health Statistical Bulletin2000/30 London, 2000.
	6.Cockburn J, Redman S, Mill D, Henry E. Public understanding ofmedical screening. J Med Screening1995; 2: 224-227.	8719153
	7.NHS Executive South Thames. Review of cervical screening ser-vices at Kent and Canterbury Hospitals NHS Trust. London: NHSExecutive South Thames, 1995.
	8.Leicester Health Authority. An audit of cervical screening inLeicestershire. Leicester: Leicester Health Authority, 2001.
	9.Wilson S. Cervical cancer screening. In: Marshall MN, CampbellS, Hacker J, Roland M (eds). Quality indicators for general prac-tice; a practical guide to clinical quality indicators for primary carehealth professionals and managers. London: Royal Society ofMedicine Press Ltd, 2001.
	10.Sawaya GF, Brown AD, Washington AE, Garber AM. Current approaches to cervical screening. N Engl J Med 2001; 34(21):1603-1607.	11372012
	11.McMeekin DS, McGonigle KF, Vasilev SA. Cervical cancer preven-tion: towards cost-effective screening. Medscape Womens Health1997; 2(12): 1. http://www.medscape.com
	12.Strabanek P, McCormick J. Follies and fallacies in medicine.Whithorn, Dumfries: Tarragon Press, 1998; 102-117.
	13.Lea R. Healthcare in the UK: the need for reform.Institute ofDirectors policy paper. London: Institute of Directors, 2000.
	14.Bryant J, Stevens A. Cervical screening interval.R&D Directorate,South and West Regional Health Authority, 1995.
	15.Cancer Research Campaign. Cancer of the cervix uteri. Factsheet12.2 1994.
	16.Wilson JMG, Junger G. Principles and practice of screening fordisease.[Public Health Papers, No 34.] Geneva: WHO, 1968.
	17.Cadman D, Chambers L, Feldman W, Sackett D. Assessing theeffectiveness of community screening programmes. JAMA1984;251:1580-1585.
	18.Sasieni PD. Use of routine data to monitor and evaluate cervicalscreening. In: Duffy SW, Hill C, Esteve J(eds). QuantitativeMethods for the Evaluation of Cancer Screening.London: Arnold,2001; 93-105.
	19.Ostor AG. Natural history of cervical intra-epithelial neoplasia: acritical review. Int J Gynecol Pathol 1993; 12:186-192.
	20.Campion MJ, McCance DJ, Cuzick J, Singer A. Progressivepotential of mild cervical atypia: prospective cytological, colpo-scopic and virological study. Lancet1986; 2:237-240.
	21.Holowaty P, Miller AB, Rohan T, To T. The natural history of dyspla-sia of the uterine cervix. J Natl Cancer Inst 1999; 91:252-258.
	22.Richart RM, Barron BA. A follow-up study of patients with cervicaldysplasia. Am J Obstet Gynecol1969; 105:386-393.
	23.Richart RM, Barron BA. Screening strategies for cervical cancerand cervical intraepithelial neoplasia. Cancer1981; 47(suppl 5):1176-1181.
	24.Woodman C, Collins S, Winter H, et al. Natural history of cervicalhuman papillomavirus infection in young women: a longitudinalcohort study. Lancet2001; 357:1831-1836.
	25.Kinney W, Sung HY, Kearney KA, et al. Missed opportunities forcervical cancer screening of HMO members developing invasivecervical cancer. Gynecol Oncol1998; 71:428-430.
	26.Womack C, Warren AY. Achievable laboratory standards: a reviewof cytology of 99 women with cervical cancer. Cytopathology1998; 9:171-177.
	27.Department of Health and Social Security. Health services man-agement: cervical cancer screening.[Health circular HC(88)1.]Heywood: DHSS, 1988.
	28.Wilson S, Woodman C. Costs and benefits of cervical screening.In: Luesley D, Jordan J, Richart RM (eds). Intraepithelial neoplasiaof the lower genital tract. New York: Churchill Livingstone, 1995:61-70.
	29.Lauver D, Rubin M. Women?s concerns about abnormalPapanicolaou results. J Obstet Gynecol Neonatal Nurs1990; 20:154-159.
	30.Campion MJ, Brown JR, McCance DJ, et al.Psychosexual traumaof an abnormal cervical smear. Br J Obstet Gynaecol1988; 95(2):175-181.
	31.Office for National Statistics. Cancer Statistics: registrations 1994.ONS Series MBI, No 27, 2000.
	32.Office for National Statistics. Mortality statistics: cause 1999. ONSSeries DH2, No 26, 2000.
	33.Shingleton HM, Patrick RL, Johnston WW, Smith RA. The currentstatus of the Papanicolaou smear. CA Cancer J Clin1995; 45:305-320.
	34.Nanda K, McCrory DC, Myers ER, et al.Accuracy of thePapanicolaou test in screening for and follow-up of cervical cyto-logical abnormalities: a systematic review. Ann Intern Med2000;132:810-819.
	35.Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy.Am J Epidemiol 1995; 141(7):680-689.
	36.Frame PS, Frame JS. Determinants of cancer screening frequen-cy: the example of screening for cervical cancer. J Am Board FamPract1998; 11:87-95.
	37.Frable WJ. Does a zero error standard exist for the Papanicolaousmear? A pathologists perspective. Arch Pathol Lab Med1997;121:301-310.
	38.Petticrew MP, Sowden AJ, Lester-Sharp D, Wright K. False-nega-tive results in screening programmes: systematic review of impactand implications. Health Technol Assess2000; 5(4):15.
	39.Hogg C. Patients, power and politics. London: Sage, 1999.
	40.Duncan ID. Guidelines for Clinical Practice and ProgrammeManagementNHSCSP Publication No.8. December 1997. NHScervical screening programme, Sheffield.
	41.Miller AB, Chamberlain J, Day NE, et al.Report on a Workshop ofthe UICC Project on Evaluation of Screening for Cancer. Int JCancer1990; 46:761-769.
	42.Flannelly G. A national screening programme: the answer to can-cer of the cervix. Irish Medical Times1999; 33: 49. 
	43.Walter SD. Optimal use of Pap Smear screening for cervical can-cer. In: Duffy SW, Hill C, Esteve J(eds). Quantitative Methods forthe Evaluation of Cancer Screening.London: Arnold, 2001: 115-126.
	44.Cancer screening. In: Miller AB, Chamberlain J, Day NE, et al(eds).International Union Against Cancer. Cambridge: CambridgeUniversity Press, 1991. 
	45.Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictivevalue of cervical smears in previously screened postmenopausalwomen: the heart and estrogen/progestin replacement study(HERS). Ann Intern Med2000; 133:942-950. 
	46.van Wijngaarden WJ, Duncan ID. Rationale for stopping cervicalscreening in women over 50. BMJ1993; 306:967-971.
	47.Sherlaw-Johnson C, Galllivan S, Jenkins D. Withdrawing low riskwomen from cervical screening programmes: mathematical mod-elling study. BMJ1999; 318:356-361.
	48.Follen-Mitchell M, Schottenfeld D. The natural history of cervicalintraepithelial neoplasia and management of abnormalPapanicolaou smears in cervical cancer and pre-invasive neopla-sia. Philadelphia: Lippincott Raven, 1996; 103-113.
	49.Herbert A, Stein K, Bryant TN, et al.Relation between the inci-dence of invasive cervical cancer and the screening interval: is afive year interval too long? J Med Screen1996;3: 140-145.
	50.Waugh N, Robertson A. Costs and benefits of cervical screeningII. Is it worth reducing the screening interval from five to threeyears? Cytopathology1996; 7:241-248.
	51.Koopmanschap MA, Lubbe KT, van Ortmarssen GJ, et al.Economic aspects of cervical screening. Soc Sci Med1990; 30:1081-1087.
	52.Parkin DM, Moss SM. An evaluation of screening policies for cervi-cal cancer in England and Wales using a computer simulationmodel. J Epidemiol Community Health1986; 40:143-153.
	53.Wilkinson C. Peters TJ, Harvey IM, Stott NCH. Risk targeting incervical screening: a new look at an old problem. Br J Gen Pract1992; 42:435-438.
	54.Knox EG. Ages and frequencies for cervical cancer screening. BrJ Cancer1976; 34:444-452
	55.Wolfendale M. Cervical samplers: most important variable is prob-ably the operator?s skill. BMJ1991; 302:1554-1555.
	56.Duguid HLD. Does mild atypia on a cervical smear warrant furtherinvestigation? Lancet1986; ii:1225. 
	57.Buntinx F, Knottnerus J, Crebolder H, et al.Does feedbackimprove the quality of cervical smears? A randomised controlledtrial. Br J Gen Pract1993; 43:194-198.
	58.Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormalresults of cervical smear test: a controlled trial. BMJ1990; 300:440.
	59.Lester H, Wilson S. Is default from colposcopy a problem, and ifso, what can we do? A systematic review of the literature. Br JGen Pract1999; 49: 223-229.
	60.Martin-Hirsch P, Lilford R, Jarvis G, Kitchener HC. Efficacy of cervi-cal smear collection devices: a systematic review and meta-analy-sis. Lancet1999; 354:1763-1770.
	61.Buntix, F, Brouwers M. Relation between sampling device anddetection of abnormality in cervical smears: a meta-analysis ofrandomised and quasi-randomised studies. BMJ1996; 313:1285-1290.
	62.Klinkhamer P, Vooijs G, de Haan A. Intra-observer variability in thequality assessment of cervical smears. Acta Cytol1989; 33: 215-218.
	63.Vet de H, Knipschild P, Schouten H, et al.Interobserver variation inhisto-pathological grading of cervical dysplasia. J Clin Epidemiol1990; 43:1395-1398.
	64.Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients inEngland after general practitioner referrals: retrospective nationalstudy. BMJ2000; 320:838-839.
	65.Pill R, French J, Harding K, Stoff N. Invitation to attend a healthcheck in a general practice setting: comparison of attenders andnon-attenders. J R Coll Gen Pract1988, 38:53-56.
	66.Townsend P, Davidson N, Whitehead M. Inequalities in health.London: Penguin, 1988.
	67.Torgerson DJ, Donaldson C. An economic view of high compli-ance as a screening object. BMJ1994; 308:117-119.
	68.Jenkins D, Gallivan S, Sherlaw-Johnson C, et al. Compliance inscreening programme: high compliance essential in cervicalscreening programme. BMJ1994; 308:652-653.
	69.Cohen MM. Why is there no progress against cervical cancer.CMAJ1996; 154(12):1867-1869. 
	70.Marshall MN, Campbell S, Hacker J, Roland M (eds). Quality indi-cators for general practice; a practical guide to clinical quality indi-cators for primary care health professionals and managers.London: The Royal Society of Medicine Press Ltd, 2001.
e171.pdf	0
0600.pdf	19
	1.Baquero,F.,J.A.Garc?ï¿½a-Rodr?ï¿½guez,J.Garc?ï¿½adeLomas,L.Aguilar,andtheSpanishSurveillanceGroupforRespiratoryPathogens.1999.Antimicrobialresistanceof1,113StreptococcuspneumoniaeisolatesfrompatientswithrespiratorytractinfectionsinSpain:resultsofa1-year(1996?1997)multi-centersurveillancestudy.Antimicrob.AgentsChemother.43:357?359.
	2.Craig,W.A.1998.Pharmacokinetic/pharmacodynamicparameters:rationaleforantibacterialdosingofmiceandmen.Clin.Infect.Dis.26:1?10.
	3.DeHennezel,L.,F.Ramisse,P.Binder,G.Marchal,andJ.Alonso.2001.Effectivecombinationtherapyforinvasivepneumococcalpneumoniawithampicillinandintravenousimmunoglobulinsinamousemodel.Antimicrob.AgentsChemother.45:316?318.
	4.Densen,P.2000.Complement,p.67?89.InG.L.Mandell,J.E.Bennett,andR.Dolin(ed.),Principlesandpracticeofinfectiousdiseases,5thed.ChurchillLivingstone,Philadelphia,Pa.
	5.Fenoll,A.,I.Jado,D.Vicioso,A.Pï¿½rez,andJ.Casal.1998.EvolutionofStreptococcuspneumoniaeserotypesandantibioticresistanceinSpain:up-date(1990to1996).J.Clin.Microbiol.36:3447?3454.
	6.Fenoll,A.,I.Jado,D.Vicioso,S.Berrï¿½n,J.E.Yuste,and,J.Casal.2000.StreptococcuspneumoniaeinchildreninSpain:1990?1999.ActaPaediatr.Suppl.435:44?50.
	7.Gemmel,C.G.,andV.Lorian.1996.Effectsoflowconcentrationsofanti-bioticsonbacterialultrastructure,virulence,andsusceptibilitytoimmuno-defenses:clinicalsignificance,p.397?452.InV.Lorian(ed.),Antibioticsinlaboratorymedicine,4thed.TheWilliams&WilkinsCo.,Baltimore,Md.
	8.Gï¿½mez-Lus,M.L.,L.Aguilar,M.Mart?ï¿½n,M.J.Gimï¿½nez,P.Mart?ï¿½nez,andJ.Prieto.1997.Intracellularandextracellularkillingofapenicillin-resistant,serotype-9strainofStreptococcuspneumoniaebypolymorphonuclearleuco-cytesinthepresenceofsub-inhibitoryconcentrationsofclavulanicacid.J.Antimicrob.Chemother.40:142?144.
	9.Gï¿½mez-Lus,M.L.,M.J.Gimï¿½nez,J.Prieto,M.Mart?ï¿½n,J.Fr?ï¿½as,andL.Aguilar.1998.Effectofpolymorphonuclearneutrophilsonserumbacteri-cidalactivityagainstStreptococcuspneumoniaeafteramoxicillinadministra-tion.Eur.J.Clin.Microbiol.Infect.Dis.17:40?43.
	10.Heinzel,F.P.2000.Antibodies,p.45?67.InG.L.Mandell,J.E.Bennett,andR.Dolin(ed.),PrinciplesandPracticeofinfectiousdiseases,5thed.ChurchillLivingstone,Philadelphia,Pa.
	11.Hostetter,M.K.2000.OpsonicandnonopsonicinteractionsofC3withStreptococcuspneumoniae,p.309?313.InA.Tomasz(ed.),Streptococcuspneumoniae.MaryAnnLiebert,Inc.,Larchmont,N.Y.
	12.Keller,M.A.,andE.R.Stiehm.2000.Passiveimmunityinpreventionandtreatmentofinfectiousdiseases.Clin.Microbiol.Rev.13:602?614.
	13.Marco,F.,E.Bouza,J.Garc?ï¿½adeLomas,L.Aguilar,andtheSpanishSurveillanceGroupforRespiratoryPathogens.2000.Streptococcuspneu-moniaeincommunity-acquiredrespiratorytractinfectionsinSpain:theimpactofserotypeandgeographical,seasonalandclinicalfactorsonitssusceptibilitytothemostcommonlyprescribedantibiotics.J.Antimicrob.Chemother.46:557?564.
	14.Mart?ï¿½n,M.,M.L.Gï¿½mez-Lus,L.Aguilar,P.Mart?ï¿½nez,M.J.Gimï¿½nez,andJ.Prieto.1997.Effectofclavulanicacidand/orpolymorphonuclearneutro-philsonamoxicillinbactericidalactivityagainstStreptococcuspneumoniae.Eur.J.Clin.Microbiol.Infect.Dis.16:512?516.
	15.Musher,D.M.2000.Streptococcuspneumoniae,p.2128?2147.InG.L.Mandell,J.E.Bennett,andR.Dolin(ed.),Principlesandpracticeofinfec-tiousdiseases,5thed.ChurchillLivingstone,Philadelphia,Pa.
	16.NationalCommitteeforClinicalLaboratoryStandards.2001.Perfomancestandardsforantimicrobialsusceptibilitytesting;11thinformationalsupple-ment.NCCLSdocumentM100-S11.NationalCommitteeforClinicalLab-oratoryStandards,Wayne,Pa.
	17.Pallarï¿½s,R.,J.Liï¿½ares,M.Vadillo,C.Cabellos,F.Manresa,P.F.Viladrich,R.Mart?ï¿½n,andF.Gudiol.1995.ResistancetopenicillinandcephalosporinandmortalityfromseverepneumococcalpneumoniainBarcelona,Spain.N.Engl.J.Med.333:474?480.
	18.Pï¿½rez-Trallero,E.,M.Alkorta,J.M.Garc?ï¿½a-Arenzana,A.Iturzaeta,andM.Gomariz.1998.In-vitro,in-vivoandex-vivostudieswithoralbeta-lactamsagainstStreptococcuspneumoniae.J.Antimicrob.Chemother.41:629?634.
	19.Severin,A.,E.Severina,andA.Tomasz.1997.AbnormalphysiologicalpropertiesandalteredcellwallcompositioninStreptococcuspneumoniaegrowninthepresenceofclavulanicacid.Antimicrob.AgentsChemother.41:504?510.
0963.pdf	59
	1.Andrews,J.M.,T.M.Weller,J.P.Ashby,R.M.Walker,andR.Wise.2000.TheinvitroactivityofABT773,anewketolideantimicrobialagent.J.Antimicrob.Chemother.46:1017?1022.
	2.Arason,V.A.1996.Doantimicrobialsincreasethecarriagerateofpenicillinresistantpneumococciinchildren?Crosssectionalprevalencestudy.Brit.Med.J.313:387?391.
	3.Austin,D.J.,K.G.Kristinsson,andR.M.Anderson.1999.Therelationshipbetweenthevolumeofantimicrobialconsumptioninhumancommunitiesandthefrequencyofresistance.Proc.Natl.Acad.Sci.USA96:1152?1156.
	4.Ban,N.,P.Nissen,J.Hansen,P.B.Moore,andT.A.Steitz.2000.Thecompleteatomicstructureofthelargeribosomalsubunitat2.4Aresolution.Science289:905?920.
	5.Barry,A.L.,P.C.Fuchs,andS.D.Brown.1998.Antipneumococcalactiv-itiesofaketolide(HMR3647),astreptogramin(quinupristin-dalfopristin),amacrolide(erythromycin),andalincosamide(clindamycin).Antimicrob.AgentsChemother.42:945?946.
	6.Bartlett,J.G.,S.F.Dowell,L.A.Mandell,T.M.File,Jr.,D.M.Musher,andA.Fine.2000.Practiceguidelinesforthemanagementofcommunity-ac-quiredpneumoniainadults.Clin.Infect.Dis.31:347?382.
	7.Bonnefoy,A.,A.M.Girard,C.Agouridas,andJ.F.Chantot.1997.KetolideslackinducibilitypropertiesofMLS(B)resistancephenotype.J.Antimicrob.Chemother.40:85?90.
	8.Bryskier,A.2000.Ketolides-telithromycin,anexampleofanewclassofantibacterialagents.Clin.Microbiol.Infect.6:661?669.
	9.Capobianco,J.O.,Z.Cao,V.D.Shortridge,Z.Ma,R.K.Flamm,andP.Zhong.2000.StudiesofthenovelketolideABT-773:transport,bindingtoribosomes,andinhibitionofproteinsynthesisinStreptococcuspneumoniae.Antimicrob.AgentsChemother.44:1562?1567.
	10.CentersforDiseaseControlandPrevention.2001.ResistanceofStreptococ-cuspneumoniaetofluoroquinolones?UnitedStates,1995?1999.Morbid.Mortal.Wkly.Rep.50:800?804.
	11.Chen,D.,A.McGeer,J.C.deAzavedo,D.E.Low,andTheCanadianBacterialSurveillanceNetwork.1999.DecreasedsusceptibilityofStrepto-coccuspneumoniaetofluoroquinolonesinCanada.N.Engl.J.Med.341:233?239.
	12.Davidson,R.,R.Cavalcanti,J.L.Brunton,D.J.Bast,J.C.deAzavedo,P.Kibsey,C.Fleming,andD.E.Low.2002.Resistancetolevofloxacinandfailureoftreatmentofpneumococcalpneumonia.N.Engl.J.Med.346:747?750.
	13.Davies,T.A.,L.M.Ednie,D.M.Hoellman,G.A.Pankuch,M.R.Jacobs,andP.C.Appelbaum.2000.AntipneumococcalactivityofABT-773com-paredtothoseof10otheragents.Antimicrob.AgentsChemother.44:1894?1899.
	14.Doern,G.V.,K.P.Heilmann,H.K.Huynh,P.R.Rhomberg,S.L.Coffman,andA.B.Brueggemann.2001.Antimicrobialresistanceamongclinicaliso-latesofStreptococcuspneumoniaeintheUnitedStatesduring1999?2000,includingacomparisonofresistanceratessince1994?1995.Antimicrob.AgentsChemother.45:1721?1729.
	15.Doit,C.,C.Loukil,F.Fitoussi,P.Geslin,andE.Bingen.1999.EmergenceinFranceofmultipleclonesofclinicalStreptococcuspneumoniaeisolateswithhigh-levelresistancetoamoxicillin.Antimicrob.AgentsChemother.43:1480?1483.
	16.Douthwaite,S.,andW.S.Champney.2001.Structuresofketolidesandmacrolidesdeterminetheirmodeofinteractionwiththeribosomaltargetsite.J.Antimicrob.Chemother.48(Suppl.T1):1?8.
	17.Fasola,E.L.,S.Bajaksouzian,P.C.Appelbaum,andM.R.Jacobs.1997.VariationinerythromycinandclindamycinsusceptibilitiesofStreptococcuspneumoniaebyfourtestmethods.Antimicrob.AgentsChemother.41:129?134.
	18.Felmingham,D.2001.Microbiologicalprofileoftelithromycin,thefirstke-tolideantimicrobial.Clin.Microbiol.Infect.7(Suppl.3):2?10.
	19.File,T.M.,Jr.,J.Segreti,L.Dunbar,R.Player,R.Kohler,R.R.Williams,C.Kojak,andA.Rubin.1997.Amulticenter,radomizedstudycomparingtheefficacyandsafetyofintravenousand/ororallevofloxacinversusceftri-axoneand/orcefuroximeaxetilintreatmentofadultswithcommunity-acquiredpneumonia.Antimicrob.AgentsChemother.41:1965?1972.
	20.Gemmell,C.G.2001.Susceptibilityofavarietyofclinicalisolatestolin-ezolid:aEuropeaninter-countrycomparison.J.Antimicrob.Chemother.48:47?52.
	21.Giovanetti,E.,M.P.Montanari,F.Marchetti,andP.E.Varaldo.2000.InvitroactivityofketolidestelithromycinandHMR3004againstItalianiso-latesofStreptococcuspyogenesandStreptococcuspneumoniaewithdifferenterythromycinsusceptibility.J.Antimicrob.Chemother.46:905?908.
	22.Heffelfinger,J.D.,S.F.Dowell,J.H.Jorgensen,K.P.Klugman,L.R.Mabry,D.M.Musher,J.F.Plouffe,A.Rakowsky,A.Schuchat,andC.G.Whitney.2000.Managementofcommunity-acquiredpneumoniaintheeraofpneumococcalresistance:areportfromtheDrug-ResistantStreptococcuspneumoniaeTherapeuticWorkingGroup.Arch.Intern.Med.160:1399?1408.
	23.Ho,P.L.,T.K.Ng,R.W.Yung,T.L.Que,E.K.Yip,C.W.Tse,andK.Y.Yuen.2001.Activityoflinezolidagainstlevofloxacin-resistantStreptococcuspneumoniae,methicillin-resistantStaphylococcusaureusandvancomycin-re-sistantenterococciinHongKong.J.Antimicrob.Chemother.48:590?592.
	24.Ho,P.L.,T.L.Que,D.N.Tsang,T.K.Ng,K.H.Chow,andW.H.Seto.1999.EmergenceoffluoroquinoloneresistanceamongmultiplyresistantstrainsofStreptococcuspneumoniaeinHongKong.Antimicrob.AgentsChemother.43:1310?1313.
	25.Hoban,D.J.,A.K.Wierzbowski,K.Nichol,andG.G.Zhanel.2001.Mac-rolide-resistantStreptococcuspneumoniaeinCanadaduring1998?1999:prevalenceofmef(A)anderm(B)andsusceptibilitiestoketolides.Antimi-crob.AgentsChemother.45:2147?2150.
	26.Hyde,T.B.,K.Gay,D.S.Stephens,D.J.Vugia,M.Pass,S.Johnson,N.L.Barrett,W.Schaffner,P.R.Cieslak,P.S.Maupin,E.R.Zell,J.H.Jor-gensen,R.R.Facklam,andC.G.Whitney.2001.MacrolideresistanceamonginvasiveStreptococcuspneumoniaeisolates.JAMA286:1857?1862.
	27.Ip,M.,D.J.Lyon,R.W.Yung,C.Chan,andA.F.Cheng.2001.MacrolideresistanceinStreptococcuspneumoniaeinHongKong.Antimicrob.AgentsChemother.45:1578?1580.
	28.Janoir,C.,V.Zeller,M.D.Kitzis,N.J.Moreau,andL.Gutmann.1996.High-levelfluoroquinoloneresistanceinStreptococcuspneumoniaerequiresmutationsinparCandgyrA.Antimicrob.AgentsChemother.40:2760?2764.
	29.Johnston,N.J.,J.C.deAzavedo,J.D.Kellner,andD.E.Low.1998.Prevalenceandcharacterizationofthemechanismsofmacrolide,lincos-amide,andstreptograminresistanceinisolatesofStreptococcuspneumoniae.Antimicrob.AgentsChemother.42:2425?2426.
	30.Klugman,K.P.2001.Antibioticselectionofmultiplyresistantpneumococci.Clin.Infect.Dis.33:489?491.
	31.Leclercq,R.2001.Overcomingantimicrobialresistance:profileofanewketolideantibacterial,telithromycin.J.Antimicrob.Chemother.48(Suppl.B):9?23.
	32.Leclercq,R.,andP.Courvalin.1991.Bacterialresistancetomacrolide,lincosamide,andstreptograminantibioticsbytargetmodification.Antimi-crob.AgentsChemother.35:1267?1272.
	33.Mandell,L.A.,T.J.Marrie,R.F.Grossman,A.W.Chow,andR.H.Hyland.2000.Canadianguidelinesfortheinitialmanagementofcommunity-ac-quiredpneumonia:anevidence-basedupdatebytheCanadianInfectiousDiseasesSocietyandtheCanadianThoracicSociety.Clin.Infect.Dis.31:383?421.
	34.McGee,L.,K.P.Klugman,A.Wasas,T.Capper,andA.Brink.2001.Serotype19fmultiresistantpneumococcalcloneharboringtwoerythromycinresistancedeterminants[erm(B)andmef(A)]inSouthAfrica.Antimicrob.AgentsChemother.45:1595?1598.
	35.Melander,E.,S.Molstad,K.Persson,H.B.Hansson,M.Soderstrom,andK.Ekdahl.1998.Previousantibioticconsumptionandotherriskfactorsforcarriageofpenicillin-resistantStreptococcuspneumoniaeinchildren.Eur.J.Clin.Microbiol.Infect.Dis.17:834?838.
	36.Montanari,M.P.,M.Mingoia,E.Giovanetti,andP.E.Varaldo.2001.Differentiationofresistancephenotypesamongerythromycin-resistantpneumococci.J.Clin.Microbiol.39:1311?1315.
	37.Morosini,M.I.,R.Canton,E.Loza,M.C.Negri,J.C.Galan,F.Almaraz,andF.Baquero.2001.InvitroactivityoftelithromycinagainstSpanishStreptococcuspneumoniaeisolateswithcharacterizedmacrolideresistancemechanisms.Antimicrob.AgentsChemother.45:2427?2431.
	38.NationalCommitteeforClinicalLaboratoryStandards.2000.Methodsfordilutionantimicrobialsusceptibilitytestsforbacteriathatgrowaerobically,5thed.ApprovedstandardM7-A5.NationalCommitteeforClinicalLabo-ratoryStandards,Wayne,Pa.
	39.NationalCommitteeforClinicalLaboratoryStandards.2000.Performancestandardsforantimicrobialdisksusceptibilitytests,7thed.Approvedstan-dardM2-A7.NationalCommitteeforClinicalLaboratoryStandards,Wayne,Pa.
	40.NationalCommitteeforClinicalLaboratoryStandards.2002.Performancestandardsforantimicrobialsusceptibilitytesting.Twelfthinformationalsup-plement,M100-S12.NationalCommitteeforClinicalLaboratoryStandards,Wayne,Pa.
	41.Niederman,M.S.,L.A.Mandell,A.Anzueto,J.B.Bass,W.A.Broughton,G.D.Campbell,N.Dean,T.File,M.J.Fine,P.A.Gross,F.Martinez,T.J.Marrie,J.F.Plouffe,J.Ramirez,G.A.Sarosi,A.Torres,R.Wilson,andV.L.Yu.2001.Guidelinesforthemanagementofadultswithcommunity-acquiredpneumonia.Diagnosis,assessmentofseverity,antimicrobialther-apy,andprevention.Am.J.Respir.Crit.CareMed.163:1730?1754.
	42.Pankuch,G.A.,M.A.Visalli,M.R.Jacobs,andP.C.Appelbaum.1998.Susceptibilitiesofpenicillin-anderythromycin-susceptibleand-resistantpneumococcitoHMR3647(RU66647),anewketolide,comparedwithsusceptibilitiesto17otheragents.Antimicrob.AgentsChemother.42:624?630.
	43.Perez-Trallero,E.,C.Fernandez-Mazarrasa,C.Garcia-Rey,E.Bouza,L.Aguilar,J.Garcia-de-Lomas,andF.Baquero.2001.Antimicrobialsuscep-tibilitiesof1,684Streptococcuspneumoniaeand2,039Streptococcuspyogenesisolatesandtheirecologicalrelationships:resultsofa1-year(1998?1999)multicentersurveillancestudyinSpain.Antimicrob.AgentsChemother.45:3334?3340.
	44.Petitpretz,P.,P.Arvis,M.Marel,J.Moita,andJ.Urueta.2001.Oralmoxifloxacinvs.high-dosageamoxicillininthetreatmentofmild-to-moder-ate,community-acquired,suspectedpneumococcalpneumoniainadults.Chest119:185?195.
	45.Pihlajamaki,M.,P.Kotilainen,T.Kaurila,T.Klaukka,E.Palva,andP.Huovinen.2001.Macrolide-resistantStreptococcuspneumoniaeanduseofantimicrobialagents.Clin.Infect.Dis.33:483?488.
	46.Richardson,D.C.,D.Bast,A.McGeer,andD.E.Low.2001.EvaluationofsusceptibilitytestingtodetectfluoroquinoloneresistancemechanismsinStreptococcuspneumoniae.Antimicrob.AgentsChemother.45:1911?1914.
	47.Roberts,M.C.,J.Sutcliffe,P.Courvalin,L.B.Jensen,J.Rood,andH.Seppala.1999.Nomenclatureformacrolideandmacrolide-lincosamide-streptograminBresistancedeterminants.Antimicrob.AgentsChemother.43:2823?2830.
	48.Seppala,H.,A.Nissinen,Q.Yu,andP.Huovinen.1993.Threedifferentphenotypesoferythromycin-resistantStreptococcuspyogenesinFinland.J.Antimicrob.Chemother.32:885?891.
	49.Shinabarger,D.L.,K.R.Marotti,R.W.Murray,A.H.Lin,E.P.Melchior,S.M.Swaney,D.S.Dunyak,W.F.Demyan,andJ.M.Buysse.1997.Mechanismofactionofoxazolidinones:effectsoflinezolidandeperezolidontranslationreactions.Antimicrob.AgentsChemother.41:2132?2136.
	50.Simor,A.E.,M.Louie,TheCanadianBacterialSurveillanceNetwork,andD.E.Low.1996.CanadiannationalsurveyofprevalenceofantimicrobialresistanceamongclinicalisolatesofStreptococcuspneumoniae.Antimicrob.AgentsChemother.40:2190?2193.
	51.Slee,A.M.,M.A.Wuonola,R.J.McRipley,I.Zajac,M.J.Zawada,P.T.Bartholomew,W.A.Gregory,andM.Forbes.1987.Oxazolidinones,anewclassofsyntheticantibacterialagents:invitroandinvivoactivitiesofDuP105andDuP721.Antimicrob.AgentsChemother.31:1791?1797.
	52.Sutcliffe,J.,A.Tait-Kamradt,andL.Wondrack.1996.Streptococcuspneu-moniaeandStreptococcuspyogenesresistanttomacrolidesbutsensitivetoclindamycin:acommonresistancepatternmediatedbyaneffluxsystem.Antimicrob.AgentsChemother.40:1817?1824.
	53.Tait-Kamradt,A.,T.Davies,P.C.Appelbaum,F.Depardieu,P.Courvalin,J.Petitpas,L.Wondrack,A.Walker,M.R.Jacobs,andJ.Sutcliffe.2000.TwonewmechanismsofmacrolideresistanceinclinicalstrainsofStrepto-coccuspneumoniaefromEasternEuropeandNorthAmerica.Antimicrob.AgentsChemother.44:3395?3401.
	54.Tait-Kamradt,A.,T.Davies,M.Cronan,M.R.Jacobs,P.C.Appelbaum,andJ.Sutcliffe.2000.Mutationsin23SrRNAandribosomalproteinL4accountforresistanceinpneumococcalstrainsselectedinvitrobymacrolidepassage.Antimicrob.AgentsChemother.44:2118?2125.
	55.Tankovic,J.,B.Perichon,J.Duval,andP.Courvalin.1996.ContributionofmutationsingyrAandparCgenestofluoroquinoloneresistanceofmutantsofStreptococcuspneumoniaeobtainedinvivoandinvitro.Antimicrob.AgentsChemother.40:2505?2510.
	56.Tsiodras,S.,H.S.Gold,G.Sakoulas,G.M.Eliopoulos,C.Wennersten,L.Venkataraman,R.C.Moellering,andM.J.Ferraro.2001.Linezolidresis-tanceinaclinicalisolateofStaphylococcusaureus.Lancet358:207?208.
	57.Whitney,C.G.,M.M.Farley,J.Hadler,L.H.Harrison,C.Lexau,A.Reingold,L.Lefkowitz,P.R.Cieslak,M.Cetron,E.R.Zell,J.H.Jorgensen,andA.Schuchat.2000.Increasingprevalenceofmultidrug-resistantStrep-tococcuspneumoniaeintheUnitedStates.N.Engl.J.Med.343:1917?1924.
	58.Yusupova,G.Z.,M.M.Yusupov,J.H.Cate,andH.F.Noller.2001.ThepathofmessengerRNAthroughtheribosome.Cell106:233?241.
	59.Zurenko,G.E.,B.H.Yagi,R.D.Schaadt,J.W.Allison,J.O.Kilburn,S.E.Glickman,D.K.Hutchinson,M.R.Barbachyn,andS.J.Brickner.1996.InvitroactivitiesofU-100592andU-100766,noveloxazolidinoneantibacterialagents.Antimicrob.AgentsChemother.40:839?845.
11788790.pdf	37
	1.Balbin EG, Ironson GH, Solomon GF. (1999) Stress and cop-ing: the psychoneuroimmunology of HIV/AIDS. Baillieres BestPract. Res. Clin. Ednocrinol. Metab.13: 615?633.	10903818
	2.Chrousos GP. (2000) Stress, chronic inflammation, and emo-tional and physical well-being: concurrent effects and chronicsequelae. J. Allergy Clin. Immunol.106:275?291.	11080744
	3.Yang EV, Glaser R. (2000) Stress-induced immunomodula-tion: impact on immune defenses against infectious disease.Biomed. Pharmacother.54: 245?250.	10917461
	4.Swain MG, Patchev V, Vergalla J, et al. (1993) Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J. Clin. Invest.91:1903?1908.	2845968
	5.Malan FS, Horak IG, de Vos V, van Wyk JA. (1997) Wildlifeparasites: lessons for parasite control in livestock. Vet. Para-sitol.71:137?153.	9261975
	6.Kraabel BJ, Miller MW. (1997) Effect of simulated stress onsusceptibility of bighorn sheep neutrophils to Pasteurellahaemolytica leukotoxin.J. Wildl. Dis. 33: 558?566.	9249702
	7.McEwen BS, Seeman T. (1999) Protective and damaging effectsof mediators of stress. Elaborating and testing the concepts ofallostasis and allostatic load. Ann. N.Y. Acad. Sci. USA896:30?47.	10681886
	8.Birmaher B, Rabin BS, Garcia MR, et al. (1994) Cellular im-munity in depressed, conduct disorder, and normal adoles-cents: role of adverse life events. J. Am. Acad. Child Adolesc.Psychiatry33: 671?678.	8056730
	9.Strange KS, Kerr LR, Andrews HN, et al. (2000) Psychosocialstressors and mammary tumor growth: an animal model.Neurotoxicol. Teratol.22: 89?102.	10642118
	10.Elenkov IJ, Chrousos GP. (1999) Stress, cytokine patternsand susceptibility to disease. Baillieres Best Pract. Res. Clin.Endocrinol. Metab.13: 583?595.	10903816
	11.Kiecolt-Glaser JK, Glaser R. (1999) Psychoneuroimmunologyand cancer: fact or fiction? Eur. J. Cancer35: 1603?1607.	10673969
	12.Bauer ME, Vedhara K, Perks P, et al. (2000) Chronic stress incaregivers of dementia patients is associated with reducedlymphocyte sensitivity to glucocorticoids. J. Neuroimmunol.103: 84?92.	10674993
	13.Lacey K, Zaharia MD, Griffiths J, et al. (2000) A prospectivestudy of neuroendocrine and immune alterations associatedwith the stress of an oral academic examination among grad-uate students. Psychoneuroendocrinol.25: 339?356.	10725611
	14.Cohen S, Miller GE, Rabin BS. (2001) Psychological stressand antibody response to immunization: a critical review ofthe human literature. Psychosom. Med.63: 7?18.	11211068
	15.Cacioppo JT, Poehlmann KM, Kiecolt-Glaser JK, et al. (1998)Cellular immune responses to acute stress in female care-givers of dementia patients and matched controls. HealthPsychol. 17: 182?189.	9548709
	16.Weicker H, Werle E. (1991) Interaction between hormonesand the immune system. Int. J. Sports Med.12: S30?S37.	1894395
	17.Ashwell JD, Lu FW, Vacchio MS. (2000) Glucocorticoids in Tcell development and function. Ann. Rev. Immunol.18: 309?345.	10837061
	18.Rook GA. (1999) Glucocorticoids and immune function. Bail-lieres Best Pract. Res. Clin. Endocrinol. Metab.13: 567?581.	10903815
	19.Nosseri C, Coppola S, Ghibelli L. (1994) Possible involve-ment of Poly(ADP-Ribosyl) polymerase in triggering stress-induced apoptosis. Exp. Cell Res.212: 367?373.	8187831
	20.Pieper AA, Verma A, Zhang J, Snyder S. (1999) Poly (ADP-ribose) polymerase, nitric oxide, and cell death. Trends Phar-macol. Sci.20: 171?181.766Molecular Medicine,Volume 7, Number 6, November, 2001	10322503
	21.Eliasson MJL, Sampei K, Mandir AS, et al. (1997) Poly(ADP-ribose) polymerase gene Disruption renders mice re-sistant to cerebral ischemia. Nature Med.3: 1089?1095.	9334719
	22.Mandir AS, Przedborski S, Jackson-Lewis V, et al. (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkin-sonism. Proc. Natl. Acad. Sci.USA 96: 5774?5779.	3872460
	23.Pieper AA, Walles T, Wei G, et al. (2000) Myocardial postis-chemic injury is reduced by poly ADP ribose polymerase-1gene disruption. Mol. Med.6: 271?282.	10949908
	24.Pieper AA, Brat DJ, Krug DK, et al. (1999) Poly (ADP-ribose)polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci.96: 3059?3064.	8620843
	25.Cossette S, Frasure-Smith N, Lesperance F. (2001) Clinicalimplications of a reduction in psychological distress on car-diac prognosis in patients participating in a psychosocial in-tervention program. Psychosom. Med.63: 257?266.	11292273
	26.Haines A, Cooper J, Meade TW. (2001) Psychological characteristics and fatal ischaemic heart disease. Heart85: 385?389.	10880655
	27.Naliboff BD, Goldstein IB, Shapiro D, Frank HJ. (1988) Mental and physical stress as moderators of the postural response in insulin-dependent diabetic patients. Health. Psychol.7:499?514.	3215159
	28.Wang ZQ, Stingl L, Morrison C, et al. (1997) PARP is important for genomic stability but dispensable in apoptosis. GenesDev.11: 2347?2358.	8080500
	29.Dixon F, Jacot-Guillarmod H, McConahey PJ. (1966) Theantibody responses of rabbits and rats to hemocyanin.J.Immunol.97: 350?355.	5925706
	30.Drazen DL, Kriegsfeld LJ, Schneider JE, Nelson RJ. (2000)Leptin, but not immune function, is linked to reproductiveresponsiveness. Am. J. Physiol.278: 1401?1407.	10848504
	31.Tsutsui N, Kamiyama T. (1998) Suppression of in vitro IFN-gamma production by spleen cells of Plasmodium chabaudi-infected C57BL/10 mice exposed to dexamethasone at a lowdose. Int. J. Immunopharmacol.20: 141?152.	9730250
	32.DeVries AC, Gerber JM, Richardson HN, et al. (1997) Stressaffects corticosteroid and immunoglobulin concentrationsin male house mice (Mus musculus) and prairie voles (Micro-tus ochrogaster). Comp. Biochem. Physiol. A Physiol.118:655?663.	9406441
	33.Shu J, Stevenson JR, Zhou X. (1993) Modulation of cellularimmune responses by cold water swim stress in the rat. DevComp Immunol17: 357?371.	8375569
	34.Song C, Kelly JP, Leonard BE. (1994) The effect of stressfulbehavioral exposure on endocrine and immune parameters inthe rat. Stress Med.10:239?245.
	35.Nelson RJ. (1997) The use of genetic ?knockout? mice inbehavioral endocrinology research. Horm. Behav.31: 188?196.	9213133
	36.Kickhoefer VA, Siva AC, Kedersha NL, et al. (1999) The 193-kD vault protein, VPARP is a novel poly (ADP-ribose) polymerase. J. Cell Biol. 146:917?928.	8390463
	37.Ame JC, Rolli V, Schreiber V, et al. (1999) PARP-2, a novelmammalian DNA damage-dependent Poly (ADP-ribose)polymerase. J. Biol. Chem.274: 17860?17868.	10364231
11788789.pdf	24
	1.Minden A, Lin A, McMahon M, et al. (1994) Differential ac-tivation of ERK and JNK mitogen-activated protein kinasesby Raf-1 and MEKK. Science266:1719?1723.	7992057
	2.Lee JC, Laydon JT, McDonnell PC, et al. (1994) A protein ki-nase involved in the regulation of inflammatory cytokinebiosynthesis. Nature372:739?746.	7997261
	3.Coso OA, Chiariello M, Yu JC, et al. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of theJNK/SAPK signaling pathway. Cell81:1137?1146.	7600581
	4.Liu MK, Herrera-Velit P, Brownsey RW, Reiner NE. (1994)CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytestreated with bacterial lipopolysaccharide. J. Immunol.153:2642?2652.	7521366
	5.Gupta S, Barrett T, Whitmarsh AJ, et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO. J.15:2760?2770.	1332967
	6.Hambleton J, Weinstein SL, Lem L, DeFranco AL. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysac-charide-stimulated macrophages. Proc. Natl. Acad. Sci. USA93:2774?2778.	2112087
	7.van den Blink B, Juffermans NP, ten Hove T, et al. (2001) p38mitogen-activated protein kinase inhibition increases cy-tokine release by macrophages in vitro and during infectionin vivo. J. Immunol.166:582?587.	11123340
	8.Beyaert R, Cuenda A, Vanden Berghe W, et al. (1996) Thep38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor.EMBO. J.15:1914?1923.	8413585
	9.Scherle PA, Jones EA, Favata MF, et al. (1998) Inhibition ofMAP kinase kinase prevents cytokine and prostaglandin E2production in lipopolysaccharide-stimulated monocytes. J.Immunol.161:5681?5686.	9820549
	10.van der Poll T, van Deventer SJH. (1999) Endotoxemia inhealthy subjects as a human model of inflammation. In:Cohen J, Marshall J (eds.) The Immune Response in the Crit-ically Ill, Springer?Verlag, USA/Germany, pg. 335?357.
	11.Carter AB, Monick MM, Hunninghake GW. (1999) Both Erkand p38 kinases are necessary for cytokine gene transcription.Am. J. Respir. Cell. Mol. Biol.20:751?758.	10101008
	12.Zhu W, Downey JS, Gu J, et al. (2000) Regulation of TNF ex-pression by multiple mitogen-activated protein kinase path-ways. J. Immunol.164:6349?6358.	10843689
	13.van der Poll T, Calvano SE, Kumar A, et al. (1995) Endotoxininduces downregulation of tumor necrosis factor receptors oncirculating monocytes and granulocytes in humans. Blood86:2754?2759.	7670115
	14.van der Poll T, Coyle SM, Barbosa K, et al. (1996) Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin.Invest.97:713?719.	1358381
	15.Versteeg HH, Nijhuis E, van den Brink GR, et al. (2000) A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinaseB and cAMP-response?element-binding protein. Biochem. J.350 Pt 3:717?722.	1322500
	16.Yokoi T, Ohmichi M, Tasaka K, et al. (2000) Activation of theluteinizing hormone beta promoter by gonadotropin-releasing hormone requires c-Jun NH2-terminal protein ki-nase. J. Biol. Chem. 275:21639?21647.760Molecular Medicine,Volume 7, Number 11, November 2001	10787426
	17.Medvedev AE, Kopydlowski KM, Vogel SN. (2000) Inhibi-tion of lipopolysaccharide-induced signal transduction inendotoxin-tolerized mouse macrophages: dysregulation ofcytokine, chemokine, and toll-like receptor 2 and 4 geneexpression. J. Immunol. 164:5564?5574.	10820230
	18.Mendez C, Kramer AA, Salhab KF, et al. (1999) Tolerance to shock: an exploration of mechanism. Ann Surg229:843?849;discussion 849?850.	8642296
	19.Jin H, Yang R, Marsters S, et al. (1995) Protection against endotoxic shock by bactericidal/permeability increasing protein in rats. J. Clin. Invest.95:1947?1952.	1660140
	20.De Cesaris P, Starace D, Riccioli A, et al. (1998) Tumor necro-sis factor-alpha induces interleukin-6 production and inte-grin ligand expression by distinct transduction pathways. J.Biol. Chem.273:7566?7571.	9516459
	21.Chan ED, Winston BW, Uh ST, et al. (1999) Evaluation of therole of mitogen-activated protein kinases in the expression ofinducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. J. Immunol.162:415?422.	9886415
	22.Nick JA, Avdi NJ, Gerwins P, et al. (1996) Activation of a p38mitogen-activated protein kinase in human neutrophils bylipopolysaccharide. J. Immunol.156:4867?4875.	8648136
	23.Hambleton J, Weinstein SL, Lem L, DeFranco AL. (1996) Activation of c-Jun N-terminal kinase in bacterial lipopolysac-charide stimulated macrophages. Proc. Natl. Acad. Sci. USA93:2774?2778.	2112087
	24.Avdi NJ, Nick JA, Whitlock BB, et al. (2001) Tumor necrosisfactor-alpha activation of the c-Jun N-terminal kinase path-way in human neutrophils. Integrin involvement in a path-way leading from cytoplasmic tyrosine kinases apoptosis. J.Biol. Chem. 276:2189?2199.	11053415
63.pdf	27
4765.full.pdf	30
	1.ClarkPA,RogolAD1996Growthhormonesandsexsteroidinteractionsatpuberty.EndocrinolMetabClinNorthAm25:665?681
	2.TheintzG,BuchsB,RizzoliR,etal.1992Longitudinalmonitoringofbonemassaccumulationinhealthyadolescents:evidenceforamarkedreductionafter16yearsofageatthelevelsoflumbarspineandfemoralneckinfemalesubjects.JClinEndocrinolMetab75:1060?1065
	3.BeunenG,MalinaRM1988Growthandphysicalperformancerelativetothetimingoftheadolescentspurt.ExerSportSciRev16:502?540
	4.ReckerRR,DaviesKM,HindersSM,HeaneyRP,StegmanMR,KimmelDB1992Bonegaininyoungadultwomen.JAMA268:2403?2408
	5.MatkovicV,JelicT,WardlawGM,etal.1994.TimingofpeakbonemassinCaucasianfemalesanditsimplicationforthepreventionofosteoporosis.Inferencefromacross-sectionalmodel.JClinInvest93:799?808
	6.KaufmanJM,TaelmanP,VermeulenA,VandewegheM1992Bonemineralstatusingrowthhormone-deficientmaleswithisolatedandmultiplepituitarydeficienciesofchildhoodonset.JClinEndocrinolMetab74:118?123
	7.LarssonL,GrimbyG,KarlssonJ1979Musclestrengthandspeedofmove-mentinrelationtoageandmusclemorphology.JApplPhysiol46:451?456
	8.BorgesO1989Isometricandisokinetickneeextensionandflexiontorqueinmenandwomenaged20?70.ScandJRehabMed21:45?53
	9.Jï¿½rgensenJOL,PedersenSA,ThuesenL,etal.1989BeneficialeffectofgrowthhormonetreatmentinGH-deficientadults.Lanceti:1221?1225
	10.NelsonDA,SimpsonPM,JohnsonCC,BarondessDA,KleerekoperM1997Theaccumulationofwholebodyskeletalmassinthird-andfourth-gradechildren:effectsofage,gender,ethnicity,andbodycomposition.Bone20:73?78
	11.JohannssonG,Albertsson-WiklandK,BengtssonB-ï¿½1999Discontinuationofgrowthhormone(GH)treatment:metaboliceffectsinGH-deficientandGH-sufficientadolescentpatientscomparedwithcontrolsubjects.SwedishStudyGroupforGrowthHormoneTreatmentinChildren.JClinEndocrinolMetab84:4516?4524
	12.TulldahlJ,PetterssonK,AnderssonSW,Hutheï¿½nL1999Modeofinfantfeedingandachievedgrowthinadolescence:earlyfeedingpatternsinrelationtogrowthandbodycompositioninadolescence.ObesRes7:431?437
	13.JohannssonG,GrimbyG,StibrantSunnerhagenK,BengtssonB-ï¿½1997Twoyearsofgrowthhormone(GH)treatmentincreasesisometricandisokineticmusclestrengthinGH-deficientadults.JClinEndocrinolMetab82:2877?2884
	14.ThorstenssonA,GrimbyG,KarlssonJ1976Force-velocityrelationsandfibercompositioninhumankneeextensormuscle.JApplPhysiol40:12?16
	15.Nordenskjoï¿½ldUM,GrimbyG1993Gripforceinpatientswithrheumatoidarthritisandfibromyalgiaandinhealthysubjects.AstudywithGrippitin-strument.ScandJRheumatol22:14?19
	16.Lagerstoï¿½mC,NordgrenB1998Onthereliabilityandusefulnessofmethodsforgripstrengthmeasurement.ScandJRehabilMed30:112?119
	17.DigglePJ,LiangK-Y,ZegerSL1994Analysisoflongitudinaldata.Oxford:OxfordUniversityPress
	18.GiustinaA,VeldhuisJD1998Pathophysiologyoftheneuroregulationofgrowthhormonesecretioninexperimentalanimalsandthehuman.EndocrRev19:717?797
	19.RudmanD,KutnerMH,RogersCM,LubinMF,FlemmingGA,BainRP1981Impairedgrowthhormonesecretionintheadultpopulation.Relationtoageandadiposity.JClinInvest67:1361?1369
	20.TaaffeDR,PruittL,JR,etal.1994Effectofrecombinanthumangrowthhormoneonthemusclestrengthresponsetoresistanceexerciseinelderlymen.JClinEndocrinolMetab79:1361?1366
	21.LambertsSWJ,VanbenBeldAW,VanderLelyA-J1997Theendocrinologyofaging.Science278:419?424
	22.ArmstongN,WelsmanJ1997Youngpeopleandphysicalactivity.Oxford:OxfordUniversityPress
	23.OgleGD,AllenJR,HumphriesIR,etal.1995Body-compositionassessmentbydual-energyx-rayabsorptiometryinsubjectsaged4?26y.AmJClinNutr61:746?753
	24.NariciMV,RoiGS,LandoniL,MinettiAE,CerretelliP1989Changesinforce,cross-sectionalareaandneuralactivationduringstrengthtrainingandde-trainingofthehumanquadriceps.EurJApplPhysiol59:310?319
	25.SegerJY,ThorstenssonA2000Musclestrengthandelectromyograminboysandgirlsfollowedthroughpuberty.EurJApplPhysiol81:54?61
	26.VahlN,JuulA,Jï¿½rgensenJOL,ï¿½rskovH,Skakkebï¿½kNE,ChristiansenJS2000Continuationofgrowthhormone(GH)replacementinGH-deficientpatientsduringtransitionfromchildhoodandadulthood:atwo-yearplacebo-controlledstudy.JClinEndocrinolMetab85:1874?1881
	27.RutherfordOM,JonesDA,RoundJM,BuchananCR,PreeceMA1991Changesinskeletalmuscleandbodycompositionafterdiscontinuingofgrowthhormonetreatmentingrowthhormonedeficientadults.ClinEndo-crinol(Oxf)34:469?475
	28.SchoenauE,NeuCM,MokovE,WassmerG,ManzF2000Influenceofpubertyonmuscleareaandcorticalboneareaoftheforearminboysandgirls.JClinEndocrinolMetab85:1095?1098
	29.BengtssonB-ï¿½,Edeï¿½nS,Loï¿½nnL,etal.1993Treatmentofadultswithgrowthhormone(GH)deficiencywithrecombinanthumanGH.JClinEndocrinolMetab76:309?317
	30.Bjoï¿½rkS,Joï¿½nssonB,WestphalO,LevinJ-E1989Qualityoflifeofadultswithgrowthhormonedeficiency:acontrolledstudy.ActaPaediatrScand356(Suppl):55?59
4717.full.pdf	37
	1.ConsensusDevelopmentConference1993Diagnosis,prophylaxis,andtreat-mentofosteoporosis.AmJMed94:646?650
	2.SalamoneLM,PressmanAR,SeeleyDG,etal.1996Estrogenreplacementtherapy:asurveyofolderwomen?sattitudes.ArchInternMed156:1293?1297
	3.BeauchesneM-F,MillerP1999Etidronateandalendronateinthetreatmentofpostmenopausalosteoporosis.AnnPharmacother33:587?599
	4.KaplanNM,PalmerBF,RubinCD1999Treatmentconsiderationsinthemanagementofage-relatedosteoporosis.AmJMedSci318:158?170
	5.KloosterboerHJ1997Tiboloneanditsmetabolites:pharmacology,tissuespecificityandeffectsinanimalmodelsoftumors.GynecolEndocrinol11(Suppl1):63?68
	6.MooreRA1999Livial:areviewofclinicalstudies.BrJObstetGynaecol106(Suppl19):1?21
	7.KlearchouN,Kanallaki-KyparissiM,DeligeorgiF,KoliakouM,Karagian-nisV,MamopoulosM,TheeffectofLivialatthemammarygland.Mammo-graphicandhypermicroscopicfindings.The9thInternationalMenopauseSocietyWorldCongressontheMenopause,Yokohama,Japan,1999;AbstractP351Gallagheretal.PreventionofPostmenopausalBoneLossJClinEndocrinolMetab,October2001,86(10):4717?47264725
	8.KloosterboerHJ,SandsR2000Intracrinology:thesecretofthetissue-spec-ificityoftibolone.JBritMenopauseSoc6(Suppl2):23?27
	9.EderveenAGH,KloosterboerHJ,Theprotectiveeffectoftiboloneonovari-ectomy-inducedbonelossisblockedbyananti-estrogen.TheFirstAmsterdamMenopauseSymposium,Amsterdam,TheNetherlands,1998;AbstractOST-04
	10.MarkiewiczL,GurpideE1990Invitroevaluationofestrogenic,estrogenantagonisticandprogestageniceffectsofasteroidaldrug(OrgOD-14)anditsmetabolitesonhumanendometrium.JSteroidBiochem35:535?541
	11.TangB,MarkiewiczL,KloosterboerHJ,GurpideE1993Humanendometrial3-hydroxysteroiddehydrogenase/isomerasecanlocallyreduceintrinsices-trogenic/progestagenicactivityratiosofasteroidaldrug(OrgOD14).JSteroidBiochemMolBiol45:345?351
	12.HammarM,ChristauS,Nathorst-BoeoesJ,RudT,GarreK1998Adouble-blind,randomisedtrialcomparingtheeffectsoftiboloneandcontinuouscombinedhormonereplacementtherapyinpostmenopausalwomenwithmenopausalsymptoms.BrJObstetGynaecol105:904?911
	13.ValdiviaI,OrtegaD2000Mammographicdensityinpostmenopausalwomentreatedwithtibolone,estriolorconventionalhormonereplacementtherapy.ClinDrugInvest20:101?107
	14.PasqualiniJR,ChetriteGS1999Estronesulfataseversusestronesulfotrans-feraseinhumanbreastcancer:potentialclinicalapplications.JSteroidBiochemMolBiol69:287?292
	15.GompelA,KandouzM,SiromachkovaM,etal.1997Theeffectoftiboloneonproliferation,differentiationandapoptosisinnormalbreastcells.GynecolEndocrinol11(Suppl1):77?79
	16.LindsayR,MackhartD,KrazewskiA,CoupeJ1980Prospectivedouble-blindtrialofsyntheticsteroid(ORGOD14)forpreventingpostmenopausalosteo-porosis.BrMedJ281:456?457
	17.RymerJ,ChapmanM,FogelmanI1990OD14:anovelsteroidfortreatmentofmenopausalsymptoms.JObstetGynaecol10:454?455
	18.GeusensP,DequekerJ,GielenJ,SchotLPC1991Non-linearincreaseinvertebraldensityinducedbyasyntheticsteroid(ORGOD14)inwomenwithestablishedosteoporosis.Maturitas13:155?162
	19.BerningB,KuijkCV,KuiperJW,CoelinghBenninkHJT,KicovicPM,FauserBCJM1996Effectsoftwodosesoftiboloneontrabecularandcorticalbonelossinearlypostmenopausalwomen:atwo-yearrandomized,placebo-controlledstudy.Bone19:395?399
	20.BjarnasonNH,BjarnasonK,JaarboJ,RosenquistC,ChristiansenC1996Tibolone:preventionofbonelossinlatepost-menopausalwomen.JClinEndocrinolMetab81:2419?2422
	21.LippunerK,HaenggiW,BirkhaeuserMH,CasezJP,JaegerP1997Preventionofpostmenopausalbonelossusingtiboloneorconventionalperoralortrans-dermalhormonereplacementtherapywith17-estradiolanddydrogesterone.JBoneMinerRes12:806?812
	22.PrelevicGM,BartramC,WoodJ,OkoloS,GinsburgJ1996Comparativeeffectsonbonemineraldensityoftibolone,transdermalestrogenandoralestrogen/progestogentherapyinpostmenopausalwomen.GynecolEndocri-nol10:413?420
	23.RiggsBL1996Editorial:tiboloneasanalternativetoestrogenforthepre-ventionofpostmenopausalosteoporosisinselectedpostmenopausalwomen.JClinEndocrinolMetab81:2417?2418
	24.RymerJM1998Theeffectsoftibolone.GynecolEndocrinol12:213?220
	25.StuddJ,ArnalaI,KicovicPM,ZambleraD,KrogerH,HollandN1998Arandomizedstudyoftiboloneonbonemineraldensityinosteoporoticpost-menopausalwomenwithpreviousfractures.ObstetGynecol92:574?579
	26.RossPD,DavisJW,EpsteinRS,WasnichRD1991Pre-existingfracturesandbonemasspredictvertebralfractureincidenceinwomen.AnnInternMed114:919?923
	27.MeltonIIILJ,AtkinsonEJ,O?FallonWM,WahnerHW,RiggsBL1993Long-termfracturepredictionbybonemineralassessedatdifferentskeletalsites.JBoneMinerRes8:1227?1233
	28.TheWritingGroupforthePEPI1996Effectsofhormonetherapyonbonemineraldensity:resultsfromthepostmenopausalestrogen/progestininter-ventions(PEPI)trial.JAMA276:1389?1396
	29.McClungM,ClemmesonB,DaifotisA,etal.fortheAlendronateOsteo-porosisPreventionStudyGroup1998Alendronatepreventspostmenopausalbonelossinwomenwithoutosteoporosis.Adouble-blind,randomized,con-trolledtrial.AnnInternMed128:253?261
	30.DelmasPD,BjarnasonJH,MitlakBH,etal.1997Effectsofraloxifeneonbonemineraldensity,serumcholesterolconcentrations,anduterineendometriuminpostmenopausalwomen.NEnglJMed337:1641?1647
	31.MortensonL,CharlesP,BekkerPJ,DigennaroJ,JohnstonJrCC1998Risedr-onateincreasesbonemassinanearlypostmenopausalpopulation:twoyearsoftreatmentplusoneyearoffollow-up.JClinEndocrinolMetab83:396?402
	32.DorenM,RubigA,CoelinghBenninkHJT,HolzgreveW1999Impactonuterinebleedingandendometrialthickness:tibolonecomparedwithcontin-uouscombinedestradiolandnorethisteroneacetatereplacementtherapy.Menopause6:299?306
	33.BjarnasonNH,BjarnasonK,HaarboJ,BenninkHJTC,ChristiansenC1997Tibolone:influenceonmarkersofcardiovasculardisease.JClinEndocrinolMetab82:1752?1756
	34.FarishE,BarnesJF,RoltonHA,SpowartK,FletcherCD,HartDM1995Effectsoftiboloneonlipoprotein(a)andHDLsubfractions.Maturitas20:215?219
	35.HanggiW,LippunerK,RiesenW,JaegerP,BirkhauserMH1997Longterminfluenceofdifferentpostmenopausalhormonereplacementregimensonserumlipidsandlipoprotein(a):arandomisedstudy.BrJObstetGynaecol104:708?717
	36.MilnerMH,SinnottMM,CookeTM,KellyA,McGillT,HarrisonRF1996A2-yearstudyoflipidandlipoproteinchangesinpostmenopausalwomenwithtiboloneandestrogen-progestin.ObstetGynecol87:593?595
	37.CummingsSR,PalermoL,BrownerW,etal.2000Monitoringosteoporosistherapywithbonedensitometry.Misleadingchangesandregressiontothemean.JAMA283:1318?1321
1204460a.pdf	49
	AlcortaDA,XiongY,PhelpsD,HannonG,BeachDandBarrettJC.(1996).Proc.Natl.Acad.Sci.USA,93,13742?13747.
	AllsoppRC,VaziriH,PattersonC,GoldsteinS,YounglaiEV,FutcherAB,GreiderCWandHarleyCB.(1992).Proc.Natl.Acad.Sci.USA,89,10114?10118.
	AllsoppRC,ChangE,Kashefi-AazamM,RogaevEI,PiatyszakMA,ShayJWandHarleyCB.(1995).Exp.CellRes.,220,194?200.
	BodnarAG,OuelletteM,FrolkisM,HoltSE,ChiuC-P,MorinGB,HarleyCB,ShayJW,LichsteinerSandWrightWE.(1998).Science,279,349?352.
	BurnsJE,BairdMC,ClarkLJ,BurnsP,EdingtonK,ChapmanC,MitchellR,RobertsonG,SoutarDandParkinsonEK.(1993).Br.J.Cancer,67,1274?1284.
	CollardoM,MedemaRH,Garcia-CaoI,DubuissonMLN,BarradasM,GlassfordJ,RivasC,BurgeringBMT,SerranoMandLamEW-F.(2000).J.Biol.Chem.,275,21960?21968.
	CristofoloVJandPignoloRJ.(1993).Physiol.Rev.,73,617?638.
	DietrichC,WallenfangK,OeschFandWieserR.(1997).Exp.CellRes.,232,72?78.
	DimriGP,LeeX,BasileG,AcostaM,ScottG,RoskelleyC,MedranoEE,LinskensM,RubeljI,Pereira-SmithO,PeacockeMandCampisiJ.(1995).Proc.Natl.Acad.Sci.USA,92,9363?9367.
	DurandB,GaoF-BandRaï¿½M.(1997).EMBOJ.,16,306?317.
	DurandB,FeroML,RobertsJMandRaï¿½MC.(1998).Curr.Biol.,8,431?440.
	GoldsteinSandSingalGP.(1974).Exp.CellRes.,88,359?364.
	HaraE,SmithR,ParryD,TaharaH,StoneSandPetersG.(1996).Mol.CellBiol.,16,859?867.
	HarleyCB.(1991).Mutat.Res.,256,271?282.
	HayflickL.(1965).Exp.CellRes.,37,614?636.
	HollidayR.(1996).BioEssays,18,3?5.
	JiangX-R,JimenezG,ChangE,FrolkisM,KuslerB,SageM,BeecheM,BodnarAG,WahlGM,TlstyTDandChiuC-P.(1999).NatureGenet.,21,111?114.
	JonesCJ,KiplingD,MorrisM,HepburnP,SkinnerJ,BounacerA,WyllieFS,IvanM,BartekJ,Wynford-ThomasandBondJA.(2000).Mol.CellBiol.,20,5690?5699.
	KamijoT,vandeKampE,ChongMJ,ZindyF,DiehlJA,SherrCJandMcKinnonPJ.(1999).CancerRes.,59,2464?2469.
	KarlsederJ,BroccoliD,DalY,HardySanddeLangeT.(1999).Science,283,1321?1324.
	KiplingDandCookeHJ.(1990).Nature,347,400?402.
	KiyonoT,FosterSA,KoopJI,McDougalJK,GallowayDAandKlingelhutzAJ.(1998).Nature,396,84?88.
	LeeHW,BlascoMA,GottliebGJ,HornerIIJW,GreiderCWandDePinhoRA.(1998).Nature,392,569?574.
	MakarovVL,HiroseYandLangmoreJP.(1997).Cell,88,657?666.
	MazarsGRandJatPS.(1997).Proc.Natl.Acad.Sci.USA,94,151?156.
	McConnellBB,StarborgM,BrookesSandPetersG.(1998).Curr.Biol.,8,351?354.
	MoralesCP,HoltSE,OuelletteM,KaurKJ,YanY,WilsonKS,WhiteMA,WrightWEandShayJW.(1999).NatureGenet.,21,115?118.
	OlovnikovAM.(1973).J.Theor.Biol.,41,181?190.
	PalmeroI,PantojaCandSerranoM.(1998).Nature,395,125?126.
	PolyakK,KatoJ-Y,SolomonMJ,SherrCJ,MassagueJ,RobertsJMandKoï¿½A.(1994).GenesDev.,8,9?22.
	RoblesSJandAdamiGR.(1998).Oncogene,16,1113?1123.
	RubeljIandVondracekZ.(1999).J.Theor.Biol.,197,425?438.
	SerranoM,LeeHW,ChinL,Cordon-CardoC,BeachDandDePinhoRA.(1996).Cell,85,27?37.
	SerranoM,LinAW,McCurrachME,BeachDandLoweSW.(1997).Cell,88,593?602.
	SchorSLandSchorAM.(1987).BioEssays,7,200?204.
	SheltonD,ChangE,WhittierPS,ChoiDandFunkWD.(1999).Curr.Biol.,9,939?945.
	SitteN,SaretzkiGandvonZglinickiT.(1998).FreeRad.Biol.Med.,24,885?893.
	SmithJRandWhitneyRG.(1980).Science,207,82?84.
	vanSteenselB,SmogorzewskaAanddeLangeT.(1998).Cell,92,401?413.
	SteinGHandDulicV.(1995).BioEssays,17,537?543.
	StottFJ,BatesS,JamesMJ,McConnellBB,StarborgM,BrookesS,PalmeroI,RyanK,HaraE,VousdenKandPetersG.(1998).EMBOJ.,17,5001?5014.
	TakuwaNandTakuwaY.(1997).Mol.CellBiol.,17,5348?5358.
	TresiniM,Mawal-DewanM,CristofoloVJandSellC.(1998).CancerRes.,58,1?4.
	VaziriHandBenchimolS.(1998).Curr.Biol.,8,279?282.
	VaziriH,WestMD,AllsoppRC,DavisonTS,WuY-S,ArrowsmithCH,PoirierGGandBenchimolS.(1997).EMBOJ.,16,6018?6033.
	WongHandRiabowolK.(1996).Exp.Geront.,31,311?325.
	WrightWE,BrasiskyteD,PiatyszekMAandShayJW.(1996).EMBOJ.,15,1734?1741.
	vonZglinickiT,SaretzkiG,DockeWandLotzeC.(1995).Exp.CellRes.,220,186?193.
	ZindyF,QuelleDE,RousselMFandSherrCJ.(1997).Oncogene,15,203?211.
1204445a.pdf	51
	AhmedFEandSetlowRB.(1977).CancerRes.,37,3414?3419.
	BalajeeAS,MayAandBohrVA.(1998).MutationRes.,404,3?11.
	BarrattRA,KaoG,McKennaWG,JuangJandMuschelRJ.(1998).CancerRes.,58,2639?2645.
	BeethamKLandTolmachLJ.(1982).J.Cell.Physiol.,113,385?397.
	BeiskerW,HittelmanWN.(1988).Exp.Cell.Res.,174,156?167.
	BiadeS,StobbeCCandChapmanJD.(1997).Radiat.Res.,147,416?421.
	CohnSMandLiebermanMW.(1984).J.Biol.Chem.,259,12463?12469.
	DolbeareF,GratznerH,PallaviciniMGandGrayJW.(1983).PNAS,80,5573?5577.
	FeatherstoneCandJacksonSP.(1999).Curr.Biol.,9,R759?R761.
	FoxMH,Arndt-JovinDJ,JovinTM,BaumannPH,Robert-NicouldM.(1991).J.Cell.Sci.,99,247?253.
	GowenLC,AvrutskayaAV,LatourAM,KollerBH,LeadonSA.(1998).Science,281,1009?1012.
	HaafT,RaderschallE,ReddyG,WardDC,RaddingCMandGolubEI.(1999).J.Cell.Biol.,144,11?20.
	HartwellLHandKastanMB.(1994).Science,266,1821?1828.
	HoyCA,CarswellCandSchimkeRT.(1993).Mutat.Res.,290,217?230.
	JacquetP,deSaint-GeorgesL,BarrioS,Baugnet-MahieuL.(1995).Int.J.Radiat.Biol.,67,347.
	JinP,HardySandMorganD.(1998).J.Cell.Biol.,141,875?885.
	JuanG,LiXandDarzynkiewiczZ.(1997).CancerRes.,57,803?807.
	JungTandStreï¿½erC.(1992).Int.J.Radiat.Biol.,62,161?168.
	KalleWHJ,Haekamp-vanDokkumAM,LohmanPHM,NataranjanAT,vanZeelandAAandMullendersLHF.(1993).Anal.Biochem.,208,228?236.
	KaoG,McKennaWG,MaityA,BlankK,MuschelRJ.(1997).CancerRes.,57,753?758.
	KaoGD,McKennaWGandMuschelRJ.(1999).J.Biol.Chem.,274,34779?34784.
	KaufmannWK,KiesPE.(1998).Mutat.Res.,400,153?167.
	KillIR,BridggerJM,CampbellKHS,Maldonado-CodinaGandHutchinsonCJ.(1991).J.CellSci.,100,869?876.
	LauCCandPardeeAB.(1982).PNASUSA,79,2942?2946.
	LiJ,MeyerAandDonoghueD.(1997).PNASUSA,94,502?507.
	LiaoH,WinkfeinRJ,MackG,RattnerJBandYenTJ.(1995).J.CellBiol.,130,507?518.
	LockRB.(1992).CancerRes.,52,1817?1822.
	MaityA,McKennaWGandMuschelRJ.(1995).EMBOJ.,14,603?609.
	MurnaneJP.(1995).CancerandMetastasisReviews,14,17?29
	NagasawaH,KengP,HarleyR,DahlbergWandLittleJB.(1994).Int.J.Radiat.Biol.,66,373?379.
	NakayasuHandBerezneyR.(1989).J.Cell.Biol.,108,1?
	NishiiK,KabarowskiJH,GibbonsDL,Griï¿½thsSD,TitleyI,WiedemannLMandGreavesMF.(1996).Oncogene,13,2225?2234.
	O?ConnorPM,FerrisDK,PaganoM,DraettaG,PinesJ,HunterT,LongoDLandKohnKW.(1993).J.Biol.Chem.,268,8298?8308.
	OhtsuboM,TheodorasAM,SchumacherJ,RobertsJMandPaganoM.(1995).Mol.Cell.Biol.,15,2612?2624.
	O?KeefeRT,HendersonSCandSpectorDL.(1992).J.Cell.Biol.,116,1095?1110.
	PaullTT,RogakouEP,YamazakiV,KirchgessnerCU,GellertMandBonnerWM.(2000).Curr.Biol.,10,886?895.
	PinesJandHunterT.(1994).EMBOJ.,13,3772?3781.
	RicholdMandArlettCF.(1972).Int.J.Radiat.Biol.Relat.Stud.Phys.Chem.Med.,21,127?136.
	RieberMSandRieberM.(1997).DNACellBiol.,16,121?125.
	ScullyR,ChenJ,OchsRL,KeeganK,HoekstraMandFeunteunJ.(1997).Cell.,90,425?435.
	SeldenJR,DolbeareF,ClairJH,NicholsWW,MillerJE,KleemeyerKM,HylandRJandDeLucaJG.(1993).Cytometry,14,154?167.
	SherwoodS,RushD,KungAandSchimkeR.(1994).Exp.CellRes.,211,275?281.
	StefaniniM,ReuserAandBootsmaD.(1982).SomaticCellGenet.,8,635?642.
	TakataM,SasakiMS,SonodaE,MorrisonC,HashimotoM,UtsumiH,Yamaguchi-IwaiY,ShinoharaAandTakedaS.(1998).EMBOJ.,17,5497?5508.
	TsaoY-P,D?ArpaPandLiuL.(1992).CancerRes.,52,1823?1829.
	VanDierendonckJH,KeyzerR,vandeVeldeCJHandCornelissseCJ.(1989).Cytometry,10,143?150.
	VijgJ,MullaartE,vanderSchansGP,LohmanPHandKnookDL.(1984).Mutat.Res.,132,129?138.
	WangXQandEllemKA.(1994).Exp.Cell.Res.,212,176?189.
	WangY,CortezD,YazdiP,Neï¿½N,ElledgeSJandQinJ.(2000).GenesDev.,14,927?939.
	ZelleB,BerendsFandLohmanPH.(1980).Mutat.Res.,73,157?169.
	ZhongQ,ChenCENP-F,LiS,ChenY,WangCC,XiaoJ,ChenPL,SharpZDandLeeWH.(1999).Science,285,747?750.
1204462a.pdf	50
	AlbertiL,BorrelloMG,GhizzoniS,TorritiF,RizzettiMGandPierottiMA.(1998).Oncogene,17,1079?1087.
	ArighiE,AlbertiL,TorritiF,GhizzoniS,RizzettiMG,PelicciG,PasiniB,BongarzoneI,PiuttiC,PierottiMAandBorrelloMG.(1997).Oncogene,14,773?782.
	AsaiN,MurakamiH,IwashitaTandTakahashiM.(1996).J.Biol.Chem.,271,17644?17649.
	BessetV,ScottRPandIbanezCF.(2000).J.Biol.Chem.,275,39159-39166.
	BongarzoneI,MonziniN,BorrelloMG,CarcanoC,FerraresiG,ArighiE,MondelliniP,DellaPortaGandPierottiMA.(1993).Mol.Cell.Biol.,13,358?366.
	BongarzoneI,PierottiMA,MonziniN,MondelliniP,ManentiG,DonghiR,PilottiS,GriecoM,SantoroM,FuscoA,VecchioGandDellaPortaG.(1989).Oncogene,4,1457?1462.
	BordeauxMC,ForcetC,GrangerL,CorsetV,BidaudC,BillaudM,BredesenDE,EderyPandMehlenP.(2000).EMBOJ.,19,4056?4063.
	BorrelloMG,PelicciG,ArighiE,DeFilippisL,GrecoA,BongarzoneI,RizzettiMG,PelicciPGandPierottiMA.(1994).Oncogene,9,1661?1668.
	BorrelloMG,AlbertiL,ArighiE,BongarzoneI,BattistiniC,BardelliA,PasiniB,PiuttiC,RizzettiMG,MondelliniP,RadiceMTandPierottiMA.(1996).Mol.Cell.Biol.,16,2151?2163.
	CreedonDJ,TanseyMG,BalohRH,OsbornePA,LampePA,FahrnerTJ,HeuckerothRO,MilbrandtJandJohnsonJrEM.(1997).Proc.Natl.Acad.Sci.USA,94,7018?7023.
	DurbecP,Marcos-GutierrezCV,KilKennyC,GrigoriouM,WartiowaaraK,SuvantoP,SmithD,PonderB,CostantiniF,SaarmaM,SariolaHandPachnisV.(1996).Nature,381,789?793.
	DurickK,YaoVJ,BorrelloMG,BongarzoneI,PierottiMAandTaylorSS.(1995).J.Biol.Chem.,270,24642?24645.
	DurickK,WuRY,GillGNandTaylorSS.(1996).J.Biol.Chem.,271,12691?12694.
	DurickK,GillGNandTaylorSS.(1998).Mol.Cell.Biol.,18,2298?2308.
	FambroughD,McClureK,KazlauskasAandLanderES.(1999).Cell,97,727?741.
	FischerAH,BondJA,TaysavangP,BattlesOEandWynford-ThomasD.(1998).Am.J.Pathol.,153,1443?1450.
	FixmanED,NaujokasMA,RodriguesGA,MoranMFandParkM.(1995).Oncogene,10,237?249.
	GotohN,ToyodaMandShibuyaM.(1997).Mol.Cell.Biol.,17,1824?1831.
	GuoMandHayBA.(1999).Curr.Opin.Cell.Biol.,11,745?752.
	HayashiH,IchiharaM,IwashitaT,MurakamiH,ShimonoY,KawaiK,KurokawaK,MurakumoYandImaiT.(2000).Oncogene,14,4469?4475.
	HennigeAM,LammersR,ArltD,HoppnerW,StrackV,NiederfellnerG,SeifFJ,HaringHandKellererM.(2000).Mol.Cell.Endocrinol.,167,69?76.
	HillRJ,ZozulyaS,LuYL,HollenbachPW,Joyce-ShaikhB,BogenbergerJandGishizkyML.(1996).CellGrowthDiï¿½.,7,1125?1134.
	IshizakaY,OchiaiM,TahiraT,SugimuraTandNagaoM.(1989).Oncogene,4,789?794.
	KavanaughWMandWilliamsLJ.(1994).Science,266,1862?1865.
	LiuX,VegaQC,DeckerRA,PandeyA,WorbyCAandDixonJE.(1996).J.Biol.Chem.,271,5309?5312.
	LorenzoMJ,GishGD,HoughtonC,StonehouseTJ,PawsonT,PonderBAJandSmithDP.(1997).Oncogene,14,763?771.
	LowensteinEJ,DalyRJ,BatzerAG,LiW,MargolisB,LammersR,UllrichA,SkolnikEY,Bar-SagiDandSchlessingerJ.(1992).Cell,70,431?442.
	MigliaccioE,GiorgioM,MeleS,PelicciG,ReboldiP,PandolfiPP,LanfranconeLandPelicciPG.(1999).Nature,402,309?313.
	MilbrandtJ,deSauvageFJ,FahrnerTJ,BalohRH,LeitnerML,TanseyMG,LampePA,HeuckerothRO,KotzbauerPT,SimburgerKS,GoldenJP,DaviesJA,VejsadaR,KatoAC,HynesM,ShermanD,NishimuraM,WangLC,VandlenR,Moï¿½atB,KleinRD,PoulsenK,GrayC,GarcesA,HendersonCE,PhillipsHSandJohnsonJrEM.(1998).Neuron,20,245?253.
	PandeyA,DuanH,DiFiorePPandDixitVM.(1995).J.Biol.Chem.,270,21461?21463.
	PandeyA,LiuX,DixonJE,DiFiorePPandDixitVM.(1996).J.Biol.Chem.,271,10607?10610.
	PasiniB,BorrelloMG,GrecoA,BongarzoneI,LuoY,MondelliniP,AlbertiL,MirandaC,ArighiE,BocciardiR,SeriM,BaroneV,RomeoGandPierottiMA.(1995).NatureGenet.,10,35?40.
	PasiniB,CeccheriniIandRomeoG.(1996).TrendsGenet.,12,138?144.
	PelicciG,LanfranconeL,GrignaniF,McGladeJ,CavalloF,ForniG,NicolettiI,PawsonTandPelicciPG.(1992).Cell,70,93?104.
	PelicciG,LanfranconeL,SalciniAE,RomanoA,MeleS,BorrelloMG,SegattoO,DiFiorePPandPelicciPG.(1995).Oncogene,11,899?907.
	PierottiMA,BongarzoneI,BorrelloMG,GrecoA,PilottiSandSozziG.(1996).GenesChrom.Cancer,16,1?14.
	PorterACandVaillancourtRR.(1998).Oncogene,17,1343?1352.
	SantoroM,WongWT,ArocaP,SantosE,MatoskovaB,GriecoM,FuscoAandDiFiorePP.(1994).Mol.Cell.Biol.,14,663?675.
	SchlessingerJ.(1993).TrendsBiochem.Sci.,18,273?275.
	Segouï¿½n-CariouCandBillaudM.(2000).J.Biol.Chem.,275,356?3576.
	SongyangZ,CarrawayIIIKL,EckMJ,HarrisonSC,FeldmanRA,MohammadiM,SchlessingerJ,HubbardSR,SmithDP,EngC,LorenzoMJ,PonderBAJ,MayerBJandCantleyLC.(1995).Nature,373,536?539.
	SongyangZ,ShoelsonSE,McGladeJ,OlivierP,PawsonT,BusteloXR,BarbacidM,SabeH,HanafusaHandYiT.(1994).Mol.Cell.Biol.,14,2777?2785.
	TakahashiM,BumaY,IwamotoT,InagumaY,IkedaHandHiaiH.(1988).Oncogene,3,571?578.
	TakahashiM,RitzJandCooperGM.(1985).Cell,42,581?588.
	ThomasDandBradshawRA.(1997).J.Biol.Chem.,272,22293?22299.
	TrubT,ChoiWE,WolfG,OttingerE,ChenYJ,WeissMandShoelsonSE.(1995).J.Biol.Chem.,270,18205?18208.
	TruppM,ArenasE,FainzilberM,NilssonAS,SieberBA,GrigoriouM,KilKennyC,Salazar-GruesoE,PachnisVandArumaeU.(1996).Nature,381,785?788.
	TruppM,ScottR,WhittemoreSRandIbanezCF.(1999).J.Biol.Chem.,274,20885?20894.
	ValiusM,BazenetCandKazlauskasA.(1993).Mol.Cell.Biol.,13,133?143.
	vanWeeringDHJandBosJL.(1997).J.Biol.Chem.,272,249?254.
v007p00083.pdf	13
v007p00155.pdf	24
v007p00146.pdf	19
v007p00135.pdf	38
Clin Infect Dis.-2001-Chandrasekar-546-51.pdf	25
	1.NosanchukJD,SepkowitzKA,PearseRN,etal.Infectiouscompli-cationsofautologousbonemarrowandperipheralstemcelltrans-plantationforrefractoryleukemiaandlymphoma.BoneMarrowTransplant1996;18:355?9.
	2.MossadJB,LongworthDL,GoormasticM,etal.Earlyinfectiouscom-plicationsinautologousbonemarrowtransplantation:areviewof219patients.BoneMarrowTransplant1996;18:265?71.
	3.D?AntonioD,IaconeA,PierelliL,etal.Patternsofrecoveryphaseinfectionafterautologousbloodprogenitorcelltransplantationinpa-tientswithmalignancies.TheGruppoItalianodiStudioperlaMan-ipolazioneCellulareinEmatologia.EurJClinMicrobiolInfectDis1995;14:552?6.
	4.KlumppTR,ManganKF,GoldbertSL,etal.Granulocytecolony-stim-ulatingfactoracceleratesneutrophilengraftmentfollowingperipheralbloodstemcelltransplantation:aprospective,randomizedtrial.JClinOncol1995;13:1323?7.
	5.HornedoJ,SolaC,SolanoC,etal.Multicenter,prospective,random-izedstudyoftheroleofgranulocytecolony-stimulatingfactor(G-CSF)intheposttransplantperiodfollowinghigh-dosechemotherapy(HDC),supportedwithG-CSFmobilized,peripheralbloodstemcells(PBSC),inbreastcancerpatients[abstract2980].AnnOncol1996;7(Suppl5):63.
	6.GilbertC,MeisenbergB,VredenburghJ,etal.Sequentialprophylacticoralandempiriconce-dailyparenteralantibioticsforneutropeniaandfeverafterhigh-dosechemotherapyandautologousbonemarrowsup-port.JClinOncol1994;12:1005?11.
	7.PetersWP,RossM,VredenburghJJ,etal.Theuseofintensiveclinicsupporttopermitoutpatientautologousbonemarrowtransplantationforbreastcancer.SeminOncol1994;21(Suppl7):25?31.
	8.MeisenbergB,GollardR,BrehmT,etal.Prophylacticantibioticselim-inatebacteremiaandallowsafeoutpatientmanagementfollowinghigh-dosechemotherapyandautologousstemcellrescue.SupportCareCancer1996;4:364?9.
	9.MeisenbergBR,MillerWE,McMillanR,etal.Outpatienthigh-dosechemotherapywithautologousstem-cellrescueforhematologicandnonhematologicmalignancies.JClinOncol1997;15:11?7.
	10.JagannathS,VesoleDH,ZhangM,etal.Feasibilityandcost-effec-tivenessofoutpatientautotransplantsinmultiplemyeloma.BoneMar-rowTransplant1997;20:445?50.
	11.KolbeK,DomkinD,DerigsHG,BhakdiS,HuberC,AulitzkyWE.Infectiouscomplicationsduringneutropeniasubsequenttoperipheralbloodstemcelltransplantation.BoneMarrowTransplant1997;19:143?7.
	12.KirkJL,GreenfieldRA,SleaseRB,etal.Analysisofearlyinfectiouscomplicationsafterautologousbonemarrowtransplantation.Cancer1988;62:2445?50.
	13.KettererN,EspinouseD,ChomaratM,etal.Infectionsfollowingpe-ripheralbloodprogenitorcelltransplantationforlymphoproliferativemalignancies:etiologyandpotentialriskfactors.AmJMed1999;106:191?7.
	14.BochudPY,EggimanP,CalandraT,etal.Bacteremiaduetoviridansstreptococcusinneutropenicpatientswithcancer:clinicalspectrumandriskfactors.ClinInfectDis1994;18:25?31.
	15.SalazarR,Solaï¿½C,MarotoP,etal.Infectiouscomplicationsin126patientstreatedwithhigh-dosechemotherapyandautologousperiph-InfectionsduringOutpatientTransplantation?CID2001:32(15February)?551eralbloodstemcelltransplantation.BoneMarrowTransplant1999;23:27?33.
	16.LouieTJ,BowEJ,KrulickiW,etal.Efficacyofquinolonesforthepreventionofbacteremiainneutropenicrats.RevInfectDis1989;11(Suppl5):1242?3.
	17.BowEJ,MandellLA,LouisTJ,etal.Quinolone-basedantibacterialchemoprophylaxisinneutropenicpatients:effectofaugmentedgram-positiveactivityoninfectiousmorbidity.AnnInternMed1996;125:183?90.
	18.GoodmanJL,WinstonDJ,GreenfieldRA,etal.Doesfluconazolepre-ventfungalinfectionsinpatientsundergoingbonemarrowtransplan-tation?Resultsofarandomizedcontrolledtrial.NEnglJMed1992;326:845?51.
	19.MalikIA,KhanWA,KarimM,etal.Feasibilityofoutpatientman-agementoffeverincancerpatientswithlow-riskneutropenia:resultsofaprospectiverandomizedtrial.AmJMed1995;98:224?31.
	20.TalcottJA,WhalenA,ClarkJ,etal.Homeantibiotictherapyforlow-riskcancerpatientswithfeverandneutropenia:apilotstudyof30patientsbasedonavalidatedpredictionrule.JClinOncol1994;12:107?14.
	21.RubensteinEB,RolstonK.Outpatientmanagementoffebrileepisodesinneutropeniccancerpatients.SupportCareCancer1994;2:369?73.
	22.BowEJ,RonaldAR.Antibacterialchemoprophylaxisforneutropenicpatients:wheredowegofromhere?ClinInfectDis1993;17:333?7.
	23.LeeCK,GingrichRD,HohlRJ,etal.Engraftmentsyndromeinau-tologousbonemarrowandperipheralstemcelltransplantation.BoneMarrowTransplant1995;16:175?82.
	24.RavoetC,FeremansW,HussonB,etal.Clinicalevidenceforengraft-mentsyndromeassociatedwithearlyandsteepneutrophilrecoveryafterautologousbloodstemcelltransplantation.BoneMarrowTrans-plant1996;18:943?7.
	25.VescioR,SchillerG,StewartAK,etal.MulticenterphaseIIItrialtoevaluateCD341selectedversusunselectedautologousperipheralbloodprogenitorcelltransplantationinmultiplemyeloma.Blood1999;93:1858?68.
5600987a.pdf	30
	AndreasenPA,KjollerL,ChristensenL,DuffyMJ:Theurokinase-typeplasminogenactivatorsystemincancermetastasis:areview.IntJCancer72:1ï¿½22,1997
	BlasiF:uPAuPARPAI-1:keyintersectionofproteolyticadhesiveandchemotactichighway?ImmunolToday18:415ï¿½417,1997
	BodeW,Fernandez-CatalanC,TschescheH,GramsF,NagaseH,MaskosK:Structuralpropertiesofmatrixmetalloproteinases.CellMolLifeSci55:639ï¿½652,1999
	BurgleM,KoppitzM,RiemerC,etal:Inhibitionoftheinteractionofurokinase-typeplasminogenactivator(uPA)withitsreceptor(uPAR)bysyntheticpeptides.BiolChem378:3ï¿½4,1997
	ClaasC,HerrmannK,MatzkuM,MollerP,ZollerM:Developmentallyregulatedexpressionofmetastasis-associatedantigensintherat.CellGrowthDiff7:663ï¿½678,1996
	CubellisMV,AndreasenP,RagnoP,MayerM,DanoK,BlasiF:Accessibilityofreceptor-boundurokinasetotype-1plasminogenactivatorinhibitor.ProcNatlAcadSciUSA86:4828ï¿½4832,1989
	CurranS,MurrayGI:Matrixmetalloproteinasesintumourinvasionandmetastasis.JPathol189:300ï¿½308,1999
	Farias-EisnerR,VicianL,SilverA,ReddyS,RabbaniSA,HerschmanHR:Theurokinaseplaminogenactivatorreceptor(UPAR)ispreferentiallyinducedbynervegrowthfactorinPC12pheochromoblastomacellsandisrequiredforNGF-drivendifferentiation.JNeurosci20:230ï¿½239,2000
	GhisoJA,AlonsoDF,FariasEF,GomezDE,deKier-JoffeEB:Deregulationofthesignalingpathwayscontrollingurokinaseproduction.Itsrelationshipwiththeinvasivephenotype.EurJBiochem263:295ï¿½304,1999
	KimJ,YuW,KovalskiK,OssowskiL:Requirementforspeciï¿½cproteasesincancercellintravasationasrevealedbyanovelsemiquantitativeRT-PCR-basedassay.Cell94:353ï¿½362,1998
	KitajimaY,AoyamaY,SeishimaM:Transmembranesignalingforadhesiveregulationofdesmosomesandhemidesmosomes,andforcell-celldetachmentinducedbypemphigusIgGinculturedkeratinocytes:involvementofproteinkinaseC.JInvestDermatol4:137ï¿½144,1999
	KristensenP:Localizationofcomponentsfromtheplasminogenactivationsysteminmammaliantissues.APIMS29:1ï¿½27,1992
	KwaanHC:Theplasminogen-plasminsysteminmalignancy.CancerMetastasisRev11:291ï¿½311,1992
	LiottaLA,Stetler-StevensonWG:Metalloproteinasesandcancerinvasion.SemCancerBiol1:99ï¿½106,1990
	LundLR,EllisV,RonneE,PykeC,DanoK:Transcriptionalandpost-transcriptionalregulationofthereceptorforurokinase-typeplasminogenactivatorbycytokinesandtumorpromotersinthehumanlungcarcinomacelllineA549.BiochemJ310:345ï¿½352,1995
	NagaseH:Activationmechanismsofmatrixmetalloproteinases.BiolChem378:151ï¿½160,1997
	NguyenDH,CatlingAD,WebbDJ,etal:MyosinlightchainkinasefunctionsdownstreamofRas/ERKtopromotemigrationofurokinase-type
	Ohtani H: Stromal reaction in cancer tissue: pathophysiologic signiÂ®cance of theexpressionofmatrix-degradingenzymesinrelationtomatrixturnoverandimmune/inï¿½ammatoryreactions.PatholInt48:1ï¿½9,1998
	PlesnerT,BehrendtN,PlougM:Structure,functionandexpressiononbloodandbonemarrowcellsoftheurokinase-typeplasminogenactivatorreceptor,uPAR.StemCells15:398ï¿½408,1997
	PlougM,EllisV:Structure-functionrelationshipsinthereceptorforurokinase-typeplasminogenactivator.ComparisontoothermembersoftheLy-6familyandsnakevenomalpha-neurotoxins.FEBSLett349:163ï¿½168,1994
	PlougM,RonneE,BehrendtN,JensenAL,BlasiF,DanoK:Cellularreceptorforurokinaseplasminogenactivator.Carboxylterminalprocessingandmembraneanchoringbyglycosylphosphatidylinositol.JBiolChem266:1926ï¿½1933,1991
	PriceJT,BonovichMT,KohnEC:Thebiochemistryofcancerdissemination.CritRevBiochemMolBiol32:175ï¿½253,1997
	ReuningU,MagdolenV,WilhelmO,FischerK,LutzV,GraeffH,SchmittM:Multifunctionalpotentialoftheplasminogenactivationsystemintumorinvasionandmetastasis.IntJOncol13:893ï¿½906,1998
	selM,ClaasC,HerlevsenM,SeiterS,ZollerM:Identiï¿½cationofanewphosphatidyl-inositolanchoredmemberofthefamilyofplasminogenactivatorsasmetastasis-associatedmolecule.Oncogene17:1989ï¿½2002,1998
	ShettyS,IdellS:AurokinasereceptormRNAbindingproteinï¿½mRNAinteractionregulatesreceptorexpressionandfunctioninhumanpleuralmesotheliomacells.ArchBiochemBiophys356:265ï¿½279,1998
	TaniguchiT,KakkarAK,TuddenhamEG,WilliamsonRC,LemoineNR:EnhancedexpressionoftheurokinasereceptorinducedthroughthetissuefactorVIIapathwayinhumanpancreaticcancer.CancerRes58:4461ï¿½4467,1998
	WangGJ,CollingeM,BlasiF,PradiR,BenderJR:PosttranscriptionalregulationofurokinaseplasminogenactivatorreceptormessengerRNAlevelsbyleukocyteintegrinengagement.ProcNatlAcadSciUSA95:6296ï¿½6301,1998
	WieY,YangX,LiuQ,WilkinsJA,ChapmanHA:Aroleforcaveolinandtheurokinasereceptorinintegrin-mediatedadhesionandsignaling.JCellBiol144:1285ï¿½1294,1999
	rfelJ,SelterS,StassarMetal:Cloningofthehumanhomologueofthemetastasis-associatedratC4.4Amolecule.Gene,inpress
	YuAE,HewittRE,ConnorEW,Stetler-StevensonWG:Matrixmetalloproteinases.Noveltargetsfordirectedcancertherapy.DrugsAging11:229ï¿½244,1997
5600968a.pdf	87
	AllavenaP,PiemontiL,LongoniD,BernasconiS,StoppacciaroA,RucoL,MantovaniA:IL-10preventsthedifferentiationofmonocytestodendriticcellsbutpromotestheirmaturationtomacrophages.EurJImmunol28:359ï¿½369,1998
	AltmeyerP,MatthesU,PawlakF,etal:Antipsoriaticeffectoffumaricacidderivatives.Resultsofamulticenterdouble-blindstudyin100patients.JAmAcadDermatol30:977ï¿½981,1994
	AsadullahK,SchmidH,FriedrichM,RandowF,VolkHD,SterryW,DockeW-D:Inï¿½uenceofmonomethylfumarateonmonocyticcytokineformationï¿½explanationforadverseandtherapeuticeffectsinpsoriasis?ArchDermatolRes189:623ï¿½630,1997
	AsadullahK,SterryW,StephanekK,etal:IL-10isakeycytokineinpsoriasis.ProofofprinciplebyIL-10therapy:anewtherapeuticapproach.JClinInvest101:783ï¿½794,1998
	Barratt-BoyesSM,KaoH,FinnOJ:Chimpanzeedendriticcellsderivedinvitrofrombloodmonocytesandpulsedwithantigenelicitspeciï¿½cimmuneresponsesinvivo.JImmunother21:142ï¿½148,1998
	DeJongP,BezemerAC,ZomerdijkTPL,VandePouw-KraanT,OttenhoffTHM,NibberingPH:SelectivestimulationofThelper2cytokineresponsesbytheanti-psoriasisagentmonomethylfumarate.EurJImmunol26:2067ï¿½2074,1996
	DrakesmithH,ChainB,BeverleyP:Howcandendriticcellscauseautoimmunedisease?ImmunolToday21:214ï¿½217,2000
	GenestierL,PaillotR,FournelS,FerraroC,MiossecP,RevillardJP:Immunosuppressivepropertiesofmethotrexate:apoptosisandclonaldeletionofactivatedperipheralTcells.JClinInvest102:322ï¿½328,1998
	GrewalIS,FlavellRA:CD40andCD154incell-mediatedimmunity.AnnuRevImmunol16:111ï¿½135,1998
	KalinskiP,HilkensCMU,WierengaEA,KapsenbergML:T-cellprimingbytype-1andtype-2polarizeddendriticcells:theconceptofathirdsignal.ImmunolToday20:561ï¿½567,1999
	vanKootenC,BanchereauJ:CD40ï¿½CD40ligand.JLeukocBiol67:2ï¿½17,2000
	LooDT,RillemaJR:Measurementofcelldeath.MethodsCellBiol57:251ï¿½264,1998
	MrowietzU,ChristophersE,AltmeyerP:Treatmentofseverepsoriasiswithfumaricacidesters:scientiï¿½cbackgroundandguidelinesfortherapeuticuse.BrJDermatol141:424ï¿½429,1999
	MullerWA,RandolphGJ:Migrationofleukocytesacrossendotheliumandbeyond:moleculesinvolvedinthetransmigrationandfateofmonocytes.JLeukocBiol66:698ï¿½704,1999
	NestleFO,ZhengXG,ThompsonCB,TurkaLA,NickoloffBJ:Characterizationofdermaldendriticcellsobtainedfromnormalhumanskinrevealsphenotypicandfunctionallydistinctivesubsets.JImmunol151:6535ï¿½6545,1993
	NestleFO,TurkaLA,NickoloffBJ:Characterizationofdermaldendriticcellsinpsoriasis.AutostimulationofTlymphocytesandinductionofTh1typecytokines.JClinInvest94:202ï¿½209,1994
	OckenfelsHM,SchultewolterT,OckenfelsG,FunkR,GoosM:TheantipsoriaticagentdimethylfumarateimmunomodulatesT-cellcytokinesecretionandinhibitscytokinesofthepsoriaticcytokinenetwork.BrJDermatol139:390ï¿½395,1998
	OzawaM,FerencziK,KikuchiT,etal:312-nanometerultravioletBlight(narrow-bandUVB)inducesapoptosisofTcellswithinpsoriaticlesions.JExpMed189:711ï¿½718,1999
	PennaG,AdoriniL:1Alpha,25-dihydroxyvitaminD3inhibitsdifferentiation,maturation,activation,andsurvivalofdendriticcellsleadingtoimpairedalloreactiveTcellactivation.JImmunol164:2405ï¿½2411,2000
	PetresJ,KalkhoffKW,BaronD,GeigerR,KunickI:DerEinï¿½uvonFumarsauremonoethylesteraufdieNukleinsaure-undProteinsynthesePHA-stimuliertermenschlicherLymphozyten.ArchDermatolRes251:295ï¿½300,1975
	PiemontiL,MontiP,SironiM,FraticelliP,LeoneBE,DalCinE,DiAllavenaPCV:VitaminD3affectsdifferentiation,maturation,andfunctionofhumanmonocyte-deriveddendriticcells.JImmunol164:4443ï¿½4451,2000
	ReichK,BruckM,GrafeA,VenteC,NeumannC,GarbeC:Treatmentofpsoriasiswithinterleukin-10.JInvestDermatol111:1235ï¿½1236,1998
	SallustoF,LanzavecchiaA:Efï¿½cientpresentationofsolubleantigenbyculturedhumandendriticcellsismaintainedbygranulocyte/macrophagecolony-stimulatingfactorplusinterleukin4anddownregulatedbytumornecrosisfactoralpha.JExpMed179:1109ï¿½1118,1994
	SchweckendiekW:HeilungvonPsoriasis.MedMonatschr13:103ï¿½104,1959
	SebokB,BonnekohB,GeiselJ,MahrleG:Antiproliferativeandcytotoxicproï¿½lesofantipsoriaticfumaricacidderivativesinkeratinocytecultures.EurJPharmacol270:79ï¿½87,1994
	SebokB,MahrleG,GollnickH,BonnekohB:DimethylfumaratistunterdenFumadermq-InhaltsstoffenderstarksteInduktorvonApoptose-Phainlympho-histiozytarenU-937-Zellen.ZHautkr75:1ï¿½5,2000
	ValdimarssonH,SigmundsdottirH,JonsdottirI:IspsoriasisinducedbystreptococcalsuperantigensandmaintainedbyM-protein-speciï¿½cTcellsthatcross-reactwithkeratin?ClinExpImmunol107(Suppl.1):21ï¿½24,1997
	ZhangC,AoZ,SethA,SchlossmanSF:Amitochondrialmembraneproteindeï¿½nedbyanovelmonoclonalantibodyispreferentiallydetectedinapoptoticcells.JImmunol157:3980ï¿½3987,1996
j.1432-1327.2001.01954.x.pdf	147
	1.Ozawa,E.,Imamura,M.,Noguchi,S.&Yoshida,M.(2000)Dystrophinopathyandsarcoglycanopathy.NeuroscienceNews3,13ï¿½19.
	2.Ervasti,J.M.,Ohlendieck,K.,Kahl,S.D.,Gaver,M.G.&Campbell,K.P.(1990)Deficiencyofaglycoproteincomponentofthedystrophincomplexindystrophicmuscle.Nature345,315ï¿½319.
	3.Yoshida,M.&Ozawa,E.(1990)Glycoproteincomplexanchoringdystrophintosarcolemma.J.Biochem.108,748ï¿½752.
	4.Yoshida,M.,Noguchi,S.,Wakabayashi,E.,Piluso,G.,Belsito,A.,Nigro,V.&Ozawa,E.(1997)Thefourthcomponentofthesarcoglycancomplex.FEBSLett.403,143ï¿½148.
	5.Roberds,S.L.,Leturcq,F.,Allamand,V.,Piccolo,F.,Jeanpierr,M.,Anderson,R.D.,Lim,L.E.,Lee,J.C.,Tome,F.M.S.,Romero,N.B.,Fardeau,M.,Beckmann,J.S.,Kaplan,J.-C.&Campbell,K.P.(1994)Missensemutationsintheadhalingenelinkedtoautosomalrecessivemusculardystrophy.Cell78,625ï¿½633.
	6.Lim,L.E.,Duclos,F.,Broux,O.,Bourg,N.,Sunada,Y.,Allamand,V.,Meyer,J.,Richard,I.,Moomaw,C.,Slaughter,C.,Tome,F.M.S.,Fardeau,M.,Jackson,C.E.,Beckmann,J.S.&Campbell,K.P.(1995)b-Sarcoglycan:characterizationandroleinlimb-girdlemusculardystrophylinkedto4q12.Nat.Genet.11,257ï¿½265.
	7.Bonnemann,C.G.,Modi,R.,Noguchi,S.,Mizuno,Y.,Yoshida,M.,Gussoni,E.,McNally,E.M.,Duggan,D.J.,Angelini,D.,Hoffman,E.P.,Ozawa,E.&Kunkel,L.M.(1995)b-Sarcoglycan(A3b)mutationscauseautosomalrecessivemusculardystrophywithlossofthesarcoglycancomplex.Nat.Genet.11,266ï¿½273.
	8.Noguchi,S.,McNally,E.M.,Othmane,K.B.,Hagiwara,Y.,Mizuno,Y.,Yoshida,M.,Yamamoto,H.,Bonnemann,C.G.,Gussoni,E.,Denton,P.H.,Kyriakides,T.,Middleton,L.,Hentati,F.,Hamida,M.B.,Nonaka,I.,Vance,J.M.,Kunkel,L.M.&Ozawa,E.(1995)Mutationsinthedystrophin-associatedprotein-g-sarcoglycaninchromosome13musculardystrophy.Science270,819ï¿½822.
	9.Nigro,V.,Moreira,E.S.,Piluso,G.,Vainzof,M.,Belsito,A.,Politano,L.,Puca,A.A.,Passos-Bueno,M.R.&Zats,M.(1996)The5qautosomalrecessivelimb-girdlemusculardystrophy(LGMD2F)iscausedbyamutationinthed-sarcoglycangene.Nat.Genet.14,195ï¿½198.
	10.Ozawa,E.,Noguchi,S.,Mizuno,Y.,Hagiwara,Y.&Yoshida,M.(1998)Fromdystrophinopathytosarcoglycanopathy:evolutionofaconceptofmusculardystrophy.MuscleNerve21,421ï¿½438.
	11.Noguchi,S.,Wakabayashi,E.,Imamura,M.,Yoshida,M.&Ozawa,E.(2000)Formationofsarcoglycancomplexwithdifferentiationinculturedmyocytes.Eur.J.Biochem.267,640ï¿½648.
	12.Durbeej,M.&Campbell,K.P.(1999)Biochemicalcharacteriza-tionoftheepithelialdystroglycancomplex.J.Biol.Chem.274,26609ï¿½26616.
	13.Ettinger,A.J.,Feng,G.&Sanes,J.R.(1997):-Sarcoglycan,abroadlyexpressedhomologueofthegenemutatedinlimb-girdlemusculardystrophy2D.J.Biol.Chem.272,32534ï¿½32538.
	14.McNally,E.M.,Ly,C.T.&Kunkel,L.M.(1998)Humanepsilon-sarcoglycanishighlyrelatedtoalpha-sarcoglycan(adhalin),thelimbgirdlemusculardystrophy2Dgene.FEBSLett.422,27ï¿½32.
	15.Straub,V.,Ettinger,A.J.,Durbeej,M.,Venzke,D.P.,Cutshall,S.,Sanes,J.R.&Campbell,K.P.(1999):-Sarcoglycanreplacesa-sarcoglycaninsmoothmuscletoformauniquedystrophinï¿½glycaproteincomplex.J.Biol.Chem.274,27989ï¿½27996.
	16.Liu,L.A.&Engvall,E.(1999)Sarcoglycanisoformsinskeletalmuscle.J.Biol.Chem.274,38171ï¿½38176.
	17.Mizuno,Y.,Yoshida,M.,Yamamoto,H.,Hirai,S.&Ozawa,E.(1993)Distributionofdystrophinisoformsanddystrophin-associatedproteins43DAG(A3a)and50DAG(A2)invariousmonkeytissues.J.Biochem.114,936ï¿½941.
	18.Yamamoto,H.,Mizuno,Y.,Hayashi,K.,Nonaka,I.,Yoshida,M.&Ozawa,E.(1994)Expressionofdystrophin-associatedprotein35DAG(A4)and50DAG(A2)isconfinedtostriatedmuscles.J.Biochem.115,162ï¿½167.
	19.Noguchi,S.,Wakabayashi,E.,Imamura,M.,Yoshida,M.&Ozawa,E.(1999)Developmentalexpressionofsarcoglycangeneproductsinculturedmyocytes.Biochem.Biophys.Res.Commun.262,88ï¿½93.
	20.Hoffman,E.P.,Brown,R.H.Jr&Kunkel,L.M.(1987)Dystrophin:theproteinproductoftheDuchennemusculardystrophylocus.Cell51,919ï¿½928.
	21.Galvagni,F.,Lestingi,M.,Cartocci,E.&Oliviero,S.(1997)Serumresponsefactorandprotein-mediatedDNAbendingcontributetotranscriptionofthedystrophinmuscle-specificpromoter.Mol.Cell.Biol.17,1731ï¿½1743.
	22.Klamut,H.J.,Bosnoyan-Collins,L.O.,Worton,R.G.,Ray,P.N.&Davis,H.L.(1996)Identificationoftranscriptionalenhancerwithinmuscleintron1ofthehumandystrophingene.Hum.Mol.Genet.5,1599ï¿½1606.
	23.Firulli,A.B.&Olson,E.N.(1997)Modularregulationofmusclegenetranscription:amechanismformusclecelldiversity.TrendsGenet.13,364ï¿½369.
	24.Araishi,K.,Sasaoka,T.,Imamura,M.,Noguchi,S.,Hama,H.,Wakabayashi,E.,Yoshida,M.,Hori,T.&Ozawa,E.(1999)Lossofthesarcoglycancomplexandsarcospanleadstomusculardystrophyinb-sarcoglycan-deficientmice.Hum.Mol.Genet.8,1589ï¿½1598.
	25.Laemmli,U.K.(1970)CleavageofstructuralproteinsduringtheassemblyoftheheadofbacteriophageT4.Nature227,680ï¿½685.
	26.Bonnemann,C.G.,Passos-Bueno,M.R.,McNally,E.M.,Vainzof,M.,Moreira,E.D.S.,Mrie,S.K.,Pavanello,R.C.M.,Noguchi,S.,Ozawa,E.,Zatz,M.&Kunkel,L.M.(1996)Genomicscreeningforb-sarcoglycangenemutations:missensemutationsmaycauseseverelimg-girdlemusculardystrophytype2E(LGMD2E).Hum.Mol.Genet.5,1953ï¿½1961.
	27.Sakamoto,A.,Abe,M.&Masaki,T.(1999)Delineationofgenomicdeletionincardiomyopathichamster.FEBSLett.447,124ï¿½128.
	28.Katoh,Y.,Molkentin,J.D.,Dave,V.,Olson,E.N.&Periasamy,M.(1998)MEF2Biscomponentofasmoothmuscle-specificcomplexthatbindsanA/T-richelementimportantforsmoothmusclemyosinheavychaingeneexpression.J.Biol.Chem.273,1511ï¿½1518.
	29.Apone,S.&Hauschka,S.D.(1995)MusclegeneE-boxcontrolelements.J.Biol.Chem.270,21420ï¿½21427.
	30.Liu,L.,Vachon,P.H.,Kuang,W.,Xu,H.,Wewer,U.M.,Kylsten,P.&Engvall,E.(1997)Mouseadhalin:primarystructureandexpressionduringlatestagesofmuscledifferentiationinvitro.Biochem.Biophys.Res.Commun.235,227ï¿½235.
	31.Amacher,S.L.,Buskin,J.N.&Hauschka,S.D.(1993)Multipleregulatoryelementscontributedifferentiallytomusclecreatinekinaseenhanceractivityinskeletalandcardiacmuscle.Mol.Cell.Biol.13,2753ï¿½2764.
	32.Yee,S.-P.&Rigby,W.J.(1993)Theregulationofmyogeningeneexpressionduringtheembryonicdevelopmentofthemouse.GenesDev.7,1277ï¿½1289.
	33.Cheng,T.-C.,Wallace,M.C.,Merlie,J.P.&Olson,E.N.(1993)Separableregulatoryelementsgoverningmyogenintranscriptioninmouseembyogenesis.Science261,215ï¿½218.
	34.Lassar,A.B.,Davis,R.L.,Wright,W.E.,Kadesch,T.,Murre,C.,Voronova,A.,Baltimore,E.&Weintraub,H.(1991)FunctionalactivityofmyogenicHLHproteinsrequireshetero-oligomerizationwithE12/E47-likeproteinsinvivo.Cell66,305ï¿½315.
	35.Molkentin,J.D.,Li,L.&Olson,E.N.(1996)Combinatorialcontrolofmuscledevelopmentbybasichelix-loop-helixandMADS-boxtranscriptionfactors.J.Biol.Chem.271,17199ï¿½17204.
	36.Cserjesi,P.&Olson,E.N.(1991)Myogenininducesthemyocyte-specificenhancerbindingfactorMEF-2independentlyofothermuscle-specificgeneproducts.Mol.Cell.Biol.11,4854ï¿½4862.
	37.Sakamoto,A.,Ono,K.,Abe,M.,Jasmin,G.,Eki,T.,Murakami,Y.,Masaki,T.,Toyo-oka,T.&Hanaoka,F.(1997)Bothhypertrophicanddilatedcardiomyopathiesarecausedbymutationofthesamegene,delta-sarcoglycan,inhamster:ananimalmodelofdisrupteddystrophin-associatedglycoproteincomplex.Proc.NatlAcad.Sci.USA94,13873ï¿½13878.
	38.Duggan,D.J.,Gorospe,J.R.,Fanin,M.,Hoffman,E.P.&Angelini,C.(1997)Mutationsinthesarcoglycangenesinpatientswithmyopathy.N.Engl.J.Med.336,618ï¿½624.qFEBS2001Transcriptionalenhancersing-sarcoglycangene(Eur.J.Biochem.268)957
Mol Pharmacol-2001-Wade-532-42.pdf	40
	BarkerEL,WestphalRS,SchmidtDandSanders-BushE(1994)Constitutivelyactive5-hydroxytryptamine2Creceptorsrevealnovelinverseagonistactivityofreceptorligands.JBiolChem269:11687?11690.
	BergKA,StoutBD,CropperJD,MaayaniSandClarkeWP(1999)Novelactionsofinverseagonistson5-HT2Creceptorsystems.MolPharmacol55:863?872.
	BondRA,LeffP,JohnsonTD,MilanoCA,RockmanHA,McMinnTR,Appar-sundaramS,HyekMF,KenakinTP,AllenLFandLefkowitzRJ(1995)Physio-logicaleffectsofinverseagonistsintransgenicmicewithmyocardialoverexpres-sionoftheb2-adrenoceptor.Nature(Lond)374:272?276.
	BradfordMM(1976)Arapidandsensitivemethodforthequantitationofmicrogramquantitiesofproteinutilizingtheprincipleofprotein-dyebinding.AnalBiochem72:248?254.
	BrinkCB,WadeSMandNeubigRR(2000)Agonist-directedtraffickingofporcinea2A-adrenergicreceptorsignalinginCHOcells.l-Isoproterenolselectivelyacti-vatesGs.JPharmacolExpTher294:539?547.
	CaylaC,SchaakS,RoquelaineC,GalesC,QuinchonFandParisH(1999)Homol-ogousregulationofthea2C-adrenoceptorsubtypeinhumanhepatocarcinoma,HepG2.BrJPharmacol126:69?78.
	ChenG,WayJ,ArmourS,WatsonC,QueenK,JayawickremeCK,ChenWJandKenakinT(2000)UseofconstitutiveGprotein-coupledreceptoractivityfordrugdiscovery.MolPharmacol57:125?134.
	ChengYandPrusoffWH(1973)Relationshipbetweentheinhibitionconstant(Ki)andtheconcentrationofinhibitorwhichcauses50percentinhibition(IC50)ofanenzymaticreaction.BiochemPharmacol22:3099?3108.
	ChidiacP,HebertTE,ValiquetteM,DennisMandBouvierM(1994)Inverseagonistactivityofb-adrenergicantagonists.MolPharmacol45:490?499.
	ConventsA,DeKeyserJ,DeBackerJ-PandVauquelinG(1989)[3H]Rauwolscinelabelsa2-adrenoceptorsand5-HT1Areceptorsinhumancerebralcortex.EurJPharmacol159:307?310.
	CostaTandHerzA(1989)AntagonistswithnegativeintrinsicactivityatdeltaopioidreceptorscoupledtoGTP-bindingproteins.ProcNatlAcadSciUSA86:7321?7325.
	CostaT,LangJ,GlessCandHerzA(1990)SpontaneousassociationbetweenopioidreceptorsandGTP-bindingregulatoryproteinsinnativemembranes:Specificregulationbyantagonistsandsodiumions.MolPharmacol37:383?394.
	DauntDA,HurtC,HeinL,KallioJ,FengFandKobilkaBK(1997)Subtype-specificintracellulartraffickingofa2-adrenergicreceptors.MolPharmacol51:711?720.
	EasonMG,KuroseH,HoltBD,RaymondJRandLiggettSB(1992)Simultaneouscouplingofa2-adrenergicreceptorstotwoG-proteinswithopposingeffects.Sub-type-selectivecouplingofa2C10,a2C4,anda2C2adrenergicreceptorstoGiandGs.JBiolChem267:15795?15801.
	ErnsbergerPandHaxhiuMA(1997)TheI1-imidazoline-bindingsiteisafunctionalreceptormediatingvasodepressionviatheventralmedulla.AmJPhysiol273:R1572?R1579.
	GerhardtMA(1992)Couplingofthea2A-AdrenergicReceptortotheG-ProteinsGi2andGi3.Ph.D.Thesis,UniversityofMichigan,AnnArbor,MI.
	HeinL,LimbirdLE,EglenRMandKobilkaBK(1999)Genesubstitution/knockouttodelineatetheroleofa2-adrenoceptorsubtypesinmediatingcentraleffectsofcatecholaminesandimidazolines.AnnNYAcadSci881:265?271.
	KenakinT(1995)Agonist-receptorefficacy.II.Agonisttraffickingofreceptorsig-nals.TrendsPharmacolSc16:232?238.
	KjelsbergMA,CotecchiaS,OstrowskiJ,CaronMGandLefkowitzRJ(1992)Con-stitutiveactivationofthea1B-adrenergicreceptorbyallaminoacidsubstitutionsatasinglesite.Evidenceforaregionwhichconstrainsreceptoractivation.JBiolChem267:1430?1433.
	LimbirdLE,SpeckJLandSmithSK(1982)Sodiumionmodulatesagonistandantagonistinteractionswiththehumanplateleta2-adrenergicreceptorinmem-braneandsolubilizedpreparations.MolPharmacol21:609?617.
	MacMillanLB,HeinL,SmithMS,PiascikMTandLimbirdLE(1996)Centralhypotensiveeffectsofthea2a-adrenergicreceptorsubtype.Science(WashDC)273:801?805.
	MeanaJJ,Herrera-MarschitzM,GoinyMandSilveiraR(1997)Modulationofcatecholaminereleasebya2-adrenoceptorsandI1-imidazolinereceptorsinratbrain.BrainRes744:216?226.
	NagarajaS,IyerS,LiuX,EichbergJandBondRA(1999)Treatmentwithinverseagonistsenhancesbaselineatrialcontractilityintransgenicmicewithchronicb2-adrenoceptoractivation.BrJPharmacol127:1099?1104.
	NeubigRR,GantzosRDandBrasierRS(1985)Agonistandantagonistbindingtoa2-adrenergicreceptorsinpurifiedmembranesfromhumanplatelets:Implica-tionsofreceptor-inhibitorynucleotidebindingproteinstoichiometry.MolPhar-macol28:475?486.
	NeubigRR,GantzosRDandThomsenWJ(1988)Mechanismofagonistandantag-onistbindingtoa2adrenergicreceptors:Evidenceforaprecoupledreceptor-guaninenucleotideproteincomplex.Biochemistry27:2374?2384.
	NeusyAJandLowensteinJ(1989)Bloodpressureandbloodpressurevariabilityfollowingwithdrawalofpropranololandclonidine.JClinPharmacol29:18?24.
	ParmaJ,DuprezL,VanSandeJ,CochauxP,GervyC,MockelJ,DumontJandVassartG(1993)Somaticmutationsinthethyrotropinreceptorgenecausehy-perfunctioningthyroidadenomas.Nature(Lond)365:649?651.
	PauwelsPJandWurchT(1998)Review:Aminoaciddomainsinvolvedinconstitu-tiveactivationofG-protein-coupledreceptors.MolNeurobiol17:109?135.
	PerezDM,HwaJ,GaivinR,MathurM,BrownFandGrahamRM(1996)Consti-tutiveactivationofasingleeffectorpathway:EvidenceformultipleactivationstatesofaGprotein-coupledreceptor.MolPharmacol49:112?122.
	RaoVR,CohenGBandOprianDD(1994)RhodopsinmutationG90Dandamolec-ularmechanismforcongenitalnightblindness.Nature(Lond)367:639?642.
	RenQ,KuroseH,LefkowitzRJandCotecchiaS(1993)Constitutivelyactivemutantsofthea2-adrenergicreceptor.JBiolChem268:16483?16487.
	SalomonY,LondosCandRodbellM(1974)Ahighlysensitiveadenylatecyclaseassay.AnalBiochem58:541?548.
	SamamaP,CotecchiaS,CostaTandLefkowitzRJ(1993)Amutation-inducedactivatedstateoftheb2-adrenergicreceptor.Extendingtheternarycomplexmodel.JBiolChem268:4625?4636.
	SamamaP,PeiG,CostaT,CotecchiaSandLefkowitzRJ(1994)Negativeantago-nistspromoteaninactiveconformationoftheb2-adrenergicreceptor.MolPhar-macol45:390?394.
	ShenkerA,LaueL,KosugiS,Merendino,JJJr,MinegishiTandCutler,GBJr(1993)Aconstitutivelyactivatingmutationoftheluteinizinghormonereceptorinfamilialmaleprecociouspuberty.Nature(Lond)365:652?654.
	TianWN,DuzicE,LanierSMandDethRC(1994)Determinantsofa2-adrenergicreceptoractivationofGproteins:Evidenceforaprecoupledreceptor/Gproteinstate.MolPharmacol45:524?531.
	WadeSM,LimWK,LanKL,ChungD,NanamoriMandNeubigRR(1999)Giactivatorregionofa2Aadrenergicreceptors:DistinctbasicresiduesmediateGivsGsactivation.MolPharmacol56:1005?1013.
	WeissJM,MorganPH,LutzMWandKenakinTP(1996)Thecubicternarycomplexreceptor-occupancymodel.III.Resurrectingefficacy.JTheorBiol181:381?397.
	WreggettKAandDeLeanA(1984)Theternarycomplexmodel:ItspropertiesandapplicationtoligandinteractionswiththeD2-dopaminereceptoroftheanteriorpituitarygland.MolPharmacol26:214?227.
	WurchT,ColpaertFCandPauwelsPJ(1999)G-proteinactivationbyputativeantagonistsatmutantThr373Lysa2Aadrenergicreceptors.BrJPharmacol126:939?948.
Mol Pharmacol-2001-Kanatani-501-5.pdf	32
	BlomqvistAGandHerzogH(1997)Y-receptorsubtypes?howmanymore?TrendsNeurolSci20:294?298.
	ClarkJT,KalraPS,CrowleyWRandKalraSP(1984)NeuropeptideYandhumanpancreaticpolypeptidestimulatefeedingbehaviorinrats.Endocrinology115:427?429.
	DanielsAJ,MatthewsJE,SlepetisRJ,JansenM,ViverosOH,TadepalliA,Har-ringtonW,HeyerD,LandavazoA,LebanJJandSpaltensteinA(1995)High-affinityneuropeptideYreceptorantagonists.ProcNatlAcadSciUSA92:9067?9071.
	DrydenS,PickavanceL,FrankishHMandWilliamsG(1995)Increasedneuropep-tideYsecretioninthehypothalamicparaventricularnucleusofobese(fa/fa)Zuckerrats.BrainRes690:185?188.
	EricksonJC,HollopeterGandPalmiterRD(1996)Attenuationoftheobesitysyndromeofob/obmicebythelossofneuropeptideY.Science(WashDC)274:1704?1707.
	GeraldC,WalkerMW,CriscioneL,GustafsonEL,Batzl-HartmannC,SmithKE,VaysseP,DurkinMM,LazTM,LinemeyerDL,SchaffhauserAO,WhitebreadS,HofbauerKG,TaberRI,BranchekTAandWeinshankRL(1996)Areceptorsubtypeinvolvedinneuropeptide-Y-inducedfoodintake.Nature(Lond)382:168?171.
	GrynkiewiczG,PoeniMandTsienRY(1985)AnewgenerationofCa21indicatorswithgreatlyimprovedfluorescenceproperties.JBiolChem260:3440?3450.
	GuanX-M,YuHandVanderPloegLHT(1998)Evidenceofalteredhypothalamicpro-opiomelanocortin/neuropeptideYmRNAexpressionintubbymice.MolBrainRes59:273?279.
	HipskindPA,LobbKL,NixonJA,BrittonTC,BrunsRF,CatlowJ,Dieckman-McGintyDK,GackenheimerSL,GitterBD,IyengarS,SchoberDA,SimmonsRMA,SwansonS,ZarrinmayehH,ZimmermanDMandGehlertDR(1997)Potentandselective1,2,3-trisubstitutedindoleNPYY-1antagonists.JMedChem40:3712?3714.
	InuiA(1999)NeuropeptideYfeedingreceptors:Aremultiplesubtypesinvolved?TrendsPharmacolSci20:43?46.
	IshiharaA,TanakaT,KanataniA,FukamiT,IharaMandFukurodaT(1998)ApotentneuropeptideYantagonist,1229U91,suppressedspontaneousfoodintakeinZuckerfattyrats.AmJPhysiol43:R1500?R1504.
	KalraSP,DubeMG,SahuA,PhelpsCPandKalraPS(1991)NeuropeptideYsecretionincreasesintheparaventricularnucleusinassociationwithincreasedappetiteforfood.ProcNatlAcadSciUSA88:10931?10935.
	KanataniA,IshiharaA,AsahiS,TanakaT,OzakiSandIharaM(1996)PotentneuropeptideYY1receptorantagonist,1229U91:BlockadeofneuropeptideY-inducedandphysiologicalfoodintake.Endocrinology137:3177?3182.
	KanataniA,IshiharaA,IwaasaH,NakamuraK,OkamotoO,HidakaM,ItoJ,FukurodaT,MacNeilDJVanderPloegLHT,IshiiY,OkabeT,FukamiTandIharaM(2000a)L-152,804orally-activeandselectiveneuropeptideYY5receptorantagonist.BiochemBiophysResCommun272:169?173.
	KanataniA,ItoJ,IshiharaA,IwaawaH,FukurodaT,FukamiT,MacNeilDJ,VanderPloegLHTandIharaM(1998)NPY-inducedfeedinginvolvestheactionofaY1-likereceptorinrodents.RegulPept75?76:409?415.
	KanataniA,KannoT,IshiharaA,HataM,SakurabaA,TanakaT,TsuchiyaY,MaseT,FukurodaT,FukamiTandIharaM(1999)ThenovelneuropeptideYY1receptorantagonistJ-104870:Apotentfeedingsuppressantwithoralbioavailabil-ity.BiochemBiophysResCommun268:88?91.
	KanataniA,MashikoS,MuraiN,SugimotoN,ItoJ,FukurodaT,FukamiT,MroinN,MacNeilDJ,VanderPloegLHT,SagaY,NishimuraSandIharaM(2000b)RoleoftheY1receptorintheregulationofneuropeptideY-mediatedfeeding:Comparisonofwild-type,Y1receptordeficient,andY5receptordeficientmice.Endocrinology141:1011?1016.
	KestersonRA,HuszarD,LynchCA,SimerlyRBandConeRD(1997)InductionofneuropeptideYgeneexpressioninthedorsalmedialhypothalamicnucleusintwomodelsoftheagoutiobesitysyndrome.MolEndocrinol11:630?637.
	MarshDJ,HollopeterG,KaferKEandPalmiterRD(1998)RoleoftheY5neuropep-tideYreceptorinfeedingandobesity.NatMed4:718?721.
	McKibbinPE,CottonSJ,McMillanS,HollowayB,MayersR,McCarthyHDandWilliamsG(1991)AlteredneuropeptideYconcentrationsinspecifichypothalamicregionsofobese(fa/fa)Zuckerrats:Possiblerelationshiptoobesityandneuroen-docrinedisturbances.Diabetes40:1423?1429.
	MullinsDE,GuzziM,XiaLandParkerEM(2000)PharmacologicalcharacterizationoftheclonedneuropeptideYy6receptor.EurJPharmacol395:87?93.
	O?SheaD,MorganDGA,MeeranK,EdwardsCMB,TurtonMD,ChoiSJ,HeathMM,GunnI,TaylorGM,HowardJK,BloomCI,SmallCJ,HaddoO,MaJJ,CallinanW,SmithDM,GhateiMAandBloomSR(1997)NeuropeptideYinducedfeedingintheratismediatedbyanovelreceptor.Endocrinology138:196?202.
	PedrazziniT,SeydouxJ,KunstnerP,AubertJF,GrouzmannE,BeermannFandBrunnerHR(1998)Cardiovascularresponse,feedingbehaviorandlocomotoractivityinmicelackingtheNPYY1receptor.NatMed4:722?726.
	SanacoraG,KershawM,FinkelsteinJAandWhiteJD(1990)Increasedhypotha-lamiccontentofpreproneuropeptideYmessengerribonucleicacidingeneticallyobeseZuckerratsanditsregulationbyfooddeprivation.Endocrinology127:730?737.
	StanleyBG,KyrkouliSE,LampertSandLeibowitzSF(1986)NeuropeptideYchronicallyinjectedintothehypothalamus:Apowerfulneurochemicalinducerofhyperphagiaandobesity.Peptides7:1189?1192.
	StanleyBGandLeibowitzSF(1984)NeuropeptideY:Stimulationoffeedinganddrinkingbyinjectionintotheparaventricularnucleus.LifeSci35:2635?2642.
	StephensTW,BasinskiM,BristowPK,Bue-ValleskeyJM,BurgettSG,CraftL,HaleJ,HoffmannJ,HsiungHM,KriauciunasA,MacKellarW,RosteckPR,SchonerB,SmithD,TinsleyFC,ZhangX-YandHeimanM(1995)TheroleofneuropeptideYintheantiobesityactionoftheobesegeneproduct.Nature(Lond)377:530?532.
	TatemotoKandMuttV(1980)Isolationoftwonovelcandidatehormonesusingachemicalmethodforfindingnaturallyoccurringpolypeptides.Nature(Lond)285:417?418.
	TatemotoK,CarlquistMandMuttV(1982)NeuropeptideY-anovelbrainpeptidewithstructuralsimilaritiestopeptideYYandpancreaticpolypeptide.Nature(Lond)296:659?660.
	WielandHA,EngelW,EberleinW,RudolfKandDoodsHN(1998)Subtypeselec-tivityofthenovelnonpeptideneuropeptideYY1receptorantagonistBIBO3304anditseffectonfeedinginrodents.BrJPharmacol125:549?555.
	WhiteJD,OlchovskyD,KershawMandBerelowitzM(1990)Increasedhypotha-lamiccontentofpreproneuropeptide-Ymessengerribonucleicacidinstreptozoto-cin-diabeticrats.Endocrinology126:765?772.
	ZarjevskiN,CusinI,VettorR,Rohner-JeanrenaudFandJeanrenaudB(1993)Chronicintracerebroventricularneuropeptide-Yadministrationtonormalratsmimicshormonalandmetabolicchangesofobesity.Endocrinology133:1753?1758.
mk000503.pdf	29
	Collas,P.(1999).SequentialPKC-,andCdc2-mediated,phosphory-lationeventselicitzebrafishnuclearenvelopedisassembly.J.CellSci.112,977?987.
	Ellenberg,J.,Siggia,E.D.,Moreira,J.E.,Smith,C.L.,Presley,J.F.,Worman,H.J.,andLippincott-Schwartz,J.(1997).Nuclearmembranedynamicsandreassemblyinlivingcells:targetingofaninnernuclearmembraneproteinininterphaseandmitosis.J.CellBiol.138,1193?1206.
	Favreau,C.,Worman,H.J.,Wozniak,R.W.,Frappier,T.,andCourvaline,J.-C.(1996).Cellcycle-dependentphosphorylationofnucleoporinsandnuclearporemembraneproteingfp210.Biochemistry35,8035?8044.
	Gallant,P.,andNigg,E.A.(1992).CyclinB2undergoescellcycle-depen-dentnucleartranslocationand,whenexpressedasanon-destructiblemutant,causesmitoticarrestinHeLacells.J.CellBiol.117,213?224.
	Gerace,L.,andBlobel,G.(1980).Thenuclearenvelopelaminaisreversiblydepolymerizedduringmitosis.Cell19,277?287.
	Heald,R.,andMcKeon,F.(1990).MutationsofphosphorylationsitesinlaminAthatpreventnuclearlaminadisassemblyinmitosis.Cell61,579?589.
	Hiramoto,Y.(1962).Microinjectionoflivespermatozoaintoseaurchineggs.Exp.CellRes.27,416?426.
	Kanatani,H.,Shirai,H.,Nakanishi,K.,andKurokawa,T.(1969).IsolationandidentificationofmeiosisinducingsubstanceinstarfishAsteriasamu-rensis.Nature221,273?274.
	Lee,K.K.,Gruenbaum,Y.,Spann,P.,Liu,J.,andWilson,K.L.(2000).C.elegansnuclearenvelopeproteinsemerin,MAN1,lamin,andnucleoporinsrevealuniquetimingofnuclearenvelopebreakdownduringmitosis.Mol.Biol.Cell11,3089?3099.Luby-Phelps,K.,Taylor,D.L.,andLanni,F.(1986).Probingthestructureofcytoplasm.J.CellBiol.,102,2015?2022.
	Macaulay,C.,Meier,E.,andForbes,D.J.(1995).Differentialmitoticphos-phorylationofproteinsofthenuclearporecomplex.J.Biol.Chem.207,254?262.
	Newport,J.,andSpann,T,1987.Disassemblyofthenucleusinmitoticcondensationareindependentprocesses.Cell48,219?230.
	Ookata,K.,Hisanaga,S.,Okano,T.,Tachibana,K.,andKishimoto,T.(1992).Relocationanddistinctsubcellularlocalizationofp34cdc2-cyclinBcomplexatmeiosisreinitiationinstarfishoocytes.EMBOJ.11,1763?1772.
	Otto,J.J.,andSchroeder,T.E.(1984).Microtubulearraysinthecortexandnearthegerminalvesicleofimmaturestarfishoocytes.Dev.Biol.101,274?281.
	Perez-Mongiovi,D.,Chang,P.,andHouliston,E.(1998).ApropagatedwaveofMPFactivationaccompaniessurfacecontractionwavesatfirstmitosisinXenopus.J.CellSci.111,385?393.
	Peter,M.,Nakagawa,J.,Doree,M.,Labbe,J.C.,andNigg,E.A.(1990).InvitrodisassemblyofthenuclearlaminaandMphase-specificphosphor-ylationoflaminsbycdc2kinase.Cell61,591?602.
	Peters,R.(1983).Nuclearenvelopepermeabilitymeasuredbyfluorescencemicrophotolysisofsinglelivercellnuclei.J.Biol.Chem.258,11427?11429.
	Peters,R.(1984).Nucleo-cytoplasmicfluxandintracellularmobilityinsinglehepatocytesmeasuredbyfluorescencemicrophotolysis.EMBOJ.3,1831?1836.
	Rolls,M.M.,Stein,P.A.,Taylor,S.S.,Ha,E.,McKeon,F.,andRapoport,T.A.(1999).AvisualscreenofaGFP-fusionlibraryidentifiesanewtypeofnuclearenvelopemembraneprotein.J.CellBiol.146,29?44.
	Rout,M.P.,Aitchison,J.D.,Suprapto,A.,Hjertaas,K.,Zhao,Y.,andChait,B.T.(2000).Theyeastnuclearporecomplex:composition,architecture,andtransportmechanism.J.CellBiol.148,635?651.
	Schaff,J.,Fink,C.C.,Slepchenko,B.,Carson,J.H.,andLoew,L.M.(1997).Ageneralcomputationalframeworkformodelingcellularstructureandfunction.Biophys.J.73,1135?1146.
	Stafstrom,J.P.,andStaehelin,L.A.(1984).Dynamicsofthenuclearenve-lopeandofnuclearporecomplexesduringmitosisintheDrosophilaembryo.Eur.J.CellBiol.34,179?189.
	Terasaki,M.,andJaffe,L.A.(1993)Imagingoftheendoplasmicreticuluminlivingmarineeggs.In:MethodsinCellBiology:CellBiologicalAppli-cationsofConfocalMicroscopy,vol.38,ed.B.Matsumoto,Orlando,FL:AcademicPress,211-220.
	Terasaki,M.(1994).Redistributionofcytoplasmiccomponentsduringgerminalvesiclebreakdowninstarfishoocytes.J.CellSci.107,1797?1805.
	Terasaki,M.,Jaffe,L.A.,Hunnicutt,G.R.,andHammerIII,J.A.(1996).Structuralchangeoftheendoplasmicreticulumduringfertilization:evi-denceforlossofmembranecontinuityusingthegreenfluorescentprotein.Dev.Biol.179,320?328.
	Terasaki,M.(2000).DynamicsoftheERandGolgiapparatusduringearlyseaurchindevelopment.Mol.Biol.Cell11,897?914.
	Ward,G.E.,andKirschner,M.W.(1990).Identificationofcellcycle-regu-latedphosphorylationsitesonnuclearlaminC.Cell61,561?577.
	Weast,R.C.(ed.)(1972).HandbookofChemistryandPhysics.Cleveland,Ohio:TheChemicalRubberCo.,F-47.
	Yang,L.,Guan,T.,andGerace,L.(1997).Integralmembraneproteinsofthenuclearenvelopearedispersedthroughouttheendoplasmicreticulumduringmitosis.J.CellBiol.137,1199?1210.
	Zaal,K.J.,Smith,C.L.,Polishchuk,R.S.,Altan,N.,Cole,N.B.,Ellenberg,J.,Hirschberg,K.,Presley,J.F.,Roberts,T.H.,Siggia,E.,Phair,R.D.,andLippincott-Schwartz,J.(1999).GolgimembranesareabsorbedintoandreemergefromtheERduringmitosis.Cell99,589?601.
tjp0531-0265.pdf	30
tjp0531-0219.pdf	53
5.pdf	28
	1.HuyseFJ:Fromconsultationtocomplexityofcarepredictionandhealthserviceneedsassessment(editorial).JPsychosomaticRes1997;43:233?240
	2.HuyseFJ,LyonsJS,StiefelFC,etal:INTERMED:amethodtoassesshealthserviceneeds:I.Developmentandreliability.GenHospPsychiatry1999;21:39?
	3.StiefelFC,deJongeP,HuyseFJ,etal:INTERMED:Amethodtoassesshealthserviceneeds:II.Resultsonitsvalidityandclinicaluse.GenHospPsychiatry1999;21:49?56
	4.StiefelFC,deJongeP,HuyseFJ,etal:INTERMED:Anassessmentandclas-sificationsystemforcasecomplexity:resultsinpatientswithlowbackpain.Spine1999;24:378?385
	5.EngelGL:Theclinicalapplicationofthebiopsychosocialmodel.AmJPsychi-atry1980;137:525?544
	6.EngelGL:Theneedforanewmedicalmodel:achallengeforbiomedicine.Science1977;196:129?136
	7.LeighH,FeinsteinAR,ReiserMF:Thepatientevaluationgrid:asystematicapproachtocomprehensivecare.GenHospPsychiatry1980;2:3?9
	8.HuyseFJ,StrainJJ,HengeveldMW,etal:Interventionsinconsultation/liaisonpsychiatry:Thedevelopmentofaschemaandachecklistforoperationalizedinterventions.GenHospPsychiatry1988;10:88?101
	9.LyonsJS,CollettaJ,DevensM,etal:ValidityoftheseverityofpsychiatricPsychosomatics42:1,January-February200113illnessratingscaleinasampleofinpatientsonapsychogeriatricunit.IntPsy-chogeriatics1995;7:407?416
	10.LyonsJS,StutsmanJ,NemeJ,etal:Predictingpsychiatricemergencyadmis-sionsandhospitaloutcome.MedicalCare1997;35:792?800
	11.EwingJA:Detectingalcoholism,theCAGEquestionnaire.JAMA1984;252:1905?1907
	12.FinkP,EwaldH,JensenJ,etal:Screeningforsomatizationandhypochondriasisinprimarycareandneurologicalin-patients:aseven-itemscaleforhypochon-driasisandsomatisation.JPsychosomaticRes1999;46:261?273
	13.FolsteinMF,FolsteinSE,McHughPR:Mini-MentalStateExamination:aprac-ticalmethodforgradingthecognitivestateofpatientsfortheclinician.JPsy-chiatricRes1975;12:189?198
	14.Frasure-SmithN,LesperanceF,TalajicM:Depressionfollowingmyocardialinfarction.Impacton6-monthsurvival.JAMA1993;270:1819?1825
	15.CurleyC,McEachernJE,SperoffT:Afirmtrialofinterdisciplinaryroundsontheinpatientmedicalwards.MedicalCare1998;36:AS4-AS12
	16.SlaetsJP,KauffmannRH,DuivenvoordeHJ,etal:Arandomizedtrialofgeriatricliaisoninterventioninelderlymedicalinpatients.PsychosomaticMedicine1997;59:585?591
	17.StrainJJ,LyonsJS,HammerJSetal:Costoffsetfromapsychiatricconsultation-liaisoninterventionwithelderlyhipfracturepatients.AmJPsychiatry1991;148:1044?1049
	18.InouyeSK,BogardusST,CharpentierPA,etal:Amulticomponentinterventiontopreventdeliriuminhospitalizedolderpatients.NewEngJMed1999;340:669?676
	19.StewartS,MarleyJE,HorowitzJD:Effectsofamultidisciplinary,home-basedinterventiononunplannedreadmissionsandsurvivalamongpatientswithchroniccongestiveheartfailure:arandomisedcontrolledstudy.TheLancet1999;354:1077?1083
	20.MazzocatoC,StiefelF,deJongeP,etal:Comprehensiveassessmentofpatientsinpalliativecare:adescriptivestudyutilizingtheINTERMED.JPainSymptomManage2000;19:83?90
	21.FischerCJ,StiefelFC,deJongeP,etal:Casecomplexityandclinicaloutcomeindiabetesmellitus:aprospectivestudyusingtheINTERMED.DiabetesMetab2000;4:295?302
	22.deJongeP,HuyseFJ,StiefelFC,etal:INTERMEDAclinicalinstrumentforbiopsychosocialassessment.Psychosomatics,inpress
	23.deJongeP,HuyseFJ,RuinemansGMF,etal:Thetimingofpsychiatriccon-sultation:Theimpactofsocialvulnerabilityandlevelofpsychiatricdysfunction.Psychosomatics2000;6:505?511
	24.GordonM:NursingDiagnosis.ProcessandApplication,editedbyGriswoldTM.3rdEdition,Mosby,St.Louis,MO,1994
	25.deJongeP,HuyseFJ,HerzogT,etal:Riskfactorsforcomplexcareneedsingeneralmedicalinpatients:resultsfromaEuropeanstudy.Acceptedforpubli-cationinPsychosomatics
	26.HuyseFJ,deJongeP,SlaetsJPJ,etal:COMPRI:aninstrumenttodetectpatientswithcomplexcareneeds:resultsfromaEuropeanstudy.Acceptedforpublica-tioninPsychosomatics
	27.deJongeP,HuyseFJ,LoboA,etal:Carecomplexityinthegeneralhospital:resultsfromaEuropeanstudy.AcceptedforpublicationinPsychosomatics
	28.deJongeP:Detectionofcomplexpatientsinthegeneralhospital.Amsterdam,ThelaThesis,1999
v077p00126.pdf	0
j.1432-1327.2001.01837.x.pdf	67
	1.Barton,N.W.,Furbish,F.S.,Murray,G.J.&Brady,R.O.(1990TherapeuticresponsetointravenousinfusionofglucocerebrosidaseinapatientwithGaucherdisease.Proc.NatlAcad.Sci.USA87,1913ï¿½1916.
	2.Stahl,P.D.,Wileman,T.E.,Diment,S.&Shepherd,V.L.(1984)Mannose-specificoligosacchariderecognitionbymononuclearpha-gocytes.Biol.Cell51,215ï¿½218.
	3.Fan,J.-Q.,Ishii,S.,Asano,N.&Suzuki,Y.(1999)Acceleratedtransportandmaturationoflysosomala-galactosidaseAinFabrylymphoblastsbyanenzymeinhibitor.Nat.Med.5,112ï¿½115.
	4.Nash,R.J.,Bell,E.A.&Williams,J.M.(1985)2-Hydroxymethyl-3,4-dihydroxypyrrolidineinfruitsofAngylocalyxboutiqueanus.Phytochemistry24,1620ï¿½1622.
	5.Molyneux,R.J.,Pan,Y.T.,Tropea,J.E.,Elbein,A.D.,Lawyer,C.H.,Hughes,D.J.&Fleet,G.W.J.(1993)2-Hydroxymethyl-3,4-dihydroxy-6-methylpyrrolidine(6-deoxy-DMDP),analkaloidb-mannosidaseinhibitorfromseedsofAngylocalyxpynaertii.J.Nat.Prod.56,1356ï¿½1364.
	6.Evans,S.V.,Fellows,L.E.,Shing,T.K.M.&Fleet,G.W.J.(1985)Glycosidaseinhibitionbyplantalkaloidswhicharestructuralanaloguesofmonosaccharides.Phytochemistry24,1953ï¿½1955.
	7.Skudlarek,M.D.,Tulsiani,D.R.P.&Orgebin-Crist,M.-C.(1992)Ratepididymalliminalfluidacidb-d-galactosidaseoptimallyhydrolysesglycoproteinsubstrateatneutralpH.Biochem.J.286,907ï¿½914.
	8.Asano,N.,Tomioka,E.,Kizu,H.&Matsui,K.(1994)SugarswithnitrogenintheringisolatedfromtheleavesofMorusbombysis.Carbohydr.Res.253,235ï¿½245.
	9.Asano,N.,Oseki,K.,Tomioka,E.,Kizu,H.&Matsui,K.(1994)N-ContainingsugarsfromMorusalbaandtheirglycosidaseinhibitoryactivities.Carbohydr.Res.259,243ï¿½255.
	10.Asano,N.,Kizu,H.,Oseki,K.,Tomioka,E.,Matsui,K.,Okamoto,M.&Baba,M.(1995)N-Alkylatednitrogen-in-the-ringsugars:conformationalbasisofinhibitionofglycosidasesandHIV-1replication.J.Med.Chem.38,2349ï¿½2356.
	11.Fleet,G.W.J.,Namgoong,S.K.,Barker,C.,Baines,S.,Jacob,G.S.&Winchester,B.(1989)Iminoheptitolsasglycosidaseinhibitors:synthesisofandspecifica-l-fucosidaseinhibitionbyb-l-homo-fuconojirimycinand1-b-C-substituteddeoxymannojirimycins.TetrahedronLett.30,4439ï¿½4442.
	12.Asano,N.,Kato,A.,Miyauchi,M.,Kizu,H.,Kameda,Y.,Watson,A.A.,Nash,R.J.&Fleet,G.W.J.(1998)Nitrogen-containingfuranoseandpyranoseanaloguesfromHyacinthusorientalis.J.Nat.Prod.61,625ï¿½628.
	13.Asano,N.,Kameda.Y.&Matsui,K.(1991)Alleightpossiblemono-b-d-glucosidesofvalidoxylamineA.I.Preparationandstructuredetermination.J.Antibiot.44,1406ï¿½1416.
	14.Welter,A.,Jadot,J.,Dardenne,G.,Marlier,M.&Casimir,J.(1976)2,5-Dihydroxymethyl3,4-dihydroxypyrrolidinedanslesfeuillesdeDerriselliptica.Phytochemistry15,747ï¿½749.
	15.Nash,R.J.,Asano,N.&Watson,A.A.(1996)Polyhydroxylatedalkaloidsthatinhibitglycosidases.InAlkaloids:ChemicalandBiologicalPerspectives(Pelletier,S.W.,ed.),Vol.11,pp.345ï¿½376.ElsevierScience,Oxford.
	16.Asano,N.,Oseki,K.,Kizu,H.&Matsui,K.(1994)Nitrogen-in-the-ringpyranosesandfuranoses:structuralbasisofinhibitionofmammalianglycosidases.J.Med.Chem.37,3701ï¿½3706.
	17.Fuhrmann,U.,Bause,E.,Legler,G.&Ploegh,H.(1984)Novelmannosidaseinhibitorblockingconversionofhighmannosetocomplexoligosaccharides.Nature307,755ï¿½758.
	18.Bischoff,J.&Kornfeld,R.(1984)Theeffectof1-deoxymannojir-imycinonratlivera-mannosidases.Biochem.Biophys.Res.Commun.125,324ï¿½331.
	19.Winchester,B.,Barker,C.,Baines,S.,Jacob,G.S.,Namgoong,S.K.&Fleet,G.(1990)Inhibitionofa-l-fucosidasebyderivativesofdeoxyfuconojirimycinanddeoxymannojirimycin.Biochem.J.265,277ï¿½282.
	20.Fleet,G.W.J.,Shaw,A.N.,Evans,S.V.&Fellows,L.E.(1985)Synthesisfromd-glucoseof1,5-dideoxy-1,5-imino-l-fucitol,apotenta-l-fucosidaseinhibitor.J.Chem.Soc.Chem.Commun.,841ï¿½842.
	21.Andrews,D.M.,Bird,M.I.,Cunningham,M.M.&Ward,P.(1993)Synthesisofandglycosidaseinhibitionbya-l-homofuconojirimycin.Bioorg.Med.Chem.Lett.3,2533ï¿½2536.
	22.Asano,N.,Nishida,M.,Kizu,H.,Matsui,K.,Watson,A.A.&Nash,R.J.(1997)HomonojirimycinisomersandglycosidesfromAglaonematreubii.J.Nat.Prod.60,98ï¿½101.
	23.Asano,N.,Nishida,M.,Kato,A.,Kizu,H.,Matsui,K.,Shimada,Y.,Itoh,T.,Baba,M.,Watson,A.A.,Nash,R.J.,deLilley,P.M.Q.,Watkin,D.J.&Fleet,G.W.J.(1998)HomonojirimycinisomerandN-alkylatedhomonojirimycins:structuralandconformationalbasisofinhibitionofglycosidases.J.Med.Chem.41,2565ï¿½2571.
	24.Zhou,P.,Salleh,H.M.,Chan,P.C.M.,Lajoie,G.,Honek,F.,Nambiar,P.T.C.&Ward,O.P.(1993)Achemoenzymicsynthesisof1,5-dideoxy-1,5-imino-l-mannitoland-l-rhamnitolandinvestigationoftheireffectsonglycosidases.Carbohydr.Res.239,155ï¿½166.
	25.Asano,N.,Ishii,S.,Kizu,H.,Ikeda,K.,Yasuda,K.,Kato,A.,Martin,O.R.&Fan,J.-Q.(2000)Invitroinhibitionandintracellularenhancementoflysosomala-galactosidaseAinFabrylymphoblastsby1-deoxygalactonojirimycinanditsderivatives.Eur.J.Biochem.267,4179ï¿½4186.
	26.Alhadeff,J.A.(1981)Humana-l-fucosidasesandfucosidosis.InLysosomesandLysosomalStorageDiseases(Callahan,J.W.&Lowden,J.A.,eds),pp.299ï¿½313.RavenPress,NewYork.
	27.RaoVeeramachaneni,D.N.,Smith,M.O.&Ellinwood,N.M.(1998)Deficiencyoffucosidaseresultsinacrosomaldysgenesisandimpairedspermmaturation.J.Androl.19,444ï¿½449.
	28.Hoshi,M.,DeSantis,R.,Pinto,M.R.,Cotelli,F.&Rosati,F.(1983)Issperma-l-fucosidaseresponsibleforsperm-eggbindinginCionaintestinalis?intheSpermCell(Andre,J.,ed.),pp.107ï¿½110.Martinus-NijhoffPublishers,TheHague.
	29.Tesarik,J.,Mendoza,C.,Ramirez,J.P.&Moos,J.(1993)Solubilizedhumanzonapellucidacompeteswithafucosylatedneoglycoproteinforbindingsitesonthehumanspermsurface.Fertil.Steril.60,344ï¿½350.
	30.Lucas,H.,Bercegeay,S.,LePendu,J.,Jean,M.,Mirallie,S.&Barriere,P.(1994)Afucose-containingepitopepotentiallyinvolvedingameteinteractiononthehumanzonapellucida.Hum.Reprod.9,1532ï¿½1538.
	31.DeCerezo,J.M.,Marquinez,A.C.,Sarchi,M.I.&Cerezo,A.S.(1996)Fucosylatedglycoconjugatesofthehumanspermatozoon.Com-parisonofthedomainsoftheseglycoconjugateswiththea-fucosylbindingsites,andwithlactosaminicglycoconjugatesandb-d-galactosylbindingsitedomains.Biocell.20,11ï¿½20.
j.1432-1327.2001.01861.x.pdf	50
	1.Cotton,R.G.H.(1997).MutationDetection.OxfordUniversityPress,Oxford,UK.
	2.Ronai,Z.&Yakubovskaya,M.G.(1995)PCRinclinicaldiagnosis.J.Clin.Lab.Anal.9,269ï¿½281.
	3.Cotton,R.G.H.&Horaitis,Q.(2000)Qualitycontrolinthediscovery,reporting,andrecordingofgenomicvariation.Hum.Mutat.15,16ï¿½21.
	4.Cotton,R.G.H.,Rodrigues,N.R.&Campbell,R.D.(1988)Reactivityofcytosineandthymineinsingle-base-pairmismatcheswithhydroxylamineandosmiumtetroxideanditsapplicationtothestudyofmutations.Proc.NatlAcad.Sci.USA85,4397ï¿½4403.
	5.Lambrinakos,A.,Humphrey,K.E.,Babon,J.J.,Ellis,T.P.&Cotton,R.G.H.(1999)Reactivityofpotassiumpermanganateandtetraethylammoniumchloridewithmismatchedbasesandasimplemutationdetectionprotocol.NucleicAcidsRes.27,1866ï¿½1873.
	6.Cotton,R.G.H.&Campbell,R.D.(1989)ChemicalreactivityofmatchedcytosineandthyminebasesnearmismatchedandunmatchedbasesinaheteroduplexbetweenDNAstrandswithmultipledifferences.NucleicAcidsRes.17,4223ï¿½4233.
	7.Lu,A.-L.&Hsu,I.-C.(1992)DetectionofsingleDNAbasemutationswithmismatchrepairenzymes.Genomics14,249ï¿½253.
	8.Youil,R.,Kemper,B.&Cotton,R.G.H.(1995)ScreeningformutationsbyenzymemismatchcleavagewithT4endonucleaseVII.Proc.NatlAcad.Sci.USA92,87ï¿½93.
	9.Youil,R.,Kemper,B.&Cotton,R.G.H.(1996)Detectionof81of81knownmousebeta-globinpromotermutationswithT4endo-nucleaseVII:theEMCmethod.Genomics32,431ï¿½437.
	10.Mashal,R.D.,Koontz,J.&Sklar,J.(1995)DetectionofmutationsbycleavageofDNAheteroduplexeswithbacteriophageresolvases.Nat.Genet.9,177ï¿½182.
	11.Gaillard,C.&Strauss,F.(1994)Associationofpoly(CA)poly(TG)DNAfragmentsintofour-strandedcomplexesboundbyHMG1and2.Science264,433ï¿½436.
	12.Belotserkovskii,B.P.&Johnston,B.H.(1996)PolypropylenetubesurfacesmayinducedenaturationandmultimerizationofDNA.Science271,222ï¿½223.
	13.Gaillard,C.&Strauss,F.(1996)PolypropylenetubesurfacesmayinducedenaturationandmultimerizationofDNA-Response.Science271,223.
	14.Belotserkovskii,B.P.&Johnston,B.H.(1997)DenaturationandassociationofDNAsequencesbycertainpolypropylenesurfaces.Anal.Biochem.251,251ï¿½262.
	15.Yakubovskaya,M.G.,Neschastnova,A.A.,Popenko,V.I.,Lipatova,Zh.V.&Belitsky,G.A.(1999)HollidayjunctionsareformedinconcentratedsolutionsofpurifiedproductsofDNAamplification.Biochemistry(Moscow)64,1310ï¿½1314.
	16.Gaillard,C.,Flavin,M.,Woisard,A.&Strauss,F.(1999)Associationofdouble-strandedDNAfragmentsintomultistrandedDNAstructures.Biopolymers50,679ï¿½689.
	17.Panyutin,I.G.&Hsieh,P.(1994)ThekineticsofspontaneousDNAbranchmigration.Proc.NatlAcad.Sci.USA91,2021ï¿½2025.
	18.Holliday,R.(1964)Amechanismforgeneconversioninfungi.Genet.Res.Camb.5,282ï¿½287.
	19.Potter,H.&Dressler,D.(1976)Onthemechanismofgeneticrecombination:electronmicroscopicobservationofrecombinationintermediates.Proc.NatlAcad.Sci.USA73,3000ï¿½3004.
	20.Lopez,B.,Rousset,S.&Coppey,J.(1987)HomologousrecombinationintermediatesbetweentwoduplexDNAcatalysedbyhumancellextracts.NucleicAcidsRes.15,5643ï¿½5655.
	21.Wasserman,S.A.&Cozzarelli,N.R.(1986)Biochemicaltopology:applicationstoDNArecombinationandreplication.Science232,951ï¿½960.
	22.Whithouse,H.L.K.(1982).GeneticRecombination:UnderstandingtheMechanism.Wiley,NewYork,USA.
	23.Cox,M.M.&Lehman,I.R.(1987)Enzymesofgeneralrecombina-tion.Annu.Rev.Biochem.56,229ï¿½254.
	24.Lilley,D.M.J.&Clegg,R.M.(1993)Thestructureofthefour-wayjunctioninDNA.Annu.Rev.Biophys.Biomol.Struct.22,299ï¿½328.
	25.Lilley,D.M.J.(1997)AllchangeatHollidayjunction.Proc.NatlAcad.Sci.USA94,9513ï¿½9515.
	26.Duckett,D.R.,Murchie,A.I.,Diekmann,S.,vonKitzing,E.,Kemper,B.&Lilley,D.M.(1988)ThestructureoftheHollidayjunction,anditsresolution.Cell55,79ï¿½89.
	27.Mizuuchi,K.,Kemper,B.,Hays,J.&Weisberg,R.A.(1982)T4endonucleaseVIIcleavesHollidaystructures.Cell29,357ï¿½365.
	28.Buchman,V.L.,Chumakov,P.M.,Ninkina,N.N.,Samarina,O.P.&Georgiev,G.P.(1988)Avariationinthestructureoftheprotein-codingregionofthehumanp53gene.Gene30,245ï¿½252.
	29.Smith,M.J.,Gardner,R.J.,Knight,M.A.,Forrest,S.M.,Beyreuther,K.,Storey,E.,McLean,C.A.,Cotton,R.G.H.,Cappal,R.&Masters,C.L.(1999)Early-onsetAlzheimer'sdiseasecausedbyanovelmutationatcodon219ofthepresenilin-1gene.Neuroreport25,503ï¿½507.
	30.Sambrook,J.,Fritsch,E.F.&Maniatis,T.(1989)MolecularCloning:aLaboratoryManual.2ndedn.ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NY,USA.
	31.Southern,E.M.(1975)DetectionofspecificsequencesamongDNAfragmentsseparatedbygelelectrophoresis.J.Mol.Biol.96,503ï¿½517.
	32.Davis,R.W.&Hyman,R.W.(1971)Astudyinevolution:theDNAbasesequencehomologybetweencoliphagesT7andT3.J.Mol.Biol.62,287ï¿½301.
	33.Lu,M.,Guo,Q.,Marky,L.A.,Seeman,N.C.&Kallenbach,N.R.(1992)ThermodynamicsofDNAbranching.J.Mol.Biol.223,781ï¿½789.
	34.Duguid,J.G.&Bloomfield,V.A.(1995)AggregationofmeltedDNAbydivalentmetalion-mediatedcross-linking.Biophys.J.69,2642ï¿½2648.
	35.Henderson,E.,Hardin,C.C.,Wolk,S.K.,Tinoco,I.&Blackburn,E.H.(1987)TelomericDNAoligonucleotidesformnovelintra-molecularstructurescontainingguanine-guaninebasepairs.Cell51,899ï¿½908.
	36.Hardin,C.C.,Henderson,E.,Watson,T.&Prosser,J.K.(1991)MonovalentcationinducedstructuraltransitionsintelomericDNAs:G-DNAfoldingintermediates.Biochemistry30,4460ï¿½4472.
	37.Mueller,J.E.,Newton,C.J.,Jensch,F.,Kemper,B.,Cunningham,R.P.,Kallenbach,N.R.&Seeman,N.C.(1990)ResolutionofHollidayjunctionanalogsbyT4endonucleaseVIIcanbedirectedbysubstratestructure.J.Biol.Chem.265,13918ï¿½13924.
	38.Muck,S.M.,Fee,R.S.,Millar,D.P.&Chazin,W.J.(1997)Crossoverisomerbiasistheprimarysequence-dependentpropertyofimmobilisedHollidayjunctions.Proc.NatlAcad.Sci.USA94,9080ï¿½9084.
	39.Saenger,W.(1984).PrinciplesofNucleicAcidStructure.Springer-Verlag,NewYork,USA.
	40.Nonin,S.,Leroy,J.L.&Gueron,M.(1995)Terminalbasepairsofoligodeoxynucleotides:iminoprotonexchangeandfraying.Biochemistry34,10652ï¿½10659.
	41.Renalldo,R.P.,Vologodskii,A.V.,Neri,B.P.&Lyamichev,V.I.(2000)Thekineticsofoligonucleotidereplacements.J.Mol.Biol.297,511ï¿½520.
	42.Boan,F.,Rodriguez,J.M.&Gomez-Marquez,J.(1998)Anon-hypervariablehumanminisatellitestronglystimulatesinvitrointramolecularhomologousrecombination.J.Mol.Biol.278,499ï¿½492.
	42a.Eichman,B.F.,Vargason,J.M.,Mooers,B.H.&Ho,P.S.(2000)TheHollidayjunctioninaninvertedrepeatDNAsequence:sequenceeffectsonthestructureoffour-wayjunctions.Proc.NatlAcad.Sci.USA97,3971ï¿½3976.
	43.Benet,A.&Azorin,F.(1999)Theformationoftriple-strandedDNApreventsspontaneousbranch-migration.J.Mol.Biol.294,851ï¿½857.
	44.Frank-Kamenetskii,M.D.&Mirkin,S.M.(1995)TriplexDNAstructures.Annu.Rev.Biochem.64,65ï¿½95.
	45.Gierer,A.(1966)ModelforDNAandproteininteractionsandfunctionoftheoperator.Nature(London)212,1480ï¿½1481.
	46.Bhattacharyy,A.,Murchie,A.I.,vonKitzing,E.,Diekmann,S.,Kemper,B.&Lilley,D.M.(1991)ModelfortheinteractionofDNAjunctionsandresolvingenzymes.J.Mol.Biol.221,1191ï¿½1207.
	47.Smith,M.J.,Humphrey,K.E.,Cappai,R.,Beyreuther,K.,Masters,C.L.&Cotton,R.G.(2000)Correctheteroduplexformationformutationdetectionanalysis.Mol.Diag.5,67ï¿½73.
	48.Verpy,E.,Biasotto,M.,Brai,M.,Misiano,G.,Meo,T.&Tosi,M.(1996)Exhaustivemutationscanningbyfluorescence-assistedmismatchanalysisdisclosesnewgenotypeï¿½phenotypecorrelationsinangiodema.Am.J.Hum.Genet.59,308ï¿½319.
	49.Hansen,L.L.,Justesen,J.&Kruse,T.A.(1996)Sensitiveandfastmutationdetectionbysolidphasechemicalcleavage.Hum.Mutat.7,256ï¿½263.
46.pdf	14
	1.KlermanGL,WeissmanMM,RounsavilleBJ,etal:Interper-sonalPsychotherapyofDepression.NewYork,BasicBooks,1984
	2.WilfleyDE,AgrasWS,etal:Groupcognitivebehaviouralther-apyandgroupinterpersonaltherapyforthenonpurgingbu-limicindividual:acontrolledcomparison.JConsultClinPsychol1993;61:296?305
	3.FairburnCG,JonesR,PevelerRC,etal:Psychotherapyandbulimianervosa:thelongertermeffectsofinterpersonalpsy-chotherapyandcognitivebehaviortherapy.ArchGenPsychi-atry1993;50:419?428
	4.PiperWE,JoyceAS:Aconsiderationoffactorsinfluencingtheutilizationoftime-limited,short-termgrouptherapy.IntJGroupPsychother1996:46:311?328
	5.McRobertsC,BurlingameGM,HoagMJ:Comparativeeffi-cacyofindividualandgrouppsychotherapy:ameta-analyticperspective.GroupDynamics:Theory,Research,andPractice1998:2:101?117
	6.WilfleyDE,MacKenzieKR,AyresVE,etal:InterpersonalPsy-chotherapyforGroup.NewYork,BasicBooks,2000
	7.BurlingameGM,LambertMJ,ReisingerCW,etal:Pragmaticsoftrackingmentalhealthoutcomesinamanagedcaresetting.TheJournalofMentalHealthAdministration1995;22:226?236
	8.AmericanPsychiatricAssociation:DiagnosticandStatisticalManualofMentalDisorders,4thedition.Washington,DC,AmericanPsychiatricAssociation,1994
	9.MacKenzieKR:Time-ManagedGroupPsychotherapy:Effec-tiveClinicalApplications.WashingtonDC,AmericanPsychi-atricPress,1997
	10.BattleCC,ImberSD,Hoehn-SaricR,etal:Targetcomplaintsasacriteriaofimprovement.AmJPsychother1966;20:184?192
	11.BeckAT,WardCH,MendelsonM,etal:Aninventoryformeasuringdepression.ArchGenPsychiatry1961;4:561?571
	12.BeckAT,SteerRA:BeckDepressionInventoryManual.SanAntonio,TX,ThePsychologicalCorporation,1993edition
	13.BarkhamM,HardyGE,StartupM:TheIIP-32:ashortversionoftheInventoryofInterpersonalProblems.BritishJournalofClinicalPsychology1996;35:21?35
	14.WeissmanMM,KlermanGL,PrusoffBA,etal:Depressedout-patients:resultsoneyearaftertreatmentwithdrugsand/orin-terpersonalpsychotherapy.ArchGenPsychiatry1981;38:51?
ac000345.pdf	5
	1.Canigia,L.F.,A.D.Martino,M.Litterio,L.Castello,M.I.Fernandez,R.Rollett,G.Greco,S.Predari,andH.Bianchini.1999.ComparativeinvitroactivitiesoffourmacrolidesattwopHvaluesagainstGram-negativeanaer-obicrodsotherthantheBacteroidesfragilisgroup.Anaerobe5:451?454.
	2.Edlund,C.,E.Sillerstrom,E.Wahlund,andC.E.Nord.1998.InvitroactivityofHMR3647againstanaerobicbacteria.J.Chemother.10:280?284.
	3.Goldstein,E.J.C.,D.M.Citron,S.H.Gerardo,M.Hudspeth,andC.V.Merriam.1998.ActivitiesofHMR3004andHMR3647comparedtothoseoferythromycin,azithromycin,clarithromycin,roxithromycin,andeightotherantimicrobialagentsagainstunusualaerobicandanaerobichumanandani-malbitepathogensisolatedfromskinandsofttissueinfectionsinhumans.Antimicrob.AgentsChemother.42:1127?1132.
	4.Goldstein,E.J.C.,V.L.Sutter,Y.Y.Kwok,R.P.Lewis,andS.M.Finegold.1981.Effectofcarbondioxideonthesusceptibilityofanaerobicbacteriatoerythromycin.Antimicrob.AgentsChemother.20:705?708.
	5.NationalCommitteeforClinicalLaboratoryStandards.1997.Methodsforantimicrobialsusceptibilitytestingofanaerobicbacteria,4thed.Approvedstandard,NCCLSdocumentM11?A4.NationalCommitteeforClinicalLab-oratoryStandards,Wayne,Pa.
ac000327.pdf	96
	1.Abruzzo,G.K.,A.M.Flattery,C.J.Gill,L.Kong,J.G.Smith,V.B.Bikounis,J.M.Balkovec,A.F.Bouffard,J.F.Dropinski,H.Rosen,H.Kropp,andK.Bartizal.1997.EvaluationoftheechinocandinantifungalMK-0991(L-743,872):efficaciesinmousemodelsofdisseminatedaspergil-losis,candidiasis,andcryptococcosis.Antimicrob.AgentsChemother.41:2333?2338.
	2.Abruzzo,G.K.,A.M.Flattery,C.J.Gill,L.Kong,J.G.Smith,D.Krupa,V.B.Pkounis,H.Kropp,andK.Bartizal.1995.Evaluationofwater-solublepneumocandinanalogsL-733560,L-705589,andL-731373withmousemod-elsofdisseminatedaspergillosis,candidiasis,andcryptococcosis.Antimi-crob.AgentsChemother.39:1077?1081.
	3.Arikan,S.,M.Lozano-Chiu,V.Paetznick,S.Nangia,andJ.H.Rex.1999.MicrodilutionsusceptibilitytestingofamphotericinB,itraconazole,andvoriconazoleagainstclinicalisolatesofAspergillusandFusariumspecies.J.Clin.Microbiol.37:3946?3951.
	4.Bartizal,K.,C.J.Gill,G.K.Abruzzo,A.M.Flattery,L.Kong,P.M.Scott,J.G.Smith,C.E.Leighton,A.Bouffard,J.F.Dropinski,andJ.Balkovec.1997.InvitropreclinicalevaluationstudieswiththeechinocandinantifungalMK-0991(L-743,872).Antimicrob.AgentsChemother.41:2326?2332.
	5.DelPoeta,M.,W.A.Schell,andJ.R.Perfect.1997.InvitroantifungalactivityofpneumocandinL-743,872againstavarietyofclinicallyimportantmolds.Antimicrob.AgentsChemother.41:1835?1836.
	6.Denning,D.W.1997.Echinocandinsandpneumocandins?anewantifungalclasswithanovelmodeofaction.J.Antimicrob.Chemother.40:611?614.
	7.Denning,D.W.,S.A.Radford,K.L.Oakley,L.Hall,E.M.Johnson,andD.W.Warnock.1997.Correlationbetweenin-vitrosusceptibilitytestingtoitraconazoleandin-vivooutcomeofAspergillusfumigatusinfection.J.Anti-microb.Chemother.40:401?414.
	8.Ernst,E.J.,M.E.Klepser,M.E.Ernst,S.A.Messer,andM.A.Pfaller.1999.InvitropharmacodynamicpropertiesofMK-0991determinedbytime-killmethods.Diagn.Microbiol.Infect.Dis.33:75?80.
	9.Ernst,M.E.,M.E.Klepser,E.J.Wolfe,andM.A.Pfaller.1996.AntifungaldynamicsofLY303366,aninvestigationalechinocandinBanalog,againstCandidaspp.Diagn.Microbiol.Infect.Dis.26:125?131.
	10.Espinel-Ingroff,A.1998.ComparisonofinvitroactivitiesofthenewtriazoleSCH56592andtheechinocandinsMK-0991(L-743,872)andLY303366againstopportunisticfilamentousanddimorphicfungiandyeasts.J.Clin.Microbiol.36:2950?2956.
	11.Franzot,S.P.,andA.Casadevall.1997.PneumocandinL-743,872enhancestheactivitiesofamphotericinBandfluconazoleagainstCryptococcusneo-formansinvitro.Antimicrob.AgentsChemother.41:331?336.
	12.Graybill,J.R.,L.K.Najvar,M.F.Luther,andA.W.Fothergill.1997.TreatmentofmurinedisseminatedcandidiasiswithL-743,872.Antimicrob.AgentsChemother.41:1775?1777.
	13.Klepser,M.E.,E.J.Ernst,M.E.Ernst,S.A.Messer,andM.A.Pfaller.1998.EvaluationofendpointsforantifungalsusceptibilitydeterminationswithLY303366.AntimicrobAgentsChemother.42:1387?1391.
	14.Klepser,M.E.,E.J.Ernst,M.E.Ernst,andM.A.Pfaller.1997.GrowthmediumeffectontheantifungalactivityofLY303366.Diagn.Microbiol.Infect.Dis.29:227?31.
	15.Krishnarao,T.V.,andJ.N.Galgiani.1997.ComparisonoftheinvitroactivitiesoftheechinocandinLY303366,thepneumocandinMK-0991,andfluconazoleagainstCandidaspeciesandCryptococcusneoformans.Antimi-crob.AgentsChemother.41:1957?1960.
	16.Kurtz,M.B.,I.B.Heath,J.Marrinan,S.Dreikorn,J.Onishi,andC.Douglas.1994.MorphologicaleffectsoflipopeptidesagainstAspergillusfu-migatuscorrelatewithactivitiesagainst(1,3)-b-D-glucansynthase.Antimi-crob.AgentsChemother.38:1480?1489.
	17.Martinez-Suarez,J.V.,andJ.L.Rodriguez-Tudela.1996.InvitroactivitiesofsemisyntheticpneumocandinL-733,560againstfluconazole-resistantand-susceptibleCandidaalbicansisolates.AntimicrobAgentsChemother.40:1277?1279.
	18.NationalCommitteeforClinicalLaboratoryStandards.1998.Referencemethodforbrothdilutionantifungalsusceptibilitytestingofconidium-form-ingfilamentousfungi.Proposedstandard.NCCLSdocumentM38-P.Na-tionalCommitteeforClinicalLaboratoryStandards,Wayne,Pa.
	19.Nelson,P.W.,M.Lozano-Chiu,andJ.H.Rex.1997.Invitrogrowth-inhibitoryactivityofpneumocandinsL-733,560andL-743,872againstputa-tivelyamphotericinB-andfluconazole-resistantCandidaisolates:influenceofassayconditions.J.Med.Vet.Mycol.35:285?287.
	20.Pfaller,M.A.,F.Marco,S.A.Messer,andR.N.Jones.1998.Invitroactivityoftwoechinocandinderivatives,LY303366andMK-0991(L-743,792),againstclinicalisolatesofAspergillus,Fusarium,Rhizopus,andotherfila-mentousfungi.Diagn.Microbiol.Infect.Dis.30:251?255.
	21.Pfaller,M.A.,S.A.Messer,andS.Coffman.1997.Invitrosusceptibilitiesofclinicalyeastisolatestoanewechinocandinderivative,LY303366,andotherantifungalagents.Antimicrob.AgentsChemother.41:763?766.
	22.Pfaller,M.A.,S.A.Messer,S.Gee,S.Joly,C.Pujol,D.J.Sullivan,D.C.Coleman,andD.R.Soll.1999.InvitrosusceptibilitiesofCandidadublini-ensisisolatestestedagainstthenewtriazoleandechinocandinantifungalagents.J.Clin.Microbiol.37:870?872.
	23.Uzun,O.,S.Kocagoz,Y.Cetinkaya,S.Arikan,andS.Unal.1997.Invitroactivityofanewechinocandin,LY303366,comparedwiththoseofampho-tericinBandfluconazoleagainstclinicalyeastisolates.Antimicrob.AgentsChemother.41:1156?1157.
	24.Vazquez,J.A.,M.Lynch,D.Boikov,andJ.D.Sobel.1997.Invitroactivityofanewpneumocandinantifungal,L-743,872,againstazole-susceptibleand-resistantCandidaspecies.Antimicrob.AgentsChemother.41:1612?1614.
	25.Wanger,A.,K.Mills,P.W.Nelson,andJ.H.Rex.1995.ComparisonofEtestandNationalCommitteeforClinicalLaboratoryStandardsbrothmacrodi-lutionmethodforantifungalsusceptibilitytesting:enhancedabilitytodetectamphotericinB-resistantCandidaisolates.Antimicrob.AgentsChemother.39:2520?2522.
	26.Zhanel,G.G.,J.A.Karlowsky,G.A.J.Harding,T.V.Balko,S.A.Zelen-itsky,M.Friesen,A.Kabani,M.Turik,andD.J.Hoban.1997.Invitroactivityofanewsemisyntheticechinocandin,LY-303366,againstsystemicisolatesofCandidaspecies,Cryptococcusneoformans,Blastomycesdermati-tidis,andAspergillusspecies.Antimicrob.AgentsChemother.41:863?865.
2_1.pdf	38
	1.TeramotoA,HirakawaK,SannoN,OsamuraY.Incidentalpituitarylesionsin1,000unselectedautopsyspecimens.Neuroradiology1994;93:161?164.
	2.SumidaM,UozumiT,MukadaK,AritaK,KurisuK,EguchiK.Rathke'scleftcysts:correlationofenhancedMRandsurgical?ndings.AJNR1994;15:525?532.
	3.El-MahdyW,PowellM.Transsphenoidalmanage-mentof28symptomaticRathke'scleftcysts,withspecialreferencetovisualandhormonalrecovery.Neurosurgery1998;42:7?17.
	4.BrassierG,MorandiX,TayiarE,etal.Rathke'scleftcysts:sugical-MRIcorrelationin16sympto-maticcases.JNeuroradiol1999;26:162?171.
	5.ChristopheC,Flamant-DurandJ,HanquinetS,etal.MRIinsevencasesofRathke'scleftcystininfantsandchildren.PediatrRadiol1993;23:79?82.
	6.KeyakiA,KimYJ,NabeshimaS.ClinicalstudyofRathkecleftcyst.NoShinkeiGeka(Jpn)1999;27:625?631.
	7.SaekiN,SunamiK,SugayaY,YamauraA.MRI?ndingsandclinicalmanifestationsinRathke'scleftcyst.ActaNeurochir(Wien)1999;141:1055?1061.
	8.AsariS,ItoT,TsuchidaS,TsutsuiT.MRappear-anceandcystcontentofRathkecleftcysts.JCom-putAssistTomogr1990;14:532?535.
	9.HuaF,AsatoR,MikiY,etal.Di?erentiationofsuprasellarnon-neoplasticcystsfromcysticneoplasmsbyGd-DTPAMRI.JComputAssistTomogr1992;16:744?749.
	10.ByunMB,KimOL,KimDS.MRimaging?ndingsofRathke'scleftcysts:signi?canceofintracysticnodules.AJNR2000;21:485?488.
	11.KucharczykW,PeckWW,KellyWM,NormanD,NewtonTH.Rathkecleftcysts:CT,MRImaging,andpathologicfeatures.Radiology1987;165:491?495.
	12.NaylorMF,ScheithauerBW,ForbesGS,TomlinsonFH,YoungWF.Rathkecleftcyst:CT,MR,andpathologyof23cases.JComputAssistTomogr1995;19:853?859.
	13.ShinJL,AsaSL,WoodhousLJ,SmythHS,EzzatS.Cysticlesionsofthepituitary:clinicopathologi-calfeaturesdistinguishingcraniopharyngioma,Rathke'scleftcyst,andarachnoiccyst.JClinEndocrinolMetab1999;84:3972?3982.
	14.RossDA,NormanD,WilsonCB.RadiologiccharacteristicsandresultsofsurgicalmanagementofRathke'scystsin43patients.Neurosurgery1992;30:173?179.
	15.VolkerJL,CampbellRJ,MullerJ.Clinical,radio-graphic,andpathologicalfeaturesofsymptomaticRathke'scleftcysts.JNeurosurg1991;74:535?544.
	16.HayashiY,TachibanaO,MuramatsuN,etal.Rathkecleftcyst:MRandbiochemicalanalysisofcystcontent.JComputAssistTomogr1999;23:34?38.
	17.NishiokaH,ItoH,MikiT,HashimotoT,NojimaH,MatsumuraH.Rathke'scleftcystwithpitui-taryapoplexy:casereport.Neuroradiology1999;41:832?834.
	18.RottenbergGT,ChongWK,PowellM,KendallBE.Cystformationofthecraniopharyngealduct.ClinRadiol1994;49:126?129.
	19.KuwaharaT,ShinoharaY,SugiuraM,HiramatsuH.ARathke'scleftcystwithamovingmassinthecyst.NoShinkeiGeka(Jpn)1997;25:177?180.
	20.SumidaM,UozumiT,YamanakaM,etal.Dis-placementofthenormalpituitaryglandbysellarandjuxtasellartumors:surgical-MRIcorrelationanduseindi?erentialdiagnosis.Neuroradiol1994;36:372?375.
	21.DonovanJL,NesbitGM.Distinctionofmassesin-volvingthesellaandsuprasellarspaces:speci?cityofimagingoffeatures.AJR1996;167:597?603.
	22.HaldJK,EldevikOP,BrunbergJA,ChandlerWF.Craniopharyngiomas?theutilityofcontrastmediumenhancementforMRimagingat1.5T.ActaRadiol1994;35:520?525.
	23.PuseyE,KortmanKE,FlanniganBD,TsurudaJ,BradleyWG.MRofcraniopharyngiomas:tumordelineationandcharacterization.AJNR1987;8:439?444.
	24.HaldJK,EldevikOP,SkalpeIO.Craniopharyn-giomaidenti?cationbyCTandMRImaging.ActaRadiol1995;36:142?147.
	25.FreemanMP,KesslerRM,AllenJH,PriceAC.Craniopharyngioma:CTandMRimaginginninecases.JComputAssistTomogr1987;11:810?814.
ar1032.pdf	45
	1.Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG,Gilkeson GS: Hormonal, environmental, and infectious riskfactors for developing systemic lupus erythematosus.ArthritisRheum1998, 41:1714-1724.	9778212
	2.Robson MG, Walport MJ: Pathogenesis of systemic lupus ery-thematosus.Clin Exp Allergy2001, 31:678-685.	11422126
	3.Du Clos TW: C-reactive protein as a regulator of autoimmunity and inflammation. Arthritis Rheum2003, 48:1475-1477.	12794828
	4.Nauta AJ, Daha MR, Kooten C, Roos A: Recognition and clear-ance of apoptotic cells: arole for complement and pentraxins.Trends Immunol2003, 24:148-154.	12615211
	5.Nagata S, Suda T: Fas and Fas ligand: lprand gldmutations.Immunol Today1995, 16:39-43.	7533498
	6.Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG,Moroy T: Features of systemic lupus erythematosus in DNase1-deficient mice.Nat Genet2000, 25:177-181.	10835621
	7.Emlen W, Niebur J, Kadera R: Accelerated in vitroapoptosis oflymphocytes from patients with systemic lupus erythemato-sus.J Immunol1994, 152:3685-3692.	8144943
	8.Botto M, Dell?Agnola C, Bygrave AE, Petry F, Loos M, PandolfiPP, Walport MJ: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.NatGenet1998, 19:56-59.	9590274
	9.Shoshan Y, Shapira I, Toubi E, Frolkis I, Yaron M, Mevorach D:Accelerated Fas-mediated apoptosis of monocytes andmaturing macrophages from patients with systemic lupuserythematosus: relevance to in vitroimpairment of interactionwith iC3b-opsonized apoptotic cells.J Immunol2001, 167:5963-5969.	11698475
	10.Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB,Kalden JR: Impaired phagocytosis of apoptotic cell material bymonocyte-derived macrophages from patients with systemiclupus erythematosus.Arthritis Rheum1998, 41:1241-1250.	9663482
	11.Fishelson Z, Attali G, Mevorach D: Complement and apoptosis.Mol Immunol2001, 38:207-219.	11532282
	12.Charles PJ: Defective waste disposal: does it induce autoanti-bodies in SLE?Ann Rheum Dis2003, 62:1-3.	12480662
	13.Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM,Kalden JR: Histone-specific Th0 and Th1 clones derived fromsystemic lupus erythematosus patients induce double-stranded DNA antibody production.Arthritis Rheum1997, 40:2162-2171.	9416853
	14.Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing Tcells of lupus.J Exp Med1993, 177:1367-1381.	2104919
	15.Spronk PE, Limburg PC, Kallenberg CGM: Serological markersof disease activity in systemic lupus erythematosus.Lupus1995, 4:86-94.	7795629
	16.Gewurz H, Zhang XH, Lint TF: Structure and function of the pentraxins.Curr Opin Immunol1995, 7:54-64.	7772283
	17.Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U,Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, TijsmaO, Hack EC, Daha MR, Roos A: Biochemical and functionalcharacterization of the interaction between pentraxin 3andC1q.Eur JImmunol2003, 33:465-473.	12645945
	18.Thompson D, Pepys MB, Wood SP: The physiological structureof human C-reactive protein and its complex with phospho-choline.Structure Fold Des1999, 7:169-177.	10368284
	19.Motie M, Brockmeier S, Potempa LA: Binding of model solubleimmune complexes to modified C-reactive protein.J Immunol1996, 156:4435-4441.	8666818
	20.Mold C, Baca R, Du Clos TW: Serum amyloid Pcomponentand C-reactive protein opsonize apoptotic cells for phagocy-tosis through Fc?Rs.J Autoimmun2002, 19:147-154.	12419285
	21.Du Clos TW: The interaction of C-reactive protein and serumamyloid Pcomponent with nuclear antigens.Mol Biol Rep1996, 23:253-260.	9112237
	22.Gershov D, Kim S, Brot N, Elkon KB: C-Reactive protein bindsto apoptotic cells, protects the cells from assembly of the ter-minal complement components, and sustains an anti-inflam-matory innate immune response: implications for systemicautoimmunity.J Exp Med2000, 192:1353-1364.
	23.Diehl EE, Haines GK III, Radosevich JA, Potempa LA: Immuno-histochemical localization of modified C-reactive proteinantigen in normal vascular tissue.Am JMed Sci2000, 319:79-Available onlinehttp://arthritis-research.com/content/6/2/R87R93
	24.Kresl JJ, Potempa LA, Anderson BE: Conversion of nativeoligomeric to amodified monomeric form of human C-reac-tive protein.Int JBiochem Cell Biol1998, 30:1415-1426.	9924810
	25.Sjï¿½wall C, Eriksson P, Almer S, Skogh T: Autoantibodies to C-reactive protein is acommon finding in SLE, but not inprimary Sjï¿½gren?s syndrome, rheumatoid arthritis or inflam-matory bowel disease.J Autoimmun2002, 19:155-160.	12419286
	26.Bell SA, Faust H, Schmid A, Meurer M: Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.Clin Exp Immunol1998, 113:327-332.	2454772
	27.Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI.Arthritis Rheum1992, 35:630-640.	1599520
	28.Sturfelt G, Roux-Lombard P, Wollheim FA, Dayer JM: Low levelsof interleukin-1 receptor antagonist coincide with kidneyinvolvement in systemic lupus erythematosus.Br JRheumatol1997, 36:1283-1289.	9448589
	29.Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H:Expression, detection and assay of aneoantigen (Neo-CRP)associated with afree, human C-reactive protein subunit.MolImmunol1987, 24:531-541.	2443837
	30.Mullis KB, Faloona FA: Specific synthesis of DNA in vitrovia apolymerase-catalyzed chain reaction.Methods Enzymol1987,155:335-350.	3431465
	31.Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M,Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J,Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythemato-sus.Arthritis Rheum1996, 39:363-369.	9870888
	32.Jonsson H, Sturfelt G, Mï¿½rtensson U, Truedsson L, Sjï¿½holm AG:Prospective analysis of C1 dissociation and complement acti-vation in patients with systemic lupus erythematosus.ClinExp Rheumatol1995, 13:573-580.	8575134
	33.Amoura Z, Koutouzov S, Piette JC: The role of nucleosomes inlupus.Curr Opin Rheumatol2000, 12:369-373.	10990171
	34.Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein inhealth and disease.J Clin Invest1993, 91:1351-1357.	6652963
	35.Sturfelt G, Sjï¿½holm AG: Complement components, comple-ment activation, and acute phase response in systemiclupus erythematosus.Int Archs Allergy Appl Immun1984, 75:75-83.	6086533
	36.Stein MP, Mold C, Du Clos TW: C-reactive protein binding tomurine leukocytes requires Fc?Rs.J Immunol2000, 164:1514-1520.	10640769
	37.Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG:Loss of pentameric symmetry of C-reactive protein is associ-ated with delayed apoptosis of human neutrophils.J BiolChem2002, 277:40775-40781.	12198121
	38.Samberg NL, Bray RA, Gewurz H, Landay AL, Potempa LA: Pref-erential expression of neo-CRP epitopes on the surface ofhuman peripheral blood lymphocytes.Cell Immunol1988,116:86-98.	2458846
	39.Bray RA, Samberg NL, Gewurz H, Potempa LA, Landay AL: C-reactive protein antigenicity on the surface of human periph-eral blood lymphocytes. Characterization of lymphocytesreactive with anti-neo-CRP.J Immunol1988, 140:4271-4278.	2453575
	40.Cocca BA, Cline AM, Radic MZ: Blebs and apoptotic bodiesare Bcell autoantigens.J Immunol2002, 169:159-166.	12077241
	41.Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M:High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.Lupus1998, 7:113-118.	9796855
	42.Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy AL,Bell AL: Increased apoptotic peripheral blood neutrophils insystemic lupus erythematosus: relation with disease activity,antibodies to double stranded DNA, and neutropenia.AnnRheum Dis1999, 58:309-314.	9448583
	43.Pascual M, Schifferli JA: Another function of erythrocytes:transport of circulating immune complexes.Infusionther Trans-fusionsmed1995, 22:310-315.	8924746
	44.Klint C, Gullstrand B, Sturfelt G, Truedsson L: Binding ofimmune complexes to erythrocyte CR1 (CD35): difference inrequirement of classical pathway components and indicationof alternative pathway-mediated binding in C2-deficiency.Scand JImmunol2000, 52:103-108.	10886790
	45.Skogh T, Stendahl O: Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.Immunology1983,49:53-59.	6074005
v14n3a13.pdf	20
	1.Abrahams JJ. The role of diagnostic imaging in dentalimplantology. Radiol Clin North Am 1993;31:163-180.	8419972
	2.Frederiksen NL. Diagnostic imaging in dental implantology. OralSurg Oral Med Oral Pathol Oral Radiol Endod 1995;80:540-554.	8556464
	3.Dharmar S. Locating the mandibular canal in panoramic radio-graphs. Int J Oral Maxillofac Implants 1997;12:113-117.	9048463
	4.Lindh C, Petersson A. Radiologic examination for location of themandibular canal: a comparison between panoramic radiographyand conventional tomography. Int J Oral Maxillofac Implants1989;4:249-253.	2639123
	5.Lindh C, Petersson A, Klinge B. Visualisation of the mandibularcanal by different radiographic techniques. Clin Oral Impl Res1992;3:90-97.	15900674
	6.Stella JP, Tharanon W. A precise radiographic method to deter-mine the location of the inferior alveolar canal in the posterioredentulous mandible: implications for dental implants. Part 2:clinical application. Int J Oral Maxillofac Implants 1990;5:23-29.	2391136
	7.Lee S, Morgano SM. A diagnostic stent for endosseous implantsto improve conventional tomographic radiographs. J ProsthetDent 1994;71:482-485.	8006844
	8.Silverstein LH, Melkonian RW, Kurtzman D, Garnick JJ, LefkoveMD. Linear tomography in conjunction with pantomography inthe assessment of dental implant recipient sites. J Oral Implantol1994;20:111-117.	7869413
	9.Butterfield KJ, Dagenais M, Clokie C. Linear tomography?s clini-cal accuracy and validity for presurgical dental implant analysis.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:203-209.	9269023
	10.Gher ME, Richardson AC. The accuracy of dental radiographictechniques used for evaluation of implant fixture placement. Int JPeriodont Rest Dent 1995;15:268-283.	7558660
	11.Mayfield-Donahoo TL, Stokely EM, Jeffcoat MK. Blur reductionof conventional film-based tomograms for pre-surgical evalua-tion of potential mandibular implant sites. J Periodontol1997;68:362-368.	9150041
	12.Todd AD, Gher ME, Quintero G, Richardson C. Interpretation oflinear and computed tomograms in the assessment of implantrecipient sites. J Periodontol 1993;64:1243-1249.	8106953
	13.Potter BJ, Shrout MK, Russell CM, Sharawy M. Implant siteassessment using panoramic cross-sectional tomographic imag-ing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1997;84:436-442.	9347511
	14.Oliveira RAP. Avaliaï¿½ï¿½o da precisï¿½o da tomografia linear e dosistema de digitalizaï¿½ï¿½o indireta de imagens na mensuraï¿½ï¿½o daregiï¿½o anterior da mandï¿½bula. [Masterï¿½s thesis]. Porto Alegre:Faculty of Dentistry, PUCRS; 1999. 109p.
	15.Kaeppler G. New radiographic programs for transverse conven-tional tomograms in the dentomaxillofacial region. QuintessenceInt 1999;30:541-549.	10635267
	16.Wyatt CCL, Pharoah MJ. Imaging techniques and image interpre-tation for dental implant treatment. Int J Prosthodont1998;11:442-452.	9922736
	17.Bahlis A. Avaliaï¿½ï¿½o in vitro, em mandï¿½bulas secas, da confiabili-dade das medidas nas tomografias lineares. [Masterï¿½s thesis].Braz Dent J 14(3) 2003Porto Alegre: Faculty of Dentistry, PUCRS; 1999. 75p.
	18.Catic A, Celebic A, Valentic-Peruzovic M, Catovic A,Vjekoslav J, Muretic I. Evaluation of the precision of dimen-sional measurements of the mandible on panoramic radiographs.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:242-248.	9720102
	19.Batenburg RHK, Stellingsma K, Raghoebar GM, Vissink A.Bone height measurements on panoramic radiographs: theeffect of shape and position of edentulous mandibles. OralSurg Oral Med Oral Pathol Oral Radiol Endod 1997;84:430-435.	9347510
	20.Xie Q, Soikkonen K, Wolf J, Mattila K, Gong M, Ainamo A.Effect of head positioning in panoramic radiography on verticalmeasurements: an in vitro study. Dentomaxillofac Radiol1996;25:61-66.	9446974
v14n3a09.pdf	20
	1.Bystrï¿½m A, Sundqvist G. Bacteriologic evaluation of the efficacyof mechanical root canal instrumentation in endodontic therapy.Scand J Dent Res 1981;89:321-328.	6947391
	2.Ohara PK, Torabinejad M, Kettering JD. Antibacterial effect ofvarious endodontic irrigants on selected anaerobic bacteria.Endod Dent Traumatol 1993;9:95-100.	8243347
	3.Silva CAG. Efetividade antimicrobiana do hipoclorito de sï¿½dio eclorexidina como irrigantes endodï¿½nticos. [Master?s thesis]. PortoAlegre: Universidade Luterana de Brasil, 1999.
	4.Ayhan H, Sultan N, Cirak M, Ruhi MZ, Bodur H. Antimicrobialeffects of various endodontic irrigants on selected microorgan-isms. Int Endod J 1999;32:99-102.	10371903
	5.Gomes BPFA, Ferraz CCR, Vianna ME, Berber VB, Teixeira FB,Souza-Filho FJ. In vitro antimicrobial activity of several concen-trations of sodium hypochlorite and chlorhexidine gluconate inthe elimination of Enterococcus faecalis. Int Endod J 2001;34:424-428.	11556507
	6.Bystrï¿½m A, Sundqvist G. The antibacterial action of sodiumhypochlorite and EDTA in 60 cases of endodontic therapy. IntEndod J 1985;18:35-40.	3922900
	7.Heling I, Chandler NP. Antimicrobial effect of irrigant combina-tions within dentinal tubules. Int Endod J 1998;31:8-14.	9823123
	8.Jeansonne MJ, White RR. A comparison of 2% chlorhexidinegluconate and 5.25% sodium hypochlorite as antimicrobial endo-dontic irrigant. J Endod 1994;20:276-278.	7931023
	9.Ringel AM, Patterson SS, Newton CW, Miller CH, Mulhern JM.In vivo evaluation of chlorhexidine gluconate solution and so-dium hypochlorite solution as root canal irrigants. J Endod1982;8:200-204.	6955420
	10.Siqueira JF, Batista MD, Fraga RC, Uzeda M. Antimicrobialeffects of endodontic irrigants on black-pigmented Gram-nega-tive anaerobes and facultative bacteria. J Endod 1998;24:414-416.	9693585
	11.Estrela C, Estrela CRA, Barbin EL, Spanï¿½ JC, Marchesan MA,Pï¿½cora JD. Mechanism of action of sodium hypochlorite. BrazilDent J 2002;2:113-117.	12238801
	12.Spangberg L, Engstrom B, Langeland K. Biological effect ofdental materials: 3 toxicity and antimicrobial effects of endodon-tic antiseptics in vitro. Oral Surg Oral Med Oral Pathol1973;36:856-871.	4208832
	13.Holland R, Soares IJ, Soares IM. Influence of irrigation andBraz Dent J 14(3) 2003192C.R.A. Estrela et al.intracanal dressing on the healing process of dog?s teeth withapical periodontitis. Endod Dent Traumatol 1992;8:223-229.	1302685
	14.Costa CAS. Teste de biocompatibilidade dos materiaisodontolï¿½gicos. In: Metodologia Cientï¿½fica: ensino e pesquisa emodontologia. Estrela C, ed. Sï¿½o Paulo: Artes Mï¿½dicas, 2001.
	15.Estrela C, Ribeiro RG, Estrela CRA, Pï¿½cora JD, Sousa-Neto MD.Antimicrobiol effect of 2% sodium hypochlorite and 2%chlorhexidine tested by different methods. Braz Dent J 2003; 14:58-62.	12656467
	16.Spanï¿½ JCE, Barbin EL, Santos TC, Guimarï¿½es LF, Pï¿½cora JD.Solvent action of sodium hypochlorite on bovine pulp andphysico-chemical properties of resulting liquid. Braz Dent J2001;12:154-157.	11696909
	17.Emilson CG. Susceptibility of various microorganisms to chlor-hexidine. J Dent Res 1977;85:255-265.	266752
	18.Emilson CG. Potential efficacy of chlorhexidine against mutansstreptococci and human dental caries. J Dent Res 1994;73:682-691.	8063995
	19.Buck RA, Cai J, Eleaser PD, Staat RH, Hurst HE. Detoxificationof endotoxin by endodontic irrigants and calcium hydroxide. JEndod 2001;27:325-327.	11485249
	20.Barbosa SV, Spangberg LSW, Almeida D. Low surface tension ofcalcium hydroxide solutions in an effective antiseptic. Int EndodJ 1994; 27:6-10.	7806414
amia2003_0954.pdf	0
amia2003_0951.pdf	1
	1.Stulbarg MS, Carrieri-Kohlman V, Demir-Deviren S, Nguyen HQ, et al. Effect of exercise training on dyspnea, exercise performance and health related quality of life: how much training is enough? Journal of Cardiopulmonary Rehabilitation. 2002;22:109-21.
amia2003_0948.pdf	0
J Pharmacol Exp Ther-2004-Patki-874-9.pdf	39
	AllenMD,GreenblattDJ,HarmatzJS,andShaderRI(1980)Desmethyldiazepamkineticsintheelderlyafteroralprazepam.ClinPharmacolTher28:196?202.
	BeaunePH,KremersPG,KaminskyLS,DeGraeveJ,AlbertA,andGuengerichFP(1986)ComparisonofmonooxygenaseactivitiesandcytochromeP-450isozymeconcentrationsinhumanlivermicrosomes.DrugMetabDispos14:437?442.
	BertzRJ,KrobothPD,KrobothFJ,ReynoldsIJ,SalekF,WrightCE,andSmithRB(1997)Alprazolaminyoungandelderlymen:sensitivityandtolerancetopsy-chomotor,sedativeandmemoryeffects.JPharmacolExpTher281:1317?1329.
	CotreauMM,vonMoltkeLL,andGreenblattDJ(2004)TheinfluenceofageandsexontheclearanceofcytochromeP450(CYP)3Asubstrates.ClinPharmacokinet,inpress.
	GeorgeJ,BythK,andFarrellGC(1995)AgebutnotgenderselectivelyaffectsexpressionofindividualcytochromeP450proteinsinhumanliver.BiochemPhar-macol50:727?730.
	GreenblattDJ,AbernethyDR,LocniskarA,HarmatzJS,LimjucoRA,andShaderRI(1984)Effectofage,genderandobesityonmidazolamkinetics.Anesthesiology61:27?35.
	GreenblattDJ,AbernethyDR,andShaderRI(1986)Pharmacokineticaspectsofdrugtherapyintheelderly.TherDrugMonit8:249?255.
	GreenblattDJ,DivollM,AbernethyDR,MoschittoLJ,SmithRB,andShaderRI(1983a)Reducedclearanceoftriazolaminoldage:relationtoantipyrineoxidizingcapacity.BrJClinPharmacol15:303?309.
	GreenblattDJ,DivollM,AbernethyDR,MoschittoLJ,SmithRB,andShaderRI(1983b)Alprazolamkineticsintheelderly:relationtoantipyrinedisposition.ArchGenPsychiatry40:287?290.
	GreenblattDJ,HarmatzJS,ShapiroL,EngelhardtN,GouthroTA,andShaderRI(1991)Sensitivitytotriazolamintheelderly.NEnglJMed324:1691?1698.
	GreenblattDJ,SellersEM,andShaderRI(1982)Drugdispositioninoldage.NEnglJMed306:1081?1088.
	GreenblattDJ,ShaderRI,andHarmatzJS(1989)Implicationsofaltereddrugdispositionintheelderly:studiesofbenzodiazepines.JClinPharmacol29:866?872.
	HarrisRZ,BenetLZ,andSchwartzJB(1995)Gendereffectsinpharmacokineticsandpharmacodynamics.Drugs50:222?239.
	HuntCM,WesterkamWR,andStaveGM(1992)EffectofageandgenderontheactivityofhumanhepaticCYP3A.BiochemPharmacol44:275?283.
	KanamoriM,TakahashiH,andEchizenH(2002)Developmentalchangesintheliverweight-andbodyweight-normalizedclearanceoftheophylline,phenytoinandcyclosporineinchildren.IntJClinPharmacolTher40:485?492.
	KremersP,BeauneP,CresteilT,deGraeveJ,ColumelliS,LerouxJP,andGielenJE(1981)CytochromeP-450monooxygenaseactivitiesinhumanandratlivermicrosomes.EurJBiochem118:599?606.
	MurryDJ,CromWR,ReddickWE,BhargavaR,andEvansWE(1995)Livervolumeasadeterminantofdrugclearanceinchildrenandadolescents.DrugMetabDispos23:1110?1116.
	PatkiKC,vonMoltkeLL,andGreenblattDJ(2003)Invitrometabolismofmidazo-lam,triazolam,nifedipineandtestosteronebyhumanlivermicrosomesandre-combinantcytochromesP450:roleofCYP3A4andCYP3A5.DrugMetabDispos31:938?944.
	PerloffMD,vonMoltkeLL,CourtMH,KotegawaT,ShaderRI,andGreenblattDJ(2000)Midazolamandtriazolambiotransformationinmouseandhumanlivermicrosomes:relativecontributionofCYP3AandCYP2Cisoforms.JPharmacolExpTher292:618?628.
	ReithDM,AppletonDB,HooperW,andEadieMJ(2000)Theeffectofbodysizeonthemetabolicclearanceofcarbamazepine.BiopharmDrugDispos21:103?111.
	SchmuckerDL(1985)Aginganddrugdisposition:anupdate.PharmacolRev37:133?148.
	SchmuckerDL(2001)LiverfunctionandphaseIdrugmetabolismintheelderly:aparadox.DrugsAging18:837?851.
	SchmuckerDL,WoodhouseKW,WangRK,WynneH,JamesOF,McManusM,andKremersP(1990)Effectsofageandgenderoninvitropropertiesofhumanlivermicrosomalmonooxygenases.ClinPharmacolTher48:365?373.
	SchragMLandWienkersLC(2001)Triazolamsubstrateinhibition:evidenceofcompetitionforheme-boundreactiveoxygenwithintheCYP3A4activesite.DrugMetabDispos29:70?75.
	ShimadaT,YamazakiH,MimurM,InuiY,andGuengerichFP(1994)Interindi-vidualvariationsinhumanlivercytochromeP-450enzymesinvolvedintheoxidationofdrugs,carcinogensandtoxicchemicals:studieswithlivermicrosomesof30Japaneseand30Caucasians.JPharmacolExpTher270:414?423.
	SmithMT,HeazlewoodV,EadieMJ,BrophyTO,andTyrerJH(1984)Pharmaco-kineticsofmidazolamintheaged.EurJClinPharmacol26:381?388.
	SotaniemiEA,ArrantoAJ,PelkonenO,andPasanenM(1997)AgeandcytochromeP450-linkeddrugmetabolisminhumans:ananalysisof226subjectswithequalhistopathologicconditions.ClinPharmacolTher61:331?339.
	StevensJC,HinesRN,GuC,KoukouritakiSB,ManroJR,TandlerPJ,andZayaMJ(2003)DevelopmentalexpressionofthemajorhumanhepaticCYP3Aenzymes.JPharmacolExpTher307:573?582.
	TransonC,LecoeurS,LeemannT,BeauneP,andDayerP(1996)InterindividualvariabilityincatalyticactivityandimmunoreactivityofthreemajorhumanlivercytochromeP450isozymes.EurJClinPharmacol51:79?85.
	TuenissenMW,SrivastavaAK,andBreimerDD(1987)Influenceofsexandoralcontraceptivesonantipyrinemetaboliteformation.ClinPharmacolTher32:240?246.
	VestalRE(1982)Pharmacologyandageing.JAmGeriatrSoc30:191?200.vonMoltkeLL,GreenblattDJ,HarmatzJS,DuanSX,HarrelLM,Cotreau-BibboMM,PritchardGA,WrightCE,andShaderRI(1996a)Triazolambiotransforma-tionbyhumanlivermicrosomesinvitro:effectsofmetabolicinhibitorsandclinicalconfirmationofapredictedinteractionwithketoconazole.JPharmacolExpTher276:370?379.
	vonMoltkeLL,GreenblattDJ,HarmatzJS,andShaderRI(1993)Alprazolammetabolisminvitro:studiesofhuman,monkey,mouseandratlivermicrosomes.Pharmacology47:268?276.
	vonMoltkeLL,GreenblattDJ,HarmatzJS,andShaderRI(1995a)Psychotropicdrugmetabolisminoldage:principlesandproblemsofassessment,inPsychop-harmacology:TheFourthGenerationofProgress(BloomFEandKupferDJeds)pp1461?1469,RavenPress,NewYork.
	vonMoltkeLL,GreenblattDJ,SchmiderJ,DuanSX,WrightCE,HarmatzJS,andShaderRI(1996b)Midazolamhydroxylationbyhumanlivermicrosomesinvitro:inhibitionbyfluoxetine,norfluoxetineandbyazoleantifungalagents.JClinPharmacol36:783?791.
	vonMoltkeLL,GreenblattDJ,SchmiderJ,HarmatzJS,andShaderRI(1995b)MetabolismofdrugsbycytochromeP450?3Aisoforms:implicationsfordruginteractionsinpsychopharmacology.ClinPharmacokinet29(Suppl1):33?44.
	Westlind-JohnssonA,MalmeboS,JohanssonA,OtterC,AnderssonTB,JohanssonI,EdwardsRJ,BoobisAR,andIngelman-SundbergM(2003)Comparativeanal-ysisofCYP3AexpressioninhumanliversuggestsonlyaminorroleforCYP3A5indrugmetabolism.DrugMetabDispos31:755?761.
	WilliamsJA,RingBJ,CantrellVE,JonesDR,EcksteinJ,RuterboriesK,HammanMA,HallSD,andWrightonSA(2002)ComparativemetaboliccapabilitiesofCYP3A4,CYP3A5,andCYP3A7.DrugMetabDispos30:883?891.
	WynneHA,MutchE,JamesOFW,WrightP,RawlinsMD,andWoodhouseKW(1988)Theeffectofageupontheaffinityofmicrosomalmonooxygenaseenzymesforsubstratesinhumanliver.AgeAgeing17:401?405.
J Pharmacol Exp Ther-2004-Xu-887-95.pdf	40
	Alonso-GaliciaM,MaierKG,GreeneAG,CowleyAW,andRomanRJ(2002)Roleof20-hydroxyeicosatetraenoicacidintherenalandvasoconstrictoractionsofangio-tensinII.AmJPhysiol283:R60?R68.
	BylundJ,HarderAG,MaierKG,RomanRJ,andHarderDR(2003)LeukotrieneB4-sidechainhydroxylationbyCYP4F5andCYP4F6.ArchBiochemBiophys412:34?41.
	BylundJandOliwEH(2001)CloningandcharacterizationofCYP4F21:aprosta-glandinE220-hydroxylaseoframseminalvesicles.ArchBiochemBiophys389:123?129.
	ChenLandHardwickJP(1993)IdentificationofanewP450subfamily,CYP4F1,expressedinrathepatictumors.ArchBiochemBiophys300:18?23.
	ChristmasP,JonesJP,PattenCJ,RockDA,ZhengY,ChengSM,WeberBM,CarlessoN,ScaddenDT,RettieAE,etal.(2001)AlternativesplicingdeterminesthefunctionofCYP4F3byswitchingsubstratespecificity.JBiolChem276:38166?38172.
	CuiX,KawashimaH,BarclayTB,PetersJM,GonzalezFJ,MorganET,andStrobelHW(2001)MolecularcloningandregulationofexpressionoftwonovelmouseCYP4Fgenes:expressioninperoxisomeproliferator-activatedreceptor-deficientmiceuponlipopolysaccharideandclofibratechallenges.JPharmacolExpTher296:542?550.
	CuiX,NelsonDR,andStrobelHW(2000)AnovelhumancytochromeP4504Fisoform(CYP4F11):cDNAcloning,expressionandgenomicstructuralcharacter-ization.Genomics68:161?166.
	DawsonJHandSonoM(1987)CytochromeP-450andchloroperoxidase:thiolate-ligatedhemeenzymes.Spectroscopicdeterminationoftheiractive-sitestructuresandmechanisticimplicationsofthiolateligation.ChemRev87:1255?1276.
	DierksEA,DavisSC,andOrtizdeMontellanoPR(1998)Glu-320andAsp-323aredeterminantsoftheCYP4A1hydroxylationregiospecificityandresistancetoin-activationby1-aminobenzotriazole.Biochemistry37:1839?1847.
	EscalanteB,ErlijD,FalckJR,andMcGiffJC(1994)CytochromeP-450arachidonatemetabolitesaffectionfluxesinrabbitmedullarythickascendinglimb.AmJPhysiol266:C1775?C1782.
	EstabrookRW,PetersonJ,BaronJ,andHildebrandtA(1972)Thespectrophoto-metricmeasurementofturbidsuspensionsofcytochromesassociatedwithdrugmetabolism,inMethodsinPharmacology(ChignellCFed)pp303?350,Appleton-CenturyCrofts,NewYork.
	FalckJR,BelosludtsevYY,ReddyKK,ReddyKM,ShorttMF,ChauhanK,Capdev-ilaJH,andWeiS(1997)Eicosanoidbiosynthesis:differentialinhibitionofcyto-chromeP450epoxygenaseand-hydroxylase.BioorgMedChemLett7:3053?3056.
	HashizumeT,ImaokaS,HiroiT,TerauchiY,FujiiT,MiyazakiH,KamatakiT,andFunaeY(2001)cDNAcloningandexpressionofanovelcytochromeP450(CYP4F12)fromhumansmallintestine.BiochemBiophysResCommun280:1135?1141.
	HochU,ZhangZ,KroetzDL,andOrtizdeMontellanoPR(2000)Structuraldeter-minationofthesubstratespecificitiesandregioselectivitiesoftheratandhumanfattyacid-hydroxylases.ArchBiochemBiophys373:63?71.
	KalsotraA,AnakkS,BoehmeCL,andStrobelHW(2002)SexualdimorphismandtissuespecificityintheexpressionofCYP4FformsinSpragueDawleyrats.DrugMetabDispos30:1022?1028.
	KawashimaH,KusunoseE,ThompsonCM,andStrobelHW(1997)Proteinexpres-sion,characterizationandregulationofCYP4F4andCYP4F5clonedfromratbrain.ArchBiochemBiophys347:148?154.
	KawashimaHandStrobelHW(1995)cDNAcloningofthreenewformsofratbraincytochromeP450belongingtotheCYP4Fsubfamily.BiochemBiophysResCom-mun217:1137?1144.
	KikutaY,KusunoseE,EndoK,YamamotoS,SogawaK,Fujii-KuriyamaY,andKusunoseM(1993)AnovelformofcytochromeP-450family4inhumanpolymor-phonuclearleukocytes.cDNAcloningandexpressionofleukotrieneB4-hydrox-ylase.JBiolChem268:9376?9380.
	KikutaY,KusunoseE,ItoM,andKusunoseM(1999)Purificationandcharacter-izationofrecombinantrathepaticCYP4F1.ArchBiochemBiophys369:193?196.
	KroetzDL,HuseLM,ThuressonA,andGrilloMP(1997)DevelopmentallyregulatedexpressionoftheCYP4Agenesinthespontaneouslyhypertensiveratkidney.MolPharmacol52:362?372.
	LaskerJM,ChenWB,WolfI,BloswickBP,WilsonPD,andPowellPK(2000)Formationof20-hydroxyeicosatetraenoicacid,avasoactiveandnatriureticeico-sanoid,inhumankidney.RoleofCYP4F2andCYP4A11.JBiolChem275:4118?4126.
	LeBrunLA,XuF,KroetzDL,andOrtizdeMontellanoPR(2002)Covalentattach-mentofthehemeprostheticgroupintheCYP4FcytochromeP450family.Bio-chemistry41:5931?5937.
	NguyenX,WangMH,ReddyKM,FalckJR,andSchwartzmanML(1999)KineticprofileoftheratCYP4Aisoforms:arachidonicacidmetabolismandisoform-specificinhibitors.AmJPhysiol276:R1691?R1700.
	OkitaRT,ClarkJE,OkitaJR,andMastersBS(1991)-and(-1)-hydroxylationofeicosanoidsandfattyacidsbyhigh-performanceliquidchromatography.MethodsEnzymol206:432?441.
	OmuraTandSatoR(1964a)Thecarbonmonoxide-bindingpigmentoflivermicro-somes.JBiolChem239:2379?2385.
	OmuraTandSatoR(1964b)Thecarbonmonoxide-bindingpigmentoflivermicro-somes.I.Evidenceforitshemoproteinnature.JBiolChem239:2370?2378.
	SchwartzmanM,FerreriNR,CarrollMA,Songu-MizeE,andMcGiffJC(1985)RenalcytochromeP450-relatedarachidonatemetaboliteinhibitsNa,K-ATPase.Nature(Lond)314:620?622.
	StecDE,DengAY,RappJP,andRomanRJ(1996)CytochromeP4504AgenotypecosegregateswithhypertensioninDahlSrats.Hypertension27:564?568.
	StecDE,FlaschA,RomanRJ,andWhiteJA(2003)DistributionofcytochromeP-4504Aand4Fisoformsalongthenephroninmice.AmJPhysiol284:F95?F102.
	SuP,KaushalKM,andKroetzDL(1998)Inhibitionofrenalarachidonicacid-hydroxylaseactivitywithABTreducesbloodpressureintheSHR.AmJPhysiol275:R426?R438.
	SumimotoJ,TakeshigeK,andMinakamiS(1988)CharacterizationofhumanneutrophilleukotrieneB4-hydroxylaseasasysteminvolvingauniquecyto-chromeP-450andNADPH-cytochromeP-450reductase.EurJBiochem172:315?324.
	WangMH,Brand-SchieberE,ZandBA,NguyenX,FalckJR,BaluN,andSchwartz-manML(1998)CytochromeP450-derivedarachidonicacidmetabolismintheratkidney:characterizationofselectiveinhibitors.JPharmacolExpTher284:966?973.
	WangMH,ZhangF,MarjiJ,ZandBA,NasjlettiA,andLaniado-SchwartzmanM(2001)CYP4A1antisenseoligonucleotidereducesmesentericvascularreactivityandbloodpressureinSHR.AmJPhysiol280:R255?R261.
	WangWandLuM(1995)EffectofarachidonicacidonactivityoftheapicalKchannelinthethickascendinglimboftheratkidney.JGenPhysiol106:727?743.
	XuF,StraubWO,PakW,SuP,MaierKG,YuM,RomanRJ,OrtizDeMontellanoPR,andKroetzDL(2002)Antihypertensiveeffectofmechanism-basedinhibitionofrenalarachidonicacid-hydroxylaseactivity.AmJPhysiol283:R710?R720.
	ZhangX,ChenL,andHardwickJP(2000)PromoteractivityandregulationoftheCYP4F2leukotrieneB4-hydroxylasegenebyperoxisomalproliferatorsandreti-noicacidinHepG2cells.ArchBiochemBiophys378:364?376.
	ZouAP,FlemingJT,FalckJR,JacobsER,GebremedhinD,HarderDR,andRomanRJ(1996)20-HETEisanendogenousinhibitorofthelarge-conductanceCa2-activatedKchannelinrenalarterioles.AmJPhysiol270:R228?R237.
	ZouAP,ImigJD,KaldunskiM,OrtizdeMontellanoPR,SuiZ,andRomanRJ(1994a)Inhibitionofrenalvascular20-HETEproductionimpairsautoregulationofrenalbloodflow.AmJPhysiol266:F275?F282.
	ZouAP,ImigJD,OrtizdeMontellanoPR,SuiZ,FalckJR,andRomanRJ(1994b)EffectofP-450-hydroxylasemetabolitesofarachidonicacidontubuloglomerularfeedback.AmJPhysiol266:F934?F941.
	ZouAP,MaYH,SuiZH,OrtizdeMontellanoPR,ClarkJE,MastersBS,andRomanRJ(1994c)Effectsof17-octadecynoicacid,asuicide-substrateinhibitorofcyto-chromeP450fattyacid-hydroxylase,onrenalfunctioninrats.JPharmacolExpTher268:474?481.
gb-2003-4-11-r73.pdf	32
	1.Dehal P, Satou Y, Campbell RK, Chapman J, Degnan B, De Tomaso A,Davidson B, Di Gregorio A, Gelpke M, Goodstein DM, et al.: The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science 2002, 298:2157-2167.	12481130
	2.Schmidtke J, Epplen JT, Engel W: Genome analysis of Amphioxusand speculation as to the origin of contrasting vertebrategenome organization patterns. Comp Biochem Physiol 1979,63:455-458.	318423
	3.Simmen MW, Bird A: Sequence analysis of transposable ele-ments in the sea squirt, Ciona intestinalis. Mol Biol Evol 2000,17:1685-1694.	11070056
	4.Charlesworth B, Sniegowski P, Stephan W: The evolutionarydynamics of repetitive DNA in eukaryotes. Nature 1994,371:215-220.	8078581
	5.Finnegan DJ: Eukaryotic transposable elements and genomeevolution. Trends Genet 1989, 5:103-107.	2543105
	6.Finnegan DJ: Transposable elements. Curr Opin Genet Dev 1992,2:861-867.	1335807
	7.Xiong Y, Eickbush TH: Origin and evolution of retro elements based upon their reverse transcriptase sequences. EMBO J1990, 9:3353-3362.	2797181
	8.Luan DD, Korman MH, Jakubczak JL, Eickbush TH: Reverse tran-scription of R2Bm RNA is primed by a nick at the chromo-somal target site: a mechanism for non-LTRretrotransposition. Cell 1993, 72:595-605.	7679954
	9.Burch JB, Davis DL, Haas NB: Chicken repeat 1 elements contain a pol-like open reading frame and belong to the non-long terminal repeat class of retrotransposons. Proc Natl AcadSci USA 1993, 90:8199-8203.	1656225
	10.Martï¿½n F, Olivares M, Lï¿½pez MC: Do non-long terminal repeatretrotransposons have nuclease activity? Trends Biochem Sci1996, 21:283-285.	8772379
	11.Malik HS, Burke WD, Eickbush TH: The age and evolution of non-LTR retrotransposable elements. Mol Biol Evol 1999, 16:793-805.	10368957
	12.Malik HS, Eickbush TH: NeSL-1, an ancient lineage of site-specific non-LTR retrotransposons from Caenorhabditis elegans.Genetics 2000, 154:193-203.	8121285
	13.Volff JN, Korting C, Schartl M: Multiple lineages of the non-LTRretrotransposon Rex1 with varying success in invading fishgenomes. Mol Biol Evol 2000, 17:1673-1684.	11070055
	14.Lovsin N, Gubensek F, Kordi D: Evolutionary dynamics in anovel L2 clade of non-LTR retrotransposons inDeuterostomia. Mol Biol Evol 2001, 18:2213-2224.	11719571
	15.Aparicio S, Chapman J, Stupka E, Putnam N, Chia JM, Dehal P, Christ-offels A, Rash S, Hoon S, Smit A, et al.: Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science2002, 297:1301-1310.	12193771
	16.Albalat R, Permanyer J, Caï¿½estro C, Martï¿½nez-Mir A, Gonzï¿½lez-Angulo O, Gonzï¿½lez-Duarte R: The first non-LTR retrotranspo-son characterised in the cephalochordate amphioxus,BfCR1, shows similarities to CR1-like elements. Cell Mol Life Sci2003, 60:803-809.	12785727
	17.Tu Z, Isoe J, Guzova JA: Structural, genomic, and phylogeneticanalysis of Lian, a novel family of non-LTR retrotransposonsin the yellow fever mosquito, Aedes aegypti. Mol Biol Evol 1998,15:837-853.	9656485
	18.Burke WD, Malik HS, Jones JP, Eickbush TH: The domain structureand retrotransposition mechanism of R2 elements are con-served throughout arthropods. Mol Biol Evol 1999, 16:502-511.	10331276
	19.Caï¿½estro C, Albalat R, Gonzï¿½lez-Duarte R: Isolation and charac-terization of the first non-autonomous transposable elementin amphioxus, ATE-1. Gene, in press.	14585499
	20.Yoder JA, Walsh CP, Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997, 13:335-340.	9260513
	21.Simmen MW, Leitgeb S, Charlton J, Jones SJ, Harris BR, Clark VH,Bird A: Nonmethylated transposable elements and methyl-ated genes in a chordate genome. Science 1999, 283:1164-1167.	10024242
	22.Chaboissier MC, Bucheton A, Finnegan DJ: Copy number control of a transposable element, the I factor, a LINE-like element in Drosophila. Proc Natl Acad Sci USA 1998, 95:11781-11785.	3246353
	23.Jensen S, Gassama MP, Heidmann T: Taming of transposable elements by homology-dependent gene silencing. Nat Genet 1999,21:209-212.	9988259
	24.Flavell RB: Inactivation of gene expression in plants as a consequence of specific sequence duplication. Proc Natl Acad SciUSA 1994, 91:3490-3496.	1886604
	25.Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997,25:3389-3402.	9000507
	26.DOE Joint Genome Institute  [http://www.jgi.doe.gov]
	27.Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad SciUSA 1984, 81:1991-1995.	6260591
	28.Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.Nucleic Acids Res 1997, 25:4876-4882.	1520737
	29.Page RDM: TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996,12:357-358.	8902363
	30.Berezikov E, Bucheton A, Busseau I: A search for reverse transcriptase-coding sequences reveals new non-LTR retrotransposons in the genome of Drosophila melanogaster. Genome Biol2000, 1:research0012.1-0012.15.	2430722
	31.Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, Wincker P, Clark AG, Ribeiro JM, Wides R, et al.: The genome sequence of the malaria mosquito Anophelesgambiae. Science 2002, 298:129-149.	12364791
	32.Fawcett DH, Lister CK, Kellett E, Finnegan DJ: Transposable ele-ments controlling I-R hybrid dysgenesis in D. melanogasterare similar to mammalian LINEs. Cell 1986, 47:1007-1015.	2430722
gb-2003-4-11-r72.pdf	42
	1.Wang Z, Moult J: SNPs, protein structure, and disease. HumMutat 2001, 17:263-270.	11295823
	2.Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, BorkP: Prediction of deleterious human alleles. Hum Mol Genet 2001,10:591-597.	11230178
	3.Ng PC, Henikoff S: Predicting deleterious amino acid substitutions. Genome Res 2001, 11:863-874.	6990017
	4.Chasman D, Adams M: Predicting the functional consequencesof non-synonymous single nucleotide polymorphisms: struc-ture-based assessment of amino acid variation. J Mol Biol 2001,307:683-706.	11254390
	5.Miller MP, Kumar S: Understanding human disease mutationsthrough the use of interspecific variation. Hum Mol Genet 2001,10:2319-2328.	11689479
	6.Terp BN, Cooper DN, Christensen IT, Jorgensen FS, Bross P,Gregersen N, Krawczak M: Assessing the relative importance ofthe biophysical properties of amino acid substitutions associ-ated with human genetic disease. Hum Mutat 2002, 20:98-109.	12124990
	7.McKusick VA: Mendelian Inheritance in Man. Catalogs of Human Genesand Genetic Disorders 12th edition. Baltimore: John Hopkins UniversityPress; 1998. 
	8.Bairoch A, Apweiler R: The SWISS-PROT protein sequencedata bank and its new supplement TrEMBL. Nucleic Acids Res1996, 24:21-25.	7937043
	9.Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE,Jiang R, Messer CJ, Chew A, Han JH, et al.: Haplotype variation andlinkage disequilibrium in 313 human genes. Science 2001,293:489-493.	11452081
	10.Dayhoff MO: A model of evolutionary change in proteins. InAtlas of Protein Sequence and Structure Edited by: Silver Spring: NationalBiomedical Research Foundation. Dayhoff MO; 1978:345-352. 
	11.Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, CooperR, Lipshutz R, Chakravarti A: Patterns of single-nucleotide poly-morphisms in candidate genes for blood-pressurehomeostasis. Nat Genet 1999, 22:239-247.	10391210
	12.Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N,Lane CR, Lim EP, Kalyanaraman N, et al.: Characterization of sin-gle-nucleotide polymorphisms in coding regions of humangenes. Nat Genet 1999, 22:231-238.	10391209
	13.Hess ST, Blake JD, Blake RD: Wide variations in neighbor-dependent substitution rates. J Mol Biol 1994, 236:1022-1033.	8120884
	14.Sonnhammer EL, von Heijne G, Krogh A: A hidden Markov modelfor predicting transmembrane helices in protein sequences.Proc Int Conf Intell Syst Mol Biol 1998, 6:175-182.	9783223
	15.Benner SA, Cohen MA, Gonnet GH: Amino acid substitutionduring functionally constrained divergent evolution of pro-tein sequences. Protein Eng 1994, 7:1323-1332.	7700864
	16.Cooper DN, Youssoufian H: The CpG dinucleotide and humangenetic disease. Hum Genet 1988, 78:151-155.	3338800
	17.Krawczak M, Ball EV, Cooper DN: Neighboring-nucleotide effects on the rates of germline single base-pair substitution in human genes. Am J Hum Genet 1998, 63:474-488.	2192981
	18.Ng PC, Henikoff S: Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002, 12:436-446.	10828087
	19.Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs:server and survey. Nucleic Acids Res 2002, 30:3894-3900.	10364531
	20.Ferrer-Costa C, Orozco M, de la Cruz X: Characterization of dis-ease-associated single amino acid polymorphisms in termsof sequence and structure properties. J Mol Biol 2002, 315:771-786.	11812146
	21.Bustamante CD, Townsend JP, Hartl DL: Solvent accessibility andpurifying selection within proteins of Escherichia coli and Sal-monella enterica. Mol Biol Evol 2000, 17:301-308.	10677853
	22.Grantham R: Amino acid difference formula to help explainprotein evolution. Science 1974, 185:862-864.	4843792
	23.Fay JC, Wyckoff GJ, Wu CI: Positive and negative selection on the human genome. Genetics 2001, 158:1227-1234.	10659848
	24.Terwilliger JD, Haghighi F, Heikkalinna TS, Goring HH: A biasedassessment of the use of SNPs in human complex traits. CurrOpin Genet Dev 2002, 12:726-734.	12433588
	25.Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribu-tion of common variants to susceptibility to commondisease. Nat Genet 2003, 33:177-182.	12524541
	26.Olins PO, Bauer SC, Braford-Goldberg S, Sterbenz K, Polazzi JO,Caparon MH, Klein BK, Easton AM, Paik K, Klover JA, et al.: Satura-tion mutagenesis of human interleukin-3. J Biol Chem 1995,270:23754-23760.	7559548
	27.Huang W, Petrosino J, Hirsch M, Shenkin PS, Palzkill T: Amino acidsequence determinants of beta-lactamase structure andactivity. J Mol Biol 1996, 258:688-703.	8637002
	28.Pakula AA, Sauer RT: Genetic analysis of protein stability andfunction. Annu Rev Genet 1989, 23:289-310.	2694933
	29.Matthews BW: Structural and genetic analysis of the foldingand function of T4 lysozyme. FASEB J 1996, 10:35-41.	8566545
	30.Nachman MW, Crowell SL: Estimate of the mutation rate per nucleotide in humans. Genetics 2000, 156:297-304.	9582070
	31.Eyre-Walker A, Keightley PD: High genomic deleterious mutation rates in hominids. Nature 1999, 397:344-347.	9950420
	32.Henikoff S, Henikoff JG: Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992, 89:10915-10919.	1849861
	33.Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E,Sing CF: Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet 2000, 66:69-83.	9736776
	34.Zavolan M, Kepler TB: Statistical inference of sequence-dependent mutation rates. Curr Opin Genet Dev 2001, 11:612-615.	11682302
	35.Rogozin I, Kondrashov F, Glazko G: Use of mutation spectraanalysis software. Hum Mutat 2001, 17:83-102.	11180592
	36.Wootton JC, Federhen S: Analysis of compositionally biasedregions in sequence databases. Methods Enzymol 1996, 266:554-571.	8743706
	37.Holm L, Sander C: Removing near-neighbour redundancy fromlarge protein sequence collections. Bioinformatics 1998, 14:423-429.	9682055
	38.Higgins DG, Thomposon JD, Gibson TJ: Using CLUSTAL for mul-tiple sequence alignments. Methods Enzymol 1996, 266:383-402.	8743695
	39.Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lip-man DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 1997,25:3389-3402.	9000507
	40.Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD,Rodgers JR, Kennard O, Shimanouchi T, Tasumi M: The ProteinData Bank: A computer based archival file for macromolecu-lar structures. J Mol Biol 1977, 112:535-542.	875032
	41.Hubbard SJ, Thornton JM: NACCESS Computer Program London:Department of Biochemistry and Molecular Biology, University Col-lege London; 1993. 
	42.Mount DW: Bioinformatics Cold Spring Harbor, NY: Cold Spring Har-bor Laboratory Press; 2001. 
621.full.pdf	35
	BlairRM,GeisertRD,ZavyMT,ShortEC,FultonRWandYellinT(1991)Endometrialmorphologicalandsecretoryalterationsassociatedwithembryonicmortalityingiltsadministeredestradiolvalerateondays9and10ofgestationBiologyofReproduction441063?1079
	BostF,Diarra-MehrpourMandMartinJP(1998)Inter--trypsininhibi-torproteoglycanfamily:agroupofproteinsbindingandstabilizingtheextracellularmatrixEuropeanJournalofBiochemistry222339?
	BowenJA,BazerFWandBurghardtRC(1996)SpatialandtemporalanalysesofintegrinandMUC-1expressioninporcineuterineepitheliumandtrophectoderminvivo.BiologyofReproduction551098?1106
	ChenL,MaoSJT,McLeanLR,PowersRWandLarsenWJ(1994)Proteinsoftheinter--trypsininhibitorfamilystabilizethecumulusextracellularmatrixthroughtheirdirectbindingwithhyaluronicacidJournalofBiologicalChemistry26928282?28287
	ChenL,ZhangH,PowersRW,RussellPTandLarsenWJ(1996)Covalentlinkagebetweenproteinsoftheinter--inhibitorfamilyandhyaluronicacidismediatedbyafactorproducedbygranulosacellsJournalofBiologicalChemistry27119409?19414
	Choi-MiuraN-H,SanoY,OdaE,NakanoY,TobeT,YanagishitaT,TaniyamaM,KatagireTandTomitaM(1995)Purificationandcharacterizationofanovelglycoproteinwhichhassignificanthomologytoheavychainsofinter--trypsininhibitorfamilyfromhumanplasmaJournalofBio-chemistry117400?407
	Choi-MiuraN-H,TakahashiK,YodaM,SaitoK,HoriM,OzakiH,MazdaTandTomitaM(2000)Thenovelacutephaseprotein,IHRP,inhibitsactinpolymerizationandphagocytosisofpolymorphonuclearcellsInflammationResearch49305?310
	DantzerV(1985)ElectronmicroscopyoftheinitialstagesofplacentationinthepigAnatomyandEmbryology172281?293
	EnghildJJ,ThogersenIB,PizzoSVandSalvesenG(1989)Analysisofinter--trypsininhibitor,pre--trypsininhibitor,fromhumanplasmaJournalofBiologicalChemistry26415975?15981
	EnghildJJ,SalvesenG,HeftaSA,ThogersenIB,RutherfurdSandPizzoSV(1991)Chondroitin4-sulfatecovalentlycross-linksthechainsofthehumanbloodproteinpre--inhibitorJournalofBiologicalChemistry266747?751
	FazleabasAT,GeisertRD,BazerFWandRobertsRM(1983)RelationshipbetweenreleaseofplasminogenactivatorandestrogenbyblastocystsandsecretionofplasmininhibitorbyuterineendometriuminthepregnantpigBiologyofReproduction29225?238
	FordSPandChristensonRK(1979)Bloodflowtouteriofsowsduringtheestrouscycleandearlypregnancy:localeffectoftheconceptusontheuterinebloodsupplyBiologyofReproduction21617?624
	FordSP,ChristensonRKandFordJJ(1982)Uterinebloodflowanduterinearterial,venousandlumenalconcentrationsofoestrogensondays11,13,and15afteroestrusinpregnantandnon-pregnantsowsJournalofReproductionandFertility64185?190
	GeisertRDandYelichJV(1997)RegulationofconceptusdevelopmentandattachmentinpigsJournalofReproductionandFertilitySupplement52133?149
	GeisertRD,RenegarRH,ThatcherWW,RobertsRMandBazerFW(1982)Establishmentofpregnancyinthepig.I.Interrelationshipsbetweenpreimplantationdevelopmentofthepigblastocystanduterineendo-metrialsecretionsBiologyofReproduction27925?939
	GeisertRD,DixonMJ,PrattT,SchmittRAM,LessleyBAandMcCannJP(1995)Isolationandcharacterizationofa30kDaendometrialglycoproteinsynthesizedduringtheestrouscycleandearlypregnancyinthepigBiologyofReproduction53942?954
	GeisertRD,YelichJV,PrattTandPompD(1998)Expressionofaninter--trypsininhibitorheavychain-likeproteininthepigendometriumduringtheoestrouscycleandearlypregnancyJournalofReproductionandFertility11435?43
	GriesLK,GeisertRD,ZavyMT,GarrettJEandMorganGL(1989)UterinesecretoryalterationscoincidentwithembryonicmortalityinthegiltafterexogenousestrogenadministrationJournalofAnimalScience67276?284
	HettingerAM,AllenMA,ZhangBR,GoadDW,MalayerJRandGeisertRD(2001)Presenceofacutephaseprotein,bikunin,intheendometriumofgiltsduringestrouscycleandearlypregnancyBiologyofReproduction65507?513
	JaegerLA,JohnsonGA,KAH,GarlowJG,BurghardtRC,SpencerTEandBazerFW(2001)Functionalanalysisofautocrineandparacrinesig-nalingattheuterine?conceptusinterfaceinpigsReproductionSupple-ment58191?207
	JessenTE,OdumLandJohnsenAH(1994)Invivobindingofhumaninter--trypsininhibitorfreeheavychainstohyaluronicacidBiologicalChemistryHoppe-Seyler375521?526
	KeysJLandKingGJ(1988)MorphologicalevidenceforincreaseduterinevascularpermeabilityatthetimeofembryonicattachmentinthepigBiologyofReproduction39473?487
	KingGJ,AtkinsonAandRobertsonHA(1982)ImplantationandearlyplacentationindomesticungulatesJournalofReproductionandFertilitySupplement3117?30
	NishimuraH,KakizakiI,MutaT,SasakiN,PuPX,YamashitaTandNagasawaS(1995)cDNAanddeducedaminoacidsequenceofhumanPK-120,aplasmakallikrein-sensitiveglycoproteinFEBSLetters357207?211
	RobertsRM,XieSandTroutWE(1993)Embryo?uterineinteractionsinpigsduringweek2ofpregnancyJournalofReproductionandFertilitySupplement48171?186
	RouetP,DaveauMandSalierJ-P(1992)Electrophoreticpatternoftheinter--inhibitorfamilyproteinsinhumanserum,characterizedbychainspecificantibodiesBiologicalChemistryHoppe-Seyler3731019?1024
	SalierJ-P,RouetP,RaguenezGandDaveauM(1996)Theinter--inhibitorfamily:fromstructuretoregulationBiochemicalJournal3151?9
	SamuelCAandPerryJS(1972)TheultrastructureofpigtrophoblasttransplantedtoanectopicsiteintheuterinewallJournalofAnatomy113139?149
	SAS/STAT(1988)User?sguide.SASInstitute,Inc.,Cary,NorthCarolina
	StrobandHWJandVanderLendeT(1990)EmbryonicanduterinedevelopmentduringearlypregnancyinpigsJournalofReproductionandFertilitySupplement40261?277
	VonnahmeKA,MalayerJR,SpiveyHO,FordSP,ClutterAandGeisertRD(1999)DetectionofkallikreingeneexpressionandenzymaticactivityinporcineendometriumduringtheestrouscycleandearlypregnancyBiologyofReproduction611235?1241
	YelichJV,PompDandGeisertRD(1997a)Detectionoftranscriptsforretinoicacidreceptors,retinolbindingprotein,andtransforminggrowthfactorsduringrapidtrophoblasticelongationintheporcineconceptusBiologyofReproduction57126?134
	YelichJV,PompDandGeisertRD(1997b)OntogenyofelongationandgeneexpressionintheearlydevelopingporcineconceptusesBiologyofReproduction571256?1264
	XuY,CarrPD,GussJMandOllisDL(1998)Thecrystalstructureofbikuninfromtheinter--inhibitorcomplex:aserineproteaseinhibitorwithtwokunitzdomainsJournalofMolecularBiology276955?966
	ZhuoL,YonedaM,ZhaoM,YingsungW,YoshidaN,KitagawaY,KawamuraK,SuzukiTandKimataK(2001)DefectinSHAP-hyaluronancomplexcausesseverefemaleinfertility:astudybyinactivationofthebikuningeneinmiceJournalofBiologicalChemistry2767693?7696
Authorize.PDF	29
	1.Gotlieb MS, Schanker HM, Fan PT, Saxon A, Weisman JD, Pozalski.Pneumocystic pneumonia. Los Angeles MMWR Weekly1981; 30:250?252.
	2.UNAIDS. Aids Epidemic Update. 1December 2002.
	3.Yunis NA, Stone VE. Cardiac Manifestationsof HIV/AIDS: Areviewof disease spectrum and clinical management. J Acq Imm Def SyndrHum Retrovirol1998; 18: 145?154.	9637579
	4.Hakim JG, Matenga JA, Siziya. Myocardial dys function in human immuno deficiency virus infection: an echocardiographic study of 157patients in hospital in Zimbabwe. Heart1996; 76: 161?165.	1733387
	5.Herskowitz A, Vlahov D, Willoughby S, et al.Prevalence and inci-dence of left ventricular dysfunction in patients with human immuno-deficiency infection. Am J Cardiol1993; 71: 955?958.	8465788
	6.Kinney EL, Brafman D, Wright RJ. Echocardiographic findings inpatients with acquired immunodeficiency syndrome (AIDS) andAIDS-related complex (ARC). Cathet Cardiocvasc Diagnosis1989;16: 182?185.	2920391
	7.Lassaigne D, Greder A, Hedoire F, Grollier G, Potier JC, Bazin C.Myocardial involvement in AIDS: Echographic study in 85 humanimmunodeficiency virus infected patients. Ann Med Interne Paris1991; 142: 205?208.	1854133
	8.Barbaro G, Di Lorenzo G, Grisario B, Bacbarini G. Incidence of dilated cardiomyopathy and detection of HIVin myocardial cells of HIVpositive patients. N Engl J Med 1998; 16: 1039?1099.	12110745
	9.Longo-Mbenza B, Seghers KV, Phuati M, Nkiabungu Bikangi F,Mubagwa K. Heart involvement in HIVinfection in African patients:Determinants of survival. Int J Cardiol 1998; 64: 63?73.	9579818
	10.Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquiredimmune deficiency syndrome. Am Heart J1991; 122: 535?544.	1858638
	11.Anderson DW, Virmani R, Reilly JM, O?Leary T, Cunnion RE,Robinowits M, et al. Prevalent myocarditis at necropsy in the acquiredimmunodeficiency syndrome. J Am Coll Cardiol 1988; 11:792?799.	3351145
	12.Autron BR, Gorin I, Leibowitch M. AIDS in a Haitian woman withKaposi?s sarcoma and Whipple?s disease. Lancet1983; 1: 767?768.
	13.Cotton P. AIDS giving rise to cardiac problems. J Am Med Assoc1990;263: 2149.	2319673
	14.Grody WW, Cheng L, Lewis W. Infection of the heart by the humanimmunodeficiency virus. Am J Cardiol1990; 66: 203?206.	2371952
	15.Flomenbaum M, Soeiro Rm Udem SA, Kress Y, Factor SM.Proliferative membranopathy and human immunodeficiency virus inAIDS hearts. J AIDS1989; 2: 129?135.	2539451
	16.Herskowitz A, Nieumann DA, Ansari AA. Concepts of auto immunity applied to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993;22: 1385?1388.	7901255
	17.Patel RC, Frishman WH. Cardiac involvement in HIVinfection. MedClin North Am 1996; 80: 1493?1512.	8941233
	18.Dworkin BM, Antonecchia PP, Smith F, et al. Reduced cardiac selenium content in AIDS. J Parenter Enteral Nutr 1989; 13: 644?647.	2614866
	19.Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis1994; 75: 429?434.	7718831
	20.Longo_Mbenza B, Tonduangu K, Seghers KV, Mubazwa D. HIV infection and pericardial disease invasion in Africa. Arch M CoeurVaiss 1997; 90: 1377?1384.	9539838
	21.Flum DR, McGinn JTJr, Tyras DH. The role of the ?pericardial win-dow?in AIDS. Chest1995; 107: 1522?1525.	7781340
	22.Herskowitz A, Willonguby SB, BaughmanKL, Schulman SP, BartlettJD. Cardiomyopathy associated with antiretroviral therapy in patientswith HIVinfection: a report of six cases. Ann Intern Med1992; 116:311?313.	1733387
	23.Domanski MJ, Sloas MM, Follmann DA. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr1995; 127: 137?146.	8627455
	24.Carr A, Samaras K, Burton S, Lan M, Freund J, Chrisholm DJ, CooperDA. Asyndrome of peripheral lipodystrophy hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS1998; 12: 51?58.	12891075
	25.Gallet B, Pulik M, Genet P, Chedin P, Hictgen M. Vascular complications associated with the use of HIV protease inhibitors (letter). Lancet1998; 351: 1959.	9643798
	26.Jï¿½tte A, Franzen C, Rï¿½mer K, Cornely D, Diet F, Diehl V, Fï¿½tkenheuerG, Salzberger B. Increased morbidity from myocardial infarction dur-ing HIVprotease inhibitor treatment (abstr 656). Sixth conference onRetrovirus and Opportunistic infections. Chicago; January/February1999.
	27.Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702.	14602888
	28.Duong M, Buisson M, Cottin Y, Piroth L, Lhuillier I, Grappin M, et al.Coronary heart disease associated with the use of human immunodefi-ciency virus (HIV)-1 protease inhibitors: Report of four cases andreview. Clin Cardiol 2001; 24: 690?694.	11594416
	29.Andrews S, Cotton M, Maartens G, Martin D, Miller S, Wood R, et al.Clinical guidelines. Antiretroviral therapy in adults: June 2002 version.Sth Afr J HIVMed 2002; 8: 22?29.
JVS004-02-15.pdf	6
j.1432-1033.2003.03803.x.pdf	115
	1.dosRemedios,C.G.,Chhabra,D.,Kekic,M.,Dedova,I.V.,Tsubakihara,M.,Berry,D.A.&Noseworthy,N.J.(2003)Actinbindingproteins:regulationofcytoskeletalmicro?laments.Phy-siol.Rev.83,433?473.
	2.Sun,H.Q.,Yamamoto,M.,Mejillano,M.&Yin,H.L.(1999)Gelsolin,amultifunctionalactinregulatoryprotein.J.Biol.Chem.274,33179?33182.
	3.Way,M.&Weeds,A.G.(1988)Nucleotidesequenceofpigplasmagelsolin.Comparisonofproteinsequencewithhumangelsolinandotheractin-severingproteinsshowsstronghomo-logiesandevidenceforlargeinternalrepeats.J.Mol.Biol.203,1127?1133.
	4.Burtnick,L.D.,Koepf,E.K.,Grimes,J.,Jones,E.Y.,Stuart,D.I.,McLaughlin,P.J.&Robinson,R.C.(1997)Thecrystalstructureofplasmagelsolin:Implicationsforactinsevering,cappingandnucleation.Cell.90,661?670.
	5.Robinson,R.C.,Mejillano,M.,Le,V.P.,Burtnick,L.D.,Yin,H.L.&Choe,S.(1999)Domainmovementingelsolin:acalcium-activatedswitch.Science.286,1939?1942.
	6.Bryan,J.(1988)Gelsolinhasthreeactin-bindingsites.J.CellBiol.106,1553?1562.
	7.Pope,B.,Way,M.&Weeds,A.G.(1991)Twoofthethreeactin-bindingdomainsofgelsolinbindtothesamesubdomainofactin.FEBSLett.280,70?74.
	8.Pope,B.,Maciver,S.&Weeds,A.G.(1995)Localizationofthecalcium-sensitiveactinmonomerbindingsiteingelsolintoseg-ment4andidenti?cationofcalcium-bindingsites.Biochemistry.34,1583?1588.
	9.Xu,Y.-S.,Kantorow,M.,Davis,J.&Piatigorsky,J.(2000)Evi-denceforgelsolinasacornealcrystallininzebra?sh.J.Biol.Chem.275,24645?24652.
	10.Steed,P.M.,Nagar,S.&Wennogle,L.P.(1996)PhospholipaseDregulationbyaphysicalinteractionwiththeactin-bindingproteingelsolin.Biochemistry.35,5229?5237.
	11.Ohtsu,M.,Sakai,N.,Fujita,H.,Kashiwagi,M.,Gasa,S.,Shi-mizu,S.,Eguchi,Y.,Tsujimoto,Y.,Sakiyama,Y.,Kobayashi,K.&Kuzumaki,N.(1997)Inhibitionofapoptosisbytheactin-regulatoryproteingelsolin.EMBOJ.16,4650?4656.
	12.Harris,H.E.,Bamburg,J.R.&Weeds,A.G.(1980)Actin?lamentdisassemblyinbloodplasma.FEBSLett.123,49?53.
	13.Haddad,J.G.,Harper,K.D.,Guoth,M.,Pietra,G.G.&Sanger,J.W.(1990)Angiogenicconsequencesofsaturatingtheplasmascavengersystemforactin.Proc.Nat.Acad.Sci.87,1381?1385.
	14.Cunningham,C.C.,Stossel,T.P.&Kwiatkowski,D.J.(1991)EnhancedmotilityinNIH3T3?broblaststhatoverexpressgel-solin.Science.251,1233?1236.
	15.Cunningham,C.C.,Vegners,R.,Bucki,R.,Funaki,M.,Korde,N.,Hartwig,J.H.,Stossel,T.P.&Janmey,P.A.(2001)Cellper-meantpolyphsophoinositide-bindingpeptidesthatblockcellmotililtyandactinassembly.J.Biol.Chem.276,43390?43399.
	16.Witke,W.,Sharpe,A.H.H.,Artwig,J.H.,Azuma,T.,Stossel,T.P.&Kwiatkowski,D.J.(1995)Hemostatic,in?ammatoryand?broblastresponsesarebluntedinmicelackinggelsolin.Cell.81,41?51.
	17.Patkowski,A.,Seils,J.,Hinssen,H.&Dorfmuller,T.(1990)Size,shapeparametersandcalcium-inducedconformationalchangeofthegelsolinmolecule.Adynamiclightscatteringstudy.Biopoly-mers.30,427?435.
	18.Hellweg,T.,Hinssen,H.&Eimer,W.(1993)TheCa2+-inducedconformationalchangeofgelsolinislocatedinthecarboxyl-ter-minalhalfofthemolecule.Biophys.J.65,799?805.
	19.Choe,H.,Burtnick,L.D.,Mejillano,M.,Yin,H.L.,Robinson,R.C.&Choe,S.(2002)Thecalciumactivationofgelsolin:Insightsfromthe3A?structureoftheG4?G6/actincomplex.J.Mol.Evol.324,691?702.
	20.Kolappan,S.P.,Gooch,J.T.,Weeds,A.G.&McLaughlin,P.J.(2003)Gelsolindomains4?6inactive,actinfreeconformationidenti?essitesofregulatorycalciumions.J.Mol.Biol.329,85?92.
	21.Lamb,J.A.,Allen,P.G.,Tuan,B.Y.&Janmey,P.A.(1993)Modulationofgelsolinfunction?activationatlowpHoverridesCa2+requirement.J.Biol.Chem.268,8999?9004.
	22.Lagarrique,E.,Maciver,S.K.,Fattoum,A.,Benyamin,Y.&Roustan,C.(2003)Co-operationofdomain-bindingandcalcium-bindingsitesintheactivationofgelsolin.Eur.J.Biochem.270,2236?2243.
	23.Spudich,J.A.&Watt,S.(1971)Theregulationofrabbitskeletalmusclecontraction.Biochemicalstudiesoftheinteractionofthetropomyosin-troponincomplexwithactinandtheproteolyticfragmentsofmyosin.J.Biol.Chem.246,4866?4871.
	24.Kouyama,T.&Mihashi,K.(1981)FluorimetrystudyofN-(1-pyrenyl)iodoacetamide-labelledF-actin.Eur.J.Biochem.114,33?38.
	25.Way,M.,Pope,B.,Gooch,J.,Hawkins,M.&Weeds,A.G.(1990)Identi?cationofaregionofsegment1ofgelsolincriticalforactinbinding.EMBOJ.9,4103?4109.
	26.Way,M.,Pope,B.&Weeds,A.G.(1992)EvidenceforfunctionalhomologyintheF-actinbindingdomainsofgelsolinandalpha-actinin:implicationsfortherequirementsofseveringandcapping.J.CellBiol.119,835?842.
	27.Way,M.,Gooch,J.,Pope,B.&Weeds,A.G.(1989)ExpressionofhumanplasmagelsolininE.colianddissectionofactinbindingsitesbysegmentaldeletionmutagenesis.J.CellBiol.109,593?605.
	28.Kurokawa,H.,Fujii,W.,Ohmi,K.,Sakurai,T.&Nonomura,Y.(1990)Simpleandrapidpuri?cationofbrevin.Biochem.Biophys.Res.Comm.168,451?457.
	29.Renoult,C.,Blondin,L.,Fattoum,A.,Ternent,D.,Maciver,S.K.,Raynaud,F.,Benyamin,Y.&Roustan,C.(2001)Bindingofgelsolindomain2toactin.Anactininterfacedistinctfromthatofgelsolindomain1andfromADF/co?lin.Eur.J.Biochem.268,6165?6175.
	30.Miki,M.&dosRemedios,C.G.(1988)Fluorescencequenchingstudiesof?uoresceinattachedtoLys-61orCys-374inactin:e?ectsofpolymerization,myosinsubfragment-1binding,andtropomyosin-troponinbinding.J.Biochem.104,232?235.
	31.Papa,I.,Astier,C.,Kwiatek,O.,Lebart,M.-C.,Raynaud,F.,Benyamin,Y.&Roustan,C.(1999)Useofachaotropicanioniodideinthepuri?cationofZ-lineproteins:isolationofCapZ.from?shwhitemuscle.Prot.ExprPurif.17,1?7.
	32.Engvall,E.(1980)EnzymeimmunoassayELISAandEMIT.Meth.Enzymol.70,419?439.
	33.Meï¿½jean,C.,Lebart,M.C.,Poyer,M.,Roustan,C.&Benyamin,Y.(1992)Localizationandidenti?cationofactinstructuresinvolvedinthe?lamin?actininteraction.Eur.J.Biochem.209,555?562.
	34.Lakowicz,J.R.(1983)PrinciplesofFluorescenceSpectroscopy.PlenumPublishingCorp,NewYork.
	35.Gill,S.C.&vonHippel,P.H.(1989)Calculationofproteinextinctioncoe?cientsfromaminoacidsequencedata.Anal.Bio-chem.182,319?326.
	36.Houmeida,A.,Hanin,V.,Feinberg,J.,Benyamin,Y.&Roustan,C.(1991)De?nitionofaCa2+-sensitiveinterfaceintheplasmagelsolin-actincomplex.Biochem.J.274,753?757.
	37.Lin,K.-M.,Mejillano,M.&Yin,H.L.(2000)Ca2+regulationofgelsolinbyitsC-terminaltail.J.Biol.Chem.275,27746?27752.
	38.Maciver,S.K.,Ternent,D.&McLaughlin,P.J.(2000)Domain2ofgelsolinbindsdirectlytotropomyosin.FEBSLett.473,71?75.
	39.Kwiatkowski,D.J.,Janmey,P.A.&Yin,H.L.(1989)Identi?ca-tionofcriticalfunctionalandregulatorydomainsingelsolin.J.CellBiol.108,1717?1726.
	40.Lueck,A.,Yin,H.L.,Kwiatkowski,D.J.&Allen,P.G.(2000)Calciumregulationofgelsolinandadseverin:anaturaltestofthehelixlatchhypothesis.Biochemistry.39,5274?5279.
	41.Hesterkamp,T.,Weeds,A.G.&Mannherz,H.G.(1993)Theactinmonomersintheternarygelsolin:2actincomplexareinanti-parallelorientation.Eur.J.Biochem.218,507?513.
	42.McLaughlin,P.J.,Gooch,J.T.,Mannherz,H.G.&Weeds,A.G.(1993)Structureofgelsolinsegment-1-actincomplexandthemechanismof?lamentsevering.Nature.364,685?692.
	43.Chaponnier,C.,Janmey,P.A.&Yin,H.L.(1986)Theactin?la-ment-severingdomainofplasmagelsolin.J.CellBiol.103,1473?1481.
	44.Selve,N.&Wegner,A.(1987)pH-dependentrateofformationofthegelsolin-actincomplexfromgelsolinandmonomericactin.Eur.J.Biochem.161,111?115.
	45.Watanabe,K.,Hamaguchi,M.S.&Hamaguchi,Y.(1997)E?ectsofintracellularpHonthemitoticapparatusandmitoitcstageinthesanddollaregg.CellMot.Cytoskel.37,263?270.
	46.VanDuijn,B.&Inouye,K.(1991)RegulationofmovementspeedbyintracellularpHduringDictyosteliumdiscoideumchemotaxis.Proc.Nat.Acad.Sci.88,4951?4955.
	47.Schwiening,C.J.&Willoughby,D.(2002)Depolarization-inducedpHmicrodomainsandtheirrelationshiptocalciumtransientsinisolatedsnailneurones.J.Physiol.538,371?382.
	48.Yonezawa,N.,Nishida,E.&Sakai,H.(1985)pHcontrolofactinpolymerizationbyco?lin.J.Biol.Chem.260,14410?14412.
	49.Edmonds,B.T.,Murray,J.&Condeelis,J.(1995)pHregulationoftheF-actinbindingpropertiesofDictyosteliumelongationfactor1a.J.Biol.Chem.270,15222?15230.
291.full.pdf	44
	AnderssonU&ScarpullaRC2001PGC-1-relatedcoactivator,anovel,serum-induciblecoactivatorofnuclearrespiratoryfactor1-dependenttranscriptioninmammaliancells.MolecularandCellularBiology213738?3749.
	BasuA,ParkK,AtchisonML,CarterRS&AvadhaniNG1993IdentificationofatranscriptionalinitiatorelementinthecytochromecoxidasesubunitVbpromoterwhichbindstotranscriptionfactorsNF-E1(YY-1,delta)andSp1.JournalofBiologicalChemistry2684188?4196.
	BerryDL,SchwartzmanRA&BrownDD1998Theexpressionpatternofthyroidhormoneresponsegenesinthetadpoletailidentifiesmultipleresorptionprograms.DevelopmentalBiology20312?23.
	ClementK,ViguerieN,DiehnM,AlizadehA,BarbeP,ThalamasC,StoreyJD,BrownPO,BarshGS&LanginD2002Invivoregulationofhumanskeletalmusclegeneexpressionbythyroidhormone.GenomeResearch12281?291.
	DavisPJ,TillmannHC,DavisFB&WehlingM2002Comparisonofthemechanismsofnongenomicactionsofthyroidhormoneandsteroidhormones.JournalofEndocrinologicalInvestigation25377?388.
	DenverRJ,PavgiS&ShiYB1997Thyroidhormone-dependentgeneexpressionprogramforXenopusneuraldevelopment.JournalofBiologicalChemistry2728179?8188.
	Dï¿½mmlerK,Mï¿½llerS&SeitzHJ1996Regulationofadeninenucleotidetranslocaseandglycerol3-phosphatedehydrogenaseexpressionbythyroidhormonesindi?erentrattissues.BiochemicalJournal317913?918.
	EisenMB&BrownPO1999DNAarraysforanalysisofgeneexpression.MethodsinEnzymology303179?205.
	EisenMB,SpellmanPT,BrownPO&BotsteinD1998Clusteranalysisanddisplayofgenome-wideexpressionpatterns.PNAS9514863?14868.
	EvansMJ&ScarpullaRC1989Interactionofnuclearfactorswithmultiplesitesinthesomaticcytochromecpromoter.CharacterizationofupstreamNRF-1,ATF,andintronSp1recognitionsequences.JournalofBiologicalChemistry26414361?14368.
	FengX,JiangY,MeltzerP&YenPM2000ThyroidhormoneregulationofhepaticgenesinvivodetectedbycomplementaryDNAmicroarray.MolecularEndocrinology14947?955.
	Flores-MoralesA,GullbergH,FernandezL,StahlbergN,LeeNH,VennstromB&NorstedtG2002PatternsofLiverGeneExpressionGovernedbyTRbeta.MolecularEndocrinology161257?1268.
	GarstkaHL,FackeM,EscribanoJR&WiesnerRJ1994StoichiometryofmitochondrialtranscriptsandregulationofgeneexpressionbymitochondrialtranscriptionfactorA.BiochemicalandBiophysicalResearchCommunications200619?626.
	HalgrenRG,FieldenMR,FongCJ&ZacharewskiTR2001Assessmentofcloneidentityandsequencefidelityfor1189IMAGEcDNAclones.NucleicAcidsResearch29582?588.
	HsuMH,SavasU,Gri?nKJ&JohnsonEF2001Identificationofperoxisomeproliferator-responsivehumangenesbyelevatedexpressionoftheperoxisomeproliferator-activatedreceptoralphainHepG2cells.JournalofBiologicalChemistry27627950?27958.
	KnuttiD&KralliA2001PGC-1,aversatilecoactivator.TrendsinEndocrinologyandMetabolism12360?365.
	KresslerD,SchreiberSN,KnuttiD&KralliA2002ThePGC-1-relatedproteinPERCisaselectivecoactivatorofestrogenreceptoralpha.JournalofBiologicalChemistry27713918?13925.
	LiR,LuciakovaK,ZaidA,BetinaS,FridellE&NelsonBD1997Thyroidhormoneactivatestranscriptionfromthepromoterregionsofsomehumannuclear-encodedgenesoftheoxidativephosphorylationsystem.MolecularandCellularEndocrinology12869?75.
	LinJ,PuigserverP,DonovanJ,TarrP&SpiegelmanBM2002Peroxisomeproliferator-activatedreceptorgammacoactivator1beta(PGC-1beta),anovelPGC-1-relatedtranscriptioncoactivatorassociatedwithhostcellfactor.JournalofBiologicalChemistry2771645?1648.
	LowellBB1999PPARgamma:anessentialregulatorofadipogenesisandmodulatoroffatcellfunction.Cell99239?242.
	LuciakovaK&NelsonBD1992Transcriptlevelsfornuclear-encodedmammalianmitochondrialrespiratory-chaincomponentsareregulatedbythyroidhormoneinanuncoordinatedfashion.EuropeanJournalofBiochemistry207247?251.
	MillerLD,ParkKS,GuoQM,AlkharoufNW,MalekRL,LeeNH,LiuET&ChengSY2001SilencingofWntsignalingandactivationofmultiplemetabolicpathwaysinresponsetothyroidhormone-stimulatedcellproliferation.MolecularandCellularBiology216626?6639.
	Mï¿½llerMJ&SeitzHJ1981Starvation-inducedchangesofhepaticglucosemetabolisminhypo-andhyperthyroidratsinvivo.JournalofNutrition1111370?1379.
	PoirierH,NiotI,MonnotMC,BraissantO,Meunier-DurmortC,CostetP,PineauT,WahliW,WillsonTM&BesnardP2001Di?erentialinvolvementofperoxisome-proliferator-activatedreceptorsalphaanddeltainfibrateandfatty-acid-mediatedinductionsofthegeneencodingliverfatty-acid-bindingproteinintheliverandthesmallintestine.BiochemicalJournal355481?488.
	PuigserverP&SpiegelmanBM2003Peroxisomeproliferator-activatedreceptor-gammacoactivator1alpha(PGC-1alpha):transcriptionalcoactivatorandmetabolicregulator.EndocrineReviews2478?90.
	RobyrD,Wol?eAP&WahliW2000Nuclearhormonereceptorcoregulatorsinaction:diversityforsharedtasks.MolecularEndocrinology14329?347.
	SadowPM,ChassandeO,GauthierK,SamarutJ,XuJ,O?MalleyBW&WeissRE2003Specificityofthyroidhormonereceptorsubtypeandsteroidreceptorcoactivator-1onthyroidhormoneaction.AmericanJournalofPhysiologyEndocrinologyandMetabolism284E36?E46.
	ScarpullaRC2002Nuclearactivatorsandcoactivatorsinmammalianmitochondrialbiogenesis.BiochimicaetBiophysicaActa15761?14.
	ScarpullaRC,KilarMC&ScarpullaKM1986CoordinateinductionofmultiplecytochromecmRNAsinresponsetothyroidhormone.JournalofBiologicalChemistry2614660?4662.
	SeelanRS&GrossmanLI1997StructuralorganizationandpromoteranalysisofthebovinecytochromecoxidasesubunitVIIcgene.AfunctionalroleforYY1.JournalofBiologicalChemistry27210175?10181.
	ShiYB,WongJ,Puzianowska-KuznickaM&StolowMA1996Tadpolecompetenceandtissue-specifictemporalregulationofamphibianmetamorphosis:rolesofthyroidhormoneanditsreceptors.Bioessays18391?399.
	TagamiT,ParkY&JamesonJL1999Mechanismsthatmediatenegativeregulationofthethyroid-stimulatinghormonealphagenebythethyroidhormonereceptor.JournalofBiologicalChemistry27422345?22353.
	TakeuchiY,MurataY,SadowP,HayashiY,SeoH,XuJ,O?MalleyBW,WeissRE&Refeto?S2002Steroidreceptorcoactivator-1deficiencycausesvariablealterationsinthemodulationofT(3)-regulatedtranscriptionofgenesinvivo.Endocrinology1431346?1352.
	TataJR,ErnsterL,LindbergO,Arrhenius,EPedersenS&HedmanR1963Theactionofthyroidhormoneatthecelllevel.BiochemicalJournal86408?428.
	WeitzelJM,KutzS,RadtkeC,GrottS&SeitzHJ2001aHormonalregulationofmultiplepromotersoftheratmitochondrialglycerol-3-phosphatedehydrogenasegene:identificationofacomplexhormone-responseelementintheubiquitouspromoterB.EuropeanJournalofBiochemistry2684095?4103.
	WeitzelJM,RadtkeC&SeitzHJ2001bTwothyroidhormone-mediatedgeneexpressionpatternsinvivoidentifiedbycDNAexpressionarraysinrat.NucleicAcidsResearch295148?5155.
	WeitzelJM,IwenKAH&SeitzHJ2003Regulationofmitochondrialbiogenesisbythyroidhormone.ExperimentalPhysiology88121?128.
	WoodWM,SarapuraVD,DowdingJM,WoodmanseeWW,HaakinsonDJ,GordonDF&RidgwayEC2002Earlygeneexpressionchangesprecedingthyroidhormone-inducedinvolutionofathyrotropetumor.Endocrinology143347?359.
	WuZ,PuigserverP,AnderssonU,ZhangC,AdelmantG,MoothaV,TroyA,CintiS,LowellB,ScarpullaRC&SpiegelmanBM1999MechanismscontrollingmitochondrialbiogenesisandrespirationthroughthethermogeniccoactivatorPGC-1.Cell98115?124.
	YenPM2001Physiologicalandmolecularbasisofthyroidhormoneaction.PhysiologicalReviews811097?1142.
	YoonJC,PuigserverP,ChenG,DonovanJ,WuZ,RheeJ,AdelmantG,Sta?ordJ,KahnCR,GrannerDK,NewgardCB&SpiegelmanBM2001ControlofhepaticgluconeogenesisthroughthetranscriptionalcoactivatorPGC-1.Nature413131?138.
	ZaidA,LiR,LuciakovaK,BarathP,NeryS&NelsonBD1999OntheroleofthegeneraltranscriptionfactorSp1intheactivationandrepressionofdiversemammalianoxidativephosphorylationgenes.JournalofBioenergeticsandBiomembranes31129?135.
	ZhangJ&LazarMA2000Themechanismofactionofthyroidhormones.AnnualReviewofPhysiology62439?466.
	ZilzND,MurrayMB&TowleHC1990IdentificationofmultiplethyroidhormoneresponseelementslocatedfarupstreamfromtheratS14promoter.JournalofBiologicalChemistry2658136?8143.
v060p00348.pdf	35
	1MillerWR,SharpeRM.Environmentaloestrogensandhumanreproductivecancers?EndocrineRelatedCancer1998;5:69?96.
	2GreenbergER,BarrettJA,LanzallLL,etal.Breastcancerinmothersgivendiethylstilboestrolinpregnancy.NEnglJMed1984;132:1059?
	3AdamiHO,LipworthL,Titus-ErnstoffL,etal.Organochlorinecompoundsandestrogen-relatedcancersinwomen.CancerCausesControl1995;6:551?66.
	4ScribnerJD,MottetNK.DDTaccelerationofmammaryglandtumoursinducedinthemaleSprague-Dawleyratby2-acetamidophenanthrene.Carcinogenesis1981;2:123?39.
	5RobinsonAK,SirbaskuDA,StancelGM.DDTsupportsthegrowthofanestrogen-responsivetumour.ToxicolLett1985;27:109?13.
	6BlairA,GraumanDJ,LubinJH,etal.Lungcancerandothercausesofdeathamonglicensedpesticideapplicators.JNatlCancerInst1983;71:31?7.
	7WolffMS,TonioloPG,LeeRW,etal.Bloodlevelsoforganochlorineresiduesandriskofbreastcancer.JNatlCancerInst1993;85:648?52.
	8DewaillyE,DodinS,VerreaultR,etal.Highorganochlorinebodyburdeninwomenwithestrogenreceptor-positivebreastcancer.JNatlCancerInst1994;86:232?4.
	9KriegerN,WolffMS,HiattRA,etal.Breastcancerandserumorganochlorines:aprospectivestudyamongwhite,black,andasianwomen.JNatlCancerInst1994;86:589?99.
	10HunterDJ,HankinsonSE,LadenF,etal.Plasmaorganochlorinelevelsandtheriskofbreastcancer.NEnglJMed1997;337:1253?8.
	11SafeSH.Environmentalanddietaryestrogensandhumanhealth:isthereaproblem?EnvironHealthPerspect1995;103:346?51.
	12WolffM,Zeleniach-JacquotteA,DubinN,etal.Riskofbreastcancerandorganochlorineexposure.CancerEpidemiolBiomarkersPrev2000;9:271?7.
	13DemersA,AyotteP,BrissonJ,etal.Riskandaggressivenessofbreastcancerinrelationtoplasmaorganochlorineconcentrations.CancerEpidemiolBiomarkersPrev2000;9:161?6.
	14WolffM,TonioloPG.Environmentalorganochlorineexposureasapotentialetiologicfactorinbreastcancer.EnvironHealthPerspect1995;103(suppl7):141?5.
	15HoyerAP,GrandjeanP,JorgensenT,etal.Organochlorineexposureandriskofbreastcancer.Lancet1998;352:1816?20.
	16HoffmannW.Organochlorinecompounds:riskofNon-Hodgkin?slymphomaandbreastcancer?ArchEnvironHealth1996;51:189?92.
	17DavisDL,BradlowHL,WolffM,etal.Medicalhypothesis:xenoestrogensaspreventablecausesofbreastcancer.EnvironHealthPerspect1993;101:372?7.
	18RomieuI,Hernandez-AvilaM,Lazcano-Pence,etal.Breastcancer,lactationhistoryandserumorganochlorines.AmJEpidemiol2000;152:363?70.
	19CharlierC,PlomteuxG.Determinationoforganochlorinespesticideresiduesinbloodofhealthyindividuals.ClinChemLabMed2002;40:361?4.
	20BoyleP.Epidemiologyofbreastcancer.BaillieresClinOncol1988;2:1?57.
	21MacMahonB,ColeP,BrownJ.Etiologyofhumanbreastcancer:areview.JNatlCancerInst1973;50:21?42.
	22GellertRJ,Leroy-HeinrichsW,SwerdloffRS.DDThomologues:estrogen-likeeffectsonthevagina,uterusandpituitaryoftherat.Endocrinology1972;91:1095?100.
	23KeyT,ReevesG.Organochlorinesintheenvironmentandbreastcancer.BMJ1994;308:1520?1.
	24NelsonJA.Effectsofdichlorodiphenyltrichloroethane(DDT)analogsandpolychlorinatedbiphenyl(PCB)mixtureson17?-[3H]estradiolbindingtorateuterinereceptor.BiochemPharmacol1974;23:447?51.
	25UngerM,KiaerH,Blichert-ToftM.Organochlorinecompoundsinhumanbreastfatfromdeceasedwithandwithoutbreastcancerandinabiopsymaterialfromnewlydiagnosedpatientsundergoingbreastsurgery.EnvironRes1984;34:24?8.
	26FalckF,RicciA,WolffMS,etal.Pesticidesandpolychlorinatedbiphenylresiduesinhumanbreastlipidsandtheirrelationtobreastcancer.ArchEnvironHealth1992;47:143?6.
	27Mussalo-RauhamaaH,Hï¿½sï¿½nenE,PyysaloH,etal.Occurrenceofbeta-hexachlorocyclohexaneinbreastcancerpatients.Cancer1990;66:2124?8.
	28DorganJF,BrockJW,RothmanN,etal.SerumorganochlorinepesticidesandPCBsandbreastcancerrisk:resultsfromaprospectiveanalysis.CancerCausesControl1999;10:1?11.
	29BordetF,MalletJ,MauriceL,etal.OrganochlorinepesticideandPCBcongenercontentoffrenchhumanmilk.BullEnvironContamToxicol1993;50:425?32.
	30LarsenBR,Turrio-BaldassarriL,NilssonT,etal.ToxicPCBcongenersandorganochlorinepesticidesinitalianhumanmilk.EcotoxicolEnvironSaf1994;28:1?13.
	31DogheimSM,MohamedE-Z,GadAllaSA,etal.Monitoringofpesticideresiduesinhumanmilk,soil,water,andfootsamplescollectedfromKafrEl-Zayatgovernorate.JAOACInt1996;79:111?16.
	32LiljegrenG,HardellL,LindstromG,etal.Case-controlstudyonbreastcancerandadiposetissueconcentrationsofcongenerspecificpolychlorinatedbiphenyls,DDEandhexachlorobenzene.EurJCancerPrev1998;7:135?40.
	33GuttesS,FailingK,NeumannK,etal.Chlororganicpesticidesandpolychlorinatedbiphenylsinbreasttissueofwomenwithbenignandmalignantbreastdisease.ArchEnvironContamToxicol1998;35:140?7.
	34ZhengT,HolfordTR,MayneST,etal.EnvironmentalexposuretohexachlorobenzeneandriskoffemalebreastcancerinConnecticut.CancerEpidemiolBiomarkersPrev1999;8:407?11.
	35KangKS,WilsonMR,HayashiT,etal.Inhibitionofgapjunctionalintercellularcommunicationinnormalhumanbreastepithelialcellsaftertreatmentwithpesticides,PCBs,andPBBs,aloneorinmixtures.EnvironHealthPerspect1996;104:192?200.
v060p00313.pdf	3
	1DockeryDW,PopeCA,XuXP,etal.Anassociationbetweenair-pollutionandmortalityin6UnitedStatescities.NEnglJMed1993;329:1753?9.
	2PopeCAIII,BurnettRT,ThunMJ,etal.Lungcancer,cardiopulmonarymortality,andlong-termexposuretofineparticulateairpollution.JAMA2002;287:1132?41.
	3ShiT,KnaapenAM,BegerowJ,etal.Temporalvariationofhydroxylradicalgenerationand8-hydroxy-2?-deoxyguanosineformationbycoarseandfineparticulatematter.OccupEnvironMed2003;60:315?21.
J. Exp. Bot.-2003-Parry-1321-33.pdf	133
	AnderssonI.1996.Largestructuresathighresolution:the1.6angstromcrystalstructureofspinachribulose-1,5-bisphosphatecarboxylase/oxygenasecomplexedwith2-carboxyarabinitolbisphosphate.JournalofMolecularBiology259,160ï¿½174.
	AnderssonI,KnightS,SchneiderG,LindqvistY,LindqvstT,BrandenCI,LorimerGH.1989.Crystalstructureoftheactivesiteofribulose-1,5-bisphosphatecarboxylase.Nature337,229ï¿½234.
	AndralojcPJ,KeysAJ,KossmannJ,ParryMAJ.2002.Elucidatingthebiosynthesisof2-carboxyarabinitol1-phosphatethroughreducedexpressionofchloroplasticfructose1,6-bisphosphatephosphataseandradiotracerstudieswith(CO14.ProceedingsoftheNationalAcademyofSciences,USA99,4742ï¿½4747.
	AndrewsTJ,LorimerGH.1978.Photorespirationstillunavoidable?FEBSLetters90,1ï¿½9.
	BainbridgeG,MadgwickP,ParmarS,MitchellR,PaulM,PittsJ,KeysAJ,ParryMAJ.1995.Engineeringrubiscotochangeitscatalyticproperties.JournalofExperimentalBotany46,1269ï¿½1276.
	BainbridgeG,AndralojcPJ,MadgwickPJ,PittsJE,ParryMAJ.1998.Effectofmutationoflysine-128ofthelargesubunitofribulosebisphosphatecarboxylase/oxygenasefromAnacystisnidulans.BiochemicalJournal336,387ï¿½393.
	BowesG,OgrenWL,HagemanR.1971.Phosphoglycolateproductioncatalysedbyribulosediphsophatecarboxylase.BiochemicalandBiophysicalResearchCommunications45,716ï¿½722.
	BradleyD,VanderViesSM,GatenbyA.1986.Expressionofcyanobacterialandhigherplantribulose-1,5-bisphosphatecarboxylasegenesinEscherichiacoli.PhilosophicalTransactionsoftheRoyalSocietyofLondon313,305ï¿½324.
	CannellRQ,BrunsWA,MossDN.1969.Asearchforhighnetphotosyntheticrateamongsoybeangenotypes.CropScience9,840ï¿½841.
	ChanPH,SakanoK,SinghS,WildmanSG.1972.Crystallinefraction1protein:preparationinlargeyield.Science176,1145ï¿½1146.
	ChanPH,WildmanSG.1972.ChloroplastDNAcodesfortheprimarystructureofthelargesubunitofFraction1protein.BiochimicaetBiophysicaActa277,677ï¿½680.
	ChapmanMS,WonSuhS,CurriePMG,CascioD,SmithWW,EisenbergD.1988.TertiarystructureofplantRubisco:domainsandtheircontacts.Science241,71ï¿½74.
	ChenZ,SpreitzerRJ.1989.Chloroplastintragenicsupressionenhancesthelowspeciï¿½cityofmutantribulose-1,5-bisphosphatecarboxylase/oxygenase.JournalofBiologicalChemistry264,3051ï¿½3053.
	ChenZX,YuWZ,LeeJH,DiaoR,SpreitzerRJ.1991.Complementingamino-acidsubstitutionswithinloop-6ofthealpha-beta-barrelactive-siteinï¿½uencetheCOspeciï¿½cityofchloroplastribulose-1,5-bisphosphatecarboxylaseoxygenase.Biochemistry30,8846ï¿½8850.
	CheneP,DayAG,FershtAR.1992.Mutationofasparagine111ofRubiscofromRhodospirillumrubrumaltersthecarboxylase/oxygenasespeciï¿½city.JournalofMolecularBiology225,891ï¿½896.
	ClelandWW,AndrewsTJ,GutteridgeS,HartmanFC,LorimerGH.1998.MechanismofRubisco:thecarbamateasgeneralbase.ChemicalReviews98,549ï¿½561.
	CollatzGJ,BerryJA,FarquharGD,PierceJ.1990.TherelationshipbetweentheRubiscoreactionmechanismandmodelsofphotosynthesis.Plant,CellandEnvironment13,219ï¿½225.
	CookCM,MulliganRM,TolbertNE.1985.Inhibitionandstimulationofribulose-1,5-bisphosphatecarboxylase-oxygenasebyglyoxylate.ArchivesofBiochemistryandBiophysics240,392ï¿½401.
	Crafts-BrandnerSJ,SalvucciME.2000.RubiscoactivaseconstrainsthephotosyntheticpotentialofleavesathightemperatureandCO.ProceedingsoftheNationalAcademyofSciences,USA97,13430ï¿½13435.
	Crafts-BrandnerSJ,VanDeLooFJ,SalvucciME.1997.TheManipulationofRubisco1329twoformsofribulose-1,5-bisphosphatecarboxylase/oxygenaseactivasedifferinsensitivitytoelevatedtemperature.PlantPhysiology114,439ï¿½444.
	DallingMJ,BolandG,WilsonJH.1976.Relationbetweenacidproteinaseactivityandredistributionofnitrogenduringgraindevelopmentinwheat.AustralianJournalofPlantPhysiology3,721ï¿½730.
	EdwardsGE,WalkerDA.1983.C-Mechanismsandcellularandenvironmentalregulationofphotosynthesis.Oxford,UK:Blackwell.
	EllisRJ.1979.Themostabundantproteinintheworld.TrendsinBiochemicalScience4,241ï¿½244.
	EllisRJ.1981.Chloroplastproteins:synthesis,transportandassembly.AnnualReviewofPlantPhysiology32,111ï¿½137.
	FarquharGD,VonCaemmererS,BerryJA.1980.AbiochemicalmodelofphotosyntheticCOassimilationinleavesofC-3species.Planta149,78ï¿½90.
	FellerU,Crafts-BrandnerSJ,SalvucciME.1998.Moderatelyhightemperaturesinhibitribulose-1,5-bisphosphatecarboxylase/oxygenase(Rubisco)activase-mediatedactivationofRubisco.PlantPhysiology116,539ï¿½546.
	FurbankRT,ChittyJA,vonCaemmererS,JenkinsCLD.1996.AntisenseRNAinhibitionofrbcSgeneexpressionreducesRubiscolevelandphotosynthesisintheC-4plantFlaveriabidentis.PlantPhysiology111,725ï¿½734.
	GatenbyAA,CastletonJA,SaulMW.1981.ExpressioninE.coliofmaizeandwheatchloroplastgenesforlargesubunitofribulosebisphosphatecarboxylase.Nature291,117ï¿½121.
	GatenbyAA,EllisRJ.1990.Chaperonefunctionï¿½theassemblyofribulosebisphosphatecarboxylase-oxygenase.AnnualReviewofCellBiology6,125ï¿½149.
	GatenbyA,VanderViesSM,BradleyD.1985.AssemblyinE.coliofafunctionalmultisubunitribulosebisphosphatecarboxylasefromblue-greenalga.Nature314,617ï¿½620.
	GutteridgeS,GatenbyAA.1995.Rubiscosynthesis,assembly,mechanismandregulation.ThePlantCell7,809ï¿½819.
	GutteridgeS,RhoadesDF,HerrmannC.1993.Site-speciï¿½cmutationsinaloopregionoftheC-terminaldomainofthelargesubunitofribulose-1,5-bisphosphatecarboxylase/oxygenasethatinï¿½uencesubstratepartitioning.JournalofBiologicalChemistry268,7818ï¿½7824.
	GutteridgeS,SigalI,ThomasB,ArentzenR,CordovaA,LorimerGH.1984.Asite-speciï¿½cmutationwithintheactivesiteofribulose-1,5-bisphosphatecarboxylaseofRhodospirillumrubrum.EMBOJournal3,2737ï¿½2743.
	HammondET,AndrewsTJ,WoodrowIE.1998.Regulationofribulose-1,5-bisphosphatecarboxylase/oxygenasebycarbamyl-ationand2-carboxyarabinitol1-phosphateintobacco:insightsfromstudiesofantisenseplantscontainingreducedamountsofRubiscoactivase.PlantPhysiology118,1463ï¿½1471.
	HartmanFC,LeeEH.1989.Examinationofthefunctionoftheactivesitelysine329ofribulose-1,5-bisphosphatecarboxylase/oxygenaseasrevealedbyprotonexchangereactions.JournalofBiologicalChemistry246,11784ï¿½11789.
	HatchMD.1976.Photosynthesis:thepathofcarbon.In:BonnerJ,VarnerJ,eds.Plantbiochemistry,3rdedn.NewYork,SanFrancisco,London:AcademicPress,797ï¿½844.
	HeZL,vonCaemmererS,HudsonGS,PriceGD,BadgerMR,AndrewsTJ.1997.Ribulose-1,5-bisphosphatecarboxylase/oxygenaseactivasedeï¿½ciencydelayssenescenceofribulose-1,5-bisphosphatecarboxylase/oxygenase,butprogressivelyimpairsitscatalysisduringtobaccoleafdevelopment.PlantPhysiology115,1569ï¿½1580.
	HudsonGS,EvansJR,vonCaemmererS,ArvidssonYBC,AndrewsTJ.1992.Reductionofribulose-1,5-bisphosphatecarboxylaseoxygenasecontentbyantisenseRNAreducesphotosynthesisintransgenictobaccoplants.PlantPhysiology98,294ï¿½302.
	JiangCZ,KliebenstienDKeN,RodermelS.1994.DestabilizationofrbcSsensetranscriptsbyantisenseRNA.PlantMolecularBiology25,569ï¿½576.
	JimenezES,MedranoL,Martï¿½nez-BarajasE.1995.Rubiscoactivase,apossiblenewmemberofthemolecularchaperonefamily.Biochemistry34,2826ï¿½2831.
	KaneHJ,VIIL,EntschB,PaulK,MorellMK,AndrewsTJ.1994.AnimprovedmethodformeasuringtheCOspeciï¿½cityofribulosebishosphatecarboxylase-oxygenase.AustralianJournalofPlantPhysiology21,449ï¿½461.
	KanevskiI,MaligaP.1994.RelocationoftheplastidrbcLgenetothenucleusyieldsfunctionalribulose-1,5-bisphosphatecarboxylaseintobaccochloroplasts.ProceedingsoftheNationalAcademyofSciences,USA5,1969ï¿½1973.
	KanevskiI,MaligaP,RhoadesDF,GutteridgeS.1999.Plastomeengineeringofribulose-1,5-bisphosphatecarboxylase/oxygenaseintobaccotoformasunï¿½owerlargesubunitandtobaccosmallsubunithybrid.PlantPhysiology119,133ï¿½141.
	KawashimaN,WildmanSG.1972.Studiesoffractionprotein.IV.ModeofinheritanceofprimarystructureinrelationtowhetherchloroplastornuclearDNAcontainsthecodeforachloroplasticprotein.BiochimicaetBiophysicaActa262,42ï¿½49.
	KhanS,AndralojcPJ,LeaPJ,ParryMAJ.1999.2ï¿½-carboxy-D-arabinitol1-phosphate(CA1P)protectsribulose-1,5-bisphosphatecarboxylase/oxygenaseagainstproteolyticbreakdown.EuropeanJournalofBiochemsitry266,840ï¿½847.
	KingBJ,SiddiqiMY,RuthTJ,WarnerRL,GlassADM.1993.Feedback-regulationofnitrateinï¿½uxinbarleyrootsbynitrate,nitriteandammonium.PlantPhysiology102,1279ï¿½1286.
	KnightS,AnderssonI,BrandenCI.1990.Crystallographicanalysisofribulose1,5-bisphosphatecarboxylasefromspinachat2.4Aresolution.JournalofMolecularBiology215,113ï¿½160.
	KungSD.1976.Tobaccofraction1protein:auniquegeneticmarker.Science191,429ï¿½434.
	KurodaH,MaligaP.2001.Sequencesdownstreamofthetranslationinitiationcodonareimportantdeterminantsoftranslationefï¿½ciencyinchloroplasts.PlantPhysiology125,430ï¿½436.
	LarsonEM,LarimerFW,HartmanFC.1995.Mechanisticinsightsprovidedbydeletionofaï¿½exibleloopattheactivesiteofribulose-1,5-bisphosphatecarboxylase/oxygenase.Biochemistry34,4531ï¿½4537.
	LarsonEM,O'BrienCM,ZhuGH,SpreitzerRJS,PortisAR.1997.Speciï¿½cityforactivaseischangedbyaPro89toArgsubstitutioninthelargesubunitofribulose1,5-bisphosphatecarboxylase/oxygenase.JournalofBiologicalChemistry272,17033ï¿½17037.
	LauererM,SafticD,QuickWP,LabateC,FichtnerK,SchulzeED,RodermelSR,BogoradL,StittM.1993.Decreasedribulose-1,5-bisphosphatecarboxylase-oxygenaseintransgenictobaccotransformedwithantisenserbcs.VI.Effectonphotosynthesisinplantsgrownatdifferentirradiance.Planta190,332ï¿½345.
	LeeGJ,McdonaldKA,McfaddenBA.1993.Leucine-332inï¿½uencestheCOspeciï¿½cityfactorofribulose-1,5-bisphosphatecarboxylaseoxygenasefromAnacystis-nidulans.ProteinScience2,1147ï¿½1154.
	LorimerGH.1981.Thecarboxylationandoxygenationofribulose1,5-bisphosphate:theprimaryeventsinphotosynthesisandphotorespiration.AnnualReviewofPlantPhysiology32,349ï¿½383.
	LorimerGH,MiziorkoHM.1980.Carbamateformationonthee-aminogroupofalysylresidueasthebasisfortheactivationofribulosebisphosphatecarboxylasebyCOandMgBiochemistry19,5321ï¿½5324.
	MadgwickPJ,ColliverSP,BanksFM,HabashDZ,DulieuH,ParryMAJ,PaulMJ.2002.Geneticmanipulationofrubisco:ChromatiumvinosumrbcLisexpressedinNicotianatabacumbutdoesnotformafunctionalprotein.AnnalsofAppliedBiology140,13ï¿½19.
	MadgwickPJ,ParmarS,ParryMAJ.1998.Effectofmutationsofresidue340inthelargesubunitpolypeptideofRubiscofromAnacystisnidulans.EuropeanJournalofBiochemistry253,476ï¿½479.
	MakinoA,HaradaM,KanekoK,MaeT,ShimadaT,YamamotoN.2000.Whole-plantgrowthandallocationintransgenicriceplantswithdecreasedcontentofribulose-1,5-bisphosphatecarboxylaseunderdifferentCOpartialpressures.AustralianJournalofPlantPhysiology27,1ï¿½12.
	MakinoA,ShimadaT,TakumiS,KanekoK,MatsuokaM,ShimamotoK,NakanoH,Miyao-TokutomiM,MaeT,YamamotoN.1997.Doesdecreaseinribulose-1,5,-bisphosphatecarboxylaseby`antisense'rbcSleadtoahighenitrogen-useefï¿½ciencyofphotosynthesisunderconditionsofsaturatingCOandlightinriceplants?PlantPhysiology114,483ï¿½491.
	MasleJ,HudsonGS,BadgerMR.1993.EffectsofambientCOconcentrationongrowthandnitrogenuseintobacco(Nicotianatabacum)plantstransformedwithanantisensegenetothesmall-subunitofribulose-1,5-bisphosphatecarboxylaseoxygenase.PlantPhysiology103,1075ï¿½1088.
	MateCJ,HudsonGS,vonCaemmererS,EvansJR,AndrewsTJ.1993.Reductionofribulosebisphosphatecarboxylaseactivaselevelsintobacco(Nicotianatabacum)byantisenseRNAreducesribulosebisphosphatecarboxylasecarbamylationandimpairsphotosynthesis.PlantPhysiology102,1119ï¿½1128.
	MateCJ,vonCaemmererS,EvansJR,HudsonGS,AndrewsTJ.1996.TherelationshipbetweenCO-assimilationrate,RubiscocarbamylationandRubiscoactivasecontentinactivase-deï¿½cienttransgenictobaccosuggestsasimplemodelofactivaseaction.Planta198,604ï¿½613.
	MedlynBE.1996.TheoptimalallocationofnitrogenwithintheC-3photosyntheticsystematelevatedCO.AustralianJournalofPlantPhysiology23,593ï¿½603.
	MedranoH,KeysAJ,LawlorDW,ParryMAJ,AzconBietoJ,DelgadoE.1995.Improvingplant-productionbyselectionforsurvivalatlowCOconcentrations.JournalofExperimentalBotany46,1389ï¿½1396.
	MedranoH,Primo-MilloE.1985.SelectionofNicotianatabacumhaploidsofhighphotosyntheticefï¿½ciency.PlantPhysiology79,505ï¿½508.
	MehtaRA,FawcettTW,PorathD,MattooAK.1992.Oxidativestresscausesrapidmembranetranslocationandinvivodegradationofribulose-1,5-bisphosphatecarboxylase/oxygenase.JournalofBiologicalChemistry267,2810ï¿½2816.
	MenzKM,MossDN,CannellRQ,BrunWA.1969.Screeningforphotosyntheticefï¿½ciency.CropScience9,692ï¿½694.
	MillardP,CattJW.1988.Theinï¿½uenceofnitrogensupplyontheuseofnitrateandribulose1,5-bisphosphatecarboxylase/oxygenaseasleafnitrogenstoresforgrowthofpotatotubers(SolanumtuberosumL.).JournalofExperimentalBotany39,1ï¿½11.
	MitchellRAC,TheobaldJC,ParryMAJ,LawlorDW.2000.IstherescopeforimprovingbalancebetweenRUBP-regenerationandcarboxylationcapacitiesinwheatatelevatedCO?JournalofExperimentalBotany51,391ï¿½397.
	NakanoH,MakinoA,MaeT.1997.TheeffectofelevatedpartialpressuresofCOontherelationshipbetweenphotosyntheticcapacityandNcontentinriceleaves.PlantPhysiology115,191ï¿½198.
	NasyrovYS.1978.Geneticcontrolofphotosynthesisandimprovingofcropproductivity.AnnualReviewofPlantPhysiology29,215ï¿½237.
	NewmanA,GutteridgeS.1993.TheX-raystructureofSynechoccusribulose-1,5-bisphosphatecarboxylase/oxygenaseactivatedquaternarycomplexat2.2Aresolution.JournalofBiologicalChemistry268,25876ï¿½25886.
	OgawaT,AmichayD,GurevitzM.1994.isolationandcharacterizationoftheccmmgenerequiredbythecyanobacteriumSynechocystisPCC6803forinorganiccarbonutilization.PhotosynthesisResearch39,183ï¿½190.
	OgrenWL.1984.Photorespiration:pathways,regulationandmodiï¿½cation.AnnualReviewofPlantPhysiology35,415ï¿½442.
	OgrenWL,BowesG.1971.Ribulosediphosphatecarboxylaseregulatessoybeanphotorespiration.NatureNewBiology230,159ï¿½160.
	PaoliGC,TabitaFR.1998.AerobicchemolithoautotrophicgrowthandRubiscofunctioninRhodobactercapsulatusandaspontaneousgainoffunctionmutantofRhodobactersphaeroides.ArchivesofMicrobiology170,8ï¿½17.
	ParryMAJ,KeysAJ,GutteridgeS.1989.Variationinthespeciï¿½cityfactorofC-3higher-plantRubiscodeterminedbythetotalconsumptionofribulose-P-2.JournalofExperimentalBotany40,317ï¿½320.
	ParryMAJ,LovelandJE,AndralojcPJ.1999.RegulationofRubisco.In:BryantJA,BurrellMM,KrugerNJ,eds.Plantcarbohdratebiochemistry.Oxford:BiosScientiï¿½cPublishersLtd,127ï¿½145.
	ParryMAJ,MadgwickP,ParmarS,CorneliusMJ,KeysAJ.1992.Mutationsinloopsixofthelargesubunitofribulose-1,5-bisphosphatecarboxylaseaffectsubstratespeciï¿½city.Planta187,109ï¿½112.
	PellnyT,PaulMJ,GoddijnJM.2002.Unravellingtheroleoftrehalose-6-phosphateinmetabolicsignallinginphotosynthetictissue.ComparativeBiochemsitryandPhysiology132,S102.
	PeoplesMB,PateJS,AtkinsCA.1983.Mobilizationofnitrogeninfruitingplantsofacultivarofcowpea.JournalofExperimentalBotany34,563ï¿½578.
	PortisAR.1990.Partialreductioninribulose-1,5-bisphosphatecarboxylase/oxygenaseactivitybycarboxypeptidaseA.ArchivesofBiochemistryandBiophysics283,397ï¿½400.
	PortisAR.1992.Regulationofribulose1,5-bisphosphatecarboxylase/oxygenaseactivity.AnnualReviewofPlantPhysiologyandPlantMolecularBiology43,415ï¿½437.
	QuickWP,FichtnerK,SchulzeED,WendlerR,LeegoodRC,MooneyH,RodermelSR,BogoradL,StittM.1992.Decreasedribulose-1,5-bisphosphatecarboxylase-oxygenaseintransgenictobaccotransformedwithantisenserbcs.4.impactonphotosynthesisinconditionsofalterednitrogensupply.Planta188,522ï¿½531.
	QuickWP,SchurrU,ScheibeR,SchulzeED,RodermelSR,BogoradL.StittM.1991.Decreasedribulose-1,5-bisphosphatecarboxylase-oxygenaseintransgenictobaccotransformedwithantisenserbcs.1.Impactonphotosynthesisinambientgrowth-conditions.Planta183,542ï¿½554.
	ReadBA,TabitaFR.1992.Ahybridribulosebisphosphatecarboxylaseoxygenaseenzymeexhibitingasubstantialincreaseinsubstrate-speciï¿½city.Biochemistry31,5553ï¿½5560.
	ReadBA,TabitaFR.1994.Highsubstrate-speciï¿½cityfactorribulose-bisphosphatecarboxylaseoxygenasefromeukaryoticmarine-algaeandpropertiesofrecombinantcyanobacterialRubiscocontainingalgalresiduemodiï¿½cations.ArchivesofBiochemistryandBiophysics312,210ï¿½218.
	RamageRT,ReadBA,TabitaFR.1998.AlterationofthealphaManipulationofRubisco1331helixregionofcyanobacterialribulose1,5-bisphosphatecarboxylase/oxygenasetoreï¿½ectsequencesfoundinhighsubstratespeciï¿½cityenzymes.ArchivesofBiochemistryandBiophysics349,81ï¿½88.
	ReynoldsMP,vanGinkelM,RibautJM.2000.Avenuesforgeneticmodiï¿½cationofradiationuseefï¿½ciencyinwheat.JournalofExperimentalBotany51,459ï¿½473.
	RobinsonSP,PortisAR.1988.Releaseofthenocturnalinhibitor,carboxyarabinitol-1-phosphate,fromribulosebisphosphatecarboxylase/oxygenasebyRubiscoactivase.FEBSLetters233,413ï¿½416.
	RobinsonSP,PortisAR.1989.Adenosinetriphosphatehydrolysisbypuriï¿½edRubiscoactivase.ArchivesofBiochemistryandBiophysics268,93ï¿½99.
	RodermelSR,AbbottMS,BogoradL.1988.Nuclearï¿½organelleinteractionsï¿½nuclearantisensegeneinhibitsribulosebisphosphatecarboxylaseenzymelevelsintransformedtobaccoplants.Cell55,673ï¿½681.
	RokkaA,ZhangL,AroEM.2001.Rubiscoactivase:anenzymewithatemperature-dependentdualfunction?ThePlantJournal25,463ï¿½471.
	SageRF.1994.AcclimationofphotosynthesistoincreasingatmosphericCOï¿½thegas-exchangeperspective.PhotosynthesisResearch39,351ï¿½368.
	SageRF.2002.VariationinthekcatofRubiscoinCandCplantsandsomeimplicationsforphotosyntheticperformanceathighandlowtemperature.JournalofExperimentalBotany53,609ï¿½620.
	SalvucciME,PortisAR,OgrenWL.1985.Asolublechloroplastproteincatalyzesribulosebisphosphatecarboxylase/oxygenaseactivationinvivo.PhotosynthesisResearch7,193ï¿½201.
	SchneiderG,LindqvistY,BrandenCI,LorimerGH.1986.Threedimensionalstructureofribulose-1,5-bisphosphatecarboxylase/oxygenasefromRhodospirillumrubrumat2.9Aresolution.EMBOJournal5,3409ï¿½3415.
	SchoefsB,DarkoE,RodermelS.2001.Photosyntheticpigments,photosynthesisandplastidultrastructureinrbcSantisenseDNAmutantsoftobacco(Nicotianatabacum).ZeitschriftfuNaturforschung56,1067ï¿½1074.
	SmithEW,TolbertNE,KuHS.1976.VariablesaffectingtheCOcompensationpoint.PlantPhysiology58,143.
	SomervilleCR,PortisAR,OgrenWL.1982.AmutantofArabidopsisthalianawhichlacksactivationofRUBPcarboxylaseinvivo.PlantPhysiology70,381ï¿½387.
	SomervilleCR,SomervilleSC.1984.CloningandexpressionoftheRhodospirillumrubrumribulosebisphosphatecarboxylasegeneinE.coli.MolecularandGeneralGenetics193,214ï¿½219.
	SomervilleCR,SomervilleSC.1986.Regulationofphotorespiration.In:NeyraCA,ed.Abiochemicalbasisofplantbreeding,Vol.I.BocaRaton(Florida):CRCPress,Inc.,89ï¿½131.
	SoperTS,LarimerFW,MuralRJ,LeeEH,HartmanFC.1992.Roleofasparagine111attheactivesiteofribulose-1,5-bisphosphatecarboxylase/oxygenasefromRhodospirillumrubrumasdemonstratedbysitedirectedmutagenesis.JournalofBiologicalChemistry267,8452ï¿½8457.
	SoperTS,MuralRJ,LarimerFW,LeeEH,MachanoffR,HartmanFC.1988.EssentialityofLys-329ofribulose-1,5-bisphosphatecarboxylase/oxygenasefromRhodospirillumrubrumasdemonstratedbysite-directedmutagenesis.ProteinEngineering2,39ï¿½44.
	SpreitzerRJ.1993.GeneticdissectionofRubiscostructureandfunction.AnnualReviewofPlantPhysiologyandPlantMolecularBiology44,411ï¿½434.
	SpreitzerRJ.1999.Questionsaboutthecomplexityofchloroplastribulose-1,5-bisphosphatecarboxylase/oxygenase.PhostosynthesisResearch60,29ï¿½42.
	SpreitzerRJ,SalvucciME.2002.Rubisco:structure,regulatoryinteractions,andpossibilitiesforabetterenzyme.AnnualReviewofPlantBiology53,449ï¿½475.
	SpreitzerRJ,ThowG,ZhuGH.1995.Pseudoreversionsubstitutionatlarge-subunitresidue-54inï¿½uencestheCOspeciï¿½cityofchloroplastribulose-bisphosphatecarboxylaseoxygenase.PlantPhysiology109,681ï¿½685.
	SteerMW,GunningBES,GrahamTA,CarrDJ.1966.Isolationandpropertiesoffraction1proteinfromAvenasativaL.Planta79,256ï¿½267.
	StittM,KrappA.1999.Theinteractionbetweenelevatedcarbondioxideandnitrogennutrition:thephysiologicalandmolecularbackground.Plant,CellandEnvironment22,583ï¿½621.
	StittM,QuickWP,SchurrU,SchulzeED,RodermelSR,BogoradL.1991.Decreasedribulose-1,5-bisphosphatecarboxylase-oxygenaseintransgenictobaccotransformedwithantisenserbcs.2.ï¿½ux-controlcoefï¿½cientsforphotosynthesisinvaryinglight,COandairhumidity.Planta183,555ï¿½566.
	StittM,SchulzeD.1994.DoesRubiscocontroltherateofphotosynthesisandplant-growthï¿½anexerciseinmolecularecophysiology.Plant,CellandEnvironment17,465ï¿½487.
	StreusandVJ,PortisAR.1987.RubiscoactivasemediatesATP-dependentactivationofribulosebisphosphatecarboxylase.PlantPhysiology85,152ï¿½154.
	SugawaraH,YamamotoH,ShihataN,InoueT,OkadaS,MiyakeC,YokotaA,KaiY.1999.Crystalstructureofcarboxylasereaction-orientedribulose1,5-bisphosphatecarboxylaseoxygenasefromathermophilicredalga,Galdieriapartita.JournalofBiologicalChemistry274,15655ï¿½15661.
	TaylorTC,BacklundA,BjorhallK,SpreitzerRJ,AnderssonI.2001.FirstcrystalstructureofRubiscofromagreenalga,Chlamydomonasreinhardtii.JournalofBiologicalChemistry276,48159ï¿½48164.
	TheobaldJC,MitchellRAC,ParryMAJ,LawlorDW.1998.Estimatingtheexcessinvestmentinribulose-1,5-bisphosphatecarboxylase/oxygenaseinleavesofspringwheatgrownunderelevatedCO.PlantPhysiology118,945ï¿½955.
	ThowG,ZhuGH,SpreitzerRJ.1994.Complementingsubstitutionswithinloopregion-2andregion-3ofthealpha/beta-barrelactive-siteinï¿½uencetheCOspeciï¿½cityofchloroplastribulose-1,5-bisphosphatecarboxylase/oxygenase.Biochemistry33,5109ï¿½5114.
	UemuraK,SuzukiY,ShikanaiT,WadanoA,JensenRG,ChmaraW,YokotaA.1996.Arapidandsensitivemethodfordeterminationofrelativespeciï¿½cityofRubiscofromvariousspeciesbyanionexchangechromatography.PlantCellPhysiology37,325ï¿½331.
	vonCaemmererS,MillgateA,FarquharGD,FurbankRT.1997.Reductionofribulose-1,5-bisphosphatecarboxylase/oxygenasebyantisenseRNAintheC-4plantFlaveriabidentisleadstoreducedassimilationratesandincreasedcarbonisotopediscrimination.PlantPhysiology113,469ï¿½477.
	WangZ-Y,SnyderGW,EsauBD,PortisAR,OgrenWL.1992.Speciesdependentvariationintheinteractionofsubstrate-boundribulose-1,5-bisphosphatecarboxylase/oxygenase(Rubisco)andRubiscoactivase.PlantPhysiology100,1858ï¿½1862.
	WangZY,PortisAR.1992.Dissociationofribulose-1,5-bisphosphateboundtoribulose-1,5-bisphosphatecarboxylase/oxygenaseanditsenhancementbyribulose-1,5-bisphosphatecarboxylase/oxygenaseactivase-mediatedhydrolysisofATP.PlantPhysiology99,1348ï¿½1353.
	WangYL,ZhouJH,WangYF,BaoJS,ChenHB.2001.PropertiesofhybridenzymesbetweenSynechococcuslargesubunitsandhigherplantsmallsubunitsofribulose-1,5-bisphosphatecarboxylase/oxygenaseinEscherichiacoli.ArchivesofBiochemistryandBiophysics396,35ï¿½42.
	WarburgO.1920.UberdieGeschwindigkeitderphotochemischenKohlensaurezersetunginlebendenZellenII.BiochemischeZeitschrift100,188ï¿½217.
	WhitneySM,AndrewsTJ.2001a.Thegenefortheribulose-1,5-bisphosphatecarboxylase/oxygenase(Rubisco)smallsubunitrelocatedtotheplastidgenomeoftobaccodirectsthesynthesisofsmallsubunitsthatassembleintoRubisco.ThePlantCell13,193ï¿½205.
	WhitneySM,AndrewsTJ.2001b.Plastome-encodedbacterialribulose-1,5-bisphosphatecarboxylase/oxygenase(Rubisco)supportsphotosynthesisandgrowthintobacco.ProceedingsoftheNationalAcademyofSciences,USA98,14738ï¿½14743.
	WhitneySM,BaldettP,HudsonGS,AndrewsTJ.2001.FormIRubiscosfromnon-greenalgaeareexpressedabundantlybutnotassembledintobaccochloroplasts.ThePlantJournal26,535ï¿½547.
	WhitneySM,vonCaemmererS,HudsonGS,AndrewsTJ.1999.DirectedmutationoftheRubiscolargesubunitoftobaccoinï¿½uencesphotorespirationandgrowth.PlantPhysiology121,579ï¿½588.
	WildnerGF.1981.Ribulose-1,5-bisphosphatecarboxylase-oxygenase;aspectsandproducts.PhysiologiaPlantarum52,385ï¿½389.
	WinglerA,LeaPJ,LeegoodRC.1999.Photorespiratorymetabolismofglyoxylateandformateinglycine-accumulatingmutantsofbarleyandAmaranthusedulis.Planta207,518ï¿½526.
	ZhangN,PortisAR.1999.MechanismoflightregulationofRubisco:aspeciï¿½croleforthelargerRubiscoactivaseisoforminvolvingreductiveactivationbythioredoxin-f.ProceedingsoftheNationalAcademyofSciences,USA96,9438ï¿½9443.
	ZhangN,KallisRP,EwyRG,PortisAR.2002.LightmodulationofRubiscoinArabidopsisrequiresacapacityforredoxregulationofthelargerRubiscoactivaseisoform.ProceedingsoftheNationalAcademyofSciences,USA.99,3330ï¿½3334.
	ZhuGH,JensenRG,BohnertHJ,WildnerGF,SchlitterJ.1998.DependenceofcatalysisandCOspeciï¿½cityofRubiscoonthecarboxy-terminusofthelargesubunitdifferenttemperatures.PhotosynthesisResearch57,71ï¿½79.
	ZhuGH,SpreitzerRJ.1996.Directedmutagenesisofchloroplastribulose-1,5-bisphosphatecarboxylase/oxygenaseï¿½Loop6substitutionscomplementforstructuralstabilitybutdecreasecatalyticefï¿½ciency.JournalofBiologicalChemistry271,18494ï¿½18498.
J. Exp. Bot.-2003-Battey-1313-6.pdf	9
	Danielson DR. 2000. The book of the cosmos. Massachusetts: Perseus.
	Dempsey C. 1992. The portrayal of love: Botticelli?s Primaveraand humanistculture at the time of Lorenzo the Magnificent. Princeton: PrincetonUniversity Press.
	Levi d?Ancona M. 1983. Botticelli?s Primavera: a botanical interpretationincluding astrology, alchemy and the Medici. Firenze: LS Olschki.Lightbown R. 1978. Sandro Botticelli: Vol. II. Complete catalogue. London:Paul Elek.
	Lucretius. The nature of the universe, 1951 edn. Translated by RE Latham.London: Penguin.
	McWatters HG, Roden LC, Staiger D. 2001. Picking out parallels: plantcircadian clocks in context.Philosophical Transactions of the Royal Society ofLondon B356, 1735-1743.
	Nagle BR. 1995. Ovid?s Fasti. Indianapolis: Indiana University Press.Pittendrigh CS. 1981. Circadian organization and the photoperiodicphenomena. In: Follett BK, Follett DE, eds. Biological clocks in seasonalreproductive cycles. Bristol: Wright, 1-35.
	Samach A, Coupland G. 2000. Time measurement and the control offlowering in plants.BioEssays22, 38-47.
	Suarez-Lopez P, Wheatley K, Robson F, Onouchi H, Valverde F, CouplandG. 2001. CONSTANSmediates between the circadian clock and thecontrol of flowering in Arabidopsis. Nature410, 1116-1120.
	Thomas B,Vince-Prue D. 1997. Photoperiodism in plants. London:Academic Press.
20030218s00018p433.pdf	12
20030218s00013p403.pdf	35
	1.Dornhorst A, Chan SP. The elusive diagnosis of gestational diabetes. DiabetMed1998;15(1):7-10.
	2.Buchanan TA, Kjos SL. Gestational diabetes: Risk or myth? J Clin EndocrinolMetab1999;84(6):1854-7.
	3.Jarrett RJ. Gestational diabetes: a non-entity? BMJ1993;306(6869):37-8.
	4.Ratner RE. Clinical review 47. Gestational diabetes mellitus: After three in-ternational workshops do we know how to diagnose and manage it yet? J ClinEndocrinol Metab1993;77(1):1-4.
	5.WHO Study Group. Prevention of diabetes mellitus. Report of a WHO StudyGroup. No 844 of Technical Reportsseries. Geneva, Switzerland: World HealthOrganization; 1994.
	6.American Diabetes Association. Gestational diabetes mellitus. Diabetes Care2002;25(Suppl 1):S94-6.
	7.Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998clinical practice guidelines for the management of diabetes in Canada. CMAJ1998;159(8 Suppl):S1-29.
	8.Canadian Task Force on the Periodic Health Examination. Periodic healthexamination, 1992 update: 1. Screening for gestational diabetes mellitus.CMAJ1992;147(4):435-43.
	9.Solomon CG, Willett WC, Rich-Edwards J, Hunter DJ, Stampfer MJ,Colditz GA, et al. Variability in diagnostic evaluation and criteria for gesta-tional diabetes. Diabetes Care1996;19(1):12-6.
	10.Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med1999;341(23):1749-56.
	11.O?Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test inpregnancy. Diabetes1964;13(3):278-85.
	12.O?Sullivan JB, Charles D, Mahan CM, Dandrow RV. Gestational diabetesand perinatal mortality rate. Am J Obstet Gynecol1973;116(7):901-4.
	13.Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestationaldiabetes mellitus. N Engl J Med1997;337(22):1591-6.
	14.Arbuckle TE, Wilkins R, Sherman GJ. Birth weight percentiles by gestationalage in Canada. Obstet Gynecol1993;81(1):39-48.
	15.Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, etal, for the Fetal/Infant Study Group of the Canadian Perinatal SurveillanceSystem. A new and improved population-based Canadian reference for birthweight for gestational age. Pediatrics2001;108(2):e35. Available: www.pedi-atrics.org/cgi/content/full/108/2/e35 (accessed 2003 Jan 7).
	16.National Diabetes Data Group. Classification and diagnosis of diabetes melli-tus and other categories of glucose intolerance. Diabetes1979;28(12):1039-57.
	17.Swets JA. Measuring the accuracy of diagnostic systems. Science1988;240(4857):1285-93.
	18.Hanley JA, McNeil BJ. The meaning and use of the area under a receiver op-erating characteristic (ROC) curve. Radiology1982;143(1):29-36.
	19.Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JWK, Farine D, et al.Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in3637 women without gestational diabetes. Toronto Tri-Hospital GestationalDiabetes Project. Am J ObstetGynecol 1995;173(1):146-56.
	20.Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus.Diabetes Care1998;21(Suppl 2):B79-84.
	21.Landy HJ, Gomez-Marin O, O?Sullivan MJ. Diagnosing gestational diabetesmellitus: use of a glucose screen without administering the glucose tolerancetest. Obstet Gynecol1996;87(3):395-400.
	22.Langer O, Mazze R. The relationship between large-for-gestational-age in-fants and glycemic control in women with gestational diabetes. Am J ObstetGynecol1988;159(6):1478-83.
	23.Moses RG, Calvert D. Pregnancy outcomes in women without gestational di-abetes mellitus related to the maternal glucose level. Is there a continuum ofrisk? Diabetes Care1995;18(12):1527-33.
	24.Sacks DA, Greenspoon JS, Abu-Fadil S, Henry HM, Wolde-Tsadik G, YaoJF. Toward universal criteria for gestational diabetes: the 75-gram glucosetolerance test in pregnancy. Am J Obstet Gynecol1995;172(2 Pt 1):607-14.
	25.Goldman M, Kitzmiller JL, Abrams B, Cowan RM, Laros RK Jr. Obstetriccomplications with GDM. Effects of maternal weight. Diabetes1991;40(Suppl2):79-82.
	26.Knopp RH, Bergelin RO, Wahl PW, Walden CE. Relationships of infant birthsize to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries,and body weight at 36 weeks gestation. Diabetes1985;34(Suppl 2):71-7.
	27.Green JR, Schumacher LB, Pawson IG, Partridge JC, Kretchmer N. Influ-ence of maternal body habitus and glucose tolerance on birth weight. ObstetGynecol1991;78(2):235-40.
	28.Langer O. Gestational diabetes: a contemporary management approach. En-docrinologist 1995;5(3):180-8.
	29.Sacks DA. Fetal macrosomia and gestational diabetes: What?s the problem?Obstet Gynecol1993;81(5 Pt 1):775-81.
	30.Homko CJ, Sivan E, Nyirjesy P, Reece EA. The interrelationship betweenethnicity and gestational diabetes in fetal macrosomia. Diabetes Care1995;18(11):1442-5.
	31.Green JR, Pawson IG, Schumacher LB, Perry J, Kretchmer N. Glucose toler-ance in pregnancy: ethnic variation and influence of body habitus. Am J ObstetGynecol1990;163(1 Pt 1):86-92.
	32.Berkus MD, Langer O. Glucose tolerance test periodicity: the effect of glu-cose loading. Obstet Gynecol1995;85(3):423-7.
	33.Castro A, Scott JP, Grettie DP, Macfarlane D, Bailey RE. Plasma insulin andglucose responses of healthy subjects to varying glucose loads during three-hour oral glucose tolerance tests. Diabetes1970;19(11):842-51.
	34.Brustman LE, Gela BD, Moore M, Reilly KD, Langer O. Variations in oralglucose tolerance tests: the 100- versus 75-g controversy. J Assoc Acad MinorPhys1995;6(2):70-2
	35.Walkinshaw SA. Dietary regulation for ?gestational diabetes? [Cochrane re-view]. In: The Cochrane Library; Issue 1, 2002. Oxford: Update Software.Maternal plasma glucose and birth weight
20030218s00008p400.pdf	1
Cancer Res-2003-Fan-873-7.pdf	21
	1.Shafman,T.,Khanna,K.K.,Kedar,P.,Spring,K.,Kozlov,S.,Yen,T.,Hobson,K.,Gatei,M.,Zhang,N.,Watters,D.,Egerton,M.,Shiloh,Y.,Kharbanda,S.,Kufe,D.,andLavin,M.F.InteractionbetweenATMproteinandc-AblinresponsetoDNAdamage.Nature(Lond.),387:520?523,1997.
	2.Baskaran,R.,Wood,L.D.,Whitaker,L.L.,Canman,C.E.,Morgan,S.E.,Xu,Y.,Barlow,C.,Baltimore,D.,Wynshaw-Boris,A.,Kastan,M.B.,andWang,J.Y.Ataxiatelangiectasiamutantproteinactivatesc-Abltyrosinekinaseinresponsetoionizingradiation.Nature(Lond.),387:516?519,1997.
	3.Plattner,R.,Kadlec,L.,DeMali,K.A.,Kazlauskas,A.,andPendergast,A.M.c-AblisactivatedbygrowthfactorsandsrcfamilykinasesandhasaroleinthecellularresponsetoPDGF.GenesDev.,13:2400?2411,1999.
	4.Franz,W.M.,Berger,P.,andWang,J.Y.DeletionofanN-terminalregulatorydomainofthec-abltyrosinekinaseactivatesitsoncogenicpotential.EMBOJ.,8:137?147,1989.
	5.Jackson,P.,andBaltimore,D.N-terminalmutationsactivatetheleukemogenicpotentialofthemyristoylatedformofc-abl.EMBOJ.,8:449?456,1989.
	6.Barila,D.,andSuperti-Furga,G.AnintramolecularSH3-domaininteractionregulatesc-Ablactivity.Nat.Genet.,18:280?282,1998.
	7.Pluk,H.,Dorey,K.,andSuperti-Furga,G.Autoinhibitionofc-Abl.Cell,108:247?259,2002.
	8.Wen,S.T.,andVanEtten,R.A.ThePAGgeneproduct,astress-inducedproteinwithantioxidantproperties,isanAblSH3-bindingproteinandaphysiologicalinhibitorofc-Abltyrosinekinaseactivity.GenesDev.,11:2456?2467,1997.
	9.McWhirter,J.R.,Galasso,D.L.,andWang,J.Y.Acoiled-coiloligomerizationdomainofBcrisessentialforthetransformingfunctionofBcr-Abloncoproteins.Mol.Cell.Biol.,13:7587?7595,1993.
	10.McWhirter,J.R.,andWang,J.Y.EffectofBcrsequencesonthecellularfunctionoftheBcr-Abloncoprotein.Oncogene,15:1625?1634,1997.
	11.Golub,T.R.,Goga,A.,Barker,G.F.,Afar,D.E.,McLaughlin,J.,Bohlander,S.K.,Rowley,J.D.,Witte,O.N.,andGilliland,D.G.OligomerizationoftheABLtyrosinekinasebytheEtsproteinTELinhumanleukemia.Mol.Cell.Biol.,16:4107?4116,1996.
	12.Okuda,K.,D?Andrea,A.,Etten,R.A.,andGriffin,J.D.Achimericreceptor/oncogenethatcanberegulatedbyaligandinvitroandinvivo.J.Clin.Investig.,100:1708?1715,1997.
	13.Jackson,P.,Baltimore,D.,andPicard,D.Hormone-conditionaltransformationbyfusionproteinsofc-Ablanditstransformingvariants.EMBOJ.,12:2809?2819,1993.
	14.Smith,K.M.,andVanEtten,R.A.Activationofc-Ablkinaseactivityandtransfor-mationbyachemicalinducerofdimerization.J.Biol.Chem.,276:24372?9,2001.
	15.Fan,P.D.,andGoff,S.P.Ablinteractor1bindstososandinhibitsepidermalgrowthfactor-andv-Abl-inducedactivationofextracellularsignal-regulatedkinases.Mol.Cell.Biol.,20:7591?601,2000.
	16.Schlessinger,J.Cellsignalingbyreceptortyrosinekinases.Cell,103:211?225,2000.
	17.Lewis,J.M.,Baskaran,R.,Taagepera,S.,Schwartz,M.A.,andWang,J.Y.Integrinregulationofc-Abltyrosinekinaseactivityandcytoplasmic-nucleartransport.Proc.Natl.Acad.Sci.USA,93:15174?9,1996.
	18.Wen,S.T.,Jackson,P.K.,andVanEtten,R.A.Thecytostaticfunctionofc-Abliscontrolledbymultiplenuclearlocalizationsignalsandrequiresthep53andRbtumorsuppressorgeneproducts.EMBOJ.,15:1583?1595,1996.
	19.Taagepera,S.,McDonald,D.,Loeb,J.E.,Whitaker,L.L.,McElroy,A.K.,Wang,J.Y.,andHope,T.J.Nuclear-cytoplasmicshuttlingofC-ABLtyrosinekinase.Proc.Natl.Acad.Sci.USA,95:7457?7462,1998.
	20.Courtney,K.D.,Grove,M.,Vandongen,H.,Vandongen,A.,LaMantia,A.S.,andPendergast,A.M.LocalizationandphosphorylationofAbl-interactorproteins,Abi-1andAbi-2,inthedevelopingnervoussystem.Mol.Cell.Neurosci.,16:244?257,2000.
	21.Stradal,T.,Courtney,K.D.,Rottner,K.,Hahne,P.,Small,J.V.,andPendergast,A.M.TheAblinteractorproteinslocalizetositesofactinpolymerizationatthetipsoflamellipodiaandfilopodia.Curr.Biol.,11:891?895,2001.877
2020.pdf	113
	1.Au,W.C.,P.A.Moore,W.Lowther,Y.T.Juang,andP.M.Pitha.1995.Identificationofamemberoftheinterferonregulatoryfactorfamilythatbindstotheinterferon-stimulatedresponseelementandactivatesexpressionofinterferon-inducedgenes.Proc.Natl.Acad.Sci.USA92:11657?11661.
	2.Bello,L.J.,A.J.Davison,M.A.Glenn,A.Whitehouse,N.Rethmeier,T.F.Schulz,andJ.BarklieClements.1999.Thehumanherpesvirus-8ORF57geneanditsproperties.J.Gen.Virol.80:3207?3215.
	3.Best,S.,J.B.Wolfinbarger,andM.E.Bloom.2002.CaspaseactivationisrequiredforpermissivereplicationofAleutianminkdiseaseparvovirusinvitro.Virology292:224?234.
	4.Blesofsky,W.A.,K.Mowen,R.M.Arduini,D.P.Baker,M.A.Murphy,D.D.Bowtell,andM.David.2001.RegulationofSTATproteinsynthesisbyc-Cbl.Oncogene20:7326?7333.
	5.Boyle,K.A.,R.L.Pietropaolo,andT.Compton.1999.EngagementofthecellularreceptorforglycoproteinBofhumancytomegalovirusactivatestheinterferon-responsivepathway.Mol.Cell.Biol.19:3607?3613.
	6.Boyle,S.M.,V.Ruvolo,A.K.Gupta,andS.Swaminathan.1999.AssociationwiththecellularexportreceptorCRM1mediatesfunctionandintracellularlocalizationofEpstein-BarrvirusSMprotein,aregulatorofgeneexpression.J.Virol.73:6872?6881.
	7.Braselmann,S.,P.Graninger,andM.Busslinger.1993.Aselectivetran-scriptionalinductionsystemformammaliancellsbasedonGal4-estrogenreceptorfusionproteins.Proc.Natl.Acad.Sci.USA90:1657?1661.
	8.Buisson,M.,F.Hans,I.Kusters,N.Duran,andA.Sergeant.1999.TheC-terminalregionbutnottheArg-X-ProrepeatofEpstein-Barrviruspro-teinEB2isrequiredforitseffectonRNAsplicingandtransport.J.Virol.73:4090?4100.
	9.Buisson,M.,E.Manet,M.C.Trescol-Biemont,H.Gruffat,B.Durand,andA.Sergeant.1989.TheEpstein-BarrVirus(EBV)earlyproteinEB2isaposttranscriptionalactivatorexpressedunderthecontrolofEBVtranscrip-tionfactorsEB1andR.J.Virol.63:5276?5284.
	10.Chee,M.,andB.Barrell.1990.Herpesviruses:astudyofparts.TrendsGenet.6:86?91.
	11.Cheung,P.,K.S.Ellison,R.Verity,andJ.R.Smiley.2000.HerpessimplexvirusICP27inducescytoplasmicaccumulationofunsplicedpolyadenylatedalpha-globinpre-mRNAininfectedHeLacells.J.Virol.74:2913?2919.
	12.Chevalier-Greco,A.,E.Manet,P.Chavrier,C.Mosnier,J.Daillie,andA.Sergeant.1986.BothEpstein-Barrvirus(EBV)-encodedtrans-actingfac-tors,EB1andEB2,arerequiredtoactivatetranscriptionfromanEBVearlypromoter.EMBOJ.5:3243?3249.
	13.Chin,K.C.,andP.Cresswell.2001.Viperin(cig5),anIFN-inducibleanti-viralproteindirectlyinducedbyhumancytomegalovirus.Proc.Natl.Acad.Sci.USA98:15125?15130.
	14.Cho,M.S.,K.T.Jeang,andS.D.Hayward.1985.LocalizationofthecodingregionforanEpstein-Barrvirusearlyantigenandinducibleexpressionofthis60-kilodaltonnuclearproteinintransfectedfibroblastcelllines.J.Virol.56:852?859.
	15.Darnell,J.E.,Jr.,I.M.Kerr,andG.R.Stark.1994.Jak-STATpathwaysandtranscriptionalactivationinresponsetoIFNsandotherextracellularsignal-ingproteins.Science264:1415?1421.
	16.Darzynkiewicz,Z.,andG.Juan.1997.Nucleicacidanalysis,p.7.5.2.InP.Robinson(ed.),Currentprotocolsinmolecularcytometry,vol.1.JohnWileyandSons,NewYork,N.Y.
	17.Davison,A.J.,andP.Taylor.1987.Geneticrelationsbetweenvaricella-zostervirusandEpstein-Barrvirus.J.Gen.Virol.68:1067?1079.
	18.Der,S.D.,A.Zhou,B.R.Williams,andR.H.Silverman.1998.Identificationofgenesdifferentiallyregulatedbyinterferonalpha,beta,orgammausingoligonucleotidearrays.Proc.Natl.Acad.Sci.USA95:15623?15628.
	19.deVeer,M.J.,M.Holko,M.Frevel,E.Walker,S.Der,J.M.Paranjape,R.H.Silverman,andB.R.Williams.2001.Functionalclassificationofinterferon-stimulatedgenesidentifiedusingmicroarrays.J.Leukoc.Biol.69:912?920.
	20.Farjot,G.,M.Buisson,M.DucDodon,L.Gazzolo,A.Sergeant,andI.Mikaelian.2000.Epstein-BarrvirusEB2proteinexportsunsplicedRNAviaaCrm-1-independentpathway.J.Virol.74:6068?6076.
	21.Farrell,P.1989.Epstein-Barrvirusgenome.Adv.ViralOncol.8:103?132.
	22.Farrell,P.J.,R.J.Broeze,andP.Lengyel.1979.AccumulationofanmRNAandproteinininterferon-treatedEhrlichascitestumourcells.Nature279:523?525.
	23.Fu,X.Y.,D.S.Kessler,S.A.Veals,D.E.Levy,andJ.E.Darnell,Jr.1990.ISGF3,thetranscriptionalactivatorinducedbyinterferonalpha,consistsofmultipleinteractingpolypeptidechains.Proc.Natl.Acad.Sci.USA87:8555?8559.
	24.Fu,X.Y.,C.Schindler,T.Improta,R.Aebersold,andJ.E.Darnell,Jr.1992.TheproteinsofISGF-3,theinterferonalpha-inducedtranscriptionalactiva-tor,defineagenefamilyinvolvedinsignaltransduction.Proc.Natl.Acad.Sci.USA89:7840?7843.
	25.Guo,J.,D.J.Hui,W.C.Merrick,andG.C.Sen.2000.Anewpathwayoftranslationalregulationmediatedbyeukaryoticinitiationfactor3.EMBOJ.19:6891?6899.
	26.Gupta,A.K.,V.Ruvolo,C.Patterson,andS.Swaminathan.2000.Thehumanherpesvirus8homologofEpstein-BarrvirusSMprotein(KS-SM)isaposttranscriptionalactivatorofgeneexpression.J.Virol.74:1038?1044.
	27.Huang,M.T.F.,andC.M.Gorman.1990.InterveningsequencesincreaseefficiencyofRNA3processingandaccumulationofcytoplasmicRNA.NucleicAcidsRes.18:937?947.
	28.Improta,T.,C.Schindler,C.M.Horvath,I.M.Kerr,G.R.Stark,andJ.E.Darnell,Jr.1994.TranscriptionfactorISGF-3formationrequiresphosphor-ylatedStat91protein,butStat113proteinisphosphorylatedindependentlyofStat91protein.Proc.Natl.Acad.Sci.USA91:4776?4780.
	29.Inchauspe,G.,S.Nagpal,andJ.M.Ostrove.1989.Mappingoftwovaricella-zostervirus-encodedgenesthatactivatetheexpressionofviralearlyandlategenes.Virology173:700?709.
	30.Kenney,S.,J.Kamine,E.Holley-Guthrie,E.C.Mar,J.C.Lin,D.Marko-vitz,andJ.Pagano.1989.TheEpstein-Barrvirusimmediate-earlygeneproduct,BMLF1,actsintransbyaposttranscriptionalmechanismwhichisreportergenedependent.J.Virol.63:3870?3877.
	31.Kenney,S.,J.Kamine,D.Markovitz,R.Fenrick,andJ.Pagano.1988.AnEpstein-Barrvirusimmediate-earlygeneproducttrans-activatesgeneex-pressionfromthehumanimmunodeficiencyviruslongterminalrepeat.Proc.Natl.Acad.Sci.USA85:1652?1656.
	32.Kieff,E.1996.Epstein-Barrvirusanditsreplication,p.2343?2396.InB.N.Fields,D.M.Knipe,andP.M.Howley(ed.),Virology.Lipincott-Raven,Philadelphia,Pa.
	33.Kirshner,J.R.,D.M.Lukac,J.Chang,andD.Ganem.2000.Kaposi?ssarcoma-associatedherpesvirusopenreadingframe57encodesaposttran-scriptionalregulatorwithmultipledistinctactivities.J.Virol.74:3586?3597.
	34.Kumar,A.,M.Commane,T.W.Flickinger,C.M.Horvath,andG.R.Stark.1997.DefectiveTNF-alpha-inducedapoptosisinSTAT1-nullcellsduetolowconstitutivelevelsofcaspases.Science278:1630?1632.
	35.Lawn,R.M.,J.Adelman,T.J.Dull,M.Gross,D.Goeddel,andA.Ullrich.1981.DNAsequenceoftwocloselylinkedhumanleukocyteinterferongenes.Science212:1159?1162.
	36.Lawn,R.M.,J.Adelman,A.E.Franke,C.M.Houck,M.Gross,R.Najarian,andD.V.Goeddel.1981.Humanfibroblastinterferongenelacksintrons.NucleicAcidsRes.9:1045?1052.
	37.Levy,D.,A.Larner,A.Chaudhuri,L.E.Babiss,andJ.E.Darnell,Jr.1986.Interferon-stimulatedtranscription:isolationofaninduciblegeneandiden-tificationofitsregulatoryregion.Proc.Natl.Acad.Sci.USA83:8929?8933.
	38.Luo,M.J.,andR.Reed.1999.SplicingisrequiredforrapidandefficientmRNAexportinmetazoans.Proc.Natl.Acad.Sci.USA96:14937?14942.
	39.Markovitz,D.M.,S.Kenney,J.Kamine,M.S.Smith,M.Davis,andE.-S.Huang.1989.Disparateeffectsoftwoherpesvirusimmediate-earlygenetrans-activatorsontheHIVLTR.Virology173:750?754.
	40.McCarthy,A.M.,L.McMahan,andP.A.Schaffer.1989.Herpessimplexvirustype1ICP27deletionmutantsexhibitalteredpatternsoftranscriptionandareDNAdeficient.J.Virol.63:18?27.
	41.Menezes,J.,W.Liebold,G.Klein,andG.Clements.1975.EstablishmentandcharacterizationofanEpstein-Barrvirus(EBV)-negativelymphoblastoidBcellline(BJA-B)fromanexceptionalEBV-genome-negativeAfricanBur-kitt?slymphoma.Biomedicine22:276?284.
	42.Morrison,T.E.,A.Mauser,A.Wong,J.P.Ting,andS.C.Kenney.2001.InhibitionofIFN-gammasignalingbyanEpstein-Barrvirusimmediate-earlyprotein.Immunity15:787?799.
	43.Mossman,K.L.,P.F.Macgregor,J.J.Rozmus,A.B.Goryachev,A.M.Edwards,andJ.R.Smiley.2001.Herpessimplexvirustriggersandthendisarmsahostantiviralresponse.J.Virol.75:750?758.
	44.Mowen,K.,andM.David.2000.RegulationofSTAT1nuclearexportbyJak1.Mol.Cell.Biol.20:7273?7281.
	45.Mowen,K.A.,J.Tang,W.Zhu,B.T.Schurter,K.Shuai,H.R.Herschman,andM.David.2001.ArgininemethylationofSTAT1modulatesIFN/-inducedtranscription.Cell104:731?741.
	46.Muller,M.,C.Laxton,J.Briscoe,C.Schindler,T.Improta,J.E.Darnell,Jr.,G.R.Stark,andI.M.Kerr.1993.Complementationofamutantcellline:centralroleofthe91kDapolypeptideofISGF3intheinterferon-alphaand-gammasignaltransductionpathways.EMBOJ.12:4221?4228.
	47.Navarro,L.,K.Mowen,S.Rodems,B.Weaver,N.Reich,D.Spector,andM.David.1998.Cytomegalovirusactivatesinterferonimmediate-earlyresponsegeneexpressionandaninterferonregulatoryfactor3-containinginterferon-stimulatedresponseelement-bindingcomplex.Mol.Cell.Biol.18:3796?3802.
	48.Ouchi,T.,S.W.Lee,M.Ouchi,S.A.Aaronson,andC.M.Horvath.2000.Collaborationofsignaltransducerandactivatoroftranscription1(STAT1)andBRCA1indifferentialregulationofIFN-gammatargetgenes.Proc.Natl.Acad.Sci.USA97:5208?5213.
	49.Ramana,C.V.,M.P.Gil,Y.Han,R.M.Ransohoff,R.D.Schreiber,andG.R.Stark.2001.Stat1-independentregulationofgeneexpressioninre-sponsetoIFN-gamma.Proc.Natl.Acad.Sci.USA98:6674?6679.
	50.Ramana,C.V.,N.Grammatikakis,M.Chernov,H.Nguyen,K.C.Goh,B.R.Williams,andG.R.Stark.2000.Regulationofc-mycexpressionbyIFN-gammathroughStat1-dependentand-independentpathways.EMBOJ.19:263?272.
	51.Ruvolo,V.,A.K.Gupta,andS.Swaminathan.2001.Epstein-BarrvirusSMproteininteractswithmRNAinvivoandmediatesagene-specificincreaseincytoplasmicmRNA.J.Virol.75:6033?6041.
	52.Ruvolo,V.,E.Wang,S.Boyle,andS.Swaminathan.1998.TheEpstein-BarrvirusnuclearproteinSMisbothapost-transcriptionalinhibitorandactivatorofgeneexpression.Proc.Natl.Acad.Sci.USA95:8852?8857.
	53.Sample,J.,G.Lancz,andM.Nonoyama.1986.MappingofgenesinBamHIfragmentMofEpstein-BarrvirusDNAthatmaydeterminethefateofviralinfection.J.Virol.57:145?154.
	54.Schindler,C.,X.Y.Fu,T.Improta,R.Aebersold,andJ.E.Darnell,Jr.1992.ProteinsoftranscriptionfactorISGF-3:onegeneencodesthe91-and84-kDaISGF-3proteinsthatareactivatedbyinterferonalpha.Proc.Natl.Acad.Sci.USA89:7836?7839.
	55.Semmes,O.J.,L.Chen,R.T.Sarisky,Z.Gao,L.Zhong,andS.D.Hayward.1998.MtahaspropertiesofanRNAexportproteinandincreasescytoplas-micaccumulationofEpstein-BarrvirusreplicationgenemRNA.J.Virol.72:9526?9534.
	56.Shuai,K.,C.M.Horvath,L.H.Huang,S.A.Qureshi,D.Cowburn,andJ.E.Darnell,Jr.1994.InterferonactivationofthetranscriptionfactorStat91involvesdimerizationthroughSH2-phosphotyrosylpeptideinteractions.Cell76:821?828.
	57.Shuai,K.,C.Schindler,V.R.Prezioso,andJ.E.Darnell,Jr.1992.Activa-tionoftranscriptionbyIFN-gamma:tyrosinephosphorylationofa91-kDDNAbindingprotein.Science258:1808?1812.
	58.Shuai,K.,G.R.Stark,I.M.Kerr,andJ.E.Darnell,Jr.1993.AsinglephosphotyrosineresidueofStat91requiredforgeneactivationbyinterferon-gamma.Science261:1744?1746.
	59.Stark,G.R.,I.M.Kerr,B.R.Williams,R.H.Silverman,andR.D.Schreiber.1998.Howcellsrespondtointerferons.Annu.Rev.Biochem.67:227?264.
	60.Swaminathan,S.,R.Hesselton,J.Sullivan,andE.Kieff.1993.Epstein-BarrvirusrecombinantswithspecificallymutatedBCRF1genes.J.Virol.67:7406?7413.
	61.Taniguchi,T.,andA.Takaoka.2002.Theinterferon-alpha/betasysteminantiviralresponses:amultimodalmachineryofgeneregulationbytheIRFfamilyoftranscriptionfactors.Curr.Opin.Immunol.14:111?116.
	62.Tavernier,J.,R.Derynck,andW.Fiers.1981.Evidenceforauniquehumanfibroblastinterferon(IFN-beta1)chromosomalgene,devoidofinterveningsequences.NucleicAcidsRes.9:461?471.
	63.Veals,S.A.,C.Schindler,D.Leonard,X.Y.Fu,R.Aebersold,J.E.Darnell,Jr.,andD.E.Levy.1992.Subunitofanalpha-interferon-responsivetran-scriptionfactorisrelatedtointerferonregulatoryfactorandMybfamiliesofDNA-bindingproteins.Mol.Cell.Biol.12:3315?3324.
	64.Wathelet,M.,S.Moutschen,P.Defilippi,A.Cravador,M.Collet,G.Huez,andJ.Content.1986.Molecularcloning,full-lengthsequenceandprelimi-narycharacterizationofa56-kDaproteininducedbyhumaninterferons.Eur.J.Biochem.155:11?17.
	65.Wilson,A.D.,andA.J.Morgan.2002.PrimaryimmuneresponsesbycordbloodCD4TcellsandNKcellsinhibitEpstein-BarrvirusB-celltransfor-mationinvitro.J.Virol.76:5071?5081.
	66.Wong,K.-M.,andA.J.Levine.1986.IdentificationandmappingofEpstein-Barrvirusearlyantigensanddemonstrationofaviralgeneactivatorthatfunctionsintrans.J.Virol.60:149?156.
1777.pdf	60
	1.Allison,S.L.,K.Stiasny,K.Stadler,C.W.Mandl,andF.X.Heinz.1999.Mappingoffunctionalelementsinthestem-anchorregionoftick-borneencephalitisvirusenvelopeproteinE.J.Virol.73:5605?5612.
	2.Bhamarapravati,N.,S.Yoksan,T.Chayaniyayothin,S.Angsubphakorn,andA.Bunyaratvej.1987.Immunizationwithaliveattenuateddengue-2-viruscandidatevaccine(16681-PDK53):clinical,immunologicalandbio-logicalresponsesinadultvolunteers.Bull.W.H.O.65:189?195.
	3.Bhamarapravati,N.,andY.Sutee.2000.Liveattenuatedtetravalentdenguevaccine.Vaccine18(Suppl.2):S44?S48.
	4.Blok,J.,S.M.McWilliam,H.C.Butler,A.J.Gibbs,G.Weiller,B.L.Herring,A.C.Hemsley,J.G.Aaskov,S.Yoksan,andN.Bhamarapravati.1992.Comparisonofadengue-2virusanditscandidatevaccinederivative:sequencerelationshipswiththeflavivirusesandotherviruses.Virology187:573?590.
	5.Bray,M.,R.Men,andC.-J.Lai.1996.Monkeysimmunizedwithintertypic3666CHAMBERSETAL.J.VIROL.chimericdenguevirusesareprotectedagainstwild-typeviruschallenge.J.Virol.70:4162?4166.
	6.Bray,M.,R.Men,I.Tokimatsu,andC.-J.Lai.1998.Geneticdeterminantsresponsibleforacquisitionofdenguetype2virusmouseneurovirulence.J.Virol.72:1647?1651.
	7.Butrapet,S.,C.Y.-H.Huang,D.J.Pierro,N.Bhamarapravati,D.J.Gubler,andR.M.Kinney.2000.Attenuationmarkersofacandidatedenguetype2vaccinevirus,strain16681(PDK-53),aredefinedbymutationsinthe5noncodingregionandnonstructuralproteins1and3.J.Virol.74:3011?3019.
	8.Calisher,C.H.,N.Karabatsos,J.M.Dalrymple,R.E.Shope,J.S.Porter-field,E.G.Westaway,andW.E.Brandt.1989.Antigenicrelationshipsbetweenflavivirusesasdeterminedbycross-neutralizationtestswithpoly-clonalantisera.J.Gen.Virol.70:37?43.
	9.Caufour,P.S.,M.C.A.Motta,A.M.Y.Yamamura.,S.Vazquez,I.I.Ferreira,A.V.Jabor,M.C.Bonaldo,M.S.Freire,andR.Galler.2001.Construction,characterizationandimmunogenicityofrecombinantyellowfever17D-denguetype2viruses.VirusRes.79:1?14.
	10.Chambers,T.J.,D.W.McCourt,andC.M.Rice.1990.Productionofyellowfevervirusproteinsininfectedcells:identificationofdiscretepolyproteinspeciesandanalysisofcleavagekineticsusingregion-specificpolyclonalantisera.Virology177:159?174.
	11.Chambers,T.J.,C.S.Hahn,R.Galler,andC.M.Rice.1990.Flavivirusgenomeorganization,expression,andreplication.Annu.Rev.Microbiol.44:649?688.
	12.Chambers,T.J.,A.Nestorowicz,P.W.Mason,andC.M.Rice.1999.Yellowfever/Japaneseencephalitischimericviruses:constructionandbiologicalproperties.J.Virol.73:3095?3101.
	13.Edelman,R.,C.O.Tacket,S.S.Wasserman,D.W.Vaughn,K.H.Eckels,D.R.Dubois,P.L.Summers,andC.H.Hoke.1994.Aliveattenuateddengue-1vaccinecandidate(45AZ5)passagedinprimarydogkidneycellcultureisattenuatedandimmunogenicforhumans.J.Infect.Dis.170:1448?1455.
	14.Fitzgeorge.R.,andC.J.Bradish.1980.Theinvivodifferentiationofstrainsofyellowfevervirusinmice.J.Gen.Virol.46:1?13.
	15.George,R.,andL.C.S.Lum.1997.Clinicalspectrumofdengueinfection,p.89?114.InD.J.GublerandG.K.Kuno(ed.),Dengueanddenguehemorrhagicfever.CABInternational,NewYork,N.Y.
	16.Gualano,R.C.,M.J.Pryor,M.R.Cauchi,P.J.Wright,andA.D.Davidson.1998.Identificationofamajordeterminantofmouseneurovirulenceofdenguevirustype2usingstablyclonedgenomic-lengthcDNA.J.Gen.Virol.79:437?446.
	17.Gubler,D.J.1997.Dengueanddenguehemorrhagicfever:itshistoryandresurgenceasaglobalpublichealthproblem,p.1?23.InD.J.GublerandG.Kuno(ed.),Dengueanddenguehemorrhagicfever.CABInternational,Wallingford,UnitedKingdom.
	18.Guirakhoo,F.,Z.-X.Zhang,T.J.Chambers,S.Delagrave,J.Arroyo,A.D.T.Barrett,andT.P.Monath.1999.Immunogenicity,geneticstability,andprotectiveefficacyofarecombinant,chimericyellowfever-Japaneseenceph-alitisvirus(ChimeriVax-JE)asalive,attenuatedvaccinecandidateagainstJapaneseencephalitis.Virology257:363?372.
	19.Guirakhoo,F.,R.Weltzin,T.J.Chambers,Z.-X.Zhang,K.Soike,M.Ratteree,J.Arroyo,K.Georgakopoulos,J.Catalan,andT.P.Monath.2000.Recombinantchimericyellowfever-denguetype2virusisimmunogenicandprotectiveinnonhumanprimates.J.Virol.74:5477?5485.
	20.Guirakhoo,F.,J.Arroyo,K.V.Pugachev,C.Miller,Z.X.Zhang,R.Weltzin,K.Georgakopoulos,J.Catalan,S.Ocran,K.Soike,M.Ratterree,andT.P.Monath.2001.Construction,safety,andimmunogenicityinnonhumanpri-matesofachimericyellowfever-denguevirustetravalentvaccine.J.Virol.75:7290?7304.
	21.Halstead,S.B.,J.S.Chou,andN.J.Marchette.1973.Immunologicalenhancementofdenguevirusreplication.Nat.NewBiol.243:24?25.
	22.Halstead,S.B.,andE.J.O?Rourke.1977.Antibody-enhanceddenguevirusinfectioninprimateleukocytes.Nature265:739?741.
	23.Halstead,S.B.1979.Invivoenhancementofdenguevirusinfectioninrhesusmonkeysbypassivelytransferredantibodies.J.Infect.Dis.140:527?533.
	24.Hoke,C.H.,F.J.Malinoski,K.H.Eckels,R.M.Scott,D.R.Dubois,P.L.Summers,T.Simms,J.Burrous,S.E.Hasty,andW.H.Bancroft.1990.Preparationofanattenuateddengue4(341750Carib)virusvaccine.II.Safetyandimmunogenicityinhumans.Am.J.Trop.Med.Hyg.43:219?226.
	25.Huang,C.Y.-H.,S.Butrapet,D.J.Pierro,G.-J.J.Chang,A.R.Hunt,N.Bhamarapravati,D.J.Gubler,andR.M.Kinney.2000.Chimericdenguetype2(vaccinestrainPDK-53)/denguetype1virusasapotentialcandidatedenguetype1virusvaccine.J.Virol.74:3020?3028.
	26.Innis,B.L.1997.Antibodyresponsestodenguevirusinfection,p.221?243.InD.J.GublerandG.Kuno(ed.),Dengueanddenguehemorrhagicfever.CABInternational,Wallingford,UnitedKingdom.
	27.Kawano,H.,V.Rostapshov,L.Rosen,andC.-J.Lai.1993.Geneticdeter-minantsofdenguetype4virusneurovirulenceformice.J.Virol.67:6567?6575.
	28.Kelly,E.P.,J.J.Greene,A.D.King,andB.L.Innis.2000.Purifieddengue2virusenvelopeglycoproteinaggregatesproducedbybaculovirusareim-munogenicinmice.Vaccine18:2549?2559.
	29.Kinney,R.M.,S.Butrapet,G.-J.J.Chang,K.R.Tsuchiya,J.T.Roehrig,N.Bhamarapravati,andD.J.Gubler.1997.ConstructionofinfectiouscDNAclonesfordengue2virus:strain16681anditsattenuatedvaccinederivative,strainPDK-53.Virology230:300?308.
	30.Kliks,S.C.,A.Nisalak,W.E.Brandt,L.Wahl,andD.S.Burke.1989.Antibody-dependentenhancementofdenguevirusgrowthinhumanmono-cytesasariskfactorfordenguehemorrhagicfever.Am.J.Trop.Med.Hyg.40:444?451.
	31.Kochel,T.J.,K.Raviprakash,C.G.Hayes,D.M.Watts,K.L.Russell,A.S.Gozalo,I.A.Phillips,D.F.Ewing.,G.S.Murphy,andK.R.Porter.2000.Adenguevirusserotype-1DNAvaccineinducesvirusneutralizingantibodiesandprovidesprotectionfromviralchallengeinAotusmonkeys.Vaccine28:3166?3173.
	32.Konishi,E.,M.Yamaoka,I.Kurane,andP.W.Mason.2000.ADNAvaccineexpressingdenguetype2viruspremembraneandenvelopegenesinducesneutralizingantibodyandmemoryBcellsinmice.Vaccine18:1133?1139.
	33.Kuno,G.,G.-J.J.Chang,K.R.Tsuchiya,N.Karabatsos,andC.B.Cropp.1998.PhylogenyofthegenusFlavivirus.J.Virol.72:73?83.
	34.Leitmeyer,K.C.,D.W.Vaughn,D.M.Watts,R.Salas,I.VillalobosdeChacon,C.Ramos,andR.Rico-Hesse.1999.Denguevirusstructuraldiffer-encesthatcorrelatewithpathogenesis.J.Virol.73:4738?4747.
	35.Mackow,E.,Y.Makino,B.Zhao,Y.-M.Zhang,L.Markoff,A.Buckler-White,M.Guiler,R.Chanock,andC.-J.Lai.1987.Thenucleotidesequenceofdenguetype4virus:analysisofgenescodingfornonstructuralproteins.Virology159:217?228.
	36.Mangada,M.N.M.,andA.Igarashi.1998.Molecularandinvitroanalysisofeightdenguetype2virusesisolatedfrompatientsexhibitingdifferentdiseaseseverities.Virology244:458?466.
	37.Markoff,L.1989.Invitroprocessingofdenguevirusstructuralproteins:cleavageofthepre-membraneprotein.J.Virol.63:3345?3352.
	38.Monath,T.P.1971.Neutralizingantibodyresponsesinthemajorimmuno-globulinclassestoyellowfever17Dvaccination.Am.J.Epidemiol.93:122?129.
	39.Monath,T.P.1986.Pathobiologyoftheflaviviruses,p.375?440.InS.SchlesingerandM.J.Schlesinger(ed.),TheTogaviridaeandtheFlaviviri-dae.PlenumPress,NewYork,N.Y.
	40.Monath,T.P.1994.Dengue:therisktodevelopedanddevelopingcountries.Proc.Natl.Acad.Sci.USA91:2395?2400.
	41.Monath,T.P.1994.Yellowfeveranddengue:theinteractionsofvirus,vectorandhostinthere-emergenceofepidemicdisease.Semin.Virol.5:133?143.
	42.Monath,T.P.,K.Soike,I.Levenbook,Z.-X.Zhang,J.Arroyo,S.Delagrave,G.Myers,A.D.T.Barrett,R.E.Shope,M.Ratterree,T.J.Chambers,andF.Guirakhoo.1999.Recombinant,chimericlive,attenuatedvaccine(Chi-meriVax)incorporatingtheenvelopegenesofJapaneseencephalitis(SA14?14?2)virusandthecapsidandnonstructuralgenesofyellowfever(17D)virusissafe,immunogenicandprotectiveinnon-humanprimates.Vaccine17:1869?1882.
	43.Monath,T.P.,K.McCarthy,P.Bedford,C.T.Johnson,R.Nichols,S.Yoksan,R.Marchesani,M.Knauber,K.H.Wells,J.Arroyo,andF.Guira-khoo.2002.ClinicalproofofprincipleforChimeriVax?:recombinantliveattenuatedvaccinesagainstflavivirusinfections.Vaccine20:1004?1018.
	44.Pletnev,A.,G.,M.Bray,J.Huggins,andC.-J.Lai.1992.Constructionandcharacterizationofchimerictick-borneencephalitis/denguetype4viruses.Proc.Natl.Acad.Sci.USA89:10532?10536.
	45.Porter,K.R.,T.J.Kochel,S.-J.Wu,K.Raviprakash,I.Phillips,andC.G.Hayes.1998.Protectiveefficacyofadengue2DNAvaccineinmiceandtheeffectofCpGimmuno-stimulatorymotifsonantibodyresponses.Arch.Vi-rol.143:997?1003.
	46.Puri,B.,W.M.Nelson,E.A.Henchal,C.H.Hoke,K.H.Eckels,D.R.Dubois,K.R.Porter,andC.G.Hayes.1997.Molecularanalysisofdenguevirusattenuationafterserialpassageinprimarydogkidneycells.J.Gen.Virol.78:2287?2291.
	47.Putnak,R.,D.A.Barvir,J.M.Burrous,D.R.Dubois,V.M.D?Andrea,C.H.Hoke,J.C.Sadoff,andK.H.Eckels.1996.Developmentofapurified,inactivated,dengue-2virusvaccineprototypeinverocells:immunogenicityandprotectioninmiceandrhesusmonkeys.J.Infect.Dis.174:1176?1184.
	48.Putnak,R.,K.Cassidy,N.Conforti,R.Lee,D.Sollazzo,T.Truong,E.Ing,D.Dubois,J.Sparkuhl,W.Gastle,andC.Hoke.1996.Immunogenicandprotectiveresponsesinmiceimmunizedwithapurified,inactivatedden-gue-2virusvaccineprototypemadeinfetalrhesuslungcells.Am.J.Trop.Med.Hyg.55:504?510.
	49.Rice,C.M.,A.Grakoui,R.Galler,andT.J.Chambers.1989.TranscriptionofinfectiousyellowfevervirusRNAfromfull-lengthcDNAtemplatespro-ducedbyinvitroligation.NewBiol.1:285?296.
	50.Rothman,A.L.,andF.A.Ennis.1999.Immunopathogenesisofdenguehemorrhagicfever.Virology257:1?6.
	51.Schlesinger,J.J.,M.W.Brandriss,andE.E.Walsh.1985.Protectionagainst17Dyellowfeverencephalitisinmicebypassivetransferofmono-clonalantibodiestothenonstructuralglycoproteingp48andbyactiveim-munizationwithgp48.J.Immunol.135:2805?2809.
	52.Simmons,M.,W.M.Nelson,S.J.Wu,andC.G.Hayes.1998.EvaluationoftheprotectiveefficacyofarecombinantdengueenvelopeBdomainfusionproteinagainstdengue2virusinfectioninmice.Am.J.Trop.Med.Hyg.58:655?662.
	53.Simmons,M.,G.S.Murphy,T.Kochel,K.Raviprakash,andC.G.Hayes.2001.Characterizationofantibodyresponsestocombinationsofadengue-2DNAanddengue-2recombinantsubunitvaccine.Am.J.Trop.Med.Hyg.65:420?426.
	54.Simmons,M.,G.S.Murphy,andC.G.Hayes.2001.Shortreport:antibodyresponseofmiceimmunizedwithatetravalentdenguerecombinantproteinsubunitvaccine.Am.J.Trop.Med.Hyg.65:159?161.
	55.Smith,G.W.,andP.J.Wright.1985.Synthesisofproteinsandglycoproteinsindenguetype2virus-infectedVeroandAedesalbopictuscells.J.Gen.Virol.66:559?571.
	56.vanderMost,R.G.,K.Murali-Krishna,R.Ahmed,andJ.H.Strauss.2000.Chimericyellowfever/denguevirusasacandidatedenguevaccine:quanti-tationofthedenguevirus-specificCD8T-cellresponse.J.Virol.74:8094?8101.
	57.Wheelock,E.F.,andW.A.Sibley.1965.Circulatingvirus,interferonandantibodyaftervaccinationwiththe17Dstrainofyellowfevervirus.N.Engl.J.Med.273:194?198.
	58.Zanotto,P.M.,E.A.Gould,G.F.Gao,P.H.Harvey,andE.C.Holmes.1996.Populationdynamicsofflavivirusesrevealedbymolecularphylogenies.Proc.Natl.Acad.Sci.USA93:548?553.
	59.Zhao,B.,E.Mackow,A.Buckler-White,L.Markoff,R.M.Chanock,C.-J.Lai,andY.Makino.1986.Cloningfull-lengthdenguetype4viralDNAse-quences:analysisofgenescodingforstructuralproteins.Virology155:77?88.
	60.Zhao,B.,G.Prince,R.Horswood,K.Eckels,P.Summers,R.Chanock,andC.-J.Lai.1987.ExpressionofdenguevirusstructuralproteinsandnonstructuralproteinNS1byarecombinantvacciniavirus.J.Virol.61:4019?4022.
2117.pdf	77
	1.Bauer,M.,V.Redecke,J.W.Ellwart,B.Scherer,J.P.Kremer,H.Wagner,andG.B.Lipford.2001.BacterialCpG-DNAtriggersactivationandmatu-rationofhumanCD11c,CD123dendriticcells.J.Immunol.166:5000?5007.
	2.Behl,C.,J.B.Davis,R.Lesley,andD.Schubert.1994.Hydrogenperoxidemediatesamyloidbetaproteintoxicity.Cell77:817?827.
	3.Bonecchi,R.,G.Bianchi,P.P.Bordignon,D.D?Ambrosio,R.Lang,A.Borsatti,S.Sozzani,P.Allavena,P.A.Gray,A.Mantovani,andF.Sini-gaglia.1998.Differentialexpressionofchemokinereceptorsandchemotacticresponsivenessoftype1Thelpercells(Th1s)andTh2s.J.Exp.Med.187:129?134.
	4.Bowen,J.C.,S.K.Nair,R.Reddy,andB.T.Rouse.1994.CholeratoxinactsasapotentadjuvantfortheinductionofcytotoxicT-lymphocyteresponseswithnon-replicatingantigens.Immunology81:338?342.
	5.Brander,C.,T.Wyss-Coray,D.Mauri,F.Bettens,andW.J.Pichler.1993.Carrier-mediateduptakeandpresentationofamajorhistocompatibilitycomplexclassI-restrictedpeptide.Eur.J.Immunol.23:3217?3223.
	6.Chackerian,B.,D.R.Lowy,andJ.T.Schiller.2001.Conjugationofaself-antigentopapillomavirus-likeparticlesallowsforefficientinductionofprotectiveautoantibodies.J.Clin.Investig.108:415?423.
	7.Chu,R.S.,O.S.Targoni,A.M.Krieg,P.V.Lehmann,andC.V.Harding.1997.CpGoligodeoxynucleotidesactasadjuvantsthatswitchonThelper1(Th1)immunity.J.Exp.Med.186:1623?1631.
	8.Coffman,R.L.,K.Varkila,P.Scott,andR.Chatelain.1991.Roleofcyto-kinesinthedifferentiationofCD4T-cellsubsetsinvivo.Immunol.Rev.123:189?207.
	9.Davis,H.L.,R.Weeratna,T.J.Waldschmidt,L.Tygrett,J.Schorr,A.M.Krieg,andR.Weeranta.1998.CpGDNAisapotentenhancerofspecificimmunityinmiceimmunizedwithrecombinanthepatitisBsurfaceantigen.J.Immunol.160:870?876.
	10.Decker,T.,andM.L.Lohmann-Matthes.1988.Aquickandsimplemethodforthequantitationoflactatedehydrogenasereleaseinmeasurementsofcellularcytotoxicityandtumornecrosisfactor(TNF)activity.J.Immunol.Methods115:61?69.
	11.Deml,L.,G.Kratochwil,N.Osterrieder,R.Knuchel,H.Wolf,andR.Wagner.1997.Increasedincorporationofchimerichumanimmunodefi-ciencyvirustype1gp120proteinsintoPr55gagvirus-likeparticlesbyanEpstein-Barrvirusgp220/350-derivedtransmembranedomain.Virology235:10?25.
	12.Edinger,A.L.,M.Ahuja,T.Sung,K.C.Baxter,B.Haggarty,R.W.Doms,andJ.A.Hoxie.2000.Characterizationandepitopemappingofneutralizingmonoclonalantibodiesproducedbyimmunizationwitholigomericsimianimmunodeficiencyvirusenvelopeprotein.J.Virol.74:7922?7935.
	13.Gallichan,W.S.,R.N.Woolstencroft,T.Guarasci,M.J.McCluskie,H.L.Davis,andK.L.Rosenthal.2001.IntranasalimmunizationwithCpGoli-godeoxynucleotidesasanadjuvantdramaticallyincreasesIgAandprotectionagainstherpessimplexvirus-2inthegenitaltract.J.Immunol.166:3451?3457.
	14.Gomez,R.S.,J.E.daCosta,T.M.Lorentz,A.GarrochoAde,andJ.A.Nogueira-Machado.1994.ChemoluminescencegenerationandMTTdyereductionbypolymorphonuclearleukocytesfromperiodontaldiseasepa-tients.J.PeriodontalRes.29:109?112.
	15.Haffar,O.,J.Garrigues,B.Travis,P.Moran,J.Zarling,andS.-L.Hu.1990.Humanimmunodeficiencyvirus-like,nonreplicating,gag-envparticlesas-sembleinarecombinantvacciniavirusexpressionsystem.J.Virol.64:2653?2659.
	16.Hameleers,D.M.,I.vanderVen,J.Biewenga,andT.Sminia.1991.Mucosalandsystemicantibodyformationintheratafterintranasaladministrationofthreedifferentantigens.Immunol.CellBiol.69:119?125.
	17.Hemmi,H.,O.Takeuchi,T.Kawai,T.Kaisho,S.Sato,H.Sanjo,M.Mat-sumoto,K.Hoshino,H.Wagner,K.Takeda,andS.Akira.2000.AToll-likereceptorrecognizesbacterialDNA.Nature408:740?745.
	18.Horner,A.A.,S.K.Datta,K.Takabayashi,I.M.Belyakov,T.Hayashi,N.Cinman,M.D.Nguyen,J.H.VanUden,J.A.Berzofsky,D.D.Richman,andE.Raz.2001.ImmunostimulatoryDNA-basedvaccineselicitmultifacetedimmuneresponsesagainstHIVatsystemicandmucosalsites.J.Immunol.167:1584?1591.
	19.Horner,A.A.,A.Ronaghy,P.M.Cheng,M.D.Nguyen,H.J.Cho,D.Broide,andE.Raz.1998.ImmunostimulatoryDNAisapotentmucosaladjuvant.Cell.Immunol.190:77?82.
	20.Isaka,M.,Y.Yasuda,M.Mizokami,S.Kozuka,T.Taniguchi,K.Matano,J.Maeyama,K.Mizuno,K.Morokuma,K.Ohkuma,N.Goto,andK.Tochi-kubo.2001.MucosalimmunizationagainsthepatitisBvirusbyintranasalco-administrationofrecombinanthepatitisBsurfaceantigenandrecombi-nantcholeratoxinBsubunitasanadjuvant.Vaccine19:1460?1466.
	21.Johansson,E.L.,C.Rask,M.Fredriksson,K.Eriksson,C.Czerkinsky,andJ.Holmgren.1998.Antibodiesandantibody-secretingcellsinthefemalegenitaltractaftervaginalorintranasalimmunizationwithcholeratoxinBsubunitorconjugates.Infect.Immun.66:514?520.
	22.Jones,D.H.,B.W.McBride,M.A.Roff,andG.H.Farrar.1995.Efficientpurificationandrigorouscharacterisationofarecombinantgp120forHIVvaccinestudies.Vaccine13:991?999.
	23.Jones,D.H.,B.W.McBride,M.A.Roff,V.Maloney,andG.H.Farrar.1994.Purificationandcharacterizationofsimianimmunodeficiencyvirus(SIVmac)envelopeglycoproteingp130fromvirus-infectedcells.Vaccine12:250?258.
	24.Jones,T.R.,N.ObaldiaIII,R.A.Gramzinski,Y.Charoenvit,N.Kolodny,S.Kitov,H.L.Davis,A.M.Krieg,andS.L.Hoffman.1999.SyntheticoligodeoxynucleotidescontainingCpGmotifsenhanceimmunogenicityofapeptidemalariavaccineinAotusmonkeysVaccine17:3065?3071.
	25.Kadowaki,N.,S.Antonenko,S.Ho,M.C.Rissoan,V.Soumelis,S.A.Porcelli,L.L.Lanier,andY.J.Liu.2001.DistinctcytokineprofilesofneonatalnaturalkillerTcellsafterexpansionwithsubsetsofdendriticcells.J.Exp.Med.193:1221?1226.
	26.Kameyoshi,Y.,A.Dorschner,A.I.Mallet,E.Christophers,andJ.M.Schroder.1992.CytokineRANTESreleasedbythrombin-stimulatedplate-letsisapotentattractantforhumaneosinophils.J.Exp.Med.176:587?592.
	27.Klinman,D.M.,A.K.Yi,S.L.Beaucage,J.Conover,andA.M.Krieg.1996.CpGmotifspresentinbacteriaDNArapidlyinducelymphocytestosecreteinterleukin6,interleukin12,andinterferongamma.Proc.Natl.Acad.Sci.USA93:2879?2883.
	28.Korzeniewski,C.,andD.M.Callewaert.1983.Anenzyme-releaseassayfornaturalcytotoxicity.J.Immunol.Methods64:313?320.
	29.Krausslich,H.G.,C.Ochsenbauer,A.M.Traenckner,K.Mergener,M.Facke,H.R.Gelderblom,andV.Bosch.1993.Analysisofproteinexpressionandvirus-likeparticleformationinmammaliancelllinesstablyexpressingHIV-1gagandenvgeneproductswithorwithoutactiveHIVproteinase.Virology192:605?617.
	30.Krieg,A.M.,A.K.Yi,S.Matson,T.J.Waldschmidt,G.A.Bishop,R.Teasdale,G.A.Koretzky,andD.M.Klinman.1995.CpGmotifsinbacterialDNAtriggerdirectB-cellactivation.Nature374:546?549.
	31.Kuper,C.F.,P.J.Koornstra,D.M.Hameleers,J.Biewenga,B.J.Spit,A.M.Duijvestijn,P.J.BredaVriesman,andT.Sminia.1992.Theroleofnaso-pharyngeallymphoidtissue.Immunol.Today13:219?224.
	32.Lacour,M.,J.F.Arrighi,K.M.Muller,C.Carlberg,J.H.Saurat,andC.Hauser.1994.cAMPup-regulatesIL-4andIL-5productionfromactivatedCD4TcellswhiledecreasingIL-2releaseandNF-ATinduction.Int.Immunol.6:1333?1343.
	33.Lagranderie,M.,N.Winter,A.M.Balazuc,B.Gicquel,andM.Gheorghiu.1998.AcocktailofMycobacteriumbovisBCGrecombinantsexpressingtheSIVNef,Env,andGagantigensinducesantibodyandcytotoxicresponsesinmicevaccinatedbydifferentmucosalroutes.AIDSRes.Hum.Retroviruses14:1625?1633.
	34.Lian,T.,T.Bui,andR.J.Ho.1999.FormulationofHIV-envelopeproteinwithlipidvesiclesexpressinggangliosideGM1associatedtocholeratoxinBenhancesmucosalimmuneresponses.Vaccine18:604?611.
	35.Lillard,J.W.,Jr.,P.N.Boyaka,D.D.Taub,andJ.R.McGhee.2001.RANTESpotentiatesantigen-specificmucosalimmuneresponses.J.Immu-nol.166:162?169.
	36.Lim,E.M.,M.Lagranderie,R.LeGrand,J.Rauzier,M.Gheorghiu,B.Gicquel,andN.Winter.1997.RecombinantMycobacteriumbovisBCGpro-ducingtheN-terminalhalfofSIVmac251EnvantigeninducesneutralizingantibodiesandcytotoxicTlymphocyteresponsesinmiceandguineapigs.AIDSRes.Hum.Retroviruses13:1573?1581.
	37.Lipford,G.B.,M.Bauer,C.Blank,R.Reiter,H.Wagner,andK.Heeg.1997.CpG-containingsyntheticoligonucleotidespromoteBandcytotoxicTcellresponsestoproteinantigen:anewclassofvaccineadjuvants.Eur.J.Im-munol.27:2340?2344.
	38.Matsukura,S.,F.Kokubu,H.Kubo,T.Tomita,H.Tokunaga,M.Kadokura,T.Yamamoto,Y.Kuroiwa,T.Ohno,H.Suzaki,andM.Adachi.1998.ExpressionofRANTESbynormalairwayepithelialcellsafterinfluenzavirusAinfection.Am.J.Respir.CellMol.Biol.18:255?264.
	39.McCluskie,M.J.,andH.L.Davis.1998.CpGDNAisapotentenhancerofsystemicandmucosalimmuneresponsesagainsthepatitisBsurfaceantigenwithintranasaladministrationtomice.J.Immunol.161:4463?4466.
	40.McCluskie,M.J.,R.D.Weeratna,andH.L.Davis.2000.Intranasalimmu-nizationofmicewithCpGDNAinducesstrongsystemicandmucosalre-sponsesthatareinfluencedbyothermucosaladjuvantsandantigendistri-bution.Mol.Med.6:867?877.
	41.McCluskie,M.J.,R.D.Weeratna,andH.L.Davis.2001.Thepotentialofoligodeoxynucleotidesasmucosalandparenteraladjuvants.Vaccine19:2657?2660.
	42.Meyer,D.,andJ.V.Torres.1999.InductionofcytotoxicandhelperTcellresponsesbymodifiedsimianimmunodeficiencyvirushypervariableepitopeconstructs.ViralImmunol.12:117?129.
	43.Moldoveanu,Z.,L.Love-Homan,W.Q.Huang,andA.M.Krieg.1998.CpGDNA,anovelimmuneenhancerforsystemicandmucosalimmunizationwithinfluenzavirus.Vaccine16:1216?1224.
	44.Moldoveanu,Z.,A.N.Vzorov,W.Q.Huang,J.Mestecky,andR.W.Com-pans.1999.InductionofimmuneresponsestoSIVantigensbymucosallyadministeredvaccines.AIDSRes.Hum.Retroviruses.15:1469?1476.
	45.Montefiori,D.C.,J.T.Safrit,S.L.Lydy,A.P.Barry,M.Bilska,H.T.T.Vo,M.Klein,J.Tartaglia,H.L.Robinson,andB.Rovinski.2001.InductionofneutralizingantibodiesandGag-specificcellularimmuneresponsestoanR5primaryisolateofhumanimmunodeficiencyvirustype1inrhesusmacaques.J.Virol.75:5879?5890.
	46.Morris,C.B.,E.Cheng,A.Thanawastien,L.Cardenas-Freytag,andJ.D.Clements.2000.EffectivenessofintranasalimmunizationwithHIV-gp160andanHIV-1envCTLepitopepeptide(E7)incombinationwiththemucosaladjuvantLT(R192G).Vaccine18:1944?1951.
	47.Munoz,E.,A.M.Zubiaga,M.Merrow,N.P.Sauter,andB.T.Huber.1990.CholeratoxindiscriminatesbetweenThelper1and2cellsinTcellreceptor-mediatedactivation:roleofcAMPinTcellproliferation.J.Exp.Med.172:95?103.
	48.Neote,K.,D.DiGregorio,J.Y.Mak,R.Horuk,andT.J.Schall.1993.Molecularcloning,functionalexpression,andsignalingcharacteristicsofaC-Cchemokinereceptor.Cell72:415?425.
	49.Niks,M.,M.Otto,B.Busova,andJ.Stefanovic.1990.QuantificationofproliferativeandsuppressiveresponsesofhumanTlymphocytesfollowingConAstimulation.J.Immunol.Methods126:263?271.
	50.Notka,F.,C.Stahl-Hennig,U.Dittmer,H.Wolf,andR.Wagner.1999.AcceleratedclearanceofSHIVinrhesusmonkeysbyvirus-likeparticlevaccinesisdependentoninductionofneutralizingantibodies.Vaccine18:291?301.
	51.Oliva,A.,A.L.Kinter,M.Vaccarezza,A.Rubbert,A.Catanzaro,S.Moir,J.Monaco,L.Ehler,S.Mizell,R.Jackson,Y.Li,J.W.Romano,andA.S.Fauci.1998.Naturalkillercellsfromhumanimmunodeficiencyvirus(HIV)-infectedindividualsareanimportantsourceofCC-chemokinesandsuppressHIV-1entryandreplicationinvitro.J.Clin.Investig.102:223?231.
	52.Olszewska-Pazdrak,B.,A.Casola,T.Saito,R.Alam,S.E.Crowe,F.Mei,P.L.Ogra,andR.P.Garofalo.1998.Cell-specificexpressionofRANTES,MCP-1,andMIP-1bylowerairwayepithelialcellsandeosinophilsinfectedwithrespiratorysyncytialvirus.J.Virol.72:4756?4764.
	53.Paliard,X.,Y.Liu,R.Wagner,H.Wolf,J.Baenziger,andC.M.Walker.2000.Primingofstrong,broad,andlong-livedHIVtype1p55gag-specificCD8cytotoxicTcellsafteradministrationofavirus-likeparticlevaccineinrhesusmacaques.AIDSRes.Hum.Retroviruses16:273?282.
	54.Porgador,A.,H.F.Staats,B.Faiola,E.Gilboa,andT.J.Palker.1997.IntranasalimmunizationwithCTLepitopepeptidesfromHIV-1orovalbu-minandthemucosaladjuvantcholeratoxininducespeptide-specificCTLsandprotectionagainsttumordevelopmentinvivo.J.Immunol.158:834?841.
	55.Roman,M.,E.Martin-Orozco,J.S.Goodman,M.D.Nguyen,Y.Sato,A.Ronaghy,R.S.Kornbluth,D.D.Richman,D.A.Carson,andE.Raz.1997.ImmunostimulatoryDNAsequencesfunctionasThelper-1-promotingad-juvants.Nat.Med.3:849?854.
	56.Rudzik,O.,R.L.Clancy,D.Y.Perey,J.Bienenstock,andD.P.Singal.1975.Thedistributionofarabbitthymicantigenandmembraneimmunoglobulinsinlymphoidtissue,withspecialreferencetomucosallymphocytes.J.Immu-nol.114:1?4.
	57.Saito,T.,R.W.Deskin,A.Casola,H.Haeberle,B.Olszewska,P.B.Ernst,R.Alam,P.L.Ogra,andR.Garofalo.1997.RespiratorysyncytialvirusinducesselectiveproductionofthechemokineRANTESbyupperairwayepithelialcells.J.Infect.Dis.175:497?504.
	58.Schall,T.J.,K.Bacon,K.J.Toy,andD.V.Goeddel.1990.SelectiveattractionofmonocytesandTlymphocytesofthememoryphenotypebycytokineRANTES.Nature347:669?671.
	59.Shi,Y.F.,B.M.Sahai,andD.R.Green.1989.CyclosporinAinhibitsactivation-inducedcelldeathinT-cellhybridomasandthymocytes.Nature339:625?626.
	60.Simmons,C.P.,P.Mastroeni,R.Fowler,M.Ghaem-Maghami,N.Lycke,M.Pizza,R.Rappuoli,andG.Dougan.1999.MHCclassI-restrictedcytotoxiclymphocyteresponsesinducedbyenterotoxin-basedmucosaladjuvants.J.Immunol.163:6502?6510.
	61.Sparwasser,T.,E.S.Koch,R.M.Vabulas,K.Heeg,G.B.Lipford,J.W.Ellwart,andH.Wagner.1998.BacterialDNAandimmunostimulatoryCpGoligonucleotidestriggermaturationandactivationofmurinedendriticcells.Eur.J.Immunol.28:2045?2054.
	62.Spit,B.J.,E.G.Hendriksen,J.P.Bruijntjes,andC.F.Kuper.1989.Nasallymphoidtissueintherat.CellTissueRes.255:193?198.
	63.Stacey,K.J.,D.P.Sester,M.J.Sweet,andD.A.Hume.2000.MacrophageactivationbyimmunostimulatoryDNA.Curr.Top.Microbiol.Immunol.247:41?58.
	64.Taub,D.D.,J.R.Ortaldo,S.M.Turcovski-Corrales,M.L.Key,D.L.Longo,andW.J.Murphy.1996.Betachemokinescostimulatelymphocytecytolysis,proliferation,andlymphokineproduction.J.Leukoc.Biol.59:81?
	65.Tilney,N.L.1971.Patternsoflymphaticdrainageintheadultlaboratoryrat.J.Anat.109:369?383.
	66.Tochikubo,K.,M.Isaka,Y.Yasuda,S.Kozuka,K.Matano,Y.Miura,andT.Taniguchi.1998.RecombinantcholeratoxinBsubunitactsasanadjuvantforthemucosalandsystemicresponsesofmicetomucosallyco-administeredbovineserumalbumin.Vaccine16:150?155.
	67.vanderVen,I.,andT.Sminia.1993.Thedevelopmentandstructureofmousenasal-associatedlymphoidtissue:animmuno-andenzyme-histo-chemicalstudy.Reg.Immunol.5:69?75.
	68.Vzorov,A.N.,andR.W.Compans.1996.AssemblyandreleaseofSIVenvproteinswithfull-lengthortruncatedcytoplasmicdomains.Virology221:22?33.
	69.Wagner,R.,V.J.Teeuwsen,L.Deml,F.Notka,A.G.Haaksma,S.S.Jhagjhoorsingh,H.Niphuis,H.Wolf,andJ.L.Heeney.1998.CytotoxicTcellsandneutralizingantibodiesinducedinrhesusmonkeysbyvirus-likeparticleHIVvaccinesintheabsenceofprotectionfromSHIVinfection.Virology245:65?74.
	70.Wu,H.Y.,H.H.Nguyen,andM.W.Russell.1997.Nasallymphoidtissue(NALT)asamucosalimmuneinductivesite.Scand.J.Immunol.46:506?513.
	71.Xu-Amano,J.,R.J.Jackson,K.Fujihashi,H.Kiyono,H.F.Staats,andJ.R.McGhee.1994.HelperTh1andTh2cellresponsesfollowingmucosalorsystemicimmunizationwithcholeratoxin.Vaccine12:903?911.
	72.Xu-Amano,J.,H.Kiyono,R.J.Jackson,H.F.Staats,K.Fujihashi,P.D.Burrows,C.O.Elson,S.Pillai,andJ.R.McGhee.1993.HelperTcellsubsetsforimmunoglobulinAresponses:oralimmunizationwithtetanustoxoidandcholeratoxinasadjuvantselectivelyinducesTh2cellsinmucosaassociatedtissues.J.Exp.Med.178:1309?1320.3622KANGANDCOMPANSJ.VIROL.
	73.Yamshchikov,G.V.,G.D.Ritter,M.Vey,andR.W.Compans.1995.AssemblyofSIVvirus-likeparticlescontainingenvelopeproteinsusingabaculovirusexpressionsystem.Virology214:50?58.
	74.Yang,S.K.,L.Eckmann,A.Panja,andM.F.Kagnoff.1997.DifferentialandregulatedexpressionofC-X-C,C-C,andC-chemokinesbyhumancolonepithelialcells.Gastroenterology113:1214?1223.
	75.Yao,Q.,F.M.Kuhlmann,R.Eller,R.W.Compans,andC.Chen.2000.Productionandcharacterizationofsimian-humanimmunodeficiencyvirus-likeparticles.AIDSRes.Hum.Retroviruses16:227?236.
	76.Yao,Q.,V.Vuong,M.Li,andR.W.Compans.2002.Intranasalimmuniza-tionwithSIVvirus-likeparticles(VLPs)elicitssystemicandmucosalimmu-nity.Vaccine20:2537?2545.
	77.Yasutomi,Y.,T.J.Palker,M.B.Gardner,B.F.Haynes,andN.L.Letvin.1993.Syntheticpeptideinmineraloiladjuvantelicitssimianimmunodefi-ciencyvirus-specificCD8cytotoxicTlymphocytesinrhesusmonkeys.J.Im-munol.151:5096?5105.
475.full.pdf	87
	Alvarez, I. and Navascuï¿½s, J. (1990). Shaping, invagination and closure ofthe chick embryo otic vesicle: Scanning electron microscope andquantitative study. Anat. Rec. 228, 315-326.
	Arenz, C., Thutewohl, M., Block, O., Waldmann, H., Altenbach, H.-J. andGiannis, A. (2001). Manumycin A and its analogues are irreversibleinhibitors of neutral sphingomyelinase. Chembiochem.2, 141-143.
	Barrett, G. L. (2000). The p75 neurotrophin receptor and neural apoptosis.Prog. Neurobiol. 61, 205-229.
	Beutler, B. and van Huffel, C. (1994). Unraveling function in the TNF ligandand receptor families. Science264, 667-668.
	Bibel, M. and Barde, Y.(2000). Neurotrophins: key regulators of cell fate andcell shape in the vertebrate nervous system. Genes Dev. 14, 2919-2937.
	Bissonnette, J. P. and Fekete, D. M.(1996). Standard atlas of the grossanatomy of the developing inner ear of the chicken. J. Comp. Neurol. 368,620-630.
	Blaschke, A. J., Staley, K. and Chun, J.(1996). Widespread programmedcell death in proliferative and postmitotic regions of the fetal cerebral cortex.Development122, 1165-1174.
	Bligh, E. G. and Dyer, W. J. (1959). A rapid method of total lipid extractionand purification. Can. J. Biochem. Physiol.37, 911-917.
	Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber,M. and Futerman, A. H. (1999). Ceramide signalling downstream of thep75 neurotrophin receptor mediates the effects of nerve growth factor onoutgrowth of cultured hippocampal neurons. J. Neurosci.19, 8199-8206.
	Brazil, D. P. and Hemmings, B. A. (2001). Ten years of protein kinase Bsignalling: a hard Akt to follow. Trends Biochem. Sci.26, 657-664.
	Burow, M. E., Weldon, C. B., Collins-Burow, B. M., Ramsey, N., McKee,A., Klippel, A., McLachlan, J. A., Clejan, S. and Beckman, B. S. (2000).Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinasepathways as a mechanism for cell survival/death decisions. J. Biol. Chem.275, 9628-9635.
	Camarero, G., Avendaï¿½o, C., Fernï¿½ndez-Moreno, C., Villar, A., Contreras,J., de Pablo, F., Pichel, J. G. and Varela-Nieto, I. (2001). Delayed innerear maturation and neuronal loss in postnatal Igf-1-deficient mice. J.Neurosci.21, 7630-7641.
	Casaccia-Bonnefil, P., Carter, B. D., Dobrowsky, R. T. and Chao, M. V.(1996). Death of oligodendrocytes mediated by the interaction of nervegrowth factor with its receptor p75. Nature 383, 716-719.
	Casaccia-Bonnefil, P., Gu, A., Khursigara, G. and Chao, M. V. (1999). Thep75 neurotrophin receptor as a modulator of survival and death decisions.Microsc. Res. Tech. 45,217-224.
	Chao, M. V. and Bothwell, M. (2002). Neurotrophins: to cleave or not tocleave. Neuron 33, 9-12.
	Chatterjee, M. and Wu, S. (2001). Cell line dependent involvement ofceramide in ultraviolet light-induced apoptosis. Mol. Cell Biochem. 219, 21-
	Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O?Rourke, K., Kischkel,F. C., Hellbardt, S., Krammer, P., Peter, M. and Dixit, V. M. (1996).FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumornecrosis factor receptor-induced apoptosis. J. Biol. Chem.271, 4961-4965.
	Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. and Birnbaum, M. J. (2001).Akt1/PKB ais required for normal growth but dispensable for maintenanceof glucose homeostasis in mice. J. Biol. Chem.276, 38349-38352.
	Chrysis, D., Calikoglu, A. S., Ye, P. and D?Ercole, A. J. (2001). Insulin-likegrowth factor-I overexpression attenuates cerebellar apoptosis by alteringthe expresiï¿½n of Bcl family proteins in a developmentally specific manner.J. Neurosci.21, 1481-1489.
	Craighead, M., Pole, J. and Waters, C. (2000). Caspases mediate C2-ceramide-induced apoptosis of the human oligodendroglial cell line,MO3.13. Neurosci. Lett. 278, 125-128.
	Cutler, R. G. and Mattson, M. P. (2001). Sphingomyelin and ceramide asregulators of development and lifespan. Mech. Ageing Dev. 122, 895-908.
	de la Rosa, E. J. and de Pablo, F. (2000). Cell death in early neuraldevelopment: beyond the neurotrophic theory. Trends Neurosci. 23, 454-458.
	Diaz, B., Pimentel, B., de Pablo, F. and de la Rosa, E. J. (1999). Apoptoticcell death of proliferating neuroepithelial cells in the embryonic retina isprevented by insulin. Eur. J. Neurosci. 11, 1624-1632.
	D?Mello, S. R.(1998). Molecular regulation of neuronal apoptosis. Curr. Top.Dev. Biol. 39, 187-213. 
	Dobrowsky, R. T. and Carter, B. D. (2000). p75 neurotrophin receptorsignalling: mechanisms for neurotrophic modulation of cell stress? J.Neurosci. Res. 61, 237-243.
	Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V. andHannun, Y. A.(1994). Activation of the sphingomyelin cycle through thelow affinity neurotrophin receptor. Science265, 1596-1599.
	Dobrowsky, R. T., Jenkins, G. M. and Hannun, Y. A. (1995). Neurotrophinsinduce sphingomyelin hydrolysis. J. Biol. Chem.270, 22135-22142.
	Dressler, K. A. and Kolesnick, R. N.(1990). Ceramide-1-Phosphate, a novelphospholipid in human leukaemia (HL-60) cells. J. Biol. Chem.265, 14917-14921.
	Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper,G. M., Segal, R. A., Kaplan, D. R. and Greenberg, M. E. (1997).Regulation of neuronal survival by the serine-threonine protein kinase Akt.Science275, 661-665.
	Fekete, D. M., Hamburger, S. A., Waring, M. T., Riedl, A. E. and Garcï¿½a,L. F.(1997). Involvement of programmed cell death in morphogenesis ofthe vertebrate inner ear. Development124, 2451-2461.
	Frade, J. M. (2000). Unschedule re-entry into the cell cycle induced byNGF precedes cell death in nascent retinal neurones. J. Cell Sci.113,1139-1148.
	Frade, J. M. and Barde, Y. A.(1998). Nerve growth factor: two receptors,multiple functions. BioEssays 20, 137-145.
	Frade, J. M., Rodrï¿½guez-Tebar, A. and Barde, Y. A. (1996). Induction ofcell death by endogenous nerve growth factor through p75. Nature383, 166-168.
	Frago, L. M., Leï¿½n, Y., de la Rosa, E. J., Gï¿½mez-Muï¿½oz, A. and Varela-Nieto, I. (1998). Nerve growth factor and ceramides modulate cell death inthe early developing inner ear. J. Cell Sci.111, 549-556.
	Frago, L. M., Camarero, G., Caï¿½ï¿½n, S., Paï¿½eda, C., Sanz, C., Leï¿½n, Y.,Girï¿½ldez, F. and Varela-Nieto, I. (2000). Role of diffusible andtranscription factors in inner ear development: implications in regeneration.Histol. Histopathol. 15, 657-666. 
	Glï¿½cksmann, A. (1951). Cell death in normal vertebrate ontogeny. Biol. Rev.26, 59-86.
	Gï¿½mez del Pulgar, T., Velasco, G., Sï¿½nchez, C., Haro, A. and Guzmï¿½n, M.(2002). De novo-synthesized ceramide is involved in cannabinoid-inducedapoptosis. Biochem. J. 363, 183-188.
	Gonzï¿½lez-Hoyuela, M., Barbas, J. A. and Rodrï¿½guez-Tï¿½bar, A. (2001). Theautoregulation of retinal ganglion cell number. Development128, 117-124.
	Grullich, C., Sullards, M. C., Fuks, Z., Merrill, A. H. and Kolesnick, R.(2000). CD95(Fas/APO-1) signals ceramide generation independent of theeffector stage of apoptosis. J. Biol. Chem. 275, 8650-8656.
	Gu, C., Cassaccia-Bonnefil, P., Srinivasan, A. and Chao, M. V. (1999).Oligodendrocyte apoptosis mediated by caspase activation. J. Neurosci. 19,3043-3049.
	Hallbook, F., Ayer-Lelievre, C., Ebendal, T. and Persson, H. (1990).Expression of nerve growth factor receptor mRNA during early developmentof the chicken embryo: emphasis on cranial ganglia. Development108, 693-704.
	Hamburger, V. and Hamilton, H. L.(1951). A series of normal stages in thedevelopment of the chick embryo. J. Morphol.88, 49-92.
	Hartfield, P. J., Bilney, A. J. and Murray, A. W.(1998). Neurotrophic factorsprevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinaseactivation in PC-12 cells. J. Neurochem. 71, 161-169.
	Hemond, S. G. and Morest, D. K.(1991). Ganglion formation from the oticplacode and the otic crest in the chick embryo: mitosis, migration, and thebasal lamina. Anat. Embryol.184, 1-13.
	Herget, T., Esdar, C., Oehrlein, S. A., Heinrich, M., Schï¿½tze, S., Maelicke,A. and van Echten-Deckert, G. (2000). Production of ceramides causesapoptosis during early neural differentiation in vitro. J. Biol. Chem. 275,30344-30354.
	Huber, L. J. and Chao, M. V.(1995). Mesenchymal and neuronal cellexpression of the p75 neurotrophin receptor gene occur by differentmechanisms. Dev. Biol. 167, 227-238.
	Jacobson, M. D., Weil, M. and Raff, M. C. (1997). Programmed cell deathin animal development. Cell 88, 347-354.
	Jiang, Y., Sakane, F., Kanoh, H. and Walsh, J. P. (2000). Selectivity of thediacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2,3-dihydro-2-thioxo-4(1H) quinazolinone (R59949)among diacylglycerol kinase subtypes. Biochem. Pharmacol. 59, 763-772.
	Kaplan, D. R. and Miller, F. D. (2000). Neurotrophin signal transduction inthe nervous system. Curr. Opin. Neurobiol. 10, 381-391.
	Kishikawa, K., Chalfant, C. E., Perry, D. K., Bielawska, A. and Hannun,Y. A. (1999). Phosphatidic acid is a potent and selective inhibitor of proteinphosphatase 1 and an inhibitor of ceramide-mediated responses. J. Biol.Chem.274, 21335-21341.
	Klesse, L. J. and Parada, L. F. (1999). Trks: Signal transduction andintracellular pathways. Microsc. Res Tech. 45, 210-215.
	Large, T. H., Weskamp, G., Helder, J. C., Radeke, M. J., Misko, T. P.,Shooter, E. M. and Reichardt, L. F. (1989). Structure and developmentalexpression of the Nerve Growth Factor receptor in the chicken centralnervous system. Neuron2, 1123-1134
	Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. andEarnshaw, W. C.(1994). Cleavage of poly(ADP-ribose)polymerase by aproteinase with properties like ICE. Nature 371, 346-347.
	Lee, F. S., Kim, A. H., Khursigara, G. and Chao, M. V. (2001). Theuniqueness of being a neurotrophin receptor. Curr. Opin. Neurobiol. 11, 281-286.
	Leï¿½n, Y., Sanz, C., Girï¿½ldez, F. and Varela-Nieto, I.(1998). Induction ofcell growth by insulin and insulin-like growth factor-I is associated with Junexpression in the otic vesicle. J. Comp. Neurol. 398, 323-332.
	Leï¿½n, Y., Sanz, C., Frago, L. M., Camarero, G., Caï¿½ï¿½n, S., Varela-Nieto,I. and Girï¿½ldez, F. (1999). Involvement of Insulin-like growth factor-Iin inner ear organogenesis and regeneration. Horm. Metab. Res. 31,126-132.
	Liepinsh, E., Ilag, L. L., Otting, G. and Ibï¿½ï¿½ez, C. F.(1997). NMR structureof the death domain of the p75. EMBO J.16, 4999-5005.
	Lievremont, J. P., Sciorati, C., Morandi, E., Paolucci, C., Bunone, G., della Valle, G., Meldolesi, J. and Clementi, E. (1999). The p75(NTR)-induced apoptotic program develops through a ceramide-caspase pathwaynegatively regulated by nitric oxide. J. Biol. Chem. 274, 15466-15472.
	Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita, H.and Miyasaka, N. (1996). Ceramide induces apoptosis via CPP32activation. FEBS Lett.395, 267-271.
	Mochizuki, T., Asai, A., Saito, N., Tanaka, S., Katagiri, H., Asano, T.,Nakane, M., Tamura, A., Kuchini, Y., Kitanaka, C. and Kirino, T.(2002). Akt protein kinase inhibits non-apoptotic programmed cell deathinduced by ceramide. J. Biol. Chem.277, 2790-2797.
	Morita, Y., Perez, G. I., Paris, F., Miranda, S. R., Ehleiter, D., Haimovitz-Friedman, A., Fuks, Z., Xie, Z., Reed, J. C., Schuchman, E. H. et al.(2000). Oocyte apoptosis is suppressed by disruption of the acidsphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med.6, 1109-1114.
	Oppenheim, R. M., Flavell, R. A., Vinsant, S., Prevette, D., Kuan, C. Y.and Rakic, P. (2001). Programmed cell death of developing mammalianneurons after genetic deletion of caspases. J. Neurosci. 21, 4752-4760.
	Paradis, S. and Ruvkun, G.(1998). Caenorhabditis elegansAkt/PKBtransduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev.12, 2488-2498.
	Peï¿½a, L.A., Fuks, Z. and Kolesnick, R.(1997). Stress-induced apoptosis andthe sphingomyelin pathway. Biochem. Pharmacol.53, 615-621.486
	Raff, M. C.(1992). Social controls on cell survival and cell death. Nature356,397-400.
	Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y. andJacobson, M. D. (1993). Programmed cell death and the control of cellsurvival: lessons from the nervous system. Science262, 695-700. 
	Roux, P. P., Bhakar, A. L., Kennedy, T. E. and Barker, P. A. (2001). Thep75 neurotrophin receptor activates Akt (Protein Kinase B) through aphosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276,23097-23104.
	Sanz, C., Leï¿½n, Y., Caï¿½ï¿½n, S., Alvarez, L., Girï¿½ldez, F. and Varela-Nieto,I. (1999a). Pattern of expression of the Jun family of transcription factorsduring the early development of the inner ear: implications in apoptosis. J.Cell Sci.112, 3967-3974.
	Sanz, C., Leï¿½n, Y., Troppmair, J., Rapp, U. R. and Varela-Nieto, I.(1999b).Strict regulation of c-Raf kinase levels is required for early organogenesisof the vertebrate inner ear. Oncogene18, 429-437.
	Schecterson, L. C. and Bothwell, M.(1994). Neurotrophin andneurotrophin receptor mRNA expression in developing inner ear. HearingRes.73, 92-100.
	Schneider, E. G. and Kennedy, E. P. (1973). Phosphorylation of ceramide bydiglyceride kinase preparations from Escherichia coli. J. Biol. Chem.248,3739-3741.
	Schubert, K. M., Scheid, M. P. and Duronio, V.(2000). Ceramide inhibitsprotein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol.Chem. 275, 13330-13335.
	Sugiura, M., Kono, K., Liu, H., Shimizugawa, T., Minekura, H., Spiegel,S. and Kohama, T.(2002). Ceramide kinase, a novel lipid kinase.Molecular cloning and functional characterization. J. Biol. Chem.277,23294-23300.
	Sweeney, E. A., Inokuchi, J. and Igarashi, Y. (1998). Inhibition ofsphingolipid induced apoptosis by caspase inhibitors indicates thatsphingosine acts in an earlier part of the apoptotic pathway than ceramide.FEBS Lett. 425, 61-65.
	Teruel, T., Hernandez, R. and Lorenzo, M.(2001). Ceramide mediatesinsulin resistance by tumor necrosis factor- ain brown adipocytes bymaintaining Akt in an inactive dephosphorylated state. Diabetes50, 2563-2571.
	Torres, M. and Giraldez, F.(1998). The development of the vertebrate innerear. Mech. Dev. 71, 5-21.
	Vaux, D. L. and Korsmeyer, S. J. (1999). Cell death in development. Cell22,245-254.
	Verdu, J., Buratovich, M. A., Wilder, E. L. and Birnbaum, M. J. (1999).Cell-autonomous regulation of cell and organ growth in DrosophilabyAkt/PKB. Nat. Cell. Biol.1, 500-506.
	von Bartheld, C. S., Patterson, S. L., Heuer, J. G., Wheeler, E. F., Bothwell,M. and Rubel, E. W.(1991). Expression of nerve growth factor receptorsin the developing inner ear of chick and rat. Development 113, 455-470.
	von Schack, D., Casademunt, E., Schweigreiter, R., Meyer, M., Bibel, M.and Dechant, G. (2001). Complete ablation of the neurotrophin receptorp75NTR causes defects both in the nervous and the vascular system. Nat.Neurosci. 4, 977-978.
	Wilkinson, D. G. (1992). Whole mount in situ hybridisation of vertebrateembryos. InIn situ hybridisation, pp. 75-83. Oxford: IRL press.
	Woods, K., Camacho-Hubner, C., Savage, M. and Clark, A. (1996).Intrauterine growth retardation and postnatal growth failure associated withdeletion of the insulin-like growth factor I gene. N. Engl. J. Med.335, 1363-1367.
	Woods, K. A., Camacho-Hubner, C., Barter, D., Clark, A. J. and Savage, M.O. (1997). Insulin-like growth factor I gene deletion causing intrauterinegrowth retardation and severe short stature. Acta Paediatr.Suppl.423, 39-45.
	Wu, D. K. and Oh, S. H.(1996). Sensory organ generation in the chick innerear. J. Neurosci.16, 6454-6462.
	Yoon, S. O., Casaccia-Bonnefil, P., Carter, B. and Chao, M. V.(1998).Competitive signaling between trkA and p75 nerve growth factor receptorsdetermines cell survival. J. Neurosci. 18, 3273-3281.
	Zheng, W. H., Kar, S., Dore, S. and Quirion, R. (2000). Insulin-like growthfactor-1 (IGF-I): a neuroprotective trophic factor acting via the Akt kinasepathway. J. Neural. Transm.Suppl.60, 261-272.
	Zundel, W. and Giaccia, A.(1998). Inhibition of the anti-apoptoticPI(3)K/Akt/Bad pathway by stress. Genes Dev.12, 1941-1946.
453.full.pdf	40
	Baudino, T. A., Kraichely, D. M., Jefcoat, S. C., Jr, Winchester, S. K.,Partridge, N. C. and MacDonald, P. N.(1998). Isolation andcharacterization of a novel coactivator protein, NCoA-62, involved invitamin D-mediated transcription. J. Biol. Chem. 273, 16434-16441.
	Boucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G. andHerz, J.(2002). Platelet-derived growth factor mediates tyrosinephosphorylation of the cytoplasmic domain of the low Density lipoproteinreceptor-related protein in caveolae. J. Biol. Chem.277, 15507-15513.
	Bunn, R. C., Jensen, M. A. and Reed, B. C. (1999). Protein interactions withthe glucose transporter binding protein GLUT1CBP that provide a linkbetween GLUT1 and the cytoskeleton. Mol. Biol. Cell10, 819-832.
	Christensen, E. I., Gliemann, J. and Moestrup, S. K.(1992). Renal tubulegp330 is a calcium binding receptor for endocytic uptake of protein. J.Histochem. Cytochem.40, 1481-1490.
	Das, A. K., Cohen, P. W. and Barford, D. (1998). The structure of thetetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J.17, 1192-1199.
	D?Arcangelo, G., Miao, G. G., Chen, S. C., Soares, H. D., Morgan, J. I.and Curran, T.(1995). A protein related to extracellular matrix proteinsdeleted in the mouse mutant reeler. Nature 374, 719-723
	D?Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M.and Curran, T.(1999). Reelin is a ligand for lipoprotein receptors. Neuron24, 471-479.
	Fraker, P. J. and Speck, J. C.(1978). Protein and cell membrane iodinationswith a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun.80, 849-857.
	Fu, X., McGrath, S., Pasillas, M., Nakazawa, S. and Kamps, M. P.(1999).EB-1, a tyrosine kinase signal transduction gene, is transcriptionallyactivated in the t(1;19) subset of pre-B ALL, which express oncoproteinE2a-Pbx1. Oncogene18, 4920-4929.
	Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M.,Calandra, S., Bertolini, S., Cossu, F., Grishin, N., Barnes, R., Cohen, J.C. and Hobbs, H. H. (2002). Autosomal recessive hypercholesterolemiacaused by mutations in a putative LDL receptor adaptor protein. Science292, 1394-1398.
	Gotthardt, M., Trommsdorff, M., Nevitt, M. F., Shelton, J., Richardson,J. A., Stockinger, W., Nimpf, J. and Herz, J.(2001). Interactions of thelow density lipoprotein receptor gene family with cytosolic adaptor andscaffold proteins suggest diverse biological functions in cellularcommunication and signal transduction. J. Biol. Chem.275, 25616-25624.
	Herz, J. and Bock, H. H.(2002). Lipoprotein receptors in the nervous system.Annu. Rev. Biochem.71, 405-434.
	Herz, J. and Strickland, D. K.(2002). LRP: a multifunctional scavenger andsignaling receptor. J. Clin. Invest.108, 779-784.
	Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M.C., Cooper, J. A. and Herz, J.(1999). Direct binding of Reelin to VLDLreceptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron24, 481-489.
	Hilpert, J., Wellner, M., Thykjaer, T., Schlichting, U., Orntoft, T. F.,Bachmann, S., Nykjaer, A. and Willnow, T. E.(2002). Expressionprofiling confirms role of endocytic receptor megalin in renal vitamin Dmetabolism. Kidney Int. (in press).
	Jackson, F. R., Banfi, S., Guffanti, A. and Rossi, E. (1997). A novel zincfinger-containing RNA-binding protein conserved from fruitflies to humans.Genomics 41, 444-452.
	Kester, H. A., Blanchetot, C., den Hertog, J., van der Saag, P. T. and vander Burg, B.(1999). Transforming growth factor-beta-stimulated clone-22is a member of a family of leucine zipper proteins that can homo- andheterodimerize and has transcriptional repressor activity. J. Biol. Chem. 274,27439-27447.
	Kirchhausen, T., Bonifacino, J. S. and Riezman, H. (1997). Linking cargoto vesicle formation: receptor tail interactions with coat proteins. Curr. Opin.Cell Biol.9, 488-495.
	Lamb, J. R., Tugendreich, S. and Hieter, P.(1995). Tetratrico peptide repeatinteractions: to TPR or not to TPR? Trends Biochem. Sci.20, 257-259.
	Loukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini,M. M., Loukinov, D., Ulery, P. G., Mikhailenko, I., Lawrence, D. A. andStrickland, D. K.(2002). Platelet-derived growth factor (PDGF)-inducedtyrosine phosphorylation of the low density lipoprotein receptor-relatedprotein (LRP). Evidence for integrated co-receptor function between LRPand the PDGF. J. Biol. Chem. 277, 15499-15506.
	McCarthy, R. A., Barth, J. L., Chintalapudi, M. R., Knaak, C. andArgraves, W. S.(2002). Megalin functions as an endocytic sonic hedgehogreceptor. J. Biol. Chem.277, 25660-25667.
	Muller, D., Ankermann, T., Stephani, U., Kirschstein, M., Szelestei, T.,Luft, F. C. and Willnow, T. E.(2001). Holoprosencephaly and lowmolecular weight proteinuria: the human homologue of murine megalindeficiency. Am. J. Kidney. Dis.37, 624-628.
	Nykjaer, A., Dragun, D., Walther, D., Vorum, H., Jacobsen, C., Herz, J.,Melsen, F., Christensen, E. I. and Willnow, T. E. (1999). An endocyticpathway essential for renal uptake and activation of the steroid 25-(OH)vitamin D3. Cell96, 507-515.
	Nykjaer, A., Fyfe, J. C., Kozyraki, R., Leheste, J. R., Jacobsen, C., Nielsen,M. S., Verroust, P. J., Aminoff, M., de la Chapelle, A., Moestrup, S. K.et al. (2001). Cubilin dysfunction causes abnormal metabolism of the steroidhormone 25(OH) vitamin D(3). Proc. Natl. Acad. Sci. USA98, 13895-13900.
	Nykjaer, A. and Willnow, T. E.(2002). The low-density lipoprotein receptorgene family: a cellular Swiss army knife? Trends. Cell Biol.12, 273-280.
	Oleinikov, A. V., Zhao, J. and Makker, S. P. (2001). Cytosolic adaptorprotein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin.Biochem. J.347, 613-621.
	Patrie, K. M., Drescher, A. J., Goyal, M., Wiggins, R. C. and Margolis, B.(2001). The membrane-associated guanylate kinase protein MAGI-1 bindsmegalin and is present in glomerular podocytes. J. Am. Soc. Nephrol.12,667-677.
	Potocki, L., Chen, K. S. and Lupski, J. R.(1999). Subunit 3 of the COP9signal transduction complex is conserved from plants to humans and mapswithin the smith-magenis syndrome critical region in 17p11.2. Genomics57, 180-182.
	Rader, K., Orlando, R. A., Lou, X. and Farquhar, M. G. (2001).Characterization of ANKRA, a novel ankyrin repeat protein that interactswith the cytoplasmic domain of megalin. J. Am. Soc. Nephrol.11, 2167-2178.
	Sambrook, J. and Russel, D. W. (eds) (2001). Molecular Cloning.ColdSpring Harbor, NJ: Cold Spring Harbor Laboratory Press.
	Sheldon, M., Rice, D. S., D?Arcangelo, G., Yoneshima, H., Nakajima, K.,Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D. and Curran,T.(1997). Scrambler and yotari disrupt the disabled gene and produce areeler-like phenotype in mice. Nature 389, 730-733.
	Shiratsuchi, T., Nishimori, H., Ichise, H., Nakamura, Y. and Tokino, T.(1997). Cloning and characterization of BAI2 and BAI3, novel geneshomologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet.Cell. Genet.79, 103-108.
	Stockinger, W., Brandes, C., Fasching, D., Hermann, M., Gotthardt, M.,Herz, J., Schneider, W. J. and Nimpf, J.(2002). The reelin receptorApoER2 recruits JNK-interacting proteins-1 and -2. J. Biol. Chem.275,25625-25632.
	The RIKEN Genome Exploration Research Group(2001). Functionalannotation of a full-length mouse cDNA collection. Nature409, 685-690.
	Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger,W., Nimpf, J., Hammer, R. E., Richardson, J. A. and Herz, J. (1999).Reeler/Disabled-like disruption of neuronal migration in knockout micelacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.
	Weston, C. R. and Davis, R. J.(2002). The JNK signal transduction pathway.Curr. Op. Genet. Dev.12, 14-21.
	Willnow, T. E., Hilpert, J., Armstrong, S. A., Rohlmann, A., Hammer,R. E., Burns, D. K. and Herz, J.(1996). Defective forebrain developmentin mice lacking gp330/ megalin. Proc. Natl. Acad. Sci. USA93, 8460-8464.
	Yasuda, J., Whitmarsh, A. J., Cavanagh, J., Sharma, M. and Davis, R. J.(1999). The JIP group of mitogen-activated protein kinase scaffold proteins.Mol. Cell. Biol.19, 7245-7254.
	Zhang, X. J., Staudinger, J. and Huganir, R. L.(1999). Clustering of AMPAreceptors by the synaptic PDZ domain-containing protein PICK1. Neuron22, 179-187.
	Zhang, C., Baudino, T. A., Dowd, D. R., Tokumaru, H., Wang, W. andMacDonald, P. N.(2002). Ternary complexes and cooperative interplaybetween NCoA-62/Ski-interacting protein and steroid receptor coactivatorsin vitamin D receptor-mediated transcription. J. Biol. Chem.276, 40614-40620.
435.full.pdf	63
	Arai, A., Nosaka, Y., Kanda, E., Yamamoto, K., Miyasaka, N. and Miura,O.(2001). Rap1 is activated by erythropoietin or interleukin-3 and isinvolved in regulation of beta1 integrin-mediated hematopoietic celladhesion. J. Biol. Chem.276, 10453-10462.
	Asha, H., de Ruiter, N. D., Wang, M. G. and Hariharan, I. K.(1999). TheRap1 GTPase functions as a regulator of morphogenesis in vivo. EMBO J.18, 605-615.
	Beglova, N., Blacklow, S. C., Takagi, J. and Springer, T. A.(2002).Cysteine-rich module structure reveals a fulcrum for integrin rearrangementupon activation. Nat. Struct. Biol.9, 282-287.
	Bï¿½ranger, F., Goud, B., Tavitian, A. and de Gunzburg, J.(1991).Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgicomplex. Proc. Natl Acad. Sci. USA 88, 1606-1610.
	Bertoni, A., Tadokoro, S., Eto, K., Pampori, N., Parise, L. V., White, G.C. and Shattil, S. J.(2002). Relationships between Rap1b, affinitymodulation of integrin alpha IIbbeta 3, and the actin cytoskeleton. J. Biol.Chem.277, 25715-25721.
	Bos, J. L., de Rooij, J. and Reedquist, K. A.(2001). Rap1 signalling:adhering to new models. Nat. Rev. Mol. Cell Biol.2, 369-377.
	Braga, V.(2000). Epithelial cell shape: cadherins and small GTPases. Exp.Cell Res.261, 83-90.
	Caron, E. and Hall, A.(1998). Identification of two distinct mechanisms ofphagocytosis controlled by different Rho GTPases. Science282, 1717-1721.
	Caron, E., Self, A. J. and Hall, A.(2000). The GTPase Rap1 controlsfunctional activation of macrophage integrin alphaMbeta2 by LPS and otherinflammatory mediators. Curr. Biol.10, 974-978.
	Chen, F., Barkett, M., Ram, K. T., Quintanilla, A. and Hariharan,I.K.(1997). Biological characterization of DrosophilaRapgap1, aGTPase activating protein for Rap1. Proc. Natl Acad. Sci. USA 94, 12485-12490.
	Cook, S. J., Rubinfeld, B., Albert, I. and McCormick, F.(1993). RapV12antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGFin Rat-1 fibroblasts. EMBO J.12, 3475-3485.
	de Bruyn, K. M., Rangarajan, S., Reedquist, K. A., Figdor, C. G. and Bos,J. L.(2002). The small GTPase Rap1 is required for Mn(2+)- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion. J. Biol. Chem.277,29468-29476.
	Gao, X., Satoh, T., Liao, Y., Song, C., Hu, C. D., Kariya Ki, K. andKataoka, T.(2001). Identification and characterization of RA-GEF-2, a Rapguanine nucleotide exchange factor that serves as a downstream target ofM-Ras. J. Biol. Chem.276, 42219-42225.
	Garin, J., Diez, R., Kieffer, S., Dermine, J. F., Duclos, S., Gagnon, E.,Sadoul, R., Rondeau, C. and Desjardins, M.(2001). The phagosomeproteome: insight into phagosome functions. J. Cell Biol.152, 165-180.
	Gulli, M.-P. and Peter, M.(2001). Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective. Genes Dev.15, 365-379.
	Haas, T. A. and Plow, E. F.(1997). Development of a structural model forthe cytoplasmic domain of an integrin. Protein Eng. 10, 1395-1405.
	Hariharan, I. K., Carthew, R. W. and Rubin, G. M. (1991). The Drosophilaroughened mutation: activation of a rap homolog disrupts eye developmentand interferes with cell determination. Cell67, 717-722.
	Harris, E. S., McIntyre, T. M., Prescott, S. M. and Zimmerman, G. A.(2000). The leukocyte integrins. J. Biol. Chem.275, 23409-23412. 
	Hughes, P. E. and Pfaff, M.(1998). Integrin affinity modulation. Trends CellBiol.8, 359-364.
	Hughes, P. E., Renshaw, M. W., Pfaff, M., Forsyth, J., Keivens, V. M.,Schwartz, M. A. and Ginsberg, M. H. (1997). Suppression of integrinactivation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell88, 521-530.
	Janoueix-Lerosey, I., Pasheva, E., de Tand, M. F., Tavitian, A. and deGunzburg, J.(1998). Identification of a specific effector of the small GTP-binding protein Rap2. Eur. J. Biochem.252, 290-298.
	Kang, P. J., Sanson, A., Lee, B. and Park, H. O. (2001). A GDP/GTPexchange factor involved in linking a spatial landmark to cell polarity.Science292, 1376-1378.
	Kang, R., Kae, H., Ip, H., Spiegelman, G. B. and Weeks, G.(2002).Evidence for a role for the DictyosteliumRap1 in cell viability and theresponse to osmotic stress. J. Cell Sci.115, 3675-3682.
	Katagiri, K., Hattori, M., Minato, N., Irie, S., Takatsu, K. and Kinashi, T.(2000). Rap1 is a potent activation signal for leukocyte function-associatedantigen 1 distinct from protein kinase C and phosphatidylinositol-3-OHkinase. Mol. Cell. Biol. 20, 1956-1969.
	Katagiri, K., Hattori, M., Minato, N. and Kinashi, T. (2002). Rap1functions as a key regulator of T-cell and antigen-presenting cell interactionsand modulates T-cell responses. Mol. Cell. Biol.22, 1001-1015.
	Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. and Noda, M. (1989).A ras-related gene with transformation suppressor activity. Cell56, 77-84.
	Klinger, M., Kudlacek, O., Seidel, M. G., Freissmuth, M. and Sexl, V.(2002). MAP kinase stimulation by cAMP does not require RAP1 but SRCfamily kinases. J. Biol. Chem.277, 32490-32497.
	Knox, A. L. and Brown, N. H.(2002). Rap1 GTPase regulation of adherensjunction positioning and cell adhesion. Science295, 1285-1288.
	Kurachi, H., Wada, Y., Tsukamoto, N., Maeda, M., Kubota, H., Hattori,M., Iwai, K. and Minato, N.(1997). Human SPA-1 gene productselectively expressed in lymphoid tissues is a specific GTPase-activatingprotein for Rap1 and Rap2. Segregate expression profiles from a rap1GAPgene product. J. Biol. Chem.272, 28081-28088.
	Laroche-Joubert, N., Marsy, S., Michelet, S., Imbert-Teboul, M. andDoucet, A.(2002). Protein kinase A-independent activation of ERK andH,K-ATPase by cAMP in native kidney cells: role of Epac I. J. Biol. Chem.277, 18598-18604.
	Lou, L., Urbani, J., Ribeiro-Neto, F. and Altschuler, D. L.(2002). cAMPinhibition of Akt is mediated by activated and phosphorylated Rap1b. J.Biol. Chem.277, 32799-32806.
	Lova, P., Paganini, S., Sinigaglia, F., Balduini, C. and Torti, M.(2002). AGi-dependent pathway is required for activation of the small GTPase Rap1Bin human platelets. J. Biol. Chem.277, 12009-12015.
	Magie, C. R., Pinto-Santini, D. and Parkhurst, S. M.(2002). Rho1 interactswith p120(ctn) and alpha-catenin, and regulates cadherin-based adherensjunction components in Drosophila. Development129, 3771-3782.
	McLeod, S. J., Li, A. H., Lee, R. L., Burgess, A. E. and Gold, M. R.(2002).The Rap GTPases regulate B cell migration toward the chemokine stromalcell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cellmigration. J. Immunol.169, 1365-1371.
	Mochizuki, N., Yamashita, S., Kurokawa, K., Ohba, Y., Nagai, T.,Miyawaki, A. and Matsuda, M.(2001). Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature411, 1065-1068.
	Ohba, Y., Ikuta, K., Ogura, A., Matsuda, J., Mochizuki, N., Nagashima,K., Kurokawa, K., Mayer, B. J., Maki, K., Miyazaki, J. and Matsuda,M.(2001). Requirement for C3G-dependent Rap1 activation for celladhesion and embryogenesis. EMBO J.20, 3333-3341.
	Pak, D. T., Yang, S., Rudolph-Correia, S., Kim, E. and Sheng, M.(2001).Regulation of dendritic spine morphology by SPAR, a PSD-95-associatedRapGAP. Neuron31, 289-303.
	Palsson, E. M., Popoff, M., Thelestam, M. and O?Neill, L. A.(2000).Divergent roles for Ras and Rap in the activation of p38 mitogen-activatedprotein kinase by interleukin-1. J. Biol. Chem.275, 7818-7825.
	Park, H. O., Kang, P. J. and Rachfal, A. W.(2002). Localization of theRsr1/Bud1 GTPase involved in selection of a proper growth site in yeast. J.Biol. Chem.277, 26721-26724.
	Pizon, V., Chardin, P., Lerosey, I., Olofsson, B. and Tavitian, A. (1988).Human cDNAs rap1 and rap2 homologous to the Drosophilagene Dras3encode proteins closely related to ras in the ?effector? region. Oncogene3,201-204.
	Pizon, V., Desjardins, M., Bucci, C., Parton, R. G. and Zerial, M.(1994).Association of Rap1a and Rap1b proteins with late endocytic/phagocyticcompartments and Rap2a with the Golgi complex. J. Cell Sci.107, 1661-1670.
	Polakis, P. G., Rubinfeld, B., Evans, T. and McCormick, F.(1991).Purification of a plasma membrane-associated GTPase-activating proteinspecific for rap1/Krev-1 from HL60 cells. Proc. Natl Acad. Sci. USA88,239-243.
	Prevost, N., Woulfe, D., Tanaka, T. and Brass, L. F.(2002). Interactionsbetween Eph kinases and ephrins provide a mechanism to support plateletaggregation once cell-to-cell contact has occurred. Proc. Natl. Acad. Sci.USA99, 9219-9224.
	Rebstein, P. J., Cardelli, J., Weeks, G. and Spiegelman, G. B. (1997).Mutational analysis of the role of Rap1 in regulating cytoskeletal functionin Dictyostelium. Exp. Cell Res.231, 276-283.
	Reedquist, K. A., Ross, E., Koop, E. A., Wolthuis, R. M., Zwartkruis, F.J., van Kooyk, Y., Salmon, M., Buckley, C. D. and Bos, J. L. (2000). Thesmall GTPase, Rap1, mediates CD31-induced integrin adhesion. J. CellBiol.148, 1151-1158.
	Reuther, G. W. and Der, C. J.(2000). The Ras branch of small GTPases: Rasfamily members don?t fall far from the tree. Curr. Opin. Cell Biol.12, 157-165.
	Ribeiro-Neto, F., Urbani, J., Lemee, N., Lou, L. and Altschuler, D. L.(2002). On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entryrequires activated and phosphorylated Rap1b. Proc. Natl Acad. Sci. USA99,5418-5423.
	Schmidt, A., Caron, E. and Hall, A.(2001). Lipopolysaccharide-inducedactivation of beta2-integrin function in macrophages requires Irak kinaseactivity, p38 mitogen-activated protein kinase, and the Rap1 GTPase. Mol.Cell. Biol.21, 438-448.
	Schmitt, J. M. and Stork, P. J.(2001). Cyclic AMP-mediated inhibition ofcell growth requires the small G protein Rap1. Mol. Cell. Biol.21, 3671-3683.
	Schoenwaelder, S. M. and Burridge, K.(1999). Bidirectional signalingbetween the cytoskeleton and integrins. Curr. Opin. Cell Biol.11, 274-286.
	Seastone, D. J., Zhang, L., Buczynski, G., Rebstein, P., Weeks, G.,Spiegelman, G. and Cardelli, J.(1999). The small Mr Ras-like GTPaseRap1 and the phospholipase C pathway act to regulate phagocytosis inDictyostelium discoideum. Mol. Biol. Cell 10, 393-406.
	Sebzda, E., Bracke, M., Tugal, T., Hogg, N. and Cantrell, D. A.(2002).Rap1A positively regulates T cells via integrin activation rather thaninhibiting lymphocyte signaling. Nat. Immunol.3, 251-258.
	Self, A. J., Caron, E., Paterson, H. F. and Hall, A.(2001). Analysis of R-Ras signalling pathways. J. Cell Sci.114, 1357-1366.Suga, K., Katagiri, K., Kinashi, T., Harazaki, M., Iizuka, T., Hattori, M.and Minato, N.(2001). CD98 induces LFA-1-mediated cell adhesion inlymphoid cells via activation of Rap1. FEBS Lett.489, 249-253.
	Takai, Y., Sasaki, T. and Matozaki, T.(2001). Small GTP-binding proteins.Physiol. Rev.81, 153-208. 
	Tsukamoto, N., Hattori, M., Yang, H., Bos, J. L. and Minato, N.(1999).Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion.J. Biol. Chem.274, 18463-18469.
	van den Berghe, N., Cool, R. H., Horn, G. and Wittinghofer, A. (1997).Biochemical characterization of C3G: an exchange factor that discriminatesbetween Rap1 and Rap2 and is not inhibited by Rap1A(S17N). Oncogene15, 845-850.
	van Kooyk, Y. and Figdor, C. G. (2000). Avidity regulation of integrins: thedriving force in leukocyte adhesion. Curr. Opin. Cell Biol.12, 542-547.
	Vetter, I. R., Linnemann, T., Wohlgemuth, S., Geyer, M., Kalbitzer, H. R.,Herrmann, C. and Wittinghofer, A.(1999). Structural and biochemicalanalysis of Ras-effector signaling via RalGDS. FEBS Lett.451, 175-180.
	Vinogradova, O., Velyvis, A., Velyviene, A., Hu, B., Haas, T., Plow, E. andQin, J.(2002). A structural mechanism of integrin alpha(IIb)beta(3) ?inside-out? activation as regulated by its cytoplasmic face. Cell110, 587-597.
	Woulfe, D., Jiang, H., Mortensen, R., Yang, J. and Brass, L. F. (2002).Activation of Rap1B by G(i) family members in platelets. J. Biol. Chem.277, 23382-23390.
	Xiong, J. P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. L.,Joachimiak, A., Goodman, S. L. and Arnaout, M. A. (2001). Crystalstructure of the extracellular segment of integrin alpha Vbeta3. Science294,339-345.
	Zhang, Z., Vuori, K., Wang, H., Reed, J. C. and Ruoslahti, E.(1996).Integrin activation by R-ras. Cell85, 61-69.
	Zhu, J., Qin, Y., Zhao, M., van Aelst, L. and Malinow, R.(2002). Ras andRap control AMPA receptor trafficking during synaptic plasticity. Cell110,443-455.
441.full.pdf	36
	Barbaux, S., Niaudet, P., Gubler, M. C., Grunfeld, J. P., Jaubert, F.,Kuttenn, F., Fekete, C. N., Souleyreau-Therville, N., Thibaud, E.,Fellous, M. and McElreavey, K.(1997). Donor splice-site mutations inWT1are responsible for Frasier syndrome. Nat. Genet.17, 467-470. 
	Bergstrom, D. E., Young, M., Albrecht, K. H. and Eicher, E. M.(2000).Related function of mouse SOX3, SOX9, and SRY HMG domains assayedby male sex determination. Genesis28, 111-124. 
	Bowles, J., Cooper, L., Berkman, J. and Koopman, P.(1999). Sryrequiresa CAG repeat domain for male sex determination in Mus musculus. Nat.Genet. 22, 405-408.
	Clarkson, M. J. and Harley, V. R.(2002). Sex with two SOX on: SRY andSOX9 in testis development. Trends Endocrinol. Metab.13, 106-111. 
	Collignon, J., Sockanathan, S., Hacker, A., Cohen-Tannoudji, M., Norris,D., Rastan, S., Stevanovic, M., Goodfellow, P. N. and Lovell-Badge, R.(1996). A comparison of the properties of Sox-3with Sryand two relatedgenes, Sox-1and Sox-2. Development 122, 509-520. 
	Davies, R. C., Calvio, C., Bratt, E., Larsson, S. H., Lamond, A. I. andHastie, N. D.(1998). WT1 interacts with the splicing factor U2AF65 in anisoform-dependent manner and can be incorporated into spliceosomes.Genes Dev.12, 3217-3225.
	Ferrari, S., Harley, V. R., Pontiggia, A., Goodfellow, P. N., Lovell-Badge,R. and Bianchi, M. E.(1992). SRY, like HMG1, recognizes sharp anglesin DNA. EMBO J.11, 4497-4506. 
	Hammes, A., Guo, J.-K., Lutsch, G., Leheste, J.-R., Landrock, D., Ziegler,U., Gubler, M.-C. and Schedl, A.(2001). Two splice variants of the Wilms?Tumor 1 gene have distinct functions during sex determination and nephronformation. Cell106, 319-329. 
	Haqq, C. M., King, C.-Y., Ukiyama, E., Falsafi, S., Haqq, T. N., Donahoe,P. K. and Weiss, M. A. (1994). Molecular basis of mammalian sexualdetermination: activation of Mï¿½llerian inhibiting substance gene expressionby SRY. Science266, 1494-1500.
	Harley, V. R., Jackson, D. I., Hextall, P. J., Hawkins, J. R., Berkovitz, G.D., Sockanathan, S., Lovell-Badge, R. and Goodfellow, P. N.(1992).DNA binding activity of recombinant SRY from normal males and XYfemales. Science255, 453-456.
	Harley, V. R., Lovell-Badge, R. and Goodfellow, P. N.(1994). Definition ofa consensus DNA binding site for SRY. Nucleic Acids Res. 22, 1500-1501. 
	Kamachi, Y., Uchikawa, M. and Kondoh, H.(2000). Pairing SOX off withpartners in the regulation of embryonic development. Trends Genet.16, 182-187. 
	Larsson, S. H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D.,Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V. and Hastie,N. D.(1995). Subnuclear localization of WT1 in splicing or transcriptionfactor domains is regulated by alternative splicing. Cell81, 391-401. 
	Little, N. A., Hastie, N. D. and Davies, R. C.(2000). Identification of WTAP,a novel Wilms? tumour 1-associating protein. Hum. Mol. Genet.9, 2231-2239. 
	Marin, I. and Baker, B. S.(1998). The evolutionary dynamics of sexdetermination. Science281, 1990-1994. 
	McElreavey, K., Vilain, E., Abbas, N., Herskowitz, I. and Fellous, M.(1993). A regulatory cascade hypothesis for mammalian sex determination:SRY represses a negative regulator of male development. Proc. Natl. Acad.Sci. USA 90, 3368-3372.
	Misteli, T.(2000). Cell biology of transcription and pre-mRNA splicing:nuclear architecture meets nuclear function. J. Cell Sci.113, 1841-1849. 
	Ohe, K., Lalli, E. and Sassone-Corsi, P.(2002). A direct role of SRY andSOX proteins in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 99, 1146-1151.
	Ottolenghi, C. and McElreavey, K.(2000). Deletions of 9p and the quest fora conserved mechanism of sex determination. Mol. Genet. Metab.71, 397-404. 
	Pailhoux, E., Vigier, B., Chaffaux, S., Servel, N., Taourit, S., Furet, J. P.,Fellous, M., Grosclaude, F., Cribiu, E. P., Cotinot, C. and Vaiman, D.(2001). A 11.7-kb deletion triggers intersexuality and polledness in goats.Nat. Genet. 29, 453-458.
	Pontiggia, A., Rimini, R., Harley, V. R., Goodfellow, P. N., Lovell-Badge,R. and Bianchi, M. E. (1994). Sex-reversing mutations affect thearchitecture of SRY-DNA complexes. EMBO J.13, 6115-6127.
	Raymond, C. S., Shamu, C. E., Shen, M. M., Seifert, K. J., Hirsch, B.,Hodgkin, J. and Zarkower, D.(1998). Evidence for evolutionaryconservation of sex-determining genes. Nature391, 691-695.
	Raymond, C. S., Murphy, M. W., O?Sullivan, M. G., Bardwell, V. J. andZarkower, D.(2000). Dmrt1, a gene related to worm and fly sexualregulators, is required for mammalian testis differentiation. Genes Dev.14,2587-2595.
	Schï¿½tt, C. and Nï¿½thiger, R. (2000). Structure, function and evolution of sex-determining systems in Dipteran insects. Development127, 667-677. 
	Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griffiths, B. L.,Smith, M. J., Foster, J. W., Frischauf, A. M., Lovell-Badge, R. andGoodfellow, P. N.(1990). A gene from the human sex-determining regionencodes a protein with homology to a conserved DNA-binding motif. Nature346, 240-244.
	Staley, J. P. and Guthrie, C.(1998). Mechanical devices of the spliceosome:motors, clocks, springs, and things. Cell 92, 315-326. 
	Steitz, J. A.(1992). Splicing takes a Holliday. Science257, 888-889. 
	Swain, A. and Lovell-Badge, R.(1999). Mamalian sex determination: amolecular drama. Genes Dev.13, 755-767.
	Trimmer, E. E., Zamble, D. B., Lippard, S. J. and Essigmann, J. M.(1998).Human testis-determining factor SRY binds to the major DNA adduct ofcisplatin and a putative target sequence with comparable affinities.Biochemistry37, 352-362. 
	Vaiman, D. and Pailhoux, E.(2000). Mammalian sex reversal andintersexuality: deciphering the sex-determination cascade. Trends Genet.16,488-494. 
	Vainio, S., Heikkila, M., Kispert, A., Chin, N. and McMahon, A. P.(1999).Female development in mammals is regulated by Wnt-4 signalling. Nature397, 405-409.
	Veretnik, S. and Gribskov, M.(1999). RNA binding domain of HDV antigenis homologous to the HMG box of SRY. Arch. Virol. 144, 1139-1158. 
	Wegner, M.(1999). From head to toes: the multiple facets of Sox proteins.Nucleic Acids Res. 27, 1409-1420. 
	Wilkins, A. S.(1995). Moving up the hierarchy: a hypothesis on the evolutionof a genetic sex determination pathway. BioEssays17, 71-77. 
	Zarkower, D.(2001). Establishing sexual dimorphism: conservation amidstdiversity? Nat. Rev. Genet.2, 175-185.
	Zhou, Z., Licklider, L. J., Gygl, S. P. and Reed, R. (2002). Comprehensiveproteomic analysis of the human spliceosome. Nature419, 182-185. 
pdf_40390.pdf	51
12149567.pdf	27
	1.Cogan DG, Toussaint D, Kuwabara T. (1961) Retinal vascu-larpatterns. IV. Diabetic retinopathy. Arch. Ophthalmol.66:366?378.
	2.Yamagishi S, Kobayashi K, Yamamoto H. (1993) Vascularpericytes not only regulate growth, but also preserveprostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells.Biochem. Biophys. Res. Commun. 190:418?425.
	3.Yamagishi S, Hsu CC, Kobayashi K, Yamamoto H. (1993) En-dothelin 1 mediates endothelial cell-dependent proliferationof vascular pericytes. Biochem. Biophys. Res. Commun.191:840?846.
	4.Podestï¿½ F, Romeo G, Liu WH, et al. (2000) Bax is increasedin the retina of diabetic subjects and is associated with peri-cyte apoptosis in vivo and in vitro. Am. J. Pathol.156: 1025?1032.
	5.Diabetes Control and Complications Trial Research Group.(1993) The effects of intensive treatment of diabetes on thedevelopment and progression of long-term complications ininsulin-dependent diabetes mellitus. N. Engl. J. Med.329:977?986.
	6.United Kingdom Prospective Diabetes Study Group (UKPDS).(1998) Intensive blood-glucose control with sulfonylureas orinsulin compared with conventional treatment and risk ofcomplications in patients with type 2 diabetes (UKPDS33).Lancet 352:837?853.
	7.Heart Outcomes Prevention Evaluation (HOPE) Study. (2000)Effects of ramipril on cardiovascular and microvascularoutcomes in people with diabetes mellitus: results of theHOPE study and MICRO-HOPE substudy. Lancet 355:253?259.
	8.Orchard TJ, Kuller LH, Forrest KYZ, Becker DJ. (2001) Lipidand blood pressure treatment goals for type 1 diabetes.Diabetes Care24:1053?1059.
	9.Shimabukuro M, Zhou YT, Levi M, Unger RH. (1998) Fattyacid-induced cell apoptosis: a link between obesity anddiabetes. Proc. Natl. Acad. Sci. U.S.A.95:2498?2502.
	10.Bjorntorp P. (1994) Fatty acids, hyperinsulinemia and insulinresistance: which comes first? Curr. Opin. Lipidol.5:166?174.
	11.Inoguchi T, Li P, Umeda F, et al. (2000) High glucose leveland free fatty acid stimulate reactive oxygen species produc-tion through protein kinase C-dependent activation ofNAD(P)H oxidase in cultured vascular cells. Diabetes49:1939?1945.
	12.Yamagishi S, Hsu CC, Taniguchi M, et al. (1995) Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in dia-betic microangiopathy. Biochem. Biophys. Res. Commun.213:681?687.
	13.Yamagishi S, Amano S, Inagaki Y, et al. (2002) Advanced gly-cation end products-induced apoptosis and overexpression ofvascular endothelial growth factor in bovine retinal pericytes.Biochem. Biophys. Res. Commun.290: 973?978.
	14.Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Ya-mamoto H. (1998) Advanced glycation endproducts inhibitprostacyclin production and induce plasminogen activatorinhibitor-1 in human microvascular endothelial cells. Dia-betologia41:1435?1441.
	15.Yamagishi S, Yonekura H, Yamamoto Y, et al. (1999) Vascularendothelial growth factor acts as a pericyte mitogen under hy-poxic conditions. Lab. Invest.79: 501?509.
	16.Yamagishi S, Edelstein D, Du XL, Kaneda Y, Guzman M,Brownlee M. (2001) Leptin induces mitochondrial superox-ide production and monocyte chemoattractant protein-1expression in aortic endothelial cells by increasing fatty acidoxidation via protein kinase A. J. Biol. Chem.276:25096?25100.
	17.Yamagishi S, Yamamoto Y, Harada S, Hsu CC, Yamamoto H.(1996) Advanced glycosylation end products stimulate thegrowth but inhibit the prostacyclin-producing ability of en-dothelial cells through interactions with their receptors. FEBSLett.384:103?106.
	18.Yamagishi S, Yonekura H, Yamamoto Y, et al. (1997) Ad-vanced glycation end products-driven angiogenesis in vitro.Induction of the growth and tube formation of human mi-crovascular endothelial cells through autocrine vascular en-dothelial growth factor. J. Biol. Chem.272:8723?8730.
	19.Yamagishi S, Kawakami T, Fujimori H, et al. (1999) Insulinstimulates the growth and tube formation of human mi-crovascular endothelial cells through autocrine vascular en-dothelial growth factor. Microvasc. Res.57:329?339.
	20.Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H.in microvascular pericytes. Biochem. Biophys. Res. Commun.258:353?357.
	21.Nomura M, Yamagishi S, Harada S, et al. (1995) Possible par-ticipation of autocrine and paracrine vascular endothelialgrowth factors in hypoxia-induced proliferation of endothe-lial cells and pericytes. J. Biol. Chem.270:28316?28324.
	22.Takeuchi M, Bucala R, Suzuki T, et al. (2000) Neurotoxicity ofadvanced glycation end-products for cultured cortical neu-rons. J. Neuropathol. Exp. Neurol.59:1094?1105.
	23.Schwartzman RA, Cidlowski JA. (1993) Apoptosis: the bio-chemistry and molecular biology of programmed cell death.Endocrine Rev. 14: 133?151.
	24.Listenberger LL, Ory DS, Schaffer JE. (2001) Palmitate-induced apoptosis can occur through a ceramide-independentpathway. J. Biol. Chem. 276:14890?14895.
	25.Chaturvedi N, Songini M, Sjoelie AK, et al. (2001) Markersof insulin resistance are strong risk factors for retinopathy in-cidence in type 1 diabetes. Diabetes Care24:284?289.
	26.Tanaka N, Yonekura H, Yamagishi S, Fujimori H, YamamotoY, Yamamoto H. (2000) The receptor for advanced glycationend products is induced by the glycation products themselvesand tumor necrosis factor-through nuclear factor-B, and byestradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275:25781?25790.
	27.Yan SD, Schmidt AM, Anderson GM, et al. (1994) Enhancedcellular oxidant stress by the interaction of advanced glyca-tion end products with their receptors/binding proteins. J. Biol. Chem.269:9889?9897.
v057p00752.pdf	2
1479.2.full.pdf	4
1464.full.pdf	47
	1.CavaghanMK,EhrmannDA,ByrneMM,PolonskyKS:Treatmentwiththeoralan-tidiabeticagenttroglitazoneimproves-cellresponsestoglucoseinsubjectswithimpairedglucosetolerance.JClinIn-vest100:530?537,1997
	2.EhrmannDA,SchneiderDJ,SobelBE,CavaghanMK,ImperialJ,RosenfieldRL,PolonskyKS:Troglitazoneimprovesde-fectsininsulinaction,insulinsecretion,ovariansteroidogenesis,andfibrinolysisinwomenwithpolycysticovarysyn-Bloomgardendrome.JClinEndocrinolMetab82:2108?2116,1997
	3.BuchananTA,XiangAH,PetersRK,KjosSL,marroquinA,GoicoJ,OchoaC,TanS,AzenSP:Protectionfromtype2diabe-tespersistsintheTRIPODcohorteightmonthsafterstoppingtroglitazone(Abstract).Diabetes50(Suppl.2):A81,2001
	4.SakurabaH,MizukamiH,YagihashiN,WadaR,HanyuC,YagihashiS:Reducedbeta-cellmassandexpressionofoxidativestress-relatedDNAdamageintheisletofJapanesetypeIIdiabeticpatients.Diabe-tologia45:85?96,2002
	5.FinegoodDT,McArthurMD,KojwangD,ThomasMJ,ToppBG,LeonardT,Buck-inghamRE:Beta-cellmassdynamicsinZuckerdiabeticfattyrats:rosiglitazonepreventstheriseinnetcelldeath.Diabetes50:1021?1029,2001
	6.ZulewskiH,AbrahamEJ,GerlachMJ,DanielPB,MoritzW,MullerB,VallejoM,ThomasMK,HabenerJF:Multipotentialnestin-positivestemcellsisolatedfromadultpancreaticisletsdifferentiateexvivointopancreaticendocrine,exocrine,andhepaticphenotypes.Diabetes50:521?533,2001
	7.DuezH,FruchartJC,StaelsB:PPRAsininflammation,atherosclerosisandthrom-bosis.JCardiovascRisk8:187?194,2001
	8.LiAC,BrownKK,SilvestreMJ,WillsonTM,PalinskiW,GlassCK:Peroxisomeproliferator-activatedreceptorgammali-gandsinhibitdevelopmentofatheroscle-rosisinLDLreceptor-deficientmiceJClinInvest106:523?531,2000
	9.MokdadAH,SerdulaMK,DietzWH,BowmanBA,MarksJS,KoplanJP:ThecontinuingepidemicofobesityintheUnitedStates.JAMA284:1650?1651,2000
	10.SchiffmanSS,GrahamBG,Sattely-MillerEA,Peterson-DancyM:Elevatedandsus-taineddesireforsweettasteinAfrican-Americans:apotentialfactorinthedevelopmentofobesity.Nutrition16:886?893,2000
	11.WoodsSC,SeeleyRJ:Adipositysignalsandthecontrolofenergyhomeostasis.Nutrition16:894?902,2000
	12.MokdadAH,FordES,BowmanBA,Nel-sonDE,EngelgauMM,VinicorF,MarksJS:DiabetestrendsintheU.S.:1990?1998.DiabetesCare23:1278?1283,2000
	13.CareyDG,JenkinsAB,CampbellLV,FreundJ,ChisholmDJ:Abdominalfatandinsulinresistanceinnormalandover-weightwomen:directmeasurementsre-vealastrongrelationshipinsubjectsatbothlowandhighriskofNIDDM.Diabe-tes45:633?638,1996
	14.PanXR,LiGW,HuYH,WangJX,YangWY,AnZX,HuZX,LinJ,XiaoJZ,CaoHB,LiuPA,JiangXG,JiangYY,WangJP,ZhengH,ZhangH,BennettPH,HowardBV:Effectsofdietandexerciseinprevent-ingNIDDMinpeoplewithimpairedglu-cosetolerance.TheDaQingIGTandDiabetesStudy.DiabetesCare.1997;20:537?544,1997
	15.TuomilehtoJ,LindstromJ,ErikssonJG,ValleTT,HamalainenH,Ilanne-ParikkaP,Keinanen-KiukaanniemiS,LaaksoM,LouherantaA,RastasM,SalminenV,UusitupaM:Preventionoftype2diabetesmellitusbychangesinlifestyleamongsubjectswithimpairedglucosetolerance.NEnglJMed344:1343?1350,2001
	16.DiabetesPreventionProgramResearchGroup:Reductionintheincidenceoftype2diabeteswithlifestyleinterventionormetformin.NEnglJMed346:393?403,2002
	17.KnowlerWC,PettittDJ,SavagePJ,Ben-nettPH:DiabetesincidenceinPimaindi-ans:contributionsofobesityandparentaldiabetes.AmJEpidemiol113:144?156,1981
	18.FosterGD,WaddenTA,VogtRA,BrewerG:Whatisareasonableweightloss?Pa-tients?expectationsandevaluationsofobesitytreatmentoutcomes.JConsultClinPsychol.1997;65:79?85,1997
	19.WaddenTA,BerkowitzRI,SarwerDB,Prus-WisniewskiR,SteinbergC:Benefitsoflifestylemodificationinthepharmaco-logictreatmentofobesity:arandomizedtrial.ArchInternMed161:218?227,2001
	20.JamesWP,AstrupA,FinerN,HilstedJ,KopelmanP,RossnerS,SarisWH,VanGaalLF:Effectofsibutramineonweightmaintenanceafterweightloss:arandom-isedtrial.STORMStudyGroup.Sibutra-mineTrialofObesityReductionandMaintenance.Lancet356:2119?2125,2000
	21.DrentML,LarssonI,William-OlssonT,QuaadeF,CzubaykoF,vonBergmannK,StrobelW,SjostromL,vanderVeenEA:Orlistat(Ro18?0647),alipaseinhibitor,inthetreatmentofhumanobesity:amul-tipledosestudy.IntJObesRelatMetabDisord19:221?226,1995
	23.HeymsfieldSB,GreenbergAS,FujiokaK,DixonRM,KushnerR,HuntT,LubinaJA,PataneJ,SelfB,HuntP,McCamishM:Recombinantleptinforweightlossinobeseandleanadults:arandomized,con-trolled,dose-escalationtrial.JAMA282:1568?1575,1999
	22.UKProspectiveDiabetesStudy(UKPDS)Group:Effectofintensiveblood-glucosecontrolwithmetforminoncomplicationsinoverweightpatientswithtype2diabe-tes(UKPDS34).Lancet352:854?865,1998
	25.Yki-JarvinenH:Combinationtherapieswithinsulinintype2diabetes.DiabetesCare24:758?767,2001
	26.WingRR,MarcusMD,EpsteinLH,SalataR:TypeIIdiabeticsubjectsloselessweightthantheiroverweightnondiabeticspouses.DiabetesCare10:563?566,1987
	27.HeathMJ,ChongE,WeinsteinSP,SeatonTB:Sibutramineenhancesweightlossandimprovesglycemiccontrolandplasmalipidprofileinobesepatientswithtype2diabetes(Abstract).Diabetes48(Suppl.1):A308,1999
	28.HollanderPA,ElbeinSC,HirschIB,KelleyD,McGillJ,TaylorT,WeissSR,CrockettSE,KaplanRA,ComstockJ,Lu-casCP,LodewickPA,CanovatchelW,ChungJ,HauptmanJ:Roleoforlistatinthetreatmentofobesepatientswithtype2diabetes:a1-yearrandomizeddouble-blindstudy.DiabetesCare21:1288?1294,1998
	29.BrayGA,Pi-SunyerFX,HollanderP,KelleyDE:Effectoforlistatinoverweightpatientswithtype2diabetesreceivingin-sulintherapy(Abstract).Diabetes50(Suppl.2):A107,2001
	30.ExecutiveSummaryofTheThirdReportofTheNationalCholesterolEducationProgram(NCEP)ExpertPanelonDetec-tion,Evaluation,AndTreatmentofHighBloodCholesterolInAdults(AdultTreat-mentPanelIII).JAMA285:2486?2497,2001
	31.ThesixthreportoftheJointNationalCommitteeonPrevention,Detection,Evaluation,andTreatmentofHighBloodPressure.ArchInternMed157:2413?2446,1997
	32.AmericanDiabetesAssociation:Evi-dence-basednutritionprinciplesandrec-ommendationsforthetreatmentandpreventionofdiabetesandrelatedcom-plications(PositionStatement).DiabetesCare25(Suppl.1):S50?S60,2002
	33.BrayGA:ComplicationsofObesity.AnnInternMed103:1052?1062,1985
	35.WattsNB,SpanheimerRG,DiGirolamoM,GebhartSS,MuseyVC,SiddiqYK,PhillipsLS:Predictionofglucosere-sponsetoweightlossinpatientswithnon-insulin-dependentdiabetesmellitus.ArchInternMed150:803?806,1990
	36.LeanME,PowrieJK,AndersonAS,Garth-waitePH:Obesity,weightlossandprog-nosisintype2diabetes.DiabetMed7:228?233,1990
	37.SteppanCM,BaileyST,BhatS,BrownEJ,BanerjeeRR,WrightCM,PatelHR,AhimaRS,LazarMA:Thehormoneresis-tinlinksobesitytodiabetes.Nature409:307?312,2001
	38.AndersonRJ,FreedlandKE,ClouseRE,LustmanP:Theprevalenceofcomorbiddepressioninadultswithdiabetes:ameta-analysis.DiabetesCare24:1069?1078,2001
	39.FordES,GilesWH,DietzWH:PrevalenceofthemetabolicsyndromeamongUSadults:findingsfromtheThirdNationalPerspectivesontheNewsHealthandNutritionExaminationSur-vey.JAMA287:356?359,2002
	40.WhorwoodCB,DonovanSJ,FlanaganD,PhillipsDI,ByrneCD:Increasedglu-cocorticoidreceptorexpressioninhumanskeletalmusclecellsmaycontributetothepathogenesisofthemetabolicsyndrome.Diabetes51:1066?1075,2002
	41.MasuzakiH,PatersonJ,ShinyamaH,MortonNM,MullinsJJ,SecklJR,FlierJS:Atransgenicmodelofvisceralobesityandthemetabolicsyndrome.Science294:2166?2170,2001
	42.HubertHB,EakerED,GarrisonRJ,Cas-telliWP:Life-stylecorrelatesofriskfactorchangeinyoungadults:aneight-yearstudyofcoronaryheartdiseaseriskfac-torsintheFraminghamoffspring.AmJEpidemiol125:812?831,1987
	43.JainP,RademakerAW,McVaryKT:Tes-tosteronesupplementationforerectiledysfunction:resultsofameta-analysis.JUrol164:371?375,2000
	44.GranataAR,RochiraV,LerchlA,Mar-ramaP,CaraniC:Relationshipbetweensleep-relatederectionsandtestosteronelev-elsinmen.JAndrol18:522?527,1997
	45.GoldsteinI,LueTF,Padma-NathanH,RosenRC,SteersWD,WickerPA:Oralsildenafilinthetreatmentoferectiledys-function.SildenafilStudyGroup.NEnglJMed338:1397?404,1998
	46.Saï¿½enzDTejadaI,EmmickJ,AnglinG,FredlundP,PullmanW:Theeffectofon-demandIC351treatmentoferectiledys-functioninmenwithdiabetes(Abstract).EurUrol39(Suppl.5):16,2001
	47.ShakirSA,WiltonLV,BoshierA,LaytonD,HeeleyE:Cardiovasculareventsinus-ersofsildenafil:resultsfromfirstphaseofprescriptioneventmonitoringinEn-gland.BMJ322:651?652,2001
1439.full.pdf	36
	1.GarciaMJ,McNamaraPM,GordonT,KannelWB:MorbidityandmortalityindiabeticsintheFraminghampopulation:sixteen-yearfollowupstudy.Diabetes23:105?111,1974
	2.ZilversmitDB:Atherogenesisapost-pran-dialphenomenon.Circulation60:473?485,1979
	3.EbenbichlerCF,KirchmairR,EggerC,PatschJR:Postprandialstateandathero-sclerosis.CurrOpinLipidol6:286?290,1995
	4.LefebvrePJ,ScheenAJ:Thepostprandialstateandriskofcardiovasculardisease.DiabetMed15(Suppl.4):S63?S68,1998
	5.CerielloA:Thepost-prandialstateandcardiovasculardisease:relevancetodia-betesmellitus.DiabeteMetabResRev16:125?132,2000
	6.CerielloA:Theemergingroleofpost-prandialhyperglycaemicspikesinthepathogenesisofdiabeticcomplications.DiabetMed15:188?193,1998
	7.GiuglianoD,CerielloA,PaolissoG:Oxi-dativestressanddiabeticvascularcompli-cations.DiabetesCare19:257?267,1996
	8.CerielloA,BortolottiN,MotzE,Crescen-tiniA,LizzioS,RussoA,TonuttiL,TabogaC:Meal-generatedoxidativestressintype2diabeticpatients.DiabetesCare21:1529?1533,1998
	9.CosentinoF,HishikawaK,KatusicZS,Luï¿½scherTF:Highglucoseincreasesnitricoxidesynthaseexpressionandsuperox-ideaniongenerationinhumanaorticen-dothelialcells.Circulation96:25?28,1997
	10.BeckmanJS,KoppenolWH:Nitricoxide,superoxide,andperoxynitrite:thegood,thebad,andugly.AmJPhysiol271:C1424?C1437,1996
	11.IschiropoulosH:Biologicaltyrosinenitra-tion:apathophysiologicalfunctionofni-tricoxideandreactiveoxygenspecies.ArchBiochemBiophys356:1?11,1998
	12.CerielloA,MercuriF,QuagliaroL,Assa-loniR,MotzE,TonuttiL,TabogaC:De-tectionofnitrotyrosineinthediabeticplasma:evidenceofoxidativestress.Dia-betologia44:834?838,2001
	13.MarfellaR,QuagliaroL,NappoF,Ceri-elloA,GiuglianoD:Acutehyperglycemiainducesanoxidativestressinhealthysub-jects(Letter).JClinInvest108:635?636,2001
	14.BrangeJ,VolundA:Insulinanalogswithimprovedpharmacokineticsprofiles.AdvDrugDelRev35:307?335,1999
	15.RosenfalckAM,ThorsbyP,KjemsL,Bir-kelandK,DejgaardA,HanssenKF,Mads-badS:Improvedpostprandialglycaemiccontrolwithinsulinaspartindiabeticpa-tientstreatedwithinsulin.ActaDiabetol37:41?46,2000
	16.StapransI,HardmanDA,PanXM,Fein-goldKR:Effectofoxidizedlipidsinthedietonoxidizedlipidlevelsinpostpran-dialserumchylomicronsofdiabeticpa-tients.DiabetesCare22:300?306,1999
	17.TerSteegeJCA,Koster-KamphuisL,VanStraatenE,ForgetP,BuurmanWA:Nitro-tyrosineinplasmaofceliacdiseasepa-tientsasdetectedbyanewsandwichELISA.FreeRadicalBiolMed25:953?963,1998
	18.SokolovskyM,RiordanJF,ValleBL:Tet-ranitromethane:areagentforthenitra-tionoftyrosilresiduesinproteins.Biochemistry5:3582?3589,1966
	19.SecchiC,BerriniA,BorromeoV:Anen-zyme-linkedimmunosorbentassayforthedeterminationofbovineprolactininplasma.JImmunolMethods136:17?22,1991
	20.AltmanDG:Clinicaltrials.InPracticalStatisticsforMedicalResearch.AltmanDG,Ed.London,Chapman&Hall,1991,p.440?476
	21.LyallF,GibsonJL,GreerIA,BrocmanDE,EisALW,MyattL:Increasednitrotyrosineinthediabeticplacenta:evidenceforoxi-dativestress.DiabetesCare21:1753?1758,1998
	22.ThuraisinghamRC,NottCA,DoddSM,YaqoobMM:Increasednitrotyrosinestaininginkidneysfrompatientswithdi-abeticnephropathy.KidneyInt57:1968?1972,2000
	23.PennathurS,WagnerJD,LeeuwenburghC,LitwakKN,HeineckeJW:Ahydroxylradical-likespeciesoxidizescynomolgusmonkeyarterywallproteinsinearlydia-Mealsandnitrotyrosineindiabetesbeticvasculardisease.JClinInvest107:853?860,2001
	24.CerielloA,QuagliaroL,D?AmicoM,DiFilippoC,MartellaR,NappoF,BerrinoL,RossiF,GiuglianoD:Acutehyperglyce-miainducesnitrotyrosineformationandapoptosisinperfusedheartfromrat.Dia-betes51:1076?1082,2002
	25.GrootPH,vanStiphoutWA,KraussXH,JansenH,vanTolA,vanRamshorstE,Chin-OnS,HofmanA,CresswellSR,HavekesL:Postprandiallipoproteinme-tabolisminnormolipidemicmenwithandwithoutcoronaryarterydisease.Ar-teriosclerThromb11:653?662,1991
	26.PatschJR,HopferwieserT,MiesenboeckG,MuehlbergerV,KnappE,DunnJK,GottoAMJr,PatschW:Therelationshipoftriglyceridemetabolismandcoronaryarterydisease:studiesinthepostprandialstate.ArteriosclerThromb12:1336?1345,1992
	27.TenoS,UtoY,NagashimaH,EndohY,IwamotoY,OmoriY,TakizawaT:Asso-ciationofpostprandialhypertriglyceride-miaandcarotidintima-mediathicknessinpatientswithtype2diabetes.DiabetesCare23:1401?1406,2000
	28.BonoraE,MuggeoM:PostprandialbloodglucoseasariskfactorforcardiovasculardiseaseintypeIIdiabetes:theepidemio-logicalevidence.Diabetologia44:2107?2114,2001
	29.MorielP,AbdallaDS:Nitrotyrosineboundtobeta-VLDL-apoproteins:abio-markerofperoxynitriteformationinexperimentalatherosclerosis.BiochemBiophysResCommun232:332?335,1997
	30.VanderVlietA,SmithD,O?NeillCA,KaurH,Darley-UsmarV,CrossCE,Hal-liwellH:Interactionsofperoxynitritewithhumanplasmaanditsconstituents:oxidativedamageandantioxidantdeple-tion.BiochemJ303:295?301,1994
	31.MacMillan-CrowLA,CrowJP,Thomp-sonJA:Peroxynitrite-mediatedinactiva-tionofmanganesesuperoxidedismutaseinvolvesnitrationandoxidationofcriticaltyrosineresidues.Biochemistry37:1613?1622,1998
	32.BeckmanJS,BeckmanTW,ChenJ,Mar-shallPA,FreemanBA:Apparenthydroxylradicalproductionbyperoxynitrite:im-plicationsforendothelialinjuryfromni-tricoxideandsuperoxide.ProcNatlAcadSciUSA87:1620?1624,1990
	33.FrustaciA,KajsturaJ,CimentiC,Jako-niukI,LeriA,MaseriA,Nadal-GinardB,AnversaP:Myocardialcelldeathinhu-mandiabetes.CircRes87:1123?1132,2000
	34.KajsturaJ,FiordalisoF,AndreoliAM,LiB,CimentiS,MedowMS,LimanaF,Nadal-GinardB,LeriA,AnversaP:IGF-1overexpressioninhibitsthedevelopmentofdiabeticcardiomyopathyandangioten-sinII-mediatedoxidativestress.Diabetes50:1414?1424,2001
	35.MihmMJ,JingL,BauerJA:Nitrotyrosinecausesselectivevascularendothelialdys-functionandDNAdamage.JCardiovascPharmacol36:182?187,2000
	36.BeckmannJS,YeYZ,AndersonPG,ChenJ,AccavittiMA,TarpeyMM,WhiteCR:Extensivenitrationofproteintyrosinesinhumanatherosclerosisdetectedbyimmu-nohistochemistry.BiolChem375:81?88,1994
31.pdf	29
	1.HirschfieldRM:EfficacyofSSRIsandnewerantidepressantsinseveredepression:comparisonwithTCAs.JClinPsychiatry1999;60:326?335
	2.SettleEC:Antidepressantdrugs:disturbingandpotentiallydangerousadverseeffects.JClinPsychiatry1998;59(suppl16):25?30
	3.GarattiniS,BarbuiC,SaracenoB:Antidepressantagents:fromtricyclicstoserotoninuptakeinhibitors.PsycholMed1998;28:1169?1178
	4.KunyS,StassenHH:Cognitiveperformanceinpatientsrecov-eringfromdepression.Psychopathology1995;28:190?207
	5.AllainH,LieuryA,Brunet-BourginF,etal:Antidepressantsandcognition:comparativeeffectsofmoclobemide,viloxazineandmaprotiline.Psychopharmacology(Berl)1992;106:S56?S61
	6.ColeJO,BranconnierR,SolomonM,etal:Tricyclicuseinthecognitivelyimpairedelderly.JClinPsychiatry1983;44:14?19
	7.AndersonIM,TomensonBM:Theefficacyofselectiveserotoninre-uptakeinhibitorsindepression:ameta-analysisofstudiesagainsttricyclicantidepressants.JPsychopharmacol1994;8:238?249
	8.PerryPJ:Pharmacotherapyformajordepressionwithmelancholicfeatures:relativeefficacyoftricyclicversusselectiveserotoninreuptakeinhibitorantidepressants.JAffectDisord1996;39:1?6
	9.OxmanTE:Antidepressantsandcognitiveimpairmentintheel-derly.JClinPsychiatry1996;57(suppl5):38?44
	10.vanLaarMW,vanWilligenburgAPP,VolkertsER:Acuteandsubchroniceffectsofnefazodoneandimipramineonhighwaydriving,cognitivefunctions,anddaytimesleepinessinhealthyadultandelderlysubjects.JClinPsychopharmacol1995;15:30?40
	11.GraySL,LaiKV,LarsonEB:Drug-inducedcognitiondisordersintheelderly.DrugSaf1999;21:101?122
	12.MooreAR,O?KeeffeST:Drug-inducedcognitiveimpairmentintheelderly.DrugsAging1999;15:15?28
	13.LyketsosCG,ChenL,AnthonyJC:Cognitivedeclineinadult-hood:an11.5yearfollow-upoftheBaltimoreEpidemiologicCatchmentAreaStudy.AmJPsychiatry1999;156:58?65
	14.FolsteinM,AnthonyJC,ParhadI,etal:Themeaningofcognitiveimpairmentintheelderly.JAmGeriatrSoc1985;33:228?235
	15.BleeckerML,Bolla-WilsonK,KawasC,etal:Age-specificnormsfortheMini-MentalStateExam.Neurology1988;38:1565?1568
	16.CrumRM,AnthonyJC,BassettSS,etal:Population-basednormsfortheMini-MentalStateExaminationbyageandeducationallevel.JAMA1993;269:2386?2391
	17.TangalosEG,SmithGE,IvnikRJ,etal:TheMini-MentalStateExaminationingeneralmedicalpractice:clinicalutilityandac-ceptance.MayoClinProc1996;71:829?837
	18.TombaughTN,McIntryreNJ:TheMini-MentalStateExamina-tion:acomprehensivereview.JAmGeriatrSoc1992;40:922?935
	19.U.S.DepartmentofCommerce,BureauoftheCensus:CurrentPopulationSurvey(CPS).Washington,DC,USGovernmentPrintingOffice,1997
	20.LeHouezecJ,BenowitzNL:Basicandclinicalpsychopharma-cologyofnicotine.ClinChestMed1991;12:681?699
	21.RezvaniAH,LevinED:Cognitiveeffectsofnicotine.BiolPsy-chiatry2001;49:258?267
	22.LaunerLJ,FeskensEJ,KalmijnS,etal:Smoking,drinkingandthinking.TheZutphenElderlyStudy.AmJEpidemiol1996;143:219?227
	23.LeiboviciD,RitchieK,LedesertB,etal:Theeffectsofwineandtobaccoconsumptiononcognitiveperformanceintheel-derly:alongitudinalstudyofrelativerisk.IntJEpidemiol1999;28:77?81
	24.SpilichCJ,JuneL,RennerJ:Cigarettesmokingandcognitiveperformance.BrJAddict1992;87:1313?1326
	25.BarefootJC,SchrollM:Symptomsofdepression,acutemyocar-dialinfarction,andtotalmortalityinacommunitysample.Cir-culation1996;93:1976?1980
	26.PenninxBW,GeerlingsSW,DeegDJ,etal:Minorandmajordepressionandtheriskofdeathinolderpersons.ArchGenPsy-chiatry1999;56:889?895
	27.DavidsonJR,Meltzer-BrodySE:Theunderrecognitionandunder-treatmentofdepression:whatisthebreadthanddepthoftheprob-lem?JClinPsychiatry1999;60(suppl7):4?9
	28.HirschfeldRM,KellerMB,PanicoS,etal:TheNationalDepres-siveandManic-DepressiveAssociationconsensusstatementontheundertreatmentofdepression.JAMA1997;277:333?340
	29.FoyA,O?ConnellD,HenryD,etal:Benzodiazepineuseasacauseofcognitiveimpairmentinelderlyhospitalinpatients.JGer-ontolABiolSciMedSci1995;50:M99?M106
tjp0540-0237.pdf	59
	B??????, K. J. (1978). Typical sympathetic noradrenergic endings ina muscle spindle of the cat. Journal of Physiology285, 61?62P.
	B?????, D. & S????, M. (1981). Autonomic innervation of receptorsand muscle fibres in cat skeletal muscle. Proceedings of the RoyalSociety B212, 317?332.
	B?????, D. & S???, H. (1987). Adrenergic innervation of rat jawmuscles. Journal of Physiology391, 114P.
	B???, I. A. (1985). Intrafusal muscle fibres in the cat and their motorcontrol. In Feedback and Motor Control in Invertebrates andVertebrates, ed. B?????, W. J. P. & G??????, M. H., pp. 123?144.Croom Helm, London.
	C??????, C. & S????, R. B. (1986). Amplitude modulation of thesoleus H-reflex in the human during walking and standing. Journalof Neuroscience6, 1308?1313.
	C??????, C. & S????, R. B. (1987). Difference in the amplitude ofthe human soleus H reflex during walking and running. Journal ofPhysiology392, 513?522.
	C????????, J. E., B??????, R. B. & P????????, G. G. (1998). Theeffects of muscle fatigue on shoulder joint position sense.American Journal of Sports Medicine26, 262?265.
	C???, F. W. J., L??, R. W. H. & T?????, A. (1972). A functionalanalysis of the components of the mesencephalic nucleus of thefifth nerve in the cat. Journal of Physiology226, 249?261.
	D???????, R. A. (1992). Skeletal muscle tone and the misunderstoodstretch reflex. Neurology42, 951?963.
	D????, F., R?????, S., G?????, C., U???????, R., M??????, G. &P????????, M. (1996). Sympathetically-induced changes inmicrovascular cerebral blood and in the morphology of its low-frequency waves. Journal of the Autonomic Nervous System59,66?74.
	D????, V. (1992). Human neuronal control of automatic functionalmovements: interaction between central programs and afferentinput. Physiological Reviews72, 33?69.246S. Roatta and othersJ. Physiol.540.1
	E?????, E., S??????????, H. N. & B???????, J. (1960). Responseof muscle spindles to simulation of the sympathetic trunk.Experimental Neurology2, 13?25.
	F?????, M. (2000). Effects of chlorobutanol on primary andsecondary endings of isolated cat muscle spindles. Brain Research854, 106?121.
	F?????, B. (1952). Impulse frequency in sympathetic vasomotorfibres correlated to the release and elimination of the transmitter.Acta Physiologica Scandinavica 25, 49?76.
	F???????, F., P??????, P., P????,L. & S????????, G. (1978). Effectsof sympathetic catecholamines (adrenaline and noradrenaline)injected intra arterially and of ischemia on the tonic vibrationreflex (TVR) of the ankle extensor muscle in decerebrate cat .Bollettino della Societï¿½ Italiana di Biologia Sperimentale54,1357?1359.
	G???????, S. C. & B????, D. (1992). Does the nervous systemdepend on kinaesthetic information to control natural limbmovements? Behavioural Brain Sciences15, 614?632.
	G??????, M. H. (1976). Structural features relative to the functionof intrafusal muscle fibres in the cat. Progress in Brain Research44,51?59.
	G?????, C., D????, F., A??????, E. & P????????, M. (1993a).Modulation of the jaw jerk reflex by the sympathetic nervoussystem. Archives Italiennes de Biologie131, 213?226.
	G?????, C., D????, F. & P????????, M. (1993b). Effect ofsympathetic nervous system activation on the tonic vibrationreflex in rabbit jaw closing muscles. Journal of Physiology469,601?613.
	G?????, C., D????, F., R?????, S., S?????????, R., A?????, G. B. &P????????, M. (1996). Sympathetic control of skeletal musclefunction: possible co-operation between noradrenaline andneuropeptide Y in rabbit jaw muscles. Neuroscience Letters212,204?208.
	H????????, F., T???????, J., R?????, S., L?????????????, M.,P????????, M. & J????????, H. (2001). Discharge responses ofmuscle spindles to stimulation of the cervical sympathetic nerve incat neck muscles. XXXIV International Congress of PhysiologicalSciences (IUPS), Aug 26?31 2001, Christchurch, New Zealand.
	H???, J. C. & R????, W. Z. (1981). Neural control of muscle lengthand tension. In Handbook of Physiology, section1, The NervousSystem, vol. II, Motor Control, ed. B????????, J. M.,M??????????, V. B., B?????, V. B. & G?????, S.R., pp. 257?324,American Phsysiological Society, Bethesda, MD, USA.
	H???, C. C. (1960). The effect of sympathetic stimulation onmammalian muscle spindle. Journal of Physiology151, 332?341.
	H???, C. C., J???, L. & L??????, Y. (1982). Effects of stimulatingthe lumbar sympathetic trunk on cat hindlimb muscle spindles.Archives Italiennes de Biologie120, 371?384.
	I????, H., M???????, T. & K???????, Y. (1981). Responsecharacteristics and classification of muscle spindles of the massetermuscle in the cat. Experimental Neurology74, 548?560.
	L??????, J. R. & D?Z??, P. A. (2000). Aspects of body self-calibration. Trends in Cognitive Sciences4, 279?288.
	L??????, E. S. & G???????, L. J. (1981). Neural mechanisms ofmandibular control: mastication and voluntary biting. InHandbook of Physiology, section1, The Nervous System, vol. II,Motor Control, ed. B????????, J. M., M??????????, V. B.,B?????, V. B. & G?????, S.R., pp. 1237?1274. AmericanPhysiological Society, Bethesda, MD, USA.
	M????, E., B????????, R. & D?????, C. (1966). Eye muscleproprioception and the semilunar ganglion. ExperimentalNeurology16, 226?236.
	M??????, M., E??????, U., B????????, J. & M????????, S. (1991).Protective role of sympathetic nerve activity to exercising skeletalmuscle in the regulation of capillary pressure and fluid filtration.Acta Physiologica Scandinavica141, 351?361.
	M?????, Y., M???????, T., H?????, O., K???, T., M?????, R.,I????, T., K????????, M. & T?????, A. (1997). Modulation ofjaw muscle spindle discharge during mastication in the rabbit.Journal of Neurophysiology77, 2227?2231.
	M?????, R., I??????, A., N?????, T. & M???????, T. (1995).Inhibitory effect of sympathetic stimulation on activities ofmasseter muscle spindles and the jaw jerk reflex in rats. Journal ofPhysiology483, 239?250.
	M???????, P. B. C. (1972). Mammalian Muscle Receptors and theirCentral Actions. Edward Arnold, London.
	M???????, T., I????, H. & K???????, Y. (1982). Diameter spectraof sensory and motor fibers in nerves to jaw-closing and jaw-opening muscles in the cat. Japanese Journal of Physiology32,171?182.
	N??????, L. M. (1976). Adapting reflexes controlling the humanposture. Experimental Brain Research26, 59?72.
	P????????, M., D????, F., G?????, C. & R?????, S. (1996a). Acomparative study of changes operated by sympathetic nervoussystem activation on spindle afferent discharge and on tonicvibration reflex in rabbit jaw muscles. Journal of the AutonomicNervous System57, 163?167.
	P????????, M., D????, F., R?????, S., G?????, C. & M??????, G.(1996b). Effects of cervical sympathetic nerve stimulation on thecerebral microcirculation: possible clinical implications. ActaNeurobiologiae Experimentalis56, 117?127.
	P????????, M., G?????, C. & F??????, G. M. (1985). Sympathetically-induced development of tension in jaw muscles: the possiblecontraction of intrafusal muscle fibres. Pflï¿½gers Archiv405,297?304.
	P????????, M., L?????, M. L., F??????, G. M., M????, E. &B????????, R. (1983). Localization of neurons innervatingmasticatory muscle spindle and periodontal receptors in themesencephalic trigeminal nucleus and their reflex actions. ArchivesItaliennes de Biologie121, 117?130.
	P????????, M., R?????, S., D????, F. & G?????, C. (1997).Sympathetic nervous system activation reduces muscle spindlesensitivity to ramp stretch, in rabbit jaw muscle. XXXIIIInternational Congress of Physiological Sciences, St Petersburg,P70.06.
	P??????, K. G. (1993). Common principles of motor control invertebrates and invertebrates. Annual Review of Neuroscience16,265?297.
	P???????, J., L???, J., H????????, F., D???????????, M. &J????????, H. (1999). Localized muscle fatigue decreases theacuity of the movement sense in the human shoulder. Medicineand Science in Sports and Exercise31, 1047?1052.
	P????????, A. (1989). Sensorimotor gain control: a basic strategy ofmotor systems? Progress in Neurobiology33, 281?307.
	P????????, A. (1996). Proprioceptive feedback and movementregulation. In Handbook of Physiology, section12, Exercise:Regulation and Integration of Multiple Systems, ed. R?????, L. &S??????, J. T., pp. 89?127. Oxford University Press, New York.
	P?????, U. & C???, R. W. (1995). The sensitivity of mammalianmuscle spindles to neuromuscular blocking agents. In Alpha andGamma Motor Systems, ed. T?????, A., G??????, M. H. &D??????, R., pp. 261?266. Plenum Press, New York and London.J. Physiol.Sympathetic modulation of spindle sensitivity540.1247
	R???, P. M. H. (1981). Limitations of somatosensory feedback incontrol of posture and movement. In Handbook of Physiology,section 1,The Nervous System, vol. II, Motor Control,ed.B????????, J. M., M??????????, V. B., B?????, V. B. &G?????, S.R., pp. 229?256. American Physiological Society,Bethesda, MD, USA.
	R?????, D., M????, B., S??????, L., D????, I. & L???????, U.(2000). Surface EMG and psychophysiological stress reactions inwomen during repetitive work. European Journal of AppliedPhysiology83, 215?222.
	R?????, S., D????, F., A??????, E. & P????????, M. (1996). Asimple, non-invasive and inexpensive method for evaluating thedisplacement of local tissue surfaces: from vascular changes tomuscle contraction. Clinical Physiology16, 83?94.
	R??????, A. (1898). On the minute anatomy of the neuromuscularspindles of the cat, and on their physiological significance. Journalof Physiology23, 190?208.
	S??????, M. & I????, Y. (1971). The fine structure of thinunmyelinated axons within muscle spindles. Brain Research33,289?302.
	S??????????, R. J. & K???????, J. (1990). The movement disorderof reflex sympathetic dystrophy. Neurology40, 57?61.
	S????, D. R. & V?????, R. G. (1991). Regulation of musclesympathetic nerve activity during exercise in humans. Exercise andSport Sciences Reviews19, 313?349.
	S?????, M. H. & M????, T. S. (1993). Position sense at the elbowafter fatiguing contractions. Experimental Brain Research94,179?182.
	S???????, G., L???????, U. & K???????, R. (2000). The role ofmuscle activity and mental load in the development of pain anddegenerative processes at the muscle cell level during computerwork. European Journal of Applied Physiology83, 99?105.
	S??????, H. B., W????, M. P., H??????, J. A., C?????, D. W. &B??????, R. L. (1986). Effect of fatigue on joint position sense ofthe knee. Journal of Orthopedic Research4, 112?118.
	S????, R. D., M????????, H. Q. & N?????, W. T. (1968). Directprojections from the masseteric nerve to the mesencephalicnucleus. Journal of Comparative Neurology133, 495?502.
	T?????, A., D??????, R. & R??????, J. F. (1992a). Theclassification of afferents from muscle spindles of the jaw-closingmuscles of the cat. Journal of Physiology456, 609?628.
	T?????, A., R??????, J. F., F????, A. J. & D??????, R. (1992b). Theeffect of succinylcholine on cat gastrocnemius muscle spindleafferents of different types. Journal of Physiology456, 629?644.
	T???????, J., H????????, F., L?????????????, M., R?????, S.,J????????, H. & P????????, M. (2000). The influence of cervicalsympathetic nerve stimulation on muscle spindles in dorsal neckmuscles in the cat. Forum of European Neuroscience (FENS), June24?28, Brighton, UK.
	W???????, M. (2000). Human muscle activity related to non-biomechanical factors in the workplace. European Journal ofApplied Physiology83, 151?158.
686.full.pdf	51
	1.Yamamoto,S.,Yamamoto,T.,Tokunaga,T.(2000)ThediscoveryofimmunostimulatoryDNAsequence.SpringerSemin.Immunopathol.22,11?19.
	2.Pisetsky,D.S.,Reich,C.,Crowley,S.D.,Halpern,M.D.(1995)Immu-nologicalpropertiesofbacterialDNA.Ann.N.Y.Acad.Sci.772,152?163.
	3.Krieg,A.M.(1996)AninnateimmunedefensemechanismbasedontherecognitionofCpGmotifsinmicrobialDNA.J.Lab.Clin.Med.128,128?133.
	4.Lipford,G.B.,Heeg,K.,Wagner,H.(1998)BacterialDNAasimmunecellactivator.TrendsMicrobiol.6,496?500.
	5.Klinman,D.M.,Verthelyi,D.,Takeshita,F.,Ishii,K.J.(1999)ImmunerecognitionofforeignDNA:acureforbioterrorism.Immunity11,123?129.
	6.Wloch,M.K.,Pasquini,S.,Ertl,H.C.,Pisetsky,D.S.(1998)TheinfluenceofDNAsequenceontheimmunostimulatorypropertiesofplas-midDNAvectors.Hum.GeneTher.9,1439?1447.
	7.Pisetsky,D.S.,Reich,C.F.(2000)InhibitionofmurinemacrophageIL-12productionbynaturalandsyntheticDNA.Clin.Immunol.96,198?204.
	8.Krieg,A.M.,Wu,T.,Weeratna,R.,Efler,S.M.,Love-Homan,L.,Yang,L.,Yi,A.K.,Short,D.,Davis,H.L.(1998)SequencemotifsinadenoviralDNAblockimmuneactivationbystimulatoryCpGmotifs.Proc.Natl.Acad.Sci.USA95,12631?12636.
	9.Chen,Y.,Lenert,P.,Weeratna,R.,McCluskie,M.,Wu,T.,Davis,H.L.,Krieg,A.M.(2001)IdentificationofmethylatedCpGmotifsasinhibitorsoftheimmunestimulatoryCpGmotifs.GeneTher.8,1024?1032.
	10.Nathan,C.(1992)Nitricoxideasasecretoryproductofmammaliancells.FASEBJ.6,3051?3064.
	11.Weinberg,J.B.(1998)Nitricoxideproductionandnitricoxidesynthasetype2expressionbyhumanmononuclearphagocytes:areview.Mol.Med.4,557?591.
	12.Ma,X.,Aste-Amezaga,M.,Trinchieri,G.(1996)Regulationofinterleu-kin-12production.Ann.N.Y.Acad.Sci.795,13?25.
	13.MacMicking,J.,Xie,Q.W.,Nathan,C.(1997)Nitricoxideandmacro-phagefunction.Annu.Rev.Immunol.15,323?350.
	14.Stacey,K.J.,Sweet,M.J.,Hume,D.A.(1996)MacrophagesingestandareactivatedbybacterialDNA.J.Immunol.157,2116?2122.
	15.Gao,J.J.,Zuvanich,E.G.,Xue,Q.,Horn,D.L.,Silverstein,R.,Morrison,D.C.(1999)Cuttingedge:bacterialDNAandLPSactinsynergyininducingnitricoxideproductioninRAW264.7macrophages.J.Immunol.163,4095?4099.
	16.Chace,J.H.,Hooker,N.A.,Mildenstein,K.L.,Krieg,A.M.,Cowdery,J.S.(1997)BacterialDNA-inducedNKcellIFN-gammaproductionisdependentonmacrophagesecretionofIL-12.Clin.Immunol.Immuno-pathol.84,185?193.
	17.Pisetsky,D.S.(2000)MechanismsofimmunestimulationbybacterialDNA.SpringerSemin.Immunopathol.22,21?33.
	18.Mosmann,T.(1983)Rapidcolorimetricassayforcellulargrowthandsurvival:applicationtoproliferationandcytotoxicityassays.J.Immunol.Methods65,55?63.
	19.Green,L.C.,Wagner,D.A.,Glogowski,J.,Skipper,P.L.,Wishnok,J.S.,Tannenbaum,S.R.(1982)Analysisofnitrate,nitrite,and[15N]nitrateinbiologicalfluids.Anal.Biochem.126,131?138.
	20.Matsukura,M.,Zon,G.,Shinozuka,K.,Stein,C.A.,Mitsuya,H.,Cohen,J.S.,Broder,S.(1988)Synthesisofphosphorothioateanaloguesofligode-oxyribonucleotidesandtheirantiviralactivityagainsthumanimmunode-ficiencyvirus(HIV).Gene72,343?347.
	21.Stein,C.A.,Subasinghe,C.,Shinozuka,K.,Cohen,J.S.(1988)Physico-chemicalpropertiesofphosphorothioateoligodeoxynucleotides.NucleicAcidsRes.16,3209?3221.
	22.Halpern,M.D.,Pisetsky,D.S.(1995)InvitroinhibitionofmurineIFNgammaproductionbyphosphorothioatedeoxyguanosineoligomers.Immu-nopharmacology29,47?52.
	23.Krieg,A.M.,Yi,A.K.,Matson,S.,Waldschmidt,T.J.,Bishop,G.A.,Teasdale,R.,Koretzky,G.A.,Klinman,D.M.(1995)CpGmotifsinbacterialDNAtriggerdirectB-cellactivation.Nature374,546?549.
	24.Manzel,L.,Macfarlane,D.E.(1999)LackofimmunestimulationbyimmobilizedCpG-oligodeoxynucleotide.AntisenseNucleicAcidDrugDev.9,459?464.
	25.Tapping,R.I.,Gegner,J.A.,Kravchenko,V.V.,Tobias,P.S.(1998)RolesforLBPandsolubleCD14incellularuptakeofLPS.Prog.Clin.Biol.Res.397,73?78.
	26.Sweet,M.J.,Hume,D.A.(1996)Endotoxinsignaltransductioninmacrophages.J.Leukoc.Biol.60,8?26.
	27.Yi,A.K.,Krieg,A.M.(1998)Rapidinductionofmitogen-activatedproteinkinasesbyimmunestimulatoryCpGDNA.J.Immunol.161,4493?4497.
	28.Hacker,H.,Mischak,H.,Miethke,T.,Liptay,S.,Schmid,R.,Sparwasser,T.,Heeg,K.,Lipford,G.B.,Wagner,H.(1998)CpG-DNA-specificactivationofantigen-presentingcellsrequiresstresskinaseactivityandisprecededbynon-specificendocytosisandendosomalmaturation.EMBOJ.17,6230?6240.
	29.Pisetsky,D.S.,ReichIII,C.F.(1998)Theinfluenceofbasesequenceontheimmunologicalpropertiesofdefinedoligonucleotides.Immunophar-macology40,199?208.
	30.Campbell,J.M.,Bacon,T.A.,Wickstrom,E.(1990)Oligodeoxynucleo-sidephosphorothioatestabilityinsubcellularextracts,culturemedia,seraandcerebrospinalfluid.J.Biochem.Biophys.Methods20,259?267.
	31.Stein,C.A.,Cheng,Y.C.(1993)Antisenseoligonucleotidesastherapeu-ticagents?isthebulletreallymagical?Science261,1004?1012.
	32.Yamamoto,T.,Yamamoto,S.,Kataoka,T.,Tokunaga,T.(1994)Abilityofoligonucleotideswithcertainpalindromestoinduceinterferonproductionandaugmentnaturalkillercellactivityisassociatedwiththeirbaselength.AntisenseRes.Dev.4,119?122.
	33.Sester,D.P.,Naik,S.,Beasley,S.J.,Hume,D.A.,Stacey,K.J.(2000)Phosphorothioatebackbonemodificationmodulatesmacrophageactiva-tionbyCpGDNA.J.Immunol.165,4165?4173.
	34.Dziarski,R.,Tapping,R.I.,Tobias,P.S.(1998)BindingofbacterialpeptidoglycantoCD14.J.Biol.Chem.273,8680?8690.
	35.Pisetsky,D.S.,Reich,C.(1993)Stimulationofinvitroproliferationofmurinelymphocytesbysyntheticoligodeoxynucleotides.Mol.Biol.Rep.18,217?221.
	36.Poltorak,A.,He,X.,Smirnova,I.,Liu,M.Y.,Huffel,C.V.,Du,X.,Birdwell,D.,Alejos,E.,Silva,M.,Galanos,C.,Freudenberg,M.,Ric-ciardi-Castagnoli,P.,Layton,B.,Beutler,B.(1998)DefectiveLPSsig-nalinginC3H/HeJandC57BL/10ScCrmice:mutationsinTlr4gene.Science282,2085?2088.
	37.Hemmi,H.,Takeuchi,O.,Kawai,T.,Kaisho,T.,Sato,S.,Sanjo,H.,Matsumoto,M.,Hoshino,K.,Wagner,H.,Takeda,K.,Akira,S.(2000)AToll-likereceptorrecognizesbacterialDNA.Nature408,740?745.
	38.Chu,W.,Gong,X.,Li,Z.,Takabayashi,K.,Ouyang,H.,Chen,Y.,Lois,A.,Chen,D.J.,Li,G.C.,Karin,M.,Raz,E.(2000)DNA-PKcsisrequiredforactivationofinnateimmunitybyimmunostimulatoryDNA.Cell103,909?918.
	39.Medzhitov,R.(2001)CpGDNA:securitycodeforhostdefense.Nat.Immunol.2,15?16.
	40.Kimura,Y.,Sonehara,K.,Kuramoto,E.,Makino,T.,Yamamoto,S.,Yamamoto,T.,Kataoka,T.,Tokunaga,T.(1994)BindingofoligoguanylatetoscavengerreceptorsisrequiredforoligonucleotidestoaugmentNKcellactivityandinduceIFN.J.Biochem.(Tokyo)116,991?994.
	41.Sen,D.,Gilbert,W.(1988)Formationofparallelfour-strandedcomplexesbyguanine-richmotifsinDNAanditsimplicationsformeiosis.Nature334,364?366.
	42.Williamson,J.R.(1994)G-quartetstructuresintelomericDNA.Annu.Rev.Biophys.Biomol.Struct.23,703?730.
	43.Lang,R.,Hultner,L.,Lipford,G.B.,Wagner,H.,Heeg,K.(1999)Guanosine-richoligodeoxynucleotidesinduceproliferationofmacrophageprogenitorsinculturesofmurinebonemarrowcells.Eur.J.Immunol.29,3496?3506.
	44.Michel,T.,Feron,O.(1997)Nitricoxidesynthases:which,where,how,andwhy?J.Clin.Investig.100,2146?2152.
	45.Sutterwala,F.S.,Mosser,D.M.(1999)ThetamingofIL-12:suppressingtheproductionofproinflammatorycytokines.J.Leukoc.Biol.65,543?551.
	46.Bogdan,C.,Rollinghoff,M.,Diefenbach,A.(2000)Reactiveoxygenandreactivenitrogenintermediatesininnateandspecificimmunity.Curr.Opin.Immunol.12,64?76.
	47.Feng,G.J.,Goodridge,H.S.,Harnett,M.M.,Wei,X.Q.,Nikolaev,A.V.,Higson,A.P.,Liew,F.Y.(1999)Extracellularsignal-relatedkinase(ERK)andp38mitogen-activatedprotein(MAP)kinasesdifferentiallyregulatethelipopolysaccharide-mediatedinductionofinduciblenitricoxidesynthaseandIL-12inmacrophages:LeishmaniaphosphoglycanssubvertmacrophageIL-12productionbytargetingERKMAPkinase.J.Immunol.163,6403?6412.
	48.Platt,N.,daSilva,R.P.,Gordon,S.(1998)Recognizingdeath:thephagocytosisofapoptoticcells.TrendsCellBiol.8,365?372.
	49.Weinberg,J.B.,Granger,D.L.,Pisetsky,D.S.,Seldin,M.F.,Misukonis,M.A.,Mason,S.N.,Pippen,A.M.,Ruiz,P.,Wood,E.R.,Gilkeson,G.S.(1994)Theroleofnitricoxideinthepathogenesisofspontaneousmurineautoimmunedisease:increasednitricoxideproductionandnitricoxidesynthaseexpressioninMRL-lpr/lprmice,andreductionofspontaneousglomerulonephritisandarthritisbyorallyadministeredNG-monomethyl-L-arginine.J.Exp.Med.179,651?660.
	50.Connor,J.R.,Manning,P.T.,Settle,S.L.,Moore,W.M.,Jerome,G.M.,Webber,R.K.,Tjoeng,F.S.,Currie,M.G.(1995)Suppressionofadjuvant-inducedarthritisbyselectiveinhibitionofinduciblenitricoxidesynthase.Eur.J.Pharmacol.273,15?24.
	51.Klinman,D.M.,Kamstrup,S.,Verthelyi,D.,Gursel,I.,Ishii,K.J.,Takeshita,F.,Gursel,M.(2000)ActivationoftheinnateimmunesystembyCpGoligodeoxynucleotides:immunoprotectiveactivityandsafety.SpringerSemin.Immunopathol.22,173?183.
J ANIM SCI-2002-Bonnet-723-8.pdf	25
J ANIM SCI-2002-Piva-670-80.pdf	48
nihms143246.pdf	28
	Beal SL, Sheiner LB. Estimating population kinetics. CRC Critical Reviews in Biomedical Engineering1982;8:195?222.
	Brumback BA, Rice JA. Smoothing spline models for the analysis of nested and crossed samples ofcurves. Journal of the American Statistical Association 1998;93:961?976.
	Daniels MJ, Kass RE. Shrinkage estimators for covariance matrices. Biometrics 2001;57:1173?1184.[PubMed: 11764258]
	Daniels, MJ.; Pourahmadi, M. Bayesian analysis of covariance matrices and dynamic models forlongitudinal data. Department of Statistics, Iowa State University; Ames: 2001. Preprint 2001?03
	Davidian, M.; Giltinan, DM. Nonlinear Models for Repeated Measurements. New York: Chapman andHall; 1995.
	Diggle, PJ.; Liang, KY.; Zeger, SL. Analysis of Longitudinal Data. Oxford: Oxford University Press;1994.
	Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD,Sotsky SM, Watkins JT. Some conceptual and statistical issues in the analysis of longitudinalpsychiatric data. Archives of General Psychiatry 1993;50:739?750. [PubMed: 8357299]
	Heitjan DF. Nonlinear modeling of serial immunologic data: A case study. Journal of the AmericanStatistical Association 1991;86:891?898.
	Hogan JW, Laird NM. Mixture models for the joint distribution of repeated measures and event times.Statistics in Medicine 1997;16:239?257. [PubMed: 9004395]
	Laird NM, Ware JJ. Random-effects models for longitudinal data. Biometrics 1982;38:973?979.
	Lindsey, JK. Models for Repeated Measurements. Vol. 2. Oxford: Clarendon Press; 1999.
	McCullagh, P.; Nelder, JA. Generalized Linear Models. Vol. 2. Cambridge: Chapman and Hall; 1989.
	Mikulich SK, Zerbe GO, Jones RH, Crowley TJ. Relating the classical covariance adjustment techniquesof multivariate growth curve models to modern univariate mixed effects models. Biometrics1999;55:957?964. [PubMed: 11315035]
	Pothoff RF, Roy SN. A generalized multivariate analysis of variance model useful especially for growthcurve problems. Biometrika 1964;52:313?326.
	Pourahmadi M. Joint mean-covariance models with applications to longitudinal data: Unconstrainedparameterisation. Biometrika 1999;86:677?690.
	Pourahmadi M. Maximum likelihood estimation of generalized linear models for multivariate normalcovariance matrix. Biometrika 2000;87:425?435.
	Rahiala M. Random coefficient autoregressive models for longitudinal data. Biometrika 1999;86:718?722.
	Ramsay, JO.; Silverman, BW. Functional Data Analysis. New York: Springer; 1997.
	Rao CR. Some statistical methods for comparison of growth curves. Biometrics 1958;14:1?17.
	Rice JA, Silverman BW. Estimating the mean and covariance structure nonparametrically when the dataare curves. Journal of the Royal Statistical Society, Series B 1991;53:233?243.
	Scott, MA.; Handcock, MS. IEE Working Paper 13. Institute of Education and the Economy, ColumbiaUniversity; 1999. Latent curve covariance models for longitudinal data.
	Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aideddrug dosing. Computers and Biomedical Research 1972;5:441?459.
	Spiegelhalter, DJ.; Best, NG.; Carlin, BP.; Van der Linde, A. Bayesian measures of model complexityand fit. Division of Biostatistics, University of Minnesota; Minneapolis: 2001. Report 2001?013
	Tanner MA, Wong WH. The calculation of posterior distributions by data augmentation. Journal of theAmerican Statistical Association 1987;82:528?540.
	Thase ME, Greenhouse JB, Frank E, Reynolds CF III, Pilkonis PA, Hurley K, Grochocinski V, KupferDJ. Treatment of major depression with psychotherapy or psychotherapy?pharmacotherapycombinations. Archives of General Psychiatry 1997;54:1009?1015. [PubMed: 9366657]
	Verbyla AP, Cullis BR, Kenward MG, Welham SJ. The analysis of designed experiments and longitudinaldata by using smoothing splines (with discussion). Applied Statistics 1999;48:269?311.
	Vonesh EF, Carter RL. Mixed effects non-linear regression for unbalanced measures. Biometrics1992;48:1?18. [PubMed: 1581479]
	Wang Y. Smoothing spline models with correlated random errors. Journal of the American StatisticalAssociation 1998;93:341?348.
pq0202000655.pdf	45
pq0202001076.pdf	0
pq0202000878.pdf	0
5601508a.pdf	23
	AlexandrowMG,MosesHL:Transforminggrowthfactorb1inhibitsmousekeratinocyteslateinG1independentofeffectsongenetranscription.CancerRes55:3928ï¿½3932,1995
	ChiangC,SwanRZ,GrachtchoukM,etal:Essentialroleforsonichedgehogduringhairfolliclemorphogenesis.DevBiol205:1ï¿½9,1999
	DaschJR,PaceDR,WaegellW,InenagaD,EllingsworthL:MonoclonalantibodiesrecognizingTGF-b.BioactivityneutralizationandTGF-b2afï¿½nitypuriï¿½cation.JImmunol142:1536ï¿½1541,1989
	DemetriousM,BinkerC,SukhuB,TenenbaumHC,DennisJW:Fetuin/ae2-HSglycoproteinisaTGF-b-typeIIreceptormimicandcytokineantagonist.JBiolChem271:12755ï¿½12761,1996
	DicksonMC,MartinJS,CousinsFM,KulkarinAB,KarlssonSK,AkhurstRJ:DefectivehaematopoiesisandvasculogenesisinTGF-b1knockoutmice.Development121:1845ï¿½1854,1995
	FoitzikK,LndnerG,Mueller-RoeverS,etal:Controlofmurinehaircycleregression(catagen)byTGF-b1invivo.FASEBJ14:752ï¿½760,2000
	GlickAB,SpornMB,YuspaSH:AlteredregulationofTGF-bandTGF-ainprimarykeratinocytesandpapillomasexpressingv-Ha-ras.MolCarcinog4:210ï¿½219,1991
	HoodlessPA,WranaJL:MechanismandfunctionofsignalingbytheTGF-bsuperfamily.CurrTopMicrobiolImmunol228:235ï¿½272,1998
	KaartinenV,VonckenJW,ShulerC,WarburtonD,BuD,HeisterkampN,GroffenJ:AbnormallungdevelopmentandcleftpalateinmicelackingTGF-b3indicatesdefectsofepithelialï¿½mesenchymalinteraction.NatureGenet11:415ï¿½421,1995
	KligmanAM:Thehumanhaircycle.JInvestDermatol33:307ï¿½316,1959
	LetterioJJ,GeiserAG,KulkarniAB,RocheNS,SpornMB,RobertsAB:Maternalrescueoftransforminggrowthfactor-b1nullmice.Science264:1936ï¿½1938,1994
	MassagueJ:TGF-bsignaltransduction.AnnuRevBiochem67:753ï¿½791,1998
	MassagueJ,CheifetzS,LaihoM,RalphDA,WeisFM,ZentellaA:Transforminggrowthfactor-beta.CancerSurv12:81ï¿½103,1992
	MillarSE,WillertK,SalinasPC,RoelinkH,NusseR,SuumanDJ,BarshGS:WNTsignalinginthecontrolofhairgrowthandstructure.DevBiol207:133ï¿½149,1999
	OberhammerFA,PavelkaM,SharmanS,TiefenbacherR,PurchioA,BurschW,Schulte-HermannR:Inductionofapoptosisinculturedhepatocytesandinregressingliverbytransforminggrowthfactor-b1.ProcNatlAcadSciUSA89:5408ï¿½5412,1992
	OhtaS,YanagiharaK,NagataY:Mechanismofapoptoticcelldeathofhumangastriccarcinomacellsmediatedbytransforminggrowthfactorb.BiochemJ324:777ï¿½782,1994
	PausR,FoitzikK,WerkerP,Bulfone-PausS,EichmullerS:Transforminggrowthfactor-breceptortypeIandtypeIIexpressionduringhairdevelopmentandcycling.JInvestDermatol109:518ï¿½526,1997
	RobertsAB,SpornMB:Thetransforminggrowthfactor-bs.In:MBSporn,ABRobert(eds).PeptideGrowthFactorsandTheirReceptorsï¿½HandbookofExperimentalPharmacology.Heidelberg:Springer-Verlag,1990,pp419ï¿½472
	SchmidP,CoxD,BilbeG,MaierR,McMasterGK:DifferentialexpressionofTGF-b1,b2andb3genesduringmouseembryogenesis.Development111:117ï¿½130,1991
	SeibergM,MarthinussJ,StennKS:Changesinexpressionofapoptosis-associatedgenesinskinmarkearlycatagen.JInvestDermatol104:78ï¿½82,1995
	SnafordLP,OrmsbyI:Gittenburger-deGrootAC,etal:TGF-b2knockoutmicehavemultipledevelopmentaldefectsthatarenooverlappingwithotherTGF-bknockoutphenotype.Development124:2659ï¿½2670,1997
	SomaT,OgoM,SuzukiJ,TakahasiT,HibinoT:Analysisofapoptoticcelldeathinhumanhairfollicles.JInvestDermatol112:518ï¿½526,1998
	St-JacquesB,DassuleHR,KaravanovaI,etal:Sonichedgehogsignalingisessentialforhairdevelopment.CurrBiol8:1058ï¿½1068,1998
5601506a.pdf	66
	AboussekhraA,BiggerstaffM,ShivjiMKK,etal:MammalianDNAnucleotideexcisionrepairreconstitutedwithpuriï¿½edproteincomponents.Cell80:859ï¿½868,1995
	ArlettCF,HarcourtSA,LehmannAR,StevensS,Ferguson-SmithWA,MorleyWN:Studiesofanewcaseofxerodermapigmentosum(XP3BR)fromcomplementation group G with cellular sensitivity to ionizing radiation.Carcinogenesis 1:745Â±751, 1980
	Barrett SF, Tarone RE, Moshell AN, Ganges MB, Robbins JH: The post-UVcolony-forming ability of normal Â®broblast strains and of the xerodermapigmentosum group G strain. J Invest Dermatol 76:59Â±62, 1981
	Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JHJ: Nucleotide excision repairsyndromes: xeroderma pigmentosum, Cockayne syndrome, andtrichothiodystrophy. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis ofHuman Cancer. New York: McGraw-Hill, 1998:pp 245Â±274
	Busch DB, Cleaver JE, Glaser DA: Large-scale isolation of UV-sensitive clones ofCHO cells. Somatic Cell Genet 6:407Â±418, 1980
	Cantani A, Bamonte G, Bellioni P, Tucci Bamonte M, Ceccoli D, Tacconi ML:Rare syndromes. I. Cockayne syndrome: a review of the 129 cases so farreported in the literature. Riv Eur Sci Med Farmacol 9:9Â±17, 1987
	Carreau M, Eveno E, Quilliet X, et al: Development of a new easy complementationassay for DNA repair deÂ®cient human syndromes using cloned repair genes.Carcinogenesis 16:1003Â±1009, 1995
	Cheesbrough MJ, Kinmont PDC: Xeroderma pigmentosum Â± a unique variant withneurological involvement. Br J Dermatol 99:61Â±61, 1978
	Cleaver JE: Sensitivity of excision repair in normal human, xeroderma pigmentosumvariant and Cockayne's syndrome Â®broblasts to inhibition by cytosinearabinoside. J Cell Physiol 108:163Â±173, 1981
	Cleaver JE, Charles WC, Thomas GH, McDowell ML: A deletion and an insertionin the alleles for the xeroderma pigmentosum (XPA) DNA-binding protein inmildly affected patients. Hum Mol Genet 4:1685Â±1687, 1995
	Cleaver JE, Thompson LH, Richardson AS, States JC: A summary of mutations inthe UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome,and trichothiodystrophy. Hum Mutat 14:9Â±22, 1999
	Clingen PH, Arlett CF, Cole J, et al: Correlation of UVC and UVB cytotoxicity withthe induction of speciÂ®c photoproducts in T-lymphocytes and Â®broblasts fromnormal human donors. Photochem Photobiol 61:163Â±170, 1995
	Constantinou A, Gunz D, Evans E, Lalle P, Bates PA, Wood RD, Clarkson SG:Conserved residues of human XPG protein important for nuclease activity andfunction in nucleotide excision repair. J Biol Chem 274:5637Â±5648, 1999
	Cooper PK, Nouspikel T, Clarkson SG, Leadon SA: Defective transcription-coupledrepair of oxidative base damage in Cockayne syndrome patients from XP groupG. Science 275:990Â±993, 1997
	De Laat WL, Jaspers NGJ, Hoeijmakers JHJ: Molecular mechanism of nucleotideexcision repair. Genes Dev 13:768Â±785, 1999
	Emmert S, Kobayashi N, Khan SG, Kraemer KH: The xeroderma pigmentosumgroup C gene leads to selective repair of cyclobutane pyrimidine dimers ratherthan 6Â±4 photoproducts. Proc Natl Acad Sci USA 97:2151Â±2156, 2000
	EmmertS,SchneiderTD,KhanSG,KraemerKH:ThehumanXPGgene:genearchitecture,alternativesplicingandsinglenucleotidepolymorphisms.NuclAcidsRes29:1443ï¿½1452,2001
	HamelBCK,RaamsA,Schuitema-DijkstraAR,SimonsP,VanderBurgtI,JaspersNGJ,KleijerWJ:Xerodermapigmentosumï¿½Cockaynesyndromecomplex:afurthercase.JMedGenet33:607ï¿½610,1996
	IchihashiM,FujiwaraY,UeharaY,MatsumotoA:AmildformofxerodermapigmentosumassignedtocomplementationgroupGanditsrepairheterogeneity.JInvestDermatol85:284ï¿½287,1985
	JaekenJ,KlockerH,SchwaigerH,BellmannR,Hirsch-KauffmannM,SchweigerM:ClinicalandbiochemicalstudiesinthreepatientswithsevereearlyinfantileCockaynesyndrome.HumGenet83:339ï¿½346,1989
	JohnsonRE,KondratickCM,PrakashS,PrakashL:hRAD30mutationsinthevariantformofxerodermapigmentosum[seecomments].Science285:263ï¿½265,1999
	KeijzerW,JaspersNG,AbrahamsPJ,etal:Aseventhcomplementationgroupinexcision-deï¿½cientxerodermapigmentosum.MutatRes62:183ï¿½190,1979
	KhanSG,LevyHL,LegerskiR,etal:XerodermapigmentosumgroupCsplicemutationassociatedwithautismandhypoglycinemia.JInvestDermatol111:791ï¿½796,1998
	KhanSG,MetterEJ,TaroneRE,etal:AnewxerodermapigmentosumgroupCpoly(AT)insertion/deletionpolymorphism.Carcinogenesis21:1821ï¿½1825,2000
	KlunglandA,HossM,GunzD,etal:BaseexcisionrepairofoxidativeDNAdamageactivatedbyXPGprotein.MolCell3:33ï¿½42,1999
	KnaufJA,PendergrassSH,MarroneBL,StrnisteGF,MacInnesMA,ParkMS:MultiplenuclearlocalizationsignalsinXPGnuclease.MutatResDNARepair363:67ï¿½75,1996
	KraemerKH,CoonHG,PetingaRA,BarrettSF,RaheAE,RobbinsJH:Geneticheterogeneityinxerodermapigmentosum:complementationgroupsandtheirrelationshiptoDNArepairrates.ProcNatlAcadSciUSA72:59ï¿½63,1975
	KraemerKH,SlorH:Xerodermapigmentosum.ClinDermatol3:33ï¿½69,1985
	KraemerKH,LeeMM,ScottoJ:Xerodermapigmentosum.Cutaneous,ocular,andneurologicabnormalitiesin830publishedcases.ArchDermatol123:241ï¿½250,1987
	KraemerKH,HerlynM,YuspaSH,ClarkWHJr,TownsendGK,NeisesGR,HearingVJ:ReducedDNArepairinculturedmelanocytesandnevuscellsfromapatientwithxerodermapigmentosum.ArchDermatol125:263ï¿½268,1989
	KraemerKH,LeeM-M,AndrewsAD,LambertWC:TheroleofsunlightandDNArepairinmelanomaandnonmelanomaskincancer:thexerodermapigmentosumparadigm.ArchDermatol130:1018ï¿½1021,1994
	LalleP,NouspikelT,ConstantinouA,ThorelF,ClarksonSG:ThefoundingmembersofxerodermapigmentosumgroupGproduceXPGproteinwithseverelyimpairedendonucleaseactivity.JInvestDermatol118:344ï¿½351,2002
	Le Page F, Gentil A, Sarasin A: Repair and mutagenesis survey of 8-hydroxyguaninein bacteria and human cells. Biochimie 81:147Â±153, 1999
	Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, Cooper PK:Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH,and CSB and implications for Cockayne syndrome. Cell 101:159Â±171, 2000
	Lindenbaum Y, Dickson D, Rosenbaum P, Kraemer K, Robbins I, Rapin I:Xeroderma pigmentosum/Cockayne syndrome complex: Â®rstneuropathological study and review of eight other cases. Europ J PaediatrNeurol 5:225Â±242, 2001
	MacInnes MA, Dickson JA, Hernandez RR, et al: Human ERCC5 cDNA-cosmidcomplementation for excision repair and bipartite amino acid domainsconserved with RAD proteins of Saccharomyces cerevisiae andSchizosaccharomyces pombe. Mol Cell Biol 13:6393Â±6402, 1993
	Madura K, Prakash S: Nucleotide sequence, transcript mapping, and regulation of theRAD2 gene of Saccharomyces cerevisiae. J Bacteriol 166:914Â±923, 1986
	Masutani C, Kusumoto R, Yamada A, et al: The XPV (xeroderma pigmentosumvariant) gene encodes human DNA polymerase eta. Nature 399:700Â±704, 1999
	Moriwaki SI, Stefanini M, Lehmann AR, et al: DNA repair and ultravioletmutagenesis in cells from a new patient with xeroderma pigmentosum group Gand Cockayne syndrome resemble xeroderma pigmentosum cells. J InvestDermatol 107:647Â±653, 1996
	Mu D, Hsu DS, Sancar A: Reaction mechanism of human DNA repair excisionnuclease. J Biol Chem 271:8285Â±8294, 1996
	Mudgett JS, MacInnes MA: Isolation of the functional human excision repair geneERCC5 by intercosmid recombination. Genomics 8:623Â±633, 1990
	Nagy E, Maquat LE: A rule for termination-codon position within intron-containinggenes: when nonsense affects RNA abundance. Trends Biochem Sci 23:198Â±199,1998
	Nance MA, Berry SA: Cockayne syndrome. Review of 140 cases. Am J Med Genet42:68Â±84, 1992
	Norris PG, Hawk JL, Avery JA, Giannelli F: Xeroderma pigmentosumcomplementation group G Â± report of two cases. Br J Dermatol 116:861Â±866,1987
	Nouspikel T, Clarkson SG: Mutations that disable the DNA repair gene XPG in axeroderma pigmentosum group G patient. Hum Mol Genet 3:963Â±967, 1994
	Nouspikel T, Lalle P, Leadon SA, Cooper PK, Clarkson SG: A common mutationalpattern in Cockayne syndrome patients from xeroderma pigmentosum groupG. Implications for a second XPG function. Proc Natl Acad Sci USA 94:3116Â±3121, 1997
	O'Donovan A, Wood RD: Identical defects in DNA repair in xerodermapigmentosumgroupGandrodentERCCgroup5[seecomments].Nature363:185ï¿½188,1993
	OkinakaRT,Perez-CastroAV,SenaA,etal:HeritablegeneticalterationsinaxerodermapigmentosumgroupG/Cockaynesyndromepedigree.MutatRes385:107ï¿½114,1997
	ParkMS,KnaufJA,PendergrassSH,CoulonCH,StrnisteGF,MarroneBL,MacInnesMA:Ultraviolet-inducedmovementofthehumanDNArepairprotein,XerodermapigmentosumtypeG,inthenucleus.ProcNatlAcadSciUSA93:8368ï¿½8373,1996
	Protic-SabljicM,KraemerKH:Onepyrimidinedimerinactivatesexpressionofatransfectedgeneinxerodermapigmentosumcells.ProcNatlAcadSciUSA82:6622ï¿½6626,1985
	RapinI,LindenbaumY,DicksonDW,KraemerKH,RobbinsJH:Cockaynesyndromeandxerodermapigmentosum.Neurology55:1442ï¿½1449,2000
	RichardsB,SkoletskyJ,ShuberAP,etal:MultiplexPCRampliï¿½cationfromtheCFTRgeneusingDNApreparedfrombuccalbrushes/swabs.HumMolGenet2:159ï¿½163,1993
	RobbinsJH,KraemerKH,LutznerMA,FestoffBW,CoonHG:Xerodermapigmentosum.Aninheriteddiseasewithsunsensitivity,multiplecutaneousneoplasms,andabnormalDNArepair.AnnInternMed80:221ï¿½248,1974
	RobbinsJH:Xerodermapigmentosum.DefectiveDNArepaircausesskincancerandneurodegeneration[clinicalconference].JAMA260:384ï¿½388,1988
	RungerTM,EmmertS,SchadendorfD,DiemC,EpeB,HellfritschD:AlterationsofDNArepairinmelanomacelllinesresistanttocisplatin,fotemustine,oretoposide.JInvestDermatol114:34ï¿½39,2000
	SatokataI,TanakaK,MiuraN,etal:ThreenonsensemutationsresponsibleforgroupAxerodermapigmentosum.MutatRes273:193ï¿½202,1992
	ScherlyD,NouspikelT,CorletJ,UclaC,BairochA,ClarksonSG:ComplementationoftheDNArepairdefectinxerodermapigmentosumgroupGcellsbyahumancDNArelatedtoyeastRad2.Nature363:182ï¿½185,1993
	ShiomiT,HaradaY,SaitoT,ShiomiN,OkunoY,YamaizumiM:AnERCC5genewithhomologytoyeastRAD2isinvolvedingroupGxerodermapigmentosum.MutatRes314:167ï¿½175,1994
	SlorH,BatkoS,KhanSG,etal:Clinical,cellular,andmolecularfeaturesofanIsraelixerodermapigmentosumfamilywithaframeshiftmutationintheXPCgene:sunprotectionprolongslife.JInvestDermatol115:974ï¿½980,2000
	StefaniniM,FawcettH,BottaE,NardoT,LehmannAR:Geneticanalysisoftwenty-twopatientswithCockaynesyndrome.HumGenet97:418ï¿½423,1996
	TakahashiE,ShiomiN,ShiomiT:Preciselocalizationoftheexcisionrepairgene,ERCC5,tohumanchromosome13q32.3-q33.1bydirectR-bandingï¿½uorescenceinsituhybridization.JpnJCancerRes83:1117ï¿½1119,1992
	VanSteegH,KraemerKH:XerodermapigmentosumandtheroleofUV-inducedDNAdamageinskincancer.MolMedToday5:86ï¿½94,1999
	VermeulenW,JaekenJ,JaspersNG,BootsmaD,HoeijmakersJH:XerodermapigmentosumcomplementationgroupGassociatedwithCockaynesyndrome.AmJHumGenet53:185ï¿½192,1993
	WakasugiM,ReardonJT,SancarA:Thenon-catalyticfunctionofXPGproteinhumannucleotideexcisionrepair.JBiolChem272:16030ï¿½16034,1997
	WoodRD:DNArepairineukaryotes.AnnuRevBiochem65:135ï¿½167,1996
	ZafeiriouDI,ThorelF,AndreouA,etal:XerodermapigmentosumgroupGwithsevereneurologicalinvolvementandfeaturesofCockaynesyndromeininfancy.PediatrRes49:407ï¿½412,2001
5601504a.pdf	24
	AbererE,SchmidtBL,BreierF,KinaciyanT,LugerA:Ampliï¿½cationofDNAofborreliaburgdorferiinurinesamplesofpatientswithgranulomaannulareandlichensclerosusetatrophicus.ArchDermatol135:210ï¿½212,1999
	ApostolouI,TakahamaY,BelmantC,etal:MurinenaturalkillerT(NKT)cellscontributetothegranulomatousreactioncausedbymycobacterialcell.ProcNatlAcadSciUSA96:5141ï¿½5146,1999
	BergeronA,BonayM,KambouchnerM,etal:Cytokinepatternsintuberculousandsarcoidgranulomas:correlationswithhistopathologicfeaturesofthegranulomatousresponse.JImmunol159:3034ï¿½3043,1997
	BuechnerSA,WinkelmannRK,BanksPM:Identiï¿½cationofTcellsubpopulationsingranulomaannulare.ArchDermatol119:125ï¿½128,1983
	FayyaziA,SchweyerS,EichmeyerB,HermsJ,HemmerleinB,RadzunHJ,BergerH:ExpressionofIFNgamma,coexpressionofTNFalphaandmatrixmetalloproteinasesandapoptosisofTlymphocytesandmacrophagesingranulomaannulare.ArchDermatolRes292:384ï¿½390,2000
	GeneveeC,DiuA,NieratJ,etal:Anexperimentallyvalidatedpanelofsubfamily-speciï¿½coligonucleotideprimers(Valpha1-w29/Vbeta1-w24)forthestudyofhumanTcellreceptorvariableVgenesegmentusagebypolymerasechainreaction.EurJImmunol22:1261ï¿½1269,1992
	HoganLH,WeinstockJV,SandorM:TCRspeciï¿½cityininfectioninducedgranulomas.ImmunolLett68:115ï¿½120,1999
	KammulaUS,LeeKH,RikerAI,WangE,OhnmachtGA,RosenbergSA,MarincolaFM:Functionalanalysisofantigen-speciï¿½cTlymphocytesbyserialmeasurementofgeneexpressioninperipheralbloodmononuclearcellsandtumorspecimens.JImmunol163:6867ï¿½6875,1999
	LimA,ToubertA,PannetierC,DougadosM,CharronDPK,EvenJ:SpreadofclonalTcellexpansionsinrheumatoidarthritispatients.HumImmunol48:77ï¿½83,1996
	MempelM,FlageulB,SuarezF,etal:ComparisonoftheTcellpatternsinleprousandcutaneoussarcoidgranulomas.PresenceofValpha24-invariantnaturalkillerTcellsinTcell-reactiveleprosytogetherwithahighlybiasedTcellreceptorValpharepertoire.AmJPathol157:509ï¿½523,2000
	ModlinRL,HorwitzDA,JordanRR,GebhardJF,TaylorCR,ReaTH:ImmunopathologicdemonstrationofTlymphocytesubpopulationsandinterleukin2ingranulomaannulare.PediatrDermatol2:26ï¿½32,1984a
	ModlinRL,VaccaroSA,GottliebB,etal:Granulomaannulare.Identiï¿½cationofcellsinthecutaneousinï¿½ltratebyimmunoperoxidasetechniques.ArchPatholLaboratoryMed108:379ï¿½382,1984b
	MuchenbergerS,SchopfE,SimonJC:PhototherapywithUV-A-Iforgeneralizedgranulomaannulare.ArchDermatol133:1605,1997
	MuhlbauerJE:Granulomaannulare.JAmAcadDermatol3:217ï¿½230,1980
	MusetteP,BureauJF,GachelinG,KourilskyP,BrahicM:TlymphocyterepertoireinTheiler'svirusencephalomyelitis:thenonspeciï¿½cinï¿½ltrationofthecentralnervoussystemofinfectedSJL/JmiceisassociatedwithaselectivelocalTcellexpansion.EurJImmunol25:1589ï¿½1593,1995
	O'MooreEJ,NandawniR,UthayakumarS,NayagamAT,DarleyCR:HIV-associatedgranulomaannulare(HAGA):areportofsixcases.BrJDermatol142:1054ï¿½1056,2000
	PannetierC,EvenJ,KourilskyP:Tcellrepertoirediversityandclonalexpansionsinnormalandclinicalsamples.ImmunolToday16:176ï¿½181,1995
	SchmutzJL:PUVAtherapyofgranulomaannulare.ClinExpDermatol25:451,2000
	SparrowG,AbellE:Granulomaannulareandnecrobiosislipoidicatreatedbyjetinjector.BrJDermatol93:85,1975
	SteinmanL:Afewautoreactivecellsinanautoimmuneinï¿½ltratecontrolavastpopulationofnonspeciï¿½ccells:ataleofsmartbombsandtheinfantry.ProcNatlAcadSciUSA93:2253ï¿½2256,1996
	ToroJR,ChuP,YenTS,LeBoitPE:Granulomaannulareandhumanimmunodeï¿½ciencyvirusinfection.ArchDermatol135:1341ï¿½1346,1999
	UmbertP,WinkelmannRK:Granulomaannulareandsarcoidosis.BrJDermatol97:481ï¿½486,1977
	WangXH,OhmenJD,UyemuraK,ReaTH,KronenbergM,ModlinRL:SelectionofTlymphocytesbearinglimitedTcellreceptorbetachainsintheresponsetoahumanpathogen.ProcNatlAcadSciUSA90:188ï¿½192,1993
	YamamuraM,UyemuraK,DeansRJ,WeinbergK,ReaTH,BloomBR,ModlinRL:Deï¿½ningprotectiveresponsestopathogens:cytokineproï¿½lesinleprosylesions.Science254:277ï¿½279,1991
5601501a.pdf	41
	ArribasM,RegazziR,GarciaE,WollheimCB,DeCamilliP:Thestimulatoryeffectofrabphilin3aonregulatedexocytosisfrominsulin-secretingcellsdoesnotrequireanassociationï¿½dissociationcyclewithmembranesmediatedbyRab3.EuropeanJCellBiol74:209ï¿½216,1997
	BennettDC,CooperPJ,HartIR:Alineofnon-tumorigenicmousemelanocytes,syngeneicwiththeB16melanomaandrequiringatumorpromoterforgrowth.IntJCancer39:414ï¿½418,1987
	BockJB,MaternHT,PedenAA,SchellerRH:Agenomicperspectiveonmembranecompartmentorganization.Nature409:839ï¿½841,2001
	CallaghanJ,NixonS,BucciC,TohBH,StenmarkH:DirectinteractionofEEA1withRab5b.EuropeanJBiochem265:361ï¿½366,1999
	CaseyP,SaeabraMC:Proteinprenyltransferases.JBiolChem271:5289ï¿½5292,1996
	ChenD,GuoJ,MikiT,TachibanaM,GahlWA:MolecularcloningandcharacterizationofRab27aandRab27b,novelhumanRabproteinssharedbymelanocytesandplatelets.BiochemMolMed60:27ï¿½37,1997
	ChristoforidisS,McBrideHM,BurgoyneRD,ZerialM:TheRab5effectorEEA1isacorecomponentofendosomedocking.Nature397:621ï¿½625,1999
	DiMaioD,TreismanR,ManiatisT:Bovinepapillomavirusvectorthatpropagatesasaplasmidinbothmouseandbacterialcells.ProcNatlAcadSciUSA79:4030ï¿½4034,1982
	Dekker-OhnoK,HayasakaS,TakagishiY,etal:EndoplasmicreticulumismissingindendriticspinesofPurkinjecellsoftheataxicmutantrat.BrainRes714:226ï¿½230,1996
	EchardA,JollivetF,MartinezO,LacapereJJ,RousseletA,Janoueix-LeroseyI,GoudB:InteractionofaGolgi-associatedkinesin-likeproteinwith.Rab6.Science279:580ï¿½585,1998
	GilmanM:PreparationandanalysisofRNA.In:AusubelF,BrentR,KingstonR,MooreD,SeidmanJ,SmithJ,StruhlK,eds.CurrentProtocolsinMolecularBiology,NewYork:JohnWiley&Sons,1997:pp414ï¿½452
	HaddadEK,WuX,HammerJA3rd,HenkartPA:DefectivegranuleexocytosisinRab27a-deï¿½cientlymphocytesfromAshenmice.[seecomments]..JCellBiol152:835ï¿½842,2001
	HoriuchiH,LippeR,McBrideHM,etal:AnovelRab5GDP/GTPexchangefactorcomplexedtoRabaptin-5linksnucleotideexchangetoeffectorrecruitmentandfunction.Cell90:1149ï¿½1159,1997
	HughesEN,AugustJT:Characterizationofplasmamembraneproteinsidentiï¿½edbymonoclonalantibodies.JBiolChem256:664ï¿½671,1981
	HumeA,CollinsonL,RapakA,GomesA,HopkinsC,SeabraM:Rab27aregulatestheperipheraldistributionofmelanosomesinmelanocytes.JCellBiol152:F21ï¿½F24,2001
	JimenezM,TsukamotoK,HearingVJ:Tyrosinasesfromtwodifferentlociareexpressedbynormalandbytransformedmelanocytes.JBiolChem266:1147ï¿½1156,1991
	JimbowK,ParkJS,KatoF,HirosakiK,ToyofukuK,HuaC,YamashitaT:Assembly,target-signalingandintracellulartransportoftyrosinasegenefamilyproteinsintheinitialstageofmelanosomebiogenesis.PigmentCellRes13:222ï¿½229,2000
	KobayashiT,UrabeK,OrlowSJ,etal:ThePmel17/silverlocusprotein.Characterizationandinvestigationofitsmelanogenicfunction.JBiolChem269:29198ï¿½29205,1994
	LinRC,SchellerRH:Mechanismsofsynapticvesicleexocytosis.AnnuRevCellDevBiology16:19ï¿½49,2000
	MasudaES,LuoY,YoungC,etal:Rab37isanovelmastcellspeciï¿½cGTPaselocalizedtosecretorygranules.FEBSLett470:61ï¿½64,2000
	MenascheG,PasturalE,FeldmannJ,etal:MutationsinRAB27AcauseGriscellisyndromeassociatedwithhaemophagocyticsyndrome.NatureGenet25:173ï¿½176,2000
	NielsenE,ChristoforidisS,Uttenweiler-JosephS,etal:Rabenosyn-5,anovelRab5effector,iscomplexedwithhVPS45andrecruitedtoendosomesthroughaFYVEï¿½ngerdomain.JCellBiol151:601ï¿½612,2000
	OrlowSJ:Thebiogenesisofmelanosomes.In:JamesE,NordlundJ,etal:eds.ThePigmentarySystem:PhysiologyandPathophysiology,NewYork:OxfordUniversityPress,1998:pp97ï¿½116
	PasturalE,BarratF,Dufourcq-LagelouseR,etal:Griscellidiseasemapstochromosome15q21andisassociatedwithmutationsinthemyosinVagene.NatGenet16:289ï¿½292,1997
	Pereira-LealJB,SeabraMC:ThemammalianRabfamilyofsmallGTPases:deï¿½nitionoffamilyandsubfamilysequencemotifssuggestsamechanismforfunctionalspeciï¿½cityintheRassuperfamily.JMolBiol301:1077ï¿½1087,2000
	PfefferSR:Transport-vesicletargeting:tethersbeforesnaresNatureCellBiol1:E17ï¿½E22,1999
	QuevedoWC,FitzpatrickTB,SzaboG,JimbowK:Biologyofmelanocytes.In:DermatologyinGeneralMedicine.NewYork:McGraw-Hill,1987:pp224ï¿½251
	RamalhoJ,TolmachovaT,HumeA,McGuiganA,Gregory-EvansC,HuxleyC,SeabraM:Chromosomalmapping,genestructureandcharacterizationofthehumanandmurineRAB27Bgene.BMCGenet2:2ï¿½13,2001
	RaposoG,TenzaaD,MurphybDM,BersonbJF,MarksbMS:Distinctproteinsortingandlocalizationtopremelanosomes,melanosomes,andlysosomesinpigmentedmelanocyticcells.JCellBiol152:809ï¿½824,2001
	SawadaK,KomatsuS,HagaH,OdaS,FukuiY:AbnormalexpressionoftyrosinehydroxylaseimmunoreactivityinPurkinjecellsprecedestheonsetofataxiaindilute-lethalmice.BrainRes844:188ï¿½191,1999
	TolmachovaT,RamalhoJS,AnantJS,SchultzRA,HuxleyCM,SeabraMC:Cloning,mappingandcharacterizationofthehumanRAB27Agene.Gene239:109ï¿½116,1999
	WestbroekW,LambertJ,NaeyaertJ:ThedilutelocusandGriscellisyndrome:gatewaystowardsabetterunderstandingofmelanosometransport.PigmentCellRes14:320ï¿½327,2001
	WilsonSM,YipR,SwingDA,etal:AmutationinRab27acausesthevesicletransportdefectsobservedinashenmice.ProcNatlAcadSciUSA97:7933ï¿½7938,2000
	WoodmanP:Vesicletransport:moreworkfortheRabs?CurrBiol8:R199ï¿½R201,1998
	WoodmanP:Biogenesisofthesortingendosome:theroleofRab5.Trafï¿½c9:695ï¿½701,2000
	WuWJ,EricksonJW,LinR,CerioneRA:Thegamma-subunitofthecoatomercomplexbindsCdc42tomediatetransformation.[seecomments].Nature405:800ï¿½804,2000
	WuX,BowersB,WeiQ,KocherB,HammerJAIII:MyosinVassociateswithmelanosomesinmousemelanocytes:evidencethatmyosinVisanorganellemotor.JCellSci110:847ï¿½859,1997
	WuX,BowersB,RaoK,WeiQ,HammerJA:Visualizationofmelanosomedynamicswithinwild-typeanddilutemelanocytessuggestsaparadigmformyosinVfunctioninvivo,JCellBiol143:1899ï¿½1918,1998
	WuX,RaoK,BowersM,CopelandN,JenkinsN,HammerJA:Rab27aenablesmyosinVa-dependentmelanosomecapturebyrecruitingthemyosintotheorganelle.JCellSci114:1091ï¿½1100,2001
	ZerialM,McBrideH:Rabproteinsasmembraneorganizers.NatureRevMolCellBiology2:107ï¿½117,2001
	ZhangW,EfanovA,YangSN,etal:Munc-18associateswithsyntaxinandservesasanegativeregulatorofexocytosisinthepancreaticbeta-cell.JBiolChem275:41521ï¿½41527,2000
5601499a.pdf	122
	AllavenaP,BianchiD,ZhouD,vanDammeJ,JilekP,SozzaniS,MantovaniA:Inductionofnaturalkillercellmigrationbymonocytechemoattractantprotein-1,-2and-3.EurJImmunol24:3233ï¿½3236,1994
	AnisowiczA,BardwellL,SagerR:Constitutiveoverexpressionofagrowth-regulatedgeneintransformedChinesehamsterandhumancells.ProcNatlAcadSciUSA84:7188ï¿½7192,1987
	AppayV,DunbarPR,CerundoloV,McMichaelA,CzaplewskiL,Rowland-JonesSL:RANTESactivatesantigen-speciï¿½ccytotoxicTlymphocytesinamitogen-likemannerthroughcellsurfaceaggregation.IntImmunol8:1173ï¿½1182,2000
	AppayV,Rowland-JonesSL:RANTES.aversatileandcontroversialchemokine.TrendsImmunol22:83ï¿½87,2001
	BaggioliniM,WalzA,KunkelSL:Neutrophil-activatingpeptide-1/interleukin-8,anovelcytokinethatactivatesneutrophils.JClinInvest84:1045ï¿½1049,1989
	BaggioliniM,DewaldB,MoserB:Interleukin-8andrelatedchemotacticcytokinesï¿½CXCandCCchemokines.AdvImmunol55:97ï¿½179,1994
	BalentienE,MufsonBE,ShattuckRL,DerynckR,RichmondA:EffectsofMGSA/GROalphaonmelanocytetransformation.Oncogene6:1115ï¿½1124,1991
	BalkwillF,MantovaniA:Inï¿½ammationandcancer:backtoVirchow?Lancet357:539ï¿½544,2001
	BelperioJA,KeaneMP,ArenbergDA,AddisonCL,EhlertJE,BurdickMD,StrieterRM:CXCchemokinesinangiogenesis.JLeukocBiol68:1ï¿½8,2000
	BergerEA,MurphyPM,FarberJM:ChemokinereceptorsasHIV-1coreceptors:rolesinviralentry,tropismanddisease.AnnuRevImmunol17:657ï¿½670,1999
	BonecchiR,BianchiG,BordignonPP,etal:Differentialexpressionofchemokinereceptorsandchemotacticresponsivenessoftype1Thelpercells.JExpMed187:129ï¿½134,1998
	BordoniR,FineR,MurrayD,RichmondA:CharacterizationoftheroleofmelanomagrowthstimulatingactivityMGSAinthegrowthofnormalmelanocytes,nevocytesandmalignantmelanocytes.JCellBiochem44:207ï¿½219,1990
	BoringL,GoslingJ,ChensueSW,KunkelSL,FareseRV:Severereductioninleukocyteadhesionandmonocyteextravasationinmicedeï¿½cientinCCchemokinereceptor2.ProcNatlAcadSciUSA94:12053ï¿½12058,1997
	BoringL,GoslingJ,ClearyM,CharoIF:DecreasedlesionformationinCCR2micerevealsaroleforchemokinesintheinitiationofatherosclerosis.Nature394:894ï¿½897,1998
	BottazziB,WalterS,GovoniD,ColottaF,MantovaniA:Monocytechemotacticcytokinegenetransfermodulatesmacrophageinï¿½ltration,growth,andsusceptibilitytoIL-2therapyofamurinemelanoma148:1280ï¿½1285,1992
	BrinckerhoffLH,ThompsonLW,SlingluffCLJ:Melanomavaccines.CurrOpinOncol12:163ï¿½173,2000
	BrockerEB,ZwadloG,HolzmannB,MacherE,SorgC:Inï¿½ammatorycellinï¿½ltratesinhumanmelanomaatdifferentstagesoftumorprogression.IntJCancer41:562ï¿½567,1988
	CampisiJ,GrayHE,PardeeAB,DeanM,SonensheinGE:Cell-cyclecontrolofc-mycbutnotc-rasexpressionislostfollowingchemicaltransformation.Cell36:241ï¿½247,1984
	CarrMW,RiothSJ,LutherE,RoseSS,SpringerA:Monocytechemoattractantprotein1actsasaT-lymphocytechemoattractant.ProcNatlAcadSciUSA91:3652ï¿½3656,1994
	ClarkEA,GolubTR,LanderES,HynesRO:GenomicanalysisofmetastasisrevealsanessentialroleforRhoC.Nature406:532ï¿½535,2000
	ColomboMP,MaccalliC,MatteiS,MelaniC,RadrizzaniM,ParmianiG:Expressionofcytokinegenes,includingIL-6,inhumanmalignantmelanomacelllines.MelanomaRes2:181ï¿½189,1992
	D'AmbosioD,IellemA,BonecchiR,MazzeoD,SozzaniS,MontovaniA,SinigagliaF:Selectiveup-regulationofchemokinereceptorsCCR4andCCR8uponactivationofpolarizedhumantype2Thcells.JImmunol161:5111ï¿½5115,1998
	DieuMC,VanbervlietB,VicariA,etal:Selectiverecruitmentofimmatureandmaturedendriticcellsbydistinctchemokinesexpressedindifferentanatomicsites.JExpMed188:373ï¿½386,1999
	FishmanD,IrenaB,Kellman-PressmanS,KarasM,SegalS:TheroleofMHCclassIglycoproteinsintheregulationofinductionofcelldeathinimmunocytesbymalignantmelanomacells.ProcNatlAcadSciUSA98:1740ï¿½1744,2001
	rsterE,KirnbauerR,UrbanskiA,KeckA,LugerTA,SchwartzT:Humanmelanomacellsproduceinterleukin-8whichfunctionsasanautocrinegrowthfactor.ArchDermatolRes283:26,1991
	rsterR,SchubelA,Breitï¿½eldD,KremmerE,Renner-MullerI,WolfE,LippM:CCR7coordinatestheprimaryimmatureresponsebyestablishingfunctionalmicroenvironmentsinsecondarylymphoidorgans.Cell99:23ï¿½33,1999
	FujisawaN,HayashiS,MillerEJ:Asyntheticpeptideinhibitorfora-chemokinesinhibitsthetumorgrowthandpulmonarymetastasisofhumanmelanomacellsinnudemice.MelanomaRes9:105ï¿½114,1999
	GeiserT,DewaldB,EhrengruberMU,Clark-LewisI,BaggioliniM:Theinterleukin-8-relatedchemotacticcytokinesGROalpha,GRObeta,andGROgammaactivatehumanneutrophilandbasophilleukocytes.JBiolChem268:15419ï¿½15424,1993
	GerberBO,ZanniMP,UguccioniM,etal:FunctionalexpressionoftheeotaxinreceptorCCR3inTlymphocytesco-localizingwitheosinophils.CurrBiol7:836ï¿½843,1997
	GiavazziR,GarofaloA,BaniMR,etal:Interleukin1-inducedaugmentationofexperimentalmetastasesfromahumanmelanomainnudemice.CancerRes50:4771ï¿½4775,1990
	GonzolezEB,WileyH,HwangST:CCchemokinereceptor7(CCR-7)-transducedB16melanomacellsshowenhancedearlymetastasistoregionallymphnodes.MeetSocInvestDermatol35:200,2001
	GravesDT,BarnhillR,GalanopoulosT,AntoniadesHN:Expressionofmonocytechemotacticprotein-1inhumanmelanomainvivo.AmJPathol140:9ï¿½14,1992
	GreeneMH,SandersRJ,ChuFC,ClarkWH,ElderDE,CoganDG:Thefamilialoccurrenceofcutaneousmelanoma,intraocularmelanoma,andthedysplasticnevussyndrome.AmJOpthalmol96:238ï¿½245,1983
	GruisN,SandkuijlL,WeberJ,ZeeA,BorgsteinA,BergmanW,FrantsR:LinkageanalysisinDutchfamilialatypicalmultiplemoleï¿½melanomasyndromefamilies.Effectofnaevuscount.MelanomaRes3:271ï¿½277,1993
	GutmanM,SinghRK,XieK,BucanaCD,FidlerIJ:Regulationofinterleukin-8expressioninhumanmelanomacellsbytheorganenvironment.CancerRes55:2470ï¿½2475,1995
	HadidaF,VieillardV,AutranB,Clark-LewisI,BaggioliniM,DebreP:HIV-speciï¿½cTcellcytotoxicitymediatedbyRANTESviathechemokinereceptorCCR3.JExpMed188:609ï¿½614,1998
	HalpernAC,GueryD4,ElderDE,ClarkWHJr,SynnestvedtM,NormanS,AyerleR:Dysplasticneviasriskmarkersofsporadic(nonfamilial)melanoma.ArchDermatol127:995ï¿½999,1991
	HammondMEW,ShyamalaV,SianiMA,etal:Receptorrecognitionandspeciï¿½cityofinterleukin-8isdeterminedbyresiduesthatclusternearasurface-accessiblehydrophobicpocket.JBiolChem271:8228ï¿½8235,1996
	HaskillS,PeaceA,MorrisJ,etal:Identiï¿½cationofthreerelatedhumanGROgenesencodingcytokinefunctions.ProcNatlAcadSciUSA87:7732ï¿½7736,1990
	HillibrandEF,NevilleAM,CoventryBJ:ImmunohistochemicallocalizationofCD1a-positiveputativetumorinï¿½ltratingdendriticcellsinhumanbreasttumors.BrJCancer79:940ï¿½944,1999
	HofmanUB,WestphalJR,WaasET,BeckerJC,RuiterDJ,vanMuijenGNP:Coexpressionofintegrinavb3andmatrixmetalloproteinase-2(MMP-2)coincideswithMMP-2activation:Correlationwithmelanomaprogression.JInvestDeratol115:625ï¿½632,2000
	HogaboamC,Bone-LarsonC,SteinhauserM,etal:NovelCXCR2-dependentliverregenerativequalitiesofELR-containingCXCchemokines.FASEBJ13:1565ï¿½1574,1999
	HolmesWE,LeeJ,KuangWJ,RiceGC,WoodWI:Structureandfunctionalexpressionofahumaninterleukin-8receptor.Science253:1278ï¿½1280,1991
	HomeyB,WangW,SotoH,etal:Cuttingedge:theorphanchemokinereceptorGprotein-coupledreceptor-2(GPR-2,CCR10)bindstheskin-associatedchemokineCCL27(CTAK/ALP/ILC).JImmunol164:3465ï¿½3470,2000
	HussussianC,StruewingJP,GoldsteinAM,etal:Germlinep16mutationsinfamilialmelanoma.NatGenet8:15ï¿½21,1994
	ImaiT,NagiraM,TakagiS,etal:SelectiverecruitmentofCCR4-bearingTh2cellstowardantigen-presentingcellsbytheCCchemokinesthymusandactivation-regulatedchemokineandmacrophage-derivedchemokine.IntImmunol11:81ï¿½88,1999
	KirkwoodJ,StrawdermanM,ErnstoffM,SmithT,BordenE,BlumR:Interferonalfa-2badjuvanttherapyofhigh-riskresectedcutaneousmelanoma:theEasternCooperativeOncologyGroupTrialEST1684.JClinOncol14:7ï¿½17,1996
	KulkeR,BornscheuerE,SchluterC,BartelsJ,RowertJ,SticherlingM,ChristophersE:TheCXCreceptor2isoverexpressedinpsoriaticepidermis.JInvestDermatol110:90ï¿½94,1998
	KuriharaT,WarrG,LoyJ,BravoR:DefectsinmacrophagerecruitmentandhostdefenseinmicelackingtheCCR2chemokinereceptor.JExpMed186:1757ï¿½1762,1997
	KuzielWA,MorganSJ,DawsonTC,Grifï¿½nS,SmithiesO,LeyK,MaedaN:Severereductioninleukocyteadhesionandmonocyteextravasationinmicedeï¿½cientinCCchemokinereceptor2.ProcNatlAcadSciUSA94:12053ï¿½12058,1997
	LawsonDH,ThomasHG,RoyRG,GordonDS,ChawlaRK,NixonDW,RichmondA:Preparationofamonoclonalantibodytoamelanomagrowth-stimulatoryactivityreleasedintoserum-freeculturemediumbyHs0294malignantmelanomacells.JCellBiochem34:169ï¿½185,1987
	LeeJ,HorukR,RiceGC,BennettGL,CameratoT,WoodWI:Characterizationoftwohighafï¿½nityhumaninterleukin-8receptors.JBiolChem267:16283ï¿½16287,1992
	LeeJ,CacalanoG,CameratoT,ToyK,MooreM,WoodW:ChemokinebindingandactivitiesmediatedbythemouseIL-8receptor.JImmunol155:2158ï¿½2164,1995
	LucaM,HuangS,GershenwaldJE,SinghRK,ReichR,Bar-EliM:Expressionofinterleukin-8byhumanmelanomacellsup-regulatesMMP-2activityandincreasestumorgrowthandmetastasis.AmJPathol151:1105ï¿½1113,1997
	LutherSA,CysterJG:ChemokinesasregulatorsofTcelldifferentiation.NatureImmunol2:102ï¿½107,2001
	MacDougallJR,BaniMR,MuschelRJ,KebelRS:``Proteolyticswitching''oppositepatternsofregulationofgelatinaseBanditsinhibitorTIMP-1duringhumanmelanomaprogressionandconsequencesofgelatinaseBoverexpression.BrJCancer80:504ï¿½512,1999
	MantovaniA,BottazziB,ColottaF,SozzaniS,RucoL:Theoriginandfunctionoftumor-associatedmacrophages.ImmunolToday13:265ï¿½270,1992
	MatsushimaK,MorishitaK,YoshimuraT,etal:Molecularcloningofahumanmonocyte-derivedneutrophilchemotacticfactor(MDNCF)andtheinductionofMDNCFmRNAbyinterleukin1andtumornecrosisfactor.JExpMed167:1883ï¿½1893,1988
	MohlerT,ScheibenbogenC,HafeleJ,WillhauckM,KeilholzU:Regulationofinterleukin-8mRNAexpressionandproteinsecretioninamelanomacelllinebytumornecrosisfactor-alphaandinterferon-gamma.MelanomaRes6:307ï¿½311,1996
	MooreJP,TrkolaA:HIVtype1coreceptors,neutralizationserotypes,andvaccinedevelopment.AIDSResHumRetroviruses13:733ï¿½736,1997
	MoralesJ,HomeyB,VicariAP,etal:CTAK,askin-associatedchemokinethatpreferentiallyattractsskin-homingmemoryTcells.ProcNatlAcadSciUSA96:14470ï¿½14475,1999
	MrowietzU,SchwenkU,MauneS,etal:ThechemokineRANTESissecretedbyhumanmelanomacellsandisassociatedwithenhancedtumourformationinnudemice.BrJCancer79:1025ï¿½1031,1999
	MuellerSG,SchrawWP,RichmondA:MelanomagrowthstimulatoryactivityenhancesthephosphorylationoftheclassIIinterleukin-8receptorinnon-hematopoieticcells.JBiolChem269:1973ï¿½80,1994
	MuellerSG,SchrawWP,RichmondA:ActivationofproteinkinaseCenhancesthephosphorylationofthetypeBinterleukin-8receptorandstimulatesitsdegradationinnon-hematopoieticcells.JBiolChem270:10439ï¿½10448,1995
	MuellerSG,WhiteJR,SchrawWP,LamC,RichmondA:Ligand-induceddesensitizationofthehumanCXCchemokinereceptor-2ismodulatedbymultipleserineresiduesinthecarboxyl-terminaldomainofthereceptor.JBiolChem272:8207ï¿½8214,1997
	MukaidaN:Interleukin8.Anexpandinguniversebeyondneutrophilchemotaxisandactivation.IntJHematol72:391ï¿½398,2000
	MullerA,HomeyB,SotoH,etal:Involvementofchemokinereceptorsinbreastcancermetastasis.Nature410:50ï¿½56,2001
	MurphyPM:Chemokinereceptors:structure,functionandroleinmicrobialpathogenesis.CytokineGrowthFactorRev7:47ï¿½64,1996
	MurphyPM,TiffanyHL:CloningofcomplementaryDNAencodingafunctionalhumaninterleukin-8receptor.Science253:1280ï¿½1283,1991
	NesbitM,SchaiderH,MillerTH,HerlynM:Low-levelmonocytechemoattractantprotein-1stimulationofmonocytesleadstotumorformationinnontumorigenicmelanomacells.JImmunol166:6483ï¿½6490,2001
	Newton-BishopJA,BatailleV,PinneyE,BishopDT:Familystudiesinmelanoma:identiï¿½cationofatypicalmolesyndrome.MelanomaRes4:199ï¿½206,1994
	Newton-BishopJA,WachsmuthRC,HarlandM,etal:Genotype/phenotypeandpenetrancestudiesinmelanomafamilieswithgermlineCDKN2Amutations.JInvestDermatol114:28ï¿½33,2000
	NietoM,FradeJMR,SanchoD,MelladoM,MartinezAC,Sanchez-MadridF:Polarizationofchemokinereceptorstotheleadingedgeduringlymphocytechemotaxis.JExpMed186:153ï¿½158,1997
	NorgauerJ,MetznerB,SchraufstutterI:Expressionandgrowth-promotingfunctionoftheIL-8receptorbetainhumanmelanomacells.JImmunol156:1132ï¿½1137,1996
	O'GarraA,McEvoyLM,ZlotnikA:T-cellsubsets:chemokinereceptorsguidetheway.CurrBiol8:R646ï¿½R649,1998
	OwenJD,StrieterR,BurdickM,HaghnegahdarH,NanneyL,Shattuck-BrandtR,RichmondA:Enhancedtumor-formingcapacityforimmortalizedmelanocytesexpressingmelanomagrowthstimulatoryactivity/growth-regulatedcytokinebandgproteins.IntJCancer73:94ï¿½103,1997
	PetersenF,FladH-D,BrandtE:Neutrophil-activatingpeptidesNAP-2andIL-8bindtothesamesitesonneutrophilsbutinteractindifferentways:
	Discrepanciesinbindingafï¿½nities,receptordensities,andbiologiceffects.JImmunol152:2467ï¿½2478,1994
	PlatzA,HanssonJ,RingborgU:ScreeningofgermlinemutationsintheCDK4,CDKN2CandTP53genesinfamilialmelanoma:aclinic-basedpopulationstudy.IntJCancer78:13ï¿½15,1998
	PlatzA,RingborgU,HanssonJ:Hereditarycutaneousmelanoma.CancerBiol10:319ï¿½326,2000
	RichmondA,LawsonDH,NixonDW,StevensJS,ChawlaRK:Characterizationofautostimulatoryandtransforminggrowthfactorsfromhumanmelanomacells.CancerRes45:6390ï¿½6394,1985
	RichmondA,ThomasHG:Puriï¿½cationofmelanomagrowthstimulatoryactivity.JCellPhysiol129:375ï¿½384,1986
	RichmondA,BalentienE,ThomasHG,etal:Molecularcharacterizationofmelanomagrowthstimulatoryactivity,agrowthfactorstructurallyrelatedtob-thromboglobulin.EMBOJ7:2025ï¿½2033,1988
	RomagnaniP,AnnunziatoF,LasagniL,etal:Cellcycle-dependentexpressionofCXCchemokinereceptor3byendothelialmediatesangiostaticactivity.JClinInvest107:53ï¿½63,2001
	RottmanJB,SmithTL,GanleyKG,KikuchiT,KruegerJG:PotentialroleofthechemokinereceptorsCXCR3,CCR4andintegrinalphaEbeta7inthepathogenesisofpsoriasisvulgaris.LabInvest81:335ï¿½347,2001
	SalcedoR,ResauJH,HalversonD,etal:Differentialexpressionandresponsivenessofchemokinereceptors(CXCR1-3)byhumanmicrovascularendothelialcellsandumbilicalveincells.FASEBJ14:2055ï¿½2064,2000
	SallustoF,MackayCR,LanzavecchiaA:SelectiveexpressionoftheeotaxinreceptorCCR3byhumanThelper2cells.Science277:2005,1997
	SallustoF,LenigD,MackayCR,LanzavecchiaA:FlexibleprogramsofchemokinereceptorexpressioninhumanpolarizedThelper1and2lymphocytes.JExpMed187:875ï¿½883,1998
	SallustoF,MackayCR,LanzavecchiaA:Theroleofchemokinereceptorsinprimaryeffectorandmemoryimmuneresponses.AnnuRevImmunol18:593ï¿½620,2000
	SchadendorfD,MuellerA,AlermissenB,WormM,SticherlingM,CzarnetzkiBM:IL-8producedbyhumanmalignantmelanomacellsinvitroisanessentialautocrinegrowthfactor.JImmunol151:2667ï¿½2675,1993
	SchallTJ,BaconK,ToyKJ,GoeddelDV:SelectiveattractionofmonocytesandTlymphocytesofthememoryphenotypebycytokineRANTES.NatureImmunol347:669ï¿½671,1990
	SchallTJ:BiologyoftheRANTES/SIScytokinefamily.Cytokine3:165ï¿½183,1999
	SchroderJ,ChristophersE:Secretionofnovelandhomologousneutrophil-activatingpeptidesbyLPS-stimulatedhumanendothelialcells.JImmunol142:244ï¿½251,1989
	SchroderJ,MrowietzU,MoritaE,ChristophersE:Puriï¿½cationandpartialbiochemicalcharacterizationofahumanmonocyte-derived,neutrophil-activatingpeptidethatlacksinterleukin1activity.JImmunol139:3474ï¿½3483,1987
	SchroderJM,SticherlingM,HenneickeHH,PreissnerWC,ChristophersE:IL-1aortumornecrosisfactor-astimulatereleaseofthreeNAP-1/IL-8-relatedneutrophilchemotacticproteinsinhumandermalï¿½broblasts.JImmunol144:2223ï¿½2232,1990
	SebastianiS,AllavenaP,AlbanesiC,etal:ChemokinereceptorexpressionandfunctioninCD4+Tlymphocyteswithregulatoryactivity.JImmunol166:996ï¿½1002,2001
	Shattuck-BrandtRL,RichmondA:EnhanceddegradationofIkBcontributestoendogenousactivaitonofNFkB.CancerRes57:3032ï¿½3039,1997
	SicaA,SaccaniA,BorsattiCA,etal:BacteriallipopolysacchariderapidlyinhibitsexpressionofC-Cchemokinereceptorsinhumanmonocytes.JExpmMed185:969ï¿½974,1997
	SicaA,SaccaniA,BottazziB,etal:Defectiveexpressionofthemonocytechemotacticprotein-1receptorCCR2inmacrophagesassociateswithhumanovariancarcinoma.JImmunol164:733ï¿½738,2000
	SinghRK,GutmanM,RadinskyR,BucanaCD,FidlerIJ:Expressionofinterleukin8correlateswiththemetastaticpotentialofhumanmelanomacellsinnudemice.CancerRes54:3242ï¿½3247,1994
	SinghRK,GutmanM,ReichR,Bar-EliM:UltravioletBirradiationpromotestumorigenicandmetastaticpropertiesinprimarycutaneousmelanomaviainductionofinterleukin8.CancerRes55:3669ï¿½3674,1995
	SinghRK,VarneyML:Regulationofinterleukin8expressioninhumanmalignantmelanomacells.CancerRes58:1532ï¿½15367,1998
	SozzaniS,AllavenaP,D'AmicoG,etal:Cuttingedge:Differentialregulationofchemokinereceptorsduringdendriticmaturation:amodelfortheirtrafï¿½ckingproperties.JImmunol161:1083ï¿½1086,1998
	StrieterRM,PolveriniPJ,KunkelSL,etal:ThefunctionalroleoftheELRmotifinCXCchemokine-mediatedangiogenesis.JBiolChem270:27348ï¿½27357,1995
	TorisuH,OnoMH,KiryuH,etal:Macrophageinï¿½ltrationcorrelateswithtumorstageandangiogenesisinhumanmelanoma.PossibleinvolvementofTNF-aandIL-1a.IntJCancer85:182ï¿½188,2000
	UenoT,ToiM,SajiH,etal:Signiï¿½canceofmacrophagechemoattractantprotein-1inmacrophagerecruitment,angiogenesisandsurvivalinhumanbreastcancer.ClinCancerRes6:3282ï¿½3289,2000
	ValenteAJ,GravesCE,Vialle-ValentinR,DelgadoR,SchwartzCJ:Puriï¿½cationofamonocytechemotacticfactorsecretedbynonhumanprimatevascularcellsinculture.Biochemistry27:4162ï¿½4168,1988
	VanRavenswaay-ClaasenHH,KluinPM,FleurenGJ:Tumorinï¿½ltratingcellsinhumancancer.OnthepossibleroleofCD16+macrophagesinantitumorcytotoxicity.LabInvest67:166ï¿½174,1992
	WalzA,PeverniP,AschauerH,BagglioniM:Puriï¿½cationandaminoacidsequencingofNAF,anovelneutrophil-activatingfactorproducedbymonocytes.BiochemBiophysResCommun149:755ï¿½761,1987
	WangJM,TaraborettiG,MatsushimaK,VanDammeJ,MantovaniA:IL-8induceshaptotaxisandchemotaxisofmelanomacells.BiochemBiophysResCommun169:165ï¿½169,1990
	WardSG,WestwickJ:Chemokines:understandingtheirroleinT-lymphocytebiology.Biochem333:457ï¿½470,1998
	WuGD,LaiEJ,HuangN,WenX:Oct-1andCCAAT/enhancer-bindingprotein(C/EBP)bindtooverlappingelementswithintheinterleukin-8promoter:theroleofOct-1asatranscriptionalrepressor.JBiolChem272:2396ï¿½2403,1997
	YangJ,RichmondA:ConstitutiveIkbkinaseactivitycorrelateswithnuclearfactor-kBactivationinhumanmelanomacells.CancerRes61:4901ï¿½4909,2001
	YangT-Y,ChenS-C,LeachMW,etal:Transgenicexpressionofthechemokinereceptorencodedbyhumanherpesvirus8inducesanangioproliferativediseaseresemblingKaposi'ssarcoma.JExpMed191:445ï¿½454,2000
	YangW,WangD,RichmondA:Roleofclathrin-mediatedendocytosisinCXCR2sequestration,resensitizationandsignaltransduction.JBiolChem274:11328ï¿½11333,1999
	Yla-HerttualaS,LiptonB,RosenfeldM,etal:Expressionofmonocytechemoattractantprotein1inmacrophage-richareasofhumanandrabbitatheroscleroticlesions.ProcNatlAcadSciUSA88:5252ï¿½5256,1991
	YoshimuraT,MatsushimaK,TanakaS,RobinsonEA,AppellaE,OppenheimJJ,LeonardEJ:Puriï¿½cationofahumanmonocyte-derivedneutrophilchemotacticfactorthathaspeptidesequencesimilaritytootherhostdefensecytokines.ProcNatlAcadSciUSA84:9233ï¿½9237,1987
	YoshimuraT,YuhkiN,MooreSK,AppellaE,LermanMI:Humanmonocytechemoattractantprotein-1.FulllengthDNAcloning,expressioninmitogen-stimulatedbloodmononuclearleukocytes,andsequencesimilaritytomousecompetencegeneJE.FEBSLett244:487ï¿½493,1989
	ZellaD,BarabitskajaO,BurnsJM,etal:Interferon-gammaincreasesexpressionofchemokinereceptorsCCR1,CCR3andCCR5,butnoCXCR4inmonocytoidU937cells.Blood91:444ï¿½450,1991
	ZhangH,ShepherdAT,EasonDD,etal:RetinoblastomaproteinexpressionleadstoreducedOct-1DNAbindingactivityandenhancesinterleukin-8expression.CellGrowthDiffer10:457ï¿½465,1999
	ZingoniA,SotoH,HedrickJA,etal:ThechemokinereceptorCCR8ispreferentiallyexpressedinTh2butnotinTh1cells.JImmunol161:547ï¿½551,1998
	ZlotnikA,YoshieO:Chemokines:anewclassiï¿½cationsystemandtheirroleinimmunity.Immunity12:121ï¿½127,2000
[36-6]0311211200_p580.pdf	20
	Bewley, J. D. and Marcus, A. (1990) Gene expression in seeddevelopment and germination. Prog. Nucleic Acid Res. Mol.Biol. 38, 165-193.
	Butler, W. M. and Cuming, A. C. (1993) Differential molecularresponses to abscisic acid and osmatic stress in viviparousmaize embryos. Planta 189, 47-54.
	Caliskan, M. and Cuming, A. C. (1998) Spatial specificity ofH2O2-generating oxalate oxidase gene expression during wheatembryo germination. Plant J. 15, 165-71.
	Caliskan, M. and Cuming, A. C. (2000) Temporal and spatialdetermination of germin biosynthesis in wheat tissues. Turk. J.Biol. 24, 775-782.
	Caliskan, M. (2000) Germin, an oxalate oxidase, has a function inmany aspects of plant life. Turk. J. Biol. 24, 717-724.
	Caliskan, M. (2001) In situ localization of germin gene expressionduring auxin induced callus formation. Turk. J. Biol. 25, 387-396.
	Cuming, A. C., Turet, M. and Butler, W. M. (1996) Geneexpression and embryonic maturation in cereals; inEmbryogenesis: the generation of a plant, Wang, T. L. andCuming, A. C. (eds), pp. 113-132, BIOS Scientific Publishers,Oxford, UK
	Fincher, G. B. (1989) Molecular and cellular biology associatedwith endosperm mobilization in germinating cereal grains. Ann.Rev. Plant Physiol. Plant Mol. Biol. 40, 305-346.
	Futers, T. S., Onde, S. and Cuming, A. C. (1993) Sequenceanalysis of two tandemly linked Em genes from wheat. PlantMol. Biol. 23, 1067-1072.
	Goldberg, R. B., Barker, S. J. and Perez-Grau, L. (1989)Regulation of gene expression during plant embryogenesis. Cell56, 149-160.
	Gurr, S. J., McPherson, M. J., Scollon, C., Atkinson, H. J. andBowles, D. J. (1991) Gene expression in nematode-infectedplant roots. Mol. Gen. Genet. 226, 361-366.
	Jackson, D. P. (1991) In situ hybridization in plants; in Molecularplant pathology: a practical approach, Bowles, D. J., Gurr, S.J. and McPhereson, M. (eds), pp. 163-174, Oxford UniversityPress, Oxford, UK
	Knight, C. D. Seghal, A., Atwal, K., Wallace, J. C., Cove, D. J.,Coates, D., Quatrano, R. S., Bahadur, S., Stockley, P. G. andCuming, A. C. (1995) Molecular responses to abscisic acid andstress are conserved between moss and cereals. Plant Cell 7,499-506.
	Lane, B. G. (2002) Oxalate, germins, and higher-plant pathogens.IUBMB Life 53, 67-75.
	Maniatis, T., Fritsch, E. F. and Sambrook, J. (1982) MolecularCloning: A Laboratory Manual, 2nd ed., Cold Spring HarborLaboratory Press, New York, USA
	Morris, P. C., Kumar, A., Bowles, D. J. and Cuming, A. C. (1990)Osmatic stress and abscisic acid induce expression of the wheatEm genes. Eur. J. Biochem. 190, 625-630.
	Reed, K. C. and Mann, D. A. (1985) Rapid transfer of DNA fromagarose gels to nylon membranes. Nucleic Acids Res. 13, 7207-7221.
	Rogers, S. O. and Quatrano, R. S. (1983) Morphological stagingof wheat caryopsis development. Amer. J. Bot. 70, 308-311.
	Scutt, C. P. and Gilmartin, P. M. (1997) High-stringencysubtraction for the identification of differentially regulatedcDNA clones. Biotechniques 23, 468-470.
	Williamson, J. D., Quatrano, R. S. and Cuming, A. C. (1985) Empolypeptide and its messenger RNA levels are modulated byabscisic acid during embryogenesis in wheat. Eur. J. Biochem.152, 501-507.
[36-6]0311211158_p552.pdf	26
	Armand, P., Kirshenbaum, K., Goldsmith, R. A., Farr-Jones, S.,Barron, A. E., Truong, K. T., Dill, K. A., Mierke, D. F.,Cohen, F. E., Zuckermann, R. N. and Bradley, E. K. (1998)NMR determination of the major solution conformation of apeptoid pentamer with chiral side-chains. Proc. Natl. Acad. Sci.USA 95, 4309-4314.
	Baek, B.-H., Lee, M.-R., Kim, K.-Y., Cho, U.-I., Boo, D. W. andShin, I. (2003) Novel consecutive beta- and gamma-turnmimetics composed of alpha-aminooxy tripeptides Org. Lett. 5,971-974.
	Bax, A. and Davis, D. G. (1985) MLEV-17 based 2Dhomonuclear magnetization transfer spectroscopy. J. Magn.Reson. 65, 355-360.
	Brï¿½ger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros,P., Gross-Kunstleve, R. W., Jing, J.-S., Kuszewski, J., Nilges,M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T. andWarren, G. (1998) Crystallography and NMR system-a newsoftware suite for macromolecular structure determination. ActaCryst. D54, 905-921.
	Chung Y. J., Huck, B. R., Christianson, L. A., Stanger, H. E.,Krauthauser, S., Powell, D. R. and Gellman, S. H. (2000)Stereochemical control of hairpin formation in beta-peptidescontaining dinipecotic acid reverse turn segments. J. Am. Chem.Soc. 122, 3995-4004.
	Clore, G. M., Brunger, A. T., Karplus, M. and Gronenborn, A. M.(1986) Application of molecular dynamics with interprotondistance restraints to three-dimensional protein structuredetermination. A model study of crambin. J. Mol. Biol. 191,523-551.
	Crisma, M., Formaggio, F., Toniolo, C., Yoshikawa, T. andWakamiya, T. (1999) Flat peptides. J. Am. Chem. Soc. 121,3272-3278.
	Datta, A. and Veeresa, G. (2000) A stereoselective route tohydroxyethylamine dipeptide isosteres. J. Org. Chem. 65, 7609-7611.
	Davis, D. G. and Bax, A. (1985) Assignment of complex 1HNMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 107, 2820-2821.
	Dï¿½ziel, R., Plante, R., Caron, V., Grenier, L., Llinas-Brunet, M.,Duceppe, J.-S., Malenfant, E. and Moss, N. (1996) Practicaland diastereoselective synthesis of ketomethylene dipeptideisosteres of the type AA-psi(Coch2)Asp. J. Org. Chem. 61,2901-2903.
	Gante, J. (1994) Peptidomimetics-tailored enzyme inhibitors.Angew. Chem. Int. Ed. Engl. 33, 1699-1720.
	Gellman, S. H. (1998) Foldamers-A manifesto. Acc. Chem. Res.31, 173-180.
	Hagihara, M., Anthony, N. J., Stout, T. J., Clardy, J. andSchreiber, S. L. (1992) Vinylogous polypeptides-an alternativepeptide backbone. J. Am. Chem. Soc. 114, 6568-6570.
	Huff, J. R. (1991) HIV Protease: A novel chemotherapeutic targetfor AIDS. J. Med. Chem. 34, 2305-2314.
	Huixiong, C., Noble, F., Coric, P., Fournie-Zaluski, M. andRoques, B. P. (1998) Aminophosphinic Inhibitors as Transition-state analogs of enkephalin-degrading enzymes-a class ofcentral analgesics. Proc. Natl. Acad. Sci. USA 96, 12028-12033.
	Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P.,Bradley, E. K., Truong, K. T., Dill, K. A., Cohen, F. E. andZuckermann, R. N. (1998) Sequence-Specific Polypeptoids - ADiverse Family of Heteropolymers with Stable SecondaryStructure. Proc. Natl. Acad. Sci. USA 95, 4303-4308.
	Koo, B. -K., Kim, M. -H., Lee, S. -T. and Lee, W. (2002)Purification and spectroscopic characterization of the humantyrosine kinase-6 SH3 domain. J. Biochem. Mol. Biol. 35, 343-347.
	Li, S.-Z., Lee, J.-H., Lee, W., Yoon, C.-J., Baik, J.-H. and Lim, S.-K. (1999) Type I ?-turn conformation is important forbiological activity of the melanocyte-stimulating hormoneanalogues. Eur. J. Biochem. 265, 1-12.
	Peter, C., Daura, X. and van Gunsteren, W. F. (2000) Peptides ofaminoxy acids: A molecular dynamics simulation study ofconformational equilibria under various conditions. J. Am.Chem. Soc. 122, 7461-7466.
	Shin, I., Lee, M-r., Lee, J., Jung, M., Lee, W. and Yoon, J. (2000)Synthesis of optically-active phthaloyl D-aminooxy acids fromL-amino-acids or L-hydroxy acids as building-blocks for thepreparation of aminooxy peptides. J. Org. Chem. 65, 7667-7675.
	Sieburth, S. M., Nittoli, T., Mutahi, A. M. and Guo, L. (1998)Silanediols-A new class of potent protease inhibitor. Angew.Chem. Int. Ed. 37, 812-814.
	Smith, A. B. III., Benowitz, A. B., Sprengeler, P. A., Barbosa, J.,Guzman, M. C., Hirshmann, R., Schweiger, E. J., Bolin, D. R.,Nagy, Z., Campbell, R. M., Cox, D. C. and Olson, G. L.(1999) Design and synthesis of a competent pyrrolinone-peptide hybrid ligand for the class-II major histocompatibilitycomplex protein HLA-DR1. J. Am. Chem. Soc. 121, 9286-9298.
	Yang, D., Ng, F.-F., Li, Z.-J., Wu, Y.-D., Chan, K. W. K. andWang, D. -P. (1996) An unusual turn structure in peptidescontaining alpha-aminoxy acids. J. Am. Chem. Soc. 118, 9794-9795.
	Yang, D., Qu, J., Ng, F.-F., Wang, X.-C., Cheung, K.-K., Wang,D.-P. and Wu, Y.-D. (1999) Novel turns and helices in peptidesof chiral alpha-aminoxy acids. J. Am Chem. Soc. 121, 589-590.
	Wu, Y.-D., Wang, D.-P., Chan, K. W. K. and Yang, D. (1999)Theoretical-study of peptides formed by aminoxy acids. J. Am.Chem. Soc. 121, 11189-11196.
	Wuthrich, K. (1986) NMR of proteins and nucleic acids, Wiley,New York, USA.
gb-2003-4-12-r80.pdf	42
	1.Buck L, Axel R: A novel multigene family may encode odorantreceptors: a molecular basis for odor recognition. Cell 1991,65:175-187.
	2.Young JM, Trask BJ: The sense of smell: genomics of vertebrateodorant receptors. Hum Mol Genet 2002, 11:1153-1160.
	3.International Human Genome Sequencing Consortium: Initialsequencing and analysis of the human genome. Nature 2001,409:860-921.
	4.Sharon D, Glusman G, Pilpel Y, Horn-Saban S, Lancet D: Genomedynamics, evolution, and protein modeling in the olfactoryreceptor gene superfamily. Ann N Y Acad Sci 1998, 855:182-193.
	5.Parmentier M, Libert F, Schurmans S, Schiffmann S, Lefort A, Egger-ickx D, Ledent C, Mollereau C, Gerard C, Perret J, et al.: Expressionof members of the putative olfactory receptor gene family inmammalian germ cells. Nature 1992, 355:453-455.
	6.Ben-Arie N, Lancet D, Taylor C, Khen M, Walker N, Ledbetter DH,Carrozzo R, Patel K, Sheer D, Lehrach H, et al.: Olfactory receptorgene cluster on human chromosome 17: possible duplicationof an ancestral receptor repertoire. Hum Mol Genet 1994, 3:229-235.
	7.Rouquier S, Taviaux S, Trask BJ, Brand-Arpon V, van den Engh G,Demaille J, Giorgi D: Distribution of olfactory receptor genes inthe human genome. Nat Genet 1998, 18:243-250.
	8.Ressler KJ, Sullivan SL, Buck LB: A zonal organization of odorantreceptor gene expression in the olfactory epithelium. Cell1993, 73:597-609.
	9.Vanderhaeghen P, Schurmans S, Vassart G, Parmentier M: Specificrepertoire of olfactory receptor genes in the male germ cellsof several mammalian species. Genomics 1997, 39:239-246.
	10.Matarazzo V, Tirard A, Renucci M, Belaich A, Clement JL: Isolationof putative olfactory receptor sequences from pig nasalepithelium. Neurosci Lett 1998, 249:87-90.
	11.Ngai J, Dowling MM, Buck L, Axel R, Chess A: The family of genesencoding odorant receptors in the channel catfish. Cell 1993,72:657-666.
	12.Freitag J, Ludwig G, Andreini I, Rossler P, Breer H: Olfactory recep-tors in aquatic and terrestrial vertebrates. J Comp Physiol A1998, 183:635-650.
	13.Freitag J, Beck A, Ludwig G, von Buchholtz L, Breer H: On the originof the olfactory receptor family: receptor genes of the jaw-less fish (Lampetra fluviatilis). Gene 1999, 226:165-174.
	14.Sun H, Kondo R, Shima A, Naruse K, Hori H, Chigusa SI: Evolution-ary analysis of putative olfactory receptor genes of medakafish Oryzias latipes. Gene 1999, 231:137-145.
	15.Clyne PJ, Warr CG, Freeman MR, Lessing D, Kim J, Carlson JR: Anovel family of divergent seven-transmembrane proteins:candidate odorant receptors in Drosophila. Neuron 1999,22:327-338.
	16.Vosshall LB, Amrein H, Morozov PS, Rzhetsky A, Axel R: A spatialmap of olfactory receptor expression in the Drosophilaantenna. Cell 1999, 96:725-736.
	17.Troemel ER, Chou JH, Dwyer ND, Colbert HA, Bargmann CI: Diver-gent seven transmembrane receptors are candidate chemo-sensory receptors in C. elegans. Cell 1995, 83:207-218.
	18.Bargmann CI: Neurobiology of the Caenorhabditis elegansgenome. Science 1998, 282:2028-2033.
	19.Glusman G, Yanai I, Rubin I, Lancet D: The complete humanolfactory subgenome. Genome Res 2001, 11:685-702.
	20.The Human Olfactory Receptor Data Exploratorium  [http://bioinfo.weizmann.ac.il/HORDE]
	21.Zhang X, Firestein S: The olfactory receptor gene superfamilyof the mouse. Nat Neurosci 2002, 5:124-133.
	22.Young JM, Friedman C, Williams EM, Ross JA, Tonnes-Priddy L, TraskBJ: Different evolutionary processes shaped the mouse andhuman olfactory receptor gene families. Hum Mol Genet 2002,11:535-546.
	23.Issel-Tarver L, Rine J: Organization and expression of canineolfactory receptor genes. Proc Natl Acad Sci USA 1996, 93:10897-10902.
	24.Priat C, Hitte C, Vignaux F, Renier C, Jiang Z, Jouquand S, Chï¿½ron A,Andrï¿½ C, Galibert F: A whole-genome radiation hybrid map ofthe dog genome. Genomics 1998, 54:361-378.Genome Biology 2003, 4:R80
	25.Vignaux F, Hitte C, Priat C, Chuat JC, Andrï¿½ C, Galibert F: Con-struction and optimization of a dog whole-genome radiationhybrid panel. Mamm Genome 1999, 10:888-894.
	26.Rouquier S, Blancher A, Giorgi D: The olfactory receptor gene80.9repertoire in primates and mouse: evidence for reduction ofthe functional fraction in primates. Proc Natl Acad Sci USA 2000,97:2870-2874.
	27.Issel-Tarver L, Rine J: The evolution of mammalian olfactoryreceptor genes. Genetics 1997, 145:185-195.
	28.Thorne C: Feeding behaviour of domestic dogs and the role ofexperience. In The Domestic Dog: Its Evolution, Behaviour and Interac-tions with People Edited by: Serpell J. Cambridge University Press,Cambridge, UK; 1995:104-114. 
	29.Guyon R, Lorentzen T, Hitte C, Kim L, Cadieu E, Parker HG, QuignonP, Lowe JK, Renier C, Gelfenbeyn B, et al.: A 1-Mb resolution radi-ation hybrid map of the canine genome. Proc Natl Acad Sci USA2003, 100:5296-301.
	30.The canine radiation hybrid project  [http://www-recomgen.univ-rennes1.fr/doggy.html]
	31.NCBI BLAST  [http://www.ncbi.nlm.nih.gov/BLAST]
	32.Ewing B, Hillier L, Wendl MC, Green P: Base-calling of automatedsequencer traces using phred. I. Accuracy assessment.Genome Res 1998, 8:175-185.
	33.Ewing B, Green P: Base-calling of automated sequencer tracesusing phred. II. Error probabilities. Genome Res 1998, 8:186-194.
	34.Gordon D, Abajian C, Green P: Consed: a graphical tool forsequence finishing. Genome Res 1998, 8:195-202.
	35.Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, SmithHO, Yandell M, Evans CA, Holt RA, et al.: The sequence of thehuman genome. Science 2001, 291:1304-1351.
	36.Vinogradov AE: Genome size and GC-percent in vertebratesas determined by flow cytometry: the triangularrelationship. Cytometry 1998, 31:100-109.
	37.Pearson WR, Lipman DJ: Improved tools for biological sequencecomparison. Proc Natl Acad Sci USA 1988, 85:2444-2448.
	38.Rozen S, Skaletsky H: Primer3 on the WWW for general usersand for biologist programmers. Methods Mol Biol 2000, 132:365-386.
	39.Matise TC, Perlin M, Chakravarti A: Automated construction ofgenetic linkage maps using an expert system (MultiMap): ahuman genome linkage map. Nat Genet 1994, 6:384-390.
	40.Mellersh CS, Hitte C, Richman M, Vignaux F, Priat C, Jouquand S,Werner P, Andrï¿½ C, DeRose S, Patterson DF, et al.: An integratedlinkage-radiation hybrid map of the canine genome. MammGenome 2000, 11:120-130.
	41.Services sur le Web d'Infobiogen  [http://www.infobiogen.fr/services/menuserv.html]
	42.Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improvingthe sensitivity of progressive multiple sequence alignmentthrough sequence weighting, position-specific gap penaltiesand weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.Genome Biology 2003, 4:R80
v074p01530.pdf	41
	1BentonD.Dolowcholesterollevelsslowmentalprocessing?PsychosomMed1995;57:50?3.
	2MuldoonMF,RyanCM,MatthewsKA,etal.Serumcholesterolandintellectualperformance.PsychosomMed1997;59:382?7.
	3RossR.Mechanismsofdisease:atherosclerosis?aninflammatorydisease.NEnglJMed1999;340:115?26.
	4HaanMN,ShemanskiL,JagustWJ,etal.TheroleofAPOEepsilon4inmodulatingeffectsofotherriskfactorsforcognitivedeclineinelderlypersons.JAMA1999;282:40?6.
	5NotkolaIL,SulkavaR,PekkanenJ,etal.Serumtotalcholesterol,apolipoproteinEe4allele,andAlzheimer?sdisease.Neuroepidemiology1998;17:14?20.
	6MoroneyJT,TangMX,BerglundL,etal.Low-densitylipoproteincholesterolandtheriskofdementiawithstroke.JAMA1999;282:254?60.
	7EvansRM,EmsleyCL,GaoS,etal.Serumcholesterol,APOEgenotype,andtheriskofAlzheimer?sdisease:apopulation-basedstudyofAfricanAmericans.Neurology2000;54:240?2.
	8SwanGE,LaRueA,CarmelliD,etal.Declineincognitiveperformanceinagingtwins:heritabilityandbiobehavioralpredictorsfromtheNationalHeart,Lung,andBloodInstitutetwinstudy.ArchNeurol1992;49:476?81.
	9LindbergG,RastamL,GullbergB,etal.Lowserumcholesterolconcentrationandshorttermmortalityfrominjuriesinmenandwomen.BMJ1992;305:277?9.
	10ModaiI,ValevskiA,DrorS,etal.Serumcholesterollevelsandsuicidaltendenciesinpsychiatricinpatients.JClinPsychiatry1994;55:252?4.
	11KunugiH,TakeiN,AokiH,etal.Lowserumcholesterolinsuicideattempters.BiolPsychiatry1997;41:196?200.
	12MorganRE,PalinkasLA,Barrett-ConnorE,etal.Plasmacholesterolanddepressivesymptomsinoldermen.Lancet1993;341:75?9.1534Henderson,Guthrie,Dennerstein
	13DennersteinL,SmithAMA,MorseCA,etal.Menopausalsymptomatology:theexperienceofAustralianwomen.MedJAust1993;159:232?6.
	14BurgerHG,DudleyEC,HopperJL,etal.Theendocrinologyofthemenopausaltransition:across-sectionalstudyofapopulation-basedsample.JClinEndocrinolMetab1995;80:3537?45.
	15CollieA,Shafiq-AntonacciR,MaruffP,etal.NormsandtheeffectsofdemographicvariablesonaneuropsychologicalbatteryforuseinhealthyageingAustralianpopulations.AustNZJPsychiatry1999;33:568?75.
	16DennersteinL,LehertP,BurgerH,etal.Moodandthemenopausaltransition.JNervMentDis1999;187:685?91.
	17DennersteinL,LehertP,DudleyE,etal.Factorscontributingtopositivemoodduringthemenopausetransition.JNervMentDis2001;189:84?9.
	18KammannR,FlettR.Affectometer2:ascaletomeasurecurrentlevelofgeneralhappiness.AustralianPsychology1983;35:259?65.
	19ShelleyJM,GreenA,SmithAMA,etal.Relationshipofendogenoussexhormonestolipidsandbloodpressureinmid-agedwomen.AnnEpidemiol1998;8:39?45.
	20FriedewaldWT,LevyRI,FredricksonDS.Estimationoftheconcentrationoflow-densitylipoproteincholesterolinplasma,withoutuseofthepreparativeultracentrifuge.ClinChem1972;18:499?502.
	21TaffeJ,DennersteinL.Retrospectiveself-reportcomparedwithmenstrualdiarydataprospectivelykeptduringthemenopausaltransition.Climacteric2000;3:183?91.
	22VermeulenA,VerdonckL.Sexhormoneconcentrationsinpost-menopausalwomen:relationtoobesity,fatmass,ageandyearspost-menopause.ClinEndocrinol(Oxf)1978;9:59?66.
	23LoboRA.Effectsofhormonalreplacementonlipidsandlipoproteinsinpostmenopausalwomen.JClinEndocrinolMetab1991;52:156?8.
	24PetersenRC,SmithGE,WaringSC,etal.Mildcognitiveimpairment:clinicalcharacterizationandoutcome.ArchNeurol1999;56:303?8.
	25YeaglePL.Modulationofmembranefunctionbycholesterol.Biochimie1991;73:1303?10.
	26HowlandDS,TruskoSP,SavageMJ,etal.Modulationofsecretedb-amyloidprecursorproteinandamyloidb-peptideinbrainbycholesterol.JBiolChem1998;273:16576?82.
	27YaffeK,Barrett-ConnorE,LinF,etal.Serumlipoproteinlevels,statinuse,andcognitivefunctioninolderwomen.ArchNeurol2002;59:378?84.
	28Paganini-HillA,HendersonVW.Theeffectsofhormonereplacetherapy,lipoproteincholesterollevels,andotherfactorsonaclockdrawingtaskinolderwomen.JAmGeriatrSoc1996;44:818?22.
	29RefoloLM,PappollaMA,LaFrancoisJ,etal.Acholesterol-loweringdrugreducesbeta-amyloidpathologyinatransgenicmousemodelofAlzheimer?sdisease.NeurobiolDis2001;8:890?9.
	30SelkoeDJ.Alzheimer?sdisease:genes,proteins,andtherapy.PhysiolRev2001;81:741?6.
	31WolozinB,KellmanW,RuosseauP,etal.DecreasedprevalenceofAlzheimerdiseaseassociatedwith3-hydroxy-3-methyglutarylcoenzymeAreductaseinhibitors.ArchNeurol2000;57:1439?43.
	32JickH,ZornbergGL,JickSS,etal.Statinsandtheriskofdementia.Lancet2000;356:1627?31.
	33RockwoodK,KirklandS,HoganDB,etal.Useoflipid-loweringagents,indicationbias,andtheriskofdementiaincommunity-dwellingelderlypeople.ArchNeurol2002;59:223?7.
	34HaleyRW,DietschyJM.IsthereaconnectionbetweentheconcentrationofcholesterolcirculatinginplasmaandtherateofneuriticplaqueformationinAlzheimerdisease?ArchNeurol2000;57:1410?12.
	35VaughanCJ,DelantyN.Neuroprotectivepropertiesofstatinsincerebralischemiaandstroke.Stroke1999;30:1969?73.
	36BrownSL,SaliveME,HarrisTB,etal.Lowcholesterolconcentrationsandseveredepressivesymptomsinelderlypeople.BMJ1994;308:1328?32.
	37WardleJ,RogersP,JuddP,etal.Randomizedtrialoftheeffectsofcholesterol-loweringdietarytreatmentonpsychologicalfunction.AmJMed2000;108:547?53.
	38MuldoonMF,BargerSD,RyanCM,etal.Effectsoflovastatinoncognitivefunctionandpsychologicalwell-being.AmJMed2000;108:538?47.
	39EliasMF,BergerA,WolfPA,etal.ThepreclinicalphaseofAlzheimer?sdisease:a22-yearprospectivestudyoftheFraminghamcohort.ArchNeurol2000;57:808?13.
	40EggerstenG,TegelmanR,EricssonS,etal.ApolipoproteinEpolymorphisminahealthySwedishpopulation:variationofallelefrequencywithageandrelationtoserumlipidconcentrations.ClinChem1993;39:2125?9.
	41Top200brand-namedrugsbyunitsin2001.DrugTopics.Com:TheOnlineNewsMagazineforPharmacists,March4,2002.www.drugtopics.com.AccessedJanuary2003.
v074p01461.pdf	20
	1StrausS,MajumdarSR,McAlisterFA.NewEvidenceforstrokeprevention.Scientificreview.JAMA2002;288:1388?95.
	2MurrayCJL,LauerJA,HutubessyRCW,etal.Effectivenessandcostsofinterventionstolowersystolicbloodpressure:aglobalandregionalanalysisonreductionofcardiovasculardiseaserisk.Lancet2003;361:717?25.
	3WangTJ,MassaroJM,LevyD,etal.Ariskscoreforpredictingstrokeordeathinindividualswithnewonsetatrialfibrillationinthecommunity.TheFraminghamHeartStudy.JAMA2003;290:1049?56.
	4RothwellP,WarlowC.OnbehalfoftheEuropeanCarotidSurgeryTrials?CollaborativeGroup.Lancet1999;353:2105?10,Onlineversionavailableathttp://www.dcn.ed.ac.uk/model/models.asp(lastaccessed18April2003).
	5JohnstonSC,GressDR,BrownerWS,etal.Short-termprognosisafteremergencydepartmentdiagnosisofTIA.JAMA2000;284:2901?6.
	6LovettJK,DennisMS,SandercockP,etal.Veryearlyriskofstrokeafterafirsttransientischemicattack.Stroke(Online)2003;32:e138?42.
	7IntercollegiateWorkingPartyforStroke(Update2002).London:RoyalCollegeofPhysicians,2002;(availableathttp://www.rcplondon.ac.uk/pubs/books/stroke/StrokeUpdate2002.pdf).
	8ClarkTG,MurphyMFG,RothwellP.Longtermrisksofstroke,myocardialinfarctionandvasculardeathin??lowrisk??patientswithanon-recenttransientischaemicattack.JNeurolNeurosurgPsychiatry2003;74:577?80.
	9WarlowCP,DennisMS,vanGijnGJ,etal.Stroke.Apracticalguidetomanagement,2nded.Oxford:BlackwellScientificPublications,2000:271?2.
	10FlossmannE,RothwellPM.Prognosisofvertebrobasilartransientischaemicattackandstroke.Brain2003;126:1940?54.
	11Prospectivestudiescollaboration.Age-specificrelevanceofusualbloodpressuretovascularmortality:ameta-analysisofindividualdataforonemillionadultsin61prospectivestudies.Lancet2002;360:1903?13.
	12PROGRESSCollaborativeGroup.Randomisedtrialofaperindopril-basedblood-pressure-loweringregimenamong6105individualswithpreviousstrokeortransientischaemicattack.Lancet2001;358:1033?41.
	13BathP.Blood-pressureloweringforsecondarypreventionofstroke:ACEinhibitionisnotthekeyStroke.2003;34:1334?5.
	14WarlowCP,DennisMS,vanGijnGJ,etal.Stroke.Apracticalguidetomanagement,2nded.Oxford:BlackwellScientificPublications,2000:672.
	15HeartProtectionStudyCollaborativeGroup.MRC/BHFheartprotectionstudyofcholesterolloweringwithsimvastatinin20536high-riskindividuals:arandomisedplacebo-controlledtrial.Lancet2002;360:7?22.
	16ShepherdJI,BlauwGJ,MurphyMB,etal.Pravastatininelderlyindividualsatriskofvasculardisease(PROSPER):arandomisedcontrolledtrial.Lancet2002;360:1623?30.
	17SeverPS,DahlofB,PoulterN,etal.Preventionofcoronaryandstrokeeventswithatorvastatininhypertensivepatientswhohaveaverageorlower-thanaveragecholesterolconcentrations,intheAnglo-Scandinaviancardiacoutcomestrial?lipidloweringarm(ASCOT-LLA):amulti-centrerandomisedcontrolledtrial.Lancet2003;361:1149?58.
	18PasternakRC,SmithSC,Bairey-MerzCN,etal.ACC/AHA/NHLBIclinicaladvisoryonthesafetyofstatins.Stroke2002;33:2337?41.
	19AntithromboticTrialists?Collaboration.Collaborativemeta-analysisofrandomisedtrialsofantiplatelettherapyforthepreventionofdeath,myocardial infarction, and stroke in high riskpatients. BMJ 2002;324:71â€“86.
	20 Hankey GJ, Sudlow CLM, Dunbabin DW.Thienopyridines or aspirin to prevent stroke andotherseriousvasculareventsinpatientsathighriskofvasculardisease?Asystematicreviewoftheevidencefromrandomizedtrials.Stroke2000;31:1779?84.
	21DeSchryverELLM,AlgraA,vanGijnJ.Dipyridamoleforpreventingstrokeandothervasculareventsinpatientswithvasculardisease(Cochranereview).In:TheCochraneLibrary,Issue1.Oxford:UpdateSoftware,2003.
	22HartRG,BenaventeO,McBrideR,etal.Antithrombotictherapytopreventstrokeinpatientswithatrialfibrillation:ameta-analysis.AnnInternMed1999;131:492?501.
	23HalperinJ.onbehalfoftheSPORTIF-IIIinvestigators.Presentedat52ndmeetingoftheAmericanCollegeofCardiology.http://www.acc03online.org/ondemand/trials3/sessions.asp?sid=3.
	24SandercockP,MielkeO,LiuM,etal.Anticoagulantsforpreventingrecurrencefollowingpresumednon-cardioembolicischaemicstrokeortransientischaemicattack(CochraneReview).In:TheCochraneLibrary,Issue1.Oxford:UpdateSoftware,2003.
	25AlgraA,DeSchryverELLM,vanGijnJ,etal.Oralanticoagulantsversusantiplatelettherapyforpreventingfurthervasculareventsaftertransientischaemicattackorminorstrokeofpresumedarterialorigin(CochraneReview).In:TheCochraneLibrary,Issue1.Oxford:UpdateSoftware,2003.
	26RothwellPM,EliasziwM,GutnikovSA,etal.FortheCarotidEndarterectomyTrialists?Collaboration.Analysisofpooleddatafromtherandomisedcontrolledtrialsofendarterectomyforsymptomaticcarotidstenosis.Lancet2003;361:107?16.
	27BenadeM,WarlowCP.Costsandbenefitsofcarotidendarterectomyandassociatedpreoperativearterialimaging.Asystematicreviewofthehealtheconomicliterature.Stroke2002;33:629?38.
	28TheGALAtrialcollaborativegroup.TheGALAtrial.http://www.dcn.ed.ac.uk/GALA.
	29CrawleyF,BrownMM.Percutaneoustrans-luminalangioplastyandstentingforcarotidarterystenosis(CochraneReview).In:TheCochraneLibrary,Issue1.Oxford:UpdateSoftware,2003.
	30CAVATASInvestigators.Endovascularversussurgicaltreatmentinpatientswithcarotidstenosisinthecarotidandvertebralarterytransluminalangioplastystudy(CAVATAS):arandomisedtrial.Lancet2001;357:1722?3.
11.03.1019.pdf	15
	1.MacIntyreNR,CookDJ,ElyEWJr,EpsteinSK,FinkJB,HeffnerJE,etal;AmericanCollegeofChestPhysicians;AmericanAssoci-ationforRespiratoryCare;AmericanCollegeofCriticalCareMed-icine.Evidence-basedguidelinesforweaninganddiscontinuingven-tilatorysupport:acollectivetaskforcefacilitatedbytheAmericanCollegeofChestPhysicians;theAmericanAssociationforRespi-ratoryCare;andtheAmericanCollegeofCriticalCareMedicine.Chest2001;120(6Suppl):375S?395S.
	2.MeadeM,GuyattG,CookD,GriffithL,SinuffT,KerglC,etal.Predictingsuccessinweaningfrommechanicalventilation.Chest2001;120(6Suppl):400S?424S.
	3.ElyEW,BakerAM,DunaganDP,BurkeHL,SmithAC,KellyPT,etal.Effectonthedurationofmechanicalventilationofidentifyingpatientscapableofbreathingspontaneously.NEnglJMed1996;335(25):1864?1869.
	4.EstebanE,AliaI,TobinMJ,GilA,GordoF,VallverduI,etal.Effectofspontaneousbreathingtrialdurationonoutcomeofat-temptstodiscontinuemechanicalventilation.SpanishLungFailureCollaborativeGroup.AmJRespirCritCareMed1999;159(2):512?518.
	5.VallverduI,CalafN,SubiranaM,NetA,BenitoS,ManceboJ.Clin-icalcharacteristics,respiratoryfunctionalparameters,andoutcomeofatwo-hourT-piecetrialinpatientsweaningfrommechanicalventilation.AmJRespirCritCareMed1998;158(6):1855?1862.
	6.MarelichGP,MurinS,BattistellaF,InciardiJ,VierraT,RobyM.Protocolweaningofmechanicalventilationinmedicalandsurgicalpatientsbyrespiratorycarepractionersandnurses:effectonweaningtimeandincidenceofventilator-associatedpneumonia.Chest2000;118(2):459?467.
	7.ZeggwaghAA,AbouqalR,MadaniN,ZekraouiA,KerkebO.Weaningfrommechanicalventilation:amodelforextubation.IntensiveCareMed1999;25(10):1077?1083.
	8.MillerR,ColeRP.Associationbetweenreducedcuffleakvolumeandpostextubationstridor.Chest1996;110(4):1035?1040.
	9.CoplinWM,PiersonDJ,CooleyKD,NewellDW,RubenfeldGD.Implicationsofextubationdelayinbrain-injuredpatientsmeetingstandardweaningcriteria.AmJRespirCritCareMed2000;161(5):1530?1536.
	10.SalamA,SminaM,GadaP,TilluckdharryL,UpadyaA,Amoateng-AdjepongY,ManthousCA.Theeffectofarterialbloodgasvaluesonextubationdecisions.RespirCare2003;48(11):1033-1037.
	11.MillbernSM,DownsJB,JumperLC,ModellJH.Evaluationofcriteriafordiscontinuingmechanicalventilatorysupport.ArchSurg1978;113(12):1441?1443.
	12.FerrerM,EsquinasA,ArancibiaF,BauerTT,GonzalezG,CarrilloA,etal.Noninvasiveventilationduringpersistentweaningfailure:arandomizedcontrolledtrial.AmJRespirCritCareMed2003;168(1):70?76.
	13.SooHooGW,ParkL.Variationsinthemeasurementofweaningparameters:asurveyofrespiratorytherapists.Chest2002;121(6):1947?1955.
	14.EpsteinSK,CiubotaruRL,WongJB.Effectoffailedextubationontheoutcomeofmechanicalventilation.Chest1997;112(1):186?192.
	15.TorresA,GatellJM,AznarE,el-EbiaryM,PuigdelaBellacasaJ,GonzalezJ,etal.Re-intubationincreasestheriskofnosocomialpneumoniainpatientsneedingmechanicalventilation.AmJRespirCritCareMed1995;152(1):137?141.
1472-6963-3-19.pdf	10
	1.Primatesta P and Erens B: Health Survey for England: Cardiovas-cular disease. London, TSO 1998.
	2.Department of Health: National Service Framework for Coro-nary Heart Disease. 2001.
	3.Kirk S: Treatment of obesity: theory into practice. Proceedingsof the Nutrition Society 1999, 58(1):53-58.
	4.Harvey E, Glenny A-M, Kirk S and Summerbell C: An updated sys-tematic review of interventions to improve health profes-sionals' management of obesity. Obesity Reviews 2002, 3:45-55.
	5.Perri MG, Sears SF Jr and Clark JE: Strategies for improvingmaintenance of weight loss. Toward a continuous caremodel of obesity management. Diabetes Care 1993,16(1):200-209.
	6.Glenny AM, O'Meara S, Melville A, Sheldon TA and Wilson C: Thetreatment and prevention of obesity: a systematic review ofthe literature. International Journal of Obesity & Related Metabolic Dis-orders 1997, 21(9):715-737.
	7.Which Report: Dieting and the Internet. London, Consumers Asso-ciation 2001.
	8.Agras WS, Taylor CB, Feldman DE and Losch M: Developing com-puter-assisted therapy for the treatment of obesity. BehaviorTherapy 1990, 21(1):99-109.
	9.Tate DF, Wing RR and Winett RA: Using Internet Technology toDeliver a Behavioural Weight loss Program. Journal of the Amer-ican Medical Association 2001, 285(9):1172-1177.
	10.Kirk SF, Cade JE and Greenhalgh A: Dietitians and the internet:are dietitians embracing the new technology? Journal of Human
1471-2296-4-16.pdf	69
	1.Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, LittleRR, Wiedmeyer HM and Byrd-Holt DD: Prevalence of diabetes,impaired fasting glucose, and impaired glucose tolerance inU.S. adults. The Third National Health and Nutrition Exam-ination Survey, 1988-1994. Diabetes Care 1998, 21:518-524.
	2.DHHS: Diabetes in America. Secondth edition. Washington DC,DHHS; 1995. 
	3.Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA and Tracy RP:Diabetes in older adults: comparison of 1997 American Dia-betes Association classification of diabetes mellitus with1985 WHO classification. Lancet 1998, 352:1012-1015.
	4.Keen H: Impact of new criteria for diabetes on pattern ofdisease. Lancet 1998, 352:1000-1001.
	5.ADA: American Diabetes Association: clinical practice rec-ommendations 1999. Diabetes Care 1999, 22:S1-S114.
	6.Dinneen SF, Maldonado D, 3rd, Leibson CL, Klee GG, Li H, Melton LJ, 3rd and Rizza RA: Effects of changing diagnostic criteria onthe risk of developing diabetes. Diabetes Care 1998,21:1408-1413.
	7.Morley JE, Mooradian AD, Rosenthal MJ and Kaiser FE: Diabetesmellitus in elderly patients. Is it different? Am J Med 1987,83:533-544.
	8.Martinson BC, O'Connor PJ and Pronk NP: Physical inactivity andshort-term all-cause mortality in adults with chronic disease.Arch Intern Med 2001, 161:1173-1180.
	9.Hofer TP, Vijan S and Hayward RA: Estimating the microvascularbenefits of screening for type 2 diabetes mellitus. Int J TechnolAssess Health Care 2000, 16:822-833.
	10.Helseth LD, Sussman SJ, Crabtree BF and O'Connor PJ: Primarycare physicians' perceptions of diabetes management. A bal-ancing act. J Fam Pract 1999, 48:37-42.
	11.Glynn RJ, Monane M,, Gurwitz JH, Choodnovsky I and Avorn J:Aging, comorbidity, and reduced rates of drug treatment fordiabetes mellitus. J Clin Epidemiol 1999, 52:781-790.
	12.Brown AF, Mangione CM, Saliba D and Sarkisian CA: Guidelines forimproving the care of the older person with diabetesmellitus. J. Am Geriatr Sc 2003, 51:S265-80.
	13.Gilmer TP, O'Connor PJ, Manning WG and Rush WA: The cost tohealth plans of poor glycemic control. Diabetes Care 1997,20:1847-1853.
	14.Testa MA and Simonson DC: Health economic benefits andquality of life during improved glycemic control in patientswith type 2 diabetes mellitus: a randomized, controlled, dou-ble-blind trial. JAMA 1998, 280:1490-1496.
	15.O'Connor PJ and Jacobson AM: Assessment of functional healthstatus in elderly diabetic persons. Geriatric Clinics of North Am1990, 6:865-882.
	16.Savage PJ: Cardiovascular complications of diabetes mellius:what we know and what we need to know about theirprevention. Ann Intern Med 1996, 124:123-136.
	17.Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC and Pahor M:Glycemic control of older adults with type 2 diabetes: find-ings from the Third National Health and Nutrition Examina-tion Survey, 1988-1994. J Am Geriatr Soc 2000, 48:264-267.
	18. ICSI: Health Care Guidelines: 1995-1996. Bloomington, MN, Institutefor Clinical Systems Integration; 1996.
	19.ICSI: Clinical care guideline: treatment of type 2 diabetesmellitus. Bloomington, MN, Institute for Clinical Systems Integration;1999. 
	20.ICSI: Clinical care guideline: treatment of type 2 diabetesmellitus. Bloomington, MN, Institute for Clinical Systems Improvement;2000. 
	21.O'Connor PJ, Crabtree BF and Yanoshik MK: Differences betweendiabetic patients who do and do not respond to a diabetescare intervention: a qualitative analysis. Fam Med 1997,29:424-428.
	22.O'Connor P, Rush WA, Pronk N and Cherney LM: Identifying dia-betes mellitus or heart disease among health maintenanceorganization members: sensitivity, specificity, predictivevalue and cost of survey and database methods. Am J ManagCare 1998, 4:335-342.
	23.Huisman TH, Henson JB and Wilson JB: A new high-performanceliquid chromatographic procedure to quantitate hemo-globin A1c and other minor hemoglobins in blood of normal,diabetic, and alcoholic individuals. J Lab Clin Med 1983,102:163-173.
	24.Hosmer DW and Lemeshow S: Applied logistic regression.Applied probability and mathematical statistics New York, Wiley; 1989:xiii,307. 
	25.Bender R and Lange S: Adjusting for multiple testing--when andhow? J Clin Epidemiol 2001, 54:343-349.
	26.Johnson PE, Veazie PJ, Kochevar L, O'Connor PJ, Potthoff SJ, VermaD and Dutta P: Understanding variation in chronic diseaseoutcomes. Health Care Manag Sci 2002, 5:175-189.
	27.Krein SL, Hofer TP, Kerr EA and Hayward RA: Whom should weprofile? Examining diabetes care practice variation amongprimary care providers, provider groups, and health carefacilities. Health Serv Res 2002, 37:1159-1180.
	28.Thompson BL, O'Connor P, Boyle R, Hindmarsh M, Salem N, Sim-mons KW, Wagner E, Oswald J and Smith SM: Measuring clinicalperformance: comparison and validity of telephone surveyand administrative data. Health Serv Res 2001, 36:813-825.
	29.O'Connor PJ, Rush WA, Peterson J, Morben P, Cherney L, Keogh Cand Lasch S: Continuous quality improvement can improveglycemic control for HMO patients with diabetes. Arch FamMed 1996, 5:502-506.
	30.O'Connor PJ, Pronk NP, Tan AW, Rush WA and Gray RJ: Does pro-fessional advice influence aspirin use to prevent heart dis-ease in an HMO population? Eff Clin Pract 1998, 1:26-32.
	31.Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG andPalmer RH: Variation in office-based quality. A claims-basedprofile of care provided to Medicare patients with diabetes.JAMA 1995, 273:1503-1508.
	32.Peterson K: Diabetes care by primary care physicians in Min-nesota and Wisconsin. J Fam Pract 1994, 38:361-367.
	33.Peters A, Legorreta A, Ossorio C and Davidson M: Quality of out-patient care provided to diabetic patients: A Health Mainte-nance Organization experience. Diabetes Care 1996, 19:601-606.
	34.Ford E and Mokdad A: Trends in glycosylated hemoglobin con-centrations among United States adults. Diabetes 2003, 52(Suppl 1):A219.
	35.Effect of intensive blood-glucose control with metformin oncomplications in overweight patients with type 2 diabetes(UKPDS 34). UK Prospective Diabetes Study (UKPDS)Group. Lancet 1998, 352:854-865.
	36.Intensive blood-glucose control with sulphonylureas or insu-lin compared with conventional treatment and risk of com-plications in patients with type 2 diabetes (UKPDS 33). UKProspective Diabetes Study (UKPDS) Group. Lancet 1998,352:837-853.
	37.Aspirin effects on mortality and morbidity in patients withdiabetes mellitus. Early Treatment Diabetic RetinopathyStudy report 14. ETDRS Investigators. JAMA 1992,268:1292-1300.
	38.Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H,Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A,Rutan GH and Stamler J: Effect of diuretic based antihyperten-sive treatment on cardiovascular disease risk in older dia-betic patients with isolated systolic hypertension. SystolicHypertension in Elderly Program Cooperative ResearchGroup. JAMA 1996, 276:1886-1892.
	39.Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, JuliusS, Menard J, Rahn KH, Wedel H and Westerling S: Effects of inten-sive blood-pressure lowering and low-dose aspirin in patientswith hypertension: principal results of the HypertensionOptimal Treatment (HOT) randomized trial. Lancet 1998,351:1755-1762.
	40.Efficacy of atenolol and captopril in reducing risk of macrov-ascular and microvascular complications in type 2 diabetes:UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998,317:713-720.
	41.Cost effectiveness analysis of improved blood pressure con-trol in hypertensive patients with type 2 diabetes: UKPDS40. UK Prospective Diabetes Study Group. BMJ 1998,317:720-726.
	42.Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG andThorgeirsson G: Cholesterol lowering with simvastatinimproves prognosis of diabetic patients with coronary heartdisease. A subgroup analysis of the Scandinavian SimvastatinSurvival Study (4S). Diabetes Care 1997, 20:614-620.
	43.Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Ped-ersen TR, Kjekshus J and Pyorala K: Reduced coronary events insimvastatin-treated patients with coronary heart diseaseand diabetes or impaired fasting glucose levels: subgroupanalyses in the Scandinavian Simvastatin Survival Study. ArchIntern Med 1999, 159:2661-2667.
	44.Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH and Pedersen O:Multifactorial intervention and cardiovascular disease inpatients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
	45.Cost-effectiveness of intensive glycemic control, intensifiedhypertension control, and serum cholesterol level reductionfor type 2 diabetes. The CDC Diabetes Cost-effectivenessGroup. JAMA 2002, 287:2542-2551.
	46.Wagner EH, Austin BT and Korff M. Von: Organizing care forpatients with chronic illness. Milbank Mem Fund Q 1996,74:511-544.
	47.Pronk NP and O'Connor PJ: Systems approach to populationhealth improvement. J Ambulatory Care Manage 1997, 20:24-31.
	48.Solberg LI, Kottke TE, Conn SA, Brekke ML, Calomeni CA and Con-boy KS: Delivering clinical preventive services is a systemsproblem. Ann Behav Med 1997, 19:271-278.
	49.Sperl-Hillen J, O'Connor PJ, Carlson RR, Lawson TB, Halstenson C,Crowson T and Wuorenma J: Improving diabetes care in a largehealth care system: an enhanced primary care approach. JtComm J Qual Improv 2000, 26:615-622.
	50.Sidorov J, Gabbay R, Harris R, Shull RD, Girolami S, Tomcavage J,Starkey R and Hughes R: Disease management for diabetesmellitus: impact on Hemoglobin A1c. Am J Manag Care 2000,6:1217-1226.
	51.Nyman MA, Murphy ME, Schryver PG, Naessens JM and Smith SA:Improving performance in diabetes care: a multicomponentintervention. Eff Clin Pract 2000, 3:205-212.
	52.Sutherland JE, Hoehns JD, O'Donnell B and Wiblin RT: Diabetesmanagement quality improvement in a family practice resi-dency program. J Am Board Fam Pract 2001, 14:243-251.
	53.Aubert RE, Herman WH, Waters J, Moore W, Sutton D, PetersonBL, Bailey CM and Koplan JP: Nurse case management toimprove glycemic control in diabetic patients in a healthmaintenance organization.  A randomized, controlled trial.Ann Intern Med 1998, 129:605-612.
	54.Pronk NP, Goodman MJ, O'Connor PJ and Martinson BC: Relation-ship between modifiable health risks and short-term healthcare charges. JAMA 1999, 282:2235-2239.
	55.Blair SN, Kampert JB, Kohl HW, Barlow CE, Macera CA, PaffenbargerRS and Gibbons LW: Influences of cardiorespiratory fitness andother precursors on cardiovascular disease and all-causemortality in men and women. JAMA 1996, 276:205-210.
	56.Paffenbarger R. S., Jr., Hyde RT, Wing AL, Lee IM, Jung DL and Kam-pert JB: The association of changes in physical-activity leveland other lifestyle characteristics with mortality amongmen. N Engl J Med 1993, 328:538-545.
	57.Haffner SM, Lehto S, Ronnemaa T, Pyorala K and Laakso M: Mortal-ity from coronary heart disease in subjects with type 2 diabe-tes and in nondiabetic subjects with and without priormyocardial infarction. N Engl J Med 1998, 339:229-234.
	58.Kleinman A: The illness narratives. Monograph New York, BasicBooks; 1988:284.
	59.Johnson P, Veazie P, O'Connor P, Kochevar L and Verma D et al.:Understanding variation in chronic disease outcomes. J FamPract Health Care Manag Sci  in press. 
	60.Crabtree BF, Miller WL, Aita VA, Flocke SA and Stange KC: Primarycare practice organization and preventive services delivery:a qualitative analysis. J Fam Pract 1998, 46:403-409.
	61.Griffin S: Diabetes care in general practice: meta-analysis ofrandomised control trials. BMJ 1998, 317:390-396.
	62.Blaum CS, Ofstedal MB, Langa KM and Wray LA: Functional Statusand Health Outcomes in Older Americans with DiabetesMellitus. J Am Geriatr Soc 2003, 51:745-753.
	63.Boyle RG, O'Connor PJ, Pronk NP and Tan A: Stages of change forphysical activity, diet, and smoking among HMO memberswith chronic conditions. Am J Health Promot 1998, 12:170-175.
	64.Hammond KR and Summers DA: Cognitive control. Psychol Rev1972, 79:58-67.
	65.Pine BJ II: Mass-customizing products and services. MassCustomization Boston, MA, Harvard Business School Press; 1999:171-212. 
	66.Schafer J, Konstan J and Reidl J: Recommender systems in e-com-merce. ACM on Electronic Conference Edited by: ACM. Association forComputing Machinery; 1999. 
	67.O'Connor PJ, Sperl-Hillen JM, Pronk NP and Murray T: Primarycare clinic-based chronic disease care. Disease ManagementHealth Outcomes 2001, 9:691-698.
	68.Solberg LI, Brekke ML, Fazio CJ, Fowles J, Jacobsen DN, Kottke TEand et al: Lessons from experienced guideline implementers:attend to many factors and use multiple strategies. Jt Comm JQual Improv 2000, 26:171-188.
	69.Klein R, Klein BE, Moss SE, DeMets DL, Kaufman I and Voss PS: Prev-alence of diabetes mellitus in southern Wisconsin. Am JEpidemiol 1984, 119:54-61.
x329_Hess.pdf	37
	  1.Weiss W. Smoking and pulmonary fibrosis. J Occup Med1988;30:33?9.
	  2.Morgan WKC. Prevalence of radiographic appearance ofpneumoconiosis in an unexposed blue collar population [let-ter]. Am Rev Respir Dis 1985;132:1139.
	  3.Kilburn KH. Classification of data on the etiologic role ofcigarette smoking in pulmonary fibrosis [letter]. Am J Ind Med1984;5:420.
	  4.Kilburn KH, Lilis R, Anderson HA, Miller A, Warshaw RH.Interaction of asbestos, age, and cigarette smoking in produc-ing radiographic evidence of diffuse pulmonary fibrosis. Am JMed 1986;80:377?81.
	  5.Castellan RM, Sanderson WT, Petersen MR. Prevalence ofradiographic appearance of pneumoconiosis in an unexposedblue collar population. Am Rev Respir Dis 1985;131:684?6.
	  6.Blanc PD, Gamsu G. Cigarette smoking and pneumoconiosis:structuring the debate. Am J Ind Med 1989;16:1?4.
	  7.Cohen D, Arai SF, Brain JD. Smoking impairs long-term dustclearance from the lung. Science 1979;204:514?7.
	  8.Weiss W. Cigarette smoke, asbestos, and small irregular opac-ities. Am Rev Respir Dis 1984;130:293?301.
	  9.Gough J. Emphysema in relation to occupation. Ind Med Surg1960;29:283?5.
	10.Chamberlain MJ, Morgan WKC, Vinitski S. Factors influenc-ing the regional deposition of inhaled particles in man. ClinSci 1983;64:69?78.
	11.International Labour Organization (ILO). International classi-fication of radiographs of pneumoconioses. Geneva: ILO;1980.
	12.Cooper WC, Sargent EN. Study of chest radiographs andpulmonary functions in perlite workers. J Occup Med 1986;28:199?206.
	13.Crosbie WA. Respiratory health of carbon black workers.Arch Environ Health 1986;41:346?53.
	14.Dick JA, Morgan WKC, Muir DFC, Reger RB, Sargent N.The significance of irregular opacities on the chest roentgeno-gram. Chest 1992;102:251?60.
	15.Irwig LM, Rocks P. Lung function and respiratory symptomsin silicotic and nonsilicotic gold miners. Am Rev Respir Dis1978;117:429?35.
	16.International Labour Organization (ILO). ILO U/C Interna-tional classification of radiographs of pneumoconioses 1971.Geneva: ILO; 1972.
	17.Cowie RL, Mabena SK. Silicosis, chronic airflow limitation,and chronic bronchitis in South African gold miners. Am RevRespir Dis 1991;143:80?4.
	18.Swaen GMH, Meijers JMM. Lung cancer risk among workerswith silicosis: potential confounding by smoking habits. Am JInd Med 1987;12:223?5.
	19.Swaen GMH, Passier PECA, van Attekum AMNG. Preva-lence of silicosis in the Dutch fine-ceramic industry. Int ArchOccup Environ Health 1988;60:71?4.
	20.Meijers JMM, Swaen GMH, van Vliet K, Borm PJA. Epide-miologic studies of inorganic dust-related lung diseases in TheNetherlands. Exp Lung Res 1990;16:15?23.
	21.Cherry NM, Burgess GL, Turner S, McDonald JC. Crystallinesilica and risk of lung cancer in the potteries. Occup EnvironMed 1998;55:779?85.
	22.McDonald JC, Burgess GL, Turner S, Cherry NM. Cohortstudy of Staffordshire pottery workers (III) lung cancer, radio-graphic changes, silica exposure and smoking habit. Ann Oc-cup Hyg 1997;41 Suppl 1:412?4.
	23.Graham WGB, Ashikaga T, Hemenway D, Weaver S,O?Grady RV. Radiographic abnormalities in Vermont graniteworkers exposed to low levels of granite dust. Chest 1991;100:1507?14.
	24.Harber P, Dahlgren J, Bunn W, Lockey J, Chase G. Radio-graphic and spirometric findings in diatomaceous earth work-ers. J Occup Environ Med 1998;40:22?8.
	25.Ng T-P, Tsin TW, O?Kelly FJ, Chan SL. A survey of therespiratory health of silica-exposed gemstone workers in HongKong. Am Rev Respir Dis 1987;135:1249?54.
	26.Hessel PA, Sluis-Cremer GK, Lee SL. Distribution of silicoticcollagenization in relation to smoking habits. Am Rev RespirDis 1991;144:297?301.
	27.Glover JR, Bevan C, Cotes JE, Elwood PC, Hodges NG, KellRL, et al. Effects of exposure to slate dust in North Wales. Br JInd Med 1980;37:152?62.
	28.Ng T-P, Chan S-L. Lung function in relation to silicosis andsilica exposure in granite workers. Eur Respir J 1992;5:986?
	29.Wang X, Yano E. Pulmonary dysfunction in silica-exposedworkers: a relationship to radiographic signs of silicosis andemphysema. Am J Ind Med 1999;36:299?306.
	30.Finkelstein MM. Silicosis surveillance in Ontario from 1979 to1992. Scand J Work Environ Health 1995;21 Suppl 2:55?7.
	31.Gardner LU, Middleton EL, Orenstein AI. Report upon medi-cal aspects of silicosis, including etiology, pathology, anddiagnostics: resolution adopted by the international conferenceheld in at Johannesburg, South Africa, Aug, 1930: p 12?27.
	32.Cavariani F, Di Pietro A, Miceli M, Forastiere F, Biggeri A,Scavalli P, et al. Incidence of silicosis among ceramic workersin central Italy. Scand J Work Environ Health 1995;21 Suppl2:58?62.
	33.Hnizdo E, Sluis-Cremer GK. Effect of tobacco smoking on thepresence of asbestosis at postmortem and on the reading orirregular opacities on roentgenograms in asbestos-exposedworkers. Am Rev Respir Dis 1988;138:1207?12.
	34.Thurlbeck WM, Churg AM. Pathology of the Lung. NewYork: Theime; 1995. p 612?5.
	35.Remy-Jardin M, Remy J, Boulenguez C, Sobaszek A, EdmeJ-L, Furon D. Morphologic effects of cigarette smoking onairways and pulmonary parenchyma in healthy adult volun-teers: CT evaluation and correlation with pulmonary functiontests. Radiology 1993;186:107?15.
	36.Finkelstein MM. Radiographic silicosis and lung cancer riskamong workers in Ontario. Am J Ind Med 1998;34:244?51.
	37.Finkelstein MM. Radiographic abnormalities and the risk oflung cancer among workers exposed to silica dust in Ontario.Can Med Assoc J 1995;152:37?43.
ymj-44-939.pdf	12
3270150.pdf	8
3270134.pdf	0
el-ppr126.pdf	13
3270121A.pdf	0
Am J Physiol Gastrointest Liver Physiol-2003-Savoye-Collet-G1147-52.pdf	38
	1.BatemanDNandWhittinghamTA.Measurementofgastricemptyingbyreal-timeultrasound.Gut23:524?527,1982.
	2.BolondiL,BortolottiM,SantiV,CallettiT,GaianiS,andLaboG.Measurementofgastricemptyingtimebyrealtimeultrasonography.Gastroenterology89:752?759,1985.
	3.EhrleinHJ,SchemannM,andSiegleML.Motorpatternsofsmallintestinedeterminedbycloselyspacedextraluminaltrans-ducersandvideofluoroscopy.AmJPhysiolGastrointestLiverPhysiol253:G259?G267,1987.
	4.FaasH,HebbardGS,FeinleC,KunzP,BrasseurJG,IndireshkumarK,DentJ,BoesigerP,ThumshirnM,FriedM,andSchwizerW.Pressure-geometryrelationshipintheantroduodenalregioninhumans.AmJPhysiolGastrointestLiverPhysiol281:G1214?G1220,2001.
	5.FassJ,SilnyJ,BraunJ,HeindrichsU,DreuwB,SchumpelickV,andRauG.Measuringesophagealmotilitywithanewintraluminalimpedancedevice.Firstclinicalresultsinrefluxpatients.ScandJGastroenterol29:693?702,1994.
	6.FrielingT,HermannnS,KuhlbuschR,EnckP,SilnyJ,andLuï¿½bkeHJ.Comparisonbetweenintraluminalmultipleelectricalimpedancemeasurementandmanometryintheoesoph-agus.NeurogastroenterolMotil8:45?50,1996.
	7.GeallMG,PhilippsSF,andSummerskillWHJ.Profileofgastricpotentialdifferenceinman.Gastroenterology8:437?443,1970.
	8.HauskenT,GiljaOH,OdegaardS,andBerstadA.Flowacrossthehumanpylorussoonafteringestionoffood,studiedwithduplexsonography.Effectofglyceryltrinitrate.ScandJGastroenterol33:484?490,1998.
	9.HauskenT,GiljaOH,UndelandKA,andBerstadA.Timingofpostprandialdyspepticsymptomsandtranspyloricpassageofgastriccontents.ScandJGastroenterol33:822?827,1998.
	10.HauskenT,MundtM,andSamsomM.Lowantroduodenalpressuregradientsareresponsibleforgastricemptyingofalowcaloricliquidmealinhumans.NeurogastroenterolMotil14:97?105,2002.
	11.HauskenT,OdegaardS,MatreK,andBerstadA.Antroduo-denalmotilityandmovementsofluminalcontentsstudiedbyduplexsonography.Gastroenterology102:1583?1590,1992.
	12.HeddleR,DentJ,ToouliJ,andReadNW.Topographyandmeasurementofpyloricpressurewavesandtoneinhumans.AmJPhysiolGastrointestLiverPhysiol255:G490?G497,1988.
	13.HoltS,McDickenWN,AndersonT,StewartIC,andHead-ingRC.Dynamicimagingofthestomachbyreal-timeultra-sound,amethodforthestudyofgastricmotility.Gut21:597?601,1980.
	14.HorowitzMandDentJ.Thestudyofgastricmechanicsandflow:amadhatter?steapartystartingtomakesense?Gastro-enterology107:302?306,1994.
	15.HveemK,HauskenT,andBerstadA.Ultrasonographicassessmentoffastingliquidcontentinthehumanstomach.ScandJGastroenterol29:786?789,1994.
	16.HveemK,JonesKL,ChattertonBE,andHorowitzM.Scintigraphicmeasurmentofgastricemptyingandultrasono-graphicassessmentofantralarea:relationtoappetite.Gut38:816?821,1996.
	17.HveemK,SunWM,HebbardG,HorowitzM,DoranS,andDentJ.Relationshipbetweenultrasonicallydetectedphasicantralcontractionsandantralpressure.AmJPhysiolGastro-intestLiverPhysiol281:G95?G101,2001.
	18.IndireshkumarK,BrasseurJG,FaasH,HebbardGS,KunzP,DentJ,FeinleC,LiM,BoesigerP,FriedM,andSchwizerW.Relativecontributionsofpressurepumpandperi-stalticpumptogastricemptying.AmJPhysiolGastrointestLiverPhysiol278:G604?G616,2000.
	19.JonesK,EdelbroekM,HorowitzM,SunWM,DentJ,RoelofsJ,MueckeT,andAkkermansL.Evaluationofantralmotilityinhumansusingmanometryandscintigraphy.Gut37:643?638,1995.
	20.KerlinP,ZinsmeisterA,andPhilippsS.Relationshipofmotilitytoflowofcontentsinthehumansmallintestine.Gas-troenterology82:701?706,1982.
	21.KingPM,AdamRD,PrydeA,McDickenWN,andHeadingRC.Relationshipsofhumanantroduodenalmotilityandtranspyloricfluidmovement:non-invasineobservationswithreal-timeultrasound.Gut25:1384?1391,1984.
	22.KingPM,HeadingRC,andPrydeA.Coordinatedmotoractivityofthehumangastroduodenalregion.DigDisSci30:219?224,1985.
	23.MalbertCHandMathisC.Antropyloricmodulationoftranspyloricflowofliquidsinpigs.Gastroenterology107:37?46,1994.
	24.NguyenHN,SilnyJ,AlbersD,RoebE,GartungC,RauG,andMaternS.Dynamicsofesophagealbolustransportinhealthysubjectsstudiedusingmultipleintraluminalimpedan-cometry.AmJPhysiolGastrointestLiverPhysiol273:G958?G964,1997.
	25.NguyenHN,SilnyJ,Wuï¿½llerS,MarshallHU,RauG,andMaternS.Chymetransportpatternsinhumanduodenumde-terminedbymultipleintraluminalimpedancemetry.AmJPhysiolGastrointestLiverPhysiol268:G700?G708,1995.
	26.NguyenHN,SilnyJ,Wuï¿½llerS,MarshallHU,RauG,andMaternS.Abnormalpostprandialduodenalchymetransportinpatientswithlongstandinginsulindependentdiabetesmellitus.Gut41:624?631,1997.
	27.PallottaN,CicalaM,FrandinaC,andCorazziariE.Antro-pyloriccontractilepatternsandtranspyloricflowaftermealingestioninhumans.AmJGastroenterol93:2513?2522,1998.
	28.RaoASC,LuR,andSchulze-DelrieuK.Duodenumasanimmediatebraketogastricoutflow:avideofluoroscopicandman-ometricassessment.Gastroenterology110:740?747.
	29.SavoyeG,Savoye-ColletC,OorsJ,andSmoutA.Interdi-gestivetranspyloricfluidtransportassessedbyintraluminalimpedancerecording.AmJPhysiolGastrointestLiverPhysiol284:G663?G669,2003.
	30.SifrimD,HollowayR,SilnyJ,XinZ,LerutA,andJans-sensJ.Acid,andgasrefluxinpatientswithgastroesophagealrefluxdiseaseduringambulatoryrecordings.Gastroenterology120:1588?1598,2001.
	31.SifrimD,SilnyJ,HollowayRH,andJanssensJJ.Patternsofgasandliquidreflexduringtransientloweroesophagealsphincterrelaxation:astudyusingintraluminalelectricalim-pedance.Gut44:47?54,1999.
	32.SilnyJ.Intraluminalmultipleelectricimpedanceprocedureformeasurementofgastrointestinalmotility.NeurogastroenterolMotil3:151?162,1991.
	33.SilnyJ,KniggeKP,FassJ,RauG,MaternS,andSchumpelickV.Verificationoftheintraluminalmultipleelec-tricalimpedancemeasurementfortherecordingofgastrointes-tinalmotility.NeurogastroenterolMotil5:107?122,1993.
	34.SkopnikH,SilnyJ,HeiberO,SchulzJ,RauG,andHeimannG.Gastroesophagealrefluxininfants:evaluationofanewintraluminalimpedancetechnique.JPediatrGastroenterolNutr23:591?598,1996.
	35.SrinivasanR,VelaMF,KatzPO,TutuianR,CastellJA,andCastellDO.Esophagealfunctiontestingusingmultichan-nelintraluminalimpedance.AmJPhysiolGastrointestLiverPhysiol280:G456?G462,2001.
	36.SunWM,HebbardGS,MalbertCH,JonesKL,DoranS,HorowitzM,andDentJ.Spatialpatternsoffastingandfedantropyloricpressurewaveinhumans.JPhysiol503:455?462,1997.
	37.TougasG,AnvariM,DentJ,SomersS,RichardsD,andStevensonGW.Relationofpyloricmotilitytopyloricopeningandclosureinhealthysubjects.Gut33:466?471,1992.
	38.VelaMF,Camacho-LobatoL,SrinivasanR,TutuianR,KatzPO,andCastellDO.Simultaneousintraesophagealim-pedanceandpHmeasurementofacidandnon-acidgastroesoph-agealreflux:effectsofomeprazole.Gastroenterology120:1599?1606,2001.
Am J Physiol Heart Circ Physiol-2003-Kuzume-H2463-70.pdf	32
	1.BausbackHHandWardPE.Degradationoflow-molecular-weightopioidpeptidesbyvascularplasmamembraneaminopep-tidaseM.BiochimBiophysActa882:437?444,1986.
	2.BirinciogluM,YangXM,CritzSD,CohenMV,andDowneyJM.S-Tsegmentvoltageduringsequentialcoronaryocclusionsisanunreliablemarkerofpreconditioning.AmJPhysiolHeartCircPhysiol277:H2435?H2441,1999.
	3.ChienGLandVanWinkleDM.Naloxoneblockadeofmyocar-dialischaemicpreconditioningisstereoselective.JMolCellCardiol28:1895?1900,1996.
	4.ChienGL,WolffRA,DavisRF,andVanWinkleDM.?Nor-mothermicrange?temperatureaffectsmyocardialinfarctsize.CardiovascRes28:1014?1017,1994.
	5.CohenMV,YangXM,LiuGS,HeuschG,andDowneyJM.Acetylcholine,bradykinin,opioids,andphenylephrine,butnotadenosine,triggerpreconditioningbygeneratingfreeradicalsandopeningmitochondrialKATPchannels.CircRes89:273?278,2001.
	6.DanaA,BaxterGF,WalkerJM,andYellonDM.Prolongingthedelayedphaseofmyocardialprotection:repetitiveadenosineA1receptoractivationmaintainsrabbitmyocardiuminaprecon-ditionedstate.JAmCollCardiol31:1142?1149,1998.
	7.FryerRM,EellsJT,HsuAK,HenryMM,andGrossGJ.Ischemicpreconditioninginrats:roleofmitochondrialKATPchannelinpreservationofmitochondrialfunction.AmJPhysiolHeartCircPhysiol278:H305?H312,2000.
	8.FryerRM,HsuAK,NagaseH,andGrossGJ.Opioid-inducedcardioprotectionagainstmyocardialinfarctionandarrhythmias:mitochondrialversussarcolemmalATP-sensitivepotassiumchannels.JPharmacolExpTher294:451?457,2000.
	9.GotoM,LiuY,YangXM,ArdellJL,CohenMV,andDowneyJM.Roleofbradykinininprotectionofischemicpre-conditioninginrabbithearts.CircRes77:611?621,1995.
	10.HashimiMW,ThorntonJD,DowneyJM,andCohenMV.LossofmyocardialprotectionfromischemicpreconditioningfollowingchronicexposuretoR()-N6-(2-phenylisopropyl)aden-osineisrelatedtodefectattheadenosineA1receptor.MolCellBiochem186:19?25,1998.
	11.JungO,EnglertHC,JungW,GogeleinH,ScholkensBA,BuschAE,andLinzW.TheKATPchannelblockerHMR1883doesnotabolishthebenefitofischemicpreconditioningonmyo-cardialinfarctmassinanesthetizedrabbits.NaunynSchmiede-bergsArchPharmacol361:445?451,2000.
	12.KatoRandFoeï¿½xP.Fentanylreducesinfarctionbutnotstun-ningvia-opioidreceptorsandproteinkinaseCinrats.BrJAnaesth84:608?614,2000.
	13.KlonerRA,DasS,PooleWK,PerritR,MullerJ,CannonCP,andBraunwaldE.Seasonalvariationofmyocardialin-farctsize.AmJCardiol88:1021?1024,2001.
	14.KrenzM,OldenburgO,WimpeeH,CohenMV,GarlidKD,CritzSD,DowneyJM,andBenoitJN.OpeningofATP-sensitivepotassiumchannelscausesgenerationoffreeradicalsinvascularsmoothmusclecells.BasicResCardiol97:365?373,2002.
	15.LiuGS,ThorntonJ,VanWinkleDM,StanleyAWH,OlssonRA,andDowneyJM.ProtectionagainstinfarctionaffordedbypreconditioningismediatedbyA1adenosinereceptorsinrabbitheart.Circulation84:350?356,1991.
	16.Llorens-CortesC,HuangH,VicartP,GascJM,PaulinD,andCorvolP.Identificationandcharacterizationofneutralendopeptidaseinendothelialcellsfromvenousorarterialori-gins.JBiolChem267:14012?14018,1992.
	17.MikiT,CohenMV,andDowneyJM.Opioidreceptorcontrib-utestoischemicpreconditioningthroughproteinkinaseCacti-vationinrabbits.MolCellBiochem186:3?12,1998.
	18.PatelHH,HsuAK,PeartJN,andGrossGJ.SarcolemmalKATPchanneltriggersopioid-induceddelayedcardioprotectionintherat.CircRes91:186?188,2002.
	19.SchultzJEJ,HsuAK,andGrossGJ.Morphinemimicsthecardioprotectiveeffectofischemicpreconditioningviaagliben-clamide-sensitivemechanisminratheart.CircRes78:1100?1104,1996.
	20.SchultzJEJ,RoseE,YaoZ,andGrossGJ.Evidenceforinvolvementofopioidreceptorsinischemicpreconditioninginrathearts.AmJPhysiolHeartCircPhysiol268:H2157?H2161,1995.
	21.SchulzR,GresP,andHeuschG.Roleofendogenousopioidsinischemicpreconditioningbutnotinshort-termhibernationinpigs.AmJPhysiolHeartCircPhysiol280:H2175?H2181,2001.
	22.SchulzR,PostH,VahlhausC,andHeuschG.Ischemicpreconditioninginpigs:agradedphenomenon.Itsrelationtoadenosineandbradykinin.Circulation98:1022?1029,1998.
	23.SchwartzJC,MalfroyB,anddelaBaumeS.Biologicalinactivationofenkephalinsandtheroleofenkephalin-dipepti-dyl-carboxypeptidase(?enkephalinase?)asneuropeptidase.LifeSci29:1715?1740,1981.
	24.SiggDC,ColesJAJr,OeltgenPR,andIaizzoPA.Roleof-opioidreceptoragonistsoninfarctsizereductioninswine.AmJPhysiolHeartCircPhysiol282:H1953?H1960,2002.
	25.TakasakiY,WolffRA,ChienGL,andVanWinkleDM.Met5-enkephalinprotectsisolatedadultrabbitcardiomyocytesvia-opioidreceptors.AmJPhysiolHeartCircPhysiol277:H2442?H2450,1999.
	26.ThorntonJD,LiuGS,OlssonRA,andDowneyJM.Intra-venouspretreatmentwithA1-selectiveadenosineanaloguespro-tectstheheartagainstinfarction.Circulation85:659?665,1992.
	27.TsuchidaA,ThompsonR,OlssonRA,andDowneyJM.Theanti-infarcteffectofanadenosineA1-selectiveagonistisdimin-ishedafterprolongedinfusionasisthecardioprotectiveeffectofischaemicpreconditioninginrabbitheart.JMolCellCardiol26:303?311,1994.
	28.Valtchanova-MatchouganskaAandOjewoleJA.Involve-mentofopioiddelta()-andkappa()-receptorsinischemicpreconditioninginaratmodelofmyocardialinfarction.MethodsFindExpClinPharmacol24:139?144,2002.
	29.WallTM,SheehyR,andHartmanJC.Roleofbradykinininmyocardialpreconditioning.JPharmacolExpTher270:681?688,1994.
	30.WuJP,ChenYT,andLeeYS.Opioidsinmyocardialischae-mia:potentiatingeffectsofdynorphinonischaemicarrhythmia,bradycardiaandcardiogenicshockfollowingcoronaryarteryocclusionintherat.EurHeartJ14:1273?1277,1993.
	31.YaoZandGrossGJ.Acetylcholinemimicsischemicprecondi-tioningviaaglibenclamide-sensitivemechanismindogs.AmJPhysiolHeartCircPhysiol264:H2221?H2225,1993.
	32.ZhuBO,SunYP,SudhirK,SieversRE,BrowneAE,GaoL,HutchisonSJ,ChouTM,DeedwaniaPC,ChatterjeeK,GlantzSA,andParmleyWW.Effectsofsecond-handsmokeandgenderoninfarctsizeofyoungratsexposedinuteroandintheneonataltoadolescentperiod.JAmCollCardiol30:1878?1885,1997.
Ann Oncol-2003-Kerr-971.pdf	3
	1.Boyle P, Autier P, Bartelink H et al. European Code Against Cancer andscientific justification: third version (2003). Ann Oncol 2003; 14: 973?1005.
	2.Quinn MJ, d?Onofrio A, Mï¿½ller B et al. Cancer mortality trends in the EUand acceding countries up to 2015. Ann Oncol 2003; 14: 1148?1152.
	3.Boyle P, d?Onofrio A, Maisonneuve P et al. Measuring progress againstcancer in Europe: has the 15% decline targeted for 2000 come about? AnnOncol 2003; 14: In press.
Am J Physiol Cell Physiol-2003-Broderick-C1207-18.pdf	46
	1.Abdel-LatifAA.Crosstalkbetweencyclicnucleotidesandpoly-phosphoinositidehydrolysis,proteinkinases,andcontractioninsmoothmuscle.ExpBiolMed(Maywood)226:153?163,2001.
	2.BachmannS.Nitricoxideinthekidney:synthesis,localization,andfunction.AmJKidneyDis24:112?129,1994.
	3.BaderM,PetersJ,BaltatuO,MullerDN,LuftFC,andGantenD.Tissuerenin-angiotensinsystems:newinsightsfromexperimentalanimalmodelsinhypertensionresearch.JMolMed79:76?102,2001.
	4.BielM,ZongX,DistlerM,BosseE,KlugbauerN,Mu-rakamiM,FlockerziV,andHofmannF.Anothermemberofthecyclicnucleotide-gatedchannelfamily,expressedintestis,kidney,andheart[seecomments].ProcNatlAcadSciUSA91:3505?3509,1994.
	5.BroderickKE.CycliccGMP-DependentSignallinginD.mela-nogasterMalpighianTubules.Glasgow,Scotland:UniversityofGlasgow,2002.
	6.CabreroP,RadfordJC,BroderickKE,VeenstraJ,SpanaE,DaviesS,andDowJAT.TheCRFgeneofDrosophilamelanogasterencodesadiureticpeptidethatactivatescAMPsignalling.JExpBiol205:3799?3807,2002.
	7.ChiangAS,WenCJ,LinCY,andYehCH.Nadph-diaphoraseactivityincorpusallatumcellsofthecockroach,Diplopterapunctata.InsectBiochemMolBiol30:747?753,2000.
	8.ChiniCC,GrandeJP,ChiniEN,andDousaTP.Compart-mentalizationofcAMPsignalinginmesangialcellsbyphospho-diesteraseisozymesPDE3andPDE4.Regulationofsuperoxida-tionandmitogenesis.JBiolChem272:9854?9859,1997.
	9.ColasantiMandVenturiniG.Nitricoxideininvertebrates.MolNeurobiol17:157?174,1998.
	10.CorbinJD,TurkoIV,BeasleyA,andFrancisSH.Phosphor-ylationofphosphodiesterase-5bycyclicnucleotide-dependentproteinkinasealtersitscatalyticandallostericcGMP-bindingactivities.EurJBiochem267:2760?2767,2000.
	11.DaviesSA.Nitricoxidesignallingininsects.InsectBiochemMolBiol30:1123?1138,2000.
	12.DaviesSA,HuesmannGR,MaddrellSHP,O?DonnellMJ,SkaerNJV,DowJAT,andTublitzNJ.CAP2b,acardioaccel-eratorypeptide,ispresentinDrosophilaandstimulatestubulefluidsecretionviacGMP.AmJPhysiolRegulIntegrCompPhysiol269:R1321?R1326,1995.
	13.DaviesSA,StewartEJ,HuesmannGR,SkaerNJV,Mad-drellSHP,TublitzNJ,andDowJAT.Neuropeptidestimu-lationofthenitricoxidesignalingpathwayinDrosophilamela-nogasterMalpighiantubules.AmJPhysiol42:R823?R827,1997.
	14.DimopoulosG,SeeleyD,WolfA,andKafatosFC.MalariainfectionofthemosquitoAnophelesgambiaeactivatesimmune-responsivegenesduringcriticaltransitionstagesoftheparasitelifecycle.EMBOJ17:6115?6123,1998.
	15.DowJAandDaviesSA.Integrativephysiology,functionalgenomicsandepithelialfunctioninageneticmodelorganism.PhysiolRev83:687?729,2003.
	16.DowJA,MaddrellSH,DaviesSA,SkaerNJ,andKaiserK.Anovelroleforthenitricoxide-cGMPsignalingpathway:thecontrolofepithelialfunctioninDrosophila.AmJPhysiolRegulIntegrCompPhysiol266:R1716?R1719,1994.
	17.DowJAT.ThemultifunctionalDrosophilamelanogasterV-ATPaseisencodedbyamultigenefamily.JBioenergBiomembr31:75?83,1999.
	18.DowJATandDaviesSA.TheDrosophilamelanogastermal-pighiantubule.AdvancesInsectPhysiol28:1?83,2001.
	19.HanafyK,KrumenackerJ,andMuradF.NO,nitrotyrosine,andcyclicGMPinsignaltransduction.MedSci7:801?819,2001.
	20.KeanL,CazenaveW,CostesL,BroderickKE,GrahamS,PollockVP,DaviesSA,VeenstraJA,andDowJA.TwonitridergicpeptidesareencodedbythegenecapabilityinDro-sophilamelanogaster.AmJPhysiolRegulIntegrCompPhysiol282:R1297?R1307,2002.
	21.KleinU.TheinsectV-ATPase,aplasma-membraneprotonpumpenergizingsecondaryactivetransport?immunologicalev-idencefortheoccurrenceofaV-ATPaseininsection-transport-ingepithelia.JExpBiol172:345?354,1992.
	22.KramerRHandMolokanovaE.Modulationofcyclic-nucle-otide-gatedchannelsandregulationofvertebratephototrans-duction.JExpBiol204:2921?2931,2001.
	23.KrebsRAandFederME.Tissue-specificvariationinHsp70expressionandthermaldamageinDrosophilamelanogasterlarvae.JExpBiol200:2007?2015,1997.
	24.KurjakM,FritschR,SaurD,SchusdziarraV,andAllescherHD.Functionalcouplingbetweennitricoxidesynthe-sisandVIPreleasewithinentericnerveterminalsoftherat:involvementofproteinkinaseGandphosphodiesterase5.JPhysiol534:827?836,2001.
	25.KuzinB,RegulskiM,StasivY,ScheinkerV,TullyT,andEnikolopovG.NitricoxideinteractswiththeretinoblastomapathwaytocontroleyedevelopmentinDrosophila.CurrBiol10:459?462,2000.
	26.LangR,LeeG,LiuW,TianS,RafiH,OriasM,SegalAS,andDesirGV.KCNA10:anovelionchannelfunctionallyre-latedtobothvoltage-gatedpotassiumandCNGcationchannels.AmJPhysiolRenalPhysiol278:F1013?F1021,2000.
	27.LiangMandKnoxFG.NitricoxidereducesthemolecularactivityofNa,K-ATPaseinopossumkidneycells.KidneyInt56:627?634,1999.
	28.LincolnTMandCornwellTL.IntracellularcyclicGMPre-ceptorproteins.FASEBJ7:328?338,1993.
	29.MacPhersonMR,PollockVP,BroderickKB,DowJA,andDaviesSA.TheroleofTRPchannelsinepithelialfluidtrans-port.ADrosResConf41:816B,2000.
	30.MacPhersonMR,PollockVP,BroderickKB,KeanL,O?ConnellFC,DowJAT,andDaviesSA.Modelorganisms:newinsightsintoionchannelandtransporterfunction:L-typecalciumchannelsregulateepithelialfluidtransportinDrosoph-ilamelanogaster.AmJPhysiolCellPhysiol280:C394?C407,2001.
	31.MorinX,DanemanR,ZavortinkM,andChiaW.AproteintrapstrategytodetectGFP-taggedproteinsexpressedfromtheirendogenouslociinDrosophila.ProcNatlAcadSciUSA98:15050?15055,2001.
	32.MullershausenF,FriebeA,FeilR,ThompsonWJ,Hof-mannF,andKoeslingD.DirectactivationofPDE5bycGMP:long-termeffectswithinNO/cGMPsignaling.JCellBiol160:719?727,2003.
	33.MurthyKS.Activationofphosphodiesterase5andinhibitionofguanylatecyclasebycGMP-dependentproteinkinaseinsmoothmuscle.BiochemJ360:199?208,2001.
	34.PietrantonioPVandGillSS.ImmunolocalizationOfthe17-kDavacuolarH-ATPasesubunit-CinHeliothis-virescensmidgutandmalpighiantubuleswithanantipeptideantibody.JExpBiol198:2609?2618,1995.
	35.RegulskiMandTullyT.Molecularandbiochemicalcharac-terizationofdNOS?aDrosophilaCa2calmodulin-dependentnitric-oxidesynthase.ProcNatlAcadSciUSA92:9072?9076,1995.
	36.RosayP,DaviesSA,YuY,SozenMA,KaiserK,andDowJAT.Cell-typespecificcalciumsignallinginaDrosophilaepi-thelium.JCellSci110:1683?1692,1997.
	37.SchubigerM,FengY,FambroughDM,andPalkaJ.AmutationoftheDrosophilasodiumpumpalphasubunitgeneresultsinbang-sensitiveparalysis.Neuron12:373?381,1994.
	38.SchulzS,ChinkersM,andGarbersDL.Theguanylatecyclase/receptorfamilyofproteins.FASEBJ3:2026?2035,1989.
	39.StuehrDJ.Mammaliannitricoxidesynthases.BiochimBio-physActa1411:217?230,1999.
	40.TheiligF,BostanjogloM,PavenstadtH,GruppC,HollandG,SlosarekI,GressnerAM,RusswurmM,KoeslingD,andBachmannS.Cellulardistributionandfunctionofsolublegua-nylylcyclaseinratkidneyandliver.JAmSocNephrol12:2209?2220,2001.
	41.ThomasRE,ArmstrongDT,andGilchristRB.Differentialeffectsofspecificphosphodiesteraseisoenzymeinhibitorsonbovineoocytemeioticmaturation.DevBiol244:215?225,2002.
	42.WangT.Roleofnitricoxidesynthase(iNOSandeNOS)inmodulatingproximaltubuletransportandacid-basebalance.AmJPhysiolRenalPhysiol283:F658?F662,2002.
	43.WelchWJandWilcoxCS.Whatisbrainnitricoxidesynthasedoinginthekidney?CurrOpinNephrolHypertens11:109?115,2002.
	44.WendehenneD,PuginA,KlessigDF,andDurnerJ.Nitricoxide:comparativesynthesisandsignalinginanimalandplantcells.TrendsPlantSci6:177?183,2001.
	45.WuF,ParkF,CowleyAWJr,andMattsonDL.Quantifica-tionofnitricoxidesynthaseactivityinmicrodissectedsegmentsoftheratkidney.AmJPhysiolRenalPhysiol276:F874?F881,1999.
	46.ZhaoY,BrandishPE,BallouDP,andMarlettaMA.Amolecularbasisfornitricoxidesensingbysolubleguanylatecyclase.ProcNatlAcadSciUSA96:14753?14758,1999.
Am J Physiol Cell Physiol-2003-Guo-C1174-87.pdf	66
	1.AdamsCL,NelsonWJ,andSmithSJ.Quantitativeanalysisofcadherin-catenin-actinreorganizationduringdevelopmentofcell-celladhesion.JCellBiol135:1899?1911,1996.
	2.AlexanderJS,BlaschukOW,andHaseltonFR.AnN-cad-herin-likeproteincontributestosolutebarriermaintenanceinculturedendothelium.JCellPhysiol156:610?618,1993.
	3.AngresB,BarthA,andNelsonWJ.Mechanismfortransitionfrominitialtostablecell-celladhesion:kineticanalysisofE-cadherin-mediatedcelladhesionusingaquantitativeadhesionassay.JCellBiol134:549?557,1996.
	4.AngstBD,MarcozziC,andMageeAI.Thecadherinsuper-family:diversityinformandfunction.JCellSci114:629?641,2001.
	5.BradfordMM.Arapidandsensitivemethodforthequantita-tionofmicrogramquantitiesofproteinutilizingtheprincipleofprotein-dyebinding.AnalBiochem72:248?254,1976.
	6.CereijidoM,ShoshaniL,andContrerasRG.Molecularphysiologyandpathophysiolgyoftightjunctions.I.Biogenesisoftightjunctionsandepithelialpolarity.AmJPhysiolGastrointestLiverPhysiol279:G477?G482,2000.
	7.CereijidoM,ValdesJ,ShoshaniL,andContrerasRG.Roleoftightjunctionsinestablishingandmaintainingcellpolarity.AnnuRevPhysiol60:161?177,1998.
	8.ChungSSW,LeeWM,andChengCY.Studyontheformationofspecializedinter-Sertolicelljunctionsinvitro.JCellPhysiol181:258?272,1999.
	9.Collares-BuzatoCB,McEwanGT,JepsonMA,SimmonsNL,andHirstBH.ParacellularbarrierandjunctionalproteindistributiondependonbasolateralextracellularCa2inculturedepithelia.BiochimBiophysActa1222:147?158,1994.
	10.DuizerE,GildeAJ,VersantvoortCH,andGrotenJP.EffectsofcadmiumchlorideontheparacellularbarrierfunctionE-CADHERINC1185ANDINTESTINALEPITHELIALBARRIERofintestinalepithelialcelllines.ToxicolApplPharmacol155:117?126,1999.
	11.FujimoriTandTakeichiM.Disruptionofepithelialcell-celladhesionbyexogenousexpressionofamutatednonfunctionalN-cadherin.MolBiolCell4:37?47,1993.
	12.GasslerN,RohrC,SchneiderA,KartenbeckJ,BachA,ObermullerN,OttoH,andAutschbachF.Inflammatoryboweldiseaseisassociatedwithchangesofenterocyticjunctions.AmJPhysiolGastrointestLiverPhysiol281:G216?G228,2001.
	13.GumbinerB,StevensonB,andGrimaldiA.Theroleofthecelladhesionmoleculeuvomorulinintheformationandmain-tenanceoftheepithelialjunctionalcomplex.JCellBiol107:1575?1587,1988.
	14.GumbinerBM.Celladhesion:themolecularbasisoftissuearchitectureandmorphogenesis.Cell84:345?357,1996.
	15.GuoX,RaoJN,LiuL,RizviM,TurnerDJ,andWangJY.Polyaminesregulate-catenintyrosinephosphorylationviaCa2duringintestinalepithelialcellmigration.AmJPhysiolCellPhysiol283:C722?C734,2002.
	16.HanbyAM,ChineryR,PoulsomR,PlayfordRJ,andPig-natelliM.DownregulationofE-cadherininthereparativeepitheliumofthehumangastrointestinaltract.AmJPathol148:723?729,1996.
	17.HarterJL.CriticalvaluesforDuncan?snewmultiplerangetests.Biometrics16:671?685,1960.
	18.HermistonMLandGordonJI.InflammatoryboweldiseaseandadenomasinmiceexpressingadominantnegativeN-cad-herin.Science270:1203?1207,1995.
	19.ItohM,NagafuchiA,MoroiS,andTsukitaS.InvolvementofZO-1incadherin-basedcelladhesionthroughitsdirectbindingto-cateninandactinfilaments.JCellBiol138:181?192,1997.
	20.JankowskiJAZ,BedfordFK,BoultonRA,CruickshankN,HallC,ElderJ,AllanR,ForbesA,KimYS,WrightNA,andSandersDSA.AlterationsinclassicalcadherinsassociatedwithprogressioninulcerativeandCrohn?scolitis.LabInvest78:1155?1167,1998.
	21.JanssensB,GoossensS,StaesK,GilbertB,HengelJV,ColpaertC,BruyneelE,MareelM,andRoyFV.T-catenin:anoveltissue-specific-catenin-bindingproteinmediatingstrongcell-celladhesion.JCellSci114:3177?3188,2001.
	22.KucharzikT,WalshSV,ChenJ,ParkosCA,andNusratA.Neutrophiltransmigrationininflammatoryboweldiseaseisassociatedwithdifferentialexpressionofepithelialintercellularjunctionproteins.AmJPathol159:2001?2009,2001.
	23.LaemmliUK.Cleavageofstructuralproteinsduringtheassem-blyoftheheadofbacteriophageT4.Nature227:680?685,1990.
	24.LiL,LiuL,RaoJN,EsmailiA,StrauchED,BassBL,andWangJY.JunDstabilizationresultsininhibitionofnormalintestinalepithelialcellgrowththroughp21afterpolyaminedepletion.Gastroenterology123:764?779,2002.
	25.LiL,RaoJN,BassBL,andWangJY.NF-Bactivationandsusceptibilitytoapoptosisafterpolyaminedepletioninintesti-nalepithelialcells.AmJPhysiolGastrointestLiverPhysiol280:G992?G1004,2001.
	26.LiL,RaoJN,GuoX,LiuL,SantoraR,BassBL,andWangJY.Polyaminedepletionstabilizesp53resultingininhibitionofnormalintestinalepithelialcellproliferation.AmJPhysiolCellPhysiol281:C941?C953,2001.
	27.MaTY,NguyenD,BuiV,NguyenH,andHoaN.Ethanolmodulationofintestinalepithelialtightjunctionbarrier.AmJPhysiolGastrointestLiverPhysiol276:G965?G974,1999.
	28.MadaraJL.Regulationofthemovementofsolutesacrosstightjunctions.AnnuRevPhysiol60:143?159,1998.
	29.ManY,HartVJ,RingCJA,SanjarS,andWestMR.LossofepithelialintegrityresultingfromE-cadherindysfunctionpre-disposesairwayepithelialcellstoadenoviralinfection.AmJRespirCellMolBiol23:610?617,2000.
	30.McCormackSA,WangJY,andJohnsonLR.PolyaminedeficiencycausesreorganizationofF-actinandtropomyosininIEC-6cells.AmJPhysiolCellPhysiol267:C715?C722,1994.
	31.MiticLLandAndersonJM.Moleculararchitectureoftightjunctions.AnnuRevPhysiol60:121?142,1998.
	32.MizunoM,OkayamaN,KasugaiK,YoshidaT,MiyataM,NittaM,KataokaH,AkitaS,JohT,ItohM,AsaiK,andKatoT.AcidstimulatesE-cadherinsurfaceexpressionongas-tricepithelialcellstostabilizebarrierfunctionsviainfluxofcalcium.EurJGastroenterolHepatol13:127?136,2001.
	33.NusratA,ParkosCA,VerkadeP,FoleyCS,LiangTW,Innis-WhitehouseEastburnKK,andMadaraJL.Tightjunctionsaremembranemicrodomains.JCellSci113:1771?1781,2000.
	34.ParekhABandPennerR.Storedepletionandcalciuminflux.PhysiolRev77:901?930,1997.
	35.PatelAR,LiJ,BassBL,andWangJY.Expressionofthetransforminggrowthfactor-geneduringgrowthinhibitionfol-lowingpolyaminedepletion.AmJPhysiolCellPhysiol275:C590?C598,1998.
	36.PatelARandWangJY.Polyaminesmodulatetranscriptionbutnotposttranscriptionofc-mycandc-juninIEC-6cells.AmJPhysiolCellPhysiol273:C1020?C1029,1997.
	37.PollardKJ,SamuelsML,CrowleyKA,HansenJC,andPetersonCL.FunctionalinteractionbetweenGCN5andpoly-amines:anewroleforcorehistoneacetylation.EMBOJ18:5622?5633,1999.
	38.ProzialeckWC.EvidencethatE-cadherinmaybeatargetforcadmiumtoxicityinepithelialcells.ToxicolApplPharmacol164:231?249,2000.
	39.QuaroniA,WandsJ,TrelstadRL,andIsselbacherKJ.Epithelialcellculturesfromratsmallintestine.JCellBiol80:248?265,1979.
	40.RaoJN,GuoX,LiuL,ZouT,MurthyKS,YuanJXJ,andWangJY.PolyaminesregulateRho-kinaseandmyosinphos-phorylationduringintestinalepithelialrestitution.AmJPhysiolCellPhysiol284:C848?C859,2003.
	41.RaoJN,LiL,GolovinaVA,LiL,PlatoshynO,StrauchED,YuanJXJ,andWangJY.Ca2-RhoAsignalingpathwayre-quiredforpolyamine-dependentintestinalepithelialcellmigra-tion.AmJPhysiolCellPhysiol280:C993?C1007,2001.
	42.RaoJN,LiJ,LiL,BassBL,andWangJY.DifferentiatedintestinalepithelialcellsexhibitincreasedmigrationthroughpolyaminesandmyosinII.AmJPhysiolGastrointestLiverPhysiol277:G1149?G1159,1999.
	43.RaoJN,PlatoshynO,LiL,GuoX,GolovinaVA,YuanJXJ,andWangJY.ActivationofKchannelsandincreasedmigra-tionofdifferentiatedintestinalepithelialcellsafterwounding.AmJPhysiolCellPhysiol282:C885?C898,2002.
	44.RayR,ViarMJ,YuanQ,andJohnsonLR.Polyaminede-pletiondelaysapoptosisofratintestinalepithelialcells.AmJPhysiolCellPhysiol278:C480?C489,2000.
	45.RimmDL,KoslovER,KebriaeiP,CianciCD,andMorrowJS.1(E)-cateninisanactin-bindingandbundlingproteinme-diatingtheattachmentofF-actintothemembraneadhesioncomplex.ProcNatlAcadSciUSA92:8813?8817,1995.
	46.ShoreEMandNelsonWJ.Biosynthesisofthecelladhesionmoleculeuvomorulin(E-cadherin)inMadin-Darbycaninekid-neyepithelialcells.JBiolChem266:19672?19680,1991.
	47.SilicianoJDandGoodenoughDA.Localizationofthetightjunctionprotein,ZO-1,ismodulatedbyextracellularcalciumandcell-cellcontactinMadin-Darbycaninekidneyepithelialcells.JCellBiol107:2389?2399,1988.
	48.SuhEandTraberPG.Anintestine-specifichomeoboxgeneregulatesproliferationanddifferentiation.MolCellBiol16:619?625,1996.
	49.TaborCWandTaborH.Polyamines.AnnuRevBiochem53:749?790,1984.
	50.TakeichiM.Cadherins:amolecularfamilyimportantinselec-tivecell-celladhesion.AnnuRevBiochem59:237?252,1990.
	51.TroxellML,ChenYT,CobbN,NelsonWJ,andMarrsJA.Cadherinfunctioninjunctionalcomplexrearrangementandposttranslationalcontrolofcadherinexpression.AmJPhysiolCellPhysiol276:C404?C418,1999.
	52.TroxellML,GopalakrishnanS,McCormackJ,PoteatBA,PenningtonJ,GarringerSM,SchneebergerEE,NelsonWJ,andMarrsJA.InhibitingcadherinfunctionbydominantmutantE-cadherinexpressionincreasestheextentoftightjunc-tionassembly.JCellSci113:985?996,2000.
	53.VarlamovO,FrickerLD,FurukawaH,SteinerDF,Lang-leySH,andLeiterEH.-CelllinesderivedfromtransgenicCpefat/CpefatmicearedefectiveincarboxypeptidaseEandpro-insulinprocessing.Endocrinology138:4883?4892,1997.
	54.VenkiteswaranK,XiaoK,SummersS,CalkinsCC,Vin-centPA,PumigliaK,andKowalczykAP.RegulationofendothelialbarrierfunctionandgrowthbyVE-cadherin,plako-globin,and-catenin.AmJPhysiolCellPhysiol283:C811?C821,2002.
	55.VielkindUandSwierengaSH.Asimplefixationprocedureforimmunofluorescencedetectionofdifferentcytoskeletalcom-ponentswithinthesamecell.Histochemistry91:81?88,1989.
	56.WangJYandJohnsonLR.Luminalpolyaminesstimulaterepairofgastricmucosalstressulcers.AmJPhysiolGastrointestLiverPhysiol259:G584?G592,1990.
	57.WangJYandJohnsonLR.Polyaminesandornithinedecar-boxylaseduringrepairofduodenalmucosaafterstressdamageinrats.Gastroenterology100:333?343,1991.
	58.WangJY,McCormackSA,andJohnsonLR.Roleofnon-musclemyosinIIinpolyamine-dependentintestinalepithelialcellmigration.AmJPhysiolGastrointestLiverPhysiol270:G355?G362,1996.
	59.WangJY,ViarMJ,LiJ,ShiHJ,McCormackSA,andJohnsonLR.Polyaminesarenecessaryfornormalexpressionofthetransforminggrowthfactor-geneduringcellmigration.AmJPhysiolGastrointestLiverPhysiol272:G713?G720,1997.
	60.WangJY,WangJ,GolovinaVA,LiL,PlatoshynO,andYuanJXJ.RoleofKchannelexpressioninpolyamine-depen-dentintestinalepithelialcellmigration.AmJPhysiolCellPhysiol278:C303?C314,2000.
	61.WatabeM,NagafuchiA,TsukitaS,andTakeichiM.Inductionofpolarizedcell-cellassociationandretardationofgrowthbyactivationoftheE-cadherin-cateninadhesionsys-teminadispersedcarcinomaline.JCellBiol127:247?256,1994.
	62.WeissEF,KroemkerM,RudigerAH,JockuschBM,andRudigerM.Vinculinispartofthecadherin-cateninjunctionalcomplex:complexformationbetween-cateninandvinculin.JCellBiol141:755?764,1998.
	63.WongVandGumbinerBM.Asyntheticpeptidecorrespondingtotheextracellulardomainofoccludinperturbsthetightjunc-tionpermeabilitybarrier.JCellBiol136:399?409,1997.
	64.YanoT,Hernandez-BlazquezFJ,OmoriY,andYamasakiH.ReductionofmalignantphenotypeofHEPG2cellisassoci-atedwiththeexpressionofconnexin26butnotconnexin32.Carcinogenesis22:1593?1600,2001.
	65.YapA,BrieherWM,andGumbinerBM.Molecularandfunctionalanalysisofcadherin-basedadherensjunctions.AnnuRevCellDevBiol13:119?146,1997.
	66.YouakimAandAhdiehM.Interferon-decreasesbarrierfunctioninT84cellsbyreducingZO-1levelsanddisruptingapicalactin.AmJPhysiolGastrointestLiverPhysiol276:G1279?G1288,1999.
Ann Bot-2003-BERTIN-415-24.pdf	32
10125.pdf	22
	1. Arnaudov D: Comparative studies of the virulent and immunogenic properties of the Toxoplasma strains isolated from domestic animals. Vet Med Nauki 1978, 15, 38-46 (in Bulgarian). 
	2. Bergmann V, Heidrich R, Kiupel H: Acute toxoplasmosis outbreak in rabbit flocks. Angew Parasitol 1980, 21, 1-6 (in German). 
	3. Beverley JK, Caley JP, Roseman CJ: Human Toxoplasma infection. J Hyg 1954, 52, 37-46. 
	4. Desmonts G, Remington JS: Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol 1980, 11, 562-568.  
	5. Dubey JP, Beattie CP: Toxoplasmosis of Animals and Man. CRC Press, Boca Raton, FL 1988. 
	6. Dubey JP, Brown CA, Carpenter JL, Moore JJ: Fatal toxoplasmosis in domestic rabbits in the USA. Vet Parasitol 1992, 44, 305-309.  
	7. Gustafsson K, Uggla A, Jarplid B: Toxoplasma gondii infection in the mountain hare (Lepus timidus) and domestic rabbit (Oryctolagus cuniculus). I. Pathology. J Comp Pathol 1997, 117, 351-360.  
	8. Ibragimova NM, Lopatinkiova VN et al.: Rabbit as an important source of toxoplasmosis in humans. Trudy Med Inst Alma Ata 1964, 21, 505-507 (in Russian).  
	9. Ishikawa T, Nishino H, Ohara M, Shimosato T, Nanba K: The identification of a rabbit-transmitted cervical toxoplasmosis mimicking malignant lymphoma. Am J Clin Pathol 1990, 94, 107-110. 
	10. Janitschke K: Animals as a source of Toxoplasma infection in man. Dtsch Med Wschr 1971, 96, 78-83 (in German).  
	11. Kapperud G: Survey for toxoplasmosis in wild and domestic animals from Norway and Sweden. J Wildl Dis 1978, 14, 157-162. 
	12. Lainson R: Toxoplasmosis in England. The rabbit (Oryctolagus cuniculus) as a host of Toxoplasma gondii. Ann Trop Med Parasitol 1955, 49, 384-390. 
	13. Leland MM, Hubbard GB, Dubey JP: Clinical toxoplasmosis in domestic rabbits. Lab Anim Sci 1992, 42, 318-319.  
	14. Levaditi C, Schoen R, Sanchis-Bayarhi V: Spontaneous encephalitis in rabbit evoked by Toxoplasma cuniculi. C R Soc Biol 1927, 97, 1692-1693 (in French).  
	15. Lin S, Ling ZC, Zeng BC, Yang HY: Prevalence of Toxoplasma gondii infection in man and animals in Guangdong, Peoples Republic of China. Vet Parasitol 1990, 34, 357-360.  
	16. Siim JC, Biering Sorensen U, Mï¿½ller T: Toxoplasmosis in domestic animals. Adv Vet Sci 1963, 8, 350-360.  
	17. ?ima O, Ra?in K: Toxoplasma gondii Nicolle et Manceaux 1909 - antibodies in domestic rabbits. Vet Med (Praha) 1973, 18, 633-640 (in Czech). 
	18. Splendore A: Novel protozoan parasite of rabbit. Rev Soc Sci Sao Paulo 1908, 3, 109-112 (in Portuguese).  
	19. Sroka J: Seroepidemiology of toxoplasmosis in the Lublin region. Ann Agric Environ Med 2001, 8, 25-31. 
	20. 7R-Luty S: Invasiveness of two selected strains of Toxoplasma gondii with respect to mice, rats and rabbits. Wiad Parazytol 1976, 22, 237-244 (in Polish). 
	21. Werner H: Spontaneous Toxoplasma infection in the domestic rabbit (Oryctolagus cuniculus L.). Zbl Bakteriol Orig 1966, 199, 259-263 (in German). 
	22. Zhang GN: Epidemiological study on Toxoplasma infection in human beings and animals in Shandong Province. Zhonghua Liu Xing Bing Xue Za Zhi 1989, 10, 30-33 (in Chinese). 
10073.pdf	44
	1. Avila R, Lacey J: The role of Penicillium frequentans in suberosis (respiratory disease in workers in the cork industry). Clin Allergy 1974, 4(2), 109-117. 
	2. Bauer J, Gareis M: Ochratoxin A in der Nahrungsmittelkette. J Vet Med B 1987, 34, 613-627. 
	3. Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K: Ochratoxin A in cow?s milk and in human milk with corresponding human blood samples. J AOAC Int 1993, 76, 842-846. 
	4. Breitholtz-Emanuelsson A, Fuchs R, Hult K: Toxicokinetics of ochratoxin A in rat following intratracheal administration. Nat Toxins 1995, 3, 101-103. 
	5. Creppy EE, Betbeder AM, Gharbi A, Counord J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirheimer G: Human ochratoxicosis in France. In: Castegnaro M, Ple?tina R, Dirheimer G, Chernozemsky IN, Bartsch H (Eds): Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, 145-151. IARC, Lyon 1991.  
	6. Di Paolo N, Guarnieri A, Loi F, Sacchi G, Mangiarotti AM, Di Paolo M: Acute renal failure from inhalation of mycotoxins. Nephron 1993, 64, 621-625. 
	7. Eduard W: Exposure to non-infectious microorganisms and endotoxins in agriculture. Ann Agric Environ Med 1997, 4, 179-186. 
	8. Frisvad JC, Samson A: Mycotoxins produced by species of Penicillium and Aspergillus occurring in cereals. In: Chelkowski J (Ed): Cereal Grain. Mycotoxins, Fungi and Quality in Drying and Storage, 441-476. Elsevier, 1991.  
	9. Gareis M, Mï¿½rtlbauer E, Bauer J, Gedek B: Bestimmung von Ochratoxin A in Muttermilch. Zeitschrift fï¿½r lebensmittel-untersuchung und forschung 1988, 186, 114-117. 
	10. Hald B: Ochratoxin A in human blood in European countries. In: Castegnaro M, Ple?tina R, Dirheimer G, Chernozemsky IN, Bartsch H (Eds): Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, 159-164. IARC, Lyon 1991. 
	11. Hill RA, Lacey J: Penicillium species associated with barley grain in the U.K. Trans Br Mycol Soc 1984, 82, 297-303.  
	12. Hjort C, Andersen P, Schonheyder H, Stenderup A: Occurrence of Aspergillus umbrosus antibodies in Danish farmers. Allergy 1986, 41, 104-109. 
	13. Hï¿½hler D: Ochratoxin A in food and feed: occurrence, legislation and mode of action. Zeitschrift fï¿½r Ernï¿½hrungswissenschaft 1998, 37, 2-12. 
	14. Holmberg T, Breitholtz-Emanuelsson A, Haggblom P, Schwan O, Hult K: Penicillium verrucosum in feed of ochratoxin A-positive swine herds. Mycopathologia 1991, 116, 169-176. 
	15. IARC. Monographs on the evaluation of carcinogenic risks to humans. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon: IARC 1993, Vol. 56. 
	16. Jï¿½rgensen K: Survey of pork, poultry, coffee, beer and pulses for ochratoxin A. Food Addit Contam 1998, 15, 550-554. 
	17. Karlsson K, Malmberg P: Characterization of exposure to molds and actinomycetes in agricultural dusts by scanning electron microscopy, fluorescence microscopy and the culture method. Scand J Work Environ Health 1989, 15, 353-359. 
	18. Katila ML, Ojanen TH, Mantyjarvi RA: Significance of IgG antibodies against environmental microbial antigens in a farming population. Clin Allergy 1986, 16 (5), 459-67. 
	19. Krogh P: Ochratoxins in food. In: Krogh P (Ed): Mycotoxins in food. Food Science and Technology. A Series of Monographs. 97-121. Academic Press 1987  
	20. Laitinen S, Linnainmaa M, Laitinen J, Kiviranta H, Reiman M, Liesivuori J: Endotoxins and IgG antibodies as indicators of occupational exposure to the microbial contaminants of metal-working fluids. Int Arch Occup Environ Health 1999, 72, 443-450.  
	21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193, 265-275. 
	22. Micco C, Miraglia M, Brera C, Corneli S, Ambruzzi A: Evaluation of ochratoxin A in human milk in Italy. Food Addit Contam 1995, 12, 351-354. 
	23. Mills JT: Mycotoxins and toxigenic fungi on cereal grains in western Canada. Can J Physiol Pharmacol 1990, 68, 982-986. 
	24. Mills JT, Seifert KA, Frisvad JC, Abramson D: Nephrotoxigenic Penicillium species occurring on farm-stored cereal grains in western Canada. Mycopathologia 1995, 130, 23-28.  
	25. Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C: Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 1999, 8, 265-269. 
	26. Pitt JI: Penicillium viridicatum, Penicillium verrucosum and production of ochratoxin A. Appl Environ Microbiol 1987, 53, 266-269. 
	27. Rautalahti M, Terho EO, Ojanen T: Changes in the titers of IgG antibodies against farmer?s lung antigens in the sera of healthy dairy farmers. Ann Allergy 1990, 64, 455-458. 
	28. Scott PM, Kanhere SR, Lau BPY, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T: Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 1998, 15, 555-562. 
	29. Scudamore KA, Clarke JH, Hetmanski MT: Isolation of Penicillium strains producing ochratoxin A, citrinin, xanthomegnin, viomellein and vioxanthin from stored cereal grains. Lett Appl Microbiol 1993, 17, 82-87.  
	30. Scudamore KA, Hetmanski MT: Natural occurrence of mycotoxins and mycotoxigenic fungi in cereals in the United Kingdom. Food Addit Contam 1995, 12, 377-382. 
	31. Skaug MA, Stï¿½rmer FC, Saugstad OD: Ochratoxin A: a naturally occurring mycotoxin found in human milk samples from Norway. Acta Paediatr 1998, 87, 1275-1279. 
	32. Skaug MA: Analysis of Norwegian milk and infant formulas for ochratoxin A. Food Addit Contam 1999, 16, 75-78.  
	33. Skaug MA, Eduard W, Stï¿½rmer FC: Ochratoxin A in airborne dust and fungal conidia. Mycopathologia 2001, 151, 93-98. 
	34. Skaug MA, Helland I, Solvoll K, Saugstad OD: Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 2001, 18, 321-327.  
	35. ?krinjar M, Stubblefield RD, Vujicic IF: Ochratoxigenic moulds and ochratoxin A in forages and grain feeds. Acta Vet Hung 1992, 40, 185-190. 
	36. Smith JE, Anderson JG, Lewis CW, Murad YM: Cytotoxic fungal spores in the indoor atmosphere of the damp domestic environment. FEMS Microbiol Lett 1992, 79, 337-343. 
	37. Speijers GJA, van Egmond HP: Worldwide ochratoxin A levels in food and feeds. In: Creppy EE, Castegnaro M, Dirheimer G (Eds): Human ochratoxicosis and its pathologies, 231, 85-100. Colloque INSERM, John Libbey Eurotext Ltd, Montrouge, France 1993  
	38. Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K, Olsen M: Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 2001, 39, 1145-1151. 
	39. Ueno Y, Maki S, Lin J, Furuya M, Sugiura Y, Kawamura O: A 4-year study of plasma ochratoxin A in a selected population in Tokyo by immunoassay and immunoaffinity column-linked HPLC. Food Chem Toxicol 1998, 36, 445-449. 
	40. Vd Stegen G, Jorissen U, Pittet A, Saccon M, Steiner W, Vincenzi M, Winkler M, Zapp J, Schlatter C: Screening of European coffee final products for occurrence of ochratoxin A (OTA). Food Addit Contam 1997, 14, 211-216. 
	41. Virtanen T, Vilhunen P, Husman K, Mï¿½ntijï¿½rvi R: Sensitation of dairy farmers to bovine antigens and effects of exposure on specific IgG and IgE titers. Int Arch Allergy Appl Immunol 1988, 87, 171-177.  
	42. Virtanen T, Kalliokoski P, Vilhunen P, Taivainen A, Mï¿½ntijï¿½rvi R: Concentrations of specific dusts in swineries and the humoral response of swinery workers. Allergy 1990, 45, 354-362. 
	43. Zimmerli B, Dick R: Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B 1995, 666, 85-99. 
	44. Zimmerli B, Dick R: Ochratoxin A in table wine and grape-juice: occurrence and risk assessment. Food Addit Contam 1996, 13, 655-668. 
AJHGv73p430.pdf	38
	BalendranN,CloughRL,ArguelloJR,BarberR,VealC,JonesAB,RosbothamJL,LittleAM,MadrigalA,BarkerJN,PowisSH,TrembathRC(1999)Characterizationofthema-jorsusceptibilityregionforpsoriasisatchromosome6p21.3.JInvestDermatol113:322?328
	BarkerJN(1998)Pathogenesisofpsoriasis.JDermatol25:778?781
	BeckerKG,SimonRM,Bailey-WilsonJE,FreidlinB,BiddisonWE,McFarlandHF,TrentJM(1998)Clusteringofnon-inhumanautoimmunediseases.ProcNatlAcadSciUSA95:9979?9984
	BhaleraoJ,BowcockAM(1998)Thegeneticsofpsoriasis:acomplexdisorderoftheskinandimmunesystem.HumMolGenet7:1537?1545
	BorgianiP,ValloL,D?ApiceMR,GiardinaE,PucciS,CaponF,NisticS,ChimentiS,PalloneF,NovelliG(2002)ExclusionofCARD15/NOD2asacandidatesusceptibilitygenetopso-riasisintheItalianpopulation.EurJDermatol12:540?542
	BromanKW,MurrayJC,SheffieldVC,WhiteRL,WeberJL(1998)Comprehensivehumangeneticmaps:individualandsex-specificvariationinrecombination.AmJHumGenet63:861?869
	CampRDR(1998)Psoriasis.In:ChampionRH,BurtonJL,BurnsDA,BreathnachSM(eds)Textbookofdermatology.Vol2.Blackwell,London,pp1589?1650
	CaponF,MunroM,BarkerJ,TrembathR(2002)Searchingforthemajorhistocompatibilitycomplexpsoriasissuscep-tibilitygene.JInvestDermatol118:745?751
	CaponF,NovelliG,SempriniS,ClementiM,NudoM,Vul-taggioP,MazzantiC,GobelloT,BottaA,FabriziG,Dal-lapiccolaB(1999)SearchingforpsoriasissusceptibilitygenesinItaly:genomescanandevidenceforanewlocusonchro-mosome1.JInvestDermatol112:32?35
	CurtisD,ShamPC(1995)Anoteontheapplicationofthetransmissiondisequilibriumtestwhenaparentismissing.AmJHumGenet56:811?812
	DibC,FaureS,FizamesC,SamsonD,DrouotN,VignalA,MillasseauP,MarcS,HazanJ,SebounE,LathropM,Gya-payG,MorissetteJ,WeissenbachJ(1996)Acomprehensivegeneticmapofthehumangenomebasedon5,264micro-satellites.Nature380:152?154
	ElderJT,NairRP,HenselerT,JenischS,StuartP,ChiaN,ChristophersE,VoorheesJJ(2001)Thegeneticsofpsoriasis2001:theodysseycontinues.ArchDermatol137:1447?1454
	ElderJT(1998)Psoriasis.In:JLJameson(ed)Principlesofmolecularmedicine.Humana,Totowa,NJ,pp793?800
	EnlundF,SamuelssonL,EnerbackC,InerotA,WahlstromJ,YhrM,TorinssonA,RileyJ,SwanbeckG,MartinssonT(1999)Psoriasissusceptibilitylocusinchromosomeregion3q21identifiedinpatientsfromsouthwestSweden.EurJHumGenet7:783?790
	HugotJP,ChamaillardM,ZoualiH,LesageS,CezardJP,BelaicheJ,AlmerS,TyskC,O?MorainCA,GassullM,BinderV,FinkelY,CortotA,ModiglianiR,Laurent-PuigP,Gower-RousseauC,MacryJ,ColombelJF,SahbatouM,ThomasG(2001)AssociationofNOD2leucine-richrepeatvariantswithsusceptibilitytoCrohn?sdisease.Nature411:599?603
	KarasonA,GudjonssonJE,UpmanyuR,AntonsdottirAA,HaukssonVB,RunasdottirEH,JonssonHH,GudbjartssonDF,FriggeML,KongA,StefanssonK,ValdimarssonH,GulcherJR(2003)Asusceptibilitygeneforpsoriaticarthritismapstochromosome16q:evidenceforimprinting.AmJHumGenet72:125?131
	KruglyakL,DalyMJ,Reeve-DalyMP,LanderES(1996)Para-metricandnonparametriclinkageanalysis:aunifiedmul-tipointapproach.AmJHumGenet58:1347?1363
	LanderE,KruglyakL(1995)Geneticdissectionofcomplextraits:guidelinesforinterpretingandreportinglinkagere-sults.NatGenet11:241?247
	LeeY-A,Ruï¿½schendorfF,WindemuthC,Schmitt-EgenolfM,StadelmannA,Nuï¿½rnbergG,Staï¿½nderM,WienkerTF,ReisA,TraupeH(2000)GenomewidescaninGermanfamiliesrevealsevidenceforanovelpsoriasis-susceptibilitylocusonchromosome19p13.AmJHumGenet67:1020?1024
	MarkianosK,DalyMJ,KruglyakL(2001)Efficientmultipointlinkageanalysisthroughreductionofinheritancespace.AmJHumGenet68:963?977
	MartinER,BassMP,KaplanNL(2001)Correctingforapo-tentialbiasinthepedigreedisequilibriumtest.AmJHumGenet68:1065?1067
	MartinER,MonksSA,WarrenLL,KaplanNL(2000)Atestforlinkageandassociationingeneralpedigrees:thepedigreedisequilibriumtest.AmJHumGenet67:146?154
	MatthewsD,FryL,PowlesA,WeberJ,McCarthyM,FisherE,DaviesK,WilliamsonR(1996)Evidencethatalocusforfamilialpsoriasismapstochromosome4q.NatGenet14:231?233
	NairRP,HenselerT,JenischS,StuartP,BichakjianCK,LenkW,WestphalE,GuoSW,ChristophersE,VoorheesJJ,ElderJT(1997)Evidencefortwopsoriasissusceptibilityloci(HLAand17q)andtwonovelcandidateregions(16qand20p)bygenome-widescan.HumMolGenet6:1349?1356
	NairRP,StuartP,HenselerT,JenischS,ChiaNVC,WestphalE,SchorkNJ,KimJ,LimHW,ChristophersE,VoorheesJJ,ElderJT(2000)Localizationofpsoriasis-susceptibilitylocusPSORS1toa60-kbintervaltelomerictoHLA-C.AmJHumGenet66:1833?1844
	NairRP,StuartP,OguraY,InoharaN,ChiaNV,YoungL,HenselerT,JenischS,ChristophersE,VoorheesJJ,NunezG,ElderJT(2001)LackofassociationbetweenNOD23020InsCframeshiftmutationandpsoriasis.JInvestDer-matol117:1671?1672
	O?ConnellJR,WeeksDE(1998)PedCheck:aprogramforiden-tificationofgenotypeincompatibilitiesinlinkageanalysis.AmJHumGenet63:259?266
	OguraY,BonenDK,InoharaN,NicolaeDL,ChenFF,RamosR,BrittonH,MoranT,KaraliuskasR,DuerrRH,AchkarJP,BrantSR,BaylessTM,KirschnerBS,HanauerSB,NunezG,ChoJH(2001)AframeshiftmutationinNOD2associatedwithsusceptibilitytoCrohn?sdisease.Nature411:603?606
	OkaA,TamiyaG,TomizawaM,OtaM,KatsuyamaY,Ma-kinoS,ShiinaT,YoshitomeM,IizukaM,SasaoY,IwashitaK,KawakuboY,SugaiJ,OzawaA,OhkidoM,KimuraM,BahramS,InokoH(1999)Associationanalysisusingrefinedmicrosatellitemarkerslocalizesasusceptibilitylocusforpsoriasisvulgariswithina111kbsegmenttelomerictotheHLA-Cgene.HumMolGenet8:2165?2170
	RischN(1990)Linkagestrategiesforgeneticallycomplextraits.I.Multilocusmodels.AmJHumGenet46:222?228
	RischNJ(2000)Searchingforgeneticdeterminantsinthenewmillennium.Nature405:847?856
	SamuelssonL,EnlundF,TorinssonA,YhrM,InerotA,Ener-backC,WahlstromJ,SwanbeckG,MartinssonT(1999)Agenome-widesearchforgenespredisposingtofamilialpso-riasisbyusingastratificationapproach.HumGenet105:523?529
	TomfohrdeJ,SilvermanA,BarnesR,Fernandez-VinaMA,YoungM,LoryD,MorrisL,WuepperKD,StastnyP,Men-terA,BowcockAM(1994)Geneforfamilialpsoriasissus-ceptibilitymappedtothedistalendofhumanchromosome17q.Science264:1141?1145
	TrembathRC,CloughRL,RosbothamJL,JonesAB,CampRD,FrodshamA,BrowneJ,BarberR,TerwilligerJ,LathropGM,BarkerJN(1997)Identificationofamajorsusceptibilitylocusonchromosome6pandevidenceforfurtherdiseaselocirevealedbyatwostagegenome-widesearchinpsoriasis.HumMolGenet6:813?820
	VealCD,CaponF,AllenMH,HeathEK,EvansJC,JonesA,PatelS,BurdenD,TillmanD,BarkerJNWN,TrembathRC(2002)Family-basedanalysisusingadensesingle-nucleotidepolymorphism?basedmapdefinesgeneticvariationatPSORS1,themajorpsoriasis-susceptibilitylocus.AmJHumGenet71:554?564
	VealCD,CloughRL,BarberRC,MasonS,TillmanD,FerryB,JonesAB,AmeenM,BalendranN,PowisSH,BurdenAD,BarkerJN,TrembathRC(2001)Identificationofanovelpsoriasissusceptibilitylocusat1pandevidenceofepistasisbetweenPSORS1andcandidateloci.JMedGenet38:7?13
	YoungC,AllenMH,CuthbertA,AmeenM,VealC,LemanJ,BurdenAD,KirbyB,GriffithsCEM,TrembathRC,Ma-thewCG,BarkerJNWN(2003)ACrohn?sdisease-associ-atedinsertionpolymorphism(3020insC)intheNOD2geneisnotassociatedwithpsoriasisvulgaris,palmo-plantarpustularpsoriasisorguttatepsoriasis.ExperDermatol12:506?509
	ZhangXJ,HePP,WangZX,ZhangJ,LiYB,WangHY,WeiSC,ChenSY,XuSJ,JinL,YangS,HuangW(2002)Evidenceforamajorpsoriasissusceptibilitylocusat6p21(PSORS1)andanovelcandidateregionat4q31bygenome-widescaninChineseHans.JInvestDermatol119:1361?1366
blagosklonnyCC2-2.pdf	0
15886.pdf	38
	ADAY, L. A. & ANDERSEN, R., 1974. A framework forstudy of access to medical care. Health ServicesResearch, 9:208-220.
	ANDERSEN, R., 1995. Revisiting the behavioral modeland access to medical care: does it matter? Jour-nal of Health and Social Behavior, 36:1-10.
	ANDERSEN, R. & NEWMAN, J. F., 1973. Societal andindividual determinants of medical care utiliza-tion in the United States. Milbank Memorial FundQuarterly, 51:95-124. 
	BORGES-YAï¿½ES, A. S. & GOMES-DANTES, H., 1998.Uso de los servï¿½cios de salud por la poblaciï¿½n de60 aï¿½os y mï¿½s em Mï¿½xico. Salud Pï¿½blica de Mï¿½xi-co, 40:13-23.
	BOULT, C.; DOWD, B.; McCAFFEY, B. A.; BOULT,L.; HERNANDEZ, R. & KRULEWITCH, H., 1993.Screening elders for risk of hospital admission.Journal of American Geriatric Society, 41:811-817.
	BRANCH, L.; JETTE, A.; EVASHWICK, C.; POLANSKY,M.; ROWE, G. & DIEHR, P., 1981. Toward under-standing elder?s health service utilization. Journalof Community Health, 7:80-92.
	COLEMAN, E. A.; WAGNER, E. H.; GROTHAUS, L. C.;HECHT, J.; SAVARINO, J. & BUCHNER, D. M.,1998. Predicting hospitalizations and functionaldecline in older health plan enrollees: Are admin-istrative data as accurate as self-report? Journalof American Geriatric Society, 46:419-425.
	CORONI-HUNTLEY, J. C.; BROCK, D. B.; OSTFELD, A.M.; TAYLOR, J. O. & WALLACE, R. B. (ed.), 1986. Es-tablished Populations for Epidemiological Stud-ies of the Elderly. NIH Publications 86-2443.Washington, DC: National Institute on Aging. 
	DATASUS (Departamento de Informï¿½tica do SUS),1997. Movimento de Autorizaï¿½ï¿½es de Internaï¿½ï¿½esHospitalares ? 1996. CD-ROM. Brasï¿½lia: Ministï¿½rioda Saï¿½de.Cad. Saï¿½de Pï¿½blica, Rio de Janeiro, 19(3):829-838, mai-jun, 2003pï¿½blicas. Informe Epidemiolï¿½gico do SUS, 9:23-
	LIMA-COSTA, M. F. F.; UCHOA, E.; GUERRA, H. L.;FIRMO, J. O. A.; VIDIGAL, P. G. & BARRETO, S. M.,2000a. The Bambuï¿½ Health and Ageing Study(BHAS): Methodological approach and prelimi-nary results of a population-based cohort studyof the elderly in Brazil. Revista de Saï¿½de Pï¿½blica,34:126-135.
	McCALL, N. & WAI, H. S., 1983. An analysis of use ofmedicare services by the continuously enrolledaged. Medical Care, 21:567-585.
	MILLER, J. E.; RUSSEL, L. B.; DAVIS, D. M.; MILAN, E.;CARSON, J. L. & TAYLOR, W. C., 1998. Biomedicalrisk factors for hospital admission in older adults.Medical Care, 36:411-421.
	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE,1998. Clinical Guidelines on the Identification,Evaluation,and Treatment of Overweight andObesity in Adults:The Evidence Report.Bethesda:US Departament of Health and Human Services,National Institutes of Health. 
	PACALA, J. T.; BOULT, C.; REED, R. L. & ALIBERTI,R. N., 1997. Predictive validity of Prainstrumentamong older recipients of managed care. Journalof American Geriatric Society, 45:614-617.
	PINHEIRO, R. S. & TRAVASSOS, C., 1999. Estudo dadesigualdade na utilizaï¿½ï¿½o de serviï¿½os de saï¿½depor idosos em trï¿½s regiï¿½es da cidade do Rio de Ja-neiro. Cadernos de Saï¿½de Pï¿½blica, 15:487-496.
	ROOS, N. P. & SHAPIRO, E., 1981. The Manitoba lon-gitudinal study on aging: Preliminary findings onhealth care utilization by the elderly. MedicalCare, 19:644-657.
	ROOS, N. P.; SHAPIRO, E. & TATE, R., 1989. Does asmall minority of elderly account for a majorityof health care expenditures? A sixteen-year per-spective. Millbank Memorial Fund Quartely, 67:347-369.
	SATISH, S.; WINOGRAD, C. H.; CHAVES, C. & BLOCH,D. A., 1996. Geriatric targeting criteria as predic-tors of survival and health care utilization. Jour-nal of American Geriatric Society, 44:914-921.
	SHARP, S. J. & POCOCK, S. J., 1997. Time trends inserum cholesterol before cancer deaths. Epidemi-ology, 8:132-136.
	TAYBACK, M.; KUMANYIKA, S. & CHEE, E., 1990. Bodyweight as a risk factor in the elderly. Archives ofInternal Medicine, 150:1065-1072.
	WOLINSKY, F. D.; JOHNSON, R. J. & FITZGERALD, J.F., 1992. The effect of falling on health status andthe use of health services by older adults. MedicalCare, 30:587-597.
	ZAR, J. H., 1984. Biostatistical Analysis. New Jersey:Prentice-Hall.
	ZOOK, C. J. & MOORE, F. D., 1980. High-cost users ofmedical care. New England Journal of Medicine,302:996-1002.
	EVANS, R. L.; HENDRICKS, R. D.; LAWRENCE, K.V. &BISHOP, D. S., 1988. Identifying factors associat-ed with health care use: A hospital-based riskscreening index. Social Science and Medicine,27:947-954.
	FREEBORN, D. K.; POPE, C. R.; MULLOOLY, J. P. & Mc-FARLAND, B. H., 1990. Consistently high usersof medical care among elderly. Medical Care, 28:567-585.
	GREENLAND, S., 1989. Modeling and variation selec-tion in epidemiologic analysis. American Journalof Public health, 79:340-349.
	GUERRA, H. L.; FIRMO, J. O. A.; UCHï¿½A, E. & LIMA-COSTA, M. F. F., 2001. The Bambuï¿½ Health andAgeing Study: Factors associated with hospital-izations among older adults in the community.Cadernos de Saï¿½de Pï¿½blica,17:1345-1356.
	HALTER, J. B., 1999. Diabetes mellitus, In: Princi-ples of Geriatric Medicine And Gerontology(W. R.Hazzard, J. P. Blass, W. H. Ettinger, J. B. Halter & J.G. Ouslander, ed.), pp. 1013-1028, New York: Mc-Graw Hill.
	HAMILTON, L. C., 1993. Interpreting multinomial lo-gistic regression. Stata Technical Bulletin, 13:24-
	HANLON, P.; WALSH, D.; WHYTE, B. W.; SCOTT, S. N.;LIGHTBODY, P. & GILHOOLY, M. L. M., 1998. Hos-pital use by an ageing cohort: An investigationbetween biological, behavioural, and social riskmarkers and subsequent hospital utilization.Journal of Public Health, 20:467-476.
	HOSMER, D. W. & LAMENSHOW, S., 1989. Applied Lo-gistic Regression. New York: John Wiley & Sons. 
	HURD, M. D. & McGARRY, K., 1997. Medical insur-ance and the use of health care services by the el-derly. Journal of Health Economics, 16:129-154.
	IBGE (Fundaï¿½ï¿½o Instituto Brasileiro de Geografia eEstatï¿½stica), 1992. Censo Demogrï¿½fico,1991. Riode Janeiro: IBGE.
	JNC (Joint National Committee), 1993. The fifth re-port of the Joint Committee on Detection, Evalu-ation, and Treatment of High Blood Pressure(JNC V). Archives of Internal Medicine, 153: 154-183. 
	JACOBS, D.; BLACKBURN, H.; HIGGINS, M.; REED,D.; ISO, H.; McMILLAN, G.; NEATON, J.; NELSON,J.; POTTER, J. & RIFKIND, B., 1992. Report of theconference on low blood cholesterol: Mortalityassociations. Circulation, 86:1046-1060.
	KAPLAN, G. A.; HAAN, M. N. & COHEN, R. D., 1992.Risk factors and the study of prevention in the el-derly: Methodological issues. In:The Epidemio-logic Study of the Elderly(R. D. Wallace & R. F.Woolson, ed.), pp. 20-36, New York: Oxford Uni-versity Press.
	LIMA-COSTA, M. F. F.; BARRETO, S. M.; GUERRA, H. L.;FIRMO, J. O. A.; UCHOA, E. & VIDIGAL, P. G.,2001.Aging with Trypanosoma cruzi infection in acommunity where the transmission has been in-terrupted: The Bambuï¿½ Health and Ageing Study(BHAS). International Journal of Epidemiology,30:887-893.
	LIMA-COSTA, M. F. F.; GUERRA, H. L.; BARRETO, S.M. & MAIA, R., 2000b. Diagnï¿½stico da situaï¿½ï¿½o desaï¿½de da populaï¿½ï¿½o idosa brasileira: Um estudoda mortalidade e das internaï¿½ï¿½es hospitalares
15884.pdf	14
	BRODEUR, J. M.; LAURIN, D.; VALLEE, R. &LACHAPELLE, D., 1993. Nutrient intake and gas-trointestinal disorders related to masticatory per-formance in the edentulous elderly. Journal ofProsthodontic Dentistry, 70:468-473.
	CARLOS, J. P. & WOLFE, M. D., 1989. Methodologicaland nutritional issues in assessing oral health ofaged subjects. American Journal of Clinical Nu-trition,50:1210-1218.
	CHAUNCEY, H. H.; MUENCH, M. E.; KAPUR, K. K. &WAYLER, A. H., 1984. The effect of the loss of teethon diet and nutrition. International Dental Jour-nal, 34:98-104.
	DOH (Department of Health), 1994. An Oral HealthStrategy for England. London: DOH.
	FINCH, S.; DOYLE, W.; LOWE, C.; BATES, C. J.; PREN-TICE, A.; SMITHERS, G. & CLARKE, P. C., 1998.National Diet and Nutrition Survey:People Aged65 and Over.Report of the Diet and Nutrition Sur-vey, v. 1. London: The Stationary Office.
	GEISSLER, C. A. & BATES, J. F., 1984. The nutritionaleffects of tooth loss. American Journal of ClinicalNutrition, 39:478-489.
	HOLLISTER, M. C. & WEINTRAUB, J. A., 1993. Theassociation of oral status with systemic health,quality of life, and economic productivity. Jour-nal of Dental Education,57:901-911.
	KRALL, E.; HAYES, C. & GARCIA, R., 1998. How denti-tion status and masticatory function affect nutri-tion intake. Journal of American Dental Associa-tion,129:1261-1269.
	MOYNIHAN, P. J., 1995. The relationship between di-et, nutrition and dental health: An overview andupdate for the 90s. Nutrition Research Review,8:193-224.
	MOYNIHAN, P. J.; SNOW, S.; JEPSON, N. J. A. & BUT-LER, T. J., 1994. Intake of non-starch polysaccha-ride (dietary fibre) in edentulous and dentatepersons: An observational study. British DentalJournal,177: 243-247.
	PAPAS, A. S.; PALMER, C. A.; ROUNDS, M. C. & RUS-SELL, R. M., 1998. The effects of denture status onnutrition. Special Care in Dentistry, 18:17-25.
	PAPAS, A. S.; PALMER, C. A.; ROUNDS, M. C.; HER-MAN, J.; McGRANDY, R.; HATZ, S.; RUSSELL, R.M. & DePAOLA, P., 1989. Longitudinal relation-ships between nutrition and oral health. Annalsof the New York Academy of Science,561:124-142.
	STEELE, J. G.; SHEIHAM, A.; MARCENES, W. & WALLS,A. W. G., 1998. National diet and Nutrition Survey:People Aged 65 Years and Over.Report of the OralHealth Survey, v. 2. London: The Stationary Office.
	WAYLER, A. H.; MUENCH, M. E.; KAPUR, K. K. &CHAUNCEY, H. H., 1984. Masticatory perfor-mance and food acceptability in persons with re-movable partial dentures, full dentures, and in-tact natural dentition. Journal of Gerontology,39:284-289.
15872.pdf	0
a08v36n2.pdf	81
	1.Aguillon JC, Bastos C, VallejosP, Hemosilla T, Morello A, PepettoY, Hellman V, Om A, Ferreira A. Purification and preliminarysequencing of Tc 45 an immunodominant Trypanosoma cruziantigen: Absence of homology with cruzipain, cruzain and 46kilodalton protein. American Journal of Tropical Medicine andHygiene 53: 211-215, 1995.
	2.Anonymous. Recommendations from a Satellite Meeting,Memï¿½rias do Instituto Oswaldo Cruz 94 (supl 1): 429-432, 1999.
	3.Araujo FG, Heilman B, Tighe L. Antigens of Trypanosoma cruzidetected by different classes and subclasses of antibodies.Transactions of the Royal Society of Tropical Medicine andHygiene 72: 672-677, 1984.
	4.Camargo M. Fluorescent antibody test for the serodiagnosis ofAmericanTrypanosomiasis. Technical modification employingpreserved cultured forms ofTrypanosoma cruzi in a slide test. Revistado Instituto de Medicina Tropical de Sï¿½o Paulo 8: 227-234, 1996.
	5.Carreira JC, Jansen AM, Lenzi H,  Deane MP. Histopathologicalstudy of  Didelphis marsupialis Natural and Experimentalinfections by Trypanosoma cruzi. Memï¿½rias do Instituto OswaldoCruz 91: 609-618, 1996.
	6.De Gaspari EN, Umezawa ES, Zingales B, Stolf AM, Colli W,Abrahamsohn IA, Trypanosoma cruzi: serum antibody reactivityto the parasite antigens in susceptible and resistant mice.Memï¿½rias do Instituto Oswaldo Cruz 85: 261-270, 1990.Revista da Sociedade Brasileira de Medicina Tropical 36:241-248, mar-abr, 2003248
	7.Deane MP, Lenzi HL, Jansen A, Trypanosoma cruzi: vertebrate andinvertebrate cycles in the same mammal host, the opossum Didelphismarsupialis. Memï¿½rias do Instituto Oswaldo Cruz 79: 513-515, 1984.
	8.Eakim AE, Mills AA, Harth G, Mckerow JH, Craik S. The sequenceorganization and expression of the major cysteine protease(Cruzain) from Trypanosoma cruzi. Journal of Biology andChemistry 267: 7411-7420, 1992.
	9.Fernandes O, Mangia RH, Lisboa CV, Pinho AP, Morel CM,Zingales B, Campbell DA, Jansen AM. The complexity of thesylvatic cycle of Trypanosoma cruzi  in Rio de Janeiro State(Brazil) revealed by the non-transcribed spacer of the mini-exongene. Parasitology 118: 161-166, 1999.
	10.Grogi M, Kuhn E. Identification of antigens of Trypanosoma cruziwhich induce antibodies during experimental Chagas Disease.Journal of Parasitology71: 183-191, 1983.
	11.Isralesky DM, Sadler R, Araï¿½jo FG. Antibody response and antigenrecognition in human infection with Trypanosoma cruzi. AmericanJournal of Tropical Medicine and Hygiene39: 445-455, 1988.
	12.Jansen AM, Leon L, Machado GM, Da Silva MH, Souza-Leï¿½oSM, Deane MP.Trypanosoma cruzi in the opossum Didelphismarsupialis: Parasitological and serological follow-up of the acuteinfection. Experimental Parasitology 73: 249-259, 1991.
	13.Jansen AM, Madeira MF, Carreira JCA, Deane MP.Trypanosomacruzi in the opossum Didelphis marsupialis: a study on thecorrelations and kinetics of the systemic and scent glandsinfection in naturally and experimentally infected animals.Experimental Parasitology 86: 37-44, 1997.
	14.Jansen AM, Moriearty PL, Galvï¿½o-Castro B, Deane MP.Trypanosoma cruzi in the opossums Didelphis marsupialis: anindirect fluorescent antibody test for the diagnosis and follow upof natural and experimental infections. Transactions of the RoyalSociety ofTropical Medicine and Hygiene 79: 474-477, 1985.
	15.Jansen AM, Pinho AP, Lisboa CV, Cupolillo E, Mangia RH, FernandesO. The Sylvatic Cycle of Trypanosoma cruzi: A still Unsolved Puzzle.Memï¿½rias do Instituto Oswaldo Cruz 94: 203-206, 1999.
	16.Juri MA, Ferreira A, Ramos A, Hoecker G. Non-lytic antibodies inH-2 controlled resistance to Trypanosoma cruzi. Brazilian Journalof Medical and Biological Research 23: 685-695, 1990.
	17.Laemmli UK. Cleavage of structural proteins during the assemblyof the head of bacteriophage T4.  Nature 227: 680-685, 1970.
	18.Legey AP, Pinho AP, Xavier SCC, Leon L, Jansen AM. HumoralImmune response kinetics in Philander opossum  and Didelphismarsupialis infected and immunized by Trypanosoma cruzi.Memï¿½rias do Instituto Oswaldo Cruz 94: 371-373, 1999.
	19.Pinho AP, Cupolillo E, Mangia RH, Fernandes O, Jansen AM.Trypanosoma cruzi in the sylvatic environment: distincttransmission cycles involving two sympatric marsupials.Transactions of the Royal Society of Tropical Medicine andHygiene 94:1-6, 2000.
	20.Scharfstein J, Rodrigues MM, Alves CA, De Souza W, PreviatoJO, Mendonï¿½a-Previato L. Trypanosoma cruzi: description of ahighly purified surface antigen defined by human antibodies.Journal of Immunology 131: 972-976, 1983.
	21.Schofield CJ.Trypanosoma cruzi ? The Vector-parasite paradox,Memï¿½rias do Instituto Oswaldo Cruz  95: 535-544, 2000.
	22.Silva LHP, Nussenzweig V.Sobre uma cepa de Trypanosomacruzi altamente virulenta para o camundongo branco. FolhaClï¿½nica e Biolï¿½gica 20: 191-208, 1953.
	23.Stevens J, Noyes H, Gibson W. The evolution of trypanosomesinfecting humans and primates. Memï¿½rias do Instituto OswaldoCruz93: 669-676, 1998.
	24.Taibi A, Espinoza AG, Ouaissi A.Trypanosoma cruzi analysis ofcellular and humoral response against a protective recombinantantigen during experimental Chagas? disease. Immunology Letters48: 193-200, 1995.
	25.Towbin H, Stachelin T, Gordon J. Electrophoretic transfer proteinsfrom polyacrylamide gels to nitrocellulose sheets: procedure andsome applications, Proceedings of  National Academy of ScienceUSA76:4350-4354, 1979.
	26.Umekita LF, Barbaro KC, Mota I. Specificity and role of anti-Trypanosoma cruzi clearance antibodies. Brazilian Journal ofMedicine and Biology Research 29: 25-31, 1996.
	27.Umezawa ES, Stolf AM, Zingales B.Trypanosoma cruzi: differentsurface antigens of trypomastigotes are targets of lytic antibodies.ActaTropica 54: 41-53, 1993.
	28.Winge H. Jordfundne og nulevende Pungdyr (Marsupialia) fraLagoa Santa, Minas Gerais, Brasilien, Med. Udsight overPungdyrenes Saegtskab. E. Museu Lundi 11: 1-149, 1893.
	29.Yoshida N, Blanco SA, Araguth MF, Russo M, Gonzalez G. Thestage-specific 90 kilodalton surface antigen of metacyclictrypomastigote of Trypanosoma cruzi. Molecular BiochemicalParasitology39: 39-45, 1990.
	30.Zingales B, Andrews NW, Kuwajima VY, Colli W.Cell surfaceantigens of Trypanosoma cruzi: Possible correlation with theinteriorization process in mammalian cells. MolecularBiochemical Parasitology 6:111-124, 1982.
6015.full.pdf	22
	1.JordanJ,ShannonJR,GroganE,BiaggioniI,RobertsonD1999Apotentpressorresponseelicitedbydrinkingwater.Lancet353:723
	2.JordanJ,ShannonJR,BlackBK,AliY,FarleyM,CostaF,DiedrichA,RobertsonRM,BiaggioniI,RobertsonD2000Thepressorresponsetowaterdrinkinginhumans:asympatheticreflex?Circulation101:504?509
	3.ScottEM,GreenwoodJP,GilbeySG,StokerJB,MaryDA2001Waterin-gestionincreasessympatheticvasoconstrictordischargeinnormalhumansubjects.ClinSciColch100:335?342
	4.TankJ,SchroederC,StoffelsM,DiedrichA,SharmaAM,LuftFC,JordanJ2003Pressoreffectofwaterdrinkingintetraplegicpatientsmaybeaspinalreflex.Hypertension41:1234?1239
	5.GeelenG,GreenleafJE,KeilLC1996Drinking-inducedplasmavasopressinandnorepinephrinechangesindehydratedhumans.JClinEndocrinolMetab81:2131?2135
	6.NonogakiK2000Newinsightsintosympatheticregulationofglucoseandfatmetabolism.Diabetologia43:533?549
	7.JordanJ,TankJ,StoffelsM,FrankeG,ChristensenNJ,LuftFC,BoschmannM2001Interactionbetween-adrenergicreceptorstimulationandnitricoxidereleaseontissueperfusionandmetabolism.JClinEndocrinolMetab86:2803?2810
	8.BoschmannM,KruppG,LuftFC,KlausS,JordanJ2002Invivoresponseto(1)-adrenoreceptorstimulationinhumanwhiteadiposetissue.ObesRes10:555?558
	9.FerranniniE1988Thetheoreticalbasesofindirectcalorimetry:areview.Metabolism37:287?301
	10.CarigaP,MathiasCJ2001Haemodynamicsofthepressoreffectoforalwaterinhumansympatheticdenervationduetoautonomicfailure.ClinSci(Lond)101:313?319
	11.SchroederC,BushVE,NorcliffeLJ,LuftFC,TankJ,JordanJ,HainsworthR2002Waterdrinkingacutelyimprovesorthostatictoleranceinhealthysub-jects.Circulation106:2806?2811
	12.RoutledgeHC,ChowdharyS,CooteJH,TownendJN2002Cardiacvagalresponsetowateringestioninnormalhumansubjects.ClinSci(Lond)103:157?162
	13.ShannonJR,GottesdienerK,JordanJ,ChenK,FlatteryS,LarsonPJ,Can-deloreMR,GertzB,RobertsonD,SunM1999Acuteeffectofephedrineon24-henergybalance.ClinSciColch96:483?491
	14.HicknerRC,EkelundU,MellanderS,UngerstedtU,HenrikssonJ1995Musclebloodflowincats:comparisonofmicrodialysisethanoltechniquewithdirectmeasurement.JApplPhysiol79:638?647
	15.HicknerRC,RosdahlH,BorgI,UngerstedtU,JorfeldtL,HenrikssonJ1992Theethanoltechniqueofmonitoringlocalbloodflowchangesinratskeletalmuscle:implicationsformicrodialysis.ActaPhysiolScand146:87?97
	16.SimoneauJA,LortieG,BoulayMR,ThibaultMC,TheriaultG,BouchardC1985Skeletalmusclehistochemicalandbiochemicalcharacteristicsinseden-tarymaleandfemalesubjects.CanJPhysiolPharmacol63:30?35
	17.JordanJ2002Acuteeffectofwateronbloodpressure.Whatdoweknow?ClinAutonRes12:250?255
	18.RossiP,AndriesseGI,OeyPL,WienekeGH,RoelofsJM,AkkermansLM1998Stomachdistensionincreasesefferentmusclesympatheticnerveactivityandbloodpressureinhealthyhumans.JNeurolSci161:148?155
	19.Ploutz-SnyderL,FoleyJ,Ploutz-SnyderR,KanaleyJ,SagendorfK,MeyerR1999Gastricgasandfluidemptyingassessedbymagneticresonanceim-aging.EurJApplPhysiolOccupPhysiol79:212?220
	20.HaberichFJ1968Osmoreceptionintheportalcirculation.FedProc27:1137?1141
	21.AdachiA1984Thermosensitiveandosmoreceptiveafferentfibersinthehe-paticbranchofthevagusnerve.JAutonNervSyst10:269?273
	22.AndrewsWH,OrbachJ1974Sodiumreceptorsactivatingsomenervesofperfusedrabbitlivers.AmJPhysiol227:1273?1275
5995.full.pdf	64
	1.RobertsJM,TaylorRN,MusciTJ,RodgersGM,HubelCA,McLaughlinMK1989Preeclampsia:anendothelialcelldisorder.AmJObstetGynecol161:1200?1204
	2.RobertsJM,TaylorRN,GoldfienA1991Clinicalandbiochemicalevidenceofendothelialcelldysfunctioninthepregnancysyndromepreeclampsia.AmJHypertens4:700?708
	3.SacksGP,StudenaK,SargentI,RedmanC1998Normalpregnancyandpre-eclampsiabothproduceinflammatorychangesinperipheralbloodleu-kocytesakintothoseofsepsis.AmJObstetGynecol179:80?86Tannettaetal.ExtraplacentalActivinAinPreeclampsiaJClinEndocrinolMetab,December2003,88(12):5995?60015999
	4.RedmanC,SacksG,SargentI1999Preeclampsia:Anexcessivematernalinflammatoryresponsetopregnancy.AmJObstetGynecol180:499?506
	5.RedmanCW1991Currenttopic:pre-eclampsiaandtheplacenta.Placenta12:301?308
	6.VinceGS,StarkeyPM,AustgulenR,KwiatkowskiD,RedmanCW1995Interleukin-6,tumournecrosisfactorandsolubletumournecrosisfactorre-ceptorsinwomenwithpre-eclampsia.BJOG102:20?25
	7.ConradKP,MilesTM,BenyoDF1998Circulatinglevelsofimmunoreactivecytokinesinwomenwithpre-eclampsia.AmJReprodImmunol40:102?111
	8.TeranE,EscuderoC,MoyaW,FloresM,VallanceP,Lopez-JaramilloP2001ElevatedC-reactiveproteinandpro-inflammatorycytokinesinAndeanwomenwithpre-eclampsia.IntJGynaecolObstet75:243?249
	9.SmarasonAK,SargentIL,StarkeyPM,RedmanCWG1993Theeffectofplacentalsyncytiotrophoblastmicrovillousmembranesfromnormalandpre-eclampticwomenonthegrowthofendothelialcellsinvitro.BJOG100:943?949
	10.KnightM,RedmanCWG,LintonEA,SargentIL1998Syncytiotrophoblastmicrovilliareshedintothematernalcirculationinincreasedamountsinpre-eclampticpregnancy.BJOG105:632?640
	11.GrangerJP,AlexanderBT,LlinasMT,BennettWA,KhalilRA2001Patho-physiologyofhypertensionduringpreeclampsialinkingplacentalischemiawithendothelialdysfunction.Hypertension38:718?722
	12.DeJongFH,GrootenhuisAJ,KlaijIA,VanBeurdenWM1990Inhibinandrelatedproteins:localization,regulationandeffects.AdvExpMedBiol274:271?293
	13.LuisiS,FlorioP,ReisFM,PetragliaF2001ExpressionandsecretionofactivinA:possiblephysiologicalandclinicalimplications.EurJEndocrinol145:225?236
	14.PetragliaF,GarutiGC,CalzaL,RobertsV,GiardinoL,GenazzaniAR,ValeW,MeunierH1991Inhibinsubunitsinhumanplacenta:localizationandmessengerribonucleicacidlevelsduringpregnancy.AmJObstetGynecol165:750?758
	15.MatherJP,MooreA,LiRH1997Activins,inhibinsandfollistatins:furtherthoughtsonagrowingfamilyofregulators.ProcSocExpBiolMed215:209?222
	16.MatherJP1996Follistatinsand2-macroglobulinsaresolublebindingpro-teinsforinhibinandactivin.HormRes45:207?210
	17.HashimotoO,NakamuraT,ShojiH,ShimasakiS,HayashiY,SuginoH1997Anovelroleoffollistatin,anactivin-bindingprotein,intheinhibitionofactivinactioninratpituitarycells.JBiolChem272:13835?13842
	18.LewisKA,GrayPC,BlountAL,MacConellLA,WiaterE,BilezikjianLM,ValeW2000Betaglycanbindsinhibinandcanmediatefunctionalantagonismofactivinsignalling.Nature404:411?414
	19.MuttukrishnaS,GeorgeL,FowlerPA,GroomeNP,KnightPG1996Serumconcentrationsof?total?activin-Aduringthehumanmenstrualcycleandpregnancy.JClinEndocrinolMetab81:3328?3334
	20.MuttukrishnaS,KnightPG,GroomeNP,RedmanCW,LedgerWL1997ActivinAandinhibinAaspossibleendocrinemarkersforpre-eclampsia.Lancet349:1285?1288
	21.BersingerNA,SmarasonAK,MuttukrishnaS,GroomeNP,RedmanCW2003Womenwithpreeclampsiahaveincreasedserumlevelsofpregnancy-associatedplasmaproteinA(PAPP-A),inhibinA,activinAandsolubleE-selectin.HypertensPregnancy22:45?55
	22.MuttukrishnaS,NorthRA,MorrisJ,SchellenbergJC,TaylorRS,AsselinJ,LedgerW,GroomeN,RedmanCWG2000SeruminhibinAandactivinAareelevatedpriortotheonsetofpre-eclampsia.HumReprod15:1640?1645
	23.BlackburnCA,KeelanJA,TaylorRS,NorthRA2003MaternalserumactivinAisnotelevatedbeforepreeclampsiainwomenwhoareathighrisk.AmJObstetGynecol188:807?811
	24.DavidsonEJ,RileySC,RobertsSA,ShearingCH,GroomeNP,MartinCW2003Maternalserumactivin,inhibin,humanchorionicgonadotrophinand-fetoproteinassecondtrimesterpredictorsofpre-eclampsia.BJOG110:46?52
	25.FlorioP,ReisFM,PezzaniI,LuisiS,SeveriFM,PetragliaF2003TheadditionofactivinAandinhibinAmeasurementtouterinearteryDopplervelocimetrytoimprovetheearlypredictionofpre-eclampsia.UltrasoundObstetGynecol21:165?169
	26.JacksonN,BiddolphSC,LedgerW,GroomeNP,ManekS2000Inhibinexpressioninnormalandpre-eclampticplacentaltissue.IntJGynecolPathol19:219?224
	27.ManuelpillaiU,Schneider-KolskyM,DoleA,WallaceEM2001ActivinAandactivinreceptorsingestationaltissuefrompreeclampticpregnancies.JEndocrinol171:57?64
	28.FlorioP,CiarmelaP,LuisiS,PalumboMA,Lambert-MesserlianG,SeveriFM,PetragliaF2002Pre-eclampsiawithfetalgrowthrestriction:placentalandserumactivinAandinhibinAlevels.GynecolEndocrinol16:365?372
	29.SilverH,Lambert-MesserlianG,ReisF,DiblasioA,PetragliaF,CanickJ2002MechanismofincreasedmaternalserumtotalactivinAandinhibinAinpre-eclampsia.JSocGynecolInvestig9:308?312
	30.BersingerA,GroomeN,MuttukrishnaS2002Pregnancy-associatedandplacentalproteinsintheplacentaltissueofnormalpregnantwomenandpatientswithpre-eclampsiaatterm.EurJEndocrinol147:785?793
	31.MohanA,AsselinJ,SargentIL,GroomeNP,MuttukrishnaS2001EffectofcytokinesandgrowthfactorsonthesecretionofinhibinA,activinAandfollistatinbytermplacentalvilloustrophoblastsinculture.EurJEndocrinol145:505?511
	32.MunnoI,ChiechiLM,LacedraG,PutignanoG,PatimoC,LobascioA,LoizziP1999Spontaneousandinducedreleaseofprostaglandins,interleukin(IL)-1,IL-6andtumournecrosisfactor-byplacentaltissuefromnormalandpre-eclampticpregnancies.AmJReprodImmunol42:369?374
	33.RinehartBK,TerroneDA,Lagoo-DeenadayalanS,BarberWH,HaleEA,MartinJrJN,BennettWA1999Expressionoftheplacentalcytokinestumournecrosisfactor,interleukin1andinterleukin10isincreasedinpre-eclamp-sia.AmJObstetGynecol181:915?920
	34.EramaaM,HurmeM,StenmanU-H,RitvosO1992ActivinA/erythroiddifferentiationfactorisinducedduringhumanmonocyteactivation.JExpMed176:1449?1452
	35.ShaoL-E,FrigonNL,SehyDW,YuAL,LofgrenJ,SchwallR,YuJ1992RegulationofproductionofactivinAinhumanmarrowstromalcellsandmonocytes.ExpHaematol20:1235?1242
	36.ShaoL-E,FrigonNL,YuAL,PalyashJ,YuJ1998ContrastingeffectsofinflammatorycytokinesandglucocorticoidsontheproductionofactivinAinhumanmarrowstromalcellsandtheirimplications.Cytokine10:227?235
	37.AbeM,ShintaniY,EtoY,HaradaK,FujinakaY,KosakaM,MatsumotoT2001Interleukin-1enhancesandinterferon-suppressesactivinAactionsbyreciprocallyregulatingactivinAandfollistatinsecretionfrombonemarrowstromalfibroblasts.ClinExpImmunol126:64?68
	38.LeungPH,SalamonsenLA,FindlayJK1998Immunolocalizationofinhibinandactivinsubunitsinhumanendometriumacrossthemenstrualcycle.HumReprod13:3469?3477
	39.KozianDH,ZicheM,AugustinHG1997Theactivin-bindingproteinfol-listatinregulatesautocrineendothelialcellactivityandinducesangiogenesis.LabInvest76:267?276
	40.McCarthySA,BicknellR1993Inhibitionofvascularendothelialcellgrowthbyactivin-A.JBiolChem268:23066?23071
	41.Schneider-KolskyM,ManuelpillaiU,GargettC,WallaceEM2001ActivinA-subunitandactivinreceptorsinhumanmyometriumattermandduringlabour.BJOG108:869?874
	42.Schneider-KolskyM,ManuelpillaiU,WaldonK,DoleA,WallaceEM2002Thedistributionofactivinandactivinreceptorsingestationaltissuesacrosshumanpregnancyandduringlabour.Placenta23:294?302
	43.DeWaardV,vandenBergVMM,VekenJ,Schultz-HeienbrokJ,PannekoekH,vanZonneveldA-J1999Serialanalysisofgeneexpressiontoassesstheendothelialcellresponsetoanatherogenicstimulus.Gene226:1?8
	44.JaffeEA,NachmanRL,BeckerCG,MinickCR1973Cultureofhumanendothelialcellsderivedfromumbilicalvein.Identificationbymorphologicandimmunologiccriteria.JClinInvest52:2745?2756
	45.LabarcaC,PaigenK1980Asimple,rapidandsensitiveDNAassayprocedure.AnalBiochem102:344?352
	46.KnightPG,MuttukrishnaS,GroomeNP1996Developmentandapplicationofatwo-siteenzymeimmunoassayforthemeasurementoftotalactivinAconcentrationsinserumandfollicularfluid.JEndocrinol148:267?279
	47.MuttukrishnaS,FowlerPA,GroomeNP,MitchellGG,RobertsonWR,KnightPG1994Serumconcentrationsofdimericinhibinduringthesponta-neoushumanmenstrualcycleandaftertreatmentwithexogenousgonado-trophin.HumReprod9:1634?1642
	48.EvansLW,MuttukrishnaS,GroomeNP1998Development,validationandapplicationofanultrasensitivetwo-siteenzymeimmunoassayforhumanfollistatin.JEndocrinol156:275?282
	49.FlorioP,CobellisL,LuisiS,CiarmelaP,SeveriFM,BocchiC,PetragliaF2001Changesininhibinsandactivinsecretioninhealthyandpathologicalpreg-nancies.MolCellEndocrinol180:123?130
	50.WallaceEM,Schneider-KolskyME,EdwardsA,BakerL,JenkinG2003MaternalserumactivinAlevelsinassociationwithintrauterinefetalgrowthrestriction.BJOG110:306?310
	51.JenkinG,WardJ,HooperS,O?ConnorA,deKretserD,WallaceE2001Feto-placentalhypoxemiaregulatesthereleaseoffetalactivinAandprosta-glandinE(2).Endocrinology142:963?966
	52.KeelanJA,TaylorR,SchellenbergJC,GroomeNP,MitchellMD,NorthRA2002SerumactivinA,inhibinA,andfollistatinconcentrationsinpreeclampsiaorsmallforgestationalagepregnancies.ObstetGynecol99:267?274
	53.MuttukrishnaS,ChildTJ,GroomeNP,LedgerWL1997bSourceofcircu-latinglevelsofinhibinA,proC-containinginhibinsandactivinAinearlypregnancy.HumReprod12:1089?1093
	54.BeekhuizenH,vanFurthR1993Monocyteadherencetohumanvascularendothelium.JLeukocBiol54:363?378
	55.BretelleF,SabatierF,DesprezD,CamoinL,GrunebaumL,CombesV,D?ErcoleC,Dignat-GeorgeF2003Circulatingmicroparticles:amarkerofprocoagulantstateinnormalpregnancyandpregnancycomplicatedbypre-eclampsiaorintrauterinegrowthrestriction.ThrombHaemost89:486?492
	56.BarakV,SchwartzA,KalickmanI,NismanB,GurmanG,ShoenfeldY1998Prevalenceofhypophosphatemiainsepsisandinfection:theroleofcytokines.AmJMed104:40?476000JClinEndocrinolMetab,December2003,88(12):5995?6001
	57.BriegelJ,JochumM,Gippner-SteppertC,ThielM2001Immunomodulationinsepticshock:hydrocortisonedifferentiallyregulatescytokineresponses.JAmSocNephrol12:S70?S74
	58.MartinC,BoissonC,HaccounM,ThomachotL,MegeJL1997Patternsofcytokineevolution(tumornecrosisfactor-andinterleukin-6)aftersepticshock,hemorrhagicshock,andseveretrauma.CritCareMed25:1813?1819
	59.D?AntonaD,ReisFM,BenedettoC,EvansLW,GroomeNP,deKretserDM,WallaceEM,PetragliaF2000IncreasedmaternalserumactivinAbutnotfollistatinlevelsinpregnantwomenwithhypertensivedisorders.JEndocrinol165:157?162
	60.NusingRM,BarsigJ1999Inductionofprosanoid,nitricoxide,andcytokineformationinratbonemarrowderivedmacrophagesbyactivinA.BrJPhar-macol127:919?926
	61.WangM,LiuA,GarciaFU,RhimJS,StearnsME1999GrowthofHPV-18immortalizedhumanprostaticintraepithelialneoplasiacelllines.InfluenceofIL-10,follistatin,activin-AandDHT.IntJOncol14:1185?1195
	62.OhguchiM,YamatoK,IshiharaY,KoideM,UedaN,OkahashiN,NoguchiT,KizakiM,IkedaY,SuginoH,NishiharaT1998ActivinAregulatestheproductionofmatureinterleukin-1andinterleukin-1receptorantagonistinhumanmonocyticcells.JInterferonCytokineRes18:491?498
	63.YuEW,DolterKE,ShaoL-E,YuJ1998SuppressionofIL-6biologicalactivitiesbyactivinAandimplicationsforinflammatoryarthropathies.ClinExpIm-munol112:126?132
	64.RussellCE,HedgerMP,BraumanJN,deKretserDM,PhillipsDJ1999ActivinAregulatesgrowthandacutephaseproteinsinthehumanlivercellline,HepG2.MolCellEndocrinol148:129?136
5989.full.pdf	25
	1.ZhdanovaIV,WurtmanRJ1997Efficacyofmelatoninasasleep-promotingagent.JBiolRhythms12:644?650
	2.CagnacciA,ElliottJA,YenSS1992Melatonin:amajorregulatorofthecircadianrhythmofcoretemperatureinhumans.JClinEndocrinolMetab75:447?452
	3.StrassmanRJ,QuallsCR,LisanskyEJ,PeakeGT1991Elevatedrectaltem-peratureproducedbyall-nightbrightlightisreversedbymelatonininfusioninmen.JApplPhysiol71:2178?2182
	4.AranginoS,CagnacciA,AngiolucciM,VaccaAM,LonguG,VolpeA,MelisGB1999Effectsofmelatoninonvascularreactivity,catecholaminelevels,andbloodpressureinhealthymen.AmJCardiol83:1417?1419
	5.Kraï¿½uchiK,CajochenC,MoriD,GrawP,Wirz-JusticeA1997EarlyeveningmelatoninandS-20098advancecircadianphaseandnocturnalregulationofcorebodytemperature.AmJPhysiol272:R1178?R1188
	6.Kraï¿½uchiK,WerthE,Wuï¿½stD,RenzC,Wirz-JusticeA1999Interactionofmelatoninwithcorebodycooling:sleepinessisprimarilyassociatedwithheatlossandnotwithadecreaseincorebodytemperature.Sleep22:S285
	7.SavaskanE,OlivieriG,BrydonL,JockersR,KrauchiK,Wirz-JusticeA,Muller-SpahnF2001CerebrovascularmelatoninMT1-receptoralterationsinpatientswithAlzheimer?sdisease.NeurosciLett308:9?12
	8.BraunAR,BalkinTJ,WesentenNJ,CarsonRE,VargoM,BaldwinP,SelbieS,BelenkyG,Herscovitch1997Regionalcerebralbloodflowthroughoutthesleep-wakecycle.AnH2(15)OPETstudy.Brain120:1173?1197
	9.CagnacciA,AranginoS,AngiolucciM,MaschioE,LonguG,MelisGB1997Potentiallybeneficialcardiovasculareffectsofmelatoninadministrationinwomen.JPinealRes22:16?19
	10.CagnacciA,AranginoS,AngiolucciM,MaschioE,MelisGB1998Influencesofmelatoninadministrationonthecirculationofwomen.AmJPhysiol274:R335?R338
	11.CagnacciA,AranginoS,AngiolucciM,MelisBG,FacchinettiF,MalmusiS,VolpeA2001Effectofexogenousmelatoninonvascularreactivityandnitricoxideinpostmenopausalwomen:roleofhormonereplacementtherapy.ClinEndocrinol(Oxf)54:261?266
	12.SpiltA,BoxFM,VanDerGeestRJ,ReiberJH,KunzP,KamperAm,BlauwGJ,VanBuchemMA2002Reproducibilityoftotalcerebralbloodflowmea-surementsusingphasecontrastmagneticresonanceimaging.JMagnResonImaging16:1?5
	13.VanSomerenEJW2000Morethanamarker:interactionbetweenthecircadianregulationoftemperatureandsleep,age-relatedchanges,andtreatmentpos-sibilities.ChronobiolInt17:313?354
	14.KitajimaT,KanbayashiT,SaitohY,OgawaY,SugiyamaT,KanekoY,SusakiY,AizawaR,ShimisuT2001Theeffectsoforalmelatoninontheautonomicfunctioninhealthysubjects.PsychiatryClinNeurosci55:299?300
	15.RubinsteinEH,SesslerDI1990Skin-surfacetemperaturegradientscorrelatewithfingertipbloodflowinhumans.Anesthesiology73:541?545
	16.LavieP,SchnallRP,SheffyJ,ShlitnerA2000PeripheralvasoconstrictionduringREMsleepdetectedbyanewplethysmographicmethod.NatMed6:606
	17.LeBarsD,ThivolleP,VittePA,BojkowskiC,ChazotG,ArendtJ,Frack-owiakRS,ClaustratB1991PETandplasmapharmacokineticstudiesafterbolusintravenousadministrationof[11C]melatonininhumans.IntJRadApplInstrum18:357?362
	18.VanMilAH,SpiltA,VanBuchemMA,BolenELEM,TeppemaL,West-endorpRGJ,BlauwGJ2002Nitricoxidemediateshypoxia-inducedcerebralvasodilationinhumans.JApplPhysiol92:962?966
	19.GeoffriauM,ClaustratB,VeldhuisJ1999Estimationoffrequentlysamplednocturnalmelatoninproductioninhumansbydeconvolutionanalysis:evi-denceforepisodicorultradiansecretion.JPinealRes27:139?144
	20.IguchiH,KatoKI,IbayashiH1982Melatoninserumlevelsandmetabolicclearancerateinpatientswithlivercirrhosis.JClinEndocrinolMetab54:1025?1027
	21.BurgessHJ,SlettenT,SavicN,GilbertSS,DawsonD2001Effectsofbrightlightandmelatoninonsleeppropensity,temperature,andcardiacactivityatnight.JApplPhysiol91:1214?1222
	22.HarrisAS,BurgessHJ,DawsonD2001Theeffectsofday-timeexogenousmelatoninadministrationoncardiacautonomicactivity.JPinealRes31:199?205
	23.NishiyamaK,YasueH,MoriyamaY,TsunodaR,OgawaY,YoshimuraM,KugiyamaK2001Acuteeffectsofmelatoninadministrationoncardiovascularautonomicregulationinhealthymen.AmHeartJ141:E9
	24.DoolenS,KrauseDN,DubocovichML,DucklesSP1998Melatoninmediatestwodistinctresponsesinvascularsmoothmuscle.EurJPharmacol345:67?69
	25.WeekleyLB1993Effectsofmelatoninonpulmonaryandcoronaryvesselsareexertedthroughperivascularnerves.ClinAutonRes3:45?47
5927.full.pdf	48
	1.FontbonneA.M.,Eschwege,E.M1991Insulinandcardiovasculardisease.ParisProspectiveStudy.DiabetesCare14:461?469
	2.Pyorala,M.,Miettinen,H.,Laakso,M.,Pyorala,K1998Hyperinsulinemiapredictscoronaryheartdiseaseriskinhealthymiddle-agedmen:the22-yearfollow-upresultsoftheHelsinkiPolicemenStudy.Circulation98:398?404
	3.PyoralaK,SavolainenE,KaukolaS,HaapakoskiJ1985Plasmainsulinascoronaryheartdiseaseriskfactor:relationshiptootherriskfactorsandpre-dictivevalueduring91/2-yearfollow-upoftheHelsinkiPolicemenStudypopulation.ActaMedScand701:(Suppl)38?52
	4.DespresJP,LamarcheB,MauriegeP,CantinB,DagenaisGR,MoorjaniS,LupienPJ1996Hyperinsulinemiaasanindependentriskfactorforischemicheartdisease.NEnglJMed334:952?957
	5.HowardG,O?LearyDH,ZaccaroD,HaffnerS,RewersM,HammanR,SelbyJV,SaadMF,SavageP,BergmanR1996Insulinsensitivityandathero-sclerosis.TheInsulinResistanceAtherosclerosisStudy(IRAS)Investigators.Circulation93:809?817
	6.ReavenGM1988Roleofinsulinresistanceinhumandisease.Diabetes37:1595?1607
	7.LilliojaS,MottDM,SpraulM,FerraroR,FoleyJE,RavussinE,KnowlerWC,BennettPH,BogardusC1993Insulinresistanceandinsulinsecretorydys-functionasprecursorsofnon-insulin-dependentdiabetesmellitus.ProspectivestudiesofPimaIndians.NEnglJMed329:1988?1992
	8.HaffnerSM,SternMP,MitchellBD,HazudaHP,PattersonJK1990IncidenceoftypeIIdiabetesinMexicanAmericanspredictedbyfastinginsulinandglucoselevels,obesity,andbody-fatdistribution.Diabetes39:283?288
	9.BergstromRW,Newell-MorrisLL,LeonettiDL,ShumanWP,WahlPW,FujimotoWY1990AssociationofelevatedfastingC-peptidelevelandin-creasedintra-abdominalfatdistributionwithdevelopmentofNIDDMinJap-anese-Americanmen.Diabetes39:104?111
	10.CharlesMA,FontbonneA,ThibultN,WarnetJM,RosselinGE,EschwegeE1991RiskfactorsforNIDDMinwhitepopulation.Parisprospectivestudy.Diabetes40:796?799
	11.BogardusC,LilliojaS,MottDM,HollenbeckC,ReavenG1985Relationshipbetweendegreeofobesityandinvivoinsulinactioninman.AmJPhysiol248:286?291
	12.AbateN,GargA,PeshockRM,Stray-GundersenJ,GrundySM1995Rela-tionshipsofgeneralizedandregionaladipositytoinsulinsensitivityinmen.JClinInvest96:88?98
	13.UKProspectiveDiabetesStudyGroup1994UKProspectiveDiabetesStudy.XII.DifferencesbetweenAsian,Afro-CaribbeanandwhiteCaucasiantype2diabeticpatientsatdiagnosisofdiabetes.DiabeticMed11:670?677
	14.McKeiguePM,ShahB,MarmotMG1991RelationofcentralobesityandinsulinresistancewithhighdiabetesprevalenceandcardiovascularriskinSouthAsians.Lancet337:382?386
	15.ChandaliaM,AbateN,GargA,Stray-GundersenJ,GrundyS.M1999RelationshipbetweengeneralizedandupperbodyobesitytoinsulinresistanceinAsianIndianmen.JClinEndocrinolMetab84:2329?2335
	16.DowseGK,GareebooH,ZimmetPZ,AlbertiKG,TuomilehtoJ,FareedD,BrissonnetteLG,FinchCF1990HighprevalenceofNIDDMandimpairedglucosetoleranceinIndian,Creole,andChineseMauritians.MauritiusNon-communicableDiseaseStudyGroup.Diabetes39:390?396
	17.RamachandranA,SnehlathaC,DharmarajD,ViswanathanM1992Preva-lenceofglucoseintoleranceinAsianIndians.Urban-ruraldifferenceandsignificanceofupperbodyadiposity.DiabetesCare15:1348?1355
	18.RamachandranA,JaliMV,MohanV,SnehalathaC,ViswanathanM1988HighprevalenceofdiabetesinanurbanpopulationinsouthIndia.BrMedJ297:587?90
	19.MatherHM,KeenH1985TheSouthallDiabetesSurvey:prevalenceofknowndiabetesinAsiansandEuropeans.BrMedJ291:1081?1084
	20.McKeiguePM,MillerGJ,MarmotMG1989CoronaryheartdiseaseinsouthAsiansoverseas.JClinEpidemiol42:597?609
	21.SarvothamSG,BerryJN1968PrevalenceofcoronaryheartdiseaseinanurbanpopulationinnorthernIndia.Circulation37:939?953
	22.DewanBD,MalhotraKC,GuptaSP1974EpidemiologicalstudyofcoronaryheartdiseaseinruralcommunityinHaryana.IndianHeartJ26:68?78
	23.ChadhaSL,RadhakrishnanS,RamachandranK,KaulU,GopinathN1990EpidemiologicalstudyofcoronaryheartdiseaseinurbanpopulationofDelhi.IndianJMedRes92:424?430
	24.BecklesGL,MillerGJ,KirkwoodBR,AlexisSD,CarsonDC,ByamNT1986HightotalandcardiovasculardiseasemortalityinadultsofIndiandescentinTrinidad,unexplainedbymajorcoronaryriskfactors.Lancet1:1298?1301
	25.GroopL2000Geneticsofthemetabolicsyndrome.BrJNutr83:39?48
	26.AlmindK,InoueG,PedersenO,KahnCR1996Acommonaminoacidpolymorphismininsulinreceptorsubstrate-1causesimpairedinsulinsignal-ing.Evidencefromtransfectionstudies.JClinInvest97:2569?2575
	27.HribalML,FedericiM,PorzioO,LauroD,BorboniP,Accili,D,LauroR,SestiG2000TheGly3Arg972aminoacidpolymorphismininsulinreceptorsubstrate-1affectsglucosemetabolisminskeletalmusclecells.JClinEndo-crinolMetab85:2004?2013
	28.CeliFS,SilverK,WaltsonJ,KnowlerWC,BogardusC,ShuldinerAR1995LackofIRS-1codon513and972polymorphisminPimaIndians.JClinEndocrinolMetab80:2827?2829
	29.HitmanGA,HawramiK,McCarthyMI,ViswanathanM,SnehalathaC,RamachandranA,TuomilehtoJ,Tuomilehto-WolfE,NissinenA,PedersenO1995Insulinreceptorsubstrate-1genemutationsinNIDDM;implicationsforthestudyofpolygenicdisease.Diabetologia38:481?486
	30.PizzuttiA,FrittittaL,ArgiolasA,BarattaR,GoldfineID,BozzaliM,ErcolinoT,ScarlatoG,IacovielloL,VigneriR,TassiV,TrischittaV1999Apoly-morphism(K121Q)ofthehumanglycoproteinPC-1genecodingregionisstronglyassociatedwithinsulinresistance.Diabetes48:1881?1884
	31.FrittittaL,BarattaR,SpampinatoD,DiPaolaR,PizzutiA,VigneriR,TrischittaV2001TheQ121PC-1variantandobesityhaveadditiveandindependenteffectsincausinginsulinresistance.JClinEndocrinolMetab86:5888?5891
	32.MadduxBA,SbracciaP,KamakuraS,SassonS,YoungrenJ,FisherA,SpencerS,GrupeA,HenzelW,StewartTA1995MembraneglycoproteinPC-1andinsulinresistanceinnon-insulin-dependentdiabetesmellitus.Na-ture373:448?451
	33.MadduxBA,GoldfineID2000MembraneglycoproteinPC-1inhibitionofinsulinreceptorfunctionoccursviadirectinteractionwiththereceptor-subunit.Diabetes49:13?19
	34.KumakuraS,MadduxBA,SungCK1998Overexpressionofmembranegly-coproteinPC-1caninfluenceinsulinactionatapost-receptorsite.JCellBiochem3:366?377
	35.YoungrenJ,MadduxBA,SassonS,SbracciaP,TapscottEB,SwansonMS,DohmGL,GoldfineID1996Skeletalmusclecontentofmembraneglyco-proteinPC-1inobesity.Relationshiptomuscleglucosetransport.Diabetes45:1324?1328
	36.FrittittaL,YoungrenJ,SbracciaP,D?AdamoM,BuongiornoA,VigneriR,GoldfineID,TrischittaV1997IncreasedadiposetissuePC-1proteincontent,butnottumournecrosisfactor-geneexpression,isassociatedwithareduc-tionofbothwholebodyinsulinsensitivityandinsulinreceptortyrosine-kinaseactivity.Diabetologia40:282?289
	37.FrittittaL,SpampinatoD,SoliniA,NosadiniR,GoldfineID,VigneriR,TrischittaV1998ElevatedPC-1contentinculturedskinfibroblastscorrelateswithdecreasedinvivoandinvitroinsulinactioninnondiabeticsubjects:evidencethatPC-1maybeanintrinsicfactorinimpairedinsulinreceptorsignaling.Diabetes47:1095?1100
	38.CostanzoBV,TrischittaV,DiPaolaR,SpampinatoD,PizzutiA,VigneriR,FrittittaL2001TheQallelevariant(GLN121)ofmembraneglycoproteinPC-1interactswiththeinsulinreceptorandinhibitsinsulinsignalingmoreeffec-tivelythanthecommonKallelevariant(LYS121).Diabetes50:831?836
	39.FrittittaL,YoungrenJ,VigneriR,MadduxBA,TrischittaV,GoldfineID1996PC-1contentinskeletalmuscleofnon-obese,non-diabeticsubjects:relation-shiptoinsulinreceptortyrosinekinaseandwholebodyinsulinsensitivity.Diabetologia39:1190?1195
	40.SiriWE1961Techniquesformeasuringbodycomposition.WashingtonDC:NationalAcademyofSciences;223?224
	41.DeFronzoRA,TobinJD,AndresR1979Glucoseclamptechnique:amethodforquantifyinginsulinsecretionandresistance.AmJPhysiol237:E214?E223
	42.GuHF,AlmgrenP,LindholmE,FrittittaL,PizzutiA,TrischittaV,GroopLC2000AssociationbetweenthehumanglycoproteinPC-1geneandelevateglucoseandinsulinlevelsinapaired-siblinganalysis.Diabetes49:1601?1603
	43.KubaszekA,PihlajamakiJ,KarhapaaP,VauhkonenI,LaaksoM2003TheK121QpolymorphismofthePC-1geneisassociatedwithinsulinresistancebutnotwithdyslipidemia.DiabetesCare26:464?467
	44.Gonzaï¿½lez-Saï¿½nchezJL,Mart?ï¿½nez-LarradMT,Fernaï¿½ndez-Peï¿½rezC,KubaszekA,LaaksoM,Serrano-R?ï¿½osM2003K121QPC-1genepolymorphismisnotassociatedwithinsulinresistanceinaSpanishpopulation.ObesRes11:603?605
	45.RasmussenSK,UrhammerSA,PizzutiA,EchwaldSM,EkstromCT,HansenL,HansenT,Borch-JohnsenK,FrittittaL,TrischittaV,PedersenO2000TheK121QvariantofthehumanPC-1geneisnotassociatedwithinsulinresistanceortype2diabetesamongDanishCaucasians.Diabetes49:1608?1611
	46.KalhanR,PuthawalaK,AgarwalS,AminiSB,KalhanSC2001Alteredlipidprofile,leptin,insulin,andanthropometryinoffspringofSouthAsianimmi-grantsintheUnitedStates.Metabolism10:1197?1202
	47.NeelJV1962Diabetesmellitus:athriftygenotyperendereddetrimentalbyprogress.AmJHumGenet14:353?362
	48.ClausenJO,HansenT,BjorbaekC,EchwaldSM,UrhammerSA,RasmussenS,AndersenCB,HansenL,AlmindK,WintherK,HaraldsdottirJ,Borch-JohnsenK1995Insulinresistance:interactionsbetweenobesityandacommonvariantofinsulinreceptorsubstrate-1.Lancet346:397?402
818.pdf	16
810.pdf	16
805.pdf	9
20030300s00015p65.pdf	6
	1.Pezzella AT, Silva WE, Lancey RA. Cardiothoracic trauma:injuries of the thoracic aorta and great vessels. Curr ProblSurg 1998;35(8):762-71.
	2.Cuadros CL, Hutchinson JE 3rd, Mogtader AH. Lacera-tion of a mitral papillary muscle and the aortic root as a re-sult of blunt trauma to the chest. Case report and review ofthe literature. J Thorac Cardiovasc Surg 1984;88:134-40.
	3.Langanay T, Verhoye JP, Corbineau H, Agnino A, DerieuxT, Menestret P, et al. Surgical treatment of acute traumaticrupture of the thoracic aorta a timing reappraisal? Eur J Car-diothorac Surg 2002;21(2):282-7.
	4.Galli R, Pacini D, Di Bartolomeo R, Fattori R, Turinetto B,Grillone G, Pierangeli A. Surgical indications and timing ofrepair of traumatic ruptures of the thoracic aorta. Ann Tho-rac Surg 1998;65:461-4.
	5.von Segesser LK, Fischer A, Vogt P, Turina M. Diagnosisand management of blunt great vessel trauma. J Card Surg1997;12(2 Suppl):181-92.
	6.Peek GJ, Killer HM, Sosnowski AW, Firmin RK. Extracor-poreal membrane oxygenation: potential for adults and chil-dren? Hosp Med 1998;59(4):304-8.Texas Heart Institute JournalEarly Stabilization of Traumatic Aortic Transection and MV Regurgitation with ECMO      67
20030300s00012p50.pdf	14
	1.Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cellmyocarditis?natural history and treatment. MulticenterGiant Cell Myocarditis Study Group Investigators. N EnglJ Med 1997;336(26):1860-6.
	2.Gries W, Farkas D, Winters GL, Costanzo-Nordin M.Giant cell myocarditis: first report of disease recurrence inthe transplanted heart. J Heart Lung Transplant 1992;11(2Pt 2):370-4.
	3.Marelli D, Laks H, Amsel B, Jett GK, Couper G, ArdehaliA, et al. Temporary mechanical support with the BVS 5000assist device during treatment of acute myocarditis. J CardSurg 1997;12:55-9.
	4.Marelli D, Laks, H, Fazio D, Hamilton MA, Fonarow GC,Meehan DA, Mariguchi JD. Mechanical assist strategyusing the BVS 5000i for patients with heart failure. AnnThorac Surg 2000;70:59-66.
	5.Champsaur G, Ninet J, Vigneron M, Cochet P, NeideckerJ, Boissonnat P. Use of the Abiomed BVS System 5000i as abridge to cardiac transplantation. J Thorac Cardiovasc Surg1990;100:122-8.
	6.Jett GK. ABIOMED BVS 5000. Experience and potentialadvantages. Ann Thorac Surg 1996;61:301-4,311-3.
	7.Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T,Suzuki K, Shibata A. Rat dilated cardiomyopathy after au-toimmune giant cell myocarditis. Circ Res 1994;75(2):278-84.
	8. Hanawa H, Inomata T, Okura Y, Hirono S, Ogawa Y, IzumiT, et al. T cells with similar T-cell receptor beta-chain complementarity-determining region 3 motifs infiltrate inflammatorylesions of synthetic peptides inducing ratautoimmune myocarditis. Circ Res 1998;83(2):133-40.
	9. Cooper LT Jr. Giant cell myocarditis: diagnosis and treatment.Herz 2000;25(3):291-8.
	10. Nieminen MS, Salminen US, Taskinen E, Heikkila P, PartanenJ. Treatment of serious heart failure by transplantationin giant cell myocarditis diagnosed by endomyocardialbiopsy. J Heart Lung Transplant 1994;13:543-5.
	11. Brilakis ES, Olson LJ, Berry GJ, Daly RC, Loisance D,Zucker M, Cooper LT Jr. Survival outcomes of patientswith giant cell myocarditis bridged by ventricular assist devices.ASAIO J 2000;46(5):569-72.
	12. Tsai FC, Marelli D, Laks H, Moriguchi J, Sopher M, BressonJ, et al. Short-term bridge to heart transplant using theBVS 5000 external ventricular assist device. Am J Transplant2002;2(7):646-51.
	13. McCarthy RE 3rd, Boehmer JP, Hruban RH, HutchinsGM, Kasper EK, Hare JM, Baughman KL. Long-term outcomeof fulminant myocarditis as compared with acute(nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
	14. Frustaci A, Chimenti C, Pieroni M, Gentiloni N. Giant cellmyocarditis responding to immunosuppressive therapy.Chest 2000;117(3):905-7.
20030300s00007p31.pdf	20
	1.Jaber SF, Koening SC, BhashkerRao B, VanHimbergen DJ,Cerrito PB, Ewert DJ, et al. Role of graft flow measurementtechnique in anastomotic quality assessment in minimallyinvasive CABG. Ann Thorac Surg 1998;66:1087-92.
	2.D?Ancona G, Karamanoukian HL, Ricci M, Schmid S,Bergsland J, Salerno TA. Graft revision after transit timeflow measurement in off-pump coronary artery bypassgrafting. Eur J Cardiothorac Surg 2000;17:287-93.
	3.Vetter HO, Driever R, Mertens H, Kempkes U, CramerBM. Contrast-enhanced magnetic resonance angiographyof mammary artery grafts after minimally invasive coronarybypass surgery. Ann Thorac Surg 2001;71:1229-32.
	4.Wintersperger BJ, Engelmann MG, von Smekal A, Knez A,Penzkofer HV, Hofling B, et al. Patency of coronary bypassgrafts: assessment with breath-hold contrast-enhanced MRangiography value of a non-electrocardiographically triggeredtechnique. Radiology 1998;208:345-51.
	5.Langerak SE, Kunz P, Vliegen HW, Lamb HJ, Jukema JW,van Der Wall EE, de Roos A. Improved MR flow mappingin coronary artery bypass grafts during adenosine-inducedstress. Radiology 2001;218:540-7.
	14.Louagie YA, Haxhe JP, Buche M, Schoevaerdts JC. Intraop-erative electromagnetic flowmeter measurements in coro-nary artery bypass grafts. Ann Thorac Surg 1994;57:357-
	15.Hirotani T, Kameda T, Shirota S, Nakao Y. An evaluationof the intraoperative transit time measurements of coronarybypass flow. Eur J Cardiothorac Surg 2001;19:848-52.
	16.Wiklund L, Johansson M, Brandrup-Wongsen G, Bugge M,Radberg G, Berglin E. Difficulties in the interpretation ofcoronary angiogram early after coronary artery bypass sur-gery on the beating heart. Eur J Cardiothorac Surg 2000;17:46-51.
	17.Dodge JT Jr, Brown BG, Bolson EL, Dodge HT. Lumendiameter of normal human coronary arteries. Influence ofage, sex, anatomic variation, and left ventricular hypertro-phy or dilation. Circulation 1992;86:232-46.
	18.Wang Y, Riederer SJ, Ehman RL. Respiratory motion of theheart: kinematics and the implications for the spatial reso-lution in coronary imaging. Magn Reson Med 1995;33:713-9.
	19.Walpoth BH, Muller MF, Genyk I, Aeschbacher B, KipferB, Althaus U, Carrel TP. Evaluation of coronary bypassflow with color-Doppler and magnetic resonance imagingtechniques: comparison with intraoperative flow measure-ments. Eur J Cardiothorac Surg 1999;15:795-802.
	20.Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, NagelE, et al. Coronary magnetic resonance angiography for thedetection of coronary stenoses. N Engl J Med 2001;345:1863-9.
	6.Beldi G, Bosshard A, Hess OM, Althaus U, Walpoth BH.Transit time flow measurement: experimental validationand comparison of three different systems. Ann ThoracSurg 2000;70:212-7.
	7.Walpoth BH, Bosshard A, Genyk I, Kipfer B, Berdat PA,Hess OM, et al. Transit-time flow measurement for detec-tion of early graft failure during myocardial revasculariza-tion. Ann Thorac Surg 1998;66:1097-100.
	8.Laustsen J, Pedersen EM, Terp K, Steinbruchel D, KureHH, Paulsen PK, et al. Validation of a new transit time ultrasound flowmeter in man. Eur J Vasc Endovasc Surg1996;12(1):91-6.
	9.Barstad RM, Fosse E, Vatne K, Andersen K, Tonnessen TI,Svennevig JL, Geiran OR. Intraoperative angiography inminimally invasive direct coronary artery bypass grafting.Ann Thorac Surg 1997;64:1835-9.
	10.Goldstein JA, Safian RD, Aliabadi D, O?Neill WW, Shan-non FL, Bassett J, Sakwa M. Intraoperative angiography toassess graft patency after minimally invasive coronary by-pass. Ann Thorac Surg 1998;66:1978-82.
	11.Canver CC, Dame N. Ultrasonic assessment of internalthoracic artery graft flow in the revascularized heart. AnnThorac Surg 1994;58:135-8.
	12.Louagie YA, Haxhe JP, Jamart J, Buche M, SchoevaerdtsJC. Intraoperative assessment of coronary artery bypassgrafts using a pulsed Doppler flowmeter. Ann Thorac Surg1994;58:742-9.
	13.Walpoth BH, Mohadjer A, Gersbach P, Rogulenko R, Wal-poth BN, Althaus U. Intraoperative internal mammary ar-tery transit-time flow measurements: comparative evaluationof two surgical pedicle preparation techniques. Eur J Cardio-thorac Surg 1996;10:1064-70.
01.pdf	45
	Atlas, R.M., Sayler, G., Burlage, R.S., and Bej, A.K. 1992.Molecular approaches for environmental monitoring ofmicroorganisms. BioTechniques 12: 706-717.
	Bruce, K.D., Hiorns, W.D., Hobman, J.L., Osborn, A.M.,Strike, P., and Ritchie, D.A. 1992. Amplification of DNAfrom native populations of soil bacteria by using thepolymerase chain reaction. Appl. Environ. Microbiol. 58:3413-3416.
	Courtois, S., Frostegï¿½rd, ï¿½., Gï¿½ransson, P., Depret, G.,Jeannin, P., and Simonet, P. 2001. Quantification ofbacterial subgroups in soil: comparison of DNA extracteddirectly from soil or from cells previously released bydensity gradient centrifugation. Environ. Microbiol. 3: 431-439.
	Cullen, D.W. and Hirsch, P.R. 1998. Simple and rapidmethod for direct extraction of microbial DNA from soilfor PCR. Soil Biol. Biochem. 30: 983-993.
	Demeke, T. and Adams, R.P. 1992. The effects of plantpolysaccharides and buffer additives on PCR.BioTechniques 12: 332-333.
	Edgcomb, V.P., McDonald, J.H., Devereux, R., and Smith,D.W. 1999. Estimation of bacterial cell numbers in humicacid-rich salt marsh sediments with probes directed to16S ribosomal DNA. Appl. Environ. Microbiol. 65: 1516-1523.
	Edwards U., Rogall H., Blï¿½cker H., Emde M., and Bï¿½ttgerE.C. 1989. Isolation and direct complete nucleotidedetermination of entire genes. Characterization of a genecoding for 16S ribosomal RNA. Nucl. Acids Res. 17: 7843-7853.
	Erb, R.W. and Wagner-Dï¿½bler, I. 1993. Detection ofpolychlorinated biphenyl degradation genes in pollutedsediments by direct DNA extraction and polymerase chainreaction. Appl. Environ. Microbiol. 59: 4065-4073.
	Frostegï¿½rd, ï¿½., Courtois, S., Ramisse, V., Clerc, S.,Bernillon, D., Le Gall, F., Jeannin, P., Nesme, X., andSimonet, P. 1999. Quantification of bias related to eachstep of an optimized protocol to extract, purify, and amplifyDNA from soils. Appl. Environ. Microbiol. 65: 5409-5420.
	Greaves, M.P. and Wilson, M.J. 1969. The adsorption ofnucleic acids by montmorillonite. Soil Biol. Biochem. 1:317-323.
	Herrick, J.B., Madsen, E.L., Batt, C.A., and Ghiorse, W.C.1993. Polymerase chain reaction amplification ofnaphthalene-catabolic and 16S rRNA gene sequencesfrom indigenous sediment bacteria. Appl. Environ.Microbiol. 59: 687-694.
	Holben W.E. 1994. Isolation and purification of bacterialDNA from soil. In: Methods of Soil Analysis, Part 2.Microbiological and Biochemical Properties. Soil ScienceSociety of America, Madison. p. 727-751.
	Holben, W.E., Jansson, J.K., Chelm, B.K., and Tiedje, J.M.1988. DNA probe method for the detection of specificmicroorganisms in the soil bacterial community. Appl.Environ. Microbiol. 54: 703-711.
	Holley, R.W., Apgar, J., Doctor, B.P., Farrow, J., Marini,M.A., and Merrill, S.H. 1961. A simplified procedure forthe preparation of tyrosine- and valine-acceptor fractionof yeast ?soluble ribonucleic acid.? J. Biol. Chem. 236:200-202.
	Jackson, C.R., Harper, J.P., Willoughby, D., Rodin, E.E.,and Churchill, P.F. 1997. A simple, efficient method forthe separation of humic substances and DNA fromenvironmental samples. Appl. Environ. Microbiol. 63:4993-4995.
	Jacobsen, C.S. and Rasmussen, O.F. 1992. Developmentand application of a new method to extract bacterial DNAfrom soil based on separation of bacteria from soil withcation-exchange resin. Appl. Environ. Microbiol. 58: 2458-2462.
	Josephson, K.L, Pillai, S.D, Way, J., Gerba, C.P., andPepper, I.L. 1991. Fecal coliforms in soil detected bypolymerase chain reaction and DNA-DNA hybridizations.Soil Sci. Soc. Am. J. 55: 1326-1332.
	Lorenz, M.G. and Wackernagel, W. 1987. Adsorption ofDNA to sand and variable degradation rates of adsorbedDNA. Appl. Environ. Microbiol. 53: 2948-2952.
	Lovell, C.R. and Piceno, Y. 1994. Purification of DNA fromestuarine sediments. J. Microbiol. Meth. 20: 161-174.
	Madsen, E.L. 1998. Epistemology of environmentalmicrobiology. Environ. Sci. Technol. 32: 429-439.
	Markov, G.G. and Ivanov, I.G. 1974. Hydroxyapatite columnchromatography in procedures for isolation of purifiedDNA. Analyt. Biochem. 59: 555-563.
	Morï¿½, M.I., Herrick, J.B., Silva, M.C., Ghiorse, W.C., andMadsen, E.L. 1994. Quantitative cell lysis of indigenousmicroorganisms and rapid extraction of microbial DNAfrom sediment. Appl. Environ. Microbiol. 60: 1572-1580.
	Ogram, A., Sayler, G.S., and Barkay, T. 1987. The extractionand purification of microbial DNA from sediments. J.Microbiol. Meth. 7: 57-66.
	Ogram, A., Sayler, G.S., Gustin, D., and Lewis, R.J. 1988.DNA adsorption to soils and sediments. Environ. Sci.Technol. 22: 982-984.
	Picard, C., Ponsonnet, C., Paget, E., Nesme, X., andSimonet, P. 1992. Detection and enumeration of bacteriain soil by direct DNA extraction and polymerase chainreaction. Appl. Environ. Microbiol. 58: 2717-2722.
	Porteous, L.A. and Armstrong, J.L. 1991. Recovery of bulkDNA from soil by a rapid, small-scale extraction method.Curr. Microbiol. 22: 345-348.
	Porteous, L.A., Seidler, R.J., and Watrud, L.S. 1997. Animproved method for purifying DNA from soil forpolymerase chain reaction amplification and molecularecology applications. Molec. Ecol. 6: 787-791.
	Ranjard, L., Poly, F., Combrisson, J., Richaume, A., andNazaret, S. 1998. A single procedure to recover DNA fromthe surface or inside aggregates and in various sizefractions of soil suitable for PCR-based assays of bacterialcommunities. Eur. J. Soil Biol. 34: 89-97.
	Rochelle, P.A. and Olson, B.H. 1991. A simple techniquefor electroelution of DNA from environmental samples.BioTechniques 11: 724-728.
	Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989.Molecular Cloning: A Laboratory Manual, 2nd ed. ColdSpring Harbor Laboratory Press, Plainview, NY.
	Schneegurt, M.A. and Kulpa, C.F., Jr. 1998. Review: Theapplication of molecular techniques in environmentalbiotechnology for monitoring microbial systems.Biotechnol. Appl. Biochem. 27: 73-79.
	Selenska, S. and Klingmï¿½ller, W. 1991. DNA recovery anddirect detection of Tn5 sequences from soil. Lett. Appl.Microbiol. 13: 21-24.
	Smalla, K., Cresswell, N., Mendonca-Hagler, L.C., Wolters,A., and van Elsas, J.D. 1993. Rapid DNA extractionprotocol from soil for polymerase chain reaction-mediatedamplification. J. Appl. Biotechnol. 74: 78-85.
	Steffan, R.J., Goksï¿½yr, J., Bej, A.K., and Atlas, R.M. 1988.Recovery of DNA from soils and sediments. Appl. Environ.Microbiol. 54: 2908-2915.
	Tebbe, C.C. and Vahjen, W. 1993. Interference of humicacids and DNA extracted directly from soil in detectionand transformation of recombinant DNA from bacteria anda yeast. Appl. Environ. Microbiol. 59: 2657-2665.
	Torsvik, V.L. 1980. Isolation of bacterial DNA from soil. SoilBiol. Biochem. 12: 15-21.
	Torsvik, V., Goksï¿½yr, J., and Daae, F.L. 1990. High diversityin DNA of soil bacteria. Appl. Environ. Microbiol. 56: 782-787.
	Tsai, Y.L. and Olson, B.H. 1990. Effects of Hg2+, CH3-Hg+,and temperature on the expression of mercury resistancegenes in environmental bacteria. Appl. Environ. Microbiol.56: 3266-3272.
	Tsai, Y.-L. and Olson, B.H. 1991. Rapid method for directextraction of DNA from soil and sediments. Appl. Environ.Microbiol. 57: 1070-1074.
	Tsai, Y.-L. and Olson, B.H. 1992. Rapid method for theseparation of bacterial DNA from humic substances insediments for polymerase chain reaction. Appl. Environ.Microbiol. 58: 2292-2295.
	Ueda, T., Suga, Y., Yahiro, N., and Matsuguchi, T. 1995.Remarkable N2-fixing bacterial diversity detected in riceroots by molecular evolutionary analysis of nifH genesequences. J. Bacteriol. 177: 1414-1417.
	Volossiouk, T., Robb, E.J., and Nazar, R.N. 1995. DirectDNA extraction for PCR-mediated assays of soilorganisms. Appl. Environ. Microbiol. 61: 3972-3976.
	Weyant, R.S., Edmonds, P., and Swaminathan, B. 1990.Effect of ionic and nonionic detergents on the Taqpolymerase. Biofeedback 9: 308-309.
	Zehr, J.P. and McReynolds, L.A. 1989. Use of degenerateoligonucleotides for amplification of the nifH gene fromthe marine cyanobacterium Trichodesmium thiebautii.Appl. Environ. Microbiol. 55: 2522-2526.
	Zhou, J., Bruns, M.A., and Tiedje, J.M. 1996. DNA recoveryfrom soils of diverse composition. Appl. Environ. Microbiol.62: 316-322.
375.pdf	74
	1.WengerNK,SperoffL,PackardR.Cardiovascularhealthanddiseaseinwomen.NEnglJMed.1992;329:247?256.
	2.O?ConnorGT,MortonJR,DiehlMJ,etal.Differencesbetweenmenandwomeninhospitalmortalityassociatedwithcoronaryarterybypassgraftsurgery.Circulation.1993;88:2104?2110.
	3.KelseySF,JamesM,HolubkovAL,etal.Resultsofpercutaneoustransluminalcoronaryangioplastyinwomen:1985?1986NationalHeart,LungandBloodInstitute?sCoronaryAngioplastyRegistry.Circulation.1993;87:720?727.
	4.VaccarinoV,AbramsonJL,VeledarE,etal.Sexdifferencesinhospitalmortalityaftercoronaryarterybypasssurgery:evidenceforahighermortalityinyoungerwomen.Circulation.2002;105:1176?1181.
	5.JacobsAK,KelseySF,BrooksMM,etal.Betteroutcomeforwomencomparedwithmenundergoingcoronaryrevascularization.areportfromtheBypassAngioplastyRevascularizationInvestigation(BARI).Circu-lation.1998;98:1279?1285.
	6.JacobsAK,JohnstonJM,HavilandA,etal.Improvedoutcomesforwomenundergoingcontemporarypercutaneouscoronaryintervention:areportfromtheNationalHeart,Lung,andBloodInstituteDynamicRegistry.JAmCollCardiol.2002;39:1606?1614.
	7.ChoL,TopolEJ,BalogC,etal.ClinicalbenefitofglycoproteinIIb/IIIablockadewithabciximabisindependentofgender:pooledanalysisfromEPIC,EPILOGandEPISTENTtrials.JAmCollCardiol.2000;36:381?386.
	8.HogueCWJr,BarzilaiB,PieperKS,etal.Sexdifferencesinneuro-logicaloutcomesandmortalityaftercardiacsurgery:aSocietyofThoracicSurgeryNationalDatabasereport.Circulation.2001;103:2133?2137.
	9.PetersonED,LanskyAJ,KramerJ,etal.Effectofgenderontheoutcomesofcontemporarypercutaneouscoronaryintervention.AmJCardiol.2001;88:359?364.
	10.EdwardsFH,CareyJS,GroverFL,etal.Impactofgenderoncoronarybypassoperativemortality.AnnThoracSurg.1998;66:125?131.
	11.SchunkertH,HarrelL,PalaciosIF.Implicationsofsmallreferencevesseldiameterinpatientsundergoingpercutaneouscoronaryrevascularization.JAmCollCardiol.1999;34:40?48.
	12.MendesLA,DavidoffR,CupplesLA,etal.Congestiveheartfailureinpatientswithcoronaryarterydisease:thegenderparadox.AmHeartJ.1997;134:207?212.
	13.WeinbergEO,ThieneltCD,KatzSE,etal.Genderdifferencesinmolecularremodelinginpressureoverloadhypertrophy.JAmCollCardiol.1999;34:264?273.
	14.KrumholzHM,LarsonM,LevyD.Sexdifferencesincardiacadaptationtoisolatedsystolichypertension.AmJCardiol.1993;72:310?313.
	15.WongSC,SleeperLA,MonradES,etal.Absenceofgenderdifferencesinclinicaloutcomesinpatientswithcardiogenicshockcomplicatingacutemyocardialinfarction:areportfromtheSHOCKTrialRegistry.JAmCollCardiol.2001;38:1395?1401.
	16.VaccarinoV,ParsonsL,EveryNR,etal.Sex-baseddifferencesinearlymortalityaftermyocardialinfarction.NEnglJMed.1999;341:314?322.
	17.WexlerLF.Studiesofacutecoronarysyndromesinwomen:lessonsforeveryone.NEnglJMed.1999;341:275?276.
	18.FergusonTB,HammillBG,PetersonED,etal.Adecadeofchange:riskprofilesandoutcomesforisolatedcoronaryarterybypassgraftingpro-cedures,1990?1999:areportfromtheSTSNationalDatabaseCom-mitteeandtheDukeClinicalResearchInstitute.SocietyofThoracicSurgeons.AnnThoracSurg.2002;73:480?489.
	19.HerlitzJ,Brandrup-WognsenG,KarlsonBW,etal.Mortality,riskindicatorsofdeath,modeofdeathandsymptomsofanginapectorisduring5yearsaftercoronaryarterybypassgraftinginmenandwomen.JInternMed.2000;247:500?506.
	20.PetroKR,DullumMK,GarciaJM,etal.Minimallyinvasivecoronaryrevascularizationinwomen:asafeapproachforahigh-riskgroup.HeartSurgForum.2000;3:41?46.
	21.WantanabeCT,MaynardC,RitchieJL.Comparisonofshort-termoutcomesfollowingcoronaryarterystentinginmenversuswomen.AmJCardiol.2001;88:848?852.
363.pdf	41
	1.RidkerPM.High-sensitivityC-reactiveprotein:potentialadjunctforglobalriskassessmentintheprimarypreventionofcardiovasculardisease.Circulation.2001;103:1813?1818.
	2.RidkerPM,CushmanM,StampferMJ,etal.Inflammation,aspirin,andtheriskofcardiovasculardiseaseinapparentlyhealthymen.NEnglJMed.1997;336:973?979.
	3.RidkerPM,HennekensCH,BuringJE,etal.C-reactiveproteinandothermarkersofinflammationinthepredictionofcardiovasculardiseaseinwomen.NEnglJMed.2000;342:836?843.
	4.RidkerPM,RifaiN,ClearfieldM,etal.MeasurementofC-reactiveproteinforthetargetingofstatintherapyintheprimarypreventionofacutecoronaryevents.NEnglJMed.2001;344:1959?1965.
	5.RidkerPM,StampferMJ,RifaiN.Novelriskfactorsforsystemicath-erosclerosis:acomparisonofC-reactiveprotein,fibrinogen,homo-cysteine,lipoprotein(a),andstandardcholesterolscreeningaspredictorsofperipheralarterialdisease.JAMA.2001;285:2481?2485.
	6.RidkerPM,RifaiN,RoseL,etal.ComparisonofC-reactiveproteinandlow-densitylipoproteincholesterollevelsinthepredictionoffirstcar-diovascularevents.NEnglJMed.2002;347:1557?1565.
	7.TracyRP,LemaitreRN,PsatyBM,etal.RelationshipofC-reactiveproteintoriskofcardiovasculardiseaseintheelderly:resultsfromtheCardiovascularHealthStudyandtheRuralHealthPromotionProject.ArteriosclerThrombVascBiol.1997;17:1121?1127.
	8.KoenigW,SundM,FroelichM,etal.C-reactiveprotein,asensitivemarkerofinflammation,predictsfutureriskofcoronaryheartdiseaseininitiallyhealthymiddle-agedmen:resultsfromtheMONICA(Moni-toringtrendsanddeterminantsincardiovasculardisease)AugsbergCohortStudy,1984to1992.Circulation.1999;99:237?242.
	9.DaneshJ,WhincupP,WalkerM,etal.Lowgradeinflammationandcoronaryheartdisease:prospectivestudyandupdatedmeta-analyses.BMJ.2000;321:199?204.
	10.PradhanAD,MansonJE,RossouwJE,etal.Inflammatorybiomarkers,hormonereplacementtherapy,andincidentcoronaryheartdisease:pro-spectiveanalysisfromtheWomen?sHealthInitiativeObservationalStudy.JAMA.2002;288:980?987.
	11.AlbertCM,MaJ,RifaiN,etal.ProspectivestudyofC-reactiveprotein,homocysteine,andplasmalipidlevelsaspredictorsofsuddencardiacdeath.Circulation.2002;105:2595?2599.
	12.KullerLH,TracyRP,ShatenJ,etal.RelationofC-reactiveproteinandcoronaryheartdiseaseintheMRFITnestedcase-controlstudy.AmJEpidemiol.1996;144:537?547.
	13.MendallMA,StrachanDP,ButlandBK,etal.C-reactiveprotein:relationtototalmortality,cardiovascularmortalityandcardiovascularriskfactorsinmen.EurHeartJ.2000;21:1584?1590.
	14.HarrisTB,FerrucciL,TracyRP,etal.Associationsofelevatedinterleukin-6andC-reactiveproteinlevelswithmortalityintheelderly.AmJMed.1999;106:506?512.
	15.SakkinenP,AbbottRD,CurbJD,etal.C-reactiveproteinandmyocardialinfarction.JClinEpidemiol.2002;55:445?451.
	16.AlbertMA,DanielsonE,RifaiN,etal.EffectofstatintherapyonC-reactiveproteinlevels:thePravastatinInflammation/CRPEvaluation(PRINCE):arandomizedtrialandcohortstudy.JAMA.2001;286;64?70.
	17.RidkerPM,GlynnRJ,HennekensCH.C-reactiveproteinaddstothepredictivevalueoftotalandHDLcholesterolindeterminingriskoffirstmyocardialinfarction.Circulation.1998;97:2007?2011.
	18.RidkerPM,BuringJE,CookNR,etal.C-reactiveprotein,themetabolicsyndrome,andriskofincidentcardiovascularevents:an8-yearfollow-upof14719initiallyhealthyAmericanwomen.Circulation.2003;107:391?397.
	19.PradhanAD,MansonJE,RifaiN,etal.C-reactiveprotein,interleukin6,andtheriskofdevelopingtype2diabetesmellitus.JAMA.2001;286:327?334.
	20.FreemanDJ,NorrieJ,CaslakeMJ,etal.C-reactiveproteinisaninde-pendentpredictorofriskforthedevelopmentofdiabetesintheWestofScotlandCoronaryPreventionStudy.Diabetes.2002;51:1596?1600.
	21.CushmanM,LegaultC,Barrett-ConnorE,etal.Effectofpostmeno-pausalhormonesoninflammationsensitiveproteins:thePostmenopausalEstrogen/ProgestinInterventions(PEPI)study.Circulation.1999;100:717?722.
	22.RidkerPM,HennekensCH,RifaiN,etal.HormonereplacementtherapyandincreasedplasmaconcentrationofC-reactiveprotein.Circulation.1999;100:713?716.
	23.OckeneIS,MatthewsCD,RifaiN,etal.Variabilityandclassificationaccuracyofserialhigh-sensitivityC-reactiveproteinmeasurementsinhealthyadults.ClinChem.2001;47:444?450.
	24.RobertsWL,MoultonL,LawTC,etal.EvaluationofnineautomatedhighsensitivityC-reactiveproteinmethods:implicationsforclinicalandepidemiologicalapplications.ClinChem.2001;47:418?423.
	25.BlakeGJ,RidkerPM,KuntzKM.Projectedlife-expectancygainswithstatintherapyforindividualswithelevatedC-reactiveproteinlevels.JAmCollCardiol.2002;40:49?55.
	26.RifaiN,BuringJE,LeeI-M,etal.IsC-reactiveproteinspecificforvasculardiseaseinwomen?AnnInternMed.2002;136:529?533.368CirculationJanuary28,2003
	27.BlakeGJ,RidkerPM.Novelclinicalmarkersofvascularwallinflam-mation.CircRes.2001;89:763?771.
	28.BlakeGJ,OtvosJD,RifaiN,etal.Low-densitylipoproteinparticleconcentrationandsizeasdeterminedbynuclearmagneticresonancespectroscopyaspredictorsofcardiovasculardiseaseinwomen.Circu-lation.2002;106:1930?1937.
	29.RidkerPM,RifaiN,PfefferM,etal.Long-termeffectsofpravastatinonplasmaconcentrationofC-reactiveprotein.Circulation.1999;100:230?235.
	30.RidkerPM,RifaiN,PfefferMA,etal.Inflammation,pravastatin,andtheriskofcoronaryeventsaftermyocardialinfarctioninpatientswithaveragecholesterollevels.Circulation.1998;98:839?844.
	31.RidkerPM.ShouldstatintherapybeconsideredforpatientswithelevatedC-reactiveprotein?Theneedforadefinitiveclinicaltrial.EurHeartJ.2001;22:2135?2137.
	32.ChewD,BhattDL,RobbinsMA,etal.EffectofclopidogreladdedtoaspirinbeforepercutaneouscoronaryinterventionontheriskassociatedwithC-reactiveprotein.AmJCardiol.2001;88:672?674.
	33.LincoffAM,KereiakesDJ,MascelliMA,etal.Abciximabsuppressestheriseinlevelsofcirculatinginflammatorymarkersafterpercutaneouscoronaryrevascularization.Circulation.2001;104:163?167.
	34.BhattDL,TopolEJ.Needtotestthearterialinflammationhypothesis.Circulation.2002;106:136?140.
	35.HaffnerSM,GreenbergAS,WestonWM,etal.Effectofrosiglitazonetreatmentonnontraditionalmarkersofcardiovasculardiseaseinpatientswithtype2diabetesmellitus.Circulation.2002;106:679?684.
	36.LiuzzoG,BiasucciLM,GallimoreJR,etal.TheprognosticvalueofC-reactiveproteinandserumamyloidaproteininsevereunstableangina.NEnglJMed.1994;331:417?424.
	37.HaverkateF,ThompsonSG,PykeSD,etal.ProductionofC-reactiveproteinandriskofcoronaryeventsinstableandunstableangina:EuropeanConcertedActiononThrombosisandDisabilitiesAnginaPectorisStudyGroup.Lancet.1997;349:462?466.
	38.LindahlB,TossH,SiegbahnA,etal.Markersofmyocardialdamageandinflammationinrelationtolong-termmortalityinunstablecoronaryarterydisease.NEnglJMed.2000;343:1139?1147.
	39.MorrowD,RifaiN,AntmanE,etal.C-reactiveproteinisapotentpredictorofmortalityindependentlyandincombinationwithtroponinTinacutecoronarysyndromes.JAmCollCardiol.1998;31:1460?1465.
	40.LindmarkE,DiderholmE,WallentinL,etal.Relationshipbetweeninterleukin-6andmortalityinpatientswithunstablecoronaryarterydisease:effectsofanearlyinvasiveornoninvasivestrategy.JAMA.2001;286:2107?2113.
	41.MuellerC,BuettnerHJ,HodgsonJD,etal.Inflammationandlong-termmortalityafternon?ST-elevationacutecoronarysyndrometreatedwithaveryearlyinvasivestrategyin1042consecutivepatients.Circulation.2002;105:1412?1415.
fj.02-0510fje.full.pdf	39
113.pdf	9
J. Biol. Chem.-2003-Castrillo-10443-9.pdf	47
	1.Brinckerhoff,C.E.,andMatrisian,L.M.(2002)Nat.Rev.Mol.CellBiol.3,207?214
	2.Overall,C.M.,andLopez-Otin,C.(2002)Nat.Rev.Cancer2,657?672
	3.Lopez-Otin,C.,andOverall,C.M.(2002)Nat.Rev.Mol.CellBiol.3,509?519
	4.Galis,Z.S.,andKhatri,J.J.(2002)Circ.Res.90,251?262
	5.Woessner,J.F.,Jr.(1999)Ann.N.Y.Acad.Sci.878,388?403
	6.Galis,Z.S.,Sukhova,G.K.,Kranzhofer,R.,Clark,S.,andLibby,P.(1995)Proc.Natl.Acad.Sci.U.S.A.92,402?406
	7.Mason,D.P.,Kenagy,R.D.,Hasenstab,D.,Bowen-Pope,D.F.,Seifert,R.A.,Coats,S.,Hawkins,S.M.,andClowes,A.W.(1999)Circ.Res.85,1179?1185
	8.Gum,R.,Lengyel,E.,Juarez,J.,Chen,J.H.,Sato,H.,Seiki,M.,andBoyd,D.(1996)J.Biol.Chem.271,10672?10680
	9.Dubois,B.,Starckx,S.,Pagenstecher,A.,Oord,J.,Arnold,B.,andOpdenakker,G.(2002)Eur.J.Immunol.32,2163?2171
	10.Bond,M.,Fabunmi,R.P.,Baker,A.H.,andNewby,A.C.(1998)FEBSLett.435,29?34
	11.Opdenakker,G.,VandenSteen,P.E.,andVanDamme,J.(2001)TrendsImmunol.22,571?579
	12.Laffitte,B.A.,Repa,J.J.,Joseph,S.B.,Wilpitz,D.C.,Kast,H.R.,Mangelsdorf,D.J.,andTontonoz,P.(2001)Proc.Natl.Acad.Sci.U.S.A.98,507?512
	13.Joseph,S.B.,Laffitte,B.A.,Patel,P.H.,Watson,M.A.,Matsukuma,K.E.,Walczak,R.,Collins,J.L.,Osborne,T.F.,andTontonoz,P.(2002)J.Biol.Chem.277,11019?11025
	14.Sanceau,J.,Boyd,D.D.,Seiki,M.,andBauvois,B.(2002)J.Biol.Chem.277,35766?35775
	15.Castrillo,A.,Pennington,D.J.,Otto,F.,Parker,P.J.,Owen,M.J.,andBosca,L.(2001)J.Exp.Med.194,1231?1242
	16.O?Farrell,A.M.,Liu,Y.,Moore,K.W.,andMui,A.L.(1998)EMBOJ.17,1006?1018
	17.Castrillo,A.,Diaz-Guerra,M.J.,Hortelano,S.,Martin-Sanz,P.,andBosca,L.(2000)Mol.Cell.Biol.20,1692?1698
	18.Laffitte,B.A.,Joseph,S.B.,Walczak,R.,Pei,L.,Wilpitz,D.C.,Collins,J.L.,andTontonoz,P.(2001)Mol.Cell.Biol.21,7558?7568
	19.Joseph,S.B.,McKilligin,E.,Pei,L.,Watson,M.A.,Collins,A.R.,Laffitte,B.A.,Chen,M.,Noh,G.,Goodman,J.,Hagger,G.N.,Tran,J.,Tippin,T.K.,Wang,X.,Lusis,A.J.,Hsueh,W.A.,Law,R.E.,Collins,J.L.,Willson,T.M.,andTontonoz,P.(2002)Proc.Natl.Acad.Sci.U.S.A.99,7604?7609
	20.Joseph,S.B.,Castrillo,A.,Laffitte,B.A.,Mangelsdorf,D.J.,andTontonoz,P.(2003)Nat.Med.9,213?219
	21.Laffitte,B.A.,Joseph,S.B.,Chen,M.,Repa,J.,Wilpitz,D.C.,CastrilloA.,Mangelsdorf,D.J.,andTontonoz,P.(2003)Mol.Cell.Biol.,inpress
	22.Collins,J.L.,Fivush,A.M.,Watson,M.A.,Galardi,C.M.,Lewis,M.C.,Moore,L.B.,Parks,D.J.,Wilson,J.G.,Tippin,T.K.,Binz,J.G.,Plunket,K.D.,Morgan,D.G.,Beaudet,E.J.,Whitney,K.D.,Kliewer,S.A.,andWillson,T.M.(2002)J.Med.Chem.45,1963?1966
	23.Schultz,J.R.,Tu,H.,Luk,A.,Repa,J.J.,Medina,J.C.,Li,L.,Schwendner,S.,Wang,S.,Thoolen,M.,Mangelsdorf,D.J.,Lustig,K.D.,andShan,B.(2000)GenesDev.14,2831?2838
	24.Ma,Z.,Qin,H.,andBenveniste,E.N.(2001)J.Immunol.167,5150?5159
	25.Jeng,A.Y.,Chou,M.,Sawyer,W.K.,Caplan,S.L.,VonLinden-Reed,J.,Jeune,M.,andPrescott,M.F.(1999)Ann.N.Y.Acad.Sci.878,555?558
	26.Prescott,M.F.,Sawyer,W.K.,VonLinden-Reed,J.,Jeune,M.,Chou,M.,Caplan,S.L.,andJeng,A.Y.(1999)Ann.N.Y.Acad.Sci.878,179?190
	27.Matsumoto,S.,Kobayashi,T.,Katoh,M.,Saito,S.,Ikeda,Y.,Kobori,M.,Masuho,Y.,andWatanabe,T.(1998)Am.J.Pathol.153,109?119
	28.Eberhardt,W.,Schulze,M.,Engels,C.,Klasmeier,E.,andPfeilschifter,J.(2002)Mol.Endocrinol.16,1752?1766
	29.Galis,Z.S.,Johnson,C.,Godin,D.,Magid,R.,Shipley,J.M.,Senior,R.M.,andIvan,E.(2002)Circ.Res.91,852?859
	30.Sato,H.,Kita,M.,andSeiki,M.(1993)J.Biol.Chem.268,23460?23468
	31.Venkateswaran,A.,Laffitte,B.A.,Joseph,S.B.,Mak,P.A.,Wilpitz,D.C.,Edwards,P.A.,andTontonoz,P.(2000)Proc.Natl.Acad.Sci.U.S.A.97,12097?12102
	32.Repa,J.J.,andMangelsdorf,D.J.(2002)Nat.Med.8,1243?1248
	33.Chawla,A.,Boisvert,W.A.,Lee,C.H.,Laffitte,B.A.,Barak,Y.,Joseph,S.B.,Liao,D.,Nagy,L.,Edwards,P.A.,Curtiss,L.K.,Evans,R.M.,andTontonoz,P.(2001)Mol.Cell7,161?171
	34.Tangirala,R.K.,Bischoff,E.D.,Joseph,S.B.,Wagner,B.L.,Walczak,R.,Laffitte,B.A.,Daige,C.L.,Thomas,D.,Heyman,R.A.,Mangelsdorf,D.J.,Wang,X.,Lusis,A.J.,Tontonoz,P.,andSchulman,I.G.(2002)Proc.Natl.Acad.Sci.U.S.A.99,11896?11901
	35.Schuster,G.U.,Parini,P.,Wang,L.,Alberti,S.,Steffensen,K.R.,Hansson,G.K.,Angelin,B.,andGustafsson,J.A.(2002)Circulation106,1147?1153
	36.Hansson,G.K.,Libby,P.,Schonbeck,U.,andYan,Z.Q.(2002)Circ.Res.91,281?291
	37.Libby,P.,andGalis,Z.S.(1995)Ann.N.Y.Acad.Sci.748,158?170
	38.Libby,P.,Ridker,P.M.,andMaseri,A.(2002)Circulation105,1135?1143
	39.Brown,D.L.,Hibbs,M.S.,Kearney,M.,Loushin,C.,andIsner,J.M.(1995)Circulation91,2125?2131
	40.Baker,A.H.,Edwards,D.R.,andMurphy,G.(2002)J.CellSci.115,3719?3727
	41.Shaulian,E.,andKarin,M.(2002)Nat.CellBiol.4,E131?136
	42.Ghosh,S.,andKarin,M.(2002)Cell109,(suppl.)S81?S96
	43.Brand,K.,Page,S.,Rogler,G.,Bartsch,A.,Brandl,R.,Knuechel,R.,Page,M.,Kaltschmidt,C.,Baeuerle,P.A.,andNeumeier,D.(1996)J.Clin.Invest.97,1715?1722
	44.Ehrt,S.,Schnappinger,D.,Bekiranov,S.,Drenkow,J.,Shi,S.,Gingeras,T.R.,Gaasterland,T.,Schoolnik,G.,andNathan,C.(2001)J.Exp.Med.194,1123?1140
	45.Li,A.C.,Brown,K.K.,Silvestre,M.J.,Willson,T.M.,Palinski,W.,andGlass,C.K.(2000)J.Clin.Invest.106,523?531
	46.Ricote,M.,Li,A.C.,Willson,T.M.,Kelly,C.J.,andGlass,C.K.(1998)Nature391,79?82
	47.Chawla,A.,Barak,Y.,Nagy,L.,Liao,D.,Tontonoz,P.,andEvans,R.M.(2001)Nat.Med.7,48?52
J. Biol. Chem.-2003-Seck-10408-16.pdf	34
	1.Azria,M.(1989)TheCalcitonins:PhysiologyandPharmacology,Karger,Basel,Switzerland
	2.Hall,R.A.,Premont,R.T.,andLefkowitz,R.J.(1999)J.CellBiol.145,927?932
	3.Tsao,P.,Cao,T.,andvonZastrow,M.(2001)TrendsPharmacol.Sci.22,91?96
	4.Ferguson,S.S.,Zhang,J.,Barak,L.S.,andCaron,M.G.(1998)LifeSci.62,1561?1565
	5.Lefkowitz,R.J.,Pitcher,J.,Krueger,K.,andDaaka,Y.(1998)Adv.Pharma-col.42,416?420
	6.Carman,C.V.,andBenovic,J.L.(1998)Curr.Opin.Neurobiol.8,335?344
	7.Signoret,N.,Oldridge,J.,Pelchen-Matthews,A.,Klasse,P.J.,Tran,T.,Brass,L.F.,Rosenkilde,M.M.,Schwartz,T.W.,Holmes,W.,Dallas,W.,Luther,M.A.,Wells,T.N.,Hoxie,J.A.,andMarsh,M.(1997)J.CellBiol.139,651?664
	8.Baratti-Elbaz,C.,Ghinea,N.,Lahuna,O.,Loosfelt,H.,Pichon,C.,andMilgrom,E.(1999)Mol.Endocrinol.13,1751?1765
	9.Roseberry,A.G.,andHosey,M.M.(1999)J.Biol.Chem.274,33671?33676
	10.Shapiro,M.,Trejo,J.,Zeng,D.,andCoughlin,S.R.(1996)J.Biol.Chem.271,32874?32880
	11.Hein,L.,Meinel,L.,Pratt,R.,Dzau,V.,andKobilka,B.(1997)Mol.Endocri-nol.11,1266?1277
	12.Anborgh,P.H.,Seachrist,J.L.,Dale,L.B.,andFerguson,S.S.(2000)Mol.Endocrinol.14,2040?2053
	13.Parent,J.,Labrecque,P.,Rochdi,M.,andBenovic,J.L.(2001)J.Biol.Chem.276,7079?7085
	14.Dale,L.B.,Bhattacharya,M.,Seachrist,J.L.,Anborgh,P.H.,andFerguson,S.S.(2001)Mol.Pharmacol.60,1243?1253
	15.Zhang,Z.,Hernandez-Lagunas,L.,Horne,W.C.,andBaron,R.(1999)J.Biol.Chem.274,25093?25098
	16.Shyu,J.F.,Zhang,Z.,Hernandez-Lagunas,L.,Camerino,C.,Chen,Y.,Inoue,D.,Baron,R.,andHorne,W.C.(1999)Eur.J.Biochem.262,95?101
	17.Wakioka,T.,Sasaki,A.,Kato,R.,Shouda,T.,Matsumoto,A.,Miyoshi,K.,Tsuneoka,M.,Komiya,S.,Baron,R.,andYoshimura,A.(2001)Nature412,647?651
	18.Herskovits,J.S.,Burgess,C.C.,Obar,R.A.,andVallee,R.B.(1993)J.CellBiol.122,565?578
	19.Stossel,T.P.,Condeelis,J.,Cooley,L.,Hartwig,J.H.,Noegel,A.,Schleicher,M.,andShapiro,S.S.(2001)Nat.Rev.Mol.Cell.Biol.2,138?145
	20.Cunningham,C.,Gorlin,J.B.,Kwiatkowski,D.J.,Hartwig,J.H.,Janmey,P.A.,Byers,H.,andStossel,T.P.(1992)Science255,325?327
	21.vanderFlier,A.,andSonnenberg,A.(2001)Biochim.Biophys.Acta1538,99?117
	22.Marzia,M.,Neff,L.,Baron,R.,andHorne,W.C.(2002)J.BoneMiner.Res.17,Suppl.1,231
	23.Ferguson,S.S.(2001)Pharmacol.Rev.53,1?24
	24.Cong,M.,Perry,S.J.,Hu,L.A.,Hanson,P.I.,Claing,A.,andLefkowitz,R.J.(2001)J.Biol.Chem.276,45145?45152
	25.Whistler,J.L.,Enquist,J.,Marley,A.,Fong,J.,Gladher,F.,Tsuruda,P.,Murray,S.R.,andvonZastrow,M.(2002)Science297,615?620
	26.Cao,T.,Deacon,H.,Reczek,D.,Bretscher,A.,andvonZastrow,M.(1999)Nature401,286?290
	27.Shiraha,H.,Glading,A.,Chou,J.,Jia,Z.,andWells,A.(2002)Mol.Cell.Biol.22,2716?2727
	28.Chen,M.,andStracher,A.(1989)J.Biol.Chem.264,14282?14289
	29.Li,M.,Bermak,J.C.,Wang,Z.W.,andZhou,Q.Y.(2000)Mol.Pharmacol.57,446?452
	30.Lin,R.,Karpa,K.,Kabbani,N.,Goldman-Rakic,P.,andLevenson,R.(2001)Proc.Natl.Acad.Sci.U.S.A.98,5258?5263
	31.Awata,H.,Huang,C.,Handlogten,M.E.,andMiller,R.T.(2001)J.Biol.Chem.276,34871?34879
	32.Hjalm,G.,MacLeod,R.J.,Kifor,O.,Chattopadhyay,N.,andBrown,E.M.(2001)J.Biol.Chem.276,34880?34887
	33.Gorlin,J.B.,Yamin,R.,Egan,S.,Stewart,M.,Stossel,T.P.,Kwiatkowski,D.J.,andHartwig,J.H.(1990)J.CellBiol.111,1089?1105
	34.Shyu,J.F.,Inoue,D.,Baron,R.,andHorne,W.C.(1996)J.Biol.Chem.271,31127?31134
JCI0317193.pdf	25
11196499.pdf	32
	1.ShuvalHI.Controlofwaterbornediseaseisstillonthepublichealthagenda.IsraelJournalofMedicalSciences,1988,24:637?639.
	2.HalperinR.RegulationsforwaterqualityinIsraelandinternationally[inHebrew].HealthintheField,1999,7:3?6.
	3.TulchinskyTHetal.WaterborneentericdiseaseoutbreaksinIsrael.In:MelnickJL,ed.Entericvirusesinwater.Basel,Karger,1984:61?69(MonographsinVirology,15).
	4.TulchinskyTHetal.WaterborneentericdiseaseoutbreaksinIsrael,1976?1985.IsraelJournalofMedicalSciences,1988,24:644?651.
	5.TulchinskyTHetal.MicrobiologicaldrinkingwaterqualityinIsrael:standards,monitoringandtreatment.IsraelJournalofMedicalSciences,1988,24:652?659.
	6.TulchinskyTHetal.Waterquality,waterbornediseaseandentericdiseaseinIsrael,1976?92.IsraelJournalofMedicalSciences,1993,29:783?790.
	7.EgozNetal.AnoutbreakoftyphoidfeverduetocontaminationofthemunicipalwatersupplyinnorthernIsrael.IsraelJournalofMedicalSciences,1988,24:640?643.
	8.EgozNetal.AnoutbreakofShigellasonneiinfectionduetocontaminationofamunicipalwatersupplyinNorthernIsrael.JournalofInfection,1991,22:87?93.
	9.McCarthyNetal.EpidemiologicalexplanationofanoutbreakofgastroenteritisinSwedenintheabsenceofdetailedmicro-biologicalinformation.EuropeanJournalofEpidemiology,1998,14:711?718.
	10.PaymentPetal.Randomizedtrialtoevaluatetheriskofgastrointestinaldiseaseduetoconsumptionofdrinkingwatermeetingcurrentmicrobiologicalstandards.AmericanJournalofPublicHealth,1991,81:703?708.
	11.FattalB.Infectiousdiseasemorbidityinkibbutzim[inHebrew].Harefuah,1998,115:111?115.
	12.IsraelCenterforDiseaseControl.HealthstatusinIsrael1999.Jerusalem,MinistryofHealth,1999.
	13.WorldHealthOrganization.Guidelinesfordrinking-waterquality.VolsI,II.Geneva,WorldHealthOrganization,1998.
	14.CentersforDiseaseControlandPrevention.Update:cholera?Westernhemisphere,1992.MorbidityandMortalityWeeklyReport,1993,42:89?91.
	15.BlakePA.EpidemiologyofcholeraintheAmericas.Gastro-enterologicalClinicsofNorthAmerica,1993,22:639?660.
	16.CraunGP.WaterbornediseaseoutbreaksintheUnitedStatesofAmerica:causesandprevention.WorldHealthStatisticsQuarterly,1992,45:192?199.
	17.LevyDAetal.Surveillanceofwaterborne-diseaseoutbreaks?UnitedStates,1995?96.MorbidityandMortalityWeeklyReport,1998,47(RR5)1?34.
	18.FurtadoCetal.OutbreaksofwaterborneinfectiousdiseaseinEnglandandWales,1992?95.EpidemiologyandInfection,1998,121:109?119.
	19.MackenzieWRetal.AmassiveoutbreakinMilwaukeeofcryptosporidiuminfectiontransmittedthroughthepublicwatersupply.NewEnglandJournalofMedicine,1994,331:161?167.
	20.CentersforDiseaseControlandPrevention.Assessingthepublichealththreatassociatedwithwaterbornecrypto-sporidiosis:reportofaworkshop.MorbidityandMortalityWeeklyReport,1995,44(RR6):1?19.
	21.MorrisRD,NaumraEN,GriffithsJK.DidMilwaukeeexperiencewaterbornecryptosporidiosisbeforethelargedocumentedoutbreakin1993?Epidemiology,1998,9:264?270.
	22.AthertonF,NewmanCP,CasemoreDP.AnoutbreakofwaterbornecryptosporidiosisassociatedwithapublicwatersupplyintheUK.EpidemiologyandInfection,1995,115:123?131.
	23.BerkelmanRL.EmerginginfectiousdiseasesintheUnitedStates.JournalofInfectiousDiseases,1994,170:272?277.
	24.HurstCJ.Presenceofentericvirusesinfreshwaterandtheirremovalbytheconventionaldrinking-watertreatmentprocess.BulletinoftheWorldHealthOrganization,1991,69:113?119.
	25.NaikSRetal.AlargewaterborneviralhepatitisEepidemicinKanpur,India.BulletinoftheWorldHealthOrganization,1992,70:597?604.
	26.GoldsteinSTetal.Cryptosporidiosis:anoutbreakassociatedwithdrinkingwaterdespitestate-of-the-artwatertreatment.AnnalsofInternalMedicine,1996;124:459?468.
	27.RoseJB,GerbaCP,JakubowskiW.Surveyofpotablewatersuppliesforcryptosporidiumandgiardia.EnvironmentalScienceandTechnology,1991,25:1393?1400.
	28.CentersforDiseaseControlandPrevention.Assessmentofinadequatelyfilteredpublicdrinkingwater?Washington,DC,December1993.MorbidityandMortalityWeeklyReport,1994,43:661?669.
	29.JohnsonCH,RiceEW,ReasonerDJ.InactivationofHelicobacterpyloribychlorination.AppliedEnvironmentalMicrobiology,1997,63:4969?4970.
	30.GoodmanKJ,CorreaP.ThetransmissionofHelicobacterpylori:acriticalreviewoftheevidence.InternationalJournalofEpidemiology,1995,24:875?887.
	31.EsreySAetal.Effectsofimprovedwatersupplyonascariasis,diarrhoea,dracunculiasis,hookworminfection,schistosomiasis,andtrachoma.BulletinoftheWorldHealthOrganization,1991,69:609?621.
	32.CentersforDiseaseControlandPrevention.Achievementsinpublichealth,1900?1999:controlofinfectiousdiseases.MorbidityandMortalityWeeklyReport,1999,48:621?629.Bulletin1473oftheWorldHealthOrganization,2000,78(12)
11196487.pdf	50
	1.CelliA.ThehistoryofmalariaontheRomanCampagnafromancienttimes.London,JohnBale,SonsDanielsson,1933.
	2.WatsonRB.Locationandmosquitoproofingofdwellings.In:BoydMF,ed.Malariology.Philadelphia,WBSaundersCo.,1949:1184?1202.
	3.RossR.Onsomepeculiarpigmentedcellsfoundintwomosquitoesfedonmalarialblood.BritishMedicalJournal,1897,2:1786?1788.
	4.GrassiB.[Studyonmalariabyazoologist].RendicontidellaRealeAccademiadeiLincei,Rome,1900(inItalian)
	5.BrownAWAetal.Malariaeradicationandcontrolfromaglobalstandpoint.JournalofMedicalEntomology,1976,13:1?25.
	6.RobertsDRetal.UseofremotesensingandgeographicinformationsystemstotargetmalariacontrolmeasuresinBelize,CentralAmerica.Availableathttp://scope.educ.washington.edu/research/malaria/ddt_ban/roberts/1999-12/(ScopeMalariaResearchandPolicyForum,commentaryarticle).
	7.BoydMF,ed.Malariology.Philadelphia,WBSaundersCo.,1949:379?525.
	8.BentleyCA.MalariainBengal.Calcutta,BengalSecretariatBookDepot,1916.
	9.ThompsonRetal.TheMatolaproject:atemporalandspatialstudyofmalariatransmissionanddiseaseinasuburbanareaofMaputo,Mozambique.AmericanJournalofTropicalMedicineandHygiene,1997,57:550?559.
	10.LindsaySWetal.Amalariacontroltrialusinginsecticide-treatedbednetsandtargetedchemoprophylaxisinaruralareaoftheGambia,WestAfrica.3.Entomologicalcharacteristicsofthestudyarea.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,1993,87(suppl2):19?23.
	11.HehirP.MalariainIndia.Bombay,OxfordUniversityPress,1927.
	12.LindsaySWetal.AbilityofAnophelesgambiaemosquitoestotransmitmalariaduringthedryandwetseasonsinanareaofirrigatedricecultivationintheGambia.JournalofTropicalMedicineandHygiene,1991,94:313?324.
	13.RejmankovaEetal.CharacterisationanddetectionofAnophelesvestitipennisandAnophelespunctimacula(Diptera:Culicidae)larvalhabitatsinBelizewithfieldsurveyandSPOTsatelliteimagery.JournalofVectorEcology,1998,23(1):74?88.
	14.RejmankovaEetal.EnvironmentalandregionaldeterminantsofAnopheleslarvaldistributioninnorthernBelize.EnvironmentalEntomology,1993,22:978?992.
	15.WatsonM.Generalconsiderationsincontrolanderadication.In:BoydMF,ed.Malariology.Philadelphia,WBSaundersCo.1949:1161?1166.
	16.ManguinSetal.CharacterisationofAnophelesdarlingi(Diptera:Culicidae)larvalhabitatsinBelize,CentralAmerica.JournalofMedicalEntomology,1996,33:205?211.
	17.CorreaRR.[Naturalinfectionwithplasmodiummalariafrom(K.)cruziiD.K.,1908].FoliaClinicaetBiologia,1943,15:23(inPortuguese).
	18.CarnevalePetal.[MalariacontrolinBurkinaFasobymeansofpyrethroid-impregnatedmosquitonets].BulletindelaSocieï¿½teï¿½dePathologieexotique,1988,81:832?846(inFrench).
	19.QuinonesMLetal.Permethrin-treatedbednetsdonothavea??mass-killingeffect??onvillagepopulationsofAnophelesgambiaes.l.intheGambia.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,1998,92:373?378.
	20.CharlwoodJD,AlecrimWA.Capture-recapturestudieswiththeSouthAmericanmalariavectorAnophelesdarlingi,Root.AnnalsofTropicalMedicineandParasitology,1989,83:569?576.
	21.CharlwoodJD,BryanJH.Amark-recaptureexperimentwiththefilariasisvectorAnophelespunculatusinPapuaNewGuinea.AnnalsofTropicalMedicineandParasitology,1987,81:429?436.
	22.TrapeJ-Fetal.VectordensitygradientsandtheepidemiologyofurbanmalariainDakar,Senegal.AmericanJournalofTropicalMedicineandHygiene,1992,47:181?189.
	23.CharlwoodJDetal.Cordonsanitaireorlaissezfaire:differentialdispersalofyoungandoldfemalesofthemalariavectorAnophelesfunestusGiles(Diptera:Culicidae)insouthernMozambique.AfricanEntomology,1998,6:1?6.
	24.TakkenWetal.DispersalandsurvivalofAnophelesfunestusandA.gambiaesl(Diptera:Culicidae)duringtherainyseasononsoutheastTanzania.BulletinofEntomologicalResearch,1998,88:561?566.
	25.SmithTetal.Mappingdensitiesofmalariavectorswithinasinglevillage.ActaTropica,1995,59:1?18.
	26.RibeiroJMCetal.TemporalandspatialdistributionofanophelinemosquitoesinanEthiopianvillage:implicationsformalariacontrolstrategies.BulletinoftheWorldHealthOrganization,1996,74:299?305.
	27.LindsaySWetal.ExposureofGambianchildrentoAnophelesgambiaemalariavectorsinanirrigatedriceproductionarea.MedicalandVeterinaryEntomology,1995,9:50?58.
	28.RossR.Thepreventionofmalaria.London,JohnMurray,1911.
	29.Gamage-MendisACetal.Theclusteringofmalariainfectionswithinanendemicpopulation:riskofmalariaassociatedwiththetypeofhousingconstruction.AmericanJournalofTropicalMedicineandHygiene,1991,45:77?85.
	30.GunawardenaDMetal.MalariariskfactorsinanendemicregionofSriLankaandtheimpactandcostimplicationsofrisk-factorbasedinterventions.AmericanJournalofTropicalMedicineandHygiene,1998,58:533?542.
	31.GhebreyesusTAetal.IncidenceofmalariaamongchildrenlivingneardamsinnorthernEthiopia:communitybasedincidencesurvey.BritishMedicalJournal,1999,319:663?666.
	32.ThomasCJ,LindsaySW.Local-scalevariationinmalariaamongstruralGambianchildrenestimatedbysatelliteremotesensing.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,2000,94:159?163.
	33.DobsonMJ.MalariainEngland:ageographicalandhistoricalperspective.Parassitologia,1994,36:35?60.
	34.HaySIetal.AnnualPlasmodiumfalciparumentomologicalinoculationrates(EIR)acrossAfrica:literaturesurvey,internetaccessandreview.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,2000,94:113?127.
	35.GhebreyesusTAetal.HouseholdriskfactorsformalariaamongchildrenintheEthiopianhighlands.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,2000,94:17?21.
	36.LindsaySW,SnowRW.Thetroublewitheaves:houseentrybyvectorsofmalaria.TransactionsoftheRoyalSocietyofTropicalMedicineandHygiene,1988,82:645?646.
	37.MackinnonMetal.Quantifyinggeneticandnon-geneticcontributionstomalarialinfectioninaSriLankanpopulation.ProceedingsoftheNationalAcademyofSciencesoftheUSA(inpress).
	38.WoolhouseMEJetal.Heterogeneitiesinthetransmissionofinfectiousagents:implicationsforthedesignofcontrolprogrammes.ProceedingsoftheNationalAcademyofSciencesUSA,1997,94:338?342.
	39.HasibederG,DyeC.Populationdynamicsofmosquito-bornedisease:persistenceinacompletelyheterogeneousenvironment.TheoreticalPopulationBiology,1988,33:31?53.
	40.BeckLetal.Remotesensingasalandscapeepidemiologicaltooltoidentifyvillagesathighriskofmalariatransmission.AmericanJournalofTropicalMedicineandHygiene,1994,51:271?280.
	41.RejmankovaEetal.PredictionsofadultAnophelesalbimanusinvillagesbasedondistancefromremotelysensedlarvalhabitats.AmericanJournalofTropicalMedicineandHygiene,1995,53:482?488.
	42.RobertsDRetal.PredictionsofmalariavectordistributionsinBelizeusingmultispectralsatellitedata.AmericanJournalofTropicalMedicineandHygiene,1996,54:304?308.
	43.FullertonHR.Screeningandmosquitoproofingaselementsinmalariacontrol.AmericanJournalofPublicHealth,1931,21:382?389.
	44.FaridMA.Simplemeasuresforinterruptingman-vectorcontact.In:WernsdorferWH,McGregorI,eds.Malaria:principlesandpracticeofmalariology.Edinburgh,ChurchillLivingstone,1988:1251?1262.
	45.MacdonaldG.Theepidemiologyandcontrolofmalaria.London,NewYork,Toronto,OxfordUniversityPress,1957.
	46.RobertsDRetal.Aprobabilitymodelofvectorbehaviour:effectsofDDTrepellency,irritancy,andtoxicityinmalariacontrol.JournalofVectorEcology,2000,25:48?61.
	47.BeierJCetal.EntomologicalinoculationratesandPlasmodiumfalciparummalariaprevalenceinAfrica.AmericanJournalofTropicalMedicineandHygiene,1999,61:109?113.
	48.AllesHetal.MalariamortalityratesinsouthAsiaandinAfrica:implicationsformalariacontrol.ParasitologyToday,1998,14:369?375.
	49.MalariaanditscontrolinVietNam.Hanoi,MinistryofHealth,1996(unpublishedreportofajointEuropeanUnionandWHOmeetingonmalariacontrol).
	50.HandunettiSMetal.Featuresofrecrudescentchloroquine-resistantPlasmodiumfalciparuminfectionsconferasurvivaladvantageonparasitesandhaveimplicationsfordiseasecontrol.TransactionoftheRoyalSocietyofTropicalMedicineandHygiene,1996,90:563?567.
11196482.pdf	0
Nucleic Acids Symp Ser-2004-Maruyama-3-4.pdf	5
tacca00001-0446.pdf	29
	1.Rowinsky,E.K.andR.C.Donehower.1995.Paclitaxel(taxol).N.Engl.J.Med.332:1004-1014.
	2.Weiss,R.B.,R.C.Donehower,P.H.Wiernik,T.Ohnuma,R.J.Gralla,D.L.Trump,J.R.Baker,D.A.anEcho,D.D.vonHoff,andB.Leyland-Jones.1990.Hypersen-sitivityreactionsfromtaxol.J.Clin.Oncol.8:1263-1268.
	3.Sharma,A.,E.Mayhew,L.Bolcsak,C.Cavanaugh,P.Harmon,A.Janoff,A.,andR.J.Bernacki.1997.Activityofpaclitaxelliposomeformulationsagainsthumanovariantumorxenografts.Int.J.Cancer71:103-107.
	4.Cabanes,A.,K.E.Briggs,P.C.,Cokhale,J.A.Treat,andA.Rahman.1998.Com-parativeinvivostudieswithpaclitaxelandliposome-encapsulatedpaclitaxel.Int.J.Oncol.12:1035-1040.
	5.Koshkina,N.V.,J.C.Waldrep,L.Roberts,E.Golunski,S.Melton,andV.Knight.2001.Paclitaxelliposomeaerosoltreatmentinducesinhibitionofpulmonarymetas-tasesinmurinerenalcarcinomamodel.Clin.CancerRes.7:3258-3262.
	6.Ross,H.J.,A.L.Canada,andL.M.Slater.1997.CyclosporinAenhancespaclitaxeltoxicityagainstleukemiaandrespiratoryepithelialcancers.Clin.Cancer.Res.3:57-
	7.Sood,A.K.,J.I.Sorosky,R.C.Squatrito,J.S.Skilling,B.Anderson,andR.E.Buller.1999.CyclosporinAreverseschemoresistanceinpatientswithgynecologicCYCLOSPORINIMPROVESANTICANCEREFFECTOFPACLITAXEL403malignancies.Neoplasia1:118-122.
	8.Sonnichsen,D.S.,Q.Liu,E.G.Schuetz,J.D.Schuetz,A.Pappo,andM.V.Relling.1995.VariabilityinhumancytochromeP450paclitaxelmetabolism.J.Pharmacol.Exp.Ther.275:566-575.
	9.Fujitaka,K.,T.Oguri,T.Isobe,Y.Fujiwara,andN.Kohno,N.2001.InductionofcytochromeP4503A4bydocetaxelinperipheralmononuclearcellsanditsexpres-sioninlungcancer.CancerChemother.Pharmacol.48:42-46.
	10.Gilbert,B.E.,C.Knight.,F.G.Alvarez,J.C.Waldrep,J.R.Rodarte,V.Knight,andW.L.Eschenbacher.1997.ToleranceofvolunteerstocyclosporinA-dilauroyl-phosphatidylcholineliposomeaerosol.Am.J.Respir.Crit.CareMed.156:1789-1793.
	11.Younes,E.,G.P.Haas,B.Dezso,E.Ali,R.L.Maughan,M.A.Kukuruga,E.Montecillo,J.E.Pontes,andG.G.Hillman.1995.LocaltumorirradiationaugmentstheresponsetoIL-2therapyinamurinerenaladenocarcinoma.CellImmunol.165:243-251.
	12.Koshkina,N.V.,V.Knight,B.E.Gilbert,E.Golunski,L.Roberts,andJ.C.Waldrep.2001.Improvedrespiratorydeliveryoftheanticancerdrugs,camptothecinandpac-litaxelwith5%C02-enrichedair:pharmacokineticstudies.CancerChemother.Pharmacol.,47:451-456.
	13.Koshkina,N.V.,E.S.Kleinerman,J.D.Waldrep,S.F.Jia,L.L.Worth,B.E.Gilbert,andV.Knight.2000.9-Nitrocamptothecinliposomeaerosoltreatmentofmelanomaandosteosarcomalungmetastasesinmice.Clin.CancerRes.6:2876-2880.
	14.Knight,V.,N.V.Koshkina,J.C.Waldrep,B.C.Giovanella,andB.E.Gilbert.1999.Anticancereffectof9-nitrocamptothecinliposomeaerosolonhumancancerxeno-graftsinnudemice.CancerChemother.Pharmacol.44:1771-86.
	15.Fairchild,G.A1972.Measurementofrespiratoryvolumeforvirusretentionstudiesinmice.Appl.Microbiol.24:812-818
	16.Phalen,R.1972.Inhalationstudies:foundationsandtechniques.CRCPress,BocaRaton.p.22
	17.Schieff,P.B.andS.B.Horwitz.1980.Taxolstabilizesmicrotubulesinmousefibro-blastcells.Proc.Natl.Acad.Sci.USA77:1561-1565.
	18.Sakai,H.,S.Yoneda,T.Tamura,Y.Nishiwaki,A.Yokoyama,K.Watanabe,andN.Saijo.2001.AphaseIIstudyofpaclitaxelpluscisplatinforadvancednon-small-celllungcancerinJapanesepatients.CancerChemother.Pharmacol.48:499-503.
	19.Choy,H.andR.MacRae.2001.Thecurrentstateofpaclitaxelandradiationinthecombined-modalitytherapyofnon-smallcelllungcancer.Semin.Oncol.28(Suppl14):17-22.
	20.Meerum-Terwogt,J.M.,M.M.Malingre,J.H.Beijnen,W.W.tenBokkelHuinink,H.Rosing,F.J.Koopman,0.vanTellingen,M.Swart,andJ.H.Schellens.1999.CoadministrationoforalcyclosporinAenablesoraltherapywithpaclitaxel.Clin.CancerRes.5:3379-3384.
	21.Sikic,B.I.,G.A.Fisher,B.L.Lum,J.Halsey,L.Beketic-Oreskovic,andG.Chen.1997.ModulationandpreventionofmultidrugresistancebyinhibitorsofP-glycop-rotein.CancerChemother.Pharmacol.40(Suppl):S13-19.
	22.Germann,U.A.2000.DetectionofrecombinantP-glycoproteininmultidrugresis-tantculturedcells.Mol.Biotechnol.14:131-145.
	23.Gottesman,M.M.andL.Pastan.1993.Biochemistryofmultidrugresistancemedi-atedbythemultidrugtransporter.Annu.Rev.Biochem.62:385-427.
	24.Wandel,C.,R.B.Kim,S.Kajiji,F.P.Guengrich,G.R.Wilkinson,andA.J.J.Wood.1999.P-glycoproteinandcytochromeP4503Ainhibition:dissociationofinhibitorypotencies.CancerRes.59:3944-3948.
	25.Cresteil,T.,B.Monsarrat,P.Alvinerie,J.M.Treluyer,I.Vieira,andM.Wright.1994.Taxolmetabolismbyhumanlivermicrosomes:identificationofcytochromeP450isoenzymesinvolvedinitsbiotransformation.CancerRes.54:386-392.
	26.Sugawara,I.,S.Akiyama,R.J.Scheper,andS.Itoyama.1997.Lungresistanceprotein(LRP)-expressioninhumannormaltissuesincomparisonwiththatofMDR1andMRP.CancerLett.112:23-31.
	27.Yokoyama,H.,T.Ishida,K.Sugio,T.Inoue,andK.Sugimachi,K.1999.Immuno-histochemicalevidencethatP-glycoproteininnon-smallcelllungcancersisassoci-atedwithshortersurvival.Surg.Today29:1141-7.
	28.Gilbert,B.E.,M.Black,J.C.Waldrep,J.Bennick,C.Montgomery,andV.Knight.1997.CyclosporinAliposomeaerosol:Lackoftoxicityinrats.InhalationToxicology9:717-730.
	29.Koshkina,N.V.,B.E.Gilbert,J.C.Waldrep,ASeryshevandV.Knight.1999.Distributionofcamptothecinafterdeliveryasaliposomeaerosolorfollowingintra-muscularadministrationinmice.CancerChemothPharmacol44:187-192.
tacca00001-0343.pdf	54
	1.DarwinC.OntheOriginofSpeciesbyMeansofNaturalSelection,orthePreser-vationofFavouredRacesintheStruggleforLife.TheEastonPress,Norwalk,Conn,1993,page63
	2.PollackRE.[BookReview]Ontheoriginofspeciesbymeansofnaturalselection,orthepreservationoffavouredracesinthestruggleforlife.NEnglJMed337:137-138,1997
	3.KorberB,MuldoonM,TheilerJ,GaoF,GuptaR,LapedesA,HahnBH,WolinskyS,300DOUGLASD.RICHMANETALBhattacharyaT.TimingtheancestoroftheHIV-1pandemicstrains.Science288:1789-1796,2000
	4.PiotP,BartosM,GhysPD,WalkerN,SchwartlanderB.TheglobalimpactofHIV/AIDS.Nature410:968-973,2001
	5.DrakeJW.RatesofspontaneousmutationamongRNAviruses.ProcNatlAcadSciUSA90:4171-4175,1993
	6.ManskyLMandTeminHM.Lowerinvivomutationrateofhumanimmunodefi-ciencyvirustype1thanthatpredictedfromthefidelityofpurifiedreversetran-scriptase.JVirol69:5087-5094,1995
	7.PerelsonAS,NeumannAU,MarkowitzM,LeonardJM,HoDD.HIV-1dynamicsinvivo:virionclearancerate,infectedcelllifetime,andviralgenerationtime.Science271:1582-1586,1996
	8.FischlMA,RichmanDD,GriecoMH,GottliebMS,VolberdingPA,LaskinOL,LeedomJM,GroopmanJE,MildvanD,SchooleyRT,JacksonGG,DurackDT,KingD,AZTCollaborativeWorkingGroup.Theefficacyofazidothymidine(AZT)inthetreatmentofpatientswithAIDSandAIDS-relatedcomplex.Adouble-blind,placebo-controlledtrial.NEnglJMed317:185-191,1987
	9.RichmanDD,FischlMA,GriecoMH,GottliebMS,VolberdingPA,LaskinOL,LeedomJM,GroopmanJE,MildvanD,HirschMS,JacksonGG,DurackDT,Nusinoff-LehrmanS,AZTCollaborativeWorkingGroup.Thetoxicityofazidothy-midine(AZT)inthetreatmentofpatientswithAIDSandAIDS-relatedcomplex.Adouble-blind,placebo-controlledtrial.NEnglJMed317:192-197,1987
	10.LarderBA,DarbyG,RichmanDD.HIVwithreducedsensitivitytozidovudine(AZT)isolatedduringprolongedtherapy.Science243:1731-1734,1989
	11.LarderBAandKempSD.MultiplemutationsinHIV-1reversetranscriptaseconferhigh-levelresistancetozidovudine(AZT).Science246:1155-1158,1989
	12.RichmanDD.Theimplicationsofdrugresistanceforstrategiesofcombinationantiviralchemotherapy.AntiviralRes29:31-33,1996
	13.RichmanDD,GrimesJM,LagakosSW.Effectofstageofdiseaseanddrugdoseonzidovudinesusceptibilitiesofisolatesofhumanimmunodeficiencyvirus.JAIDS3:743-746,1990
	14.GulickRM,MellorsJW,HavlirD,EronJJ,GonzalezC,McMahonD,RichmanDD,ValentineFT,JonasL,DeutschP,MeibohmA,HolderD,SchleifWA,CondraJH,EminiEA,ChodakewitzJA.Treatmentwithindinavir,zidovudine,andlamivudineinadultswithhumanimmunodeficiencyvirusinfectionandpriorantiretroviraltherapy.NEnglJMed337:734-739,1997
	15.GunthardHF,WongJK,IgnacioCC,GuatelliJC,RiggsNL,HavlirDV,RichmanDD.Humanimmunodeficiencyvirusreplicationandgenotypicresistanceinbloodandlymphnodesafterayearofpotentantiretroviraltherapy.JVirol72:2422-2428,1998
	16.HirschMS,ConwayB,D'AquilaRT,JohnsonVA,Brun-VezinetF,ClotetB,DemeterLM,HammerSM,JacobsenDM,KuritzkesDR,LovedayC,MellorsJW,VellaS,RichmanDD.AntiretroviraldrugresistancetestinginadultswithHIVinfection.JAMA279:1984-1991,1998
	17.HirschMS,Brun-VezinetF,D'AquilaRT,HammerSM,JohnsonVA,KuritzkesDR,LovedayC,MellorsJW,ClotetB,ConwayB,DemeterLM,VellaS,JacobsenDM,RichmanDD.AntiretroviraldrugresistancetestinginadultHIV-1infection.JAMA283:2417-2426,2000
	18.HirschMS,Brun-VezinetF,ClotetB,ConwayB,KuritzkesDR,D'AquilaRT,Deme-terLM,HammerSM,JohnsonVA,LovedayC,MellorsJW,JacobsenDM,RichmanDD.Antiretroviraldrugresistancetestinginadultsinfectedwithhumanimmuno-deficiencyvirustype1:2003recommendationsofanInternationalAIDSSociety-USApanel.ClinInfectDis37:113-128,2003
	19.LittleSJ,HolteS,RoutyJP,DaarES,MarkowitzM,CollierAC,KoupRA,MellorsJW,ConnickE,WhitcombJM,HellmannNS,RichmanDD.Antiretroviral-drugresistanceamongpatientsrecentlyinfectedwithHIV.NEnglJMed347:385-394,2002
	20.KorberBTM,KunstmanKJ,PattersonBK,FurtadoM,McEvillyMM,LevyR,WolinskySM.Geneticdifferencesbetweenblood-andbrain-derivedviralsequencesfromhumanimmunodeficiencyvirustype1-infectedpatients:evidenceofconservedelementsintheV3regionoftheenvelopeproteinofbrain-derivedsequences.JVirol68:7467-7481,1994
	21.HaggertySandStevensonM.PredominanceofdistinctviralgenotypesinbrainandlymphnodecompartmentsofHIV-1-infectedindividuals.ViralImmunology4:123-131,1991
	22.PangS,VintersHV,AkashiT,O'BrienWA,ChenISY.HIV-1envsequencevariationinbraintissueofpatientswithAIDS-relatedneurologicdisease.JAIDS4:1082-1092,1991
	23.EpsteinLG,KuikenC,BlumbergBM,HartmanS,SharerLR,ClementM,GoudsmitJ.HIV-1V3domainvariationinbrainandspleenofchildrenwithAIDS:Tissue-specificevolutionwithinhost-determinedquasispecies.Virology180:583-590,1991
	24.PowerC,McArthurJC,JohnsonRT,GriffinDE,GlassJD,PerrymanS,ChesebroB.DementedandnondementedpatientswithAIDSdifferinbrain-derivedhumanimmunodeficiencyvirustype1envelopesequences.JVirol68:4643-4649,1994
	25.EdwardsTG,HoffmanTL,BaribaudF,WyssS,LaBrancheCC,RomanoJ,AdkinsonJ,SharronM,HoxieJA,DomsRW.RelationshipsbetweenCD4independence,neutralizationsensitivity,andexposureofaCD4-inducedepitopeinahumanim-munodeficiencyvirustype1envelopeprotein.JVirol75:5230-5239,2001
	26.PufferBA,PohlmannS,EdingerAL,CarlinD,SanchezMD,ReitterJ,WatryDD,FoxHS,DesrosiersRC,DomsRW.CD4independenceofsimianimmunodeficiencyvirusEnvsisassociatedwithmacrophagetropism,neutralizationsensitivity,andattenuatedpathogenicity.JVirol76:2595-2605,2002
	27.GorryPR,TaylorJ,HolmGH,MehleA,MorganT,CayabyabM,FarzanM,WangH,BellJE,KunstmanK,MooreJP,WolinskySM,GabuzdaD.IncreasedCCR5affinityandreducedCCR5/CD4dependenceofaneurovirulentprimaryhumanimmunodeficiencyvirustype1isolate.JVirol76:6277-6292,2002
	28.EdingerAL,MankowskiJL,DoranzBJ,MarguliesBJ,LeeB,RuckerJ,SharronM,HoffmanTL,BersonJF,ZinkMC,HirschVM,ClementsJE,DomsRW.CD4-independent,CCR5-dependentinfectionofbraincapillaryendothelialcellsbyaneurovirulentsimianimmunodeficiencyvirusstrain.ProcNatlAcadSciUSA94:14742-14747,1997
	29.ReddyYS,KashubaA,GerberJ,MillerV.Roundtablereport:importanceofanti-retroviraldrugconcentrationsinsanctuarysitesandviralreservoirs.AIDSResHumRetroviruses19:167-176,2003
	30.WongJK,IgnacioCC,TorrianiF,HavlirD,FitchNJS,RichmanDD.Invivocom-partmentalizationofHIV:evidencefromtheexaminationofpolsequencesfromautopsytissues.JVirol70:2059-2071,1997
	31.VenturiG,CatucciM,RomanoL,CorsiP,LeonciniF,ValensinPE,ZazziM.Antiretroviralresistancemutationsinhumanimmunodeficiencyvirustype1re-versetranscriptaseandproteasefrompairedcerebrospinalfluidandplasmasamples.JInfectDis181:740-745,2000
	32.CunninghamPH,SmithDG,SatchellC,CooperDA,BrewB.Evidenceforindepen-302DOUGLASD.RICHMANETALdentdevelopmentofresistancetoHIV-1reversetranscriptaseinhibitorsinthecerebrospinalfluid.AIDS14:1949-1954,2000
	33.SrinivasakumarN,ChazalN,Helga-MariaC,PrasadS,HammarskjoldM-L,Re-koshD.Theeffectofviralregulatoryproteinexpressionongenedeliverybyhumanimmunodeficiencyvirustype1vectorsproducedinstablepackagingcelllines.JVirol71(8):5841-5848,1997
	34.DezzuttiCS,GuenthnerPC,CumminsJE,Jr.,CabreraT,MarshallJH,DillbergerA,LalRB.Cervicalandprostateprimaryepithelialcellsarenotproductivelyin-fectedbutsequesterhumanimmunodeficiencyvirustype1.JInfectDis183:1204-1213,2001
	35.EyreRC,ZhengG,KiesslingAA.Multipledrugresistancemutationsinhumanimmunodeficiencyvirusinsemenbutnotbloodofamanonantiretroviraltherapy.Urology55:5912000
	36.GuptaP,LerouxC,PattersonBK,KingsleyL,RinaldoC,DingM,ChenY,KulkaK,BuchananW,McKeonB,MontelaroR.Humanimmunodeficiencyvirustype1shed-dingpatterninsemencorrelateswiththecompartmentalizationofviralquasispe-ciesbetweenbloodandsemen.JInfectDis182:79-87,2000
	37.KiesslingAA,FitzgeraldLM,ZhangD,ChhayH,BrettlerD,EyreRC,SteinbergJ,McGowanK,ByrnRA.Humanimmunodeficiencyvirusinsemenarisesfromageneticallydistinctvirusreservoir.AIDSResHumRetroviruses14Suppl1:S33-S411998
	38.KriegerJN,NirapathpongpornA,ChaiyapornM,PetersonG,NikolaevaI,AkridgeR,RossSO,CoombsRW.Vasectomyandhumanimmunodeficiencyvirustype1insemen.JUrol159:820-825,1998
	39.XuC,PolitchJA,TuckerL,MayerKH,SeageGR,III,AndersonDJ.Factorsasso-ciatedwithincreasedlevelsofhumanimmunodeficiencyvirustype1DNAinsemen.JInfectDis176:941-947,1997
	40.CoombsRW,ReichelderferPS,LandayAL.RecentobservationsonHIVtype-1infectioninthegenitaltractofmenandwomen.AIDS17:455-480,2003
	41.PossM,RodrigoAG,GosinkJJ,LearnGH,deVangePD,MartinHL,Jr.,BwayoJ,KreissJK,OverbaughJ.EvolutionofenvelopesequencesfromthegenitaltractandperipheralbloodofwomeninfectedwithcladeAhumanimmunodeficiencyvirustype1.JVirol72:8240-8251,1998
	42.GeijtenbeekTB,KwonDS,TorensmaR,vanVlietSJ,vanDuijnhovenGC,MiddelJ,CornelissenIL,NottetHS,KewalRamaniVN,LittmanDR,FigdorCG,vanKooykY.DC-SIGN,adendriticcell-specificHIV-1-bindingproteinthatenhancestransin-fectionofTcells.Cell100:587-597,2000
	43.PillaiS,GoodB,RichmanD,CorbeilJ.AnewperspectiveonV3phenotypepredic-tion.AIDSResHumRetroviruses19:145-149,2003
	44.ParanjpeS,CraigoJ,PattersonB,DingM,BarrosoP,HarrisonL,MontelaroR,GuptaP.SubcompartmentalizationofHIV-1quasispeciesbetweenseminalcellsandseminalplasmaindicatestheiroriginindistinctgenitaltissues.AIDSResHumRetroviruses18:1271-1280,2002
	45.LarsenRA,BozzetteS,McCutchanJA,ChiuJ,LealMA,RichmanDD,TheCali-forniaCollaborativeTreatmentGroup.Persistentcryptococcusneoformansinfectionoftheprostateaftersuccessfultreatmentofmeningitis.AnnInternMed111:125-128,1989
	46.SmithDM,KingeryJD,IgnacioCC,HavlirDV,RichmanDD,LittleSJ.TheprostateasareservoirforHIV-1,The10thConferenceonRetrovirusesandOpportunisticInfectionsBoston,MA:February10-14(2003)(Abstract)
	47.ParrenPWandBurtonDR.Theantiviralactivityofantibodiesinvitroandinvivo.AdvImmunol77:195-262,2001
	48.BurtonDR.AvaccineforHIVtype1:Theantibodyperspective.ProcNatlAcadSciUSA94:10018-10023,1997
	49.RichmanDD,WrinT,LittleSJ,PetropoulosCJ.RapidevolutionoftheneutralizingantibodyresponsetoHIVtype1infection.ProcNatlAcadSciUSA100:4144-4149,2003
	50.PetropoulosCJ,ParkinNT,LimoliKL,LieYS,WrinT,HuangW,TianH,SmithD,WinslowGA,CaponDJ,WhitcombJM.Anovelphenotypicdrugsusceptibilityassayforhumanimmunodeficiencyvirustype1.AntimicrobAgentsChemother44:920-928,2000
	51.FrancisT,Jr.Influenza:theneweacquayantance.AnnInternMed39:203-221,1953
	52.FazekasdeStGrothSandWebsterRG.DisquisitionsofOriginalAntigenicSin.I.Evidenceinman.JExpMed124:331-345,1966
	53.MoutouhL,CorbeilJ,RichmanDD.RecombinationleadstotherapidemergenceofHIV-1duallyresistantmutantsunderselectivedrugpressure.ProcNatlAcadSciUSA93:6106-6111,1996
	54.PalumbiSR.Humansastheworld'sgreatestevolutionaryforce.Science293:1786-1790,2001
tacca00001-0242.pdf	26
	1.McKusickVA.MendelianInheritanceinMan,6thedition.Baltimore,JohnsHopkinsUniversityPress,1983,pp.506-507.
	2.KjeldsenAD,VaseP,GreenA.Hereditaryhemorrhagictelangiectasiainapopula-tion-basedstudyofprevalenceandmortalityinDanishpatients.JIntMed1999;245:31-39.
	3.MassarOS,FriedmanCM,WhiteRI.Thenaturalhistoryofepistaxisinhereditaryhemorrhagictelangiectasia.Laryngoscope1991;101:977-980.
	4.DinesDE,ArmsRA,BernatzPE,etal.Pulmonaryarteriovenousfistulas.MayoClinProc1974;49:460-465.
	5.BurkeCM,SafaiC,NelsonDPetal.Pulmonaryarteriovenousmalformations:Acriticalupdate.AmRevRespDis1986;134:334-339.
	6.GossageJR,KanjG.Pulmonaryarteriovenousmalformations:Astateoftheartreview.AmJRespCritCareMed1998;158:643-661.
	7.WhiteRJ,Lynch-NahmA,TerryPetal.Pulmonaryarteriovenousmalformations:Techniquesandlong-termoutcomeofembolotherapy.Radiology1988;169:663-669.
	8.RomanG,FisherM,PerlDPetal.Neurologicalmanifestationsofhereditaryhem-orrhagictelangiectasia(Rendu-Osler-Weberdisease).Reportoftwocasesandreviewoftheliterature.AnnNeurol1978;4:130-144.
	9.PressOW,RamseyPG.Centralnervoussysteminfectionsassociatedwithheredi-taryhemorrhagictelangiectasia.AmJMed1984;77:86-92.
	10.DyerNH.Cerebralabscessinhereditaryhemorrhagictelangiectasia:Reportoftwocasesinafamily.JNeurolNeurosurgPsychiatr1967;30:563-567.
	11.Garcia-TsaoG,KorzenikJR,YoungLetal.Liverdiseaseinpatientswithhereditaryhemorrhagictelangiectasia.NEnglJMed2000;343:931-936.
	12.ShovlinCL,GuttmacherAE,BuscariniEetal.Diagnosticcriteriainhereditaryhemorrhagictelangiectasia(Rendu-Osler-WeberSyndrome).AmJMedGenetics2000;91:66-67.
	13.BarzilaiB,WaggonerA,SpessertCetal.Two-dimensionalcontrastechocardiogra-phyinthedetectionandfollow-upofcongenitalpulmonaryarteriovenousmalfor-mations.AmJCardiol1991;68:1507-1510.
	14.ShubC,TajikA,SewardJetal.Detectingintrapulmonaryright-to-leftshuntwithcontrastechocardiography.MayoClinProc1976;51:81-84.
	15.HernandezA,StraussA,McKnightJetal.Diagnosisofpulmonaryarteriovenousfistulabyechocardiography.JPediatr1978;51:81-84.
	16.TaylorBG,CockerillEM,ManfrediFetal.Therapeuticembolizationofthepulmo-naryarteryinpulmonaryarteriovenousfistula.AmerJMed1978;69:360-365.
	17.TerryPB,BarthKH,KaufmanSLetal.Balloonembolizationfortreatmentofpulmonaryarteriovenousfistulas.NEnglJMed1980;302:1189-1190.d
	18.GoodenbergerD,BarzilaiB,PicusD.Incidenceandtimingofpleuriticchestpainaftertherapeuticpulmonaryembolization.Chest1993:103:159S.
	19.FulbrightRK,ChaloupkaJCJ,PutmanCMetal.MRofhereditaryhemorrhagictelangiectasia:Prevalenceandspectrumofcerebrovascularmalformations.AmJNeuroradiol1998;19:477-484.
	20.WillenseRG,MagerJJ,WestermannCJJetal.Bleedingriskofcerebralvascularmalformationsinhereditaryhemorrhagictelangiectasia.JNeurosurg2000;92:779-784.
	21.OndraSL.TrouppH.GeorgeEDetal.Thenaturalhistoryofsymptomaticarterio-venousmalformationsofthebrain:a24-yearfollow-upassessment.JNeurosurg1990;73:387-391.
	22.WhitingJH,KorzenikJR,MillerFJetal.Fataloutcomeafteremobolotherapyforhepaticarteriovenousmalformationsoftheliverintwopatientswithhereditaryhemorrhagictelangiectasia.JVascInterventRadiol2000;11:855-858.
	23.GoodmanJ,FallahM,GoodenbergerDM,etal.LiverTransplantationforHeredi-taryHemorrhagicTelangiectasia.Posteratthe2003AmericanHepato-Pancreato-BiliaryCongress,Miami,Florida,February27-March2,2003.
	24.LongoA,CeriatiM,GallitelliGetal.Orthotopiclivertransplantationandheredi-taryhemorrhagictelangiectasia:along-termfollowupstudyon2patients.5thHHTScientificConference,Bonaire,DutchAntilles,April2003.
	25.MillerF,TietzeC,MarkewitzBetal.CharacteristicsandoutcomeinHHTpatientsreferredforlivertransplantation.5thHHTScientificConference,Bonaire,DutchAntilles,April2003.
	26.PfitzmannR,HeiseM,LangvehrJMetal.LivertransplantationfortreatmentofintrahepaticOsler'sdisease:Firstexperiences.Transplantation2001;72:237-241.
index.pdf	0
3659.full.pdf	62
	Ali,N.&Siddiqui,A.(1995).Interactionofpolypyrimidinetract-bindingproteinwiththe59noncodingregionofthehepatitisCvirusRNAgenomeanditsfunctionalrequirementininternalinitiationoftranslation.JVirol69,6367?6375.
	Basset,S.E.,Thomas,D.L.,Brasky,K.M.&Lanford,R.E.(1999).Viralpersistence,antibodytoE1andE2,andhypervariableregion1sequencestabilityinhepatitisCvirus-inoculatedchimpanzees.JVirol73,1118?1126.
	Baumert,T.F.,Ito,S.,Wong,D.&Liang,J.(1998).HepatitisCvirusstructuralproteinsassembleintoviruslikeparticlesininsectcells.JVirol72,3827?3836.
	Bender,M.A.,Palmer,T.D.,Gelinas,R.E.&Miller,A.D.(1987).EvidencethatthepackagingsignalofMoloneymurineleukemiavirusextendsintothegaggene.JVirol61,1639?1646.
	Bertolini,L.,Iacovacci,S.,Ponzetto,A.,Gorini,G.,Battaglia,M.&Carloni,G.(1993).Thehumanbone-marrow-derivedB-celllineCE,susceptibletohepatitisCvirusinfection.ResVirol144,281?285.
	Brown,E.A.,Zhang,H.,Ping,L.-H.&Lemon,S.M.(1992).Secondarystructureofthe59nontranslatedregionsofthehepatitisCvirusandpestivirusgenomicRNAs.NucleicAcidsRes20,5041?5045.
	Chaabihi,H.,Ogliastro,M.H.,Martin,M.,Giraud,C.,Devauchelle,G.&Ceï¿½rutti,M.(1993).Competitionbetweenbaculoviruspolyhedrinandp10geneexpressionduringinfectionofinsectcells.JVirol67,2664?2671.
	Chiba,J.,Ohba,H.,Matsuura,Y.,Watanabe,Y.,Katayama,T.,Kikushi,S.,Saito,I.&Miyamura,T.(1991).SerodiagnosisofhepatitisCvirus(HCV)infectionwithanHCVcoreproteinmolecularlyexpressedbyarecombinantbaculovirus.ProcNatlAcadSciUSA88,4641?4645.
	Chien,D.Y.,Choo,Q.L.,Tabrizi,A.&16otherauthors(1992).DiagnosisofhepatitisCvirus(HCV)infectionusinganimmuno-dominantchimericpolyproteintocapturecirculatingantibody:reevaluationoftheroleofHCVinliverdisease.ProcNatlAcadSciUSA89,10011?10015.
	Choo,Q.L.,Kuo,G.,Weiner,A.J.,Overby,L.R.,Bradley,D.W.&Houghton,M.(1989).IsolationofacDNAclonederivedfromablood-bornenon-Anon-Bviralhepatitisgenome.Science244,359?362.
	Croizier,G.,Coizier,L.,Quiot,J.M.&Lereclus,D.(1988).Recom-binationofAutographacalifornicaandRachiplusiaounuclearpoly-hedrosisvirusesinGalleriamellonellaL.JGenVirol69,177?185.
	Croizier,L.,Jousset,F.-X.,Veyrunes,J.-C.,Lopez-Ferber,M.,Bergoin,M.&Croizier,G.(2000).Proteinrequirementsforassemblyofvirus-likeparticlesofJunoniacoeniadensovirusininsectcells.JGenVirol81,1605?1613.
	Deleersnyder,V.,Pillez,A.,Wychowski,C.,Blight,K.,Xu,J.,Hahn,S.,Rice,C.M.&Dubuisson,J.(1997).FormationofnativehepatitisCvirusglycoproteincomplexes.JVirol71,697?704.
	Feinstone,S.M.,Kapikiana,A.Z.,Purcell,R.H.&Holland,P.V.(1975).TransfusionassociatedhepatitisnotduetohepatitisAorB.NEnglJMed292,767?770.
	Felgner,P.L.&Ringold,G.M.(1989).Cationicliposome-mediatedtransfection.Nature337,387?388.
	Fukushi,S.,Kurihara,C.,Ishiyama,N.,Hoshino,F.B.,Oya,A.&Katayama,K.(1997).Thesequenceelementoftheinternalribosomeentrysiteanda25-kilodaltoncellularproteincontributetoefficientinternalinitiationoftranslationofhepatitisCvirusRNA.JVirol71,1662?1666.
	Gaymard,F.,Ceï¿½rutti,M.,Horeau,C.,Lemaillet,G.,Urbach,S.,Ravallec,M.,Devauchelle,G.,Sentenac,H.&Thibaud,J.B.(1996).Thebaculovirus/insectcellsystemasanalternativetoXenopusoocytes.FirstcharacterizationoftheAKT1K+channelfromArabidopsisthaliana.JBiolChem271,22863?22870.
	Grakoui,A.,Wyshowski,C.,Lin,C.,Feinstone,S.M.&Rice,C.M.(1993).ExpressionandidentificationofhepatitisCviruspolyproteincleavageproducts.JVirol67,1385?1395.
	Hirowatari,Y.,Hijikata,M.,Tanji,Y.,Nyunoya,H.,Mizushima,H.,Kimura,K.,Tanaka,T.,Kato,N.&Shimotohno,H.(1993).TwoproteinaseactivitiesinHCVpolypeptideexpressedininsectcellsusingbaculovirusvector.ArchVirol133,349?356.
	Honda,M.,Brown,E.A.&Lemon,S.M.(1996).Stabilityofastem-loopinvolvingtheinitiatorAUGcontrolstheefficiencyofinternalinitiationoftranslationonhepatitisCvirusRNA.RNA2,955?968.
	Hsu,H.H.,Donets,M.,Greenberg,H.B.&Feinstone,S.M.(1993).CharacterisationofhepatitisCvirusstructuralproteinswitharecombinantbaculovirusexpressionsystem.Hepatology17,763?771.
	Huï¿½ssy,P.,Langen,H.,Mous,J.&Jacobsen,H.(1996a).HepatitisCviruscoreprotein:carboxy-terminalboundariesoftwoprocessedspeciessuggestcleavagebyasignalpeptidepeptidase.Virology224,93?104.
	Huï¿½ssy,P.,Schmid,G.,Mous,J.&Jacobsen,H.(1996b).Purificationandinvitro-phospholabelingofsecretoryenvelopeproteinsE1andE2ofhepatitisCvirusexpressedininsectcells.VirusRes45,45?57.
	Huï¿½ssy,P.,Faust,H.,Wagner,J.C.,Schmid,G.,Mous,J.&Jacobse,H.(1997).EvaluationofhepatitisCvirusenvelopeproteinsexpressedinE.coliandinsectcellsforuseastoolsforantibodyscreening.JHepatol26,1179?1186.
	Hwang,S.B.,Park,K.J.,Kim,Y.-S.,Sung,Y.C.&Lai,M.C.(1997).HepatitisCvirusNS5Bproteinisamembrane-associatedphospho-proteinwithapredominantlyperinuclearlocalisation.Virology227,439?446.
	Iacovacci,S.,Manzin,A.,Barca,S.&9otherauthors(1997).MolecularcharacterisationanddynamicsofhepatitisCvirusreplica-tioninhumanfetalhepatocytesinfectedinvitro.Hepatology26,1328?1337.
	Inchauspeï¿½,G.,Zebedee,S.,Lee,D.-H.,Sugitani,M.,Nasoff,M.&Prince,A.M.(1991).GenomicstructureofthehumanprototypestrainHofhepatitisCvirus:comparisonwithAmericanandJapaneseisolates.ProcNatlAcadSciUSA88,10292?10296.
	Inoue,Y.,Suzuki,R.,Matsuura,Y.,Harada,S.,Chiba,J.,Watanabe,Y.,Saito,I.&Miyamura,T.(1992).ExpressionoftheaminoterminalhalfoftheNS1regionofthehepatitisCvirusgenomeanddetectionofanantibodytotheexpressedproteininpatientswithliverdisease.JGenVirol73,2151?2154.
	Ito,T.,Mukaigawa,J.,Zuo,J.,Hirabayashi,Y.,Mitamura,K.&Yasui,K.(1996).CultivationofhepatitisCvirusinprimaryhepatocyteculturefrompatientswithchronichepatitisCresultsinreleaseofhightitreinfectiousvirus.JGenVirol77,1043?1054.
	Kaito,M.,Watanabe,S.,Tsukiyama,K.K.&7otherauthors(1994).HepatitisCvirusparticledetectedbyimmunoelectronmicroscopicstudy.JGenVirol75,1755?1760.
	Kato,N.,Nakazawa,T.,Mizutani,T.&Shimotohno,K.(1995).SusceptibilityofhumanT-lymphotropicvirustypeIinfectedcelllineMT-2tohepatitisCvirusinfection.BiochemBiophysResCommun206,863?869.
	Kato,N.,Ikeda,M.,Mizutani,T.,Sugiyama,K.,Noguchi,M.,Hirohashi,S.&Shimotohno,K.(1996).ReplicationofhepatitisCvirusinculturednon-neoplastichumanhepatocytes.JCancerRes87,787?792.
	Khromykh,A.A.,Varnavsky,A.N.&Westaway,E.G.(1998).EncapsidationoftheflavivirusKunjinrepliconRNAbyusingacomplementationsystemprovidingKunjinvirusstructuralproteinsintrans.JVirol72,5967?5977.
	Laemmli,U.K.(1970).CleavageofstructuralproteinsduringtheassemblyoftheheadofbacteriophageT4.Nature227,680?685.
	Lanford,R.E.,Notvall,L.,Chavez,D.,White,R.,Frenzel,G.,Simonsen,C.&Kim,J.(1993).AnalysisofhepatitisCviruscapsid,E,andE2/NS1proteinsexpressedininsectcells.Virology197,225?235.
	Le,S.,Sonenberg,N.&Maizel,J.V.(1995).UnusualfoldingregionsandribosomelandingpadwithinhepatitisCvirusandpestivirusRNAs.Gene154,137?143.
	Matsumoto,M.,Hwang,S.B.,Jeng,K.-S.,Zhu,N.&Lai,M.M.C.(1996).HomotypicinteractionandmultimerizationofhepatitisCviruscoreprotein.Virology218,43?51.
	Matsuura,Y.,Harada,S.,Suzuki,R.,Watanabe,Y.,Inoue,Y.,Saito,I.&Miyamura,T.(1992).ExpressionofprocessedenvelopeproteinofhepatitisCvirusinmammalianandinsectcells.JVirol66,1425?1431.
	Matsuura,Y.,Suzuki,T.,Suzuki,R.,Sato,M.,Aizaki,H.,Saito,I.&Miyamura,T.(1994).ProcessingofE1andE2glycoproteinsofhepatitisCvirusexpressedinmammalianandinsectcells.Virology205,141?150.
	Miyamoto,H.,Okamoto,H.,Sato,K.,Tanaka,T.&Mishiro,S.(1992).ExtraordinarilylowdensityofhepatitisCvirusestimatedbysucrosedensitygradientcentrifugationandthepolymerasechainreaction.JGenVirol73,715?718.
	Nakajima,N.,Hijikata,M.,Yoshikura,H.&Shimizu,Y.K.(1996).Characterizationoflong-termculturesofhepatitisCvirus.JVirol70,3325?3329.
	Nishihara,T.,Nozaki,C.,Nakatake,H.&7otherauthors(1993).SecretionandpurificationofhepatitisCvirusNS1glycoproteinproducedbyrecombinantbaculovirusinfectedinsectcells.Gene129,207?214.
	Overton,H.,McMillan,D.,Gillespie,F.&Mills,J.(1995).Recombinantbaculovirus-expressedNS3proteinaseofhepatitisCvirusshowsactivityincell-basedandinvitroassays.JGenVirol76,3009?3019.
	Reggio,H.&Boller,K.(1989).Immunocytochemistryandultra-cryotomy.InImmunocytochemistry,PracticalMethods,pp.37?46.Paris:SFME.
	Reynolds,J.E.,Kaminski,A.,Kettinen,H.J.,Grace,K.,Clarke,B.E.,Caroll,A.R.,Rowlands,D.J.&Jackson,R.J.(1995).UniquefeaturesofinternalinitiationofhepatitisCvirusRNAtranslation.EMBOJ14,6010?6020.
	Rice,C.M.(1996).Flaviviridae:thevirusesandtheirreplication.InFieldsVirology,3rdedn,vol.1,pp.931?959.EditedbyB.N.Fields,D.M.Knipe&P.M.Howley.Philadelphia:Lippincott?Raven.
	Rijnbrand,R.C.&Lemon,S.M.(2000).Internalribosomeentrysite-mediatedtranslationinhepatitisCvirusreplication.CurrTopMicrobiolImmunol242,85?116.
	Santolini,E.,Migliaccio,G.&LaMonica,N.(1994).BiosynthesisandbiochemicalpropertiesofthehepatitisCviruscoreprotein.JVirol68,3631?3641.
	Shimizu,Y.K.&Yoshikura,H.(1994).MulticycleinfectionofhepatitisCvirusincellcultureandinhibitionbyalphaandbetainterferons.JVirol68,8406?8408.
	Shimizu,Y.K.,Purcell,R.H.&Yoshikura,H.(1993).CorrelationbetweentheinfectivityofhepatitisCvirusinvivoanditsinfectivityinvitro.ProcNatlAcadSciUSA90,6037?6041.
	Shimoike,T.,Mimori,S.,Tani,H.,Matsuura,Y.&Miyamura,T.(1999).InteractionofhepatitisCviruscoreproteinwithviralsenseRNAandsuppressionofitstranslation.JVirol73,9718?9725.
	Simmonds,P.,Holmes,E.C.,Cha,T.A.&7otherauthors(1993).ClassificationofhepatitisCvirusintosixmajorgenotypesandaseriesofsubtypesbyphylogeneticanalysisoftheNS-5region.JGenVirol74,2391?2399.
	Smith,D.B.,Mellor,J.,Jarvis,L.M.,Davidson,F.,Kolberg,J.,Urdea,M.,Yap,P.,Simmonds,P.&TheInternationalHCVCollaborativeStudyGroup(1995).VariationofthehepatitisCvirus59non-codingregion:implicationsforsecondarystructure,virusdetectionandtyping.JGenVirol76,1749?1761.
	Summers,M.D.&Smith,G.E.(1987).Amanualofmethodsforbaculovirusvectorsinsectcellcultureprocedure.TexasAgricExpStatBull1555,1?56.
	Suzuki,T.,Sato,M.,Chieda,S.,Shoji,I.,Harada,T.,Yamakawa,Y.,Watanabe,S.,Matsuura,Y.&Miyamura,T.(1995).Invivoandinvitrotrans-cleavageactivityofhepatitisCvirusserineproteinaseexpressedbyrecombinantbaculoviruses.JGenVirol76,3021?3029.
	Tagawa,N.,Kato,N.,Yokosura,I.,Ishikawa,T.,Ohto,M.&Omata,M.(1995).InfectionofhumanhepatocytecelllineswithhepatitisCvirusinvitro.JGastroenterolHepatol10,523?527.
	Tsukiyama-Kohara,K.,Lizuka,N.,Kohara,M.&Nomoto,A.(1992).InternalribosomeentrysitewithinhepatitisCvirusRNA.JVirol66,1476?1483.
	Vaughn,J.L.,Goodwin,R.H.,Tompkins,G.L.&McCawley,P.(1977).TheestablishmentoftwocelllinesfromtheinsectSpodop-terafrugiperda(Lepidoptera:Noctuidae).InVitroCellDevBiol13,213?217.
	Wang,C.,Sarnow,P.&Siddiqui,A.(1993).TranslationofhumanhepatitisCvirusRNAinculturedcellsismediatedbyaninternalribosome-bindingmechanism.JVirol67,3338?3344.
	Wang,C.,Le,S.Y.,Ali,N.&Siddiqui,A.(1995).AnRNApseudo-knotisanessentialstructuralelementoftheinternalribosomeentrysitelocatedwithinthehepatitisCvirus54noncodingregion.RNA1,526?537.
	Wang,Y.H.,Trowbridge,R.&Gowans,E.J.(1997).ExpressionandinteractionofthehepatitisCvirusstructuralproteinsandthe59untranslatedregioninbaculovirusinfectedcells.ArchVirol142,2211?2223.
	Yen,J.-H.,Chang,S.C.,Hu,C.-R.,Chu,S.-C.,Lin,S.-S.,Hsieh,Y.-S.&Chang,M.-F.(1995).Cellularproteinsspecificallybindtothe59-noncodingregionofhepatitisCvirusRNA.Virology208,723?732.
gkh765.pdf	50
	1.Saenger,W.(1984)PrinciplesofNucleicAcidStructure.Springer,NY.
	2.Dickerson,R.E.andDrew,H.R.(1981)StructureofaB-DNAdodecamer:influenceofbasesequenceonhelixstructure.J.Mol.Biol.,149,761?786.
	3.Nelson,H.C.,Finch,J.T.,Luisi,B.F.andKlug,A.(1987)Thestructureofanoligo(dA) oligo(dT)tractanditsbiologicalimplications.Nature,330,221?226.
	4.Drew,H.R.andDickerson,R.E.(1981)StructureofaB-DNAdodecamer.III.Geometryofhydration.J.Mol.Biol.,151,535?556.
	5.Kopka,M.L.,Fratini,A.V.,Drew,H.R.andDickerson,R.E.(1983)OrderedwaterstructurearoundaB-DNAdodecamer.Aquantitativestudy.J.Mol.Biol.,163,129?146.
	6.Shui,X.,Sines,C.C.,McFail-Isom,L.,VanDerveer,D.andWilliams,L.D.(1998)StructureofthepotassiumformofCGCGAATTCGCG:DNAdeformationbyelectrostaticcollapsearoundinorganiccations.Biochemistry,37,16877?16887.
	7.Shui,X.,McFail-Isom,L.,Hu,G.G.andWilliams,L.D.(1998)TheB-DNAdodecamerathighresolutionrevealsaspineofwateronsodium.Biochemistry,37,8341?8355.
	8.Tereshko,V.,Minasov,G.andEgli,M.(1999)TheDickerson?DrewB-DNAdodecamerrevisitedatatomicresolution.J.Am.Chem.Soc.,121,470?471.
	9.Chiu,T.K.,Kaczor-Grzeskowiak,M.andDickerson,R.E.(1999)AbsenceofminorgroovemonovalentcationsinthecrosslinkeddodecamerCGCGAATTCGCG.J.Mol.Biol.,292,589?608.
	10.Tereshko,V.,Minasov,G.andEgli,M.(1999)A?hydrat-ion?spineinaB-DNAminorgroove.J.Am.Chem.Soc.,121,3590?3595.
	11.McFail-Isom,L.,Sines,C.C.andWilliams,L.D.(1999)DNAstructure:cationsincharge?Curr.Opin.Struct.Biol.,9,298?304.
	12.Howerton,S.B.,Sines,C.C.,VanDerveer,D.andWilliams,L.D.(2001)LocatingmonovalentcationsinthegroovesofB-DNA.Biochemistry,40,10023?10031.
	13.Hud,N.V.,Sklenar,V.andFeigon,J.(1999)LocalizationofammoniumionsintheminorgrooveofDNAduplexesinsolutionandtheoriginofDNAA-tractbending.J.Mol.Biol.,286,651?660.
	14.Denisov,V.P.andHalle,B.(2000)Sequence-specificbindingofcounterionstoB-DNA.Proc.NatlAcad.Sci.USA,97,629?633.
	15.Cheatham,T.E.,IIIandYoung,M.A.(2001)Moleculardynamicssimulationofnucleicacids:successes,limitations,andpromise.Biopolymers,56,232?256.
	16.Young,M.A.,Jarayam,B.andBeveridge,D.L.(1997)IntrusionofcounterionsintothespineofhydrationintheminorgrooveofB-DNA:fractionaloccupancyofelectronegativepockets.J.Am.Chem.Soc.,119,59?69.
	17.McConnell,K.J.andBeveridge,D.L.(2000)DNAstructure:what?sincharge?J.Mol.Biol.,304,803?820.
	18.Hamelberg,D.,McFail-Isom,L.,Williams,L.D.andWilson,W.D.(2000)FlexiblestructureofDNA:iondependenceofminor-groovestructureanddynamics.J.Am.Chem.Soc.,122,10513?10520.
	19.Mocci,F.andSaba,G.(2003)MoleculardynamicssimulationsofA T-richoligomers:sequence-specificbindingofNa+intheminorgrooveofB-DNA.Biopolymers,68,471?485.
	20.Feig,M.andPettitt,B.M.(1999)SodiumandchlorineionsaspartoftheDNAsolvationshell.Biophys.J.,77,1769?1781.
	21.Korolev,N.,Lyubartsev,A.P.,Laaksonen,A.andNordenskiold,L.(2002)Onthecompetitionbetweenwater,sodiumions,andspermineinbindingtoDNA:amoleculardynamicscomputersimulationstudy.Biophys.J.,82,2860?2875.
	22.Auffinger,P.andWesthof,E.(2000)WaterandionbindingaroundRNAandDNA(C,G)oligomers.J.Mol.Biol.,300,1113?1131.
	23.Auffinger,P.andWesthof,E.(2001)Waterandionbindingaroundr(UpA)12andd(TpA)12oligomers.ComparisonwithRNAandDNA(CpG)12duplexes.J.Mol.Biol.,305,1057?1072.
	24.Reddy,S.Y.,Leclerc,F.andKarplus,M.(2003)DNApolymorphism:acomparisonofforcefieldsfornucleicacids.Biophys.J.,84,1421?1449.
	25.Vaï¿½rnai,P.andLavery,R.(2002)BaseflippinginDNA:pathwaysandenergeticsstudiedwithmoleculardynamicssimulations.J.Am.Chem.Soc.,124,7272?7273.
	26.Case,D.A.,Pearlman,D.A.,Caldwell,J.W.,Cheatham,T.E.,III,Ross,W.S.,Simmerling,C.L.,Darden,T.A.,Metz,K.M.,Stanton,R.V.,Cheng,A.L.etal.(1999)AMBER6.UniversityofCalifornia,SanFrancisco,CA.
	27.Wang,J.,Cieplak,P.andKollman,P.A.(2000)Howwelldoesarestrainedelectrostaticpotential(RESP)modelperformincalculatingconformationalenergiesoforganicandbiologicalmolecules?J.Comput.Chem.,21,1049?1074.
	28.Patra,M.andKarttunen,M.(2004)SystematiccomparisonofforcefieldsformicroscopicsimulationsofNaClinaqueoussolutions:diffusion,freeenergyofhydration,andstructuralproperties.J.Comput.Chem.,25,678?689.
	29.Cheatham,T.E.,III(2004)Simulationandmodelingofnucleicacidstructure,dynamicsandinteractions.Curr.Opin.Struct.Biol.,14,360?367.
	30.Kastenholtz,M.A.andH?unenberger,H.P.(2004)InfluenceofartificialperiodicityandionicstrengthinMDsimulationsofchargedbiomoleculesemployinglattice-summethods.J.Phys.Chem.B,108,774?788.
	31.Berendsen,H.J.C.,Postma,J.P.M.,vanGunsteren,W.F.,DiNola,A.andHaak,J.R.(1984)Moleculardynamicswithcouplingtoanexternalbath.J.Chem.Phys.,81,3684?3690.
	32.Ryckaert,J.P.,Ciccotti,G.andBerendsen,H.J.C.(1977)Numericalintegrationofthecartesianequationsofmotionofasystemwithconstraints:Moleculardynamicsofn-alkanes.J.Comp.Phys.,23,327?341.
	33.Darden,T.,York,D.andPedersen,L.(1993)Particlemeshewald:anN log(N)methodsforEwaldsumsinlargesystems.J.Chem.Phys.,98,10089?10092.
	34.Brunne,R.M.,Liepinsh,E.,Otting,G.,Wuthrich,K.andvanGunsteren,W.F.(1993)Hydrationofproteins.Acomparisonofexperimentalresidencetimesofwatermoleculessolvatingthebovinepancreatictrypsininhibitorwiththeoreticalmodelcalculations.J.Mol.Biol.,231,1040?1048.
	35.Lavery,R.andSklenar,H.(1989)Definingthestructureofirregularnucleicacids:conventionandprinciples.J.Biomol.Struct.Dyn.,6,655?667.
	36.Stofer,E.andLavery,R.(1994)MeasuringthegeometryofDNAgrooves.Biopolymers,34,337?346.
	37.Sharp,K.A.andHonig,B.(1990)Electrostaticinteractionsinmacromolecules:theoryandapplications.Annu.Rev.Biophys.Chem.,19,301?332.
	38.Makarov,V.A.,Feig,M.,Andrews,B.K.andPettitt,B.M.(1998)Diffusionofsolventaroundbiomolecularsolutes:amoleculardynamicssimulationstudy.Biophys.J.,75,150?158.
	39.Atkins,P.W.(1998)PhysicalChemistry.OxfordUniversityPress,Oxford.
	40.Koneshan,S.,Rasaiah,J.C.,Lynden-Bell,R.M.andLee,S.H.(1998)Solventstructure,dynamics,andionmobilityinaqueoussolutionsat25C.J.Phys.Chem.B,102,4193?4204.
	41.Kennard,O.,Isaacs,N.W.,Motherwell,W.D.,Coppola,J.C.,Wampler,D.L.,Larson,A.C.andWatson,D.G.(1971)Thecrystalandmolecularstructureofadenosinetriphosphate.Proc.R.Soc.Lond.A,325,401?436.
	42.Reblova,K.,Spackova,N.,Sponer,J.E.,Koca,J.andSponer,J.(2003)MoleculardynamicssimulationsofRNAkissing-loopmotifsrevealstructuraldynamicsandformationofcation-bindingpockets.NucleicAcidsRes.,31,6942?6952.
	43.Reblova,K.,Spackova,N.,Stefl,R.,Csaszar,K.,Koca,J.,Leontis,N.B.andSponer,J.(2003)Non-Watson?CrickbasepairingandhydrationinRNAmotifs:moleculardynamicsof5SrRNAloopE.Biophys.J.,84,3564?3582.
	44.Stefl,R.,Cheatham,T.E.,III,Spackova,N.,Fadrna,E.,Berger,I.,Koca,J.andSponer,J.(2003)Formationpathwaysofaguanine-quadruplexDNArevealedbymoleculardynamicsandthermodynamicanalysisofthesubstates.Biophys.J.,85,1787?1804.
	45.Spackova,N.,Berger,I.andSponer,J.(2001)StructuraldynamicsandcationinteractionsofDNAquadruplexmoleculescontainingmixedguanine/cytosinequartetsrevealedbylarge-scaleMDsimulations.J.Am.Chem.Soc.,123,3295?3307.
	46.Kosikov,K.M.,Gorin,A.A.,Lu,X.-J.,Olson,W.K.andManning,G.S.(2002)BendingofDNAbyasymmetricchargeneutralization:all-atomenergysimulations.J.Am.Chem.Soc.,124,4838?4847.
	47.Hud,N.V.andPlavec,J.(2003)AunifiedmodelfortheoriginofDNAsequence-directedcurvature.Biopolymers,69,144?159.
	48.Pearlman,D.A.andKollman,P.A.(1991)Aretime-averagedrestraintsnecessaryfornuclearmagneticresonancerefinement?AmodelstudyforDNA.J.Mol.Biol.,220,457?479.
	49.Schmitz,U.,Ulyanov,N.B.,Kumar,A.andJames,T.L.(1993)Moleculardynamicswithweightedtime-averagedrestraintsforaDNAoctamer.Dynamicinterpretationofnuclearmagneticresonancedata.J.Mol.Biol.,234,373?389.
	50.Ojha,R.P.,Dhingra,M.M.,Sarma,M.H.,Shibata,M.,Farrar,M.,Turner,C.J.andSarma,R.H.(1999)DNAbendingandsequence-dependentbackboneconformationNMRandcomputerexperiments.Eur.J.Biochem.,265,35?53.4280NucleicAcidsResearch,2004,Vol.32,No.14
200.full.pdf	99
	1.  Gilman, A.G. G proteins: Transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615?649 (1987).
	2.  Iiri, T., Farfel, Z., and Bourne, H.R. G-protein diseases furnish a model for the turn-on switch. Nature 394, 35?38 (1998).
	3.  Yasuda, H., Lindorfer, M.A., Woodfork, K.A., Fletcher, J.E., and Garrison, J.C. Role of the prenyl group on the G protein gamma subunit in cou-pling trimeric G proteins to A1 adenosine receptors. J. Biol. Chem. 271, 18588?18595 (1996).
	4.  Blumer, K.J. and Thorner, J. Beta and gamma subunits of a yeast gua-nine nucleotide-binding protein are not essential for membrane associa-tion of the alpha subunit but are required for receptor coupling. Proc. Natl. Acad. Sci. USA 87, 4363?4367 (1990).
	5.  Florio, V.A. and Sternweis, P.C. Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles. J. Biol. Chem. 264, 3909?3915 (1989).
	6.  Rubenstein, R.C., Linder, M.E., and Ross, E.M. Selectivity of the beta-adrenergic receptor among Gs, Gi?s, and Go: Assay using recombinant alpha subunits in reconstituted phospholipid vesicles. Biochemistry 30, 10769?10777 (1991).
	7.  Fawzi, A.B., Fay, D.S., Murphy, E.A., Tamir, H., Erdos, J.J., and Northup, J.K. Rhodopsin and the retinal G-protein distinguish among G-protein beta gamma subunit forms. J. Biol. Chem. 266, 12194?12200 (1991).
	8.  Hildebrandt, J.D. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem. Pharmacol. 54, 325?339 (1997).
	9.  Berstein, G., Blank, J.L., Jhon, D.Y., Exton, J.H., Rhee, S.G., and Ross, E.M. Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. Cell 70, 411?418 (1992).
	10.  Siderovski, D.P., Hessel, A., Chung, S., Mak, T.W., and Tyers, M. A new family of regulators of G-protein-coupled receptors? Curr. Biol. 6, 211?212 (1996).
	11.  De Vries, L., Mousli, M., Wurmser, A., and Farquhar, M.G. GAIP, a pro-tein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc. Natl. Acad. Sci. USA 92, 11916?11920 (1995).
	12.  Dohlman, H.G., Song, J., Ma, D., Courchesne, W.E., and Thorner, J. Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: Expression, localization, and genetic interac-tion and physical association with Gpa1 (the G-protein alpha subunit). Mol. Cell. Biol. 16, 5194?5209 (1996).
	13.  Koelle, M.R. and Horvitz, H.R. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84, 115?125 (1996).
	14.  Clapham, D.E. and Neer, E.J. G protein beta gamma subunits. Annu. Rev. Pharmacol. Toxicol. 37, 167?203 (1997).
	15.  Schmidt, C.J., Thomas, T.C., Levine, M.A., and Neer, E.J. Specificity of G protein beta and gamma subunit interactions. J. Biol. Chem. 267, 13807?13810 (1992).
	16.  Cabrera-Vera, T.M., Vanhauwe, J., Thomas, T.O., Medkova, M., Preininger, A., Mazzoni, M.R., and Hamm, H.E. Insights into G protein structure, function, and regulation. Endocr. Rev. 24, 765?781 (2003).
	17.  Gudermann, T., Kalkbrenner, F., and Schultz, G. Diversity and selectiv-ity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36, 429?459 (1996).
	18.  Albert, P.R. and Robillard, L. G protein specificity: Traffic direction required. Cell. Signal. 14, 407?418 (2002).
	19.  McIntire, W.E., MacCleery, G., and Garrison, J.C. The G Protein beta Subunit Is a Determinant in the Coupling of Gs to the beta 1-Adrenergic and A2a Adenosine Receptors. J. Biol. Chem. 276, 15801?15809 (2001). This detailed in vitro study illustrated a role for G?? dimers in determining the selectivity of receptors in coupling to G protein heterotrimers.
	20.  Fletcher, J.E., Lindorfer, M.A., DeFilippo, J.M., Yasuda, H., Guilmard, M., and Garrison, J.C. The G protein beta5 subunit interacts selectively with the Gq alpha subunit. J. Biol. Chem. 273, 636?644 (1998).
	21.  Wang, Q., Mullah, B.K., and Robishaw, J.D. Ribozyme approach identi-fies a functional association between the G protein beta1gamma7 sub-units in the beta-adrenergic receptor signaling pathway. J. Biol. Chem. 274, 17365?17371 (1999).
	22.  Wang, Q., Mullah, B., Hansen, C., Asundi, J., and Robishaw, J.D. Ribozyme-mediated suppression of the G protein gamma7 subunit sug-gests a role in hormone regulation of adenylylcyclase activity. J. Biol. Chem. 272, 26040?26048 (1997).
	23.  Schwindinger, W.F., Betz, K.S., Giger, K.E., Sabol, A., Bronson, S.K., and Robishaw, J.D. Loss of G Protein gamma 7 Alters Behavior and Reduces Striatal alpha olf Level and cAMP Production. J. Biol. Chem. 278, 6575?6579 (2003). This paper was the culmination of a series of exquisite studies demonstrating the signaling specificity and physiological significance of the G?7 subunit, shown to influence coupling of adrenergic receptors and dopamine receptors to adeny-lyl cyclase activation.
	24.  Wang, Q., Jolly, J.P., Surmeier, J.D., Mullah, B.M., Lidow, M.S., Bergson, C.M., and Robishaw, J.D. Differential Dependence of the D1 and D5 Dopamine Receptors on the G Protein gamma 7 Subunit for Activation of Adenylylcyclase. J. Biol. Chem. 276, 39386?39393 (2001).
	25.  Wolfe, J.T., Wang, H., Howard, J., Garrison, J.C., and Barrett, P.Q. T-type calcium channel regulation by specific G-protein betagamma subunits. Nature 424, 209?213 (2003). Despite the high sequence similarity among G? subunits, this study demonstrated marked specificity of G?2-containing G?? dimers in the regulation of T-type calcium channel ?1H.
	26.  Diverse-Pierluissi, M., McIntire, W.E., Myung, C.S., Lindorfer, M.A., Garrison, J.C., Goy, M.F., and Dunlap, K. Selective coupling of G protein beta gamma complexes to inhibition of Ca2+ channels. J. Biol. Chem. 275, 28380?28385 (2000).
	27.  Siffert, W., Rosskopf, D., Siffert, G. et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet. 18, 45?48 (1998). Expression of the G?3 splice variant, G?3s, was shown to Selectivity in the G?? Dimer212correlate with increased hypertension, implicating a role for a spe-cific G protein subunit in a pathological state.
	28.  Morrison, A.C., Doris, P.A., Folsom, A.R., Nieto, F.J., and Boerwinkle, E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 32, 822?829 (2001).
	29.  Poch, E., Gonzalez, D., Gomez-Angelats, E., Enjuto, M., Pare, J.C., Rivera, F., and de La Sierra, A. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 35, 214?218 (2000).
	30.  Virchow, S., Ansorge, N., Rubben, H., Siffert, G., and Siffert, W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from indi-viduals carrying the G protein beta3 subunit 825 T-allele. FEBS Lett. 436, 155?158 (1998).
	31.  Nuckel, H., Frey, U., Aralh, N., Durig, J., Duhrsen, U., and Siffert, W. The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia. Leuk. Lymphoma 44, 1739?1743 (2003).
	32.  Rosskopf, D., Manthey, I., Habich, C.et al. Identification and character-ization of G beta 3s2, a novel splice variant of the G-protein beta 3 sub-unit. Biochem. J. 371, 223?232 (2003).
	33.  Watson, A.J., Katz, A., and Simon, M.I. A fifth member of the mamma-lian G-protein beta-subunit family. Expression in brain and activation of the beta 2 isotype of phospholipase C. J. Biol. Chem. 269, 22150?22156 (1994).
	34.  Jones, P.G., Lombardi, S.J., and Cockett, M.I. Cloning and tissue dis-tribution of the human G protein beta 5 cDNA. Biochim. Biophys. Acta 1402, 288?291 (1998).
	35.  Watson, A.J., Aragay, A.M., Slepak, V.Z., and Simon, M.I. A novel form of the G protein beta subunit Gbeta5 is specifically expressed in the ver-tebrate retina. J. Biol. Chem. 271, 28154?28160 (1996).
	36.  Snow, B.E., Krumins, A.M., Brothers, G.M.et al. A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits. Proc. Natl. Acad. Sci. USA 95, 13307?13312 (1998). This paper identified the G gamma-like (GGL) domain and defined the molecular basis for specificity of the GGL?G?5 interaction. 
	37.  Betty, M., Harnish, S.W., Rhodes, K.J., and Cockett, M.I. Distribution of heterotrimeric G-protein beta and gamma subunits in the rat brain. Neuroscience 85, 475?486 (1998).
	38.  Liang, J.J., Cockett, M., and Khawaja, X.Z. Immunohistochemical local-ization of G protein beta1, beta2, beta3, beta4, beta5, and gamma3 subunits in the adult rat brain. J. Neurochem. 71, 345?355 (1998).
	39.  Cabrera, J.L., de Freitas, F., Satpaev, D.K., and Slepak, V.Z. Identification of the Gbeta5-RGS7 protein complex in the retina. Biochem. Biophys. Res. Commun. 249, 898?902 (1998).
	40.  Makino, E.R., Handy, J.W., Li, T., and Arshavsky, V.Y. The GTPase acti-vating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5 G protein beta subunit. Proc. Natl. Acad. Sci. USA 96, 1947?1952 (1999). This study defined the G?5?RGS9-1 dimer as the GTPase-activating component of the phototransduction cascade, representing the most clearly defined physiologic function for an RGS protein. 
	41.  Zhang, J.H. and Simonds, W.F. Copurification of brain G-protein beta5 with RGS6 and RGS7. J. Neurosci. 20, RC59 (2000).
	42.  Siderovski, D.P., Strockbine, B., and Behe, C.I. Whither goest the RGS proteins?. Crit. Rev. Biochem. Mol. Biol. 34, 215?251 (1999).
	43.  Neubig, R.R. and Siderovski, D.P. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1, 187?197 (2002).
	44.  Ross, E.M. and Wilkie, T.M. GTPase-activating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like pro-teins. Annu. Rev. Biochem. 69, 795?827 (2000).
	45.  Hu, G. and Wensel, T.G. R9AP, a membrane anchor for the photorecep-tor GTPase accelerating protein, RGS9-1. Proc. Natl. Acad. Sci. USA 99, 9755?9760 (2002).
	46.  Martemyanov, K.A., Lishko, P.V., Calero, N.et al. The DEP domain deter-mines subcellular targeting of the GTPase activating protein RGS9 in vivo. J. Neurosci. 23, 10175?10181 (2003).
	47.  Snow, B.E., Betts, L., Mangion, J., Sondek, J., and Siderovski, D.P. Fidelity of G protein beta-subunit association by the G protein gamma-subunit-like domains of RGS6, RGS7, and RGS11. Proc. Natl. Acad. Sci. USA 96, 6489?6494 (1999).
	48.  Levay, K., Cabrera, J.L., Satpaev, D.K., and Slepak, V.Z. Gbeta5 prevents the RGS7-Galphao interaction through binding to a distinct Ggamma-like domain found in RGS7 and other RGS proteins. Proc. Natl. Acad. Sci. USA 96, 2503?2507 (1999).
	49.  Posner, B.A., Gilman, A.G., and Harris, B.A. Regulators of G protein signaling 6 and 7. Purification of complexes with gbeta5 and assessment of their effects on g protein-mediated signaling pathways. J. Biol. Chem. 274, 31087?31093 (1999).
	50.  Sondek, J. and Siderovski, D.P. Ggamma-like (GGL) domains: New frontiers in G-protein signaling and beta-propeller scaffolding. Biochem. Pharmacol. 61, 1329?1337 (2001).
	51.  Witherow, D.S., Wang, Q., Levay, K., Cabrera, J.L., Chen, J., Willars, G.B., and Slepak, V.Z. Complexes of the G protein subunit gbeta 5 with the regulators of G protein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells. J. Biol. Chem. 275, 24872?24880 (2000).
	52.  Chen, C.K., Eversole-Cire, P., Zhang, H., Mancino, V., Chen, Y.J., He, W., Wensel, T.G., and Simon, M.I. Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc. Natl. Acad. Sci. USA 100, 6604?6609 (2003).
	53.  Chen, C.K., Burns, M.E., He, W., Wensel, T.G., Baylor, D.A., and Simon, M.I. Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 403, 557?560 (2000).
	54.  Zhou, J.Y., Siderovski, D.P., and Miller, R.J. Selective regulation of N-type Ca channels by different combinations of G-protein beta/gamma subunits and RGS proteins. J. Neurosci. 20, 7143?7148 (2000).
	55.  Robatzek, M., Niacaris, T., Steger, K., Avery, L., and Thomas, J.H. eat-11 encodes GPB-2, a Gbeta(5) ortholog that interacts with G(o)alpha and G(q)alpha to regulate C. elegans behavior. Curr. Biol. 11, 288?293 (2001).
	56.  Dong, M.Q., Chase, D., Patikoglou, G.A., and Koelle, M.R. Multiple RGS proteins alter neural G protein signaling to allow C. elegans to rapidly change behavior when fed. Genes Devel. 14, 2003?2014 (2000).
	57.  Hajdu-Cronin, Y.M., Chen, W.J., Patikoglou, G., Koelle, M.R., and Sternberg, P.W. Antagonism between G(o)alpha and G(q)alpha in Caenorhabditis elegans: The RGS protein EAT-16 is necessary for G(o)alpha signaling and regulates G(q)alpha activity. Genes Devel. 13, 1780?1793 (1999).
	58.  van der Linden, A.M., Simmer, F., Cuppen, E., and Plasterk, R.H.A. The G-Protein beta-Subunit GPB-2 in Caenorhabditis elegans Regulates the Go alpha-Gq alpha Signaling Network Through Interactions With the Regulator of G-Protein Signaling Proteins EGL-10 and EAT-16. Genetics 158, 221?235 (2001).
	59.  Chase, D.L., Patikoglou, G.A., and Koelle, M.R. Two RGS proteins that inhibit Galpha(o) and Galpha(q) signaling in C. elegans neurons require a Gbeta(5)-like subunit for function. Curr. Biol. 11, 222?231 (2001).
	60.  Shuey, D.J., Betty, M., Jones, P.G., Khawaja, X.Z., and Cockett, M.I. RGS7 attenuates signal transduction through the G(alpha q) family of heterotrimeric G proteins in mammalian cells. J. Neurochem. 70, 1964?1972 (1998).
	61.  Posner, B.A., Gilman, A.G., and Harris, B.A. Regulators of G protein signaling 6 and 7. Purification of complexes with gbeta5 and assessment of their effects on g protein-mediated signaling pathways. J. Biol. Chem. 274, 31087?31093 (1999).
	62.  Hooks, S.B., Waldo, G.L., Corbitt, J., Bodor, E.T., Krumins, A.M., and Harden, T.K. RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activ-ity of Gi family G-proteins with differential selectivity and maximal activ-ity. J. Biol. Chem. 278, 10087?10093 (2003). This study represents a comprehensive analysis of G protein selectivity of the R7 family of 4RGS proteins. Purified G?5?R7 dimers were demonstrated to accel-erate the steady-state GTPase activity of the G?i family with varying efficacy and potency.
	63.  Witherow, D.S., Tovey, S.C., Wang, Q., Willars, G.B., and Slepak, V.Z. G beta 5.RGS7 inhibits G alpha q-mediated signaling via a direct protein-protein interaction. J. Biol. Chem. 278, 21307?21313 (2003).
	64.  Witherow, D.S., Wang, Q., Levay, K., Cabrera, J.L., Chen, J., Willars, G.B., and Slepak, V.Z. Complexes of the G protein subunit gbeta 5 with the regulators of G protein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells. J. Biol. Chem. 275, 24872?24880 (2000).
	65.  Kovoor, A., Chen, C.K., He, W., Wensel, T.G., Simon, M.I., and Lester, H.A. Co-expression of Gbeta5 enhances the function of two Ggamma subunit-like domain-containing regulators of G protein signaling proteins. J. Biol. Chem. 275, 3397?3402 (2000).
	66.  He, W., Cowan, C.W., and Wensel, T.G. RGS9, a GTPase accelerator for phototransduction. Neuron 20, 95?102 (1998).
	67.  Cowan, C.W., Fariss, R.N., Sokal, I., Palczewski, K., and Wensel, T.G. High expression levels in cones of RGS9, the predominant GTPase accelerating protein of rods. Proc. Natl. Acad. Sci. USA95, 5351?5356 (1998).
	68.  He, W., Lu, L., Zhang, X., El-Hodiri, H.M., Chen, C.K., Slep, K.C., Simon, M.I., Jamrich, M., and Wensel, T.G. Modules in the photoreceptor RGS9-1.Gbeta 5L GTPase-accelerating protein complex control effector cou-pling, GTPase acceleration, protein folding, and stability. J. Biol. Chem. 275, 37093?37100 (2000).
	69.  Lishko, P.V., Martemyanov, K.A., Hopp, J.A., and Arshavsky, V.Y. Specific binding of RGS9-Gbeta 5L to protein anchor in photoreceptor mem-branes greatly enhances its catalytic activity. J. Biol. Chem. 277, 24376?24381 (2002).
	70.  Nishiguchi, K.M., Sandberg, M.A., Kooijman, A.C., Martemyanov, K.A., Pott, J.W., Hagstrom, S.A., Arshavsky, V.Y., Berson, E.L., and Dryja, T.P. Defects in RGS9 or its anchor protein R9AP in patients with slow photo-receptor deactivation. Nature 427, 75?78 (2004). This paper describes a genetic visual disorder mediated by mutations in RGS9-1 and its anchor protein R9AP, further highlighting the significance of RGS9 function in phototransduction. This finding represents the first human disease state associated with a defective RGS protein.
	71.  Hu, G., Zhang, Z., and Wensel, T.G. Activation of RGS9-1 GTPase acceleration by its membrane anchor, R9AP. J. Biol. Chem. 278, 14550?14554 (2003).
	72.  Keresztes, G., Martemyanov, K.A., Krispel, C.M., Mutai, H., Yoo, P.J., Maison, S.F., Burns, M.E., Arshavsky, V.Y., and Heller, S. Absence of the RGS9.Gbeta5 GTPase-activating complex in photoreceptors of the R9AP knockout mouse. J. Biol. Chem. 279, 1581?1584 (2004).
	73.  Hunt, R.A., Edris, W., Chanda, P.K., Nieuwenhuijsen, B., and Young, K.H. Snapin interacts with the N-terminus of regulator of G protein signaling 7. Biochem. Biophys. Res. Commun. 303, 594?599 (2003).
	74.  Martemyanov, K.A., Hopp, J.A., and Arshavsky, V.Y. Specificity of G pro-tein-RGS protein recognition is regulated by affinity adapters. Neuron 38, 857?862 (2003).
	75.  Bouhamdan, M., Michelhaugh, S.K., Calin-Jageman, I., Ahern-Djamali, S., and Bannon, M.J. Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain. Biochim. Biophys. Acta 1691, 141?150 (2004).
	76.  Granneman, J.G., Zhai, Y., Zhu, Z., Bannon, M.J., Burchett, S.A., Schmidt, C.J., Andrade, R., and Cooper, J. Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. Mol. Pharmacol. 54, 687?694 (1998).
	77.  Rahman, Z., Schwarz, J., Gold, S.J. et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941?952 (2003). In this study, responsiveness to cocaine was shown to be affected by either overexpression or loss of expression of RGS9 in the stria-tum, suggesting a role for RGS9-2 in the regulation of dopamine signaling in vivo. 
	78.  Potenza, M.N., Gold, S.J., Roby-Shemkowitz, A., Lerner, M.R., and Nestler, E.J. Effects of regulators of G protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay. J. Pharmacol. Exp. Ther. 291, 482?491 (1999).
	79.  Zachariou, V., Georgescu, D., Sanchez, N.et al. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. USA 100, 13656?13661 (2003).
	80.  Garzon, J., Lopez-Fando, A., and Sanchez-Blazquez, P. The R7 subfam-ily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opi-oid receptors. Neuropsychopharmacology 28, 1983?1990 (2003).
	81.  Ehringer, H. and Hornykiewicz, O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin. Wochenschr. 38, 1236?1239 (1960).
	82.  Yahr, M.D. and Duvoisin, R.C. Drug therapy of parkinsonism. N. Engl. J. Med. 287, 20?24 (1972).
	83.  Romrell, J., Fernandez, H.H., and Okun, M.S. Rationale for current ther-apies in Parkinson?s disease. Expert. Opin. Pharmacother. 4, 1747?1761 (2003).
	84.  Tekumalla, P.K., Calon, F., Rahman, Z., Birdi, S., Rajput, A.H., Hornykiewicz, O., Di Paolo, T., Bedard, P.J., and Nestler, E.J. Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson?s disease. Biol. Psychiatry 50, 813?816 (2001).
	85.  Witherow, D.S. and Slepak, V.Z. A novel kind of G protein heterodimer: The G beta5-RGS complex. Recept. Channels 9, 205?212 (2003).
	86.  Zhang, S., Coso, O.A., Lee, C., Gutkind, J.S., and Simonds, W.F. Selective activation of effector pathways by brain-specific G protein beta5. J. Biol. Chem. 271, 33575?33579 (1996).
	87.  Lindorfer, M.A., Myung, C.S., Savino, Y., Yasuda, H., Khazan, R., and Garrison, J.C. Differential activity of the G protein beta5 gamma2 subunit at receptors and effectors. J. Biol. Chem. 273, 34429?34436 (1998). This represents one of two papers demonstrating the ability of G?5-containing G?? dimers to specifically interact with G?q and couple to G?q-linked receptors, providing significant in vitro evidence for the existence of G?5-containing G?? dimers.
	88.  Maier, U., Babich, A., Macrez, N., Leopoldt, D., Gierschik, P., Illenberger, D., and Nurnberg, B. Gbeta 5gamma 2 is a highly selective activator of phospholipid- dependent enzymes. J. Biol. Chem. 275, 13746?13754 (2000).
	89.  Yoshikawa, D.M., Hatwar, M., and Smrcka, A.V. G protein beta 5 subunit interactions with alpha subunits and effectors. Biochemistry 39, 11340?11347 (2000).
	90.  Leopoldt, D., Hanck, T., Exner, T., Maier, U., Wetzker, R., and Nurnberg, B. Gbetagamma stimulates phosphoinositide 3-kinase-gamma by direct interaction with two domains of the catalytic p110 subunit. J. Biol. Chem. 273, 7024?7029 (1998).
	91.  Maier, U., Babich, A., and Nurnberg, B. Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma. J. Biol. Chem. 274, 29311?29317 (1999).
	92.  Kurosu, H., Maehama, T., Okada, T., Yamamoto, T., Hoshino, S., Fukui, Y., Ui, M., Hazeki, O., and Katada, T. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J. Biol. Chem. 272, 24252?24256 (1997).
	93.  Lopez-Ilasaca, M., Gutkind, J.S., and Wetzker, R. Phosphoinositide 3-kinase gamma is a mediator of Gbetagamma-dependent Jun kinase activation. J. Biol. Chem. 273, 2505?2508 (1998).
	94.  Lopez-Ilasaca, M., Crespo, P., Pellici, P.G., Gutkind, J.S., and Wetzker, R. Linkage of G protein-coupled receptors to the MAPK signaling path-way through PI 3-kinase gamma. Science 275, 394?397 (1997).
	95.  Hawes, B.E., Luttrell, L.M., van Biesen, T., and Lefkowitz, R.J. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271, 12133?12136 (1996).
	96.  Lei, Q., Jones, M.B., Talley, E.M., Schrier, A.D., McIntire, W.E., Garrison, J.C., and Bayliss, D.A. Activation and inhibition of G protein-coupled inwardly rectifying potassium (Kir3) channels by G protein beta gamma subunits. Proc. Natl. Acad. Sci. USA 97, 9771?9776 (2000).
	97.  Lei, Q., Jones, M.B., Talley, E.M., Garrison, J.C., and Bayliss, D.A. Molecular mechanisms mediating inhibition of G protein-coupled inward-ly-rectifying K+ channels. Mol. Cells 15, 1?9 (2003).
	98.  Jones, M.B. and Garrison, J.C. Instability of the G-protein beta5 subunit in detergent. Anal. Biochem. 268, 126?133 (1999).
	99.  Rojkova, A.M., Woodard, G.E., Huang, T.C., Combs, C.A., Zhang, J.H., and Simonds, W.F. Ggamma subunit-selective G protein beta 5 mutant defines regulators of G protein signaling protein binding requirement for nuclear localization. J. Biol. Chem. 278, 12507?12512 (2003).
06.pdf	58
02.pdf	55
b404946b.PDF	20
J Pharmacol Exp Ther-2004-O'Dell-711-9.pdf	48
	ArboreliusL,CherguiK,MuraseS,NomikosGG,HookBB,ChouvetG,HacksellU,andSvenssonTH(1993)The5-HT1Areceptorselectiveligands,(R)-8-OH-DPATand(S)-UH-301,differentiallyaffecttheactivityofmidbraindopamineneurons.Naunyn-Schmiedeberg?sArchPharmacol347:353?362.
	BellK,DuffyP,andKalivasPW(2000)Context-specificenhancementofglutamatetransmissionbycocaine.Neuropsychopharmacology23:335?344.
	BonciAandMalenkaRC(1999)Propertiesandplasticityofexcitatorysynapseson718O?DellandParsonsdopaminergicandGABAergiccellsintheventraltegmentalarea.JNeurosci19:3723?3730.
	BoulenguezP,PetersSL,MitchellSN,ChauveauJ,GrayJA,andJosephMH(1998)Dopaminereleaseinthenucleusaccumbensandlatentinhibitionintheratfollowingmicroinjectionsofa5-HT1Bagonistintothedorsalsubiculum:implica-tionsforschizophrenia.JPsychopharmacol12:258?267.
	BruinvelsAT,LandwehrmeyerB,GustafsonEL,DurkinMM,MengodG,BranchekTA,HoyerD,andPalaciosJM(1994)Localizationof5-HT1B,5-HT1Dalpha,5-HT1Eand5-HT1FreceptormessengerRNAinrodentandprimatebrain.Neu-ropsychopharmacology33:367?386.
	BruinvelsAT,PalaciosJM,andHoyerD(1993)Autoradiographiccharacterisationandlocalisationof5-HT1Dcomparedto5-HT1Bbindingsitesinratbrain.Nau-nyn-Schmiedeberg?sArchPharmacol347:569?582.
	CallahanPMandCunninghamKA(1995)Modulationofthediscriminativestimuluspropertiesofcocaineby5-HT1Band5-HT2Creceptors.JPharmacolExpTher274:1414?1424.
	CallahanPMandCunninghamKA(1997)Modulationofthediscriminativestimuluspropertiesofcocaine:comparisonoftheeffectsoffluoxetinewith5-HT1Aand5-HT1Breceptoragonists.Neuropsychopharmacology36:373?381.
	CameronDLandWilliamsJT(1994)CocaineinhibitsGABAreleaseintheVTAthroughendogenous5-HT.JNeurosci14:6763?6767.
	CameronDLandWilliamsJT(1995)Opposingrolesfordopamineandserotoninatpresynapticreceptorsintheventraltegmentalarea.ClinExpPharmacolPhysiol22:841?845.
	CastanonN,Scearce-LevieK,LucasJJ,RochaB,andHenR(2000)Modulationoftheeffectsofcocaineby5-HT1Breceptors:acomparisonofknockoutsandantag-onists.PharmacolBiochemBehav67:559?566.
	CervoL,RozioM,Ekalle-SoppoCB,CarnovaliF,SantangeloE,andSamaninR(2002)Stimulationofserotonin1Breceptorsinducesconditionedplaceaversionandfacilitatescocaineplaceconditioninginrats.Psychopharmacology163:142?150.
	ChaouloffF,CourvoisierH,MoisanMP,andMormedeP(1999)GR127935reducesbasallocomotoractivityandpreventsRU24969-,butnotD-amphetamine-inducedhyperlocomotion,intheWistar-Kyotohyperactive(WKHA)rat.Psychopharmacol-ogy141:326?331.
	FilipM,NowakE,PaplaI,andPrzegalinskiE(2001)Roleof5-hydroxytryptamine1Breceptorsand5-hydroxytryptamineuptakeinhibitioninthecocaine-evokeddis-criminativestimuluseffectsinrats.JPhysiolPharmacol52:249?263.
	FilipM,PaplaI,NowakE,CzepielK,andPrzegalinskiE(2003)Effectsof5-HT1Breceptorligandsmicroinjectedintotheventraltegmentalareaoncocainediscrim-inationinrats.EurJPharmacol459:239?245.
	FilipM,PaplaI,NowakE,JungersmithK,andPrzegalinskiE(2002)Effectsofserotonin(5-HT)(1B)receptorligands,microinjectedintoaccumbenssubregions,oncocainediscriminationinrats.Naunyn-Schmiedeberg?sArchPharmacol366:226?234.
	FiorilloCDandWilliamsJT(1998)Glutamatemediatesaninhibitorypostsynapticpotentialindopamineneurons.Nature(Lond)394:78?82.
	FletcherPJ,GrottickAJ,andHigginsGA(2002)Differentialeffectsofthe5-HT(2A)receptorantagonistM100907andthe5-HT(2C)receptorantagonistSB242084oncocaine-inducedlocomotoractivity,cocaineself-administrationandcocaine-inducedreinstatementofresponding.Neuropsychopharmacology27:576?586.
	GuanXMandMcBrideWJ(1989)Serotoninmicroinfusionintotheventraltegmen-talareaincreasesaccumbensdopaminerelease.BrainResBull23:541?547.
	Hï¿½llbusM,MagnussonT,andMagnussonO(1997)Influenceof5-HT1B/1Drecep-torsondopaminereleaseintheguineapignucleusaccumbens:amicrodialysisstudy.NeurosciLett225:57?60.
	JohnsonSW,MercuriNB,andNorthRA(1992a)5-Hydroxytryptamine1BreceptorsblocktheGABABsynapticpotentialinratdopamineneurons.JNeurosci12:2000?2006.
	JohnsonSW,SeutinV,andNorthRA(1992b)BurstfiringindopamineneuronsinducedbyN-methyl-D-aspartate:roleofelectrogenicsodiumpump.Science(WashDC)258:665?667.
	KalivasPWandDuffyP(1995)D1receptorsmodulateglutamatetransmissionintheventraltegmentalarea.JNeurosci15:5379?5388.
	KalivasPWandDuffyP(1998)Repeatedcocaineadministrationaltersextracellularglutamateintheventraltegmentalarea.JNeurochem70:1497?1502.
	KoeBK,NeilsonJA,MacorJE,andHeymJ(1992)Biochemicalandbehavioralstudiesofthe5-HT1BreceptoragonistCP94,253.DrugDevRes26:241?250.
	KoobGF,CaineB,MarkouA,PulverentiL,andWeissF(1994)Roleforthemesocorticaldopaminesysteminthemotivatingeffectsofcocaine.NIDAResMonogr145:1?18.
	KreissDSandLuckiI(1994)Differentialregulationofserotonin(5-HT)releaseinthestriatumandhippocampusby5-HT1Aautoreceptorsofthedorsalandmedianraphenuclei.JPharmacolExpTher269:1268?1279.
	LamotheM,PauwelsPJ,BelliardK,SchambelP,andHalazyS(1997)Differentia-tionbetweenpartialagonistsandneutral5-HT1Bantagonistsbychemicalmod-ulationof3-[3-(N,N-dimethylamino)propyl]-4-hydroxy-N-[4-(pyridin-4-yl)phenyl-]benzamide(GR55562).JMedChem40:3542?3550.
	LejeuneFandMillanMJ(1998)Inductionofburstfiringinventraltegmentalareadopaminergicneuronsbyactivationofserotonin(5-HT)1Areceptors:WAY100,635-reversibleactionsofthehighlyselectiveligands,flesinoxanandS15535.Synapse30:172?180.
	MacorJE,BurkhartCA,HeymJH,IvesJL,LebelLA,NewmanME,NielsenJA,RyanK,ShultzDW,TorgersenLK,etal.(1990)3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrolo[3,2-b]pyrid-5-one:apotentandselectiveserotonin(5-HT1B)agonistandrotationallyrestrictedphenolicanalogueof5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole.JMedChem33:2087?2093.
	MuramatsuM,LapizMD,TanakaE,andGrenhoffJ(1998)Serotonininhibitssynapticglutamatecurrentsinratnucleusaccumbensneuronsviapresynaptic5-HT1Breceptors.EurJNeurosci10:2371?2379.
	NeumaierJF,VincowES,ArvanitogiannisA,WiseRA,andCarlezonWAJr(2002)Elevatedexpressionof5-HT1Breceptorsinnucleusaccumbensefferentssensi-tizesanimalstococaine.JNeurosci22:10856?10863.
	O?NeillMF,DobsonDR,andSangerGJ(2000)5-HT(1B/D)receptoragonist,SKF99101H,induceslocomotorhyperactivityintheguineapig.EurJPharmacol399:49?55.
	ParsonsLH,KoobGF,andWeissF(1999)RU24969,a5-HT1B/1Areceptoragonist,potentiatescocaine-inducedincreasesinnucleusaccumbensdopamine.Synapse32:132?135.
	ParsonsLH,WeissF,andKoobGF(1998)Serotonin1Breceptorstimulationen-hancescocainereinforcement.JNeurosci18:10078?10089.
	PaxinosGandWatsonC(1988)TheRatBraininStereotaxicCoordinates,2nded.AcademicPress,NewYork.
	PrzegalinskiE,CzepielK,NowakE,DlabogaD,andFilipM(2003)Withdrawalfromchroniccocaineup-regulates5-HT1Breceptorsintheratbrain.NeurosciLett35:169?172.
	PrzegalinskiE,FilipM,PaplaI,andCzepielK(2002)Effectsof5-HT1Breceptorligandsmicroinjectedintotheaccumbalshellorcoreonthecocaine-inducedlocomotorhyperactivityinrats.PhysiolPharmacol53:383?394.
	PrzegalinskiE,FilipM,PaplaI,andSiwanowiczJ(2001)Effectofserotonin(5-HT)1Breceptorligandsoncocainesensitizationinrats.BehavPharmacol12:109?116.
	RahmanSandMcBrideWJ(2002)InvolvementofGABAandcholinergicreceptorsinthenucleusaccumbensonfeedbackcontrolofsomatodendriticdopaminereleaseintheventraltegmentalarea.JNeurochem80:646?654.
	RochaBA,GouldingEH,O?DellLE,MeadAN,CoufalNG,ParsonsLH,andTecottLH(2002)Enhancedlocomotor,reinforcingandneurochemicaleffectsofcocaineinserotonin5-hydroxytryptamine2Creceptormutantmice.JNeurosci22:10039?10045.
	RochaBA,Scearce-LevieK,LucasJJ,HiroiN,CastanonN,CrabbeJC,NestlerEJ,andHenR(1998)Increasedvulnerabilitytococaineinmicelackingtheseroto-nin-1Breceptor.Nature(Lond)393:175?178.
	TakahataRandMoghaddamB(2000)Target-specificglutamatergicregulationofdopamineneuronsintheventraltegmentalarea.JNeurochem75:1775?1778.
	TaoR,MaZ,andAuerbachSB(2000)Differentialeffectoflocalinfusionofserotoninreuptakeinhibitorsintherapheversusforebrainandtheroleofdepolarization-inducedreleaseofextracellularserotonin.JPharmacolExpTher294:571?579.
	WalshSLandCunninghamKA(1997)Serotonergicmechanismsinvolvedinthediscriminativestimulus,reinforcingandsubjectiveeffectsofcocaine.Psychophar-macology130:41?58.
	WiseRA(1996)Neurobiologyofaddiction.CurrOpinNeurobiol6:243?251.
	YanQSandYanSE(2001a)Activationof5-HT(1B/1D)receptorsinthemesolimbicdopaminesystemincreasesdopaminereleasefromthenucleusaccumbens:amicrodialysisstudy.EurJPharmacol418:55?64.
	YanQSandYanSE(2001b)Serotonin-1Breceptor-mediatedinhibitionof[(3)H]GABAreleasefromratventraltegmentalareaslices.JNeurochem79:914?922.
2392-03.pdf	121
	1.Abken,H.J.,M.Tietze,J.Brodersen,S.Baumer,U.Beifuss,andU.Dep-penmeier.1998.Isolationandcharacterizationofmethanophenazineandfunctionofphenazinesinmembrane-boundelectrontransportofMethano-sarcinamazeiGol.J.Bacteriol.180:2027?2032.
	2.Andersen,C.,C.Hughes,andV.Koronakis.2001.Proteinexportanddrugeffluxthroughbacterialchannel-tunnels.Curr.Opin.CellBiol.13:412?416.
	3.Ausubel,F.M.,R.Brent,R.E.Kingston,D.D.Moore,J.G.Seidman,J.A.Smith,andK.Struhl(ed.).1993.Currentprotocolsinmolecularbiology,vol.1.GreenePublishing&Wiley-Interscience,NewYork,N.Y.
	4.Bates,G.W.,C.Billups,andP.Saltman.1967.Thekineticsandmechanismofiron(III)exchangebetweenchelatesandtransferrin.J.Biol.Chem.242:2810?2815.
	5.Benz,M.,B.Schink,andA.Brune.1998.HumicacidreductionbyPropi-onibacteriumfreudenreichiiandotherfermentingbacteria.Appl.Environ.Microbiol.64:4507?4512.
	6.Bond,D.R.,D.E.Holmes,L.M.Tender,andD.R.Lovley.2002.Electrode-reducingmicroorganismsthatharvestenergyfrommarinesediments.Sci-ence295:483?485.
	7.Braun,V.2003.IronuptakebyEscherichiacoli.Front.Biosci.8:S1409?S1421.
	8.Braun,V.,andM.Braun.2002.Activetransportofironandsiderophoreantibiotics.Curr.Opin.Microbiol.5:194?201.
	9.Brodersen,J.,S.Baumer,H.J.Abken,G.Gottschalk,andU.Deppenmeier.1999.Inhibitionofmembrane-boundelectrontransportofthemethanogenicarchaeonMethanosarcinamazeiGolbydiphenyleneiodonium.Eur.J.Bio-chem.259:218?224.
	10.Cowart,R.E.2002.Reductionofironbyextracellularironreductases:implicationsformicrobialironacquisition.Arch.Biochem.Biophys.400:273?281.
	11.Cox,C.D.1986.Roleofpyocyaninintheacquisitionofironfromtransferrin.Infect.Immun.52:263?270.
	12.Delaney,G.M.,H.P.Bennetto,J.R.Mason,S.D.Roller,J.L.Stirling,andC.F.Thurston.1984.Electron-transfercouplinginmicrobialfuelcells.2.Performanceoffuelcellscontainingselectedmicroorganism-mediator-sub-stratecombinations.J.Chem.Technol.Biotechnol.34B:13?27.
	13.Dorman,C.J.,G.C.Barr,N.N.Bhriain,andC.F.Higgins.1988.DNAsupercoilingandtheanaerobicandgrowthphaseregulationoftonBgeneexpression.J.Bacteriol.170:2816?2826.
	14.Dubini,A.,R.L.Pye,R.L.Jack,T.Palmer,andF.Sargent.2002.Howbacteriagetenergyfromhydrogen:ageneticanalysisofperiplasmichydro-genoxidationinEscherichiacoli.Int.J.HydrogenEnerg.27:1413?1420.
	15.Gaspard,S.,F.Vazquez,andC.Holliger.1998.Localizationandsolubiliza-tionoftheiron(III)reductaseofGeobactersulfurreducens.Appl.Environ.Microbiol.64:3188?3194.
	16.Harle,C.,I.Kim,A.Angerer,andV.Braun.1995.Signaltransferthroughthreecompartments:transcriptioninitiationoftheEscherichiacoliferriccitratetransportsystemfromthecellsurface.EMBOJ.14:1430?1438.
	17.Harris,R.F.,andS.S.Adams.1979.Determinationofthecarbon-boundelectroncompositionofmicrobialcellsandmetabolitesbydichromateoxi-dation.Appl.Environ.Microbiol.37:237?243.
	18.Hernandez,M.,andD.Newman.2001.Extracellularelectrontransfer.Cell.Mol.LifeSci.58:1562?1571.
	19.Kaufmann,F.,andD.R.Lovley.2001.IsolationandcharacterizationofasolubleNADPH-dependentFe(III)reductasefromGeobactersulfurredu-cens.J.Bacteriol.183:4468?4476.
	20.Kim,B.H.,andJ.G.Zeikus.1992.HydrogenmetabolisminClostridiumacetobutylicumfermentation.J.Microbiol.Biotechnol.2:248?254.
	21.Kim,N.,Y.Choi,S.Jung,andS.Kim.2000.EffectofinitialcarbonsourcesontheperformanceofmicrobialfuelcellscontainingProteusvulgaris.Bio-technol.Bioeng.70:109?114.
	22.Laurinavichene,T.V.,N.A.Zorin,andA.A.Tsygankov.2002.Effectofredoxpotentialonactivityofhydrogenase1andhydrogenase2inEsche-richiacoli.Arch.Microbiol.178:437?442.
	23.Lee,J.H.,P.Patel,P.Sankar,andK.T.Shanmugam.1985.IsolationandcharacterizationofmutantstrainsofEscherichiacolialteredinH2metabo-lism.J.Bacteriol.162:344?352.
	24.Lovely,D.1991.DissimilatoryFe(III)andMn(IV)reduction.Microbiol.Rev.55:259?287.
	25.Lovely,D.2000.DissimilatoryFe(III)-andMn(IV)-reducingprokaryotes.InMartinDworkin(ed.),Theprokaryotes.Springer-Verlag[Online.]http://141.150.157.117:8080/prokPUB/index.htm.AccessedDecember2003.
	26.Lovely,D.,andE.J.P.Phillips.1986.AvailabilityofferricironformicrobialreductioninbottomsedimentsofthefreshwatertidalPotomacRiver.Appl.Environ.Microbiol.52:751?757.
	27.Lovely,D.R.,andE.J.P.Phillips.1986.Organicmattermineralizationwithreductionofferricironinanaerobicsediments.Appl.Environ.Microbiol.51:683?689.
	28.Lovely,D.R.,andE.J.P.Phillips.1987.Rapidassayformicrobiallyreduc-ibleferricironinaquaticsediments.Appl.Environ.Microbiol.53:1536?1540.
	29.Myers,C.,andJ.Myers.1992.LocalizationofcytochromestotheoutermembraneofanaerobicallygrownShewanellaputrefaciensMR-1.J.Bacte-riol.174:3429?3438.
	30.Nauhaus,K.,A.Boetius,M.Kruger,andF.Widdel.2002.Invitrodemon-strationofanaerobicoxidationofmethanecoupledtosulphatereductioninsedimentfromamarinegashydratearea.Environ.Microbiol.4:296?305.
	31.Newman,D.K.,andR.Kolter.2000.Aroleforexcretedquinonesinextra-cellularelectrontransfer.Nature405:94?97.
	32.Park,D.H.2000.Electricityproductioninbiofuelcellusingmodifiedgraph-iteelectrodewithneutralred.Biotechnol.Lett.22:1301?1304.
	33.Park,D.H.,M.Laivenieks,M.V.Guettler,M.K.Jain,andJ.G.Zeikus.1999.Microbialutilizationofelectricallyreducedneutralredasthesoleelectrondonorforgrowthandmetaboliteproduction.Appl.Environ.Mi-crobiol.65:2912?2917.
	34.Park,D.H.,andJ.G.Zeikus.2000.Electricitygenerationinmicrobialfuelcellsusingneutralredasanelectronophore.Appl.Environ.Microbiol.66:1292?1297.
	35.Park,D.H.,andJ.G.Zeikus.2002.Impactofelectrodecompositiononelectricitygenerationinasingle-compartmentfuelcellusingShewanellaputrefaciens.Appl.Microbiol.Biotechnol.59:58?61.
	36.Park,D.H.,andJ.G.Zeikus.2003.Improvedfuelcellandelectrodedesignsforproducingelectricityfrommicrobialdegradation.Biotechnol.Bioeng.81:348?355.
	37.Park,D.H.,andJ.G.Zeikus.1999.UtilizationofelectricallyreducedneutralredbyActinobacillussuccinogenes:physiologicalfunctionofneu-tralredinmembrane-drivenfumaratereductionandenergyconservation.J.Bacteriol.181:2403?2410.
	38.Sankar,P.,J.H.Lee,andK.T.Shanmugam.1985.CloningofhydrogenasegenesandfinestructureanalysisofanoperonessentialforH2metabolisminEscherichiacoli.J.Bacteriol.162:353?360.
	39.Sargent,F.,S.P.Ballantine,P.A.Rugman,T.Palmer,andD.Boxer.1998.ReassignmentofthegeneencodingtheEscherichiacolihydrogenase2smallsubunit.Eur.J.Biochem.255:746?754.
	40.Sawers,G.1994.ThehydrogenasesandformatedehydrogenasesofEsche-richiacoli.AntonieLeeuwenhoek66:57?88.
	41.Sawers,R.G.,D.J.Jamieson,C.F.Higgins,andD.H.Boxer.1986.Char-acterizationandphysiologicalrolesofmembrane-boundhydrogenaseisoen-zymesfromSalmonellatyphimurium.J.Bacteriol.168:398?404.
	42.Shen,G.-J.,B.A.Annous,R.W.Lovitt,M.K.Jain,andJ.G.Zeikus.1996.BiochemicalrouteandcontrolofbutyratesynthesisinButyribacteriummeth-yltrophicum.Appl.Microbiol.Biotechnol.45:355?362.
	43.Shyu,J.,D.Lies,andD.Newman.2002.ProtectiveroleoftolCineffluxoftheelectronshuttleanthraquinone-2,6-disulfonate.J.Bacteriol.184:1806?1810.
	44.Stookey,L.1970.Ferrozinenewspectrophotometricreagentforiron.Anal.Chem.42:779?782.
	45.VanderWerf,M.J.,M.V.Guettler,M.K.Jain,andJ.G.Zeikus.1997.EnvironmentalandphysiologicalfactorsaffectingthesuccinateproductratioduringcarbohydratefermentationbyActinobacillussp.130Z.Arch.Micro-biol.167:332?342.
	46.Vartivarian,S.E.,andR.E.Cowart.1999.Extracellularironreductases:identificationofanewclassofenzymesbysiderophore-producingmicroor-ganisms.Arch.Biochem.Biophys.364:75?82.
	47.Wolin,E.,M.Wolin,andR.Wolfe.1963.Formationofmethanebybacterialextracts.J.Biol.Chem.238:2882?2886.
	48.Worst,D.J.,M.Gerrits,C.Vandenbroucke-Grauls,andJ.Kusters.1998.HelicobacterpyloriribBA-mediatedriboflavinproductionisinvolvedinironacquisition.J.Bacteriol.180:1473?1479.
	49.Zeikus,J.G.2003.Bioelectricalsynthesisofchemicals,fuelsanddrugs.InC.H.Hou(ed.),Handbookofindustrialbiocatalysis,inpress.MarcelDecker,Inc.,NewYork,N.Y.
	50.Zeikus,J.G.,G.Fuchs,W.Kenealy,andR.K.Thauer.1977.Oxidoreduc-tasesinvolvedincellcarbonsynthesisofMethanobacteriumthermoautotro-phicum.J.Bacteriol.132:604?613.
1979-03.pdf	45
	1.Barrow,P.2001.Theuseofbacteriophagesfortreatmentandpreventionofbacterialdiseaseinanimalsandanimalmodelsofhumaninfection.J.Chem.Technol.Biotechnol.76:677?682.
	2.Barrow,P.,M.Lovell,andA.Berchieri,Jr.1998.UseoflyticbacteriophageforcontrolofexperimentalEscherichiacolisepticemiaandmeningitisinchickensandcalves.Clin.Diagn.Lab.Immunol.5:294?298.
	3.Berchieri,A.,Jr.,M.A.Lovell,andP.A.Barrow.1991.TheactivityinthechickenalimentarytractofbacteriophageslyticforSalmonellatyphimurium.Res.Microbiol.142:541?549.
	4.Biswas,B.,S.Adhya,P.Washart,B.Paul,A.N.Trostel,B.Powell,R.Carlton,andC.R.Merril.2002.Bacteriophagetherapyrescuesmicebac-teremicfromaclinicalisolateofvancomycin-resistantEnterococcusfaecium.Infect.Immun.70:204?210.
	4a.Cagney,C.,H.Crowley,G.Duffy,J.J.Sheridan,S.O?Brien,E.Carney,W.A.Anderson,D.A.McDowell,andI.S.Blair.2004.PrevalenceandnumbersofEscherichiacoliO157:H7inmincedbeefandbeefburgersfrombutchershopsandsupermarketsintheRepublicofIreland.FoodMicrobiol.21:203?212.
	5.Chanishvili,N.,T.Chanishvili,M.Tediashvili,andP.A.Barrow.2001.Phagesandtheirapplicationagainstdrug-resistantbacteria.J.Chem.Tech-nol.Biotechnol.76:689?699.
	6.Cray,W.C.,Jr.,andH.W.Moon.1995.ExperimentalinfectionofcalvesandadultcattlewithEscherichiacoliO157:H7.Appl.Environ.Microbiol.61:1586?1590.
	7.Dhillon,T.S.,E.K.Dhillon,H.C.Chau,W.K.Li,andA.H.Tsang.1976.Studiesonbacteriophagedistribution:virulentandtemperatebacteriophagecontentofmammalianfeces.Appl.Environ.Microbiol.32:68?74.
	8.Duckworth,D.H.,J.Glenn,andD.J.McCorquodale.1981.Inhibitionofbacteriophagereplicationbyextrachromosomalgeneticelements.Microbiol.Rev.45:52?71.
	9.Duffy,G.2003.VerocytoxigenicEscherichiacoliinanimalfaeces,manuresandslurries.J.Appl.Microbiol.94(Suppl.1):94?103.
	10.Elder,R.O.,J.E.Keen,G.R.Siragusa,G.A.Barkocy-Gallagher,M.Koohmaraie,andW.W.Laegreid.2000.CorrelationofenterohemorrhagicEscherichiacoliO157prevalenceinfeces,hides,andcarcassesofbeefcattleduringprocessing.Proc.Natl.Acad.Sci.USA97:2999?3003.
	11.Faith,N.G.,J.A.Shere,R.Brosch,K.W.Arnold,S.E.Ansay,M.S.Lee,J.B.Luchansky,andC.W.Kaspar.1996.PrevalenceandclonalnatureofEscherichiacoliO157:H7ondairyfarmsinWisconsin.Appl.Environ.Mi-crobiol.62:1519?1525.
	12.Heuvelink,A.E.,F.L.vandenBiggelaar,E.deBoer,R.G.Herbes,W.J.Melchers,J.H.Huisin?tVeld,andL.A.Monnens.1998.Isolationandcharacterizationofverocytotoxin-producingEscherichiacoliO157strainsfromDutchcattleandsheep.J.Clin.Microbiol.36:878?882.
	13.Hill,C.1993.Bacteriophageandbacteriophageresistanceinlacticacidbacteria.FEMSMicrobiol.Rev.12:87?108.
	14.Hovde,C.J.,P.R.Austin,K.A.Cloud,C.J.Williams,andC.W.Hunt.1999.EffectofcattledietonEscherichiacoliO157:H7acidresistance.Appl.Environ.Microbiol.65:3233?3235.
	15.Huff,W.E.,G.R.Huff,N.C.Rath,J.M.Balog,andA.M.Donoghue.2002.PreventionofEscherichiacoliinfectioninbroilerchickenswithabacterio-phageaerosolspray.Poult.Sci.81:1486?1491.
	16.Huff,W.E.,G.R.Huff,N.C.Rath,J.M.Balog,H.Xie,P.A.Moore,Jr.,andA.M.Donoghue.2002.PreventionofEscherichiacolirespiratoryinfectioninbroilerchickenswithbacteriophage(SPR02).Poult.Sci.81:437?441.
	17.Joerger,R.D.2003.Alternativestoantibiotics:bacteriocins,antimicrobialpeptidesandbacteriophages.Poult.Sci.82:640?647.
	18.Jordan,K.N.,L.Oxford,andC.P.O?Byrne.1999.Survivaloflow-pHstressbyEscherichiacoliO157:H7:correlationbetweenalterationsinthecellenvelopeandincreasedacidtolerance.Appl.Environ.Microbiol.65:3048?3055.
	19.Kudva,I.T.,S.Jelacic,P.I.Tarr,P.Youderian,andC.J.Hovde.1999.BiocontrolofEscherichiacoliO157withO157-specificbacteriophages.Appl.Environ.Microbiol.65:3767?3773.
	20.Kutter,E.,T.Stidham,B.Guttman,E.Kutter,D.Batts,S.Peterson,T.Djavakhishvili,F.Arisaka,V.Mesyanzhinov,W.Ruger,andG.Mosig.1994.GenomicmapofbacteriophageT4,p.491?519.InJ.D.Karam(ed.),Mo-lecularbiologyofbacteriophageT4.ASMPress,Washington,D.C.
	21.Lema,M.,L.Williams,andD.R.Rao.2001.ReductionoffecalsheddingofenterohemorrhagicEscherichiacoliO157:H7inlambsbyfeedingmicrobialfeedsupplement.SmallRumin.Res.39:31?39.
	22.Maher,M.M.,K.N.Jordan,M.E.Upton,andA.Coffey.2001.GrowthandsurvivalofE.coliO157:H7duringthemanufactureandripeningofasmear-ripenedcheeseproducedfromrawmilk.J.Appl.Microbiol.90:201?207.
	23.Matsuzaki,S.,M.Yasuda,H.Nishikawa,M.Kuroda,T.Ujihara,T.Shuin,Y.Shen,Z.Jin,S.Fujimoto,M.D.Nasimuzzaman,H.Wakiguchi,S.Sugi-hara,T.Sugiura,S.Koda,A.Muraoka,andS.Imai.2003.ExperimentalprotectionofmiceagainstlethalStaphylococcusaureusinfectionbynovelbacteriophagephiMR11.J.Infect.Dis.187:613?624.
	24.Merril,C.R.,D.Scholl,andS.L.Adhya.2003.Theprospectforbacterio-phagetherapyinWesternmedicine.Nat.Rev.Drug.Discov.2:489?497.
	25.Mizoguchi,K.,M.Morita,C.R.Fischer,M.Yoichi,Y.Tanji,andH.Unno.2003.CoevolutionofbacteriophagePP01andEscherichiacoliO157:H7incontinuousculture.Appl.Environ.Microbiol.69:170?176.
	26.Morita,M.,Y.Tanji,K.Mizoguchi,T.Akitsu,N.Kijima,andH.Unno.2002.CharacterizationofavirulentbacteriophagespecificforEscherichiacoliO157:H7andanalysisofitscellularreceptorandtwotailfibergenes.FEMSMicrobiol.Lett.211:77?83.
	27.Murphy,F.A.,C.M.Fauquet,D.H.L.Bishop,S.A.Ghabrial,A.W.Jarvis,G.P.Martelli,M.A.Mayo,andM.D.Summers.1995.Virustaxonomy:sixthreportoftheInternationalCommitteeonTaxonomyofViruses.Springer-Verlag,Vienna,Austria.
	28.Omisakin,F.,M.MacRae,I.D.Ogden,andN.J.Strachan.2003.Concen-trationandprevalenceofEscherichiacoliO157incattlefecesatslaughter.Appl.Environ.Microbiol.69:2444?2447.
	29.O?Sullivan,D.,D.P.Twomey,A.Coffey,C.Hill,G.F.Fitzgerald,andR.P.Ross.2000.NoveltypeIrestrictionspecificitiesthroughdomainshufflingofHsdSsubunitsinLactococcuslactis.Mol.Microbiol.36:866?875.
	30.Riley,L.W.,R.S.Remis,S.D.Helgerson,H.B.McGee,J.G.Wells,B.R.Davis,R.J.Hebert,E.S.Olcott,L.M.Johnson,N.T.Hargrett,P.A.Blake,andM.L.Cohen.1983.HemorrhagiccolitisassociatedwitharareEsche-richiacoliserotype.N.Engl.J.Med.308:681?685.
	31.Ronner,A.B.,andD.O.Cliver.1990.IsolationandcharacterizationofacoliphagespecificforEscherichiacoliO157:H7.J.FoodProt.53:944?947.
	32.Sambrook,J.,andD.W.Russell.2001.Molecularcloning:alaboratorymanual,3rded.ColdSpringHarborLaboratoryPress,ColdSpringHarbor,
	33.Smith,H.W.,andM.B.Huggins.1983.EffectivenessofphagesintreatingexperimentalEscherichiacolidiarrhoeaincalves,pigletsandlambs.J.Gen.Microbiol.129:2659?2675.
	34.Smith,H.W.,andM.B.Huggins.1982.Successfultreatmentofexperimen-talEscherichiacoliinfectionsinmiceusingphage:itsgeneralsuperiorityoverantibiotics.J.Gen.Microbiol.128:307?318.
	35.Smith,H.W.,M.B.Huggins,andK.M.Shaw.1987.Thecontrolofexper-imentalEscherichiacolidiarrhoeaincalvesbymeansofbacteriophages.J.Gen.Microbiol.133:1111?1126.
	36.Smith,H.W.,M.B.Huggins,andK.M.Shaw.1987.Factorsinfluencingthesurvivalandmultiplicationofbacteriophagesincalvesandintheirenviron-ment.J.Gen.Microbiol.133:1127?1135.
	37.Sulakvelidze,A.,Z.Alavidze,andJ.G.Morris,Jr.2001.Bacteriophagetherapy.Antimicrob.AgentsChemother.45:649?659.
	38.Tanji,Y.,K.Mizoguchi,M.Yoichi,M.Morita,N.Kijima,H.Kator,andH.Unno.2003.SeasonalchangeandfateofcoliphagesinfectedtoEscherichiacoliO157:H7inawastewatertreatmentplant.WaterRes.37:1136?1142.
	39.Tarr,P.I.1995.EscherichiacoliO157:H7:clinical,diagnostic,andepidemi-ologicalaspectsofhumaninfection.Clin.Infect.Dis.20:1?8;quiz,9?10.
	40.Vuddhakul,V.,N.Patararungrong,P.Pungrasamee,S.Jitsurong,T.Morigaki,N.Asai,andM.Nishibuchi.2000.IsolationandcharacterizationofEscherichiacoliO157fromretailbeefandbovinefecesinThailand.FEMSMicrobiol.Lett.182:343?347.
	41.Wang,G.,T.Zhao,andM.P.Doyle.1996.FateofenterohemorrhagicEscherichiacoliO157:H7inbovinefeces.Appl.Environ.Microbiol.62:2567?2570.
	42.Yu,S.L.,K.L.Ko,C.S.Chen,Y.C.Chang,andW.J.Syu.2000.Charac-terizationofthedistaltailfiberlocusanddeterminationofthereceptorforphageAR1,whichspecificallyinfectsEscherichiacoliO157:H7.J.Bacteriol.182:5962?5968.
	43.Zhao,T.,M.P.Doyle,B.G.Harmon,C.A.Brown,P.O.Mueller,andA.H.Parks.1998.ReductionofcarriageofenterohemorrhagicEscherichiacoliO157:H7incattlebyinoculationwithprobioticbacteria.J.Clin.Microbiol.36:641?647.
	44.Zhao,T.,M.P.Doyle,J.Shere,andL.Garber.1995.Prevalenceofentero-hemorrhagicEscherichiacoliO157:H7inasurveyofdairyherds.Appl.Environ.Microbiol.61:1290?1293.
1655-03.pdf	68
	1.Abed,R.,S.Golubic,F.Garcia-Pichel,G.F.Camoin,andS.Sprachta.2003.Characterizationofmicrobialite-formingcyanobacteriainatropicallagoon:TikehauAtoll,Tuamotu,FrenchPolynesia.J.Phycol.39:862?873.
	2.Baker,J.A.,B.Entsch,B.A.Neilan,andD.B.McKay.2002.Monitoringchangingtoxigenicityofacyanobacterialbloombymolecularmethods.Appl.Environ.Microbiol.68:6070?6076.
	3.Barker,G.L.A.,B.A.Handley,P.Vacharapiyasophon,J.R.Stevens,andP.K.Hayes.2000.Allele-specificPCRshowsthatgeneticexchangeoccursamonggeneticallydiverseNodularia(cyanobacteria)filamentsintheBalticSea.Microbiology146:2865?2875.
	4.Cardellina,J.H.,II,D.Dalietos,F.-J.Marner,J.S.Mynderse,andR.E.Moore.1978.()-Trans-7(S)-methoxytetradec-4-enoicacidandrelatedamidesfromthemarinecyanophyteLyngbyamajuscula.Phytochemistry17:2091?2095.
	5.Cardellina,J.H.,II,F.-J.Marner,andR.E.Moore.1979.MalyngamideA,anovelchlorinatedmetaboliteofthemarinecyanophyteLyngbyamajuscula.J.Am.Chem.Soc.101:240?241.
	6.Cardellina,J.H.,II,F.-J.Marner,andR.E.Moore.1979.Seaweedderma-titis:structureoflyngbyatoxinA.Science204:193?195.
	7.Cardellina,J.H.,II,R.E.Moore,E.V.Arnold,andJ.Clardy.1979.Structureandabsoluteconfigurationofmalyngolide,anantibioticfromthemarineblue-greenalgaLyngbyamajusculaGomont.J.Org.Chem.44:4039?4042.
	8.Cruz-Rivera,E.,andV.J.Paul.2002.Coralreefbenthiccyanobacteriaasfoodandrefuge:diversity,chemistry,andcomplexinteractions,p.515?520.InM.K.KasimMoosa,S.Soemodihardjo,A.Nontji,A.Soegiarto,K.Rominohtarto,Sukarno,andSuharsono(ed.),ProceedingsoftheNinthInternationalCoralReefSymposium.IndonesianInstituteofSciencesandStateMinistryforEnvironment,Jakarta,RepublicofIndonesia.
	9.Desikachary,T.V.1959.Cyanophyta.IndianCouncilofCulturalResearch,NewDelhi,India.
	10.Gerwick,W.H.,L.T.Tan,andN.Sitachitta.2001.Nitrogen-containingmetabolitesfrommarinecyanobacteria.AlkaloidsChem.Biol.57:75?184.
	11.Gugger,M.,C.Lyra,P.Henriksen,A.Couteï¿½,J.-F.Humbert,andK.Sivonen.2002.PhylogeneticcomparisonofthecyanobacterialgeneraAnabaenaandAphanizomenon.Int.J.Syst.Evol.Microbiol.52:1867?1880.
	12.Gugger,M.,C.Lyra,I.Suominen,I.Tsitko,J.-F.Humbert,M.S.Salkinoja-Salonen,andK.Sivonen.2002.CellularfattyacidsaschemotaxonomicmarkersofthegeneraAnabaena,Aphanizomenon,Microcystis,Nostoc,andPlanktothrix(cyanobacteria).Int.J.Syst.Evol.Microbiol.52:1007?1015.
	13.Hall,G.C.,M.B.Flick,R.L.Gherna,andR.A.Jensen.1982.Biochemicaldiversityforbiosynthesisofaromaticaminoacidsamongthecyanobacteria.J.Bacteriol.149:65?78.
	14.Harrigan,G.G.,H.Luesch,W.Y.Yoshida,R.E.Moore,D.G.Nagle,V.J.Paul,S.L.Mooberry,T.H.Corbett,andF.A.Valeriote.1998.Symplostatin1:adolastatin10analoguefromthemarinecyanobacteriumSymplocahyd-noides.J.Nat.Prod.61:1075?1077.
	15.Harrigan,G.G.,H.Luesch,W.Y.Yoshida,R.E.Moore,D.G.Nagle,andV.J.Paul.1999.Symplostatin2:adolastatin13analoguefromthemarinecyanobacteriumSymplocahydnoides.J.Nat.Prod.62:655?658.
	16.Harrigan,G.G.,W.Y.Yoshida,R.E.Moore,D.G.Nagle,P.U.Park,J.Biggs,V.J.Paul,S.L.Mooberry,T.H.Corbett,andF.A.Valeriote.1998.Isolation,structuredetermination,andbiologicalactivityofdolastatin12andlyngbyastatin1fromLyngbyamajuscula/Schizothrixcalcicolacyanobac-terialassemblages.J.Nat.Prod.61:1221?1225.
	17.Hertzberg,S.,S.Liaaen-Jensen,andH.W.Siegelman.1971.Thecarote-noidsofblue-greenalgae.Phytochemistry10:3121?3127.
	18.Hoffmann,L.1994.MarineCyanophyceaeofPapuaNewGuinea.VI.ThegenusLyngbyaS.L.Belg.J.Bot.127:79?86.
	19.Hoffmann,L.,andV.Demoulin.1991.MarineCyanophyceaeofPapuaNewGuinea.II.Lyngbyabouilloniisp.nov.,aremarkabletropicalreef-inhabitingblue-greenalga.Belg.J.Bot.124:82?88.
	20.Holton,R.W.,H.H.Blecker,andT.S.Stevens.1968.Fattyacidsinblue-greenalgae:possiblerelationtophylogeneticposition.Science160:545?547.
	21.Kaebernick,M.,andB.A.Neilan.2001.Ecologicalandmolecularinvesti-gationsofcyanotoxinproduction.FEMSMicrobiol.Ecol.35:1?9.
	22.Kenyon,C.N.,andR.Y.Stanier.1970.Possibleevolutionarysignificanceofpolyunsaturatedfattyacidsinblue-greenalgae.Nature227:1164?1166.
	23.Laamanen,M.J.,L.Forsstroï¿½m,andK.Sivonen.2002.DiversityofApha-nizomenonflos-aquae(Cyanobacterium)populationsalongaBalticSeasa-linitygradient.Appl.Environ.Microbiol.68:5296?5303.
	24.Littler,D.S.,andM.M.Littler.2000.Caribbeanreefplants.OffshoreGraphics,Inc.,Washington,D.C.
	25.Luesch,H.,R.Pangilinan,W.Y.Yoshida,R.E.Moore,andV.J.Paul.2001.PitipeptolidesAandB,newcyclodepsipeptidesfromthemarinecyanobac-teriumLyngbyamajuscula.J.Nat.Prod.64:304?307.
	26.Luesch,H.,P.G.Williams,W.Y.Yoshida,R.E.Moore,andV.J.Paul.2002.UlongamidesA-F,new-aminoacidcontainingcyclodepsipeptidesfromPalauancollectionsofthemarinecyanobacteriumLyngbyasp.J.Nat.Prod.65:996?1000.
	27.Luesch,H.,W.Y.Yoshida,R.E.Moore,andV.J.Paul.1999.Lyngbyastatin2andnorlyngbyastatin2,analoguesofdolastatinGandnordolastatinGfromthemarinecyanobacteriumLyngbyamajuscula.J.Nat.Prod.62:1702?1706.
	28.Luesch,H.,W.Y.Yoshida,R.E.Moore,andV.J.Paul.2002.NewapratoxinsofmarinecyanobacterialoriginfromGuamandPalau.Bioorg.Med.Chem.10:1973?1978.
	29.Luesch,H.,W.Y.Yoshida,R.E.Moore,andV.J.Paul.2002.StructurallydiversenewalkaloidsfromPalauancollectionsoftheapratoxin-producingmarinecyanobacteriumLyngbyasp.Tetrahedron58:7959?7966.
	30.Luesch,H.,W.Y.Yoshida,R.E.Moore,V.J.Paul,andT.H.Corbett.2001.TotalstructuredeterminationofapratoxinA,apotentnovelcytotoxinfromthemarinecyanobacteriumLyngbyamajuscula.J.Am.Chem.Soc.123:5418?5423.
	31.Luesch,H.,W.Y.Yoshida,R.E.Moore,V.J.Paul,andS.L.Mooberry.2000.Isolation,structuredetermination,andbiologicalactivityoflyngbya-bellinAfromthemarinecyanobacteriumLyngbyamajuscula.J.Nat.Prod.63:611?615.
	32.Luesch,H.,W.Y.Yoshida,R.E.Moore,V.J.Paul,andS.L.Mooberry.2000.IsolationandstructureofthecytotoxinlyngbyabellinBandabsoluteconfigurationoflyngbyapeptinAfromthemarinecyanobacteriumLyngbyamajuscula.J.Nat.Prod.63:1437?1439.
	33.Lyra,C.,S.Suomalainen,M.Gugger,C.Vezie,P.Sundman,L.Paulin,andK.Sivonen.2001.MolecularcharacterizationofplankticcyanobacteriaofAnabaena,Aphanizomenon,Microcystis,andPlanktothrixgenera.Int.J.Syst.Evol.Microbiol.51:513?526.
	34.Manen,J.F.,andJ.Falquet.2002.ThecpcB-cpcAlocusasatoolforthegeneticcharacterizationofthegenusArthrospira(Cyanobacteria):evidenceforhorizontaltransfer.Int.J.Syst.Evol.Microbiol.52:861?867.
	35.Marner,F.-J.,andR.E.Moore.1977.MajusculamidesAandB,twoepimericlipodipeptidesfromLyngbyamajusculaGomont.J.Org.Chem.42:2815?2819.
	36.Mikalsen,B.,G.Boison,O.M.Skulberg,J.Fastner,W.Davies,T.M.Gabrielsen,K.Rudi,andK.S.Jakobsen.2003.NaturalvariationinthemicrocystinsynthetaseoperonmcyABCandimpactonmicrocystinproduc-tioninMicrocystisstrains.J.Bacteriol.185:2774?2785.
	37.Moore,B.S.,andC.Hertweck.2002.Biosynthesisandattachmentofnovelbacterialpolyketidesynthasestarterunits.Nat.Prod.Rep.19:70?99.
	38.Moore,R.E.1981.Constituentsofblue-greenalgae,p.1?52.InP.J.Scheuer(ed.),Marinenaturalproducts,vol.4.AcademicPress,NewYork,N.Y.
	39.Moore,R.E.1996.Cyclicpeptidesanddepsipeptidesfromcyanobacteria:areview.J.Ind.Microbiol.16:134?143.
	40.Nagai,H.,T.Yasumoto,andY.Hokama.1996.Aplysiatoxinanddebro-moaplysiatoxinasthecausativeagentsofaredalgaGracilariacoronopifoliapoisoninginHawaii.Toxicon37:753?761.
	41.Nagle,D.G.,F.T.Camacho,andV.J.Paul.1998.DietarypreferencesoftheopisthobranchmolluscStylocheiluslongicaudaforsecondarymetabolitesproducedbythetropicalcyanobacteriumLyngbyamajuscula.Mar.Biol.132:267?273.
	42.Nagle,D.G.,P.U.Park,andV.J.Paul.1997.PitiamideA,anewchlorinatedlipidfromamixedmarinecyanobacterialassemblage.TetrahedronLett.38:6969?6972.
	43.Nagle,D.G.,andV.J.Paul.1999.Productionofsecondarymetabolitesbyfilamentoustropicalmarinecyanobacteria:ecologicalfunctionsofthecom-pounds.J.Phycol.35:1412?1421.
	44.Nagle,D.G.,V.J.Paul,andM.A.Roberts.1996.Ypaoamide,anewbroadlyactingfeedingdeterrentfromthemarinecyanobacteriumLyngbyamajus-cula.TetrahedronLett.37:6263?6266.
	45.Nagle,D.G.,Y-D.Zhou,P.U.Park,V.J.Paul,I.Rajbhandari,C.J.G.Duncan,andD.S.Pasco.2000.Anewindanonefromthemarinecyanobac-teriumLyngbyamajusculathatinhibitshypoxia-inducedactivationoftheVEGFpromoterinHep3Bcells.J.Nat.Prod.63:1431?1433.
	46.Neilan,B.A.,B.P.Burns,D.A.Relman,andD.R.Lowe.2002.Molecularidentificationofcyanobacteriaassociatedwithstromatolitesfromdistinctgeographiclocations.Astrobiology2:271?280.
	47.Neilan,B.A.,D.Jacobs,andA.E.Goodman.1995.GeneticdiversityandphylogenyoftoxiccyanobacteriadeterminedbyDNApolymorphismswithinthephycocyaninlocus.Appl.Environ.Microbiol.61:3875?3883.
	48.Nelissen,B.,R.DeBaere,A.Wilmotte,andR.DeWachter.1996.Phyloge-neticrelationshipsofnonaxenicfilamentouscyanobacterialstrainsbasedon16SrRNAsequenceanalysis.J.Mol.Evol.42:194?200.
	49.Nuï¿½bel,U.,F.Garcia-Pichel,andG.Muyzer.1997.PCRprimerstoamplify16SrRNAgenesfromcyanobacteria.Appl.Environ.Microbiol.63:3327?
	50.Paul,V.J.,R.W.Thacker,andE.Cruz-Rivera.2001.Chemicalmediationofseaweed-herbivoreinteractions:ecologicalandevolutionaryperspectives,p.227?265.InJ.McClintockandB.Baker(ed.),Marinechemicalecology.CRCPress,NewYork,N.Y.
	51.Pennings,S.C.,A.M.Weiss,andV.J.Paul.1996.SecondarymetabolitesofthecyanobacteriumMicrocoleuslyngbyaceusandtheseahareStylocheiluslongicauda:palatabilityandtoxicity.Mar.Biol.126:735?743.
	52.Posada,D.,andK.A.Crandall.1998.Modeltest:testingthemodelofDNAsubstitution.Bioinformatics14:817?818.
	53.Rodrï¿½guez,F.,J.L.Oliver,A.Marï¿½n,andJ.R.Medina.1990.Thegeneralstochasticmodelofnucleotidesubstitution.J.Theor.Biol.142:485?501.
	54.Rudi,K.,O.M.Skulberg,andK.S.Jakobsen.1998.Evolutionofcyanobac-teriabyexchangeofgeneticmaterialamongphyleticallyrelatedstrains.J.Bacteriol.180:3453?3461.
	55.Rudi,K.,T.Fossheim,andK.S.Jakobsen.2002.NestedevolutionofatRNALeu(UAA)groupIintronbybothhorizontalintrontransferandre-combinationoftheentiretRNAlocus.J.Bacteriol.184:666?671.
	56.Scheldeman,P.,D.Baurain,R.Bouhy,M.Scott,M.Muï¿½hling,B.A.Whitton,A.Belay,andA.Wilmotte.1999.Arthrospira(Spirulina?)strainsfromfourcontinentsareresolvedintoonlytwoclusters,basedonamplifiedribosomalDNArestrictionanalysisoftheinternallytranscribedspacer.FEMSMicro-biol.Lett.172:213?222.
	57.Thacker,R.W.,D.G.Nagle,andV.J.Paul.1997.Effectsofrepeatedexposurestomarinecyanobacterialsecondarymetabolitesonfeedingbyjuvenilerabbitfishandparrotfish.Mar.Ecol.Prog.Ser.167:21?29.
	58.Thacker,R.W.,andV.J.Paul.2001.Arebenthiccyanobacteriaindicatorsofnutrientenrichment?RelationshipsbetweencyanobacterialabundanceandenvironmentalfactorsonthereefflatsofGuam.Bull.Mar.Sci.69:497?508.
	59.Thacker,R.W.,D.W.Ginsburg,andV.J.Paul.2001.Effectsofherbivoreexclusionandnutrientenrichmentoncoralreefmacroalgaeandcyanobac-teria.CoralReefs19:318?329.
	60.Tillett,D.,D.L.Parker,andB.A.Neilan.2001.DetectionoftoxigenicitybyaprobeforthemicrocystinsynthetaseAgene(mcyA)ofthecyanobacterialgenusMicrocystis:comparisonoftoxicitieswith16SrRNAandphycocyaninoperon(phycocyaninintergenicspacer)phylogenies.Appl.Environ.Micro-biol.67:2810?2818.
	61.Whitton,B.A.,andM.Potts.1982.Marinelittoral,p.515?542.InN.G.CarrandB.A.Whitton(ed.),Thebiologyofcyanobacteria.BlackwellScience,Oxford,England.
	62.Whitton,B.A.,andM.Potts.2000.Theecologyofcyanobacteria.KluwerAcademicPublishers,Dordrecht,TheNetherlands.
	63.Williams,P.G.,H.Luesch,W.Y.Yoshida,R.E.Moore,andV.J.Paul.2003.ContinuingstudiesonthecyanobacteriumLyngbyasp.:isolationandstruc-turedeterminationof15-norlyngbyapeptinAandlyngbyabellinD.J.Nat.Prod.66:595?598.
	64.Williams,P.G.,R.E.Moore,andV.J.Paul.2003.Isolationandstructuredeterminationoflyngbyastatin3,alyngbyastatin1homologuefromthemarinecyanobacteriumLyngbyamajuscula.Determinationoftheconfigu-rationofthe4-amino-2,2-dimethyl-3-oxopentanoicacidunitinmajuscul-amideC,dolastatin12,lyngbyastatin1,andlyngbyastatin3fromcyanobac-teria.J.Nat.Prod.66:1356?1363.
	65.Wilmotte,A.1991.Taxonomicstudyofmarineoscillatoriaceanstrains(Cy-anophyceae,Cyanobacteria)withnarrowtrichomes.I.Morphologicalvari-abilityandautecologicalfeatures.Algol.Stud.64:215?248.
	66.Wilmotte,A.1992.Taxonomicstudyofmarineoscillatoriaceanstrains(Cya-nobacteria)withnarrowtrichomes.II.Nucleotidesequenceanalysisofthe16SribosomalRNA.J.Phycol.28:828?838.
	67.Wilmotte,A.1994.MolecularevolutionandtaxonomyoftheCyanobacteria,p.1?25.InD.A.Bryant(ed.),Themolecularbiologyofcyanobacteria.KluwerAcademicPublishers,Dordrecht,TheNetherlands.
	68.Zehr,J.P.,M.T.Mellon,andW.D.Hiorns.1997.Phylogenyofcyanobac-terialnifHgenes:evolutionaryimplicationsandpotentialapplicationstonaturalassemblages.Microbiology143:1443?1450.
2268-03.pdf	38
	1. Abee, T. 1995. Pore-forming bacteriocins of gram-positive bacteria and selfprotectionmechanisms of producer organisms. FEMS Microbiol. Lett. 129:1â€“10.
	2. Altena, K., A. Guder, C. Cramer, and G. Bierbaum. 2000. Biosynthesis of thelantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl.Environ. Microbiol. 66:2565â€“2571.
	3. Augustin, J., and F. GoÂ¨tz. 1990. Transformation of Staphylococcus epidermidisand other staphylococcal species with plasmid DNA by electroporation.FEMS Microbiol. Lett. 66:203â€“208.
	4. Augustin, J., R. Rosenstein, B. Wieland, U. Schneider, N. Schnell, G. Engelke,K.-D. Entian, and F. GoÂ¨tz. 1992. Genetic analysis of epidermin biosyntheticgenes and epidermin-negative mutants of Staphylococcus epidermidis.Eur. J. Biochem. 204:1149â€“1154.
	5. Bierbaum, G., M. Reis, C. Szekat, and H.-G. Sahl. 1994. Construction of anexpression system for engineering of the lantibiotic Pep5. Appl. Environ.Microbiol. 60:4332â€“4338.
	6.Breukink,E.,I.Wiedemann,C.vanKraaij,O.P.Kuipers,H.-G.Sahl,andB.deKruijff.1999.UseofthecellwallprecursorlipidIIbyapore-formingpeptideantibiotic.Science286:2361?2364.
	7.Broï¿½tz,H.,G.Bierbaum,K.Leopold,P.E.Reynolds,andH.-G.Sahl.1998.ThelantibioticmersacidininhibitspeptidoglycansynthesisbytargetinglipidII.Antimicrob.AgentsChemother.42:154?160.
	8.Cowley,S.C.,andY.Av-Gay.2001.Monitoringpromoteractivityandpro-teinlocalizationinMycobacteriumspp.usinggreenfluorescentprotein.Gene264:225?231.
	9.Ersfeld-Dressen,H.,H.-G.Sahl,andH.Brandis.1984.Plasmidinvolvementinproductionofandimmunitytothestaphylococcin-likepeptidePep5.J.Gen.Microbiol.130:3029?3035.
	10.Geli,V.,D.Baty,F.Pattus,andC.Lazdunski.1989.TopologyandfunctionoftheintegralmembraneproteinconferringimmunitytocolicinA.Mol.Microbiol.3:679?687.
	11.Goï¿½tz,F.,andB.Schumacher.1987.Improvementsofprotoplasttransfor-mationinStaphylococcuscarnosus.FEMSMicrobiol.Lett.40:285?288.
	12.Guder,A.,T.Schmitter,I.Wiedemann,H.G.Sahl,andG.Bierbaum.2002.RoleofthesingleregulatorMrsR1andthetwo-componentsystemMrsR2/K2intheregulationofmersacidinproductionandimmunity.Appl.Environ.Microbiol.68:106?113.
	13.Heidrich,C.,U.Pag,M.Josten,J.W.Metzger,R.W.Jack,G.Bierbaum,G.Jung,andH.-G.Sahl.1998.Isolation,characterization,andheterologousexpressionofthenovellantibioticepicidin280andanalysisofitsbiosyntheticgenecluster.Appl.Environ.Microbiol.64:3140?3146.
	14.Johnston,T.C.,R.B.Thompson,andT.O.Baldwin.1986.NucleotidesequenceoftheluxBgeneofVibrioharveyiandthecompleteaminoacidsequenceofthebetasubunitofbacterialluciferase.J.Biol.Chem.261:4805?4811.
	15.Klein,C.,andK.-D.Entian.1994.Genesinvolvedinself-protectionagainstthelantibioticsubtilinproducedbyBacillussubtilisATCC6633.Appl.En-viron.Microbiol.60:2793?2801.
	16.Kuipers,O.P.,M.M.Beerthuyzen,R.J.Siezen,andW.M.deVos.1993.CharacterizationofthenisingeneclusternisABTCIPRofLactococcuslactisRequirementofexpressionofthenisAandnisIgenesfordevelopmentofimmunity.Eur.J.Biochem.216:281?291.
	17.McAuliffe,O.,C.Hill,andR.P.Ross.2000.Identificationandoverexpres-sionofltnl,anovelgenewhichconfersimmunitytothetwo-componentlantibiotic lacticin 3147. Microbiology 146:129â€“138.
	18. Meyer, C., G. Bierbaum, C. Heidrich, M. Reis, J. SuÂ¨ling, M. I. Iglesias-Wind,C. Kempter, E. Molitor, and H.-G. Sahl. 1995. Nucleotide sequence of thelantibiotic Pep5 biosynthesis gene cluster and functional analysis of PepPand PepC. Eur. J. Biochem. 232:478â€“489.
	19. Otto, M., A. Peschel, and F. GoÂ¨tz. 1998. Producer self-protection against thelantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcusepidermidis TuÂ¨3298. FEMS Microbiol. Lett. 166:203â€“211.
	20. Pag, U., C. Heidrich, G. Bierbaum, and H.-G. Sahl. 1999. Molecular analysisof expression of the lantibiotic Pep5 immunity phenotype. Appl. Environ.Microbiol. 65:591â€“598.
	21. Peschel, A., and F. GoÂ¨tz. 1996. Analysis of the Staphylococcus epidermidisgenes epiF, -E, and - G involved in epidermin immunity. J. Bacteriol. 178:531â€“536.
	22. Peschel, A., B. OttenwaÂ¨lder, and F. GoÂ¨tz. 1996. Inducible production andcellular location of the epidermin biosynthetic enzyme EpiB using an improvedstaphylococcal expression system. FEMS Microbiol. Lett. 137:279â€“284.
	23. Qiao, M., T. Immonen, O. Koponen, and P. E. J. Saris. 1995. The cellularlocation and effect on nisin immunity of the NisI protein from Lactococcuslactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol. Lett.131:75â€“80.
	24. Reis, M., M. Eschbach-Bludau, M. I. Iglesias-Wind, T. Kupke, and H.-G.Sahl. 1994. Producer immunity towards the lantibiotic Pep5: identification ofthe immunity gene pepI and localization and functional analysis of its geneproduct. Appl. Environ. Microbiol. 60:2876â€“2883.
	25. Reis, M., and H.-G. Sahl. 1991. Genetic analysis of the producer self-protectionmechanism (â€œimmunityâ€�) against Pep5, p. 320â€“331. In G. Jung andH.-G. Sahl (ed.), Nisin and novel lantibiotics. Escom, Leiden, The Netherlands.
	26. RinceÂ´, A., A. Dufour, P. Uguen, J. P. Le Pennec, and D. Haras. 1997.Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF,lctE, and lctG encode a putative ABC transporter involved in bacteriocinimmunity. Appl. Environ. Microbiol. 63:4252â€“4260.
	27. Sahl, H.-G., and G. Bierbaum. 1998. Lantibiotics: biosynthesis and biologicalactivities of uniquely modified peptides from Gram-positive bacteria. Annu.Rev. Microbiol. 52:41â€“79.
	28. Sahl, H.-G., and H. Brandis. 1981. Production, purification and chemicalproperties of an antistaphylococcal agent produced by Staphylococcus epidermidis.J. Gen. Microbiol. 127:377â€“384.
	29. Saris, P. E. J., T. Immonen, M. Reis, and H.-G. Sahl. 1996. Immunity tolantibiotics. Antonie Leeuwenhoek 69:151â€“159.
	30. Schleifer, K. H., and U. Fischer. 1982. Description of a new species of thegenusStaphylococcus:Staphylococcuscarnosus.Int.J.Syst.Bacteriol.32:153?156.
	31.Schnell,N.,K.-D.Entian,U.Schneider,F.Goï¿½tz,H.Zaï¿½hner,R.Kellner,andG.Jung.1988.Prepeptidesequenceofepidermin,aribosomallysynthesizedantibioticwithfoursulphide-rings.Nature333:276?278.
	32.Schramm,E.,T.Oï¿½lschlaï¿½ger,W.Troger,andV.Braun.1988.Sequence,expressionandlocalizationoftheimmunityproteinforcolicinB.Mol.Gen.Genet.211:176?182.
	33.Shi,H.,andS.W.Wen.2001.DisplayofgreenfluorescentproteinonEscherichiacolicellsurface.EnzymeMicrob.Technol.28:25?34.
	34.Siegers,K.,andK.-D.Entian.1995.GenesinvolvedinimmunitytothelantibioticnisinproducedbyLactococcuslactis6F3.Appl.Environ.Micro-biol.61:1082?1089.
	35.Skaugen,M.,C.I.M.Abildgaard,andI.F.Nes.1997.OrganizationandexpressionofageneclusterinvolvedinthebiosynthesisofthelantibioticlactocinS.Mol.Gen.Genet.253:674?686.
	36.Song,H.Y.,andW.A.Cramer.1991.MembranetopographyofColE1geneproducts:theimmunityprotein.J.Bacteriol.173:2935?2943.
	37.Wiedemann,I.,E.Breukink,C.vanKraaij,O.P.Kuipers,G.Bierbaum,B.deKruijff,andH.G.Sahl.2001.Specificbindingofnisintothepep-tidoglycanprecursorlipidIIcombinesporeformationandinhibitionofcellwallbiosynthesisforpotentantibioticactivity.J.Biol.Chem.276:1772?1779.
	38.Worobo,R.W.,M.J.vanBelkum,M.Sailer,K.L.Roy,J.C.Vederas,andM.E.Stiles.1995.Asignalpeptidesecretion-dependentbacteriocinfromCarnobacteriumdivergens.J.Bacteriol.177:3143?3149.
nihms-136728.pdf	23
	[1]. Hayat, MA., editor. Colloidal Gold: Principles, Methods, and Applications. Academic Press; SanDiego: 1991.
	[2]. Dai, HL.; Ho, W., editors. Laser Spectroscopy and Photochemistry on Metal Surfaces Parts I and II.World Scientific; Singapore: 1995.
	[3]. Allara, D. Characterization of Organic Thin Films. Ulman, A., editor. Butterworth-Heinemann;Boston: 1995. Chapter 4
	[4]. Ulman, A. Ultrathin Organic Films. Academic Press; San Diego: 1991.
	[5]. Ulman A. Formation and structure of self-assembled monolayers. Chem. Rev 1996;96:1533?1554.[PubMed: 11848802]
	[6]. Kamat PV. Photophysical, photochemical and photocatalytic aspects of metal nanoparticles. J. Phys.Chem. B 2002;106:7729?7744.
	[7]. He L, Musick MD, Nicewarner SR, Salinas FG, Benkovic SJ, Natan MJ, Keating CD. Colloidal Au-enhanced surface plasmon resonance for ultrasensitive detection of DNA hybridization. J. Am.Chem. Soc 2000;122:9071?9077.
	[8]. Nicewarner Pena SR, Raina S, Goodrich GP, Fedoroff NV, Keating CD. Hybridization and enzymaticextension of Au nanoparticle-bound oligonucleotides. J. Am. Chem. Soc 2002;124:7314?7323.[PubMed: 12071740]
	[9]. Reynolds RA III, Mirkin CA, Letsinger RL. Homogeneous, nanoparticle-based quantitativecolorimetric detection of oligonucleotides. J. Am. Chem. Soc 2000;122:3795?3796.
	[10]. Taton TA, Mucic RC, Mirkin CA, Letsinger RL. The DNA-mediated formation of supramolecularmono- and multilayered nanoparticle structures. J. Am. Chem. Soc 2000;122:6305?6306.
	[11]. Templeton AC, Wuelfing WP, Murray RW. Monolayer-protected cluster molecules. Acc. Chem.Res 2000;33:27?36. [PubMed: 10639073]
	[12]. Ingram RS, Hostetler MJ, Murray RW. Poly-hetero-?-functionalized alkanethiolate-stabilized goldcluster compounds. J. Am. Chem. Soc 1997;119:9175?9178.
	[13]. Templeton AC, Hostetler MJ, Kraft CT, Murray RW. Reactivity of monolayer-protected gold clustermolecules: steric effects. J. Am. Chem. Soc 1998;120:1906?1911.
	[14]. Hostetler MJ, Templeton AC, Murray RW. Dynamics of place-exchange reactions on monolayer-protected gold cluster molecules. Langmuir 1999;15:3782?3789.
	[15]. Hostetler MJ, Green SJ, Stokes JJ, Murray RW. Monolayers in three dimensions: synthesis andelectrochemistry of ?-functionalized alkanethiolate-stabilized gold cluster compounds. J. Am.Chem. Soc 1996;118:4212?4213.
	[16]. Hostetler MJ, Wingate JE, Zhong C-J, Harris JE, Vachet RW, Clark MR, Londono JD, Green SJ,Stokes JJ, Wignall GD, Glish GL, Porter MD, Evans ND, Murray RW. Alkanethiolate gold clustermolecules with core diameters from 1.5 to 5.2 nm: core and monolayer properties as a function ofcore size. Langmuir 1998;14:17?30.
	[17]. Malicka J, Gryczynski I, Lakowicz JR. Enhanced emission of highly labeled DNA oligomers nearsilver metallic surfaces. Anal. Chem 2003;75:4408?4414. [PubMed: 14632044]
	[18]. Geddes CD, Cao H, Gryczynski I, Gryczynski Z, Fang JY, Lakowicz JR. metal-enhancedfluorescence (mef) due to silver colloids on a planar surface: potential applications of indocyaninegreen to in vivo imaging. J. Phys. Chem. A 2003;107:3443?3449.
	[19]. Lakowicz JR, Shen YB, D?Auria S, Malicka J, Fang JY, Gryczynski Z, Gryczynski I. Radiativedecay engineering. Effects of silver island films on fluorescence intensity, lifetimes, and resonanceenergy transfer. Anal. Biochem 2002;301:261?277. [PubMed: 11814297]
	[20]. Lakowicz JR. Radiative decay engineering: biophysical and biomedical applications. Anal.Biochem 2001;298:1?24. [PubMed: 11673890]Zhang et al.Page 5
	[21]. Huang T, Murray RW. Visible luminescence of water-soluble monolayer-protected gold clusters.J. Phys. Chem. B 2001;105:12498â€“12502.
	[22]. Huang T, Murray RW. Quenching of [Ru(bpy) fluorescence by binding to Au nanoparticles.Langmuir 2002;18:7077?7081.
	[23]. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman RJ. Synthesis of thiol-derivatized goldnanoparticles in a 2-phase liquid system. Chem. Soc., Chem. Commun 1994:801?802.
	[24]. Zhang J, Whitesell JK, Fox MA. Photophysical behavior of variously sized colloidal gold clusterscapped with monolayers of an alkylstilbenethiolate. J. Phys. Chem. B 2003;107:6051?6055.
nihms5059.pdf	59
	The Framingham Eye Study and the Framingham Offspring Eye Study. Familial aggregation of lensopacities. Am J Epidemiol 1994a;140:555?564.
	The Italian-American Cataract Study Group. Incidence and progression of cortical, nuclear, and posteriorsubcapsular cataracts. Am J Ophthalmol 1994b;118:623?631.
	Alberti G, Oguni M, Podgor M, Sperduto RD, Tomarev S, Grassi C, Williams S, Kaiser-Kupfer M,Maraini G, Hejtmancik JF. Glutathione S-transferase M1 genotype and age-related cataracts. Lack ofassociation in an Italian population. Invest Ophthalmol Vis Sci 1996;37:1167?1173. [PubMed:8631631]
	Bassnett S, Kuszak JR, Reinish L, Brown HG, Beebe DC. Intercellular communication between epithelialand fiber cells of the eye lens. J Cell Sci 1994;107:799?811. [PubMed: 8056837]
	Beaumont C, Leneuve P, Devaux I, Scoazec JY, Berthier M, Loiseau MN, Grandchamp B, Bonneau D.Mutation in the iron responsive element of the L ferritin mRNA in a family with dominanthyperferritinaemia and cataract. Nat Genet 1995;11:444?446. [PubMed: 7493028]
	Benedek GB. Theory of transparency of the eye. Appl Optics 1971;10:459?473.
	Carper D, John M, Chen Z, Subramanian S, Wang R, Ma W, Spector A. Gene expression analysis of an- resistant lens epithelial cell line. Free Radic Biol Med 2001;31:90?97. [PubMed: 11425494]
	Carver JA, Nicholls KA, Aquilina JA, Truscott RJ. Age-related changes in bovine alpha-crystallin andhigh-molecular-weight protein. Exp Eye Res 1996;63:639?647. [PubMed: 9068371]
	Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA2003;290:2057?2060. [PubMed: 14559961]
	Conley YP, Erturk D, Keverline A, Mah TS, Keravala A, Barnes LR, Bruchis A, Hess JF, FitzGeraldPG, Weeks DE, Ferrell RE, Gorin MB. A juvenile-onset, progressive cataract locus on chromosome3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am JHum Genet 2000;66:1426?1431. [PubMed: 10729115]
	Davies MJ, Truscott RJ. Photo-oxidation of proteins and its role in cataractogenesis. J PhotochemPhotobiol B 2001;63:114?125. [PubMed: 11684458]
	Delaye M, Tardieu A. Short-range order of crystallin proteins accounts for eye lens transparency. Nature1983;302:415?417. [PubMed: 6835373]
	Dickerson JE Jr, Lou MF, Gracy RW. The culture of rat lenses in high sugar media: effect on mixeddisulfide levels. Curr Eye Res 1995;14:109?118. [PubMed: 7768104]
	Eiberg H, Lund AM, Warburg M, Rosenberg T. Assignment of congenital cataract Volkmann type (CCV)to chromosome 1p36. Hum Genet 1995;96:33?38. [PubMed: 7607651]
	Francis P, Berry V, Bhattacharya S, Moore A. Congenital progressive polymorphic cataract caused by amutation in the major intrinsic protein of the lens, MIP (AQP0). Br J Ophthalmol 2000a;84:1376?1379. [PubMed: 11090476]
	Francis P, Chung JJ, Yasui M, Berry V, Moore A, Wyatt MK, Wistow G, Bhattacharya SS, Agre P.Functional impairment of lens aquaporin in two families with dominantly inherited cataracts. HumMol Genet 2000b;9:2329?2334. [PubMed: 11001937]
	Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, Hogan BL, Evans MJ,Colledge WH. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 developnormally but show severe age-onset cataract formation and disruption of the lens. EMBO J1998;17:1860?1870. [PubMed: 9524110]
	Goswami S, Sheets NL, Zavadil J, Chauhan BK, Bottinger EP, Reddy VN, Kantorow M, Cvekl A.Spectrum and range of oxidative stress responses of human lens epithelial cells to H insult. IOVS2003;44:2084?2093.
	Graw J, Loster J. Developmental genetics in ophthalmology. Ophthalmic Genet 2003;24:1?33. [PubMed:12660863]
	Hammond CJ, Duncan DD, Snieder H, de Lange M, West SK, Spector TD, Gilbert CE. The heritabilityof age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci 2001;42:601?605.[PubMed: 11222516]
	Hammond CJ, Sneider H, Spector TD, Gilbert CE. Genetic and Environmental Factors in age-relatednuclear cataracts in mono-zygotic and dizygotic twins. New England J Med 2000;342:1786?1790.[PubMed: 10853001]
	Hao Y, He S, Gu Z, Zhao Y, Li X, Wang C, Li Q, Liu T. [Relationship between GSTM1 genotype andsusceptibility to senile cataract]. Zhonghua YanKeZa Zhi 1999;35:104?106.
	Hawse R, Hejtmancik F, James, Huang Q, Sheets, Nancy L, Hosack Douglas A, Lempicki Richard A,Joseph Horwitz, Kantorow M. Identification and functional clustering of global gene expressiondifferences between human age-related cataract and clear lenses. Molecular Vision 2003;9:515?537.[PubMed: 14551530]
	Heiba IM, Elston RC, Klein BE, Klein R. Evidence for a major gene for cortical cataract. InvestOphthalmol Vis Sci 1995;36:227?235. [PubMed: 7822150]
	Hejtmancik, Kaiser-Kupfer, M.I., Piatigorsky, J., 2001. Molecular biology and inherited disorders of theeye lens. In: Scriver, CR, Beaudet, AL (Eds.), The Metabolic and Molecular Basis of InheritedDisease, 8, McGraw Hill, New York, pp. 6033?6062.
	Heon E, Paterson AD, Fraser M, Billingsley G, Priston M, Balmer A, Schorderet DF, Verner A, HudsonTJ, Munier FL. A Progressive Autosomal Recessive Cataract Locus Maps to Chromosome 9q13-q22. Am J Hum Genet 2001;68:772?777. [PubMed: 11179024]
	Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Nat Acad Sci USA1992;89:10449?10453. [PubMed: 1438232]
	Javitt JC. Who does cataract surgery in the United States? Arch Ophthalmol 1993;111:1329. [PubMed:8216011]
	Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, Panov A, Soovere L, Koka K, MikelsaarAV. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract inEstonians. Invest Ophthalmol Vis Sci 2000;41:2262?2267. [PubMed: 10892871]
	Kantorow M, Horwitz J, Carper D. Up-regulation of osteonectin/SPARC in age-related cataractoushuman lens epithelia. Mol Vis 1998a;4:17. [PubMed: 9743541]
	Kantorow M, Kays T, Horwitz J, Huang Q, Sun J, Piatigorsky J, Carper D. Differential display detectsaltered gene expression between cataractous and normal human lenses. Invest Ophthalmol Vis Sci1998b;39:2344?2354. [PubMed: 9804143]
	Kmoch S, Brynda J, Asfaw B, Bezouska K, Novak P, Rezacova P, Ondrova L, Filipec M, Sedlacek J,Elleder M. Link between a novel human gamma D-crystallin allele and a unique cataract phenotypeexplained by protein crystallography. Hum Mol Genet 2000;9:1779?1786. [PubMed: 10915766]
	Kupfer C. On presentation of the Friedenwald Award of the Association for Research in Vision andOphthalmology to Dr Joram Piatigorsky. Invest Ophthalmol Vis Sci 1987;28:2?8. [PubMed:3542882]
	Lapko VN, Smith DL, Smith JB. Methylation and carbamylation of human gamma-crystallins. ProteinSci 2003;12:1762?1774. [PubMed: 12876325]
	Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabeticcataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Nat AcadSci USA 1995;92:2780?2784. [PubMed: 7708723]
	Lee EH, Seomun Y, Hwang KH, Kim JE, Kim IS, Kim JH, Joo CK. Over-expression of the transforminggrowth factor-beta-inducible gene betaig-h3 in anterior polar cataracts. IOVS 2000;41:1840?1845.
	Lee SC, Wang Y, Ko GT, Ma RC, Critchley JA, Cockram CS, Chan JC. Risk factors for cataract inChinese patients with type 2 diabetes: evidence for the influence of the aldose reductase gene. ClinGenet 2001;59:356?359. [PubMed: 11359468]
	Lerman, S., 1980. Radiant Energy and the Eye, MacMillan, New York.
	Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract.Arch Ophthalmol 1991;109:244?251. [PubMed: 1993036]
	Lim JM, Lee JH, Wee WR, Joo CK. Downregulated expression of ADAM9 in anterior polar cataracts.J Cataract Refract Surg 2002;28:697?702. [PubMed: 11955914]
	Maraini G, Hejtmancik JF, Shiels A, Mackay DS, Aldigeri R, Jiao XD, Williams SL, Sperduto RD, ReedG. Galactokinase gene mutations and age-related cataract. Lack of association in an Italianpopulation. Mol Vis 2003;9:397?400. [PubMed: 12942049]
	Marner E, Rosenberg T, Eiberg H. Autosomal dominant congenital cataract: morphology and geneticmapping. Acta Ophthalmol 1989;67:151?158. [PubMed: 2728866]
	McCarty CA, Taylor HR. The genetics of cataract. Invest Ophthalmol Vis Sci 2001;42:1677?1678.[PubMed: 11431427]
	Okano Y, Asada M, Fujimoto A, Ohtake A, Murayama K, Hsiao KJ, Choeh K, Yang Y, Cao Q, ReichardtJK, Niihira S, Imamura T, Yamano T. A genetic factor for age-related cataract: identification andcharacterization of a novel galactokinase variant Osaka, in Asians. Am J Hum Genet 2001;68:1036?1042. [PubMed: 11231902]
	Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King J, Benedek GB. Crystal cataracts: human geneticcataract caused by protein crystallization. Proc Nat Acad Sci USA 2001;98:6116?6120. [PubMed:11371638]
	Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King JA, Lubsen NH, Walton D, Benedek GB.Molecular basis of a progressive juvenile-onset hereditary cataract. Proc Nat Acad Sci USA2000;97:1993?1998. [PubMed: 10688888]
	Rae JL, Bartling C, Rae J, Mathias RT. Dye transfer between cells of the lens. J Membr Biol 1996;150:89?103. [PubMed: 8699483]
	Raghavachari N, Krysan K, Xing K, Lou MF. Regulation of thioltransferase expression in human lensepithelial cells. Invest Ophthalmol Vis Sci 2001;42:1002?1008. [PubMed: 11274078]
	Ren Z, Li A, Shastry BS, Padma T, Ayyagari R, Scott MH, Parks MM, Kaiser-Kupfer M, HejtmancikJF. A 5-base insertion in the ?-crystallin gene is associated with autosomal dominant variable zonularpulverulent cataract. Hum Genet 2000;106:531?537. [PubMed: 10914683]
	Ruotolo R, Grassi F, Percudani R, Rivetti C, Martorana D, Maraini G, Ottonello S. Gene expressionprofiling in human age-related nuclear cataract. Mol Vis 2003;9:538?548. [PubMed: 14551529]
	Sekine Y, Hommura S, Harada S. Frequency of glutathione-S-transferase 1 gene deletion and its possiblecorrelation with cataract formation. Exp Eye Res 1995;60:159?163. [PubMed: 7781744]
	Sheets NL, Chauhan BK, Wawrousek E, Hejtmancik JF, Cvekl A, Kantorow M. Cataract and lens-specificupregulation of ARK receptor tyrosine kinase in Emory mouse cataract. IOVS 2002;43:1870?1875.
	Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 1995;9:1173?1182.[PubMed: 7672510]
	Spector A, Li D, Ma W, Sun F, Paulidis P. Differential amplification of gene expression in lens cell linesconditioned to survive peroxide stress. IOVS 2002a;43:3251?3264.
	Spector A, Ma W, Sun F, Li D, Kleiman NJ. The effect of H and tertiary butyl hydroperoxide upona murine immortal lens epithelial cell line, alpha TN4-1. EER 2002b;75:573?582.
	Tielsh JM, Sommer A, Witt K, Royall RM. Blindness and visual impairment in an American urbanpopulation. The Baltimore Eye Survey. Arch Ophthalmol 1990;108:286?290. [PubMed: 2271016]
	Truscott RJ. Human cataract: the mechanisms responsible; light and butterfly eyes. Int J Biochem CellBiol 2003;35:1500?1504. [PubMed: 12824061]
	Zhang W, Hawse J, Huang Q, Sheets N, Miller KM, Horwitz J, Kantorow M. Decreased expression ofribosomal proteins in human age-related cataract. Invest Ophthalmol Vis Sci 2002;43:198?204.[PubMed: 11773032]
	Wan XH, Lee EH, Koh HJ, Song J, Kim EK, Kim CY, Lee JB, Kim SY, Yao K, Lee JH. Enhancedexpression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-beta in vitro.Br J Ophthalmol 2002;86:1293?1298. [PubMed: 12386092]
j.1432-1033.2004.04156.x.pdf	35
	1.Campbell,E.J.,Campbell,M.A.&Owen,C.A.(2000)Bioactiveproteinase3onthecellsurfaceofhumanneutrophils:quanti?-cation,catalyticactivity,andsusceptibilitytoinhibition.J.Immunol.165,3366?3374.
	2.Campbell,E.J.,Silverman,E.K.&Campbell,M.A.(1989)Elas-taseandcathepsinGofhumanmonocytes.Quanti?cationofcellularcontent,releaseinresponsetostimuli,andheterogeneityinelastase-mediatedproteolyticactivity.J.Immunol.143,2961?2968.
	3.Owen,C.A.&Campbell,E.J.(1999)Thecellbiologyofleukocyte-mediatedproteolysis.J.Leukoc.Biol.65,137?150.
	4.Perlmutter,D.H.&Pierce,J.A.(1989)Thealpha1-antitrypsingeneandemphysema.Am.J.Physiol.257,147?162.
	5.Birrer,P.,McElvaney,N.G.,Rudeberg,A.,Sommer,C.W.,Liechti-Gallati,S.,Kraemer,R.,Hubbard,R.&Crystal,R.G.(1994)Protease-antiproteaseimbalanceinthelungsofchildrenwithcystic?brosis.Am.J.Respir.Crit.CareMed.150,207?213.
	6.Doring,G.(1994)Theroleofneutrophilelastaseinchronicin?ammation.Am.J.Respir.Crit.CareMed.150,S114?S117.
	7.McElvaney,N.G.,Nakamura,H.,Birrer,P.,Hebert,C.A.,Wong,W.L.,Alphonso,M.,Baker,J.B.,Catalano,M.A.&Crystal,R.G.(1992)Modulationofairwayin?ammationincystic?brosis.Invivosuppressionofinterleukin-8levelsontherespiratoryepithelialsurfacebyaerosolizationofrecombinantsecretoryleu-koproteaseinhibitor.J.Clin.Invest.90,1296?1301.
	8.Vogelmeier,C.,Gillissen,A.&Buhl,R.(1996)Useofsecretoryleukoproteaseinhibitortoaugmentlungantineutrophilelastaseactivity.Chest110,261S?266S.
	9.Vogelmeier,C.,Hubbard,R.C.,Fells,G.A.,Schnebli,H.P.,Thompson,R.C.,Fritz,H.&Crystal,R.G.(1991)Anti-neutrophilelastasedefenseofthenormalhumanrespiratoryepithelialsurfaceprovidedbythesecretoryleukoproteaseinhibitor.J.Clin.Invest.87,482?488.
	10.McElvaney,N.G.,Hubbard,R.C.,Birrer,P.,Chernick,M.S.,Caplan,D.B.,Frank,M.M.&Crystal,R.G.(1991)Aerosolalpha1-antitrypsintreatmentforcystic?brosis.Lancet337,392?394.
	11.Delacourt,C.,Herigault,S.,Delclaux,C.,Poncin,A.,Levame,M.,Harf,A.,Saudubray,F.&Lafuma,C.(2002)Protectionagainstacutelunginjurybyintravenousorintratrachealpre-treatmentwithEPI-HNE-4,anewpotentneutrophilelastaseinhibitor.Am.J.Respir.Cell.Mol.Biol.26,290?297.
	12.Bradbury,J.(2001)Neutrophilelastaseinhibitorsforcystic?brosis.DrugDiscov.Today6,441?442.
	13.Tremblay,G.M.,Janelle,M.F.&Bourbonnais,Y.(2003)Anti-in?ammatoryactivityofneutrophilelastaseinhibitors.Curr.Opin.Invest.Drugs4,556?565.
	14.Nara,K.,Ito,S.,Ito,T.,Suzuki,Y.,Ghoneim,M.A.,Tachibana,S.&Hirose,S.(1994)Elastaseinhibitorela?nisanewtypeofproteinaseinhibitorwhichhasatransglutaminase-mediatedanchoringsequencetermedcementoin.J.Biochem.115,441?448.
	15.Sallenave,J.M.&Silva,A.(1993)Characterizationandgenesequenceoftheprecursorofela?n,anelastase-speci?cinhibitorinbronchialsecretions.Am.J.Respir.Cell.Mol.Biol.8,439?445.
	16.Tremblay,G.M.,Sallenave,J.M.,Israel-Assayag,E.,Cormier,Y.&Gauldie,J.(1996)Ela?n/elastase-speci?cinhibitorinbroncho-alveolarlavageofnormalsubjectsandfarmer?slung.Am.J.Respir.Crit.CareMed.154,1092?1098.
	17.Pfundt,R.,vanRuissen,F.,vanVlijmen-Willems,I.M.,Alke-made,H.A.,Zeeuwen,P.L.,Jap,P.H.,Dijkman,H.,Fransen,J.,Croes,H.,vanErp,P.E.&Schalkwijk,J.(1996)ConstitutiveandinducibleexpressionofSKALP/ela?nprovidesanti-elastasedef-enseinhumanepithelia.J.Clin.Invest.98,1389?1399.
	18.Shotton,D.M.(1970)Elastase.MethodsEnzymol.19,113?140.
	19.Boudier,C.&Bieth,J.G.(1992)Theproteinase:mucusproteinaseinhibitorbindingstoichiometry.J.Biol.Chem.267,4370?4375.
	20.Rao,N.V.,Wehner,N.G.,Marshall,B.C.,Gray,W.R.,Gray,B.H.&Hoidal,J.R.(1991)Characterizationofproteinase-3(PR-3),aneutrophilserineproteinase.Structuralandfunctionalproperties.J.Biol.Chem.266,9540?9548.
	21.Schaï¿½gger,H.&vonJagow,G.(1987)Tricine-sodiumdodecylsulfate-polyacrylamidegelelectrophoresisfortheseparationofproteinsintherangefrom1to100kDa.Anal.Biochem.166,368?379.
	22.Zani,M.,Brillard-Bourdet,M.,Lazure,C.,Juliano,L.,Courty,Y.,Gauthier,F.&Moreau,T.(2001)Puri?cationandchar-acterizationofactiverecombinantratkallikreinrK9.Biochim.Biophys.Acta1547,387?396.
	23.Ying,Q.L.&Simon,S.R.(1993)Kineticsoftheinhibitionofhumanleukocyteelastasebyela?n,a6-kilodaltonelastase-speci?cinhibitorfromhumanskin.Biochemistry32,1866?1874.
	24.Ying,Q.L.&Simon,S.R.(2001)KineticsoftheInhibitionofProteinase3byEla?n.Am.J.Respir.CellMol.Biol.24,83?89.
	25.Bieth,J.G.(1995)Theoreticalandpracticalaspectsofproteinaseinhibitionkinetics.MethodsEnzymol.248,59?84.
	26.Bieth,J.G.,Spiess,B.&Wermuth,C.G.(1974)Thesynthesisandanalyticaluseofahighlysensitiveandconvenientsubstrateofelastase.Biochem.Med.11,350?357.
	27.Capellos,C.&Bielski,B.H.J.(1980)KineticSystems.Mathema-ticalDescriptionofChemicalKineticsinSolution.KriegerPub-licationCo.,Huntington,NY.
	28.Nakajima,K.,Powers,J.C.,Ashe,B.M.&Zimmerman,M.(1979)MappingtheextendedsubstratebindingsiteofcathepsinGandhumanleukocyteelastase.Studieswithpeptidesubstratesrelatedtothealpha1-proteaseinhibitorreactivesite.J.Biol.Chem.254,4027?4032.
	29.Duranton,J.&Bieth,J.G.(2003)InhibitionofProteinase3byalpha1-AntitrypsinInVitroPredictsVeryFastInhibitionInVivo.Am.J.Respir.CellMol.Biol.29,57?61.
	30.Bourbonnais,Y.,Larouche,C.&Tremblay,G.M.(2000)Productionoffull-lengthhumanpre-ela?n,anelastasespeci?cinhibitor,fromyeastrequirestheabsenceofafunctionalyapsin1(Yps1p)endoprotease.ProteinExpr.Purif.20,485?491.
	31.Cereghino,G.P.,Cereghino,J.L.,Ilgen,C.&Cregg,J.M.(2002)ProductionofrecombinantproteinsinfermenterculturesoftheyeastPichiapastoris.Curr.Opin.Biotechnol.13,329?332.
	32.Wiedow,O.,Schroder,J.M.,Gregory,H.,Young,J.A.&Chris-tophers,E.(1990)Ela?n:anelastase-speci?cinhibitorofhumanskin.Puri?cation,characterization,andcompleteaminoacidsequence.J.Biol.Chem.265,14791?14795.
	33.Tremblay,G.M.,Vachon,E.,Larouche,C.&Bourbonnais,Y.(2002)Inhibitionofhumanneutrophilelastase-inducedacutelunginjuryinhamstersbyrecombinanthumanpre-ela?n(trappin-2).Chest121,582?588.
	34.Vachon,E.,Bourbonnais,Y.,Bingle,C.D.,Rowe,S.J.,Janelle,M.F.&Tremblay,G.M.(2002)Anti-in?ammatorye?ectofpre-ela?ninlipopolysaccharide-inducedacutelungin?ammation.Biol.Chem.383,1249?1256.
	35.Bieth,J.G.(1984)Invivosigni?canceofkineticconstantsofpro-teinproteinaseinhibitors.Biochem.Med.32,387?397.2378M.-L.Zanietal.(Eur.J.Biochem.271)FEBS2004
774.full.pdf	13
	1.Mellema JD, Bratton SL, Inglis A Jr, Morray JP. Use of cardiopul-monary bypass during bronchoscopy following sand aspiration: acase report. Chest. 1995;108:1176-1177.
	2.MSDS Resource Library. Available at: www.reade.com/MSDS_Links.html. Accessibility verified April 19, 2004.
	3.Bender EM, Moore EE, Kashuk JL, Hopeman AR. Conservativemanagement of sand aspiration: case report. Mil Med. 1984;149:98-99.
	4.Bergeson PS, Hinchcliffe WA, Crawford RF, Sorenson MJ, TrumpDS. Asphyxia secondary to massive dirt aspiration. J Pediatr.1978;92:506-507.
	5.Bonilla-Santiago J, Fill WL. Sand aspiration in drowning and neardrowning. Radiology. 1978;128:301-302.
	6.Choy IO, Idowu O. Sand aspiration: a case report. J Pediatr Surg.1996;31:1448-1450.
	7.Dunagan DP, Cox JE, Chang MC, Haponik EF. Sand aspirationwith near-drowning: radiographic and bronchoscopic findings. AmJ Respir Crit Care Med. 1997;156:292-295.
	8.Efron PA, Beierle EA. Pediatric sand aspiration: case report andliterature review. Pediatr Surg Int. 2003;19:409-412.
	9.Imburg J, Hartney TC. Drowning and the treatment of non-fatalsubmersion. Pediatrics. 1966;37:684-698.
	10.Maharaj RJ, Whitton I, Blyth D. Emergency extracorporeal oxy-genation for an intratracheal foreign body. Anaesthesia. 1983;38:471-474.
	11.Maron BA, Maron BJ. Sudden death and other risks associated withdry-sand beach holes [letter]. JAMA. 2001;285:1964.
	12.Van Dyke JJ, Lake KB. Survival after asphyxia secondary to gravelaspiration. Arch Intern Med. 1976;136:471-473.
	13.Wales J, Jackimczyk K, Rosen P. Aspiration following a cave-in.Ann Emerg Med. 1983;12:99-101.
2260.full.pdf	43
	1.ChangY,CesarmanE,PessinMS,etal.Identificationofherpesvirus-likeDNAsequencesinAIDS-associatedKaposi?ssarcoma.Science1994;266:1865?9.
	2.GaoSJ,KingsleyL,LiM,etal.KSHVantibodiesamongAmericans,ItaliansandUgandanswithandwithoutKaposi?ssarcoma.NatMed1996;2:925?8.
	3.SimpsonGR,SchulzTF,WhitbyD,etal.PrevalenceofKaposi?ssarcomaassociatedherpesvirusinfectionmeasuredbyantibodiestorecombinantcapsidproteinandlatentimmunofluorescenceantigen.Lancet1996;348:1133?8.
	4.MayamaS,CuevasLE,SheldonJ,etal.PrevalenceandtransmissionofKaposi?ssarcoma?associatedherpesvirus(humanherpesvirus8)inUgandanchildrenandadolescents.IntJCancer1998;77:817?20.
	5.ChintuC,AthaleUH,PatilPS.ChildhoodcancersinZambiabeforeandaftertheHIVepidemic.ArchDisChild1995;73:100?4;discussion104?5.
	6.AmirH,KaayaEE,ManjiKP,KwesigaboG,BiberfeldP.Kaposi?ssarcomabeforeandduringahumanimmunodeficiencyvirusepidemicinTanzanianchildren.PediatrInfectDisJ2001;20:518?21.
	7.DukersNH,RenwickN,PrinsM,etal.Riskfactorsforhumanher-pesvirus8seropositivityandseroconversioninacohortofhomosexualmen.AmJEpidemiol2000;151:213?24.
	8.CasperC,WaldA,PaukJ,TabetSR,CoreyL,CelumCL.Correlates2270?JID2004:189(15June)?Brayfieldetal.ofprevalentandincidentKaposi?ssarcoma?associatedherpesvirusin-fectioninmenwhohavesexwithmen.JInfectDis2002;185:990?3.
	9.MartinJN,GanemDE,OsmondDH,Page-ShaferKA,MacraeD,KedesDH.Sexualtransmissionandthenaturalhistoryofhumanherpesvirus8infection.NEnglJMed1998;338:948?54.
	10.KoelleDM,HuangML,ChandranB,VieiraJ,PiepkornM,CoreyL.FrequentdetectionofKaposi?ssarcoma?associatedherpesvirus(humanherpesvirus8)DNAinsalivaofhumanimmunodeficiencyvirus?infectedmen:clinicalandimmunologiccorrelates.JInfectDis1997;176:94?102.
	11.AndreoniM,El-SawafG,RezzaG,etal.Highseroprevalenceofan-tibodiestohumanherpesvirus?8inEgyptianchildren:evidenceofnonsexualtransmission.JNatlCancerInst1999;91:465?9.
	12.HamprechtK,WitzelS,MaschmannJ,SpeerCP,JahnG.Transmissionofcytomegalovirusinfectionthroughbreastmilkintermandpreterminfants:theroleofcellfreemilkwheyandmilkcells.AdvExpMedBiol2000;478:231?9.
	13.HamprechtK,VochemM,BaumeisterA,BoniekM,SpeerCP,JahnG.DetectionofcytomegaloviralDNAinhumanmilkcellsandcellfreemilkwheybynestedPCR.JVirolMethods1998;70:167?76.
	14.BrayfieldBP,PhiriS,KankasaC,etal.Postnatalhumanherpesvirus8andhumanimmunodeficiencyvirustype1infectioninmothersandinfantsfromZambia.JInfectDis2003;187:559?68.
	15.MantinaH,KankasaC,KlaskalaW,etal.VerticaltransmissionofKaposi?ssarcoma?associatedherpesvirus.IntJCancer2001;94:749?52.
	16.GorryPR,BristolG,ZackJA,etal.Macrophagetropismofhumanimmunodeficiencyvirustype1isolatesfrombrainandlymphoidtis-suespredictsneurotropismindependentofcoreceptorspecificity.JVi-rol2001;75:10073?89.
	17.MengYX,SpiraTJ,BhatGJ,etal.IndividualsfromNorthAmerica,Australasia,andAfricaareinfectedwithfourdifferentgenotypesofhumanherpesvirus8.Virology1999;261:106?19.
	18.YunZ,FredrikssonE,SonnerborgA.Quantificationofhumanim-munodeficiencyvirustype1proviralDNAbytheTaqManreal-timePCRassay.JClinMicrobiol2002;40:3883?4.
	19.DittmerD,StoddartC,RenneR,etal.ExperimentaltransmissionofKaposi?ssarcoma?associatedherpesvirus(KSHV/HHV-8)toSCID-huThy/Livmice.JExpMed1999;190:1857?68.
	20.ZongJC,CiufoDM,AlcendorDJ,etal.High-levelvariabilityintheORF-K1membraneproteingeneattheleftendoftheKaposi?ssar-coma?associatedherpesvirusgenomedefinesfourmajorvirussubtypesandmultiplevariantsorcladesindifferenthumanpopulations.JVirol1999;73:4156?70.
	21.ThompsonJD,HigginsDG,GibsonTJ.CLUSTALW:improvingthesensitivityofprogressivemultiplesequencealignmentthroughse-quenceweighting,position-specificgappenaltiesandweightmatrixchoice.NucleicAcidsRes1994;22:4673?80.
	22.ZongJ,CiufoDM,ViscidiR,etal.GenotypicanalysisatmultiplelociacrossKaposi?ssarcomaherpesvirus(KSHV)DNAmolecules:clusteringpatterns,novelvariantsandchimerism.JClinVirol2002;23:119?48.
	23.StebbingJ,BourbouliaD,JohnsonM,etal.Kaposi?ssarcoma?as-sociatedherpesviruscytotoxicTlymphocytesrecognizeandtargetDar-winianpositivelyselectedautologousK1epitopes.JVirol2003;77:4306?14.
	24.CookPM,WhitbyD,CalabroML,etal.VariabilityandevolutionofKaposi?ssarcoma?associatedherpesvirusinEuropeandAfrica.Inter-nationalCollaborativeGroup.AIDS1999;13:1165?76.
	25.PlancoulaineS,AbelL,vanBeverenM,etal.Humanherpesvirus8transmissionfrommothertochildandbetweensiblingsinanendemicpopulation.Lancet2000;356:1062?5.
	26.FujisakiH,Tanaka-TayaK,TanabeH,etal.Detectionofhumanher-pesvirus7(HHV-7)DNAinbreastmilkbypolymerasechainreactionandprevalenceofHHV-7antibodyinbreast-fedandbottle-fedchil-dren.JMedVirol1998;56:275?9.
	27.HamprechtK,MaschmannJ,VochemM,DietzK,SpeerCP,JahnG.Epidemiologyoftransmissionofcytomegalovirusfrommothertopre-terminfantbybreastfeeding.Lancet2001;357:513?8.
	28.JunkerAK,ThomasEE,RadcliffeA,ForsythRB,DavidsonAG,RymoL.Epstein-Barrvirussheddinginbreastmilk.AmJMedSci1991;302:220?3.
	29.KotroniasD,KapranosN.DetectionofherpessimplexvirusDNAinmaternalbreastmilkbyinsituhybridizationwithtyramidesignalam-plification.InVivo1999;13:463?6.
	30.PeckhamCS,JohnsonC,AdesA,PearlK,ChinKS.Earlyacquisitionofcytomegalovirusinfection.ArchDisChild1987;62:780?5.
	31.DworskyM,YowM,StagnoS,PassRF,AlfordC.Cytomegalovirusinfectionofbreastmilkandtransmissionininfancy.Pediatrics1983;72:295?9.
	32.StagnoS,PassRF,DworskyME,BrittWJ,AlfordCA.Congenitalandperinatalcytomegalovirusinfections:clinicalcharacteristicsandpath-ogenicfactors.BirthDefectsOrigArticSer1984;20:65?85.
	33.FieldsBN,KnipeDM,HowleyPM.Fieldsvirology.3rded.Philadel-phia:Lippincott-Raven,1996.
	34.OgraPL,OgraSS.Cellularaspectsofimmunologicreactivityinhumanmilk:biologyofhumanmilk.NewYork:Nestleï¿½Nutrition;RavenPress,1988:171?184.
	35.PaukJ,HuangML,BrodieSJ,etal.Mucosalsheddingofhumanherpesvirus8inmen.NEnglJMed2000;343:1369?77.
	36.BlackbournDJ,LennetteE,KlenckeB,etal.Therestrictedcellularhostrangeofhumanherpesvirus8.AIDS2000;14:1123?33.
	37.MayJT.Microbialcontaminantsandantimicrobialpropertiesofhu-manmilk.MicrobiolSci1988;5:42?6.
	38.JohnGC,NduatiRW,Mbori-NgachaDA,etal.Correlatesofmother-to-childhumanimmunodeficiencyvirustype1(HIV-1)transmission:associationwithmaternalplasmaHIV-1RNAload,genitalHIV-1DNAshedding,andbreastinfections.JInfectDis2001;183:206?12.
	39.BlackbournDJ,LennetteET,AmbroziakJ,MourichDV,LevyJA.Hu-manherpesvirus8detectioninnasalsecretionsandsaliva.JInfectDis1998;177:213?6.
	40.LaDucaJR,LoveJL,AbbottLZ,DubeS,Freidman-KienAE,PoieszBJ.Detectionofhumanherpesvirus8DNAsequencesintissuesandbodilyfluids.JInfectDis1998;178:1610?5.
	41.AndreoniM,SarmatiL,NicastriE,etal.Primaryhumanherpesvirus8infectioninimmunocompetentchildren.JAMA2002;287:1295?300.
	42.CookRD,HodgsonTA,WaughAC,etal.Mixedpatternsoftrans-missionofhumanherpesvirus-8(Kaposi?ssarcoma?associatedher-pesvirus)inMalawianfamilies.JGenVirol2002;83:1613?19.
	43.AngeloniA,HestonL,UcciniS,etal.Highprevalenceofantibodiestohumanherpesvirus8inrelativesofpatientswithclassicKaposi?ssarcomafromSardinia.JInfectDis1998;177:1715?8.
J Infect Dis.-2004-Uhlemann-2227-34.pdf	37
	1.RosenGM,PouS,RamosCL,CohenMS,BritiganBE.Freeradicalsandphagocyticcells.FASEBJ1995;9:200?9.
	2.ReevesEP,LuH,JacobsHL,etal.KillingactivityofneutrophilsismediatedthroughactivationofproteasesbyK+flux.Nature2002;416:291?7.
	3.NewburgerPE,SkalnikDG,HopkinsPJ,EklundEA,CurnutteJT.Mutationsinthepromoterregionofthegeneforgp91-phoxinX-linkedchronicgranulomatousdiseasewithdecreasedexpressionofcy-tochromeb558.JClinInvest1994;94:1205?11.
	4.SunT,ChakrabartiC.Schizonts,merozoites,andphagocytosisinfal-ciparummalaria.AnnClinLabSci1985;15:465?9.
	5.KumaratilakeLM,FerranteA.T-cellcytokinesinmalaria:theirroleintheregulationofneutrophil-andmacrophage-mediatedkillingofPlasmodiumfalciparumasexualbloodforms.ResImmunol1994;145:423?9.
	6.BrownJ,SmalleyME.InhibitionoftheinvitrogrowthofPlasmodiumfalciparumbyhumanpolymorphonuclearneutrophilleucocytes.ClinExpImmunol1981;46:106?9.
	7.CeladaA,CruchaudA,PerrinLH.PhagocytosisofPlasmodiumfalci-parum?parasitizederythrocytesbyhumanpolymorphonuclearleu-kocytes.JParasitol1983;69:49?53.
	8.KharazmiA,JepsenS.EnhancedinhibitionofinvitromultiplicationofPlasmodiumfalciparumbystimulatedhumanpolymorphonuclearleucocytes.ClinExpImmunol1984;57:287?92.
	9.ClarkIA,HuntNH.Evidenceforreactiveoxygenintermediatescausinghemolysisandparasitedeathinmalaria.InfectImmun1983;39:1?6.
	10.KharazmiA,JepsenS,AndersenBJ.GenerationofreactiveoxygenradicalsbyhumanphagocyticcellsactivatedbyPlasmodiumfalciparum.ScandJImmunol1987;25:335?41.
	11.GreveB,KremsnerPG,LellB,LucknerD,SchmidD.MalarialanaemiainAfricanchildrenassociatedwithhighoxygen-radicalproduction.Lancet2000;355:40?1.
	12.GreveB,LehmanLG,LellB,LucknerD,Schmidt-OttR,KremsnerPG.HighoxygenradicalproductionisassociatedwithfastparasiteclearanceinchildrenwithPlasmodiumfalciparummalaria.JInfectDis1999;179:1584?6.
	13.GlabinskiA,TawsekNS,BartoszG.IncreasedgenerationofsuperoxideradicalsinthebloodofMSpatients.ActaNeurolScand1993;88:174?7.
	14.KunJF,Schmidt-OttRJ,LehmanLG,etal.Merozoitesurfaceantigen1and2genotypingandrosettingofPlasmodiumfalciparuminsevereversusmildmalariainLambareï¿½neï¿½,Gabon.TransRSocTropMedHyg1998;92:110?4.
	15.WarrellDA,MolyneuxME,BealesPF.Severeandcomplicatedmalaria.TransRSocTropMedHyg1990;84(Suppl2):1?65.
	16.CooperG,AmosW,HoffmanD,RubinszteinD.NetworkanalysisofhumanYmicrosatellitehaplotypes.HumMolGenet1996;5:1759?66.
	17.TsuchiyaS,YamabeM,YamaguchiY,KobayashiY,KonnoT,TadaK.Establishmentandcharacterizationofahumanacutemonocyticleu-kemiacellline(THP-1).IntJCancer1980;26:171?6.
	18.DahlgrenC,KarlssonA.Respiratoryburstinhumanneutrophils.JImmunolMethods1999;232:3?14.
	19.RaymondM,RoussetF.Anexacttestforpopulationdifferentiation.Evolution1995;49:1280?3.
	20.NeiM.Molecularevolutionarygenetics.NewYork:ColumbiaUni-versityPress,1987:183.
	21.ShamPC,CurtisD.MonteCarlotestsforassociationsbetweendiseaseandallelesathighlypolymorphicloci.AnnHumGenet1995;59:97?105.
	22.KunJF,Mordmuï¿½llerB,LellB,LehmanLG,LucknerD,KremsnerPG.Polymorphisminthepromoterregionoftheinduciblenitricoxidesynthasegeneandprotectionagainstmalaria.Lancet1998;351:265?6.
	23.EskdaleJ,GallagherG,VerweijCL,KeijsersV,WestendorpRG,Hui-zingaTW.Interleukin10secretioninrelationtohumanIL-10locushaplotypes.ProcNatlAcadSciUSA1998;95:9465?70.
	24.ChambersGK,MacAvoyES.Microsatellites:consensusandcontro-versy.CompBiochemPhysiolBBiochemMolBiol2000;126:455?76.
	25.LiYC,KorolAB,FahimaT,BeilesA,NevoE.Microsatellites:genomicdistribution,putativefunctionsandmutationalmechanisms:areview.MolEcol2002;11:2453?65.
	26.BeutlerE,GelbartT,DeminaA.RacialvariabilityintheUDP-glu-curonosyltransferase1(UGT1A1)promoter:abalancedpolymorphismforregulationofbilirubinmetabolism?ProcNatlAcadSciUSA1998;95:8170?4.
	27.FerrandPE,ParryS,SammelM,etal.Apolymorphisminthematrixmetalloproteinase?9promoterisassociatedwithincreasedriskofpre-termprematureruptureofmembranesinAfricanAmericans.MolHumReprod2002;8:494?501.
	28.ChenYH,LinSJ,LinMW,etal.Microsatellitepolymorphisminpromoterofhemeoxygenase?1geneisassociatedwithsusceptibilitytocoronaryarterydiseaseintype2diabeticpatients.HumGenet2002;111:1?8.
	29.WarpehaKM,XuW,LiuL,etal.Genotypingandfunctionalanalysisofapolymorphic(CCTTT)(n)repeatofNOS2Aindiabeticretinop-athy.FASEBJ1999;13:1825?32.
	30.MaedaS,HanedaM,GuoB,etal.Dinucleotiderepeatpolymorphismofmatrixmetalloproteinase?9geneisassociatedwithdiabeticnephrop-athy.KidneyInt2001;60:1428?34.
	31.Kraï¿½merH,Niemoï¿½llerM,AmouyalM,RevetB,vonWilcken-BergmannB,Muï¿½ller-HillB.LacrepressorformsloopswithlinearDNAcarryingtwosuitablyspacedlacoperators.EMBOJ1987;6:1481?91.
	32.MossingMC,RecordMTJr.Upstreamoperatorsenhancerepressionofthelacpromoter.Science1986;233:889?92.
	33.LewisDE,AdhyaS.InvitrorepressionofthegalpromotersbyGalRandHUdependsontheproperhelicalphasingofthetwooperators.JBiolChem2002;277:2498?2504.
	34.JeffreysAJ,BarberR,BoisP,etal.Humanminisatellites,repeatDNAinstabilityandmeioticrecombination.Electrophoresis1999;20:1665?75.
	35.KunJFJ,KlabundeJ,LellB,etal.AssociationoftheIcam-1KilifimutationwithprotectionagainstseveremalariainLambareï¿½neï¿½,Gabon.AmJTropMedHyg1999;61:776?9.
	36.ArmourJA,AnttinenT,MayCA,etal.MinisatellitediversitysupportsarecentAfricanoriginformodernhumans.NatGenet1996;13:154?60.
	37.SteadJD,JeffreysAJ.StructuralanalysisofinsulinminisatelliteallelesrevealsunusuallylargedifferencesindiversitybetweenAfricansandnon-Africans.AmJHumGenet2002;71:1273?84.
4506cr2.pdf	10
	1.Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms?tumor: results from the First National Wilms? Tumor study. Cancer1978; 41:1937-48.
	2.Rorke LB, Parker RJ, Biegel JA. Central nervous system atypicalteratoid/rhabdoid tumours of the infancy and childhood: definition ofan entity. J Neurosurg 1996; 85:56-65.
	3.Caldemeyer KS, Smith RR, Azzarelli B, Boaz JC. Primary centralnervous system malignant rhabdoid tumour: CT and MR appearancestimulates a primitive neuroectodermal tumour. Pediatr Neurosurg1994; 21:232-6.
	4.Chung YN, Wang KC, Shin SH, Kim N, Chi JG, Min KS, et al.Primary intracranial atypical teratoid/rhabdoid tumor in a child:a case report. J Korean Med Sci 2002; 17:723-6.
	5.Evans A, Ganatra R, Morris SJ. Imaging features of primary malignantrhabdoid tumour of the brain. Pediatr Radiol 2001; 31:631-3.
	6.Yoon CS, Chuang S, Jay V. Primary malignant rhabdoid tumor of thebrain : CT and MR findings. Yonsei Med J 2000; 41:8-16.
	7.Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G,Burger PC, et al. The WHO classification of tumors of the nervoussystem. J Neuropathol Exp Neurol 2002; 61:215-25.
	8.Biegel JA, Rorke LB, Packer RJ, Emanuel BS. Monosomy 22 inrhabdoid or atypical teratoid tumour of the brain. J Neurosurg 1990;73:710-4.
	9.Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM,Fogelgren B. Germ-line and acquired mutations of INI1 in atypicalteratoid and rhabdoid tumours. Cancer Res 1999; 59:74-9.
	10.Ronghe MD, Moss TH, Lowis SP. Treatment of CNS malignantrhabdoid tumors. Pediatr Blood Cancer 2004; 42:254-60.
4401462a.pdf	50
	1.NakabeppuY,RyderKandNathansD(1988)DNAbindingactivitiesofthreemurineJunproteins:stimulationbyFos.Cell55:907?915
	2.ChinenovYandKerppolaTK(2001)Closeencountersofmanykinds:Fos?Juninteractionsthatmediatetranscriptionregulatoryspecificity.Oncogene20:2438?2452
	3.JochumW,Passegueï¿½EandWagnerEF(2001)AP-1inmousedevelopmentandtumorigenesis.Oncogene20:2401?2412
	4.ShaulianEandKarinM(2001)AP-1incellproliferationandsurvival.Oncogene20:2390?2400
	5.NakabeppuYandNathansD(1991)AnaturallyoccurringtruncatedformofFosBthatinhibitsFos/Juntranscriptionalactivity.Cell64:751?759
	6.NishiokaT,SakumiK,MiuraT,TaharaK,HorieH,KadoyaTandNakabeppuY(2002)FosBgeneproductstriggercellproliferationandmorphologicalalterationwithanincreasedexpressionofanovelprocessedformofgalectin-1intherat3Y1embryocellline.J.Biochem.(Tokyo)131:653?661
	7.TaharaK,TsuchimotoD,TominagaY,AsohS,OhtaS,KitagawaM,HorieH,KadoyaTandNakabeppuY(2003)DeltaFosB,butnotFosB,inducesdelayedapoptosisindependentofcellproliferationintheRat1aembryocellline.CellDeathDiffer.10:496?507
	8.BarondesSH,CastronovoV,CooperDN,CummingsRD,DrickamerK,FeiziT,GittMA,HirabayashiJ,HughesC,KasaiK,LefflerH,LiuF-T,LotanR,MercurioAM,MonsignyM,PillaiS,PoirierF,RazA,RigbyPW,RiniJMandWangJL(1994)Galectins:afamilyofanimalbeta-galactoside-bindinglectins.Cell76:597?598
	9.deWaardA,HickmanSandKornfeldS(1976)Isolationandpropertiesofbeta-galactosidebindinglectinsofcalfheartandlung.J.Biol.Chem.251:7581?7587
	10.PoirierF,TimmonsPM,ChanCT,Gueï¿½netJLandRigbyPW(1992)ExpressionoftheL14lectinduringmouseembryogenesissuggestsmultiplerolesduringpre-andpost-implantationdevelopment.Development115:143?155
	11.AllenHJ,GottstineS,SharmaA,DiCioccioRA,SwankRTandLiH(1991)Synthesis,isolation,andcharacterizationofendogenousbeta-galactoside-bindinglectinsinhumanleukocytes.Biochemistry30:8904?8910
	12.LeviGandTeichbergVI(1984)Thedistributionofelectrolectininmouse:geneticandontogenicvariations.Biochem.Biophys.Res.Commun.119:801?806
	13.CattJW,HarrisonFLandCarletonJS(1987)Distributionofanendogenousbeta-galactoside-specificlectinduringfoetalandneonatalrabbitdevelopment.J.Cell.Sci.87(Part5):623?633
	14.PowellJT(1980)Purificationandpropertiesoflunglectin.Ratlungandhumanlungbeta-galactoside-bindingproteins.Biochem.J.187:123?129
	15.HirabayashiJandKasaiK(1984)Humanplacentabeta-galactoside-bindinglectin.Purificationandsomeproperties.Biochem.Biophys.Res.Commun.122:938?944
	16.AllenHJ,SucatoD,WoynarowskaB,GottstineS,SharmaAandBernackiRJ(1990)Roleofgalaptininovariancarcinomaadhesiontoextracellularmatrixinvitro.J.Cell.Biochem.43:43?57
	17.WellsVandMallucciL(1991)Identificationofanautocrinenegativegrowthfactor:mousebeta-galactoside-bindingproteinisacytostaticfactorandcellgrowthregulator.Cell64:91?97
	18.PerilloNL,PaceKE,SeilhamerJJandBaumLG(1995)ApoptosisofTcellsmediatedbygalectin-1.Nature378:736?739
	19.PerilloNL,UittenbogaartCH,NguyenJTandBaumLG(1997)Galectin-1,anendogenouslectinproducedbythymicepithelialcells,inducesapoptosisofhumanthymocytes.J.Exp.Med.185:1851?1858
	20.PazA,HaklaiR,Elad-SfadiaG,BallanEandKloogY(2001)Galectin-1bindsoncogenicH-RastomediateRasmembraneanchorageandcelltransformation.Oncogene20:7486?7493
	21.Elad-SfadiaG,HaklaiR,BallanE,GabiusHJandKloogY(2002)Galectin-1augmentsRasactivationanddivertsRassignalstoRaf-1attheexpenseofphosphoinositide3-kinase.J.Biol.Chem.277:37169?37175
	22.VyakarnamA,LennemanAJ,LakkidesKM,PattersonRJandWangJL(1998)Acomparativenuclearlocalizationstudyofgalectin-1withothersplicingcomponents.Exp.Cell.Res.242:419?428
	23.ParkJW,VossPG,GrabskiS,WangJLandPattersonRJ(2001)Associationofgalectin-1andgalectin-3withGemin4incomplexescontainingtheSMNprotein.NucleicAcidsRes.29:3595?3602
	24.ClerchLB,WhitneyP,HassM,BrewK,MillerT,WernerRandMassaroD(1988)Sequenceofafull-lengthcDNAforratlungbeta-galactoside-bindingprotein:primaryandsecondarystructureofthelectin.Biochemistry27:692?699
	25.LiaoDI,KapadiaG,AhmedH,VastaGRandHerzbergO(1994)StructureofS-lectin,adevelopmentallyregulatedvertebratebeta-galactoside-bindingprotein.Proc.Natl.Acad.Sci.USA91:1428?1432
	26.BourneY,BolgianoB,Neï¿½saMP,PenfoldP,JohnsonD,FeiziTandCambillauC(1994)CrystallizationandpreliminaryX-raydiffractionstudiesofthesoluble14kDabeta-galactoside-bindinglectinfrombovineheart.J.Mol.Biol.235:787?789
	27.HorieH,InagakiY,SohmaY,NozawaR,OkawaK,HasegawaM,MuramatsuN,KawanoH,HorieM,KoyamaH,SakaiI,TakeshitaK,KowadaY,TakanoMandKadoyaT(1999)Galectin-1regulatesinitialaxonalgrowthinperipheralnervesafteraxotomy.J.Neurosci.19:9964?9974
	28.HorieHandKadoyaT(2000)Identificationofoxidizedgalectin-1asaninitialrepairregulatoryfactorafteraxotomyinperipheralnerves.Neurosci.Res.38:131?137
	29.InagakiY,SohmaY,HorieH,NozawaRandKadoyaT(2000)Oxidizedgalectin-1promotesaxonalregenerationinperipheralnervesbutdoesnotpossesslectinproperties.Eur.J.Biochem.267:2955?2964Galectin-1bpromotesaxonalregeneration
	30.ChoMandCummingsRD(1996)Characterizationofmonomericformsofgalectin-1generatedbysite-directedmutagenesis.Biochemistry35:13081?13088
	31.YangJT,WuCSandMartinezHM(1986)Calculationofproteinconformationfromcirculardichroism.MethodsEnzymol.130:208?269
	32.JohnsonJrWC(1990)Proteinsecondarystructureandcirculardichroism:apracticalguide.Proteins7:205?214
	33.BarondesSH,CooperDN,GittMAandLefflerH(1994)Galectins.Structureandfunctionofalargefamilyofanimallectins.J.Biol.Chem.269:20807?20810
	34.LakowicsJR(1999)PrinciplesofFluorescenceSpectroscopy,2nded.NewYork:Plenumpublisherspp456?458
	35.ChoMandCummingsRD(1995)Galectin-1,abeta-galactoside-bindinglectininChinesehamsterovarycells.I.Physicalandchemicalcharacterization.J.Biol.Chem.270:5198?5206
	36.FouillitM,Leï¿½vi-StraussM,GiudicelliV,LutomskiD,BladierD,CaronMandJoubert-CaronR(1998)Affinitypurificationandcharacterizationofrecombinanthumangalectin-1.J.Chromatogr.BBiomed.Sci.Appl.706:167?171
	37.WalzelH,SchulzU,NeelsPandBrockJ(1999)Galectin-1,anaturalligandforthereceptor-typeproteintyrosinephosphataseCD45.Immunol.Lett.67:193?202
	38.Fajka-BojaR,SzemesM,IonG,Leï¿½graï¿½diA,CaronMandMonostoriE(2002)Receptortyrosinephosphatase,CD45bindsgalectin-1butdoesnotmediateitsapoptoticsignalinTcelllines.Immunol.Lett.82:149?154
	39.GiudicelliV,LutomskiD,Leï¿½vi-StraussM,BladierD,Joubert-CaronRandCaronM(1997)Ishumangalectin-1activitymodulatedbymonomer/dimerequilibrium?Glycobiology7viii?x
	40.TraceyBM,FeiziT,AbbottWM,CarruthersRA,GreenBNandLawsonAM(1992)Subunitmolecularmassassignmentof14,654Datothesolublebeta-galactoside-bindinglectinfrombovineheartmuscleanddemonstrationofintramoleculardisulfidebondingassociatedwithoxidativeinactivation.J.Biol.Chem.267:10342?10347
	41.ImbeH,OkamotoK,KadoyaT,HorieHandSenbaE(2003)Galectin-1isinvolvedinthepotentiationofneuropathicpaininthedorsalhorn.BrainRes.993:72?83
	42.HorieH,KadoyaT,HikawaN,SangoK,InoueH,TakeshitaK,AsawaR,HiroiT,SatoM,YoshiokaTandIshikawaY(2004)Oxidizedgalectin-1stimulatesmacrophagestopromoteaxonalregenerationinperipheralnervesafteraxotomy.J.Neurosci.24:1873?1880
	43.McGahanL,HakimAM,NakabeppuYandRobertsonGS(1998)Ischemia-inducedCA1neuronaldeathisprecededbyelevatedFosBandJunexpressionandreducedNGFI-AandJunBlevels.BrainRes.Mol.BrainRes.56:146?161
	44.HopeBT,NyeHE,KelzMB,SelfDW,IadarolaMJ,NakabeppuY,DumanRSandNestlerEJ(1994)Inductionofalong-lastingAP-1complexcomposedofalteredFos-likeproteinsinbrainbychroniccocaineandotherchronictreatments.Neuron13:1235?1244
	45.ChenJ,NyeHE,KelzMB,HiroiN,NakabeppuY,HopeBTandNestlerEJ(1995)RegulationofdeltaFosBandFosB-likeproteinsbyelectroconvulsiveseizureandcocainetreatments.Mol.Pharmacol.48:880?889
	46.HiranoS,TominagaY,IchinoeA,UshijimaY,TsuchimotoD,Honda-OhnishiY,OhtsuboT,SakumiKandNakabeppuY(2003)MutatorphenotypeofMUTYH-nullmouseembryonicstemcells.J.Biol.Chem.278:38121?38124
	47.StudierFW,RosenbergAH,DunnJJandDubendorffJW(1990)UseofT7RNApolymerasetodirectexpressionofclonedgenes.MethodsEnzymol.185:60?89
	48.BladierD,JoubertR,Avellana-AdalidV,KemenyJL,DoinelC,AmourouxJandCaronM(1989)Purificationandcharacterizationofagalactoside-bindinglectinfromhumanbrain.Arch.Biochem.Biophys.269:433?439
	49.HorieH,SakaiI,AkahoriYandKadoyaT(1997)IL-1betaenhancesneuriteregenerationfromtransected-nerveterminalsofadultratDRG.NeuroReport8:1955?1959
	50.MartzE(2002)Proteinexplorer:easyyetpowerfulmacromolecularvisualization.TrendsBiochem.Sci.27:107?109
3800168a.pdf	112
	1EricksonPF,RobinsonM,OwensG,etal.TheETOportionofacutemyeloidleukemiat(8;21)fusiontranscriptencodesahighlyevolutionarilyconserved,putativetranscriptionfactor.CancerRes1994;54:1782?1786.
	2LutterbachB,WestendorfJJ,LinggiB,etal.ETO,atargetoft(8;21)inacuteleukemia,interactswiththeN-CoRandmSin3corepressors.MolCellBiol1998;18:7176?7184.
	3MeyersS,LennyN,HiebertSW.Thet(8;21)fusionproteininterferswithAML-1-B-dependanttranscrip-tionalactivation.MolCellBiol1995;15:1974?1982.
	4YuanY,ZhouL,MiamotoT,etal.AML-ETOexpres-sionisdirectlyinvolvedinthedevelopmentofacutemyeloidleukemiainthepresenceofadditionalmutations.ProcNatlAcadSciUSA2001;98:10398?10403.
	5HarrisNL,JaffeES,DieboldJ,etal.WorldHealthOrganizationClassificationofneoplasticdiseasesofthehematopoieticandlymphoidtissues.JClinOncol1999;17:3835?3849.
	6AndrieuV,Radford-WeissI,TroussardX,etal.Moleculardetectionoft(8;21)/AML1-ETOinAMLM1/M2:correlationwithcytogenetics,morphologyandimmunophenotype.BrJHaematol1996;92:855?865.
	7ByrdJC,WeissRB.Recurrentgranulocyticsarcoma.Anunusualvariationofacutemyelogenousleukemiaassociatedwith8;21chromosomaltranslocationandblastexpressionofneuralcelladhesionmolecule.Cancer1994;15:2107?2112.
	8BloomfieldCD,LawrenceD,ByrdJC,etal.Frequencyofprolongedremissiondurationafterhigh-dosecytar-abineintensificationinacutemyeloidleukemiavariesbycytogeneticsubtype.CancerRes1998;58:4173?4179.
	9NuciforaG,DicksteinJI,TorbensonV,etal.CorrelationbetweencellmorphologyandexpressionoftheAML1/ETOchimerictranscriptinpatientswithacutemye-loidleukemiawithoutthet(8;21).Leukemia1994;8:1533?1538.
	10HaferlachT,BennettJM,LofflerH,etal.Acutemyeloidleukemiawithtranslocation(8;21).Cytomor-phology,dysplasiaandprognosticfactorsin41cases.LeukLymphoma1996;23:227?234.
	11HurwitzCA,RaimondiSC,HeadD,etal.Distinctiveimmunophenotypicfeaturesoft(8;21)(q22;q22)acutet(8;21)AMLimmunophenotypeHKhouryetalmyeloblasticleukemiainchildren.Blood1992;80:3182?3188.
	12KitaK,NakaseK,MiwaH,etal.Phenotypicalcharacteristicsofacutemyelocyticleukemiaasso-ciatedwitht(8;21)chromosomalabnormality:frequentexpressionofimmatureB-cellantigenstogetherwithstemcellantigenCD34.Blood1992;80:470?477.
	13Porwit-MacDonaldA,JanossyG,IvoryK,etal.Leukemiaassociatedchangesidentifiedbyquantita-tiveflowcytometry.IV.CD34overexpressioninacutemyelogenousleukemiaM2witht(8;21).Blood1996;87:1162?1169.
	14KhouryH,DalalBI,NevillTJ,etal.Acutemyelogen-ousleukemia(AML)witht(8;21)-identificationofaspecificimmunophenotype.LeukLymphoma2003;44:1713?1718.
	15TaberneroMD,BortoluciAM,AlaejosI,etal.AdultB-ALLwithBCR/ABLgenerearrangementdisplaysauniqueimmunophenotypebasedonthepatternofCD10,CD34,Cd13andCD38expression.Leukemia2001;15:406?414.
	16DeZenL,OrfaoA,CazzangiaG,etal.Quantitativemultiparametricimmunophenotypinginacutelym-phoidleukemia:correlationwithspecificgenotype.I.ETV6/AML1ALLsidentification.Leukemia2000;14:1225?1231.
	17Lavabre-BertrandT,JanossyG,IvoryK,etal.Leuke-mia-associatedchangesidentifiedbyquantitativeflowcytometry:I.CD10expression.Cytometry1994;18:209?217.
	18FarahatN,LensD,ZomasA,etal.QuantitativeflowcytometrycandistinguishbetweennormalandleukemicB-cellprecursors.BrJHaematol1995;91:640?646.
	19DworzakMN,FritschG,FleischerC,etal.Compara-tivephenotypemappingofnormalvsmalignantpediatricB-lymphopoiesisunveilsleukemia-asso-ciatedaberrations.ExpHematol.1998;26:305?313.
	20LubbertM,HerrmannF,KoefflerPh.Expressionandregulationofmyeloid-specificgenesinnormalandleukemicmyeloidcells.Blood1991;77:909?924.
	21BennettJM,CatovskyD,DanielMT,etal.Proposedrevisedcriteriaforclassificationofacutemyeloidleukemia.AnnInternMed1985;103:621?625.
	22MitelmanF,ed.ISCN,AnInternationalSystemforHumanCytogeneticNomenclature.Basel:S.Kargar,1995.
	23BreimanL,FriedmanJH,OlshenR,etal.ClassificationandRegressionTrees.Belmont,CA:WadsworthInter-nationalGroup,1984.
	24MortonRF,HebelJR(eds).Screening.In:AStudyGuidetoEpidemiologyandBiostatics,2ndedn.Gaithersburg,MD:AnAspenPublishers,1990,pp63?81.
	25DowningJR.TheAML1-ETOchimericproteintran-scriptionfactorinacutemyeloidleukemia:biologyandclinicalsignificance.BrJHaematol1999;106:296?308.
	26OkudaT,CaiZ,YangS,etal.Expressionofknock-inAML1-ETOleukemiageneinhibitstheestablishmentofnormaldefinitivehematopoiesisanddirectlygen-eratesdysplastichematopoieticprogenitors.Blood1998;91:3134?3143.
	27TsuchiyaH,ElsonbatySS,NganoK,etal.AcutevariantexpressinglymphoidsurfaceantigenswithhighnumberofG-CSFreceptors.LeukRes1993;17:375?377.
	28SamdaniA,VijapurkarU,GrimmMA,etal.Cytoge-neticandP-glycoprotein(PGP)areindependentpre-dictorsoftreatmentoutcomeinacutemyeloidleukemia(AML).LeukRes1996;20:175?180.
	29RhoadesKL,HetheringtonCJ,RowleyJD,etal.Synergisticup-regulationofthemyeloid-specificpro-moterforthemacrophagecolony-stimulatingfactorreceptorbyAML1andthet(8;21)fusionproteinmaycontributetoleukemogenesis.ProcNatlAcadSciUSA1996;93:11895?11900.
	30MitterbauerM,KusecR,SchwarzingerI,etal.ComparisonofkaryotypeanalysisandRT-PCRforAML1/ETOin204unselectedpatientswithAML.AnnHematol1998;76:139?143.
	31RoweD,CotterillSJ,RossFM,etal.CytogeneticallycrypticAML1-ETOandCBFb-MYH11generearrange-ments:incidencein412casesofacutemyeloidleukemia.BrJHaematol2000;111:1051?1056.
	32GrimwadeD,WalkerH,OliverF,etal.TheimportanceofdiagnosticcytogeneticsonoutcomeinAML:analysisof1,612patientsenteredintotheMRCAML10trial.TheMedicalResearchCouncilAdultandChildren?sLeukaemiaWorkingParties.Blood1998;92:2322?2333.
	33StroblH,TakimotoM,MajidicO,etal.Myeloperox-idaseexpressioninCD34+normalhematopoieticcells.Blood1993;82:2069?2078.
1017223.pdf	15
1017347.pdf	36
Age Ageing-2004-Myint-320.pdf	5
Age Ageing-2004-Lam-307-9.pdf	9
Age Ageing-2004-Bennett-230-5.pdf	38
	1.Touche R. The Cost of Pressure Sores. Report to the Depart-ment of Health. London: Department of Health, 1993. 
	2.Health Council of the Netherlands. Pressure Ulcers. TheHague: Health Council of the Netherlands, Publication No1999/23, 1999. 
	3.Netten A, Curtis L. Unit Costs of Health and Social Care 2000.Canterbury: Personal Social Services Research Unit, Universityof Kent at Canterbury, 2000. 
	4.Department of Health. Drug Tariff. London: The StationeryOfWce, 2000. 
	5.British National Formulary. London: British Medical Associ-ation and Royal Pharmaceutical Society of Great Britain, 2000. 
	6.Gerding GA, Browning JS. Oxyquinoline-containing ointmentvs standard therapy for stage I and stage II skin lesions.Dermatol Nurs 1992; 4: 389?8. 
	7.Bale S, Squires D, Varnon T, Walker A, Benbow M, HardingKG. A comparison of two dressings in pressure sore man-agement. J Wound Care 1997; 6: 463?6. 235
	8.Thomas S, Banks V, Bale S et al. A comparison of two dress-ings in the management of chronic wounds. J Wound Care1997; 6: 383?6. 
	9.Berlowitz D, Van B Wilking S. The short term outcome ofpressure sores. J Am Geriatr Soc 1990; 38: 748?52. 
	10.Bale S, Hagelstein S, Banks V, Harding KG. Costs of dressingsin the community. J Wound Care 1998; 7: 327?30. 
	11.Motta G, Dunham L, Dye T, Mentz J, O?Connell-Gifford E,Smith E. Clinical efWcacy and cost-effectiveness of a newsynthetic polymer sheet wound dressing. Ostomy/WoundManage 1999; 45: 41?9. 
	12.Sebern MD. Pressure ulcer management in home health care:efWcacy and cost effectiveness of moisture vapor permeabledressing. Arch Phys Med Rehabil 1986; 67: 726?9. 
	13.Brandeis GH, Morris JN, Nash DJ, Lipsitz LA. The epi-demiology and natural history of pressure ulcers in elderlynursing home residents. JAMA 1990; 264: 2905?9. 
	14.Burgos A, Gimenez J, Moreno E et al. Cost, efWcacy, efWciencyand tolerability of collagenese ointment versus hydrocolloidocclusive dressing in the treatment of pressure ulcers. ClinDrug Invest 2000; 19: 357?65. 
	15.Kraft MR, Lawson L, Pohlmann B, Reid-Lokos C, Barder L. Acomparison of Epi-Lock and saline dressings in the treatmentof pressure ulcers. Decubitis 1993; 6: 42?48. 
	16.Xakellis GC, Chrischilles EA. Hydrocolloid versus saline-gauze dressings in treating pressure ulcers: a cost-effectivenessanalysis. Arch Phys Med Rehabil 1992; 73: 463?9. 
	17.Xakellis GC, Franz R. The cost of healing pressure ulcersacross multiple health care settings. Adv Wound Care 1996; 9:18?22. 
	18.Clark M, Watts S. The incidence of pressure sores within aNational Health Service Trust hospital during 1991. J AdvNurs 1994; 20: 33?36. 
	19.Martin BJ, Devine BL, MacDonald JB et al. Incidence of pres-sure sores in geriatric long-term hospital care. J Tissue Viabil-ity 1995; 5: 83?87. 
	20.Potter MS. Incidence of pressure sores in nursing homepatients. J Wound Care 1994; 3: 37?41. 
	21.Davis CM, Caseby NG. Prevalence and incidence studies ofpressure ulcers in two long-term care facilities in Canada.Ostomy/Wound Manag 2001; 47: 28?34. 
	22.Department of Health. Community Care Statistics 2000.London: Department of Health, Statistical Bulletin 28, 2000. 
	23.Inman C, Firth JR. Pressure sore prevalence in the com-munity. Prof Nurse 1998; 13: 515?20. 
	24.Torrance C, Naylor M. Pressure sore survey: Part 1. J WoundCare 1999; 8: 27?30. 
	25.Margolis DJ, Bilker W, Knauss J, Baumgarten M, Strom BL.The incidence and prevalence of pressure ulcers among elderlypatients in general medical practice. Ann Epidemiol 2002; 12:321?5. 
	26.O?Dea K. The prevalence of pressure damage in acute carehospital patients in the UK. J Wound Care 1999; 8: 192?4. 
	27.Dealey C. Monitoring the pressure sore problem in a teachinghospital. J Adv Nurs 1994; 20: 652?9. 
	28.Nyquist R, Hawthorn PJ. The prevalence of pressure soreswithin an area health authority. J Adv Nurs 1987; 12: 183?7. 
	29.Clough NP. The cost of pressure area management in anintensive care unit. J Wound Care 1994; 3: 33?35. 
	30.Thompson JS, Brooks RG. The economics of preventing andtreating pressure ulcers: a pilot study. J Wound Care 1999; 8:312?16. 
	31.Hirshberg J, Rees RS, Marchant B, Dean S. Osteomyelitisrelated to pressure ulcers: the cost of neglect. Adv SkinWound Care 2000; 13: 25?29. 
	32.Allman RM, Goode PS, Burst N, Bartolucci AA, Thomas DR.Pressure ulcers, hospital complications and disease severity:impact on hospital costs and length of stay. Adv Wound Care1999; 12: 22?30. 
	33.Rees RS, Hirshberg J. Wound care centres: costs, care andstrategies. Adv Wound Care 1999; 12 (Supp): 4?7. 
	34.Department of Health. NHS Annual Report 2000/2001.London: Department of Health, 2001. 
	35.United Nations. World Population Prospects. London: UnitedNations (Annual). 
	36.Bennett RG, O?Sullivan J, DeVito EM, Remsburg R. Theincreasing medical malpractice risk related to pressure ulcers inthe United States. J Am Geriatr Soc 2000; 48: 73?81. 
	37.National Audit OfWce. Handling Clinical Negligence Claims inEngland. Report by the Comptroller and Auditor General, HC403 Session 2000?2001. London: Stationery OfWce, 2001. 
	38.Tingle J. Pressure sores: counting the legal cost of nursingneglect. Br J Nurs 1997; 6: 757?8.
Age Ageing-2004-Youngman-406-7.pdf	5
0810.pdf	24
	1.Avant,T.2002.It?salive.Sci.Teach.69:42?44.2.Bozzola,J.J.,andL.D.Russell.1999.Electronmicroscopy:principlesandtechniquesforbiologists,2nded.,p.19?2
	2.JonesandBartlettPublishers,Sudbury,Mass.
	3.Dahlback,B.,M.Hermansson,S.Kjelleberg,andB.Norkrans.1981.Thehydrophobicityofbacteria?animportantfactorintheirinitialadhesionattheair-waterinterface.Arch.Microbiol.128:267?270.
	4.Dahlberg,C.,C.Linberg,V.L.Torsvik,andM.Hermansson.1997.Conju-gativeplasmidsforbacteriainmarineenvironmentsshowvariousdegreesofhomologytoeachotherandarenotcloselyrelatedtowell-characterizedplasmids.Appl.Environ.Microbiol.63:4692?4697.
	5.Derrick,K.S.,andR.H.Brlansky.1976.Assayforvirusesandmycoplasmasusingserologicallyspecificelectronmicroscopy.Phytopathology66:815?820.
	6.Don,R.H.,P.T.Cox,B.J.Wainwright,K.Baker,andJ.S.Mattick.1991.?Touchdown?PCRtocircumventspuriousprimingduringgeneamplifica-tion.NucleicAcidsRes.19:4008.
	7.Fuerst,J.A.,A.McGregor,andM.R.Dickson.1987.Negativestainingoffresh-waterbacterioneustonsampleddirectlywithelectron-microscopespec-imensupportgrids.Microb.Ecol.13:219?228.
	8.Glockner,F.O.,H.-D.Babenzein,andR.Amann.1998.PhylogenyandidentificationinsituofNevskiaramosa.Appl.Environ.Microbiol.64:1895?1901.
	9.Hermansson,M.1990.Thedynamicsofdissolvedandparticulateorganicmaterialinsurfacemicrolayers,p.145?159.InR.S.Wotton(ed.),Thebiologyofparticlesinaquaticsystems.CRCPress,BocaRaton,Fla.
	10.Hermansson,M.,andCristelLinberg.1994.Genetransferinthemarineenvironment.FEMSMicrobiol.Ecol.15:47?54.
	11.Jones,G.W.,L.Baines,andF.J.Genthner.1991.Heterotrophicbacteriaofthefreshwaterneustonandtheirabilitytoactasplasmidrecipientsundernutrientdeprivedconditions.Microb.Ecol.22:15?26.
	12.MacGregor,B.J.1999.Molecularapproachestothestudyofaquaticmi-crobialcommunities.Curr.Opin.Biotechnol.10:220?224.
	13.Monger,B.C.,M.R.Landry,andS.L.Brown.1999.Feedingselectionofheterotrophicmarinenanoflagellatesbasedonthesurfacehydrophobicityoftheirpicoplanktonprey.Limnol.Oceanogr.44:1917?1927.
	14.Neu,T.1996.Significanceofbacterialsurface-activecompoundsininterac-tionofbacteriawithinterfaces.Microbiol.Rev.60:151?166.
	15.Norkrans,B.1980.Surfacemicrolayersinaquaticenvironments,p.51?85.InM.Alexander(ed.),Advancesinmicrobialecology,vol.4.PlenumPress,NewYork,N.Y.
	16.Plusquellec,A.,M.Beucher,C.Lelay,Y.Legal,andJ.J.Cleret.1991.Quantitativeandqualitativebacteriologyofthemarinewater-surfacemicro-layerinasewage-pollutedarea.Mar.Environ.Res.31:227?239.
	17.Preston,T.M.,H.Richards,andR.S.Wotton.2001.LocomotionandfeedingofAcanthamoebaatthewater-airinterfaceofponds.FEMSMicro-biol.Lett.194:143?147.
	18.Rainey,F.A.,N.Ward-Rainey,R.M.Kroppenstedt,andE.Stackebrandt.1996.ThegenusNocardiopsisrepresentsaphylogeneticallycoherenttaxonandadistinctactinomycetelineage:proposalofNocardiopsaceaefam.nov.Int.J.Syst.Bacteriol.46:1088?1092.
	19.Ricci,N.,F.Erra,A.Russo,andR.Banchetti.1991.Theair-water-inter-face?amicrohabitatforhypotrictioussettlers(Protista,Ciliata).Limnol.Oceanogr.36:1178?1188.
	20.Schafer,A.,H.Harms,andA.J.B.Zehnder.1998.Bacterialaccumulationattheair-waterinterface.Environ.Sci.Technol.32:3704?3712.
	21.Sekiguchi,H.,M.Watanabe,T.Nakahara,B.Xu,andH.Uchiyama.2002.SuccessionofbacterialcommunitystructurealongtheChangjiangRiverdeterminedbydenaturinggradientgelelectrophoresisandclonelibraryanalysis.Appl.Environ.Microbiol.68:5142?5150.
	22.Sletyr,U.B.,M.Sara,D.Pum,andB.Schuster.2001.Characterizationanduseofcrystallinebacterialcellsurfacelayers.Prog.Surf.Sci.68:231?278.
	23.Teske,A.,C.Wawer,G.Muyzer,andN.B.Ramsing.1996.Distributionofsulphate-reducingbacteriainastratifiedfjord(MariagerFjord,Denmark)asevaluatedbymost-probable-numbercountsanddenaturinggradientgelelectrophoresisofPCR-amplifiedribosomalDNAfragments.Appl.Environ.Microbiol.62:1405?1415.
	24.Zuev,B.K.,V.V.Chudinova,V.V.Kovalenko,andV.V.Yagov.2001.Theconditionsofformationofthechemicalcompositionoftheseasurfacemicrolayerandtechniquesforstudyingorganicmatterinit.Geochem.Int.39:702?710.
2087.pdf	50
	1.Ahmed,R.,C.Bopp,A.Borczyk,andS.Kasatiya.1987.Phage-typingschemeforEscherichiacoliO157:H7.J.Infect.Dis.155:806?809.
	2.Blattner,F.R.,G.Plunkett,III,C.A.Bloch,N.T.Perna,V.Burland,M.Riley,J.Collado-Vides,J.D.Glasner,C.K.Rode,G.F.Mayhew,J.Gregor,N.W.Davis,H.A.Kirkpatrick,M.A.Goeden,D.J.Rose,B.Mau,andY.Shao.1997.ThecompletegenomesequenceofEscherichiacoliK-12.Sci-ence277:1453?1474.
	3.Dietrich,W.F.,J.L.Weber,D.A.Nickerson,andP.-Y.Kwok.1999.Iden-tificationandanalysisofDNApolymorphisms,p.135?186.InB.Birren,E.DGreen,P.Hieter,S.Klapholz,R.M.Myers,H.Reithman,andJ.Roskama(ed.),Genomeanalysis:alaboratorymanual.ColdSpringHarborLabora-toryPress,ColdSpringHarbor,N.Y.
	4.Farris,J.S.,M.Kallersjo,A.G.Kluge,andC.Bult.1994.Testingsignifi-canceofincongruence.Cladistics10:315?319.
	5.Feldman,M.W.,J.Kumm,andJ.Pritchard.1999.Mutationandmigrationinmodelsofmicrosatelliteevolution,p.98?115.InD.B.GoldsteinandC.Schlotterer(ed.),Microsatellites:evolutionandapplications.OxfordUni-versityPress,Inc.,NewYork,N.Y.
	6.Felsenstein,J.1989.PHYLIP?phylogenyinferencepackage(version3.2).Cladistics5:164?166.
	7.Field,D.,andC.Wills.1996.Long,polymorphicmicrosatellitesinsimpleorganisms.Proc.R.Soc.LondonBBiol.Sci.263:209?215.
	8.Field,D.,andC.Wills.1998.AbundantmicrosatellitepolymorphisminSaccharomycescerevisiae,andthedifferentdistributionsofmicrosatellitesineightprokaryotesandS.cerevisiae,resultfromstrongmutationpressuresandavarietyofselectiveforces.Proc.Natl.Acad.Sci.USA95:1647?1652.
	9.Gur-Arie,R.,C.J.Cohen,Y.Eitan,L.Shelef,E.M.Hallerman,andY.Kashi.2000.SimplesequencerepeatsinEscherichiacoli:abundance,dis-tribution,composition,andpolymorphism.GenomeRes.10:62?71.
	10.Guttman,D.S.,andD.E.Dykhuizen.1994.ClonaldivergenceinEscherichiacoliasaresultofrecombination,notmutation.Science266:1380?1383.
	11.Guttman,D.S.1997.RecombinationandclonalityinnaturalpopulationsofEscherichiacoli.TrendsEcol.Evol.12:16?22.
	12.Herzer,P.J.,S.Inouye,M.Inouye,andT.S.Whittam.1990.PhylogeneticdistributionofbranchedRNA-linkedmulticopysingle-strandedDNAamongnaturalisolatesofEscherichiacoli.J.Bacteriol.172:6175?6181.
	13.Jakobsen,I.B.,andS.Easteal.1996.Aprogramforcalculatinganddisplay-ingcompatibilitymatricesasanaidindeterminingreticulateevolutioninmolecularsequences.Comput.Appl.Biosci.12:291?295.
	14.Kashi,Y.,D.King,andM.Soller.1997.Simplesequencerepeatsasasourceofquantitativegeneticvariation.TrendsGenet.13:74?78.
	15.Keim,P.,L.B.Price,A.M.Klevytska,K.L.Smith,J.M.Schupp,R.Okinaka,P.J.Jackson,andM.E.Hugh-Jones.2000.Multiple-locusvari-able-numbertandemrepeatanalysisrevealsgeneticrelationshipswithinBacillusanthracis.J.Bacteriol.182:2928?2936.
	16.King,D.G.,M.Soller,andY.Kashi.1997.Evolutionarytuningknobs.Endeavour21:36?40.
	17.Kudva,I.T.,P.S.Evans,N.T.Perna,T.J.Barrett,F.M.Ausubel,F.R.Blattner,andS.B.Calderwood.2002.StrainsofEscherichiacoliO157:H7differprimarilybyinsertionsordeletions,notsingle-nucleotidepolymor-phisms.J.Bacteriol.184:1873?1879.
	18.Kunzler,P.,K.Matsuo,andW.Schaffner.1995.Pathological,physiological,andevolutionaryaspectsofshortunstableDNArepeatsinthehumangenome.Biol.Chem.HoppeSeyler376:201?211.
	19.Lawrence,J.G.,andD.L.Hartl.1992.Inferenceofhorizontalgenetictransferfrommoleculardata:anapproachusingthebootstrap.Genetics131:753?760.
	20.Lawrence,J.G.,andH.Ochman.1998.MoleculararchaeologyoftheEsch-erichiacoligenome.Proc.Natl.Acad.Sci.USA95:9413?9417.
	21.Lecointre,G.,L.Rachdi,P.Darlu,andE.Denamur.1998.Escherichiacolimolecularphylogenyusingtheincongruencelengthdifferencetest.Mol.Biol.Evol.15:1685?1695.
	22.Levine,M.M.1987.Escherichiacolithatcausediarrhea:enterotoxigenic,enteropathogenic,enteroinvasive,enterohemorrhagic,andenteroadherent.J.Infect.Dis.155:377?389.
	23.Maiden,M.C.,J.A.Bygraves,E.Feil,G.Morelli,J.E.Russell,R.Urwin,Q.Zhang,J.Zhou,K.Zurth,D.A.Caugant,I.M.Feavers,M.Achtman,andB.G.Spratt.1998.Multilocussequencetyping:aportableapproachtotheidentificationofcloneswithinpopulationsofpathogenicmicroorganisms.Proc.Natl.Acad.Sci.USA95:3140?3145.
	24.Metzgar,D.,E.Thomas,C.Davis,D.Field,andC.Wills.2001.Themicro-satellitesofEscherichiacoli:rapidlyevolvingrepetitiveDNAsinanon-pathogenicprokaryote.Mol.Microbiol.39:183?190.
	25.Milkman,R.1997.RecombinationandpopulationstructureinEscherichiacoli.Genetics146:745?750.
	26.Milkman,R.,andM.M.Bridges.1993.MolecularevolutionoftheEsche-richiacolichromosome.IV.Sequencecomparisons.Genetics133:455?468.
	27.MontgomeryD.C.1991.Designandanalysisofexperiments,p.649.JohnWileyandSons,NewYork,N.Y.
	28.Moxon,E.R.,andC.Wills.1999.DNAmicrosatellites:agentsofevolution?Sci.Am.280:94?99.
	29.Nei,M.,andS.Kumar.2000.Molecularevolutionandphylogenetics,p.352.OxfordUniversityPress,Inc.,NewYork,N.Y.
	30.Noller,A.C.,M.C.McEllistrem,O.C.Stine,J.G.Morris,Jr.,D.J.Boxrud,B.Dixon,andL.H.Harrison.2003.MultilocussequencetypingrevealsalackofdiversityamongEscherichiacoliO157:H7isolatesthataredistinctbypulsed-fieldgelelectrophoresis.J.Clin.Microbiol.41:675?679.
	31.Ochman,H.,andR.K.Selander.1984.StandardreferencestrainsofEsch-erichiacolifromnaturalpopulations.J.Bacteriol.157:690?693.
	32.Ochman,H.,T.S.Whittam,D.A.Caugant,andR.K.Selander.1983.EnzymepolymorphismandgeneticpopulationstructureinEscherichiacoliandShigella.J.Gen.Microbiol.129:2715?2726.
	33.Ohta,T.1982.Linkagedisequalibriumduetorandomgeneticdriftinfinitesubdividedpopulations.Proc.Natl.Acad.Sci.USA79:1940?1944.
	34.Perna,N.T.,G.Plunkett,V.Burland,B.Mau,J.D.Glasner,D.J.Rose,G.F.Mayhew,P.S.Evans,J.Gregor,H.A.Kirkpatrick,G.Posfai,J.Hackett,S.Klink,A.Boutin,Y.Shao,L.Miller,E.J.Grotbeck,N.W.Davis,A.Lim,E.T.Dimalanta,K.D.Potamousis,J.Apodaca,T.S.Ananthara-man,J.Lin,G.Yen,D.C.Schwartz,R.A.Welch,andF.R.Blattner.2001.GenomesequenceofenterohaemorrhagicEscherichiacoliO157:H7.Nature409:529?533.
	35.Pupo,G.M.,D.K.Karaolis,R.Lan,andP.R.Reeves.1997.EvolutionaryrelationshipsamongpathogenicandnonpathogenicEscherichiacolistrainsinferredfrommultilocusenzymeelectrophoresisandmdhsequencestudies.Infect.Immun.65:2685?2692.
	36.Reid,S.D.,C.J.Herbelin,A.C.Bumbaugh,R.K.Selander,andT.S.Whittam.2000.ParallelevolutionofvirulenceinpathogenicEscherichiacoli.Nature406:64?67.
	37.Renders,N.,L.Licciardello,C.IJsseldijk,M.Sijmons,L.vanAlphen,H.Verbrugh,andA.vanBelkum.1999.VariablenumbersoftandemrepeatlociingeneticallyhomogeneousHaemophilusinfluenzaestrainsalterduringpersistentcolonisationofcysticfibrosispatients.FEMSMicrobiol.Lett.173:95?102.
	38.Rokas,A.,B.L.Williams,N.King,andS.B.Carroll.2003.Genome-scaleapproachestoresolvingincongruenceinmolecularphylogenies.Nature425:798?804.
	39.Rosenberg,S.M.,S.Longerich,P.Gee,andR.S.Harris.1994.Adaptivemutationbydeletionsinsmallmononucleotiderepeats.Science265:405?407.
	40.Sears,C.L.,andJ.B.Kaper.1996.Entericbacterialtoxins:mechanismsofactionandlinkagetointestinalsecretion.Microbiol.Rev.60:167?215.
	41.Selander,R.K.,D.A.Caugant,H.Ochman,J.M.Musser,M.N.Gilmour,andT.S.Whittam.1986.Methodsofmultilocusenzymeelectrophoresisforbacterialpopulationgeneticsandsystematics.Appl.Environ.Microbiol.51:873?884.
	42.Smith,J.M.,N.H.Smith,M.O?Rourke,andB.G.Spratt.1993.Howclonalarebacteria?Proc.Natl.Acad.Sci.USA90:4384?4388.
	43.Tautz,D.1989.HypervariabilityofsimplesequencesasageneralsourceforpolymorphicDNAmarkers.NucleicAcidsRes.17:6463?6471.
	44.Tonjum,T.,D.A.Caugant,S.A.Dunham,andM.Koomey.1998.Structureandfunctionofrepetitivesequenceelementsassociatedwithahighlypoly-morphicdomainoftheNeisseriameningitidisPilQprotein.Mol.Microbiol.29:111?124.
	45.vanBelkum,A.1999.Shortsequencerepeatsinmicrobialpathogenesisandevolution.Cell.Mol.LifeSci.56:729?734.
	46.vanBelkum,A.,S.Scherer,L.vanAlphen,andH.Verbrugh.1998.Short-sequenceDNArepeatsinprokaryoticgenomes.Microbiol.Mol.Biol.Rev.62:275?293.
	47.Vogt,P.1990.PotentialgeneticfunctionsoftandemrepeatedDNAse-quenceblocksinthehumangenomearebasedonahighlyconserved?chro-matinfoldingcode.?Hum.Genet.84:301?336.
	48.Weber,J.L.1990.Informativenessofhuman(dC-dA)n.(dG-dT)npolymor-phisms.Genomics7:524?530.
	49.Whittam,T.S.,H.Ochman,andR.K.Selander.1983.MultilocusgeneticstructureinnaturalpopulationsofEscherichiacoli.Proc.Natl.Acad.Sci.USA80:1751?1755.
	50.Whittam,T.S.,M.L.Wolfe,I.K.Wachsmuth,F.Orskov,I.Orskov,andR.A.Wilson.1993.ClonalrelationshipsamongEscherichiacolistrainsthatcausehemorrhagiccolitisandinfantilediarrhea.Infect.Immun.61:1619?1629.
1506.pdf	31
	1.Alm,E.,D.Oerther,N.Larsen,D.Stahl,andL.Raskin.1996.TheOligo-nucleotideProbeDatabase.Appl.Environ.Microbiol.62:3557?3559.
	2.Amann,R.I.,B.J.Binder,R.J.Olson,S.W.Chisholm,R.Devereux,andD.A.Stahl.1990.Combinationof16SrRNA-targetedoligonucleotideprobeswithflowcytometryforanalyzingmixedmicrobialpopulations.Appl.Environ.Microbiol.56:1919?1925.
	3.Beer,M.,E.M.Seviour,Y.Kong,M.Cunningham,L.L.Blackall,andR.J.Seviour.2002.PhylogenyofthefilamentousbacteriumEikelboomType1851,anddesignandapplicationofa16SrRNAtargetedoligonucleotideprobeforitsfluorescenceinsituidentificationinactivatedsludge.FEMSMicrobiol.Lett.207:179?183.
	4.Bjornsson,L.,P.Hugenholtz,G.W.Tyson,andL.L.Blackall.2002.Fila-mentouschloroflexi(greennon-sulfurbacteria)areabundantinwastewatertreatmentprocesseswithbiologicalnutrientremoval.Microbiology148:2309?2318.
	5.Blackall,L.L.1999.Bulking,p.147?160.InR.J.SeviourandL.L.Blackall(ed.),Themicrobiologyofactivatedsludge.KluwerAcademicPublishers,Dordrecht,TheNetherlands.
	6.Cenens,C.,I.Y.Smets,V.G.Ryckaert,andJ.F.V.Impe.2000.Modelingthecompetitionbetweenfloc-formingandfilamentousbacteriainactivatedsludgewastewatertreatmentsystems.I.Evaluationofmathematicalmodelsbasedonkineticselectiontheory.WaterRes.34:2525?2534.
	7.Chudoba,J.,J.S.Cech,J.Farkac,andP.Grau.1985.Controlofactivatedsludgefilamenousbulking:experimentalverificationofakineticselectiontheory.WaterRes.19:191?196.
	8.daMotta,M.,M.N.Pons,andN.Roche.2001.Automatedmonitoringofactivatedsludgeinapilotplantusingimageanalysis.WaterSci.Technol.43:91?96.
	9.Davenport,R.J.,T.P.Curtis,M.Goodfellow,F.M.Stainsby,andM.Bingley.2000.Quantitativeuseoffluorescentinsituhybridizationtoexam-inerelationshipsbetweenmycolicacid-containingactinomycetesandfoam-inginactivatedsludgeplants.Appl.Environ.Microbiol.66:1158?1166.
	10.delosReyes,F.,W.Ritter,andL.Raskin.1997.Group-specificsmall-subunitrRNAhybridizationprobestocharacterizefilamentousfoaminginactivatedsludgesystems.Appl.Environ.Microbiol.63:1107?1117.
	11.delosReyes,F.L.,D.B.Oerther,M.F.delosReyes,M.Hernandez,andL.Raskin.1998.Characterizationoffilamentousfoaminginactivatedsludgesystemsusingoligonucleotidehybridizationprobesandantibodyprobes.WaterSci.Technol.37:485?493.
	12.delosReyes,F.L.,andL.Raskin.2002.Theroleoffilamentsinactivatedsludgefoamingrelationshipofmycolatalevelstofoaminginitiationandstability.WaterRes.36:445?459.
	13.Eikelboom,D.H.1977.Identificationoffilamentousorganismsinbulkingactivatedsludge.Prog.WaterTechnol.8:153?161.
	14.Eikelboom,D.H.1982.Microscopicsludgeinvestigationinrelationtotreat-mentplantoperation,p.47?74.InB.ChambersandE.J.Tomlinson(ed.),Bulkingofactivatedsludge:preventativeandremedialmethods.EllisHor-woodLtd.,Chichester,UnitedKingdom.
	15.Erhart,R.,D.Bradford,R.J.Seviour,R.Amann,andL.L.Blackall.1997.DevelopmentanduseoffluorescentinsituhybridizationprobesforthedetectionandidentificationofMicrothrixparvicellainactivatedsludge.Syst.Appl.Microbiol.20:310?318.
	16.Finstein,M.S.,andH.Heukelekian.1967.Grossdimensionsofactivatedsludgeflocswithreferencetobulking.J.WaterPoll.ControlFed.39:33?40.
	17.Gaval,G.,P.Duchene,andJ.J.Pernelle.2002.Filamentousbacterialpop-ulationdominanceinactivatedsludgessubjecttostresses.WaterSci.Tech-nol.46:49?53.
	18.Greenberg,A.E.,L.S.Clesceri,andA.D.Eaton.1998.Standardmethodsfortheexaminationofwaterandwastewater.AmericanPublicHealthAs-sociation,AmericanWaterWorksAssociation,WaterEnvironmentFeder-ation,Washington,D.C.
	19.Hernandez,M.,D.Jenkins,andB.Beaman.1994.Massandviabilityesti-mationsofNocardiainactivatedsludgeandanaerobicdigestersusingcon-ventionalstainsandimmunofluorescentmethods.WaterSci.Technol.29:249?259.
	20.Jenkins,D.,M.Richard,andG.T.Daigger.1993.Manualonthecausesandcontrolofactivatedsludgebulkingandfoaming.LewisPublishers,Inc.,Chelsea,Mich.
	21.Kohno,T.,K.Sei,andK.Mori.2002.Characterizationoftype1851organ-ismisolatedfromactivatedsludgesamples.WaterSci.Technol.46:111?114.
	22.Liu,J.R.,andR.J.Seviour.2001.DesignandapplicationofoligonucleotideprobesforfluorescentinsituidentificationofthefilamentousbacterialmorphotypeNostocoidalimicolainactivatedsludge.Environ.Microbiol.3:551?560.
	23.Manz,W.,R.Amann,W.Ludwig,M.Wagner,andK.H.Schleifer.1992.Phylogeneticoligodeoxynucleotideprobesforthemajorsubclassesofpro-teobacteria:problemsandsolutions.Syst.Appl.Microbiol.15:593?600.
	24.Martins,A.M.P.,J.J.Heijnen,andM.C.M.vanLoosdrecht.2003.Effectoffeedingpatternandstorageonthesludgesettleabilityunderaerobicconditions.WaterRes.37:2555?2570.
	25.Oerther,D.B.,F.L.delosReyes,andL.Raskin.1999.Interfacingphylo-geneticoligonucleotideprobehybridizationswithrepresentationsofmicro-bialpopulationsandspecificgrowthratesinmathematicalmodelsofacti-vatedsludgeprocesses.WaterSci.Technol.39:11?20.
	26.Palm,J.C.,D.Jenkins,andD.S.Parker.1980.Relationshipbetweenorganicloading,dissolvedoxygenconcentrationandsludgesettleabilityinthecompletelymixedactivatedsludgeprocess.J.WaterPollut.ControlFed.52:2484?2506.
	27.Raskin,L.,J.M.Stromley,B.E.Rittmann,andD.A.Stahl.1994.Group-specific16SrRNAhybridizationprobestodescribenaturalcommunitiesofmethanogens.Appl.Environ.Microbiol.60:1232?1240.
	28.Sezgin,M.,D.Jenkins,andD.Parker.1978.Aunifiedtheoryoffilamentousactivatedsludgebulking.J.WaterPollut.ControlFed.50:362?381.
	29.Stahl,D.A.,B.Flesher,H.R.Mansfield,andL.Montgomery.1988.Useofphylogeneticallybasedhybridizationprobesforstudiesofruminalmicrobialecology.Appl.Environ.Microbiol.54:1079?1084.
	30.Wagner,M.,R.Amann,P.Kampfer,B.Assmus,A.Hartmann,P.Hutzler,N.SpringerandK.Schleifer.1994.Identificationandin-situdetectionofGram-negativefilamentousbacteriainactivatedsludge.Syst.Appl.Micro-biol.17:405?417.
	31.Zheng,D.,E.Alm,D.A.Stahl,andL.Raskin.1996.Characterizationofuniversalsmall-subunitrRNAhybridizationprobesforquantitativemolec-ularmicrobialecologystudies.Appl.Environ.Microbiol.62:4504?4513.
0745.pdf	67
	1.Barbet,N.C.,U.Schneider,S.B.Helliwell,I.Stansfield,M.F.Tuite,andM.N.Hall.1996.TORcontrolstranslationinitiationandearlyG1progres-sioninyeast.Mol.Biol.Cell7:25?42.
	2.Beck,T.,andM.N.Hall.1999.TheTORsignallingpathwaycontrolsnuclearlocalizationofnutrient-regulatedtranscriptionfactors.Nature402:689?692.
	3.Beck,T.,A.Schmidt,andM.N.Hall.1999.Starvationinducesvacuolartargetinganddegradationofthetryptophanpermeaseinyeast.J.CellBiol.146:1227?1238.
	4.Bertram,P.G.,J.H.Choi,J.Carvalho,W.Ai,C.Zeng,T.F.Chan,andX.F.Zheng.2000.TripartiteregulationofGln3pbyTOR,Ure2p,andphospha-tases.J.Biol.Chem.275:35727?35733.
	5.Bertram,P.G.,C.Zeng,J.Thorson,A.S.Shaw,andX.F.Zheng.1998.The14?3-3proteinspositivelyregulaterapamycin-sensitivesignaling.Curr.Biol.8:1259?1267.
	6.Boy-Marcotte,E.,M.Perrot,F.Bussereau,H.Boucherie,andM.Jacquet.1998.Msn2pandMsn4pcontrolalargenumberofgenesinducedatthediauxictransitionwhicharerepressedbycyclicAMPinSaccharomycescerevisiae.J.Bacteriol.180:1044?1052.
	7.Broach,J.R.1991.RASgenesinSaccharomycescerevisiae:signaltransduc-tioninsearchofapathway.TrendsGenet.7:28?33.
	8.Cameron,S.,L.Levin,M.Zoller,andM.Wigler.1988.cAMP-independentcontrolofsporulation,glycogenmetabolism,andheatshockresistanceinS.cerevisiae.Cell53:555?566.
	9.Cardenas,M.E.,N.S.Cutler,M.C.Lorenz,C.J.DiComo,andJ.Heitman.1999.TheTORsignalingcascaderegulatesgeneexpressioninresponsetonutrients.GenesDev.13:3271?3279.
	10.Chan,T.F.,P.G.Bertram,W.Ai,andX.F.Zheng.2001.RegulationofAPG14expressionbytheGATA-typetranscriptionfactorGln3p.J.Biol.Chem.276:6463?6467.
	11.Collart,M.A.,andS.Oliviero.1993.PreparationofyeastRNA,p.13.12.1?13.12.5.InF.M.Ausubel,R.Brent,R.E.Kingston,D.D.Moore,J.G.Seidman,J.A.Smith,andK.Struhl(ed.),Currentprotocolsinmolecularbiology.JohnWiley&Sons,Inc.,NewYork,N.Y.
	12.Crespo,J.L.,andM.N.Hall.2002.ElucidatingTORsignalingandrapa-mycinaction:lessonsfromSaccharomycescerevisiae.Microbiol.Mol.Biol.Rev.66:579?591.
	13.Crespo,J.L.,T.Powers,B.Fowler,andM.N.Hall.2002.TheTOR-controlledtranscriptionactivatorsGLN3,RTG1,andRTG3areregulatedinresponsetointracellularlevelsofglutamine.Proc.Natl.Acad.Sci.USA99:6784?6789.
	14.Cutler,N.S.,X.Pan,J.Heitman,andM.E.Cardenas.2001.TheTORsignaltransductioncascadecontrolscellulardifferentiationinresponsetonutrients.Mol.Biol.Cell12:4103?4113.
	15.DeCraene,J.O.,O.Soetens,andB.Andre.2001.TheNpr1kinasecontrolsbiosyntheticandendocyticsortingoftheyeastGap1permease.J.Biol.Chem.276:43939?43948.
	16.DiComo,C.J.,andK.T.Arndt.1996.Nutrients,viatheTorproteins,stimulatetheassociationofTap42withtype2Aphosphatases.GenesDev.10:1904?1916.
	17.Duvel,K.,A.Santhanam,S.Garrett,L.Schneper,andJ.R.Broach.2003.MultiplerolesofTap42inmediatingrapamycin-inducedtranscriptionalchangesinyeast.Mol.Cell11:1467?1478.
	18.Edinger,A.L.,andC.B.Thompson.2002.AktmaintainscellsizeandsurvivalbyincreasingmTOR-dependentnutrientuptake.Mol.Biol.Cell13:2276?2288.
	19.Garrett,S.,andJ.Broach.1989.LossofRasactivityinSaccharomycescerevisiaeissuppressedbydisruptionsofanewkinasegene,YAKI,whoseproductmayactdownstreamofthecAMP-dependentproteinkinase.GenesDev.3:1336?1348.
	20.Gorner,W.,E.Durchschlag,M.T.Martinez-Pastor,F.Estruch,G.Am-merer,B.Hamilton,H.Ruis,andC.Schuller.1998.NuclearlocalizationoftheC2H2zincfingerproteinMsn2pisregulatedbystressandproteinkinaseAactivity.GenesDev.12:586?597.
	21.Gorner,W.,E.Durchschlag,J.Wolf,E.L.Brown,G.Ammerer,H.Ruis,andC.Schuller.2002.Acuteglucosestarvationactivatesthenuclearlocalizationsignalofastress-specificyeasttranscriptionfactor.EMBOJ.21:135?144.
	22.Griffioen,G.,P.Anghileri,E.Imre,M.D.Baroni,andH.Ruis.2000.NutritionalcontrolofnucleocytoplasmiclocalizationofcAMP-dependentproteinkinasecatalyticandregulatorysubunitsinSaccharomycescerevisiae.J.Biol.Chem.275:1449?1456.
	23.Griffioen,G.,andJ.M.Thevelein.2002.MolecularmechanismscontrollingthelocalisationofproteinkinaseA.Curr.Genet.41:199?207.
	24.Hara,K.,Y.Maruki,X.Long,K.Yoshino,N.Oshiro,S.Hidayat,C.Toku-naga,J.Avruch,andK.Yonezawa.2002.Raptor,abindingpartneroftargetofrapamycin(TOR),mediatesTORaction.Cell110:177?189.
	25.Hardwick,J.S.,F.G.Kuruvilla,J.K.Tong,A.F.Shamji,andS.L.Schreiber.1999.Rapamycin-modulatedtranscriptiondefinesthesubsetofnutrient-sensitivesignalingpathwaysdirectlycontrolledbytheTorproteins.Proc.Natl.Acad.Sci.USA96:14866?14870.
	26.Hein,C.,J.Y.Springael,C.Volland,R.Haguenauer-Tsapis,andB.Andre.1995.NPl1,anessentialyeastgeneinvolvedininduceddegradationofGap1andFur4permeases,encodestheRsp5ubiquitin-proteinligase.Mol.Mi-crobiol.18:77?87.
	27.Helliwell,S.B.,P.Wagner,J.Kunz,M.Deuter-Reinhard,R.Henriquez,andM.N.Hall.1994.TOR1andTOR2arestructurallyandfunctionallysimilarbutnotidenticalphosphatidylinositolkinasehomologuesinyeast.Mol.Biol.Cell5:105?118.
	28.Ito,H.,Y.Fukuda,K.Murata,andA.Kimura.1983.Transformationofintactyeastcellstreatedwithalkalications.J.Bacteriol.153:163?168.
	29.Jacinto,E.,B.Guo,K.T.Arndt,T.Schmelzle,andM.N.Hall.2001.TIP41interactswithTAP42andnegativelyregulatestheTORsignalingpathway.Mol.Cell8:1017?1026.
	30.Jacinto,E.,andM.N.Hall.2003.Torsignallinginbugs,brainandbrawn.Nat.Rev.Mol.Cell.Biol.4:117?126.
	31.Jiang,Y.,andJ.R.Broach.1999.Torproteinsandproteinphosphatase2AreciprocallyregulateTap42incontrollingcellgrowthinyeast.EMBOJ.18:2782?2792.
	32.Kamada,Y.,T.Funakoshi,T.Shintani,K.Nagano,M.Ohsumi,andY.Ohsumi.2000.Tor-mediatedinductionofautophagyviaanApg1proteinkinasecomplex.J.CellBiol.150:1507?1513.
	33.Kim,D.H.,D.D.Sarbassov,S.M.Ali,J.E.King,R.R.Latek,H.Erdju-ment-Bromage,P.Tempst,andD.M.Sabatini.2002.mTORinteractswithraptortoformanutrient-sensitivecomplexthatsignalstothecellgrowthmachinery.Cell110:163?175.
	34.Klein,C.,andK.Struhl.1994.ProteinkinaseAmediatesgrowth-regulatedexpressionofyeastribosomalproteingenesbymodulatingRAP1transcrip-tionalactivity.Mol.Cell.Biol.14:1920?1928.
	35.Komeili,A.,K.P.Wedaman,E.K.O?Shea,andT.Powers.2000.Mechanismofmetaboliccontrol.TargetofrapamycinsignalinglinksnitrogenqualitytotheactivityoftheRtg1andRtg3transcriptionfactors.J.CellBiol.151:863?878.
	36.Kraakman,L.,K.Lemaire,P.Ma,A.W.Teunissen,M.C.Donaton,P.VanDijck,J.Winderickx,J.H.deWinde,andJ.M.Thevelein.1999.ASaccha-romycescerevisiaeG-proteincoupledreceptor,Gpr1,isspecificallyrequiredforglucoseactivationofthecAMPpathwayduringthetransitiontogrowthonglucose.Mol.Microbiol.32:1002?1012.
	37.Liu,Z.,T.Sekito,C.B.Epstein,andR.A.Butow.2001.RTG-dependentmitochondriatonucleussignalingisnegativelyregulatedbythesevenWD-repeatproteinLst8p.EMBOJ.20:7209?7219.
	38.Loewith,R.,E.Jacinto,S.Wullschleger,A.Lorberg,J.L.Crespo,D.Bonen-fant,W.Oppliger,P.Jenoe,andM.N.Hall.2002.TwoTORcomplexes,onlyoneofwhichisrapamycinsensitive,havedistinctrolesincellgrowthcontrol.Mol.Cell10:457?468.
	39.Longtine,M.S.,A.McKenzieIII,D.J.Demarini,N.G.Shah,A.Wach,A.Brachat,P.Philippsen,andJ.R.Pringle.1998.AdditionalmodulesforversatileandeconomicalPCR-basedgenedeletionandmodificationinSac-charomycescerevisiae.Yeast14:953?961.
	40.Lorenz,M.C.,X.Pan,T.Harashima,M.E.Cardenas,Y.Xue,J.P.Hirsch,andJ.Heitman.2000.TheGprotein-coupledreceptorgpr1isanutrientsensorthatregulatespseudohyphaldifferentiationinSaccharomycescerevi-siae.Genetics154:609?622.
	41.Martinez-Pastor,M.T.,G.Marchler,C.Schuller,A.Marchler-Bauer,H.Ruis,andF.Estruch.1996.TheSaccharomycescerevisiaezincfingerproteinsMsn2pandMsn4parerequiredfortranscriptionalinductionthroughthestressresponseelement(STRE).EMBOJ.15:2227?2235.
	42.Moriya,H.,Y.Shimizu-Yoshida,A.Omori,S.Iwashita,M.Katoh,andA.Sakai.2001.Yak1p,aDYRKfamilykinase,translocatestothenucleusandphosphorylatesyeastPop2pinresponsetoaglucosesignal.GenesDev.15:1217?1228.
	43.Moskvina,E.,C.Schuller,C.T.Maurer,W.H.Mager,andH.Ruis.1998.AsearchinthegenomeofSaccharomycescerevisiaeforgenesregulatedviastressresponseelements.Yeast14:1041?1050.
	44.Neuman-Silberberg,F.S.,S.Bhattacharya,andJ.R.Broach.1995.NutrientavailabilityandtheRAS/cyclicAMPpathwaybothinduceexpressionofribosomalproteingenesinSaccharomycescerevisiaebutbydifferentmech-anisms.Mol.Cell.Biol.15:3187?3196.
	45.Noda,T.,A.Matsuura,Y.Wada,andY.Ohsumi.1995.NovelsystemformonitoringautophagyintheyeastSaccharomycescerevisiae.Biochem.Bio-phys.Res.Commun.210:126?132.
	46.Noda,T.,andY.Ohsumi.1998.Tor,aphosphatidylinositolkinasehomo-logue,controlsautophagyinyeast.J.Biol.Chem.273:3963?3969.
	47.Ozcan,S.,andM.Johnston.1999.Functionandregulationofyeasthexosetransporters.Microbiol.Mol.Biol.Rev.63:554?569.
	48.Pedruzzi,I.,N.Burckert,P.Egger,andC.DeVirgilio.2000.SaccharomycescerevisiaeRas/cAMPpathwaycontrolspost-diauxicshiftelement-dependenttranscriptionthroughthezincfingerproteinGis1.EMBOJ.19:2569?2579.
	49.Powers,T.,andP.Walter.1999.Regulationofribosomebiogenesisbytherapamycin-sensitiveTOR-signalingpathwayinSaccharomycescerevisiae.Mol.Biol.Cell10:987?1000.
	50.Raths,S.,J.Rohrer,F.Crausaz,andH.Riezman.1993.end3andend4:twomutantsdefectiveinreceptor-mediatedandfluid-phaseendocytosisinSac-charomycescerevisiae.J.CellBiol.120:55?65.
	51.Reinders,A.,N.Burckert,T.Boller,A.Wiemken,andC.DeVirgilio.1998.SaccharomycescerevisiaecAMP-dependentproteinkinasecontrolsentryintostationaryphasethroughtheRim15pproteinkinase.GenesDev.12:2943?2955.
	52.Rohde,J.,J.Heitman,andM.E.Cardenas.2001.TheTORkinaseslinknutrientsensingtocellgrowth.J.Biol.Chem.276:9583?9586.
	53.Schmelzle,T.,andM.N.Hall.2000.TOR,acentralcontrollerofcellgrowth.Cell103:253?262.
	54.Schmidt,A.,T.Beck,A.Koller,J.Kunz,andM.N.Hall.1998.TheTORnutrientsignallingpathwayphosphorylatesNPR1andinhibitsturnoverofthetryptophanpermease.EMBOJ.17:6924?6931.
	55.Schmitt,A.P.,andK.McEntee.1996.Msn2p,azincfingerDNA-bindingprotein,isthetranscriptionalactivatorofthemultistressresponseinSac-charomycescerevisiae.Proc.Natl.Acad.Sci.USA93:5777?5782.
	56.Shamji,A.F.,F.G.Kuruvilla,andS.L.Schreiber.2000.PartitioningthetranscriptionalprograminducedbyrapamycinamongtheeffectorsoftheTorproteins.Curr.Biol.10:1574?1581.
	57.Sherman,F.1991.Gettingstartedwithyeast.MethodsEnzymol.194:3?21.
	58.Smith,A.,M.P.Ward,andS.Garrett.1998.YeastPKArepressesMsn2p/Msn4p-dependentgeneexpressiontoregulategrowth,stressresponseandglycogenaccumulation.EMBOJ.17:3556?3564.
	59.Thevelein,J.M.,andJ.H.deWinde.1999.NovelsensingmechanismsandtargetsforthecAMP-proteinkinaseApathwayintheyeastSaccharomycescerevisiae.Mol.Microbiol.33:904?918.
	60.Toda,T.,S.Cameron,P.Sass,M.Zoller,J.D.Scott,B.McMullen,M.Hurwitz,E.G.Krebs,andM.Wigler.1987.CloningandcharacterizationofBCY1,alocusencodingaregulatorysubunitofthecyclicAMP-dependentproteinkinaseinSaccharomycescerevisiae.Mol.Cell.Biol.7:1371?1377.
	61.Ward,M.P.,andS.Garrett.1994.SuppressionofayeastcyclicAMP-dependentproteinkinasedefectbyoverexpressionofSOK1,ayeastgeneexhibitingsequencesimilaritytoadevelopmentallyregulatedmousegene.Mol.Cell.Biol.14:5619?5627.
	62.Warner,J.R.1999.Theeconomicsofribosomebiosynthesisinyeast.TrendsBiochem.Sci.24:437?440.
	63.Warner,J.R.1991.LabelingofRNAandphosphoproteinsinSaccharomycescerevisiae.MethodsEnzymol.194:423?428.
	64.Wedaman,K.P.,A.Reinke,S.Anderson,J.Yates,III,J.M.McCaffery,andT.Powers.2003.Torkinasesareindistinctmembrane-associatedproteincomplexesinSaccharomycescerevisiae.Mol.Biol.Cell14:1204?1220.
	65.Xia,Y.,H.Y.Wen,M.E.Young,P.H.Guthrie,H.Taegtmeyer,andR.E.Kellems.2003.MammaliantargetofrapamycinandproteinkinaseAsig-nalingmediatethecardiactranscriptionalresponsetoglutamine.J.Biol.Chem.278:13143?13150.
	66.Xue,Y.,M.Battle,andJ.P.Hirsch.1998.GPR1encodesaputativeGprotein-coupledreceptorthatassociateswiththeGpa2pGsubunitandfunctionsinaRas-independentpathway.EMBOJ.17:1996?2007.
	67.Zaragoza,D.,A.Ghavidel,J.Heitman,andM.C.Schultz.1998.RapamycininducestheG0programoftranscriptionalrepressioninyeastbyinterferingwiththeTORsignalingpathway.Mol.Cell.Biol.18:4463?4470.
tjp0554-0815.pdf	45
	AzadoziKM,PontariM,VlachiotisJ&SirokyMB(1996).Caninebladderbloodflowandoxygenation:changesinducedbyfilling,contractionandoutletobstruction.JUrol155,1459?1465.
	AzadzoiKM,TarcanT,KozlowskiR,KraneRJ&SirokyMB(1999).Overactivityandstructuralchangesinthechronicallyischemicbladder.JUrol162,1768?1778.
	BardalesRH,HaileyLS,XieSS,SchaeferRF&HsuSM(1996).Insituapoptosisassayforthedetectionofearlyacutemyocardialinfarction.AmJPathol149,821?830.
	BernardoNL,ChelleyaJ,D?AngeloM,LoesserKB,GrantS&KukrejaRC(1997).Thesecondwindowofprotectioninducesexpressionofproto-oncogeneBcl-2andinhibitsapoptosisinrabbitheart.Circulation,Suppl.96,I-553(Abstract).
	CaiM&OgawaR(1994).Effectsoffreeradicalscavengers,methylprednisolone,andulinastatinonacutexanthineandxanthineoxidase-inducedlunginjuryinrats.CircShock43,71?78.
	CarpenterFG(1983).Impairmentandrestorationofraturinarybladderresponsivenessfollowingdistension.AmJPhysiol244,R106?R113.
	ChienCT,FuTC,WuMS&ChenCF(1997).Attenuatedresponseofrenalmechanoreceptorstovolumeexpansioninchronicallyhypoxicrats.AmJPhysiol273,F712?F717.
	ChienCT,HsuSM,ChenCF,LeePH&LaiMK(2000b).Hypoxicpreconditioningreducesischemia/reperfusion-inducedapoptosiscelldeathinratkidney.TransplantProc32,1653?1664.
	ChienCT,LeePH,ChenCF,MaMC,LaiMK&HsuSM(2001).Denovodemonstrationandco-localizationoffree-radicalproductionandapoptosisformationinratkidneysubjectedtoischemia/reperfusion.JAmSocNephrol12,973?982.
	ChienCT,YuHJ,ChengYJ,WuMS,ChenCF&HsuSM(2000a).Reductioninrenalhaemodynamicsbyexaggeratedvesicovascularreflexinratswithacuteurinaryretention.JPhysiol526,397?408.
	ChienCT,YuHJ,LinTB&ChenCF(2000c).Neuralmechanismsofimpairedmicturitionreflexinratswithacutepartialbladderoutletobstruction.Neuroscience96,221?230.
	ChienCT,YuHJ,LinTB,LaiMK&HsuSM(2003).SubstancePviaNK1receptorfacilitateshyperactivebladderafferentsignalingviaactionofROS.AmJPhysiolRenalPhysiol284,F840?F851.
	EngelmanDT,ChenCZ,WatanabeM,EngelmanRM,RousouJA,FlackJE3rd,DeatonDW,MaulikN&DasDK(1995).Improved4-and6-hourmyocardialpreservationbyhypoxicpreconditioning.Circulation92(Suppl.),II417?422.
	FreemanBA&CrapoJD(1982).Biologyofdisease:freeradicalandtissueinjury.LaboratoryInvest47,412?426.
	GoslingJA,KungLS,DixonJS,HoranP,WhitbeckC&LevinRM(2000).Correlationbetweenthestructureandfunctionoftherabbiturinarybladderfollowingpartialoutletobstruction.JUrol163,1349?1356.
	GreenlandJE&BradingAF(2001).Theeffectofbladderoutflowobstructionondetrusorbloodflowchangesduringthevoidingcycleinconsciouspigs.JUrol165,245?248.
	HeurteauxC,LauritzenI,WidmannC&LazdunskiM(1995).Essentialroleofadenosine,adenosineA1receptors,andATP-sensitiveK+channelsincerebralischemicpreconditioning.ProcNatlAcadSciUSA92,4666?4670.
	JacksonMJ(1990).Freeradicalsandskeletalmuscledisorders.In:OxygenRadicals:SystemicEventsandDiseaseProcess,ed.Das,DK,pp.149?171.Karger,NewYork.
	KatoK,WeinAJ,RadzinskiC,LonghuratPA,McGuireMillerLF,ElbadawiA&LevinRM(1990).Short-termfunctionaleffectsofbladderoutletobstructioninthecat.JUrol143,1020?1025.
	KershenRT,AzadzoiKM&SirokyMB(2002).Bloodflow,pressureandcomplianceinthemalehumanbladder.JUrol168,121?125.
	KontosCD,WeiEP,WilliamsJ,KontosHA&PolvisshockJT(1992).Cytochemicaldetectionofsuperoxideincerebralinflammationandischemiainvivo.AmJPhysiol263,H1234?H1242.
	KozlowskiR,SirokyMB,KraneRJ&AzadzoiKM(2002).Regulationofbloodflowandmicrocirculationresistanceinrabbitbladder.JUrol168,1608?1614.
	LeeTM,SuSF,ChenMF&TsaiCH(2000).Acuteeffectsofurinarybladderdistentiononthecoronarycirculationinpatientswithearlyatherosclerosis.JAmCollCardiol36,453?460.
	LiebJ,KoganB,DasAK,LeggettRE,SchroederA&LevinRM(2001).Theeffectofurinevolumeandnitricoxideonbasalbladderbloodflow:responsetocatheterizationanddrainage.NeurourolUrodyn20,115?124.
	LinAT,ChangLA,ChenMT,YangCH,ShiaoMS,ChenCJ&LevinRM(1992).Energeticsofdetrusorcontraction:effectsofoutletobstruction.NeurourolUrodyn11,605?614.
	LinAT,ChenKK,YangCH&ChangLS(1998).Effectsofoutletobstructionanditsreversalonmitochondrialenzymeactivityinrabbiturinarybladders.JUrol160,2258?2262.
	LinAT,ChenKK,YangCH&ChangLS(2000).Mannitolfacilitatesrabbiturinarybladderrecoveryfromoverdistensioninjury.Urology56,702?707.
	MarberMS,LatchmanDS,WalkerJM&YellonDM(1993).Cardiacstressproteinelevation24hoursafterbriefischemiaorheatstressisassociatedwithresistancetomyocardialinfarction.Circulation88,1264?1272.
	MurryCE,JenningsRB&ReimerKA(1986).Preconditioningwithischemia:adelayoflethalcellinjuryinischemicmyocardium.Circulation74,1124?1136.
	MustonenS,Ala-HouhalaI&TammelaTL(1999).Proteinuriaandrenalfunctionduringacuteurineretention.JUrol161,1781?1784.
	OkudaM,LeeHC,KumarC&ChanceB(1992).Oxygenradicalgenerationduringischemia-reperfusionintheisolatedperfusedratlivermonitoredbyenhancedchemiluminescence.CircShock38,228?237.
	PiotC,PadmanabanD,UrsellPC,SieversRE&WolfeCE(1997).Ischemicpreconditioningdecreasesapoptosisinratheartsinvivo.Circulation96,1598?1604.
	Schroï¿½derA,LiebJ,KoganBA&LevinRM(2001).Increasedbloodflowaftercatheterizationanddrainageinthechronicallyobstructedrabbiturinarybladder.Urology58,295?300.
	SchumerM,ColombelMC,SawczukIS,GobeG,ConnorJ,O?TooleKM,OlssonCA,WiseGJ&ButtyanR(1992).Morphologic,biochemical,andmolecularevidenceofapoptosisduringthereperfusionphaseafterbriefperiodsofrenalischemia.AmJPathol40,831?838.
	ShimizuS,NagayamaT,JinKL,ZhuL,LoeffertJE,WatkinsSC,GrahamSH&SimonRP(2001).Bcl-2Antisensetreatmentpreventsinductionoftolerancetofocalischemiaintheratbrain.JCerebBloodFlowMetab21,233?243.
	ShizukudaY,MalletRT,LeeSC&DowneyHF(1992).Hypoxicpreconditioningoftheischemiccaninemyocardium.CardiovascRes26,534?542.
	SohalRS,SohalBH&OrrWC(1995).Mitochondrialsuperoxideandhydrogenperoxidegeneration,proteinoxidativedamage,andlongevityindifferentspeciesofflies.FreeRadicBiolMed19,499?504.
	SutherlandRS,BaskinLS,KoganBA&CunhaG(1998).Neuroanatomicalchangesintheratbladderafterbladderoutletobstruction.BrJUrol82,895?901.
	TammelaT,LasanenL&WarisT(1990).Effectofdistentiononadrenergicinnervationoftheraturinarybladder.UrolRes18,345?348.
	TarcanT,SirokyMB,KraneRJ&AzadzoiKM(2000).Isoprostane8-epiPGF2alpha,aproductofoxidativestress,issynthesizedinthebladderandcausesdetrusorsmoothmusclecontraction.NeurourolUrodyn19,43?51.
	TemsahRM,NetticadanT&ChapmanD(1999).Alterationsofsarcoplasmicreticulumfunctionandgeneexpressioninischemic-reperfusedratheart.AmJPhysiol277,H584?H594.
	TheobaldRJ(1995).Purinergicandcholinergiccomponentsofbladdercontractilityandflow.LifeSci56,445?454.
	TsaoPS,AokiN,LeferDJ,JohnsonGIII&LeferAM(1990).Timecourseofendothelialdysfunctionandmyocardialinjuryduringmyocardialischemiaandreperfusioninthecat.Circulation82,1402?1412.
	ZdericSA,WeinA,RohrmanD,GongC,NigroD,HaugaardN&LevinRM(1998).Mechanismsofbladdersmoothmusclehypertrophyanddecompensation:lessonsfromnormaldevelopmentandtheresponsetooutletobstruction.WorldJUrol16,350?358.
	ZhaoY,ChackoS&LevinRM(1994).Expressionofstressproteins(Hsp-70andHsp-90)intherabbiturinarybladdersubjectedtopartialoutletobstruction.MolCellBiochem130,49?55.
J. Biol. Chem.-2004-Rao-3949-55.pdf	12
	1.Doble,B.W.,andWoodgett,J.R.(2003)J.CellSci.116,1175?1186
	2.Hao,C.M.,Yull,F.,Blackwell,T.,Komhoff,M.,Davis,L.S.,andBreyer,M.D.(2000)J.Clin.Investig.106,973?982
	3.Bach,P.H.,andNguyen,T.K.(1998)Toxicol.Pathol.26,73?91
	4.Garcia-Perez,A.,andBurg,M.B.(1991)Physiol.Rev.71,1081?1115
	5.Burg,M.B.(1997)Curr.Opin.Nephrol.Hypertens.6,430?433
	6.Neuhofer,W.,Muller,E.,Burger-Kentischer,A.,andBeck,F.X.(1998)KidneyInt.67,(suppl.)S165?167
	7.Cohen,D.M.,Wasserman,J.C.,andGullans,S.R.(1991)Am.J.Physiol.261,C594?601
	8.Guan,Y.,Chang,M.,Cho,W.,Zhang,Y.,Redha,R.,Davis,L.,Chang,S.,DuBois,R.N.,Hao,C.M.,andBreyer,M.(1997)Am.J.Physiol.273,F18?26
	9.Hao,C.M.,Redha,R.,Morrow,J.,andBreyer,M.D.(2002)J.Biol.Chem.277,21341?21345
	10.Grimes,C.A.,andJope,R.S.(2001)Prog.Neurobiol.65,391?426
	11.Woodgett,J.R.(2001)Science?sSTKEhttp://stke.sciencemag.org/cgi/content/full/sigtrans;2001/100/re12
	12.Bijur,G.N.,DeSarno,P.,andJope,R.S.(2000)J.Biol.Chem.275,7583?7590
	13.Nonaka,S.,andChuang,D.M.(1998)Neuroreport9,2081?2084
	14.Inouye,M.,Yamamura,H.,andNakano,A.(1995)J.Radiat.Res.(Tokyo)36,203?208
	15.Centeno,F.,Mora,A.,Fuentes,J.M.,Soler,G.,andClaro,E.(1998)Neuro-report9,4199?4203
	16.Chalecka-Franaszek,E.,andChuang,D.M.(1999)Proc.Natl.Acad.Sci.U.S.A.96,8745?8750
	17.Mora,A.,Sabio,G.,Gonzalez-Polo,R.A.,Cuenda,A.,Alessi,D.R.,Alonso,J.C.,Fuentes,J.M.,Soler,G.,andCenteno,F.(2001)J.Neurochem.78,199?206
	18.Stoothoff,W.H.,andJohnson,G.V.(2001)J.Neurosci.Res.65,573?582
	19.Howe,L.R.,Crawford,H.C.,Subbaramaiah,K.,Hassell,J.A.,Dannenberg,A.J.,andBrown,A.M.(2001)J.Biol.Chem.276,20108?20115
	20.Hao,C.M.,Komhoff,M.,Guan,Y.,Redha,R.,andBreyer,M.D.(1999)Am.J.Physiol.277,F352?359
	21.Wang,H.,Li,J.,Bostock,R.M.,andGilchrist,D.G.(1996)PlantCell8,375?391
	22.Mehlen,P.,Kretz-Remy,C.,Preville,X.,andArrigo,A.P.(1996)EMBOJ.15,2695?2706
	23.Baskiewicz-Masiuk,M.,Masiuk,M.,andMachalinski,B.(2003)CellProlif.36,265?278
	24.Li,J.,Kleeff,J.,Guo,J.,Fischer,L.,Giese,N.,Buchler,M.W.,andFriess,H.(2003)Mol.Cancer2,32
	25.Korinek,V.,Barker,N.,Morin,P.J.,vanWichen,D.,deWeger,R.,Kinzler,K.W.,Vogelstein,B.,andClevers,H.(1997)Science275,1784?1787
	26.Blackwell,T.S.,Yull,F.E.,Chen,C.L.,Venkatakrishnan,A.,Blackwell,T.R.,Hicks,D.J.,Lancaster,L.H.,Christman,J.W.,andKerr,L.D.(1999)Chest116,73S-74S
	27.Inoue,H.,Tanabe,T.,andUmesono,K.(2000)J.Biol.Chem.275,28028?28032
	28.Haq,S.,Choukroun,G.,Kang,Z.B.,Ranu,H.,Matsui,T.,Rosenzweig,A.,Molkentin,J.D.,Alessandrini,A.,Woodgett,J.,Hajjar,R.,Michael,A.,andForce,T.(2000)J.CellBiol.151,117?130
	29.Kypta,R.M.,Su,H.,andReichardt,L.F.(1996)J.CellBiol.134,1519?1529
	30.Oyama,T.,Ran,S.,Ishida,T.,Nadaf,S.,Kerr,L.,Carbone,D.P.,andGabrilovich,D.I.(1998)J.Immunol.160,1224?1232
	31.Sekhar,K.R.,Meredith,M.J.,Kerr,L.D.,Soltaninassab,S.R.,Spitz,D.R.,Xu,Z.Q.,andFreeman,M.L.(1997)Biochem.Biophys.Res.Commun.234,588?593
	32.Coghlan,M.P.,Culbert,A.A.,Cross,D.A.,Corcoran,S.L.,Yates,J.W.,Pearce,N.J.,Rausch,O.L.,Murphy,G.J.,Carter,P.S.,RoxbeeCox,L.,Mills,D.,Brown,M.J.,Haigh,D.,Ward,R.W.,Smith,D.G.,Murray,K.J.,Reith,A.D.,andHolder,J.C.(2000)Chem.Biol.7,793?803
	33.Newton,R.,Kuitert,L.M.,Bergmann,M.,Adcock,I.M.,andBarnes,P.J.(1997)Biochem.Biophys.Res.Commun.237,28?32
	34.Bournat,J.C.,Brown,A.M.,andSoler,A.P.(2000)J.Neurosci.Res.61,21?32
	35.Hoeflich,K.P.,Luo,J.,Rubie,E.A.,Tsao,M.S.,Jin,O.,andWoodgett,J.R.(2000)Nature406,86?90
	36.Orford,K.,Crockett,C.,Jensen,J.P.,Weissman,A.M.,andByers,S.W.(1997)J.Biol.Chem.272,24735?24738
	37.vanEs,J.H.,Giles,R.H.,andClevers,H.C.(2001)Exp.CellRes.264,126?134
	38.Cross,D.A.,Alessi,D.R.,Cohen,P.,Andjelkovich,M.,andHemmings,B.A.(1995)Nature378,785?789
	39.Loberg,R.D.,Vesely,E.,andBrosius,F.C.,III(2002)J.Biol.Chem.277,41667?41673
	40.Cross,D.A.,Culbert,A.A.,Chalmers,K.A.,Facci,L.,Skaper,S.D.,andReith,A.D.(2001)J.Neurochem.77,94?102
	41.Markowitz,G.S.,Radhakrishnan,J.,Kambham,N.,Valeri,A.M.,Hines,W.H.,andD?Agati,V.D.(2000)J.Am.Soc.Nephrol.11,1439?1448
	42.Sugawara,M.,Hashimoto,K.,andOta,Z.(1988)Am.J.Physiol.254,R863?869
	43.Yang,A.H.,Chen,J.Y.,Lin,Y.P.,Huang,T.P.,andWu,C.W.(1997)KidneyInt.51,1280?1288
	44.Haertel-Wiesmann,M.,Liang,Y.,Fantl,W.J.,andWilliams,L.T.(2000)J.Biol.Chem.
	45.Harris,R.C.,andBreyer,M.D.(2001)Am.J.Physiol.RenalPhysiol281,F1?11
	46.Eldar-Finkelman,H.(2002)TrendsMol.Med.8,126?132
	47.Araki,Y.,Okamura,S.,Hussain,S.P.,Nagashima,M.,He,P.,Shiseki,M.,Miura,K.,andHarris,C.C.(2003)CancerRes.63,728?734
	48.Taglialatela,G.,Robinson,R.,andPerez-Polo,J.R.(1997)J.Neurosci.Res.47,155?162
	49.Baeuerle,P.A.,andBaltimore,D.(1988)Science242,540?546
	50.Baldwin,A.S.,Jr.(1996)Annu.Rev.Immunol.14,649?683
	51.Schwabe,R.F.,andBrenner,D.A.(2002)Am.J.Physiol.GastrointestLiverPhysiol283,G204?211
	52.Sanchez,J.F.,Sniderhan,L.F.,Williamson,A.L.,Fan,S.,Chakraborty-Sett,S.,andMaggirwar,S.B.(2003)Mol.Cell.Biol.23,4649?4662
	53.Martinez,A.,Castro,A.,Dorronsoro,I.,andAlonso,M.(2002)Med.Res.Rev.22,373?384
	54.Harwood,A.J.,andAgam,G.(2003)Biochem.Pharmacol.66,179?189GSK3InhibitionPromotesRenalInterstitialCellSurvival3955
J. Biol. Chem.-2004-Vaysse-5555-64.pdf	10
	1.Uherek,C.,andWels,W.(2000)Adv.DrugDeliveryRev.44,153?166
	2.Nishikawa,M.,andHuang,L.(2001)Hum.GeneTher.12,861?870
	3.Pollard,H.,Remy,J.S.,Loussouarn,G.,Demolombe,S.,Behr,J.P.,andEscande,D.(1998)J.Biol.Chem.273,7507?7511
	4.Labat-Moleur,F.,Steffan,A.M.,Brisson,C.,Perron,H.,Feugeas,O.,Furst-enberger,P.,Oberling,F.,Brambilla,E.,andBehr,J.P.(1996)GeneTher.3,1010?1017
	5.Zabner,J.,Fasbender,A.J.,Moninger,T.,Poellinger,K.A.,andWelsh,M.J.(1995)J.Biol.Chem.270,18997?19007
	6.Wilke,M.,Fortunati,E.,vandenBroek,M.,Hoogeveen,A.T.,andScholte,B.J.(1996)GeneTher.3,1133?1142
	7.Gorlich,D.(1998)EMBOJ.17,2721?2727
	8.Macara,I.G.(2001)Microbiol.Mol.Biol.Rev.65,570?594
	9.Christophe,D.,Christophe-Hobertus,C.,andPichon,B.(2000)Cell.Signal.12,337?341
	10.Jans,D.A.,Xiao,C.Y.,andLam,M.H.(2000)Bioessays22,532?544
	11.Harel,A.,andForbes,D.J.(2001)Nat.CellBiol.3,E267?E269
	12.Collas,P.,andAlestrom,P.(1996)Mol.Reprod.Dev.45,431?438
	13.Zanta,M.A.,Belguise-Valladier,P.,andBehr,J.P.(1999)Proc.Natl.Acad.Sci.U.S.A.96,91?96
	14.Gao,X.,andHuang,L.(1996)Biochemistry35,1027?1036
	15.Fritz,J.D.,Herweijer,H.,Zhang,G.,andWolff,J.A.(1996)Hum.GeneTher.7,1395?1404
	16.Chan,C.K.,Hubner,S.,Hu,W.,andJans,D.A.(1998)GeneTher.5,1204?1212
	17.Cartier,R.,andReszka,R.(2002)GeneTher.9,157?167
	18.Sebestyen,M.G.,Ludtke,J.J.,Bassik,M.C.,Zhang,G.,Budker,V.,Lukhtanov,E.A.,Hagstrom,J.E.,andWolff,J.A.(1998)Nat.Biotechnol.16,80?85
	19.Neves,C.,Escriou,V.,Byk,G.,Scherman,D.,andWils,P.(1999)CellBiol.Toxicol.15,193?202
	20.Neves,C.,Byk,G.,Scherman,D.,andWils,P.(1999)FEBSLett.453,41?45
	21.Hillen,W.,Unger,B.,andKlock,G.(1982)NucleicAcidsRes.10,6085?6097
	22.Saenger,W.,Orth,P.,Kisker,C.,Hillen,W.,andHinrichs,W.(2000)Angew.Chem.Int.Ed.Engl.39,2042?2052
	23.Baron,U.,andBujard,H.(2000)MethodsEnzymol.327,401?421
	24.Larsen,H.J.,andNielsen,P.E.(1996)NucleicAcidsRes.24,458?463
	25.Nielsen,P.E.,andEgholm,M.(1999)Curr.IssuesMol.Biol.1,89?104
	26.Branden,L.J.,Mohamed,A.J.,andSmith,C.I.(1999)Nat.Biotechnol.17,784?787
	27.Branden,L.J.,Christensson,B.,andSmith,C.I.(2001)GeneTher.8,84?87
	28.Bigger,B.W.,Tolmachov,O.,Collombet,J.M.,Fragkos,M.,Palaszewski,I.,andCoutelle,C.(2001)J.Biol.Chem.276,23018?23027
	29.Orth,P.,Alings,C.,Schnappinger,D.,Saenger,W.,andHinrichs,W.(1998)ActaCrystallogr.Sect.DBiol.Crystallogr.54,99?100
	30.Gossen,M.,andBujard,H.(1992)Proc.Natl.Acad.Sci.U.S.A.89,5547?5551
	31.Hillen,W.,Gatz,C.,Altschmied,L.,Schollmeier,K.,andMeier,I.(1983)J.Mol.Biol.169,707?721
	32.Gossen,M.,Freundlieb,S.,Bender,G.,Muller,G.,Hillen,W.,andBujard,H.(1995)Science268,1766?1769
	33.Escriou,V.,Carriere,M.,Bussone,F.,Wils,P.,andScherman,D.(2001)J.GeneMed.3,179?187
	34.Kuhn,H.,Demidov,V.V.,Nielsen,P.E.,andFrank-Kamenetskii,M.D.(1999)J.Mol.Biol.286,1337?1345
	35.Nielsen,P.E.,Egholm,M.,Berg,R.H.,andBuchardt,O.(1993)NucleicAcidsRes.21,197?200
	36.Devine,S.M.(2002)J.CellBiochem.Suppl.38,73?79
	37.Ludtke,J.J.,Zhang,G.,Sebestyen,M.G.,andWolff,J.A.(1999)J.CellSci.112,2033?2041
	38.Chan,C.K.,andJans,D.A.(2001)GeneTher.8,166?171
	39.Nakielny,S.,Siomi,M.C.,Siomi,H.,Michael,W.M.,Pollard,V.,andDrey-fuss,G.(1996)Exp.CellRes.229,261?266
	40.Subramanian,A.,Ranganathan,P.,andDiamond,S.L.(1999)Nat.Biotech-nol.17,873?877
	41.Hansen,G.I.,Bentin,T.,Larsen,H.J.,andNielsen,P.E.(2001)J.Mol.Biol.307,67?74
	42.Wittung,P.,Nielsen,P.,andNorden,B.(1997)Biochemistry36,7973?7979
	43.Vitiello,L.,Chonn,A.,Wasserman,J.D.,Duff,C.,andWorton,R.G.(1996)GeneTher.3,396?404
	44.Wadhwa,M.S.,Collard,W.T.,Adami,R.C.,McKenzie,D.L.,andRice,K.G.(1997)BioconjuguateChem.8,81?88
	45.McKenzie,D.L.,Collard,W.T.,andRice,K.G.(1999)J.Pept.Res.54,311?318Self-assemblingNuclearTargeting5564Vectors
627.pdf	34
	1.DiMango,E.,H.J.Zar,R.Bryan,andA.Prince.1995.DiversePseudomonasaeruginosageneproductsstimulaterespiratoryepithelialcellstoproduceinterleukin-8.J.Clin.Invest.96:2204?2210.
	2.Koyama,S.,E.Sato,H.Nomura,K.Kubo,M.Miura,T.Yamashita,S.Nagai,andT.Izumi.2000.ThepotentialofvariouslipopolysaccharidestoreleaseIL-8andG-CSF.Am.J.Physiol.LungCell.Mol.Physiol.278:L658?L666.
	3.Cario,E.,D.Brown,M.McKee,K.Lynch-Devaney,G.Gerken,andD.K.Podolsky.2002.Commensal-associatedmolecularpatternsinduceselectivetoll-likereceptor-traffickingfromapicalmembranetocytoplasmiccompart-mentsinpolarizedintestinalepithelium.Am.J.Pathol.160:165?173.
	4.McNamara,N.,A.Khong,D.McKemy,M.Caterina,J.Boyer,D.Julius,andC.Basbaum.2001.ATPtransducessignalsfromASGM1,aglycolipidthatfunctionsasabacterialreceptor.Proc.Natl.Acad.Sci.USA98:9086?9091.
	5.Ratner,A.J.,R.Bryan,A.Weber,S.Nguyen,D.Barnes,A.Pitt,S.Gelber,A.Cheung,andA.Prince.2001.CysticfibrosispathogensactivateCa2-dependentmitogen-activatedproteinkinasesignalingpathwaysinairwayepithelialcells.J.Biol.Chem.276:19267?19275.
	6.Gewirtz,A.T.,P.O.Simon,Jr.,C.K.Schmitt,L.J.Taylor,C.H.Hagedorn,A.D.O?Brien,A.S.Neish,andJ.L.Madara.2001.Salmonellatyphimuriumtranslocatesflagellinacrossintestinalepithelia,inducingaproinflammatoryresponse.J.Clin.Invest.107:99?109.
	7.Aderem,A.,andR.J.Ulevitch.2000.Toll-likereceptorsintheinductionoftheinnateimmuneresponse.Nature406:782?787.
	8.Ulevitch,R.J.,andP.S.Tobias.1995.Receptor-dependentmechanismsofcellstimulationbybacterialendotoxin.Annu.Rev.Immunol.13:437?457.
	9.Zarember,K.A.,andP.J.Godowski.2002.TissueexpressionofhumanToll-likereceptorsanddifferentialregulationofToll-likereceptormRNAsinleukocytesinresponsetomicrobes,theirproducts,andcytokines.J.Immu-nol.168:554?561.
	10.Becker,M.N.,G.Diamond,M.W.Verghese,andS.H.Randell.2000.CD-14?dependentlipopolysaccharideinducedbeta-defensin-2expressioninhu-mantracheobronchialepithelium.J.Biol.Chem.275:29731?29736.
	11.Krivan,H.C.,D.D.Roberts,andV.Ginsburg.1988.Manypulmonarypatho-genicbacteriabindspecificallytothecarbohydratesequenceGalNAcbeta1?4Galfoundinsomeglycolipids.Proc.Natl.Acad.Sci.USA85:6157?6161.
	12.Feldman,M.,R.Bryan,S.Rajan,L.Scheffler,S.Brunnert,H.Tang,andA.Prince.1998.RoleofflagellainpathogenesisofPseudomonasaeruginosapulmonaryinfection.Infect.Immun.66:43?51.
	13.Lopez-Boado,Y.S.,C.L.Wilson,andW.C.Parks.2001.RegulationofmatrilysinexpressioninairwayepithelialcellsbyPseudomonasaeruginosaflagellin.J.Biol.Chem.276:41417?41423.
	14.Eaves-Pyles,T.D.,H.R.Wong,K.Odoms,andR.B.Pyles.2001.Salmonellaflagellin-dependentproinflammatoryresponsesarelocalizedtothecon-servedaminoandcarboxylregionsoftheprotein.J.Immunol.167:7009?7016.
	15.Eaves-Pyles,T.,K.Murthy,L.Liaudet,L.Virag,G.Ross,F.G.Soriano,C.Szabo,andA.L.Salzman.2001.Flagellin,anovelmediatorofSalmonella-inducedepithelialactivationandsystemicinflammation:IkappaBalphadegradation,inductionofnitricoxidesynthase,inductionofproinflamma-torymediators,andcardiovasculardysfunction.J.Immunol.166:1248?1260.
	16.Izadpanah,A.,M.B.Dwinell,L.Eckmann,N.M.Varki,andM.F.Kagnoff.2001.RegulatedMIP-3alpha/CCL20productionbyhumanintestinalepithe-lium:mechanismformodulatingmucosalimmunity.Am.J.Physiol.Gas-trointest.LiverPhysiol.280:G710?G719.
	17.Sierro,F.,B.Dubois,A.Coste,D.Kaiserlian,J.P.Kraehenbuhl,andJ.C.Sirard.2001.FlagellinstimulationofintestinalepithelialcellstriggersCCL20-mediatedmigrationofdendriticcells.Proc.Natl.Acad.Sci.USA98:13722?13727.
	18.Zeng,H.C.,A.Q.Carlson,Y.Guo,Y.Yu,L.S.Collier-Hyams,J.L.Madara,A.T.Gewirtz,andA.S.Neish.2003.Flagellinisthemajorproinflammatorydeterminantofenteropathogenicsalmonella.J.Immunol.171:3668?3674.
	19.Hayashi,F.,K.D.Smith,A.Ozinsky,T.R.Hawn,E.C.Yi,D.R.Goodlett,J.K.Eng,S.Akira,D.M.Underhill,andA.Aderem.2001.TheinnateimmuneresponsetobacterialflagellinismediatedbyToll-likereceptor5.Nature410:1099?1103.
	20.Gewirtz,A.T.,T.A.Navas,S.Lyons,P.J.Godowski,andJ.L.Madara.2001.Cuttingedge:bacterialflagellinactivatesbasolaterallyexpressedTLR5toinduceepithelialproinflammatorygeneexpression.J.Immunol.167:1882?1885.
	21.Moors,M.A.,L.Li,andS.B.Mizel.2001.Activationofinterleukin-1receptor-associatedkinasebygram-negativeflagellin.Infect.Immun.69:4424?4429.
	22.Mizel,S.B.,A.P.West,andR.R.Hantgan.2003.Identificationofasequenceinhumantoll-likereceptor5requiredforthebindingofGram-negativeflagellin.J.Biol.Chem.278:23624?23629.
	23.DiMango,E.,A.J.Ratner,R.Bryan,S.Tabibi,andA.Prince.1998.ActivationofNF-kappaBbyadherentPseudomonasaeruginosainnormalandcysticfibrosisrespiratoryepithelialcells.J.Clin.Invest.101:2598?2605.
	24.Weber,A.J.,G.Soong,R.Bryan,S.Saba,andA.Prince.2001.ActivationofNF-kappaBinairwayepithelialcellsisdependentonCFTRtraffickingandCl-channelfunction.Am.J.Physiol.LungCell.Mol.Physiol.281:L71?L78.
	25.Yang,R.,M.R.Mark,A.Gray,A.Huang,M.H.Xie,M.Zhang,A.Goddard,W.I.Wood,A.L.Gurney,andP.J.Godowski.1998.Toll-likereceptor-2mediateslipopolysaccharide-inducedcellularsignaling.Nature395:284?288.
	26.Katagiri,Y.U.,T.Mori,H.Nakajima,C.Katagiri,T.Taguchi,T.Takeda,N.Kiyokawa,andJ.Fujimoto.1999.ActivationofSrcfamilykinaseyesin-ducedbyShigatoxinbindingtoglobotriaosylceramide(Gb3/CD77)inlowdensity,detergent-insolublemicrodomains.J.Biol.Chem.274:35278?35282.
	27.Andreev,J.,M.L.Galisteo,O.Kranenburg,S.K.Logan,E.S.Chiu,M.Okigaki,L.A.Cary,W.H.Moolenaar,andJ.Schlessinger.2001.SrcandPyk2mediateG-protein-coupledreceptoractivationofepidermalgrowthfactorreceptor(EGFR)butarenotrequiredforcouplingtothemitogen-activatedprotein(MAP)kinasesignalingcascade.J.Biol.Chem.276:20130?20135.
	28.Wyant,T.L.,M.K.Tanner,andM.B.Sztein.1999.Salmonellatyphiflagellaarepotentinducersofproinflammatorycytokinesecretionbyhumanmono-cytes.Infect.Immun.67:3619?3624.
	29.Ogushi,K.,A.Wada,T.Niidome,N.Mori,K.Oishi,T.Nagatake,A.Takahashi,H.Asakura,S.Makino,H.Hojo,Y.Nakahara,M.Ohsaki,T.Hatakeyama,H.Aoyagi,H.Kurazono,J.Moss,andT.Hirayama.2001.SalmonellaenteritidisFliC(flagellafilamentprotein)induceshumanbeta-defensin-2mRNAproduc-tionbyCaco-2cells.J.Biol.Chem.276:30521?30526.
	30.Zhou,X.,J.A.Giron,A.G.Torres,J.A.Crawford,E.Negrete,S.N.Vogel,andJ.B.Kaper.2003.FlagellinofenteropathogenicEscherichiacolistimu-latesinterleukin-8productioninT84cells.Infect.Immun.71:2120?2129.
	31.Yu,Y.,H.Zeng,S.Lyons,A.Carlson,D.Merlin,A.S.Neish,andA.T.Gewirtz.2003.TLR5-mediatedactivationofp38MAPKregulatesepithelialIL-8expressionviaapost-transcriptionalmechanism.Am.J.Physiol.Gas-trointest.LiverPhysiol.285:282?290.
	32.Baltimore,R.,C.D.Christie,andG.J.Smith.1989.ImmunohistopathologiclocalizationofPseudomonasaeruginosainlungsfrompatientswithcysticfibrosis.Am.Rev.Respir.Dis.140:1650?1661.
	33.Mahenthiralingam,E.,M.E.Campbell,andD.P.Speert.1994.NonmotilityandphagocyticresistanceofPseudomonasaeruginosaisolatesfromchroni-callycolonizedpatientswithcysticfibrosis.Infect.Immun.62:596?605.
	34.Saiman,L.,andA.Prince.1993.Pseudomonasaeruginosapilibindtoasia-loGM1whichisincreasedonthesurfaceofcysticfibrosisepithelialcells.J.Clin.Invest.92:1875?1880.
Brain-2004-Ginsberg-193-202.pdf	45
	AdHocSubcommitteeoftheAmericanAcademyofNeurologyAIDSTaskForce.Researchcriteriaforthediagnosisofchronicinï¿½ammatorydemyelinatingpolyneuropathy(CIDP).Neurology1991;41:617ï¿½8.
	Balice-GordonRJ,BoneLJ,SchererSS.FunctionalgapjunctionsintheSchwanncellmyelinsheath.JCellBiol1998;142:1095ï¿½104.
	BergoffenJ,SchererSS,WangS,ScottMO,BoneLJ,PaulDL,etal.ConnexinmutationsinX-linkedCharcotï¿½Marieï¿½Toothdisease.Science1993;262:2039ï¿½42.
	BirdSJ,SladkyJT.Corticosteroid-responsivedominantlyinheritedneuropathyinchildhood.Neurology1991;41:437ï¿½9.
	BoerkoelCF,TakashimaH,GarciaCA,OlneyRK,JohnsonJ,BerryK,etal.Charcotï¿½Marieï¿½Toothdiseaseandrelatedneuropathies:mutationdistributionandgenotypeï¿½phenotypecorrelation.AnnNeurol2002;51:190ï¿½201.
	BruzzoneR,WhiteTW,PaulDL.Connectionswithconnexins:theHereditaryandinï¿½ammatoryneuropathy201molecularbasisofdirectintercellularsignaling.EurJBiochem1996;238:1ï¿½27.
	ChadDA,SmithTW,DeGirolamiU,HammerK.Perineuritisandulcerativecolitis.Neurology1986;36:1377ï¿½9.
	D'UrsoD,BrophyPJ,StaugaitisSM,GillespieCS,FreyAB,StempakJG,etal.Proteinzeroofperipheralnervemyelin:biosynthesis,membraneinsertion,andevidenceforhomotypicinteraction.Neuron1990;4:449ï¿½
	D'UrsoD,EhrhardtP,MullerHW.Peripheralmyelinprotein22andproteinzero:anovelassociationinperipheralnervoussystemmyelin.JNeurosci1999;19:3396ï¿½403.
	DonaghyM,SisodiyaSM,KennettR,McDonaldB,HaitesN,BellC.Steroidresponsivepolyneuropathyinafamilywithanovelmyelinproteinzeromutation.JNeurolNeurosurgPsychiatry2000;69:799ï¿½805.
	DyckPJ,SwansonCJ,LowPA,BartlesonJD,LambertEH.Prednisone-responsivehereditarymotorandsensoryneuropathy.MayoClinProc1982;57:239ï¿½46.
	FairweatherN,BellC,CochraneS,ChellyJ,WangS,MostacciuoloML,etal.Mutationsintheconnexin32geneinX-linkeddominantCharcotï¿½Marieï¿½Toothdisease(CMTX1).HumMolGenet1994;3:29ï¿½34.
	FilbinMT,WalshFS,TrappBD,PizzeyJA,TennekoonGI.RoleofmyelinP0proteinasahomophilicadhesionmolecule.Nature1990;344:871ï¿½2.
	FitzsimonsRB.Facioscapulohumeraldystrophy:theroleofinï¿½ammation.Lancet1994;344:902ï¿½3.
	Gabreels-FestenAA,GabreelsFJ,HoogendijkJE,BolhuisPA,JongenPJ,VingerhoetsHM.Chronicinï¿½ammatorydemyelinatingpolyneuropathyorhereditarymotorandsensoryneuropathy?Diagnosticvalueofmorphologicalcriteria.ActaNeuropathol(Berl)1993;86:630ï¿½5.
	GabrielCM,HughesRAC,MooreSE,SmithKJ,WalshFS.Inductionofexperimentalautoimmuneneuritiswithperipheralmyelinprotein-22.Brain1998;121:1895ï¿½902.
	GabrielCM,GregsonNA,HughesRAC.Anti-PMP22antibodiesinpatientswithinï¿½ammatoryneuropathy.JNeuroimmunol2000;104:139ï¿½46.
	GabrielCM,GregsonNA,WoodNW,HughesRAC.Immunologicalstudyofhereditarymotorandsensoryneuropathytype1a(HMSN1a).JNeurolNeurosurgPsychiatry2002;72:230ï¿½5.
	GinsbergL.Complexfamilialneuropathy.In:SchapiraAHV,RowlandLP,editors.Clinicalcasesinneurology.Oxford:Butterworth-Heinemann;2001.p.247ï¿½53.
	GutierrezA,EnglandJD,SumnerAJ,FererS,WarnerLE,LupskiJR,etal.Unusualelectrophysiologicalï¿½ndingsinX-linkeddominantCharcotï¿½Marieï¿½Toothdisease.MuscleNerve2000;23:182ï¿½8.
	HardingAE,ThomasPK.TheclinicalfeaturesofhereditarymotorandsensoryneuropathytypesIandII.Brain1980;103:259ï¿½80.
	InheritedPeripheralNeuropathiesMutationDatabaseonline.http://molgen-www.uia.ac.be/CMTmutations/[26August2003].
	LewisRA,SumnerAJ.Theelectrodiagnosticdistinctionsbetweenchronicfamilialandacquireddemyelinativeneuropathies.Neurology1982;32:592ï¿½6.
	LiljeO.TheprocessingandpresentationofendogenousandexogenousantigenbySchwanncellsinvitro.CellMolLifeSci2002;59:2191ï¿½8.
	LunnMP,ManjiH,ChoudharyPP,HughesRA,ThomasPK.Chronicinï¿½ammatorydemyelinatingpolyradiculoneuropathy:aprevalencestudyinsoutheastEngland.JNeurolNeurosurgPsychiatry1999;66:677ï¿½80.
	LupskiJR,deOca-LunaRM,SlaugenhauptS,PentaoL,GuzzettaV,TraskBJ,etal.DNAduplicationassociatedwithCharcotï¿½Marieï¿½ToothdiseasetypeIA.Cell1991;66:219ï¿½32.
	MalikO,SharpD,KingRHM,OrrellR,GinsbergL.Coexistenthereditaryandinï¿½ammatoryneuropathy[abstract].JNeurolNeurosurgPsychiatry2000;69:415.
	MatsunamiN,SmithB,BallardL,LenschMW,RobertsonM,AlbertsonH,etal.Peripheralmyelinprotein-22genemapsintheduplicationinchromosome17p11.2associatedwithCharcotï¿½Marieï¿½Tooth1A.NatGenet1992;1:176ï¿½9.
	NicholsonG,NashJ.Intermediatenerveconductionvelocitiesdeï¿½neX-linkedCharcotï¿½Marieï¿½Toothneuropathyfamilies.Neurology1993;43:2558ï¿½64.
	PatelPI,RoaBB,WelcherAA,Schoener-ScottR,TraskBJ,PentaoL,etal.ThegenefortheperipheralmyelinproteinPMP-22isacandidateforCharcotï¿½Marieï¿½Toothdiseasetype1A.NatGenet1992;1:159ï¿½65.
	PrenskyAL,DodsonWE.Thesteroidtreatmentofhereditarymotorandsensoryneuropathy.Neuropediatrics1984;15:203ï¿½7.
	RaeymaekersP,TimmermanV,NelisE,DeJongheP,HoogendijkJE,BaasF,etal.Duplicationinchromosome17p11.2inCharcotï¿½Marieï¿½Toothneuropathytype1a(CMT1a).TheHMSNCollaborativeResearchGroup.NeuromusculDisord1991;1:93ï¿½7.
	RitzMF,Lechner-ScottJ,ScottRJ,FuhrP,MalikN,ErneB,etal.Characterisationofautoantibodiestoperipheralmyelinprotein22inpatientswithhereditaryandacquiredneuropathies.JNeuroimmunol2000;104:155ï¿½63.
	SchaumburgHH,PowersJM,RaineCS,SuzukiK,RichardsonEPJr.Adrenoleukodystrophy.Aclinicalandpathologicalstudyof17cases.ArchNeurol1975;32:577ï¿½91.
	SchmidCD,StienekemeierM,OehenS,BootzF,ZielasekJ,GoldR,etal.Immunedeï¿½ciencyinmousemodelsforinheritedperipheralneuropathiesleadstoimprovedmyelinmaintenance.JNeurosci2000;20:729ï¿½35.
	SchmidtB,ToykaKV,KieferR,FullJ,HartungHP,PollardJ.Inï¿½ammatoryinï¿½ltratesinsuralnervebiopsiesinGuillainï¿½Barresyndromeandchronicinï¿½ammatorydemyelinatingneuropathy.MuscleNerve1996;19:474ï¿½87.
	SieversJ.Basictwo-dyestainsforepoxy-embedded0.3ï¿½1msections.StainTechnol1971;46:195ï¿½9.
	SkreH.GeneticandclinicalaspectsofCharcotï¿½Marieï¿½Tooth'sdisease.ClinGenet1974;6:98ï¿½118.
	TabaraudF,LagrangeE,SindouP,VandenbergheA,LevyN,VallatJM.DemyelinatingX-linkedCharcotï¿½Marieï¿½Toothdisease:unusualelectrophysiologicalï¿½ndings.MuscleNerve1999;22:1442ï¿½7.
	ThomasPK,LascellesRG,StewartG.Hypertrophicneuropathy.In:VinkenPJ,BruynGW,editors.Handbookofclinicalneurology,Vol.21.Amsterdam:Elsevier;1975.p.145ï¿½70.
	ThomasPK,MarquesWJr,DavisMB,SweeneyMG,KingRHM,BradleyJL,etal.Thephenotypicmanifestationsofchromosome17p11.2duplication.Brain1997;120:465ï¿½78.
	TimmermanV,NelisE,VanHulW,NieuwenhuijsenBW,ChenKL,WangS,etal.TheperipheralmyelinproteingenePMP-22iscontainedwithintheCharcotï¿½Marieï¿½Toothdiseasetype1Aduplication.NatGenet1992;1:171ï¿½5.
	ValentijnLJ,BolhuisPA,ZornI,HoogendijkJE,vandenBoschN,HenselsGW,etal.TheperipheralmyelingenePMP-22/GAS-3isduplicatedinCharcotï¿½Marieï¿½Toothdiseasetype1A.NatGenet1992;1:166ï¿½70.
	VallatJM,TabaraudF,MagyL,TornyF,Bernet-BernadyP,MacianF,etal.Diagnosticvalueofnervebiopsyforatypicalchronicinï¿½ammatorydemyelinatingpolyneuropathy:evaluationofeightcases.MuscleNerve2003;27:478ï¿½85.
	WatanabeM,YamamotoN,OhkoshiN,NagataH,KohnoY,HayashiA,etal.Corticosteroid-responsiveasymmetricneuropathywithamyelinproteinzerogenemutation.Neurology2002;59:767ï¿½9.
Brain-2004-Hassan-212-9.pdf	53
	AdamsHPJr,BendixenBH,KappelleLJ,BillerJ,LoveBB,GordonDL,etal.Classiï¿½cationofsubtypeofacuteischemicstroke.Deï¿½nitionsforuseinamulticenterclinicaltrial.TOAST.TrialofOrg10172inAcuteStrokeTreatment.Stroke1993;24:35ï¿½41.
	AltmanDG.Practicalstatisticsformedicalresearch.London:ChapmanandHall;1991.p.404ï¿½8.
	AwadIA,JohnsonPC,SpetzlerRF,HodakJA.Incidentalsubcorticallesionsidentiï¿½edonmagneticresonanceimagingintheelderly.II.Postmortempathologicalcorrelations.Stroke1986;17:1090ï¿½7.
	BakkerSL,deLeeuwFE,deGrootJC,HofmanA,KoudstaalPJ,BretelerMM.Cerebralvasomotorreactivityandcerebralwhitematterlesionsintheelderly.Neurology1999;52:578ï¿½83.
	BamfordJ,SandercockP,JonesL,WarlowC.Thenaturalhistoryoflacunarinfarction:theOxfordshireCommunityStrokeProject.Stroke1987;18:545ï¿½51.
	BevilacquaMP,StengelinS,GimbroneMAJr,SeedB.Endothelialleukocyteadhesionmolecule1:aninduciblereceptorforneutrophilsrelatedtocomplementregulatoryproteinsandlectins.Science1989;243:1160ï¿½5.
	BoitenJ,LodderJ.Riskfactorsforlacunarinfarction.In:DonnanG,NorrvingB,BamfordJ,BogousslavskyJ,editors.Lacunarandothersubcorticalinfarctions.Oxford:OxfordUniversityPress;1995.p.56ï¿½69.
	BraffmanBH,ZimmermanRA,TrojanowskiJQ,GonatasNK,HickeyWF,SchlaepferWW.BrainMR:pathologiccorrelationwithgrossandhistopathology.1.LacunarinfarctionandVirchowï¿½Robinspaces.AJRAmJRoentgenol1988;151:551ï¿½8.
	CarmelliD,DeCarliC,SwanGE,JackLM,ReedT,WolfPA,etal.Evidenceforgeneticvarianceinwhitematterhyperintensityvolumeinnormalelderlymaletwins.Stroke1998;29:1177ï¿½81.
	ChambersJC,UelandPM,ObeidOA,WrigleyJ,RefsumH,KoonerJS.ImprovedvascularendothelialfunctionafteroralBvitamins:aneffectmediatedthroughreducedconcentrationsoffreeplasmahomocysteine.Circulation2000;102:2479ï¿½83.
	CinesDB,PollakES,BuckCA,LoscalzoJ,ZimmermanGA,McEverRP,etal.Endothelialcellsinphysiologyandinthepathophysiologyofvasculardisorders.Blood1998;91:3527ï¿½61.
	ConstansJ,BlannAD,ResplandyF,ParrotF,RenardM,SeigneurM,etal.ThreemonthssupplementationofhyperhomocysteinaemicpatientswithfolicacidandvitaminB6improvesbiologicalmarkersofendothelialdysfunction.BrJHaematol1999;107:776ï¿½8.
	deJongG,KesselsF,LodderJ.Twotypesoflacunarinfarcts:furtherargumentsfromastudyonprognosis.Stroke2002;33:2072ï¿½6.
	EikelboomJW,HankeyGJ,AnandSS,LofthouseE,StaplesN,BakerRI.Associationbetweenhighhomocyst(e)ineandischemicstrokeduetolarge-andsmall-arterydiseasebutnototheretiologicsubtypesofischemicstroke.Stroke2000;31:1069ï¿½75.
	EversS,KochHG,GrotemeyerKH,LangeB,DeufelT,RingelsteinEB.Features,symptoms,andneurophysiologicalï¿½ndingsinstrokeassociatedwithhyperhomocysteinemia.ArchNeurol1997;54:1276ï¿½82.
	FassbenderK,MossnerR,MotschL,KischkaU,GrauA,HennericiM.Circulatingselectin-andimmunoglobulin-typeadhesionmoleculesinacuteischemicstroke.Stroke1995;26:1361ï¿½4.
	FassbenderK,BertschT,MielkeO,MuhlhauserF,HennericiM.Adhesionmoleculesincerebrovasculardisease.Evidenceforaninï¿½ammatory218A.Hassanetal.endothelialactivationincerebrallarge-andsmall-vesseldisease.Stroke1999a;30:1647ï¿½50.
	FassbenderK,MielkeO,BertschT,NafeB,FroschenS,HennericiM.Homocysteineincerebralmacroangiographyandmicroangiopathy.Lancet1999b;353:1586ï¿½7.
	FazekasF,KleinertR,OffenbacherH,SchmidtR,KleinertG,PayerF,etal.PathologiccorrelatesofincidentalMRIwhitemattersignalhyperintensities.Neurology1993;43:1683ï¿½9.
	FisherCM.Thearteriallesionsunderlyinglacunes.ActaNeuropathol(Berl)1968;12:1ï¿½15.
	FisherCM.Capsularinfarcts:theunderlyingvascularlesions.ArchNeurol1979;36:65ï¿½73.
	FrosstP,BlomHJ,MilosR,GoyetteP,SheppardCA,MatthewsRG,etal.Acandidategeneticriskfactorforvasculardisease:acommonmutationinmethylenetetrahydrofolatereductase.NatureGenet1995;10:111ï¿½3.
	HankeyGJ,EikelboomJW.Homocysteineandstroke.CurrOpinNeurol2001;14:95ï¿½102.
	HassanA,HuntB,O'SullivanM,ParmarK,BamfordJ,BrileyD,etal.Markersofendothelialdysfunctioninlacunarinfarctionandischaemicleukoaraiosis.Brain2003;126:424ï¿½32.
	HomocysteineLoweringTrialists'Collaboration.Loweringbloodhomocysteinewithfolicacidbasedsupplements:meta-analysisofrandomisedtrials.BMJ1998;316:894ï¿½8.
	IshiiH,UchiyamaH,KazamaM.Solublethrombomodulinantigeninconditionedmediumisincreasedbydamageofendothelialcells.ThrombHaemost1991;65:618ï¿½23.
	JacquesPF,BostomAG,WilliamsRR,EllisonRC,EckfeldtJH,RosenbergIH,etal.Relationbetweenfolatestatus,acommonmutationinmethylenetetrahydrofolatereductase,andplasmahomocysteineconcentrations.Circulation1996;93:7ï¿½9.
	JonesDK,LythgoeD,Horsï¿½eldMA,SimmonsA,WilliamsSC,MarkusHS.CharacterizationofwhitematterdamageinischemicleukoaraiosiswithdiffusiontensorMRI.Stroke1999;30:393ï¿½7.
	KarioK,MatsuoT,KobayashiH,AsadaR,MatsuoM.`Silent'cerebralinfarctionisassociatedwithhypercoagulability,endothelialcelldamage,andhighLp(a)levelsinelderlyJapanese.ArteriosclerThrombVascBiol1996;16:734ï¿½41.
	KrumanII,CulmseeC,ChanSL,KrumanY,GuoZ,PenixL,etal.HomocysteineelicitsaDNAdamageresponseinneuronsthatpromotesapoptosisandhypersensitivitytoexcitotoxicity.JNeurosci2000;20:6920ï¿½6.
	LentzSR,SobeyCG,PiegorsDJ,BhopatkarMY,FaraciFM,MalinowMR,etal.Vasculardysfunctioninmonkeyswithdiet-inducedhyperhomocyst(e)inemia.JClinInvest1996;98:24ï¿½9.
	LinJX,TomimotoH,AkiguchiI,MatsuoA,WakitaH,ShibasakiH,etal.VascularcellcomponentsofthemedullaryarteriesinBinswanger'sdiseasebrains:amorphometricandimmunoelectronmicroscopicstudy.Stroke2000;31:1838ï¿½42.
	LindgrenA,BrattstromL,NorrvingB,HultbergB,AnderssonA,JohanssonBB.Plasmahomocysteineintheacuteandconvalescentphasesafterstroke.Stroke1995;26:795ï¿½800.
	LindsbergPJ,CarpenO,PaetauA,Karjalainen-LindsbergML,KasteM.EndothelialICAM-1expressionassociatedwithinï¿½ammatorycellresponseinhumanischemicstroke.Circulation1996;94:939ï¿½45.
	LiptonSA,KimWK,ChoiYB,KumarS,D'EmiliaDM,RayuduPV,etal.NeurotoxicityassociatedwithdualactionsofhomocysteineattheN-methyl-D-aspartatereceptor.ProcNatlAcadSciUSA1997;94:5923ï¿½8.
	MalinowMR,NietoFJ,KrugerWD,DuellPB,HessDL,GluckmanRA,etal.Theeffectsoffolicacidsupplementationonplasmatotalhomocysteinearemodulatedbymultivitaminuseandmethylene-tetrahydrofolatereductasegenotypes.ArteriosclerThrombVascBiol1997;17:1157ï¿½62.
	MatsuiT,AraiH,YuzurihaT,YaoH,MiuraM,HashimotoS,etal.Elevatedplasmahomocysteinelevelsandriskofsilentbraininfarctioninelderlypeople.Stroke2001;32:1116ï¿½9.
	McQuillanBM,BeilbyJP,NidorfM,ThompsonPL,HungJ.HyperhomocysteinemiabutnottheC677Tmutationofmethylenetetrahydrofolatereductaseisanindependentriskdeterminantofcarotidwallthickening.ThePerthCarotidUltrasoundDiseaseAssessmentStudy(CUDAS).Circulation1999;99:2383ï¿½8.
	PantoniL,GarciaJH.Pathogenesisofleukoaraiosis:areview.Stroke1997;28:652ï¿½9.
	PolychronopoulosP,GioldasisG,EllulJ,MetallinosIC,LekkaNP,PaschalisC,etal.Familyhistoryofstrokeinstroketypesandsubtypes.JNeurolSci2002;195:117ï¿½22.
	RohdeLE,HennekensCH,RidkerPM.Cross-sectionalstudyofsolubleintercellularadhesionmolecule-1andcardiovascularriskfactorsinapparentlyhealthymen.ArteriosclerThrombVascBiol1999;19:1595ï¿½
	SeshadriS,BeiserA,SelhubJ,JacquesPF,RosenbergIH,D'AgostinoRB,etal.PlasmahomocysteineasariskfactorfordementiaandAlzheimerï¿½sdisease.NewEnglJMed2002;346:476ï¿½83.
	SpenceJD,MalinowMR,BarnettPA,MarianAJ,FreemanD,HegeleRA.Plasmahomocyst(e)ineconcentration,butnotMTHFRgenotype,isassociatedwithvariationincarotidplaquearea.Stroke1999;30:969ï¿½73.
	StamlerJS,OsborneJA,JarakiO,RabbaniLE,MullinsM,SingelD,etal.Adversevasculareffectsofhomocysteinearemodulatedbyendothelium-derivedrelaxingfactorandrelatedoxidesofnitrogen.JClinInvest1993;91:308ï¿½18.
	SteinJH,McBridePE.Hyperhomocysteinemiaandatheroscleroticvasculardisease:pathophysiology,screening,andtreatment.off.ArchInternMed1998;158:1301ï¿½6.
	TawakolA,OmlandT,GerhardM,WuJT,CreagerMA.Hyperhomocyst(e)inemiaisassociatedwithimpairedendothelium-dependentvasodilationinhumans.Circulation1997;95:1119ï¿½21.
	TerborgC,GoraF,WeillerC,RotherJ.Reducedvasomotorreactivityincerebralmicroangiopathy:astudywithnear-infraredspectroscopyandtranscranialDopplersonography.Stroke2000;31:924ï¿½9.
	TomimotoH,AkiguchiI,SuenagaT,NishimuraM,WakitaH,NakamuraS,etal.Alterationsofthebloodï¿½brainbarrierandglialcellsinwhite-matterlesionsincerebrovascularandAlzheimer'sdiseasepatients.Stroke1996;27:2069ï¿½74.
	VermeerSE,vanDijkEJ,KoudstaalPJ,OudkerkM,HofmanA,ClarkeR,etal.Homocysteine,silentbraininfarcts,andwhitematterlesions:TheRotterdamScanStudy.AnnNeurol2002;51:285ï¿½9.
	WallRT,HarlanJM,HarkerLA,StrikerGE.Homocysteine-inducedendothelialcellinjuryinvitro:amodelforthestudyofvascularinjury.ThrombRes1980;18:113ï¿½21.
	WooKS,ChookP,LolinYI,CheungAS,ChanLT,SunYY,etal.Hyperhomocyst(e)inemiaisariskfactorforarterialendothelialdysfunctioninhumans.Circulation1997;96:2542ï¿½4.
	WorldHealthOrganizationï¿½InternationalSocietyofHypertension.Summaryof1993WorldHealthOrganizationï¿½InternationalSocietyofHypertensionguidelinesforthemanagementofmildhypertension.SubcommitteeofWHO/ISHMildHypertensionLiaisoncommittee.BMJ1993;307:1541ï¿½6.
	YooJH,ChungCS,KangSS.Relationofplasmahomocyst(e)inetocerebralinfarctionandcerebralatherosclerosis.Stroke1998;29:2478ï¿½83.
Brain-2004-Yordanova-351-62.pdf	63
	AlainC,WoodsDL.Age-relatedchangesinprocessingauditorystimuliduringvisualattention:evidencefordeï¿½citsininhibitorycontrolandsensorymemory.PsycholAging1999;14:507ï¿½19.
	AllisonT.Developmentandagingchangesinhumansevokedpotentials.In:BarberC,BlumT,editors.EvokedpotentialsIII.Boston:Butherworths;1987.p.72ï¿½90.
	AmenedoE,DiazF.Aging-relatedchangesinprocessingofnon-targetandtargetstimuliduringanauditoryoddballtask.BiolPsychol1998;48:235ï¿½67.
	BabiloniF,BabiloniC,CarducciF,FattoriniL,OnoratiP,UrbanoA.SplineLaplacianestimateofEEGpotentialsoverarealisticmagneticresonance-constructedscalpsurfacemodel.ElectroencephalogrClinNeurophysiol1996;98:363ï¿½73.
	BabiloniF,CarducciF,BabiloniC,UrbanoA.ImprovedrealisticLaplacianestimateofhighly-sampledEEGpotentialsbyregularizationtechniques.ElectroencephalogrClinNeurophysiol1998;106:336ï¿½43.
	BandG,KokA.Ageeffectsonresponsemonitoringinamental-rotationtask.[Review].BiolPsychol2000;51:201ï¿½21.360J.Yordanovaetal.
	BriggsS,RazN,MarksW.Age-relateddeï¿½citsingenerationandmanipulationofmentalimages:I.Theroleofsensorimotorspeedandworkingmemory.PsycholAging1999;14:427ï¿½35.
	BruniaCH.Neuralaspectsofanticipatorybehavior.ActaPsychol(Amst)1999;101:213ï¿½42.
	BruniaCH,vanBoxtelGJ.Waitandsee.IntJPsychophysiol2001;43:59ï¿½75.
	CabezaR,McIntoshA,TulvingE,NybergL,GradyC.Age-relateddifferencesineffectiveneuralconnectivityduringencodingandrecall.Neuroreport1997;8:3479ï¿½83.
	CabezaR,AndersonND,LocantoreJK,McIntoshAR.Aginggracefully:compensatorybrainactivityinhigh-performingolderadults.Neuroimage2002;17:1394ï¿½402.
	ChaoLL,KnightRT.Prefrontaldeï¿½citsinattentionandinhibitorycontrolwithaging.CerebCortex1997;7:63ï¿½69.
	ColesMG.Modernmind-brainreading:psychophysiology,physiology,andcognition.Psychophysiology1989;26:251ï¿½69.
	CurranT,HillsA,PattersonMB,StraussME.Effectsofagingonvisuospatialattention:anERPstudy.Neuropsychologia2001;39:288ï¿½301.
	deJongR,WierdaM,MulderG,MulderLJ.Useofpartialstimulusinformationinresponseprocessing.JExpPsycholHumPerceptPerform1988;14:682ï¿½92.
	FalkensteinM,HoormannJ,HohnsbeinJ.Changesoferror-relatedERPswithage.ExpBrainRes2001;138:258ï¿½62.
	GazzanigaMS,IvryRB,MangunGR.Cognitiveneuroscience:thebiologyofthemind.NewYork:WWNorton;1998.
	GerloffC,UenishiN,HallettM.Corticalactivationduringfastrepetitiveï¿½ngermovementsinhumans:dipolesourcesofsteady-statemovement-relatedcorticalpotentials.JClinNeurophysiol1998;15:502ï¿½13.
	GhafouriM,LestienneFG.Alteredrepresentationofperipersonalspaceintheelderlyhumansubject:asensorimotorapproach.NeurosciLett2000;289:193ï¿½6.
	GoddeB,BerkefeldT,David-JurgensM,DinseHR.Age-relatedchangesinprimarysomatosensorycortexofrats:evidenceforparalleldegenerativeandplastic-adaptiveprocesses.NeurosciBiobehavRev2002;26:743ï¿½52.
	Goldman-RakicPS.Architectureoftheprefrontalcortexandthecentralexecutive.AnnNYAcadSci1995;769:71ï¿½83.
	GradyCL.Brainimagingandage-relatedchangesincognition.ExpGerontol1998;33:661ï¿½73.
	GrattonG,ColesMGH,DonchinE.Anewmethodforoff-lineremovalofocularartifact.ElectroencephalogrClinNeurophysiol1983;55:468ï¿½84.
	HillyardSA,Anllo-VentoL.Event-relatedbrainpotentialsinthestudyofvisualselectiveattention.ProcNatlAcadSciUSA1998;95:781ï¿½7.
	HutchinsonS,KobayashiM,HorkanCM,Pascual-LeoneA,AlexanderMP,SchlaugG.Age-relateddifferencesinmovementrepresentation.Neuroimage2002;17:1720ï¿½8.
	KaasinenV,VilkmanH,HietalaJ,NagrenK,HeleniusH,OlssonH,etal.Age-relateddopamineD2/D3receptorlossinextrastriatalregionsofthehumanbrain.NeurobiolAging2000;21:683ï¿½8.
	KenemansJ,SmuldersF,KokA.Selectiveprocessingoftwo-dimensionalvisualstimuliinyoungandoldsubjects:electrophysiologicalanalysis.Psychophysiology1995;32:108ï¿½20.
	KnightRT,GraboweckyMF,ScabiniD.Roleofhumanprefrontalcortexinattentioncontrol.AdvNeurol1995;66:21ï¿½36.
	KokA.Age-relatedchangesininvoluntaryandvoluntaryattentionasreï¿½ectedincomponentsoftheevent-relatedpotential(ERP).BiolPsychol2000;54:107ï¿½43.
	KolevV,YordanovaJ,Basar-ErogluC,BasarE.AgeeffectsonvisualEEGresponsesrevealdistinctfrontalalphanetworks.ClinNeurophysiol2002;113:901ï¿½10.
	KristevaR,CheyneD,DeeckeL.Neuromagneticï¿½eldsaccompanyingunilateralandbilateralvoluntarymovements:topographyandanalysisofcorticalsources.ElectroencephalogrClinNeurophysiol1991;81:284ï¿½98.
	LiKZH,LindenbergerU.Relationsbetweenagingsensory/sensorimotorandcognitivefunctions.NeurosciBiobehavRev2002;26:777ï¿½83.
	LiSC,DinseHR.Agingofthebrain,sensorimotor,andcognitiveprocesses.NeurosciBiobehavRev2002;26:729ï¿½32.
	LuuP,TuckerDM.Regulatingaction:alternatingactivationofmidlinefrontalandmotorcorticalnetworks.ClinNeurophysiol2001;112:1295ï¿½306.
	MattayVS,FeraF,TessitoreA,HaririAR,DasS,CallicottJH,etal.Neurophysiologicalcorrelatesofage-relatedchangesinhumanmotorfunction.Neurology2002;58:630ï¿½35.
	MednikovaYuS,KopytovaFV.Somephysiologicalcharacteristicsofmotorcortexneuronsofagedrabbits.Neuroscience1994;63:611ï¿½15.
	MesulamMM.Fromsensationtocognition.Brain1998;121:1013ï¿½52.
	MolenaarPC,vanderMolenMW.Onthediscriminationbetweenglobalandlocaltrendhypothesesoflife-spanchangesinprocessingspeed.ActaPsychol(Amst)1994;86:273ï¿½93.
	MordkoffJT,GianarosPJ.Detectingtheonsetofthelateralizedreadinesspotential:acomparisonofavailablemethodsandprocedures.Psychophysiology2000;37:347ï¿½60
	.llerNG,KnightRT.Age-relatedchangesinfronto-parietalnetworksduringspatialmemory:anERPstudy.BrainResCognBrainRes2002;13:221ï¿½34.
	NunezPL.Electricï¿½eldsofthebrain:theneurophysicsofEEG.NewYork:OxfordUniversityPress;1981.
	NybergL,PerssonJ,NilssonLG.Individualdifferencesinmemoryenhancementbyencodingenactment:relationshipstoadultageandbiologicalfactors.NeurosciBiobehavRev,2002;26:835ï¿½9.
	PeinemannA,LehnerC,ConradB,SiebnerHR.Age-relateddecreaseinpaired-pulseintracorticalinhibitioninthehumanprimarymotorcortex.NeurosciLett2001;313:33ï¿½6.
	PelosiL,BlumhardtL.Effectsofageonworkingmemory:anevent-relatedpotentialstudy.CognBrainRes1999;7:321ï¿½34.
	PerrinF,PernierJ,BertrandO,EchallierJF.Sphericalsplinesforscalppotentialandcurrentdensitymapping.ElectroencephalogrClinNeurophysiol1989;72:184ï¿½187[corrigenda:ElectroencephalogrClinNeurophysiol1990;76:565).
	PoeBH,LinvilleC,Brunso-BechtoldJ.Age-relateddeclineofpresumptiveinhibitorysynapsesinthesensorimotorcortexasrevealedbythephysicaldisector.JCompNeurol2001;439:65ï¿½72.
	PolichJ.OntherelationshipbetweenEEGandP300:individualdifferences,aging,andultradianrhythms.IntJPsychophysiol1997;26:299ï¿½317.
	PolichJ.P300clinicalutilityandcontrolofvariability.JClinNeurophysiol1998;15:14ï¿½33.
	PolichJ.TheoreticaloverviewofP3aandP3b.In:PolichJ,editor.Detectionofchange:event-relatedpotentialandfMRIï¿½ndings.Boston:KluwerAcademic;2003,p.83ï¿½98.
	RazN.Ageingandthebrain.In:Encyclopediaoflifesciences.NaturePublishingGroup;2001.p.1ï¿½6.
	RazN,BriggsS,MarksW,AckerJ.Age-relateddeï¿½citsingenerationandmanipulationofmentalimages:II.Theroleofdorsolateralprefrontalcortex.PsycholAging1999;14:436ï¿½44.
	ReganD.Humanbrainelectrophysiology.Evokedpotentialsandevokedmagneticï¿½eldsinscienceandmedicine.Amsterdam:Elsevier;1989.
	Reuter-LorenzP.Newvisionsoftheagingmindandbrain.TrendsCognSci2002;6:394ï¿½400.
	RockstrohB,ElbertT,CanavanA,LutzenbergerW,BirbaumerN.Slowcorticalpotentialsandbehaviour.2ndedn.Baltimore:UrbanandSchwarzenberg;1989.
	RossiniPM,DesiatoMT,CaramiaMD.Age-relatedchangesofmotorevokedpotentialsinhealthyhumans:non-invasiveevaluationofcentralandperipheralmotortractsexcitabilityandconductivity.BrainRes1992;593:14ï¿½9.
	SailerA,DichgansJ,GerloffC.Theinï¿½uenceofnormalagingonthecorticalprocessingofasimplemotortask.Neurology2000;55:979ï¿½85.
	SalthouseTA.Agingandmeasuresofprocessingspeed.BiolPsychol2000;54:35ï¿½54.
	SchwarzenauP,FalkensteinM,HoormannJ,HohnsbeinJ.Anewmethodfortheestimationoftheonsetofthelateralizedreadinesspotential(LRP).BehavResMethInstrComp1998;30:110ï¿½7.
	TaniguchiY,BurleB,VidalF,BonnetM.Deï¿½citinmotorcorticalactivityforsimultaneousbimanualresponses.ExpBrainRes2001;137:259ï¿½68.Sensorimotorslowingwithageing361
	vanderLubbeR,VerlegerR.AgingandtheSimontask.Psychophysiology2002;39:100ï¿½10.
	VolkowND,GurRC,WangGJ,FowlerJS,MobergPJ,DingYS,etal.Associationbetweendeclineinbraindopamineactivitywithageandcognitiveandmotorimpairmentinhealthyindividuals.AmJPsychiatry1998;155:344ï¿½9.
	YordanovaJ,KolevV,BasarE.EEGthetaandfrontalalphaoscillationsduringauditoryprocessingchangewithaging.ElectroencephalogrClinNeurophysiol1998;108:497ï¿½505.
	YordanovaJ,KolevV,HoormannJ,HohnsbeinA,FalkensteinM.Effectsofagingonsensory-motorprocessinginhumans.In:ReinvangI,GreenleeMW,HermannM,editors.Thecognitiveneuroscienceofindividualdifferences.Oldenburg:Biblioteks-undInformationssystemderCarlvonOssietzkyUniversitatOldenburg(BIS)-Verlag.Inpress2004.
434.full.pdf	54
	1.PierceKL,LefkowitzRJ2001Classicalandnewrolesof-arrestinsintheregulationofG-protein-coupledrecep-tors.NatRevNeurosci2:727?733
	2.MillerWE,LefkowitzRJ2001Expandingrolesfor-arrestinsasscaffoldsandadaptersinGPCRsignalingandtrafficking.CurrOpinCellBiol13:139?145
	3.FergusonSSG2001EvolvingconceptsinGprotein-coupledreceptorendocytosis:theroleinreceptorde-sensitizationandsignaling.PharmacolRev53:1?24
	4.PerrySJ,LefkowitzRJ2002Arrestingdevelopmentsinheptahelicalreceptorsignalingandregulation.TrendsCellBiol12:130?138
	5.SorkinA,vonZastrowM2002Signaltransductionandendocytosis:closeencountersofmanykinds.NatRevMolCellBiol3:600?614
	6.MarcheseA,ChenC,KimY-M,BenovicJL2003TheinsandoutsofGprotein-coupledreceptortrafficking.TrendsBiochemSci28:369?376
	7.TsaoP,CaoT,vonZastrowM2001RoleofendocytosisinmediatingdownregulationofG-protein-coupledre-ceptors.TrendsPharmacolSci22:91?96
	8.HickeL2001Proteinregulationbymonoubiquitin.NatRevMolCellBiol2:195?201
	9.HickeL2001Anewticketforentryintobuddingvesi-cles?ubiquitin.Cell106:527?530
	10.AscoliM1984Lysosomalaccumulationofthehormone-receptorcomplexduringreceptor-mediatedendocytosisofhumanchoriogonadotropin.JCellBiol99:1242?1250
	11.GhineaN,VuhaiMT,Groyer-PicardM-T,HoullierA,Schoeï¿½vaeï¿½rtD,MilgromE1992Pathwaysofinternaliza-tionofthehCG/LHreceptor:immunoelectronmicro-scopicstudiesinLeydigcellsandtransfectedLcells.JCellBiol118:1347?1358
	12.Baratti-ElbazC,ChineaN,LahunaO,LoosfeltH,PichonC,MilgromE1999Internalizationandrecyclingpath-waysofthethyrotropinreceptor.MolEndocrinol13:1751?1765
	13.KishiM,AscoliM2000TheC-terminaltailoftheratlutropin/choriogonadotropinreceptorindependentlymodulateshCG-inducedinternalizationofthecellsur-facereceptorandthelysosomaltargetingoftheinter-nalizedhCG-receptorcomplex.MolEndocrinol14:926?936
	14.KishiM,LiuX,HirakawaT,ReczekD,BretscherA,AscoliM2001Identificationoftwodistinctstructuralmotifsthat,whenaddedtotheC-terminaltailoftheratlutropinreceptor,redirecttheinternalizedhormone-receptorcomplexfromadegradationtoarecyclingpathway.MolEndocrinol15:1624?1635
	15.HeinL,IshiiK,CoughlinSR,KobilkaBK1994Intracel-lulartargetingandtraffickingofthrombinreceptors.JBiolChem269:27719?27726
	16.TrejoJ,CoughlinSR1999Thecytoplasmictailsofpro-tease-activatedreceptor-1andsubstancePreceptorspecifysortingtolysosomesversusrecycling.JBiolChem274:2216?2224
	17.WangY,ZhouY,SzaboK,HaftCR,TrejoJ2002Down-regulationofprotease-activatedreceptor-1isregulatedbysortinnexin1.MolBiolCell13:1965?1976
	18.LawP,HomD,LohH1984Down-regulationofopiatereceptorinneuroblastomaxgliomaNG108?15hybridcells.Chloroquinepromotesaccumulationoftritiateden-kephalininthelysosomes.JBiolChem259:4096?4104
	19.GageRM,KimK-A,CaoTT,vonZastrowM2001AtransplantablesortingsignalthatissufficienttomediaterapidrecyclingofGprotein-coupledreceptors.JBiolChem276:44712?44720
	20.TanowitzM,vonZastrowM2003Anovelendocyticrecyclingsignalthatdistinguishesthemembranetraffick-ingofnaturallyoccurringopioidreceptors.JBiolChem278:45978?45986
	21.WangW,LohHH,LawP-Y2003Theintracellulartraf-fickingofopioidreceptorsdirectedbycarboxyltailandaDi-leucinemotifinNeuro2Acells.JBiolChem278:36848?36858
	22.OkscheA,BoeseG,HorstmeyerA,FurkertJ,BeyermannM,BienertM,RosenthalW2000Lateendosomal/lyso-somaltargetingandlackofrecyclingoftheligand-occu-piedendothelinBreceptor.MolPharmacol57:1104?1113
	23.AbeY,NakayamaK,YamanakaA,SauraiT,GotoK2000Subtype-specifictraffickingofendothelinreceptors.JBiolChem275:8664?8671
	24.BremnesT,PaascheJD,MehlumA,SandbergC,BremnesB,AttramadalH2000Regulationandintracel-lulartraffickingpathwaysoftheendothelinreceptors.JBiolChem275:17596?17604
	25.TrejoJ,HammesSR,CoughlinSR1998Terminationofsignalingbyprotease-activatedreceptor-1islinkedtolysosomalsorting.ProcNatlAcadSciUSA95:13698?13702
	26.WangH,SegaloffDL,AscoliM1991Lutropin/choriogo-nadotropindown-regulatesitsreceptorbybothreceptormediatedendocytosisandacAMP-dependentreductioninreceptormRNA.JBiolChem266:780?785
	27.AscoliM,FanelliF,SegaloffDL2002Thelutropin/cho-riogonadotropinreceptor.A2002perspective.EndocrRev23:141?174
	28.GaletC,MinL,NarayananR,KishiM,WeigelNL,AscoliM2003Identificationofatransferabletwoaminoacidmotif(GT)presentintheC-terminaltailofthehumanlutropinreceptorthatredirectsinternalizedGprotein-coupledreceptorsfromadegradationtoarecyclingpathway.MolEndocrinol17:411?422
	29.NakamuraK,LazariMFM,LiS,KorgaonkarC,AscoliM1999Roleoftherateofinternalizationoftheagonist-receptorcomplexontheagonist-induceddown-regula-tionofthelutropin/choriogonadotropinreceptor.MolEn-docrinol13:1295?1304
	30.AscoliM1981CharacterizationofseveralclonallinesofculturedLeydigtumorcells:gonadotropinreceptorsandsteroidogenicresponses.Endocrinology108:88?95
	31.HirakawaT,GaletC,AscoliM2002MA-10cellstrans-fectedwiththehumanlutropin/choriogonadotropinre-ceptor(hLHR).AnovelexperimentalparadigmtostudythefunctionalpropertiesofthehLHR.Endocrinology143:1026?1035
	32.KrishnamurthyH,KishiH,ShiM,GaletC,BhaskaranRS,HirakawaT,AscoliM2003Post-endocytotictraffickingoftheFSH/FSHreceptorcomplex.MolEndocrinol10.12/me2003-0118
	33.MinL,AscoliM2000Effectofactivatingandinactivatingmutationsonthephosphorylationandtraffickingofthehumanlutropin/choriogonadotropinreceptor.MolEndo-crinol14:1797?1810
	34.ChaturvediK,BandariP,ChinenN,HowellsRD2001Proteasomeinvolvementinagonist-induceddown-regulationofandopioidreceptors.JBiolChem276:12345?12355
	35.MarcheseA,BenovicJL2001Agonist-promotedubiq-uitinationoftheGprotein-coupledreceptorCXCR4me-diateslysosomalsorting.JBiolChem276:45509?45512Galetetal.PostendocytoticTraffickingofhLHRMolEndocrinol,February2004,18(2):434?446445
	36.TanowitzMB,vonZastrowM2002Ubiquitination-inde-pendenttraffickingofGprotein-coupledreceptorstolysosomes.JBiolChem277:50219?50222
	37.WhistlerJL,TsaoP,vonZastrowM2001Aphosphory-lation-regulatedbrakemechanismcontrolstheinitialen-docytosisofopioidreceptorsbutisnotrequiredforpost-endocyticsortingtolysosomes.JBiolChem276:34331?34338
	38.CaoTT,DeaconHW,ReczekD,BretscherA,vonZas-trowM1999Akinase-regulatedPDZ-domaininteractioncontrolsendocyticsortingofthe2-adrenergicreceptor.Nature401:286?290
	39.ShenoySK,McDonaldPH,KohoutTA,LefkowitzRJ2001Regulationofreceptorfatebyubiquitinationofactivated2-arenergicreceptorand-arrestin.Science294:1307?1313
	40.OakleyRH,LaporteSA,HoltJA,BarakLS,CaronMG2001MoleculardeterminantsunderlyingtheformationofstableintracellularGPCR/arrestincomplexesfollowingreceptorendocytosis.JBiolChem276:19452?19460
	41.CongM,PerrySJ,HuLA,HansonPI,ClaingA,LefkowitzRJ2001Bindingofthe2adrenergicreceptortoN-ethylmaleimide-sensitivefactorregulatesreceptorrecy-cling.JBiolChem276:45145?45152
	42.WhistlerJL,EnquistJ,MarleyA,FongJ,GladherF,TsurudaP,MurraySR,vonZastrowM2002ModulationofpostendocytoticsortingofGprotein-coupledrecep-tors.Science297:615?620
	43.WangZ,LiuX,AscoliM1997Phosphorylationofthelutropin/choriogonadotropinreceptorfacilitatesuncou-plingofthereceptorfromadenylylcyclaseandendocy-tosisoftheboundhormone.MolEndocrinol11:183?192
	44.HipkinRW,WangZ,AscoliM1995Humanchorionicgonadotropin-andphorbolesterstimulatedphosphory-lationoftheLH/CGreceptormapstoserines635,639,645and652intheC-terminalcytoplasmictail.MolEn-docrinol9:151?158
	45.HirakawaT,GaletC,KishiM,AscoliM2003GIPCbindstothehumanlutropinreceptor(LHR)throughanunusualPDZdomainbindingmotifanditregulatesthesortingoftheinternalizedhumanchoriogonadotropin(hCG)andthedensityofcellsurfaceLHR.JBiolChem278:49348?49357
	46.KishiH,KrishnamurthyH,GaletC,BhaskaranRS,AscoliM2002IdentificationofashortlinearsequencepresentintheC-terminaltailoftheratfollitropinreceptorthatmodulatesarrestin-3bindinginaphosphorylation-inde-pendentfashion.JBiolChem277:21939?21946
	47.FabritzJ,RyanS,AscoliM1998Transfectedcellsex-pressmostlytheintracellularprecursorofthelutropin/choriogonadotropinreceptorbutthisprecursorbindschoriogonadotropinwithhighaffinity.Biochemistry37:664?672
	48.ChenC,OkayamaH1987High-efficiencytransformationofmammaliancellsbyplasmidDNA.MolCellBiol7:2745?2752
	49.AscoliM1982Internalizationanddegradationofrecep-tor-boundhumanchoriogonadotropininLeydigtumorcells.Fateofthehormonesubunits.JBiolChem257:13306?13311
	50.NakamuraK,AscoliM1999Adileucine-basedmotifintheC-terminaltailofthelutropin/choriogonadotropinre-ceptorinhibitsendocytosisoftheagonist-receptorcom-plex.MolPharmacol56:728?736
	51.QuintanaJ,HipkinRW,AscoliM1993Apolyclonalan-tibodytoasyntheticpeptidederivedfromtheratFSHreceptorrevealstherecombinantreceptorasa74kDaprotein.Endocrinology133:2098?2104
	52.MinL,GaletC,AscoliM2002Theassociationofarres-tin-3withthehumanlutropin/choriogonadotropinrecep-tordependsmostlyonreceptoractivationratherthanonreceptorphosphorylation.JBiolChem277:702?710
	53.MargolskeeR,McHenry-RindeB,HornR1993Panningtransfectedcellsforelectrophysiologicalstudies.Bio-techniques15:906?911
	54.AscoliM,PuettD1978Gonadotropinbindingandstim-ulationofsteroidogenesisinLeydigtumorcells.ProcNatlAcadSciUSA75:99?102
J. Biol. Chem.-2004-Hong-Geller-5676-84.pdf	8
	1.Marrack,P.,andKappler,J.(1990)Science248,1066
	2.Ulrich,R.G.,Bavari,S.,andOlson,M.A.(1995)TrendsMicrobiol.3,463?468
	3.Schiffenbauer,J.,Johnson,H.M.,Butfiloski,E.J.,Wegrzyn,L.,andSoos,J.M.(1993)Proc.Natl.Acad.Sci.U.S.A.90,8543?8546
	4.Laurence,J.,Hodtsev,A.S.,andPosnett,D.N.(1992)Nature358,255?259
	5.Yarwood,J.M.,Leung,D.Y.,andSchlievert,P.M.(2000)FEMSMicrobiol.Lett.192,1?7
	6.Jardetzky,T.S.,Brown,J.H.,Gorga,J.C.,Stern,L.J.,Urban,R.G.,Chi,Y.I.,Stauffacher,C.,Strominger,J.L.,andWiley,D.C.(1994)Nature368,711?718
	7.Kim,J.,Urban,R.G.,Strominger,J.L.,andWiley,D.C.(1994)Science266,1870?1874
	8.Fields,B.A.,Malchiodi,E.L.,Li,H.,Ysern,X.,Stauffacher,C.V.,Schlievert,P.M.,Karjalainen,K.,andMariuzza,R.A.(1996)Nature384,188?192
	9.Li,H.,Lera,A.,Tsuchiya,D.,Leder,L.,Ysern,X.,Schlievert,P.,Karjalainen,K.,andMariuzza,R.(1998)Immunity9,807?816
	10.Reiser,H.,andStadecker,M.J.(1996)N.Engl.J.Med.335,1369?1377
	11.Haddad,J.(2002)Biochem.Biophys.Res.Comm.297,700?713
	12.Choi,Y.W.,Kotzin,B.,Herron,L.,Callahan,J.,Marrack,P.,andKappler,J.(1989)Proc.Natl.Acad.Sci.U.S.A.86,8941?8945
	13.Sundberg,E.,Li,Y.,andMariuzza,R.(2002)Curr.Opin.Immunol.14,36?44
	14.Kreiswirth,B.,Kornblum,J.,Arbeit,R.D.,Eisner,W.,Maslow,J.N.,McGeer,A.,Low,D.E.,andNovick,R.P.(1993)Science259,227?230
	15.Pearson,H.(2002)Nature418,469
	16.Hong-Geller,E.,andGupta,G.(2003)J.Mol.Recog.16,91?101
	17.Shinefield,H.,Black,S.,Fattom,A.,Horwith,G.,Rasgon,S.,Ordonez,J.,Yeoh,H.,Law,D.,Robbins,J.B.,Schneerson,R.,Muenz,L.,Fuller,S.,Johnson,J.,Fireman,B.,Alcorn,H.,andNaso,R.(2002)N.Engl.J.Med.346,491?496
	18.Balaban,N.,Goldkorn,T.,Nhan,R.T.,Dang,L.B.,Scott,S.,Ridgley,R.M.,Rasooly,A.,Wright,S.C.,Larrick,J.W.,Rasooly,R.,andCarlson,J.R.(1998)Science280,438?440
	19.Arad,G.,Levy,R.,Hillman,D.,andKaempfer,R.(2000)Nat.Med.6,414?421
	20.Papageorgiou,A.,Tranter,H.,andAcharya,K.(1998)J.Mol.Biol.277,61?79
	21.Prasad,G.,Radhakrishnan,R.,Mitchell,D.,Earhart,C.,Dinges,M.,Cook,W.,Schlievert,P.,andOhlendorf,D.(1997)ProteinSci.6,1220?1227
	22.Chi,Y.,Sadler,I.,Jablonski,L.,Callantine,S.,Deobald,C.,Stauffacher,C.,andBohach,G.(2002)J.Biol.Chem.277,22839?22846
	23.Lehnert,N.M.,Allen,D.L.,Allen,B.L.,Catasti,P.,Shiflett,P.R.,Chen,M.,Lehnert,B.E.,andGupta,G.(2001)Biochemistry40,4222?4228
	24.Kappler,J.,White,J.,Kozono,H.,Clements,J.,andMarrack,P.(1994)Proc.Natl.Acad.Sci.U.S.A.91,8462?8466
	25.Malchiodi,E.L.,Eisenstein,E.,Fields,B.A.,Ohlendorf,D.H.,Schlievert,P.M.,Karjalainen,K.,andMariuzza,R.A.(1995)J.Exp.Med.182,1833?1845
	26.Leder,L.,Llera,A.,Lavoie,P.M.,Lebedeva,M.I.,Li,H.,Sekaly,R.P.,Bohach,G.A.,Gahr,P.J.,Schlievert,P.M.,Karjalainen,K.,andMariuzza,R.A.(1998)J.Exp.Med.187,823?833
	27.Kieke,M.C.,Sundberg,E.,Shusta,E.V.,Mariuzza,R.A.,Wittrup,K.D.,andKranz,D.M.(2001)J.Mol.Biol.307,1305?1315
	28.Arcus,V.,Proft,T.,Sigrell,J.,Baker,H.,Fraser,J.,andBaker,E.(2000)J.Mol.Biol.299,157?1682M.Mollhoff,H.VanderZanden,P.R.Shiflett,andG.Gupta,manu-scriptinpreparation.ReceptorMimicsThatInhibitSuperantigenPathogenesis5683
	29.Altschul,S.,Madden,T.,Schaffer,A.,Zhang,J.,Zhang,Z.,Miller,W.,andLipman,D.(1997)NucleicAcidsRes.25,3389?3402
	30.Sanchez,R.,andSali,A.(1999)J.Comp.Phys.151,388?401
	31.Papageorgiou,A.,Quinn,C.,Beer,D.,Brehm,R.,Tranter,H.,Bonventre,P.,andAcharya,K.(1996)ProteinSci.5,1737?1741
	32.Pearlman,D.,Case,D.,Caldwell,J.,Ross,W.,Cheatham,T.,III,Ferguson,D.,Seibel,G.,ChandraSingh,U.,Weiner,P.,andKollman,P.(1995)AMBER4.1,UniversityofCalifornia,SanFrancisco,CA
	33.Koradi,R.,Billeter,M.,andWuthrich,K.(1996)J.Mol.Graph.14,51?55
	34.Fontenot,J.,Gatewood,J.,Mariappan,S.,Pau,C.,Parekh,B.,George,J.,andGupta,G.(1995)Proc.Natl.Acad.Sci.U.S.A.92,315?319
	35.Arcus,V.,Langley,R.,Proft,T.,Fraser,J.,andBaker,E.(2002)J.Biol.Chem.277,32274?32281
	36.Fraser,J.,Arcus,V.,Kong,P.,Baker,E.,andProft,T.(2000)Mol.Med.Today6,125?132
	37.Papageorgiou,A.C.,andAcharya,K.R.(2000)TrendsMicrobiol.8,369?375
	38.Guex,N.,andPeitsch,M.(1997)Electrophoresis18,2714?2723
	39.Orengo,C.,andTaylor,W.(1996)MethodsEnzym.266,617?634ReceptorMimicsThatInhibit5684SuperantigenPathogenesis
J. Biol. Chem.-2004-Thevissen-3900-5.pdf	48
	1.Thomma,B.P.H.J.,Cammue,B.P.A.,andThevissen,K.(2002)Planta216,193?202
	2.Bonmatin,J.M.,Bonnat,J.L.,Gallet,X.,Vovelle,F.,Ptak,M.,Reichhart,J.M.,Hoffmann,J.A.,Keppi,E.,Legrain,M.,andAchstetter,T.(1992)J.Biomol.NMR2,235?256
	3.Cornet,B.,Bonmatin,J.M.,Hetru,C.,Hoffmann,J.A.,Ptak,M.,andVovelle,F.(1995)Structure3,435?448
	4.Lamberty,M.,Caille,A.,Landon,C.,Tassin-Moindrot,S.,Hetru,C.,Bulet,P.,andVovelle,F.(2001)Biochemistry40,11995?12003
	5.Lamberty,M.,Ades,S.,Uttenweiler-Joseph,S.,Brookhart,G.,Bushey,D.,Hoffmann,J.A.,andBulet,P.(1999)J.Biol.Chem.274,9320?9326
	6.Terras,F.R.,Schoofs,H.M.,DeBolle,M.F.,VanLeuven,F.,Rees,S.B.,Vanderleyden,J.,Cammue,B.P.,andBroekaert,W.F.(1992)J.Biol.Chem.267,15301?15309
	7.Thevissen,K.,Osborn,R.W.,Acland,D.P.,andBroekaert,W.F.(1997)J.Biol.Chem.272,32176?32181
	8.Thevissen,K.,Osborn,R.W.,Acland,D.P.,andBroekaert,W.F.(2000)Mol.PlantMicrobeInteract.13,54?61
	9.Thevissen,K.,Terras,F.R.,andBroekaert,W.F.(1999)Appl.Environ.Microbiol.65,5451?5458
	10.Thevissen,K.,Cammue,B.P.,Lemaire,K.,Winderickx,J.,Dickson,R.C.,Lester,R.L.,Ferket,K.K.,VanEven,F.,Parret,A.H.,andBroekaert,W.F.(2000)Proc.Natl.Acad.Sci.U.S.A.97,9531?9536
	11.Dickson,R.C.,Nagiec,E.E.,Wells,G.B.,Nagiec,M.M.,andLester,R.L.(1997)J.Biol.Chem.272,29620?29625
	12.Thevissen,K.,Francois,I.E.J.A.,Takemoto,J.Y.,Ferket,K.K.A.,Meert,E.M.K.,andCammue,B.P.A.(2003)FEMSMicrobiol.Lett.226,169?173
	13.Leipelt,M.,Warnecke,D.,Zaï¿½hringer,U.,Ott,C.,Muï¿½ller,F.,Hube,B.,andHeinz,E.(2001)J.Biol.Chem.276,33621?33629
	14.Toledo,M.S.,Levery,S.B.,Straus,A.H.,andTakahashi,H.K.(2000)J.LipidRes.41,797?806
	15.Toledo,M.S.,Levery,S.B.,Suzuki,E.,Straus,A.H.,andTakahashi,H.K.(2001)Glycobiology11,113?124
	16.Sakaki,T.,Zaï¿½hringer,U.,Warnecke,D.C.,Fahl,A.,Knogge,W.,andHeinz,E.(2001)Yeast18,679?695
	17.Warnecke,D.,andHeinz,E.(2003)Cell.Mol.LifeSci.60,919?941
	18.Dickson,R.C.,andLester,R.L.(1999)Biochim.Biophys.Acta1426,347?357
	19.Matsubara,T.,Hayashi,A.,Banno,Y.,Morita,T.,andNozawa,Y.(1987)Chem.Phys.Lipids43,1?12
	20.Osborn,R.W.,DeSamblanx,G.W.,Thevissen,K.,Goderis,I.,Torrekens,S.,VanLeuven,F.,Attenborough,S.,Rees,S.B.,andBroekaert,W.F.(1995)FEBSLett.368,257?262
	21.DeSamblanx,G.W.,Goderis,I.J.,Thevissen,K.,Raemaekers,R.,Fant,F.,Borremans,F.,Acland,D.P.,Osborn,R.W.,Patel,S.,andBroekaert,W.F.(1997)J.Biol.Chem.272,1171?1179
	22.Brade,L.,Vielhaber,G.,Heinz,E.,andBrade,H.(2000)Glycobiology10,629?636
	23.Fonzi,W.A.,andIrwin,M.Y.(1993)Genetics134,717?728
	24.Morris,D.L.(1948)Science107,254?257
	25.Ternes,P.,Franke,S.,Zaï¿½hringer,U.,Sperling,P.,andHeinz,E.(2002)J.Biol.Chem.277,25512?25518
	26.Sperling,P.,Zaï¿½hringer,U.,andHeinz,E.(1998)J.Biol.Chem.273,28590?28596
	27.Mamelak,D.,andLingwood,C.(2001)J.Biol.Chem.276,449?456
	28.Mylvaganam,M.,Binnington,B.,Hansen,H.C.,Magnusson,G.,Nyholm,P.G.,andLingwood,C.A.(2002)Biochem.J.368,769?776
	29.Mamelak,D.,Mylvaganam,M.,Tanahashi,E.,Ito,H.,Ishida,H.,Kiso,M.,andLingwood,C.(2001)Carbohydr.Res.335,91?100
	30.Toledo,M.S.,Suzuki,E.,Levery,S.B.,Straus,A.H.,andTakahashi,H.K.(2001)Glycobiology11,105?112
	31.Xu,X.,Bittman,R.,Duportail,G.,Heissler,D.,Vilcheze,C.,andLondon,E.(2001)J.Biol.Chem.276,33540?33546
	32.Bagnat,M.,Keranen,S.,Shevchenko,A.,Shevchenko,A.,andSimons,K.(2000)Proc.Natl.Acad.Sci.U.S.A.97,3254?3259
	33.Roth,B.L.,Poot,M.,Yue,S.T.,andMillard,P.J.(1997)Appl.Environ.Microbiol.63,2421?2431
	34.Kawai,G.,andIkeda,Y.(1985)J.LipidRes.26,338?343
	35.Pinto,M.R.,Rodrigues,M.L.,Travassos,L.R.,Haido,R.M.,Wait,R.,andBarreto-Bergter,E.(2002)Glycobiology12,251?260
	36.Levery,S.B.,Toledo,M.S.,Doong,R.L.,Straus,A.H.,andTakahashi,H.K.(2000)RapidCommun.MassSpectrom.14,551?563
	37.Rodrigues,M.L.,Travassos,L.R.,Miranda,K.R.,Franzen,A.J.,Rozental,S.,deSouza,W.,Alviano,C.S.,andBarreto-Bergter,E.(2000)Infect.Immun.68,7049?7060
	38.Schneiter,R.,Brugger,B.,Sandhoff,R.,Zellnig,G.,Leber,A.,Lampl,M.,Athenstaedt,K.,Hrastnik,C.,Eder,S.,Daum,G.,Paltauf,F.,Wieland,F.T.,andKohlwein,S.D.(1999)J.CellBiol.146,741?754
	39.Mendez,E.,Moreno,A.,Colilla,F.,Pelaez,F.,Limas,G.G.,Mendez,R.,Soriano,F.,Salinas,M.,anddeHaro,C.(1990)Eur.J.Biochem.194,533?539
	40.Mendez,E.,Rocher,A.,Calero,M.,Girbes,T.,Citores,L.,andSoriano,F.(1996)Eur.J.Biochem.239,67?73
	41.Banzet,N.,Latorse,M.-P.,Bulet,P.,Francois,E.,Derpierre,C.,andDubald,M.(2002)PlantSci.162,995?1006
	42.Waddell,T.,Cohen,A.,andLingwood,C.A.(1990)Proc.Natl.Acad.Sci.U.S.A.87,7898?7901
	43.Lingwood,C.A.(1994)Nephron66,21?28
	44.Mori,T.,Kiyokawa,N.,Katagiri,Y.U.,Taguchi,T.,Suzuki,T.,Sekino,T.,Sato,N.,Ohmi,K.,Nakajima,H.,Takeda,T.,andFujimoto,J.(2000)Exp.Hematol.28,1260?1268
	45.Sandvig,K.,Olsnes,S.,Brown,J.E.,Petersen,O.W.,andvanDeurs,B.(1989)J.CellBiol.108,1331?1343
	46.Kiyokawa,N.,Taguchi,T.,Mori,T.,Uchida,H.,Sato,N.,Takeda,T.,andFujimoto,J.(1998)J.Infect.Dis.178,178?184
	47.Gordon,J.,Challa,A.,Levens,J.M.,Gregory,C.D.,Williams,J.M.,Armitage,R.J.,Cook,J.P.,Roberts,L.M.,andLord,J.M.(2000)CellDeathDiffer.7,785?794
	48.Sullards,M.C.,Lynch,D.V.,Merrill,A.H.,Jr.,andAdams,J.(2000)J.MassSpectrom.35,347?353
89.pdf	63
	1.MaltaisF,JobinJ,SullivanMJ,BernardS,WhittomF,KillianKJ,DesmeulesM,BelangerM,LeBlancP.MetabolicandhemodynamicresponsesoflowerlimbduringexerciseinpatientswithCOPD.JApplPhysiol1998;84:1573?1580.
	2.KutsuzawaT,ShioyaS,KuritaD,HaidaM,OhtaY,YamabayashiH.Muscleenergymetabolismandnutritionalstatusinpatientswithchronicobstructivedisease:a31Pmagneticresonancestudy.AmJRespirCritCareMed1995;152:647?652.
	3.MaltaisF,SimmardA,SimardC,JobinJ,DesagnesP,LeBlancP.Oxida-tivecapacityoftheskeletalmuscleandlacticacidkineticsduringexerciseinnormalsubjectsandinpatientswithCOPD.AmJRespirCritCareMed1996;153:288?293.
	4.MattsonJ,PooleD.Pulmonaryemphysemadecreasesskeletalmuscleoxidativeenzymecapacity.JApplPhysiol1998;85:210?214.
	5.BernardS,LeBlancP,WhittomF,CarrierG,JobinJ,BelleauR,MaltaisF.Peripheralmuscleweaknessinpatientswithchronicobstructivepulmonarydisease.AmJRespirCritCareMed1998;158:629?634.
	6.Skeletalmuscledysfunctioninchronicobstructivepulmonarydisease:astatementoftheAmericanThoracicSocietyandEuropeanRespira-torySociety.AmJRespirCritCareMed1999;159:S1?S40.
	7.RichardsonRS.Skeletalmuscledysfunctionvs.muscledisuseinpatientswithCOPD.JApplPhysiol1999;86:1751?1753.
	8.SerresI,GautierV,VarryA,PrefautC.Impairedskeletalmuscleendur-ancerelatedtophysicalinactivityandalteredlungfunctioninCOPDpatients.Chest1998;113:900?905.
	9.MaltaisF,LeBlancP,SimardC,JobinJ,BerbueC,BruneauJ,CarrierL,BelleauR.Skeletalmuscleadaptationtoendurancetraininginpatientswithchronicobstructivepulmonarydisease.AmJRespirCritCareMed1996;154:442?447.
	10.SalaE,RocaJ,MarradesR,AlonsoJ,GonzalezdeSusoJ,MorenoA,BarberaJ,NadalJ,deJoverL,Rodriguez-RoisinR,etal.Effectsofendurancetrainingonskeletalmusclebioenergeticsinchronicob-structivepulmonarydisease.AmJRespirCritCareMed1999;159:1726?1734.
	11.AndersenP,AdamsRP,SjogaardG,ThorbeA,SaltinB.Dynamickneeextensionasamodelforstudyofisolatedexercisingmuscleinhumans.JApplPhysiol1985;59:1647?1653.
	12.RichardsonRS,FrankRL,HaselerLJ.Dynamicknee-extensorandcycleexercise:functionalMRIofmuscularactivity.IntJSportsMed1998;19:182?187.
	13.RichardsonRS,SheldonJ,PooleDC,HopkinsSR,RiesAL,WagnerPD.Evidenceofskeletalmusclemetabolicreserveduringwholebodyexerciseinpatientswithchronicobstructivepulmonarydisease.AmJRespirCritCareMed1999;159:881?885.
	14.RichardsonR,LeakB,HaselerL,GavinT,SheldonJ,EltinP,OlfertI,RiesA,WagnerP.NormalskeletalmusclefunctioninpatientswithCOPDwhenexerciseisnotcentrallylimited[abstract].MedSciSportsExerc1999;31:S277.
	15.CrapoRO,MorrisAH,GardnerRM.ReferencespirometricvaluesusingtechniquesandequipmentthatmeetATSrecommendations.AmRevRespirDis1981;123:659?664.
	16.FolsomAR,JacobsDRJr,CaspersenCJ,Gomez-MarinO,KnudsenJ.Test-retestreliabilityoftheMinnesotaLeisureTimePhysicalActivityQuestionnaire.JChronicDis1986;39:505?511.
	17.TaylorHL,JacobsDRJr,SchuckerB,KnudsenJ,LeonAS,DebackerG.Aquestionnairefortheassessmentofleisuretimephysicalactivities.JChronicDis1978;31:741?755.
	18.JacobsD,LuepkerR,MittelmarkM,FolsomA,PirieP,MascioliS,HannanP,PechacekT,BrachtN,CarlawR,etal.Community-widepreventionstratergies:evaluationdesignoftheMinnesotaHeartHealthProgram.JChronicDis1986;39:775?788.
	19.RichardsonRS,PooleDC,KnightDR,KurdakSS,HoganMC,GrassiB,JohnsonEC,KendrickK,EricksonBK,WagnerPD.Highmusclebloodflowinman:ismaximalO2extractioncompromised?JApplPhysiol1993;75:1911?1916.
	20.RichardsonRS,NoyszewskiEA,KendrickKF,LeighJS,WagnerPD.MyoglobinO2desaturationduringexercise:evidenceoflimitedO2transport.JClinInvest1995;96:1916?1926.
	21.PooleDC,GaesserGA,HoganMC,KnightDR,WagnerPD.PulmonaryandlegVO2duringsubmaximalexercise:implicationsformuscularefficiency.JApplPhysiol1992;72:805?810.
	22.AndersenP,SaltinB.Maximalperfusionofskeletalmuscleinman.JPhysiol1985;366:233?249.
	23.JonesPRM,PearsonJ.Anthropometricdeterminationoflegfatandmuscleplusbonevolumesinyoungmaleandfemaleadults.JPhysiol1969;294:63P?66P.
	24.HoppelerH,LuthiP,ClaasenH,WeibelER,HowaldH.Theultrastruc-tureofnormalhumanskeletalmuscle:amorphometricanalysisonuntrainedmen,womenandwell-trainedorienteers.PflugersArch1973;344:217?232.
	25.ReynafarjeB.Simplifiedmethodforthedeterminationofmyoglobin.JLabClinMed1963;61:138?145.
	26.JobinJ,MaltaisF,DoyonJF,LeBlancP,SimardPM,SimardAA,SimardC.Chronicobstructivepulmonarydisease:capillarityandfiber-typecharacteristicsofskeletalmuscle.JCardiopulmRehabil1998;18:432?437.
	27.JakobssonP,JordfeldtL,BrundenA.Skeletalmusclemetabolitesandfibretypesinpatientswithadvancedchronicobstructivepulmonarydisease(COPD),withandwithoutchronicrespiratoryfailure.EurRespirJ1990;3:192?196.
	28.MaltaisF,SullivanMJ,LeBlancP,DuschaBD,SchachatFH,SimardC,BlankJM,JobinJ.AlteredexpressionofmyosinheavychaininthevastuslateralismuscleinpatientswithCOPD.EurRespirJ1999;13:850?854.
	29.SattaA,MiglioriGB,SpanevelloA,NeriM,BottinelliR,CanepariM,PellegrinoMA,ReggianiC.Fibretypesinskeletalmusclesofchronicobstructivepulmonarydiseasepatientsrelatedtorespiratoryfunctionandexericsetolerance.EurRespirJ1997;10:2853?2860.
	30.LarssonL.Histochemicalcharacteristicsofhumanskeletalmuscleduringaging.ActaPhysiolScand1983;117:469?471.
	31.ItohK,MoritaniT,IshidaK,HirofujiC,TaguchiS,ItohM.Hypoxia-inducedfibretypetransformationinrathindlimbmuscles:histochemi-calandelectro-mechanicalchanges.EurJApplPhysiolOccupPhysiol1990;60:331?336.
	32.ThomasonDB,BoothFW.Atrophyofthesoleusmusclebyhindlimbunweighting.JApplPhysiol1990;68:1?12.
	33.AndersenJL,MohrT,Biering-SorensenF,GalboH,KjaerM.Myosinheavychainisoformtransformationinsinglefibresfromm.vastuslateralisinspinalcordinjuredindividuals:effectsoflong-termfunc-tionalelectricalstimulation(FES).PflugersArch1996;431:513?518.
	34.BaldwinKM,HaddadF.Effectsofdifferentactivityandinactivitypara-digmsonmyosinheavychaingeneexpressioninstriatedmuscle.JApplPhysiol2001;90:345?357.
	35.BigardAX,SanchezH,BirotO,SerrurierB.Myosinheavychaincompo-sitionofskeletalmusclesinyoungratsgrowingunderhypobarichyp-oxiaconditions.JApplPhysiol2000;88:479?486.
	36.HunterGR,NewcomerBR,Larson-MeyerDE,BammanMM,WeinsierRL.Musclemetaboliceconomyisinverselyrelatedtoexerciseinten-sityandtypeIImyofiberdistribution.MuscleNerve2001;24:654?661.
	37.PooleDC,BarstowTJ,GaesserGA,WillisWT,WhippBJ.VO2slowcomponent:physiologicalandfunctionalsignificance.MedSciSportsExerc1994;26:1354?1358.
	38.CoyleEF,SidossisLS,HorowitzJF,BeltzJD.CyclingefficiencyisrelatedtothepercentageoftypeImusclefibers.MedSciSportsExerc1992;24:782?788.
	39.GibbsCL,GibsonWR.Energyproductionofratsoleusmuscle.AmJPhysiol1972;223:864?871.
	40.WendtIR,GibbsCL.Energyproductionofratextensordigitorumlongusmuscle.AmJPhysiol1973;224:1081?1086.
	41.BaranyM.ATPaseactivityofmyosincorrelatedwithspeedofmuscleshortening.JGenPhysiol1967;50:197?218.
	42.CrowMT,KushmerickMJ.Chemicalenergeticsofslow-andfast-twitchmusclesofthemouse.JGenPhysiol1982;79:147?166.
	43.MaltaisF,SimonM,JobinJ,DesmeulesM,SullivanMJ,BelangerM,LeblancP.EffectsofoxygenonlowerlimbbloodflowandO2uptakeduringexerciseinCOPD.MedSciSportsExerc2001;33:916?922.
	44.O?DonnellDE,BertleyJC,ChauLK,WebbKA.Qualitativeaspectsofexertionalbreathlessnessinchronicairflowlimitation:pathophysio-logicmechanisms.AmJRespirCritCareMed1997;155:109?115.
	45.LevisonH,CherniackRM.Ventilatorycostofexerciseinchronicob-structivepulmonarydisease.JApplPhysiol1968;25:21?27.
	46.HarmsCA,BabcockMA,McClaranSR,PegelowDF,NickeleGA,NelsonWB,DempseyJA.Respiratorymuscleworkcompromiseslegbloodflowduringmaximalexercise.JApplPhysiol1997;82:1573?1583.
	47.Gonzalez-AlonsoJ,RichardsonRS,SaltinB.Exercisingskeletalmusclebloodflowinhumansrespondstoreductioninarterialoxyhaemog-lobin,butnottoalteredfreeoxygen.JPhysiol2001;530:331?341.
	48.RichardsonRS,GrassiB,GavinTP,HaselerLJ,TagoreK,RocaJ,WagnerPD.EvidenceofO2supply-dependentVO2maxintheexer-cise-trainedhumanquadriceps.JApplPhysiol1999;86:1048?1053.
	49.RichardsonRS,NewcomerSC,NoyszewskiEA.Skeletalmuscleintracel-lularPO(2)assessedbymyoglobindesaturation:responsetogradedexercise.JApplPhysiol2001;91:2679?2685.
	50.MollerP,HellstromK,HermanssonIL.Myoglobincontentinlegskeletalmuscleinpatientswithchronicobstructivelungdisease.Respiration(Herrlisheim)1984;45:35?38.
	51.MollerP,SylvenC.Myoglobininhumanskeletalmuscle.ScandJClinLabInvest1981;41:479?482.
	52.KendrewJ,ParrishR,MarrackJ,OrlansE.Thespeciesspecfictiyofmyoglobin.Nature1977;174:946.
	53.ConleyKE,OrdwayGA,RichardsonRS.Decipheringthemysteriesofmyoglobininstriatedmuscle.ActaPhysiolScand2000;168:623?634.
	54.PattengalePK,HolloszyJO.Augmentationofskeletalmusclemyoglobinbyaprogramoftreadmillrunning.AmJPhysiol1967;213:783?785.
	55.OshiroT.Experimentalstudiesofmyoglobininskeletalmusclefollowingdenervationandreinervation.ActaMedFukuoka1966;36:531?567.
	56.WhittomF,JobinJ,SimardPM,LeblancP,SimardC,BernardS,BelleauR,MaltaisF.Histochemicalandmorphologicalcharacteristicsofthevastuslateralismuscleinpatientswithchronicobstructivepulmonarydisease.MedSciSportsExerc1998;30:1467?1474.
	57.Mathieu-CostelloO,SaurezRK,HowchachkaPW.Capillary-to-fibergeometryandmitochondrialdensityinhummingbirdflightmuscle.RespirPhysiol1992;89:113?132.
	58.Mathieu-CostelloO.Compartiveaspectsofmusclecapillarysupply.AnnuRevPhysiol1993;55:503?525.
	59.RichardsonRS,WagnerH,MudaliarSR,HenryR,NoyszewskiEA,WagnerPD.HumanVEGFgeneexpressioninskeletalmuscle:effectofacutenormoxicandhypoxicexercise.AmJPhysiol1999;277:H2247?H2252.
	60.MaltaisF,LeBlancP,WhittomF,SimardC,MarquisK,BelangerM,BretonMJ,JobinJ.OxidativeenzymeactivitiesofthevastuslateralismuscleandthefunctionalstatusinpatientswithCOPD.Thorax2000;55:848?853.
	61.HoppelerH,HowaldH,ConleyK,LindstedtSL,ClaasenH,VockP,WeibelER.Endurancetraininginhumans:aerobiccapacityandstructureofskeletalmuscle.JApplPhysiol1985;59:320?327.
	62.LeekBT,MudaliarSR,HenryR,Mathieu-CostelloO,RichardsonRS.Effectofacuteexerciseoncitratesynthaseactivityinuntrainedandtrainedhumanskeletalmuscle.AmJPhysiolRegulIntegrCompPhys-iol2001;280:R441?R447.
	63.GallagherD,VisserM,DeMeersmanRE,SepulvedaD,BaumgartnerRN,PiersonRN,HarrisT,HeymsfieldSB.Appendicularskeletalmusclemass:effectsofage,genderandethnicity.JApplPhysiol1997;83:229?239.
Am J Physiol Heart Circ Physiol-2004-Miura-H214-21.pdf	50
	1.ArmstrongSC,KaoR,GaoW,SchivellLC,DowneyJM,HonkanenRE,andGanoteCE.Comparisonofinvitropreconditioningresponsesofisolatedpigandrabbitcardiomyocytes:effectsofaproteinphosphataseinhibitor,fostriecin.JMolCellCardiol29:3009?3024,1997.
	2.BeardsleeMA,LernerDL,TadrosPN,LaingJG,BeyerEC,YamadaKA,KleberAG,SchuesslerRB,andSaffitzJE.Dephosphorylationandintracellularredistributionofventricularconnexin43duringelectricaluncouplinginducedbyischemia.CircRes87:656?662,2000.
	3.CohenMV,BainesCP,andDowneyJM.Ischemicpreconditioning:fromadenosinereceptortoKATPchannel.AnnuRevPhysiol62:79?109,2000.
	4.DaleauP,BoudriauS,MichaudM,JolicoeurC,andKingmaJG.Preconditioningintheabsenceorpresenceofsustainedischemiamodu-latesmyocardialCx43proteinlevelsandgapjunctiondistribution.CanJPhysiolPharmacol79:371?378,2001.
	5.DavidsonJSandBaumgartenIM.Glycyrrhetinicacidderivatives:anovelclassofinhibitorsofgap-junctionalintercellularcommunication.Structure-activityrelationships.JPharmacolExpTher246:1104?1107,1988.
	6.DheinS.Gapjunctionchannelsinthecardiovascularsystem:pharmaco-logicalandphysiologicalmodulation.TrendsPharmacolSci19:229?241,1998.
	7.DobleBW,PingP,andKardamiE.TheepsilonsubtypeofproteinkinaseCisrequiredforcardiomyocyteconnexin-43phorphorylation.CircRes86:293?301,2000.
	8.EngS,MaddafordTG,KardamiE,andPierceGN.Protectionagainstmyocardialischemia/reperfusioninjurybyinhibitorsoftwoseparatepathwaysofNaentry.JMolCellCardiol30:829?835,1998.
	9.Garcia-DoradoD,InserteJ,Ruiz-MeanaM,GonzalezMA,SoleresJ,JuliaM,BarrabesJA,andSoler-SolerJ.Gapjunctionuncouplerheptanolpreventscell-to-cellprogressionofhypercontractureandlimitsnecrosisduringmyocardialreperfusion.Circulation96:3579?3586,1997.
	10.Garcia-DoradoD,Ruiz-MeanaM,PadillaF,Rodriguez-SinovasA,andMirabetM.Gapjunction-mediatedintracellularcommunicationinischemicpreconditioning.CardiovascRes55:456?465,2002.
	11.GuanX,WilsonS,SchlenderKK,andRuchRJ.Gap-junctiondisas-semblyandconnexin43dephosphorylationinducedby18-glycyrrhetinicacid.MolCarcinog16:157?164,1996.
	12.GysemberghA,KlonerRA,andPrzyklenkK.Pretreatmentwiththegapjunctionuncouplerheptanoldoesnotlimitinfarctsizeinrabbitheart.CardiovascPathol10:13?17,2001.
	13.JainSK,SchuesslerRB,andSaffitzJE.Mechanismsofdelayedelec-tricaluncouplinginducedbyischemicpreconditioning.CircRes92:1138?1144,2003.
	14.JenningsRB,MurryCE,andReimerKA.Energymetabolisminpreconditionedandcontrolmyocardium:effectoftotalischemia.JMolCellCardiol23:1449?1458,1991.
	15.JeyaramanM,TanguyS,FandrichRR,LukasA,andKardamiE.Ischemia-induceddephosphorylationofcardiomyocyteconnexin-43isreducedbyokadaicacidandcalyculinAbutnotfostriecin.MolCellBiochem242:129?134,2003.
	16.KondoRP,WangSY,JohnSA,WeissJN,andGoldhaberJI.Meta-bolicinhibitionactivatesanon-selectivecurrentthroughconnexinhemichannelsinisolatedventricularmyocytes.JMolCellCardiol32:1859?1872,2000.
	17.KriegT,QinQ,McIntoshEC,CohenMV,andDowneyJM.AChandadenosineactivatePI3-kinaseinrabbitheartsthroughtransactivationofreceptortyrosinekinases.AmJPhysiolHeartCircPhysiol283:H2322?H2330,2002.
	18.KwakBRandJongsmaHJ.Regulationofcardiacgapjunctionchannelpermeabilityandconductancebyseveralphosphorylatingconditions.MolCellBiochem157:93?99,1996.
	19.KwakBR,vanVeenTA,AnalbersLJ,andJongsmaHJ.TPAincreasesconductancebutdecreasespermeabilityinneonatalratcardiomyocytegapjunctionchannels.ExpCellRes220:456?463,1995.
	20.LampePDandLauAF.Regulationofgapjunctionsbyphosphorylationofconnexins.ArchBiochemBiophys384:205?215,2000.
	21.LampePD,TenBroekEM,BurtJM,KurataWE,JohnsonRG,andLauAF.Phosphorylationofconnexin43onserine368byproteinkinaseCregulatesgapjunctioncommunication.JCellBiol149:1503?1512,2000.
	22.LiF,SugishitaK,SuZ,UedaI,andBarryWH.Activationofconnexin-43hemichannelscanelevate[Ca2]iand[Na]iinrabbitven-tricularmyocytesduringmetabolicinhibition.JMolCellCardiol33:2145?2155,2001.
	23.LiG,WhittakerP,YaoM,KlonerRA,andPrzyklenkK.Thegapjunctionuncouplerheptanolabrogatesinfarctsizereductionwithprecon-ditioninginmousehearts.CardiovascPathol11:158?165,2002.
	24.LiWandNagyJI.Connexin43phosphorylationstateandintercellularcommunicationinculturedastrocytesfollowinghypoxiaandproteinphosphataseinhibition.EurJNeurosci12:2644?2650,2000.
	25.LiangB.ProteinkinaseC-mediatedpreconditioningofcardiacmyocytes:roleofadenosinereceptorandKATPchannel.AmJPhysiolHeartCircPhysiol273:H847?H853,1997.
	26.LiuGS,CohenMV,Mochly-RosenD,andDowneyJM.ProteinkinaseC-isresponsiblefortheprotectionofpreconditioninginrabbitcardio-myocytes.JMolCellCardiol31:1937?1948,1999.
	27.LiuY,SatoT,O?RourkeB,andMarbanE.MitochondrialATP-dependentpotassiumchannels.Noveleffectorsofcardioprotection?Cir-culation97:2467?2469,1998.
	28.MikiT,MiuraT,TannoM,SakamotoJ,KunoA,GendaS,Matsu-motoT,IchikawaY,andShimamotoK.Postinfarctventricularremod-elingimpairsthemechanismofischemicpreconditioningatthelevelofPKC-activation.MolCellBiochem247:185?193,2003.
	29.MiuraT,LiuY,KitaH,OgawaT,andShimamotoK.RolesofmitochondrialATP-sensitiveKchannelsandPKCinanti-infarcttoleranceaffordedbyadenosineA1receptoractivation.JAmCollCardiol35:238?245,2000.
	30.MiuraT,OgawaT,SuzukiK,GotoM,andShimamotoK.InfarctsizelimitationbyanewNa-Hexchangeinhibitor,Hoe642:differencefrompreconditioningintheroleofproteinkinaseC.JAmCollCardiol29:693?701,1997.
	31.MurryCE,JenningsRB,andReimerKA.Preconditioningwithische-mia:adelayoflethalcellinjuryinischemicmyocardium.Circulation74:1124?1136,1986.
	32.MurryCE,RichardVJ,ReimerKA,andJenningsRB.Ischemicpreconditioningslowsenergymetabolismanddelaysultrastructuraldam-ageduringasustainedischemicepisode.CircRes66:913?931,1990.
	33.NozawaY,MiuraT,MikiT,OhnumaY,YanoT,andShimamotoK.MitochondrialKATPchannel-dependentand-independentphasesofische-micpreconditioningagainstmyocardialinfarctionintherat.BasicResCardiol98:50?58,2003.
	34.OhnumaY,MiuraT,MikiT,TannoM,KunoA,TsuchidaA,andShimamotoK.OpeningofmitochondrialKATPchanneloccursdown-streamofPKC-activationinthemechanismofpreconditioning.AmJPhysiolHeartCircPhysiol283:H440?H447,2002.
	35.PainTS,YangY,CritzSD,YueY,NakanoA,LiuGS,HeuschG,CohenMV,andDowneyJM.OpeningofmitochondrialKATPchannelstriggersthepreconditioningstatebygeneratingfreeradicals.CircRes87:460?466,2000.
	36.PikeMM,LuoCS,ClarkMD,KirkKA,KitakazeM,MaddenM,CragoeEJ,andPohostGM.NMRmeasurementsofNaandcellularenergyinischemicratheart:roleofNa/Hexchange.AmJPhysiolHeartCircPhysiol265:H2017?H2026,1993.
	37.PiperM,Garcia-DoradoD,andOvizeM.Afreshlookatreperfusioninjury.CardiovascRes38:291?300,1998.
	38.Ruiz-MeanaM,Garcia-DoradoD,HofstaetterB,PiperM,andSoler-SolerJ.PropagationofcardiomyocytehypercontracturebypassageofNathroughgapjunctions.CircRes85:280?287,1999.
	39.Ruiz-MeanaM,Garcia-DoradoD,LaneS,PinaP,InserteJ,MirabetM,andSoler-SolerJ.Persistenceofgapjunctioncommunicationduringmyocardialischemia.AmJPhysiolHeartCircPhysiol280:H2563?H2571,2001.
	40.SatoT,O?RourkeB,andMarbanE.ModulationofmitochondrialATP-dependentKchannelsbyproteinkinaseC.CircRes83:110?114,1998.
	41.SchlackW,UebingA,Schaï¿½ferM,BierF,Schaï¿½ferS,PiperHM,andThaï¿½merV.Regionalcontractileblockadeattheonsetofreperfusionreducesinfarctsizeinthedogheart.Pfluï¿½gersArch428:134?141,1994.
	42.SchwankeU,KonietzkaI,DuschinA,LiX,SchulzR,andHeuschG.Noischemicpreconditioninginheterozygousconnexin43-deficientmice.AmJPhysiolHeartCircPhysiol283:H1740?H1742,2002.
	43.SchulzR,CohenMV,BehrendsM,DowneyJM,andHeuschG.Signaltransductionofischemicpreconditioning.CardiovascRes52:181?198,2001.
	44.SchulzR,GresP,SkyschallyA,DuschinA,BelosjorowS,KonietzkaI,andHeuschG.Ischemicpreconditioningpreservesconnexin43phos-phorylationduringsustainedischemiainpigheartsinvivo.FASEBJ17:1355?7,2003.
	45.SebbagL,VerbinskiSG,ReimerKA,andJenningsRB.Protectionofischemicmyocardiumindogsusingintracoronary2,3-butanedionemon-oxime(BDM).JMolCellCardiol35:165?176,2003.
	46.TanHL,MazonP,VerberneHJ,SleeswijkME,CoronelR,OpthofT,andJanseMJ.IschaemicpreconditioningdelaysischaemiainducedcellularelectricaluncouplinginrabbitmyocardiumbyactivationofATPsensitivepotassiumchannels.CardiovascRes27:644?651,1993.
	47.TsuchidaA,MiuraT,TannoM,SakamotoJ,MikiT,KunoA,MatsumotoT,OhnumaY,IchikawaY,andShimamotoK.Infarctsizelimitationbynicorandil:rolesofmitochondrialKATPchannels,sarcolem-malKATPchannels,andproteinkinaseC.JAmCollCardiol40:1523?1530,2002.
	48.VerrecchiaFandHerveJC.Reversibleblockadeofgapjunctionalcommunicationby2,3-butanedionemonoximeinratcardiacmyocytes.AmJPhysiolCellPhysiol272:C875?C885,1997.
	49.WangS,ConeJ,andLiuY.DualrolesofmitochondrialKATPchannelsindiazoxide-mediatedprotectioninisolatedrabbithearts.AmJPhysiolHeartCircPhysiol280:H246?H256,2001.
	50.ZhaoL,NaberN,andCookeR.Musclecross-bridgesboundtoactinaredisorderedinthepresenceof2,3-butanedionemonoxime.BiophysJ68:1980?1990,1995.
J Neurophysiol-2004-Inoue-372-81.pdf	26
	AdrianED.Theelectricalactivityofthemammalianolfactorybulb.Electro-encephalogrClinNeurophysiol2:377?388,1950.
	ChangJJ,GelperinA,andJohnsonFH.Intracellularlyinjectedaequorindetectstransmembranecalciumfluxduringactionpotentialsinanidentifiedneuronfromtheterrestrialslug,Limaxmaximus.BrainRes77:431?442,1974.
	ChaseR.Responsestoodorsmappedinsnailtentacleandbrainby[14C]-2-deoxyglucoseautoradiography.JNeurosci5:2930?2939,1985.
	ChaseR.Lessonsfromsnailstentacles.ChemSenses11:411?426,1986.
	ChaseRandKamilR.Neuronalcomponentinsnailtentaclesasrevealedbyhorseradishperoxidasebackfilling.JNeurobiol14:29?42,1983.
	ChaseRandTolloczkoB.Interganglionicdendritesconstituteanoutputpathwayfromtheprocerebrumofthesnail,Achatinafulica.JCompNeurol283:143?152,1989.
	CookeIRandGelperinA.Invivorecordingsofspontaneousandodor-modulateddynamicsintheLimaxolfactorylobe.JNeurobiol46:126?41,2001.
	FreemanWJ.SpatialpropertiesofanEEGeventintheolfactorybulbandcortex.ElectroencephalogrClinNeurophysiol44:586?605,1978.
	GelperinAandFloresJ.Vitalstainingfromdye-coatedmicroprobesiden-tifiesnewolfactoryinterneuronsforopticalandelectricalrecording.JNeu-rosciMethods72:97?108,1997.
	GelperinAandTankDW.Odor-modulatedcollectivenetworkoscillationsofolfactoryinterneuronsinaterrestrialmollusk.Nature345:437?440,1990.
	GelperinA,RhinesLD,FloresJ,andTankDW.Coherentnetworkoscil-lationsbyolfactoryinterneurons:modulationbyendogenousamines.JNeu-rophysiol69:1930?1939,1993.
	GervaisR,KleinfeldD,DelaneyKR,andGelperinA.Centralandreflexneuronalresponseselicitedbyodorinaterrestrialmollusk.JNeurophysiol76:1327?1339,1996.
	InokumaY,InoueT,WatanabeS,andKirinoY.Twotypesofnetworkoscillationsandtheirodorresponsesintheprimaryolfactorycenterofaterrestrialmollusk.JNeurophysiol87:3160?3164,2002.
	InoueT,WatanabeS,KawaharaS,andKirinoY.Phase-dependentfilteringofsensoryinformationintheoscillatingolfactorycenterofaterrestrialmollusk.JNeurophysiol84:1112?1115,2000.
	InoueT,WatanabeS,andKirinoY.Invitroodor-aversionconditioninginaterrestrialmollusk.SocNeurosciAbstr25:126,1999.
	ItoI,NakamuraH,KimuraT,SuzukiH,SekiguchiT,KawabataK,andItoE.Neuronalcomponentsofthesuperiorandinferiortentaclesintheterrestrialslug,Limaxmarginatus.NeurosciRes37:191?200,2000.
	KemenesG,ElekesK,HiripiL,andBenjaminPRA.Comparisonoffourtechniquesformappingthedistributionofserotoninandserotonin-contain-ingneuronsinfixedandlivinggangliaofthesnail,Lymnaea.JNeurocytol18:193?208,1989.
	KimuraT,SuzukiH,KonoE,andSekiguchiT.Mappingofinterneuronsthatcontributetofoodaversiveconditioningintheslugbrain.LearnMem4:376?388,1998a.
	KimuraT,TodaS,SekiguchiT,andKirinoY.Behavioralmodulationinducedbyfoododoraversiveconditioninganditsinfluenceontheolfac-toryresponsesofanoscillatorybrainnetworkintheslugLimaxmarginatus.LearnMem4:365?375,1998b.
	KleinfeldD,DelaneyKR,FeeMS,FloresJA,TankDWandGelperinA.Dynamicsofpropagatingwavesintheolfactorynetworkofaterrestrialmollusk:Anelectricalandopticalstudy.JNeurophysiol72:1402?1419,1994.
	LaurentGandNaraghiM.Odorant-inducedoscillationsinthemushroombodiesofthelocust.JNeurosci14:2993?3004,1994.
	LentCM.Fluorescentpropertiesofmonoamineneuronsfollowingglyoxylicacidtreatmentofintactleechganglia.Histochemistry75:77?89,1982.
	SahleyC,GelperinA,andRudyJW.One-trialassociativelearningmodifiesfoododorpreferencesofaterrestrialmollusk.ProcNatlAcadSciUSA78:640?642,1981a.
	SahleyC,RudyJW,andGelperinA.Ananalysisofassociativelearninginaterrestrialmollusk.I.Higher-orderconditioning,blockingandatransientUSpre-exposureeffect.JCompPhysiol[A]144:1?8,1981b.
	ShimozonoS,WatanabeS,InoueT,andKirinoY.Identificationandcharacterizationofanoutputneuronfromtheoscillatorymolluscanolfac-torynetwork.BrainRes921:98?105,2001.
	TeykeTandGelperinA.OlfactoryoscillationsaugmentodordiscriminationnotodoridentificationbyLimaxCNS.Neuroreport10:1061?1068,1999.
J Neurophysiol-2004-Peterka-410-23.pdf	51
	AngelakiDE,McHenryMQ,DickmanJD,NewlandsSD,andHessBJ.Computationofinertialmotion:neuralstrategiestoresolveambiguousotolithinformation.JNeurosci19:316?327,1999.
	BendatJSandPiersolAG.RandomData:AnalysisandMeasurementPro-cedures.NewYork:Wiley,2000.
	BennettDJ,GorassiniM,andProchazkaA.Catchingaball:contributionsofintrinsicmusclestiffness,reflexes,andhigherorderresponses.CanJPhysiolPharmacol72:525?534,1994.
	BloemBR,AllumJH,CarpenterMG,VerschuurenJJ,andHoneggerF.Triggeringofbalancecorrectionsandcompensatorystrategiesinapatientwithtotallegproprioceptiveloss.ExpBrainRes142:91?107,2002.
	CohenL.Time-FrequencyAnalysis.NewYork:Prentice-Hall,1995.
	CollinsJJandDeLucaCJ.Open-loopandclosed-loopcontrolofposture:arandom-walkanalysisofcenter-of-pressuretrajectories.ExpBrainRes95:308?318,1993.
	CordoPJ,Flores-VieireC,VerschuerenSMP,InglisJT,andGurfinkelV.Positionsensitivityofhumanmusclespindles:singleafferentandpopula-tionrepresentations.ExpBrainRes87:1186?1195,2002.
	CordoPJandNashnerLM.Propertiesofposturaladjustmentsassociatedwithrapidarmmovements.JNeurophysiol47:287?302,1982.
	CreathR,KiemelT,HorakF,StephensM,Carlson-KuhtaP,andJekaJ.TheinfluenceofvelocityinformationonposturalswayinParkinsonianpatients:preliminaryfindings.SocNeurosciAbstr666.12,2002.
	DayBL,SeveracCauquilA,BartolomeiL,PastorMA,andLyonIN.Humanbody-segmenttiltsinducedbygalvanicstimulation:avestibularlydrivenbalanceprotectionmechanism.JPhysiol500:661?672,1997.
	DienerHC,DichgansJ,BacherM,andGompfB.Quantificationofposturalswayinnormalsandpatientswithcerebellardiseases.ElectroencephalogrClinNeurophysiol57:134?142,1984a.
	DienerHC,DichgansJ,GuschlbauerB,andMauH.Thesignificanceofproprioceptiononposturalstabilizationasassessedbyischemia.BrainRes296:103?109,1984b.
	DuysensJ,ClaracF,andCruseH.Load-regulatingmechanismsingaitandposture:comparativeaspects.PhysiolRev80:83?133,2000.
	FitzpatrickR,BurkeD,andGandeviaSC.Loopgainofreflexescontrollinghumanstandingmeasuredwiththeuseofposturalandvestibulardistur-bances.JNeurophysiol76:3994?4008,1996.
	GardinerEP,MartinJH,andJessellTM.Thebodilysenses.In:PrinciplesofNeuralScience(4thed.),editedbyKandelER,SchwartzJH,andJessellTM.NewYork:McGraw-Hill,2000,p.430?450.
	HayL,BardC,FleuryM,andTeasdaleN.Availabilityofvisualandproprioceptiveafferentmessagesandposturalcontrolinelderlyadults.ExpBrainRes108:129?139,1996.
	HorakFB,DienerHC,andNashnerLM.Influenceofcentralsetonhumanposturalresponses.JNeurophysiol62:841?853,1989.
	HorakFBandMacphersonJM.Posturalorientationandequilibrium.In:HandbookofPhysiology.Exercise:RegulationandIntegrationofMultipleSystems,editedbyRowellLBandShepherdJT.NewYork:Oxford,1996,sect.12,p.255?292.
	JacksA,ProchazkaA,andTrendPSJ.Instabilityinhumanforearmmove-mentsstudiedwithfeed-back-controlledelectricalstimulationofmuscles.JPhysiol402:443?461,1988.
	JekaJJandLacknerJR.Fingertipcontactinfluenceshumanposturalcon-trol.ExpBrainRes100:495?502,1994.
	JohanssonRandMagnussonM.Humanposturaldynamics.BiomedEng18:413?437,1991.
	KavounoudiasA,GilhodesJC,RollR,andRollJP.Frombalanceregula-tiontobodyorientation:twogoalsformuscleproprioceptiveinformationprocessing?ExpBrainRes124:80?88,1999.
	KeshnerEA,HainTC,andChenKJ.Predictingcontrolmechanismsforhumanheadstabilizationbyalteringthepassivemechanics.JVestRes9:423?434,1999.
	LeeDNandLishmanJR.Visualproprioceptivecontrolofstance.JHumMoveStudies1:87?95,1975.
	LordSR,ClarkRD,andWebsterIW.Posturalstabilityandassociatedphysiologicalfactorsinapopulationofagedpersons.JGerontol46:M69?M76,1991.
	LoughlinPJ,PittonJ,andAtlasL.Constructionofpositivetime-frequencydistributions.IEEETransSignalProcess42:2697?2705,1994.
	LoughlinPJandRedfernMS.Spectralcharacteristicsofvisuallyinducedposturalswayinhealthyelderlyandhealthyyoungsubjects.IEEETransRehabEng9:24?30,2001.
	LoughlinPJ,RedfernMS,andFurmanJM.Time-varyingcharacteristicsofvisuallyinducedposturalsway.IEEETransRehabilEng4:416?424,1996.
	MauritzKHandDietzV.Characteristicsofposturalinstabilityinducedbyischemicblockingoflegafferents.ExpBrainRes38:117?119,1980.
	MerfeldDMandZupanLH.Neuralprocessingofgravitoinertialcuesinhumans.III.Modelingtiltandtranslationresponses.JNeurophysiol87:819?833,2002.
	MergnerT,SieboldC,SchweigartG,andBeckerW.Humanperceptionofhorizontaltrunkandheadrotationinspaceduringvestibularandneckstimulation.ExpBrainRes85:389?404,1991.
	MittelstaedtH.Originandprocessingofposturalinformation.NeurosciBiobehavRev22:473?478,1998.
	MorassoPG,BarattoL,CapraR,andSpadaG.Internalmodelsinthecontrolofposture.NeuralNetworks12:1173?1180,1999.
	NashnerLM.Adaptationofhumanmovementtoalteredenvironments.TrendsNeurosci5:358?361,1982.
	NashnerLMandBerthozA.Visualcontributiontorapidmotorresponsesduringposturecontrol.BrainRes150:403?407,1978.
	NashnerLM,BlackFO,andWallCIII.Adaptationtoalteredsupportandvisualconditionsduringstance:patientswithvestibulardeficits.JNeurosci2:536?544,1982.
	PaiYCandPattonJ.Centerofmassvelocity-positionpredictionsforbalancecontrol.JBiomech30:347?354,1997.
	PeterkaRJ.Posturalcontrolmodelinterpretationofstabilogramdiffusionanalysis.BiolCybern82:335?343,2000.
	PeterkaRJ.Sensorimotorintegrationinhumanposturalcontrol.JNeuro-physiol88:1097?1118,2002.
	PeterkaRJandBenolkenMS.Roleofsomatosensoryandvestibularcuesinattenuatingvisuallyinducedhumanposturalsway.ExpBrainRes105:101?110,1995.
	PeterkaRJandBlackFO.Age-relatedchangesinhumanposturecontrol:sensoryorganizationtests.JVestibRes1:73?85,1990.
	PrietoTE,MyklebustJB,HoffmanRG,LovettEG,andMyklebustBM.Measuresofposturalsteadiness:differencesbetweenhealthyyoungandelderlyadults.IEEETransBiomedEng43:956?966,1996.
	RogersMW,WardmanDL,LordSR,andFitzpatrickRC.Passivetactilesensoryinputimprovesstabilityduringstanding.ExpBrainRes136:514?522,2001.
	SimoneauM,TeasdaleN,BourdinC,BardC,FleuryM,andNougierV.Agingandposturalcontrol:posturalperturbationscausedbychangingthevisualanchor.JAmGeriatrSoc47:235?240,1999.
	TeasdaleN,StelmachGE,BreunigA,andMeeuwsenHJ.Agedifferencesinvisualsensoryintegration.ExpBrainRes85:691?696,1991.
	vanBeersRJ,WolpertDM,andHaggardP.Whenfeelingismoreimpor-tantthanseeinginsensorimotoradaptation.CurrBiol12:834?837,2002.
	vanderKooijH,JacobsR,KoopmanB,andGrootenboerH.Amultisen-soryintegrationmodelofhumanstancecontrol.BiolCybern80:299?308,1999.
	vanderKooijH,JacobsR,KoopmanB,andvanderHelmF.Anadaptivemodelofsensoryintegrationinadynamicenvironmentappliedtohumanstancecontrol.BiolCybern84:103?115,2001.
	VuillermeN,TeasdaleN,andNougierV.Theeffectofexpertiseingym-nasticsonproprioceptivesensoryintegrationinhumansubjects.NeurosciLett311:73?76,2001.
	WolpertDM,GhahramaniZ,andJordanMI.Aninternalmodelforsensorimotorintegration.Science269:1880?1882,1995.
	ZupanL,MerfeldDM,andDarlotC.Usingsensoryweightingtomodeltheinfluenceofcanal,otolithandvisualcuesonspatialorientationandeyemovements.BiolCybern86:209?230,2002.
J Neurophysiol-2004-Paninski-515-32.pdf	51
	AsheJandGeorgopoulosA.Movementparametersandneuralactivityinmotorcortexandarea5.CerebCortex4:590?600,1994.
	BrownEN,FrankLM,TangD,QuirkMC,andWilsonMA.Astatisticalparadigmforneuralspiketraindecodingappliedtopositionpredictionfromensemblefiringpatternsofrathippocampalplacecells.JNeurosci18:7411?7425,1998.
	BuracasGT,ZadorAM,DeWeeseMR,andAlbrightTD.Efficientdis-criminationoftemporalpatternsbymotion-sensitiveneuronsinprimatevisualcortex.Neuron5:959?969,1998.
	CoverTandThomasJ.ElementsofInformationTheory.NewYork:Wiley,1991.
	DeAngelisGC,GhoseGM,OhzawaI,andFreemanRD.Functionalmicro-organizationofprimaryvisualcortex:receptivefieldanalysisofnearbyneurons.JNeurosci19:4046?4064,1999.
	DonoghueJP,SanesJN,HatsopoulosNG,andGaalG.Neuraldischargeandlocalfieldpotentialoscillationsinprimatemotorcortexduringvolun-tarymovements.JNeurophysiol79:159?173,1998.
	FuQG,FlamentD,ColtzJD,andEbnerTJ.Temporalencodingofmovementkinematicsinthedischargeofprimateprimarymotorandpre-motorneurons.JNeurophysiol73:836?854,1995.
	GeorgopoulosAP,CaminitiR,andKalaskaJ.Staticspatialeffectsinmotorcortexandarea5:quantitativerelationsinatwo-dimensionalspace.ExpBrainRes54:446?454,1984.
	GeorgopoulosAP,KalaskaJF,CaminitiR,andMasseyJT.Ontherela-tionsbetweenthedirectionoftwo-dimensionalarmmovementsandcelldischargeinprimarymotorcortex.JNeurosci2:1527?1537,1982.
	GeorgopoulosAP,LuritoJT,PetridesM,SchwartzAB,andMasseyJT.Mentalrotationoftheneuronalpopulationvector.Science243:234?236,1989.
	GeorgopoulosAP,SchwartzAB,andKettnerRE.Neuronalpopulationcodingofmovementdirection.Science233:1416?1419,1986.
	HaagJandBorstA.Activemembranepropertiesandsignalencodingingradedpotentialneurons.JNeurosci18:7972?7986,1998.
	HatsopoulosNH,OjakangasCL,PaninskiL,andDonoghueJP.Informa-tionaboutmovementdirectionobtainedfromsynchronousactivityofmotorcorticalneurons.ProcNatlAcadSciUSA95:15706?15711,1998.
	HumphreyDR,SchmidtEM,andThompsonWD.Predictingmeasuresofmotorperformancefrommultiplecorticalspiketrains.Science170:758?762,1970.
	JohnsonMTV,ColtzJD,HagenMC,andEbnerTJ.Visuomotorprocess-ingasreflectedinthedirectionaldischargeofpremotorandprimarymotorcortexneurons.JNeurophysiol81:875?878,1999.
	KakeiS,HoffmanDS,andStrickPL.Muscleandmovementrepresentationsintheprimarymotorcortex.Science285:2136?2139,1999.
	KalaskaJF,CohenDAD,HydeML,andPrud?hommeMA.Comparisonofmovementdirection-relatedversusloaddirection-relatedactivityinprimatemotorcortexusingatwo-dimensionalreachingtask.JNeurosci9:2080?2102,1989.
	KennedyPRandBakayRA.Restorationofneuraloutputfromaparalyzedpatientbyadirectbrainconnection.Neuroreport9:1707?1711,1998.
	KettnerRE,SchwartzAB,andGeorgopoulosAP.Primatemotorcortexandfreearmmovementstovisualtargetsinthree-dimensionalspace.III.Posi-tionalgradientsandpopulationcodingofmovementdirectionfromvariousmovementorigins.JNeurosci8:2938?2947,1988.
	KolmogorovAN.InformationTheoryandtheTheoryofAlgorithms,editedbyShiriaevAN.Boston,MA:KluwerAcademic,1993.
	KowalskiN,DepireuxDA,andShammaSA.Analysisofdynamicspectrainferretprimaryauditorycortex.JNeurophysiol76:3524?3534,1996.
	LemonR.Theoutputmapoftheprimatemotorcortex.TrendsNeurosci11:501?506,1988.
	MainenZFandSejnowskiTJ.Reliabilityofspiketiminginneocorticalneurons.Science268:1503?1506,1995.
	MaynardEM,HatsopoulosNG,OjakangasCL,AcunaBD,SanesJN,NormannRA,andDonoghueJP.Neuronalinteractionsimprovecorticalpopulationcodingofmovementdirection.JNeurosci19:8083?8093,1999.
	MoranDWandSchwartzAB.Motorcorticalrepresentationofspeedanddirectionduringreaching.JNeurophysiol82:2676?2692,1999a.
	MoranDWandSchwartzAB.Motorcorticalactivityduringdrawingmove-ments:populationrepresentationduringspiraltracing.JNeurophysiol82:2693?2704,1999b.
	MoxonKA,MarkowitzRS,NicolelisMAL,andChapinJK.Realtimecontrolofarobotarmusingsimultaneouslyrecordedneuronsinthemotorcortex.NatNeurosci2:664?667,1999.
	Mussa-IvaldiFA.Doneuronsinthemotorcortexencodemovementdirec-tion?Analternativehypothesis.NeurosciLett91:106?111,1988.
	NeterJ,WassermanW,andKutnerMH.AppliedLinearStatisticalModels.Homewood,IL:Irwin,1985.
	NordhausenCT,MaynardEM,andNormannRA.Singleunitrecordingcapabilitiesofa100microelectrodearray.BrainRes726:129?140,1996.
	PaninskiL,FellowsM,HatsopoulosN,andDonoghueJ.Codingdynamicvariablesinpopulationsofmotorcortex.SocNeurosciAbstr6:665.9,1999.
	PorterRandLemonR.CorticospinalFunctionandVoluntaryMovement.Oxford,UK:ClarendonPress,1993.
	PressWH,TeukolskySA,VetterlingWT,andFlanneryBP.NumericalRecipesinC.Cambridge,UK:CambridgeUniv.Press,1992.
	PughM,RingachD,ShapleyR,andShelleyM.Computationalmodelingoforientationtuningdynamicsinmonkeyprimaryvisualcortex.JComputNeurosci8:143?159,2000.
	RiekeF,WarlandD,deRuytervanSteveninckR,andBialekW.Spikes:ExploringtheNeuralCode.Cambridge,MA:MITPress,1997.
	RingachDL,HawkenMJ,andShapleyR.Dynamicsoforientationtuninginmacaqueprimaryvisualcortex.Nature387:281?284,1997.
	SalinasEandAbbottLF.Coordinatetransformationsinthevisualsystem:howtogenerategainfieldsandwhattocomputewiththem.ProgBrainRes130:175?190,2001.
	SanesJNandDonoghueJP.Staticanddynamicorganizationofmotorcortex.AdvNeurol73:277?296,1997.
	SangerTD.Probabilitydensityestimationfortheinterpretationofneuralpopulationcodes.JNeurophysiol76:2790?2793,1996.
	SchwartzA.Motorcorticalactivityduringdrawingmovements:populationrepresentationduringsinusoidtracing.JNeurophysiol70:28?36,1993.
	SchwartzAandMoranDW.Motorcorticalactivityduringdrawingmove-ments:populationrepresentationduringlemniscatetracing.J.Neurophysiol82:2705?2718,1999.
	SchwartzAB,TaylorDM,andTillerySI.Extractionalgorithmsforcorticalcontrolofarmprosthetics.CurrOpinNeurobiol11:701?708,2001.
	ScottSHandKalaskaJF.Reachingmovementswithsimilarhandpathsbutdifferentarmorientations.I.Activityofindividualcellsinmotorcortex.JNeurophysiol77:826?852,1997.
	SergioLEandKalaskaJF.Changesinthetemporalpatternofprimarymotorcortexactivityinadirectionalisometricforceversuslimbmovementtask.JNeurophysiol80:1577?1583,1998.
	SerruyaMD,HatsopoulosNG,PaninskiL,FellowsMR,andDonoghueJP.Brain-machineinterface:instantneuralcontrolofamovementsignal.Nature416:141?142,2002.
	TairaM,BolineJ,SmyrnisN,GeorgopoulosA,andAsheJ.Ontherelationsbetweensinglecellactivityinthemotorcortexandthedirectionandmagnitudeofthree-dimensionalstaticisometricforce.ExpBrainRes109:367?376,1996.
	TaylorDM,TillerySI,andSchwartzAB.Directcorticalcontrolof3Dneuroprostheticdevices.Science296:1829?1832,2002.
	TodorovE.Directcorticalcontrolofmuscleactivationinvoluntaryarmmovements:amodel.NatNeurosci3:391?398,2000.
	TodorovE.Cosinetuningminimizesmotorerrors.NeuralComput14:1233?1260,2002.
	WarlandD,ReinagelP,andMeisterM.Decodingvisualinformationfromapopulationofretinalganglioncells.JNeurophysiol78:2336?2350,1997.
	WessbergJ,StambaughCR,KralikJD,BeckPD,LaubachM,ChapinJK,KimJ,BiggsSJ,SrinivasanMA,andNicolelisMA.Real-timepredictionofhandtrajectorybyensemblesofcorticalneuronsinprimates.Nature408:361?365,2000.
BTN_A_05394SU04_O_4802a.pdf	7
	 1. Niv, M.Y., H. Rubin, J. Cohen, L. Tsirulnikov, T. Licht, A. Peretzman-Shemer, E. Cna?an, A. Tartakovsky, et al. 2004. Sequence-based design of kinase inhibitors applicable for therapeutics and target identification. J. Biol. Chem. 279:1242-1255.
	 2. Ben-Sasson, S.A., inventor. The Children?s Medical Center Corp, Boston, MA and Yisum Research Development Company of the Hebrew University, Jerusa-lem, IL, assignees. Short peptides which selectively modulate the activity of ser-ine-theronine kinases. 1997. U.S. patent no. 6,174,993. 
	 3. Goldenberg-Furmanov, M., I. Stein, E. Pikarsky, H. Rubin, S. Kasem, M. Wygoda, I. Weinstein, H. Reuveni, and S.A. Ben-Sasson. 2004. Lyn is a target gene for prostate cancer: sequence-based inhibition induces regression of human tumor xenografts. Cancer Res. 64:1058-1066.
	 4. Anis, Y., O. Leshem, H. Reuveni, I. Wexler, R. Ben Sasson, B. Yahalom, M. Laster, I. Raz, et al. 2004. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 47:1232-1244.
	 5. Licht, T., L. Tsirulnikov, H. Reuveni, T. Yarnitzky, and S.A. Ben-Sasson. 2003. Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 102:2099-2107.
	 6. Matthews, T., M. Salgo, M. Greenberg, J. Chung, R. DeMasi, and D. Bolognesi. 2004. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 intohost CD4 lymphocytes. Nat. Rev. Drug Discov. 3:215-225. 
	 7. Levitzki, A. 2003. Protein kinase inhibitors as a therapeutic modality. Acc. Chem. Res. 36:462-4699.
BTN_A_05394SU07_O_4829a.pdf	5
	 1. RBC Capital Markets. 2003. Equity research report, The In-Vitro Diagnostics Industry, Dec. 5th, 2003. 
	 2. Robert W. Baird & Co. 2003. Equity research report on Beckman Coulter, Inc., Sept. 23rd, 2003. 
	 3. Lagay, F. 2003. Pharmacogenomics: revolution in a bottle? American Medical Association; http://www.ama-assn.org/ama/pub/category/7459.html. 
	 4. Ingelman-Sundberg, M. 2001. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J. Intern. Med. 250:186.
	 5. Lander, E., B. Austin, J. Peterson, and J. Schloss. 2002. Sequencing 
spp-03-1-38.pdf	3
	Hunter, S., et al., 2005. Training substance abuse treatment staff to care for co-occurring disorders. Journal of Substance Abuse Treatment28(3):239-245.
	Watkins, K.E. 2003. Health, Wellness, and Recovery. Santa Monica, CA: RAND.
	Watkins, K.E., et al., 2004. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.  American Journal of Drug and Alcohol Abuse30(4):749-761. 
spp-03-1-13.pdf	34
	Albanese, M.J.; Clodfelter, R.C. Jr.; and Khantzian, E.J., 2000. Divalproex sodium in substance abusers with mood disorder. Journal of Clinical Psychiatry61(12):916-921.
	Brady, K.T., et al., 1995. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study. Journal of Clinical Psychiatry56(3):118-121.
	Brady, K.T., et al., 2002. Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder. Experimental and Clinical Psychopharmacology10(3):276-285. 
	Brady, K.T.; Myrick, H.; and Sonne, S., 1998. Comorbid addiction and affective disorders. In: A.W. Graham, T.K. Schultz, and B.B. Wilford (Eds.), Principles of Addiction Medicine(2nd ed.).Arlington, VA: American Society of Addiction Medicine, pp. 983-992.
	Brown, E.S., et al., 2003. Lamotrigine in patients with bipolar disorder and cocaine dependence.Journal of Clinical Psychiatry64(2):197-201.
	Brown, R.A., et al., 1997. Cognitive-behavioral treatment for depression in alcoholism. Journal of Consulting & Clinical Psychology65(5):715-726.
	Carpenter, K.M., et al., 2004. The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependentpatients: A controlled clinical trial. Drug and Alcohol Dependence 74:123-134.
	Comfort, M., et al., 1999. Assessing the needs of substance abusing women. Psychometric data on the psychosocial history. Journal ofSubstance Abuse Treatment17:79-83.
	Cornelius, J.R., et al., 1997.  Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry54(8):700-705.
	Geller, B., et al., 1998. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.Journal of the American Academy ofAdolescent Psychiatry37(2):171-178.
	Goldsmith, R.J., and Ries, R.K., 2003. Substance-induced mental disorders. In: A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries, and B.B. Wilford (Eds.), Principles of AddictionMedicine(3rd ed.). Chevy Chase, MD: American Society of Addiction Medicine, pp. 1263-1276.
	Hasin, D., et al., 2002. Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry 59(4):375-380.
	Hertzman, M., 2000.  Divalproex sodium to treat concomitant substance abuse and mood disorders. Journal of Substance Abuse Treatment 18(4):371-372.
	Hirschfeld, R.M., et al., 2003. Validity of the mood disorder questionnaire: A general population study. American Journal of Psychiatry 160(1):178-180.
	Keller, M.B., et al., 1986. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up.American Journal of Psychiatry143(1):24-28.
	Kessler, R.C., et al., 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.Archives of GeneralPsychiatry51(1):8-19.
	Kessler, R.C., et al., 1997. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of GeneralPsychiatry 54(4):313-321. 
	LeFauve, C.E., et al., 2004. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcoholism: Clinical and Experimental Research28(2):302-312.
	Markou, A.; Kosten, T.R.; and Koob, G.F., 1998. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 19(3):135-174.
	McLellan, A.T.; Carise, D.; and Kleber, H.D., 2003. Can the national addiction treatment infrastructure support the public?s demand for quality care? Journal of Substance Abuse Treatment25:117-121.
	Nuï¿½es, E.V., and Levin, F.R., 2004. Treatment of depression in patients with alcohol or other drug dependence. A meta-analysis. Journal of the American Medical Association291(15):1887-1896.
	Post, R.M.; Rubinow, D.R.; and Ballenger, J.C., 1984. Conditioning, sensitization, and kindling: Implications for the course of affective illness. In: R.M. Post and J.C. Ballenger (Eds.),Neurobiology of Mood Disorders. Baltimore, MD: Williams and Wilkins, pp. 432-466.
	Project MATCH Research Group, 1997. Matching alcohol treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 58(1):7-29.
	Regier, D.A., et al., 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association264(19):2511-2518.
	Rich, C.L.; Fowler, R.C.; and Young, D., 1989. Substance abuse and suicide: The San Diego suicide study. Annals of Clinical Psychiatry2(2):79-85.
	Rounsaville, B.J., et al., 1991. Psychiatric diagnoses of treatment seeking cocaine abusers. Archives of General Psychiatry 48(1):43-51.
	Salloum, I.M.; Cornelius, J.R.; and Chakravorthy, S., 2003. Utility of combined naltrexone valproate treatment in bipolar alcoholics: A randomized, open-label, pilot study. Abstracts ofPapers, 26th Annual Scientific Meeting of the Research Society on Alcoholism, Ft. Lauderdale, FL, June 21-25, 2003; I. Diamond (Ed.); Baltimore, MD: Lippincott, Williams & Wilkins,pp. 843, 146A. 
	Sattar, S.P., et al., 2003. Potential use of olanzapine in treatment of substance dependence disorders. Journal of Clinical Psychopharmacology23(4):413-414. 
	Sonne, S.C., and Brady, K.T., 1999. Substance abuse and bipolar comorbidity. Psychiatric Clinics of North America22(3):609-627.
	Sonne, S.C.; Brady, K.T.; and Morton W.A., 1994.  Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease182(6):349-352.
	Swann, A.C., et al., 1999. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. American Journal of Psychiatry156(8):1264-1266.
	Swann, A.C., et al., 2002. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 26(4):530-536.
	Weiss, R.D., et al., 1998. Medication compliance among patients with bipolar disorder and substance use disorder. Journal of Clinical Psychiatry59(4):172-174.
	Weiss, R.D., et al., 2000. Group therapy for patients with bipolar disorder and substance dependence: Results of a pilot study. Journal of Clinical Psychiatry61(5):361-367.
	Young, M.A., et al., 1994. Interactions of risk factors in predicting suicide. American Journal of Psychiatry151(3):434-435.
spp-03-1-4.pdf	12
	Goldstein, A., 2001. Addiction: From Biology to Drug Policy(2nd ed.). Oxford: Oxford University Press.
	Hyman, S.E., and Malenka, R.C., 2001. Addiction and the brain: The neurobiology of compulsion and its persistence. Nature Reviews. Neuroscience2(10):695-703.
	Kalivas, P.W., and McFarland, K., 2003. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology(Berlin) 168(1-2):44-56.
	Koob, G.F.; Sanna, P.P.; and Bloom, F.E., 1998. Neuroscience of addiction. Neuron21(3):467-476.
	McClung, C.A., and Nestler, E.J., 2003. Regulation of gene expression and cocaine reward by CREB and ?FosB. Nature Neuroscience 6(11):1208-1215.
	McClung, C.A. et al., 2004. ?FosB: A molecular switch for long-term adaptation. Molecular Brain Research132(2):146-154.
	Nestler, E.J., 2001. Molecular basis of neural plasticity underlying addiction. Nature Reviews. Neuroscience2(2):119-128.
	Nestler, E.J.; Barrot, M.; and Self, D.W., 2001. ?FosB: A molecular switch for addiction. Proceedings of the National Academy of Sciences of the USA 98(20):11042-11046.
	Nestler, E.J., and Malenka, R.C., 2004. The addicted brain. Scientific American290(3):78-85.
	O?Brien, C.P., 2003. Research advances in the understanding and treatment of addiction. American Journal on Addictions12(Suppl 2):S36-S47.
	Robinson, T.E., and Berridge, K.C., 2001. Incentive-sensitization and addiction. Addiction96(1):103-114. 
	Volkow, N.D.; Fowler, J.S.; and Wang, G.J., 2003. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigation111(10):1444-1451.
mol11_1p059.pdf	58
	1.Jin L et al. (1999) Indole-3-carbinol prevents cervical cancer in human papillo-ma virus type 16 (HPV16) transgenic mice. Cancer Res.59:3991-7.
	2.Grubbs CJ et al. (1995) Chemoprevention of chemically-induced mammarycarcinogenesis by indole-3-carbinol. Anticancer Res.15:709-16.
	3.Garikapaty VP et al. (2005) Anti-carcinogenic and anti-metastatic properties ofindole-3-carbinol in prostate cancer. Oncol. Rep.13:89-93.
	4.Kojima T, Tanaka T, Mori H (1994) Chemoprevention of spontaneous endometrialcancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res.54:1446-9.
	5.Srivastava B, Shukla Y (1998) Antitumour promoting activity of indole-3-carbinolin mouse skin carcinogenesis. Cancer Lett.134:91-5.
	6.Carter TH et al. (2002) Diindolylmethane alters gene expression in human ker-atinocytes in vitro. J. Nutr.132:3314-24.
	7.Jellinck PH et al. (1993) Ah receptor binding properties of indole carbinols andinduction of hepatic estradiol hydroxylation. Biochem. Pharmacol.45:1129-36.
	8.Chen I, McDougal A, Wang F, Safe S (1998) Aryl hydrocarbon receptor-mediatedantiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis19:1631-9.
	9.Auborn KJ et al. (2003) Indole-3-carbinol is a negative regulator of estrogen. J. Nutr.133:2470S-5S.
	10. Nho CW, Jeffery E (2001) The synergistic upregulation of phase II detoxificationenzymes by glucosinolate breakdown products in cruciferous vegetables.Toxicol. Appl. Pharmacol.174:146-52.
	11. Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential ofindole-3-carbinol and its derivatives. Cell Cycle 4:1201-15.
	12.Cover CM et al. (1998) Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancercells independent of estrogen receptor signaling. J. Biol. Chem.273:3838-47.
	13.Cram EJ, Liu BD, Bjeldanes LF, Firestone GL (2001) Indole-3-carbinol inhibits CDK6expression in human MCF-7 breast cancer cells by disrupting Sp1 transcriptionfactor interactions with a composite element in the CDK6 gene promoter. J. Biol. Chem.276:22332-40.
	14.Hong C, Kim HA, Firestone GL, Bjeldanes LF (2002) 3,3?-Diindolylmethane (DIM)induces a G(1) cell cycle arrest in human breast cancer cells that is accompa-nied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis23:1297-1305.
	15. Sun S et al. (2004) Endoplasmic reticulum stress as a correlate of cytotoxicity inhuman tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones9:76-87.
	16.Chen DZ, Qi M, Auborn KJ, Carter TH (2001) Indole-3-carbinol and diindolyl-methane induce apoptosis of human cervical cancer cells and in murineHPV16-transgenic preneoplastic cervical epithelium. J. Nutr.131:3294-302.
	17. Bonnesen C, Eggleston IM, Hayes JD (2001) Dietary indoles and isothiocyanatesthat are generated from cruciferous vegetables can both stimulate apoptosisand confer protection against DNA damage in human colon cell lines. CancerRes61:6120-30.
	18. Rahman KM, Li Y, Sarkar FH (2004) Inactivation of akt and NF-kappaB play impor-tant roles during indole-3-carbinol-induced apoptosis in breast cancer cells.Nutr. Cancer48:84-94.
	19.Chinni SR, Sarkar FH (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res.8:1228-36.
	20.Meng Q, Goldberg ID, Rosen EM, Fan S (2000) Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast CancerRes. Treat.63:147-52.
	21.Howells LM, Gallacher-Horley B, Houghton CE, Manson MM, Hudson EA (2002)Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in thehuman breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100line. Mol. Cancer Ther.1:1161-72.
	22. Arbeit JM, Howley PM, Hanahan D. (1999) Chronic estrogen-induced cervicaland vaginal squamous carcinogenesis in human papillomavirus type 16 trans-genic mice. Proc. Natl. Acad. Sci. U. S. A. 93:2930-5.
	23.Bell MC et al. (2000) Placebo-controlled trial of indole-3-carbinol in the treat-ment of CIN. Gynecol. Oncol.78:123-9.
	24. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppress-es tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.Proc. Natl. Acad. Sci. U. S. A.96:4240-5.
	25Li J et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated inhuman brain, breast, and prostate cancer [see comments]. Science275:1943-7.
	26.Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997) PTEN/MMAC1 mutations inendometrial cancers. Cancer Res.57:4736-8.
	27.Tashiro H et al. (1997) Mutations in PTEN are frequent in endometrial carcinomabut rare in other common gynecological malignancies. Cancer Res.57:3935-40.
	28.Su TH et al. (2000) Mutation analysis of the putative tumor suppressor genePTEN/MMAC1 in cervical cancer. Gynecol. Oncol.76:193-9.
	29.Cheung TH et al. (2004) Epigenetic and genetic alternation of PTEN in cervicalneoplasm. Gynecol. Oncol.93:621-7.
	30.Salvesen HB et al. (2001) PTEN methylation is associated with advanced stageand microsatellite instability in endometrial carcinoma. Int. J. Cancer91:22-6.
	31.Kang YH, Lee HS, Kim WH (2002) Promoter methylation and silencing of PTEN ingastric carcinoma. Lab. Invest.82:285-91.
	32Garcia JM et al. (2004) Promoter methylation of the PTEN gene is a com-mon molecular change in breast cancer. Genes Chromosomes Cancer41:117-24.
	33Goel A et al. (2004) Frequent inactivation of PTEN by promoter hypermethyla-tion in microsatellite instability-high sporadic colorectal cancers. Cancer Res.64:3014-21.
	34.Myers MP, Stolarov JP, Eng C (1997) P-TEN, the tumor suppressor from humanchromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci.U. S. A.94:9052-7.
	35.Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephospho-rylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.J. Biol. Chem.273:13375-8.
	36.Stokoe D et al. (1997) Dual role of phosphatidylinositol-3,4,5-trisphosphate in theactivation of protein kinase B. Science277:567-70.
	37.Andjelkovic M et al. (1997) Role of translocation in the activation and functionof protein kinase B. J. Biol. Chem.272:31515-24.
	38.Alessi DR et al. (1997) 3-Phosphoinositide-dependent protein kinase-1 (PDK1):structural and functional homology with the Drosophila DSTPK61 kinase. Curr.Biol.7:776-89.
	39.Delcommenne M et al. (1998) Phosphoinositide-3-OH kinase-dependent regu-lation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A.95:11211-6.
	40.Hresko RC, Murata H, Mueckler M (2003) Phosphoinositide-dependent kinase-2is a distinct protein kinase enriched in a novel cytoskeletal fraction associatedwith adipocyte plasma membranes. J. Biol. Chem.278:21615-22.
	41.Myers MP et al. (1998) The lipid phosphatase activity of PTEN is critical for itstumor suppressor function. Proc. Natl. Acad. Sci. U. S. A.95:13513-8.
	42.Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM (2003) PTEN inducescell cycle arrest by decreasing the level and nuclear localization of cyclin D1.Mol. Cell. Biol.23:6139-49.
	43.Nakamura N et al. (2000) Forkhead transcription factors are critical effectorsof cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol.20:8969-82.
	44.Lu Y et al. (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cellgrowth and induces apoptosis and anoikis in breast cancer cells. Oncogene18:7034-45.
	45.Sun S, Steinberg BM (2002) Identification of PTEN as a negative regulator ofSTAT3 activation. J. Gen. Virol.83:1651-8.
	46.Gu J et al. (1999) Shc and FAK differentially regulate cell motility and direction-ality modulated by PTEN. J. Cell. Biol.146:389-403.
	47. Dellas A et al. (1997) Angiogenesis in cervical neoplasia: microvessel quantita-tion in precancerous lesions and invasive carcinomas with clinicopathologicalcorrelations. Gynecol. Oncol.67:27-33.
	48.Davidson B, Goldberg I, Kopolovic J (1997) Angiogenesis in uterine cervicalintraepithelial neoplasia and squamous cell carcinoma: an immunohistochem-ical study. Int. J. Gynecol. Pathol.16:335-8.
	49.Lee JS, Kim HS, Jung JJ, Lee MC, Park CS (2002) Angiogenesis, cell proliferationand apoptosis in progression of cervical neoplasia. Anal. Quant. Cytol. Histol.24:103-13.
	50. Smith-McCune K, Zhu YH, Hanahan D, Arbeit J (1997) Cross-species compar-ison of angiogenesis during the premalignant stages of squamous carcino-genesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res.57:1294-300.
	51.Chang X et al. (2005) 3,3?-Diindolylmethane inhibits angiogenesis and the growthof transplantable human breast carcinoma in athymic mice. Carcinogenesis26:771-8.
	52. Wen S et al. (2001) PTEN controls tumor-induced angiogenesis. Proc. Natl. Acad.Sci. U. S. A.98:4622-7.
	53.Pore N, Liu S, Haas-Kogan DA, O?Rourke DM, Maity A (2003) PTEN mutation andepidermal growth factor receptor activation regulate vascular endothelialgrowth factor (VEGF) mRNA expression in human glioblastoma cells by trans-activating the proximal VEGF promoter. Cancer Res.63:236-41.
	54.Smith-McCune KK, Weidner N (1994) Demonstration and characterization of theangiogenic properties of cervical dysplasia. Cancer Res.54:800-4.
	55. Riby JE, Chang GH, Firestone GL, Bjeldanes LF (2000) Ligand-independent acti-vation of estrogen receptor function by 3,3?-diindolylmethane in human breastcancer cells. Biochem. Pharmacol.60:167-77.
	56.Waite KA, Sinden MR, Eng C (2005) Phytoestrogen exposure elevates PTEN lev-els. Hum. Mol. Genet.14:1457-63.
	57. Fang MX et al. (2005) Reversal of hypermethylation and reactivation ofP161NK4a, RARbeta, and MGMT genes by genistein and other isoflavones fromsoy. Clin. Cancer Res.11:7033-41.
	58.Virolle T et al. (2001) The Egr-1 transcription factor directly activates PTEN duringirradiation-induced signaling. Nat. Cell. Biol.3:1124-8.
283-284.pdf	15
	1.Karthikeyan,ThappaDM,JaisankarTJ,Balamourougane,AnanthakrishnanN,RatnakarC.Cutaneoushornofglanspenis.SexTransmInfect1998;74:456?457.
	2.LoweFC,McCulloughAR.Cutaneoushornsofthepenis:anapproachtomanagement.Casereportandreviewoftheliterature.JAmAcadDermatol1985;13:369?373.
	3.SolivanGA,SmithKJ,JamesWD.Cutaneoushornofthepenis:itsassociationwithsquamouscellcarcinomaandHPV-16infection.JAmAcadDermatol1990;23:969?972.
	4.SchellhammerPF,JordanGH,RobeyEL,SpauldingJT.Premalignantlesionsandnonsquamousmalignancyofthepenisandcarcinomaofthescrotum.UrolClinNorthAm1992;19:131?142.
	5.AlgabaF,HorenblasS,PizzocaroLPG,SolsonaE,WindahlT.EuropeanAssociationofUrology.EAUguidelinesonpenilecancer.EurUrol2002;42:199?203.
	6.AgarwallaA,AgrawalCS,ThakurA,GargVK,JoshiA,AgrawalS,etal.Cutaneoushornoncondylomaacuminatum.ActaDermVenereol2000;80:159.
	7.JenkinsDJr,JakubovicHR.Pseudoepitheliomatous,keratotic,micaceousbalanitis.Aclinicallesionwithtwohistologicsubsets:hyperplasticdystrophyandverrucouscarcinoma.JAmAcadDermatol1988;18:419?422.
	8.DasguptaP,BoothCM.?Ram?shornpenis?:anunusualpresentationofprostatecancer.BJUInt2000;85:1154.
	9.GarciaPanosJM,BuendiaGonzalezE,JimenezLeiroF,SampietroCrespoA,GandiaBlascoV,AlvarezFernandezF,etal.Penilecutaneoushorn.Reportofacaseandreviewoftheliterature.ArchEspUrol1999;52:173?174.
	10.BartRS,KopfAW.Onadilemmaofpenilehorns:pseudoepitheliomatous,hyperkeratoticandmicaceousbalanitis?JDermatolSurgOncol1977;3:580?582.
	11.Lortat-JacobE,CivatteJ.Balanitepseudoepithelioma-teuse,keratosiquemicacee.BullSocFrDermatolSyphilol1961;68:164?167.
	12.GrayMR,AnsellID.Pseudo-epitheliomatoushyper-keratoticandmicaceousbalanitis:evidenceforregardingitaspre-malignant.BrJUrol1990;66:103?104.
	13.EmeryRT,JohnsonDE,FranksHH.Malignantpenilehorn.InfectUrol2000;13:110?111.
	14.WillscherMK,DalyKJ,ConwayJFJr,MittelmanMA.Penilehorns:reportof2cases.JUrol1984;132:1192?1193.
	15.MarcialVA,PurasA,Marcial-VegaVA.Neoplasmsofthepenis.In:BastRC,KufeDW,PollockRE,WeichselbaumRR,HollandJF,FreiE,eds.Cancermedicine.5thedn.,Hamilton,Canada:BCDecker,2000:1589?1595.
272-273.pdf	12
	1.SchnitzlerL.Leï¿½sionsurticarienneschroniquespermanents(eï¿½rythe`mepeï¿½taloide?).Casecliniquesn.46B.Journeeï¿½Dermatologiqued?Angers1972;28October(Abstr.46).
	2.AlmerigognaF,GiudiziMG,CappelliF,RomagnaniS.Schnitzler?ssyndrome:what?snew?JEurAcadDermatolVenereol2002;16:214?219.
	3.AkimotoR,YoshidaM,MatsudaR,MiyasakaK,ItohM.Schnitzler?ssyndromewithIgGkappagammopathy.JDermatol2002;29:735?738.
	4.HusakR,NestorisS,GoerdtS,OrfanosCE.Severecourseofchronicurticaria,arthralgia,feverandelevationoferythrocytesedimentationrate:Schnitzler?ssyndromewithoutmonoclonalgammopathy?BrJDermatol2000;142:581?582.
	5.LipskerD,VeranY,GrunenbergerF,CribierB,HeidE,GrosshansE.TheSchnitzlersyndrome.Fournewcasesandreviewoftheliterature.Medicine2001;80:37?44.
	6.PudduP,CianchiniG,GirardelliCR,ColonnaL,GattiS,dePitaO.Schnitzler?ssyndrome:reportofanewcaseand
	7.BerdySS,BlochKJ.Schnitzler?ssyndrome:abroader
	8.deCastroFR,MasouyeI,WinkelmannRK,SauratJH.UrticarialpathologyinSchnitzler?s(hyper-IgM)syndrome.Dermatology1996;193:94?99.
	9.WormM,KoldeG.Schnitzler?ssyndrome:successfultreatmentoftwopatientsusingthalidomide.BrJDermatol2003;148:601?602.
	10.Pascual-LopezM,Hernandez-NunezA,Sanchez-PerezJ,Fernandez-HerreraJ,Garcia-DiezA.Schnitzler?ssyndromewithmonoclonalIgGkappagammopathy:goodresponsetocyclosporin.JEurAcadDermatolVenereol2002;16:267?270.
	11.SchartzNE,BuderS,SperlH,AudringH,PausR,TebbeB,etal.ReportofacaseofSchnitzler?ssyndrometreatedsuccessfullywithinterferonalpha2b.Dermatology2002;205:54?56.
	12.KuenzliS,BuchetS,SauratJH.SuccessfultreatmentofSchnitzler?ssyndromewithinterferonalfa-2b.Dermatology2002;205:74.
a05v65n1.pdf	8
	BERGE, M., MUNIR, A. K. & DREBORG, S., 1998,Concentrations of cat (Fel d 1), dog (Can f 1) and mite (Derf 1 and Der p 1) allergens in the clothing and schoolenvironment of Swedish schoolchildren with and withoutpets at home. Pediatr. Allergy Immunol., 9: 25-30.
	BINOTTI, R. S., MUNIZ, J. R. O., PASCHOAL, I. A., PRADO,A. P. & OLIVEIRA, C. H., 2001, House dust mites in Brazil ?an annotated bibliography.Mem. Inst. Oswaldo Cruz.,96:1177-1184.
	KRANTZ, G. W., 1978, A manual of acarology. 2nd ed. OregonState University Bookstores, Inc. Corvallis, 509p.
	COLLOFF, M. J. & SPIEKSMA, F. M., 1992, Pictorial keysfor the identification of domestic mites. Clin. Exp. Allergy.,22: 823-830.
	MUNIR, A. K. M., EINARSSON, R. & DREBORG, S. K. G.,1995, Mite (Der p I, Der f I), cat (Fel d I) and dog (Canf I) allergens in dust from Swedish day-care centres. Clin.Exp. Allergy.,25: 119-126.
	ROSA, A. E. & FLECHTMAN, C. H. W., 1979, Mites in housedust from Brazil. Intl. J. Acar..,5: 195-198.
	SMITH, T. F., KELLY, L. B., HEYMANN, P. W., WILKINS,S. R. & PLATTS-MILLS, T. A. E., 1985, Natural exposureand serum antibodies to house dust mite of mite-allergicchildren with asthma in Atlanta. J. Allergy Clin. Immunol.,76: 782-788.
	vAN BRONSWIJK, J. E. M. H., 1981, House dust biology forallergists, acarologists and mycologists. NIB Publishers,Zoelmond, The Netherlands, 316p.
a02v65n1.pdf	15
	ARAï¿½JO,F. G. & SANTOS, L. N., 2001, Distribution offish assemblages in Lajes reservoir, Rio de Janeiro, Brazil.Rev. Brasil. Biol.,61(4): 563-576.
	BASILE-MARTINS, M. A., CIPï¿½LI, M. N. & GODINHO,H. M., 1983, Alimentaï¿½ï¿½o do mandi PimelodusmaculatusLacï¿½pï¿½de, 1803 (Osteichthyes, Pimelodidae) de trechos dosrios Jaguari e Piracicaba, Sï¿½o Paulo, Brasil. Bol. Inst. Pesca,Sï¿½o Paulo, 13(1): 17-19.
	FONTENELE, O., 1982, Contribuiï¿½ï¿½o para o estudo dabiologia dos tucunarï¿½s (Actinopterygii, Cichlidae) emcativeiro ? aparelho de reproduï¿½ï¿½o, hï¿½bitos de desovae incubaï¿½ï¿½o. Colet. de Trab. Tï¿½cn. DNOCS, Fortaleza,2: 256-276.
	GEALH, A. M. & HAHN, N. S., 1998, Alimentaï¿½ï¿½o deOligosarcus longirostris do reservatï¿½rio de Salto Segredo,Paranï¿½, Brasil. Revta. Bras. Zool., 15(4): 985-993.
	HAHN, N. S., FUGI, R., ALMEIDA, V. L. L., RUSSO, M. R.& LOUREIRO, V. E., 1997, Dieta e atividade alimentar depeixes do reservatï¿½rio de Segredo. pp. 141-153. In: A. A.Agostinho & L. C. Gomes (eds.), Reservatï¿½rio de Segredo:bases ecolï¿½gicas para o manejo. EDUEM, Maringï¿½, 381p.
	HARTZ, S. M., MARTINS, A., & BARBIERI, G., 1996,Dinï¿½mica da alimentaï¿½ï¿½o e dieta de Oligorsacus jenynsii(Gï¿½nther, 1864) na lagoa Caconde, Rio Grande do Sul, Brasil(Teleoestei, Characidae). Bol. Inst. Pesca, Sï¿½o Paulo, 23:21-29.
	LIGHT/IESA, 1991, Reservatï¿½rio de Lajes ? estudo de viabi-lidade para o alteamento do nï¿½vel da ï¿½gua. Relatï¿½rio finalSLP (RMD ? 6102 ? RE), Rio de Janeiro, 102p.
	LOWE-McCONNEL, R. L., 1975, Fish communities in tropicalfreshwaters. Longman, London, 337p.
	NIKOLSKY, G. V., 1963, The ecology of fishes. Academic Press,London, 352p.
	OLIVEIRA, S. L. DE, MENDES, Z. C., CRISï¿½STOMO, L. C.& ARAï¿½JO, F. G., 1986, Resultados preliminares dolevantamento ictiolï¿½gico na represa de Ribeirï¿½o das Lajes,estado do Rio de Janeiro. Public.Avulsas Mus. Nac. do Riode Janeiro, Rio de Janeiro, 65: 87-90.
	PINKAS, L., 1971, Food habits study. pp. 5-10. In: L. Pinkas,M. S. Oliphant, I. L. K. Iverson (eds.), Food habits of albacorebluefin tuna and bonito in California waters. Fish. Bull.,152: 1-105.
	SANTOS, L. N., GONZALEZ, A. F. & ARAï¿½JO, F. G., 2001,Dieta do tucunarï¿½ amareloCichla monoculus (Bloch &Schneider) (Osteichthyes, Ciclidae), no reservatï¿½rio de Lajes,RJ.Revta. Bras. Zool.,Curitiba,18(Supl. 1): 191-204.
	VIEIRA,F., 1994, Estrutura de comunidade e aspectos daalimentaï¿½ï¿½o e reproduï¿½ï¿½o dos peixes em dois lagos do mï¿½dioRio Doce, MG. Editora Universidade Federal de MinasGerais, Belo Horizonte, 78p.
	WOOTTON, R. J., 1992, Fish ecology. Chapman and Hall, NewYork, 212p.
	ZAVALA-CAMIN, L. A., 1996, Introduï¿½ï¿½o ao estudo sobrealimentaï¿½ï¿½o natural em peixes. EDUEM, Maringï¿½, 129p.
Acupunct Med-2005-Guerreiro da Silva-47-51.pdf	25
16025763.pdf	60
	1FairA,GriffithsK,OsmanLM.AttitudestofertilityissuesamongadultswithCFinScotland.Thorax2000;55:672
	2NixonGM,GlaznerJA,MartinJM,SawyerSM.FemalesexualhealthcareinCF.ArchDisChild2003;88:265?6
	3EdenboroughFP.WomenwithCFandtheirpotentialforreproduction.Thorax2001;56:649?56
	4WeylerRT,AltschulerSM,ReenstraWW,etal.RegulationofneurosecretionbyCFTR.PaediatrPulmonol1998;17(suppl):A76
	5SawyerSM,BowesG,PhelanPD.ReproductivehealthinyoungwomenwithCF.JAdolescHealth1995;17:46?50
	6SawyerSM,TullyMA,DoveyM,ColinAA.ReproductivehealthinmaleswithCF.PaediatrPulmonol1998;25:226?30
	7WellingsK,FieldJ,JohnsonAM,WadsworthJ.SexualBehaviourinBritain.Middlesex:Penguin,1994
	8NationalStatisticsOnline.SexualHealth;TeenInfectionAlmostDoubledDuring90s[www.statistics.gov.uk/cci/nugget_print.asp?ID:721]
	9HealthProtectionAgencyUKStatistics[www.hpa.org.uk/infections/topics_a-z/hiv_and_sti/default.htm](accessed31January2005)
	10AbuhammourW,KumarA,PattersonMJ.Pulmonaryinfectionsintheadolescentwithimmunodeficiency.AdolescMed2000;11:663?80
	11AsboeD,GantV,AuckenHM,etal.PersistenceofPseudomonasaeruginosastrainsinrespiratoryinfectionsinAIDSpatients.AIDS1998;12:1771?5
	12DenningCR,SommersSC,QuigleyHJ.InfertilityinmalepatientswithCF.Pediatrics1968;41:7?17
	13KaplanE,SchwachmanH,PerlmutterAD.ReproductivefailureinmaleswithCF.NEnglJMed1968;279:65?9
	14LandingBH,WellsTR,WangCI.AbnormalityoftheepididymisandvasdeferensinCF.ArchPathol1969;88:569?80
	15PalermoG,JorisH,DevroeyP,VanSteirteghemA.Pregnanciesafterintracytoplasmicinjectionsinglespermatozoonintoanoocyte.Lancet1992;340:17?18
	16VanSteirteghenAC,NagyZ,JorisH,etal.Highfertilizationandimplantationratesafterintracytoplasmicsperminjection.HumReprod1993;8:1061?6
	17ThePractiseCommitteeoftheAmericanSocietyforReproductiveMedicine.Intracytoplasmicsperminjection.FertilSteril2004;82(suppl1):205
	18ThePractiseCommitteeoftheAmericanSocietyforReproductiveMedicine.DoesIntracytoplasmicsperminjectioncarryinherentgeneticrisks?FertilSteril2004;82(suppl1):151?2
	19KurnczukJJ,BowerC.BirthdefectsininfantsconceivedbyICSI:analternativeinterpretation.BMJ1997;315:1260?5
	20JohnsonMD.GeneticrisksofICSIinthetreatmentofmaleinfertility:recommendationsforgeneticcounselingandscreening.FertilSteril1998;70:397?411
	21KopitoLE,KosaskyHJ,SchwachmanH.WaterandelectrolytesincervicalmucusfrompatientswithCF.FertilSteril1973;24:512?16
	22OppenheimerEA,CaseAL,EsterlyJR,etal.CervicalmucusinCF,apossiblecauseofinfertility.AmJObstetGynecol1970;108:673?4
	23HilmanBC,AitkenM,ConstantinescuM.PregnancyinpatientswithCF.ClinObstetGynecol1996;39:70?86
	24WHOMedicalEligibilityCriteriaforContraceptiveUse.3rdedn.[www.who.int/reproductive-health/publications/RHR_00_2_medical_eligibility_criteria_3rd/](accessed31January2005)
	25NeinsteinLS,KatzB.Carefulcounsellingisrequiredforpatientswithpulmonarydisease.ContraceptTechnolUpdate1984;5:142?3
	26NeinsteinLS,KatzB.Contraceptiveuseinthechronicallyilladolescentfemale:Part1.JAdolescHealthCare1986;7:123?33
	27WillettMJ,EllisAG.Reproductivehealthinwomenwithcysticfibrosis.HospMed1999;60:863?7
	28OwensK,HonebrinkA.Gynaecologiccareofmedicallycomplicatedadolescents.PaediatrClinNorthAm1999;46:ix,631?42
	29SteadRJ,GrimmerSF,RogersSM,etal.Pharmacokineticsofcontraceptivesteroidsinpatientswithcysticfibrosis.Thorax1987;42:59?64
	30FitzpatrickSB,StokesDC,RosensteinBJ,TerryP,HubbardVS.Useoforalcontraceptivesinwomenwithcysticfibrosis.Chest1984;86:863?7
	31ConwayS.Pregnancyandfertility[www.cysticfibrosismedicine.com]
	32FacultyofFamilyPlanningandReproductiveHealthCareGuidance(October2003)FirstprescriptionofCombinedOralContraception.JFamPlannReprodHealthCare2003;29:209?23
	33AitkenML,TonelliMR.Complicationsofindwellingcathetersincysticfibrosis:a10yearreview.Chest2000;118:1598?602
	34A-RahmanA,SpencerD.Totallyimplantablevascularaccessdevicesforcysticfibrosiscombinedoralcontraceptivepill.CochraneDatabaseSystRev2003;(3):CD00411115
	35BarkerM,ThoenesD,PfannenstielC,etal.Prevalenceofthrombophiliaandcatheter-relatedeventsincysticfibrosis[www.ersnetsecure.org/public/prg_congres.abstract?ww_i_presentation=7038](accessed31January2005)
	36EllimanA.Interactionswithhormonalcontraception.FacultyofFamilyPlanningandReproductiveHealthCare,ReviewNo:2000/02[www.ffprhc.org.uk/meetings/fact_drug.pdf](accessed31January2005)
	37GuillebaudJ.ContraceptionyourQuestionsAnswered,3rdedn.London:ChurchillLivingstone,1999:311?16
	38ClinicalEffectivenessUnitFFPRHC.ShortScientificReview?UseofRifampicinandContraceptiveSteroids[www.ffprhc.org.uk/clinical_effect/recommend_rifampicin_steroids.html](accessed31January2005)
	39ClinicalEffectivenessUnitFFPRHC.Cerazette:NewProductReview[www.ffprhc.org.uk/clinical_effect/cerazette%20CEC20Approved%2029.04.03.pdf](accessed31January2005)
	40RiceCF,KillickSR,DiebenT,CoelinghBenninkH.Acomparisonoftheinhibitionofovulationachievedbydesogestrel75mcgandlevonorgestrel30mcgdaily.HumReprod1999;14:982?5
	41BeerlhuizenR,VanBeekA,MassaiR,etal.Bonemineraldensityduringlong-termuseoftheprogestogencontraceptiveimplantImplanoncomparedtoanon-hormonalmethodofcontraception.HumReprod2000;15:118?22
	42CommitteeonSafetyofMedicines[www.mhra.gov.uk]CEM/CMO/2004/10
	43GboladeB.DepoProvera1andbonedensity.JFamPlannReprodHealthCare2002;28:7?11
	44ConwayS.Impactoflunginflammationonbonemetabolisminadolescentswithcysticfibrosis.PaediatrRespirRev2001;2:324?31
	45OlotoE,MascarenhasL.SubdermalContraceptiveImplants[www.ffhrhc.org.uk/meetings/fact_implants.pdf](accessed31January2005)
	46PenneyG,BrechinS,deSouzaA,etal.FFPRHCGuidance(January2004).Thecopperintrauterinedeviceaslong-termcontraception.JFamPlannReprodHealthCare2004;30:134
	47FacultyofFamilyPlanningandReproductiveHealthCareClinicalEffectivenessUnit.FFPRHCGuidance:emergencycontraception.JFamPlannReprodHealthCare2003;29:159
	48EdenboroughFP,MackenzieWE,ConwaySP,etal.TheeffectofpregnancyonmaternalCFvsnulliparousseveritymatchedcontrols.Thorax1996;51(suppl3):A50
	49BoseD,YentisSM,FauvelNJ.CaesareansectioninaparturientwithrespiratoryfailurecausedbyCF.Anaesthesia1997;52:578?82
	50BriggsGE,FreemanRK,YaffeSJ.DrugsinPregnancyandLactation.AReferenceGuidetoFetalandNeonatalRisk,5thedn.Williams&Wilkins,1998
	51FielSB,FitzsimmonsS.PregnancyinpatientswithCF.PaediatrPulmonol1995;12(suppl):S4.2
	52GilljamM,AntoniouM,ShinJ,etal.PregnancyinCF:fetalandmaternaloutcome.Chest2000;118:85?9
	53EdenboroughFP,StableforthDE,MackenzieWE.Theoutcomeof72pregnanciesin55womenwithCFintheUK1977?1996.ObstetGynaecol2000;107:254?61
	54ShiffmanML,SealeTW,FluxM,etal.BreastmilkcompositioninwomenwithCF:reportoftwocasesandareviewoftheliterature.AmJClinNutr1989;49:612?17
	55EdenboroughFP,MackenzieWE,ConwaySP,etal.IstheriskoffetalanomaliesgreaterinmotherswithCF.Thorax1996;51(suppl3):A50
	56RoyalCollegeofPaediatricsandChildHealth.BridgingtheGaps:HealthcareforAdolescents.London:RCPCH,2003
	57MetcalfeT.Sexualhealth:meetingadolescents?needs.NursStandard2004;18:40?3
	58CanadianCysticFibrosisFoundation.Sexuality,FertilityandCysticFibrosis;informationforadolescents[www.cysticfibrosis.ca/pdf/AdolesSexualitEng2001.pdf](accessed31January2005)
	59SawyerS,RosebyC.ThingsTheyDon?tTellYou:aYoungPerson?sGuidetoSexualandReproductiveHealthIssuesinCF.Melbourne:CentreforAdolescentHealth,RoyalChildren?sHospital,2001
	60Confidentialityandpeopleunder16.GuidanceissuedjointlybytheBMA,GMSC,HEA,BrookAdvisoryCentres,FPAandRCGP.London:BMApublication,1986
tjp0567-0757.pdf	44
	BeguinP,NagashimaK,GonoiT,ShibasakiT,TakahashiK,KashimaY,OzakiN,GeeringK,IwanagaT&SeinoS(2001).RegulationofCa2+channelexpressionatthecellsurfacebythesmallG-proteinkir/Gem.Nature411,701?706.
	BirnbaumerL,QinN,OlceseR,TareilusE,PlatanoD,CostantinJ&StefaniE(1998).Structuresandfunctionsofcalciumchannel?subunits.JBioenergBiomembr30,357?375.
	BriceNL,BerrowNS,CampbellV,PageKM,BrickleyK,TedderI&DolphinAC(1997).Importanceofthedifferent?subunitsinthemembraneexpressionofthe?1Aand?2calciumchannelsubunits:studiesusingadepolarization-sensitive?1Aantibody.EurJNeurosci9,749?759.
	BrodyDL,PatilPG,MulleJG,SnutchTP&YueDT(1997).BurstsofactionpotentialwaveformsrelieveG-proteininhibitionofrecombinantP/Q-typeCa2+channelsinHEK293cells.JPhysiol499,637?644.
	CantiC,DaviesA,BerrowNS,ButcherAJ,PageKM&DolphinAC(2001).Evidencefortwoconcentration-dependentprocessesfor?-subuniteffectson?1Bcalciumchannels.BiophysJ81,1439?1451.
	CatterallWA(2000).Structureandregulationofvoltage-gatedCa2+channels.AnnuRevCellDevBiol16,521?555.
	ChenY,LiM,ZhangY,HeL,YamadaY,FitzmauriceA,ShenY,ZhangH,TongL&YangJ(2004).Structuralbasisofthe?1??subunitinteractionofvoltage-gatedCa2+channels.Nature429,675?680.
	ChienAJ,ZhaoX,ShirokovRE,PuriTS,ChangCF,SunD,RiosE&HoseyMM(1995).Rolesofamembrane-localized?subunitintheformationandtargetingoffunctionalL-typeCa2+channels.JBiolChem270,30036?30044.
	CohenRM,FoellJD,BalijepalliRC,ShahV,HellJW&KampTJ(2004).UniquemodulationofL-typeCa2+channelsbyshortauxiliary?1dsubunitpresentincardiacmuscle.AmJPhysiolHeartCircPhysiol288,H2363?H2374.
	ColecraftHM,AlseikhanB,TakahashiSX,ChaudhuriD,MittmanS,YegnasubramanianV,AlvaniaRS,JohnsDC,MarbanE&YueDT(2002).NovelfunctionalpropertiesofCa2+channel?subunitsrevealedbytheirexpressioninadultratheartcells.JPhysiol541,435?452.
	CostantinJ,NocetiF,QinN,WeiX,BirnbaumerL&StefaniE(1998).Facilitationbythe?2asubunitofporeopeningsincardiacCa2+channels.JPhysiol507,93?103.
	DeWaardM,PragnellM&CampbellKP(1994).Ca2+channelregulationbyaconserved?subunitdomain.Neuron13,495?503.
	DolphinAC(2003).?subunitsofvoltage-gatedcalciumchannels.JBioenergBiomemb35,620.
	FinlinBS,CrumpSM,SatinJ&AndresDA(2003).Regulationofvoltage-gatedcalciumchannelactivitybytheRemandRadGTPases.ProcNatlAcadSciUSA100,14469?14474.
	GaoT,ChienAJ&HoseyMM(1999).Complexesofthe?1Cand?subunitsgeneratethenecessarysignalformembranetargetingofclassCL-typecalciumchannels.JBiolChem274,2137?2144.
	GarciaR,CarrilloE,RebolledoS,GarciaMC&SanchezJA(2002).The?1asubunitregulatesthefunctionalpropertiesoffrogandmouseL-typeCa2+channelsofskeletalmuscle.JPhysiol545,407?419.
	GersterU,NeuhuberB,GroschnerK,StriessnigJ&FlucherBE(1999).Currentmodulationandmembranetargetingofthecalciumchannel?1Csubunitareindependentfunctionsofthe?subunit.JPhysiol517,353?368.
	HullinR,KhanIFY,WirtzS,MohacsiP,VaradiG,SchwartzA&HerzigS(2003).CardiacL-typecalciumchannel?subunitsexpressedinhumanhearthavedifferentialeffectsonsinglechannelcharacteristics.JBiolChem278,21623?21630.
	JonesSW(2002).Calciumchannels:whenisasubunitnotasubunit?JPhysiol545,334.
	JonesLP,WeiSK&YueDT(1998).Mechanismofauxiliarysubunitmodulationofneuronal?1Ecalciumchannels.JGeneralPhysiol112,125?143.
	LudwigA,FlockerziV&HofmannF(1997).Regionalexpressionandcellularlocalizationofthe?1and?subunitofhighvoltage-activatedcalciumchannelsinratbrain.JNeurosci17,1339?1349.
	McGeeAW,NunziatoDA,MaltezJM,PrehodaKE,PittGS&BredtDS(2004).CalciumchannelfunctionregulatedbytheSH3-GKmodulein?subunits.Neuron42,89?99.
	OpatowskyY,ChenC-C,CampbellKP&HirschJA(2004).Structuralanalysisofthevoltage-dependentcalciumchannel?subunitfunctionalcoreanditscomplexwiththe?1interactiondomain.Neuron42,387?399.
	OpatowskyY,Chomsky-HechtO,KangMG,CampbellKP&HirschJA(2003).Thevoltage-dependentcalciumchannel?subunitcontainstwostableinteractingdomains.JBiolChem278,52323?52332.
	Perez-ReyesE,CastellanoA,KimHS,BertrandP,BaggstromE,LacerdaAE,WeiXY&BirnbaumerL(1992).Cloningandexpressionofacardiac/brain?subunitoftheL-typecalciumchannel.JBiolChem267,1792?1797.
	PragnellM,DeWaardM,MoriY,TanabeT,SnutchTP&CampbellKP(1994).Calciumchannel?-subunitbindstoaconservedmotifintheI?IIcytoplasmiclinkerofthe?1-subunit.Nature368,67?70.
	QinN,PlatanoD,OlceseR,StefaniE&BirnbaumerL(1997).DirectinteractionofG??withaC-terminalG??-bindingdomainoftheCa2+channel?1subunitisresponsibleforchannelinhibitionbyGprotein-coupledreceptors.ProcNatlAcadSciUSA94,8866?8871.
	ScottVE,DeWaardM,LiuH,GurnettCA,VenzkeDP,LennonVA&CampbellKP(1996).?subunitheterogeneityinN-typeCa2+channels.JBiolChem271,3207?3212.
	SingerD,BielM,LotanI,FlockerziV,HofmannF&DascalN(1991).Therolesofthesubunitsinthefunctionofthecalciumchannel.Science253,1553?1557.
	SpaffordJD,VanMinnenJ,LarsenP,SmitAB,SyedNI&ZamponiGW(2004).Uncouplingofcalciumchannel?1and?subunitsindevelopingneurons.JBiolChem279,41157?41167.
	TakahashiSX,MiriyalaJ&ColecraftHM(2004).Membrane-associatedguanylatekinase-likepropertiesof?subunitsrequiredformodulationofvoltage-dependentCa2+channels.ProcNatlAcadSciUSA101,7193?7198.
	TakahashiSX,MittmanS&ColecraftHM(2003).Distinctivemodulatoryeffectsoffivehumanauxiliary?2subunitsplicevariantsonL-typecalciumchannelgating.BiophysJ84,3007?3021.
	TareilusE,RouxM,QinN,OlceseR,ZhouJ,StefaniE&BirnbaumerL(1997).AXenopusoocyte?subunit:evidenceforaroleintheassembly/expressionofvoltage-gatedcalciumchannelsthatisseparatefromitsroleasaregulatorysubunit.ProcNatlAcadSciUSA94,1703?1708.
	TomlinsonWJ,SteaA,BourinetE,CharnetP,NargeotJ&SnutchTP(1993).FunctionalpropertiesofaneuronalclassCL-typecalciumchannel.Neuropharmacology32,1117?1126.
	VanPetegemF,ClarkKA,ChatelainFC&MinorDL(2004).Structureofacomplexbetweenavoltage-gatedcalciumchannel?-subunitandan?-subunitdomain.Nature429,671?675.
	WalkerD,BichetD,CampbellKP&DeWaardM(1998).Abeta4isoform?specificinteractionsiteinthecarboxyl-terminalregionofthevoltage-dependentCa2+channel?1Asubunit.JBiolChem273,2361?2367.
	WalkerD,BichetD,GeibS,MoriE,CornetV,SnutchTP,MoriY&DeWaardM(1999).Anew?subtype?specificinteractionin?1AsubunitcontrolsP/Q-typeCa2+channelactivation.JBiolChem274,12383?12390.
	WalkerD&DeWaardM(1998).Subunitinteractionsitesinvoltage-dependentCa2+channels:roleinchannelfunction.TrendsNeurosci21,148?154.
	WeiXY,Perez-ReyesE,LacerdaAE,SchusterG,BrownAM&BirnbaumerL(1991).HeterologousregulationofthecardiacCa2+channel?1subunitbyskeletalmuscle?and?subunits.ImplicationsforthestructureofcardiacL-typeCa2+channels.JBiolChem266,21943?21947.
	WitcherDR,DeWaardM,LiuH,PragnellM&CampbellKP(1995).AssociationofnativeCa2+channel?subunitswiththe?1subunitinteractiondomain.JBiolChem270,18088?18093.
	WitcherDR,DeWaardM,SakamotoJ,Franzini-ArmstrongC,PragnellM,KahlSD&CampbellKP(1993).SubunitidentificationandreconstitutionoftheN-typeCa2+channelcomplexpurifiedfrombrain.Science261,486?489.
	YamaguchiH,HaraM,StrobeckM,FukasawaK,SchwartzA&VaradiG(1998).Multiplemodulationpathwaysofcalciumchannelactivitybya?subunit.Directevidenceof?subunitparticipationinmembranetraffickingofthe?1Csubunit.JBiolChem273,19348?19356.
	YamaguchiH,OkudaM,MikalaG,FukasawaK&VaradiG(2000).Cloningofthe?2asubunitofthevoltage-dependentcalciumchannelfromhumanheart:cooperativeeffectof?2?and?2aonthemembraneexpressionofthe?1Csubunit.BiochemBiophysResCommun267,156?163.
	YoungK,LinS,SunL,LeeE,ModiM,HellingsS,HusbandsM,OzenbergerB&FrancoR(1998).Identificationofacalciumchannelmodulatorusingahighthroughputyeasttwo-hybridscreen.NatBiotechnol16,946?950.
J Appl Physiol-2005-Matthie-780-1.pdf	13
	1.ColeKS.Permeabilityandimpermeabilityofcellmembranesforions.ColdSpringHarbSympQuantBiol8:110?122,1940.
	2.DeLorenzoA,AndreoliA,MatthieJ,andWithersP.Predictingbodycellmasswithbioimpedancebyusingtheoreticalmethods:atechnologicalreview[publishederratumappearsinJApplPhysiol83(6):followingtableofcontents,1997].JApplPhysiol82:1542?1558,1997.
	3.DeVriesPMJM,MeijerJH,VlaanderenK,VisserV,OePL,DonkerAJM,andSchneiderH.Measurementoftranscellularfluidshiftduringhaemodialysis.MedBiolEngComput27:152?158,1989.
	4.EarthmanCP,MatthieJR,ReidPM,HarperIT,RavussinE,andHowellWH.AcomparisonofbioimpedancemethodsfordetectionofbodycellmasschangeinHIVinfection.JApplPhysiol88:944?956,2000.
	5.EllisKJ,ShypailoRJ,andWongWW.Measurementofbodywaterbymultifrequencybioelectricalimpedancespectroscopyinamultiethnicpediatricpopulation.AmJClinNutr70:847?853,1999.
	6.GeddesLAandBakerLE.Thespecificresistanceofbiologicalmaterial:acompendiumofdataforthebiomedicalengineerandphysiologist.MedBiolEng5:271?293,1967.
	7.GudivakaR,SchoellerDA,KushnerRF,andBoltMJG.Single-andmultifrequencymodelsforbioelectricalimpedanceanalysisofbodywatercompartments.JApplPhysiol87:1087?1096,1999.
	8.HanaiT.Electricalpropertiesofemulsions.In:EmulsionScience,editedbyShermanPH.London:Academic,1968,p.354?477.
	9.HoLT,KushnerRF,SchoellerDA,GudivakaR,andSpiegelDM.Bioimpedanceanalysisoftotalbodywaterinhemodialysispatients.KidneyInt46:1438?1442,1994.
	10.MatthieJR,WithersPO,VanLoanMD,andMayclinPL.Develop-mentofacommercialcomplexbio-impedancespectroscopic(CBIS)systemfordeterminingintracellularwater(ICW)andextracellularwater(ECW)volumes.In:Proceedingsofthe8thInternationalConferenceonElectricalBio-impedance.Kuopio,Finland:UniversityofKuopio,Fin-land,1992,p.203?205.
	11.VanKreelBK,Cox-ReyvenN,andSoetersP.Determinationoftotalbodywaterbymultifrequencybio-electricimpedance:developmentofseveralmodels.MedBiolEngComput36:337?345,1998.
	12.WardLC,EliaM,andCornishBH.Potentialerrorsintheapplicationofmixturetheorytomultifrequencybioelectricalimpedanceanalysis.PhysiolMeas19:53?60,1998.
	13.WithersP.Multi-frequencyimpedancemeasurementsofextracellularfluidvolume.PhysiolMeas16:71?76,1995.
J Appl Physiol-2005-Beneke-499-504.pdf	51
	1.ArmstrongN,WelsmanJR,andKirbyBJ.PerformanceontheWingateAnaerobicTestandmaturation.PediatrExercSci9:253?261,1997.
	2.Bar-OrO.DiePraxisderSportmedizininderKinderheilkunde.Berlin:Springer-Verlag,1986,p.12?23.
	3.BenekeR.Maximallactatesteadystateconcentration(MLSS):experi-mentalandmodellingapproaches.EurJApplPhysiol88:361?369,2003.
	4.BenekeR.Experimentandcomputeraidedsimulationcomplementarytoolstounderstandexercisemetabolism.BiochemSocTrans31:1263?1266,2003.
	5.BenekeR,HeckH,SchwarzV,andLeithaï¿½userR.Maximallactatesteadystateduringtheseconddecadeofage.MedSciSportsExerc28:1474?1478,1996.
	6.BenekeR,Leithaï¿½userRM,SchwarzV,andHeckH.MaximalesLaktat-Steady-StatebeiKindernundErwachsenen.DtschZSportmed51:100?104,2000.
	7.BenekeR,Leithaï¿½userRM,andHuï¿½tlerM.Leistungsfaï¿½higkeitundTrainierbarkeitimKindes-undJugendalter.In:Kinder-undJugendsport-medizin,editedbyHebestreitH,FerrariR,Meyer-HolzJ,LawerenzW,andJuï¿½ngstBK.Stuttgart,Germany:Thieme,2003,p.15?20.
	8.BenekeR,PollmannC,BleifI,Leithaï¿½userRM,andHuï¿½tlerM.HowanaerobicistheWingateAnaerobicTestforhumans?EurJApplPhysiol87:388?392,2002.
	9.BergA,KimSS,andKeulJ.Skeletalmuscleenzymeactivitiesinhealthyyoungsubjects.IntJSportsMed7:236?239,1986.
	10.BouchardCandThibaultMC.JugendundSport.DtschZSportmed28:206?220,1977.
	11.ChiaM,ArmstrongN,andChildsD.Theassessmentofchildren?sanaerobicperformanceusingmodificationsoftheWingateAnaerobicTest.PediatrExercSci9:80?89,1997.
	12.DiPramperoPE.GrundlagenderanaerobenEnergiebereitstellungundderO2-Schuldbeikoï¿½rperlichenHoï¿½chstleistungen.MeduSport13:1?13,1973.
	13.DiPramperoPE.Energeticsofmuscularexercise.RevPhysiolBiochemPharmacol89:144?222,1981.
	14.DoreE,BeduM,FrancaNM,DialloO,DucheP,andvanPraaghE.Testingpeakperformance:effectsofbrakingforceduringgrowth.MedSciSportsExerc32:493?498,2000.
	15.DostFH.GrundlagenderPharmakokinetik(BasicsofPharmacokinetics).Stuttgart,Germany:Thieme,1968,p.29?62.
	16.DotanR,FalkB,andRazA.Intensityeffectofactiverecoveryfromglycolyticexerciseondecreasingbloodlactateconcentrationinprepuber-talchildren.MedSciSportsExerc32:564?540,2000.
	17.DotanR,OhanaS,BedizC,andFalkB.Bloodlactatedisappearancedynamicsinboysandmenfollowingexerciseofsimilaranddissimilarpeak-lactateconcentrations.JPediatrEndocrinolMetab16:419?429,2003.
	18.ErikssonBO,KarlssonJ,andSaltinB.Musclemetabolitesduringexerciseinpubertalboys.ActaPaediatrScand217:154?207,1971.
	19.ErikssonBOandSaltinB.Musclemetabolismduringexerciseinboysaged11to16yearscomparedtoadults.ActaPaediatrBelg28:257?265,1974.
	20.FalgairetteG,BeduM,FellmannN,vanPraaghE,andCoudertJ.Bioenergeticprofilein144boysagedfrom6to15yearswithspecialreferencetosexualmaturation.EurJApplPhysiol62:151?156,1991.
	21.FalgairetteG,DucheP,BeduM,FellmanN,andCoudertJ.Bioen-ergeticcharacteristicsinpubertalswimmers:comparisonwithactiveandnon-activeboys.IntJSportsMed14:444?448,1993.
	22.FellmannN,BeduM,SpielvogelH,FalgairetteG,vanPraaghE,JarrigeJ,andCoudertJ.Anaerobicmetabolismduringpubertaldevel-opmentathighaltitude.JApplPhysiol64:1382?1386,1988.
	23.FournierM,RicciJ,TaylorAW,FergusonRJ,MontpetitRR,andChaitmanBR.Skeletalmuscleadaptationinadolescentboys:sprintandendurancetraininganddetraining.MedSciSportsExerc14:453?456,1982.
	24.GollnickPD,ArmstrongRB,SaubertCW,PiehlK,andSaltinB.Enzymeactivityandfibrecompositioninskeletalmuscleofuntrainedandtrainedmen.JApplPhysiol33:312?319,1972.
	25.HaralambieG.Enzymeactivitiesinskeletalmuscleof13?15yearsoldadolescents.BullEurPhysiopathResp18:65?74,1982.
	26.HebestreitH,MeyerF,HeigenhauserGJ,andBar-OrO.Plasmametabolites,volumeandelectrolytesfollowing30-shigh-intensityexer-ciseinboysandmen.EurJApplPhysiol72:563?569,1996.
	27.HollmannWandHettingerT.Sportmedizin.Stuttgart,Germany:Schat-tauer,2000.
	28.InbarOandBar-OrO.Anaerobiccharacteristicsinmalechildrenandadolescents.MedSciSportsExerc18:264?269,1986.
	29.InbarO,Bar-OrO,andSkinnerJS.TheWingateAnaerobicTest.Champaign,IL:HumanKinetics,1996,p.8?24.
	30.JacobsI,TeschPA,Bar-OrO,KarlssonJ,andDotanR.Lactateinhumanskeletalmuscleafter10and30sofsupramaximalexercise.JApplPhysiol55:365?367,1983.
	31.JonesNL,McCartneyN,GrahamT,SprietLL,KowalchukJM,HeigenhauserGJF,andSuttonJR.Muscleperformanceandmetabo-lisminmaximalisokineticcyclingatslowandfastspeeds.JApplPhysiol59:132?136,1985.
	32.KarlssonJ,NordesjoLO,JorfeldtL,andSaltinB.Musclelactate,ATPandCPlevelsduringexerciseafterphysicaltraininginman.JApplPhysiol33:199?203,1972.
	33.KunoS,TakahashiH,FujimotoK,AkimaH,MiyamaruM,andNemotoI.Musclemetabolismduringexerciseusingphosphorus-31nuclearmagneticresonancespectroscopyinadolescents.EurJApplPhysiol70:301?304,1995.
	34.MacekMandVavraJ.Theadjustmentofoxygenuptakeattheonsetofexercise:acomparisonbetweenprepubertalboysandyoungadults.IntJSportsMed1:70?72,1980.
	35.MaderA.Glycolysisandoxidativephosphorylationasafunctionofcytosolicphosphorylationstateandpoweroutputofthemusclecell.EurJApplPhysiol88:317?339,2003.
	36.MaderA.Evaluationoftheenduranceperformanceofmarathonrunnersandtheoreticalanalysisoftestresults.JSportsMedPhysFitness31:1?19,1991.
	37.MaderAandHeckH.Atheoryofthemetabolicoriginof?anaerobicthreshold.?IntJSportsMed7,Suppl1:45?65,1986.
	38.MalinaRMandBouchardC.Growth,Maturation,andPhysicalActiv-ity.Champaign,IL:HumanKinetics,1991,p.39?100.
	39.McLellanTMandSkinnerJS.Bloodlactateremovalduringrecoveryrelatedtotheaerobicthreshold.IntJSportsMed3:224?229,1982.
	40.MercierB,MercierJ,GranierP,LeGallaisD,andPrefautC.Maxi-malanaerobicpower:relationshiptoanthropometriccharacteristicsduringgrowth.IntJSportsMed13:21?26,1992.
	41.MeroA.Bloodlactateproductionandrecoveryfromanaerobicexerciseintrainedanduntrainedboys.EurJApplPhysiol57:660?666,1988.
	42.PatersonDH,CunninghamDA,andBumsteadLA.RecoveryO2andbloodlacticacid:longitudinalanalysisinboysaged11to15years.EurJApplPhysiol55:93?99,1986.
	43.PetersenSR,GaulCA,StantonMM,andHanstockCC.Skeletalmusclemetabolismduringshort-termhigh-intensityexerciseinprepuber-talandpubertalgirls.JApplPhysiol87:2151?2156,1999.
	44.RossiterHB,WardSA,HoweFA,KowalchukJM,GriffithsJR,andWhippBJ.Dynamicofintramuscular31P-MRSPipeaksplittingandtheslowcomponentofPCrandO2uptakeduringexercise.JApplPhysiol93:2059?2069,2002.
	45.SadySP.TransientOsuptakeandheartrateresponseattheonsetofrelativeenduranceexerciseinprepubertalboysandadultmen.IntJSportsMed2:240?244,1981.
	46.SprietLL,SoderlundK,BergstromM,andHultmanE.Anaerobicenergyreleaseinskeletalmuscleduringelectricalstimulationinmen.JApplPhysiol62:611?615,1987.
	47.TanakaHandShindoM.Runningvelocityatbloodlactatethresholdofboysaged5?15yearscomparedwithuntrainedandtrainedyoungmales.IntJSportsMed6:90?94,1985.
	48.VanPraaghE,FellmannN,BeduM,FalgaitetteG,andCoudertJ.Genderdifferenceintherelationshipofanaerobicpoweroutputtobodycompositioninchildren.PediatrExercSci2:336?348,1990.
	49.WhippBJ,RossiterHB,andWardSA.Exertionaloxygenuptakekinetics:astamenofstamina?BiochemSocTrans30:237?247,2002.
	50.WelsmanJRandArmstrongN.Assessingpostexerciselactatesinchildrenandadolescents.In:PediatricAnaerobicPerformance,editedbyvanPraaghE.Chicago,IL:HumanKinetics,1998,p.137?153.
	51.ZanconatoS,BuchthalS,BarstowTJ,andCooperDM.31P-magneticresonancespectroscopyoflegmusclemetabolismduringexerciseinchildrenandadults.JApplPhysiol74:2214?2218,1993.
J Immunol-2005-Shiraishi-1014-21.pdf	50
J Immunol-2005-Giabbai-977-84.pdf	54
J Immunol-2005-Sun-884-90.pdf	36
J Immunol-2005-McGargill-656-64.pdf	48
0049-05.pdf	61
	1.Amaar,Y.G.,andM.M.Moore.1998.Mappingofthenitrate-assimilationgenecluster(crnA-niiA-niaD)andcharacterizationofthenitritereductasegene(niiA)intheopportunisticfungalpathogenAspergillusfumigatus.Curr.Genet.33:206?215.
	2.Ayoubi,P.,X.Jin,S.Leite,X.Liu,J.Martajaja,A.Abduraham,Q.Wan,W.Yan,E.Misawa,andR.A.Prade.2002.PipeOnline2.0:automatedESTprocessingandfunctionaldatasorting.NucleicAcidsRes.30:4761?4769.
	3.Baganz,F.,A.Hayes,D.Marren,D.C.Gardner,andS.G.Oliver.1997.SuitabilityofreplacementmarkersforfunctionalanalysisstudiesinSaccha-romycescerevisiae.Yeast13:1563?1573.
	4.Borkovich,K.A.,L.A.Alex,O.Yarden,M.Freitag,G.E.Turner,N.D.Read,S.Seiler,D.Bell-Pedersen,J.Paietta,N.Plesofsky,M.Plamann,M.Goodrich-Tanrikulu,U.Schulte,G.Mannhaupt,F.E.Nargang,A.Radford,C.Selitrennikoff,J.E.Galagan,J.C.Dunlap,J.J.Loros,D.Catcheside,H.Inoue,R.Aramayo,M.Polymenis,E.U.Selker,M.S.Sachs,G.A.Marzluf,I.Paulsen,R.Davis,D.J.Ebbole,A.Zelter,E.R.Kalkman,R.O?Rourke,F.Bowring,J.Yeadon,C.Ishii,K.Suzuki,W.Sakai,andR.Pratt.2004.LessonsfromthegenomesequenceofNeurosporacrassa:tracingthepathfromgenomicblueprinttomulticellularorganism.Microbiol.Mol.Biol.Rev.68:1?108.
	5.Brakhage,A.A.,andK.Langfelder.2002.Menacingmold:themolecularbiologyofAspergillusfumigatus.Annu.Rev.Microbiol.56:433?455.
	6.Brand,A.,D.M.MacCallum,A.J.Brown,N.A.Gow,andF.C.Odds.2004.EctopicExpressionofURA3caninfluencethevirulencephenotypesandproteomeofCandidaalbicansbutcanbeovercomebytargetedreintegrationofURA3attheRPS10locus.Eukaryot.Cell3:900?909.
	7.Braus,G.H.,S.Krappmann,andS.E.Eckert.2002.SexualDevelopmentinAscomycetes-FruitBodyFormationofAspergillusnidulans,p.215?244.InH.D.Osiewacz(ed.),MolecularBiologyofFungalDevelopment.MarcelDekker,Inc.,NewYork,NY.
	8.Brown,J.S.,A.Aufauvre-Brown,J.Brown,J.M.Jennings,H.Arst,Jr.,andD.W.Holden.2000.Signature-taggedanddirectedmutagenesisidentifyPABAsynthetaseasessentialforAspergillusfumigatuspathogenicity.Mol.Microbiol.36:1371?1380.
	9.Brown,T.,andK.Mackey.1997.AnalysisofRNAbyNorthernandslotblothybridization.,p.4.9.1?4.9.16.InCurrentprotocolsinmolecularbiology.JohnWileyandSonsInc.,NewYork,NY.
	10.Calvo,A.M.,J.Bok,W.Brooks,andN.P.Keller.2004.veAisrequiredfortoxinandsclerotialproductioninAspergillusparasiticus.Appl.EnvironMi-crobiol.70:4733?4739.
	11.Champe,S.P.,M.B.Kurtz,L.N.Yager,N.J.Butnick,andD.E.Axelrod.1981.SporeformationinAspergillusnidulans:competenceandotherdevel-opmentalprocesses,p.255?276.InH.R.HohlandG.Turian(ed.),Thefungalspores:morphogeniccontrols.Academic,NewYork,NY.
	12.Chaveroche,M.K.,J.M.Ghigo,andC.d?Enfert.2000.ArapidmethodforefficientgenereplacementinthefilamentousfungusAspergillusnidulans.NucleicAcidsRes.28:E97.
	13.d?Enfert,C.1996.SelectionofmultipledisruptioneventsinAspergillusfu-migatususingtheorotidine-5-decarboxylasegene,pyrG,asauniquetrans-formationmarker.Curr.Genet.30:76?82.
	14.Delneri,D.,G.C.Tomlin,J.L.Wixon,A.Hutter,M.Sefton,E.J.Louis,anS.G.Oliver.2000.Exploringredundancyintheyeastgenome:animprovedstrategyforuseofthecre-loxPsystem.Gene252:127?135.
	15.Dietrich,F.S.,S.Voegeli,S.Brachat,A.Lerch,K.Gates,S.Steiner,C.Mohr,R.Pohlmann,P.Luedi,S.Choi,R.A.Wing,A.Flavier,T.D.Gaffney,andP.Philippsen.2004.TheAshbyagossypiigenomeasatoolformappingtheancientSaccharomycescerevisiaegenome.Science304:304?307.
	16.Dyer,P.S.,M.Paoletti,andD.B.Archer.2003.GenomicsrevealssexualsecretsofAspergillus.Microbiology149:2301?2303.
	17.Falkow,S.2004.MolecularKoch?spostulatesappliedtobacterialpathoge-nicity-apersonalrecollection15yearslater.Nat.Rev.Microbiol.2:67?72.
	18.Falkow,S.1988.MolecularKoch?spostulatesappliedtomicrobialpathoge-nicity.Rev.Infect.Dis.10:S274?276.
	19.Feinberg,A.P.,andB.Vogelstein.1983.AtechniqueforradiolabelingDNArestrictionendonucleasefragmentstohighspecificactivity.Anal.Biochem.132:6?13.
	20.Firon,A.,A.Beauvais,J.P.Latge,E.Couve,M.C.Grosjean-Cournoyer,andC.d?Enfert.2002.CharacterizationofessentialgenesbyparasexualgeneticsinthehumanfungalpathogenAspergillusfumigatus:impactofgenomicrearrangementsassociatedwithelectroporationofDNA.Genetics161:1077?1087.
	21.Galagan,J.E.,S.E.Calvo,K.A.Borkovich,E.U.Selker,N.D.Read,D.Jaffe,W.FitzHugh,L.J.Ma,S.Smirnov,S.Purcell,B.Rehman,T.Elkins,R.Engels,S.Wang,C.B.Nielsen,J.Butler,M.Endrizzi,D.Qui,P.Ianak-iev,D.Bell-Pedersen,M.A.Nelson,M.Werner-Washburne,C.P.Selitren-nikoff,J.A.Kinsey,E.L.Braun,A.Zelter,U.Schulte,G.O.Kothe,G.Jedd,W.Mewes,C.Staben,E.Marcotte,D.Greenberg,A.Roy,K.Foley,J.Naylor,N.Stange-Thomann,R.Barrett,S.Gnerre,M.Kamal,M.Kamvysselis,E.Mauceli,C.Bielke,S.Rudd,D.Frishman,S.Krystofova,C.Rasmussen,R.L.Metzenberg,D.D.Perkins,S.Kroken,C.Cogoni,G.Macino,D.Catcheside,W.Li,R.J.Pratt,S.A.Osmani,C.P.DeSouza,L.Glass,M.J.Orbach,J.A.Berglund,R.Voelker,O.Yarden,M.Plamann,S.Seiler,J.Dunlap,A.Radford,R.Aramayo,D.O.Natvig,L.A.Alex,G.Mannhaupt,D.J.Ebbole,M.Freitag,I.Paulsen,M.S.Sachs,E.S.Lander,C.Nusbaum,andB.Birren.2003.ThegenomesequenceofthefilamentousfungusNeu-rosporacrassa.Nature422:859?868.
	22.Girardin,H.,M.Monod,andJ.P.Latge.1995.Molecularcharacterizationofthefood-bornefungusNeosartoryafischeri(MallochandCain).Appl.Environ.Microbiol.61:1378?1383.
	23.Goffeau,A.,B.G.Barrell,H.Bussey,R.W.Davis,B.Dujon,H.Feldmann,F.Galibert,J.D.Hoheisel,C.Jacq,M.Johnston,E.J.Louis,H.W.Mewes,Y.Murakami,P.Philippsen,H.Tettelin,andS.G.Oliver.1996.Lifewith6000genes.Science274:546?567.
	24.Grivell,A.R.,andJ.F.Jackson.1968.Thymidinekinase:evidenceforitsabsencefromNeurosporacrassaandsomeothermicro-organisms,andtherelevanceofthistothespecificlabellingofdeoxyribonucleicacid.J.Gen.Microbiol.54:307?317.
	25.Guï¿½ldener,U.,S.Heck,T.Fielder,J.Beinhauer,andJ.H.Hegemann.1996.Anewefficientgenedisruptioncassetteforrepeateduseinbuddingyeast.NucleicAcidsRes.24:2519?2524.
	26.Hanahan,D.,J.Jessee,andF.R.Bloom.1991.PlasmidtransformationofEscherichiacoliandotherbacteria.MethodsEnzymol.204:63?113.
	27.Jeong,H.Y.,H.Kim,D.M.Han,K.Y.Jahng,andK.S.Chae.2003.ExpressionofthemnpAgenethatencodesthemannoproteinofAspergillusnidulansisdependentonfadAandflbAaswellasveA.FungalGenet.Biol.38:228?236.
	28.Jeong,H.Y.,M.H.Song,J.H.Back,D.M.Han,X.Wu,V.Monnier,K.Y.Jahng,andK.S.Chae.2002.TheveAgeneisnecessaryfortheinducibleexpressionbyfructosylaminesoftheAspergillusnidulansfaoAgeneencodingfructosylaminoacidoxidase(amadoriase,EC1.5.3).Arch.Microbiol.178:344?350.
	29.Kaï¿½fer,E.1977.MeioticandmitoticrecombinationinAspergillusanditschromosomalaberrations.Adv.Genet.19:33?131.
	30.Kaï¿½fer,E.1965.OriginsoftranslocationsinAspergillusnidulans.Genetics52:217?232.
	31.Kato,N.,W.Brooks,andA.M.Calvo.2003.Theexpressionofsterigmato-cystinandpenicillingenesinAspergillusnidulansiscontrolledbyveA,agenerequiredforsexualdevelopment.Eukaryot.Cell2:1178?1186.
	32.Kim,H.,K.Han,K.Kim,D.Han,K.Jahng,andK.Chae.2002.TheveAgeneactivatessexualdevelopmentinAspergillusnidulans.FungalGenet.Biol.37:72?80.
	33.Kolar,M.,P.J.Punt,C.A.vandenHondel,andH.Schwab.1988.Trans-formationofPenicilliumchrysogenumusingdominantselectionmarkersandexpressionofanEscherichiacolilacZfusiongene.Gene62:127?134.
	34.Kontoyiannis,D.P.,andG.P.Bodey.2002.Invasiveaspergillosisin2002:anupdate.Eur.J.Clin.Microbiol.Infect.Dis.21:161?172.
	35.Krappmann,S.,andG.H.Braus.2003.DeletionofAspergillusnidulansaroCusinganovelblastermodulethatcombinesETcloningandmarkerrescue.Mol.Genet.Genomics268:675?683.
	36.Kubodera,T.,N.Yamashita,andA.Nishimura.2002.TransformationofAspergillussp.andTrichodermareeseiusingthepyrithiamineresistancegene(ptrA)ofAspergillusoryzae.Biosci.Biotechnol.Biochem.66:404?406.
	37.Langfelder,K.,S.Gattung,andA.A.Brakhage.2002.AnovelmethodusedtodeleteanewAspergillusfumigatusABCtransporter-encodinggene.Curr.Genet.41:268?274.
	38.Latge,J.P.1999.Aspergillusfumigatusandaspergillosis.Clin.Microbiol.Rev.12:310?350.
	39.Latge,J.P.2001.ThepathobiologyofAspergillusfumigatus.TrendsMicro-biol.9:382?389.
	40.Lipman,D.J.,andW.R.Pearson.1985.Rapidandsensitiveproteinsimi-laritysearches.Science227:1435?1441.
	41.Lupton,S.D.,L.L.Brunton,V.A.Kalberg,andR.W.Overell.1991.Dominantpositiveandnegativeselectionusingahygromycinphosphotrans-ferase-thymidinekinasefusiongene.Mol.Cell.Biol.11:3374?3378.
	42.Monnerjahn,C.,andM.Konrad.2003.Modulatednucleosidekinasesastoolstoimprovetheactivationoftherapeuticnucleosideanalogues.Chem.Biochem.4:143?146.
	43.Mooney,J.L.,andL.N.Yager.1990.LightisrequiredforconidiationinAspergillusnidulans.GenesDev.4:1473?1482.
	44.Muyrers,J.P.,Y.Zhang,andA.F.Stewart.2000.ET-cloning:thinkrecom-binationfirst.Genet.Eng.(N.Y.)22:77?98.
	45.Osherov,N.,J.Mathew,andG.S.May.2000.Polarity-defectivemutantsofAspergillusnidulans.FungalGenet.Biol.31:181?188.
	46.Pain,A.,J.Woodward,M.A.Quail,M.J.Anderson,R.Clark,M.Collins,N.Fosker,A.Fraser,D.Harris,N.Larke,L.Murphy,S.Humphray,S.O?Neil,M.Pertea,C.Price,E.Rabbinowitsch,M.A.Rajandream,S.Sal-zberg,D.Saunders,K.Seeger,S.Sharp,T.Warren,D.W.Denning,B.Barrell,andN.Hall.2004.InsightintothegenomeofAspergillusfumigatus:analysisofa922kbregionencompassingthenitrateassimilationgeneclus-ter.FungalGenet.Biol.41:443?453.
	47.Poï¿½ggeler,S.2002.GenomicevidenceformatingabilitiesintheasexualpathogenAspergillusfumigatus.Curr.Genet.42:153?160.
	48.Pratt,R.J.,andR.Aramayo.2002.Improvingtheefficiencyofgenereplace-mentsinNeurosporacrassa:afirststeptowardsalarge-scalefunctionalgenomicsproject.FungalGenet.Biol.37:56?71.
	49.Punt,P.J.,andC.A.vandenHondel.1992.TransformationoffilamentousfungibasedonhygromycinBandphleomycinresistancemarkers.MethodsEnzymol.216:447?457.
	50.Reichard,U.,S.Buttner,H.Eiffert,F.Staib,andR.Ruï¿½chel.1990.Purifica-tionandcharacterisationofanextracellularserineproteinasefromAspergil-lusfumigatusanditsdetectionintissue.J.Med.Microbiol.33:243?251.
	51.Sachs,M.S.,E.U.Selker,B.Lin,C.J.Roberts,Z.Luo,D.Vaught-Alexander,andB.S.Margolin.1997.ExpressionofherpesvirusthymidinekinaseinNeurosporacrassa.NucleicAcidsRes.25:2389?2395.
	52.Saiki,R.K.,T.L.Bugawan,G.T.Horn,K.B.Mullis,andH.A.Erlich.1986.Analysisofenzymaticallyamplifiedbeta-globinandHLA-DQalphaDNAwithallele-specificoligonucleotideprobes.Nature324:163?166.
	53.Sambrook,J.,E.F.Fritsch,andT.Maniatis.1989.Molecularcloning:alaboratorymanual.ColdSpringHarborLaboratoryPress,ColdSpringHar-bor,N.Y.
	54.Sandhu,D.K.,R.S.Sandhu,Z.U.Khan,andV.N.Damodaran.1976.Conditionalvirulenceofap-aminobenzoicacid-requiringmutantofAspergil-lusfumigatus.Infect.Immun.13:527?532.
	55.Sauer,B.1987.Functionalexpressionofthecre-loxsite-specificrecombina-tionsystemintheyeastSaccharomycescerevisiae.Mol.Cell.Biol.7:2087?2096.
	56.Song,S.,T.Zhang,W.Qi,W.Zhao,B.Xu,andJ.Liu.1993.TransformationofEscherichiacoliwithforeignDNAbyelectroporation.Chin.J.Biotechnol.9:197?201.
	57.Southern,E.M.1975.DetectionofspecificsequencesamongDNAfrag-mentsseparatedbygelelectrophoresis.J.Mol.Biol.98:503?517.
	58.Varga,J.2003.MatingtypegenehomologuesinAspergillusfumigatus.Mi-crobiology149:816?819.
	59.Weidner,G.,C.d?Enfert,A.Koch,P.C.Mol,andA.A.Brakhage.1998.Developmentofahomologoustransformationsystemforthehumanpatho-genicfungusAspergillusfumigatusbasedonthepyrGgeneencodingoroti-dine5-monophosphatedecarboxylase.Curr.Genet.33:378?385.
	60.Wieczorke,R.,S.Krampe,T.Weierstall,K.Freidel,C.P.Hollenberg,andE.Boles.1999.Concurrentknock-outofatleast20transportergenesisre-quiredtoblockuptakeofhexosesinSaccharomycescerevisiae.FEBSLett.464:123?128.
	61.Woodcock,D.M.,P.J.Crowther,J.Doherty,S.Jefferson,E.DeCruz,M.Noyer-Weidner,S.S.Smith,M.Z.Michael,andM.W.Graham.1989.QuantitativeevaluationofEscherichiacolihoststrainsfortolerancetocy-tosinemethylationinplasmidandphagerecombinants.NucleicAcidsRes.17:3469?3478.
0093-05.pdf	162
	1.Alarco,A.M.,andM.Raymond.1999.ThebZiptranscriptionfactorCap1pisinvolvedinmultidrugresistanceandoxidativestressresponseinCandidaalbicans.J.Bacteriol.181:700?708.
	2.Anderson,J.M.,andD.R.Soll.1987.Uniquephenotypeofopaquecellsinthewhite-opaquetransitionofCandidaalbicans.J.Bacteriol.169:5579?5588.
	3.Bedell,G.W.,andD.R.Soll.1979.EffectsoflowconcentrationsofzinconthegrowthanddimorphismofCandidaalbicans:evidenceforzinc-resistantand-sensitivepathwaysformyceliumformation.Infect.Immun.26:348?354.
	4.Bedell,G.W.,A.Werth,andD.R.Soll.1980.Theregulationofnuclearmigrationanddivisionduringsynchronousbudformationinreleasedsta-tionaryphaseculturesoftheyeastCandidaalbicans.Exp.CellRes.127:103?113.
	5.Bennett,R.J.,M.A.Uhl,M.G.Miller,andA.D.Johnson.2003.Identifi-cationandcharacterizationofaCandidaalbicansmatingpheromone.Mol.Cell.Biol.23:8189?8201.
	6.Birse,C.E.,M.Y.Irwin,W.A.Fonzi,andP.S.Sypherd.1993.CloningandcharacterizationofECE1,ageneexpressedinassociationwithcellelonga-tionofthedimorphicpathogenCandidaalbicans.Infect.Immun.61:3648?3655.
	7.Boyartchuk,V.L.,M.N.Ashby,andJ.Rine.1997.ModulationofRasanda-factorfunctionbycarboxyl-terminalproteolysis.Science275:1796?1800.
	8.Braun,B.R.,D.Kadosh,andA.D.Johnson.2001.NRG1,arepressoroffilamentousgrowthinC.albicans,isdown-regulatedduringfilamentinduc-tion.EMBOJ.20:4753?4761.
	9.Braun,B.R.,W.S.Head,M.X.Wang,andA.D.Johnson.2000.Identifi-cationandcharacterizationofTUP1-regulatedgenesinCandidaalbicans.Genetics156:31?44.
	10.Brown,D.H.,Jr.,A.D.Giusani,X.Chen,andC.A.Kumamoto.1999.FilamentousgrowthofCandidaalbicansinresponsetophysicalenvironmen-talcuesanditsregulationbytheuniqueCZF1gene.Mol.Microbiol.34:651?662.
	11.Chen,J.,J.Chen,S.Lane,andH.Liu.2002.Aconservedmitogen-activatedproteinkinasepathwayisrequiredformatinginCandidaalbicans.Mol.Microbiol.46:1335?1344.
	12.Chen,T.,andJ.Kurjan.1997.SaccharomycescerevisiaeMpt5pinteractswithSst2pandplaysrolesinpheromonesensitivityandrecoveryfrompheromonarrest.Mol.Cell.Biol.17:3429?3439.
	13.Choi,K.Y.,B.Satterberg,D.M.Lyons,andE.A.Elion.1994.Ste5tethersmultipleproteinkinasesintheMAPkinasecascaderequiredformatinginS.cerevisiae.Cell78:499?512.
	14.Church,G.M.,andW.Gilbert.1984.Genomicsequencing.Proc.Natl.Acad.Sci.USA81:1991?1995.
	15.Csank,C.,K.Schroppel,E.Leberer,D.Harcus,O.Mohamed,S.Meloche,D.Y.Thomas,andM.Whiteway.1998.RolesoftheCandidaalbicansmitogen-activatedproteinkinasehomolog,Cek1p,inhyphaldevelopmentandsystemiccandidiasis.Infect.Immun.66:2713?2721.
	16.Daniels,K.J.,S.R.Lockhart,J.F.Staab,P.Sundstrom,andD.R.Soll.2003.TheadhesinHwp1andthefirstdaughtercelllocalizetothea/aportionoftheconjugationbridgeduringCandidaalbicansmating.Mol.Biol.Cell14:4920?4930.
	17.Davis,D.,R.B.Wilson,andA.P.Mitchell.2000.RIM101-dependentand-independentpathwaysgovernpHresponsesinCandidaalbicans.Mol.Cell.Biol.20:971?978.
	18.Dudoit,S.,Y.H.Yang,M.J.Callow,andT.P.Speed.2002.StatisticalmethodsforidentifyinggeneswithdifferentialexpressioninreplicatedcDNAmicroarrayexperiments.Stat.Silica12:111?139.
	19.Geiger,J.,D.Wessels,S.R.Lockhart,andD.R.Soll.2004.Releaseofapotentpolymorphonuclearleukocytechemoattractantisregulatedbywhite-opaqueswitchinginCandidaalbicans.Infect.Immun.72:667?677.
	20.Haber,J.E.1998.Mating-typegeneswitchinginSaccharomycescerevisiae.Annu.Rev.Genet.32:561?599.
	21.Hagen,D.C.,G.McCaffrey,andG.F.Sprague,Jr.1986.EvidencetheyeastSTE3geneencodesareceptorforthepeptidepheromoneafactor:genesequenceandimplicationsforthestructureofthepresumedreceptor.Proc.Natl.Acad.Sci.USA83:1418?1422.
	22.Hedge,P.,R.Qi,R.Abernathy,C.Gay,S.Dharap,R.Gaspard,J.Earle-Hughes,E.Snesrud,N.H.Lee,andJ.Quackenbush.2000.AconciseguidetocDNAmicroarrayanalysis.BioTechniques29:548?562.
	23.Hube,B.,M.Monod,D.Schofield,A.Brown,andN.Gow.1994.ExpressionofsevenmembersofthegenefamilyencodingaspartylproteinasesinCan-didaalbicans.Mol.Microbiol.14:87?99.
	24.Hull,C.M.,R.M.Raisner,andA.D.Johnson.2000.Evidenceformatingofthe?asexual?yeastCandidaalbicansinamammalianhost.Science289:307?310.
	25.Hull,C.M.,andA.D.Johnson.1999.Identificationofamatingtype-likelocusintheasexualpathogenicyeastCandidaalbicans.Science285:1271?1275.
	25a.Johnson,A.2003.ThebiologyofmatinginCandidaalbicans.Nat.Rev.Microbiol.1:106?116.
	26.Kvaal,C.,S.A.Lachke,T.Srikantha,K.Daniels,J.McCoy,andD.R.Soll.1999.Misexpressionoftheopaque-phase-specificgenePEP1(SAP1)inthewhitephaseofCandidaalbicansconfersincreasedvirulenceinamousemodelofcutaneousinfection.Infect.Immun.67:6652?6662.
	27.Lachke,S.A.,S.R.Lockhart,K.J.Daniels,andD.R.Soll.2003.SkinfacilitatesCandidaalbicansmating.Infect.Immun.71:4970?4976.
	28.Lan,C.Y.,G.Newport,L.A.Murillo,T.Jones,S.Scherer,R.W.Davis,andN.Agabian.2002.MetabolicspecializationassociatedwithphenotypicswitchinginCandidaalbicans.Proc.Natl.Acad.Sci.USA99:14907?14912.
	29.Lane,S.,C.Birse,S.Zhou,R.Matson,andH.Liu.2001.DNAarraystudiesdemonstrateconvergentregulationofvirulencefactorsbyCph1,Cph2,andEfg1inCandidaalbicans.J.Biol.Chem.276:48988?48996.
	30.Lee,K.L.,H.R.Buckley,andC.C.Campbell.1975.AnaminoacidliquidsyntheticmediumforthedevelopmentofmycelialandyeastformsofCan-didaalbicans.Sabouraudia13:148?153.
	31.Littell,R.C.,G.A.Milleken,W.W.Stroup,andR.D.Wolfinger.1996.SASsystemformixedmodels.SASInstitute,Inc.,Cary,N.C.
	32.Liu,H.,J.Kohler,andG.R.Fink.1994.SuppressionofhyphalformationinCandidaalbicansbymutationofaSTE12homolog.Science266:1723?1726.
	33.Lockhart,S.R.,C.Pujol,K.J.Daniels,M.G.Miller,A.D.Johnson,M.A.Pfaller,andD.R.Soll.2002.InCandidaalbicans,white-opaqueswitchersarehomozygousformatingtype.Genetics162:737?745.
	34.Lockhart,S.R.,K.J.Daniels,R.Zhao,D.Wessels,andD.R.Soll.2003.CellbiologyofmatinginCandidaalbicans.Eukaryot.Cell2:49?61.
	35.Lockhart,S.R.,R.Zhao,K.J.Daniels,andD.R.Soll.2003.-Pheromone-induced?shmooing?andgeneregulationrequirewhite-opaqueswitchingduringCandidaalbicansmating.Eukaryot.Cell2:847?855.
	36.Magee,B.B.,andP.T.Magee.2000.InductionofmatinginCandidaalbicansbyconstructionofMTLaandMTLstrains.Science289:310?313.
	37.Magee,B.B.,M.Legrand,A.Alarco,M.Raymond,andP.T.Magee.2002.ManyofthegenesrequiredformatinginSaccharomycescerevisiaearealsorequiredformatinginCandidaalbicans.Mol.Microbiol.46:1345?1351.
	38.Magee,P.T.,andB.B.Magee.2004.Throughaglassopaquely:thebiolog-icalsignificanceofmatinginCandidaalbicans.Curr.Opin.Microbiol.7:661?665.
	39.Miller,M.G.,andA.D.Johnson.2002.White-opaqueswitchinginCandidaalbicansiscontrolledbymating-typelocushomeodomainproteinsandal-lowsefficientmating.Cell110:293?302.
	40.Morrow,B.,T.Srikantha,andD.R.Soll.1992.Transcriptionofthegeneforapepsinogen,PEP1,isregulatedbywhite-opaqueswitchinginCandidaalbicans.Mol.Cell.Biol.12:2997?3005.
	41.Morrow,B.,T.Srikantha,J.Anderson,andD.R.Soll.1993.Coordinateregulationoftwoopaque-phase-specificgenesduringwhite-opaqueswitch-inginCandidaalbicans.Infect.Immun.61:1823?1828.
	42.Murad,A.M.,P.Leng,M.Straffon,J.Wishart,S.Macaskill,D.MacCallum,N.Schnell,D.Talibi,D.Marechal,F.Tekaia,C.d?Enfert,C.Gaillardin,F.C.Odds,andA.J.Brown.2001.NRG1repressesyeast-hyphamorpho-genesisandhypha-specificgeneexpressioninCandidaalbicans.EMBOJ.20:4742?4752.
	43.Panwar,S.L.,M.Legrand,D.Pinard,M.Whitecap,andP.T.Magee.2003.MF1,thegeneencodingthematingpheromoneofCandidaalbicans.Eukaryot.Cell2:1350?1360.
	44.Peter,M.,A.Gartner,J.Horecka,G.Ammerer,andI.Herskowitz.1993.FAR1linksthesignaltransductionpathwaytothecellcyclemachineryinyeast.Cell73:747?760.
	45.Ramon,A.M.,A.Porta,andW.A.Fonzi.1999.EffectofenvironmentalpHonmorphologicaldevelopmentofCandidaalbicansismediatedviathePacC-relatedtranscriptionfactorencodedbyPRR2.J.Bacteriol.181:7524?7530.
	46.Roberts,C.J.,B.Nelson,M.J.Matron,R.Stoughton,M.R.Meyer,H.A.Bennett,Y.D.He,H.Dai,W.L.Walker,T.R.Hughes,M.Tyers,C.Boone,andS.H.Friend.2000.SignalingandcircuitryofmultipleMAPKpathwaysrevealedbyamatrixofglobalgeneexpressionprofiles.Science287:873?880.
	47.Schweizer,A.,S.Rupp,B.N.Taylor,M.Rollinghoff,andK.Schroppel.2000.TheTEA/ATTStranscriptionfactorCaTec1pregulateshyphaldevelopmentandvirulenceinCandidaalbicans.Mol.Microbiol.38:435?445.
	48.Slutsky,B.,M.Staebell,J.Anderson,L.Risen,M.Pfaller,andD.R.Soll.1987.?White-opaquetransition?:asecondhigh-frequencyswitchingsysteminCandidaalbicans.J.Bacteriol.169:189?197.
	49.Sohn,K.,C.Urban,H.Brunner,andS.Rupp.2003.EFG1isamajorregulatorofcellwalldynamicsinCandidaalbicansasrevealedbyDNAmicroarrays.Mol.Microbiol.47:89?102.
	50.Soll,D.R.2004.Mating-typelocushomozygosis,phenotypicswitchingandmating:auniquesequenceofdependenciesinCandidaalbicans.BioEssays26:10?20.
	51.Soll,D.R.,andG.Bedell.1978.BudformationandtheinducibilityofpseudomyceliumoutgrowthduringreleasefromstationaryphaseinCandidaalbicans.J.Gen.Microbiol.108:173?180.
	52.Srikantha,T.,andD.R.Soll.1993.Awhite-specificgeneinthewhite-opaqueswitchingsystemofCandidaalbicans.Gene131:53?60.
	53.Srikantha,T.,L.K.Tsai,K.Daniels,andD.R.Soll.2000.EFG1nullmutantsofCandidaalbicansswitchbutcannotexpressthecompletepheno-typeofwhite-phasebuddingcells.J.Bacteriol.182:1580?1591.
	54.Staab,J.F.,C.A.Ferrer,andP.Sundstrom.1996.Developmentalexpres-sionofatandemlyrepeated,proline-andglutamine-richaminoacidmotifonhyphalsurfacesonCandidaalbicans.J.Biol.Chem.271:6298?6305.
	55.Stoldt,V.R.,A.Sonneborn,C.E.Leuker,andJ.F.Ernst.1997.Efg1p,anessentialregulatorofmorphogenesisofthehumanpathogenCandidaalbi-cans,isamemberofaconservedclassofbHLHproteinsregulatingmor-phogeneticprocessesinfungi.EMBOJ.16:1982?1991.
	56.Tsong,A.E.,M.G.Miller,R.M.Raisner,andA.D.Johnson.2003.Evo-lutionofacombinatorialtranscriptionalcircuit:acasestudyinyeasts.Cell115:389?399.
	57.Wilkinson,L.E.,andJ.R.Pringle.1974.TransientG1arrestofS.cerevisiaecellsofmatingtypealphabyafactorproducedbycellsofmatingtypea.Exp.CellRes.89:175?187.
	58.Wu,C.,M.Whiteway,D.Y.Thomas,andE.Leberer.1995.MolecularcharacterizationofSte20p,apotentialmitogen-activatedproteinorextra-cellularsignal-regulatedkinasekinase(MEK)kinasekinasefromSaccharo-mycescerevisiae.J.Biol.Chem.270:15984?15992.
	59.Zhao,R.,S.R.Lockhart,K.Daniels,andD.R.Soll.2002.RolesofTUP1inswitching,phasemaintenance,andphase-specificgeneexpressioninCan-didaalbicans.Eukaryot.Cell1:353?365.
ane_6522.pdf	27
J. Biol. Chem.-2005-Kuzmenko-25913-9.pdf	18
	1.McCormack,F.X.,andWhitsett,J.A.(2002)J.Clin.Investig.109,707?712
	2.Wu,H.,Kuzmenko,A.,Wan,S.,Schaffer,L.,Weiss,A.,Fisher,J.H.,Kim,K.S.,andMcCormack,F.X.(2003)J.Clin.Investig.111,1589?1602
	3.McCormack,F.X.,Gibbons,R.,Ward,S.R.,Kuzmenko,A.,Wu,H.,andDeepe,G.S.,Jr.(2003)J.Biol.Chem.278,36250?36256
	4.Kuzmenko,A.I.,Wu,H.,Bridges,J.P.,andMcCormack,F.X.(2004)J.LipidRes.45,1061?1068
	5.Korfhagen,T.R.,Bruno,M.D.,Ross,G.F.,Huelsman,K.M.,Ikegami,M.,Jobe,A.H.,Wert,S.E.,Stripp,B.R.,Morris,R.E.,Glasser,S.W.,Bachurski,C.J.,Iwamoto,H.S.,andWhitsett,J.A.(1996)Proc.Natl.Acad.Sci.U.S.A.93,9594?9599
	6.Suwabe,A.,Mason,R.J.,andVoelker,D.R.(1991)Am.J.Respir.CellMol.Biol.5,80?86
	7.Gregoriadis,G.,andRyman,B.E.(1972)Biochem.J.129,123?133
	8.Gelvan,D.,andSaltman,P.(1990)Biochim.Biophys.Acta1035,353?360
	9.McCormack,F.X.,Kuroki,Y.,Stewart,J.J.,Mason,R.J.,andVoelker,D.R.(1994)J.Biol.Chem.269,29801?29807
	10.Ganz,T.,Selsted,M.E.,Szklarek,D.,Harwig,S.S.,Daher,K.,Bainton,D.F.,andLehrer,R.I.(1985)J.Clin.Investig.76,1427?1435
	11.Newman,S.L.,Gootee,L.,andGabay,J.E.(1993)J.Clin.Investig.92,624?631
	12.Saeed,F.A.,andCastle,G.E.(1998)Clin.Diagn.Lab.Immunol.5,740?743
	13.Levine,R.L.,Wehr,N.,Williams,J.A.,Stadtman,E.R.,andShacter,E.(2000)MethodsMol.Biol.99,15?24
	14.Wang,G.,Bates-Kenney,S.R.,Tao,J.Q.,Phelps,D.S.,andFloros,J.(2004)Biochemistry43,4227?4239
	15.Haddad,I.Y.,Ischiropoulos,H.,Holm,B.A.,Beckman,J.S.,Baker,J.R.,andMatalon,S.(1993)Am.J.Physiol.265,L555?L564
	16.Zhu,S.,Basiouny,K.F.,Crow,J.P.,andMatalon,S.(2000)Am.J.Physiol.278,L1025?L1031
	17.Zhu,S.,Ware,L.B.,Geiser,T.,Matthay,M.A.,andMatalon,S.(2001)Am.J.Respir.Crit.CareMed.163,166?172
	18.Mark,L.,andIngenito,E.P.(1999)Am.J.Physiol.276,L491?L500
J. Biol. Chem.-2005-Clement-27121-9.pdf	48
	1.Miura,S.,andSaku,K.(2003)Seikagaku75,382?386
	2.Miura,S.,Zhang,J.,Boros,J.,andKarnik,S.S.(2003)J.Biol.Chem.278,3720?3725
	3.Yamano,Y.,Ohyama,K.,Chaki,S.,Guo,D.F.,andInagami,T.(1992)Biochem.Biophys.Res.Commun.187,1426?1431
	4.Marie,J.,Maigret,B.,Joseph,M.P.,Larguier,R.,Nouet,S.,Lombard,C.,andBonnafous,J.C.(1994)J.Biol.Chem.269,20815?20818
	5.Karnik,S.S.,Husain,A.,andGraham,R.M.(1996)Clin.Exp.Pharmacol.Physiol.Suppl.3,S58?S66
	6.Servant,G.,Dudley,D.T.,Escher,E.,andGuillemette,G.(1996)Biochem.J.313,297?304
	7.Sachon,E.,Bolbach,G.,Lavielle,S.,Karoyan,P.,andSagan,S.(2003)FEBSLett.544,45?49
	8.Kennedy,A.P.,Mangum,K.C.,Linden,J.,andWells,J.N.(1996)Mol.Pharmacol.50,789?798
	9.Dohlman,H.G.,Song,J.,Apanovitch,D.M.,DiBello,P.R.,andGillen,K.M.(1998)Semin.CellDev.Biol.9,135?141
	10.Strader,C.D.,Fong,T.M.,Tota,M.R.,Underwood,D.,andDixon,R.A.(1994)Annu.Rev.Biochem.63,101?132
	11.Servant,G.,Laporte,S.A.,Leduc,R.,Escher,E.,andGuillemette,G.(1997)J.Biol.Chem.272,8653?8659
	12.Laporte,S.A.,Boucard,A.A.,Servant,G.,Guillemette,G.,Leduc,R.,andEscher,E.(1999)Mol.Endocrinol.13,578?586
	13.Bremer,A.A.,Leeman,S.E.,andBoyd,N.D.(2001)J.Biol.Chem.276,22857?22861
	14.Dong,M.,Wang,Y.,Pinon,D.I.,Hadac,E.M.,andMiller,L.J.(1999)J.Biol.Chem.274,903?909
	15.Boucard,A.A.,Wilkes,B.C.,Laporte,S.A.,Escher,E.,Guillemette,G.,andLeduc,R.(2000)Biochemistry39,9662?9670
	16.Perodin,J.,Deraet,M.,Auger-Messier,M.,Boucard,A.A.,Rihakova,L.,Beaulieu,M.E.,Lavigne,P.,Parent,J.L.,Guillemette,G.,Leduc,R.,andEscher,E.(2002)Biochemistry41,14348?14356
	17.Li,Y.M.,Marnerakis,M.,Stimson,E.R.,andMaggio,J.E.(1995)J.Biol.Chem.270,1213?1220
	18.Kage,R.,Leeman,S.E.,Krause,J.E.,Costello,C.E.,andBoyd,N.D.(1996)J.Biol.Chem.271,25797?25800
	19.Bisello,A.,Adams,A.E.,Mierke,D.F.,Pellegrini,M.,Rosenblatt,M.,Suva,L.J.,andChorev,M.(1998)J.Biol.Chem.273,22498?22505
	20.Bobrowski,K.,Marciniak,B.,andHug,G.L.(1992)J.Am.Chem.Soc.104,10279?10288
	21.Marciniak,B.,Bobrowski,K.,andHug,G.L.(1993)J.Phys.Chem.97,11937?11943
	22.Bosse,R.,Servant,G.,Zhou,L.M.,Boulay,G.,Guillemette,G.,andEscher,E.(1993)Regul.Pept.44,215?223
	23.Ballesteros,J.A.,andWeinstein,H.(1995)MethodsNeurosci.25,366?428
	24.Boucard,A.A.,Sauve,S.S.,Guillemette,G.,Escher,E.,andLeduc,R.(2003)Biochem.J.370,829?838
	25.Horner,M.(1952)Chem.Ber.85,520?530
	26.Fraker,P.J.,andSpeck,J.C.,Jr.(1978)Biochem.Biophys.Res.Commun.80,849?857
	27.Swillens,S.(1992)TrendsPharmacol.Sci.13,430?434
	28.Laemmli,U.K.(1970)Nature227,680?685
	29.Blanton,M.P.,andCohen,J.B.(1994)Biochemistry33,2859?2872
	30.Okada,T.,Fujiyoshi,Y.,Silow,M.,Navarro,J.,Landau,E.M.,andShichida,Y.(2002)Proc.Natl.Acad.Sci.U.S.A.99,5982?5987
	31.Dauber-Osguthorpe,P.,Roberts,V.A.,Osguthorpe,D.J.,Wolff,J.,Genest,M.,andHagler,A.T.(1988)Proteins4,31?47
	32.Tan,Y.V.,Couvineau,A.,VanRampelbergh,J.,andLaburthe,M.(2003)J.Biol.Chem.278,36531?36536
	33.Dong,M.,Wang,Y.,Hadac,E.M.,Pinon,D.I.,Holicky,E.,andMiller,L.J.(1999)J.Biol.Chem.274,19161?19167
	34.Wu,Z.,Hasan,A.,Liu,T.,Teller,D.C.,andCrabb,J.W.(2004)J.Biol.Chem.279,27357?27364
	35.Boucard,A.A.,Roy,M.,Beaulieu,M.E.,Lavigne,P.,Escher,E.,Guillemette,G.,andLeduc,R.(2003)J.Biol.Chem.278,36628?36636
	36.Sachon,E.,Bolbach,G.,Chassaing,G.,Lavielle,S.,andSagan,S.(2002)J.Biol.Chem.277,50409?50414
	37.Inoue,Y.,Nakamura,N.,andInagami,T.(1997)J.Hypertens.15,703?714
	38.Martin,S.S.,Boucard,A.A.,Clement,M.,Escher,E.,Leduc,R.,andGuil-lemette,G.(2004)J.Biol.Chem.279,51415?51423
	39.Fu,D.,Ballesteros,J.A.,Weinstein,H.,Chen,J.,andJavitch,J.A.(1996)Biochemistry35,11278?11285
	40.Javitch,J.A.,Ballesteros,J.A.,Weinstein,H.,andChen,J.(1998)Biochem-istry37,998?1006
	41.Javitch,J.A.,Fu,D.,Chen,J.,andKarlin,A.(1995)Neuron14,825?831
	42.Sakmar,T.P.,Menon,S.T.,Marin,E.P.,andAwad,E.S.(2002)Annu.Rev.Biophys.Biomol.Struct.31,443?484
	43.Palczewski,K.,Kumasaka,T.,Hori,T.,Behnke,C.A.,Motoshima,H.,Fox,B.A.,LeTrong,I.,Teller,D.C.,Okada,T.,Stenkamp,R.E.,Yamamoto,M.,andMiyano,M.(2000)Science289,739?745
	44.Krebs,A.,Edwards,P.C.,Villa,C.,Li,J.,andSchertler,G.F.(2003)J.Biol.Chem.278,50217?50225
	45.Dorman,G.,andPrestwich,G.D.(1994)Biochemistry33,5661?5673
	46.Hunyady,L.,Ji,H.,Jagadeesh,G.,Zhang,M.,Gaborik,Z.,Mihalik,B.,andCatt,K.J.(1998)Mol.Pharmacol.54,427?434
	47.Kalatskaya,I.,Schussler,S.,Blaukat,A.,Muller-Esterl,W.,Jochum,M.,Proud,D.,andFaussner,A.(2004)J.Biol.Chem.279,31268?31276
	48.Laporte,S.A.,Servant,G.,Richard,D.E.,Escher,E.,Guillemette,G.,andLeduc,R.(1996)Mol.Pharmacol.49,89?95
J. Biol. Chem.-2005-Zhang-26032-8.pdf	36
	1.Dowhan,W.,Mileykovskaya,E.,andBogdanov,M.(2004)Biochim.Biophys.Acta1666,19?39
	2.vanKlompenburg,W.,Nilsson,I.,vonHeijne,G.,anddeKruijff,B.(1997)EMBOJ.16,4261?4266
	3.Zhang,W.,Bogdanov,M.,Pi,J.,Pittard,A.J.,andDowhan,W.(2003)J.Biol.Chem.278,50128?50135
	4.Bogdanov,M.,Heacock,P.N.,andDowhan,W.(2002)EMBOJ.21,2107?2116
	5.DeChavigny,A.,Heacock,P.N.,andDowhan,W.(1991)J.Biol.Chem.266,5323?5332
	6.Pao,S.S.,Paulsen,I.T.,andSaier,M.H.,Jr.(1998)Microbiol.Mol.Biol.Rev.62,1?34
	7.Bogdanov,M.,andDowhan,W.(1995)J.Biol.Chem.270,732?739
	8.Chen,C.-C.,andWilson,T.H.(1984)J.Biol.Chem.259,10150?10158
	9.Wang,X.,Bogdanov,M.,andDowhan,W.(2002)EMBOJ.21,5673?5681
	10.Driessen,A.J.,Zheng,T.,In?tVeld,G.,OpdenKamp,J.A.,andKonings,W.N.(1988)Biochemistry27,865?872
	11.vanderHeide,T.,Stuart,M.C.A.,andPoolman,B.(2001)EMBOJ.20,7022?7032
	12.Jack,D.L.,Paulsen,I.T.,andSaier,M.H.,Jr.(2000)Microbiol.146,1797?1814
	13.King,S.C.(2004)BMCBiochem.5,16
	14.King,S.C.,andBrown-Istvan,L.(2003)Biochem.J.376,633?644
	15.Chung,C.T.,Niemela,S.L.,andMiller,R.H.(1989)Proc.Natl.Acad.Sci.U.S.A.86,2172?2175
	16.Hu,L.A.,andKing,S.C.(1998)J.Biol.Chem.273,20162?20167
	17.Motulsky,H.J.(1999)inAnalyzingDatawithGraphPadPrism,pp.174?175,GraphPadSoftwareInc.,SanDiego,CA
	18.Cheng,Y.,andPrusoff,W.H.(1973)Biochem.Pharmacol.22,3099?3108
	19.Bogdanov,M.,Sun,J.,Kaback,H.R.,andDowhan,W.(1996)J.Biol.Chem.271,11615?11618
	20.Bogdanov,M.,Zhang,W.,Xie,J.,andDowhan,W.(2005)Methods36,148?171
	21.Loo,T.W.,andClarke,D.M.(1995)J.Biol.Chem.270,843?848
	22.Long,J.C.,Wang,S.,andVik,S.B.(1998)J.Biol.Chem.273,16235?16240
	23.Wada,T.,Long,J.C.,Zhang,D.,andVik,S.B.(1999)J.Biol.Chem.274,17353?17357
	24.Jackson,R.W.,andDeMoss,J.A.(1965)J.Bacteriol.90,1420?1425
	25.Hu,L.A.,andKing,S.C.(1998)Biochem.J.336,69?76
	26.Abramson,J.,Smirnova,I.,Kasho,V.,Verner,G.,Kaback,H.R.,andIwata,S.(2003)Science301,610?615
	27.Murata,K.,Mitsuoka,K.,Hirai,T.,Walz,T.,Agre,P.,Heymann,J.B.,Engel,A.,andFujiyoshi,Y.(2000)Nature407,599?605
	28.Fu,D.,Libson,A.,Miercke,L.J.,Weitzman,C.,Nollert,P.,Krucinski,J.,andStroud,R.M.(2000)Science290,481?486
	29.vonHeijne,G.(1994)Subcell.Biochem.22,1?19
	30.Rutz,C.,Rosenthal,W.,andSchulien,R.(1999)J.Biol.Chem.274,33757?33763
	31.Schneider,D.,andEngelman,D.M.(2004)J.Mol.Biol.343,799?804
	32.Wikstroï¿½m,M.,Xie,J.,Bogdanov,M.,Mileykovskaya,E.,Heacock,P.,Wies-lander,ï¿½.,andDowhan,W.(2004)J.Biol.Chem.279,10284?10292
	33.Linton,K.J.,andHiggins,C.F.(2002)Mol.Membr.Biol.19,51?58
	34.vanGeest,M.,Nilsson,I.,vonHeijne,G.,andLolkema,J.S.(1999)J.Biol.Chem.274,2816?2823
	35.Pi,J.,andPittard,A.J.(1996)J.Bacteriol.178,2650?2655
	36.King,S.C.,Fleming,S.R.,andBrechtel,C.E.(1995)J.Biol.Chem.270,219893?19897
J. Nutr.-2005-Klevay-1266-7.pdf	29
J. Nutr.-2005-Sandstead-1257-62.pdf	96
J. Nutr.-2005-Cameron-1253-5.pdf	12
J. Nutr.-2005-Santerre-1248-52.pdf	4
nihms2768.pdf	61
	Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P, Laurila A. Chlamydiapneumoniae infection in human monocytes. Infect Immun 1999;67:1445?1449. [PubMed: 10024593]
	Baldini RL, Lau GW, Rahme LG. Use of plant and insect hosts to model bacterial pathogenesis. MethodsEnzymol 2002;358:3?13. [PubMed: 12474375]
	Barry CE, Brickman TJ, Hackstadt T. Hc1-mediated effects on DNA structure: a potential regulator ofchlamydial development. Mol Microbiol 1993;9:273?283. [PubMed: 8412680]
	Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD. Chlamydiatrachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad SciUSA 2001;98:13984?13989. [PubMed: 11707582]
	Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, Koch B, et al. Genome-wide RNAi analysis ofgrowth and viability in Drosophila cells. Science 2004;303:832?835. [PubMed: 14764878]Elwell and EngelPage 11
	Brickman TJ, Barry CE III, Hackstadt T. Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol 1993;175:4274?4281.[PubMed: 7687246]
	Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outermembrane protein of Chlamydia trachomatis. Infect Immun 1981;31:1161?1176. [PubMed: 7228399]
	Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003;18:48?54. [PubMed: 12652454]
	Carabeo RA, Hackstadt T. Isolation and characterization of a mutant Chinese hamster ovary cell line thatis resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun2001;69:5899?5904. [PubMed: 11500469]
	Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T. Chlamydia trachomatis induces remodeling of theactin cytoskeleton during attachment and entry into HeLa cells. Infect Immun 2002;70:3793?3803.[PubMed: 12065523]
	Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C, Hackstadt T. Requirement for the Rac GTPase inChlamydia trachomatis invasion of non-phagocytic cells. Traffic 2004;5:418?425. [PubMed:15117316]
	Cheng LW, Portnoy DA. Drosophila S2 cells: an alternative infection model for Listeriamonocytogenes. Cell Microbiol 2003;5:875?885. [PubMed: 14641173]
	D?Argenio DA, Gallagher LA, Berg CA, Manoil C. Drosophila as a model host for Pseudomonasaeruginosa infection. J Bacteriol 2001;183:1466?1471. [PubMed: 11157963]
	Dionne MS, Schneider DS. Screening the fruitfly immune system. Genome Biol 2002;3:REVIEWS 1010.
	Dionne MS, Ghori N, Schneider DS. Drosophila melanogaster is a genetically tractable model host forMycobacterium marinum. Infect Immun 2003;71:3540?3550. [PubMed: 12761139]
	Echalier, G. (1997) Drosophila Cells in Culture New York: Academic Press.
	Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs.Genes Dev 2001;15:188?200. [PubMed: 11157775]
	Fields KA, Hackstadt T. The Chlamydial inclusion: escape from the endocytic pathway. Annu Rev CellDev Biol 2002;18:221?245. [PubMed: 12142274]
	Fields KA, Fischer E, Hackstadt T. Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degreesC correlates with restricted export of IncA. Infect Immun 2002;70:3816?3823. [PubMed: 12065525]
	Fields KA, Mead DJ, Dooley CA, Hackstadt T. Chlamydia trachomatis type III secretion: evidence fora functional apparatus during early-cycle development. Mol Microbiol 2003;48:671?683. [PubMed:12694613]
	Foley E, O?Farrell PH. Functional dissection of an innate immune response by a genome-wide RNAiscreen. PLos Biol 2004;2:E203. [PubMed: 15221030]
	Fudyk T, Olinger L, Stephens RS. Selection of mutant cell lines resistant to infection by Chlamydiatrachomatis and Chlamydia pneumoniae. Infect Immun 2002;70:6444?6447. [PubMed: 12379725]
	Gottar M, Gobert V, Michel T, Belvin M, Duyk G, Hoffmann JA, et al. The Drosophila immune responseagainst Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature2002;416:640?644. [PubMed: 11912488]
	Grieshaber NA, Fischer ER, Mead DJ, Dooley CA, Hackstadt T. Chlamydial histone?DNA interactionsare disrupted by a metabolite in the methylerythritol phosphate pathway of isoprenoid biosynthesis.Proc Natl Acad Sci USA 2004;101:7451?7456. [PubMed: 15123794]
	Grieshaber SS, Grieshaber NA, Hackstadt T. Chlamydia trachomatis uses host cell dynein to traffic tothe microtubule-organizing center in a p50 dynamitin-independent process. J Cell Sci2003;116:3793?3802. [PubMed: 12902405]
	Gutierrez-Martin CB, Ojcius DM, Hsia R, Hellio R, Bavoil PM, Dautry-Varsat A. Heparin-mediatedinhibition of Chlamydia psittaci adherence to HeLa cells. Microb Pathog 1997;22:47?57. [PubMed:9032762]
	Hackstadt T, Rockey D, Heinzen R, Scidmore M. Chlamydia trachomatis interrupts an exocytic pathwayto acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasmamembrane. EMBO J 1996;15:964?977. [PubMed: 8605892]
	Hackstadt T, Scidmore MA, Rockey DD. Lipid metabolism in Chlamydia trachomatis-infected cells:directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad SciUSA 1995;92:4877?4881. [PubMed: 7761416]
	Hoffmann JA. The immune response of Drosophila. Nature 2003;426:33?38. [PubMed: 14603309]
	Innocenti M, Zucconi A, Disanza A, Frittoli E, Areces LB, Steffen A, et al. Abi1 is essential for theformation and activation of a WAVE2 signalling complex. Nat Cell Biol 2004;6:319?327. [PubMed:15048123]
	Kiger A, Baum B, Jones S, Jones M, Coulson A, Echeverri C, Perrimon N. A functional genomic analysisof cell morphology using RNA interference. J Biol 2003;2:27. [PubMed: 14527345]
	Kramer MJ, Gordon FB. Ultrastructural analysis of the effect of penicillin and chlortetracyline on thedevelopment of a genital tract Chlamydia. Infect Immun 1971;3:333?341. [PubMed: 16557974]
	Lau GW, Goumnerov BC, Walendziewicz CL, Hewitson J, Xiao W, Mahajan-Miklos S, et al. TheDrosophila melanogaster toll pathway participates in resistance to infection by the gram-negativehuman pathogen Pseudomonas aeruginosa. Infect Immun 2003;71:4059?4066. [PubMed:12819096]
	Lipsky NG, Pagano RE. Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts:endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgiapparatus en route to the plasma membrane. J Cell Biol 1985;100:27?34. [PubMed: 3965473]
	Manor E, Sarov I. Fate of Chlamydia trachomatis in human monocytes and monocyte-derivedmacrophages. Infect Immun 1986;54:90?95. [PubMed: 3759241]
	Mansfield BE, Dionne MS, Schneider DS, Freitag NE. Exploration of host?pathogen interactions usingListeria monocytogenes and Drosophila melanogaster. Cell Microbiol 2003;5:901?911. [PubMed:14641175]
	Matsumoto A, Manire GP. Electron microscopic observations on the effects of penicillin on themophology of Chlamydia psittaci. J Bacteriol 1970;101:278?285. [PubMed: 5413965]
	Morrison RP. New insights into a persistent problem ? chlamydial infections. J Clin Invest2003;111:1647?1649. [PubMed: 12782667]
	Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 1991;55:143?190.[PubMed: 2030670]
	Moulder JW, Levy NJ, Schulman LP. Persistent infection of mouse fibroblasts (L cells) with Chlamydiapsittaci: evidence for a cryptic chlamydial form. Infect Immun 1980;30:874?883. [PubMed:6262243]
	van Ooij C, Apodaca G, Engel J. Characterization of the Chlamydia trachomatis vacuole and itsinteraction with the host endocytic pathway in HeLa cells. Infect Immun 1997;65:758?766. [PubMed:9009339]
	van Ooij C, Homola E, Kincaid E, Engel J. Fusion of vacuoles containing Chlamydia trachomatis isinhibited at low temperature and requires bacterial protein synthesis. Infect Immun 1998;66:5364?5371. [PubMed: 9784545]
	Pascopella L, Raupach B, Ghori N, Monack D, Falkow S, Small PL. Host restriction phenotypes ofSalmonella typhi and Salmonella gallinarum. Infect Immun 1995;63:4329?4335. [PubMed:7591067]
	Pedersen LB, Birkelund S, Christiansen G. Purification of recombinant Chlamydia trachomatis histoneH1-like protein Hc2, and comparative functional analysis of Hc2 and Hc1. Mol Microbiol 1996a;20:295?311. [PubMed: 8733229]
	Pedersen LB, Birkelund S, Holm A, Ostergaard S, Christiansen G. The 18-kilodalton Chlamydiatrachomatis histone H1-like protein (Hc1) contains a potential N-terminal dimerization site and a C-terminal nucleic acid-binding domain. J Bacteriol 1996b;178:994?1002. [PubMed: 8576073]
	Perara E, Ganem D, Engel JN. A developmentally regulated chlamydial gene with apparent homologyto eukaryotic histone H1. Proc Natl Acad Sci USA 1992;89:2125?2129. [PubMed: 1549572]
	Rahme LG, Ausubel FM, Cao H, Drenkard E, Goumnerov BC, Lau GW, et al. Plants and animals sharefunctionally common bacterial virulence factors. Proc Natl Acad Sci USA 2000;97:8815?8821.[PubMed: 10922040]
	Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA. Functional genomic analysis ofphagocytosis and identification of a Drosophila receptor for E. coli. Nature 2002;416:644?648.[PubMed: 11912489]
	Rogers SL, Wiedemann U, Stuurman N, Vale RD. Molecular requirements for actin-based lamellaformation in Drosophila S2 cells. J Cell Biol 2003;162:1079?1088. [PubMed: 12975351]
	Schachter J. The intracellular life of Chlamydia. Curr Top Microbiol Immunol 1988;138:109?139.[PubMed: 3058387]
	Schramm N, Wyrick PB. Cytoskeletal requirements in Chlamydia trachomatis infection of host cells.Infect Immun 1995;63:324?332. [PubMed: 7806372]
	Scidmore MA, Hackstadt T. Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusionmembrane via its interaction with IncG. Mol Microbiol 2001;39:1638?1650. [PubMed: 11260479]
	Scidmore MA, Fischer ER, Hackstadt T. Restricted fusion of Chlamydia trachomatis vesicles withendocytic compartments during the initial stages of infection. Infect Immun 2003;71:973?984.[PubMed: 12540580]
	Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T. Identification andcharacterization of a Chlamydia trachomatis early operon encoding four novel inclusion membraneproteins. Mol Microbiol 1999;33:753?765. [PubMed: 10447885]
	Somma MP, Fasulo B, Cenci G, Cundari E, Gatti M. Molecular dissection of cytokinesis by RNAinterference in Drosophila cultured cells. Mol Biol Cell 2002;13:2448?2460. [PubMed: 12134082]
	Stamm, W.E., and Holmes, K.K. (1990) Chlamydia trachomatis infections of the adult. In SexuallyTransmitted Diseases Holmes, K., Mardh, P.-A., Sparling, P.F., Weisner, P.J., Cates, W., Lemon,S.M., and Stamm, W.E. (eds). New York: McGraw-Hill, pp. 181?194.
	Taraktchoglou M, Pacey AA, Turnbull JE, Eley A. Infectivity of Chlamydia trachomatis serovar LGVbut not E is dependent on host cell heparan sulfate. Infect Immun 2001;69:968?976. [PubMed:11159992]
	Vodovar N, Acosta C, Lemaitre B, Boccard F. Drosophila: a polyvalent model to decipher host?pathogeninteractions. Trends Microbiol 2004;12:235?242. [PubMed: 15120143]
	Wolf K, Hackstadt T. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell Microbiol2001;3:145?152. [PubMed: 11260137]
	Wuppermann FN, Hegemann JH, Jantos CA. Heparan sulfate-like glycosaminoglycan is a cellularreceptor for Chlamydia pneumoniae. J Infect Dis 2001;184:181?187. [PubMed: 11424015]
	Zhang JP, Stephens RS. Mechanism of Chlamydia trachomatis attachment to eukaryotic host cells. Cell1992;69:861?869. [PubMed: 1591780]
nihms84060.pdf	27
	Alam MN, McGinty D, Szymusiak R. Neuronal discharge of preoptic/anterior hypothalamicthermosensitive neurons: Relation to NREM sleep. American Journal of Physiology 1995a;269:R1240?R1249. [PubMed: 7503316]
	Alam MN, McGinty D, Szymusiak R. Preoptic/anterior hypothalamic neurons: Thermosensitivity inrapid eye movement sleep. American Journal of Physiology 1995b;269:R1250?R1257. [PubMed:7503317]
	Bignall KE, Heggeness FW, Palmer JE. Effects of acute starvation on cold-induced thermogenesis in thepreweanling rat. American Journal of Physiology 1974;227:1088?1093. [PubMed: 4440749]
	Blumberg, MS. The developmental context of thermal homeostasis. In: Blass, EM., editor. Handbook ofBehavioral Neurobiology. Vol. Vol. 13. New York: Plenum Press; 2001. p. 199-228.
	Blumberg MS, Deaver K, Kirby RF. Leptin disinhibits BAT thermogenesis in infant rats after maternalseparation. American Journal of Physiology 1999;276:R606?R610. [PubMed: 9950943]
	Blumberg MS, Karlsson Kï¿½, Seelke AMH, Mohns EJ. The ontogeny of mammalian sleep: A responseto Frank and Heller. Journal of Sleep Research. 2003(in press)
	Blumberg MS, Lucas DE. Dual mechanisms of twitching during sleep in neonatal rats. BehavioralNeuroscience 1994;108:1196?1202. [PubMed: 7893412]
	Blumberg MS, Lucas DE. A developmental and component analysis of active sleep. DevelopmentalPsychobiology 1996;29:1?22. [PubMed: 8719180]
	Blumberg MS, Middlemis-Brown JE, Johnson ED. Sleep homeostasis in infant rats. BehavioralNeuroscience. (in press)
	Blumberg MS, Stolba MA. Thermogenesis, myoclonic twitching, and ultrasonic vocalization in neonatalrats during moderate and extreme cold exposure. Behavioral Neuroscience 1996;110:305?314.[PubMed: 8731057]
	Borbely AA. Sleep in the rat during food deprivation and subsequent restitution of food. Brain Res1977;124:457?471. [PubMed: 558034]
	Corner MA. Sleep and the beginnings of behavior in the animal kingdom -- Studies of ultradian motilitycycles in early life. Progress in Neurobiology 1977;8:279?295. [PubMed: 335440]
	Danguir J, Nicolaidis S. Dependence of sleep on nutrients' availability. Physiol Behav 1979;22:735?740.[PubMed: 225752]
	Datta S, Siwek DF, Patterson EH, Cipolloni PB. Localization of pontine PGO wave generation sites andtheir anatomical projections in the rat. Synapse 1998;30:409?423. [PubMed: 9826233]
	Dewasmes G, Duchamp C, Minaire Y. Sleep changes in fasting rats. Physiol Behav 1989;46:179?184.[PubMed: 2602455]
	Dugovic C, Turek FW. Similar genetic mechanisms may underlie sleep-wake states in neonatal and adultrats. Neuroreport 2001;12(14):3085?3089. [PubMed: 11568642]
	Fagen, RM.; Young, DY. Temporal patterns of behaviors: durations, intervals, latencies and sequences.In: Colgan, PW., editor. Quantitative Ethology. New York: Wiley; 1978. p. 79-114.
	Frank MG, Heller HC. The ontogeny of mammalian sleep: a reappraisal of alternative hypotheses. Journalof Sleep Research 2003;12:25?34. [PubMed: 12603784]
	Gramsbergen A, Schwartze P, Prechtl HFR. The postnatal development of behavioral states in the rat.Developmental Psychobiology 1970;3(4):267?280. [PubMed: 5527425]
	Jacobs BL, McGinty DJ. Effects of food deprivation on sleep and wakefulness in the rat. ExperimentalNeurology 1971;30:212?222. [PubMed: 4323120]
	Jouvet-Mounier D, Astic L, Lacote D. Ontogenesis of the states of sleep in rat, cat, and guinea pig duringthe first postnatal month. Developmental Psychobiology 1970;2:216?239. [PubMed: 5527153]
	Karlsson Kï¿½, Blumberg MS. Active medullary control of atonia in week-old rats. Neuroscience. (inpress)
	Karlsson Kï¿½, Kreider JC, Blumberg MS. Hypothalamic contribution to sleep-wake cycle development.Neuroscience 2004;123:575?582. [PubMed: 14698764]
	Lorenz DN, Poppe CJ, Quail C, Seipel K, Stordeur SA, Johnson E. Filling the Gut Activates ParadoxicalSleep in Suckling Rats. Dev Psychobiol 1998;32:1?12. [PubMed: 9452903]
	Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms oftemperature sensation. Nature Reviews Neuroscience 2003;4(7):529?539.
	Sokoloff G, Blumberg MS. Active sleep in cold-exposed infant Norway rats and Syrian golden hamsters:The role of brown adipose tissue thermogenesis. Behavioral Neuroscience 1998;112:695?706.[PubMed: 9676984]
	Van Someren EJW, Mirmiran M, Bos NPA, Lamur A, Kumar A, Molenaar PCM. Quantitative analysisof eye movements during REM-sleep in developing rats. Developmental Psychobiology 1990;23:55?61. [PubMed: 2340957]
pmed.0020121.pdf	3
	1. Nautiyal A, Singh S, DiSalle M, O?Sullivan J (2005) Painful Horner syndrome as a harbinger of silent carotid dissection. PLoS Med 2: e19. DOI: 10.1371/journal.pmed.0020019
	2. Loewenfeld IE (1999) The Pupil: Anatomy, physiology, and clinical applications, Volume 1. Boston: Butterworth-Heinemann. 2 v.
	3. Thompson HS, Miller NR (1998) Disorders of pupillary function, accommodation, and lacrimation. In: Miller NR, Newman NJ, editors. Walsh and Hoyt?s Clinical Neuro-ophthalmology, Volume 1, 5th ed. Baltimore: Williams and Wilkins. pp. 961?1040.
J Appl Physiol-2005-Signorile-1213-20.pdf	61
	1.AbeT,DeHoyosDV,PollackML,andGarzarellaL.Timecourseforstrengthandmusclethicknesschangesfollowingupperandlowerbodyresistancetraininginmenandwomen.EurJApplPhysiol81:174?180,2000.
	2.AbernethyPJandJurimaeJ.Cross-sectionalandlongitudinalusesofisoinertial,isometricandisokineticdynamometry.MedSciSportsExerc28:1180?1187,1996.
	3.BompaTO.TheoryandMethodologyofTraining.Dubuque,IA:KendallHunt,1990.
	4.BompaTO.Variationsofperiodizationofstrength.StrCond18:58?61,1996.
	5.BompaTOandCornacchiaL.SeriousStrengthTraining.Champaign,IL:HumanKinetics,1998.
	6.BrownAB,McCartneyN,andSaleDG.Positiveadaptationstoweight-liftingtrainingintheelderly.JApplPhysiol69:1725?1733,1990.
	7.BrydenMP.Handedness,cerebrallateralization,andmeasuresof?latentleft-handedness.?IntJNeurosci44:227?233,1989.
	8.CaiozzoVJ,PerrineJJ,andEdgertonVR.Training-inducedalterationsintheinvivoforce-velocityrelationshipofhumanmuscles.JApplPhysiol51:750?754,1981.
	9.CarusoJ,SignorileJF,PerryAC,andClarkM.Timecoursechangesincontractilestrengthresultingfromisokineticexerciseand2agonistadministration.JStrCondRes11:8?13,1997.
	10.CoyleEF,FeiringDC,RotkisTC,CotteeRWIII,RobyFB,LeeW,andWilmoreJH.Specificityofpowerimprovementsthroughslowandfastisokinetictraining.JApplPhysiol51:1437?1442,1981.
	11.DeVitoG,BernardiM,ForteR,PulejoC,MacalusoA,andFiguraF.Determinantsofmaximalinstantaneousmusclepowerinwomenaged50?75years.EurJApplPhysiolOccupPhysiol78:59?64,1998.
	12.DohertyTJandCampagnaPD.Theeffectsofperiodizedvelocity-specificresistancetrainingonmaximalandsustainedforceproductioninwomen.JSportsSci11:77?82,1993.
	13.FeesM,DeckerT,Snyder-MacklerL,andAxeMJ.Upperextremityweight-trainingmodificationsfortheinjuredathlete.AmJSportsMed26:732?742,1998.
	14.FiataroneMA,MarksEC,RyanND,MeredithCN,LipsitzLA,andEvansWJ.Highintensitystrengthtraininginnonagenarians.JAMA263:3029?3034,1990.
	15.FieldingRA,LeBrasseurNK,CuocoA,BeanJ,MizerK,andFiat-aroneSinghMA.High-velocityresistancetrainingincreasesskeletalmusclepeakpowerinolderwomen.JAmGeriatrSoc50:655?662,2002.
	16.FleckSJandKraemerWJ.DesigningResistanceTrainingPrograms.Champaign,IL:HumanKinetics,1997.
	17.FronteraWR,HughesVA,DullalGE,andEvansWJ.Reliabilityofisokineticmuscletestingin45-to78-year-oldmenandwomen.ArchPhysMedRehabil74:1181?1185,1993.
	18.FronteraWR,MeredithCN,O?ReillyKP,KnuttgenHG,andEvansWJ.Strengthconditioninginoldermen:skeletalmusclehypertrophyandimprovedfunction.JApplPhysiol64:1038?1044,1988.
	19.FryAC,KraemerWJ,andRamsyLT.Pituitary-adrenal-gonadalre-sponsestohigh-intensityresistanceexerciseovertraining.JApplPhysiol85:2352?2359,1998.
	20.FryAC,KraemerWJ,VanBorselenF,LynchJM,MarsitJL,RoyEP,TriplettNT,andKnuttgenHG.Performancedecrementswithhigh-intensityresistanceexerciseovertraining.MedSciSportsExerc26:1165?1173,1994.
	21.FryAC,KraemerWJ,VanBorselenF,LynchJM,TriplettNT,KozirisLP,andFleckSJ.Catecholamineresponsestoshort-termhigh-intensityresistanceexerciseovertraining.JApplPhysiol77:941?946,1994.
	22.FryR,GroveJR,MortonAR,ZeroniPM,GauderieriS,andKeastD.Psychologicalandimmunologicalcorrelatesofacuteovertraining.BrJSportsMed28:241?246,1994.
	23.FryR,MortonA,andKeastD.Periodisationandthepreventionofovertraining.CanJSportSci17:241?248,1992.
	24.GibalaMJ,MacDougallJD,andSaleDG.Theeffectsoftaperingonstrengthperformanceintrainedathletes.IntJSportsMed15:492?497,1994.
	25.GravesJE,PollackML,LeggettSH,BraithRW,CarpenterDM,andBishopLE.Effectofreducedtrainingfrequencyonmuscularstrength.IntJSportsMed9:316?319,1988.
	26.Haï¿½kkinenKandKomiPV.Changesinelectricalandmechanicalbehavioroflegextensormusclesduringheavyresistancestrengthtraining.ScandJMedSciSports7:55?64,1985.
	27.Haï¿½kkinenKandKomiPV.Effectofexplosivetypestrengthtrainingonelectromyographicandforceproductioncharacteristicsoflegextensormusclesduringconcentricandvariousstretchshorteningcycleexercises.ScandJSportsSci7:65?76,1985.
	28.HicksonRC,FosterC,PollackML,GalassiTM,andRichS.Reducedtrainingintensitiesandlossofaerobicpower,endurance,andcardiacgrowth.JApplPhysiol58:492?499,1985.
	29.HuMHandWoollacottMH.Mulitsensorytrainingofstandingbalanceinolderadults:II.Kinematicandelectromyographicposturalresponses.JGerontol49:M62?M71,1994.
	30.HuangM,LinY,YangR,andLeeC.Acomparisonofvarioustherapeuticexercisesonthefunctionalstatusofpatientswithkneeosteo-arthritis.SeminArthritisRheum31:398?406,2003.
	31.JacobsI,BellDG,andPopeJ.Comparisonofisokineticandisoinertialliftingtestsaspredictorsofmaximalliftingcapacity.EurJApplPhysiolOccupPhysiol57:146?153,1988.
	32.JohnsRA,HoumardJA,KobeRW,HortobagyiT,BrunoNJ,WellsJM,andShinebargerMH.Effectsoftaperonswimpower,strokedistance,andperformance.MedSciSportsExerc24:1141?1146,1992.
	33.JozsiAC,CampbellWW,JosephL,DaveySL,andEvansWJ.Changesinpowerwithresistancetraininginolderandyoungermenandwomen.JGerontolABiolSciMedSci54:M591?M596,1999.
	34.KanekoM,FuchimotoT,TojiH,andSueiK.Trainingeffectofdifferentloadsontheforce-velocityrelationshipandmechanicalpoweroutputinhumanmuscle.ScandJSportsSci5:50?55,1983.
	35.KiblerWBandChandlerTJ.Sport-specificconditioning.AmJSportsMed22:424?432,1994.
	36.KomiPV.Trainingofmusclestrengthandpower:interactionofneuro-motoric,hypertrophic,andmechanicalfactors.IntJSportsMed7,Suppl1:10?15,1986.
	37.KomiPV,KarlssonJ,TeschPA,SuominenH,andHeikkinenE.Effectsofheavyresistanceandexplosivetypestrengthtrainingonme-chanical,functional,andmetabolicaspectsofperformance.In:ExerciseandSportsBiology,editedbyKomiPV.Champaign,IL:HumanKinetics,1982,p.90?102.
	38.KubukeliZN,NoakesTD,andDennisSC.Trainingtechniquestoimproveenduranceexerciseperformance.SportsMed32:489?509,2002.
	39.LinnamoV,HakkinenK,andKomiPV.Neuromuscularfatigueandrecoveryinmaximalcomparedtoexplosivestrengthtraining.EurJApplPhysiol77:176?181,1998.
	40.MacRaePG,AsplundLA,SchnelleJF,OuslanderJG,AbrahamseA,andMorrisC.Awalkingprogramfornursinghomeresidents:effectsonwalkendurance,physicalactivity,mobility,andqualityoflife.JAmGeriatrSoc44:175?180,1996.
	41.MartinDT,ScifresJC,ZimmermanSD,andWilkinsonJG.Effectsoftrainingandtaperoncyclingperformanceandisokineticlegstrength.IntJSportsMed15:485?491,1994.
	42.McCartneyN,HicksAL,MartinJ,andWebberCE.Long-termresistancetrainingintheelderly:effectsondynamicstrength,exercisecapacity,muscle,andbone.JGerontolABiolSciMedSci50:B97?B104,1995.
	43.McCartneyN,HicksAL,MartinJ,andWebberCE.Alongitudinaltrialofweighttrainingintheelderly:continuedimprovementsinyear2.JGerontolABiolSciMedSci51:B425?B433,1996.
	44.MorganWP,BrownDR,RaglinJS,O?ConnorPJ,andEllicksonKA.Psychologicalmonitoringofovertrainingandstaleness.BrJSportsMed21:107?114,1987.
	45.MoritaniTandDeVriesHA.Potentialforgrossmusclehypertrophyinoldermen.JGerontol35:672?682,1980.
	46.MujikaIandPadillaS.Scientificbasesforprecompetitiontaperingstrategies.MedSciSportsExerc35:1182?1187,2003.
	47.MurphyAJandWilsonGJ.Themeasurementofhumandynamicmuscularfunction:acomparisonofisoinertialandisokinetictests.JSportsMedPhysFitness36:169?177,1996.
	48.O?BryantH,ByrdR,andStoneMH.Cycleergometryperformanceandmaximumlegandhipstrengthadaptationstotwodifferentmethodsofweight-training.JApplSportsSciRes2:27?30,1988.
	49.O?ConnorPJ,MorganWP,RaglinJS,BarksdaleCM,andKalinNH.Moodstateandsalivarycortisollevelsfollowingovertraininginfemaleswimmers.Psychoneuroendocrinology14:303?310,1989.
	50.PerrinD.IsokineticExerciseandAssessment.Champaign,IL:HumanKinetics,1993.
	51.PykaG,LindenbergerE,CharetteSL,andMarcusR.Musclestrengthandfiberadaptationstoayear-longresistancetrainingprograminelderlymenandwomen.JGerontol49:M22?M27,1994.
	52.PykaG,TaaffeDR,andMarcusR.Effectofasustainedprogramofresistancetrainingontheacutegrowthhormoneresponsetoresistanceexerciseinolderadults.HormMetabRes26:330?333,1994.
	53.RutherfordOMandJonesDA.Theroleoflearningandcoordinationinstrengthtraining.EurJApplPhysiolOccupPhysiol55:100?105,1986.
	54.SeidlerRDandMartinPE.Theeffectsofshorttermbalancetrainingontheposturalcontrolofolderadults.GaitPosture6:224?236,1997.
	55.SignorileJF,CarmelMP,CzajaSJ,AsfourSS,MorganRO,KhalilTM,MaF,andRoosBA.Differentialincreasesinaverageisokineticpowerbyspecificmusclegroupsofolderwomenduetovariationsintrainingandtesting.JGerontolABiolSciMedSci57:M683?M690,2002.
	56.SignorileJFandMillerP.Shiftsintheforce-velocityrelationshipintheelderlyduetodifferencesinresistancetrainingprograms(Abstract).MedSciSportsExerc29:S22,1997.
	57.SkeltonDA,YoungA,GreigCA,andMalbutKE.Effectsofresistancetrainingonstrength,power,andselectedfunctionalabilitiesofwomenaged75andolder.JAmGeriatrSoc43:1081?1087,1995.
	58.StoneMH.Muscleconditioningandmuscleinjuries.MedSciSportsExerc22:457?462,1990.
	59.SwaineIL.Time-courseofchangesinbilateralarmpowerofswimmersduringrecoveryfrominjuryusingaswimbench.BrJSportsMed31:213?216,1997.
	60.WilloughbyDS.Acomparisonofthreeselectedweighttrainingprogramsonupperandlowerbodystrengthoftrainedmales.AnnJApplResCoachingAthletics9:124?146,1992.
	61.WilsonGJ,NewtonRU,MurphyAJ,andHumphriesBJ.Theoptimaltrainingloadforthedevelopmentofdynamicathleticperformance.MedSciSportsExerc25:1279?1286,1993.
J Appl Physiol-2005-Petersen-1154-62.pdf	162
	1.AbramsonJLandVaccarinoV.Relationshipbetweenphysicalactivityandinflammationamongapparentlyhealthymiddle-agedandolderUSadults.ArchInternMed162:1286?1292,2002.
	2.AkiraSandKishimotoT.IL-6andNF-IL6inacute-phaseresponseandviralinfection.ImmunolRev127:25?50,1992.
	3.AkiraS,TagaT,andKishimotoT.Interleukin-6inbiologyandmedicine.AdvImmunol54:1?78,1993.
	4.BallouSP,LozanskiFB,HodderS,RzewnickiDL,MionLC,SipeJD,FordAB,andKushnerI.Quantitativeandqualitativealterationsofacute-phaseproteinsinhealthyelderlypersons.AgeAgeing25:224?230,1996.
	5.BarzilayJI,AbrahamL,HeckbertSR,CushmanM,KullerLH,ResnickHE,andTracyRP.Therelationofmarkersofinflammationtothedevelopmentofglucosedisordersintheelderly:theCardiovascularHealthStudy.Diabetes50:2384?2389,2001.
	6.BastardJP,MaachiM,VanNhieuJT,JardelC,BruckertE,GrimaldiA,RobertJJ,CapeauJ,andHainqueB.AdiposetissueIL-6contentcorrelateswithresistancetoinsulinactivationofglucoseuptakebothinvivoandinvitro.JClinEndocrinolMetab87:2084?2089,2002.
	7.BlairSN,ChengY,andHolderJS.Isphysicalactivityorphysicalfitnessmoreimportantindefininghealthbenefits?MedSciSportsExerc33:S379?S399,2001.
	8.BogdanC,PaikJ,VodovotzY,andNathanC.Contrastingmecha-nismsforsuppressionofmacrophagecytokinereleasebytransforminggrowthfactor-betaandinterleukin-10.JBiolChem267:23301?23308,1992.
	9.BorstSEandBagbyGJ.Neutralizationoftumornecrosisfactorreversesage-inducedimpairmentofinsulinresponsivenessinskeletalmuscleofSprague-Dawleyrats.Metabolism51:1061?1064,2002.
	10.BotionLM,BrasierAR,TianB,UdupiV,andGreenA.InhibitionofproteasomeactivityblockstheabilityofTNFtodown-regulateGiproteinsandstimulatelipolysis.Endocrinology142:5069?5075,2001.
	11.BouleNG,HaddadE,KennyGP,WellsGA,andSigalRJ.Effectsofexerciseonglycemiccontrolandbodymassintype2diabetesmellitus:ameta-analysisofcontrolledclinicaltrials.JAMA286:1218?1227,2001.
	12.BruceCRandDyckDJ.Cytokineregulationofskeletalmusclefattyacidmetabolism:effectofinterleukin-6andtumornecrosisfactor-.AmJPhysiolEndocrinolMetab287:E616?E621,2004.
	13.BruunsgaardH,Andersen-RanbergK,JeuneB,PedersenAN,Skin-hojP,andPedersenBK.AhighplasmaconcentrationofTNF-alphaisassociatedwithdementiaincentenarians.JGerontolABiolSciMedSci54:M357?M364,1999.
	14.BruunsgaardH,ChristiansenL,PedersenAN,SchrollM,JorgensenT,andPedersenBK.TheIL-6-174Cpolymorphismisassociatedwithcardiovasculardiseasesandmortalityin80-year-oldhumans.ExpGerontol39:255?261,2004.
	15.BruunsgaardH,JensenMS,SchjerlingP,Halkjaer-KristensenJ,OgawaK,SkinhojP,andPedersenBK.Exerciseinducesrecruitmentoflymphocyteswithanactivatedphenotypeandshorttelomerelengthsinyoungandelderlyhumans.LifeSci65:2623?2633,1999.
	16.BruunsgaardH,LadelundS,PedersenAN,SchrollM,JorgensenT,andPedersenBK.Predictingdeathfromtumournecrosisfactor-alphaandinterleukin-6in80-year-oldpeople.ClinExpImmunol132:24?31,2003.
	17.BruunsgaardH,SkinhojP,PedersenAN,SchrollM,andPedersenBK.Ageing,tumournecrosisfactor-alpha(TNF-alpha)andatheroscle-rosis.ClinExpImmunol121:255?260,2000.
	18.CareyAL,BruceCR,SacchettiM,AndersonMJ,OlsonD,SaltinB,HawleyJA,andFebbraioMA.Interleukin-6andtumornecrosisfactor-alphaarenotincreasedinpatientswithtype2diabetes:evidencethatplasmaIL-6isrelatedtofatmassandnotinsulinresponsiveness.Diabetologia47:1029?1037,2004.
	19.CarlingD.TheAMP-activatedproteinkinasecascade?aunifyingsystemforenergycontrol.TrendsBiochemSci29:18?24,2004.
	20.CastellJV,GeigerT,GrossV,AndusT,WalterE,HiranoT,KishimotoT,andHeinrichPC.Plasmaclearance,organdistributionandtargetcellsofinterleukin-6/hepatocyte-stimulatingfactorintherat.EurJBiochem177:357?361,1988.
	21.CastellLM,PoortmansJR,LeclercqR,BrasseurM,DuchateauJ,andNewsholmeEA.Someaspectsoftheacutephaseresponseafteramarathonrace,andtheeffectsofglutaminesupplementation.EurJApplPhysiol75:47?53,1997.
	22.CataniaA,AiragiL,MottaP,ManfrediMG,AnnoniG,PettenatiC,BrambillaF,andLiptonJM.Cytokineantagonistsinagedsubjectsandtheirrelationwithcellularimmunity.JGerontolABiolSciMedSci52:B93?B97,1997.
	23.CoppackSW.Pro-inflammatorycytokinesandadiposetissue.ProcNutrSoc60:349?356,2001.
	24.DandonaP,AljadaA,andBandyopadhyayA.Inflammation:thelinkbetweeninsulinresistance,obesityanddiabetes.TrendsImmunol25:4?7,2004.
	25.DinarelloCA.Interleukin-1andinterleukin-1antagonism.Blood77:1627?1652,1991.
	26.DinarelloCA.Interleukin-1andtumornecrosisfactor:effectorcyto-kinesinautoimmunediseases.SeminImmunol4:133?145,1992.
	27.DinarelloCA.Theroleoftheinterleukin-1-receptorantagonistinblockinginflammationmediatedbyinterleukin-1.NEnglJMed343:732?734,2000.
	28.DobbsRJ,CharlettA,PurkissAG,DobbsSM,WellerC,andPetersonDW.AssociationofcirculatingTNF-alphaandIL-6withageingandparkinsonism.ActaNeurolScand100:34?41,1999.
	29.DrenthJP,vanUumSH,vanDeurenM,PesmanGJ,vandervenJongekrugJ,andvanderMeerJ.EndurancerunincreasescirculatingIL-6andIL-1rabutdownregulatesexvivoTNF-andIL-1production.JApplPhysiol79:1497?1503,1995.
	30.DuncanBB,SchmidtMI,PankowJS,BallantyneCM,CouperD,VigoA,HoogeveenR,FolsomAR,andHeissG.Low-gradesystemicinflammationandthedevelopmentoftype2diabetes:theatherosclerosisriskincommunitiesstudy.Diabetes52:1799?1805,2003.
	31.FallonKE,FallonSK,andBostonT.Theacutephaseresponseandexercise:courtandfieldsports.BrJSportsMed35:170?173,2001.
	32.FebbraioMA,HiscockN,SacchettiM,FischerCP,andPedersenBK.Interleukin-6isanovelfactormediatingglucosehomeostasisduringskeletalmusclecontraction.Diabetes53:1643?1648,2004.
	33.FebbraioMAandPedersenBK.Muscle-derivedinterleukin-6:mech-anismsforactivationandpossiblebiologicalroles.FASEBJ16:1335?1347,2002.
	34.FebbraioMA,SteensbergA,KellerC,StarkieRL,KrustrupP,OttP,SecherNH,andPedersenBK.Glucoseingestionattenuatesinter-leukin-6releasefromcontractingskeletalmuscleinhumans.JPhysiol549:607?612,2003.
	35.FeingoldKRandGrunfeldC.Roleofcytokinesininducinghyperlip-idemia.Diabetes41,Suppl2:97?101,1992.
	36.FestaA,D?AgostinoRJr,TracyRP,andHaffnerSM.Elevatedlevelsofacute-phaseproteinsandplasminogenactivatorinhibitor-1predictthedevelopmentoftype2diabetes:theinsulinresistanceatherosclerosisstudy.Diabetes51:1131?1137,2002.
	37.FiersW.Tumornecrosisfactor.Characterizationatthemolecular,cellularandinvivolevel.FEBSLett285:199?212,1991.
	38.FischerCP,HiscockNJ,PenkowaM,BasuS,VessbyB,KallnerA,SjobergLB,andPedersenBK.SupplementationwithvitaminsCandEinhibitsthereleaseofinterleukin-6fromcontractinghumanskeletalmuscle.JPhysiol558:633?645,2004.
	39.FordES.Leukocytecount,erythrocytesedimentationrate,anddiabetesincidenceinanationalsampleofUSadults.AmJEpidemiol155:57?64,2002.
	40.FreemanDJ,NorrieJ,CaslakeMJ,GawA,FordI,LoweGD,O?ReillyDS,PackardCJ,andSattarN.C-reactiveproteinisanindependentpredictorofriskforthedevelopmentofdiabetesintheWestofScotlandCoronaryPreventionStudy.Diabetes51:1596?1600,2002.
	41.FriedSK,BunkinDA,andGreenbergAS.Omentalandsubcutaneousadiposetissuesofobesesubjectsreleaseinterleukin-6:depotdifferenceandregulationbyglucocorticoid.JClinEndocrinolMetab83:847?850,1998.
	42.GabayC,SmithMF,EidlenD,andArendWP.Interleukin1receptorantagonist(IL-1Ra)isanacute-phaseprotein.JClinInvest99:2930?2940,1997.
	43.GadientRAandPattersonPH.Leukemiainhibitoryfactor,Interleukin6,andothercytokinesusingtheGP130transducingreceptor:rolesininflammationandinjury.StemCells17:127?137,1999.
	44.GasicS,TianB,andGreenA.TumornecrosisfactoralphastimulateslipolysisinadipocytesbydecreasingGiproteinconcentrations.JBiolChem274:6770?6775,1999.
	45.GeffkenDF,CushmanM,BurkeGL,PolakJF,SakkinenPA,andTracyRP.Associationbetweenphysicalactivityandmarkersofinflam-mationinahealthyelderlypopulation.AmJEpidemiol153:242?250,2001.
	46.GreenA,DobiasSB,WaltersDJ,andBrasierAR.Tumornecrosisfactorincreasestherateoflipolysisinprimaryculturesofadipocyteswithoutalteringlevelsofhormone-sensitivelipase.Endocrinology134:2581?2588,1994.
	47.HalseR,PearsonSL,McCormackJG,YeamanSJ,andTaylorR.Effectsoftumornecrosisfactor-alphaoninsulinactioninculturedhumanmusclecells.Diabetes50:1102?1109,2001.
	48.HanTS,SattarN,WilliamsK,Gonzalez-VillalpandoC,LeanME,andHaffnerSM.ProspectivestudyofC-reactiveproteininrelationtothedevelopmentofdiabetesandmetabolicsyndromeintheMexicoCityDiabetesStudy.DiabetesCare25:2016?2021,2002.
	49.HarrisTB,SavagePJ,TellGS,HaanM,KumanyikaS,andLynchJC.Carryingtheburdenofcardiovascularriskinoldage:associationsofweightandweightchangewithprevalentcardiovasculardisease,riskfactors,andhealthstatusintheCardiovascularHealthStudy.AmJClinNutr66:837?844,1997.
	50.HellstenY,FrandsenU,OrthenbladN,SjodinN,andRichterEA.Xanthineoxidaseinhumanskeletalmusclefollowingeccentricexercise:aroleofinflammation.JPhysiol498:239?248,1997.
	51.HiscockN,ChanMH,BisucciT,DarbyIA,andFebbraioMA.Skeletalmyocytesareasourceofinterleukin-6mRNAexpressionandproteinreleaseduringcontraction:evidenceoffibertypespecificity.FASEBJ18:992?994,2004.
	52.HotamisligilGS.MechanismsofTNF-alpha-inducedinsulinresistance.ExpClinEndocrinolDiabetes107:119?125,1999.
	53.HotamisligilGS,PeraldiP,BudavariA,EllisR,WhiteMF,andSpiegelmanBM.IRS-1-mediatedinhibitionofinsulinreceptortyrosinekinaseactivityinTNF-alpha-andobesity-inducedinsulinresistance.Science271:665?668,1996.
	54.HotamisligilGS,ShargillNS,andSpiegelmanBM.Adiposeexpres-sionoftumornecrosisfactor-alpha:directroleinobesity-linkedinsulinresistance.Science259:87?91,1993.
	55.JolliffeJA,ReesK,TaylorRS,ThompsonD,OldridgeN,andEbrahimS.Exercise-basedrehabilitationforcoronaryheartdisease.CochraneDatabaseSystRev4:CD001800,2000.
	56.JonsdottirIH,SchjerlingP,OstrowskiK,AspS,RichterEA,andPedersenBK.Musclecontractionsinduceinterleukin-6mRNAproduc-tioninratskeletalmuscles.JPhysiol528:157?163,2000.
	57.KellerC,KellerP,GiraltM,HidalgoJ,andPedersenBK.ExercisenormalisesoverexpressionofTNF-alphainknockoutmice.BiochemBiophysResCommun321:179?182,2004.
	58.KellerC,SteensbergA,PilegaardH,OsadaT,SaltinB,PedersenBK,andNeuferPD.TranscriptionalactivationoftheIL-6geneinhumancontractingskeletalmuscle:influenceofmuscleglycogencon-tent.FASEBJ15:2748?2750,2001.
	59.KellerP,KellerC,CareyAL,JauffredS,FischerCP,SteensbergA,andPedersenBK.Interleukin-6productionbycontractinghumanskel-etalmuscle:autocrineregulationbyIL-6.BiochemBiophysResCommun319:550?554,2003.
	60.KellyM,KellerC,AviluceaPR,KellerP,LuoZ,XiangX,GiraltM,HidalgoJ,SahaAK,andPedersenBK.AMPKactivityisdiminishedintissuesoftheIL-6knockoutmice:theeffectofexercise.BiochemBiophysResCommun320:449?454,2004.
	61.KimHJ,HigashimoriT,ParkSY,ChoiH,DongJ,KimYJ,NohHL,ChoYR,ClineG,KimYB,andKimJK.Differentialeffectsofinterleukin-6and-10onskeletalmuscleandliverinsulinactioninvivo.Diabetes53:1060?1067,2004.
	62.KingDE,CarekP,MainousAGIII,andPearsonWS.Inflammatorymarkersandexercise:differencesrelatedtoexercisetype.MedSciSportsExerc35:575?581,2003.
	63.KroegerKM,CarvilleKS,andAbrahamLJ.The-308tumornecrosisfactor-alphapromoterpolymorphismeffectstranscription.MolImmunol34:391?399,1997.
	64.KubaszekA,PihlajamakiJ,KomarovskiV,LindiV,LindstromJ,ErikssonJ,ValleTT,HamalainenH,Ilanne-ParikkaP,Keinanen-KiukaanniemiS,TuomilehtoJ,UusitupaM,andLaaksoM.Pro-moterpolymorphismsoftheTNF-alpha(G-308A)andIL-6(C-174G)genespredicttheconversionfromimpairedglucosetolerancetotype2diabetes:theFinnishDiabetesPreventionStudy.Diabetes52:1872?1876,2003.
	65.KubaszekA,PihlajamakiJ,PunnonenK,KarhapaaP,VauhkonenI,andLaaksoM.TheC-174GpromoterpolymorphismoftheIL-6geneaffectsenergyexpenditureandinsulinsensitivity.Diabetes52:558?561,2003.
	66.LacasseY,BrosseauL,MilneS,MartinS,WongE,GuyattGH,andGoldsteinRS.Pulmonaryrehabilitationforchronicobstructivepulmo-narydisease.CochraneDatabaseSystRev3:CD003793,2002.
	67.LangbergH,OlesenJL,GemmerC,andKjaerM.Substantialelevationofinterleukin-6concentrationinperitendinoustissue,incon-trasttomuscle,followingprolongedexerciseinhumans.JPhysiol542:985?990,2002.
	68.LibbyP.Inflammationinatherosclerosis.Nature420:868?874,2002.
	69.LibbyP,RidkerPM,andMaseriA.Inflammationandatherosclerosis.Circulation105:1135?1143,2002.
	70.LindsayRS,FunahashiT,HansonRL,MatsuzawaY,TanakaS,TataranniPA,KnowlerWC,andKrakoffJ.Adiponectinanddevel-opmentoftype2diabetesinthePimaIndianpopulation.Lancet360:57?58,2002.
	71.LyngsoD,SimonsenL,andBulowJ.Interleukin-6productioninhumansubcutaneousabdominaladiposetissue:theeffectofexercise.JPhysiol543:373?378,2002.
	72.MatthysP,MiteraT,HeremansH,VanDammeJ,andBilliauA.Anti-gammainterferonandanti-interleukin-6antibodiesaffectstaphylo-coccalenterotoxinB-inducedweightloss,hypoglycemia,andcytokinereleaseinD-galactosamine-sensitizedandunsensitizedmice.InfectIm-mun63:1158?1164,1995.
	73.MattuschF,DufauxB,HeineO,MertensI,andRostR.ReductionoftheplasmaconcentrationofC-reactiveproteinfollowingninemonthsofendurancetraining.IntJSportsMed21:21?24,2000.
	74.MishimaY,KuyamaA,TadaA,TakahashiK,IshiokaT,andKibataM.Relationshipbetweenserumtumornecrosisfactor-alphaandinsulinresistanceinobesemenwithType2diabetesmellitus.DiabetesResClinPract52:119?123,2001.
	75.MizuharaH,O?NeillE,SekiN,OgawaT,KusunokiC,OtsukaK,SatohS,NiwaM,SenohH,andFujiwaraH.Tcellactivation-associatedhepaticinjury:mediationbytumornecrosisfactorsandprotectionbyinterleukin6.JExpMed179:1529?1537,1994.
	76.Mohamed-AliV,GoodrickS,BulmerK,HollyJM,YudkinJS,andCoppackSW.Productionofsolubletumornecrosisfactorreceptorsbyhumansubcutaneousadiposetissueinvivo.AmJPhysiolEndocrinolMetab277:E971?E975,1999.
	77.MoldoveanuAI,ShephardRJ,andShekPN.ExerciseelevatesplasmalevelsbutnotgeneexpressionofIL-1,IL-6,andTNF-inbloodmononuclearcells.JApplPhysiol89:1499?1504,2000.
	78.MooreKW,O?GarraA,deWaalMR,VieiraP,andMosmannTR.Interleukin-10.AnnuRevImmunol11:165?190,1993.
	79.MurrayCJandLopezAD.Globalmortality,disability,andthecon-tributionofriskfactors:GlobalBurdenofDiseaseStudy.Lancet349:1436?1442,1997.
	80.NakanishiN,YoshidaH,MatsuoY,SuzukiK,andTataraK.Whiteblood-cellcountandtheriskofimpairedfastingglucoseorTypeIIdiabetesinmiddle-agedJapanesemen.Diabetologia45:42?48,2002.
	81.Nehlsen-CanarellaSL,FagoagaOR,andNiemanDC.Carbohydrateandthecytokineresponseto2.5hoursofrunning.JApplPhysiol82:1662?1667,1997.
	82.NielsenHB,SecherN,andPedersenBK.LymphocytesandNKcellactivityduringrepeatedboutsofmaximalexercise.AmJPhysiolRegulIntegrCompPhysiol271:R222?R227,1996.
	83.NiemanDC,DavisJM,HensonDA,Walberg-RankinJ,ShuteM,DumkeCL,UtterAC,VinciDM,CarsonJA,BrownA,LeeWJ,McAnultySR,andMcAnultyLS.CarbohydrateingestioninfluencesskeletalmusclecytokinemRNAandplasmacytokinelevelsaftera3-hrun.JApplPhysiol94:1917?1925,2003.
	84.NiemanDC,Nehlsen-CanarellaSL,FagoagaOR,HensonDA,UtterA,DavisJM,WilliamsF,andButterworthDE.Effectsofmodeandcarbohydrateonthegranulocyteandmonocyteresponsetointensiveprolongedexercise.JApplPhysiol84:1252?1259,1998.
	85.NiemanDC,Nehlsen-CanarellaSL,FagoagaOR,HensonDA,UtterA,DavisJM,WilliamsF,andButterworthDE.Influenceofmodeandcarbohydrateonthecytokineresponsetoheavyexertion.MedSciSportsExerc30:671?678,1998.
	86.NishimotoN,YoshizakiK,MiyasakaN,YamamotoK,KawaiS,TakeuchiT,HashimotoJ,AzumaJ,andKishimotoT.Treatmentofrheumatoidarthritiswithhumanizedanti-interleukin-6receptorantibody:amulticenter,double-blind,placebo-controlledtrial.ArthritisRheum50:1761?1769,2004.
	87.NonogakiK,FullerGM,FuentesNL,MoserAH,StapransI,Grun-feldC,andFeingoldKR.Interleukin-6stimulateshepatictriglyceridesecretioninrats.Endocrinology136:2143?2149,1995.
	88.NorthoffH,WeinstockC,andBergA.Thecytokineresponsetostrenuousexercise.IntJSportsMed15:167?171,1994.
	89.NyboL,NielsenB,PedersenBK,MollerK,andSecherNH.Inter-leukin-6releasefromthehumanbrainduringprolongedexercise.JPhysiol542:991?995,2002.
	90.OgawaH,NielsenS,andKawakamiM.Cachectin/tumornecrosisfactorandinterleukin-1showdifferentmodesofcombinedeffectonlipoproteinlipaseactivityandintracellularlipolysisin3T3?L1cells.BiochimBiophysActa1003:131?135,1989.
	91.OstrowskiK,HermannC,BangashA,SchjerlingP,NielsenJN,andPedersenBK.Atrauma-likeelevationinplasmacytokinesinhumansinresponsetotreadmillrunning.JPhysiol508:949?953,1998.
	92.OstrowskiK,RohdeT,AspA,SchjerlingP,andPedersenBK.Chemokinesareelevatedinplasmaafterstrenuousexerciseinhumans.EurJApplPhysiol84:244?245,2001.
	93.OstrowskiK,RohdeT,AspS,SchjerlingP,andPedersenBK.Pro-andanti-inflammatorycytokinebalanceinstrenuousexerciseinhumans.JPhysiol515:287?291,1999.
	94.OstrowskiK,RohdeT,ZachoM,AspS,andPedersenBK.EvidencethatIL-6isproducedinskeletalmuscleduringprolongedrunning.JPhysiol508:949?953,1998.
	95.OstrowskiK,SchjerlingP,andPedersenBK.Physicalactivityandplasmainterleukin-6inhumans?effectofintensityofexercise.EurJApplPhysiol83:512?515,2000.
	96.PaolissoG,RizzoMR,MazziottiG,TagliamonteMR,GambardellaA,RotondiM,CarellaC,GiuglianoD,VarricchioM,andD?OnofrioF.Advancingageandinsulinresistance:roleofplasmatumornecrosisfactor-.AmJPhysiolEndocrinolMetab275:E294?E299,1998.
	97.PathG,BornsteinSR,GurniakM,ChrousosGP,ScherbaumWA,andHaunerH.Humanbreastadipocytesexpressinterleukin-6(IL-6)anditsreceptorsystem:increasedIL-6productionbybeta-adrenergicactivationandeffectsofIL-6onadipocytefunction.JClinEndocrinolMetab86:2281?2288,2001.
	98.PedersenBKandHoffman-GoetzL.Exerciseandtheimmunesystem:regulation,integrationandadaptation.PhysiolRev80:1055?1081,2000.
	99.PedersenBK,SteensbergA,FischerC,KellerC,KellerP,Plom-gaardP,FebbraioM,andSaltinB.Searchingfortheexercisefactor:isIL-6acandidate.JMuscleResCellMotil24:113?119,2003.
	100.PedersenBK,SteensbergA,andSchjerlingP.Muscle-derivedinter-leukin-6:possiblebiologicaleffects.JPhysiol536:329?337,2001.
	101.PedersenM,BruunsgaardH,WeisN,HendelHW,AndreassenBU,EldrupE,DelaF,andPedersenBK.CirculatinglevelsofTNF-alphaandIL-6-relationtotruncalfatmassandmusclemassinhealthyelderlyindividualsandinpatientswithtype-2diabetes.MechAgeingDev124:495?502,2003.
	102.PedersenM,SteensbergA,KellerC,OsadaT,ZachoM,SaltinB,FebbraioMA,andPedersenBK.Doestheagingskeletalmusclemaintainitsendocrinefunction?ExercImmunolRev10:42?55,2004.
	103.PenkowaM,KellerC,KellerP,JauffredS,andPedersenBK.Immunohistochemicaldetectionofinterleukin-6inhumanskeletalmus-clefibersfollowingexercise.FASEBJ17:2166?2168,2003.
	104.PeraldiP,HotamisligilGS,BuurmanWA,WhiteMF,andSpiegelmanBM.Tumornecrosisfactor(TNF)-alphainhibitsinsulinsignalingthroughstimulationofthep55TNFreceptorandactivationofsphingomyelinase.JBiolChem271:13018?13022,1996.
	105.PetersenEW,CareyAL,SacchettiM,SteinbergGR,MacaulaySL,FebbraioMA,andPedersenBK.AcuteIL-6treatmentincreasesfattyacidturnoverinelderlyhumansinvivoandintissuecultureinvitro:evidencethatIL-6actsindependentlyoflipolytichormones.AmJPhysiolEndocrinolMetab288:E155?E162,2005.
	106.PetersenKF,DufourS,BefroyD,GarciaR,andShulmanGI.Impairedmitochondrialactivityintheinsulin-resistantoffspringofpatientswithtype2diabetes.NEnglJMed350:664?671,2004.
	107.PickupJC,MattockMB,ChusneyGD,andBurtD.NIDDMasadiseaseoftheinnateimmunesystem:associationofacute-phasereactantsandinterleukin-6withmetabolicsyndromeX.Diabetologia40:1286?1292,1997.
	108.PiepoliMF,DavosC,FrancisDP,andCoatsAJ.Exercisetrainingmeta-analysisoftrialsinpatientswithchronicheartfailure(ExTra-MATCH).BMJ328:189?195,2004.
	109.PopaC,NeteaMG,RadstakeT,vanderMeerJW,StalenhoefAF,VanRielPL,andBarreraP.Influenceofanti-TNFtreatmentonthecardiovascularriskfactorsinpatientswithactiverheumatoidarthritis.AnnRheumDisJul1[Epubaheadofprint]:2004.
	110.PradhanAD,MansonJE,RifaiN,BuringJE,andRidkerPM.C-reactiveprotein,interleukin6,andriskofdevelopingtype2diabetesmellitus.JAMA286:327?334,2001.
	111.PretolaniM.Interleukin-10:ananti-inflammatorycytokinewiththera-peuticpotential.ClinExpAllergy29:1164?1171,1999.
	112.PueCA,MortensenRF,MarshCB,PopeHA,andWewersMD.AcutephaselevelsofC-reactiveproteinenhanceIL-1betaandIL-1raproductionbyhumanbloodmonocytesbutinhibitIL-1betaandIL-1raproductionbyalveolarmacrophages.JImmunol156:1594?1600,1996.
	113.Rahn-LandstromT,MeiJ,KarlssonM,ManganielloV,andDeger-manE.Down-regulationofcyclic-nucleotidephosphodiesterase3Bin3T3?L1adipocytesinducedbytumournecrosisfactoralphaandcAMP.BiochemJ346:337?343,2000.
	114.RidkerPM,HennekensCH,BuringJE,andRifaiNC.Reactiveproteinandothermarkersofinflammationinthepredictionofcardio-vasculardiseaseinwomen.NEnglJMed342:836?843,2000.
	115.RidkerPM,RifaiN,StampferMJ,andHennekensCH.Plasmaconcentrationofinterleukin-6andtheriskoffuturemyocardialinfarctionamongapparentlyhealthymen.Circulation101:1767?1772,2000.
	116.RidkerPM,RifaiN,RoseL,BuringJE,andCookNR.ComparisonofC-reactiveproteinandlow-densitylipoproteincholesterollevelsinthepredictionoffirstcardiovascularevents.NEnglJMed347:1557?1565,2002.
	117.RohdeT,MacLeanDA,RichterEA,KiensB,andPedersenBK.ProlongedsubmaximaleccentricexerciseisassociatedwithincreasedlevelsofplasmaIL-6.AmJPhysiolEndocrinolMetab273:E85?E91,1997.
	118.RossR.Atherosclerosis?aninflammatorydisease.NEnglJMed340:115?126,1999.
	119.RossRandHarkerL.Hyperlipidemiaandatherosclerosis.Science193:1094?1100,1976.
	120.RotterV,NagaevI,andSmithU.Interleukin-6(IL-6)inducesinsulinresistancein3T3?L1adipocytesandis,likeIL-8andtumornecrosisfactor-alpha,overexpressedinhumanfatcellsfrominsulin-resistantsubjects.JBiolChem278:45777?45784,2003.
	121.RydenM,DickerA,vanHarmelenV,HaunerH,BrunnbergM,PerbeckL,LonnqvistF,andArnerP.Mappingofearlysignalingeventsintumornecrosisfactor-alpha-mediatedlipolysisinhumanfatcells.JBiolChem277:1085?1091,2002.
	122.SaghizadehM,OngJM,GarveyWT,HenryRR,andKernPA.TheexpressionofTNFalphabyhumanmuscle.Relationshiptoinsulinresistance.JClinInvest97:1111?1116,1996.
	123.SchindlerR,MancillaJ,EndresS,GhorbaniR,ClarkSC,andDinarelloCA.Correlationsandinteractionsintheproductionofinter-leukin-6(IL-6),IL-1,andtumornecrosisfactor(TNF)inhumanbloodmononuclearcells:IL-6suppressesIL-1andTNF.Blood75:40?47,1990.
	124.SmithJK,DykesR,DouglasJE,KrishnaswamyG,andBerkS.Long-termexerciseandatherogenicactivityofbloodmononuclearcellsinpersonsatriskofdevelopingischemicheartdisease.JAMA281:1722?1727,1999.
	125.SouzaSC,deVargasLM,YamamotoMT,LienP,FranciosaMD,MossLG,andGreenbergAS.OverexpressionofperilipinAandBblockstheabilityoftumornecrosisfactoralphatoincreaselipolysisin3T3?L1adipocytes.JBiolChem273:24665?24669,1998.
	126.SouzaSC,YamamotoMT,FranciosaMD,LienP,andGreenbergAS.BRL49653blocksthelipolyticactionsoftumornecrosisfactor-alpha:apotentialnewinsulin-sensitizingmechanismforthiazolidinedio-nes.Diabetes47:691?695,1998.
	127.StarkieR,OstrowskiSR,JauffredS,FebbraioM,andPedersenBK.ExerciseandIL-6infusioninhibitendotoxin-inducedTNF-productioninhumans.FASEBJ17:884?886,2003.
	128.StarkieRL,ArkinstallMJ,KoukoulasI,HawleyJA,andFebbraioMA.Carbohydrateingestionattenuatestheincreaseinplasmainterleu-kin-6,butnotskeletalmuscleinterleukin-6mRNA,duringexerciseinhumans.JPhysiol533:585?591,2001.
	129.StarkieRL,RollandJ,AngusDJ,AndersonMJ,andFebbraioMA.CirculatingmonocytesarenotthesourceofelevationsinplasmaIL-6andTNF-levelsafterprolongedrunning.AmJPhysiolCellPhysiol280:C769?C774,2001.
	130.SteensbergA,FebbraioMA,OsadaT,SchjerlingP,vanHallG,SaltinB,andPedersenBK.Interleukin-6productionincontractinghumanskeletalmuscleisinfluencedbypre-exercisemuscleglycogencontent.JPhysiol537:633?639,2001.
	131.SteensbergA,FischerCP,KellerC,MollerK,andPedersenBK.IL-6enhancesplasmaIL-1ra,IL-10,andcortisolinhumans.AmJPhysiolEndocrinolMetab285:E433?E437,2003.
	132.SteensbergA,FischerCP,SacchettiM,KellerC,OsadaT,Schjer-lingP,vanHallG,FebbraioMA,andPedersenBK.Acuteinterleu-kin-6administrationdoesnotimpairmuscleglucoseuptakeorwholebodyglucosedisposalinhealthyhumans.JPhysiol548:631?638,2003.
	133.SteensbergA,KellerC,StarkieRL,OsadaT,FebbraioMA,andPedersenBK.IL-6andTNF-expressionin,andreleasefrom,con-tractinghumanskeletalmuscle.AmJPhysiolEndocrinolMetab283:E1272?E1278,2002.
	134.SteensbergA,ToftAD,SchjerlingP,Halkjaer-KristensenJ,andPedersenBK.Plasmainterleukin-6duringstrenuousexercise:roleofadrenaline.AmJPhysiolCellPhysiol281:C1001?C1004,2001.
	135.SteensbergA,vanHallG,OsadaT,SacchettiM,SaltinB,andKlarlundPB.Productionofinterleukin-6incontractinghumanskeletalmusclescanaccountfortheexercise-inducedincreaseinplasmainter-leukin-6.JPhysiol529:237?242,2000.
	136.StouthardJM,RomijnJA,vanderPT,EndertE,KleinS,BakkerPJ,VeenhofCH,andSauerweinHP.Endocrinologicandmetaboliceffectsofinterleukin-6inhumans.AmJPhysiolEndocrinolMetab268:E813?E819,1995.
	137.SuzukiK,NakajiS,KurakakeS,TotsukaM,SatoK,KuriyamaT,FujimotoH,ShibusawaK,MachidaK,andSugawaraK.Exhaustiveexerciseandtype-1/type-2cytokinebalancewithspecialfocusoninter-leukin-12p40/p70.ExercImmunolRev9:48?57,2003.
	138.SuzukiK,NakajiS,YamadaM,TotsukaM,SatoK,andSugawaraK.Systemicinflammatoryresponsetoexhaustiveexercise.Cytokinekinetics.ExercImmunolRev8:6?48,2002.
	139.SuzukiK,YamadaM,KurakakeS,OkamuraN,YamayaK,LiuQ,KudohS,KowatariK,NakajiS,andSugawaraK.Circulatingcytokinesandhormoneswithimmunosuppressivebutneutrophil-primingpotentialsriseafterenduranceexerciseinhumans.EurJApplPhysiol81:281?287,2000.
	140.TaaffeDR,HarrisTB,FerrucciL,RoweJ,andSeemanTE.Cross-sectionalandprospectiverelationshipsofinterleukin-6andC-reactiveproteinwithphysicalperformanceinelderlypersons:MacArthurstudiesofsuccessfulaging.JGerontolABiolSciMedSci55:M709?M715,2000.
	141.TerryCF,LoukaciV,andGreenFR.Cooperativeinfluenceofgeneticpolymorphismsoninterleukin6transcriptionalregulation.JBiolChem275:18138?18144,2000.
	142.TilgH,DinarelloCA,andMierJW.IL-6andAPPs:anti-inflammatoryandimmunosuppressivemediators.ImmunolToday18:428?432,1997.
	143.TisiPV,HulseM,ChulakadabbaA,GoslingP,andShearmanCP.Exercisetrainingforintermittentclaudication:doesitadverselyaffectbiochemicalmarkersoftheexercise-inducedinflammatoryresponse?EurJVascEndovascSurg14:344?350,1997.
	144.ToftAD,OstrowskiK,AspS,Mï¿½llerK,IversenS,HermannC,Sï¿½ndergaardSR,andPedersenBK.Theeffectsofn-3PUFAonthecytokineresponsetostrenuousexercise.JApplPhysiol89:2401?2405,2000.
	145.TsigosC,KyrouI,ChalaE,TsapogasP,StavridisJC,andRaptisSA.Circulatingtumournecrosisfactoralphaconcentrationsarehigherinabdominalversusperipheralobesity.Metabolism48:1332?1335,1999.
	146.UllumH,HaahrPM,DiamantM,PalmoJ,Halkjaer-KristensenJ,andPedersenBK.BicycleexerciseenhancesplasmaIL-6butdoesnotchangeIL-1,IL-1,IL-6,orTNF-pre-mRNAinBMNC.JApplPhysiol77:93?97,1994.
	147.UysalKT,WiesbrockSM,MarinoMW,andHotamisligilGS.Pro-tectionfromobesity-inducedinsulinresistanceinmicelackingTNF-alphafunction.Nature389:610?614,1997.
	148.VanderPollT,CoyleSM,BarbosaK,BraxtonCC,andLowrySF.Epinephrineinhibitstumornecrosisfactor-alphaandpotentiatesinter-leukin10productionduringhumanendotoxemia.JClinInvest97:713?719,1996.
	149.VanHallG,SteensbergA,SacchettiM,FischerC,KellerC,Schjer-lingP,HiscockN,MollerK,SaltinB,FebbraioMA,andPedersenBK.Interleukin-6stimulateslipolysisandfatoxidationinhumans.JClinEndocrinolMetab88:3005?3010,2003.
	150.VgontzasAN,PapanicolaouDA,BixlerEO,HopperK,LotsikasA,andLinHM.Sleepapneaanddaytimesleepinessandfatigue:relationtovisceralobesity,insulinresistance,andhypercytokinemia.JClinEndo-crinolMetab85:1151?1158,2000.
	151.VolpatoS,GuralnikJM,FerrucciL,BalfourJ,ChavesP,FriedLP,andHarrisTB.Cardiovasculardisease,interleukin-6,andriskofmor-talityinolderwomen:thewomen?shealthandagingstudy.Circulation103:947?953,2001.
	152.VozarovaB,WeyerC,LindsayRS,PratleyRE,BogardusC,andTataranniPA.Highwhitebloodcellcountisassociatedwithawors-eningofinsulinsensitivityandpredictsthedevelopmentoftype2diabetes.Diabetes51:455?461,2002.
	153.WalleniusV,WalleniusK,AhrenB,RudlingM,CarlstenH,DicksonSL,OhlssonC,andJanssonJO.Interleukin-6-deficientmicedevelopmature-onsetobesity.NatMed8:75?79,2002.
	154.WangP,WuP,AnthesJC,SiegelMI,EganRW,andBillahMM.Interleukin-10inhibitsinterleukin-8productioninhumanneutrophils.Blood83:2678?2683,1994.
	155.WangP,WuP,SiegelMI,EganRW,andBillahMM.IL-10inhibitstranscriptionofcytokinegenesinhumanperipheralbloodmononuclearcells.JImmunol153:811?816,1994.
	156.WannametheeSG,LoweGD,WhincupPH,RumleyA,WalkerM,andLennonL.Physicalactivityandhemostaticandinflammatoryvariablesinelderlymen.Circulation105:1785?1790,2002.
	157.WeigertC,BrodbeckK,StaigerH,KauschC,MachicaoF,HaringHU,andSchleicherED.Palmitate,butnotunsaturatedfattyacids,inducestheexpressionofinterleukin-6inhumanmyotubesthroughproteasome-dependentactivationofnuclearfactorkappaB.JBiolChem279:23942?23952,2004.
	158.WilsonAG,SymonsJA,McDowellTL,McDevittHO,andDuffGW.Effectsofapolymorphisminthehumantumornecrosisfactoralphapromoterontranscriptionalactivation.ProcNatlAcadSciUSA94:3195?3199,1997.
	159.WinklerG,SalamonF,HarmosG,SalamonD,SpeerG,SzekeresO,HajosP,KovacsM,SimonK,andCsehK.Elevatedserumtumornecrosisfactor-alphaconcentrationsandbioactivityinType2diabeticsandpatientswithandroidtypeobesity.DiabetesResClinPract42:169?174,1998.
	160.YachD,HawkesC,GouldCL,andHofmanKJ.Theglobalburdenofchronicdiseases:overcomingimpedimentstopreventionandcontrol.JAMA291:2616?2622,2004.
	161.YoudJM,RattiganS,andClarkMG.Acuteimpairmentofinsulin-mediatedcapillaryrecruitmentandglucoseuptakeinratskeletalmuscleinvivobyTNF-alpha.Diabetes49:1904?1909,2000.
	162.ZhangHH,HalbleibM,AhmadF,ManganielloVC,andGreenbergAS.Tumornecrosisfactor-alphastimulateslipolysisindifferentiatedhumanadipocytesthroughactivationofextracellularsignal-relatedki-naseandelevationofintracellularcAMP.Diabetes51:2929?2935,2002
200503246.pdf	15
pp1371302.pdf	53
Cereb. Cortex-2005-Hamker-431-47.pdf	104
	AsaadWF,RainerG,MillerEK(2000)Task-speci?cneuralactivityintheprimateprefrontalcortex.JNeurophysiol84:451--459.
	BahillAT,AdlerD,StarkL(1975)Mostnaturallyoccurringhumansaccadeshavemagnitudesof15degreesorless.InvestOphthalmol14:468--469.
	BaizerJS,UngerleiderLG,DesimoneR(1991)Organizationofvisualinputstotheinferiortemporalandposteriorparietalcortexinmacaques.JNeurosci11:168--190.
	BichotNP,SchallJD(1999a)Effectsofsimilarityandhistoryonneuralmechanismsofvisualselection.NatNeurosci2:549--554.
	BichotNP,SchallJD(1999b)Saccadetargetselectioninmacaqueduringfeatureandconjunctionvisualsearch.VisNeurosci16:81--89.
	BichotNP,ThompsonKG,RaoSC,SchallJD(2001a)Reliabilityofmacaquefrontaleye?eldneuronssignalingsaccadetargetsduringvisualsearch.JNeurosci21:713--725.
	BichotNP,RaoSC,SchallJD(2001b)Continuousprocessinginmacaquefrontaleyecortexduringvisualsearch.Neuropsychologia39:972--982.
	BisleyJW,GoldbergME.(2003)Neuronalactivityinthelateralintra-parietalareaandspatialattention.Science299:81--86.
	BruceCJ,GoldbergME(1985)Primatefrontaleye?elds.I.Singleneuronsdischargingbeforesaccades.JNeurophysiol53:603--635.
	BundesenC(1990)Atheoryofvisualattention.PsycholRev97:523--547.
	BundesenC.(1999)Acomputationaltheoryofvisualattention.In:Attention,spaceandaction:studiesincognitiveneuroscience(HumphreysGW,DuncanJ,TreismanA,eds),pp.54--71.Oxford:OxfordUniversityPress.
	BurmanDD,BruceCJ(1997)Suppressionoftask-relatedsaccadesbyelectricalstimulationintheprimate?sfrontaleye?eld.JNeuro-physiol77:2252--2267.
	ChanceFS,NelsonSB,AbbottLF(1998)SynapticdepressionandthetemporalresponsecharacteristicsofV1cells.JNeurosci18:4785--4799.
	ChanceFS,NelsonSB,AbbottLF(1999)Complexcellsascorticallyampli?edsimplecells.NatNeurosci2:277--282.
	ChelazziL(1999)Serialattentionmechanismsinvisualsearch:acriticallookattheevidence.PsycholRes62:195--219.
	ChelazziL,MillerEK,DuncanJ,DesimoneR(1993)Aneuralbasisforvisualsearchininferiortemporalcortex.Nature363:345--347.
	ChelazziL,Duncan,J,MillerEK,DesimoneR(1998)Responsesofneuronsininferiortemporalcortexduringmemory-guidedvisualsearch.JNeurophysiol80:2918--2940.
	ChelazziL,MillerEK,DuncanJ,DesimoneR(2001)ResponsesofneuronsinmacaqueareaV4duringmemory-guidedvisualsearch.CerebCortex11:761--772.
	CorbettaM,ShulmanGL,MiezinFM,PetersenSE(1995)Superiorparietalcortexactivationduringspatialattentionshiftsandvisualfeatureconjunction.Science270:802--805.
	CorchsS,DecoG(2002)Large-scaleneuralmodelforvisualattention:integrationofexperimentalsingle-cellandfMRIdata.CerebCortex12:339--348.
	DecoG,PollatosO,ZihlJ(2002)Thetimecourseofselectivevisualattention:theoryandexperiments.VisionRes42:2925--2945.
	DesimoneR,ScheinSJ.(1987)VisualpropertiesofneuronsinareaV4ofthemacaque:sensitivitytostimulusform.JNeurophysiol.57:835--868.
	DesimoneR,DuncanJ(1995)Neuralmechanismsofselectiveattention.AnnuRevNeurosci18:193--222.
	DiasEC,BruceCJ(1994)Physiologicalcorrelateof?xationdisen-gagementintheprimate?sfrontaleye?eld.JNeurophysiol72:2532--2537.
	DonnerT,KettermannA,DieschE,OstendorfF,VillringerA,BrandtSA(2000)Involvementofthehumanfrontaleye?eldandmultipleparietalareasincovertvisualselectionduringconjunctionsearch.EurJNeurosci12:3407--3414.
	DuncanJ,HumphreysGW(1989)Visualsearchandstimulussimilarity.PsycholRev96:433--458.
	DuncanJ,HumphreysGW(1992)Beyondthesearchsurface:visualsearchandattentionalengagement.JExpPsycholHumPerceptPerform18:578--588.
	DuncanJ,HumphreysGW,WardR(1997)Competitivebrainactivityinvisualattention.CurrOpinNeurobiol7:255--261.
	EskandarEN,OpticanLM,RichmondBJ(1993)Roleofinferiortemporalneuronsinvisualmemory.II.Multiplyingtemporalwaveformsrelatedtovisionandmemory.JNeurophysiol68:1296--1306.
	FreedmanDJ,RiesenhuberM,PoggioT,MillerEK(2001)Categoricalrepresentationofvisualstimuliintheprimateprefrontalcortex.Science291:312--316.
	FreedmanDJ,RiesenhuberM,PoggioT,MillerEK(2002)Visualcategorizationandtheprimateprefrontalcortex:neurophysiologyandbehavior.JNeurophysiol88:929--941.
	GrossbergS(1973)Contourenhancementshorttermmemory,andconstanciesinreverberatingneuralnetworks.StudApplMath52:217--257.
	HamkerFH(1999)Theroleoffeedbackconnectionsintask-drivenvisualsearch.In:Connectionistmodelsincognitiveneuroscience(HeinkeD,HumphreysGW,OlsonA,eds),pp.252--261.London:SpringerVerlag.
	HamkerFH(2000)Distributedcompetitionindirectedattention.In:Proceedingsinarti?cialintelligence,Vol.9:DynamischePerzeption(BaratoffG,NeumannH,eds),pp39--44.Berlin:AKA,AkademischeVerlagsgesellschaft.
	HamkerFH(2001)Attentionasaresultofdistributedcompetition.SocNeurosciAbstr27:348.10.
	HamkerFH(2002)Howdoestheventralpathwaycontributetospatialattentionandtheplanningofeyemovements?In:Dynamicperception(Wuï¿½rtzRP,LappeM,eds),pp.83--88.StAugustin:In?xVerlag.
	HamkerFH(2003)Thereentryhypothesis:linkingeyemovementstovisualperception.JVision11:808--816.
	HamkerFH(2004a)Predictionsofamodelofspatialattentionusingsum-andmax-poolingfunctions.Neurocomputing.56C:329--343.
	HamkerFH(2004b)Adynamicmodelofhowfeaturecuesguidespatialattention.VisionResearch44:501--521.
	HamkerFH,WorcesterJ(2002)Objectdetectioninnaturalscenesbyfeedback.In:Biologicallymotivatedcomputervision(Buï¿½lthoffHHetal.,eds),pp.398--407.Berlin:SpringerVerlag.
	HanesDP,SchallJD(1996)Neuralcontrolofvoluntarymovementinitiation.Science274:427--430.
	HanesDP,PattersonWF2nd,SchallJD(1998)Roleoffrontaleye?eldsincountermandingsaccades:visual,movement,and?xationactivity.JNeurophysiol79:817--834.
	HasegawaRP,BlitzAM,GellerNL,GoldbergME(2000)Neuronsinmonkeyprefrontalcortexthattrackpastorpredictfutureperfor-mance.Science290:1786--1789.
	HochsteinS,AhissarM.(2002)Viewfromthetop:hierarchiesandreversehierarchiesinthevisualsystem.Neuron36:791--804.
	HopfJM,LuckSJ,GirelliM,HagnerT,MangunGR,ScheichH,HeinzeHJ(2000)Neuralsourcesoffocusedattentioninvisualsearch.CerebCortex.10:1233--1241.
	Hupeï¿½JM,JamesAC,GirardP,LomberSG,PayneBR,BullierJ(2001)Feedbackconnectionsactontheearlypartoftheresponsesinmonkeyvisualcortex.JNeurophysiol85:134--145.
	IgnashchenkovaA,DickePW,HaarmeierT,ThierP.(2004)Neuron-speci?ccontributionofthesuperiorcolliculustoovertandcovertshiftsofattention.NatNeurosci.7:56--64.
	IttiL,KochC(2000)Asaliency-basedsearchmechanismforovertandcovertshiftsofvisualattention.VisionRes40:1489--1506.
	KapadiaMK,WestheimerG,GilbertCD(2000)Spatialdistributionofcontextualinteractionsinprimaryvisualcortexandinvisualperception.JNeurophysiol84:2048--2062.
	KirklandKL,GersteinGL(1999)Afeedbackmodelofattentionandcontextdependenceinvisualcorticalnetworks.JComputNeurosci7:255--267.
	KoechlinE,AntonJL,BurnodY(1999)Bayesianinferenceinpopula-tionsofcorticalneurons:amodelofmotionintegrationandsegmentationinareaMT.BiolCybern80:25--44.
	KnoblauchA,PalmG.(2002)Scenesegmentationbyspikesynchroni-zationinreciprocallyconnectedvisualareas.II.Globalassembliesandsynchronizationonlargerspaceandtimescales.BiolCybern.87:168--184.
	LeonardsU,SunaertS,VanHeckeP,OrbanGA(2000)Attentionmechanismsinvisualsearch?anfMRIstudy.JCognNeurosci12(suppl):61--75.
	LiZ(2002)Asaliencymapinprimaryvisualcortex.TrendsCognSci6:9--16.
	LuckSJ,ChelazziL,HillyardSA,DesimoneR(1997)MechanismsofspatialselectiveattentioninareasV1,V2andV4ofmacaquevisualcortex.JNeurophysiol77:24--42.
	MallotHA,vonSeelenW,GiannakopoulosF(1990)Neuralmappingandspace-variantimageprocessing.NeuralNetworks3:245--263.
	McAdamsCJ,MaunsellJH(1999)Effectsofattentiononorientation-tuningfunctionsofsingleneuronsinmacaquecorticalareaV4.JNeurosci19:431--441.
	MillerEK,CohenJD(2001)Anintegrativetheoryofprefrontalcortexfunction.AnnuRevNeurosci24:167--202.
	MillerEK,LiL,DesimoneR(1993)Activityofneuronsinanteriorinferiortemporalcortexduringashort-termmemorytask.JNeuro-sci13:1460--1478.
	MillerEK,EricksonCA,DesimoneR(1996)Neuralmechanismsofvisualworkingmemoryinprefrontalcortexofthemacaque.JNeurosci16:5154--5167.
	MooreT(1999)Shaperepresentationsandvisualguidanceofsaccadiceyemovements.Science285:1914--1917.
	MooreT,FallahM(2001)Controlofeyemovementsandspatialattention.ProcNatlAcadSciUSA98:1273--1276.
	MooreT,ArmstrongKM(2003)Selectivegatingofvisualsignalsbymicrostimulationoffrontalcortex.Nature421:370--373.
	MumfordD(1992)Onthecomputationalarchitectureoftheneocortex.II.Theroleofcortico-corticalloops.BiolCybern66:241--251.
	MurthyA,ThompsonKG,SchallJD(2001)Dynamicdissociationofvisualselectionfromsaccadeprogramminginfrontaleye?eld.JNeurophysiol86:2634--2637.
	NothdurftHC,GallantJL,VanEssenDC(1999)ResponsemodulationbytexturesurroundinprimateareaV1:correlatesof?popout?underanesthesia.VisNeurosci16:15--34.
	OlhausenB,AndersonC,vanEssenD(1993)Aneurobiologicalmodelofvisualattentionandinvariantpatternrecognitionbasedondynamicroutingofinformation.JNeurosci13:4700--4719.
	PalmerJ(1995)Attentioninvisualsearch:distinguishingfourcausesofset-sizeeffects.CurrDirPsycholSci4:118--123.
	PosnerMI,DehaeneS(1994)Attentionalnetworks.TrendsNeurosci17:75--79.
	ReynoldsJH,ChelazziL,DesimoneR(1999)Competetivemechanismsub-serveattentioninmacaqueareasV2andV4.JNeurosci19:1736--1753.
	ReynoldsJH,PasternakT,DesimoneR(2000)AttentionincreasessensitivityofV4neurons.Neuron26:703--714.
	RiesenhuberM,PoggioT(1999)Hierarchicalmodelsofobjectrecognitionincortex.NatNeurosci2:1019--1025.
	RocklandKS,vanHoesenGW(1994)Directtemporal-occipitalfeed-backconnectionstostriatecortex(V1)inthemacaquemonkey.CerebCortex4:300--313.
	RocklandKS,SaleemKS,TanakaK(1994)Divergentfeedbackcon-nectionsfromareasV4andTEOinthemacaque.VisNeurosci11:579--600.
	SalinasE,AbbottLF(1997)Invariantvisualresponsesfromattentionalgain?elds.JNeurophysiol77:3267--3272.
	SatoT,SchallJD(2001)Pre-excitatorypauseinfrontaleye?eldresponses.ExpBrainRes139:53--58.
	SatoTR,SchallJD(2003)Effectsofstimulus-responsecompatibilityonneuralselectioninfrontaleye?eld.Neuron38:637--648.
	SatoT,MurthyA,ThompsonKG,SchallJD(2001)Searchef?ciencybutnotresponseinterferenceaffectsvisualselectioninfrontaleye?eld.Neuron30:583--591.
	SchallJD(1995)Neuralbasisofsaccadetargetselection.RevNeurosci6:63--85.
	SchallJD(2002)Theneuralselectionandcontrolofsaccadesbythefrontaleye?eld.PhilTransRSocLondB357:1073--1082.
	SchallJD,MorelA,KingDJ,BullierJ(1995a)Topographyofvisualcortexconnectionswithfrontaleye?eldinmacaque:convergenceandsegregationofprocessingstreams.JNeurosci15:4464--4487.
	SchallJD,HanesDP,ThompsonKG,KingDJ(1995b)Saccadetargetselectioninfrontaleye?eldofmacaque.I.Visualandpremovementactivation.JNeurosci15:6905--6918.
	ShaoZ,BurkhalterA(1999)RoleofGABABreceptor-mediatedin-hibitioninreciprocalinterarealpathwaysofratvisualcortex.JNeurophysiol81:1014--1024.
	SommerMA,WurtzRH(2000)Compositionandtopographicorganiza-tionofsignalssentfromthefrontaleye?eldtothesuperiorcolliculus.JNeurophysiol83:1979--2001.
	StantonGB,BruceCJ,GoldbergME(1993)Topographyofprojectionstothefrontallobefromthemacaquefrontaleye?elds.JCompNeurol330:286--301.
	StantonGB,BruceCJ,GoldbergME(1995)Topographyofprojectionstoposteriorcorticalareasfromthemacaquefrontaleye?elds.JCompNeurol353:291--305.
	StantonGB,GoldbergME,BruceCJ(1988)Frontaleye?eldefferentsinthemacaquemonkey:I.Subcorticalpathwaysandtopographyofstriatalandthalamicterminal?elds.JournalofComparativeNeurol-ogy271:473--492.
	TanakaK,SaitoHA,FukadaY,MoriyaM(1991)Codingvisualimagesofobjectsintheinferotemporalcortexofthemacaquemonkey.JNeurophysiol66:170--189.
	TanjiJ,HoshiE(2001)Behavioralplanningintheprefrontalcortex.CurrOpinNeurobiol11:164--170.
	ThompsonKG,SchallJD(2000)Antecedentsandcorrelatesofvisualdetectionandawarenessinmacaqueprefrontalcortex.VisionRes40:1523--1538.
	ThompsonKG,BichotNP,SchallJD(1997)Dissociationofvisualdiscriminationfromsaccadeprogramminginmacaquefrontaleye?eld.JNeurophysiol77:1046--1050.
	ToliasAS,MooreT,SmirnakisSM,TehovnikEJ,SiapasAG,SchillerPH(2001)Eyemovementsmodulatevisualreceptive?eldsofV4neurons.Neuron29:757--767.
	TomitaH,OhbayashiM,NakaharaK,HasegawaI,MiyashitaY(1999)Top-downsignalfromprefrontalcortexinexecutivecontrolofmemoryretrieval.Nature401:699--703.
	TononiG,SpornsO,EdelmanG(1992)Reentryandtheproblemofintegratingmultiplecorticalareas:Simulationofdynamicintegrationinthevisualsystem.CerebCortex2:310--335.
	TreismanA,GeladeG(1980)Afeatureintegrationtheoryofattention.CognPsychol12:97--136.
	TreismanA,SatoS,(1990)Conjunctionsearchrevisited.JExpPsycholHumPerceptPerform16:459--478.
	TreueS,MaunsellJH(1999)Effectsofattentionontheprocessingofmotioninmacaquemiddletemporalandmedialsuperiortemporalvisualcorticalareas.JNeurosci19:7591--7602.
	TreueS,Mart?ï¿½nezTrujilloJC(1999)Feature-basedattentionin?uencesmotionprocessinggaininmacaquevisualcortex.Nature399:575--579.
	TsotsosJK,CulhaneSM,WaiW,LaiY,DavisN,Nu?oF(1995)Modelingvisualattentionviaselectivetuning.Arti?cialIntelligence78:507--545.
	UsherM,NieburE(1996)ModelingthetemporaldynamicsofITneuronsinvisualsearch:amechanismfortop-downselectiveattention.JCognNeurosci8:311--327.
	WebsterMJ,BachevalierJ,UngerleiderLG(1994)ConnectionsofinferiortemporalareasTEOandTEwithparietalandfrontalcortexinmacaquemonkeys.CerebCortex4:470--483.
	WhiteIM,WiseSP(1999)Rule-dependentneuronalactivityintheprefrontalcortex.ExpBrainRes126:315--335.
	WoodmanGF,LuckSJ(1999)Electrophysiologicalmeasurementofrapidshiftsofattentionduringvisualsearch.Nature400:867--869.
	WolfeJ(1994)Guidedsearch2.0Arevisedmodelofvisualsearch.PsychonomBullRev1:202--238.
106.full.pdf	28
	1.FalkS,KrishnanJ,MeisJM.Primaryan-giosarcomaofthespleen:aclinicopatho-logicstudyof40cases.AmJSurgPathol1993;17:959?970.
	2.NeuhauserTS,DerringerGA,ThompsonLD,etal.Splenicangiosarcoma:aclinico-pathologicandimmunophenotypicstudyof28cases.ModPathol2000;13:978?987.
	3.MorteleKJ,MergoPJ,KunnenM,RosPR.Tumoralpathologyofthespleen.In:De-SchepperAM,VanhoenackerF,eds.Med-icalimagingofthespleen.Berlin,Ger-many:Springer-Verlag,2000;115?116.
	4.ArbonaGL,LloydTV,LucasJ,SharmaHM.Computedtomographicdemonstra-tionofangiosarcomaofthespleen.SouthMedJ1982;75:348?350.
	5.MahonyB,JeffreyRB,FederleMP.Spon-taneousruptureofhepaticandsplenicangiosarcomademonstratedbyCT.AJRAmJRoentgenol1982;138:965?966.
	6.NahmanB,CunninghamJJ.Sonographyofsplenicangiosarcoma.JClinUltra-sound1985;13:354?356.
	7.WafulaJM.UltrasoundandCTdemon-strationofprimaryangiosarcomaofthespleen.BrJRadiol1985;58:903?907.
	8.KanekoK,OnitsukaH,MurakamiJ,etal.MRIofprimaryspleenangiosarcomawithironaccumulation.JComputAssistTo-mogr1992;16:298?300.
	9.FerrozziF,BovaD,DraghiF,GarlaschiG.CTfindingsinprimaryvasculartumorsofthespleen.AJRAmJRoentgenol1996;166:1097?1101.
	10.KinoshitaT,IshiiK,YajimaY,SakaiN,NaganumaH.Splenichemangiosarcomawithmassivecalcification.AbdomImag-ing1999;24:185?187.
	11.VrachliotisTG,BennettWF,VaswaniKK,NiemannTH,BovaJG.Primaryangiosar-comaofthespleen:CT,MRIandsono-graphiccharacteristics?reportoftwocases.AbdomImaging2000;25:283?285.
	12.KarakasHM,DemirM,OzyilmazF,CakirB.Primaryangiosarcomaofthespleen:invivoandinvitroMRIfindings.ClinIm-aging2001;25:192?196.
	13.RabushkaLS,KawashimaA,FishmanEK.Imagingofthespleen:CTwithsupple-mentalMRexamination.RadioGraphics1994;14:307?332.
	14.IshibashiH,HiguchiN,ShimamuraR,HirataY,KudoJ,NihoY.Sonographicassessmentandgradingofspleensize.JClinUltrasound1991;19:21?25.
	15.DachmanAH.Spleen:normalanatomyandexaminationtechniques.In:GoreRM,LevineMS,eds.Textbookofgastro-intestinalradiology.Philadelphia,Pa:Saunders,2000;1849.
	16.PrassopoulosP,DaskalogiannakiM,Rais-sakiM,HatjidakisA,GourtsoyiannisN.Determinationofnormalsplenicvolumeoncomputedtomographyinrelationtoage,genderandbodyhabitus.EurRadiol1997;7:246?248.
	17.GlazerGM,AxelL,GoldbergHI,MossAA.DynamicCTofthenormalspleen.AJRAmJRoentgenol1981;137:343?346.
	18.MilesKA,McPhearsonSJ,HaybalMP.TransientsplenicinhomogeneitywithcontrastenhancedCT:mechanismandeffectofliverdisease.Radiology1995;194:91?95.
	19.WarnkeRA,WeissLM,ChanJK,ClearyML,DorfmanRF.Atlasoftumorpathol-ogy:tumorsofthelymphnodesandspleen.Washington,DC:ArmedForcesInstituteofPathology,1995.
	20.RosPR,MoserRPJr,DachmanAH,Mu-rariPJ,OlmstedWW.Hemangiomaofthespleen:radiologic-pathologiccorrela-tionintencases.Radiology1987;162:73?77.
	21.RamaniM,ReinholdC,SemelkaRC,etal.Splenichemangiomasandhamartomas:MRimagingcharacteristicsof28lesions.Radiology1997;202:166?172.
	22.LevyAD,AbbottRM,AbbondanzoSL.Littoralcellangiomaofthespleen:CTfeatureswithclinicopathologiccompari-son.Radiology2004;230:485?490.
	23.Oliver-GoldaracenaJM,BlancoA,MirallesM,Martin-GonzalezMA.Littoralcellangiomaofthespleen:USandMRimagingfindings.AbdomImaging1998;23:636?639.
	24.TiuCM,ChouYH,WangHT,ChangT.Epithelioidhemangioendotheliomaofspleenwithintrasplenicmetastasis:ultra-soundandcomputed-tomographyap-pearance.ComputMedImagingGraph1992;16:287?290.
	25.VilanovaJC,CapdevilaA,AldomaJ,Del-gadoE.Splenicepithelioidhemangioma:MRfindings.AJRAmJRoentgenol1994;163:747?748.
	26.HeeseJ,BocklageT.Specimenfine-needleaspirationcytologyoflittoralcellangi-omawithhistologicandimmunohisto-chemicalconfirmation.DiagnCyto-pathol2000;22:39?44.
	27.LuceyBC,BolandGW,MaherMM,HahnPF,GervaisDA,MuellerPR.Percutaneousnonvascularsplenicintervention:a10-yearreview.AJRAmJRoentgenol2002;179:1591?1596.
	28.KeoganMT,FreedKS,PaulsonEK,NelsonRC,DoddLG.Imaging-guidedpercutane-ousbiopsyoffocalspleniclesions:updateonsafetyandeffectiveness.AJRAmJRoentgenol1999;172:933?937.
371.full.pdf	33
	AnsahG&BucklandR1982Geneticvariationinfowlsemencholes-terolandphospholipidlevelsandtherelationshipoftheselipidswithfertilityoffrozen?thawedandfreshsemen.PoultryScience92604?615.
	BlancoJM,GeeG,WildtDE&DonoghueAM2000Speciesvari-ationsinosmotic,cryoprotectantandcoolingratetoleranceinpoultry,eagle,andperegrinefalconspermatozoa.BiologyofReproduction631164?1171.
	BlesboisE,LessireM&HermierD1997Effectofcryopreservationanddietonlipidsoffowlspermandfertility.PoultryandAvianBi-ologyReviews8149?154.
	BlesboisE&GrasseauI2001Seminalplasmaaffectsliquidstorageandcryopreservationofturkeysperm.InCryo2001,38thMeetingoftheSocietyforCryobiology,p103.London:SocietyforCryo-biology.
	BlesboisE&HermierD2003Specificityoffattyacidsindomesticbirdsspermatozoa.InPhospholipidsandMaleFertility,ch7,pp73?85.Ed.SDeVriese.ChampaignIL:AmericanOilChemist?sSocietyPress.
	BlesboisE&Labbeï¿½C2003Mainimprovementsinsemenandembryocryopreservationforfishandfowl.InCryopreservationofAnimalGeneticResourcesinEurope,pp55?66.Ed.DPlanchenault.Paris,France:BureaudesRessourcesGeï¿½neï¿½tiques.
	BlighE&DyerW1959Arapidmethodoftotallipidextractionandpurification.CanadianJournalofBiochemicalPhysiology37911?917.
	BlomE1950Live-deadspermstainbymeansofeosin-nigrosinsmears.FertilityandSterility1176?177.
	BurrowsW&QuinnsJ1936Thecollectionofspermatozoafromthedomesticfowlandturkey.PoultryScience408?10.
	CrossNL1998Roleofcholesterolinspermcapacitation.BiologyofReproduction597?11.
	CrossNL2003Decreaseinorderofhumanspermlipidsduringcapacitation.BiologyofReproduction69529?534.
	CrossNL2004Reorganizationoflipidraftsduringcapacitationofhumanspermatozoa.BiologyofReproduction711367?1373.
	EtchesR1996Themale.InReproductioninPoultry,pp208?233.NewYork,USA:CABInternational.
	DohnerJV2001Theencyclopaediaofhistoricandendangeredlive-stockandpoultrybreeds.NewHaven,CT,USA:Yaleuniversitypress.
	DouardV,HermierD&BlesboisE2000Changesinturkeysemenlipidsduringliquidinvitrostorage.BiologyofReproduction631450?1456.
	GiraudNM,MottaC,BoucherD&GrizardG2000Membranefluiditypredictstheoutcomeofcryopreservationofhumanspermatozoa.HumanReproduction152160?2164.
	Hinkovska-GalchevaV&SrivastavaPN1993Phopsholipidsofrabbitandbullspermmembranes:structuralorderparameterandsteady-statefluorescenceanisotropyofmembranesandmembraneleaflets.MolecularReproductionandDevelopment35209?217.
	HammerstedtRH1995CryopreservationofPoultrySemen?CurrentStatusandEconomics.InProceedingsFirstInternationalSymposiumontheArtificialInseminationofPoultry,pp229?250.Savoy,Illinois,USA:PoultryScienceAssociation.
	HoltWV2000Fundamentalaspectsofspermcryobiology:theimportanceofspeciesandindividualdifferences.Theriogenology5347?58.
	KelsoKA,CeroliniS,NobleRC,NobleRC&SpeakeBK1997Lipidandantioxidantchangesinsemenofbroilerfowlfrom25to60weeksold.JournalofReproductionandFertility106201?206.
	Labbeï¿½C,BlesboisE,LeboeufB,GuillouetP,StradaioliG&MagistriniM2002Technologiedelaconservationduspermechezplusieursverteï¿½breï¿½sdomestiques:protectiondeslipidesmembra-naires,inteï¿½griteï¿½dunoyaueteï¿½largissementdesmeï¿½thodes.InCongre`sduBureaudesRessourcesGeï¿½neï¿½tiques,pp25?33.France:LaCha?tre.
	LadhaS1998Lipidheterogeneityandmembranefluidityinahighlypolarizedcell,themammalianspermatozoon.JournalofMem-braneBiology1651?10.
	MassipA,LeiboSP&BlesboisE2004Cryobiologyandthebreedingofdomesticanimals.InLifeintheFrozenState,pp371?393.EdsEBenson,BFuller&NLane.London,UK:Taylor&FrancisGroup.
	SaintJalmeM,LecoqR,SeigneurinF,BlesboisE&PlouzeauE2003Cryopreservationofsemenfromendangeredpheasants:thefirststeptowardscryobankforendangeredavianspecies.Theriogenol-ogy59875?888.
	SextonT1982Beltsvillepoultrysemenextender6holdingturkeysemenforsixhoursat158C.PoultryScience611202?1208.
	ShinitzkyM&YuliI1982Lipidfluidityatthesubmacroscopicallevel:determinationbyfluorescencepolarization.BiochimicaBio-physicalActa515367?394.
	SimonsK&IkonenE1997Functionalraftsincellmembranes.Nature387569?572.
	Sura?ï¿½PF&WishartGJ1996Poultryartificialinseminationtechnol-ogyinthecountriesoftheformerUSSR.World?sPoultryScienceJournal5227?43.
	SuraiPF,BlesboisE,GrasseauI,ChalahT,BrillardJP,WishartGJ,CeroliniS&SparksNHC1998Fattyacidcomposition,glutathioneperoxidaseandsuperoxidedismutaseactivityandtotalantioxidantactivityofaviansemen.ComparativeBiochemistryandPhysiology120B527?533.
	TajimaA2002Productionofgerm-linechimerasandtheirappli-cationindomesticchicken.AvianandPoultryBiologyReview1315?30.
	TravisA&KopfGS2002Theroleofcholesteroleffluxinregulatingthefertilizationpotentialofmammalianspermatozoa.Thejournalofclinicalinvestigation110731?736.
	TselutinK,NarubinaT,MavrodinaT&TurB1995Cryopreservationofpoultrysemen.BritishPoultryScience36805?811.
	TselutinK,SeigneurinF&BlesboisE1999Comparisonofcryopro-tectantsandmethodsofcryopreservationoffowlspermatozoa.PoultryScience78586?590.
283.full.pdf	32
	AbaigarT,HoltWV,HarrisonRA&delBarrioG1999Spermsub-populationsinboar(Susscrofa)andgazelle(Gazelladamamhorr)semenasrevealedbypatternanalysisofcomputer-assistedmotilityassessments.BiologyofReproduction6032?41.
	AmannRP&KatzDF2004ReflectionsonCASAafter25years.JournalofAndrology25317?325.
	AndersonKE&JacksonSP2003ClassIphosphoinositide3-kinases.InternationalJournalofBiochemistryandCellBiology351028?1033.
	AparicioIM,Garcia-MarinLJ,AndreolottiAG,BodegaG,JensenRT&BragadoMJ2003Hepatocytegrowthfactoractivatesseveraltransductionpathwaysinratpancreaticacini.BiochimicaetBiophysicaActa164337?46.
	BrizMD,BonetS,PinartB,EgozcueJ&CampsR1995Comparativestudyofboarspermcomingfromthecaput,corpus,andcaudaregionsoftheepididymis.JournalofAndrology16175?188.
	duPlessisSS,FrankenDR,BaldiE&LuconiM2004Phosphatidyl-inositol3-kinaseinhibitionenhanceshumanspermmotilityandsperm-zonapellucidabinding.InternationalJournalofAndrology2719?26.
	ErikssonBM,VazquezJM,MartinezEA,RocaJ,LucasX&Rodriguez-MartinezH2001Effectsofholdingtimeduringcoolingandoftypeofpackageonplasmamembraneintegrity,motilityandinvitrooocytepenetrationabilityoffrozen-thawedboarspermatozoa.Theriogenology551593?1605.
	FengH,SandlowJI&SandraA1998Thec-kitreceptoranditspossiblesignalingtransductionpathwayinmousespermatozoa.MolecularReproductionandDevelopment49317?326.
	FerrisHA,TapiaJA,Garc?ï¿½aLJ&JensenRT1999CCKAreceptoractivationstimulatesp130Castyrosinephosphorylation,transloca-tionandassociationwithCrkinratpancreaticacinarcells.Biochemistry381497?1508.
	GadellaBM&HarrisonRA2000ThecapacitatingagentbicarbonateinducesproteinkinaseA-dependentchangesinphospholipidtransbilayerbehaviorinthespermplasmamembrane.Develop-ment1272407?2420.
	GadellaBM&HarrisonRA2002Capacitationinducescyclicadenosine30,50-monophosphate-dependent,butapoptosis-unre-lated,exposureofaminophospholipidsattheapicalheadplasmamembraneofboarspermcells.BiologyofReproduction67340?350.
	GreenCE&WatsonPF2001Comparisonofthecapacitation-likestateofcooledboarspermatozoawithtruecapacitation.Repro-duction122889?898.
	GrossMK,ToscanoDG&ToscanoWAJr1987Calmodulin-mediatedadenylatecyclasefrommammaliansperm.JournalofBiologicalChemistry2628672?8676.
	HarrisonRA2003CyclicAMPsignallingduringmammalianspermcapacitation?stilllargelyterraincognita.ReproductioninDomesticAnimals38102?110.
	HarrisonRA&MillerNG2000cAMP-dependentproteinkinasecontrolofplasmamembranelipidarchitectureinboarsperm.MolecularReproductionandDevelopment55220?228.
	HoltC,HoltWV&MooreHD1996Choiceofoperatingconditionstominimizespermsubpopulationsamplingbiasintheassessmentofboarsemenbycomputer-assistedsemenanalysis.JournalofAndrology17587?596.
	HoltWV&HarrisonRA2002BicarbonatestimulationofboarspermmotilityviaaproteinkinaseA-dependentpathway:between-cellandbetween-ejaculatedifferencesarenotduetodeficienciesinproteinkinaseAactivation.JournalofAndrology23557?565.
	LuconiM,MarraF,GandiniL,FilimbertiE,LenziA,FortiGetal.2001Phosphatidylinositol3-kinaseinhibitionenhanceshumanspermmotility.HumanReproduction161931?1937.
	LuconiM,CarloniV,MarraF,FerruzziP,FortiG&BaldiE2004IncreasedphosphorylationofAKAPbyinhibitionofphosphatidyl-inositol3-kinaseenhanceshumanspermmotilitythroughtailrecruitmentofproteinkinaseA.JournalofCellScience1171235?1246.
	MortimerST2000CASApracticalaspects.JournalofAndrology21515?524.
	NagDasSK,WinfreyVP&OlsonGE2002Identificationofrasanditsdownstreamsignalingelementsandtheirpotentialroleinhamsterspermmotility.BiologyofReproduction671058?1066.
	NaucV,deLamirandeE,LeclercP&GagnonC2004Inhibitorsofphosphoinositide3-kinase,ly294002andwortmannin,affectspermcapacitationandassociatedphosphorylationofproteinsdifferently:Ca(2ï¿½)-dependentdivergences.JournalofAndrology25573?585.
	OkamuraN,TajimaY,SoejimaA,MasudaH&SugitaY1985Sodiumbicarbonateinseminalplasmastimulatesthemotilityofmammalianspermatozoathroughdirectactivationofadenylatecyclase.JournalofBiologicalChemistry2609699?9705.
	Pen?aFJ,JohannissonA,WallgrenM&RodriguezMH2003aAntioxidantsupplementationinvitroimprovesboarspermmotilityandmitochondrialmembranepotentialaftercryopreservationofdifferentfractionsoftheejaculate.AnimalReproductionScience7885?98.
	Pen?aFJ,JohannissonA,WallgrenM&Rodriguez-MartinezH2003bAssessmentoffreshandfrozen-thawedboarsemenusinganannexin-Vassay:anewmethodofevaluatingspermmembraneintegrity.Theriogenology60677?689.
	PonsS,AsanoT,GlasheenE,MiralpeixM,ZhangY,FisherTLetal.1995Thestructureandfunctionofp55PIKrevealanewregulatorysubunitforphosphatidylinositol3-kinase.MolecularandCellularBiology154453?4465.
	Quintero-MorenoA,RigauT&Rodriguez-GilJE2004Regressionanalysesandmotilespermsubpopulationstructurestudyasimprovingtoolsinboarsemenqualityanalysis.Theriogenology61673?690.
	TapiaJA,FerrisHA,JensenRT&GarciaLJ1999CholecystokininactivatesPYK2/CAKbetabyaphospholipaseC-dependentmechan-ismanditsassociationwiththemitogen-activatedproteinkinasesignalingpathwayinpancreaticacinarcells.JournalofBiologicalChemistry2741261?1271.
	TashJS&BrachoGE1994Regulationofspermmotility:emergingevidenceforamajorroleforproteinphosphatases.JournalofAndrology15505?509.
	VijayaraghavanS,MohanJ,GrayH,KhatraB&CarrDW2000Aroleforphosphorylationofglycogensynthasekinase-3alphainbovinespermmotilityregulation.BiologyofReproduction621647?1654.
	WuttkeMS,BuckJ&LevinLR2001Bicarbonate-regulatedsolubleadenylylcyclase.JournalofthePancreas2154?158.
	WymannMP&PirolaL1998Structureandfunctionofphosphoino-sitide3-kinases.BiochimicaetBiophysicaActa1436127?150.
338.pdf	44
	1.Chambers DW, Abrams RG. Dental communication.Norwalk, CT: Appleton-Century-Crofts, 1986.
	2.Grace EG, Sarlani E, Balciunas BA. Referring patientsfor stress-related disorders. Gen Dent 2002;50(6):538-9.
	3.Marzola R, Derbabian K, Donovan TE, Arcidiacono A.The science of communicating the art of esthetic dentistry.Part I: Patient-dentist-patient communication. J EsthetDent 2000;12(3):131-8.
	4.Sarnat H, Arad P, Hanauer D, Shohami E. Communica-tion strategies used during pediatric dental treatment: apilot study. Pediatr Dent 2001;23(3):337-41.
	5.Sondell K, Soderfeldt B, Pamqvist S. Dentist-patient com-munication and patient satisfaction in prosthetic dentistry.Int J Prosthod 2002;15(1):28-37.
	6.Rogers CR. Client centered therapy: its current practice,implications, and theory. Boston: Houghton Mifflin, 1951.
	7.Hojat M, Gonnella JS, Nasca TJ, Mangione S, VergareM, Magee M. Physician empathy: definition, components,measurement, and relationship to gender and specialty.Am J Psychol 2002;159:1563-9.
	8.Hojat M, Gonnella JS, Mangione S, Nasca TJ, Magee M.Physician empathy in medical education and practice:experience with the Jefferson Scale of Physician Empa-thy. Semin Integrative Med 2003;1:25-41.
	9.Stephan WG, Finlay KA. The role of empathy in improv-ing inter-groups relations. J Social Issues 1999;55:729-43.
	10.Colliver JA, Willis MS, Robbs RS, Cohen DS, SchartzMH. Assessment of empathy in a standardized-patientexamination. Teach Learn Med 1998;10:8-11.
	11.Suchman LA, Roter D, Green M, Lipkin M. Physiciansatisfaction with primary care office visits: collaborativestudy group of the American Academy of Physician andPatient. Med Care 1993;31:1083-92.
	12.Avery JK. Lawyers tell what turns some patients litigious.Med Malpractice Rev 1985;2:35-7.
	13.Beckman GB, Markakis KM, Suchman AL, Frankel RM.The doctor-patient relationship and malpractice: lessonsfrom plaintiff depositions. Arch Intern Med 1994;154:1365-70.
	14.Hickson GB, Clayton EW, Entman SS, Miller CS,Ginthens PB, Whetten-Goldstein K, Sloan FA. Obstetri-cians? prior malpractice experience and patients? satisfac-tion with care. JAMA 1994;272:1583-7.
	15.Levinson W. Physician-patient communication: a key tomalpractice prevention. JAMA 1994;273:1619-20.
	16.Squier RW. A mode of empathic understanding and ad-herence to treatment regimens in practitioner-patient re-lationships. Social Science Med 1990;30:325-39.
	17.Schouten BC, Eijkman MA, Hoogstraten J. Dentists andpatients communicative behavior. Community DentHealth 2003;20(1):11-5.
	18.Weinstein P, Getz T, Ratener P, Domoto P. Dentists? re-sponses to fear and non-fear related behaviors in children.J Am Dent Assoc 1982;104:38-40.
	19.Kleinknecht RA, Klepac RK, Alexander LD. Origins andcharacteristics of fear of dentistry. J Am Dent Assoc1973;86(4):842-8.
	20.Laskin DM, Greene CS. Influence of the doctor-patientrelationship on placebo therapy for patients withmyofascial pain-dysfunction (MPD) syndrome. J Am DentAssoc 1972;85(4):892-4.
	21.Sinha PK, Nanda RS, McNeil DW. Perceived orthodon-tist behaviors that predict patient satisfaction,orthodondist-patient relationship, and patient adherencein orthodontic treatment. Am J Orthod Dentofac Orthoped1996;110(4):370-6.
	22.Corah NL, O?Shea RM, Bissell GD. The dentist-patientrelationship: perceived dentist behaviors that reduce pa-tient anxiety and increase satisfaction. J Am Dent Assoc1988;116:73-6.
	23.Association of American Medical Colleges. Report I:learning objectives for medical student education-guide-lines for medical school. Acad Med 1999;74:13-8.
	24.American Dental Education Association. Competenciesfor the new dentist. J Dent Educ 2002;66(7):849-51.
	25.Evans BJ, Stanley RO, Burrows GD. Measuring medicalstudents? empathy skills. Br J Med Psychol 1993;66(2):121-33.
	26.Hojat M, Gonnella JS, Mangione S, Nasca TJ, Veloski JJ,Erdmann JB, et al. Empathy in medical students as re-lated to academic performance, clinical competence, andgender. Med Educ 2002;36:522-7.
	27.Hojat M, Mangione S, Nasca TJ, Cohen MJM, GonnellaJS, Erdmann JB, Veloski J. The Jefferson scale of empa-thy: development and preliminary psychometric data.Educ Psychol Meas 2001;61:349-65.
	28.Babbie E. Survey research methods. 2nd ed. Belmont,CA: Wadsworth Publishing Co., 1990:182.
	29.Hojat M, Gonnella JS, Nasca TJ, Mangione S, Veloski JJ,Magee M. The Jefferson scale of physician empathy: fur-ther psychometric data and difference by gender and spe-cialty at item level. Acad Med 2002;77(10):58-60.
	30.Shugars DA, Bader JD, O?Neil EH. Attitudes of dentiststoward emerging competencies for health care practitio-ners. J Dent Educ 1992;56:640-5.
	31.At: www.dental.washington.edu/sodoc. Accessed: Sep-tember 2004.
	32.Kaiser HF. An index of factoral simplicity. Psychometrika1974;39:31-6.
	33.Cattell RB. The scree test for the number of factors.Multivar Behav Res 1966;1:245-76.
	34.Diseker RA, Michielutte R. An analysis of empathy inmedical students before and following clinical experi-ences. J Med Educ 1981;56:1004-10.
	35.Hojat M, Mangione S, Nasca TJ, Rattner S, Erdmann JB,Gonnella JS, Magee M. An empirical study of decline inempathy in medical school. Med Educ 2004;38:934-41.
	36.Bellini LM, Baime M, Shea JA. Variation of mood andempathy during internship. JAMA 2002;287:3143-6.
	37.Mangione S, Kane GC, Caruso JW, Gonnella JS, NascaTJ, Hojat M. Assessment of empathy in different years ofinternal medicine training. Med Teacher 2002;24:371-4.
	38.Marcus ER. Psychodynamic social science and medicaleducation. J Psychother Pract Res 1999;8(3):191-4.
	39.Feighny KM, Arnold L, Monaco M, Munro S, Earl B. Inpursuit of empathy and its relationship to physician com-munication skills: multidimensional empathy training formedical students. Ann Behav Sci Med Educ 1998;5:13-21.
	40.Kramer D, Ber R, Moore M. Impact of workshop on stu-dents? and physicians? rejecting behaviour in patient in-terviews. J Med Educ 1987;62:904-10.
	41.Winefield HR, Chur-Hansen A. Evaluating the outcomeof communication skill teaching for entry-level medicalstudents: does knowledge of empathy increase? Med Educ2000;34(2):90-4.
	42.Mofidi M, Strauss R, Pitner LL, Sandler ES. Dental stu-dents? relection on their community-based experiences:the use of critical incidents. J Dent Educ 2003;67(5):515-23.
	43.Nestel D, Betson C. An evaluation of a communicationskills workshop for dentists: cultural and clinical relevanceof the patient-centred interview. Br Dent J 1999;187:385-8.
	44.Wiltshire AD, Ross MW, Brimlow DL. Empathetic com-munication between dental professionals and persons liv-ing with HIV and AIDS. J Dent Educ 2002;66(1):86-93.
92-6602316a.pdf	44
	Andreï¿½F,SchartzNE,ChaputN,FlamentC,RaposoG,AmogorenaS,AngevinE,ZitvogelL(2002a)Tumour-derivedexosomes:anewsourceoftumourrejectionantigens.Vaccine20:A28?A31
	Andreï¿½F,SchartzNEC,MovassaghM,FlamentC,PautierP,MoriceP,PomelC,LhommeC,EscudierB,LeChevalierT,TurszT,AmigorenaS,RaposoG,AngevinE,ZitvogelL(2002b)Malignanteffusionsandimmunogenictumour-derivedexosomes.Lancet360:295?305
	BrownR,ClugstonC,BurnsP,EdlinA,VaseyP,VojtesekB,KayeSB(1993)Increasedaccumulationofp53proteinincisplatin-resistantovariancelllines.IntJCancer55:678?684
	ChaputN,SchartzNE,Andreï¿½F,ZitvogelL(2003)Exosomesforimmunotherapyofcancer.AdvExpMedBiol532:215?221
	ChaputN,TaiebJ,SchartzNEC,AndreF,AngevinE,ZitvogelL(2004)Exosome-basedimmuno-therapy.CancerImmunolImmunother53:234?239
	DenzerK,KleijmeerMJ,HeijnenHFG,StoorvogelW,GeuzeHJ(2000)Exosome:frominternalvesicleofthemultivesicularbodytointercellularsignalingdevice.JCellSci113:3365?3374
	Gercï¿½el-TaylorC,BazzettLB,TaylorDD(2001)Presenceofaberranttumour-reactiveimmunoglobulinsinthecirculationofpatientswithgynecologicmalignancies.GynecolOncol81:71?76
	Gercï¿½el-TaylorC,O?ConnorSM,LamGK,TaylorDD(2002)ShedmembranefragmentmodulationofCD3-zduringpregnancy:linkwithinductionofapoptosis.JReprodImmunol56:29?44
	GibbRK,TaylorDD,WanT,O?ConnorDM,DoeringDL,Gercï¿½el-TaylorC(1997)Apoptosisasameasureofcheomsensitivitytocisplatinandtaxoltherapyinovariancancercelllines.GynecolOncol65:13?22
	GoldsmithJD,PawelB,GoldblumJR,PashaTL,RobertsS,NelsonP,KhuranaJS,FredericG,ZhangPJ(2002)Detectionanddiagnosticutilizationofplacentalalkalinephosphataseinmusculartissueandtumourswithmyogenicdifferentiation.AmJSurgPathol26:1627?1633
	GravesLE,AriztiaEV,NavariJR,MatzelHJ,StackMS,FishmanDA(2004)Preinvasivepropertiesofovariancancerascites-derivedmembranevesicles.CancerRes64:7045?7049
	GreenDR,DroinN,PinkoskiM(2003)Activation-inducedcelldeathinTcells.ImmunolRev193:70?81
	HeijnenHFG,SchielAE,FijnheerR,GeuzeHJ,SixmaJJ(1999)Activatedplateletsreleasetwotypesofmembranevesicles:microvesiclesbysurfacesheddingandexosomesderivedfromexocytosisofmultivesicularbodiesandalphagranules.Blood94:3791?3799
	JohnstoneRM,AdamM,HammondJR,OrrL,TurbideC(1987)Vesicleformationduringreticulocytematuration.Associationofplasmamembraneactivateswithreleasedvesicles(exosomes).JBiolChem262:9412?9420
	KatsanisWA,ShieldsLBE,SpinnatoJA,Gercï¿½el-TaylorC,TaylorDD(1998)Immunerecognitionofendometrialtumourantigensinducedbymultiparity.GynecolOncol70:33?39
	KimJV,LatoucheJB,Rivieï¿½reI,SadelainM(2004)TheABCsofartificialantigenpresentation.NatBiotechnol22:403?410
	LaemmliUK(1970)Cleavageofstructuralproteinsduringtheassemblyoftheheadofbacterio-phageT4.Nature227:680?685
	Martinez-LorenzoMJ,AnelA,GamenS,MonleNI,LasierraP,LarradL,PineiroA,AlavaMA,NavalJ(1999)ActivatedhumanTcellsreleasebioactiveFasligandandAPO2ligandinmicrovesicles.J.Immunol163:1274?1281
	PanBT,TengK,WuC,AdamM,JohnstoneRM(1985)Electronmicroscopicevidenceforexternalizationofthetransferringreceptorinvesicularforminsheepreticulocytes.JCellBiol101:942?948
	PeltonJJ,TaylorDD,FowlerWC,TaylorCG,CarpNZ,WeeseJL(1991)Lymphokineactivatedkiller(LAK)cellsuppressorfactorinmalignanteffusions.ArchSurg126:476?480
	PoutsiakaDD,SchroderEW,TaylorDD,LevyEM,BlackPH(1985a)ShedmembranevesiclesfrommurinemelanomacellsselectivelyinhibittheexpressionofIaantigensbymacrophages.JImmunol134:138?144
	PoutsiakaDD,TaylorDD,LevyEM,BlackPH(1985b)Inhibitionofrecombinantinterferon-gammainducedIaantigenexpression.JImmunol134:145?150
	RabinowichH,ReichertTE,KashiiY,GastmanBR,BellMC,WhitesideTLcarcinomacells:implicationsforalteredexpressionofTcellreceptorintumourassociatedlymphocytes.JClinInvest101:2579?2588
	RaposoG,NijmanHW,StoorvogelW,LiejendekkerR,HardingCV,MeliefCJ,GeuzeHJ(1996)Blymphocytessecreteantigen-presentingvesicles.JExpMed183:1161?1172
	RaposoG,TenzaD,MecheriS,PeronetR,BonnerotC,DesaymardC(1997)mastcellsecretorygranulesandtheirreleaseupondegranulation.MolBiolCell8:2631?2645
	ShigenariA,AndoA,BabaT,YamamotoT,KatsuokaY,InokoH(1998)CharacterizationofalkalinephosphatasegenesexpressedinseminomabycDNAcloning.CancerRes58:5079?5082
	StoorvogelW,KleijmeerMJ,GeuzeHJ,RaposoG(2002)Thebiogenesisandfunctionsofexosomes.Traffic3:321?330
	TaylorDD,BlackPH(1985)InhibitionofmacrophageIaantigenexpressionbyshedplasmamembranevesiclesfrommetastaticmurinemelanomalines.JNatlCancerInst74:859?867
	TaylorDD,BlackPH(1986)Sheddingofplasmamembranefragments:neoplasticanddevelopmentalimportance.InDevelopmentalBiology,Vol.3,SteinbergMS(ed)pp33?57.NewYork:PlenumPress
	TaylorDD,BlackPH(1987)Neoplasticanddevelopmentalimportanceofplasmamembranevesicles.AmerZool26:411?415
	TaylorDD,ChouIN,BlackPH(1983a)Isolationofplasmamembranefragmentsfromculturedmurinemelanomacells.BiochemBiophysResComm113:470?476
	TaylorDD,DoellgastGJ(1979)Quantitationofperoxidase-antibodybindingtomembranefragmentsusingcolumnchromatography.AnalBiochem98:53?59
	TaylorDD,Gercï¿½el-TaylorC,GallSA(1996)ExpressionandsheddingofCD44isoformsbygynecologiccancerpatients.JSocGynecolInvest3:289?294
	TaylorDD,Gercï¿½el-TaylorC,JiangCG,BlackPH(1988)Characterizationofplasmamembranesheddingfrommurinemelanomacells.IntJCancer41:629?635
	TaylorDD,Gercï¿½el-TaylorC,LyonsKS,StansonJ,WhitesideTL(2003)SuppressionofTcR/CD3-zbyshedmembranevesiclesfromovariantumours.ClinCancerRes9:5113?5119
	TaylorDD,Gercï¿½el-TaylorC,WeeseJL(1989)Expressionandsheddingofmdr-1antigenbyvariantsofthemurineB16melanoma.SurgForum40:406?408
	TaylorDD,HomesleyHD,DoellgastGJ(1980)Bindingofspecificperoxidase-labeledantibodytoplacental-typealkalinephosphataseontumour-derivedmembranefragments.CancerRes40:4064?4069
	TaylorDD,HomesleyHD,DoellgastGJ(1984)Identificationofcompo-nentsresponsiblefortheautologoushumoralresponsesofovariancancerpatients.AmJReprodImmunol6:179?184
	TaylorDD,HomesleyHD,DoellgastGJ(1983b)Membrane-associatedimmunoglobulinsincystandascitesfluidsofovariancancerpatients.AmJReprodImmunol3:7?11
	TaylorDD,LyonsKS,Gercï¿½el-TaylorC(2002)Shedmembranefragment-associatedmarkersforendometrialandovariancancers.GynecolOncol84:443?448
	Theï¿½ryC,RegnaultA,GarinJ,WolfersJ,ZitvogelL,Ricciardi-CastagnoliP,RaposoG,AmigorenaS(1999)Molecularcharacterizationofdendriticcell-derivedexosomes.Selectiveaccumulationoftheheatshockproteinhsc73.JCellBiol147:599?610
	Theï¿½ryC,ZitvogelL,AmigorenaS(2002)Exosomes:composition,biogenesis,andfunction.NatRevImmunol2:569?579
	WhitesideTL(2002)Tumour-induceddeathofimmunecells:Itsmechanismsandconsequences.SemCancerBiol12:43?50
	WolfersJ,LozierA,RaposoG,RegnaultA,Theï¿½ryC,MasurierC,FlamentC,PouzieuxS,FaureF,TurszT,AngevinE,AmogorenaS,ZitvogelL(2001)Tumour-derivedexosomesareasourceofsharedtumourrejectionantigensforCTLcross-priming.NatMed7:297?303
92-6602323a.pdf	19
	BerrinoF,CapocacciaR,ColemanMP,Este`veJ,GattaG,HakulinenT,MicheliA,SantM,VerdecchiaA(eds.)(2003)SurvivalofcancerpatientsinEurope:theEUROCARE-3study.AnnOncol14(Suppl5):v1?v155
	BerrinoF,CapocacciaR,Este`veJ,GattaG,HakulinenT,MicheliA,SantM,VerdecchiaA(eds.)(1999)SurvivalofCancerPatientsinEurope:TheEUROCARE-2Study.IARCScientificPublicationsNo.151.Lyon:InternationalAgencyforResearchonCancer
	BerrinoF,SantM,VerdecchiaA,CapocacciaR,HakulinenT,Este`veJ(eds.)(1995)SurvivalofCancerPatientsinEurope:TheEUROCAREStudy.IARCScientificPublicationsNo.132.Lyon:InternationalAgencyforResearchonCancer
	Brenner H, Arndt V, Gefeller O, Hakulinen T (2004a) An alternativeapproach to age adjustment of cancer survival rates. Eur J Cancer 40:2317â€“ 2322
	Brenner H, Gefeller O (1996) An alternative approach to monitoring cancerpatient survival. Cancer 78: 2004â€“2010
	BrennerH,GefellerO(1997)Derivingmoreup-to-dateestimatesoflong-termpatientsurvival.JClinEpidemiol50:211?216
	BrennerH,GefellerO,HakulinenT(2004b)Periodanalysisforup-to-datecancersurvivaldata:theory,empiricalevaluation,computationalrealisationandapplications.EurJCancer40:326?335
	BrennerH,HakulinenT(2002a)Advanceddetectionoftimetrendsinlong-termcancerpatientsurvival:experiencefrom50yearsofcancerregistrationinFinland.AmJEpidemiol156:566?577
	BrennerH,HakulinenT(2002b)Up-to-datesurvivalcurvesofpatientswithcancerbyperiodanalysis.JClinOncol20:826?832
	Brenner H, Rachet B (2004c) Hybrid analysis for up-to-date long-termsurvival rates in cancer registries with delayed recording of incidentcases. Eur J Cancer 40: 2494â€“2501
	Brenner H, SoÂ¨derman B, Hakulinen T (2002c) Use of period analysis forproviding more up-to-date estimates of long-term survival rates:empiricalevaluationamong370000cancerpatientsinFinland.IntJEpidemiol31:456?462
	DickmanPW,HakulinenT,LuostarinenT,PukkalaE,SankilaR,Soï¿½dermanB,TeppoL(1999)SurvivalofcancerpatientsinFinland1955?1994.ActaOncol38(Suppl12):1?103
	EdererF,AxtellLM,CutlerSJ(1961)Therelativesurvivalrate:astatisticalmethodology.MonogrNatlCancerInst6:101?121
	HakulinenT(1982)Cancersurvivalcorrectedforheterogeneityinpatientwithdrawal.Biometrics39:933?942
	MonnetE,FaivreJ,RaymondL,GarauL(1998)ComparabilityofcolorectalcancersurvivaldatainthreeEuropeanpopulation-basedregistries.EurJCancerPrev7:127?134
	PriorP,WoodmanCB,CollinsS(1998)Internationaldifferencesinsurvivalfromcoloncancer:moreeffectivecareversuslesscompletecancerregistration.BrJSurg85:101?104
	Talbaï¿½ckM,StenbeckM,Roseï¿½nM(2004)Up-to-datelong-termsurvivalofcancerpatients:anevaluationofperiodanalysisonSwedishCancerRegistrydata.EurJCancer40:1361?1372
	Talbaï¿½ckM,StenbeckM,Roseï¿½nM,BarlowL,GlimeliusB(2003)CancersurvivalinSweden1960?1998.Developmentsacrossfourdecades.ActaOncol42:637?659
	TeppoL,PukkalaE,LehtonenM(1994)Dataqualityandqualitycontrolofapopulation-basedcancerregistry.ExperienceinFinland.ActaOncol33:365?369
92-6602343a.pdf	8
	GordinierME,MalpicaA,BurkeTW,BordukaDC,WolfJK,JhingramA,RamirezPT,LevenbackC(2003)Groinrecurrenceinpatientswithvulvalcancerwithnegativenodeonsuperficiallymphadenectomy.GynecolOncol90(3):625?628
	GrayRJ,CoxCE,ReintgenDS(2001)Importanceofmissedaxillarymicrometastasesinbreastcancerpatients.BreastJ7(5):303?307
	JuretzkaMM,JensenKC,LongacreTA,TengNN,HusainA(2004)DetectionofpelviclymphnodemicrometastasesinStageIA2-cervicalcancerbyimmunohistochemicalanalysis.GynecolOncol93(1):107?111
	MalfetanoJ,PiverMS,TsukadaY(1985)Univariateandmultivariateanalysisof5yearsurvival,recurrenceandinguinalnodemetastasesinStageIandIIvulvalcarcinoma.JSurgOncol30:124?131
	MarchioleP,BuenerdA,ScoazeeJY,DargentD,MathavetP(2004)Sentinellymphnodestatusisnotaccurateinpredictinglymphnodestatusforpatientswithcervicalcarcinoma.Cancer100(10):2154?2159
	TamussinoKF,BaderAA,LaxSF,ReingardAM,WinterR(2002)Groinrecurrenceaftermicrometastasesinasentinellymphnodeinapatientwithvulvalcancer.GynecolOncol86:99?101
	UmekitaY,OhiY,SagaraY,YoshidaH(2002)Clinicalsignificanceofoccultmicrometastasesin?nodenegative?breastcancerpatients.JpnJCancerRes93(6):695?698
	VanTrappenPO,GyselmanVG,LoweDG,RyanA,OramDH,BoszeP,WeekesAR,ShepherdJH,DorudiS,BustinSA,JacobsIJ(2001)Molecularquantificationandmappingoflymph-nodemicrometastasesincervicalcancer.Lancet357(9249):15?20
144-0706089a.pdf	40
	ABOUD,R.,SHAFI,M.&DOCHERTY,J.R.(1993).Investigationofthesubtypesofa1-adrenoceptormediatingcontractionsofrataorta,vasdeferensandspleen.Br.J.Pharmacol.,109,80?87.
	ALEXANDER,S.P.H.,MATHIE,A.&PETERS,J.A.(2004).Guidetoreceptorsandchannels.Br.J.Pharmacol.,141,S1?S126.
	ARUNLAKSHANA,O.&SCHILD,H.O.(1959).Somequantitativeusesofdrugantagonists.Br.J.Pharmacol.,14,48?58.
	BYLUND,D.B.,EIKENBERG,D.C.,HIEBLE,J.P.,LANGER,S.Z.,LEFKOWITZ,R.J.,MINNEMAN,K.P.,MOLLINOF,P.B.,RUFFOLOJR,R.R.&TRENDELENBURG,U.(1994).InternationalUnionofPharmacology:nomenclatureofARs.Pharmacol.Rev.,46,121?136.
	CAVALLI,A.,LATTION,A.-L.,HUMMLER,E.,NENNIGER,M.,PEDRAZZINI,T.,AUBERT,J.-F.,MICHEL,M.C.,YANG,M.,LEMBO,G.,VECCHIONE,C.,MOSTARDININ,M.,SCMIDT,A.,BEERMANN,F.&COTECCHIA,S.(1997).Decreasedbloodpressureresponseinmicedeficientofthea1b-AR.Proc.Natl.Acad.Sci.U.S.A.,94,11589?11594.
	CHALTHORN,D.,MCCUNE,D.F.,EDELMANN,S.E.,GARCIA-CAZARIN,M.L.,TSUJIMOTO,G.&PIASCIK,M.T.(2002).Differenceinthecellularlocalizationandagonist-mediatedinter-nalisationpropertiesofthea1-ARsubtypes.Mol.Pharmacol.,61,1008?1016.
	DALY,C.J.,DEIGHAN,C.,MCGEE,A.,MENNIE,D.,ALI,Z.,MCBRIDE,M.&MCGRATH,J.C.(2002).Aknockoutapproachindicatesaminorvasoconstrictorroleforvasculara1b-ARsinmouse.Physiol.Genomics,9,85?91.
	DEOLIVEIRA,A.M.,CAMPOS-MELLO,C.,LEITAO,M.C.&CORREA,F.M.A.(1998).Maturationandageing-relateddifferencesinresponsivenessofrataortaandcarotidarteriestoa1-adrenoceptorstimulation.Pharmacology,57,305?313.
	DEIGHAN,C.(2001).Acombinedpharmacological/knockoutap-proachtosubtypinga1-ARsinmurinetissues.PhDthesis,UniversityofGlasgow.
	DEIGHAN,C.,WOOLLHEAD,A.M.,COLSTON,J.F.&MCGRATH,J.C.(2004).Hepatocytesfroma1B-adrenoceptorknockoutmicerevealcompensatoryadrenoceptorsubtypesubstitution.Br.J.Pharmacol.,142,1031?1037.
	GARCIA-SAINZ,J.A.,CASAS-GONZALEZ,P.,ROMERO-AVILA,M.T.&GONZALEZ-ESPINOSA,C.(1994).Characterizationofthehepatica1B-adrenoceptorsofrats,miceandhamsters.LifeSci.,52,1995?2003.
	GISBERT,R.,MADRERO,Y.,SABINO,V.,NOGUERA,M.A.,IVORRA,M.D.&D?OCON,P.(2003).Functionalcharacterizationofalpha1-adrenoceptorsubtypesinvasculartissuesusingdifferentexperimentalapproaches:acomparativestudy.Br.J.Pharmacol.,138,359?368.
	GOETZ,A.S.,KING,H.K.,WARD,S.D.C.,TRUE,T.A.,RIMELE,T.J.&SAUSSY,D.L.(1995).BMY7378isaselectiveantagonistoftheDsubtypeofa1-ARs.Eur.J.Pharmacol.,272,R5?R6.
	GROSS,G.,HANFT,G.&RUGEVICS,C.(1988).5-Methylurapidildiscriminatesbetweensubtypesofthea1-AR.Eur.J.Pharmacol.,151,333?335.
	HAGUE,C.,UBERTI,M.A.,CHEN,Z.,HALL,R.A.&MINNEMAN,K.P.(2004).Cellsurfaceexpressionofalpha1D-adrenergicrecep-torsiscontrolledbyheterodimerizationwithalpha1B-adrenergicreceptors.J.Biol.Chem.,279,15541?15549.
	HROMETZ,S.L.,EDELMANN,S.E.,MCCUNE,D.F.,OLGES,J.R.,HADLEY,R.W.,PEREZ,D.M.&PIASCIK,M.T.(1999).Expressionofmultiplea1-ARsonvascularsmoothmuscle:correlationwiththeregulationofcontraction.J.Pharmacol.Exp.Ther.,290,452?463.
	JARAJAPU,Y.P.R.,COATS,P.,MCGRATH,J.C.,HILLIER,C.&MACDONALD,A.(2001a).Functionalcharacterizationofa1-ARsubtypesinhumanskeletalmuscleresistancearteries.Br.J.Pharmacol.,133,679?686.
	JARAJAPU,Y.P.R.,HILLIER,C.&MACDONALD,A.(2001b).Thea1A-ARsubtypemediatescontractioninratfemoralresistancearteries.Eur.J.Pharmacol.,422,127?135.
	KENNY,B.A.,CHALMERS,D.H.,PHILPOTT,P.C.&NAYLOR,A.M.(1995).Characterizationofana1D-ARmediatingthecontractileresponseofrataortatoNA.Br.J.Pharmacol.,115,981?986.
	KNEPPER,S.M.,BUCKNER,S.A.,BRUNE,M.E.,DEBERNARDIS,J.F.,MEYER,M.D.&HANCOCK,A.A.(1995).A-61603,apotenta1-adrenergicreceptoragonist,selectiveforthea1A-receptorsubtype.J.Pharmacol.Exp.Ther.,274,97?103.
	KOHNO,Y.,SAITO,H.,TAKITA,M.,KIGOSKI,S.&MURAMATSU,I.(1994).Heterogeneityofa1-adrenoceptorsubtypesinvolvedinadrenergiccontractionsofdogbloodvessels.Br.J.Pharmacol.,112,1167?1173.
	MARTINEZ,L.,CARMONA,L.&VILLALOBOS-MOLINA,R.(1999).Vasculara1D-adrenoceptorfunctionismaintainedduringcongestiveheartfailureaftermyocardialinfarctionintherat.Arch.Med.Res.,30,290?297.
	MINNEMAN,K.P.,THEROUX,T.L.,HOLLINGER,S.,HAN,C.&ESBENSHADE,T.A.(1994).Selectivityofagonistsforcloneda1-adrenergicreceptorsubtypes.Mol.Pharmacol.,46,929?936.
	MURAMATSU,I.,KIGOSHI,S.&OHMURA,T.(1991).Subtypesofa1-adrenoceptorinvolvedinnoradrenaline-inducedcontractionsofratthoracicaortaanddogcarotidartery.Jpn.J.Pharmacol.,57,535?544.
	MURAMATSU,I.,OHMURA,T.,HASHIMOTO,S.&OSHITA,M.(1995).Functionalsubclassificationofvasculara1-adrenoceptors.Pharmacol.Commun.,6,23?28.
	PIASCIK,M.T.,GUARINO,R.D.,SMITH,M.S.,SOLTIS,E.E.,SAUSSYJR,D.L.&PEREZ,D.M.(1995).Thespecificcontributionofthenovela1D-ARtothecontractionofvascularsmoothmuscle.J.Pharmacol.Exp.Ther.,275,1583?1589.
	PIASCIK,M.T.,HROMETZ,S.L.,EDELMANN,S.E.,GUARINO,R.D.&HADLEYR.W.BROWN,R.D.(1997).Immunocytochemicallocalizationofthea1B-ARandthecontributionofthisandtheothersubtypestovascularsmoothmusclecontraction:analysiswithselectiveligandsandantisenseoligonucleotides.J.Pharmacol.Exp.Ther.,283,854?868.
	ROKOSH,G.D.&SIMPSON,P.C.(2002).Knockoutofthea1A/C-ARsubtype:thea1A/Cisexpressedinresistancearteriesandisrequiredtomaintainarterialbloodpressure.ProcNatlAcadSciU.S.A.,99,9474?9479.
	SAUSSYJR,D.L.,GOETZ,A.S.,KING,H.K.&TRUE,T.A.(1994).BMY7378isaselectiveantagonistofa1D-ARs:evidencethatratvasculara1-ARsareofthea1D-subtype.Can.J.Physiol.Pharmacol.,72(Suppl.1),323.
	SCHWINN,D.A.,JOHNSTON,G.I.,PAGE,S.O.,MOSLEY,M.J.,WILSON,K.H.,WORMAN,N.P.,CAMPBELL,S.,FIDOCK,M.D.,FURNESS,M.,PARRY-SMITH,D.J.,PETER,B.&BAILEY,S.(1995).Cloningandpharmacologicalcharacterizationofhumana1-ARs:sequencecorrectionsanddirectcomparisonwithotherspecieshomologues.J.Pharmacol.Exp.Ther.,272,134?142.
	SCOFIELD,M.A.,LIU,F.,ABEL,P.W.&JEFFRIES,W.B.(1995).QuantificationofsteadystateexpressionofmRNAfora1-adrenergicreceptorsubtypesusingreversetranscriptionandacompetitivepolymerasechainreaction.J.Pharmacol.Exp.Ther.,275,1035?1042.
	STANASILA,L.,PEREZ,J.B.,VOGEL,H.&COTECCHIA,S.(2003).Oligomerizationofthea1a-anda1b-adrenergicreceptorsubtypes.Potentialimplicationsinreceptorinternalization.J.Biol.Chem.,278,40239?40251.
	STASSEN,F.R.,MAAS,R.G.,SCHIFFERS,P.M.,JANSSEN,G.M.&DEMEY,JG.(1998).Apositiveandreversiblerelationshipbetweenadrenergicnervesandalpha-1Aadrenoceptorsinratarteries.J.Pharmacol.Exp.Ther.,284,399?405.
	TANOUE,A.,NASA,Y.,KOSHIMIZU,T.,SHINOURA,H.,OSHIKAWA,S.,KAWAI,T.,SUNADA,S.,TAKEO,S.&TSUJIMOTO,G.(2002).Thea1D-ARdirectlyregulatesarterialbloodpressureviavasocon-striction.J.Clin.Invest.,109,765?775.
	TESTA,R.,DESTEFANI,C.,GUARNERI,L.,POGGESI,E.,SIMO-NAZZI,I.,TADDEI,C.&LEONARDI,A.(1995a).Thea1D-adrenoceptorsubtypeisinvolvedinthenoradrenaline-inducedcontractionsofrataorta.LifeSci.,57,PL159?PL163.
	TESTA,R.,GUARNERI,L.,POGGESI,E.,SIMONAZZI,I.,TADDEI,C.&LEONARDI,A.(1995b).Mediationofnoradrenaline-inducedcontractionsofrataortabythea1B-adrenoceptorsubtype.Br.J.Pharmacol.,114,745?750.
	UBERTI,M.A.,HALL,R.A.&MINNEMAN,K.P.(2003).Subtype-specificdimerizationofa1-adrenoceptors:effectsonreceptorexpressionandpharmacologicalproperties.Mol.Pharmacol.,64,1379?1390.
	VILLALOBOS-MOLINA,R.&IBARRA,M.(1996).a1-Adrenoceptorsmediatingcontractioninarteriesofnormotensiveandsponta-neouslyhypertensiveratsareofthea1Dora1Asubtypes.Eur.J.Pharmacol.,298,257?263.
	WILLIAMS,T.J.,BLUE,D.R.,DANIELS,D.V.,DAVIS,B.,ELWORTHY,T.,GEVER,J.R.,KAVA,M.S.,MORGANS,D.,PADILLA,F.,TASSA,S.,VIMONT,R.L.,CHAPPLE,C.R.,CHESS-WILLIAMS,R.,EGLEN,R.M.,CLARKE,D.E.&FORD,A.P.D.W.(1999).Invitroa1-ARpharmacologyofRo70-0004andRS100329,novela1A-ARselectiveantagonists.Br.J.Pharmacol.,127,252?258.
	YANG,M.,VERFURTH,F.,BUSCHER,R.&MICHEL,M.C.(1997).Isa1D-adrenoceptorproteindetectableinrattissues?Naunyn-Schmiedeberg?sArch.Pharmacol.,355,438?446.(ReceivedJuly14,2004RevisedSeptember29,2004AcceptedNovember5,2004)
144-0706093a.pdf	77
	AHERN,G.P.(2003).ActivationofTRPV1bythesatietyfactoroleoylethanolamide.J.Biol.Chem.,278,30429?30434.
	BEN-SHABAT,S.,FRIDE,E.,SHESKIN,T.,TAMIRI,T.,RHEE,M.H.,VOGEL,Z.,BISOGNO,T.,DEPETROCELLIS,L.,DIMARZO,V.&MECHOULAM,R.(1998).Anentourageeffect:inactiveendogenousfattyacidglycerolestersenhance2-arachidonoyl-glycerolcannabi-noidactivity.Eur.J.Pharmacol.,353,23?31.
	BERDYSHEV,E.V.(1999).Inhibitionofseaurchinfertilizationbyfattyacidethanolamidesandcannabinoids.Comp.Biochem.Physiol.CPharmacol.Toxicol.Endocrinol.,122,327?330.
	BISOGNO,T.,VENTRIGLIA,M.,MILONE,A.,MOSCA,M.,CIMINO,G.&DIMARZO,V.(1997).Occurrenceandmetabolismofanandamideandrelatedacyl-ethanolamidesinovariesoftheseaurchinParacentrotuslividus.Biochim.Biophys.Acta,1345,338?348.
	BOGER,D.L.,HENRIKSEN,S.J.&CRAVATT,B.F.(1998a).Oleamide:anendogenoussleep-inducinglipidandprototypicalmemberofanewclassofbiologicalsignalingmolecules.Curr.Pharm.Des.,4,303?314.
	BOGER,D.L.,PATTERSON,J.E.,GUAN,X.,CRAVATT,B.F.,LERNER,R.A.&GILULA,N.B.(1998b).Chemicalrequirementsforinhibitionofgapjunctioncommunicationbythebiologicallyactivelipidoleamide.Proc.Natl.Acad.Sci.U.S.A.,95,4810?4815.
	BOGER,D.L.,SATO,H.,LERNER,A.E.,GUAN,X.&GILULA,N.B.(1999).Arachidonicacidamideinhibitorsofgapjunctioncell?cellcommunication.Bioorg.Med.Chem.Lett.,9,1151?1154.
	BRADSHAW,H.B.,KREY,J.K.&WALKER,J.M.(2003).Levelsofendocannabinoidsandrelatedlipidmediatorsinthefemalereproductivetractchangeasafunctionofestrouscycle.Soc.Neuro.,AbstractsOnlineProg.Number464.3.
	BURSTEIN,S.H.(1999).Thecannabinoidacids:nonpsychoactivederivativeswiththerapeuticpotential.Pharmacol.Ther.,82,87?96.
	BURSTEIN,S.H.,HUANG,S.M.,PETROS,T.J.,ROSSETTI,R.G.,WALKER,J.M.&ZURIER,R.B.(2002).RegulationofanandamidetissuelevelsbyN-arachidonylglycine.Biochem.Pharmacol.,64,1147?1150.
	BUTELMAN,E.R.,BALL,J.W.,HARRIS,T.J.&KREEK,M.J.(2003).Topicalcapsaicin-inducedallodyniainunanesthetizedprimates:pharmacologicalmodulation.J.Pharmacol.Exp.Ther.,311,155?163.
	BUTELMAN,E.R.,HARRIS,T.J.&KREEK,M.J.(2004).Antiallodyniceffectsofloperamideandfentanylagainsttopicalcapsicin-inducedallodyndiainunanesthetizedprimates.J.Pharmacol.Exp.Ther.,306,1106?1114.
	CALIGNANO,A.,LARANA,G.,GIUFFRIDA,A.&PIOMELLI,D.(1998).Controlofpaininitiationbyendogenouscannabinoids.Nature,394,277?281.
	CALIGNANO,A.,LARANA,G.&PIOMELLI,D.(2001).Antinoci-ceptiveactivityoftheendogenousfattyacidamide,palmityletha-nolamide.Eur.J.Pharmacol.,419,191?198.
	CASCIO,M.G.,MINASSI,A.,LIGRESTI,A.,APPENDINO,G.,BURSTEIN,S.&DIMARZO,V.(2004).Astructure-activityrelationshipstudyonN-arachidonoyl-aminoacidsaspossibleendogenousinhibitorsoffattyacidamidehydrolase.Biochem.Biophys.Res.Comm.,314,192?196.
	CHU,C.J.,HUANG,S.M.,DEPETROCELLIS,L.,BISOGNO,T.,EWING,S.A.,MILLER,J.D.,ZIPKIN,R.E.,DADDARIO,N.,APPENDINO,G.,DIMARZO,V.&WALKER,J.M.(2003).N-oleoyldopamine,anovelendogenouscapsaicin-likelipidthatproduceshyperalgesia.J.Biol.Chem.,278,13633?13639.
	CRAVATT,B.F.,GIANG,D.K.,MAYFIELD,S.P.,BOGER,D.L.,LERNER,R.A.&GILULA,N.B.(1996).Molecularcharacterizationofanenzymethatdegradesneuromodulatoryfatty-acidamides.Nature,384,83?87.
	CRAVATT,B.F.,PROSPERO-GARCIA,O.,SIUZDAK,G.,GILULA,N.B.,HENRIKSEN,S.J.,BOGER,D.L.&LERNER,R.A.(1995).Chemicalcharacterizationofafamilyofbrainlipidsthatinducesleep.Science,268,1506?1509.
	DEPETROCELLIS,L.,DAVIS,J.B.&DIMARZO,V.(2001).Palmitoylethanolamideenhancesanandamidestimulationofhu-manvanilloidVR1receptors.FEBSLett.,506,253?256.
	DEPETROCELLIS,L.,CHU,C.J.,MORIELLO,A.S.,KELLNER,J.C.,WALKER,J.M.&DIMARZO,V.(2004).ActionsoftwonaturallyoccurringsaturatedN-acyldopaminesontransientreceptorpotentialvanilloid1(TRPV1)channels.Br.J.Pharmacol.,143,251?256.
	DEVANE,W.A.,HANUS,L.,BREUER,A.,PERTWEE,R.G.,STEVENSON,L.A.,GRIFFIN,G.,GIBSON,D.,MANDELBAUM,A.,ETINGER,A.&MECHOULAM,R.(1992).Isolationandstructureofabrainconstituentthatbindstothecannabinoidreceptor.Science,258,1946?1949.
	DIMARZO,V.,DEPETROCELLIS,L.,SEPE,N.&BUONO,A.(1996).BiosynthesisofanandamideandrelatedacylethanolamidesinmouseJ774macrophagesandN18neuroblastomacells.Biochem.J.,316(Part3),977?984.
	DIMARZO,V.,MELCK,D.,ORLANDO,P.,BISOGNO,T.,ZAGOORY,O.,BIFULCO,M.,VOGEL,Z.&DEPETROCELLIS,L.(2001).Palmitoylethanolamideinhibitstheexpressionoffattyacidamidehydrolaseandenhancestheanti-proliferativeeffectofanandamideinhumanbreastcancercells.Biochem.J.,358,249?255.
	FACCI,L.,DALTOSO,R.,ROMANELLO,S.,BURIANI,A.,SKAPER,S.D.&LEON,A.(1995).Mastcellsexpressaperipheralcannabinoidreceptorwithdifferentialsensitivitytoanandamideandpalmitoylethanolamide.Proc.Natl.Acad.Sci.U.S.A.,92,3376?3380.
	FEDOROVA,I.,HASHIMOTO,A.,FECIK,R.A.,HEDRICK,M.P.,HANUS,L.O.,BOGER,D.L.,RICE,K.C.&BASILE,A.S.(2001).Behavioralevidencefortheinteractionofoleamidewithmultipleneurotransmittersystems.J.Pharmacol.Exp.Ther.,299,332?342.
	FEZZA,F.,BISOGNO,T.,MINASSI,A.,APPENDINO,G.,MECHOU-LAM,R.&DIMARZO,V.(2002).Noladinether,aputativenovelendocannabinoid:inactivationmechanismsandasensitivemethodforitsquantificationinrattissues.FEBSLett.,513,294?298.
	FOWLER,C.J.(2004).Oleamide:amemberoftheendocannabinoidsfamily?Br.J.Pharmacol.,141,195?196.
	FU,J.,GAETANI,S.,OVEISI,F.,LOVERME,J.,SERRANO,A.,DEFONSESCA,F.R.,ROSENGARTH,A.,LUECKE,H.,DIGIACOMO,B.,TARZIA,G.&PIOMELLI,D.(2003).OleylethanolamideregulatesfeedingandbodyweightthroughactivationofthenuclearreceptorPPAR-a.Nature,425,90?93.
	GAVVA,N.R.,KLIONSKY,L.,QU,Y.,SHI,L.,TAMIR,R.,EDENSON,S.,ZHANG,T.J.,VISWANDADHAN,V.N.,TOTH,A.,PEARCE,L.V.,VANDERAH,T.W.,PORRECA,F.,BLUMBERG,M.,LILE,J.,SUN,Y.,WILD,K.,LOUIS,J.-C.&TREANOR,J.S.(2004).MoleculardeterminantsofvanilloidsensitivityinTRPV1.J.Biol.Chem.,279,20283?20295.
	GOMEZ,R.,NAVARRO,M.,FERRER,B.,TRIGO,J.M.,BILBAO,A.,DELARCO,I.,CIPPITELLI,A.,NAVA,F.,PIOMELLI,D.,RODRIGUEZ,D.E.&FONSECA,F.(2002).Aperipheralmechan-ismforCB1cannabinoidreceptor-dependentmodulationoffeeding.J.Neurosci.,22,9612?9617.
	GUAN,X.,CRAVATT,B.F.,EHRING,G.R.,HALL,J.E.,BOGER,D.L.,LERNER,R.A.&GILULA,N.B.(1997).Thesleep-inducinglipidoleamidedeconvolutesgapjunctioncommunicationandcalciumwavetransmissioninglialcells.J.Cell.Biol.,139,1785?1792.
	GUZMAN,M.,LOVERME,J.,FU,J.,OVEISI,F.,BLAZQUEZ,C.&PIOMELLI,D.(2004).Oleoylethanolamidestimulateslipolysisbyactivatingthenuclearreceptorperoxisomeproliferator-activatedreceptora(PPAR-a).J.Biol.Chem.,279,27849?27854.
	HANUS,L.,ABU-LAFI,S.,FRIDE,E.,BREUER,A.,VOGEL,Z.,SHALEV,D.E.,KUSTANOVICH,I.&MECHOULAM,R.(2001).2-arachidonylglycerylether,anendogenousagonistofthecannabinoidCB1receptor.Proc.Natl.Acad.Sci.U.S.A.,98,3662?3665.
	HANUS,L.,GOPHER,A.,ALMOG,S.&MECHOULAM,R.(1993).Twonewunsaturatedfattyacidethanolamidesinbrainthatbindtothecannabinoidreceptor.J.Med.Chem.,36,3032?3034.
	HARRISON,S.,DEPETROCELLIS,L.,TREVISANI,M.,BENVENUTI,F.,BIFULCO,M.,GEPPETTI,P.&DIMARZO,V.(2003).Capsaicin-likeeffectsofN-arachidonoyl-dopamineintheisolatedguineapigbronchiandurinarybladder.Eur.J.Pharmacol.,475,107?114.
	HUANG,J.K.&JAN,C.R.(2001).Linoleamide,abrainlipidthatinducessleep,increasescytosolicCa2+levelsinMDCKrenaltubularcells.LifeSci.,68,997?1004.ZIPKIN,R.E.,SIVAKUMAR,R.,COOP,A.,MAEDA,D.Y.,DEPETROCELLIS,L.,BURSTEIN,S.,DIMARZO,V.&WALKER,J.M.(2001).Identificationofanewclassofmolecules,thearachidonylaminoacids,andcharacterizationofonememberthatinhibitspain.J.Biol.Chem.,276,42639?42644.
	HUANG,S.M.,BISOGNO,T.,TREVISANI,M.,AL-HAYANI,A.,DEPETROCELLIS,L.,FEZZA,F.,TOGNETTO,M.,PETROS,T.J.,KREY,J.F.,CHU,C.J.,MILLER,J.D.,DAVIES,S.N.,GEPPETTI,P.,WALKER,J.M.&DIMARZO,V.(2002).Anendogenouscapsaicin-likesubstancewithhighpotencyatrecombinantandnativevanilloidVR1receptors.Proc.Natl.Acad.Sci.U.S.A.,99,8400?8405.
	HUIDOBRO-TORO,J.P.&HARRIS,R.A.(1996).Brainlipidsthatinducesleeparenovelmodulatorsof5-hydroxytrypaminerecep-tors.Proc.Natl.Acad.Sci.U.S.A.,93,8078?8082.
	JAGGAR,S.I.,HASNIE,F.S.,SELLATURAY,S.&RICE,A.S.(1998).Theanti-hyperalgesicactionsofthecannabinoidanandamideandtheputativeCB2receptoragonistpalmitoylethanolamideinvisceralandsomaticinflammatorypain.Pain,76,189?199.
	JARAI,Z.,WAGNER,J.A.,VARGA,K.,LAKE,K.D.,COMPTON,D.R.,MARTIN,B.R.,ZIMMER,A.M.,BONNER,T.I.,BUCKLEY,N.E.,MEZEY,E.,RAZDAN,R.K.,ZIMMER,A.&KUNOS,G.(1999).Cannabinoid-inducedmesentericvasodilationthroughanendothe-lialsitedistinctfromCB1orCB2receptors.Proc.Natl.Acad.Sci.U.S.A.,96,14136?14141.
	JONSSON,K.O.,VANDEVOORDE,S.,LAMBERT,D.M.,TIGER,G.&FOWLER,C.J.(2001).Effectsofhomologuesandanaloguesofpalmitoylethanolamideupontheinactivationoftheendocannabi-noidanandamide.Br.J.Pharmacol.,133,1263?1275.
	KARAVA,V.,FASIA,L.&SIAFAKA-KAPADAI,A.(2001).Ananda-mideamidohydrolaseactivity,releasedinthemediumbyTetra-hymenapyriformis.Identificationandpartialcharacterization.FEBSLett.,508,327?331.
	KOZAK,K.R.,CREW,B.C.,MORROW,J.D.,WANG,L.H.,MA,Y.H.,WEINANDER,R.,JAKOBSSON,P.J.&MARNETT,L.J.(2002).Metabolismoftheendocannabinoids,2-arachidonoylglycerolandanandamide,intoprostaglandin,thromboxane,andprostacyclinglycerolestersandethanolamides.J.Biol.Chem.,277,44877?44885.
	KUEHL,F.A.,JACOB,T.A.,GANLEY,O.H.,ORMOND,R.E.&MEISINGER,M.A.P.(1957).TheidentificationofN-2(hydro-xyethyl)-palmitamideasanaturallyoccurringanti-inflammatoryagent.J.Am.Chem.Soc.,79,5577?5578.
	LAINE,K.,JARVINEN,K.,MECHOULAM,R.,BREUER,A.&JARVINEN,T.(2002).Comparisonoftheenzymaticstabilityandintraocularpressureeffectsof2-arachidonylglycerolandnoladinether,anovelputativeendocannabinoid.Invest.Ophthalmol.Vis.Sci.,43,3216?3222.
	LAMBERT,D.M.,DIPAOLO,F.G.,SONVEAUX,P.,KANYONYO,M.,GOVAERTS,S.J.,HERMANS,E.,BUEB,J.,DELZENNE,N.M.&TSCHIRHART,E.J.(1999).AnaloguesandhomologuesofN-palmitoylethanolamide,aputativeendogenousCB(2)cannabinoid,aspotentialligandsforthecannabinoidreceptors.Biochim.Biophys.Acta,1440,266?274.
	LAMBERT,D.M.,VANDEVOORDE,S.,JONSSON,K.O.&FOWLER,C.J.(2002).Thepalmitoylethanolamidefamily:anewclassofanti-inflammatoryagents?Curr.Med.Chem.,9,663?674.
	LEGGETT,J.D.,ASPLEY,S.,BECKETT,S.R.,D?ANTONA,A.M.&KENDALL,D.A.(2004).OleamideisaselectiveendogenousagonistofratandhumanCB1cannabinoidreceptors.Br.J.Pharmacol.,141,253?262.
	MACCARRONE,M.,ATTINA,M.,BARI,M.,CARTONI,A.,LEDENT,C.&FINAZZI-AGRO,A.(2001).AnandamidedegradationandN-acylethanolamineslevelinwild-typeandCB1cannabinoidreceptorknockoutmiceofdifferentages.J.Neurochem.,78,339?348.
	MACCARRONE,M.,VANDERSTELT,M.,ROSSI,A.,VELDINK,G.A.,VLIEGENTHART,J.F.&AGRO,A.F.(1998).Anandamidehydro-lysisbyhumancellsincultureandbrain.J.Biol.Chem.,273,32332?32339.
	MARTINEZ-GONZALEZ,D.,BONILLA-JAIME,H.,MORALES-OTAL,A.,HENRIKSON,S.J.,VELAZQUEZ-MOCTEZUMA,J.&PROSPERO-GARCIA,O.(2004).Oleamideandanandamideeffectsonfoodintakeandsexualbehaviorofrats.Neuro.Lett.,364,1?6.
	MAURELLI,S.,BISOGNO,T.,DEPETROCELLIS,L.,DILUCCIA,A.,MARINO,G.&DIMARZO,V.(1995).Twonovelclassesofneuroactivefattyacidamidesaresubstratesformouseneuroblas-toma?anandamideamidohydrolase?.FEBSLett.,377,82?86.
	MAZZARI,S.,CANELLA,R.,PETRELLI,L.,MARCOLONGO,G.&LEON,A.(1996).N-(2-hydroxyethyl)hexadecanamideisorallyactiveinreducingedemaformationandinflammatoryhyperalgesiabydown-modulatingmastcellactivation.Eur.J.Pharmacol.,300,227?236.
	MECHOULAM,R.,BEN-SHABAT,S.,HANUS,L.,LIGUMSKY,M.,KAMINSKI,N.E.,SCHATZ,A.R.,GOPHER,A.,ALMOG,S.,MARTIN,B.R.,COMPTON,D.R.,PERTWBEE,R.G.,GRIFFIN,G.,BAYEWITCH,M.,BARG,J.&VOGEL,Z.(1995).Identificationofanendogenous2-monoglyceride,presentincaninegut,thatbindstocannabinoidreceptors.Biochem.Pharmacol.,50,83?90.
	MECHOULAM,R.,FRIDE,E.&DIMARZO,V.(1998).Endocannabi-noids.Eur.J.Pharmacol.,359,1?18.
	MILMAN,G.,MAOR,Y.,HOROWITZ,M.,GALLILY,R.,HANUS,L.&MECHOULAM,R.(2004).Arachidonoyl-serine,anendocanna-binoids-likebioactiveconstituentofratbrain.ICRSAbstractsOnline133.
	OKA,S.,TSUCHIE,A.,TOKUMURA,A.,MURAMATSU,M.,SUHARA,Y.,TAKAYAMA,H.,WAKU,K.&SUGIURA,T.(2003).Ether-linkedanalogueof2-arachidonoylglycerol(noladinether)wasnotdetectedinthebrainsofvariousmammalianspecies.J.Neurochem.,85,1374?1381.
	PINTO,J.C.,POTIE,F.,RICE,K.C.,BORING,D.,JOHNSON,M.R.,EVANS,D.M.,WILKEN,G.H.,CANTRELL,C.H.&HOWLETT,A.C.(1994).Cannabinoidreceptorbindingandagonistactivityofamidesandestersofarachidonicacid.Mol.Pharmacol.,46,516?522.
	PREMKUMAR,L.S.,QI,Z.-H.,VANBUREN,J.&RAISINGHANI,M.(2004).EnhancementofpotencyandefficacyofNADAbyPKC-mediatedphosphorylationofvanilloidreceptor.J.Neurophys.,91,1442?1449.
	PRUSAKIEWICZ,J.J.,KINGSLEY,P.J.,KOZAK,K.R.&MARNETT,L.J.(2002).SelectiveoxygenationofN-arachidonylglycinebycyclooxygenase-2.Biochem.Biophys.Res.Commun.,296,612?617.
	RAKHSHAN,F.,DAY,T.A.,BLAKELY,R.D.&BARKER,E.L.(2000).Carrier-mediateduptakeoftheendogenouscannabinoidananda-mideinRBL-2H3cells.J.Pharmacol.Exp.Ther.,292,960?967.
	RANDALL,M.D.,KENDALL,D.A.&O?SULLIVAN,S.(2004).Thecomplexitiesofthecardiovascularactionsofcannabinoids.Br.J.Pharmacol.,142,20?26.
	RODRIGUEZDEFONSECA,F.,NAVARRO,M.,GOMEZ,R.,ESCUR-EDO,L.,NAVA,F.,FU,J.,MURILLO-RODRIGUEZ,E.,GIUF-FRIDA,A.,LOVERME,J.,GAETANI,S.,KATHURIA,S.,GALL,C.&PIOMELLI,D.(2001).Ananorexiclipidmediatorregulatedbyfeeding.Nature,414,209?212.
	ROSS,R.A.(2003).AnandamideandvanilloidTRPV1receptors.Br.J.Pharmacol.,140,790?801.
	SAGAR,D.R.,SMITH,P.A.,MILLNS,P.J.,SMART,D.,KENDALL,D.A.&CHAPMAN,V.(2004).TRPV1andCB1receptor-mediatedeffectsoftheendovanilloid/endocannabinoidsN-arachidonoyl-dopamineonprimaryafferentfibreandspinalcordneuronalresponsesintherat.Eur.J.Neurol.,20,175?184.
	SALZET,M.&STEFANO,G.B.(2002).Theendocannabinoidsystemininvertebrates.ProstaglandinsLeukot.Essent.FattyAcids,66,353?361.
	SANCHO,R.,MACHO,A.,DELAVEGA,L.,CALZADO,M.A.,FIEBICH,B.L.,APPENDINO,G.&MUNOZ,E.(2004).Immuno-suppressiveactivityofendovanilloidsN-arachidonoyl-dopamineinhibitsactivationoftheNF-kB,NFAT,andactivatorprotein1signalingpathways.J.Immunol.,172,2341?2351.
	SCHMID,H.H.&BERDYSHEV,E.V.(2002).Cannabinoidreceptor-inactiveN-acylethanolaminesandotherfattyacidamides:metabo-lismandfunction.ProstaglandinsLeukot.Essent.FattyAcids,66,363?376.
	SCHUEL,H.,BURKMAN,L.J.,LIPPES,J.,CRICKARD,K.,FORESTER,E.,PIOMELLI,D.&GIUFFRIDA,A.(2002).N-acylethanolaminesinhumanreproductivefluids.Chem.Phys.Lipids,121,211?227.
	SHESKIN,T.,HANUS,L.,SLAGER,J.,VOGEL,Z.&MECHOULAM,R.(1997).Structuralrequirementsforbindingofanandamide-typecompoundstothebraincannabinoidreceptor.J.Med.Chem.,40,659?667.
	SUGIURA,T.,KONDO,S.,SUKAGAWA,A.,NAKANE,S.,SHINODA,A.,ITOH,K.,YAMASHITA,A.&WAKU,K.(1995).2-arachido-noylglycerol:apossibleendogenouscannabinoidreceptorligandinbrain.Biochem.Biophys.Res.Commun.,215,89?97.
	THOMAS,E.A.,CRAVATT,B.F.,DANIELSON,P.E.,GILULA,N.B.&SUTCLIFFE,J.G.(1997).Fattyacidamidehydrolase,thedegrada-tiveenzymeforanandamideandoleamide,hasselectivedistributioninneuronswithintheratcentralnervoussystem.J.Neurosci.Res.,50,1047?1052.
	TOTH,A.,KEDEI,N.,WANG,Y.&BLUMBERG,P.M.(2003).ArachidonyldopamineasaligandforthevanilloidreceptorVR1oftherat.LifeSci.,73,487?498.
	WALTER,L.&STELLA,N.(2004).Cannabinoidsandneuroinflamma-tion.Br.J.Pharmacol.,141,775?785.
	YOST,C.S.,HAMPSON,A.J.,LEONOUDAKIS,D.,KOBLIN,D.D.,BORNHEIM,L.M.&GRAY,A.T.(1998).Oleamidepotentiatesbenzodiazepine-sensitivegamma-aminobutyricacidreceptoractiv-itybutdoesnotalterminimumalveolaranestheticconcentration.Anesth.Analg.,86,1294?1300.
	YU,M.,IVES,D.&RAMESHA,C.S.(1997).SynthesisofprostaglandinE2ethanolamidefromanandamidebycyclooxygenase-2.J.Biol.Chem.,22,21181?21186.
J. Biol. Chem.-2005-Beaulieu-8452-63.pdf	92
	1.Mitchison,T.J.,andCramer,L.P.(1996)Cell84,371?379
	2.Hartwig,J.H.,andKwiatkowski,D.J.(1991)Curr.Opin.CellBiol.3,87?97
	3.Lauffenburger,D.A.,andHorwitz,A.F.(1996)Cell84,359?369
	4.Blanchoin,L.,Amann,K.J.,Higgs,H.N.,Marchand,J.B.,Kaiser,D.A.,andPollard,T.D.(2000)Nature404,1007?1011
	5.Machesky,L.M.,andInsall,R.H.(1999)J.CellBiol.146,267?272
	6.Cunningham,C.C.,Stossel,T.P.,andKwiatkowski,D.J.(1991)Science251,1233?1236
	7.Wong,G.K.,Allen,P.G.,andBegg,D.A.(1997)CellMotil.Cytoskeleton36,30?42
	8.Pavalko,F.M.,andOtey,C.A.(1994)Proc.Soc.Exp.Biol.Med.205,282?293
	9.Bernstein,B.W.,DeWit,M.,andBamburg,J.R.(1998)Mol.BrainRes.53,236?251
	10.Lang,T.,Wacker,I.,Wunderlich,I.,Rohrbach,A.,Giese,G.,Soldati,T.,andAlmers,W.(2000)Biophys.J.78,2863?2877
	11.Kjeken,R.,Egeberg,M.,Habermann,A.,Kuehnel,M.,Peyron,P.,Floeten-meyer,M.,Walther,P.,Jahraus,A.,Defacque,H.,Kuznetsov,S.A.,andGriffiths,G.(2004)Mol.Biol.Cell15,345?358
	12.Hartwig,J.H.,Brown,D.,Ausiello,D.A.,Stossel,T.P.,andOrci,L.(1990)J.Histochem.Cytochem.38,1145?1153
	13.Orci,L.,Gabbay,K.H.,andMalaisse,W.J.(1972)Science175,1128?1130
	14.Fath,K.R.,Mamajiwalla,S.N.,andBurgess,D.R.(1993)J.CellSci.Suppl.17,65?73
	15.Durrbach,A.,Louvard,D.,andCoudrier,E.(1996)J.CellSci.109,457?465
	16.Riezman,H.,Munn,A.,Geli,M.I.,andHicke,L.(1996)Experientia(Basel)52,1033?1041
	17.Buss,F.,Luzio,J.P.,andKendrick-Jones,J.(2001)FEBSLett.508,295?299
	18.Muallem,S.,Kwiatkowska,K.,Xu,X.,andYin,H.L.(1995)J.CellBiol.128,589?598
	19.Brown,D.(2003)Am.J.Physiol.284,F893?F901
	20.Apodaca,G.(2001)Traffic2,149?159
	21.Hoekstra,D.,Tyteca,D.,andvanIJzendoorn,S.C.(2004)J.CellSci.117,2183?2192S.C.D.
	22.Sontag,J.M.,Aunis,D.,andBader,M.F.(1988)Eur.J.CellBiol.46,316?326
	23.Morita,K.,Oka,M.,andHamano,S.(1988)Biochem.Pharmacol.37,3357?3359
	24.Brozinick,J.T.,Jr.,Hawkins,E.D.,Strawbridge,A.B.,andElmendorf,J.S.(2004)J.Biol.Chem.279,40699?40706
	25.Klussmann,E.,Tamma,G.,Lorenz,D.,Wiesner,B.,Maric,K.,Hofmann,F.,Aktories,K.,Valenti,G.,andRosenthal,W.(2001)J.Biol.Chem.276,20451?20457
	26.Ausiello,D.A.,Hartwig,J.,andBrown,D.(1987)Soc.Gen.Physiol.Ser.42,259?275
	27.Hays,R.M.,Condeelis,J.,Gao,Y.,Simon,H.,Ding,G.,andFranki,N.(1993)Pediatr.Nephrol.7,672?679
	28.Dibas,A.,Mia,A.,andYorio,T.(2000)Proc.Soc.Exp.Biol.Med.223,203?209
	29.Gottlieb,T.A.,Ivanov,I.E.,Adesnik,M.,andSabatini,D.D.(1993)J.CellBiol.120,695?710
	30.Jackman,M.R.,Shurety,W.,Ellis,J.A.,andLuzio,J.P.(1994)J.CellSci.107,2547?2556
	31.Fujimoto,L.M.,Roth,R.,Heuser,J.E.,andSchmid,S.L.(2000)Traffic1,161?171
	32.Janmey,P.A.(1994)Annu.Rev.Physiol.56,169?191
	33.DosRemedios,C.G.,Chhabra,D.,Kekic,M.,Dedova,I.V.,Tsubakihara,M.,Berry,D.A.,andNosworthy,N.J.(2003)Physiol.Rev.83,433?473I.V.
	34.Kwiatkowski,D.J.(1999)Curr.Opin.CellBiol.11,103?108
	35.Azuma,T.,Witke,W.,Stossel,T.P.,Hartwig,J.H.,andKwiatkowski,D.J.(1998)EMBOJ.17,1362?1370
	36.Hartwig,J.H.,Bokoch,G.M.,Carpenter,C.L.,Janmey,P.A.,Taylor,L.A.,Toker,A.,andStossel,T.P.(1995)Cell82,643?653
	37.Janmey,P.A.,andStossel,T.P.(1987)Nature325,362?364
	38.Kwiatkowski,D.J.,Janmey,P.A.,andYin,H.L.(1989)J.CellBiol.108,1717?1726
	39.Lueck,A.,Brown,D.,andKwiatkowski,D.J.(1998)J.CellSci.111,3633?3643
	40.Cabello-Agueros,J.F.,Hernandez-Gonzalez,E.O.,andMujica,A.(2003)CellMotil.Cytoskeleton56,94?108
	41.Biswas,R.S.,Baker,D.A.,Hruska,K.A.,andChellaiah,M.A.(2004)BMCCellBiol.http://www.biomedcentral.com/1471-2121/5/19
	42.Breton,S.,Nsumu,N.N.,Galli,T.,Sabolic,I.,Smith,P.J.,andBrown,D.(2000)Am.J.Physiol.278,F717?F725
	43.Breton,S.,Smith,P.J.,Lui,B.,andBrown,D.(1996)Nat.Med.2,470?472
	44.Brown,D.,Lui,B.,Gluck,S.,andSabolic,I.(1992)Am.J.Physiol.263,C913?C916
	45.Brown,D.,Hirsch,S.,andGluck,S.(1988)J.Clin.Investig.82,2114?2126
	46.Gluck,S.L.,Lee,B.S.,Wang,S.P.,Underhill,D.,Nemoto,J.,andHolliday,L.S.(1998)ActaPhysiol.Scand.Suppl.643,203?212
	47.Lee,B.S.,Holliday,L.S.,Ojikutu,B.,Krits,I.,andGluck,S.L.(1996)Am.J.Physiol.270,C382?C388
	48.Brown,D.,andBreton,S.(2000)J.Exp.Biol.203,137?145
	49.Wagner,C.A.,Finberg,K.E.,Breton,S.,Marshansky,V.,Brown,D.,andGeibel,J.P.(2004)Physiol.Rev.84,1263?1314
	50.Sun-Wada,G.H.,Wada,Y.,andFutai,M.(2004)Biochim.Biophys.Acta1658,106?114
	51.Brown,D.,andBreton,S.(1996)J.Exp.Biol.199,2345?2358
	52.Toyomura,T.,Oka,T.,Yamaguchi,C.,Wada,Y.,andFutai,M.(2000)J.Biol.Chem.275,8760?8765
	53.Madsen,K.M.,Verlander,J.W.,Kim,J.,andTisher,C.C.(1991)KidneyInt.Suppl.33,S57?S63
	54.Steinmetz,P.R.(1986)Am.J.Physiol.251,F173?F187
	55.Lee,B.S.,Gluck,S.L.,andHolliday,L.S.(1999)J.Biol.Chem.274,29164?29171
	56.Chen,S.H.,Bubb,M.R.,Yarmola,E.G.,Zuo,J.,Jiang,J.,Lee,B.S.,Lu,M.,Gluck,S.L.,Hurst,I.R.,andHolliday,L.S.(2004)J.Biol.Chem.279,7988?7998
	57.Vitavska,O.,Wieczorek,H.,andMerzendorfer,H.(2003)J.Biol.Chem.278,18499?18505
	58.Holliday,L.S.,Lu,M.,Lee,B.S.,Nelson,R.D.,Solivan,S.,Zhang,L.,andGluck,S.L.(2000)J.Biol.Chem.275,32331?32337
	59.Breton,S.,Wiederhold,T.,Marshansky,V.,Nsumu,N.N.,Ramesh,V.,andBrown,D.(2000)J.Biol.Chem.275,18219?18224
	60.Paunescu,T.G.,DaSilva,N.,Marshansky,V.,McKee,M.,Breton,S.,andBrown,D.(2004)Am.J.Physiol.287,C149?C162
	61.Weinman,E.J.,Steplock,D.,Tate,K.,Hall,R.A.,Spurney,R.F.,andShenolikar,S.(1998)J.Clin.Investig.101,2199?2206
	62.Shenolikar,S.,andWeinman,E.J.(2001)Am.J.Physiol.280,F389?F395
	63.Guilherme,A.,Soriano,N.A.,Bose,S.,Holik,J.,Bose,A.,Pomerleau,D.P.,Furcinitti,P.,Leszyk,J.,Corvera,S.,andCzech,M.P.(2004)J.Biol.Chem.279,10593?10605
	64.Breton,S.,Lisanti,M.P.,Tyszkowski,R.,McLaughlin,M.,andBrown,D.(1998)J.Histochem.Cytochem.46,205?214
	65.Pastor-Soler,N.,Beaulieu,V.,Litvin,T.N.,DaSilva,N.,Chen,Y.,Brown,D.,Buck,J.,Levin,L.R.,andBreton,S.(2003)J.Biol.Chem.278,49523?49529
	66.Brown,D.,Lydon,J.,McLaughlin,M.,Stuart-Tilley,A.,Tyszkowski,R.,andAlper,S.(1996)Histochem.CellBiol.105,261?267
	67.Breton,S.,Hammar,K.,Smith,P.J.S.,andBrown,D.(1998)Am.J.Physiol.275,C1134?C1142
	68.Cunningham,C.C.,Vegners,R.,Bucki,R.,Funaki,M.,Korde,N.,Hartwig,J.H.,Stossel,T.P.,andJanmey,P.A.(2001)J.Biol.Chem.276,43390?43399
	69.Stevens,A.L.,Breton,S.,Gustafson,C.E.,Bouley,R.,Nelson,R.D.,Kohan,D.E.,andBrown,D.(2000)Am.J.Physiol.278,C791?C802
	70.Shurety,W.,Stewart,N.L.,andStow,J.L.(1998)Mol.Biol.Cell9,957?975
	71.Kwiatkowski,D.J.,Stossel,T.P.,Orkin,S.H.,Mole,J.E.,Colten,H.R.,andYin,H.L.(1986)Nature323,455?458
	72.Pastor-Soler,N.,Isnard-Bagnis,C.,Herak-Kramberger,C.,Sabolic,I.,VanHoek,A.,Brown,D.,andBreton,S.(2002)Biol.Reprod.66,1716?1722
	73.Sun,H.,Lin,K.,andYin,H.L.(1997)J.CellBiol.138,811?820
	74.Banno,Y.,Nakashima,T.,Kumada,T.,Ebisawa,K.,Nonomura,Y.,andNozawa,Y.(1992)J.Biol.Chem.267,6488?6494
	75.Schwartz,J.H.,Masino,S.A.,Nichols,R.D.,andAlexander,E.A.(1994)Am.J.Physiol.266,F94?F101
	76.Cannon,C.,vanAdelsberg,J.,Kelly,S.,andAl-Awqati,Q.(1985)Nature314,443?446
	77.Litvin,T.N.,Kamenetsky,M.,Zarifyan,A.,Buck,J.,andLevin,L.R.(2003)J.Biol.Chem.278,15922?15926
	78.Lu,H.,Sun,T.X.,Bouley,R.,Blackburn,K.,McLaughlin,M.,andBrown,D.(2004)Am.J.Physiol.286,F233?F243
	79.Sun,T.X.,VanHoek,A.,Huang,Y.,Bouley,R.,McLaughlin,M.,andBrown,D.(2002)Am.J.Physiol.282,F998?F1011
	80.Gundelfinger,E.D.,Kessels,M.M.,andQualmann,B.(2003)Nat.Rev.Mol.CellBiol.4,127?139
	81.Szaszi,K.,Kurashima,K.,Kaibuchi,K.,Grinstein,S.,andOrlowski,J.(2001)J.Biol.Chem.276,40761?40768
	82.Shapiro,M.,Matthews,J.,Hecht,G.,Delp,C.,andMadara,J.L.(1991)J.Clin.Investig.87,1903?1909
	83.Wu,M.S.,Bens,M.,Cluzeaud,F.,andVandewalle,A.(1994)J.Membr.Biol.142,323?336
	84.Reshkin,S.J.,andMurer,H.(1992)Am.J.Physiol.262,F572?F577
	85.Prat,A.G.,Cunningham,C.C.,Jackson,G.R.,Jr.,Borkan,S.C.,Wang,Y.,Ausiello,D.A.,andCantiello,H.F.(1999)Am.J.Physiol.277,C1160?C1169
	86.Tamma,G.,Klussmann,E.,Procino,G.,Svelto,M.,Rosenthal,W.,andVal-enti,G.(2003)J.CellSci.116,1519?1525
	87.Lin,K.M.,Wenegieme,E.,Lu,P.J.,Chen,C.S.,andYin,H.L.(1997)J.Biol.Chem.272,20443?20450
	88.Yin,H.L.,andStossel,T.P.(1979)Nature281,583?586
	89.Kumar,N.,andKhurana,S.(2004)J.Biol.Chem.279,24915?24918
	90.Arpin,M.,Pringault,E.,Finidori,J.,Garcia,A.,Jeltsch,J.M.,Vandekerck-hove,J.,andLouvard,D.(1988)J.CellBiol.107,1759?1766
	91.Finidori,J.,Friederich,E.,Kwiatkowski,D.J.,andLouvard,D.(1992)J.CellBiol.116,1145?1155
	92.Lamb,J.A.,Allen,P.G.,Tuan,B.Y.,andJanmey,P.A.(1993)J.Biol.Chem.268,8999?9004
J. Biol. Chem.-2005-Zissimopoulos-5475-85.pdf	69
	1.Berridge,M.,Lipp,P.,andBootman,M.(2000)Nat.Rev.Mol.CellBiol.1,11?21
	2.Franzini-Armstrong,C.,andProtasi,F.(1997)Physiol.Rev.77,699?729
	3.Sutko,J.,andAirey,J.(1996)Physiol.Rev.76,1027?1071
	4.Zucchi,R.,andRonca-Testoni,S.(1997)Pharmacol.Rev.49,1?51
	5.Mackrill,J.(1999)Biochem.J.337,345?361
	6.Galat,A.(2000)Eur.J.Biochem.267,4945?4959
	7.Kay,J.(1996)Biochem.J.314,361?385
	8.Schreiber,S.(1991)Science251,283?287
	9.Clardy,J.(1995)Proc.Natl.Acad.Sci.U.S.A.92,56?61
	10.Timerman,A.,Ogunbumni,E.,Freund,E.,Wiederrecht,G.,Marks,A.,andFleischer,S.(1993)J.Biol.Chem.268,22992?22999
	11.Qi,Y.,Ogunbunmi,E.,Freund,E.,Timerman,A.,andFleischer,S.(1998)J.Biol.Chem.273,34813?34819
	12.Timerman,A.,Onoue,H.,Xin,H.,Barg,S.,Copello,J.,Wiederrecht,G.,andFleischer,S.(1996)J.Biol.Chem.271,20385?20391
	13.Xin,H.,Rogers,K.,Qi,Y.,Kanematsu,T.,andFleischer,S.(1999)J.Biol.Chem.274,15315?15319
	14.Brillantes,A.,Ondrias,K.,Scott,A.,Kobrinsky,E.,Ondriasova,E.,Moschella,M.,Jayaraman,T.,Landers,M.,Ehrlich,B.,andMarks,A.(1994)Cell77,513?523
	15.Ahern,G.,Junankar,P.,andDulhunty,A.(1997)Biophys.J.72,146?162
	16.Marx,S.,Reiken,S.,Hisamatsu,Y.,Jayaraman,T.,Burkhoff,D.,Rosemblit,N.,andMarks,A.(2000)Cell101,365?376
	17.Prestle,J.,Janssen,P.,Janssen,A.,Zeitz,O.,Lehnart,S.,Bruce,L.,Smith,G.,andHasenfuss,G.(2001)Circ.Res.88,188?194
	18.George,C.,Sorathia,R.,Bertrand,B.,andLai,F.A.(2003)Biochem.J.370,579?589
	19.Marx,S.,Ondrias,K.,andMarks,A.(1998)Science281,818?821
	20.Marx,S.,Gaburjakova,J.,Gaburjakova,M.,Henrikson,C.,Ondrias,K.,andMarks,A.(2001)Circ.Res.88,1151?1158
	21.Lamb,G.,andStephenson,D.(1996)J.Physiol.494,569?576
	22.Avila,G.,Lee,E.,Perez,C.,Allen,P.,andDirksen,R.(2003)J.Biol.Chem.278,22600?22608
	23.Jayaraman,T.,Brillantes,A.,Timerman,A.,Fleischer,S.,Erdjument-Bro-mage,H.,Tempst,P.,andMarks,A.(1992)J.Biol.Chem.267,9474?9477
	24.Ahern,G.,Junankar,P.,andDulhunty,A.(1994)FEBSLett.352,369?374
	25.Ma,J.,Bhat,M.,andZhao,J.(1995)Biophys.J.69,2398?2404
	26.Cameron,A.,Nucifora,F.,Fung,E.,Livingston,D.,Aldape,R.,Ross,C.,andSnyder,S.(1997)J.Biol.Chem.272,27582?27588
	27.Gaburjakova,M.,Gaburjakova,J.,Reiken,S.,Huang,F.,Marx,S.,Rosemblit,N.,andMarks,A.(2001)J.Biol.Chem.276,16931?16935
	28.Bultynck,G.,Rossi,D.,Callewaert,G.,Missiaen,L.,Sorrentino,V.,Parys,J.,andDeSmet,H.(2001)J.Biol.Chem.276,47715?47724
	29.VanAcker,K.,Bultynck,G.,Rossi,D.,Sorrentino,V.,Boens,N.,Missiaen,L.,DeSmedt,H.,Parys,J.,andCallewaert,G.(2004)J.CellSci.117,1129?1137
	30.Masumiya,H.,Wang,R.,Zhang,J.,Xiao,B.,andChen,S.R.(2003)J.Biol.Chem.278,3786?3792
	31.Zissimopoulos,S.,andLai,F.A.(2005)CellBiochem.Biophys.,inpress
	32.Xiao,B.,Sutherland,C.,Walsh,M.,andChen,S.R.(2004)Circ.Res.94,487?495
	33.Xiao,B.,Masumiya,H.,Jiang,D.,Wang,R.,Sei,Y.,Zhang,L.,Murayama,T.,Ogawa,Y.,Lai,F.,Wagenknecht,T.,andChen,S.(2002)J.Biol.Chem.277,41778?41785
	34.Tunwell,R.,Wickenden,C.,Bertrand,B.,Shevchenko,V.,Walsh,M.,Allen,P.,andLai,F.A.(1996)Biochem.J.318,477?487
	35.Llano,I.,Gonzalez,J.,Caputo,C.,Lai,F.A.,Blayney,L.,Tan,Y.,andMarty,A.(2000)Nat.Neurosci.3,1256?1265
	36.Sambrook,J.,Fritsch,E.,andManiatis,T.(1989)MolecularCloning:ALab-oratoryManual,2ndEd.,ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NY
	37.Meissner,G.,andHenderson,J.(1987)J.Biol.Chem.262,3065?3073
	38.Sitsapesan,R.,andWilliams,A.(1990)J.Physiol.423,425?439
	39.Grunwald,R.,andMeissner,G.(1995)J.Biol.Chem.270,11338?11347
	40.Tong,J.,Du,G.,Chen,S.,andMacLennan,D.(1999)Biochem.J.343,39?44
	41.Rossi,D.,Simeoni,I.,Micheli,M.,Bootman,M.,Lipp,P.,Allen,P.,andSorrentino,V.(2002)J.CellSci.115,2497?2504
	42.Thomas,L.,George,C.,andLai,F.A.(2004)Cardiovasc.Res.64,52?60
	43.Carmody,M.,Mackrill,J.,Sorrentino,V.,andO?Neill,C.(2001)FEBSLett.505,97?102
	44.George,C.,Higgs,G.,andLai,F.A.(2003)Circ.Res.93,531?540
	45.Balshaw,D.,Xu,L.,Yamaguchi,N.,Pasek,D.,andMeissner,G.(2001)J.Biol.Chem.276,20144?20153
	46.Zhang,J.,Liu,Z.,Masumiya,H.,Wang,R.,Jiang,D.,Li,F.,Wagenknecht,T.,andChen,S.(2003)J.Biol.Chem.278,14211?14218
	47.Shou,W.,Aghdasi,B.,Armstrong,D.,Guo,Q.,Bao,S.,Charng,M.,Mathews,L.,Schneider,M.,Hamilton,S.,andMatzuk,M.(1998)Nature391,489?492
	48.Xin,H.-B.,Senbonmatsu,T.,Cheng,D.-S.,Wang,Y.-X.,Copello,J.,Ji,G.-J.,Collier,M.,Deng,K.-Y.,Jeyakumar,L.,Magnuson,M.,Inagami,T.,Kot-likoff,M.,andFleischer,S.(2002)Nature416,334?337
	49.Doi,M.,Yano,M.,Kobayashi,S.,Kohno,M.,Tokuhisa,T.,Okuda,S.,Suet-sugu,M.,Hisamatsu,Y.,Ohkusa,T.,Kohno,M.,andMatsuzaki,M.(2002)Circulation105,1374?1379
	50.Wehrens,X.,Lenhart,S.,Huang,F.,Vest,J.,Reiken,S.,Mohler,P.,Sun,J.,Guatimosim,S.,Song,L.-S.,Rosemblit,N.,D?Armiento,J.,Napolitano,C.,Memmi,M.,Priori,S.,Lederer,W.,andMarks,A.(2003)Cell113,829?840
	51.Wehrens,X.,andMarks,A.(2004)Nat.Rev.DrugDiscov.3,565?573
	52.Alarcon,C.,andHeitman,J.(1997)Mol.Cell.Biol.17,5968?5975
	53.Neye,H.(2001)RegulatoryPeptides97,147?152
	54.Wang,T.,Donahoe,P.,andZervos,A.(1994)Science265,674?676
	55.Okadome,T.,Oeda,E.,Saitoh,M.,Ichijo,H.,Moses,H.,Miyazono,K.,andKawabata,M.(1996)J.Biol.Chem.271,21687?21690
	56.Zorzato,F.,Fujii,J.,Otsu,K.,Phillips,M.,Green,N.,Lai,F.,Meissner,G.,andMacLennan,D.(1990)J.Biol.Chem.265,2244?2256
	57.Sansom,M.,andWeinstein,H.(2000)TrendsPharmacol.Sci.21,445?451
	58.Brandl,C.,andDeber,C.(1986)Proc.Natl.Acad.Sci.U.S.A.83,917?921
	59.Huse,M.,Chen,Y.-G.,Massague,J.,andKuriyan,J.(1999)Cell96,425?436
	60.Chen,S.,Airey,J.,andMacLennan,D.(1993)J.Biol.Chem.268,22642?22649
	61.Boehning,D.,andJoseph,S.(2000)EMBOJ.19,5450?5459
	62.Yoshikawa,F.,Iwasaki,H.,Michikawa,T.,Furuichi,T.,andMikoshiba,K.(1999)J.Biol.Chem.274,316?327
	63.Joseph,S.,Pierson,S.,andSamanta,S.(1995)Biochem.J.307,859?865
	64.Patzelt,H.,Rudiger,S.,Brehmer,D.,Kramer,G.,Vorderwulbecke,S.,Schaf-fitzel,E.,Waitz,A.,Hesterkamp,T.,Dong,L.,Schneider-Mergener,J.,Bukau,B.,andDeuerling,E.(2001)Proc.Natl.Acad.Sci.U.S.A.98,14244?14249
	65.Wagenknecht,T.,Radermacher,M.,Grassucci,R.,Berkowitz,J.,Xin,H.,andFleisher,S.(1997)J.Biol.Chem.272,32463?32471
	66.Rodney,G.,Moore,C.,Williams,B.,Zhang,J.,Krol,J.,Pedersen,S.,andHamilton,S.(2001)J.Biol.Chem.276,2069?2074
	67.Xiong,L.,Newman,R.,Rodney,G.,Thomas,O.,Zhang,J.,Persechini,A.,Shea,M.,andHamilton,S.(2002)J.Biol.Chem.277,40862?40870
	68.Zhang,H.,Zhang,J.,Danila,C.,andHamilton,S.(2003)J.Biol.Chem.278,8348?8355
	69.Sorrentino,V.,andVolpe,P.(1993)TrendsPharmacol.Sci.14,98?103
J. Biol. Chem.-2005-Armache-7131-4.pdf	26
	1.Cramer,P.(2004)Adv.ProteinChem.67,1?42
	2.Hahn,S.(2004)Nat.Struct.Mol.Biol.11,394?403
	3.Asturias,F.J.(2004)Curr.Opin.Struct.Biol.14,121?129
	4.Woychik,N.A.,andHampsey,M.(2002)Cell108,453?463
	5.Edwards,A.M.,Kane,C.M.,Young,R.A.,andKornberg,R.D.(1991)J.Biol.Chem.266,71?75
	6.Cramer,P.,Bushnell,D.A.,Fu,J.,Gnatt,A.L.,Maier-Davis,B.,Thompson,N.E.,Burgess,R.R.,Edwards,A.M.,David,P.R.,andKornberg,R.D.(2000)Science288,640?649
	7.Cramer,P.,Bushnell,D.A.,andKornberg,R.D.(2001)Science292,1863?1876
	8.Gnatt,A.L.,Cramer,P.,Fu,J.,Bushnell,D.A.,andKornberg,R.D.(2001)Science292,1876?1882
	9.Bushnell,D.A.,Cramer,P.,andKornberg,R.D.(2002)Proc.Natl.Acad.Sci.U.S.A.99,1218?1222
	10.Westover,K.D.,Bushnell,D.A.,andKornberg,R.D.(2004)Science303,1014?1016
	11.Bushnell,D.A.,Westover,K.D.,Davis,R.E.,andKornberg,R.D.(2004)Science303,983?988
	12.Armache,K.-J.,Kettenberger,H.,andCramer,P.(2003)Proc.Natl.Acad.Sci.U.S.A.100,6964?6968
	13.Bushnell,D.A.,andKornberg,R.D.(2003)Proc.Natl.Acad.Sci.U.S.A.100,6969?6972
	14.Kettenberger,H.,Armache,K.-J.,andCramer,P.(2003)Cell114,347?357
	15.Todone,F.,Brick,P.,Werner,F.,Weinzierl,R.O.,andOnesti,S.(2001)Mol.Cell8,1137?1143
	16.Kettenberger,H.,Armache,K.-J.,andCramer,P.(2004)Mol.Cell16,955?965
	17.Otwinowski,Z.,andMinor,W.(1996)MethodsEnzymol.276,307?326
	18.Terwilliger,T.C.(2002)ActaCrystallogr.Sect.DBiol.Crystallogr.58,1937?1940
	19.deLaFortelle,E.,andBricogne,G.(1997)MethodsEnzymol.276,472?494
	20.Jones,T.A.,Zou,J.Y.,Cowan,S.W.,andKjeldgaard,M.(1991)ActaCrys-tallogr.Sect.A47,110?119
	21.Brunger,A.T.,Adams,P.D.,Clore,G.M.,DeLano,W.L.,Gros,P.,Grosse-Kunstleve,R.W.,Jiang,J.S.,Kuszewski,J.,Nilges,M.,Pannu,N.S.,Read,R.J.,Rice,L.M.,Simonson,T.,andWarren,G.L.(1998)ActaCrystallogr.Sect.DBiol.Crystallogr.54,905?921
	22.Navaza,J.(1994)ActaCrystallogr.Sect.A50,157?163
	23.Tan,Q.,Prysak,M.H.,andWoychik,N.A.(2003)Mol.Cell.Biol.23,3329?3338
	24.Barton,G.J.(1993)ProteinEng.6,37?40
	25.Kraulis,P.J.(1991)J.Appl.Crystallogr.24,946?950
	26.Esnouf,R.M.(1997)J.Mol.Graph.15,132?134
J Appl Physiol-2005-Aughey-186-92.pdf	45
	1.AbbateF,BrutonJD,DeHaanA,andWesterbladH.Prolongedforceincreasefollowingahigh-frequencyburstisnotduetoasustainedelevationof[Ca2]i.AmJPhysiolCellPhysiol283:C42?C47,2002.
	2.AshendenMJ,GoreCJ,DobsonGP,andHahnAG.?Livehigh,trainlow?doesnotchangethetotalhaemoglobinmassofmaleenduranceathletessleepingatasimulatedaltitudeof3000mfor23nights.EurJApplPhysiol80:479?484,1999.
	3.BrosnanMJ,MartinDT,HahnAG,GoreCJ,andHawleyJA.Impairedintervalexerciseresponsesinelitefemalecyclistsatmoderatealtitude.JApplPhysiol89:1819?1824,2000.
	4.ClausenT.Na-Kpumpregulationandskeletalmusclecontractility.PhysiolRev83:1269?1324,2003.
	5.EvertsonF,Medbï¿½JI,JebensE,andNicolaysenK.Hardtrainingfor5moincreasesNa-Kpumpconcentrationinskeletalmuscleofcross-countryskiers.AmJPhysiolRegulIntegrCompPhysiol272:R1417?R1424,1997.
	6.ForsterHV,DempseyJA,ThomsonJ,VidrukE,anddoPicoGA.EstimationofarterialPO2,PCO2,pH,andlactatefromarterializedvenousblood.JApplPhysiol32:134?137,1972.
	7.FowlesJR,GreenHJ,SchertzerJD,andTuplingAR.ReducedactivityofmuscleNa-K-ATPaseafterprolongedrunninginrats.JApplPhysiol93:1703?1708,2002.
	8.FowlesJR,GreenHJ,TuplingR,O?BrienS,andRoyBD.HumanneuromuscularfatigueisassociatedwithalteredNa-K-ATPaseactivityfollowingisometricexercise.JApplPhysiol92:1585?1593,2002.
	9.FraserSF,LiJL,CareyMF,WangXN,SangkabutraT,SostaricS,SeligSE,KjeldsenK,andMcKennaMJ.FatiguedepressesmaximalinvitroskeletalmuscleNa-K-ATPaseactivityinuntrainedandtrainedindividuals.JApplPhysiol93:1650?1659,2002.
	10.FraserSFandMcKennaMJ.MeasurementofNa,K-ATPaseactivityinhumanskeletalmuscle.AnalBiochem258:63?67,1998.
	11.GoreCJ,HahnAG,AugheyRJ,MartinDT,AshendenMJ,ClarkSA,GarnhamAP,RobertsAD,SlaterGJ,andMcKennaMJ.Livehigh:trainlowincreasesmusclebuffercapacityandsubmaximalcyclingeffi-ciency.ActaPhysiolScand173:275?286,2001.
	12.GreenH,DahlyA,ShoemakerK,GorehamC,BombardierE,andBall-BurnettM.Serialeffectsofhigh-resistanceandprolongedendur-ancetrainingonNa-Kpumpconcentrationandenzymaticactivitiesinhumanvastuslateralis.ActaPhysiolScand165:177?184,1999.
	13.GreenH,MacDougallJ,TarnopolskyM,andMelissaNL.Downregu-lationofNa-KATPasepumpsinskeletalmusclewithtraininginnormobarichypoxia.JApplPhysiol86:1745?1748,1999.
	14.GreenH,RoyB,GrantS,BurnettM,TuplingR,OttoC,PipeA,andMcKenzieD.DownregulationinmuscleNa-K-ATPasefollowinga21-dayexpeditionto6,194m.JApplPhysiol88:634?640,2000.
	15.GreenH,RoyB,GrantS,TuplingR,OttoC,PipeA,McKenzieD,andOuyangJ.Effectsofa21-dayexpeditionto6194monhumanskeletalmuscleSRCa2-ATPase.HighAltMedBiol1:301?310,2000.
	16.GreenHJ,ChinER,Ball-BurnettM,andRanneyD.IncreasesinhumanskeletalmuscleNa-K-ATPaseconcentrationwithshort-termtraining.AmJPhysiolCellPhysiol264:C1538?C1541,1993.
	17.GreenS,LangbergH,SkovgaardD,BulowJ,andKjaerM.Interstitialandarterial-venous[K]inhumancalfmuscleduringdynamicexercise:effectofischaemiaandrelationtomusclepain.JPhysiol529:849?861,2000.
	18.HahnAGandGoreCJ.Theeffectofaltitudeoncyclingperformance:achallengetotraditionalconcepts.SportsMed31:533?557,2001.
	19.HahnAG,GoreCJ,MartinDT,AshendenMJ,RobertsAD,andLoganPA.Anevaluationoftheconceptoflivingatmoderatealtitudeandtrainingatsealevel.CompBiochemPhysiolA128:777?789,2001.
	20.Halle?nJ.Kbalanceinhumansduringexercise.ActaPhysiolScand156:279?286,1996.
	21.Halle?nJ,GullestadL,andSejerstedOM.Kshiftsofskeletalmuscleduringstepwisebicycleexercisewithandwithoutbeta-adrenoceptorblockade.JPhysiol477:149?159,1994.
	22.HuckSWandMcLeanR.UsingarepeatedmeasuresANOVAtoanalyzethedatafromapretest-posttestdesign:apotentiallyconfusingtask.PsycholBull82:511?518,1975.
	23.JonesDA.High-andlow-frequencyfatiguerevisited.ActaPhysiolScand156:265?270,1996.
	24.JuelC.Potassiumandsodiumshiftsduringinvitroisometricmusclecontraction,andthetimecourseoftheion-gradientrecovery.Pfluï¿½gersArch406:458?463,1986.
	25.JuelC,PilegaardH,NielsenJJ,andBangsboJ.InterstitialKinhumanskeletalmuscleduringandafterdynamicgradedexercisedeter-minedbymicrodialysis.AmJPhysiolRegulIntegrCompPhysiol278:R400?R406,2000.
	26.KjeldsenK,RichterEA,GalboH,LoriteG,andClausenT.Trainingincreasestheconcentrationof[3H]-ouabainbindingsitesinratskeletalmuscle.BiochimBiophysActa860:708?712,1986.
	27.KourieJI.Interactionofreactiveoxygenspecieswithiontransportmechanisms.AmJPhysiolCellPhysiol275:C1?C24,1998.
	28.LevineBDandStray-GundersenJ.?Livinghighandtraininglow?:effectofmoderate-altitudeacclimatizationwithlow-altitudetrainingonperformance.JApplPhysiol83:102?112,1997.
	29.LowryOH,RosenbroughNJ,FarrAL,andRankinJ.Proteinmea-surementwiththefolinphenolreagent.JBiolChem193:265?275,1951.
	30.MadsenK,FranchJ,andClausenT.EffectsofintensifiedendurancetrainingontheconcentrationofNa,K-ATPaseandCa2-ATPaseinhumanskeletalmuscle.ActaPhysiolScand150:251?258,1994.
	31.MankovskayaIN,SerebrovskayaTV,SwansonRJ,VavilovaGL,andKharlamovaON.Mechanismsoftaurineantihypoxicandantioxidantaction.HighAltMedBiol1:105?110,2000.
	32.McKennaMJ,GisselH,andClausenT.EffectsofelectricalstimulationandinsulinonNa-K-ATPase([3H]ouabainbinding)inratskeletalmuscle.JPhysiol547:567?580,2003.
	33.McKennaMJ,HeigenhauserGJF,McKelvieRS,MacDougallJD,andJonesNL.Sprinttrainingenhancesionicregulationduringintenseexer-ciseinman.JPhysiol501:687?702,1997.
	34.McKennaMJ,SchmidtTA,HargreavesM,CameronL,SkinnerSL,andKjeldsenK.SprinttrainingincreaseshumanskeletalmuscleNa-K-ATPaseconcentrationandimprovesKregulation.JApplPhysiol75:173?180,1993.
	35.McLoughlinP,PophamP,LintonAF,BruceRCH,andBandDM.Useofarterializedvenousbloodsamplingduringincrementalexercise.JApplPhysiol73:937?940,1992.
	36.Medbï¿½JI,JebensE,VikneH,RefsnesPE,andGramvikP.EffectofstrenuousstrengthtrainingontheNa-Kpumpconcentrationinskeletalmuscleofwell-trainedmen.EurJApplPhysiol84:148?154,2001.
	37.MurphyKT,SnowRJ,PetersenAC,MurphyRM,MollicaJ,LeeJS,GarnhamAP,AugheyRJ,LeppikJA,MedvedI,Cameron-SmithD,andMcKennaMJ.IntenseexerciseupregulatesNa,K-ATPaseiso-formmRNA,butnotproteinexpressioninhumanskeletalmuscle.JPhysiol556:507?519,2004.
	38.NielsenOBandClausenT.RegulationofNa-Kpumpactivityincontractingratmuscle.JPhysiol503:571?581,1997.
	39.Nï¿½rgaardA,KjeldsenK,andClausenT.Amethodforthedetermina-tionofthetotalnumberof[3H]ouabainbindingsitesinbiopsiesofhumanskeletalmuscle.ScandJClinLabInvest44:509?518,1984.
	40.RoosMR,RiceCL,ConnellyDM,andVandervoortAA.Quadricepsmusclestrength,contractileproperties,andmotorunitfiringratesinyoungandoldmen.MuscleNerve22:1094?1103,1999.
	41.RuffRL.EffectsoftemperatureonslowandfastinactivationofratskeletalmuscleNachannels.AmJPhysiolCellPhysiol277:C937?C947,1999.
	42.SandifordSD,GreenHJ,DuhamelTA,PercoJG,SchertzerJD,andOuyangJ.InactivationofhumanmuscleNa-K-ATPaseinvitroduringprolongedexerciseisincreasedwithhypoxia.JApplPhysiol96:1767?1775,2004.
	43.SejerstedOMandSjï¿½gaardG.Dynamicsandconsequencesofpotas-siumshiftsinskeletalmuscleandheartduringexercise.PhysiolRev80:1411?1481,2000.
	44.Sjï¿½gaardG,AdamsRP,andSaltinB.Waterandionshiftsinskeletalmuscleofhumanswithintensedynamickneeextension.AmJPhysiolRegulIntegrCompPhysiol248:R190?R196,1985.
	45.StankovicovaT,ZemkovaH,BreierA,AmlerE,BurkhardM,andVyskocilF.Theeffectsofcalciumandcalciumchannelblockersonsodiumpump.Pfluï¿½gersArch429:716?721,1995.
signalingimmuneresponse.pdf	58
	Aballay,A.,andAusubel,F.M.(2001).Programmedcelldeathmediatedbyced-3andced-4protectsCaenorhabditiselegansfromSalmonellatyphimurium-mediatedkilling.Proc.Natl.Acad.Sci.USA98,2735?2739.AbstractArticle
	Aballay,A.,Drenkard,E.,Hilbun,L.R.,andAusubel,F.M.(2003).CaenorhabditiselegansinnateimmuneresponsetriggeredbySalmonellaentericarequiresintactLPSandismediatedbyaMAPKsignalingpathway.Curr.Biol.13,47?52.AbstractArticle
	Aballay,A.,Yorgey,P.,andAusubel,F.M.(2000).SalmonellatyphimuriumproliferatesandestablishesapersistentinfectionintheintestineofCaenorhabditiselegans.Curr.Biol.10,1539?1542.AbstractArticle
	Alegado,R.A.,Campbell,M.C.,Chen,W.C.,Slutz,S.S.,andTan,M.W.(2003).CharacterizationofmediatorsofmicrobialvirulenceandinnateimmunityusingtheCaenorhabditiseleganshost-pathogenmodel.CellMicrobiol.5,435?444.AbstractArticle
	Barsyte,D.,Lovejoy,D.A.,andLithgow,G.J.(2001).Longevityandheavymetalresistanceindaf-2andage-1long-livedmutantsofCaenorhabditiselegans.FASEBJ.15,627?634.AbstractArticle
	Chuang,C.F.,andBargmann,C.I.(2005).AToll-interleukin1repeatproteinatthesynapsespecifiesasymmetricodorantreceptorexpressionviaASK1MAPKKKsignaling.GenesDev.19,270?281.AbstractArticle
	Couillault,C.,Pujol,N.,Reboul,J.,Sabatier,L.,Guichou,J.F.,Kohara,Y.,andEwbank,J.J.(2004).TLR-independentcontrolofinnateimmunityinCaenorhabditiselegansbytheTIRdomainadaptorproteinTIR-1,anorthologofhumanSARM.Nat.Immunol.5,488?494.AbstractArticle
	Darby,C.,Cosma,C.L.,Thomas,J.H.,andManoil,C.(1999).LethalparalysisofCaenorhabditiselegansbyPseudomonasaeruginosa.Proc.Natl.Acad.Sci.USA96,15202?15207.Article
	Epstein,A.C.,Gleadle,J.M.,McNeill,L.A.,Hewitson,K.S.,O'Rourke,J.,Mole,D.R.,Mukherji,M.,Metzen,E.,Wilson,M.I.,Dhanda,A.,etal.(2001).C.elegansEGL-9andmammalianhomologsdefineafamilyofdioxygenasesthatregulateHIFbyprolylhydroxylation.Cell107,43?54.AbstractArticle
	Ewbank,J.J.(2002).Tacklingbothsidesofthehost-pathogenequationwithCaenorhabditiselegans.MicrobesInfect.4,247?256.AbstractArticle
	Fujii,M.,Matsumoto,Y.,Tanaka,N.,Miki,K.,Suzuki,T.,Ishii,N.,andAyusawa,D.(2004).MutationsinchemosensoryciliacauseresistancetoparaquatinnematodeCaenorhabditiselegans.J.Biol.Chem.279,20277?20282.AbstractArticle
	Gallagher,L.A.,andManoil,C.(2001).PseudomonasaeruginosaPAO1killsCaenorhabditiselegansbycyanidepoisoning.J.Bacteriol.183,6207?6214.AbstractArticle
	Garsin,D.A.,Sifri,C.D.,Mylonakis,E.,Qin,X.,Singh,K.V.,Murray,B.E.,Calderwood,S.B.,andAusubel,F.M.(2001).AsimplemodelhostforidentifyingGram-positivevirulencefactors.Proc.Natl.Acad.Sci.USA98,10892?10897.AbstractArticle
	Garsin,D.A.,Villanueva,J.M.,Begun,J.,Kim,D.H.,Sifri,C.D.,Calderwood,S.B.,Ruvkun,G.,andAusubel,F.M.(2003).Long-livedC.elegansdaf-2mutantsareresistanttobacterialpathogens.Science300,1921.AbstractArticle
	Gems,D.,andRiddle,D.L.(2000).Genetic,behavioralandenvironmentaldeterminantsofmalelongevityinCaenorhabditiselegans.Genetics154,1597?1610.Abstract
	Gravato-Nobre,M.J.,Nicholas,H.R.,Nijland,R.,O'Rourke,D.,Whittington,D.E.,Yook,K.J.,andHodgkin,J.(2005).MultiplegenesaffectsensitivityofCaenorhabditiseleganstothebacterialpathogenMicrobacteriumnematophilum.Genetics171,1033?1045.AbstractArticle
	Herndon,L.A.,Schmeissner,P.J.,Dudaronek,J.M.,Brown,P.A.,Listner,K.M.,Sakano,Y.,Paupard,M.C.,Hall,D.H.,andDriscoll,M.(2002).Stochasticandgeneticfactorsinfluencetissue-specificdeclineinageingC.elegans.Nature419,808?814.AbstractArticle
	Hodgkin,J.,Kuwabara,P.E.,andCorneliussen,B.(2000).Anovelbacterialpathogen,Microbacteriumnematophilum,inducesmorphologicalchangeinthenematodeC.elegans.Curr.Biol.10,1615?1618.AbstractArticle
	Huffman,D.L.,Abrami,L.,Sasik,R.,Corbeil,J.,vanderGoot,F.G.,andAroian,R.V.(2004).Mitogen-activatedproteinkinasepathwaysdefendagainstbacterialpore-formingtoxins.Proc.Natl.Acad.Sci.USA101,10995?11000.AbstractArticle
	Kanzok,S.M.,Hoa,N.T.,Bonizzoni,M.,Luna,C.,Huang,Y.,Malacrida,A.R.,andZheng,L.(2004).OriginofToll-likereceptor-mediatedinnateimmunity.J.Mol.Evol.58,442?448.AbstractArticle
	Kato,Y.,Aizawa,T.,Hoshino,H.,Kawano,K.,Nitta,K.,andZhang,H.(2002).abf-1andabf-2,ASABF-typeantimicrobialpeptidegenesinCaenorhabditiselegans.Biochem.J.361,221?230.AbstractArticle
	Kim,D.H.,Feinbaum,R.,Alloing,G.,Emerson,F.E.,Garsin,D.A.,Inoue,H.,Tanaka-Hino,M.,Hisamoto,N.,Matsumoto,K.,Tan,M.W.,andAusubel,F.M.(2002).Aconservedp38MAPkinasepathwayinCaenorhabditiselegansinnateimmunity.Science297,623?626.AbstractArticle
	Kim,D.H.,Liberati,N.T.,Mizuno,T.,Inoue,H.,Hisamoto,N.,Matsumoto,K.,andAusubel,F.M.(2004).IntegrationofCaenorhabditiselegansMAPKpathwaysmediatingimmunityandstressresistancebyMEK-1MAPKkinaseandVHP-1MAPKphosphatase.Proc.Natl.Acad.Sci.USA101,10990?10994.AbstractArticle
	Koga,M.,Zwaal,R.,Guan,K.L.,Avery,L.,andOhshima,Y.(2000).ACaenorhabditiselegansMAPkinasekinase,MEK-1,isinvolvedinstressresponses.EMBOJ.19,5148?5156.AbstractArticle
	Kondo,M.,Yanase,S.,Ishii,T.,Hartman,P.S.,Matsumoto,K.,andIshii,N.(2005).Thep38signaltransductionpathwayparticipatesintheoxidativestress-mediatedtranslocationofDAF-16toCaenorhabditiselegansnuclei.Mech.AgeingDev.126,642?647.AbstractArticle
	Oh,S.W.,Mukhopadhyay,A.,Svrzikapa,N.,Jiang,F.,Davis,R.J.,andTissenbaum,H.A.(2005).JNKregulateslifespaninCaenorhabditiselegansbymodulatingnucleartranslocationofforkheadtranscriptionfactor/DAF-16.Proc.Natl.Acad.Sci.USA102,4494?4499.AbstractArticle
	Kurz,C.L.,andEwbank,J.J.(2003).Caenorhabditiselegans:anemerginggeneticmodelforthestudyofinnateimmunity.Nat.Rev.Genet.4,380?390.AbstractArticle
	Kurz,C.L.,andTan,M.W.(2004).RegulationofagingandinnateimmunityinC.elegans.AgingCell3,185?193.AbstractArticle
	Labrousse,A.,Chauvet,S.,Couillault,C.,Kurz,C.L.,andEwbank,J.J.(2000).CaenorhabditiselegansisamodelhostforSalmonellatyphimurium.Curr.Biol.10,1543?1545.AbstractArticle
	Liang,J.,Lints,R.,Foehr,M.L.,Tokarz,R.,Yu,L.,Emmons,S.W.,Liu,J.,andSavage-Dunn,C.(2003).TheCaenorhabditiselegansschnurrihomologsma-9mediatesstage-andcelltype-specificresponsestoDBL-1BMP-relatedsignaling.Development130,6453?6464.AbstractArticle
	Liberati,N.T.,Fitzgerald,K.A.,Kim,D.H.,Feinbaum,R.,Golenbock,D.T.,andAusubel,F.M.(2004).RequirementforaconservedToll/interleukin-1resistancedomainproteinintheCaenorhabditiselegansimmuneresponse.Proc.Natl.Acad.Sci.USA101,6593?6598.AbstractArticle
	Lu,R.,Maduro,M.,Li,F.,Li,H.W.,Broitman-Maduro,G.,Li,W.X.,andDing,S.W.(2005).AnimalvirusreplicationandRNAi-mediatedantiviralsilencinginCaenorhabditiselegans.Nature436,1040?1043.AbstractArticle
	Maduzia,L.L.,Gumienny,T.L.,Zimmerman,C.M.,Wang,H.,Shetgiri,P.,Krishna,S.,Roberts,A.F.,andPadgett,R.W.(2002).lon-1regulatesCaenorhabditiselegansbodysizedownstreamofthedbl-1TGF[x0392]signalingpathway.Dev.Biol.246,418?428.AbstractArticle
	Mahajan-Miklos,S.,Rahme,L.G.,andAusubel,F.M.(2000).Elucidatingthemolecularmechanismsofbacterialvirulenceusingnon-mammalianhosts.Mol.Microbiol.37,981?988.AbstractArticle
	Mahajan-Miklos,S.,Tan,M.W.,Rahme,L.G.,andAusubel,F.M.(1999).MolecularmechanismsofbacterialvirulenceelucidatedusingaPseudomonasaeruginosa-Caenorhabditiseleganspathogenesismodel.Cell96,47?56.Article
	Mallo,G.V.,Kurz,C.L.,Couillault,C.,Pujol,N.,Granjeaud,S.,Kohara,Y.,andEwbank,J.J.(2002).InducibleantibacterialdefensesysteminC.elegans.Curr.Biol.12,1209?1214.AbstractArticle
	Millet,A.C.,andEwbank,J.J.(2004).ImmunityinCaenorhabditiselegans.Curr.Opin.Immunol.16,4?9.AbstractArticle
	Mizuno,T.,Hisamoto,N.,Terada,T.,Kondo,T.,Adachi,M.,Nishida,E.,Kim,D.H.,Ausubel,F.M.,andMatsumoto,K.(2004).TheCaenorhabditiselegansMAPKphosphataseVHP-1mediatesanovelJNK-likesignalingpathwayinstressresponse.EMBOJ.23,2226?2234.AbstractArticle
	Morita,K.,Chow,K.L.,andUeno,N.(1999).RegulationofbodylengthandmaletailraypatternformationofCaenorhabditiselegansbyamemberofTGF-?family.Development126,1337?1347.Abstract
	Morita,K.,Flemming,A.J.,Sugihara,Y.,Mochii,M.,Suzuki,Y.,Yoshida,S.,Wood,W.B.,Kohara,Y.,Leroi,A.M.,andUeno,N.(2002).ACaenorhabditiselegansTGF-?,DBL-1,controlstheexpressionofLON-1,aPR-relatedprotein,thatregulatespolyploidizationandbodylength.EMBOJ.21,1063?1073.AbstractArticle
	Murphy,C.T.,McCarroll,S.A.,Bargmann,C.I.,Fraser,A.,Kamath,R.S.,Ahringer,J.,Li,H.,andKenyon,C.(2003).GenesthatactdownstreamofDAF-16toinfluencethelifespanofCaenorhabditiselegans.Nature424,277?283.AbstractArticle
	Nicholas,H.R.,andHodgkin,J.(2004).TheERKMAPkinasecascademediatestailswellingandaprotectiveresponsetorectalinfectioninC.elegans.Curr.Biol.14,1256?1261.AbstractArticle
	Pujol,N.,andEwbank,J.J.(2003).PathogenavoidanceusingTollsignalling.InTollReceptors,T.Rich,ed.(Georgetown,TX:LandesBiosciencePress).
	Pujol,N.,Link,E.M.,Liu,L.X.,Kurz,L.C.,Alloing,G.,Tan,M.W.,Ray,K.P.,Solari,R.,Johnson,C.D.,andEwbank,J.J.(2001).AreversegeneticanalysisofcomponentsoftheTollsignallingpathwayinCaenorhabditiselegans.Curr.Biol.11,809?821.AbstractArticle
	Sagasti,A.,Hisamoto,N.,Hyodo,J.,Tanaka-Hino,M.,Matsumoto,K.,andBargmann,C.I.(2001).TheCaMKIIUNC-43activatestheMAPKKKNSY-1toexecutealateralsignalingdecisionrequiredforasymmetricolfactoryneuronfates.Cell105,221?232.AbstractArticle
	Sakaguchi,A.,Matsumoto,K.,andHisamoto,N.(2004).RolesofMAPkinasecascadesinCaenorhabditiselegans.J.Biochem.(Tokyo)136,7?11.AbstractArticle
	Schulenburg,H.,andEwbank,J.J.(2004).DiversityandspecificityintheinteractionbetweenCaenorhabditiselegansandthepathogenSerratiamarcescens.BMCEvol.Biol.4,49.AbstractArticle
	Schulenburg,H.,Kurz,C.L.,andEwbank,J.J.(2004).Evolutionoftheinnateimmunesystem:thewormperspective.Immunol.Rev.198,36?58.AbstractArticle
	Scott,B.A.,Avidan,M.S.,andCrowder,C.M.(2002).RegulationofhypoxicdeathinC.elegansbytheinsulin/IGFreceptorhomologDAF-2.Science296,2388?2391.AbstractArticle
	Schott,D.H.,Cureton,D.K.,Whelan,S.P.,andHunter,C.P.(2005).AnantiviralrolefortheRNAinterferencemachineryinCaenorhabditiselegans.Proc.Natl.Acad.Sci.USA102,18420?18424.AbstractArticle
	Seet,B.T.,andPawson,T.(2004).MAPKsignaling:Shobusiness.Curr.Biol.14,R708-R710.AbstractArticle
	Tan,M.W.(2001).Geneticandgenomicdissectionofhost-pathogeninteractionsusingaP.aeruginosa-C.eleganspathogenesismodel.Pediatr.Pulmonol.32,96?97.
	Tan,M.W.,Mahajan-Miklos,S.,andAusubel,F.M.(1999a).KillingofCaenorhabditiselegansbyPseudomonasaeruginosausedtomodelmammalianbacterialpathogenesis.Proc.Natl.Acad.Sci.USA96,715?720.Article
	Tan,M.W.,Rahme,L.G.,Sternberg,J.A.,Tompkins,R.G.,andAusubel,F.M.(1999b).PseudomonasaeruginosakillingofCaenorhabditiselegansusedtoidentifyP.aeruginosavirulencefactors.Proc.Natl.Acad.Sci.USA96,2408?2413.Article
	Tanaka-Hino,M.,Sagasti,A.,Hisamoto,N.,Kawasaki,M.,Nakano,S.,Ninomiya-Tsuji,J.,Bargmann,C.I.,andMatsumoto,K.(2002).SEK-1MAPKKmediatesCa2+signalingtodetermineneuronalasymmetricdevelopmentinCaenorhabditiselegans.EMBORep.3,56?62.AbstractArticle
	Villanueva,A.,Lozano,J.,Morales,A.,Lin,X.,Deng,X.,Hengartner,M.O.,andKolesnick,R.N.(2001).jkk-1andmek-1regulatebodymovementcoordinationandresponsetoheavymetalsthroughjnk-1inCaenorhabditiselegans.EMBOJ.20,5114?5128.AbstractArticle
	Wilkins,C.,Dishongh,R.,Moore,S.C.,Whitt,M.A.,Chow,M.,Machaca,K.(2005).RNAinterferenceisanantiviraldefencemechanisminCaenorhabditiselegans.Nature436,1044?1047.AbstractArticle
	Young,J.A.,andDillin,A.(2004).MAPpinginnateimmunity.Proc.Natl.Acad.Sci.USA101,12781?12782.AbstractArticleSignalingintheimmuneresponse
quicktourdiversity.pdf	27
	Armstrong,M.R.,Blok,V.C.,andPhillips,M.S.(2000).AmultipartitemitochondrialgenomeinthepotatocystnematodeGloboderapallida.Genetics154,181?192.Abstract
	Baldwin,J.G.,Souza,R.M.,andDolinski,C.M.(2001).FinestructureandphylogeneticsignificanceofamuscularbasalbulbinBasiriagracilis(Tylenchidae).Nematology3,681?688.Article
	Blaxter,M.L.,DeLey,P.,Garey,J.R.,Liu,L.X.,Scheldeman,P.,Vierstraete,A.,Vanfleteren,J.R.,Mackey,L.Y.,Dorris,M.,Frisse,L.M.,Vida,J.T.,andThomas,W.K.(1998).AmolecularevolutionaryframeworkforthephylumNematoda.Nature392,71?75.AbstractArticle
	Coomans,A.,VerschurenD.,andVanderhaeghen,R.(1988).Thedemaniansystem,traumaticinseminationandreproductivestrategyinOncholaimusoxyurisDitlevsen(Nematoda,Oncholaimina).ZoologicaScripta17,15?23.Article
	DeConinck,L.A.P.(1965)Systï¿½matiquedesnï¿½matodes.In:Traitï¿½deZoologie:Anatomie,Systï¿½matique,Biologie,Vol.4,P.P.Grassï¿½,ed.Paris:MassonetCie.,pp.586?731.
	DeLey,P.,andBert,W.(2002).Videocaptureandeditingasatoolforthestorage,distributionandillustrationofmorphologicalcharactersofnematodes.J.Nematol.34,296?302.
	DeLey,P.,andBlaxter,M.L.(2002).Systematicpositionandphylogeny.In:TheBiologyofNematodes,D.L.Lee,ed.,London:TaylorandFrancis,pp.1?30.
	DeLey,P.,andBlaxter,M.(2004).AnewsystemforNematoda:combiningmorphologicalcharacterswithmoleculartrees,andtranslatingcladesintoranksandtaxa.NematologyMonographsandPerspectives2,633?653.
	DeLey,P.,andMundo-Ocampo,M.(2004).Thecultivationofnematodes.In:Nematology:AdvancesandPerspectives,Vol.1,Chen,Z.X.,Chen,S.Y.,andDickson,D.W.,eds.,Tsinghua:TsinghuaUniversityPress,pp.541?619.
	Fï¿½rstvonLieven,A.(2002).ThesistergroupoftheDiplogastrina(Nematoda).Russ.J.Nematol.127?137.
	Fï¿½rstvonLieven,A.,andSudhaus,W.(2000).ComparativeandfunctionalmorphologyofthebuccalcavityofDiplogastrina(Nematoda)andafirstoutlineofthephylogenyofthistaxon.J.Zool.Syst.Evol.Res.38,37?63.Article
	Goldstein,B.,Frisse,L.M.,andThomas,W.K.(1998)Embryonicaxisspecificationinnematodes:evolutionofthefirststepindevelopment.Curr.Biol.8,157?160.AbstractArticle
	Hunt,D.J.,andMoore,D.(1999).RhigonematidafromNewBritaindiplopods.2.ThegeneraRhigonemaCobb,1898andZalophoraHunt,1994(Rhigonematoidea:Rhigonematidae)withdescriptionsofthreenewspecies.Nematology1,225?242.Article
	Inglis,W.G.(1983).AnoutlineclassificationofthephylumNematoda.Aust.J.Zool.31,243?255.Article
	Justine,J.-L.(2002).Embryology,developmentalbiologyandthegenome.InTheBiologyofNematodes,D.L.Lee,ed.,London:TaylorandFrancis,pp.121?137.
	Lee,D.L.(2002).Maleandfemalegametesandfertilisation.InTheBiologyofNematodes,D.L.Lee,ed.,London:TaylorandFrancis,pp.73?121.
	Lorenzen,S.(1981).EntwurfeinesphylogenetischenSystemsderfreilebendenNematoden.Verï¿½ffentlichungendesInstitutfï¿½rMeeresforschungenBremerhaven,7(Suppl.),472pp.
	Lorenzen,S.(1994).ThePhylogeneticSystematicsofFreelivingNematodes.London:TheRaySociety.
	Luong,L.T.,Platzer,E.G.,DeLey,P.,andThomas,W.K.(1999).MorphologicalandmolecularcharacterizationofMehdinemaalii(Nematoda:Diplogasterida)fromthedecoratedcricket(Gryllodessigillatus).J.Parasitol.85,1053?1064.
	Nelson,F.K.,Albert,P.S.,andRiddle,D.L.(1983).FinestructureoftheCaenorhabditiseleganssecretory?excretorysystem.J.Ultra.Struct.Res.82,156?171.
	Nussbaumer,A.D.,Bright,M.,Baranyi,C.,Beisser,C.J.,andOtt,J.A.(2004).Attachmentmechanisminahighlyspecificassociationbetweenectosymbioticbacteriaandmarinenematodes.Aqua.Microb.Ecol.34,239?246.
	Schierenberg,E.(2005).Unusualcleavageandgastrulationinafreshwaternematode:developmentalandphylogeneticimplications.Dev.GenesEvol.215,103?108.AbstractArticle
	Siddiqi,M.R.(1980).TheoriginandphylogenyofthenematodeordersTylenchidaThorne,1949andAphelenchida,n.ord.HelminthologicalAbstracts-SeriesB49,143?170.
	SudhausW.,andFitchD.H.A.(2001).ComparativestudiesonthephylogenyandsystematicsoftheRhabditidae(Nematoda).J.Nemat.33,1?72
	Tchesunov,A.V.,andRiemann,F.(1995).Arcticseaicenematodes(Monhysteroidea),withdescriptionsofCryonemacrassumgen.n.,sp.n.andC.tenuesp.n.Nematologica41,35?50.
	VanfleterenJ.R.,andVierstraeteA.R.(1999).InsertionalRNAeditinginmetazoanmitochondria:ThecytochromebgeneinthenematodeTeratocephaluslirellus.RNA5,622?624.AbstractArticle
	YushinV.V.,YoshidaM.,andSpiridonovS.E.(2003).Self-movingspermatophores:spermatozoandimorphisminSteinernema(Steinernematidae,Rhabditida).Russ.J.Nematol.11,151?152.Aquicktourofnematodediversityandthebackboneofnematodephylogeny
threepointmapmarkers.pdf	0
nihms19571.pdf	56
	1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition.Biochem J 2001;357:593?615. [PubMed: 11463332]
	2. Lancaster JR Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. ProcNatl Acad Sci U S A 1994;91:8137?8141. [PubMed: 8058769]
	3. Huang A, Sun D, Shesely EG, Levee EM, Koller A, Kaley G. Neuronal NOS-dependent dilation toflow in coronary arteries of male eNOS-KO mice. Am J Physiol Heart Circ Physiol 2002;282:H429?436. [PubMed: 11788389]
	4. Kashiwagi S, Kajimura M, Yoshimura Y, Suematsu M. Nonendothelial source of nitric oxide inarterioles but not in venules: alternative source revealed in vivo by diaminofluoresceinmicrofluorography. Circ Res 2002;91:e55?64. [PubMed: 12480826]
	5. Talukder MA, Fujiki T, Morikawa K, Motoishi M, Kubota H, Morishita T, Tsutsui M, Takeshita A,Shimokawa H. Up-regulated neuronal nitric oxide synthase compensates coronary flow response tobradykinin in endothelial nitric oxide synthase-deficient mice. J Cardiovasc Pharmacol 2004;44:437?445. [PubMed: 15454851]
	6. Kavdia M, Popel AS. Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscleNO exposure. J Appl Physiol 2004;97:293?301. [PubMed: 15033959]
	7. Lamkin-Kennard KA, Buerk DG, Jaron D. Interactions between NO and O2 in the microcirculation:a mathematical analysis. Microvasc Res 2004;68:38?50. [PubMed: 15219419]
	8. Vaughn MW, Kuo L, Liao JC. Estimation of nitric oxide production and reaction rates in tissue by useof a mathematical model. Am J Physiol 1998;274:H2163?2176. [PubMed: 9841542]
	9. Bidri M, Feger F, Varadaradjalou S, Ben Hamouda N, Guillosson JJ, Arock M. Mast cells as a sourceand target for nitric oxide. Int Immunopharmacol 2001;1:1543?1558. [PubMed: 11515818]
	10. Brown LA, Key BJ, Lovick TA. Fluorescent imaging of nitric oxide production in neuronalvaricosities associated with intraparenchymal arterioles in rat hippocampal slices. Neurosci Lett2000;294:9?12. [PubMed: 11044574]
	11. Chen K, Popel AS. Theoretical analysis of biochemical pathways of nitric oxide release from vascularendothelial cells. Free Radic Biol Med 2006;41:668 ? 680. [PubMed: 16864000]
	12. Santolini J, Adak S, Curran CM, Stuehr DJ. A kinetic simulation model that describes catalysis andregulation in nitric-oxide synthase. J Biol Chem 2001;276:1233?1243. [PubMed: 11038356]
	13. Santolini J, Meade AL, Stuehr DJ. Differences in three kinetic parameters underpin the uniquecatalytic profiles of nitric-oxide synthases I, II, and III. J Biol Chem 2001;276:48887?48898.[PubMed: 11684690]
	14. Gorren AC, Schmidt K, Mayer B. Binding of L-arginine and imidazole suggests heterogeneity of ratbrain neuronal nitric oxide synthase. Biochemistry 2002;41:7819?7829. [PubMed: 12056914]
	15. Ost TW, Daff S. Thermodynamic and kinetic analysis of the nitrosyl, carbonyl, and dioxy hemecomplexes of neuronal nitric-oxide synthase. The roles of substrate and tetrahydrobiopterin in oxygenactivation. J Biol Chem 2005;280:965?973. [PubMed: 15507439]
	16. Wehling M, Stull JT, McCabe TJ, Tidball JG. Sparing of mdx extraocular muscles from dystrophicpathology is not attributable to normalized concentration or distribution of neuronal nitric oxidesynthase. Neuromuscul Disord 1998;8:22?29. [PubMed: 9565987]
	17. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, Salvayre R, Bayard F.Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cellsbut increases the release of bioactive nitric oxide by inhibiting superoxide anion production. ProcNatl Acad Sci U S A 1996;93:4108?4113. [PubMed: 8633024]
	18. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998;336( Pt 1):1?17. [PubMed: 9806879]
	19. Schulman ES, Kagey-Sobotka A, MacGlashan DW Jr, Adkinson NF Jr, Peters SP, Schleimer RP,Lichtenstein LM. Heterogeneity of human mast cells. J Immunol 1983;131:1936?1941. [PubMed:6194221]
	20. Kavdia M, Popel AS. Wall shear stress differentially affects NO level in arterioles for volumeexpanders and Hb-based O2 carriers. Microvasc Res 2003;66:49?58. [PubMed: 12826074]
	21. Singel DJ, Stamler JS. Blood traffic control. Nature 2004;430:297. [PubMed: 15254518]
	22. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, Kelm M3rd, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR, Feelisch M Jr,Lundberg JO. The emerging biology of the nitrite anion. Nat Chem Biol 2005;1:308?314. [PubMed:16408064]
	23. Lewis RS, Deen WM. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. ChemRes Toxicol 1994;7:568?574. [PubMed: 7981422]
	24. Thomas DD, Liu X, Kantrow SP, Lancaster JR Jr. The biological lifetime of nitric oxide: implicationsfor the perivascular dynamics of NO and O2. Proc Natl Acad Sci U S A 2001;98:355?360. [PubMed:11134509]
	25. Gardner PR, Martin LA, Hall D, Gardner AM. Dioxygen-dependent metabolism of nitric oxide inmammalian cells. Free Radic Biol Med 2001;31:191?204. [PubMed: 11440831]
	26. Elayan IM, Axley MJ, Prasad PV, Ahlers ST, Auker CR. Effect of hyperbaric oxygen treatment onnitric oxide and oxygen free radicals in rat brain. J Neurophysiol 2000;83:2022?2029. [PubMed:10758112]
	27. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulationin the NO synthases. J Biol Chem 2004;279:36167?36170. [PubMed: 15133020]
	28. Gladwin MT. Hemoglobin as a nitrite reductase regulating red cell-dependent hypoxic vasodilation.Am J Respir Cell Mol Biol 2005;32:363?366. [PubMed: 15837723]
	29. Condorelli P, George SC. In vivo control of soluble guanylate cyclase activation by nitric oxide: akinetic analysis. Biophys J 2001;80:2110?2119. [PubMed: 11325714]
	30. Kollau A, Hofer A, Russwurm M, Koesling D, Keung WM, Schmidt K, Brunner F, Mayer B.Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidencefor the activation of purified soluble guanylate cyclase through direct formation of nitric oxide.Biochem J 2005;385:769?777. [PubMed: 15377279]
	31. Stone JR, Marletta MA. Spectral and kinetic studies on the activation of soluble guanylate cyclaseby nitric oxide. Biochemistry 1996;35:1093?1099. [PubMed: 8573563]
	32. Tsai AG, Acero C, Nance PR, Cabrales P, Frangos JA, Buerk DG, Intaglietta M. Elevated plasmaviscosity in extreme hemodilution increases perivascular nitric oxide concentration andmicrovascular perfusion. Am J Physiol Heart Circ Physiol 2005;288:H1730?1739. [PubMed:15576432]
	33. Vukosavljevic N, Jaron D, Barbee KA, Buerk DG. Quantifying the L-arginine paradox in vivo.Microvasc Res 2006;71:48?54. [PubMed: 16316668]
	34. Zani BG, Bohlen HG. Transport of extracellular l-arginine via cationic amino acid transporter isrequired during in vivo endothelial nitric oxide production. Am J Physiol Heart Circ Physiol2005;289:H1381?1390. [PubMed: 15849232]
	35. Buerk DG, Lamkin-Kennard K, Jaron D. Modeling the influence of superoxide dismutase onsuperoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. FreeRadic Biol Med 2003;34:1488?1503. [PubMed: 12757859]
	36. Malinski T, Taha Z, Grunfeld S, Patton S, Kapturczak M, Tomboulian P. Diffusion of nitric oxide inthe aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun1993;193:1076?1082. [PubMed: 8323533]
	37. Suematsu M, Suganuma K, Kashiwagi S. Mechanistic probing of gaseous signal transduction inmicrocirculation. Antioxid Redox Signal 2003;5:485?492. [PubMed: 13678537]
	38. Allen BW, Piantadosi CA. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobinparadigm. Am J Physiol Heart Circ Physiol 2006;291:H1507?1512. [PubMed: 16751292]
	39. Robinson JM, Lancaster JR Jr. Hemoglobin-mediated, hypoxia-induced vasodilation via nitric oxide:mechanism(s) and physiologic versus pathophysiologic relevance. Am J Respir Cell Mol Biol2005;32:257?261. [PubMed: 15778415]
	40. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S,Ozuyaman B, Schnurch HG, Godecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rosen P,Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood2006;107:2943?2951. [PubMed: 16368881]
	41. Lacza Z, Snipes JA, Zhang J, Horvath EM, Figueroa JP, Szabo C, Busija DW. Mitochondrial nitricoxide synthase is not eNOS, nNOS or iNOS. Free Radic Biol Med 2003;35:1217?1228. [PubMed:14607521]
	42. Thom SR, Buerk DG. Nitric oxide synthesis in brain is stimulated by oxygen. Adv Exp Med Biol2003;510:133?137. [PubMed: 12580417]
	43. Nase GP, Tuttle J, Bohlen HG. Reduced perivascular PO2 increases nitric oxide release fromendothelial cells. Am J Physiol Heart Circ Physiol 2003;285:H507?515. [PubMed: 12860561]
	44. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RM, Moncada S, Cobb FR. Effects of inhibitionof nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronaryarteries in awake dogs. J Clin Invest 1991;87:1964?1968. [PubMed: 2040689]
	45. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation fromL-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989;96:418?424.[PubMed: 2924084]
	46. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in theabnormal endothelium-dependent vascular relaxation of patients with essential hypertension.Circulation 1993;87:1468?1474. [PubMed: 8491001]
	47. Kimura C, Oike M, Ohnaka K, Nose Y, Ito Y. Constitutive nitric oxide production in bovine aorticand brain microvascular endothelial cells: a comparative study. J Physiol 2004;554:721?730.[PubMed: 14617679]
	48. de Wit C, Jahrbeck B, Schafer C, Bolz SS, Pohl U. Nitric oxide opposes myogenic pressure responsespredominantly in large arterioles in vivo. Hypertension 1998;31:787?794. [PubMed: 9495262]
	49. Kim MH, Harris NR, Korzick DH, Tarbell JM. Control of the arteriolar myogenic response bytransvascular fluid filtration. Microvasc Res 2004;68:30?37. [PubMed: 15219418]
	50. Nellore K, Harris NR. Nitric oxide measurements in rat mesentery reveal disrupted venulo-arteriolarcommunication in diabetes. Microcirculation 2004;11:415?423. [PubMed: 15280067]
	51. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitricoxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc NatlAcad Sci U S A 1992;89:7674?7677. [PubMed: 1502182]
	52. Chen X, Jaron D, Barbee KA, Buerk DG. The influence of radial RBC distribution, blood velocityprofiles, and glycocalyx on coupled NO/O2 transport. J Appl Physiol 2006;100:482?492. [PubMed:16210436]
	53. Rengasamy A, Johns RA. Determination of Km for oxygen of nitric oxide synthase isoforms. JPharmacol Exp Ther 1996;276:30?33. [PubMed: 8558447]
	54. Tsai AG, Cabrales P, Hangai-Hoger N, Intaglietta M. Oxygen distribution and respiration by themicrocirculation. Antioxid Redox Signal 2004;6:1011?1018. [PubMed: 15548898]
	55. Mansuy D, Boucher JL. Alternative nitric oxide-producing substrates for NO synthases. Free RadicBiol Med 2004;37:1105?1121. [PubMed: 15451052]
pg164.pdf	19
	1.Fothergill NJ, Hunt MT, Touquet R. Audit of patients with chestpain presenting to an accident and emergency department over a6-month period. Arch Emerg Med 1993;10(3):155-60.
	2.Engelberg S, Singer AJ, Moldashel J, et al. Effects of prehospi-tal nitroglycerin on hemodynamics and chest pain intensity. Pre-hosp Emerg Care 2000;4:290-3.
	3.Braunwald E, Zipes DP, Libby P, editors. Heart disease: a text-book of cardiovascualr medicine. 6th ed. Philadelphia: WBSaunders; 2001. p. 27-44.
	4.O?Rourke RA, Shaver JA, Salerni R, et al. The history, physicalexamination, and cardiac auscultation. In: Alexander RW,Schlant RC, Furster V, editors. Hurst?s The heart. 9th ed. NewYork: Mcgraw-Hill; 1998. p. 229-342.
	5.Weiner DA, Ryan TJ, McCabe CH, et al. Exercise stress testing:correlations among history of angina, ST-segment response andprevalence of coronary artery disease in the coronary arterysurgery study (CASS). N Engl J Med 1979;301:230-5.
	6.Diamond GA, Forrester JS, Hirsch M, et al. Application of con-ditional probability analysis to the clinical diagnosis of coronaryartery disease. J Clin Invest 1980;65:1210-21.
	7.Decker WW, Prina LD, Smars PA, et al. Continous 12-leadelectrocardiographic monitoring in an emergency departmentchest pain unit: an assessment of potential clinical effect. AnnEmerg Med 2003;41:342-51.
	8.Braunwald E, Antman EM, Beasley JW, et al. ACC/AHAguidelines for the management of patients with unstable anginaand non-ST-segment elevation myocardial infarction: executivesummary and recommendations. A report of the American Col-lege of Cardiology/American Heart Association task force onpractice guidelines (committee on the management of patientswith unstable angina) [published erratum appears in Circulation2000;102(14):1739]. Circulation 2000;102(10):1193-209.
	9.McCarthy BD, Beshansky JR, D?Agostino RB, et al. Missed di-agnosis of acute myocardial infarction in the emergency depart-ment: results from a multicenter study. Ann Emerg Med1993;22:579-82.
	10.Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnosesof acute cardiac ischemia in the emergency department. N EnglJMed 2000;342:1163-70.
	11.Selker HP, Beshansky JR, Griffith JL, et al. Use of the acutecardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with the triage of patients with chest pain or othersymptoms suggestive of acute cardiac ischemia. Ann Intern Med1998;129:845-55.
	12.Selker HP, Zalenski RJ, Antman EM, et al. An evaluation oftechnologies for identifying acute cardiac ischemia in the emer-gency department: executive summary of the National Heart At-tack Alert Program Working Group Report. Ann Emerg Med1997;29:1-12.
	13.Zalenski RJ, McCarren M, Roberts R, et al. An evaluation of achest pain diagnostic protocol to exclude cardiac ischemia in theemergency department. Arch Intern Med 1997;157:1085-91.
	14.Gisolf J, Westerhof BE, van Dijk N, et al. Sublingual nitroglyc-erin used in routine tilt testing provokes a cardiac output-medi-ated vasovagal response. J Am Coll Cardiol 2004;44:588-93.
	15.Shry EA, Dacus J, Van De Graaff E, et al. Usefulness of the re-sponse to sublingual nitroglycerin as a predictor of ischemicchest pain in the emergency department. Am J Cardiol2002;90:1264-6.
	16.Henrikson C, Howell E, Bush D, et al. Chest pain relief does notpredict active coronary artery disease. Ann Intern Med2003;139:979-86.
	17.Diercks D, Boghos E, Guzman H, et al. Changes in the numericdescriptive scale for pain after sublingual nitroglycerin do notpredict cardiac etiology of chest pain. Ann Emerg Med2005;45:581-5.
	18.Antman EM, Cohen M, Bernink P, et al. The TIMI risk scorefor unstable angina/non-ST elevation MI. A method for prog-nostication and therapeutic decision-making. JAMA2000;284:835-42.
	19.Mackinnon A. A spreadsheet for the calculation of comprehen-sive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med 2000;30:127-34.
vhrm0201-087.pdf	34
	Bhargava S. 2004. Evaluation of efficacy of non-drug therapy (dietary)and drug therapy in hypercholesterolemic subjects. MSc Dissertation.Jaipur: University of Rajasthan.
	Bhatnagar D. 1998. The metabolic basis of increased coronary riskattributed to people from the Indian subcontinent. Current Science,74:1087?94.
	Botorrof MB. 2004. Statin safety: what to know. Am J Geriatr Cardiol,13:34?8.
	Cannon CP, Braunwald E, McCabe C, et al. 2004. Pravastatin or atorvastatinevaluation and infection therapy-thrombolysis in myocardialinfarction-22 investigators (PROVE-IT TIMI-22). Intensive versusmoderate lipid lowering with statins after acute coronary syndromes.N Engl J Med, 350:1495?504.
	Chong PH, Bachenheimer BS. 2000. Current, new and future treatmentsin dyslipidemia and atherosclerosis. Drugs, 60:55?93.
	Davignon J, Roederer G, Montigny M, et al. 1994. Comparative efficacyand safety of pravastatin, nicotinic acid and two combined in patientswith hypercholesterolemia. Am J Cardiol, 73:339?45.
	Deedwania PC, Hunninghake DB, Bays H. 2004. Effects of lipid alteringtreatment in diabetes mellitus and the metabolic syndrome. Am JCardiol, 93(Suppl):18C?26C.
	Deedwania PC, Gupta R. 2005. East Asians and South Asians, and Asianand Pacific Islander Americans. In Wong ND, Black HR, Gardin JM(ed). Preventive Cardiology. 2nd Edition. New York: McGraw Hill.p 456?72.
	Dhanjal TS, Lal M, Haynes R, Lip G. 2001. A comparison ofcardiovascular risk factors among Indo-Asian and Caucasian patientsadmitted with acute myocardial infarction in Kuala Lumpur, Malaysiaand Birmingham, England. Int J Clin Pract, 55:665?8.
	Grundy SM. 2004. Obesity, metabolic syndrome and cardiovasculardisease. J Clin Endocrinol Metab, 89:2595?600.
	Grundy SM, Cleeman N, Bairey-Merz CN, et al. 2004. Implications ofrecent clinical trials for the National Cholesterol Education ProgramAdult Treatment Panel III guidelines. Circulation, 110:227?39.
	Gupta EK, Ito MK. 2002. Lovastatin and extended-release niacincombination product: The first drug combination for the managementof hyperlipidemia. Heart Disease, 4:124?37.
	Gupta R. 2000. Preventing coronary heart disease in India: focus on primaryprevention. J Indian Med Assoc, 98:703?9.
	Gupta R, Kaul V, Prakash H, et al. 2001. Lipid abnormalities in coronaryheart disease: a population based case-control study. Indian Heart J,53:332?36.
	Guyton JR, Goldberg CA, Kreisberg RA, et al. 1998. Effectiveness ofonce-nightly dosing of extended-release niacin alone and incombination for hypercholesterolemia. Am J Cardiol, 82:737?43.
	Henkin Y, Oberman A, Hurst DC, et al. 1991. Niacin revisited: clinicalobservations on an important but underutilized drug. Am J Med,91:239?46.
	Illingworth DR, Bacon S. 1989. Treatment of heterozygous familialhypercholesterolemia with lipid-lowering drugs. Atherosclerosis,9(Suppl 1):1121?34.
	Jones PH. 2004. Statins as the cornerstone of drug therapy for dyslipidemia:monotherapy and combination therapy options. Am Heart J, 148:S9?S13.
	Kashyap ML, McGovern ME, Berra K, et al (2002). Long term safety andefficacy of a once daily niacin-lovastatin formulation for patients withdyslipidemia. Am J Cardiol, 89:672?78.
	Kumar M, Chakravarti RN, Singh A, et al. 1976. Serum lipid profiles inpatients of myocardial infarction in Chandigarh area (Northern India).Atherosclerosis, 24:355?61.
	Kumar P, Luthra K, Dwivedi M, et al. 2003. Apolipoprotein E genepolymorphism in patients with premature myocardial infarction: acase-control study in northern Asian Indians. Ann Clin Biochem,40:382?6.
	Luthra K, Bhargava B, Chhabra S, et al. 2002. Apolipoprotein Epolymorphism in northern Indian patients with coronary heart disease:phenotype distribution and relation to serum lipids and lipoproteins.Mol Cell Biochem, 232:97?102.
	[NCEP] National Cholesterol Education Program. 2002. Third report ofthe National Cholesterol Education Program expert panel on detection,evaluation and treatment of high blood cholesterol in adults (ATP-III)final report. Circulation, 106:3143?421.
	O?Keefe JH, Harris WS, Nelson J, et al. 1995. Effects of pravastatin withniacin or magnesium on lipid levels ans postprandial lipemia. Am JCardiol, 6:480?4.
	Pais P, Pogue S, Gerstein H, et al. 1996. Risk factors for acute myocardialinfarction in Indians: a case-control study. Lancet, 348:358?63.
	Panacea-Biotec. 2004. Niacin extended release tablet pharmacokinetics.Data on file.
	Pasternak RC, Smith SC, Bairey-Merz CN, et al. 2002. ACC/AHA/NHLBIclinical advisory on the use and safety of statins. J Am Coll Cardiol,40:567?72.
	Sahi N, Pahlajani DB, Sainani GS. 1993. Apolipoproteins Al and B aspredictors of angiographicaIly assessed coronary artery disease.J Assoc Physicians India, 41:713?15.
	Thompson GR. 2004. Combination therapy with statins. In: Gaw A, PackardCJ, Shepherd J. Editors. Statins. 2nd edition. London: Martin Dunitz.p 189?99.
	Vacek JL, Dittmeir G, Chiarelli T, et al. 1995. Comparison of lovastatin(20 mg) and nicotinic acid (1.2 g) with either drug alone for type IIhyperlipoprotenemia. Am J Cardiol, 76:182?4.
	Vashist S, Narula J, Awtade A, et al. 1990. Lipids and lipoproteins in normalcontrols and clinically documented coronary heart disease patients.Ann Natl Acad Med Sci (India), 26:57?66.
	Warnica JW. 2004. The CARE trial: the effect of pravastatin on coronaryevents after myocardial infarction in patients with average cholesterollevels. In Gaw A, Packard CJ, Shepherd J (ed). Statins. 2nd edition.London: Martin Dunitz. p 123?43.
	Wasir HS, Bharani A, Bhatia ML. 1987. Correlation of risk factors withcoronary angiographic findings in patients of ischemic heart disease.J Assoc Physicians India, 35:483?7.
	Wolfe ML, Vartianen SF, Ross JL, et al. 2001. Safety and effectiveness ofNiaspan when added sequentially to a statin for treatment ofdyslipidemia. Am J Cardiol, 87:476?9.
nihms18235.pdf	60
	Adler LE, Freedman R, Ross RG, Olincy A, Waldo MC. Elementary phenotypes in the neurobiologicaland genetic study of schizophrenia. Biol Psychiatry 1999;46:8?18. [PubMed: 10394470]
	Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smokingin schizophrenic patients. Am J Psychiatry 1993;150:1856?1861. [PubMed: 8238642]
	Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidencefor a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry1982;17:639?654. [PubMed: 7104417]
	Basar E, Basar-Eroglu C, Karakas S, Schurmann M. Gamma, alpha, delta, and theta oscillations governcognitive processes. Int J Psychophysiol 2001;39:241?248. [PubMed: 11163901]
	Basar-Eroglu C, Struber D, Schurmann M, Stadler M, Basar E. Gamma-band responses in the brain: ashort review of psychophysiological correlates and functional significance. Int J Psychophysiol1996;24:101?112. [PubMed: 8978437]
	Bertrand O, Tallon-Baudry C. Oscillatory gamma activity in humans: a possible role for objectrepresentation. Int J Psychophysiol 2000;38:211?223. [PubMed: 11102663]
	Boutros N, Zouridakis G, Rustin T, Peabody C, Warner D. The P50 component of the auditory evokedpotential and subtypes of schizophrenia. Psychiatry Res 1993;47:243?254. [PubMed: 8372162]
	Boutros NN, Zouridakis G, Overall J. Replication and extension of P50 findings in schizophrenia. ClinElectroencephalogr 1991;22:40?45. [PubMed: 1991411]
	Clementz BA, Blumenfeld LD. Multichannel electroencephalographic assessment of auditory evokedresponse suppression in schizophrenia. Exp Brain Res 2001;139:377?390. [PubMed: 11534861]
	Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppressionin schizophrenia. Neuroreport 1997;8:3889?3893. [PubMed: 9462461]
	Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, Siegel SJ. Theeffects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but notP20 or N40 auditory ERP components. Neurochem Res 2004;29:1179?1188. [PubMed: 15176475]
	Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J, Bilker WB, Turetsky BI, Gur RE,Siegel SJ. Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J andDBA/2Hsd inbred mouse substrains. Brain Res 2003;992:85?95. [PubMed: 14604776]
	Crawford HJ, McClain-Furmanski D, Castagnoli N Jr, Castagnoli K. Enhancement of auditory sensorygating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers. NeurosciLett 2002;317:151?155. [PubMed: 11755262]
	Damaj MI, Kao W, Martin BR. Characterization of spontaneous and precipitated nicotine withdrawal inthe mouse. J Pharmacol Exp Ther 2003;307:526?534. [PubMed: 12970387]
	Debruyne D, Sobrio F, Hinschberger A, Camsonne R, Coquerel A, Barre L. Short-term pharmacokineticsand brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptorinvestigation. J Pharm Sci 2003;92:1051?1057. [PubMed: 12712425]
	Demiralp T, Basar-Eroglu C, Basar E. Distributed gamma band responses in the brain studied in cortex,reticular formation, hippocampus and cerebellum. Int J Neurosci 1996;84:1?13. [PubMed: 8707470]
	Demiralp T, Herrmann CS, Erdal ME, Ergenoglu T, Keskin YH, Ergen M, Beydagi H. DRD4 and DAT1Polymorphisms Modulate Human Gamma Band Responses. Cereb Cortex. 2006
	Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW. Differential prevalence ofcigarette smoking in patients with schizophrenic vs mood disorders. Schizophr Res 1998;33:113?118. [PubMed: 9783351]
	Engel AK, Singer W. Temporal binding and the neural correlates of sensory awareness. Trends Cogn Sci2001;5:16?25. [PubMed: 11164732]
	Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, LeonardS, Miller C, et al. Schizophrenia and nicotinic receptors. Harv Rev Psychiatry 1994;2:179?192.[PubMed: 9384901]
	Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defectin inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. BiolPsychiatry 1983;18:537?551. [PubMed: 6134559]
	Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, HolikJ, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, BreeseCR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. Linkage of aneurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A1997;94:587?592. [PubMed: 9012828]
	Gallinat J, Winterer G, Herrmann CS, Senkowski D. Reduced oscillatory gamma-band responses inunmedicated schizophrenic patients indicate impaired frontal network processing. Clin Neurophysiol2004;115:1863?1874. [PubMed: 15261865]
	Gould TJ, Stephen Higgins J. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and7 days post-training. Neurobiol Learn Mem 2003;80:147?157. [PubMed: 12932430]
	Griffith JM, O?Neill JE, Petty F, Garver D, Young D, Freedman R. Nicotinic receptor desensitizationand sensory gating deficits in schizophrenia. Biol Psychiatry 1998;44:98?106. [PubMed: 9646891]
	Haig AR, Gordon E, De Pascalis V, Meares RA, Bahramali H, Harris A. Gamma activity in schizophrenia:evidence of impaired network binding? Clin Neurophysiol 2000;111:1461?1468. [PubMed:10904228]
	Herrmann CS, Demiralp T. Human EEG gamma oscillations in neuropsychiatric disorders. ClinNeurophysiol 2005;116:2719?2733. [PubMed: 16253555]
	Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, Schulze-Bonhage A, Kahana MJ. Gamma oscillations correlate with working memory load in humans. CerebCortex 2003;13:1369?1374. [PubMed: 14615302]
	Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatricoutpatients. Am J Psychiatry 1986;143:993?997. [PubMed: 3487983]
	Jin Y, Potkin SG. P50 changes with visual interference in normal subjects: a sensory distraction modelfor schizophrenia. Clin Electroencephalogr 1996;27:151?154. [PubMed: 8828978]
	Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney WE Jr. Effects of P50 temporalvariability on sensory gating in schizophrenia. Psychiatry Res 1997;70:71?81. [PubMed: 9194201]
	Johannesen JK, Kieffaber PD, O?Donnell BF, Shekhar A, Evans JD, Hetrick WP. Contributions ofsubtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression inschizophrenia. Schizophr Res 2005;78:269?284. [PubMed: 16002265]
	Kumari V, Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci BiobehavRev 2005;29:1021?1034. [PubMed: 15964073]
	Lee KH, Williams LM, Haig A, Gordon E. ?Gamma (40 Hz) phase synchronicity? and symptomdimensions in schizophrenia. Cognit Neuropsychiatry 2003;8:57?71.
	Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C,Myles-Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R. Nicotinic receptorfunction in schizophrenia. Schizophr Bull 1996;22:431?445. [PubMed: 8873294]
	Levin ED. Nicotinic receptor subtypes and cognitive function. J Neurobiol 2002;53:633?640. [PubMed:12436426]
	Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioralcharacterization, pharmacological specification, and anatomic localization. Psychopharmacology(Berl) 2006;184:523?539. [PubMed: 16220335]
	Levin ED, Rezvani AH. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol2000;393:141?146. [PubMed: 10771007]
	Light GA, Braff DL. Human and animal studies of schizophrenia-related gating deficits. Curr PsychiatryRep 1999;1:31?40. [PubMed: 11122903]
	Maxwell CR, Kanes SJ, Abel T, Siegel SJ. Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. Neuroscience 2004a;129:101?107. [PubMed: 15489033]
	Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE, Turetsky BI, Bilker WB, Lenox RH,Siegel SJ. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evokedpotential. Neuropsychopharmacology 2004b;29:739?746. [PubMed: 14735128]
	Metzger KL, Maxwell CR, Liang Y, Siegel SJ. Effects of Nicotine Vary Across Two Auditory EvokedPotentials in the Mouse. Biol Psychiatry. 2006
	Moxon KA, Gerhardt GA, Adler LE. Dopaminergic modulation of the P50 auditory-evoked potential ina computer model of the CA3 region of the hippocampus: its relationship to sensory gating inschizophrenia. Biol Cybern 2003;88:265?275. [PubMed: 12690485]
	O?Neill HC, Rieger K, Kem WR, Stevens KE. DMXB, an alpha7 nicotinic agonist, normalizes auditory
	Pantev C, Makeig S, Hoke M, Galambos R, Hampson S, Gallen C. Human auditory evoked gamma-bandmagnetic fields. Proc Natl Acad Sci U S A 1991;88:8996?9000. [PubMed: 1924362]
	Petersen DR, Norris KJ, Thompson JA. A comparative study of the disposition of nicotine and itsmetabolites in three inbred strains of mice. Drug Metab Dispos 1984;12:725?731. [PubMed:6150822]
	Radek RJ, Miner HM, Bratcher NA, Decker MW, Gopalakrishnan M, Bitner RS. alpha(4)beta (2)Nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model ofsensory gating. Psychopharmacology (Berl) 2006;187:47?55. [PubMed: 16767415]
	Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry 2001;49:258?267. [PubMed:11230877]
	Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states andneuropsychiatric disorders. J Psychopharmacol 2004;18:457?474. [PubMed: 15582913]
	Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB, Kanes SJ, Turetsky BI. Effects of strain,novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology2003;28:675?682. [PubMed: 12655312]
	Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoaminereuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evokedpotentials. Neuroscience 2005;133:729?738. [PubMed: 15908134]
	Simosky JK, Stevens KE, Adler LE, Freedman R. Clozapine improves deficient inhibitory auditoryprocessing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl)2003;165:386?396. [PubMed: 12459928]
	Simosky JK, Stevens KE, Kem WR, Freedman R. Intragastric DMXB-A, an alpha7 nicotinic agonist,improves deficient sensory inhibition in DBA/2 mice. Biol Psychiatry 2001;50:493?500. [PubMed:11600102]
	Song C, Murray TA, Kimura R, Wakui M, Ellsworth K, Javedan SP, Marxer-Miller S, Lukas RJ, Wu J.Role of alpha7-nicotinic acetylcholine receptors in tetanic stimulation-induced gamma oscillationsin rat hippocampal slices. Neuropharmacology 2005;48:869?880. [PubMed: 15829257]
	Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW. Abnormal neuralsynchrony in schizophrenia. J Neurosci 2003;23:7407?7411. [PubMed: 12917376]
	Stevens KE, Kem WR, Mahnir VM, Freedman R. Selective alpha7-nicotinic agonists normalizeinhibition of auditory response in DBA mice. Psychopharmacology (Berl) 1998;136:320?327.[PubMed: 9600576]
	Stevens KE, Wear KD. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampalauditory gating in two animal models. Pharmacol Biochem Behav 1997;57:869?874. [PubMed:9259018]
	Tallon-Baudry C, Bertrand O. Oscillatory gamma activity in humans and its role in object representation.Trends Cogn Sci 1999;3:151?162. [PubMed: 10322469]
	Umbricht D, Vyssotky D, Latanov A, Nitsch R, Brambilla R, D?Adamo P, Lipp HP. Midlatency auditoryevent-related potentials in mice: comparison to midlatency auditory ERPs in humans. Brain Res2004;1019:189?200. [PubMed: 15306253]
	Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. HospCommunity Psychiatry 1994;45:204?206. [PubMed: 7910577]
nihms-22399.pdf	56
	1. Mooberry SL. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.Curr. Opin. Oncol 2003;15:425?430. [PubMed: 14624224]
	2. Gokmen-Polar Y, Escuin D, Walls CD, Soule SE, Wang Y, Sanders KL, Lavallee TM, Wang M,Guenther BD, Giannakakou P, Sledge GW Jr. ?-Tubulin mutations are associated with resistance to2-methoxyestradiol in MDA-MB-435 cancer cells. Cancer Res 2005;65:9406?9414. [PubMed:16230404]
	3. Han GZ, Liu ZJ, Shimoi K, Zhu BT. Synergism between the anticancer actions of 2-methoxyestradioland microtubule-disrupting agents in human breast cancer. Cancer Res 2005;65:387?393. [PubMed:15695378]
	4. Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C. 2-Methoxyestradiol inhibitshypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy inhead and neck squamous cell carcinoma. Clin. Cancer Res 2004;10:8665?8673. [PubMed: 15623651]
	5. Fowke JH, Qi D, Bradlow HL, Shu XO, Gao YT, Cheng JR, Jin F, Zheng W. Urinary estrogenmetabolites and breast cancer: differential pattern of risk found with pre-versus post-treatmentcollection. Steroids 2003;68:65?72. [PubMed: 12475724]
	6. Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammarycarcinogenesis? Cancer Res 1998;58:2269?2277. [PubMed: 9622057]
	7. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT. Genetic polymorphism ofcytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev 2000;9:147?150. [PubMed: 10698474]
	8. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiolby human uterine myometrium and myoma microsomes: implications for the mechanism of uterinetumorigenesis. Proc. Natl. Acad. Sci. USA 1995;92:9220?9224. [PubMed: 7568105]
	9. Russo J, Hasan LM, Balogh G, Guo S, Russo IH, Estrogen and its metabolites are carcinogenic agentsin human breast epithelial cells. J. Steroid Biochem Mol. Biol 2003;87:1?25. [PubMed: 14630087]
	10. Berg D, Sonsalla R, Kuss E. Concentrations of 2-methoxyoestrogens in human serum measured bya heterologous immunoassay with an 125I-labelled ligand. Acta Endocrinol (Copenh) 1983;103:282?288. [PubMed: 6858558]
	11. Sweeney C, Liu G, Yiannoutsos C, Kolesar J, Horvath D, Staab MJ, et al. A phase II multicenter,randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, andefficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin. Cancer Res2005;11:6625?6633. [PubMed: 16166441]
	12. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent.Pharmacotherapy 2003;23:165?712. [PubMed: 12587805]
	13. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 2-Methoxyestradiol, an endogenous mammalianmetabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci.USA 1994;91:3964?3968. [PubMed: 8171020]
	14. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesanno R, Nawroth PP, Schwelgerer L. Theendogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumorgrowth. Nature 1994;368:237?239. [PubMed: 7511798]
	15. Golebiewska J, Rozwadowski P, Spodnik JH, Knap N, Wakabayashi T, Wozniak M. Dual effect of2-methoxyestradiol on cell cycle events in human osteosarcoma 143B cells. Acta Biochim Pol2002;49:59?65. [PubMed: 12136957]
	16. Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT, Thomas T. Physiologicallevels of 2-methoxyestradiol interfere with nongenomic signaling of 17?-Estradiol in human breastcancer cells. Clinical Cancer Res 2006;12:2038?2048. [PubMed: 16609013]
	17. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for theselective killing of cancer cells. Nature 2000;407:390?395. [PubMed: 11014196]
	18. Liu ZJ, Zhu BT. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J. Steroid Biochem Mol.Biol 2004;88:265?275. [PubMed: 15120420]
	19. Thomas T, Balabhadrapathruni S, Gallo MA, Thomas TJ. Development of polyamine analogs ascancer therapeutic agents. Oncol. Res 2002;13:123?135. [PubMed: 12555742]
	20. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat RevCancer 2004;4:781?792. [PubMed: 15510159]
	21. Huang Y, Pledgie A, Casero RA Jr, Davidson NE. Molecular mechanisms of polyamine analogs incancer cells. Anticancer Drugs 2005;16:229?241. [PubMed: 15711175]
	22. Dolan ME, Fleig MJ, Feuerstein BG, Basu HS, Luk GD, Casero RA Jr, Marton LJ. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res 1994;54:4698?4702. [PubMed: 8062267]
	23. Canizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Penafiel R. Prognostic value ofornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologicparameters. Clin Cancer Res 1999;5:2035?41. [PubMed: 10473083]
	24. Thomas T, Thomas TJ. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, andpolyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res. Treat1994;29:189?101. [PubMed: 8012036]
	25. Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW. Preclinical antitumorefficacy of the polyamine analogue N-diethylnorspermine administered by multiple injectionor continuous infusion. Clin. Cancer Res 1995;1:847?857. [PubMed: 9816054]
	26. Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, Casero RA Jr. Phase I study of-diethylnorspermine in patients with non-small cell lung cancer. Clin Cancer Res2002;8:684?690. [PubMed: 11895896]
	27. Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, Casero RA Jr, DavidsonNE. A Phase II study of the polyamine analog N-diethylnorspermine (DENSpm) daily for fivedays every 21 days in patients with previously treated metastatic breast cancer. Clin. Cancer Res2003;9:5922?5928. [PubMed: 14676116]
	28. Kumar R, Hung MC. Signaling intricacies take center stage in cancer cells. Cancer Res 2005;65:2511?2515. [PubMed: 15805240]
	29. Thompson JE, Thompson CB. Putting the rap on Akt. J. Clin. Oncol 2004;22:4217?4226. [PubMed:15483033]
	30. Tokunaga E, Kimura Y, Oki E, Ueda N, Futatsugi M, Mashino K, et al. Akt is frequently activatedin HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treatedpatients. Int. J. Cancer 2005;118:284?289. [PubMed: 16049961]
	31. Stal O, Perez-Tenorio G, Akerberg L, Olsson B, Nordenskjold L. Skoog, Rutqvist LE. Akt kinasesin breast cancer and the results of adjuvant therapy. Breast Cancer Res 2003;5:R37?44. [PubMed:12631397]
	32. Clark AS, West K, Streicher S, Dennis PA. Constitutive and inducible Akt activity promotes resistanceto chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 2002;1:707?717. [PubMed: 12479367]
	33. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou DS, Nakshatri H. Phosphatidylinositol3-kinase/AKT-mediated activation of estrogen receptor a: a new model for anti-estrogen resistance.J. Biol. Chem 2001;276:9817?9824. [PubMed: 11139588]
	34. Ariazi EA, Ariazi JL, Cordera F, Jordan VC. Estrogen receptors as therapeutic targets in breast cancer.Curr. Top. Med. Chem 2006;6:181?202. [PubMed: 16515478]
	35. Thomas T, Gallo MA, Thomas TJ. Estrogen receptors as targets for drug development for breastcancer, osteoporosis and cardiovascular diseases. Curr. Cancer Drug Targets 2004;4:483?99.[PubMed: 15379634]
	36. Lee AJ, Kosh JW, Conney AH, Zhu BT. Characterization of the NADPH-dependent metabolism of17?-estradiol to multiple metabolites by human liver microsomes and selectively expressed humancytochrome P450 3A4 and 3A5. J. Pharmacol. Exp. Ther 2001;298:420?432. [PubMed: 11454902]
	37. Chou, TC. The median-effect principle and combination index for quantitation of synergism andantagonism. In: Chou, TC.; Rideout, DC., editors. Synergism and Antagonism in Chemotherapy.Academic press; San Diego: 1991. p. 61-102.
	38. Chou TC, Talalay P. Quantitiative analysis of dose-effect relationships: the combined effects ofmultiple drugs or enzyme inhibitors. Ad. Enzyme Regul 1984;22:27?55.
	39. Chou, TC.; Martin, N. A computer program for quantitation of synergism and antagonism in drugcombinations, and the determination of IC50 and ED50 and LD50 values. ComboSyn; Paramus, NJ:2005. CompuSyn for Drug Combinations: PC Software and User's Guide.
	40. Chou TC, Motzer RJ, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism oftaxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach toclinical protocol design. J, Natl Cancer Inst 1994;86:1517?1524. [PubMed: 7932806]
	41. Lewis JS, Thomas TJ, Pestell RG, Albanese C, Gallo MA, Thomas T. Differential effects of 16?-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 inMCF-7 breast cancer cells. J. Mol. Endocrinol 2005;34:91?105. [PubMed: 15691880]
	42. Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK. Modulationof cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediatedthrough multiple signal transduction pathways. Biochemistry 2006;45:3703?3713. [PubMed:16533053]
	43. Chen B, Pan H, Zhu L, Deng Y, Pollard JW. Progesterone inhibits the estrogen-inducedphosphoinositide 3-kinase-->AKT-->GSK-3?-->cyclin D1-->pRB pathway to block uterineepithelial cell proliferation. Mol. Endocrinol 2005;19:1978?1990. [PubMed: 15845746]
	44. Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivationof BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol BiolCell 2004;15:3266?3284. [PubMed: 15121878]
	45. Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest bydecreasing the level and nuclear localization of cyclin D1. Mol. Cell Biol 2003;23:6139?6149.[PubMed: 12917336]
	46. Wolff J. Promotion of microtubule assembly by oligocations: cooperativity between charged groups.Biochemistry 1998;37:10722?9. [PubMed: 9692962]
	47. Nogales E. Structural insight into microtubule function. Annu. Rev. Biophys. Biomol. Struct2001;30:397?420. [PubMed: 11441808]
	48. Flusberg DA, Numaguchi Y, Ingber DE. Cooperative control of Akt phosphorylation, bcl-2expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelialcells. Mol. Biol. Cell 2001;12:3087?3094. [PubMed: 11598193]
	49. Mollinedo F, Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis2003;8:413?450. [PubMed: 12975575]
	50. Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. G(1) and G(2) cell-cycle arrest followingmicrotubule depolymerization in human breast cancer cells. J. Clin. Invest 110:91?99. [PubMed:12093892]20020
	51. Kramer DL, Vujcic S, Diegelman P, Alderfer J, Miller JT, Black JD, Bergeron RJ, Porter CW.Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in humanmelanoma cells. Cancer Res 1999;59:1278?1286. [PubMed: 10096560]
	52. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ.Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is inducedby estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res2001;61:5985?5991. [PubMed: 11507039]
	53. Chauhan D, Li G, Auclair D, Hideshima T, Richardson P, Podar K, et al. Identification of genesregulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.Blood 2003;101:3606?3614. [PubMed: 12480690]N.
	54. Pledgie A, Huang Y, Hacker A, Zhang Z, Woster PM, Davidson NE, Casero RA Jr. Spermine oxidaseSMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 inpolyamine analogue-treated human breast cancer cell lines. J. Biol. Chem 2005;280:39843?39851.[PubMed: 16207710]
	55. Gao N, Rahmani M, Dent P, Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cellsproceeds through a reactive oxygen species and Akt-dependent process. Oncogene 2005;24:3797?3809. [PubMed: 15782127]
	56. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S, Kondo T. 17Beta-estradiol protectsagainst oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redoxregulation of Akt in myocardiac H9c2 cells. J. Biol. Chem May;2006 281:13092?13102. [PubMed:16549430]
nihms43166.pdf	77
	1. Amedi A, von Kriegstein K, van Atteveldt NM, Beauchamp MS, Naumer MJ. Functional imaging ofhuman crossmodal identification and object recognition. Exp Brain Res 2005;166:559?571. [PubMed:16028028]
	2. Anderson ND, Iidaka T, Cabeza R, Kapur S, McIntosh AR, Craik FI. The effects of divided attentionon encoding- and retrieval-related brain activity: A PET study of younger and older adults. J CognNeurosci 2000;12:775?792. [PubMed: 11054920]
	3. Annoni JM, Khateb A, Gramigna S, Staub F, Carota A, Maeder P, Bogousslavsky J. Chronic cognitiveimpairment following laterothalamic infarcts: a study of 9 cases. Arch Neurol 2003;60:1439?1443.[PubMed: 14568815]
	4. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical andneuroanatomical disrtibution of neurofibrillary tangles and neuritic plaques in the cerebral cortex ofpatients with Alzheimer's disease. Cerebral Cortex 1991;1:103?116. [PubMed: 1822725]
	5. Backman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Lï¿½ngstrom B. BrainActivation in Young and Older Adults During Implicit and Explicit Retrieval. Journal CognitiveNeuroscience 1997;9:378?391.
	6. Beason-Held L, Golski S, Kraut M, Esposito G, Resnick S. Brain activation during encoding andrecognition of verbal and figural information in older adults. Neurobiol Aging 2005;26:237?250.[PubMed: 15582751]
	7. Beason-Held LL, Purpura KP, Van Meter JW, Azari NP, Mangot DJ, Optican LM, Mentis MJ,Alexander GE, Grady CL, Horwitz B, Rapoport SI, Schapiro MB. PET reveals occipitotemporalpathway activation during elementary form perception in humans. Vis Neurosci 1998;15:503?510.[PubMed: 9685203]
	8. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories.Neurobiol Aging 1997;18:351?357. [PubMed: 9330961]
	9. Cabeza R, Anderson ND, Locantore JK, McIntosh AR. Aging gracefully: compensatory brain activityin high-performing older adults. Neuroimage 2002;17:1394?1402. [PubMed: 12414279]
	10. Cabeza R, Grady CL, Nyberg L, McIntosh AR, Tulving E, Kapur S, Jennings JM, Houle S, Craik FI.Age-related differences in neural activity during memory encoding and retrieval: a positron emissiontomography study. J. Neurosci 1997;17:391?400. [PubMed: 8987764]
	11. Cabeza R, Grady CL, Nyberg L, McIntosh AR, Tulving E, Kapur S, Jennings JM, Houle S, Craik FI.Age-related differences in neural activity during memory encoding and retrieval: a positron emissiontomography study. J Neurosci 1997;17:391?400. [PubMed: 8987764]
	12. Courtney S, Ungerleider L, Keil K, Haxby J. Object and spatial visual working memory activateseparate neural systems in human cortex. Cerebral Cortex 1996;6:39?49. [PubMed: 8670637]
	13. Dolcos F, Rice HJ, Cabeza R. Hemispheric asymmetry and aging: right hemisphere decline orasymmetry reduction. Neurosci Biobehav Rev 2002;26:819?825. [PubMed: 12470693]
	14. Elderkin-Thompson V, Boone KB, Hwang S, Kumar A. Neurocognitive profiles in elderly patientswith frontotemporal degeneration or major depressive disorder. J Int Neuropsychol Soc2004;10:753?771. [PubMed: 15327722]
	15. Eslinger PJ, Flaherty-Craig CV, Benton AL. Developmental outcomes after early prefrontal cortexdamage. Brain Cogn 2004;55:84?103. [PubMed: 15134845]
	16. Gilboa A. Autobiographical and episodic memory--one and the same? Evidence from prefrontalactivation in neuroimaging studies. Neuropsychologia 2004;42:1336?1349. [PubMed: 15193941]
	17. Golski S, Zonderman A, Malamut B, Resnick S. Verbal and figural recognition memory: taskdevelopment and age associations. Exp Aging Res 1998;24:359?385. [PubMed: 9783155]
	18. Grady CL, Craik FI. Changes in memory processing with age. Curr Opin Neurobiol 2000;10:224?231. [PubMed: 10753795]
	19. Grady CL, Haxby JV, Horwitz B, Schapiro MB, Rapoport SI. Dissociation of object and spatial visionin human extrastriate cortex: age-related changes in activation of regional cerebral blood flowmeasured with 15O water and positron emission tomography. J. Cogn. Neurosci 1992;4:23?34.
	20. Grady CL, Maisog JM, Horwitz B, Ungerleider LG, Mentis MJ, Salerno JA, Pietrini P, Wagner E,Haxby JV. Age-related changes in cortical blood flow activation during visual processing of facesand location. J. Neurosci 1994;14:1450?1462. [PubMed: 8126548]
	21. Grady CL, McIntosh AR, Horwitz B, Maisog JM, Ungeleider LG, Mentis MJ, Pietrini P, SchapiroMB, Haxby JV. Age-related reductions in human recognition memory due to impaired encoding.Science 1995;269:218?221. [PubMed: 7618082]
	22. Grady CL, McIntosh AR, Rajah MN, Beig S, Craik FI. The effects of age on the neural correlates ofepisodic encoding. Cereb Cortex 1999;9:805?814. [PubMed: 10600999]
	23. Groenewegen HJ. The basal ganglia and motor control. Neural Plast 2003;10:107?120. [PubMed:14640312]
	24. Hazlett EA, Buchsbaum MS, Mohs RC, Spiegel-Cohen J, Wei TC, Azueta R, Haznedar MM, SingerMB, Shihabuddin L, Luu-Hsia C, Harvey PD. Age-related shift in brain region activity duringsucessful memory performance. Neurobiol Aging 1998;19:437?445. [PubMed: 9880046]
	25. Heyder K, Suchan B, Daum I. Cortico-subcortical contributions to executive control. Acta Psychol(Amst) 2004;115:271?289. [PubMed: 14962404]
	26. Hof P, Giannakopoulos P, Bouras C. The neuropathological changes associated with normal brainaging. Histol Histopathol 1996;11:1075?1088. [PubMed: 8930649]
	27. Hyman BT, Van Hoeson GW, Damasio AR. Memory-related neural systems in Alzheimer's disease.An anatomic study. Neurol 1990;40:1721?1730.
	28. Jernigan TL, Archibald MT, Berhow MT, Sowell ER, Foster DS, Hesselink JR. Cerebral structureon MRI, part 1: localization of age-related changes. Biol. Psychiatry 1991;29:55?67. [PubMed:2001446]
	29. Joliot M, Ribary U, Llinas R. Human oscillatory brain activity near 40 Hz coexists with cognitivetemporal binding. Proc Natl Acad Sci U S A 1994;91:11748?11751. [PubMed: 7972135]
	30. Karussis D, Leker RR, Abramsky O. Cognitive dysfunction following thalamic stroke: a study of 16cases and review of the literature. J Neurol Sci 2000;172:25?29. [PubMed: 10620656]
	31. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer'sdisease: the Baltimore Longitudinal Study of Aging. Neurology 2000;54:2072?2077. [PubMed:10851365]
	32. Kirschen MP, Chen SH, Schraedley-Desmond P, Desmond JE. Load- and practice-dependentincreases in cerebro-cerebellar activation in verbal working memory: an fMRI study. Neuroimage2005;24:462?472. [PubMed: 15627588]
	33. Kosslyn SM, Alpert NM, Thompson WL, Chabris CF, Rauch SL, Anderson AK. Identifying objectsseen from different viewpoints, a PET investigation. Brain 1994;117:1055?1071. [PubMed:7953588]
	34. Kostopoulos GK. Involvement of the thalamocortical system in epileptic loss of consciousness.Epilepsia 2001;42:13?19. [PubMed: 11520316]
	35. Landau SM, Schumacher EH, Garavan H, Druzgal TJ, D'Esposito M. A functional MRI study of theinfluence of practice on component processes of working memory. Neuroimage 2004;22:211?221.[PubMed: 15110011]
	36. Leenders KL, Perani D, Lammertsma A, Heather JD, Buckingham P, Helay MJR, Gibbs JM, WiseRJS, Hatazawa J, Herold S, Beany RP, Brooks DJ, Spinks T, Rhodes C, Frackowiak RSJ, Jones T.Cerebral blood flow, blood volume, and oxygen utilization. Normal values and the effect of age.Brain 1990;113:27?47. [PubMed: 2302536]
	37. Li SC, Lindenberger U, Sikstrom S. Aging cognition: from neuromodulation to representation. TrendsCogn Sci 2001;5:479?486. [PubMed: 11684480]
	38. Li SC, Sikstrom S. Integrative neurocomputational perspectives on cognitive aging, neuromodulation,and representation. Neurosci Biobehav Rev 2002;26:795?808. [PubMed: 12470691]
	39. Lindenberger U, Scherer H, Baltes PB. The strong connection between sensory and cognitiveperformance in old age: not due to sensory acuity reductions operating during cognitive assessment.Psychol Aging 2001;16:196?205. [PubMed: 11405308]
	40. Logan JM, Sanders AL, Snyder AZ, Morris JC, Buckner RL. Under-recruitment and nonselectiverecruitment: dissociable neural mechanisms associated with aging. Neuron 2002;33:827?840.[PubMed: 11879658]
	41. Lucas-Meunier E, Fossier P, Baux G, Amar M. Cholinergic modulation of the cortical neuronalnetwork. Pflugers Arch 2003;446:17?29. [PubMed: 12690458]
	42. Madden DJ, Gottlob LR, Allen PA. Adult age differences in visual search accuracy: attentionalguidance and target detectability. Psychol Aging 1999;14:683?694. [PubMed: 10632154]
	43. Madden DJ, Turkington TG, Coleman RE, Provenzale JM, DeGrado TR, Hoffman JM. Adult agedifferences in regional cerebral blood flow during visual world identification: evidence from H215OPET. Neuroimage 1996;3:127?142. [PubMed: 9345484]
	44. Madden DJ, Turkington TG, Provenzale JM, Denny LL, Hawk TC, Gottlob LR, Coleman RE. Adultage differences in the functional neuroanatomy of verbal recognition memory. Hum Brain Mapp1999;7:115?135. [PubMed: 9950069]
	45. Malach R, Reppas JB, Benson RR, Kwong KK, Jiang H, Kennedy WA, Ledden PJ, Brady TJ, RosenBR, Tootell RBH. Object-related activity revealed by functional magnetic resonance imaging in thehuman occipital cortex. Proc. Natl. Acad. Sci 1995;92:8135?8139. [PubMed: 7667258]
	46. Marsolek CJ, Kosslyn SM, Squire LR. Form-specific visual priming in the right cerebral hemisphere.J. Exp. Psychol 1992;18:492?508.
	47. Mishkin M, Ungerleider LG, Macko KA. Object vision and spatial vision: two cortical pathways.TINS 1983;6:414?417.
	48. Moffat S, Elkins W, Resnick S. Age Differences in the Neural Systems Supporting Human AllocentricSpatial Navigation. Neurobiol Aging. in press
	49. Paivio A, Yuille J, Madigan S. Concreteness, imagery, and meaningfulness values for 925 nouns. JExp Psychol 1968;76:1?25. [PubMed: 5672258]
	50. Pantano P, Baron J-C, Lebrun-Grandie P, Duquesnoy N, Bousser M-G, Comar M. Regional cerebralblood flow and oxygen consumption in human aging. Stroke 1984;15:635?641. [PubMed: 6611613]
	51. Park D, Polk T, Mikels J, Taylor S, Marshuetz C. Cerebral aging: integration of brain and behavioralmodels of cognitive function. Dialogues in Clinical Neuroscience 2001;3:151?166.
	52. Passingham D, Sakai K. The prefrontal cortex and working memory: physiology and brain imaging.Curr Opin Neurobiol 2004;14:163?168. [PubMed: 15082320]
	53. Powers, RE. Neurobiology of aging. In: Coffey, C.; Cummings, J.; Coffey, C.; Cummings, Js, editors.Textbook of Geriatric Neuropsychiatry. Washington, DC: The American Psychiatric Press; 1994. p.35-70.
	54. Puce A, Allison T, Asgari M, Gore JC, McCarthy G. Differential sensitivity of human visual cortexto faces, letterstrings and textures: a functional magnetic resonance study. J. Neurosci 1996;16:5205?5215. [PubMed: 8756449]
	55. Purpura KP, Victor JD. Processing of form in monkey area V1. Soc. Neurosci. Abstr 1990;16:293.
	56. Resnick S, Pham D, Kraut M, Zonderman A, Davatzikos C. Longitudinal magnetic resonance imagingstudies of older adults: a shrinking brain. J Neurosci 2003;23:3295?3301. [PubMed: 12716936]
	57. Resnick SM, Goldszal AF, Davatzikos C, Golski S, Kraut MA, Metter EJ, Bryan RN, ZondermanAB. One-year age changes in MRI brain volumes in older adults. Cereb Cortex 2000;10:464?472.[PubMed: 10847596]
	58. Resnick SM, Maki PM. Effects of hormone replacement therapy on cognitive and brain aging. AnnN Y Acad Sci 2001;949:203?214. [PubMed: 11795355]
	59. Reuter-Lorenz P, Jonides J, Smith E, Hartley A, Miller A, Marshuetz C, Koeppe R. Age differencesin the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci2000;12:174?187. [PubMed: 10769314]
	60. Reuter-Lorenz P, Marshuetz C, Jonides J, Smith E, Hartley A, Koeppe R. Neurocognitive ageing ofstorage and executive processes. Eur J Cogn Psychol 2001;13:257?278.
	61. Roland P, Gulyas B. Visual memory, visual imagery, and visual recognition of large field patternsby the human brain: functional anatomy by positron emission tomography. Cerebral Cortex1995;5:79?93. [PubMed: 7719132]
	62. Ronnlund M, Nyberg L, Backman L, Nilsson LG. Stability, growth, and decline in adult life spandevelopment of declarative memory: cross-sectional and longitudinal data from a population-basedstudy. Psychol Aging 2005;20:3?18. [PubMed: 15769210]
	63. Rypma B, D'Esposito M. Isolating the neural mechanisms of age-related changes in human workingmemory. Nat Neurosci 2000;3:509?515. [PubMed: 10769393]
	64. Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. BrainRes Brain Res Rev 1997;23:28?46. [PubMed: 9063585]
	65. Sayala S, Sala JB, Courtney SM. Increased Neural Efficiency with Repeated Performance of aWorking Memory Task is Information-type Dependent. Cereb Cortex. 2005
	66. Schacter DL, Rieman E, Uecker A, Polster MR, Yun LS, Cooper LA. Brain regions associated withretrieval of structurally coherent visual information. Nature 1995;376:587?590. [PubMed: 7637806]
	67. Schacter DL, Savage CR, Alpert NM, Rauch SL, Albert MS. The role of the hippocampus and frontalcortex in age-related memory changes: a PET study. NeuroReport 1996;7:1165?1169. [PubMed:8817525]
	68. Scheibel, A. Handbook on the Psychology of Aging. Fourth Edition. Academic Press, Inc.; 1996.Structural and functional changes in the aging brain.
	69. Schochet SS. Neuropathology of Aging. Neurol Clin 1988;16:569?580. [PubMed: 9666037]
	70. Schonknecht P, Pantel J, Kruse A, Schroder J. Prevalence and natural course of aging-associatedcognitive decline in a population-based sample of young-old subjects. Am J Psychiatry2005;162:2071?2077. [PubMed: 16263846]
	71. Shock, NW.; Greulich, RC.; Andres, R.; Arenberg, D.; Costa, PT., Jr; Lakatta, E.; Tobin, JD. Normalhuman aging: the Baltimore Longitudinal Study of Aging. Washington, D.C.: U.S. GovernmentPrinting Office; 1984.
	72. Talairach, J.; Tournoux, P. Co-planar stereotaxic atlas of the human brain. New York: Thieme MedicalPublishers, Inc.; 1988.
	73. Tomasi D, Ernst T, Caparelli EC, Chang L. Practice-induced changes of brain function during visualattention: a parametric fMRI study at 4 Tesla. Neuroimage 2004;23:1414?1421. [PubMed:15589105]
	74. Van der Werf YD, Scheltens P, Lindeboom J, Witter MP, Uylings HB, Jolles J. Deficits of memory,executive functioning and attention following infarction in the thalamus; a study of 22 cases withlocalised lesions. Neuropsychologia 2003;41:1330?1344. [PubMed: 12757906]
	75. van Turennout M, Bielamowicz L, Martin A. Modulation of neural activity during object naming:effects of time and practice. Cereb Cortex 2003;13:381?391. [PubMed: 12631567]
	76. Wiltgen BJ, Brown RA, Talton LE, Silva AJ. New circuits for old memories: the role of the neocortexin consolidation. Neuron 2004;44:101?108. [PubMed: 15450163]
	77. Yue NC, Arnold AM, Longstreth WT Jr, Elster AD, Jungreis CA, O'Leary DH, Poirier VC, BryanRN. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from thecardiovascular health study. Radiology 1997;202:33?39. [PubMed: 8988189]
nihms-17370.pdf	82
	1. Litsky W. Wanted: plastics with antimicrobial properties. Am J Public Health 1990;80:13?15.[PubMed: 2293796]
	2. Wendt C, Wiesenthal E, Dietz E, Rï¿½den H. Survival of vancomycin-resistant and vancomycin-susceptible Enterococci on dry surfaces. J Clin Microbiol 1998;36:3734?3736. [PubMed: 9817912]
	3. Neely AN, Maley MP. Survival of Enterococci and Staphylococci on hospital fabrics and plastic. JClin Microbiol 2000;38:724?726. [PubMed: 10655374]
	4. Scott E, Bloomfield SF, Barlow CG. An investigation of microbial contamination in the home. J HygCamb 1982;89:279?293. [PubMed: 7130703]
	5. Rubbo SD, Saunders J. Liberation of organisms from contaminated textiles. J Hyg Camb 1963;61:507?513. [PubMed: 14099028]
	6. Scott E, Bloomfield SF. The survival and transfer of microbial contamination via cloths, hands andutensils. J App Bacteriol 1990;68:271?278.
	7. Sattar SA, Springthorpe S, Mani S, Gallant M, Nair RC, Scott E. Transfer of bacteria from fabrics tohands and other fabrics: development and application of a quantitative method using Staphylococcusaureus as a model. J Appl Microbiol 2001;90:962?970. [PubMed: 11412326]
	8. Mackintosh CA, Hoffman PN. An extended model for transfer of micro-organisms via the hands:differences between organisms and the effect of alcohol disinfection. J Hyg Camb 1984;82:345?355.[PubMed: 6429238]
	9. McNeil E. Dissemination of microorganisms by fabrics and leather. Develop Ind Microbiol 1964;5:30?
	10. Whyte W. The role of clothing and drapes in the operating room. J Hosp Infect 1988;11(Suppl C):2?17. [PubMed: 2899119]
	11. Marples RR, Towers AG. A laboratory model for the investigation of contact transfer of micro-organisms. J Hyg Camb 1979;82:237?248. [PubMed: 429788]
	12. Fujita K, Lilly HA, Kidson A, Ayliffe GA. Gentamicin-resistant Pseudomonas aeruginosa infectionfrom mattresses in a burns unit. Br Med J 1981;283:219?220. [PubMed: 6789973]
	13. Sherertz RJ, Sullivan ML. An outbreak of infections with Acinetobacter calcoaceticus in burnpatients: contamination of patients' mattress. J Infect Dis 1985;151:252?258. [PubMed: 3968451]
	14. Weernink SWPJ, Tjernberg I, Dijkshoorn L. Pillows, an unexpected source of Acinetobacter. J HospInfect 1995;29:189?199. [PubMed: 7615936]
	15. Oliphant JW, Gordon DA, Meis A, Parker RR. Q fever in laundry workers, presumably transmittedfrom contaminated clothing. Am J Hyg 1949;49:76?82. [PubMed: 18108523]
	16. Standaert SM, Hutcheson RH, Schaffner W. Nosocomial transmission of Salmonella gastroenteritisto laundry workers in a nursing home. Infect Contr Hosp Epidemiol 1994;15:22?26.
	17. Binder S, Levitt AM, Sacks JJ, Hughes JM. Emerging infectious diseases: Public health issues forthe 21st century. Science 1999;284:1311?1313. [PubMed: 10334978]
	18. Lederberg J. Infectious history. Science 2000;288:287?293. [PubMed: 10777411]
	19. Vigo, TL. Advances in antimicrobial polymers and materials. In: Gebelein, C.; Carraher, C., editors.Biotechnology and Bioactive Polymers. Plenum Press; New York: 1994. p. 225-237.
	20. Gagliardi DD. Antibacterial finishes. Am Dyestuff Reptr 1962;51:31?40.
	21. Schierholz JM, Steinhauser H, Rump AFE, Berkels R, Pulverer G. Controlled release of antibioticsfrom biomedical polyurethanes: morphological and structural features. Biomaterials 1997;18:839?844. [PubMed: 9184747]
	22. Phaneuf MD, Bide MJ, Hannel SL, Platek MJ, Monahan TS, Contreras MA, Phaneuf TM, LoGerfoFW. Development of an infection-resistant, bioactive wound dressing surface. J Biomed Mater Res2005;74A:666?676.
	23. Aggarwal P, Phaneuf MD, Bide MJ, Sousa KA, LoGerfo FW. Development of an infection-resistantbifunctionalized Dacron biomaterial. J Biomed Mater Res 2005;75A:224?231.
	24. Klueh U, Wagner V, Kelly S, Johnson A, Bryers JD. Efficacy of silver-coated fabric to preventbacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res2000;53:621?631. [PubMed: 11074419]
	25. Bottenbos B, van der Mei HC, Klatter F, Nieuwenhuis P, Busscher HJ. In vitro and in vivoantimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber.Biomaterials 2002;23:1417?1423. [PubMed: 11829437]
	26. Liang J, Chen Y, Barnes K, Wu R, Worley SD, Huang TS. N-halamine/quat siloxane copolymers foruse in biocidal coatings. Biomaterials 2006;27:2495?2501. [PubMed: 16352336]
	27. Wehner, W.; Grade, R. Preparation of ammonium and phosphonium salts as biocides in the protectionof a variety of materials and water systems. Canadian Patent. No. CA2082994. 1993.
	28. Kobase, S.; Takerchi, H.; Sumita, M. Antimicrobial mats containing phosphonium compounds.Japanese Patent. No. JP2000316701. 2000.
	29. Sun G, Xu XJ. Durable and regenerable antibacterial finishing of fabrics: biocidal properties. TextileChemist and Colorist 1998;30:26?30.
	30. Sun YY, Sun G. Novel refreshable N-halamine polymeric biocides: grafting hydantoin-containingmonomers onto high performance fibers by a continuous process. J Appl Polym Sci 2003;88:1032?1039.
	31. Worley SD, Williams DE. Halamine water disinfectants. CRC Crit Rev Environ Control1988;18:133?175.
	32. Sun G, Chen TY, Worley SD. A novel biocidal styrenetriazinedione polymer. Polymer 1996;37:3753?3756.
	33. Sun YY, Sun G. Synthesis, characterization, and antibacterial activities of novel N-halamine polymerbeads prepared by suspension copolymerization. Macromolecules 2002;35:8909?8912.
	34. Chen ZB, Sun YY. N-chloro-hindered amines as multifunctional polymer additives. Macromolecules2005;38:8116?8119.
	35. Makal U, Wood L, Ohman DE, Wynne KJ. Polyurethane biocidal polymeric surface modifier.Biomaterials 2006;27:1316?1326. [PubMed: 16181672]
	36. Mora EC, Kohl HH, Wheatley WB, Worley SD, Faison JH, Burkett HD, Boder N. Properties of anew chloramines disinfectant and detoxicant. Poultry Science 1982;61:1968?1971.
	37. Burkett HD, Faison JH, Kohl HH, Wheatley WB, Worley SD, Bodor N. A novel chloraminescompound for water disinfection. Water Resources Bulletin 1981;17:874?879.
	38. Worley SD, Burkett HD, Price JF. The tendency of a new water disinfectant to produce toxictrihalomethanes. Water Resources Bulletin 1984;20:369?371.
	39. Chen ZB, Sun YY. Antimicrobial polymers containing melamine derivatives. II. Biocidal polymersderived from 2-vinyl-4,6-diamino-1,3,5-triazine. J Polym Sci Part A; Polym Chem 2005;43:4089?4098.
	40. Chen ZB, Sun YY. N-Halamine-based antimicrobial additives for polymers: Preparation,characterization, and antimicrobial activity. Ind Eng Chem Res 2006;45:2634?2640.
	41. Luo J, Chen ZB, Sun YY. Controlling biofilm formation with an N-halamine-based polymericadditive. J Biomed Mater Res 2006;77A:823?831.
	42. Dychdala, GR. Chlorine and chlorine compounds. In: Block, SS., editor. Disinfection, sterilizationand preservation. 3rd edition. Lea & Febiger; Philadelphia: 1983. p. 157-182.
	43. Kim SH, Bartholomew DG, Allen LB. Imidazo[1,2-a]-s-triazine nucleosides. Synthesis and antiviralactivity of the N-bridgehead guanine, guanosine, and guanosine monophosphate analogues ofimidazo[1,2-a]-s-triazine. J Med Chem 1978;21:883?889. [PubMed: 214563]
	44. Sun YY, Chen ZB, Braun M. Preparation, and physical and antimicrobial properties of a cellulose-supported chloromelamine derivative. Ind Eng Chem Res 2005;44:7916?7920.
	45. Richmond, JY.; McKinney, RW. Biosafaty in Microbiological and Biomedical Laboratories. 4th ed..U.S. Government Printing Office; Washington, DC: 1999.
	46. Tiller JC, Liao CJ, Lewis K, Klibanov AM. Designing surfaces that kill bacteria on contact. Proc NatlAcad Sci U.S.A 2001;98:5981?5985. [PubMed: 11353851]
	47. Tiller JC, Lee SB, Lewis K, Klibanov AM. Polymer surfaces derivatized with poly(vinyl-N-hexylpyridinium) kill airborne and water borne bacteria. Biotech and Bioeng 2002;79:465?471.
	48. Cen L, Neoh KG, Kang ET. Antibacterial activity of cloth functionalized with N-alkylated poly(4-vinylpyridine). J Biomed Mater Res 2004;74A:70?80.
	49. Miyamoto T, Sato Y, Shibata T, Inagaki H. C nuclear magnetic resonance studies of celluloseacetate. J Polym Sci: Polym Chem Ed 1984;22:2363?2370.
	50. Doyle S, Pethrick RA, Harris RK, Lane JM, Packer KJ, Heatley F. C nuclear magnetic resonancestudies of cellulose acetate in the solution and solid states. Polymer 1986;27:19?24.
	51. Goodlett VW, Dougherty JT, Patton HW. Characterization of cellulose acetates by nuclear magneticresonance. J Polym Sci: Part A-1 1971;9:155?160.
	52. Buchanan CM, Edgar KJ, Hyatt JA, Wilson AK. Preparation of cellulose [1-C] acetate anddetermination of monomer composition by NMR spectroscopy. Macromolecules 1991;24:3050?3059.
	53. Wu TK. Carbon-13 and proton nuclear magnetic resonance studies of cellulose nitrates.Macromolecules 1980;13:74?79.
	54. Helmer RD, Finch GR. Use of MS2 coliphage as a surrogate for enteric viruses in surface watersdisinfected with ozone. Ozone: Science and Engineering 1993;15:279?293.
	55. Duran AE, Muniesa M, Mendez X, Valero F, Lucena F, Jofre J. Removal and inactivation of indicatorbacteriophages in fresh waters. J App Microbiol 2002;92:338?347.
	56. Allwood PB, Malik YS, Hedberg CW, Goyal SM. Effect of temperature and sanitizers on survivalof feline calicivirus, Escherichia coli, and F-specific coliphage MS2 on leafy salad vegetables. J FoodProt 2004;67:1451?1456. [PubMed: 15270500]
	57. Allwood PB, Malik YS, Hedgerg CW, Goyal SM. Survival of F-specific RNA coliphage, felinecalicivirus, and Escherichia coli in water: a comparative study. App Environ Microbiol2003;69:5707?5710.
	58. Bloomfield SF, Arthur M. Mechanisms of inactivation and resistance of spores to chemical biocides.J Appl Bacteriol Symp Suppl 1994;76:91S?104S.
	59. Bloomfield SF, Megid R. Interaction of iodine with Bacillus subtilis spores and spore forms. J AppBacteriol 1994;76:492?499.
	60. Bayliss CE, Waites WM. The effect of hydrogen peroxide on spores of Clostridium bifermentans. JGen Microbiol 1976;96:401?407. [PubMed: 11274]
	61. Sheth NK, Franson TR, Sohnle PG. Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet 1985;326:1266?1268. [PubMed: 2866335]
	62. An YH, Friedman RJ. Prevention of sepsis in total joint arthroplasty. J Hosp Infect 1996;33:93?108.[PubMed: 8808743]
	63. Gray ED, Verstegen M, Peters G, Regelmann W. Effect of extracellular slime substance fromStaphylococcus epidermidis on the human cellular immune response. Lancet 1984;323:365?367.[PubMed: 6141426]
	64. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilmsin nature and disease. Ann Rev Microbiol 1987;41:435?464. [PubMed: 3318676]
	65. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms.Annu Rev Microbiol 1995;49:711?745. [PubMed: 8561477]
	66. Costerton JW, Stewart P, Greenberg EP. Bacterial biofilms: A common cause of persistant infections.Science 1999;284:1318?1322. [PubMed: 10334980]
	67. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999?1007. [PubMed:11257008]
	68. Ruseska I, Robbins J, Costerton JW, Lashen ES. Biocide testing against corrosion-causing oil-filedbacteria helps control plugging. Oil Gas J 1982;80:253?254,256.261-262,264
	69. Costerton JW. The formation of biocide-resistant biofilms in industrial, natural and medical systems.Dev Ind Microbiol 1984;25:363?372.
	70. http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html
	71. Zobell CE. The effect of solid surfaces upon bacterial activity. J Bacteriol 1943;46:39?56. [PubMed:16560677]
	72. An YH, Friedman RJ. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces.J Biomed Mater Res 1998;43:338?348. [PubMed: 9730073]
	73. Bodor N, Kaminski JJ, Worley SD, Colton RJ, Lee TH, Rabalais JW. Photoelectron spectra, hydrolyticstability, and antimicrobial activity of N-chlorinated piperidines. J Pharm Sci 1974;63:1387?1391.[PubMed: 4214917]
	74. Kaminski JJ, Bodor N, Higuchi T. N-halo derivatives III: stabilization of nitrogen-chlorine bond inN-chloramino acid derivatives. J Pharm Sci 1976;65:553?557. [PubMed: 1271254]
	75. Dychdala, GR. Disinfection, Sterilization and Preservation. 3rd edition. Block, SS., editor. Lea &Febiger; Philadelphia: 1983. p. 157-182.
	76. Williams DE, Swango LJ, Wilt GR, Worley SD. Effect of organic N-halamines on selected membranefunctions in intact Staphylococcus aureus cells. Appl Environ Microbio 1991;57:1121?1127.
	77. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. ClinMicrobiol Rev 1999;12:147?179. [PubMed: 9880479]
	78. Bloomfield SF, Arthur M. Effect of chlorine-releasing agents on Bacillus subtilis vegetative cells andspores. Lett Appl Microbiol 1989;8:101?104.
	79. Williams DE, Elder ED, Worley SD. Is free chlorine necessary for disinfection? App EnvironMicrobiol 1988;54:2583?2585.
	80. Wyatt LR, Waites WM. The effect of chlorine on spores of Clostridium bifermentans, Bacillussubtilis and Bacillus cereus. J Gen Microbiol 1975;89:337?344. [PubMed: 809541]
	81. Foegeding PM, Busta FF. Proposed mechanism for sensitization by hypochlorite treatment ofClostridium botulinum spores. Appl Environ Microbiol 1983;45:1374?1379. [PubMed: 6305269]
	82. Bloomfield SF, Arthur M. Interaction of Bacillus subtilis spores with sodium hypochlorite, sodiumdichloroisocyanurate and chloramine-T. J Appl Bacteriol 1992;72:166?172. [PubMed: 1556040]Chen et al.Page 15Scheme 1.Synthesis of ACHT through controlled hydrolysis of ADCTChen et al.Page 16Scheme 2.Preparation and probable structure of ACHT-immobilized cotton celluloseChen et al.Page 17Scheme 3.Dissociation of N-chloramine in aqueous solution.Chen et al.Page 18Fig. 1.C NMR spectra of esterified ACHT-immobilized cotton cellulose and pure ACHT (Solventsused were DMSO-d for the former and 70% DMSO-d + 15% DO + 15% NaOD for thelatter.)Chen et al.Page 19Fig. 2.UV-VIS spectra of pristine cotton and ACHT-immobilized cotton (Sample concentration was1 mg/ml in DMAc containing 8 wt% of LiCl)Chen et al.Page 20Fig. 3.Thermal properties of pristine cotton, ACHT-immobilized cotton and chlorinated ACHT-immobilized cotton fabricsChen et al.Page 21Fig. 4.Bactericidal effects of chlorinated ACHT-immobilized cotton fabrics against E. coli 15597 andS. aureus 6538 in airborne bactericidal testsChen et al.Page 22Fig. 5.SEM micrographs of unchlorinated and chlorinated ACHT-immobilized cotton fabrics inbiofilms-controlling studies (Bacteria species: E. coli, ATCC 15597).Chen et al.Page 23Fig. 6.Zone of inhibition of unchlorinated and chlorinated ACHT-immobilized cotton fabrics. Beforethis test, the ?dry? samples were conditioned at 23 ï¿½ 2 ï¿½C and 70 ï¿½ 5% RH for 24 h, and the?wet? samples were wetted with 100 ?l of sterile distilled water.Chen et al.Page 24Fig. 7.Positive chlorine content in the releasing solution (The initial chlorine content of thechlorinated ACHT-immobilized cotton fabrics was 7007 ppm.)Chen et al.Page 25Chen et al.Page 26Chen et al.Page 27Table 2Minimum contact time of chlorinated ACHT-immobilized cotton for a total kill of bacteria, yeast, and virus.MicroorganismsMinimum contact time for a total kill (min)Common bacteriaE. coli 155971.0S. aureus 65381.0E. coli 292140.5S. aureus 141540.5YeastC. tropicalis 626901.0VirusE. coli bacteriophage MS2 15597-B130 CFU (or PFU for MS2 virus)/ml; the biocidal tests followed AATCC Test Method 100-1999.Chen et al.Page 28Table 3Sporicidal efficacies of chlorinated ACHT-immobilized cotton fabrics against B. atrophaeus spores.Anti-spore activity at different original spore concentration (% reduction compared with the control)2ï¿½10 cells/ml2ï¿½10 cells/ml7ï¿½10 cells/ml5 min99%99%99%15 min99%99.50%99.43%30 min99.35%99.75%99.86%120 min100%99.95%99.99%240 min100%100%99.99%360 min100%100%100%
nihms27594.pdf	61
	Anonymous. Names for hi-jacking. Nature 1995;373:370. [PubMed: 7830775]
	Baumann K. Neue mikrotubuli-stabilisatoren. Jenseits von paclitaxel und docetaxel. Pharm Unserer Zeit2005;34:110?114. [PubMed: 15803794]
	Chase, M. The Wall Street Journal. New York: 1991 9 April. Clashing priorities: A new cancer drug mayextend lives - at cost of rare trees - that angers conservationists, who say taxol extraction endangersthe prized yew - pressure on Bristol-Myers too; p. A1
	Chaudhary AG, Rimoldi JM, Kingston DGI. Modified taxols. 10 Preparation of 7-deoxytaxol, a highlybioactive taxol derivative, and interconversions of taxol and 7-epitaxol. J Org Chem 1993;58:3798?3799.
	Chaudhary AG, Kingston DGI. Synthesis of 10-deacetoxytaxol and 10-deoxytaxotere. Tetrahedron Lett1993;34:4921?4924.
	Chaudhary AG, Gharpure MM, Rimoldi JM, Chordia MD, Gunatilaka AAL, Kingston DGI, Grover S,Lin CM, Hamel E. Unexpectedly facile hydrolysis of the 2-benzoate group of taxol and synthesis ofanalogs with increased activities. J Am Chem Soc 1994;116:4097?4098.
	Chen SH, Huang S, Kant J, Fairchild C, Wei J, Farina V. Synthesis of 7-deoxy- and 7,10-dideoxytaxolvia radical intermediates. J Org Chem 1993;58:5028?5029.
	Chordia MD, Chaudhary AG, Kingston DGI, Jiang YQ, Hamel E. Synthesis and biological evaluationof 4-deacetoxypaclitaxel. Tetrahedron Lett 1994;35:6843?6846.
	Cragg GM, Newman DJ. Plants as a source of anti-cancer and anti-HIV agents. Ann Appl Biol2003;143:127?133.
	Croteau R, Ketchum REB, Long RM, Kaspera R, Wildung MR. Taxol biosynthesis and moleculargenetics. Phytochem Rev 2006;5:75?97.
	Davies AM, Lara PN, Mack PC, Gandara DR. Docetaxel in non-small cell lung cancer: A review. ExpertOpin Pharmacother 2003;4:553?65. [PubMed: 12667118]
	Denis JN, Greene AE, Guenard D, Gueritte-Voegelein F, Mangatal L, Potier P. A highly efficient,practical approach to natural taxol. J Am Chem Soc 1988;110:5917?5919.
	Dubois J, Guenard D, Gueritte-Voeglein F, Guedira N, Potier P, Gillet B, Betoeil JC. Conformation oftaxotere and analogues determined by NMR spectroscopy and molecular modeling studies.Tetrahedron 1993;49:6533?6544.
	Fang WS, Liang XT. Recent progress in structure activity relationship and mechanistic studies of taxolanalogues. Mini-Rev Med Chem 2005;5:1?12. [PubMed: 15638787]
	Ganesh T, Guza RC, Bane S, Ravindra R, Shanker N, Lakdawala AS, Snyder JP, Kingston DGI. Thebioactive taxol conformation of ?-tubulin: Experimental evidence from highly active constrainedanalogs. Proc Natl Acad Sci USA 2004;101:10006?10011. [PubMed: 15226503]
	Ganesh T, Norris A, Sharma S, Bane S, Alcaraz AA, Snyder JP, Kingston DGI. Design, synthesis, andbioactivity of simplified paclitaxel analogs based on the T-taxol bioactive conformation. Bioorg MedChem 2006a;14:3447?3454. [PubMed: 16434198]
	Ganesh T, Yang C, Norris A, Glass T, Bane S, Ravindra R, Banerjee A, Metaferia B, Thomas SL,Giannakakou P, Alcaraz AA, Lakdawala AS, Snyder JP, Kingston DGI. Evaluation of the tubulin-bound paclitaxel conformation: Synthesis, biology and SAR studies of C-4 to C-3? bridged paclitaxelanalogs. J Med Chem 2007;5:713?725. [PubMed: 17263521]
	Geney R, Chen J, Ojima I. Recent advances in the new generation taxane anticancer agents. MedicinalChemistry 2005a;1:125?139. [PubMed: 16787308]
	Geney R, Sun L, Pera P, Bernacki RJ, Xia S, Horwitz SB, Simmerling CL, Ojima I. Use of the tubulinbound paclitaxel conformation for structure-based rational drug design. Chem & Biol 2005b;12:339?348. [PubMed: 15797218]
	Gueritte, F.; Fahy, J. The vinca alkaloids. In: Cragg, GM.; Kingston, DGI.; Newman, DJ., editors.Anticancer Agents from Natural Products. Taylor and Francis; Boca Raton, Florida: 2005. p. 123-136.
	Gueritte-Voegelein F, Senilh V, David B, Guenard D, Potier P. Chemical studies of 10-deacetyl baccatinIII. Hemisynthesis of taxol derivatives. Tetrahedron 1986;42:4451?4460.
	Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK,Hortobagyi GN. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. JNat Cancer Inst 1991;83:1797?1805. [PubMed: 1683908]
	Holton, RA.; Biediger, RJ.; Boatman, PD. Semisynthesis of taxol and taxotere. In: Suffness, M., editor.Taxol: Science and Applications. CRC Press, Inc; Boca Raton, FL: 1995. p. 97-121.
	Itokawa, H. Introduction. In: Itokawa, H.; Lee, K-H., editors. Taxus The Genus Taxus. Taylor and Francis;London and New York: 2003. p. 1-18.
	Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drugconjugates. Bioorg & Med Chem 2005;13:5043?5054. [PubMed: 15955702]
	Johnson SA, Alcaraz AA, Snyder JP. T-taxol and the electron crystallographic density in ?-tubulin. OrgLett 2005;7:5549?5552. [PubMed: 16320988]
	Kingston DGI. Taxol, a molecule for all seasons. Chem Commun 2001:867?880.
	Kingston DGI, Chordia MD, Jagtap PG. Synthesis and biological evaluation of 1-deoxypaclitaxelanalogues. J Org Chem 1999;64:1814?1822. [PubMed: 11674269]
	Kingston DGI, Newman DJ. Mother nature?s combinatorial libraries; their influence on the synthesis ofdrugs. Curr Opinion Drug Disc Develop 2002;5:304?316.
	Kingston, DGI.; Jagtap, PG.; Yuan, H.; Samala, L. The chemistry of taxol and related taxoids. In: Herz,W.; Falk, H.; Kirby, GW., editors. Progress in the Chemistry of Organic Natural Products. 84.Springer; Wien: 2002. p. 53-225.
	Kingston DGI, Bane S, Snyder JP. The taxol pharmacophore and the T-taxol bridging principle. CellCycle 2005;4:279?289. [PubMed: 15611640]
	Leistner E. Arzneimittel aus der natur. Die Biologie der taxane. Pharm Unserer Zeit 2005;34:98?103.[PubMed: 15803792]
	Li Y, Poliks B, Cegelski L, Poliks M, Cryczynski Z, Piszczek G, Jagtap PG, Studelska DR, KingstonDGI, Schaefer J, Bane S. Conformation of microtubule-bound paclitaxel determined by fluorescencespectroscopy and redor nmr. Biochemistry 2000;39:281?291. [PubMed: 10630987]
	McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, DonehowerRC. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelialneoplasms. Ann Intern Med 1989;111:273?279. [PubMed: 2569287]
	Metaferia BB, Hoch J, Glass TE, Bane SL, Chatterjee SK, Snyder JP, Lakdawala A, Cornett B, KingstonDGI. Synthesis and biological evaluation of novel macrocyclic paclitaxel analogues. Org Lett2001;3:2461?2464. [PubMed: 11483035]
	Nabholtz JM, Tonkin K, Smylie M, Au HJ, Lindsay MA, Mackey J. Chemotherapy of breast cancer: Arethe taxanes going to change the natural history of breast cancer. Expert Opin Pharmacother2000;1:187?206. [PubMed: 11249542]
	Neidigh KA, Gharpure MM, Rimoldi JM, Kingston DGI, Jiang YQ, Hamel E. Synthesis and biologicalevaluation of 4-deacetylpaclitaxel. Tetrahedron Lett 1994;35:6839?6842.
	Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981?2002. J Nat Prod 2003;66:1022?1037. [PubMed: 12880330]
	Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ. A commonpharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci1999;96:4256?4261. [PubMed: 10200249]
	Ozols RF. Progress in ovarian cancer: An overview and perspective. EJC Supp 2003;1:43?55.
	Paik Y, Yang C, Metaferia B, Tang S, Bane S, Ravindra R, Shanker N, Alcaraz AA, Snyder JP, SchaeferJ, O?Connor RD, Cegelski L, Kingston DGI. REDOR NMR distance measurements of the tubulin-bound paclitaxel conformation. J Am Chem Soc 2007;129:361?370. [PubMed: 17212416]
	Paloma LG, Guy RK, Wrasidlo W, Nicolaou KC. Conformation of a water-soluble derivative of taxol inwater by 2d-nmr spectroscopy. Chem Biol 1994;1:107?112. [PubMed: 9383378]
	Phillipson JD. Phytochemistry and medicinal plants. Phytochemistry 2001;56:237?243. [PubMed:11243450]
	Piccart MJ, Cardoso F. Progress in systemic therapy for breast cancer: An overview and perspectives.EJC Supp 2003;1:56?69.
	Samaranayake G, Magri NF, Jitrangsri C, Kingston DGI. Modified taxols. 5. Reaction of taxol withelectrophilic reagents and preparation of a rearranged taxol derivative with tubulin assembly activity.J Org Chem 1991;56:5114?5119.
	Sankawa, U.; Itokawa, H. Biosynthesis of taxoids. In: Itokawa, H.; lee, K-H., editors. Taxus. The genustaxus. Taylor and Francis; London and New York: 1993. p. 19-34.
	Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature1979;277:665?667. [PubMed: 423966]
	Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E. The binding conformation of taxol in ?-tubulin: A model based on the electron crystallographic density. Proc Natl Acad Sci USA2001;98:5312?5316. [PubMed: 11309480]
	Srivastava V, Negi AS, Kumar JK, Gupta MM, Khanuja PS. Plant-based anticancer molecules: Achemical and biological profile of some important leads. Bioorg Med Chem 2005;13:5892?5908.[PubMed: 16129603]
	Stierle A, Strobel G, Stierle D. Taxol and taxane production by Taxomyces andreanae, an endophyticfungus of pacific yew. Science 1993;260:214?216. [PubMed: 8097061]
	Suffness, M.; Wall, ME. Discovery and development of taxol. In: Suffness, M., editor. Taxol: Scienceand Applications. CRC Press, Inc; Boca Raton, FL: 1995. p. 3-25.
	Tang S, Yang C, Brodie P, Bane S, Ravindra R, Sharma S, Jiang Y, Snyder JP, Kingston DGI. Bridgingconverts a noncytotoxic nor-paclitaxel derivative to a cytotoxic analogue by constraining it to the T-taxol conformation. Org Lett 200 2006;8:3938?3986.
	Vander Velde DG, Georg GI, Grunewald GL, Gunn CW, Mitscher LA. ?Hydrophobic collapse? Of taxoland taxotere solution conformations in mixtures of water and organic solvent. J Am Chem Soc1993;115:11650?11651.
	Walker, K.; Croteau, R. Taxol biosynthesis: A review of some determinant steps. In: Romeo, editor.Phytochemicals in Human Health Protection, Nutrition, and Plant Defense. Kluwer Academic/Plenum Publishers; New York: 1999. p. 31-51.
	Walsh V, Goodman J. From taxol to Taxol: The changing identities and ownership of an anticancerdrug. Med Anthropol 2002;21:307?336. [PubMed: 12458837]
	Wang, H-K.; Ohtsu, H.; Itokawa, I. Chemistry of taxol and related taxoids. In: Itokawa, H.; Lee, K-H.,editors. Taxus. The Genus Taxus. Taylor and Francis; London and New York: 2003. p. 213-244.
	Wang, X.; Itokawa, I.; Lee, K-H. Structure-activity relationships of taxoids. In: Itokawa, H.; Lee, K-H.,editors. Taxus. The Genus Taxus. Taylor and Francis; London and New York: 2003. p. 298-386.
	Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI The isolation andstructure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc1971;93:2325?2327. [PubMed: 5553076]
	Wiernik PH, Schwartz EL, Enzig A, Strauman JJ, Lipton RB, Dutcher JP. Phase I trial of taxol given asa 24-hour infusion every 21 days: Responses observed in metastatic melanoma. J Clin Oncol1987;5:1232?1239. [PubMed: 2887641]
	Williams HJ, Scott AI, Dieden RA, Swindell CS, Chirlian LE, Francl MM, Heerding JM, Krauss NE.NMR and molecular modeling study of active and inactive taxol analogues in aqueous andnonaqueous solution. Can J Chem 1994;72:252?260.
	Zhang ZX, Zhang HX, Yang Q-l. Advances on research and development of taxol analogues. Nat ProdRes Dev 2005;17:810?817.
Hum. Reprod.-2007-Ng-1134-41.pdf	44
	AbulafiaOandShererDM(2000)Angiogenesisoftheovary.AmJObstetGynecol182,240?246.
	AlcazarJLandRuiz-PerezML(2000)Uteroplacentalcirculationinpatientswithfirsttrimesterthreatenedabortion.FertilSteril73,130?135.
	AlemanA,AlthabeF,BelizanJandBergelE(2005)Bedrestduringpregnancyforpreventingmiscarriage.CochraneDatabaseSystRev2,CD003576.
	AltmanDGandBlandJM(1994)Diagnostictests3:receiveroperatingcharacteristicplots.BMJ309,188?190.
	CliffordK,RaiRandReganL(1997)Futurepregnancyoutcomeinunexplainedrecurrentfirsttrimestermiscarriage.HumReprod12,387?389.
	DickeyRP(1997)Dopplerultrasoundinvestigationofuterineandovarianbloodflowininfertilityandearlypregnancy.HumReprodUpdate3,467?503.
	FauserBC,DevroeyPandMacklonNS(2005)Multiplebirthresultingfromovarianstimulationforsubfertilitytreatment.Lancet365,1807?1816.
	FratesMC,DoubiletPM,BrownDL,BensonCB,DiSalvoDN,LaingFC,BerckDJandHillJA(1996)RoleofDopplerultrasonographyinthepredictionofpregnancyoutcomeinwomenwithrecurrentspontaneousabortion.JUltrasoundMed15,557?562.
	FriedlerS,SchenkerJG,HermanAandLewinA(1996)Theroleofultrasonographyintheevaluationofendometrialreceptivityfollowingassistedreproductivetreatments:acriticalreview.HumReprodUpdate2,323?335.
	GannonBJ,CaratiCJandVercoCJ(1977)EndometrialperfusionacrossthenormalhumanmenstrualcycleassessedbylaserDopplerfluxmetry.HumReprod12,132?139.
	GiacobbeM,ZeferinoLC,FranzinCMandFaundesA(2002)Uteroplacentalcirculationduringthefirsttrimesterofnormalandabnormalpregnancy.ReprodBiomedOnline4,62?67.
	HabaraT,NakatsukaM,KonishiH,AsagiriK,NoguchiSandKudoT(2002)Elevatedbloodflowresistanceinuterinearteriesofwomenwithunexplainedrecurrentpregnancyloss.HumReprod17,190?194.
	HassoldTJ(1986)Chromosomeabnormalitiesinhumanreproductivewastage.TrendsGenet2,105?110.
	HustinJ,JauniauxERandSchappsJP(1990)Histologicalstudyofthematerno-embryonicinterfaceinspontaneousabortion.Placenta11,477?486.
	IsakssonR,TiitinenAandCacciatroreB(2000)Uterinearteryimpedancetobloodflowonthedayofembryotransferdoesnotpredictobstetricoutcome.UltrasoundObstetGynecol15,527?530.
	JauniauxE,JohnsJandBurtonGJ(2005)Theroleofultrasoundimagingindiagnosingandinvestigatingearlypregnancyfailure.UltrasoundObstetGynecol25,613?624.
	JinnoM,OzakiT,IwashitaM,NakamuraY,KudoAandHiranoH(2001)Measurementofendometrialtissuebloodflow:anovelwaytoassessuterinereceptivityforimplantation.FertilSteril76,1168?1174.
	KupesicS,BekavacI,BjelosDandKurjakA(2001)AssessmentofendometrialreceptivitybytransvaginalcolorDopplerandthree-dimensionalpowerDopplerultrasonographyinpatientsundergoinginvitrofertilizationprocedures.JUltrasoundMed20,125?134.
	LaSalaGB,NuceraG,GallinelliA,NicoliA,VillaniMTandBlicksteinI(2004)Spontaneousembryoniclossfollowinginvitrofertilization:incidenceandeffectonoutcomes.AmJObstetGynecol191,741?746.
	MakikallioK,TekayAandJouppilaP(2001)Effectsofbleedingonuteroplacental,umbilicoplacentalandyolk-sachemodynamicsinearlypregnancy.UltrasoundObstetGynecol18,352?356.
	NakatsukaM,HabaraT,NoguchiS,KonishiHandKudoT(2003)Impaireduterinearterialbloodflowinpregnantwomenwithrecurrentpregnancyloss.JUltrasoundMed22,27?31.
	NgEHYandHoPC(2002)Dopplerultrasoundexaminationofuterinearteriesonthedayofoocyteretrievalinpatientswithuterinefibroidsundergoinginvitrofertilizationtreatment.HumReprod17,765?770.
	NgEHY,YeungWSB,LauEYL,SoWWKandHoPC(2000)HighserumoestradiollevelsinfreshIVFcyclesdonotimpairimplantationandpregnancyratesinsubsequentFETcycles.HumReprod15,250?255.
	NgEHY,ChanCCW,TangOS,YeungWSBandHoPC(2004a)Endometrialandsubendometrialbloodflowmeasuredduringearlylutealphasebythree-dimensionalPowerDopplerultrasoundinexcessiveovarianresponders.HumReprod19,924?931.
	NgEHY,ChanCCW,TangOS,YeungWSBandHoPC(2004b)Comparisonofendometrialandsubendometrialbloodflowmeasuredbythree-dimensionalpowerDopplerultrasoundbetweenstimulatedandnaturalcyclesinthesamepatients.HumReprod19,2385?2390.
	NgEHY,ChanCCW,TangOS,YeungWSBandHoPC(2005)Endometrialandsubendometrialbloodflowmeasuredbythree-dimensionalpowerDopplerultrasoundinpatientswithsmallintramuralfibroidsduringinvitrofertilizationtreatment.HumReprod20,501?506.
	NgEHY,ChanCCW,TangOS,WSBYeungandHoPC(2006a)Theroleofendometrialandsubendometrialbloodflowmeasuredbythree-dimensionalpowerDopplerultrasoundinthepredictionofpregnancyduringinvitrofertilizationtreatment.HumReprod21,164?170.
	NgEHY,ChanCCW,TangOS,WSBYeungandHoPC(2006b)Theroleofendometrialandsubendometrialvascularitymeasuredbythree-dimensionalpowerDopplerultrasoundinthepredictionofpregnancyduringfrozen-thawedembryotransfercycles.HumReprod21,1612?1617.
	NgEHY,ChanCCW,TangOS,WSBYeungandHoPC(2006c)Relationshipbetweenuterinebloodflowandendometrialandsubendometrialbloodflowduringstimulatedandnaturalcycles.FertilSteril85,721?727.
	NyboAndersenAM,WohlfahrtJ,ChristensP,OlsenJandMelbyeM(2000)Maternalageandfetalloss:populationbasedregisterlinkagestudy.BMJ320,1708?1712.
	PairleitnerH,SteinerH,HasenoehrlGandStaudachA(1999)Three-dimensionalpowerDopplersonography:imagingandquantifyingbloodflowandvascularization.UltrasoundObstetGynecol14,139?143.
	PellizzariP,PozzanC,MarchioriS,ZenTandGangemiM(2002)Assessmentofuterinearterybloodflowinnormalfirsttrimesterpregnanciesandinthosecomplicatedbyuterinebleeding.UltrasoundObstetGynecol19,366?370.
	Raine-FenningNJ,CampbellBK,KendallNR,ClewesJSandJohnsonIR(2004)Quantifyingthechangesinendometrialvascularitythroughoutthenormalmenstrualcyclewiththree-dimensionalpowerDopplerangiography.HumReprod19,330?338.
	RubinsteinM,MarazziAandPolakdeFriedE(1999)Low-doseaspirintreatmentimprovesovarianresponsiveness,uterineandovarianbloodflowvelocity,implantation,andpregnancyratesinpatientsundergoinginvitrofertilization:aprospective,randomized,double-blindplacebo-controlledassay.FertilSteril71,825?829.
	SchieveLA,TathamL,PetersonHB,TonerJandJengG(2003)SpontaneousabortionamongpregnanciesconceivedusingassistedreproductivetechnologyintheUnitedStates.ObstetGynecol101,959?967.
	SchildRL,HolthanusS,AlquenJD,FimmersR,DornC,vanderVenHandHansmannM(2000)Quantitativeassessmentofsubendometrialbloodflowbythree-dimensional-ultrasoundisanimportantpredictivefactorofimplantationinanin-vitrofertilizationprogramme.HumReprod15,89?94.
	SherGandFischJD(2000)Vaginalsildenafil(Viagra):apreliminaryreportofanovelmethodtoimproveuterinearterybloodflowandendometrialdevelopmentinpatientsundergoingIVF.HumReprod15,806?809.
	SherG,HerbertC,MaassaraniGandJacobsMH(1991)Assessmentofthelateproliferativephaseendometriumbyultrasonographyinpatientsundergoingin-vitrofertilizationandembryotransfer(IVF/ET).HumReprod6,232?237.
	SmithSK(2001)Regulationofangiogenesisintheendometrium.TrendsEndocrinolMetab12,147?151.
	TheRotterdamESHRE/ASRM-SponsoredPCOSConsensusWorkshopGroup(2004)Revised2003consensusondiagnosticcriteriaandlong-termhealthrisksrelatedtopolycysticovarysyndrome.HumReprod19,41?47.
	TurnbullLW,LesnyPandKillickSR(1995)Assessmentofuterinereceptivitypriortoembryotransfer:areviewofcurrentlyavailableimagingmodalities.HumReprodUpdate1,505?514.
	WinterE,WangJ,DaviesMJandNormanR(2002)Earlypregnancylossfollowingassistedreproductivetechnologytreatment.HumReprod17,3220?3223.
	WoelferB,SalimR,BanerjeeS,ElsonJ,ReganLandJurkovicD(2001)Reproductiveoutcomesinwomenwithcongenitaluterineanomaliesdetectedbythree-dimensionalultrasoundscreening.ObstetGynecol98,1099?1103.
	WuHM,ChiangCH,HuangHY,ChaoAS,WangHSandSoongYK(2003)Detectionofthesubendometrialvascularizationflowindexbythree-dimensionalultrasoundmaybeusefulforpredictingthepregnancyrateforpatientsundergoinginvitrofertilization-embryotransfer.FertilSteril79,507?511.
23.full.pdf	58
	Audebert, M., Charbonnier, J. B., Boiteux, S. and Radicella, J. P.(2002).Mitochondrial targeting of human 8-oxoguanine DNA glycosylase hOGG1 is impairedby a somatic mutation found in kidney cancer. DNA Repair Amst.1, 497-505.
	Banerjee, A., Yang, W., Karplus, M. and Verdine, G. L.(2005). Structure of a repairenzyme interrogating undamaged DNA elucidates recognition of damaged DNA.Nature434, 612-618.
	Besaratinia, A., Bates, S. E., Synold, T. W. and Pfeifer, G. P.(2004a). Similarmutagenicity of photoactivated porphyrins and ultraviolet A radiation in mouseembryonic fibroblasts: involvement of oxidative DNA lesions in mutagenesis.Biochemistry43, 15557-15566.
	Besaratinia, A., Synold, T. W., Xi, B. and Pfeifer, G. P.(2004b). G-to-T transversionsand small tandem base deletions are the hallmark of mutations induced by ultravioleta radiation in mammalian cells. Biochemistry43, 8169-8177.
	Bhakat, K. K., Mokkapati, S. K., Boldogh, I., Hazra, T. K. and Mitra, S.(2006).Acetylation of human 8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol. Cell. Biol. 26, 1654-1665.
	Bode, J., Benham, C., Ernst, E., Knopp, A., Marschalek, R., Strick, R. and Strissel,P.(2000). Fatal connections: when DNA ends meet on the nuclear matrix.J. CellBiochem. Suppl.35, 3-22.
	Bravard, A., Vacher, M., Gouget, B., Coutant, A., Hillairet de Boisferon, F., Marsin,S., Chevillard, S. and Radicella, J. P.(2006). Redox regulation of human OGG1activity in response to cellular oxidative stress. Mol. Cell. Biol. 26, 7430-7436.
	Campalans, A., Marsin, S., Nakabeppu, Y., O?Connor, T. R., Boiteux, S. andRadicella, J. P.(2005). XRCC1 interactions with multiple DNA glycosylases: a modelfor its recruitment to base excision repair. DNA Repair Amst.4, 826-835.
	Ching, R. W., Dellaire, G., Eskiw, C. H. and Bazett-Jones, D. P.(2005). PML bodies:a meeting place for genomic loci? J. Cell Sci. 118, 847-854.
	Cook, P. R.(1999). The organization of replication and transcription. Science284, 1790-1795.
	Cremer, T. and Cremer, C.(2001). Chromosome territories, nuclear architecture andgene regulation in mammalian cells.Nat. Rev. Genet.2, 292-301.
	Dantzer, F., Luna, L., Bjoras, M. and Seeberg, E.(2002). Human OGG1 undergoesserine phosphorylation and associates with the nuclear matrix and mitotic chromatinin vivo. Nucleic Acids Res. 30, 2349-2357.
	Dellaire, G. and Bazett-Jones, D. P.(2004). PML nuclear bodies: dynamic sensors ofDNA damage and cellular stress. BioEssays 26, 963-977.
	Drouet, J., Delteil, C., Lefrancois, J., Concannon, P., Salles, B. and Calsou, P.(2005).DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell inresponse to DNA double strand breaks. J. Biol. Chem.280, 7060-7069.
	Duez, P., Hanocq, M. and Dubois, J.(2001). Photodynamic DNA damage mediated bydelta-aminolevulinic acid-induced porphyrins. Carcinogenesis22, 771-778.
	El-Khamisy, S. F., Masutani, M., Suzuki, H. and Caldecott, K. W.(2003). Arequirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sitesof oxidative DNA damage. Nucleic Acids Res. 31, 5526-5533.
	Emonet, N., Leccia, M. T., Favier, A., Beani, J. C. and Richard, M. J.(1997). Thiolsand selenium: protective effect on human skin fibroblasts exposed to UVA radiation.J. Photochem. Photobiol. B Biol.40, 84-90.
	Fujita, M., Ishimi, Y., Nakamura, H., Kiyono, T. and Tsurumi, T.(2002). Nuclearorganization of DNA replication initiation proteins in mammalian cells. J. Biol. Chem.277, 10354-10361.
	Gorski, S. A., Dundr, M. and Misteli, T.(2006). The road much traveled: trafficking inthe cell nucleus.Curr. Opin. Cell Biol. 18, 284-290.
	Halford, S. E. and Marko, J. F.(2004). How do site-specific DNA-binding proteins findtheir targets? Nucleic Acids Res. 32, 3040-3052.
	Handwerger, K. E. and Gall, J. G.(2006). Subnuclear organelles: new insights into formand function. Trends Cell Biol. 16, 19-26.
	He, Y. Y., Huang, J. L., Ramirez, D. C. and Chignell, C. F.(2003). Role of reducedglutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA.J. Biol. Chem.278, 8058-8064.
	Hollenbach, S., Dhenaut, A., Eckert, I., Radicella, J. P. and Epe, B.(1999).Overexpression of Ogg1 in mammalian cells: effects on induced and spontaneousoxidative DNA damage and mutagenesis. Carcinogenesis20, 1863-1868.
	Houstis, N., Rosen, E. D. and Lander, E. S.(2006). Reactive oxygen species have acausal role in multiple forms of insulin resistance. Nature440, 944-948.
	Hu, J., Imam, S. Z., Hashiguchi, K., de Souza-Pinto, N. C. and Bohr, V. A.(2005).Phosphorylation of human oxoguanine DNA glycosylase (alpha-OGG1) modulates itsfunction. Nucleic Acids Res. 33, 3271-3282.
	Jin, Y. H., Clark, A. B., Slebos, R. J., Al-Refai, H., Taylor, J. A., Kunkel, T. A.,Resnick, M. A. and Gordenin, D. A.(2003). Cadmium is a mutagen that acts byinhibiting mismatch repair. Nat. Genet. 34, 326-329.
	Jurkiewicz, B. A. and Buettner, G. R.(1994). Ultraviolet light-induced free radicalformation in skin: an electron paramagnetic resonance study. Photochem. Photobiol.59, 1-4.
	Kozmin, S., Slezak, G., Reynaud-Angelin, A., Elie, C., de Rycke, Y., Boiteux, S. andSage, E.(2005). UVA radiation is highly mutagenic in cells that are unable to repair7,8-dihydro-8-oxoguanine in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA102, 13538-13543.
	Lamond, A. I. and Spector, D. L.(2003). Nuclear speckles: a model for nuclearorganelles.Nat. Rev. Mol. Cell Biol. 4, 605-612.
	Lan, L., Nakajima, S., Oohata, Y., Takao, M., Okano, S., Masutani, M., Wilson, S.H. and Yasui, A.(2004). In situ analysis of repair processes for oxidative DNA damagein mammalian cells. Proc. Natl. Acad. Sci. USA101, 13738-13743.
	Lee, J. H. and Skalnik, D. G.(2005). CpG-binding protein (CXXC finger protein 1)is a component of the mammalian Set1 histone H3-Lys4 methyltransferase complex,the analogue of the yeast Set1/COMPASS complex. J. Biol. Chem.280, 41725-41731.
	Liu, B., Wang, J., Chan, K. M., Tjia, W. M., Deng, W., Guan, X., Huang, J. D., Li,K. M., Chau, P. Y., Chen, D. J. et al.(2005). Genomic instability in laminopathy-based premature aging.Nat. Med.11, 780-785.
	Luna, L., Rolseth, V., Hildrestrand, G. A., Otterlei, M., Dantzer, F., Bjoras, M. andSeeberg, E.(2005). Dynamic relocalization of hOGG1 during the cell cycle isdisrupted in cells harbouring the hOGG1-Cys326 polymorphic variant. Nucleic AcidsRes. 33, 1813-1824.
	Marsin, S., Vidal, A. E., Sossou, M., Menissier-de Murcia, J., Le Page, F., Boiteux,S., de Murcia, G. and Radicella, J. P.(2003). Role of XRCC1 in the coordinationand stimulation of oxidative DNA damage repair initiated by the DNA glycosylasehOGG1. J. Biol. Chem.278, 44068-44074.
	Misteli, T.(2000). Cell biology of transcription and pre-mRNA splicing: nucleararchitecture meets nuclear function. J. Cell Sci. 113, 1841-1849.
	Misteli, T.(2005). Concepts in nuclear architecture. BioEssays 27, 477-487.
	Misteli, T., Caceres, J. F. and Spector, D. L.(1997). The dynamics of a pre-mRNAsplicing factor in living cells. Nature387, 523-527.
	Monï¿½, M. J., Volker, M., Nikaido, O., Mullenders, L. H., van Zeeland, A. A.,Verschure, P. J., Manders, E. M. and van Driel, R.(2001). Local UV-induced DNAdamage in cell nuclei results in local transcription inhibition. EMBO Rep.2, 1013-1017.
	Morley, N., Curnow, A., Salter, L., Campbell, S. and Gould, D.(2003). N-acetyl-L-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in humanfibroblasts. J. Photochem. Photobiol. B Biol.72, 55-60.
	Mortier, E., Wuytens, G., Leenaerts, I., Hannes, F., Heung, M. Y., Degeest, G., David,G. and Zimmermann, P.(2005). Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions. EMBO J. 24, 2556-2565.
	Mullenders, L. H., van Kesteren van Leeuwen, A. C., van Zeeland, A. A. andNatarajan, A. T.(1988). Nuclear matrix associated DNA is preferentially repaired innormal human fibroblasts, exposed to a low dose of ultraviolet light but not inCockayne?s syndrome fibroblasts. Nucleic Acids Res. 16, 10607-10622.
	Nash, H. M., Lu, R., Lane, W. S. and Verdine, G. L.(1997). The critical active-siteamine of the human 8-oxoguanine DNA glycosylase, hOgg1: direct identification,ablation and chemical reconstitution. Chem. Biol. 4, 693-702.
	Nelms, B. E., Maser, R. S., MacKay, J. F., Lagally, M. G. and Petrini, J. H.(1998).In situ visualization of DNA double-strand break repair in human fibroblasts. Science280, 590-592.
	Okano, S., Lan, L., Caldecott, K. W., Mori, T. and Yasui, A.(2003). Spatial andtemporal cellular responses to single-strand breaks in human cells. Mol. Cell. Biol. 23,3974-3981.
	Osborne, S. L., Thomas, C. L., Gschmeissner, S. and Schiavo, G.(2001). NuclearPtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNAsplicing. J. Cell Sci. 114, 2501-2511.
	Pfeifer, G. P., You, Y. H. and Besaratinia, A.(2005). Mutations induced by ultravioletlight. Mutat. Res.571, 19-31.
	Pflaum, M., Will, O. and Epe, B.(1997). Determination of steady-state levels ofoxidative DNA base modifications in mammalian cells by means of repairendonucleases. Carcinogenesis18, 2225-2231.
	Phillipson, R. P., Tobi, S. E., Morris, J. A. and McMillan, T. J.(2002). UV-A inducespersistent genomic instability in human keratinocytes through an oxidative stressmechanism. Free Radic. Biol. Med.32, 474-480.
	Rockel, T. D., Stuhlmann, D. and von Mikecz, A.(2005). Proteasomes degrade proteinsin focal subdomains of the human cell nucleus. J. Cell Sci. 118, 5231-5242.
	Saitoh, N., Spahr, C. S., Patterson, S. D., Bubulya, P., Neuwald, A. F. and Spector,D. L.(2004). Proteomic analysis of interchromatin granule clusters. Mol. Biol. Cell 15,3876-3890.
	Scaffidi, P. and Misteli, T.(2006). Lamin A-dependent nuclear defects in human aging.Science312, 1059-1063.
	Spector, D. L.(2001). Nuclear domains. J. Cell Sci. 114, 2891-2893.
	Stein, G. S., Zaidi, S. K., Braastad, C. D., Montecino, M., van Wijnen, A. J., Choi,J. Y., Stein, J. L., Lian, J. B. and Javed, A.(2003). Functional architecture of thenucleus: organizing the regulatory machinery for gene expression, replication andrepair. Trends Cell Biol. 13, 584-592.
	van der Kemp, P. A., Charbonnier, J. B., Audebert, M. and Boiteux, S.(2004).Catalytic and DNA-binding properties of the human Ogg1 DNA N-glycosylase/APlyase: biochemical exploration of H270, Q315 and F319, three amino acids of the 8-oxoguanine-binding pocket. Nucleic Acids Res. 32, 570-578.
	van Steensel, B., van Binnendijk, E. P., Hornsby, C. D., van der Voort, H. T.,Krozowski, Z. S., de Kloet, E. R. and van Driel, R.(1996). Partial colocalization ofglucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei ofrat hippocampus neurons. J. Cell Sci. 109, 787-792.
	Volker, M., Mone, M. J., Karmakar, P., van Hoffen, A., Schul, W., Vermeulen, W.,Hoeijmakers, J. H., van Driel, R., van Zeeland, A. A. and Mullenders, L. H.(2001).Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell 8, 213-224.
	Zhang, X., Rosenstein, B. S., Wang, Y., Lebwohl, M., Mitchell, D. M. and Wei, H.(1997a). Induction of 8-oxo-7,8-dihydro-2-deoxyguanosine by ultraviolet radiation incalf thymus DNA and HeLa cells. Photochem. Photobiol.65, 119-124.
	Zhang, X., Rosenstein, B. S., Wang, Y., Lebwohl, M. and Wei, H.(1997b).Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic. Biol. Med.23, 980-985.
nihms107088.pdf	34
	1. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J. Comparison ofthe effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formationand resorption in postmenopausal women. J Clin Endocrinol Metab 1996;81:37?43. [PubMed:8550780]
	2. Writing Group for the Women?s Health Initiative Investigators. Risks and benefits of estrogen plusprogestin in healthy postmenopausal women: principal results From the Women?s Health Initiativerandomized controlled trial. JAMA 2002;288:321?333. [PubMed: 12117397]
	3. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW. Soy protein and isoflavones: theireffects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl):1375S?1379S. [PubMed: 9848502]
	4. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy proteinisolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr2000;72:844?852. [PubMed: 10966908]
	5. Anderson JJB, Chen X, Boass A, Symons M, Kohlmeier M, Renner JB, Garner SC. Soy isoflavones:no effects on bone mineral content and bone mineral density in healthy, menstruating young adultwomen after one year. J Am Coll Nutr 2002;21:388?393. [PubMed: 12356779]
	6. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bonemetabolism. Menopause 2004;11:290?298. [PubMed: 15167308]
	7. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EHF, Aleman A, Lampe JW, van der SchouwYT. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, andplasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004;292:65?74.[PubMed: 15238592]
	8. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C,Reginster JY. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlledtrial. JAMA 2001;285:1482?1488. [PubMed: 11255425]
	9. Zhang X, Shu X, Li H, Yang G, Li Q, Gao Y, Zheng W. Prospective cohort study of soy foodconsumption and risk of bone fracture among postmenopausal women. Arch Intern Med2005;165:1890?1895. [PubMed: 16157834]
	10. Srivastava AK, Vliet EL, Lewiecki EM, Maricic M, Abdelmalek A, Gluck O, Baylink DJ. Clinicaluse of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin2005;21:1015?1026. [PubMed: 16004668]
	11. Jackson GS, Weaver CM, Elmore D. Use of accelerator mass spectrometry for studies in nutrition.Nutr Res Rev 2001;14:317?334. [PubMed: 19087429]
	12. Rink D, Klein J, Middleton R. Ca: past, present and future. Nucl Instrum Methods Phys Res B1990;52:572?582.
	13. Fitzgerald RL, Hillegonds DJ, Burton DW, Griffin TL, Mullaney S, Vogel JS, Deftos LJ, Harold DA.Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal diseasepatients. Clin Chem 2005;51:2095?2102. [PubMed: 16141289]
	14. Freeman SPHT, Beck B, Bierman JM, Caffee MW, Heaney RP, Holloway L, Marcus R, Southon JR,Vogel JS. The study of skeletal calcium metabolism with Ca and Ca. Nucl Instrum MethodsPhys Res B 2000;172:930?933.
	15. Nieves JW, Koniar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitoninon bone mass: review and analysis. Am J Clin Nutr 1998;67:18?24. [PubMed: 9440370]
	16. Heaney RP, Recker RR. Estimating true fractional calcium absorption. Ann Int Med 1988;108:905?906. [PubMed: 3369781]
	17. Barnes S, Coward L, Kirk M, Sfakianos J. HPLC-mass spectrometry analysis of isoflavones. ExpBiol Med 1998;217:254?262.
	18. National Center for Health Statistics. Third National Health and Nutrition Examination Survey(NHANES III). Anthropometric Reference Data, 1988?1994 National Center for Health Statistics.2005 [Accessed September 28]. Available at:http://www.cdc.gov/nchs/about/major/nhanes/Anthropometric%20Measures.htm Tables 6, 9, 15
	19. Looker AC, Wahner HW, Dunn WL, Calvo MS, Marris TB, Heyse SP, Johnston CC Jr, Lindsay R.Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468?489.[PubMed: 9850356]
	20. Kleerkoper M, Nelson DA, Peterson EL, Flynn MJ, Pawluska AS, Jacobsen G, Wilson P. Referencedata for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older(55?78) postmenopausal white and black women. J Bone Miner Res 1994;9:1267?1276. [PubMed:7976509]
	21. Favus, MJ. Primer on the metabolic bone diseases and disorders of mineral metabolism. Vol. 5.Philadelphia: Lippincott Williams, Wilkins; 2003. Laboratory values related to calcium metabolism/metabolic bone disease; p. 546-550.
	22. Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD. Relationship of early changes inbone resorption to the reduction in fracture risk with Risedronate. J Bone Miner Res 2003;18:1051?1056. [PubMed: 12817758]
	23. Wong WW. Effects of soy isoflavones on blood lipids, blood pressure and biochemical markers ofbone metabolism in postmenopausal women. J Nutr 2000;130(686S)(Abstract)
	24. Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM. Comparativeeffect of soy protein, soy isoflavones, and 17?-estradiol on bone metabolism in adult ovariectomizedrats. J Bone Miner Res 2005;20:828?839. [PubMed: 15824856]
	25. Spence LA, Lipscomb ER, Cadogan J, Martin B, Wastney ME, Peacock M, Weaver CM. The effectof soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomizedcrossover study. Am J Clin Nutr 2005;81:916?922. [PubMed: 15817872]
	26. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS. Effects ofsoy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J ClinEndocrinol Metab 2000;85:3043?3048. [PubMed: 10999783]
	27. Lydeking-Olsen E, Beck-Jensen J-E, Setchell KDR, Holm-Jensen T. Soymilk or progesterone forprevention of bone loss: a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004;43:246?257.[PubMed: 15309425]
	28. Devine A, Prince RL, Kerr DA, Dick IM, Criddle RA, Kent GN, Price RI, Webb PG. Correlates ofintestinal calcium absorption in women 10 years past the menopause. Calcif Tissue Int 1993;52:358?360. [PubMed: 8504373]
	29. Arjmandi BH, Hollis BW, Kalu DN. In vivo effect of 17 ?-estradiol on intestinal calcium absorptionin rats. Bone Miner 1994;26:181?189. [PubMed: 7994189]
	30. Chailurkita L, Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R. Biochemical markers ofbone turnover and response of bone mineral density to intervention in early postmenopausal women:an experience in a clinical laboratory. Clin Chem 2001;47:1083?1088. [PubMed: 11375295]
	31. Eastel R, Colwell A, Hampton L, Reev J. Biochemical markers of bone resorption compared withestimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res1997;12:59?65. [PubMed: 9240726]
	32. Villareal DT, Binder EF, Williams DB, Schechitman KB, Yarasheski KE, Kohrt WM. Bone mineraldensity response to estrogen replacement in frail elderly women. JAMA 2001;286:815?820.[PubMed: 11497535]
	33. Leung JYY, Ho AYY, IP TP, Lee G, Kung AWC. The efficacy and tolerability of risedronate onbone mineral density and bone turnover markers in osteoporotic Chinese women: a randomizedplacebo-controlled study. Bone 2005;36:358?364. [PubMed: 15780963]
	34. Harris ST, Ericksen EF, Davidson M, Ettinger MP, Moffett AH Jr, Baylink DJ, Crusan CE, ChinesAA. Effect of combined residronate and hormone replacement therapies on bone mineral density inpostmenopausal women. J Clin Endocrinol Metab 2001;86:1890?1897. [PubMed: 11344179]
J Appl Physiol-2007-Ravikumar-1170-7.pdf	36
	1.BeckKC,RehderK.Differencesinregionalvascularconductancesinisolateddoglungs.JApplPhysiol61:530?538,1986.
	2.ChangH,Lai-FookSJ,DominoKB,SchimmelC,HildebrandtJ,RobertsonHT,GlennyRW,HlastalaMP.Spatialdistributionofven-tilationandperfusioninanesthetizeddogsinlateralpostures.JApplPhysiol92:745?762,2002.
	3.CoxsonHO,HoggJC,MayoJR,BehzadH,WhittallKP,SchwartzDA,HartleyPG,GalvinJR,WilsonJS,HunninghakeGW.Quantifi-cationofidiopathicpulmonaryfibrosisusingcomputedtomographyandhistology.AmJRespirCritCareMed155:1649?1656,1997.
	4.CoxsonHO,MayoJR,BehzadH,MooreBJ,VerburgtLM,StaplesCA,ParePD,HoggJC.Measurementoflungexpansionwithcomputedtomographyandcomparisonwithquantitativehistology.JApplPhysiol79:1525?1530,1995.
	5.DaneDM,JohnsonRLJr,HsiaCCW.DysanapticgrowthofconductingairwaysafterpneumonectomyassessedbyCTscan.JApplPhysiol93:1235?1242,2002.
	6.DeJongPA,LongFR,WongJC,MerkusPJ,TiddensHA,HoggJC,CoxsonHO.Computedtomographicestimationoflungdimensionsthroughoutthegrowthperiod.EurRespirJ27:261?267,2006.
	7.DeJongPA,NakanoY,LequinMH,MerkusPJ,TiddensHA,HoggJC,CoxsonHO.Estimationoflunggrowthusingcomputedtomography.EurRespirJ22:235?238,2003.
	8.DePaepeME,SardesaiMP,JohnsonBD,Lesieur-BrooksAM,Pa-padakisK,LuksFI.Theroleofapoptosisinnormalandacceleratedlungdevelopmentinfetalrabbits.JPediatrSurg34:861?870,1999.
	9.GlazierJB,HughesJM,MaloneyJE,WestJB.Measurementsofcapillarydimensionsandbloodvolumeinrapidlyfrozenlungs.JApplPhysiol26:65?76,1969.
	10.GlazierJB,HughesJM,MaloneyJE,WestJB.Verticalgradientofalveolarsizeinlungsofdogsfrozenintact.JApplPhysiol23:694?705,1967.
	11.HoffmanEA.Effectofbodyorientationonregionallungexpansion:acomputedtomographicapproach.JApplPhysiol59:468?480,1985.
	12.HoffmanEA,RitmanEL.Effectofbodyorientationonregionallungexpansionindogandsloth.JApplPhysiol59:481?491,1985.
	13.HsiaCC.Signalsandmechanismsofcompensatorylunggrowth.JApplPhysiol97:1992?1998,2004.
	14.HsiaCC,TakedaSI,WuEY,GlennyRW,JohnsonRLJr.Adaptationofrespiratorymuscleperfusionduringexercisetochronicallyelevatedventilatorywork.JApplPhysiol89:1725?1736,2000.
	15.HsiaCCW,Fryder-DoffeyF,Stalder-NavarroV,JohnsonRLJr,WeibelER.Structuralchangesunderlyingcompensatoryincreaseofdiffusingcapacityafterleftpneumonectomyinadultdogs.JClinInvest92:758?764,1993[PublishederratuminJClinInvest93:913,1994].
	16.HsiaCCW,HerazoLF,Fryder-DoffeyF,WeibelER.Compensatorylunggrowthoccursinadultdogsafterrightpneumonectomy.JClinInvest94:405?412,1994.
	17.HsiaCCW,HerazoLF,RamanathanM,ClaassenH,Fryder-DoffeyF,HoppelerH,JohnsonRLJr.Cardiopulmonaryadaptationstopneu-monectomyindogs.IIIVentilatorypowerrequirementsandmusclestructure.JApplPhysiol76:2191?2198,1994.
	18.HsiaCCW,HerazoLF,RamanathanM,JohnsonRLJr.Cardiopul-monaryadaptationstopneumonectomyindogs.IVMembranediffusingcapacityandcapillarybloodvolume.JApplPhysiol77:998?1005,1994.
	19.HsiaCCW,HerazoLF,RamanathanM,JohnsonRLJr,WagnerPD.Cardiopulmonaryadaptationstopneumonectomyindogs.II.Ventilation-perfusionrelationshipsandmicrovascularrecruitment.JApplPhysiol74:1299?1309,1993.
	20.HsiaCCW,JohnsonRLJr,WuEY,EstreraAS,WagnerH,WagnerPD.Reducinglungstrainafterpneumonectomyimpairsdiffusingcapacitybutnotventilation-perfusionmatching.JApplPhysiol95:1370?1378,2003.
	21.HsiaCCW,WuEY,WagnerE,WeibelER.Preventingmediastinalshiftafterpneumonectomyimpairsregenerativealveolartissuegrowth.AmJPhysiolLungCellMolPhysiol281:L1279?L1287,2001.
	22.HydeRW,WandtkeJC,FaheyPJ,UtellMJ,PlewesDB,GoskeM.Lungweightinvivomeasuredwithcomputedtomographyandrebreathingofsolublegases.JApplPhysiol67:166?173,1989.
	23.JohnsonRLJr,CassidySS,GroverRF,SchutteJE,EpsteinRH.Functionalcapacitiesoflungsandthoraxinbeaglesafterprolongedresidenceat3,100m.JApplPhysiol59:1773?1782,1985.
	24.NewellJDJr,HoggJC,SniderGL.Reportofaworkshop:quantitativecomputedtomographyscanninginlongitudinalstudiesofemphysema.EurRespirJ23:769?775,2004.
	25.PerezAT,CoxsonHO,HoggJC,GibsonK,ThompsonPF,RogersRM.UseofCTmorphometrytodetectchangesinlungweightandgasvolume.Chest128:2471?2477,2005.
	26.RahnH,RossBB.Bronchialtreecasts,lobeweightsandanatomicaldeadspacemeasurementsinthedog?slung.JApplPhysiol10:154?157,1957.
	27.RannelsDE.Roleofphysicalforcesincompensatorygrowthofthelung.AmJPhysiolLungCellMolPhysiol257:L179?L189,1989.
	28.RavikumarP,YilmazC,DaneDM,JohnsonRLJr,EstreraAS,HsiaCC.Regionallunggrowthfollowingpneumonectomyassessedbycom-putedtomography.JApplPhysiol97:1567?1574,2004.
	29.TakedaS,HsiaCCW,WagnerE,RamanathanM,EstreraAS,WeibelER.Compensatoryalveolargrowthnormalizesgasexchangefunctioninimmaturedogsafterpneumonectomy.JApplPhysiol86:1301?1310,1999.
	30.TakedaS,RamanathanM,EstreraAS,HsiaCCW.Postpneumonec-tomyalveolargrowthdoesnotnormalizehemodynamicandmechanicalfunction.JApplPhysiol87:491?497,1999.
	31.TakedaS,RamanathanM,WuEY,EstreraAS,HsiaCCW.Temporalcourseofgasexchangeandmechanicalcompensationafterrightpneumo-nectomyinimmaturedogs.JApplPhysiol80:1304?1312,1996[Pub-lishedcorrigendainJApplPhysiol80:1996].
	32.TakedaS,WuEY,EpsteinRH,EstreraAS,HsiaCCW.Invivoassessmentofchangesinairandtissuevolumesafterpneumonectomy.JApplPhysiol82:1340?1348,1997.
	33.WandtkeJC,HydeRW,FaheyPJ,UtellMJ,PlewesDB,GoskeMJ,FischerHW.Measurementoflunggasvolumeandregionaldensitybycomputedtomographyindogs.InvestRadiol21:108?117,1986.
	34.WirtzHR,DobbsLG.Theeffectsofmechanicalforcesonlungfunc-tions.RespirPhysiol119:1?17,2000.
	35.WuEY,HsiaCC,EstreraAS,EpsteinRH,RamanathanM,JohnsonRLJr.Preventingmediastinalshiftafterpneumonectomydoesnotabol-ishphysiologiccompensation.JApplPhysiol89:182?191,2000.
	36.ZeltnerTB,BurriPH.Thepostnataldevelopmentandgrowthofthehumanlung.II.Morphologyrespiration.Physiology67:269?282,1987.
J Appl Physiol-2007-Ito-859-69.pdf	42
	1.BaldiS,MiniatiM,BellinaCR,BattollaL,CatapanoG,BegliominiE,GlustiniD,GluntiniC.Relationshipbetweenextentofpulmonaryemphysemabyhigh-resolutioncomputedtomographyandlungelasticrecoilinpatientswithchronicobstructivepulmonarydisease.AmJRespirCritCareMed164:585?589,2001.
	2.BarnasGM,CampbellDN,MackenzieCF,MendhamJE,FahyBG,RuncieCJ,MendhamGE.Lung,chestwall,andtotalrespiratorysystemresistancesandelastancesinthenormalrangeofbreathing.AmRevRespirDis145:110?113,1992.
	3.BarnasGM,SprungJ.Effectsofmeanairwaypressureandtidalvolumeonlungandchestwallmechanicsinthedog.JApplPhysiol74:2286?2293,1993.
	4.BarnasGM,StamenovicD,LutchenKR.Lungandchestwallimped-anceinthedog:effectsoffrequencyandtidalvolume.JApplPhysiol72:87?93,1992.
	5.BatesJHT,IrvinCG.Measuringlungfunctioninmice:thephenotypinguncertaintyprinciple.JApplPhysiol94:1297?1306,2003.
	6.BatesJHT,LauzonAM,DechmannGS,MaksymGN,SchuesslerTF.Temporaldynamicsofpulmonaryresponsetointravenoushistamineindogs:effectofdoseandlungvolume.JApplPhysiol76:616?626,1994.
	7.BellardineCL,IngenitoEP,HoffmanA,LopezF,SanbornW,SukiB,LutchenKR.Heterogeneousairwayversustissuemechanicsandtheirrelationtogasexchangefunctionduringmechanicalventilation.AnnBiomedEng33:626?641,2005.
	8.CsendesT.Nonlinearparameterestimationbyglobaloptimization:effi-ciencyandreliability.ActaCybernetica8:361?370,1988.
	8a.Curran-EverettD,BenosDJ.GuidelinesforreportingstatisticsinjournalspublishedbytheAmericanPhysiologicalSociety.JApplPhysiol97:457?459,2004.
	9.DechmanGS,ChartrandDA,Ruiz-NetoPP,BatesJHT.Theeffectofchangingend-expiratorypressureonrespiratorysystemmechanicsinopen-andclosed-chestanesthetized,paralyzedpatients.AnesthAnalg81:279?286,1995.
	10.DrazenJM,FinnPW,DeSanctisGT.Mousemodelsofairwayhyper-responsiveness:physiologicalbasisofobservedoutcomesandanalysisofselectedexamplesusingtheseoutcomeindicators.AnnuRevPhysiol61:593?625,1999.
	11.FredbergJJ,StamenovicD.Ontheimperfectelasticityoflungtissue.JApplPhysiol67:2408?2419,1989.
	12.GomesRFM,ShenX,RamchandaniR,TepperRS,BatesJHT.Comparativerespiratorysystemmechanicsinrodents.JApplPhysiol89:908?916,2000.
	13.HantosZ,AdamiczaA,GovaertsE,DaroczyB.Mechanicalimped-ancesoflungsandchestwallinthecat.JApplPhysiol73:427?433,1992.
	14.HantosZ,DaroczyB,SukiB,NagyS,FredbergJJ.Inputimpedanceandperipheralinhomogeneityofdoglungs.JApplPhysiol72:168?178,1992.
	15.HiraiT,McKeonKA,GomesRFM,BatesJHT.Effectsoflungvolumeonlungandchestwallmechanicsinrats.JApplPhysiol86:16?21,1999.
	16.IkegamiM,WeaverTE,ConkrightJJ,SlyPD,RossGF,WhitsettJA,GlasserSW.DeficiencyofSP-BrevealsprotectiveroleofSP-Cduringoxygenlunginjury.JApplPhysiol92:519?526,2002.
	17.IngenitoEP,MoraR,CullivanM,MarzanY,HaleyK,MarkL,SonnaLA.Decreasedsurfactantprotein-Bexpressionandsurfactantdysfunctioninamurinemodelofacutelunginjury.AmJRespirCellMolBiol25:35?44,2001.
	18.IngenitoEP,ReillyJJ,MentzerSJ,SwansonSJ,VinR,KeuhnH,BergerRL,HoffmanA.Bronchoscopicvolumereduction:asafeandeffectivealternativetosurgicaltherapyforemphysema.AmJRespirCritCareMed164:295?301,2001.
	19.ItoS,Bartolak-SukiE,ShipleyJM,ParameswaranH,MajumdarA,SukiB.Earlyemphysemainthetightskinandpallidmice:rolesofmicrofibril-associatedglycoproteins,collagen,andmechanicalforces.AmJRespirCellMolBiol34:688?694,2006.
	20.ItoS,IngenitoEP,AroldSP,ParameswaranH,TgavalekosNT,LutchenKR,SukiB.Tissueheterogeneityinthemouselung:effectsofelastasetreatment.JApplPhysiol97:204?212,2004.
	21.ItoS,IngenitoEP,BrewerKK,BlackLD,ParameswaranH,LutchenKR,SukiB.Mechanics,nonlinearity,andfailurestrengthoflungtissueinamousemodelofemphysema:possibleroleofcollagenremodeling.JApplPhysiol98:503?511,2005.
	22.KaczkaDW,HagerDN,HawleyML,SimonBA.Quantifyingmechan-icalheterogeneityincanineacutelunginjury:impactofmeanairwaypressure.Anesthesiology103:306?317,2005.
	23.KussH,HoefgenN,JohanssenS,KronbachT,RundfeldtC.InvivoefficacyinairwaydiseasemodelsofN-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylicacidamide(AWD12?281),aselectivephosphodiesterase4inhibitorforinhaledadministration.JPharmacolExpTher307:373?385,2003.
	24.LeithDE.Comparativemammalianrespiratorymechanics.Physiologist19:485?510,1976.
	25.LumH,MitznerW.Aspeciescomparisonofalveolarsizeandsurfaceforces.JApplPhysiol62:1865?1871,1987.
	26.LutchenKR,HantosZ,PetakF,AdamiczaA,SukiB.Airwayinho-mogeneitiescontributetoapparentlungtissuemechanicsduringconstric-tion.JApplPhysiol80:1841?1849,1996.
	27.LutchenKR,YangK,KaczkaDW,SukiB.Optimalventilatorwave-formforestimatinglow-frequencyrespiratorimpedanceinhealthyanddiseasedsubjects.JApplPhysiol75:478?488,1993.
	28.MartoranaPA,BrandT,GardiC,vanEvenP,deSantiMM,CalzoniP,MarcolongoP,LungarellaG.Thepallidmouse.Amodelofgenetic1-antitrypsindeficiency.LabInvest68:233?241,1993.
	29.MichaelsonED,GrassmanED,PetersWR.Pulmonarymechanicsbyspectralanalysisofforcedrandomnoise.JClinInvest56:1210?1230,1975.
	30.MoriyaHT,MoraesJC,BatesJHT.Nonlinearandfrequency-dependentmechanicalbehaviorofthemouserespiratorysystem.AnnBiomedEng31:318?326,2003.
	31.MuraiA,AbeM,HayashiY,SakataN,KatsuragiT,TanakaK.Comparisonstudybetweenthemechanismsofallergicasthmaamelio-rationbyacysteinyl-leukotrienetype1receptorantagonistmonte-lukastandmethylprednisolone.JPharmacolExpTher312:432?440,2005.
	32.PetakF,HabreW,DonateYR,HantosZ,andBarazzone-ArgiroffoC.Hypoxia-inducedchangesinmouselungmechanics:forcedoscillationsvs.barometricplethysmography.JApplPhysiol90:2221?2230,2001.
	33.PillowJJ,KorfhagenTR,IkegamiM,SlyPD.OverexpressionofTGF-increaseslungtissuehysteresivityintransgenicmice.JApplPhysiol91:2730?2734,2001.
	34.RussiEW,BlochKE,WederW.Functionalandmorphologicalhetero-geneityofemphysemaanditsimplicationforselectionofpatientsforlungvolumereductionsurgery.EurRespirJ14:230?236,1999.
	35.SakaiH,IngenitoEP,MoraR,AbbayS,CavalcanteFSA,LutchenKR,SukiB.Hysteresivityofthelungandtissuestripinthenormalrat:effectsofheterogeneities.JApplPhysiol91:737?747,2001.
	36.SlyPD,CollinsRA,ThamrinC,TurnerDJ,HantosZ.Volumedependenceofairwayandtissueimpedancesinmice.JApplPhysiol94:1460?1466,2003.
	37.SoutiereSE,MitznerW.Ondefiningtotallungcapacityinthemouse.JApplPhysiol96:1658?1664,2004.
	38.SukiB,LutchenKR.Pseudorandomsignalstoestimateapparenttransferandcoherencefunctionsofnonlinearsystems:applicationstorespiratorymechanics.IEEETransBiomedEng39:1142?1151,1992.
	39.SukiB,YuanH,ZhangQ,LutchenKR.Partitioningoflungtissueresponseandinhomogeneousairwayconstrictionattheairwayopening.JApplPhysiol82:1349?1359,1997.
	40.TankersleyCG,RaboldR,MitznerW.Differentiallungmechanicsaregeneticallydeterminedininbredmurinestrains.JApplPhysiol86:1764?1769,1999.
	41.TomiokaS,BatesJHT,IrvinCG.Airwayandtissuemechanicsinamurinemodelofasthma:alveolarcapsulevs.forced.JApplPhysiol93:263?270,2002.
1753.pdf	31
131.pdf	13
	 1. Loop FD. (1998) Coronary artery surgery: the end of the begin-ning. Eur J Cardio-thorac Surg 14, 554?571.
	 2.  Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R, McCarthy PM, Cosgrove DM. (1999) Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 117, 855?872. 
	 3. Pevni D, Kramer A, Paz Y, Lev-Run O, Locker Ch, Metsa M, Shapira I, Mohr R. (2001) Composite arterial grafting with double skeletonised internal thoracic arteries. Eur J Cardio-thorac Surg 20, 299?304.
	 4.  Deja MA, Golba KS, Malinowski M, Wos S, Kolowca M, Biernat J, Kajor M, Spyt TJ (2005) Skeletonization of internal thoracic artery a?ects its innervation and reactivity. Eur J Cardio-thorac Surg 28, 551?557. 
	 5.  Walpoth BH, Mohadjer A, Gersbach P, Rogulanko R,Walpoth BN, Althuas U. (1996) Intraoperative internal mammary artery tran-sit-time ?ow measurements: comparative evaluation of two surgi-cal pedicle preparation techniques. Eur J Cardio-thorac Surg 10, 1064?1070.
	 6.  Canver CHC, Dame NA. (1994) Ultrasonic assessment of internal thoracic artery graft ?ow in the revascularized heart. Ann Thorac Surg 58, 135?138. 
	 7.  Hassanein W, Albert AA, Arnrich B, Walter J, Ennker IC, Rossendahl U, Bauer S, Ennker J. (2005) Intraoperative transit time ?ow measurement: O?-pump versus on-pump coronary artery bypass. Ann Thorac Surg 80, 2155?2161. 
	 8.  Gaudino M, Di Mauro M, Iaco AL, Canosa C, Vitolla G, Cala?ore AM. (2003) Immediate ?ow reserve of Y thoracic artery grafts: an intraoperative ?owmetric study. J Thorac Cardiovasc Surg 126, 1076?1079.
	 9.  Royse AG, Royse CF, Groves KL, Bus B, Yu G. (1999) Blood ?ow in composite arterial grafts and e?ect of native coronary ?ow. Ann Thorac Surg 68, 1619?1622.
	 10.  Delatore JR, Theman TE, Garzia FM. (1999) Intraoperative ?ow rate measurement of T-grafts: calculation a ?ow reserve. Heart Surg Forum 2, 235?238.
	 11.  Speziale G, Ruvolo G, Coppola R, Marino B. (2000) Intraoperative ?ow measurement in composite Y arterial grafts. Eur J Cardio-thorac Surg 17, 505?508.
	 12.  Tagusari O, Kobayashi J, Bando K, Niwaya K, Nakajima H, Ishida M, Nakatani T, Yagihara T, Kitamura S. (2003) Early adaptation of the left internal thoracic artery as a blood source of Y-composite radial artery grafts in o?-pump coronary artery bypass grafting. Heart Surg Forum 6, E93?98.
	 13.  Leong DKH, Ashok V, Nishkantha A, Shang YH, Sim EKW. (2005) Transit-time ?ow measurement is essential in coronary artery bypass grafting. Ann Thorac Surg 79, 854?857.
117.pdf	14
	 1. Speller DCE, Lynn WA, Rogers TR. (1995) Glycopeptide resist-ance in gram-positive bacteria. Clin Microbiol Inf 1, 54?59.
	 2. Leclercq R, Derlot E, Duval J, Courvalin P. (1988) Plasmid-medi-ated resistance to vancomycin and teicoplanin in E. faecium. N Engl J Med 319, 157?161.
	 3. Utlley AHC, Collins CH, Naidoo J, George RC. (1988) Vanco-mycin-resistant enterococci. Lancet 1, 57?58.
	 4. Kaplan RR, Gilligan PH, Facklam RR. (1988) Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 26, 1216?1218.
	 5. Kolï¿½? M, Vï¿½gnerovï¿½ I, Kohnovï¿½ I. (1997) Zï¿½chyt vankomycin- rezistentnï¿½ch enterokok? ve Fakultnï¿½ nemocnici v Olomouci. Klin Mikrobiol Inf Lï¿½k 3, 189?191.
	 6. Facklam RR, Collins MD. (1989) Identi?cation of Enterococcus spe-cies isolated from human infections by conventional test scheme. J Clin Microbiol 27, 731?734.
	 7. National Committee for Clinical Laboratory Standards. Per for-mance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-S12. NCCLS, Wayne, Pennsylvania, USA 2002.
	 8. Dutka-Malen S, Evers S, Courvalin P. (1995) Detection of glyco-peptide resistance genotypes and identi?cation to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33, 24?27.
	 9. Goering RV. The molecular epidemiology of nosocomial infection. In: Specter S, editor. Rapid detection of infectious agents. New York: Plenum Press, 1998. p. 131?157.
	10. Kolï¿½? M, Pant??ek R, Bardo? J, Vagnerova I, Typovska H, Valka I, Doskar J. (2002) Occurrence of antibiotic-resistant bacterial strains isolated in poultry. Vet Med Czech 47, 52?59. 
	11. Peta M, Carretto E, Barbarini D, Zamperoni A, Carnevale L, Perversi L, Pagani M, Bonora MG, Fontana R, Marone P, Langer M. (2006) Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect 12, 163?169.
	12. Murray BE. (1997) Vancomycin-resistant enterococci. Am J Med 101, 284?293.
	13. Murray BE. (1998) Diversity among multidrug-resistant entero-cocci. Emerg Infect Dis 4, 37?47.
	14. Kolar M, Pantucek R, Vagnerova I, Kesselova M, Sauer P, Matouskova I, Doskar J, Koukalova D, Hejnar P. (2006) Genotypic characterisation of vancomycin-resistant Enterococcus faecium iso-lates from haemato-oncological patients at Olomouc University Hospital, Czech Republic. Clin Microbiol Infect 12, 353?360.
85.pdf	11
	 1. Garcia KC, de Sauvage FJ, Struble M et al. (1993) Processing and characterization of human guanylin in Escheriachia Coli. J BiolChem, 136:22397?22401.
	 2. Nakazato M, Yamaguchi H, Shiomi K et al. (1994) Identi?cation of 10-kDa proguanylin as a major guanylin molecule in human in-testine and plasma and its increase in renal insu?ciency. Biochem Biophys Res Commun, 205:1966?1975.
	 3. Schulz S, Chrisman TD, Garbers DL. (1992) Cloning and expres-sion of guanylin. Its existence in various mammalian tissues. J Biol Chem, 267:16019?16021.
	 4. Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Du?n KL, Smith CE. (1992) Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A., 89:947?51
	 5. Forte LR, Currie MG. (1995) Guanylin: a peptide regulator of epithelial transport. FASEB J, 9:643?650.
	 6. Hamra FK, Fan X, Krause WJ, Freeman RH, Chin DT, Smith CE, Currie MG, Forte LR. (1996) Prouroguanylin and proguanylin: puri?cation from colon, structure, and modulation of bioactivity by proteases. Endocrinology, 137:257?265.
	 7. Fan X, Hamra FK, Freeman RH, Eber SL, Krause WJ, Lim RW, Pace VM, Currie MG, Forte LR. (1996) Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma. Biochem Biophys Res Commun, 219:457?462.
	 8. Forte LR, Fan X, Hamra FK (1996) Salt and water homeostasis:uroguanylin is a circulating peptide hormone with natriuretic aktivity.Am J Kidney Dis, 2:296â€“304.
	 9. Perkins A, Goy MF, Li Z. (1997) Uroguanylin is expressed by ente-rochroma?n cells in the rat gastrointestinal tract. Gastroenterology, 113:1007?1014.
	10. Kinoshita H, Fujimoto S, Nakazato M, Yokota N, Date Y, Yamaguchi H, Hisanaga S, Eto T. (1997) Urine and plasma levels of uroguanylin and its molecular forms in renal diseases. Kidney Int, 52:1028?1034.
	11. Fan X, Wang Y, London RM, Eber SL, Krause WJ, Freeman RH, Forte LR. (1997) Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems. Endocrinology, 138:4636?4648.
	12. Ieda H, Naruse S, Furuya S, Ozaki T, Ando E, Nokihara K, Hori S, Kitagawa M, Hayakawa T. (1998) Coexistence of proguanylin (1-15) and somatostatin in the gastrointestinal tract. J Gastroenterol Hepatol, 13: 1225?1233.
	13. Martin S, Adermann K, Forssmann WG, Kuhn M. (1999) Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa. Endocrinology, 140:5022?5029.
	14. Kita T, Kitamura K, Sakata J, Eto T. (1999) Marked increase of guanylin secretion in response to salt loading in the rat small in-testine Am J Physiol, 277:960?966.
	15. Forte RF. (2004) Uroguanylin and guanylin peptides: pharmac ology, and experimental therapeutics. Pharmacology & Therapeutics, 104:137?162.
ocallaghansunolCC5-13.pdf	51
	1.Fryer BH, Field J. Rho, Rac, Pak and angiogenesis: Old roles and newly identified respon-sibilities in endothelial cells. Cancer Lett 2005; 229:13-23.
	2.Drake CJ, Cheresh DA, Little CD. An antagonist of integrin alpha v beta 3 prevents mat-uration of blood vessels during embryonic neovascularization. J Cell Sci 1995; 108:2655-61.
	3.Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in alpha 5 integrin-defi-cient mice. Development 1993; 119:1093-105.
	4.Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
	5.Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A.Clowes memorial award lecture. Cancer Res 1990; 50:6130-8.
	6.Marmor MD, Skaria KB, Yarden Y. Signal transduction and oncogenesis by ErbB/HERreceptors. Int J Radiat Oncol Biol Phys 2004; 58:903-13.
	7.Kurokawa H, Arteaga CL. Inhibition of erbB receptor (HER) tyrosine kinases as a strategyto abrogate antiestrogen resistance in human breast cancer. Clin Cancer Res 2001;7:4436s-42s, (discussion 4411s-2s).
	8.Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: Receptorheterodimerization in development and cancer. EMBOJ 2000; 19:3159-67.
	9.Spencer KS, Graus-Porta D, Leng J, Hynes NE, Klemke RL. ErbB2 is necessary for inductionof carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 2000;148:385-97.
	10.Le Stunff H, Mikami A, Giussani P, Hobson JP, Jolly PS, Milstien S, Spiegel S. Role ofsphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis.J Biol Chem 2004; 279:34290-7.
	11.Shien T, Doihara H, Hara H, Takahashi H, Yoshitomi S, Taira N, Ishibe Y, Teramoto J, AoeM, Shimizu N. PLC and PI3K pathways are important in the inhibition of EGF-inducedcell migration by gefitinib (?Iressa?, ZD1839). Breast Cancer 2004; 11:367-73.
	12.Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, VogelsteinB. Structural alterations of the epidermal growth factor receptor gene in human gliomas.Proc Natl Acad Sci USA 1992; 89:2965-9.
	13.Rasheed BK, Wiltshire RN, Bigner SH, Bigner DD. Molecular pathogenesis of malignantgliomas. Curr Opin Oncol 1999; 11:162-7.
	14.Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S,Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A,Tonato M, Franklin WA, Crino L, Bunn Jr PA, Varella-Garcia M. Epidermal growth factorreceptor gene and protein and gefitinib sensitivity in nonsmall-cell lung cancer. J NatlCancer Inst 2005; 97:643-55.
	15.Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breastcancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene.Science 1987; 235:177-82.
	16.Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. BiochimBiophys Acta 1994; 1198:165-84.
	17.Downward J. Role of receptor tyrosine kinases in G-protein-coupled receptor regulation ofRas: Transactivation or parallel pathways? Biochem J 2003; 376:e9-10.
	18.Salvatore G, De Falco V, Salerno P, Nappi TC, Pepe S, Troncone G, Carlomagno F, MelilloRM, Wilhelm SM, Santoro M. BRAF is a therapeutic target in aggressive thyroid carcino-ma. Clin Cancer Res 2006; 12:1623-9.
	19.Rapp UR, Gotz R, Albert S. BuCy RAFs drive cells into MEK addiction. Cancer Cell2006; 9:9-12.
	20.Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH. Expression of heat-shock proteinshsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. Correlation withclinicopathologic factors and survival. Apmis 2003; 111:523-30.
	21.John M, Luk C-TL, Annie F, Siu M, Brian Y, Lam, Irene OL, Ng, Mei-Yu Hu, Chi-MingChe, Sheung-Tat Fan. Proteomic profiling of hepatocellular carcinoma in Chinese cohortreveals heat-shock proteins (Hsp27, Hsp70, GRP78) upregulation and their associatedprognostic values. PROTEOMICS 2006; 9999:NA.
	22.O?Neill PA, Shaaban AM, West CR, Dodson A, Jarvis C, Moore P, Davies MP, Sibson DR,Foster CS. Increased risk of malignant progression in benign proliferating breast lesionsdefined by expression of heat shock protein 27. Br J Cancer 2004; 90:182-8.
	23.Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock pro-tein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic impli-cations. Journal of the National Cancer Institute 1993; 85:570-574.
	24.Vargasroig LM, Fanelli MA, Lopez LA, Gago FE, Tello O, Aznar JC, Ciocca DR. Heatshock proteins and cell proliferation in human breast cancer biopsy samples. CancerDetection and Prevention 1997; 21:441-51.
	25.Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer:Chaperones of tumorigenesis. Trends Biochem Sci 2006; 31:164-72.
	26.Costa MJM, Rosas SLB, Chindano A, Lima PDS, Madi K, Carvalho MDD. Expression ofheat shock protein 70 and P53 in human lung cancer. Oncology Rep 1997; 4:1113-6.
	27.Nanbu K, Konishi I, Komatsu T, et al. Expression of heat shock proteins HSP70 andHSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptorstatus, and p53 protein expression. Cancer 1996; 77:330-8.
	28.Burrows F, Zhang H, Kamal A. Hsp90 activation and cell cycle regulation. Cell Cycle2004; 3:1530-6.
	29.Daugaard M, Jaattela M, Rohde M. Hsp70-2 is required for tumor cell growth and sur-vival. Cell Cycle 2005; 4:877-80.
	30.Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion ofheat shock protein 70 (Hsp70) activates a tumor-specific death program that is independentof caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97:7871-6.
	31.Pirkkala L, Nykanen P, Sistonen L. Roles of the heat shock transcription factors in regula-tion of the heat shock response and beyond. Faseb J 2001; 15:1118-1131.
	32.Hoang AT, Huang J, Rudra-Ganguly N, Zheng J, Powell WC, Rabindran SK, Wu C,Roy-Burman P. A novel association between the human heat shock transcription factor 1(HSF1) and prostate adenocarcinoma. Am J Pathol 2000; 156:857-64.
	33.Tang D, Khaleque MA, Jones EL, Theriault JR, Li C, Wong WH, Stevenson MA,Calderwood SK. Expression of heat shock proteins and heat shock protein messengerribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell StressChaperones 2005; 10:46-58.
	34.Khaleque MA, Bharti A, Sawyer D, Gong J, Benjamin IJ, Stevenson MA, Calderwood SK.Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis andanchorage-independent growth. Oncogene 2005; 24:6564-73.
	35.Meriin AB, Yaglom JA, Gabai VL, Mosser DD, Zon L, Sherman MY. Protein damagingstresses activate JNK via inhibition of its phosphatase: A novel pathway controlled byHsp72. Mol Cell Biol 1999; 19:2547-55.
	36.McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ. Targeted disruption of heat shocktranscription factor 1 abolishes thermotolerance and protection against heat-inducibleapoptosis. J Biol Chem 1998; 273:7523-8.
	37.Wang SJ, Saadi W, Lin F, Minh-Canh Nguyen C, Li Jeon N. Differential effects of EGFgradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 2004;300:180-9.
	38.White SR, Tse R, Marroquin BA. Stress-activated protein kinases mediate cell migration inhuman airway epithelial cells. Am J Respir Cell Mol Biol 2005; 32:301-10.
	39.Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation ofcell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137:481-92.
	40.Viala E, Pouyssegur J. Regulation of tumor cell motility by ERKmitogen-activated proteinkinases. Ann NY Acad Sci 2004; 1030:208-18.
	41.Huang C, Jacobson K, Schaller MD. A role for JNK-paxillin signaling in cell migration.Cell Cycle 2004; 3:4-6.
	42.Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E,Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-bindingEGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity.Mol Biol Cell 1995; 6:967-80.
	43.Amos S, Martin PM, Polar GA, Parsons SJ, Hussaini IM. Phorbol 12-myristate 13-acetateinduces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Srcpathways in glioblastoma cells. J Biol Chem 2005; 280:7729-38.
	44.Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanylnucleotide-releasing protein with calcium-and diacylglycerol-binding motifs. Science 1998;280:1082-6.
	45.Tognon CE, Kirk HE, Passmore LA, Whitehead IP, Der CJ, Kay RJ. Regulation ofRasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol 1998; 18:6995-7008.
	46.Greulich H, Erikson RL. An analysis of Mek1 signaling in cell proliferation and transfor-mation. J Biol Chem 1998; 273:13280-8.
	47.Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med2002; 8:S55-61.
	48.Auer KL, Contessa J, Brenz-Verca S, Pirola L, Rusconi S, Cooper G, Abo A, Wymann MP,Davis RJ, Birrer M, Dent P. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathwayby which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol BiolCell 1998; 9:561-73.
	49.He H, Chen C, Xie Y, Asea A, Calderwood SK. HSP70 and heat shock factor 1 cooperateto repress Ras-induced transcriptional activation of the c-fosgene. Cell Stress Chaperones2000; 5:406-11.
	50.Xie Y, Zhong R, Chen C, Calderwood SK. Heat shock factor 1 contains two functionaldomains that mediate transcriptional repression of the c-fosand c-fmsgenes. J Biol Chem2003; 278:4687-98.
	51.Wirth D, Bureau F, Melotte D, Christians E, Gustin P. Evidence for a role of heat shockfactor 1 in inhibition of NF-kappaB pathway during heat shock response-mediated lungprotection. Am J Physiol Lung Cell Mol Physiol 2004; 287:L953-61.
gonzalezCC5-13.pdf	26
	1.Ruas M, Brookes S, McDonald NQ, Peters G. Functional evaluation of tumour-specificvariants of p16INK4a/CDKN2A: Correlation with protein structure information.Oncogene 1999; 18:5423-34.
	2.Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of humancancer. Cancer Res 2001; 61:3225-9.
	3.Malumbres M, Barbacid M. To cycle or not to cycle: A critical decision in cancer. Nat RevCancer 2001; 1:222-31.
	4.Sherr CJ. An Arf(GFP/GFP)reporter mouse reveals that the Arftumor suppressor monitorslatent oncogenic signals in vivo. Cell Cycle 2004; 3:239-40.
	5.Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokespremature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
	6.Palmero I, Pantoja C, Serrano M. p19ARFlinks the tumour suppressor p53to Ras. Nature1998; 395:125-6.
	7.Malumbres M, Perez De Castro I, Hernandez MI, Jimenez M, Corral T, Pellicer A. Cellularresponse to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).Mol Cell Biol 2000; 20:2915-25.
	8.Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene andPolycomb-group gene bmi-1regulates cell proliferation and senescence through the ink4alocus. Nature 1999; 397:164-8.
	9.Voncken JW, Roelen BA, Roefs M, de Vries S, Verhoeven E, Marino S, Deschamps J, vanLohuizen M. Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition.Proc Natl Acad Sci USA 2003; 100:2468-73.
	10.Gil J, Bernard D, Martinez D, Beach D. Polycomb CBX7 has a unifying role in cellularlifespan. Nat Cell Biol 2004; 6:67-72.
	11.Isono K, Fujimura Y, Shinga J, Yamaki M, O-Wang J, Takihara Y, Murahashi Y, Takada Y,Mizutani-Koseki Y, Koseki H. Mammalian polyhomeotic homologues Phc2and Phc1actinsynergy to mediate polycomb repression of Hoxgenes. Mol Cell Biol 2005; 25:6694-706.
	12.Pennacchio LA, Rubin EM. Genomic strategies to identify mammalian regulatorysequences. Nat Rev Genet 2001; 2:100-9.
	13.Delgado S, Gomez M, Bird A, Antequera F. Initiation of DNA replication at CpG islandsin mammalian chromosomes. EMBOJ 1998; 17:2426-35.
	14.Antequera F. Genomic specification and epigenetic regulation of eukaryotic DNA replicationorigins. EMBOJ 2004; 23:4365-70.
	15.Todorovic V, Giadrossi S, Pelizon C, Mendoza-Maldonado R, Masai H, Giacca M. Humanorigins of DNA replication selected from a library of nascent DNA. Mol Cell 2005;19:567-75.
	16.Gonzalez S, Klatt P, Delgado S, Conde E, Lopez-Rios F, Sanchez-Cespedes M, Mendez J,Antequera F, Serrano M. Oncogenic activity of Cdc6 through repression of the INK4/ARFlocus. Nature 2006; 440:702-6.
	17.Kawasaki H, Taira K. Induction of DNAmethylation and gene silencing by short interferingRNAs in human cells. Nature 2004; 431:211-7.
	18.Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcrip-tional gene silencing in human cells. Science 2004; 305:1289-92.
	19.Matzke MA, Birchler JA. RNAi-mediated pathways in the nucleus. Nat Rev Genet 2005;6:24-35.
	20.Ting AH, Schuebel KE, Herman JG, Baylin SB. Short double-stranded RNAinducestranscriptional gene silencing in human cancer cells in the absence of DNAmethylation.Nat Genet 2005; 37:906-10.
	21. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D,Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG.Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes asubset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumorgrowth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.Am J Pathol 2004; 165:1351-65.
	22. Semple JW, Duncker BP. ORC-associated replication factors as biomarkers for cancer.Biotechnol Adv 2004; 22:621-31.
	23. Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM,McGuinness E, Sheils O, O'Leary JJ. p16INK4A, CDC6, and MCM5: Predictive biomarkersin cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005; 58:525-34.
	24. Gonzalez MA, Tachibana KE, Laskey RA, Coleman N. Control of DNA replication and itspotential clinical exploitation. Nat Rev Cancer 2005; 5:135-41.
	25. Triolo T, Sternglanz R. Role of interactions between the origin recognition complex andSIR1 in transcriptional silencing. Nature 1996; 381:251-3.
	26. Fox CA, AM, KH. Toward biochemeical understanding of a transcriptionally silencedchromosomal domain in Saccharomyces cerevisiae. J Biol Chem 2005; 280:8629-32.
gao5-8.pdf	36
	1.Evert M, Schneider-Stock R, Dombrowski F. Overexpression of fatty acid synthase inchemically and hormonally induced hepatocarcinogenesis of the rat. Lab Invest 2005;85:99-108.
	2.Semenkovich CF, Coleman T, Goforth R. Physiologic concentrations of glucose regulatefatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stabil-ity. J Biol Chem 1993; 268:6961-70.
	3.Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: A metabolic oncogene in prostatecancer? J Cell Biochem 2004; 91:47-53.
	4.Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, La Torre G, Ricciardi G, BosmanC, Calvieri S. Fatty acid synthase expression in melanoma. J Cutan Pathol 2003; 30:23-8.
	5.Kuhajda FP. Fatty-acid synthase and human cancer: New perspectives on its role in tumorbiology. Proc Natl Acad Sci USA 2000; 16:202-8.
	6.Visca P, Alo PL, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi S, Di TondoU, Donnorso RP. Immunohistochemical expression of fatty acid synthase, apoptotic-regu-lating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas,and adjacent nonneoplastic mucosa. Clin Cancer Res 1999; 5:4111-8.
	7.Camassei FD, Cozza R, Acquaviva A, Jenkner A, Rava L, Gareri R, Donfrancesco A,Bosman C, Vadala P, Hadjistilianou T, Boldrini R. Expression of the lipogenic enzyme fattyacid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness. InvestOphthalmol Vis Sci 2003; 44:2399-403.
	8.De Schrijver E, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morpho-logical changes and apoptosis of LNCaPprostate cancer cells. Cancer Res 2003;63:3799-804.
	9.Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R. Inhibition offatty acid synthase (FAS) suppresses HER2/neu(erbB-2) oncogene overexpression in cancercells. Proc Natl Acad Sci USA 2004; 101:10715-20.
	10.Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES.Pharmacological inhibition of fatty acid synthase activity produces both cytostatic andcytotoxic effects modulated by p53. Cancer Res 2001; 61:1493-9.
	11.Knowles LM, Axelrod F, Browne CD, Smith JW. A fatty acid synthase blockade inducestumor cell-cycle arrest by down-regulating Skp2. J Biol Chem 2004; 279:30540-5.
	12.Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP. Fatty acid synthase inhibitorsare chemopreventive for mammary cancer in neu-Ntransgenic mice. Oncogene 2004;24:39-46.
	13.Lu S, Archer MC. Fatty acid synthase is a potential molecular target for the chemopreventionof breast cancer. Carcinogenesis 2005; 26:153-7.
	14.Leonhardt M, Langhans W. Fatty acid oxidation and control of food intake. Physiol Behav2004; 83:645-51.
	15.Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structureand expression of p53gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA1990; 87:1973-7.
	16.Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, YamamotoH, Fujimoto J, Okamoto E, Hayashi N, Hori M. Activation of mitogen-activated proteinkinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.Hepatology 1998; 27:951-8.
	17.Dils R, Carey EM. Fatty acid synthase from rabbit mammary gland. Methods Enzymol1975; 35:74-83.
	18.Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptomeanalysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 2003;63:132-9.
	19.Camassei FD, Jenkner A, Rava L, Bosman C, Francalanci P, Donfrancesco A, Alo PL,Boldrini R. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor ofpoor outcome in nephroblastoma: An interinstitutional study. Med Pediatr Oncol 2003;40:302-8.
	20.Schwartz D, Rotter V. p53-dependent cell cycle control: Response to genotoxic stress.Semin Cancer Biol 1998; 8:325-36.
	21.Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20:1803-15.
	22.Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependentG0/G1cell cycle arrest induced by ribonucleotide depletion in the absence of detectableDNA damage. Genes Dev 1996; 10:934-47.
	23.Schmaltz C, Hardenbergh PH, Wells A, Fisher DE. Regulation of proliferation-survivaldecisions during tumor cell hypoxia. Mol Cell Biol 1998; 18:2845-54.
	24.Alessenko AV, Boikov PYa, Filippova GN, Khrenov AV, Loginov AS, Makarieva ED.Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Lett 1997; 416:113-6.
	25.Pritchard DM, Watson AJ, Potten CS, Jackman AL, Hickman JA. Inhibition by uridinebut not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil:Evidence for the involvement of RNA perturbation. Proc Natl Acad Sci USA 1997;94:1795-9.
	26.An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilizationof wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392:405-8.
	27.Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: The p38 MAPKpathway. Crit Care Med 2000; 28:N67-77.
	28.Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Novel signaling molecules impli-cated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation andsurvival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK,p27KIP1, BRCA1, and NF-kappaB. Int J Oncol 2004; 24:591-608.
	29.Fan M, Chambers TC. Role of mitogen-activated protein kinases in the response of tumorcells to chemotherapy. Drug Resist Updat 2001; 4:253-67.
	30.MacKeigan JP, Taxman DJ, Hunter D, Earp IIIrd HS, Graves LM, Ting JP. Inactivation ofthe antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatmentof taxol and mitogen-activated protein kinase kinase inhibition. Clin Cancer Res 2002;8:2091-9.
	31.Menendez JA, Vellon L, Colomer R, Lupu R. Pharmacological and small interferenceRNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenicantigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Int J Cancer2005; 115(1):19-35.
	32.Olson JM, Hallahan AR. p38 MAP kinase: A convergence point in cancer therapy. TrendsMol Med 2004; 10:125-9.
	33.Schafer KA. The cell cycle: A review. Vet Pathol 1998; 35:461-78.
	34.Vermeulen K, Berneman ZN, Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif2003; 36:165-75.
	35.Schwartz D, Rotter V. p53-dependent cell cycle control: Response to genotoxic stress.Semin Cancer Biol 1998; 8:325-36.
	36.Wu GS. The functional interactions between the p53 and MAPK signaling pathways.Cancer Biol Ther 2004; 3:156-61.
crj13219.pdf	35
	1.Chan S, Abadco DL, Steiner P. Role of flexible fiberopticbronchoscopy in the diagnosis of childhood endobronchialtuberculosis. Pediatr Infect Dis J 1994;13:506-9.
	2.Tagarro Garcia A, Barrio Gomez de Aguero MI, Martinez Carrasco C, et al. Fiberoptic bronchoscopy in childhoodendobronchial tuberculosis. An Pediatr (Barc) 2004;61:314-9.
	3.Papagiannopoulos KA, Linegar AG, Harris DG, Rossouw GJ.Surgical management of airway obstruction in primary tuberculosis inchildren. Ann Thorac Surg 1999;68:1182-6.
	4.Chung HS, Lee JH. Bronchoscopic assessment of the evolution ofendobronchial tuberculosis. Chest 2000;117:385-92.
	5.Freixinet J, Varela A, Lopez Rivero L, Caminero JA, Rodriguez de Castro F, Serrano A. Surgical treatment of childhoodmediastinal tuberculous lymphadenitis. Ann Thorac Surg1995;59:644-6.
	6.Wan IY, Lee TW, Lam HC, Abdullah V, YimAP. Tracheobronchialstenting for tuberculous airway stenosis. Chest 2002;122:370-4.
	7.Jacobs JP, Quintessenza JA, Botero LM, et al. The role of airwaystents in the management of pediatric tracheal, carinal, andbronchial disease. Eur J Cardiothorac Surg 2000;18:505-12.
	8.Fayon M, Donato L, de Blic J, et al. French experience of siliconetracheobronchial stenting in children. Pediatr Pulmonol 2005;39:21-7.
	9.Rikimaru T. Therapeutic management of endobronchial tuberculosis.Expert Opin Pharmacother 2004;5:1463-70.
	10.Park IW, Choi BW, Hue SH. Prospective study of corticosteroid asan adjunct in the treatment of endobronchial tuberculosis in adults.Respirology 1997;2:275-81.
	11.Lee KH, Ko GY, Song HY, Shim TS, Kim WS. Benigntracheobronchial stenoses: Long-term clinical experience withballoon dilation. J Vasc Interv Radiol 2002;13:909-14.
	12.Kumar P, Bush AP, Ladas GP, Goldstraw P. Tracheobronchialobstruction in children: Experience with endoscopic airway stenting.Ann Thorac Surg 2003;75:1579-86.
nihms55611.pdf	78
	Adams KL, Wendel JF. Exploring the genomic mysteries of polyploidy in cotton. Biological Journal ofthe Linnean Society 2004;82:573?581.
	Adams KL, Cronn RC, Percifield R, Wendel JF. Genes duplicated by polyploidy show unequalcontributions to the transcriptome and organ-specific reciprocal silencing. Proceedings of the NationalAcademy of Sciences, USA 2003;100:4649?4654.
	Aharoni A, Vorst O. DNA microarrays for functional plant genomics. Plant Molecular Biology2001;48:99?118. [PubMed: 11860216]
	Anderson, E. Introgressive Hybridization. Wiley; New York: 1948.
	Arnold, ML. Natural Hybridization and Evolution. Oxford University Press; New York: 1997.
	Aronson J, Kigel J, Shmida A. Reproductive allocation strategies in desert and Mediterranean populationsof annual plants grown with and without water stress. Oecologia 1993;93:336?342.
	Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach tomultiple testing. Journal of the Royal Statistical Society 1995;57:289?300.
	Blanc G, Wolfe KH. Functional divergence of duplicated genes formed by polyploidy duringArabidopsis evolution. The Plant Cell 2004;16:1679?1691. [PubMed: 15208398]
	Brochmann C, Borgen L, Stabbetorp OE. Multiple diploid hybrid speciation of the Canary Island endemicArgyranthemum sundingii (Asteraceae). Plant Systematics and Evolution 2000;220:77?92.
	Buerkle CA, Morris RJ, Asmussen MA, Rieseberg LH. The likelihood of homoploid hybrid speciation.Heredity 2000;84:441?451. [PubMed: 10849068]
	Burke JM, Lai Z, Salmaso M, et al. Comparative mapping and rapid karyotypic evolution in the genusHelianthus. Genetics 2004;167:449?457. [PubMed: 15166168]
	Burke JM, Tang S, Knapp SJ, Rieseberg LH. Genetic analysis of sunflower domestication. Genetics2002;161:1257?1267. [PubMed: 12136028]
	Coyne, JA.; Orr, HA. Speciation. Sinauer Associates; Sunderland, Massachusetts: 2004.
	Dowling TE, Secor CL. The role of hybridization and introgression in the diversification of animals.Annual Review of Ecology and Systematics 1997;28:593?619.
	Ellstrand NC, Whitkus R, Rieseberg LH. Distribution of spontaneous plant hybrids. Proceedings of theNational Academy of Sciences, USA 1996;93:5090?5093.
	Enard W, Khaitovich P, Klose J, et al. Intra- and interspecific variation in primate gene expressionpatterns. Science 2002;296:340?343. [PubMed: 11951044]
	Galen C. Why do flowers vary? Bioscience 1999;49:631?640.
	Gibson G. Microarrays in ecology and evolution: a preview. Molecular Ecology 2002;11:17?24.[PubMed: 11903901]
	Grant, V. Plant Speciation. 1. Columbia University Press; New York: 1981.
	Grant PR, Grant BR. Hybridization of bird species. Science 1992;256:193?197. [PubMed: 17744718]
	Greig D, Louis EJ, Borts RH, Travisano M. Hybrid speciation in experimental populations of yeast.Science 2002;298:1773?1775. [PubMed: 12459586]
	Gross BL, Rieseberg LH. The ecological genetics of homoploid hybrid speciation. Journal of Heredity2005;96:241?252. [PubMed: 15618301]
	Gross BL, Schwarzbach AE, Rieseberg LH. Origin(s) of the diploid hybrid species Helianthusdeserticola (Asteraceae). American Journal of Botany 2003;90:1708?1719.
	Gross BL, Kane NC, Lexer C, et al. Reconstructing the origin of Helianthus deserticola: survival andselection on the desert floor. American Naturalist 2004;164:145?156.
	Halgren RG, Fielden MR, Fong CJ, Zacharewski TR. Assessment of clone identity and sequence fidelityfor 1189 IMAGE cDNA clones. Nucleic Acids Research 2001;29:582?588. [PubMed: 11139630]
	Hegarty MJ, Hiscock SJ. Hybrid speciation in plants: new insights from molecular studies. NewPhytologist 2005;165:411?423. [PubMed: 15720652]
	Hegde P, Qi R, Abernathy K, et al. A concise guide to cDNA microarray analysis. BioTechniques2000;29:548?562. [PubMed: 10997270]
	Heiser C, Smith D, Clevenger S, Martin W. The North American sunflowers (Helianthus). Memoirs ofthe Torrey Botanical Club 1969;22:1?218.
	Herrera J. Flower size variation in Rosmarinus officinalis: individuals, populations and habitats. Annalsof Botany 2005;9:431?437. [PubMed: 15585545]
	Hodges SA, Burke JM, Arnold ML. Natural formation of iris hybrids: experimental evidence on theestablishment of hybrid zones. Evolution 1996;50:2504?2509.
	Hubbs CL. Hybridization between fish species in nature. Systematic Zoology 1955;4:1?20.
	Jang JY, Kim DG, Kim YO, Kim JS, Kang H. An expression analysis of a gene family encoding plasmamembrane aquaporins in response to abiotic stresses in Arabidopsis thaliana. Plant MolecularBiology 2004;54:713?725. [PubMed: 15356390]
	Jin Y-K, Bennetzen JL. Integration and nonrandom mutation of a plasma membrane proton ATPase genefragment within the Bs1 retroelement of maize. The Plant Cell 1994;6:1177?1186. [PubMed:7919987]
	Kashkush K, Feldman M, Levy AA. Gene loss, silencing and activation in a newly synthesized wheatallotetraploid. Genetics 2002;160:1651?1659. [PubMed: 11973318]
	Knight J. When the chips are down. Nature 2001;410:860?861. [PubMed: 11309581]
	Lai Z, Livingstone K, Zou Y, Church SA, Knapp SJ, Andrews J, Rieseberg LH. Identification andmapping of SNPs from ESTs in sunflower. Theoretical and Applied Genetics. in press
	Lai Z, Nakazato T, Salmaso M, et al. Extensive chromosomal repatterning and the evolution of sterilitybarriers in hybrid sunflower species. Genetics 2005;171:291?303. [PubMed: 16183908]
	Lee C, Roy M. Analysis of alternative splicing with microarrays: successes and challenges. GenomeBiology 2004;5:231.1?231.4. [PubMed: 15239822]
	Lee H, Wang J, Tian L, et al. Sensitivity of 70-mer oligonucleotides and cDNAs for microarray analysisof gene expression in Arabidopsis and its related species. Plant Biotechnology Journal 2004;2:45?57. [PubMed: 17166142]
	Lexer C, Welch ME, Durphy JL, Rieseberg LH. Natural selection for salt tolerance quantitative trait loci(QTLs) in wild sunflower hybrids: implications for the origin of Helianthus paradoxus, a diploidhybrid species. Molecular Ecology 2003a;12:1225?1235. [PubMed: 12694286]
	Lexer C, Welch ME, Raymond O, Rieseberg LH. The origin of ecological divergence in Helianthusparadoxus (Asteraceae): selection on transgressive characters in a novel hybrid habitat. Evolution2003b;57:1989?2000. [PubMed: 14575321]
	Lexer C, Rosenthal DM, Raymond O, Donovan LA, Rieseberg LH. Genetics of species differences inthe wild annual sunflowers, Helianthus annuus and H. petiolaris. Genetics 2005;169:2225?2239.[PubMed: 15545657]
	Liu B, Brubaker CL, Mergeai G, Cronn RC, Wendel JF. Polyploid formation in cotton is not accompaniedby rapid genomic changes. Genome 2001;44:321?330. [PubMed: 11444689]
	Ludwig F, Rosenthal DM, Johnston JA, et al. Selection on leaf ecophysiological traits in a desert hybridHelianthus species and early-generation hybrids. Evolution 2004;58:2682?2692. [PubMed:15696747]
	Ma L, Li J, Qu L, et al. Light control of Arabidopsis development entails coordinated regulation of genomeexpression and cellular pathways. The Plant Cell 2001;13:2589?2607. [PubMed: 11752374]
	Madlung A, Masuelli RW, Watson B, et al. Remodeling of DNA methylation and phenotypic andtranscriptional changes in synthetic Arabidopsis allotetraploids. Plant Physiology 2002;129:733?746. [PubMed: 12068115]
	Madlung A, Tyagi AP, Watson B, et al. Genomic changes in synthetic Arabidopsis polyploids. The PlantJournal 2005;41:221?230. [PubMed: 15634199]
	Martienssen RA, Barkan A, Taylor WC, Freeling M. Somatically heritable switches in the DNAmodification of Mu transposable elements monitored with a suppressible mutation in maize. Genesand Development 1989;4:331?343. [PubMed: 2159936]
	Noor MAF, Grams KL, Bertucci LA, Reiland J. Chromosomal inversions and the reproductive isolationof species. Proceedings of the National Academy of Sciences, USA 2001;98:12084?12088.
	Osborn TC, Pires CJ, Birchler JA, et al. Understanding mechanisms of novel gene expression inpolyploids. Trends in Genetics 2003;19:141?147. [PubMed: 12615008]
	Ozkan H, Levy AA, Feldman M. Allopolyploidy-induced rapid genome evolution in the wheat (Aegilops-Triticum) group. The Plant Cell 2001;13:1735?1747. [PubMed: 11487689]
	Renn SC, Aubin-Horth N, Hofmann HA. Biologically meaningful expression profiling across speciesusing heterologous hybridization to a cDNA microarray. BMC Genomics2004:5.10.1186/1471-2164-5-42 [PubMed: 14720308]
	Richmond T, Somerville S. Chasing the dream: plant EST microarrays. Current Opinion in Plant Biology2000;3:108?116. [PubMed: 10712953]
	Rieseberg LH. Homoploid reticulate evolution in Helianthus (Asteraceae): evidence from ribosomalgenes. American Journal of Botany 1991;78:1218?1237.
	Rieseberg LH. Hybrid origins of plant species. Annual Review of Ecology and Systematics 1997;28:359?389.
	Rieseberg LH. Crossing relationships among ancient and experimental sunflower hybrid lineages.Evolution 2000;54:859?865. [PubMed: 10937259]
	Rieseberg LH. Chromosomal rearrangements and speciation. Trends in Ecology & Evolution2001;16:351?357. [PubMed: 11403867]
	Rieseberg LH, Archer MA, Wayne RK. Transgressive segregation, adaptation and speciation. Heredity1999;83:363?372. [PubMed: 10583537]
	Rieseberg LH, Carter R, Zona S. Molecular tests of the hypothesized hybrid origin of two diploidHelianthus species (Asteraceae). Evolution 1990;44:1498?1511.
	Rieseberg LH, Beckstrom-Sternberg SM, Liston A, Arias DM. Phylogenetic and systematic inferencesfrom chloroplast DNA and isozyme variation in Helianthus sect. Helianthus (Asteraceae). SystematicBotany 1991;16:50?76.
	Rieseberg LH, Van Fossen C, Desrochers AM. Hybrid speciation accompanied by genomicreorganization in wild sunflowers. Nature 1995;375:313?316.
	Rieseberg LH, Sinervo B, Linder CR, Ungerer MC, Arias DM. Role of gene interaction in hybridspeciation: evidence from ancient and experimental hybrids. Science 1996;272:741?745. [PubMed:8662570]
	Rieseberg LH, Raymond O, Rosenthal DM, et al. Major ecological transitions in wild sunflowersfacilitated by hybridization. Science 2003;301:1211?1216. [PubMed: 12907807]
	Rogers, C.; Thompson, T.; Seiler, GJ. Sunflower Species of the United States. National SunflowerAssociation; Bismarck, North Dakota: 1982.
	Rosenthal DM, Schwarzbach AE, Donovan LA, Raymond O, Rieseberg LH. Phenotypic differentiationbetween three ancient hybrid taxa and their parental species. International Journal of Plant Sciences2002;163:387?398.
	Salmon A, Ainouche ML, Wendel JF. Genetic and epigenetic consequences of recent hybridization andpolyploidy in Spartina (Poaceae). Molecular Ecology 2005;14:1163?1175. [PubMed: 15773943]
	Seehausen O. Hybridization and adaptive radiation. Trends in Ecology & Evolution 2004;19:198?207.[PubMed: 16701254]
	Shaked H, Kashkush K, Ozkan H, Feldman M, Levy AA. Sequence elimination and cytosine methylationare rapid and reproducible responses of the genome to wide hybridization and allopolyploidy inwheat. The Plant Cell 2001;13:1749?1759. [PubMed: 11487690]
	Smyth G. Linear models and empirical Bayes methods for assessing differential expression in microarrayexperiments. Statistical Applications in Genetics and Molecular Biology 2004:3.Article 3
	Soltis DE, Soltis PS, Tate JA. Advances in the study of polyploidy since Plant speciation. NewPhytologist 2003;161:173?191.
	Soltis DE, Soltis PS, Pires CJ, et al. Recent and recurrent polyploidy in Tragopogon (Asteraceae):cytogenetic, genomic and genetic comparisons. Biological Journal of the Linnean Society2004;82:485?501.
	Taji T, Seki M, Satou M, et al. Comparative genomics in salt tolerance between Arabidopsis andArabidopsis-related halophyte salt cress using Arabidopsis microarray. Plant Physiology2004;135:1697?1709. [PubMed: 15247402]
	Wang J, Tian L, Madlung A, et al. Stochastic and epigenetic changes of gene expression inArabidopsis polyploids. Genetics 2004;167:1961?1973. [PubMed: 15342533]
	Weil CF, Wessler SR. Molecular evidence that chromosome breakage by Ds elements is caused byaberrant transposition. Plant Cell 1993;5:515?522. [PubMed: 8390878]
	Welch ME, Rieseberg LH. Habitat divergence between a homoploid hybrid sunflower species, Helianthusparadoxus (Asteraceae), and its progenitors. American Journal of Botany 2002;89:472?478.
	Wendel JF. Genome evolution in polyploids. Plant Molecular Biology 2000;42:225?249. [PubMed:10688139]
	Xiao W, Oefner PJ. Denaturing high-performance liquid chromatography: a review. Human Mutation2001;17:439?474. [PubMed: 11385705]
	Zhu J-K. Salt and drought stress signal transduction in plants. Annual Review of Plant Biology2002;53:247?273.
bj3970519.pdf	32
	1Guarente,L.andPicard,F.(2005)Calorierestriction?theSIR2connection.Cell120,473?482
	2Wood,J.G.,Rogina,B.,Lavu,S.,Howitz,K.,Helfand,S.L.,Tatar,M.andSinclair,D.(2004)Sirtuinactivatorsmimiccaloricrestrictionanddelayageinginmetazoans.Nature(London)430,686?689
	3Blander,G.andGuarente,L.(2004)TheSir2familyofproteindeacetylases.Annu.Rev.Biochem.73,417?435
	4Tissenbaum,H.A.andGuarente,L.(2001)Increaseddosageofasir-2geneextendslifespaninCaenorhabditiselegans.Nature(London)410,227?230
	5Lin,S.J.,Defossez,P.A.andGuarente,L.(2000)RequirementofNADandSIR2forlife-spanextensionbycalorierestrictioninSaccharomycescerevisiae.Science289,2126?2128
	6Rogina,B.andHelfand,S.L.(2004)Sir2mediateslongevityintheflythroughapathwayrelatedtocalorierestriction.Proc.Natl.Acad.Sci.U.S.A.101,15998?16003
	7Lamming,D.W.,Wood,J.G.andSinclair,D.A.(2004)Smallmoleculesthatregulatelifespan:evidenceforxenohormesis.Mol.Microbiol.53,1003?1009
	8Tatar,M.,Bartke,A.andAntebi,A.(2003)Theendocrineregulationofagingbyinsulin-likesignals.Science299,1346?1351
	9Kenyon,C.(2005)Theplasticityofaging:insightsfromlong-livedmutants.Cell120,449?460
	10Bluher,M.,Kahn,B.B.andKahn,C.R.(2003)Extendedlongevityinmicelackingtheinsulinreceptorinadiposetissue.Science299,572?574
	11Holzenberger,M.,Dupont,J.,Ducos,B.,Leneuve,P.,Geloen,A.,Even,P.C.,Cervera,P.andLeBouc,Y.(2003)IGF-1receptorregulateslifespanandresistancetooxidativestressinmice.Nature(London)421,182?187
	12Barbieri,M.,Bonafe,M.,Franceschi,C.andPaolisso,G.(2003)Insulin/IGF-I-signalingpathway:anevolutionarilyconservedmechanismoflongevityfromyeasttohumans.Am.J.Physiol.Endocrinol.Metab.285,E1064?E1071
	13Hsieh,C.C.,DeFord,J.H.,Flurkey,K.,Harrison,D.E.andPapaconstantinou,J.(2002)ImplicationsfortheinsulinsignalingpathwayinSnelldwarfmouselongevity:asimilaritywiththeC.eleganslongevityparadigm.Mech.AgeingDev.123,1229?1244
	14Bartke,A.andBrown-Borg,H.(2004)Lifeextensioninthedwarfmouse.Curr.Top.Dev.Biol.63,189?225
	15Liang,H.,Masoro,E.J.,Nelson,J.F.,Strong,R.,McMahan,C.A.andRichardson,A.(2003)Geneticmousemodelsofextendedlifespan.Exp.Gerontol.38,1353?1364
	16Hsieh,C.C.,DeFord,J.H.,Flurkey,K.,Harrison,D.E.andPapaconstantinou,J.(2002)EffectsofthePit1mutationontheinsulinsignalingpathway:implicationsonthelongevityofthelong-livedSnelldwarfmouse.Mech.AgeingDev.123,1245?1255
	17Pervaiz,S.(2003)Resveratrol:fromgrapevinestomammalianbiology.FASEBJ.17,1975?1985
	18Howitz,K.T.,Bitterman,K.J.,Cohen,H.Y.,Lamming,D.W.,Lavu,S.,Wood,J.G.,Zipkin,R.E.,Chung,P.,Kisielewski,A.,Zhang,L.L.etal.(2003)SmallmoleculeactivatorsofsirtuinsextendSaccharomycescerevisiaelifespan.Nature(London)425,191?196
	19Yeung,F.,Hoberg,J.E.,Ramsey,C.S.,Keller,M.D.,Jones,D.R.,Frye,R.A.andMayo,M.W.(2004)ModulationofNF-?B-dependenttranscriptionandcellsurvivalbytheSIRT1deacetylase.EMBOJ.23,2369?2380
	20Zhang,J.,Ou,J.,Bashmakov,Y.,Horton,J.D.,Brown,M.S.andGoldstein,J.L.(2001)InsulininhibitstranscriptionofIRS-2geneinratliverthroughaninsulinresponseelement(IRE)thatresemblesIREsofotherinsulin-repressedgenes.Proc.Natl.Acad.Sci.U.S.A.98,3756?3761
	21Picard,F.,Kurtev,M.,Chung,N.,Topark-Ngarm,A.,Senawong,T.,Oliveira,R.M.,Leid,M.,McBurney,M.W.andGuarente,L.(2004)Sirt1promotesfatmobilizationinwhiteadipocytesbyrepressingPPAR-gamma.Nature(London)429,771?776
	22Granner,D.,Andreone,T.,Sasaki,K.andBeale,E.(1983)Inhibitionoftranscriptionofthephosphoenolpyruvatecarboxykinasegenebyinsulin.Nature(London)305,549?551
	23Kahn,C.R.,Vicent,D.andDoria,A.(1996)Geneticsofnon-insulin-dependent(type-II)diabetesmellitus.Annu.Rev.Med.47,509?531
	24Myers,Jr,M.G.,Backer,J.M.,Sun,X.J.,Shoelson,S.,Hu,P.,Schlessinger,J.,Yoakim,M.,Schaffhausen,B.andWhite,M.F.(1992)IRS-1activatesphosphatidylinositol3?-kinasebyassociatingwithsrchomology2domainsofp85.Proc.Natl.Acad.Sci.U.S.A.89,10350?10354
	25Patti,M.,Sun,X.J.,Bruening,J.C.,Araki,E.,Lipes,M.A.,White,M.F.andKahn,C.R.(1995)4PS/Insulinreceptorsubstrate(IRS)-2isthealternativesubstrateoftheinsulinreceptorinIRS-1-deficientmice.J.Biol.Chem.270,24670?24673
	26Ui,M.,Okada,T.,Hazeki,K.andHazeki,O.(1995)Wortmanninasauniqueprobeforanintracellularsignallingprotein,phosphoinositide3-kinase.TrendsBiochem.Sci.20,303?307
	27Huppi,K.,Martin,S.E.andCaplen,N.J.(2005)DefiningandassayingRNAiinmammaliancells.Mol.Cell17,1?10
	28Schmidt,M.T.,Smith,B.C.,Jackson,M.D.andDenu,J.M.(2004)Co-enzymespecificityofSir2proteindeacetylases:Implicationsforphysiologicalregulation.J.Biol.Chem.279,40122?40129
	29Kaeberlein,M.,McDonagh,T.,Heltweg,B.,Hixon,J.,Westman,E.A.,Caldwell,S.,Napper,A.,Curtis,R.,Distefano,P.S.,Fields,S.etal.(2005)Substratespecificactivationfosirtuinsbyresveratrol.J.Biol.Chem.280,17038?17045
	30Kaeberlein,M.,Kirkland,K.T.,Fields,S.andKennedy,B.K.(2004)Sir2-independentlifespanextensionbycalorierestrictioninyeast.PLoSBiol.2,E296
	31Zimmet,P.,Alberti,K.G.andShaw,J.(2001)Globalandsocietalimplicationsofthediabetesepidemic.Nature(London)414,782?787
	32Fontana,L.,Meyer,T.E.,Klein,S.andHolloszy,J.O.(2004)Long-termcalorierestrictionishighlyeffectiveinreducingtheriskforatherosclerosisinhumans.Proc.Natl.Acad.Sci.U.S.A.101,6659?6663
nihms63099.pdf	21
	1. (a) Lotagawa O, Inoue T, Taguchi T. Rev Heteroatom Chem 1996;15:243. b Frederickson M, GriggR. Org Prep Proc Int 1997;29:33. c Cardillo G, Orena M. Tetrahedron 1990;46:3321.
	2. Drenth, W. Chemistry of Triple-Bonded Functional Groups. Patai, S., editor. 2. J. Wiley; Chichester,UK: 1994. p. 873-915.Schmid, GH. Chemistry of the Carbon-Carbon Triple Bond. Patai, S., editor.1. J. Wiley; Chichester, UK: 1978. p. 275-341.Larock, RC. Acetylene Chemistry. Diederich, F.; Stang,PJ.; Tykwinski, RR., editors. Wiley-VCH; Weinheim, Germany: 2005. p. 51-99.
	3. (a) Arcadi A, Cacchi S, Fabrizi G, Marinelli F, Moro L. Synlett 1999:1432. b Yue D, Yao T, LarockRC. J Org Chem 2005;70:10292. [PubMed: 16323837] c Yao T, Yue D, Larock RC. J Comb Chem2005;7:809. [PubMed: 16283788]
	4. (a) Yue D, Larock RC. J Org Chem 2002;67:1905. [PubMed: 11895409] b Hessian K, Flynn B. OrgLett 2003;5:4377. [PubMed: 14602004] c Flynn BL, Verdier-Pinard P, Hamel E. Org Lett 2001;5:651.[PubMed: 11259028]
	5. Huang Q, Hunter JA, Larock RC. J Org Chem 2002;67:3437. [PubMed: 12003556]
	6. (a) Yue D, Larock RC. Org Lett 2004;6:1037. [PubMed: 15012094] b Barluenga J, Trincado M, RubioE, Gonzï¿½lez JM. Angew Chem, Int Ed 2003;42:2406. c Amjad M, Knight DW. Tetrahedron Lett2004;45:539.
	7. (a) Yao T, Larock RC. J Org Chem 2003;68:5936. [PubMed: 12868929] b Bellina F, Biagetti M,Carpita A, Rossi R. Tetrahedron 2001;57:2857. c Bellina F, Biagetti M, Carpita A, Rossi R.Tetrahedron Lett 2001;42:2859.
	8. Yao T, Larock RC. J Org Chem 2005;70:1432. [PubMed: 15704980]
	9. (a) Yao T, Campo MA, Larock RC. Org Lett 2004;6:2677. [PubMed: 15281742] b Yao T, Campo MA,Larock RC. J Org Chem 2005;70:3511. [PubMed: 15844984] c Goldfinger MB, Crawford KB, SwagerTM. J Am Chem Soc 1997;119:4578. d Goldfinger MB, Swager TM. J Am Chem Soc 1994;116:7895.
	10. (a) Knight DW, Redfern AL, Gilmore J. J Chem Soc, Perkin Trans 1 2002:622. b Arcadi A, CacchiS, Giuseppe SD, Fabrizi G, Marinelli F. Org Lett 2002;4:2409. [PubMed: 12098259] c Djuardi E,McNelis E. Tetrahedron Lett 1999;40:7193. f Marshall JA, Yanik MM. J Org Chem 1999;64:3798.d Arcadi A, Cacchi S, Fabrizi G, Marinelli F, Moro L. Synlett 1999:1432. e Knight DW, RedfernAL, Gilmore J. J Chem Soc, Chem Commun 1998:2207. f Redfern AL, Gilmore J. Synlett 1998:731.g Ren XF, Konaklieva MI, Shi H, Dicy H, Lim DV, Gonzales J, Turos E. J Org Chem 1998;63:8898.h Bew SP, Knight DW. J Chem Soc, Chem Commun 1996:1007. i El-Taeb GMM, Evans AB, JonesS, Knight DW. Tetrahedron Lett 2001;42:5945. j Zhang X, Campo MA, Yao T, Larock RC. Org Lett2005;7:763. [PubMed: 15727435] k Zhang X, Larock RC. J Am Chem Soc 2005;127:12230.[PubMed: 16131194] l Yao T, Zhang X, Larock RC. J Org Chem 2005;70:7679. [PubMed: 16149799]
	11. (a) Asao N, Nogami T, Takahashi K, Yamamoto Y. J Am Chem Soc 2002;124:764. [PubMed:11817947] b Nakamura H, Ohtaka M, Yamamoto Y. Tetrahedron Lett 2002;43:7631.
	12. Barluenga J, Vazquez-Villa H, Ballesteros A, Gonzï¿½lez JM. J Am Chem Soc 2003;125:9028.[PubMed: 15369355]
	13. For a recent review on multicomponent reactions, see: Dï¿½mling A, Ugi I. Angew Chem, Int Ed2000;39:3168.
	14. For a previous communication, see: Yue D, Della Cï¿½ N, Larock RC. Org Lett 2004;6:1581. [PubMed:15128241]
	15. Tovar JD, Swager TM. J Org Chem 1999;64:6499.
	16. Sonogashira, K. Metal-Catalyzed Cross-Coupling Reactions. Diederich, F.; Stang, PJ., editors. Chpt5. Wiley-VCH; Weinheim: 1998. p. 203-229. (b) Sonogashira K, Tohda Y, Hagihara N. TetrahedronLett 1975:4467.
	17. For metal-catalyzed synthesis of naphthalenes, see: (a) Asao N, Takahashi K, Lee S, Kasahara T,Yamamoto Y. J Am Chem Soc 2002;124:12650. [PubMed: 12392398] b Asao N, Nogami T, Lee S,Yamamoto Y. J Am Chem Soc 2003;125:10921. [PubMed: 12952473] c Asao N, Kasahara T,Yamamoto Y. Angew Chem, Int Ed 2003;42:3504.For the iodonium ion-prompted synthesis ofnapthalenes, see: (d) Barluenga J, Vazquez-Villa H, Ballesteros A, Gonzï¿½lez JM. Org Lett2003;5:4121. [PubMed: 14572264] e Barluenga J, Vï¿½zquez-Villa H, Ballesteros A, Gonzï¿½lez JM.Adv Synth Catal 2005;347:526.
	18. (a) Suzuki A. J Organomet Chem 1999;576:147. b Lloyd-Williams P, Giralt E. Chem Soc Rev2001;30:145.Suzuki, A. Metal-Catalyzed Cross-Coupling Reactions. Diederich, F.; Stang, PJ.,editors. Wiley-VCH; Weinheim: 1998. p. 49-97. (d) Miyaura N. Chem Rev 1995;95:2457.
	19. (a) Negishi E, Dumond Y. Handbook of Organopalladium Chemistry for Organic Synthesis2002;1:767. b Kosugi M, Fugami K. Handbook of Organopalladium Chemistry for Organic Synthesis2002;1:263. c Kosugi M, Fugami K. J Organomet Chem 2002;653:50.
	20. (a) Crisp GT. Chem Soc Rev 1998;27:427.Brase, S.; De Meijere, A. Metal-Catalyzed Cross-CouplingReactions. Diederich, F.; Stang, PJ., editors. Wiley-VCH; Weinheim: 1998. p. 99-166.Heck, RF.Palladium Reagents in Organic Synthesis. Academic Press; San Diego: 1985. p. 276-287.
	21. Larock RC, Doty MJ, Han X. J Org Chem 1999;64:8770. [PubMed: 11674778]
0759-05.pdf	20
	1.Augustin,J.,andF.Gotz.1990.TransformationofStaphylococcusepider-midisandotherstaphylococcalspecieswithplasmidDNAbyelectropora-tion.FEMSMicrobiol.Lett.66:203?208.
	2.Boyle-Vavra,S.,R.B.Carey,andR.S.Daum.2001.Developmentofvan-comycinandlysostaphinresistanceinamethicillin-resistantStaphylococcusaureusisolate.J.Antimicrob.Chemother.48:617?625.
	3.Boyle-Vavra,S.,S.Yin,M.Challapalli,andR.S.Daum.2002.Transcrip-tionalinductionofthepenicillin-bindingprotein2geneinStaphylococcusaureusbycellwall-activeantibioticsoxacillinandvancomycin.Antimicrob.AgentsChemother.2003:1028?1036.
	4.Hanaki,H.,K.Kuwahara-Arai,S.Boyle-Vavra,R.S.Daum,H.Labischinski,andK.Hiramatsu.1998.Activatedcell-wallsynthesisisassociatedwithvanco-Mu3andMu50.J.Antimicrob.Chemother.42:199?209.
	5.Henze,U.U.,andB.Berger-Bachi.1995.Staphylococcusaureuspenicillin-bindingprotein4andintrinsic-lactamresistance.Antimicrob.AgentsChe-mother.39:2415?2422.
	6.Kreiswirth,B.N.,S.Lofdahl,M.J.Betley,M.O?Reilly,P.M.Schlievert,M.S.Bergdoll,andR.P.Novick.1983.Thetoxicshocksyndromeexotoxinstructuralgeneisnotdetectablytransmittedbyaprophage.Nature305:709?712.
	7.Kuroda,M.,H.Kuroda,T.Oshima,F.Takeuchi,H.Mori,andK.Hira-matsu.2003.Two-componentsystemVraSRpositivelymodulatestheregu-lationofcell-wallbiosynthesispathwayinStaphylococcusaureus.Mol.Mi-crobiol.49:807?821.
	8.Kuroda,M.,K.Kuwahara-Arai,andK.Hiramatsu.2000.Identificationoftheup-anddown-regulatedgenesinvancomycin-resistantStaphylococcusaureusstrainsMu3andMu50bycDNAdifferentialhybridizationmethod.Biochem.Biophys.Res.Commun.269:485?490.
	9.Kuroda,M.,T.Ohta,I.Uchiyama,T.Baba,H.Yuzawa,I.Kobayashi,L.Cui,A.Oguchi,K.-I.Aoki,Y.Nagai,J.-Q.Lian,T.Ito,M.Kanamori,H.Matsumaru,A.Maruyama,H.Murakami,A.Hosoyama,Y.Mizutani-Ui,N.K.Takahashi,T.Sawano,R.-I.Inoue,C.Kaito,K.Sekimizu,H.Hirakawa,S.Kuhara,S.Goto,J.Yabuzaki,M.Kanehisa,A.Yamashita,K.Oshima,K.Furuya,C.Yoshino,T.Shiba,M.Hattori,N.Ogasawara,H.Hayashi,andK.Hiramatsu.2001.Wholegenomicsequencingofmethicillin-resistantStaphylococcusau-reus.Lancet357:1225?1240.
	10.Lin,W.S.,T.Cunneen,andC.Y.Lee.1994.Sequenceanalysisandmolec-ularcharacterizationofgenesrequiredforthebiosynthesisoftype1capsularpolysaccharideinStaphylococcusaureus.J.Bacteriol.176:7005?7016.
	11.Moreira,B.,S.Boyle-Vavra,B.L.M.deJonge,andR.S.Daum.1997.Increasedproductionofpenicillin-bindingprotein2,increaseddetectionofotherpenicillin-bindingproteins,anddecreasedcoagulaseactivityassociatedwithglycopeptideresistanceinStaphylococcusaureus.Antimicrob.AgentsChemother.41:1788?1793.
	12.Murakami,K.,T.Fujimura,andM.Doi.1994.Nucleotidesequenceofthestructuralgeneforthepenicillin-bindingprotein2ofStaphylococcusaureusandthepresenceofahomologousgeneinotherstaphylococci.FEMSMicrobiol.Lett.117:131?136.
	13.Pechous,R.,N.Ledala,B.J.Wilkinson,andR.K.Jayaswal.2004.Regula-tionoftheexpressionofcellwallstressstimulonmembergenemsrA1inChemother.48:3057?3063.
	14.Pinho,M.G.,H.deLencastre,andA.Tomasz.2001.Anacquiredandanativepenicillin-bindingproteincooperateinbuildingthecellwallofdrug-resistantstaphylococci.Proc.Natl.Acad.Sci.USA98:10886?10891.
	15.Pinho,M.G.,H.deLencastre,andA.Tomasz.2000.Cloning,characteriza-tion,andinactivationofthegenepbpC,encodingpenicillin-bindingprotein3ofStaphylococcusaureus.J.Bacteriol.182:1074?1079.
	16.Pinho,M.G.,H.deLencastre,andA.Tomasz.1998.TranscriptionalanalysisoftheStaphylococcusaureuspenicillinbindingprotein2gene.J.Bacteriol.180:6077?6081.
	17.Severin,A.,S.W.Wu,K.Tabei,andA.Tomasz.2004.Penicillin-bindingprotein2isessentialforexpressionofhigh-levelvancomycinresistanceandcellwallsynthesisinvancomycin-resistantStaphylococcusaureuscarryingtheenterococcalvanAgenecomplex.Antimicrob.AgentsChemother.48:4566?4573.
	18.Sieradzki,K.,andA.Tomasz.1999.Gradualalterationsincellwallstructureandmetabolisminvancomycin-resistantmutantsofStaphylococcusaureus.J.Bacteriol.181:7566?7570.
	19.Utaida,S.,P.M.Dunman,D.Macapagal,E.Murphy,S.J.Projan,V.K.Singh,R.K.Jayaswal,andB.J.Wilkinson.2003.Genome-widetranscrip-tionalprofilingoftheresponseofStaphylococcusaureustocell-wall-activeantibioticsrevealsacell-wall-stressstimulon.Microbiology149:2719?2732.
	20.Wada,A.,andH.Watanabe.1998.Penicillin-bindingprotein1ofStaphylo-coccusaureusisessentialforgrowth.J.Bacteriol.180:2759?2765.
1000.pdf	61
	1.Saenger,W.1984.PrinciplesofNucleicAcidStructure.Springer-Verlag,NewYork,NY.
	2.Bloomfield,V.A.,D.N.Crothers,andI.Tinoco.2000.NucleicAcids:Structures,PropertiesandFunctions.V.A.Bloomfield,D.N.Crothers,andI.Tinoco,editors.UniversityScienceBooks,Sausalito,CA.
	3.Blackburn,G.M.,andM.J.Gait.1990.NucleicAcidsinChemistryandBiology.G.M.BlackburnandM.J.Gait,editors.IRLPress,Oxford,UK.
	4.Robles,J.,A.Grandas,E.Pedroso,F.J.Luque,R.Eritja,andM.Orozco.2002.Nucleicacidtriplehelices:stabilityeffectsofnucleobasemodifications.Curr.Org.Chem.6:1333?1368.
	5.Gehring,K.,J.L.Leroy,andM.Gueï¿½ron.1993.AtetramericDNAstructurewithprotonatedcytosine-cytosinebasepairs.Nature.363:561?565.
	6.Gray,D.M.,M.Vaughn,R.L.Ratliff,andF.N.Hayes.1980.CirculardichroismspectrashowthatrepeatingdinucleotideDNAsmayformhelicesinwhicheveryotherbaseisloopedout.NucleicAcidsRes.8:3695?3707.
	7.Laughlan,G.,A.I.Murchie,M.H.Norman,P.C.Moody,D.M.Lilley,andB.Luisi.1994.Thehigh-resolutioncrystalstructureofaparallel-strandedguaninetetraplex.Science.265:520?524.
	8.Wang,A.H.,G.J.Quiqkey,F.J.Kolpak,J.L.Crawford,J.H.vanBoom,G.vanderMarel,andA.Rich.1979.Molecularstructureofaleft-handeddoublehelicalDNAfragmentatatomicresolution.Nature.282:680?686.
	9.Cubero,E.,F.J.Luque,andM.Orozco.2001.Theoreticalstudiesofd(A:T)-basedparallel-strandedDNAduplexes.J.Am.Chem.Soc.123:12018?12025.
	10.Cubero,E.,A.Avin?oï¿½,B.G.delaTorre,M.Frieden,R.Eritja,F.J.Luque,C.Gonzaï¿½lez,andM.Orozco.2002.Hoogsteen-basedparallel-strandedduplexesofDNA.Effectof8-amino-purinederivatives.J.Am.Chem.Soc.124:3133?3142.
	11.Guzikevich-Guerstein,G.,andZ.Shakked.1996.AnovelformoftheDNAdoubleheliximposedontheTATA-boxbytheTATA-bindingprotein.Nat.Struct.Biol.3:32?37.
	12.Viswamitra,M.A.,P.Kennard,P.G.Jones,G.M.Sheldrick,S.Salisbury,L.Falvello,andZ.Shakked.1978.DNAdoublehelicalfragmentatatomicresolution.Nature.273:687?688.
	13.Viswamitra,M.A.,Z.Shakked,P.G.Jones,G.M.Sheldrick,S.A.Salisbury,andO.Kennard.1982.Structureofthedeoxytetranucleotided-pApTpApTandasequence-dependentmodelforpoly(dA-dT).Biopolymers.21:513?533.
	14.Brahms,S.,J.Brahms,andK.E.VanHolde.1976.Natureofcon-formationalchangesinpoly[d(A-T)d(A-T)]inthepremeltingregion.Proc.Natl.Acad.Sci.USA.73:3453?3457.
	15.Davis,D.R.,andR.L.Baldwin.1963.X-raystudiesontwosyntheticDNAcopolymers.J.Mol.Biol.6:251?255.
	16.Radwan,M.M.,andH.R.Wilson.1982.Fibreandmolecularstructureofthymidylyl-39,59-deoxyadenosine.Int.J.Biol.Macromol.4:145?149.
	17.Abrescia,N.G.A.,A.Thompson,T.H.Dinh,andJ.A.Subirana.2002.CrystalstructureofanantiparallelDNAfragmentwithHoogsteenbasepairing.Proc.Natl.Acad.Sci.USA.99:2806?2811.
	18.Abrescia,N.G.A.,C.Gonzaï¿½lez,C.Gouyette,andJ.A.Subirana.2004.X-rayandNMRstudiesoftheDNAoligomerd(ATATAT):HoogsteenbasepairinginduplexDNA.Biochemistry.43:4092?4100.
	19.Cubero,E.,N.G.A.Abrescia,J.A.Subirana,F.J.Luque,andM.Orozco.2003.TheoreticalstudyofanewDNAstructure:theanti-parallelHoogsteenduplex.J.Am.Chem.Soc.125:14603?14612.
	20.Felsenfeld,G.,D.R.Davis,andA.Rich.1957.Formationofathree-strandedpolynucleotidemolecule.J.Am.Chem.Soc.79:2023?2024.
	21.Pauling,L.,andR.B.Corey.1953.Aproposedstructureforthenucleicacids.Proc.Natl.Acad.Sci.USA.39:84?97.
	22.Aishima,J.,R.K.Gitti,J.E.Noah,H.H.Gan,T.Schlick,andC.Wolberger.2002.AHoogsteenbasepairembeddedinundistortedB-DNA.NucleicAcidsRes.30:5244?5252.
	23.Gilbert,D.E.,G.A.vanderMarel,J.H.vanBoom,andH.Feigon.1989.UnstableHoogsteenbasepairsadjacenttoechinomycinbindingsiteswithinaDNAduplex.Proc.Natl.Acad.Sci.USA.86:3006?3010.
	24.Patikoglou,G.A.,J.L.Kim,L.Sun,S.-H.Yang,T.Kodadek,andS.K.Burley.1999.TATAelementrecognitionbytheTATAbox-bindingproteinhasbeenconservedthroughoutevolution.GenesDev.13:3217?3230.
	25.Rice,P.A.,S.Yang,K.Mizuuchi,andH.A.Nash.1996.CrystalstructureofanIHF-DNAcomplex:aprotein-inducedDNAU-turn.Cell.87:1295?1306.
	26.Wang,A.H.,G.Ughetto,G.J.Quigley,T.Hakoshima,G.A.vanderMarel,J.H.vanBoom,andA.Rich.1984.ThemolecularstructureofaDNA-triostinAcomplex.Science.225:1115?1121.
	27.Moreau,J.,L.Marcaud,F.Maschat,J.Kejzlarova-Lepesant,J.A.Lepesant,andK.Scherer.1982.A1T-richlinkersdefinefunctionaldomainsineukaryoticDNA.Nature.295:260?262.
	28.Oosumi,T.,B.Garlick,andW.R.Belknap.1995.IdentificationandcharacterizationofputativetransposableDNAelementsinsolanaceousplantsandcaenorhabditiselegans.Proc.Natl.Acad.Sci.USA.92:8886?8890.
	29.Arnott,S.,andD.W.L.Hukins.1972.OptimizedparametersforA-DNAandB-DNA.Biochem.Biophys.Res.Commun.47:1504?1509.
	30.Shields,G.C.,C.A.Laughton,andM.Orozco.1997.Moleculardynamicssimulationsofthed(TAT)triplehelix.J.Am.Chem.Soc.119:7463?7469.
	31.Shields,G.C.,C.A.Laughton,andM.Orozco.1998.MoleculardynamicssimulationofaPNADNAPNAtriplehelixinaqueoussolu-tion.J.Am.Chem.Soc.120:5895?5904.
	32.Soliva,R.,C.A.Laughton,F.J.Luque,andM.Orozco.1998.Moleculardynamicssimulationsinaqueoussolutionoftriplehelicescontainingd(GCC)trios.J.Am.Chem.Soc.120:11226?11233.
	33.Darden,T.A.,D.M.York,andL.G.Pedersen.1993.ParticlemeshEwald:anNlog(N)methodforEwaldsumsinlargesystems.J.Chem.Phys.98:10089?10092.
	34.Ryckaert,J.P.,G.Ciccotti,andH.J.C.Berendsen.1977.NumericalintegrationoftheCartesianequationsofmotionofasystemwithconstraints:moleculardynamicsofn-alkanes.J.Comput.Phys.23:327?341.
	35.Cheatham,T.E.,P.Cieplak,andP.A.Kollman.1999.AmodifiedversionoftheCornelletal.forcefieldwithimprovedsugarpuckerphasesandhelicalrepeat.J.Biomol.Struct.Dyn.16:845?862.
	36.Cornell,W.D.,P.Cieplak,C.I.Bayly,I.R.Gould,K.M.Merz,D.M.Fergurson,D.C.Spellmeyer,T.Fox,J.W.Caldwell,andP.A.Kollman.1995.Asecondgenerationforcefieldforthesimulationofproteins,nucleicacids,andorganicmolecules.J.Am.Chem.Soc.117:5179?5197.
	37.Jorgensen,W.L.,J.Chandrasekhar,J.D.Madura,R.W.Impey,andM.L.Klein.1983.Comparisonofsimplepotentialfunctionsforsim-ulatingliquidwater.J.Chem.Phys.79:926?935.
	38.Case,D.A.,D.A.Pearlman,J.W.Caldwell,T.E.Cheatham,W.S.Ross,C.L.Simmerling,T.A.Darden,K.M.Merz,R.V.Stanton,A.L.Cheng,J.J.Vincent,M.Crowley,etal.1999.AMBER6.0.UniversityofCalifornia,SanFrancisco,CA.
	39.Orozco,M.,A.Perez,A.Noy,andF.J.Luque.2003.Theoreticalmethodsforthesimulationofnucleicacids.Chem.Soc.Rev.32:350?364.
	40.Srinivasan,J.,T.E.Cheatham,P.Cieplak,P.A.Kollman,andD.A.Case.1998.ContinuumsolventstudiesofthestabilityofDNA,RNA,andphosphoramidate-DNAhelices.J.Am.Chem.Soc.120:9401?9409.
	41.Bashford,D.,andK.Gerwert.1992.ElectrostaticcalculationsofthepKavaluesofionizablegroupsinbacteriorhodopsin.J.Mol.Biol.224:473?486.
	42.Bashford,D.1997.Anobject-orientedprogrammingsuiteforelectrostaticeffectsinbiologicalmolecules.InScientificComputinginObject-OrientedParallelEnvironments.Y.Ishikawa,R.Rodney,R.R.Oldehoeft,J.V.M.Reynders,andM.Tholburn,editors.LectureNotesinComputerScience.Springer,Berlin,Germany.1343:233?240.
	43.Still,W.C.,A.Tempcyck,R.C.Hawley,andT.Hendrickson.1990.Semianalyticaltreatmentofsolvationformolecularmechanicsanddynamics.J.Am.Chem.Soc.112:6127?6129.
	44.Orozco,M.,andF.J.Luque.2000.Theoreticalmethodsforthedescriptionofthesolventeffectinbiomolecularsystems.Chem.Rev.100:4187?4226.
	45.Andricioaei,I.,andM.Karplus.2001.Onthecalculationofentropyfromcovariancematricesoftheatomicfluctuations.J.Chem.Phys.115:6289?6292.
	46.Schlitter,J.1993.Estimationofabsoluteandrelativeentropiesofmacromoleculesusingthecovariancematrix.Chem.Phys.Lett.215:617?621.
	47.Harris,S.A.,E.Gavathiotis,M.S.Searle,M.Orozco,andC.A.Laughton.2001.Cooperativityindrug-DNArecognition:amoleculardynamicsstudy.J.Am.Chem.Soc.123:12658?12663.
	48.Gelp?ï¿½,J.L.,S.G.Kalko,X.delaCruz,X.Barril,J.Cirera,F.J.Luque,andM.Orozco.2001.Classicalmolecularinteractionpotentials:im-provedsetupprocedureinmoleculardynamicssimulationsofproteins.Proteins.45:428?437.
	49.Sherer,E.,S.A.Harris,R.Soliva,M.Orozco,andC.A.Laughton.1999.MoleculardynamicsstudiesofDNAA-tractstructureandflexi-bility.J.Am.Chem.Soc.121:5981?5991.
	50.Noy,A.,A.Peï¿½rez,F.Lankas,F.J.Luque,andM.Orozco.2004.RelativeflexibilityofDNAandRNA:amoleculardynamicsstudy.J.Mol.Biol.343:627?638.
	51.Peï¿½rez,A.,A.Noy,F.Lankas,F.J.Luque,andM.Orozco.2004.TherelativeflexibilityofB-DNAandA-RNAduplexes:databaseanalysis.NucleicAcidsRes.32:6144?6151.
	52.Rueda,M.,S.G.Kalko,F.J.Luque,andM.Orozco.2003.ThestructureanddynamicsofDNAinthegasphase.J.Am.Chem.Soc.125:8007?8014.
	53.Peï¿½rez,A.,J.R.Blas,M.Rueda,J.M.Loï¿½pez-Bes,X.delaCruz,andM.Orozco.2005.ExploringtheessentialdynamicsofB-DNA.J.Chem.TheoryandComput.1:790?800.
	54.Lu,X.-J.,andW.K.Olson.2003.3DNA:asoftwarepackagefortheanalysis,rebuildingandvisualizationofthree-dimensionalnucleicacidstructures.NucleicAcidsRes.31:5108?5121.
	55.Lavery,R.,andJ.Sklenar.1988.Thedefinitionofgeneralizedhelicoidalparametersandofaxiscurvatureofirregularnucleicacids.J.Biomol.Struct.Dyn.6:63?91.
	56.Drew,H.R.,R.M.Wing,T.Tanako,C.Broka,S.Tanaka,K.Itakura,andR.Dickerson.1981.StructureofaB-DNAdodecamer:confor-mationanddynamics.Proc.Natl.Acad.Sci.USA.78:2179?2183.
	57.Stolarski,R.,A.Pohorille,L.Dudycz,andD.Shugar.1980.Comparisonoftheoreticalandexperimentalapproachestodetermina-tionofconformationofnucleosidesabouttheglycosidicbond.Biochim.Biophys.Acta.610:1?19.
	58.Hoogsteen,K.1959.Thestructureofcrystalscontainingahydrogen-bondedcomplexof1-methylthymineand9-methyladenine.ActaCrystallogr.12:822?823.
	59.Sponer,J.,J.Leszczynski,andP.Hobza.1996.Structuresandenergiesofhydrogen-bondedDNAbasepairs.Anonempiricalstudywithinclusionofelectroncorrelation.J.Phys.Chem.100:1965?1974.
	60.Ponomarev,S.Y.,K.M.Thayer,andD.L.Beveridge.2004.IonmotionsinmoleculardynamicssimulationsonDNA.Proc.Natl.Acad.Sci.USA.101:14771?14775.
	61.Rueda,M.,E.Cubero,C.A.Laughton,andM.Orozco.2004.ExploringthecounterionatmospherearoundDNA:whatcanbelearnedfrommoleculardynamicssimulations?Biophys.J.87:800?811.
